In	O	ADP	O
the	O	DET	O
8	O	NUM	O
patients	O	NOUN	B
the	O	DET	O
difference	O	NOUN	B
betweent	O	ADJ	I
he	O	PRON	O
mean	O	VERB	O
diastolic	O	ADJ	B
values	O	NOUN	I
of	O	ADP	O
delta	O	NOUN	B
PU	O	NOUN	I
and	O	CCONJ	O
delta	O	NOUN	B
PM	O	PROPN	I
was	O	AUX	O
-	O	PUNCT	O
0	O	NUM	O
.	O	PUNCT	O
54	O	NUM	O
+	O	CCONJ	O
/	O	SYM	O
-	O	PUNCT	O
1	O	NUM	O
.	O	PUNCT	O
0	O	NUM	O
(	O	PUNCT	O
SD	O	NOUN	B
)	O	PUNCT	O
mmHg	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
biochemistry	O	NOUN	B
of	O	ADP	O
amniotic	O	ADJ	B
fluid	O	NOUN	I
with	O	ADP	O
poor	O	ADJ	B
fetal	O	ADJ	I
growth	O	NOUN	I
.	O	PUNCT	O


Resistance	O	NOUN	B
to	O	ADP	O
the	O	DET	O
simulated	O	ADJ	B
physiologic	O	ADJ	B
environment	O	NOUN	I
was	O	AUX	O
tested	O	VERB	B
by	O	ADP	O
measured	O	VERB	B
retention	O	NOUN	B
of	O	ADP	O
mechanical	O	ADJ	B
properties	O	NOUN	I
after	O	ADP	O
immersion	O	NOUN	B
times	O	NOUN	O
in	O	ADP	O
pseudo	O	ADJ	B
-	O	PUNCT	O
extracellular	O	ADJ	B
fluid	O	NOUN	O
(	O	PUNCT	O
PECF	O	NOUN	B
)	O	PUNCT	O
at	O	ADP	O
37	O	NUM	O
degrees	O	NOUN	B
C	O	NOUN	O
for	O	ADP	O
as	O	ADV	O
long	O	ADV	O
as	O	ADP	O
three	O	NUM	O
years	O	NOUN	B
.	O	PUNCT	O


This	O	DET	O
expression	O	NOUN	B
assumes	O	VERB	O
:	O	PUNCT	O
(	O	PUNCT	O
1	O	X	O
)	O	PUNCT	O
a	O	DET	O
laminar	O	ADJ	B
flow	O	NOUN	I
regimen	O	NOUN	B
during	O	ADP	O
expiration	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
(	O	PUNCT	O
2	O	X	O
)	O	PUNCT	O
a	O	DET	O
constant	O	ADJ	B
CT	O	NOUN	B
value	O	NOUN	O
over	O	ADP	O
the	O	DET	O
range	O	NOUN	B
of	O	ADP	O
VT	O	PROPN	B
.	O	PUNCT	O


Their	O	PRON	O
conduction	O	NOUN	B
velocity	O	NOUN	I
ranged	O	VERB	O
from	O	ADP	O
0	O	NUM	O
.	O	PUNCT	O
23	O	NUM	O
to	O	PART	O
0	O	NUM	O
.	O	PUNCT	O
98	O	NUM	O
m	O	NOUN	O
/	O	SYM	O
sec	O	NOUN	B
(	O	PUNCT	O
group	O	NOUN	B
C	O	NOUN	I
)	O	PUNCT	O
.	O	PUNCT	O


The	O	DET	O
major	O	ADJ	O
urinary	O	ADJ	B
metabolites	O	NOUN	I
were	O	AUX	O
3	O	NUM	O
-	O	PUNCT	O
(	O	PUNCT	O
3	O	NUM	O
-	O	PUNCT	O
carboxyphenyl	O	NOUN	B
)	O	PUNCT	O
-	O	PUNCT	O
5	O	NUM	O
-	O	PUNCT	O
hydroxymethyl	O	NOUN	B
-	O	PUNCT	O
2	O	NUM	B
-	O	PUNCT	O
oxazolidinone	O	NOUN	B
and	O	CCONJ	O
a	O	DET	O
glucuronide	O	NOUN	B
of	O	ADP	O
toloxatone	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
ventilation	O	NOUN	B
did	O	AUX	O
not	O	PART	O
increase	O	VERB	B
when	O	SCONJ	O
PACO2	O	NOUN	B
was	O	AUX	O
increased	O	VERB	B
.	O	PUNCT	O


Changes	O	NOUN	B
of	O	ADP	O
thirtynine	O	NUM	B
serum	O	NOUN	B
protein	O	NOUN	I
components	O	NOUN	I
following	O	VERB	O
surgical	O	ADJ	B
stress	O	NOUN	I
.	O	PUNCT	O


These	O	DET	O
differences	O	NOUN	B
are	O	AUX	O
smaller	O	ADJ	O
than	O	ADP	O
those	O	DET	O
described	O	VERB	O
in	O	ADP	O
standard	O	ADJ	B
textbooks	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
present	O	ADJ	O
study	O	NOUN	B
examined	O	VERB	O
the	O	DET	O
dependence	O	NOUN	B
of	O	ADP	O
difference	O	NOUN	O
tone	O	NOUN	O
level	O	NOUN	O
[	O	PUNCT	O
L	O	PROPN	B
(	O	PUNCT	O
f2	O	PROPN	B
-	O	PUNCT	O
f1	O	PROPN	B
)	O	PUNCT	O
]	O	PUNCT	O
on	O	ADP	O
the	O	DET	O
following	O	VERB	O
parameters	O	NOUN	B
of	O	ADP	O
the	O	DET	O
two	O	NUM	O
-	O	PUNCT	O
tone	O	NOUN	B
input	O	NOUN	B
:	O	PUNCT	O
f1	O	NOUN	B
,	O	PUNCT	O
f2	O	PROPN	B
/	O	SYM	O
f1	O	PROPN	B
(	O	PUNCT	O
f2	O	NOUN	O
greater	O	ADJ	O
than	O	ADP	O
f1	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
L1	O	NOUN	B
,	O	PUNCT	O
L2	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
L1	O	NOUN	O
=	O	ADJ	O
L2	O	NOUN	B
.	O	PUNCT	O


With	O	ADP	O
certain	O	ADJ	O
exceptions	O	NOUN	O
the	O	DET	O
method	O	NOUN	B
was	O	AUX	O
considered	O	VERB	O
suitable	O	ADJ	O
in	O	ADP	O
the	O	DET	O
routine	O	ADJ	B
intravenous	O	ADJ	B
cholangiography	O	NOUN	O
.	O	PUNCT	O


Delayed	O	VERB	B
mortality	O	NOUN	B
of	O	ADP	O
mice	O	NOUN	B
following	O	VERB	O
inhalation	O	NOUN	B
of	O	ADP	O
acute	O	ADJ	B
doses	O	NOUN	I
of	O	ADP	O
CH2O	O	NOUN	B
,	O	PUNCT	O
SO2Cl2	O	ADJ	B
,	O	PUNCT	O
and	O	CCONJ	O
Br2	O	NOUN	B
.	O	PUNCT	O


Guinea	O	NOUN	B
pigs	O	NOUN	B
weighing	O	VERB	O
300	O	NUM	O
approximately	O	ADV	O
350	O	NUM	O
g	O	NOUN	O
were	O	AUX	O
used	O	VERB	O
.	O	PUNCT	O


None	O	NOUN	O
of	O	ADP	O
the	O	DET	O
cystometrograms	O	NOUN	B
showed	O	VERB	O
uninhibited	O	ADJ	O
detrusor	O	NOUN	B
contractions	O	NOUN	I
.	O	PUNCT	O


Treatment	O	NOUN	B
of	O	ADP	O
Graves	O	NOUN	B
'	O	PART	I
disease	O	NOUN	I
.	O	PUNCT	O


Allergic	O	ADJ	B
reaction	O	NOUN	I
to	O	ADP	O
Patent	O	PROPN	B
Blue	O	PROPN	I
Violet	O	PROPN	B
during	O	ADP	O
lymphography	O	NOUN	B
.	O	PUNCT	O


One	O	NUM	O
-	O	PUNCT	O
third	O	NOUN	O
of	O	ADP	O
the	O	DET	O
men	O	NOUN	B
with	O	ADP	O
azoospermia	O	NOUN	B
and	O	CCONJ	O
with	O	ADP	O
sperm	O	NOUN	B
density	O	NOUN	B
of	O	ADP	O
less	O	ADJ	O
than	O	ADP	O
10	O	NUM	O
million	O	NUM	O
had	O	AUX	O
marked	O	ADJ	O
FSH	B-GENE	NOUN	B
elevation	O	NOUN	B
and	O	CCONJ	O
our	O	PRON	O
experience	O	NOUN	O
confirms	O	VERB	O
the	O	DET	O
work	O	NOUN	O
of	O	ADP	O
others	O	NOUN	O
that	O	SCONJ	O
this	O	DET	O
indicates	O	VERB	O
a	O	DET	O
poor	O	ADJ	B
prognosis	O	NOUN	I
.	O	PUNCT	O


It	O	PRON	O
was	O	AUX	O
concluded	O	VERB	O
that	O	SCONJ	O
both	O	DET	O
of	O	ADP	O
these	O	DET	O
surgical	O	ADJ	B
procedures	O	NOUN	I
were	O	AUX	O
as	O	ADV	O
effective	O	ADJ	B
as	O	ADP	O
pinealectomy	O	NOUN	B
in	O	ADP	O
reversing	O	VERB	B
the	O	DET	O
pineal	O	ADJ	B
-	O	PUNCT	O
induced	O	VERB	B
alterations	O	NOUN	B
in	O	ADP	O
the	O	DET	O
reproductive	O	ADJ	B
physiology	O	NOUN	I
of	O	ADP	O
the	O	DET	O
blind	O	ADJ	B
-	O	PUNCT	O
anosmic	O	ADJ	B
female	O	NOUN	B
rat	O	NOUN	B
.	O	PUNCT	O


This	O	DET	O
implies	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
groups	O	NOUN	B
do	O	AUX	O
not	O	PART	O
just	O	ADV	O
differ	O	VERB	O
along	O	ADP	O
one	O	NUM	O
dimension	O	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
along	O	ADP	O
three	O	NUM	O
dimensions	O	NOUN	B
.	O	PUNCT	O


Deep	O	ADJ	B
tans	O	NOUN	I
were	O	AUX	O
induced	O	VERB	B
over	O	ADP	O
the	O	DET	O
backs	O	NOUN	B
of	O	ADP	O
volunteers	O	NOUN	B
with	O	ADP	O
repeated	O	ADJ	O
exposure	O	NOUN	B
to	O	PART	O
longwave	O	VERB	B
ultraviolet	O	ADJ	I
radiation	O	NOUN	I
(	O	PUNCT	O
UV	O	NOUN	B
-	O	PUNCT	O
A	O	PROPN	B
)	O	PUNCT	O
.	O	PUNCT	O


Elimination	O	NOUN	B
of	O	ADP	O
bagassosis	O	NOUN	B
in	O	ADP	O
Louisiana	O	PROPN	B
paper	O	NOUN	I
manufacturing	O	NOUN	B
plant	O	NOUN	B
workers	O	NOUN	I
.	O	PUNCT	O


Evaluation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
Du	O	PROPN	B
Pont	O	PROPN	I
aca	O	DET	I
ammonia	O	NOUN	I
procedure	O	NOUN	I
.	O	PUNCT	O


2	O	X	O
)	O	PUNCT	O
The	O	DET	O
time	O	NOUN	B
-	O	PUNCT	O
sharing	O	NOUN	B
principle	O	NOUN	B
was	O	AUX	O
applied	O	VERB	O
to	O	PART	O
gain	O	VERB	O
high	O	ADJ	O
stability	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
three	O	NUM	O
of	O	ADP	O
the	O	DET	O
seven	O	NUM	O
,	O	PUNCT	O
inhalation	O	NOUN	B
of	O	ADP	O
2	O	NUM	O
ml	O	NOUN	O
normal	O	ADJ	B
saline	O	NOUN	I
produced	O	VERB	O
FEV1	O	NOUN	B
falls	O	NOUN	B
of	O	ADP	O
25	O	NUM	O
%	O	NOUN	O
to	O	PART	O
30	O	NUM	O
%	O	NOUN	O
,	O	PUNCT	O
but	O	CCONJ	O
these	O	DET	O
falls	O	NOUN	B
were	O	AUX	O
not	O	PART	O
as	O	ADV	O
great	O	ADJ	O
as	O	ADP	O
each	O	DET	O
subject	O	NOUN	B
'	O	PART	O
s	O	NOUN	O
reactions	O	NOUN	B
to	O	ADP	O
the	O	DET	O
test	O	NOUN	B
solutions	O	NOUN	I
.	O	PUNCT	O


Potency	O	NOUN	B
of	O	ADP	O
enflurane	O	NOUN	B
in	O	ADP	O
dogs	O	NOUN	B
:	O	PUNCT	O
comparison	O	NOUN	B
with	O	ADP	O
halothane	O	NOUN	B
and	O	CCONJ	O
isoflurane	O	NOUN	B
.	O	PUNCT	O


Measurement	O	NOUN	B
of	O	ADP	O
magnesium	O	NOUN	B
absorption	O	NOUN	I
in	O	ADP	O
man	O	NOUN	B
using	O	VERB	O
stable	O	ADJ	B
26Mg	O	NOUN	O
as	O	ADP	O
a	O	DET	O
tracer	O	NOUN	B
.	O	PUNCT	O


Female	O	ADJ	B
mice	O	NOUN	I
were	O	AUX	O
significantly	O	ADV	O
more	O	ADV	O
resistant	O	ADJ	B
to	O	PART	O
infection	O	NOUN	B
than	O	ADP	O
males	O	NOUN	B
.	O	PUNCT	O


During	O	ADP	O
the	O	DET	O
following	O	VERB	O
9	O	NUM	O
1	O	NUM	O
/	O	SYM	O
2	O	NUM	O
years	O	NOUN	B
three	O	NUM	O
sequential	O	ADJ	B
liver	O	NOUN	B
biopsies	O	NOUN	I
were	O	AUX	O
performed	O	VERB	O
.	O	PUNCT	O


Thromboplastic	O	ADJ	B
and	O	CCONJ	O
fibrynolytic	O	ADJ	B
activity	O	NOUN	I
of	O	ADP	O
the	O	DET	O
blood	O	NOUN	B
after	O	ADP	O
administration	O	NOUN	B
of	O	ADP	O
intralipid	O	NOUN	B
in	O	ADP	O
men	O	NOUN	B
with	O	ADP	O
history	O	NOUN	B
of	O	ADP	O
myocardial	O	ADJ	B
infarction	O	NOUN	I
up	O	ADP	O
to	O	PART	O
45	O	NUM	O
year	O	NOUN	B
of	O	ADP	O
life	O	NOUN	O


The	O	DET	O
authors	O	NOUN	B
report	O	VERB	O
the	O	DET	O
clinicopathologic	O	ADJ	B
findings	O	NOUN	B
in	O	ADP	O
four	O	NUM	O
cases	O	NOUN	B
of	O	ADP	O
adult	O	ADJ	B
women	O	NOUN	B
with	O	ADP	O
rhabdomyosarcomas	O	NOUN	B
that	O	PRON	O
originated	O	VERB	O
in	O	ADP	O
the	O	DET	O
endometrium	O	NOUN	B
or	O	CCONJ	O
cervix	O	NOUN	B
,	O	PUNCT	O
or	O	CCONJ	O
both	O	DET	O
.	O	PUNCT	O


Urine	O	NOUN	B
antibodies	O	NOUN	I
could	O	AUX	O
not	O	PART	O
be	O	AUX	O
demonstrated	O	VERB	O
in	O	ADP	O
any	O	DET	O
other	O	ADJ	O
cases	O	NOUN	B
.	O	PUNCT	O


99mTc	O	ADJ	O
phytate	O	NOUN	B
,	O	PUNCT	O
198Au	O	PROPN	O
colloid	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
99mTc	O	ADJ	O
antimony	O	NOUN	B
sulfide	O	NOUN	O
have	O	AUX	O
been	O	AUX	O
used	O	VERB	O
;	O	PUNCT	O
the	O	DET	O
last	O	ADJ	O
appears	O	VERB	O
to	O	PART	O
have	O	AUX	O
been	O	AUX	O
the	O	DET	O
most	O	ADV	O
satisfactory	O	ADJ	B
.	O	PUNCT	O


A	O	DET	O
suspected	O	ADJ	B
hypothalamic	O	ADJ	B
dysfunction	O	NOUN	I
and	O	CCONJ	O
a	O	DET	O
slightly	O	ADV	O
impaired	O	ADJ	B
pituitary	O	ADJ	B
function	O	NOUN	I
manifested	O	VERB	O
as	O	ADP	O
GH	B-GENE	NOUN	B
deficiency	O	NOUN	I
were	O	AUX	O
their	O	PRON	O
common	O	ADJ	O
endocrinological	O	ADJ	B
features	O	NOUN	I
.	O	PUNCT	O


A	O	DET	O
one	O	NUM	O
-	O	PUNCT	O
way	O	NOUN	B
analysis	O	NOUN	B
of	O	ADP	O
variance	O	NOUN	B
,	O	PUNCT	O
performed	O	VERB	O
separately	O	ADV	O
for	O	ADP	O
men	O	NOUN	B
and	O	CCONJ	O
women	O	NOUN	B
for	O	ADP	O
differences	O	NOUN	B
among	O	ADP	O
the	O	DET	O
three	O	NUM	O
phobic	O	ADJ	B
groups	O	NOUN	B
on	O	ADP	O
field	O	NOUN	B
dependence	O	NOUN	I
,	O	PUNCT	O
showed	O	VERB	O
significance	O	NOUN	B
(	O	PUNCT	O
rho	O	NOUN	O
less	O	ADJ	O
than	O	ADP	O
.	O	PUNCT	O
05	O	NUM	O
)	O	PUNCT	O
for	O	ADP	O
the	O	DET	O
females	O	NOUN	B
,	O	PUNCT	O
with	O	ADP	O
the	O	DET	O
famale	O	NOUN	O
agoraphobic	O	NOUN	B
being	O	AUX	O
more	O	ADJ	O
field	O	NOUN	B
dependent	O	ADJ	I
than	O	ADP	O
the	O	DET	O
female	O	ADJ	B
simple	O	ADJ	O
phobic	O	NOUN	B
groups	O	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
not	O	PART	O
for	O	ADP	O
the	O	DET	O
males	O	NOUN	B
.	O	PUNCT	O


Residues	O	NOUN	B
removed	O	VERB	O
from	O	ADP	O
transcripts	O	NOUN	B
by	O	ADP	O
splicing	O	NOUN	B
were	O	AUX	O
identified	O	VERB	B
.	O	PUNCT	O


The	O	DET	O
histochemistry	O	NOUN	B
and	O	CCONJ	O
ultrastructure	O	NOUN	B
of	O	ADP	O
calcified	O	VERB	B
cerebellar	O	ADJ	I
deposits	O	NOUN	I
described	O	VERB	O
by	O	ADP	O
Tonge	O	PROPN	O
et	O	X	O
al	O	X	O
.	O	PUNCT	O


A	O	DET	O
36	O	NUM	O
year	O	NOUN	B
-	O	PUNCT	O
old	O	ADJ	B
woman	O	NOUN	B
was	O	AUX	O
given	O	VERB	O
Ergotamine	O	PROPN	B
Tartrate	O	PROPN	B
4	O	NUM	I
.	O	PUNCT	O
5	O	NUM	O
mg	O	NOUN	O
p	O	NOUN	O
.	O	PUNCT	O
d	O	NOUN	O
.	O	PUNCT	O
during	O	ADP	O
seven	O	NUM	O
days	O	NOUN	B
,	O	PUNCT	O
after	O	ADP	O
an	O	DET	O
abortion	O	NOUN	B
(	O	PUNCT	O
a	O	DET	O
still	O	ADV	O
birth	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


As	O	ADP	O
expected	O	VERB	O
,	O	PUNCT	O
the	O	DET	O
heparin	O	NOUN	B
did	O	AUX	O
produce	O	VERB	O
increased	O	VERB	B
recalcification	O	NOUN	B
times	O	NOUN	O
and	O	CCONJ	O
the	O	DET	O
development	O	NOUN	B
of	O	ADP	O
occasional	O	ADJ	O
subcutaneous	O	ADJ	B
hematomas	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
overall	O	ADJ	O
incidence	O	NOUN	B
of	O	ADP	O
SIDS	O	NOUN	B
was	O	AUX	O
1	O	NUM	O
.	O	PUNCT	O
43	O	NUM	O
per	O	ADP	O
1	O	NUM	O
,	O	PUNCT	O
000	O	NUM	O
live	O	ADJ	B
births	O	NOUN	I
.	O	PUNCT	O


Significant	O	ADJ	B
increases	O	NOUN	B
in	O	ADP	O
mean	O	ADJ	O
serum	O	NOUN	B
E2	O	NOUN	B
concentration	O	NOUN	B
(	O	PUNCT	O
100	O	NUM	O
to	O	PART	O
150	O	NUM	O
pg	O	NOUN	O
/	O	PUNCT	O
ml	O	NOUN	O
)	O	PUNCT	O
were	O	AUX	O
noted	O	VERB	O
at	O	ADP	O
6	O	NUM	O
and	O	CCONJ	O
8	O	NUM	O
hours	O	NOUN	O
after	O	ADP	O
administration	O	NOUN	B
on	O	ADP	O
day	O	NOUN	B
1	O	NUM	O
and	O	CCONJ	O
at	O	ADP	O
8	O	NUM	O
hours	O	NOUN	B
on	O	ADP	O
day	O	NOUN	B
4	O	NUM	O
.	O	PUNCT	O


We	O	PRON	O
remain	O	VERB	O
convinced	O	ADJ	O
that	O	SCONJ	O
antilymphocyte	B-GENE	NOUN	B
globulin	I-GENE	NOUN	I
(	O	PUNCT	O
ALG	B-GENE	NOUN	B
)	O	PUNCT	O
is	O	AUX	O
a	O	DET	O
potent	O	ADJ	O
immunosuppressive	O	ADJ	B
agent	O	NOUN	I
in	O	ADP	O
humans	O	NOUN	B
.	O	PUNCT	O


Patients	O	NOUN	B
were	O	AUX	O
subclassified	O	VERB	B
into	O	ADP	O
age	O	NOUN	B
-	O	PUNCT	O
matched	O	VERB	B
groups	O	NOUN	B
of	O	ADP	O
primary	O	ADJ	B
untreated	O	ADJ	I
cancer	O	NOUN	I
(	O	PUNCT	O
21	O	NUM	O
)	O	PUNCT	O
,	O	PUNCT	O
recurrent	O	ADJ	B
cancer	O	NOUN	I
(	O	PUNCT	O
18	O	NUM	O
)	O	PUNCT	O
,	O	PUNCT	O
and	O	CCONJ	O
"	O	PUNCT	O
cured	O	VERB	B
"	O	PUNCT	O
patients	O	NOUN	B
who	O	PRON	O
had	O	AUX	O
been	O	AUX	O
free	O	ADJ	B
of	O	ADP	I
disease	O	NOUN	O
for	O	ADP	O
at	O	ADP	O
least	O	ADJ	O
9	O	NUM	O
months	O	NOUN	B
(	O	PUNCT	O
16	O	NUM	O
)	O	PUNCT	O
.	O	PUNCT	O


Bacteriostatic	O	ADJ	B
and	O	CCONJ	O
bacteriacidal	O	ADJ	B
activity	O	NOUN	I
of	O	ADP	O
hydroxy	O	NOUN	B
-	O	PUNCT	O
9	O	NUM	B
ellipticine	O	NOUN	B
in	O	X	B
vitro	O	X	I


Personal	O	ADJ	B
satisfaction	O	NOUN	I
in	O	ADP	O
nursing	O	NOUN	B
:	O	PUNCT	O
an	O	DET	O
encounter	O	NOUN	B
with	O	ADP	O
extremely	O	ADV	B
hostile	O	ADJ	O
patients	O	NOUN	B


The	O	DET	O
effect	O	NOUN	B
of	O	ADP	O
hydrostatic	O	ADJ	B
pressure	O	NOUN	I
on	O	ADP	O
the	O	DET	O
swimming	O	NOUN	B
activity	O	NOUN	B
of	O	ADP	O
three	O	NUM	O
hyponeustonic	O	ADJ	B
crustacea	O	NOUN	I
,	O	PUNCT	O
Anomalocera	O	PROPN	B
patersoni	O	NOUN	I
,	O	PUNCT	O
Pontella	O	PROPN	B
mediterranea	O	PROPN	I
,	O	PUNCT	O
Labidocera	O	PROPN	B
wollastoni	O	NOUN	O


Abnormal	O	ADJ	B
calcium	O	NOUN	B
metabolism	O	NOUN	I
in	O	ADP	O
normocalcaemic	O	ADJ	B
sarcoidosis	O	NOUN	I
.	O	PUNCT	O


A	O	DET	O
five	O	NUM	B
-	O	PUNCT	O
phase	O	NOUN	B
experiment	O	NOUN	B
was	O	AUX	O
designed	O	VERB	O
to	O	PART	O
investigate	O	VERB	B
(	O	PUNCT	O
a	O	X	O
)	O	PUNCT	O
whether	O	SCONJ	O
contingent	O	ADJ	B
music	O	NOUN	B
-	O	PUNCT	O
listening	O	NOUN	B
would	O	AUX	O
act	O	VERB	O
as	O	ADP	O
a	O	DET	O
reinforcer	O	NOUN	B
to	O	PART	O
increase	O	VERB	B
arithmetic	O	ADJ	B
performance	O	NOUN	I
of	O	ADP	O
EMR	O	PROPN	B
children	O	NOUN	B
and	O	CCONJ	O
(	O	PUNCT	O
b	O	X	O
)	O	PUNCT	O
whether	O	SCONJ	O
this	O	DET	O
contingent	O	NOUN	B
reinforcement	O	NOUN	B
would	O	AUX	O
affect	O	VERB	O
preference	O	NOUN	B
for	O	ADP	O
that	O	DET	O
reinforcer	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
responsiveness	O	NOUN	B
of	O	ADP	O
visual	O	ADJ	B
cortex	O	NOUN	I
(	O	PUNCT	O
VC	O	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
superior	O	ADJ	B
colliculus	O	NOUN	I
(	O	PUNCT	O
SC	O	NOUN	B
)	O	PUNCT	O
was	O	AUX	O
simultaneously	O	ADV	B
compared	O	VERB	B
following	O	VERB	O
conditioning	O	NOUN	B
"	O	PUNCT	O
ON	O	NOUN	B
"	O	PUNCT	O
or	O	CCONJ	O
"	O	PUNCT	O
OFF	O	NOUN	B
"	O	PUNCT	O
stimulation	O	NOUN	B
,	O	PUNCT	O
in	O	ADP	O
the	O	DET	O
rabbit	O	NOUN	B
.	O	PUNCT	O


During	O	ADP	O
activity	O	NOUN	B
III	O	NUM	I
,	O	PUNCT	O
one	O	NUM	O
patient	O	NOUN	B
developed	O	VERB	O
angina	O	ADJ	B
.	O	PUNCT	O


Estimation	O	NOUN	B
of	O	ADP	O
L	O	NOUN	B
-	O	PUNCT	O
alanine	O	NOUN	B
in	O	ADP	O
serum	O	NOUN	B
or	O	CCONJ	O
plasma	O	NOUN	B
using	O	VERB	O
the	O	DET	O
LKB	O	NOUN	B
reaction	O	NOUN	I
rate	O	NOUN	I
analyser	O	NOUN	I
.	O	PUNCT	O


Infants	O	NOUN	B
who	O	PRON	O
died	O	VERB	B
in	O	ADP	O
the	O	DET	O
first	O	ADJ	O
12	O	NUM	O
hours	O	NOUN	B
from	O	ADP	O
'	O	PUNCT	O
IVH	O	NOUN	B
only	O	ADV	O
'	O	PUNCT	O
had	O	AUX	O
suffered	O	VERB	O
severe	O	ADJ	B
birth	O	NOUN	B
asphyxia	O	NOUN	I
but	O	CCONJ	O
in	O	ADP	O
those	O	DET	O
who	O	PRON	O
died	O	VERB	B
later	O	ADV	O
the	O	DET	O
main	O	ADJ	O
symptom	O	NOUN	B
was	O	AUX	O
recurrent	O	ADJ	B
apnoea	O	NOUN	I
.	O	PUNCT	O


Wherever	O	SCONJ	B
the	O	DET	O
site	O	NOUN	B
of	O	ADP	O
the	O	DET	O
conditioning	O	NOUN	B
stimulation	O	NOUN	I
,	O	PUNCT	O
these	O	DET	O
modifications	O	NOUN	B
disappeared	O	VERB	O
after	O	ADP	O
ischaemia	O	NOUN	B
of	O	ADP	O
the	O	DET	O
leg	O	NOUN	B
.	O	PUNCT	O


Near	O	ADJ	B
term	O	NOUN	O
,	O	PUNCT	O
under	O	ADP	O
experimental	O	ADJ	B
conditions	O	NOUN	I
,	O	PUNCT	O
maternal	O	ADJ	B
and	O	CCONJ	O
fetal	O	ADJ	B
blood	O	NOUN	I
gases	O	NOUN	I
,	O	PUNCT	O
pH	O	NOUN	B
,	O	PUNCT	O
uterine	O	NOUN	B
and	O	CCONJ	O
umbilical	O	ADJ	B
blood	O	NOUN	I
flows	O	NOUN	I
were	O	AUX	O
measured	O	VERB	B
or	O	CCONJ	O
calculated	O	VERB	B
.	O	PUNCT	O


It	O	PRON	O
was	O	AUX	O
concluded	O	VERB	O
that	O	SCONJ	O
patients	O	NOUN	B
with	O	ADP	O
acute	O	ADJ	B
respiratory	O	ADJ	I
failure	O	NOUN	I
requiring	O	VERB	O
artificial	O	ADJ	B
ventilation	O	NOUN	I
have	O	AUX	O
two	O	NUM	O
componenents	O	NOUN	B
of	O	ADP	O
the	O	DET	O
pulmonary	O	ADJ	B
shunt	O	NOUN	I
,	O	PUNCT	O
one	O	NUM	O
parallel	O	NOUN	O
with	O	ADP	O
and	O	CCONJ	O
the	O	DET	O
other	O	ADJ	O
inversely	O	ADV	B
related	O	VERB	O
with	O	ADP	O
the	O	DET	O
PAO2	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
most	O	ADV	O
common	O	ADJ	O
cause	O	NOUN	B
of	O	ADP	O
renal	O	ADJ	B
deterioration	O	NOUN	I
in	O	ADP	O
the	O	DET	O
spinal	O	ADJ	B
cord	O	NOUN	I
injured	O	ADJ	B
patient	O	NOUN	B
is	O	AUX	O
irreversible	O	ADJ	B
vesicoureteral	O	ADJ	B
reflux	O	NOUN	I
.	O	PUNCT	O


Circulatory	O	ADJ	B
arrest	O	NOUN	I
in	O	ADP	O
the	O	DET	O
operating	O	NOUN	B
room	O	NOUN	I
.	O	PUNCT	O


Iodine	O	NOUN	B
-	O	PUNCT	O
123	O	NUM	O
was	O	AUX	O
satisfactorily	O	ADV	O
imaged	O	VERB	B
only	O	ADV	O
with	O	ADP	O
the	O	DET	O
MEC	O	NOUN	B
and	O	CCONJ	O
pinhole	O	NOUN	B
collimators	O	NOUN	I
,	O	PUNCT	O
which	O	DET	O
in	O	ADP	O
turn	O	NOUN	O
yielded	O	VERB	O
MTF	O	NOUN	B
values	O	NOUN	B
comparable	O	ADJ	O
to	O	PART	O
those	O	DET	O
measured	O	VERB	B
for	O	ADP	O
99mTc	O	NOUN	B
.	O	PUNCT	O


Petrous	O	ADJ	B
meningioma	O	NOUN	I
en	O	ADP	O
plaque	O	NOUN	B
presenting	O	VERB	O
as	O	ADP	O
a	O	DET	O
right	O	ADJ	B
middle	O	ADJ	I
ear	O	NOUN	I
tumor	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
difficulties	O	NOUN	B
to	O	PART	O
analyse	O	VERB	O
prostaglandins	O	NOUN	B
(	O	PUNCT	O
PG	O	NOUN	B
)	O	PUNCT	O
by	O	ADP	O
gas	O	NOUN	B
-	O	PUNCT	O
liquid	O	ADJ	B
chromatography	O	NOUN	I
are	O	AUX	O
mainly	O	ADV	O
due	O	ADJ	O
to	O	PART	O
the	O	DET	O
lack	O	NOUN	B
of	O	ADP	O
sensitivity	O	NOUN	B
of	O	ADP	O
the	O	DET	O
gas	O	NOUN	B
-	O	PUNCT	O
chromatograph	O	NOUN	B
itself	O	PRON	O
(	O	PUNCT	O
higher	O	ADJ	O
than	O	ADP	O
200	O	NUM	O
ng	O	NOUN	O
)	O	PUNCT	O
and	O	CCONJ	O
to	O	ADP	O
the	O	DET	O
poor	O	ADJ	B
resolution	O	NOUN	I
of	O	ADP	O
the	O	DET	O
packed	O	ADJ	B
columns	O	NOUN	I
.	O	PUNCT	O


Also	O	ADV	O
,	O	PUNCT	O
samples	O	NOUN	B
of	O	ADP	O
serum	O	NOUN	B
were	O	AUX	O
absorbed	O	VERB	B
with	O	ADP	O
the	O	DET	O
various	O	ADJ	O
solid	O	ADJ	B
-	O	PUNCT	O
phase	O	NOUN	B
allergens	O	NOUN	I
and	O	CCONJ	O
the	O	DET	O
reactivity	O	NOUN	B
of	O	ADP	O
the	O	DET	O
remaining	O	VERB	O
IgE	B-GENE	NOUN	B
antibodies	I-GENE	NOUN	I
was	O	AUX	O
determined	O	VERB	O
.	O	PUNCT	O


Extramedullary	O	ADJ	B
plasmacytoma	O	NOUN	I
of	O	ADP	I
the	O	DET	O
parotid	O	NOUN	B
gland	O	NOUN	I


The	O	DET	O
recovered	O	ADJ	B
calves	O	NOUN	B
were	O	AUX	O
tested	O	VERB	B
for	O	ADP	O
immunity	O	NOUN	B
to	O	PART	O
homologous	O	ADJ	B
severe	O	ADJ	I
challenge	O	NOUN	O
,	O	PUNCT	O
50	O	NUM	O
or	O	CCONJ	O
73	O	NUM	O
days	O	NOUN	B
after	O	ADP	O
the	O	DET	O
first	O	ADJ	O
infection	O	NOUN	B
.	O	PUNCT	O


Oxygen	O	NOUN	B
tension	O	NOUN	I
of	O	ADP	O
the	O	DET	O
small	O	ADJ	B
lymph	O	NOUN	I
vessels	O	NOUN	I
(	O	PUNCT	O
PLO2	O	NOUN	B
)	O	PUNCT	O
of	O	ADP	O
the	O	DET	O
rabbit	O	NOUN	B
hind	O	NOUN	B
limb	O	NOUN	I
was	O	AUX	O
measured	O	VERB	B
with	O	ADP	O
both	O	CCONJ	O
a	O	DET	O
flow	O	NOUN	B
-	O	PUNCT	O
through	O	ADP	B
micro	O	ADJ	B
chamber	O	NOUN	I
and	O	CCONJ	O
a	O	DET	O
polarographic	O	ADJ	B
catheter	O	NOUN	I
-	O	PUNCT	O
tip	O	NOUN	B
oxygen	O	NOUN	B
electrode	O	NOUN	I
to	O	PART	O
obtain	O	VERB	O
experimental	O	ADJ	B
data	O	NOUN	B
on	O	ADP	O
the	O	DET	O
source	O	NOUN	B
of	O	ADP	O
oxygen	O	NOUN	B
in	O	ADP	O
the	O	DET	O
lymph	O	NOUN	B
.	O	PUNCT	O


I	O	PRON	O
.	O	PUNCT	O


Since	O	SCONJ	O
1968	O	NUM	O
,	O	PUNCT	O
a	O	DET	O
steep	O	ADJ	O
decrease	O	NOUN	B
in	O	ADP	O
the	O	DET	O
number	O	NOUN	O
of	O	ADP	O
strains	O	NOUN	B
resistant	O	ADJ	B
to	O	PART	O
three	O	NUM	O
or	O	CCONJ	O
more	O	ADJ	O
antibiotics	O	NOUN	B
(	O	PUNCT	O
multiple	O	ADJ	B
-	O	PUNCT	O
resistant	O	ADJ	B
)	O	PUNCT	O
and	O	CCONJ	O
in	O	ADP	O
strains	O	NOUN	B
of	O	ADP	O
the	O	DET	O
83A	O	NOUN	B
complex	O	NOUN	I
was	O	AUX	O
noticed	O	VERB	O
.	O	PUNCT	O


The	O	DET	O
contraceptive	O	ADJ	B
pattern	O	NOUN	I
of	O	ADP	O
157	O	NUM	O
women	O	NOUN	B
was	O	AUX	O
analysed	O	VERB	B
and	O	CCONJ	O
13	O	NUM	O
.	O	PUNCT	O
8	O	NUM	O
percent	O	NOUN	O
were	O	AUX	O
using	O	VERB	O
inefficient	O	ADJ	O
methods	O	NOUN	B
.	O	PUNCT	O


I	O	PRON	O
.	O	PUNCT	O


Nerve	O	NOUN	B
stimulation	O	NOUN	I
(	O	PUNCT	O
1	O	NUM	O
.	O	PUNCT	O
5	O	NUM	O
-	O	PUNCT	O
12	O	NUM	O
cycles	O	NOUN	B
/	O	PUNCT	O
s	O	NOUN	B
)	O	PUNCT	O
produced	O	VERB	O
frequency	O	NOUN	B
-	O	PUNCT	O
dependent	O	ADJ	B
reductions	O	NOUN	B
in	O	ADP	O
CBF	O	NOUN	B
,	O	PUNCT	O
a	O	DET	O
decrease	O	NOUN	B
of	O	ADP	O
50	O	NUM	O
percent	O	NOUN	O
occurring	O	VERB	O
with	O	ADP	O
the	O	DET	O
highest	O	ADJ	B
frequency	O	NOUN	B
.	O	PUNCT	O


Risk	O	NOUN	B
of	O	ADP	O
infection	O	NOUN	B
in	O	ADP	O
the	O	DET	O
treatment	O	NOUN	B
of	O	ADP	O
fractures	O	NOUN	B


Prolonged	O	ADJ	B
heavy	O	ADJ	B
work	O	NOUN	I
effected	O	VERB	O
an	O	DET	O
increase	O	NOUN	B
of	O	ADP	O
10	O	NUM	O
.	O	PUNCT	O
3	O	NUM	O
plus	O	CCONJ	B
or	O	CCONJ	O
minus	O	ADV	B
0	O	NUM	O
.	O	PUNCT	O
9	O	NUM	O
mmHg	O	NOUN	B
in	O	ADP	O
in	O	X	B
vivo	O	X	I
P50	O	NOUN	B
(	O	PUNCT	O
7	O	NUM	O
.	O	PUNCT	O
30	O	NUM	O
PH	O	NOUN	B
-	O	PUNCT	O
v	O	PROPN	O
,	O	PUNCT	O
41	O	NUM	O
degrees	O	NOUN	B
C	O	NOUN	O
-	O	PUNCT	O
v	O	PROPN	O
,	O	PUNCT	O
and	O	CCONJ	O
45	O	NUM	O
Pv	O	PROPN	B
-	O	PUNCT	O
CO2	O	NOUN	B
)	O	PUNCT	O
;	O	PUNCT	O
due	O	ADJ	O
entirely	O	ADV	O
to	O	PART	O
the	O	DET	O
additive	O	ADJ	B
effects	O	NOUN	I
of	O	ADP	O
increased	O	VERB	B
venous	O	ADJ	B
temperature	O	NOUN	I
and	O	CCONJ	O
[	O	PUNCT	O
H	O	NOUN	O
+	O	CCONJ	O
]	O	PUNCT	O
.	O	PUNCT	O


This	O	DET	O
sequence	O	NOUN	B
is	O	AUX	O
almost	O	ADV	O
identical	O	ADJ	B
with	O	ADP	O
that	O	DET	O
of	O	ADP	O
human	B-GENE	ADJ	B
luteinizing	I-GENE	NOUN	I
hormone	I-GENE	NOUN	I
(	O	PUNCT	O
Sairam	O	PROPN	B
,	O	PUNCT	O
M	O	PROPN	B
.	O	PUNCT	O


At	O	ADP	O
the	O	DET	O
very	O	ADV	O
high	O	ADJ	O
dose	O	NOUN	O
levels	O	NOUN	O
used	O	VERB	O
,	O	PUNCT	O
sodium	O	NOUN	B
saccharin	O	NOUN	I
and	O	CCONJ	O
sodium	O	NOUN	B
cyclamate	O	NOUN	I
were	O	AUX	O
weak	O	ADJ	B
solitary	O	ADJ	B
carcinogens	O	NOUN	I
producing	O	VERB	O
4	O	NUM	O
/	O	SYM	O
253	O	NUM	B
and	O	CCONJ	O
3	O	NUM	O
/	O	SYM	O
228	O	NUM	B
bladder	O	NOUN	B
tumours	O	NOUN	I
respectively	O	ADV	O
,	O	PUNCT	O
and	O	CCONJ	O
the	O	DET	O
first	O	ADJ	O
of	O	ADP	O
these	O	DET	O
tumours	O	NOUN	B
did	O	AUX	O
not	O	PART	O
appear	O	VERB	O
for	O	ADP	O
more	O	ADJ	O
than	O	ADP	O
80	O	NUM	O
weeks	O	NOUN	B
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
a	O	DET	O
10	O	NUM	O
-	O	PUNCT	O
-	O	PUNCT	O
15	O	NUM	O
%	O	NOUN	O
lengthening	O	NOUN	B
of	O	ADP	O
the	O	DET	O
partial	O	ADJ	B
thromboplastin	B-GENE	NOUN	I
time	O	NOUN	I
is	O	AUX	O
evident	O	ADJ	O
after	O	ADP	O
24	O	NUM	O
hours	O	NOUN	O
of	O	ADP	O
storage	O	NOUN	B
.	O	PUNCT	O


No	O	DET	O
evidence	O	NOUN	O
of	O	ADP	O
either	O	CCONJ	O
positive	O	ADJ	B
or	O	CCONJ	O
negative	O	ADJ	B
chemography	O	NOUN	O
was	O	AUX	O
found	O	VERB	O
.	O	PUNCT	O


A	O	DET	O
study	O	NOUN	B
of	O	ADP	O
chromosomes	O	NOUN	B
of	O	ADP	O
lymphocytes	O	NOUN	B
from	O	ADP	O
patients	O	NOUN	B
treated	O	VERB	B
with	O	ADP	I
hycanthone	O	NOUN	B
.	O	PUNCT	O


Study	O	NOUN	B
of	O	ADP	O
the	O	DET	O
physico	O	NOUN	B
-	O	PUNCT	O
chemical	O	NOUN	B
state	O	NOUN	I
of	O	ADP	O
plutonium	O	NOUN	B
-	O	PUNCT	O
239	O	NUM	O
in	O	ADP	O
a	O	DET	O
citrate	O	NOUN	B
solution	O	NOUN	I
-	O	PUNCT	O
blood	O	NOUN	B
system	O	NOUN	I


Maternal	O	ADJ	B
lactation	O	NOUN	O


In	O	ADP	O
both	O	DET	O
cases	O	NOUN	B
,	O	PUNCT	O
at	O	ADP	O
the	O	DET	O
end	O	NOUN	O
of	O	ADP	O
exposure	O	NOUN	B
the	O	DET	O
same	O	ADJ	O
level	O	NOUN	B
of	O	ADP	O
blood	B-GENE	NOUN	B
carboxyhemoglobin	I-GENE	NOUN	I
(	O	PUNCT	O
COHb	B-GENE	NOUN	B
)	O	PUNCT	O
(	O	PUNCT	O
about	O	ADV	O
50	O	NUM	O
%	O	NOUN	O
)	O	PUNCT	O
was	O	AUX	O
reached	O	VERB	O
.	O	PUNCT	O


The	O	DET	O
results	O	NOUN	B
indicate	O	VERB	O
that	O	SCONJ	O
increased	O	VERB	B
pulmonary	O	ADJ	B
blood	O	NOUN	I
flow	O	NOUN	I
and	O	CCONJ	O
decreased	O	VERB	B
pulmonary	O	ADJ	B
vascular	O	ADJ	O
resistance	O	NOUN	O
with	O	ADP	O
advancing	O	VERB	O
gestation	O	NOUN	B
are	O	AUX	O
due	O	ADJ	O
to	O	PART	O
an	O	DET	O
increase	O	NOUN	B
in	O	ADP	O
the	O	DET	O
total	O	ADJ	O
number	O	NOUN	O
of	O	ADP	O
vessels	O	NOUN	B
and	O	CCONJ	O
increased	O	VERB	B
vasomotor	O	NOUN	B
reactivity	O	NOUN	I
is	O	AUX	O
related	O	ADJ	O
to	O	PART	O
an	O	DET	O
increase	O	NOUN	B
in	O	ADP	O
the	O	DET	O
total	O	ADJ	O
amount	O	NOUN	O
of	O	ADP	O
smooth	O	ADJ	B
muscle	O	NOUN	I
while	O	SCONJ	O
the	O	DET	O
thickness	O	NOUN	B
of	O	ADP	O
muscle	O	NOUN	B
in	O	ADP	O
individual	O	ADJ	O
vessels	O	NOUN	B
remains	O	VERB	O
constant	O	ADJ	B
.	O	PUNCT	O


Reduction	O	NOUN	B
in	O	ADP	O
dosage	O	NOUN	B
restored	O	VERB	O
normal	O	ADJ	B
taste	O	NOUN	I
sense	O	NOUN	O
in	O	ADP	O
all	O	DET	O
three	O	NUM	O
,	O	PUNCT	O
but	O	CCONJ	O
in	O	ADP	O
two	O	NUM	O
the	O	DET	O
drug	O	NOUN	B
had	O	AUX	O
to	O	PART	O
be	O	AUX	O
discontinued	O	VERB	B
because	O	SCONJ	O
of	O	ADP	O
persisting	O	VERB	O
high	O	ADJ	O
transaminase	O	NOUN	B
levels	O	NOUN	B
.	O	PUNCT	O


A	O	DET	O
late	O	ADJ	B
diagnosis	O	NOUN	I
of	O	ADP	O
retinoblastoma	O	NOUN	B
is	O	AUX	O
an	O	DET	O
unquestionable	O	ADJ	O
fact	O	NOUN	O
that	O	PRON	O
allows	O	VERB	O
its	O	PRON	O
growth	O	NOUN	B
and	O	CCONJ	O
leads	O	VERB	O
to	O	PART	O
a	O	DET	O
deterioration	O	NOUN	B
in	O	ADP	O
the	O	DET	O
outlook	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
concept	O	NOUN	B
of	O	ADP	O
"	O	PUNCT	O
structural	O	ADJ	B
identifiability	O	NOUN	B
"	O	PUNCT	O
is	O	AUX	O
employed	O	VERB	O
in	O	ADP	O
this	O	DET	O
analysis	O	NOUN	B
to	O	PART	O
determine	O	VERB	O
which	O	DET	O
model	O	NOUN	B
parameters	O	NOUN	B
can	O	AUX	O
be	O	AUX	O
and	O	CCONJ	O
which	O	DET	O
cannot	O	VERB	O
be	O	AUX	O
determined	O	VERB	O
"	O	PUNCT	O
uniquely	O	ADV	B
"	O	PUNCT	O
from	O	ADP	O
given	O	VERB	O
input	O	NOUN	B
-	O	PUNCT	O
output	O	NOUN	B
data	O	NOUN	B
;	O	PUNCT	O
a	O	DET	O
step	O	NOUN	B
-	O	PUNCT	O
by	O	ADP	O
-	O	PUNCT	O
step	O	NOUN	B
procedure	O	NOUN	B
based	O	VERB	O
on	O	ADP	O
an	O	DET	O
extension	O	NOUN	B
of	O	ADP	O
this	O	DET	O
concept	O	NOUN	B
is	O	AUX	O
presented	O	VERB	O
for	O	ADP	O
adapting	O	VERB	O
the	O	DET	O
overall	O	ADJ	O
approach	O	NOUN	O
to	O	ADP	O
the	O	DET	O
experimental	O	ADJ	B
design	O	NOUN	I
problem	O	NOUN	B
.	O	PUNCT	O


Acquired	O	VERB	B
factor	B-GENE	NOUN	I
VIII	I-GENE	NOUN	I
inhibitor	O	NOUN	I
in	O	ADP	O
non	O	ADJ	B
-	O	PUNCT	O
hemophilic	O	ADJ	B
patients	O	NOUN	B


The	O	DET	O
study	O	NOUN	B
of	O	ADP	O
calcium	O	NOUN	B
metabolism	O	NOUN	I
in	O	ADP	O
ten	O	NUM	O
thalassaemic	O	ADJ	B
children	O	NOUN	B
comperatively	O	ADV	O
with	O	ADP	O
controls	O	NOUN	B
after	O	ADP	O
oral	O	ADJ	B
administration	O	NOUN	I
of	O	ADP	O
47Ca	O	NOUN	B
has	O	AUX	O
shown	O	VERB	O
diminished	O	VERB	B
intestinal	O	ADJ	B
absorption	O	NOUN	B
.	O	PUNCT	O


AP	O	PROPN	B
was	O	AUX	O
induced	O	VERB	B
by	O	ADP	O
intraductal	O	ADJ	B
infusion	O	NOUN	B
of	O	ADP	O
two	O	NUM	O
different	O	ADJ	O
concentrations	O	NOUN	B
of	O	ADP	O
glycodeoxycholic	O	ADJ	B
acid	O	NOUN	I
(	O	PUNCT	O
GDOC	O	NOUN	B
17	O	NUM	O
mmol	O	NOUN	O
and	O	CCONJ	O
34	O	NUM	O
mmol	O	NOUN	O
)	O	PUNCT	O
.	O	PUNCT	O


Tissue	B-GENE	NOUN	B
plasminogen	I-GENE	NOUN	I
activator	I-GENE	NOUN	I
,	O	PUNCT	O
its	O	PRON	O
inhibitor	O	NOUN	B
and	O	CCONJ	O
other	O	ADJ	O
parameters	O	NOUN	B
of	O	ADP	O
fibrinolysis	O	NOUN	B
in	O	ADP	O
blood	O	NOUN	B
of	O	ADP	O
patients	O	NOUN	B
operated	O	VERB	O
for	O	ADP	O
mild	O	ADJ	B
hypertrophy	O	NOUN	I
of	O	ADP	O
the	O	DET	O
prostate	O	NOUN	B


The	O	DET	O
mean	O	NOUN	B
(	O	PUNCT	O
+	O	CCONJ	O
/	O	SYM	O
-	O	PUNCT	O
SD	O	NOUN	B
)	O	PUNCT	O
PaO2	O	NOUN	B
increased	O	VERB	B
from	O	ADP	O
80	O	NUM	O
.	O	PUNCT	O
8	O	NUM	O
+	O	CCONJ	O
/	O	SYM	O
-	O	PUNCT	O
26	O	NUM	O
.	O	PUNCT	O
9	O	NUM	O
mmHg	O	NOUN	B
before	O	ADP	O
to	O	ADP	O
89	O	NUM	O
.	O	PUNCT	O
8	O	NUM	O
+	O	CCONJ	O
/	O	SYM	O
-	O	PUNCT	O
27	O	NUM	O
.	O	PUNCT	O
3	O	NUM	O
mmHg	O	NOUN	B
after	O	ADP	O
the	O	DET	O
infusion	O	NOUN	B
(	O	PUNCT	O
P	O	NOUN	O
<	O	X	O
0	O	NUM	O
.	O	PUNCT	O
05	O	NUM	O
)	O	PUNCT	O
and	O	CCONJ	O
the	O	DET	O
PaCO2	O	NOUN	B
decreased	O	VERB	B
from	O	ADP	O
42	O	NUM	O
.	O	PUNCT	O
4	O	NUM	O
+	O	CCONJ	O
/	O	SYM	O
-	O	PUNCT	O
8	O	NUM	O
.	O	PUNCT	O
3	O	NUM	O
to	O	PART	O
39	O	NUM	O
.	O	PUNCT	O
6	O	NUM	O
+	O	CCONJ	O
/	O	SYM	O
-	O	PUNCT	O
7	O	NUM	O
.	O	PUNCT	O
9	O	NUM	O
mmHg	O	NOUN	B
(	O	PUNCT	O
P	O	NOUN	O
<	O	X	O
0	O	NUM	O
.	O	PUNCT	O
05	O	NUM	O
)	O	PUNCT	O
.	O	PUNCT	O


The	O	DET	O
two	O	NUM	O
drugs	O	NOUN	B
increase	O	VERB	B
the	O	DET	O
rate	O	NOUN	B
of	O	ADP	O
early	O	ADJ	B
diastolic	O	ADJ	B
filling	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
cloned	O	VERB	B
the	O	DET	O
third	O	ADJ	O
human	O	ADJ	B
gene	O	NOUN	O
for	O	ADP	O
the	O	DET	O
LD78	B-GENE	NOUN	B
,	O	PUNCT	O
termed	O	VERB	O
LD78	B-GENE	NOUN	B
gamma	I-GENE	NOUN	I
and	O	CCONJ	O
the	O	DET	O
sequence	O	NOUN	B
analysis	O	NOUN	I
showed	O	VERB	O
that	O	SCONJ	O
it	O	PRON	O
is	O	AUX	O
a	O	DET	O
5	O	NUM	O
'	O	PUNCT	O
-	O	PUNCT	O
truncated	O	VERB	B
pseudogene	O	NOUN	O
.	O	PUNCT	O


In	O	ADP	O
the	O	DET	O
absence	O	NOUN	B
of	O	ADP	O
histological	O	ADJ	B
criteria	O	NOUN	I
,	O	PUNCT	O
which	O	DET	O
it	O	PRON	O
is	O	AUX	O
difficult	O	ADJ	O
to	O	PART	O
demand	O	VERB	O
in	O	ADP	O
view	O	NOUN	O
of	O	ADP	O
the	O	DET	O
variability	O	NOUN	B
of	O	ADP	O
results	O	NOUN	B
and	O	CCONJ	O
potential	O	ADJ	B
dangers	O	NOUN	B
of	O	ADP	O
endomyocardial	O	ADJ	B
biopsy	O	NOUN	I
involving	O	VERB	O
such	O	ADJ	O
thin	O	ADJ	B
and	O	CCONJ	O
fragile	O	ADJ	B
ventricular	O	ADJ	I
walls	O	NOUN	I
,	O	PUNCT	O
the	O	DET	O
diagnosis	O	NOUN	B
of	O	ADP	O
ACRV	O	NOUN	B
is	O	AUX	O
based	O	VERB	O
upon	O	SCONJ	O
the	O	DET	O
concomitant	O	ADJ	B
existence	O	NOUN	O
of	O	ADP	O
:	O	PUNCT	O
(	O	PUNCT	O
1	O	X	O
)	O	PUNCT	O
electrophysiological	O	ADJ	B
criteria	O	NOUN	I
:	O	PUNCT	O
ventricular	O	ADJ	B
arrhythmias	O	NOUN	I
,	O	PUNCT	O
in	O	ADP	O
particular	O	ADJ	O
sustained	O	ADJ	O
monomorphous	O	ADJ	B
VT	O	NOUN	I
,	O	PUNCT	O
with	O	ADP	O
the	O	DET	O
particular	O	ADJ	O
feature	O	NOUN	O
of	O	ADP	O
a	O	DET	O
very	O	ADV	O
high	O	ADJ	O
degree	O	NOUN	B
of	O	ADP	O
sensitivity	O	NOUN	B
to	O	PART	O
adrenergic	O	ADJ	B
stimulation	O	NOUN	I
(	O	PUNCT	O
exercise	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
the	O	DET	O
existence	O	NOUN	O
of	O	ADP	O
late	O	ADJ	B
potentials	O	NOUN	I
on	O	ADP	O
the	O	DET	O
high	O	ADJ	B
amplification	O	NOUN	I
ECG	O	PROPN	B
,	O	PUNCT	O
a	O	DET	O
highly	O	ADV	O
specific	O	ADJ	O
sign	O	NOUN	O
,	O	PUNCT	O
though	O	SCONJ	O
unfortunately	O	ADV	O
of	O	ADP	O
poor	O	ADJ	B
sensitivity	O	NOUN	I
in	O	ADP	O
localized	O	ADJ	B
froms	O	NOUN	B
,	O	PUNCT	O
those	O	DET	O
which	O	DET	O
are	O	AUX	O
most	O	ADV	O
difficult	O	ADJ	O
to	O	PART	O
identify	O	VERB	O
(	O	PUNCT	O
2	O	NUM	O
)	O	PUNCT	O
;	O	PUNCT	O
segmentary	O	ADJ	B
morphological	O	ADJ	B
and	O	CCONJ	O
kinetic	O	ADJ	B
RV	O	ADJ	I
abnormalities	O	NOUN	I
,	O	PUNCT	O
most	O	ADV	O
often	O	ADV	O
resulting	O	VERB	O
in	O	ADP	O
localized	O	ADJ	B
akinetic	O	ADJ	B
or	O	CCONJ	O
dyskinetic	O	ADJ	B
parietal	O	ADJ	O
vaulting	O	NOUN	O
,	O	PUNCT	O
with	O	ADP	O
stasis	O	NOUN	B
"	O	PUNCT	O
in	O	X	B
situ	O	X	I
"	O	PUNCT	O
.	O	PUNCT	O


66	O	NUM	O
:	O	PUNCT	O
469	O	NUM	O
-	O	SYM	O
479	O	NUM	O
,	O	PUNCT	O
1992	O	NUM	O
)	O	PUNCT	O
.	O	PUNCT	O


Possibly	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
scr1	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	O
mutation	I-GENE	NOUN	B
does	O	AUX	O
not	O	PART	O
affect	O	VERB	O
signal	O	NOUN	B
recognition	O	NOUN	I
or	O	CCONJ	O
translational	O	ADJ	B
arrest	O	NOUN	I
but	O	CCONJ	O
instead	O	ADV	O
results	O	NOUN	B
in	O	ADP	O
maintenance	O	NOUN	B
of	O	ADP	O
translational	O	ADJ	B
arrest	O	NOUN	I
of	O	ADP	O
AEP	B-GENE	NOUN	B
synthesis	O	NOUN	B
.	O	PUNCT	O


Both	O	CCONJ	O
Rep78	B-GENE	NOUN	B
and	O	CCONJ	O
Rep68	B-GENE	NOUN	B
cut	O	VERB	O
the	O	DET	O
terminal	O	ADJ	B
AAV	O	NOUN	B
sequence	O	NOUN	O
at	O	ADP	O
the	O	DET	O
same	O	ADJ	O
site	O	NOUN	B
(	O	PUNCT	O
nucleotide	O	NOUN	B
124	O	NUM	I
)	O	PUNCT	O
.	O	PUNCT	O


Nucleotide	O	NOUN	B
sequence	O	NOUN	I
analysis	O	NOUN	I
revealed	O	VERB	O
that	O	SCONJ	O
TAR	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
binding	I-GENE	VERB	B
protein	I-GENE	NOUN	I
is	O	AUX	O
very	O	ADV	O
similar	O	ADJ	O
to	O	PART	O
the	O	DET	O
CREB2	B-GENE	NOUN	B
protein	I-GENE	NOUN	I
.	O	PUNCT	O


A	O	DET	O
patient	O	NOUN	B
suffering	O	VERB	O
from	O	ADP	O
heparin	O	NOUN	B
-	O	PUNCT	O
associated	O	VERB	B
thrombocytopenia	O	NOUN	I
(	O	PUNCT	O
HAT	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
recurrent	O	ADJ	B
arteriothromboses	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
acute	O	ADJ	B
renal	O	ADJ	I
failure	O	NOUN	I
after	O	ADP	O
treatment	O	NOUN	B
with	O	ADP	O
standard	O	ADJ	B
heparin	O	NOUN	B
is	O	AUX	O
described	O	VERB	O
.	O	PUNCT	O


Comparison	O	NOUN	B
with	O	ADP	O
the	O	DET	O
sequence	O	NOUN	B
databanks	O	NOUN	I
show	O	VERB	O
that	O	SCONJ	O
Tactile	B-GENE	NOUN	B
is	O	AUX	O
a	O	DET	O
member	O	NOUN	B
of	O	ADP	O
the	O	DET	O
immunoglobulin	B-GENE	NOUN	B
gene	I-GENE	NOUN	I
superfamily	I-GENE	NOUN	O
,	O	PUNCT	O
with	O	ADP	O
similarity	O	NOUN	B
to	O	PART	O
Drosophila	B-GENE	NOUN	B
amalgam	I-GENE	NOUN	B
,	O	PUNCT	O
the	O	DET	O
melanoma	B-GENE	NOUN	B
Ag	I-GENE	NOUN	B
MUC	I-GENE	PROPN	B
-	I-GENE	PUNCT	O
18	I-GENE	NUM	O
,	O	PUNCT	O
members	O	NOUN	B
of	O	ADP	O
the	O	DET	O
carcinoembryonic	B-GENE	ADJ	B
Ag	I-GENE	NOUN	B
family	I-GENE	NOUN	B
,	O	PUNCT	O
the	O	DET	O
poliovirus	B-GENE	NOUN	B
receptor	I-GENE	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
the	O	DET	O
neural	B-GENE	ADJ	B
cell	I-GENE	NOUN	I
adhesion	I-GENE	NOUN	I
molecule	I-GENE	NOUN	I
.	O	PUNCT	O


The	O	DET	O
phenotypes	O	NOUN	B
of	O	ADP	O
the	O	DET	O
ICP0	B-GENE	NOUN	B
nonsense	O	NOUN	B
mutants	O	NOUN	I
were	O	AUX	O
intermediate	O	ADJ	B
between	O	ADP	O
those	O	DET	O
of	O	ADP	O
the	O	DET	O
wild	O	ADJ	B
-	O	PUNCT	O
type	O	NOUN	B
virus	O	NOUN	I
and	O	CCONJ	O
7134	O	NUM	O
in	O	ADP	O
that	O	SCONJ	O
the	O	DET	O
more	O	ADJ	O
ICP0	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
coding	I-GENE	VERB	B
sequence	I-GENE	NOUN	I
expressed	O	VERB	B
by	O	ADP	O
a	O	DET	O
given	O	VERB	O
nonsense	O	ADJ	B
mutant	O	NOUN	I
,	O	PUNCT	O
the	O	DET	O
more	O	ADV	O
wild	O	ADJ	B
type	O	NOUN	I
-	O	PUNCT	O
like	O	ADJ	O
was	O	AUX	O
its	O	PRON	O
phenotype	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
contrast	O	NOUN	O
,	O	PUNCT	O
gel	O	NOUN	B
mobility	O	NOUN	I
shift	O	NOUN	I
experiments	O	NOUN	I
have	O	AUX	O
failed	O	VERB	B
to	O	PART	O
reveal	O	VERB	O
that	O	SCONJ	O
HAP2	B-GENE	NOUN	B
or	O	CCONJ	O
HAP3	B-GENE	NOUN	B
binds	O	VERB	B
to	O	PART	O
domain	O	NOUN	O
1	O	NUM	O
or	O	CCONJ	O
that	O	SCONJ	O
hap3	B-GENE	NOUN	B
mutations	O	NOUN	B
affect	O	VERB	O
the	O	DET	O
complexes	O	NOUN	B
bound	O	VERB	O
to	O	PART	O
it	O	PRON	O
.	O	PUNCT	O


The	O	DET	O
experiment	O	NOUN	B
results	O	NOUN	B
showed	O	VERB	O
:	O	PUNCT	O
(	O	PUNCT	O
i	O	X	O
)	O	PUNCT	O
not	O	PART	O
only	O	ADV	O
1O2	O	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
also	O	ADV	O
free	O	ADJ	B
radicals	O	NOUN	I
(	O	PUNCT	O
O2	O	NOUN	B
-	O	PUNCT	O
.	O	PUNCT	O
.	O	PUNCT	O
OH	O	NOUN	B
and	O	CCONJ	O
YHPD	O	NOUN	B
-	O	PUNCT	O
.	O	PUNCT	O
)	O	PUNCT	O
can	O	AUX	O
be	O	AUX	O
formed	O	VERB	O
by	O	ADP	O
the	O	DET	O
aid	O	NOUN	O
of	O	ADP	O
YHPD	O	NOUN	B
;	O	PUNCT	O
and	O	CCONJ	O
(	O	PUNCT	O
ii	O	X	O
)	O	PUNCT	O
as	O	ADP	O
to	O	PART	O
the	O	DET	O
ability	O	NOUN	O
of	O	ADP	O
producing	O	VERB	O
1O2	O	NOUN	B
,	O	PUNCT	O
YHPD	O	NOUN	B
less	O	ADJ	O
than	O	ADP	O
BHPD	O	NOUN	B
,	O	PUNCT	O
while	O	SCONJ	O
for	O	ADP	O
generating	O	VERB	O
O2	O	NOUN	B
-	O	PUNCT	O
.	O	PUNCT	O
and	O	CCONJ	O
.	O	PUNCT	O
OH	O	ADJ	B
,	O	PUNCT	O
YHPD	O	NOUN	B
greater	O	ADJ	O
than	O	ADP	O
BHPD	O	NOUN	B
.	O	PUNCT	O


Two	O	NUM	O
points	O	NOUN	O
are	O	AUX	O
indicated	O	VERB	O
:	O	PUNCT	O
first	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
photosensitized	O	ADJ	B
damage	O	NOUN	B
of	O	ADP	O
YHPD	O	NOUN	B
is	O	AUX	O
interrelated	O	ADJ	O
to	O	PART	O
not	O	PART	O
only	O	ADV	O
1O2	O	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
also	O	ADV	O
free	O	ADJ	B
radicals	O	NOUN	I
(	O	PUNCT	O
O2	O	NOUN	B
-	O	PUNCT	O
.	O	PUNCT	O
.	O	PUNCT	O
OH	O	NOUN	B
and	O	CCONJ	O
YHPD	O	NOUN	B
-	O	PUNCT	O
.	O	PUNCT	O
)	O	PUNCT	O
;	O	PUNCT	O
second	O	ADV	O
,	O	PUNCT	O
although	O	SCONJ	O
the	O	DET	O
photosensitized	O	ADJ	B
damage	O	NOUN	B
of	O	ADP	O
YHPD	O	NOUN	B
is	O	AUX	O
stronger	O	ADJ	O
than	O	ADP	O
that	O	DET	O
of	O	ADP	O
BHPD	O	NOUN	B
,	O	PUNCT	O
yet	O	CCONJ	O
the	O	DET	O
photosensitized	O	ADJ	B
damage	O	NOUN	O
is	O	AUX	O
negatively	O	ADV	O
correlated	O	VERB	B
to	O	ADP	O
the	O	DET	O
yield	O	NOUN	B
of	O	ADP	O
1O2	O	NOUN	B
but	O	CCONJ	O
positively	O	ADV	B
correlated	O	VERB	B
to	O	PART	O
those	O	DET	O
of	O	ADP	O
O2	O	NOUN	B
-	O	PUNCT	O
.	O	PUNCT	O
and	O	CCONJ	O
OH	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
unphosphorylated	O	ADJ	B
form	O	NOUN	O
of	O	ADP	O
RNA	B-GENE	NOUN	B
polymerase	I-GENE	NOUN	I
II	I-GENE	NUM	I
is	O	AUX	O
designated	O	VERB	O
IIA	O	NOUN	B
,	O	PUNCT	O
whereas	O	SCONJ	O
the	O	DET	O
phosphorylated	O	ADJ	B
form	O	NOUN	O
is	O	AUX	O
designated	O	VERB	O
IIO	O	NOUN	B
.	O	PUNCT	O


RNA	B-GENE	NOUN	B
polymerase	I-GENE	NOUN	I
IIA	I-GENE	NOUN	I
was	O	AUX	O
recovered	O	VERB	O
in	O	ADP	O
transcriptionally	O	ADV	B
active	O	ADJ	O
complexes	O	NOUN	O
in	O	ADP	O
reactions	O	NOUN	B
in	O	ADP	O
which	O	DET	O
the	O	DET	O
input	O	NOUN	O
enzyme	O	NOUN	B
was	O	AUX	O
RNA	B-GENE	NOUN	B
polymerase	I-GENE	NOUN	I
IIA	I-GENE	NOUN	I
.	O	PUNCT	O


Fructokinase	B-GENE	NOUN	B
activity	O	NOUN	O
is	O	AUX	O
elevated	O	VERB	B
up	O	ADV	O
to	O	PART	O
twofold	O	ADV	O
when	O	SCONJ	O
Z	O	NOUN	B
.	O	PUNCT	O
mobilis	O	NOUN	B
was	O	AUX	O
grown	O	VERB	O
on	O	ADP	O
fructose	O	NOUN	B
instead	O	ADV	O
of	O	ADP	O
glucose	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
there	O	PRON	O
was	O	AUX	O
a	O	DET	O
parallel	O	ADJ	O
increase	O	NOUN	B
in	O	ADP	O
frk	B-GENE	NOUN	O
mRNA	I-GENE	NOUN	B
levels	O	NOUN	O
.	O	PUNCT	O


The	O	DET	O
enhancer	O	NOUN	B
region	O	NOUN	I
of	O	ADP	O
Akv	O	NOUN	B
murine	O	ADJ	I
leukemia	O	NOUN	I
virus	O	NOUN	B
contains	O	VERB	O
the	O	DET	O
sequence	O	NOUN	B
motif	O	NOUN	O
ACAGATGG	O	NOUN	O
.	O	PUNCT	O


Two	O	NUM	O
splice	O	NOUN	B
variants	O	NOUN	I
of	O	ADP	O
ALF1	B-GENE	NOUN	B
cDNA	I-GENE	NOUN	B
have	O	AUX	O
been	O	AUX	O
found	O	VERB	O
,	O	PUNCT	O
differing	O	VERB	O
by	O	ADP	O
a	O	DET	O
72	O	NUM	O
-	O	PUNCT	O
bp	O	NOUN	B
insertion	O	NOUN	B
,	O	PUNCT	O
coding	O	VERB	B
for	O	ADP	O
putative	O	ADJ	B
proteins	O	NOUN	I
of	O	ADP	O
682	O	NUM	O
and	O	CCONJ	O
706	O	NUM	O
amino	O	NOUN	B
acids	O	NOUN	I
.	O	PUNCT	O


Cloning	O	NOUN	B
and	O	CCONJ	O
primary	O	ADJ	B
structure	O	NOUN	I
of	O	ADP	O
neurocan	O	NOUN	B
,	O	PUNCT	O
a	O	DET	O
developmentally	O	ADV	O
regulated	O	VERB	O
,	O	PUNCT	O
aggregating	O	VERB	O
chondroitin	O	NOUN	B
sulfate	O	NOUN	I
proteoglycan	O	NOUN	I
of	O	ADP	O
brain	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
-	O	PUNCT	O
64	O	NUM	B
/	O	SYM	O
-	O	PUNCT	O
37	O	NUM	O
region	O	NOUN	B
interacted	O	VERB	B
with	O	ADP	O
purified	O	VERB	B
Sp1	B-GENE	NOUN	B
and	O	CCONJ	O
an	O	DET	O
unidentified	O	ADJ	O
protein	O	NOUN	B
(	O	PUNCT	O
s	O	NOUN	O
)	O	PUNCT	O
,	O	PUNCT	O
proximal	B-GENE	ADJ	B
regulatory	I-GENE	ADJ	I
factor	I-GENE	NOUN	I
(	I-GENE	PUNCT	O
s	I-GENE	NOUN	O
)	I-GENE	PUNCT	O
I	I-GENE	NOUN	O
(	O	PUNCT	O
PRF	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
I	I-GENE	PROPN	B
)	O	PUNCT	O
.	O	PUNCT	O


This	O	DET	O
soluble	O	ADJ	B
form	O	NOUN	O
of	O	ADP	O
the	O	DET	O
HGFr	B-GENE	NOUN	B
(	O	PUNCT	O
sHGFr	B-GENE	NOUN	B
)	O	PUNCT	O
bound	O	VERB	B
HGF	B-GENE	NOUN	B
with	O	ADP	O
an	O	DET	O
affinity	O	NOUN	B
similar	O	ADJ	O
to	O	PART	O
that	O	DET	O
of	O	ADP	O
the	O	DET	O
authentic	O	ADJ	B
,	O	PUNCT	O
membrane	O	NOUN	B
-	O	PUNCT	O
associated	O	VERB	B
receptor	O	NOUN	I
.	O	PUNCT	O


Also	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
human	B-GENE	ADJ	B
glycoprotein	I-GENE	NOUN	I
alpha	I-GENE	NOUN	I
-	I-GENE	PUNCT	O
subunit	I-GENE	NOUN	B
promoter	I-GENE	NOUN	B
was	O	AUX	O
induced	O	VERB	B
10	O	NUM	O
-	O	PUNCT	O
fold	O	NOUN	B
by	O	ADP	O
FSK	B-GENE	NOUN	B
in	O	ADP	O
GH4	O	NOUN	B
rat	O	NOUN	B
pituitary	O	ADJ	B
cells	O	NOUN	I
.	O	PUNCT	O
(	O	PUNCT	O
ABSTRACT	O	NOUN	B
TRUNCATED	O	VERB	I
AT	O	ADP	I
400	O	NUM	I
WORDS	O	NOUN	I
)	O	PUNCT	O


Some	O	DET	O
research	O	NOUN	B
studies	O	NOUN	I
have	O	AUX	O
related	O	VERB	O
this	O	DET	O
kind	O	NOUN	O
of	O	ADP	O
tumors	O	NOUN	B
with	O	ADP	O
prolonged	O	ADJ	B
ingestion	O	NOUN	B
of	O	ADP	O
H2	O	NOUN	B
inhibitors	O	NOUN	I
and	O	CCONJ	O
others	O	NOUN	O
antacid	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
rationale	O	NOUN	O
for	O	ADP	O
continuous	O	ADJ	B
dopaminergic	O	ADJ	B
stimulation	O	NOUN	I
in	O	ADP	O
patients	O	NOUN	B
with	O	ADP	O
Parkinson	O	NOUN	B
'	O	PART	I
s	O	NOUN	I
disease	O	NOUN	I
.	O	PUNCT	O


Amino	O	NOUN	B
acid	O	NOUN	I
sequence	O	NOUN	I
comparison	O	NOUN	O
revealed	O	VERB	O
significant	O	ADJ	O
homology	O	NOUN	B
between	O	ADP	O
the	O	DET	O
yeast	B-GENE	NOUN	B
and	I-GENE	CCONJ	O
Escherichia	I-GENE	X	B
coli	I-GENE	X	I
gamma	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
glutamyl	I-GENE	NOUN	B
kinases	I-GENE	NOUN	I
throughout	O	ADP	O
their	O	PRON	O
lengths	O	NOUN	B
.	O	PUNCT	O


This	O	DET	O
computation	O	NOUN	B
is	O	AUX	O
performed	O	VERB	O
by	O	ADP	O
a	O	DET	O
parallel	O	ADJ	O
network	O	NOUN	B
of	O	ADP	O
locally	O	ADV	B
connected	O	VERB	O
neuron	O	NOUN	B
-	O	PUNCT	O
like	O	ADJ	B
elements	O	NOUN	I
.	O	PUNCT	O


Neither	O	DET	O
gene	O	NOUN	B
possesses	O	VERB	O
a	O	DET	O
distinct	O	ADJ	O
transcriptional	O	ADJ	B
start	O	NOUN	O
site	O	NOUN	O
as	O	ADP	O
shown	O	VERB	O
by	O	ADP	O
nuclease	B-GENE	NOUN	B
S1	I-GENE	NOUN	I
analysis	O	NOUN	I
.	O	PUNCT	O


Gene	O	NOUN	B
and	O	CCONJ	O
pseudogene	O	NOUN	B
of	O	ADP	O
the	O	DET	O
mouse	O	NOUN	B
cation	O	NOUN	B
-	O	PUNCT	O
dependent	O	ADJ	B
mannose	B-GENE	NOUN	B
6	I-GENE	NUM	O
-	I-GENE	PUNCT	O
phosphate	I-GENE	NOUN	B
receptor	I-GENE	NOUN	I
.	O	PUNCT	O


The	O	DET	O
chick	O	NOUN	B
axon	O	NOUN	B
-	O	PUNCT	O
associated	O	VERB	B
surface	O	NOUN	B
glycoprotein	O	NOUN	O
neurofascin	B-GENE	NOUN	B
is	O	AUX	O
implicated	O	VERB	O
in	O	ADP	O
axonal	O	ADJ	B
growth	O	NOUN	I
and	O	CCONJ	O
fasciculation	O	NOUN	B
as	O	ADP	O
revealed	O	VERB	O
by	O	ADP	O
antibody	O	NOUN	B
perturbation	O	NOUN	O
experiments	O	NOUN	O
.	O	PUNCT	O


Entry	O	NOUN	B
of	O	ADP	O
yeast	O	NOUN	B
cells	O	NOUN	I
into	O	ADP	O
the	O	DET	O
mitotic	O	ADJ	B
cell	O	NOUN	I
cycle	O	NOUN	I
(	O	PUNCT	O
Start	O	NOUN	B
)	O	PUNCT	O
involves	O	VERB	O
a	O	DET	O
form	O	NOUN	O
of	O	ADP	O
the	O	DET	O
CDC28	B-GENE	NOUN	B
kinase	I-GENE	NOUN	I
that	O	PRON	O
associates	O	VERB	B
with	O	ADP	I
G1	O	NOUN	B
-	O	PUNCT	O
specific	O	ADJ	B
cyclins	B-GENE	NOUN	B
encoded	O	VERB	B
by	O	ADP	O
CLN1	B-GENE	NOUN	B
and	O	CCONJ	O
CLN2	B-GENE	NOUN	B
(	O	PUNCT	O
ref	O	NOUN	O
.	O	PUNCT	O


From	O	ADP	O
all	O	DET	O
clinically	O	ADV	B
important	O	ADJ	O
yeasts	O	NOUN	B
species	O	NOUN	B
,	O	PUNCT	O
a	O	DET	O
total	O	NOUN	O
of	O	ADP	O
96	O	NUM	O
%	O	NOUN	O
were	O	AUX	O
identified	O	VERB	O
by	O	ADP	O
ATB	O	NOUN	B
method	O	NOUN	B
according	O	VERB	O
to	O	ADP	O
conventional	O	ADJ	B
methods	O	NOUN	O
.	O	PUNCT	O


Consequently	O	ADV	O
,	O	PUNCT	O
significant	O	ADJ	O
differences	O	NOUN	O
between	O	ADP	O
the	O	DET	O
measured	O	VERB	B
and	O	CCONJ	O
calculated	O	VERB	B
methods	O	NOUN	B
were	O	AUX	O
noted	O	VERB	O
in	O	ADP	O
oxygen	O	NOUN	B
uptake	O	NOUN	I
(	O	PUNCT	O
213	O	NUM	O
+	O	CCONJ	O
/	O	SYM	O
-	O	PUNCT	O
41	O	NUM	O
ml	O	NOUN	O
/	O	SYM	O
min	O	NOUN	B
vs	O	CCONJ	O
193	O	NUM	O
+	O	CCONJ	O
/	O	SYM	O
-	O	PUNCT	O
25	O	NUM	O
ml	O	NOUN	O
/	O	SYM	O
min	O	NOUN	B
,	O	PUNCT	O
p	O	NOUN	O
<	O	X	O
0	O	NUM	O
.	O	PUNCT	O
001	O	NUM	O
)	O	PUNCT	O
,	O	PUNCT	O
oxygen	O	NOUN	B
delivery	O	NOUN	I
(	O	PUNCT	O
780	O	NUM	O
+	O	CCONJ	O
/	O	SYM	O
-	O	PUNCT	O
297	O	NUM	O
ml	O	NOUN	O
/	O	SYM	O
min	O	NOUN	B
vs	O	CCONJ	O
716	O	NUM	O
+	O	CCONJ	O
/	O	SYM	O
-	O	PUNCT	O
296	O	NUM	O
ml	O	NOUN	O
/	O	SYM	O
min	O	NOUN	B
,	O	PUNCT	O
p	O	NOUN	O
<	O	X	O
0	O	NUM	O
.	O	PUNCT	O
001	O	NUM	O
)	O	PUNCT	O
,	O	PUNCT	O
and	O	CCONJ	O
cardiac	O	ADJ	B
output	O	NOUN	I
(	O	PUNCT	O
5	O	NUM	O
.	O	PUNCT	O
8	O	NUM	O
+	O	CCONJ	O
/	O	SYM	O
-	O	PUNCT	O
2	O	NUM	O
.	O	PUNCT	O
2	O	NUM	O
L	O	NOUN	B
/	O	PUNCT	O
min	O	NOUN	B
vs	O	CCONJ	O
5	O	NUM	O
.	O	PUNCT	O
3	O	NUM	O
+	O	CCONJ	O
/	O	SYM	O
-	O	PUNCT	O
1	O	NUM	O
.	O	PUNCT	O
8	O	NUM	O
L	O	NOUN	B
/	O	PUNCT	O
min	O	NOUN	B
,	O	PUNCT	O
p	O	NOUN	O
<	O	X	O
0	O	NUM	O
.	O	PUNCT	O
001	O	NUM	O
)	O	PUNCT	O
.	O	PUNCT	O


Negatively	O	ADV	O
supercoiled	O	ADJ	B
plasmid	O	NOUN	I
pUC19	O	NOUN	B
did	O	AUX	O
not	O	PART	O
compete	O	VERB	O
,	O	PUNCT	O
whereas	O	SCONJ	O
an	O	DET	O
otherwise	O	ADV	O
identical	O	ADJ	O
plasmid	O	NOUN	B
pUC19	O	NOUN	B
(	O	PUNCT	O
CG	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
which	O	DET	O
contained	O	VERB	O
a	O	DET	O
(	O	PUNCT	O
dG	O	NOUN	B
-	O	PUNCT	O
dC	O	NOUN	B
)	O	PUNCT	O
7	O	NUM	O
segment	O	NOUN	B
in	O	ADP	O
the	O	DET	O
Z	O	PROPN	B
-	O	PUNCT	O
form	O	NOUN	O
was	O	AUX	O
an	O	DET	O
excellent	O	ADJ	B
competitor	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
contrast	O	NOUN	O
,	O	PUNCT	O
the	O	DET	O
lumenal	O	ADJ	B
domains	O	NOUN	I
of	O	ADP	O
Sec12p	B-GENE	NOUN	B
,	O	PUNCT	O
Stl1p	B-GENE	NOUN	B
and	O	CCONJ	O
Stl2p	B-GENE	NOUN	B
are	O	AUX	O
very	O	ADV	O
different	O	ADJ	O
in	O	ADP	O
size	O	NOUN	B
and	O	CCONJ	O
do	O	AUX	O
not	O	PART	O
show	O	VERB	O
any	O	DET	O
appreciable	O	ADJ	O
homology	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
gene	O	NOUN	B
sequence	O	NOUN	I
also	O	ADV	O
identified	O	VERB	B
a	O	DET	O
340	O	NUM	O
-	O	PUNCT	O
nucleotide	O	NOUN	B
RNA	O	NOUN	I
in	O	ADP	O
total	O	ADJ	O
yeast	O	NOUN	O
RNA	O	NOUN	O
and	O	CCONJ	O
in	O	ADP	O
purified	O	VERB	B
RNase	B-GENE	NOUN	B
MRP	I-GENE	NOUN	B
enzyme	I-GENE	NOUN	B
preparations	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
RNase	B-GENE	NOUN	B
MRP	I-GENE	NOUN	B
RNA	I-GENE	NOUN	B
gene	I-GENE	NOUN	I
was	O	AUX	O
deleted	O	VERB	O
by	O	ADP	O
insertional	O	ADJ	B
replacement	O	NOUN	I
and	O	CCONJ	O
found	O	VERB	O
to	O	PART	O
be	O	AUX	O
essential	O	ADJ	B
for	O	ADP	O
cellular	O	ADJ	B
viability	O	NOUN	I
,	O	PUNCT	O
indicating	O	VERB	O
a	O	DET	O
critical	O	ADJ	O
nuclear	O	ADJ	B
role	O	NOUN	O
for	O	ADP	O
RNase	B-GENE	NOUN	B
MRP	I-GENE	NOUN	B
.	O	PUNCT	O


Mutational	O	ADJ	B
analysis	O	NOUN	I
of	O	ADP	O
essential	O	ADJ	O
IncP	O	NOUN	B
alpha	O	NOUN	I
plasmid	O	NOUN	O
transfer	O	NOUN	B
genes	O	NOUN	I
traF	B-GENE	NOUN	B
and	O	CCONJ	O
traG	B-GENE	NOUN	B
and	O	CCONJ	O
involvement	O	NOUN	B
of	O	ADP	O
traF	B-GENE	NOUN	B
in	O	ADP	O
phage	O	NOUN	B
sensitivity	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
promoter	O	NOUN	B
was	O	AUX	O
stimulated	O	VERB	B
8	O	NUM	O
-	O	PUNCT	O
20	O	NUM	O
-	O	PUNCT	O
fold	O	NOUN	B
by	O	ADP	O
phorbol	O	NOUN	B
esters	O	NOUN	I
accounting	O	VERB	O
for	O	ADP	O
the	O	DET	O
previously	O	ADV	O
observed	O	VERB	O
transcriptional	O	ADJ	B
activation	O	NOUN	I
of	O	ADP	O
protein	B-GENE	NOUN	B
kinase	I-GENE	NOUN	I
C	I-GENE	NOUN	I
beta	I-GENE	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
the	O	DET	O
eight	O	NUM	O
patients	O	NOUN	B
with	O	ADP	O
persistent	O	ADJ	B
generalized	O	VERB	O
lymph	O	NOUN	B
-	O	PUNCT	O
adenopathy	O	NOUN	B
(	O	PUNCT	O
PGL	O	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
nontender	O	ADJ	B
,	O	PUNCT	O
nonenlarging	O	ADJ	B
nodes	O	NOUN	I
,	O	PUNCT	O
pathologic	O	ADJ	B
analysis	O	NOUN	I
revealed	O	VERB	O
lymphoid	O	ADJ	B
hyperplasia	O	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
found	O	VERB	O
that	O	SCONJ	O
both	O	CCONJ	O
the	O	DET	O
E26	O	NOUN	B
virus	O	NOUN	I
-	O	PUNCT	O
encoded	O	VERB	B
v	B-GENE	NOUN	O
-	I-GENE	PUNCT	O
ets	I-GENE	NOUN	B
and	O	CCONJ	O
the	O	DET	O
myeloid	B-GENE	ADJ	B
/	I-GENE	SYM	O
B	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
cell	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
specific	I-GENE	ADJ	B
factor	I-GENE	NOUN	B
PU	I-GENE	NOUN	B
.	I-GENE	PUNCT	O
1	I-GENE	NUM	O
bind	O	VERB	B
efficiently	O	ADV	O
to	O	PART	O
this	O	DET	O
site	O	NOUN	B
in	O	X	B
vitro	O	X	I
.	O	PUNCT	O


Localization	O	NOUN	B
of	O	ADP	O
the	O	DET	O
brachial	O	ADJ	B
plexus	O	NOUN	I
with	O	ADP	O
the	O	DET	O
nerve	O	NOUN	B
stimulator	O	NOUN	I
is	O	AUX	O
equally	O	ADV	O
effective	O	ADJ	B
at	O	ADP	O
the	O	DET	O
interscalene	O	NOUN	B
,	O	PUNCT	O
supraclavicular	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
axillary	O	ADJ	B
sites	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
second	O	ADJ	O
method	O	NOUN	B
,	O	PUNCT	O
the	O	DET	O
"	O	PUNCT	O
macro	O	ADJ	B
"	O	PUNCT	O
assay	O	NOUN	B
,	O	PUNCT	O
has	O	AUX	O
a	O	DET	O
sensitivity	O	NOUN	B
range	O	NOUN	O
of	O	ADP	O
0	O	NUM	O
.	O	PUNCT	O
03	O	NUM	O
-	O	SYM	O
5	O	NUM	O
.	O	PUNCT	O
0	O	NUM	O
micrograms	O	NOUN	B
phosphorus	O	NOUN	B
with	O	ADP	O
100	O	NUM	O
-	O	PUNCT	O
500	O	NUM	O
microliters	O	NOUN	B
HClO4	O	NOUN	B
.	O	PUNCT	O


Anti	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
CRK	I-GENE	NOUN	B
antibodies	I-GENE	NOUN	B
detect	O	VERB	B
a	O	DET	O
53kDa	O	ADJ	O
protein	O	NOUN	B
in	O	ADP	O
extracts	O	NOUN	B
of	O	ADP	O
C	O	NOUN	B
.	O	PUNCT	O
fasciculata	O	NOUN	B
in	O	ADP	O
agreement	O	NOUN	O
with	O	ADP	O
the	O	DET	O
size	O	NOUN	B
predicted	O	VERB	B
from	O	ADP	O
the	O	DET	O
nucleotide	O	NOUN	B
sequence	O	NOUN	I
of	O	ADP	O
the	O	DET	O
cloned	O	VERB	B
gene	O	NOUN	I
.	O	PUNCT	O


Use	O	PROPN	B
of	O	ADP	I
free	O	ADJ	B
-	O	PUNCT	O
access	O	NOUN	B
minerals	O	NOUN	B
.	O	PUNCT	O


Respiratory	O	ADJ	B
interaction	O	NOUN	I
after	O	ADP	O
spinal	O	ADJ	B
anesthesia	O	NOUN	I
and	O	CCONJ	O
sedation	O	NOUN	B
with	O	ADP	O
midazolam	O	NOUN	B
.	O	PUNCT	O


V	O	NOUN	O
.	O	PUNCT	O


Rice	B-GENE	NOUN	B
dwarf	I-GENE	NOUN	I
phytoreovirus	I-GENE	NOUN	I
segment	I-GENE	NOUN	O
S12	I-GENE	NOUN	O
transcript	I-GENE	NOUN	B
is	O	AUX	O
tricistronic	O	ADJ	B
in	O	X	B
vitro	O	X	I
.	O	PUNCT	O


Cold	O	ADJ	B
cardioplegia	O	NOUN	I
was	O	AUX	O
administered	O	VERB	B
at	O	ADP	O
45	O	NUM	O
mm	O	X	B
Hg	O	PROPN	I
every	O	DET	O
20	O	NUM	O
minutes	O	NOUN	B
for	O	ADP	O
2	O	NUM	O
hours	O	NOUN	B
.	O	PUNCT	O


Comparable	O	ADJ	O
amounts	O	NOUN	O
of	O	ADP	O
alpha	B-GENE	NOUN	B
5	I-GENE	NUM	O
beta	I-GENE	NOUN	B
1	I-GENE	NUM	I
integrin	I-GENE	NOUN	B
were	O	AUX	O
isolated	O	VERB	B
from	O	ADP	O
these	O	DET	O
cells	O	NOUN	B
by	O	ADP	O
chromatography	O	NOUN	B
of	O	ADP	O
detergent	O	NOUN	B
extracts	O	NOUN	O
on	O	ADP	O
a	O	DET	O
fibronectin	B-GENE	NOUN	B
cell	O	NOUN	B
-	O	PUNCT	O
binding	O	VERB	B
fragment	O	NOUN	I
affinity	O	NOUN	I
column	O	NOUN	I
and	O	CCONJ	O
elution	O	NOUN	B
with	O	ADP	O
EDTA	O	NOUN	B
.	O	PUNCT	O


From	O	ADP	O
this	O	DET	O
library	O	NOUN	B
,	O	PUNCT	O
LEU2	B-GENE	NOUN	B
and	O	CCONJ	O
HIS3	B-GENE	NOUN	B
cDNAs	O	NOUN	I
were	O	AUX	O
recovered	O	VERB	B
at	O	ADP	O
a	O	DET	O
frequency	O	NOUN	B
of	O	ADP	O
about	O	ADV	O
1	O	NUM	O
in	O	ADP	O
10	O	NUM	O
(	O	PUNCT	O
4	O	NUM	O
)	O	PUNCT	O
and	O	CCONJ	O
in	O	ADP	O
12	O	NUM	O
out	O	ADP	O
of	O	ADP	O
13	O	NUM	O
cases	O	NOUN	B
these	O	DET	O
were	O	AUX	O
expressed	O	VERB	B
in	O	ADP	O
a	O	DET	O
galactose	O	NOUN	B
-	O	PUNCT	O
dependent	O	ADJ	B
manner	O	NOUN	O
.	O	PUNCT	O


Among	O	ADP	O
these	O	DET	O
,	O	PUNCT	O
ACT1	B-GENE	NOUN	B
was	O	AUX	O
isolated	O	VERB	B
four	O	NUM	O
times	O	NOUN	O
,	O	PUNCT	O
and	O	CCONJ	O
NSR1	B-GENE	NOUN	B
three	O	NUM	O
times	O	NOUN	O
.	O	PUNCT	O


BiP670	B-GENE	NOUN	B
retains	O	VERB	O
basal	O	ADJ	B
and	O	CCONJ	O
Ca2	O	NOUN	B
+	O	CCONJ	O
ionophore	O	NOUN	B
A23187	O	NOUN	I
-	O	PUNCT	O
inducible	O	ADJ	B
activities	O	NOUN	B
.	O	PUNCT	O


As	O	ADP	O
a	O	DET	O
part	O	NOUN	O
of	O	ADP	O
a	O	DET	O
large	O	ADJ	O
examination	O	NOUN	B
,	O	PUNCT	O
total	O	NOUN	O
and	O	CCONJ	O
free	O	ADJ	B
serum	O	NOUN	O
cholesterol	O	NOUN	O
,	O	PUNCT	O
total	O	ADJ	O
lipid	O	NOUN	B
and	O	CCONJ	O
triglyceride	O	NOUN	B
levels	O	NOUN	O
were	O	AUX	O
determined	O	VERB	O
.	O	PUNCT	O


DIBA	O	NOUN	B
was	O	AUX	O
more	O	ADV	O
sensitive	O	ADJ	B
and	O	CCONJ	O
had	O	AUX	O
a	O	DET	O
better	O	ADV	O
negative	O	ADJ	B
predictive	O	ADJ	O
value	O	NOUN	O
and	O	CCONJ	O
a	O	DET	O
lower	O	ADV	O
false	O	ADJ	O
negative	O	ADJ	O
percentage	O	NOUN	O
than	O	ADP	O
DFAT	O	NOUN	B
.	O	PUNCT	O


Caries	O	NOUN	B
and	O	CCONJ	O
parodontitis	O	NOUN	B
have	O	AUX	O
been	O	AUX	O
one	O	NUM	O
of	O	ADP	O
the	O	DET	O
most	O	ADV	O
spread	O	NOUN	B
diseases	O	NOUN	B
of	O	ADP	O
mankind	O	NOUN	B
.	O	PUNCT	O


ME1a1	B-GENE	NOUN	B
,	O	PUNCT	O
a	O	DET	O
16	O	NUM	O
-	O	PUNCT	O
base	O	NOUN	B
-	O	PUNCT	O
pair	O	NOUN	B
nuclear	O	ADJ	B
factor	O	NOUN	I
binding	O	NOUN	I
site	O	NOUN	I
residing	O	VERB	O
between	O	ADP	O
the	O	DET	O
c	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
MYC	I-GENE	NOUN	B
P1	I-GENE	NOUN	B
and	I-GENE	CCONJ	O
P2	I-GENE	NOUN	B
transcription	I-GENE	NOUN	I
initiation	I-GENE	NOUN	I
sites	I-GENE	NOUN	I
,	O	PUNCT	O
is	O	AUX	O
required	O	VERB	O
for	O	ADP	O
P2	O	NOUN	O
activity	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
next	O	ADJ	O
twenty	O	NUM	O
years	O	NOUN	B
of	O	ADP	O
prevention	O	NOUN	B
in	O	ADP	O
Indian	O	ADJ	B
country	O	NOUN	B
:	O	PUNCT	O
visionary	O	NOUN	B
,	O	PUNCT	O
complex	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
practical	O	ADJ	B
.	O	PUNCT	O


The	O	DET	O
cDNA	O	NOUN	B
has	O	AUX	O
an	O	DET	O
open	O	ADJ	B
reading	O	NOUN	I
frame	O	NOUN	I
of	O	ADP	O
900	O	NUM	O
amino	O	NOUN	B
acids	O	NOUN	I
capable	O	ADJ	O
of	O	ADP	O
encoding	O	VERB	B
a	O	DET	O
97	O	NUM	O
-	O	PUNCT	O
kDa	O	NOUN	B
protein	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
gene	O	NOUN	B
encoding	O	VERB	O
TRP	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
2	I-GENE	NUM	B
maps	O	NOUN	B
to	O	PART	O
mouse	O	NOUN	B
chromosome	O	NOUN	I
14	O	NUM	O
,	O	PUNCT	O
in	O	ADP	O
the	O	DET	O
region	O	NOUN	B
of	O	ADP	O
the	O	DET	O
coat	B-GENE	NOUN	B
colour	I-GENE	NOUN	I
mutation	I-GENE	NOUN	B
slaty	I-GENE	NOUN	B
.	O	PUNCT	O


A	O	DET	O
comparison	O	NOUN	B
of	O	ADP	O
the	O	DET	O
amino	O	NOUN	B
acid	O	NOUN	I
sequence	O	NOUN	I
of	O	ADP	O
the	O	DET	O
T	O	NOUN	B
.	O	PUNCT	O
thermophilus	O	ADJ	B
enzyme	O	NOUN	B
with	O	ADP	O
that	O	DET	O
of	O	ADP	O
the	O	DET	O
Escherichia	O	X	B
coli	O	X	I
enzyme	O	NOUN	B
showed	O	VERB	O
(	O	PUNCT	O
i	O	X	O
)	O	PUNCT	O
a	O	DET	O
37	O	NUM	O
%	O	NOUN	O
overall	O	ADJ	O
similarity	O	NOUN	B
;	O	PUNCT	O
(	O	PUNCT	O
ii	O	X	O
)	O	PUNCT	O
the	O	DET	O
conservation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
Ser	O	NOUN	B
residue	O	NOUN	B
,	O	PUNCT	O
which	O	DET	O
is	O	AUX	O
known	O	VERB	O
to	O	PART	O
be	O	AUX	O
phosphorylated	O	VERB	B
in	O	ADP	O
the	O	DET	O
E	O	NOUN	B
.	O	PUNCT	O
coli	O	X	B
enzyme	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
of	O	ADP	O
the	O	DET	O
surrounding	O	VERB	B
sequence	O	NOUN	B
;	O	PUNCT	O
and	O	CCONJ	O
(	O	PUNCT	O
iii	O	X	O
)	O	PUNCT	O
the	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
141	O	NUM	O
extra	O	ADJ	B
residues	O	NOUN	I
at	O	ADP	O
the	O	DET	O
C	O	NOUN	O
terminus	O	NOUN	B
of	O	ADP	O
the	O	DET	O
T	O	NOUN	B
.	O	PUNCT	O
thermophilus	O	ADJ	B
enzyme	O	NOUN	B
.	O	PUNCT	O


Because	O	SCONJ	O
single	O	ADJ	B
-	O	PUNCT	O
chamber	O	NOUN	B
rate	O	NOUN	B
-	O	PUNCT	O
adaptive	O	ADJ	B
atrial	O	ADJ	I
pacing	O	NOUN	I
leaves	O	VERB	I
the	O	DET	O
patient	O	NOUN	B
exposed	O	VERB	B
to	O	ADP	O
the	O	DET	O
risk	O	NOUN	B
of	O	ADP	O
future	O	ADJ	O
development	O	NOUN	B
of	O	ADP	O
AV	O	NOUN	B
block	O	NOUN	I
and	O	CCONJ	O
DDD	O	PROPN	B
pacing	O	NOUN	B
does	O	AUX	O
not	O	PART	O
provide	O	VERB	O
chronotropic	O	ADJ	B
support	O	NOUN	I
,	O	PUNCT	O
it	O	PRON	O
is	O	AUX	O
likely	O	ADJ	O
that	O	SCONJ	O
the	O	DET	O
new	O	ADJ	O
rate	O	NOUN	B
-	O	PUNCT	O
adaptive	O	ADJ	B
dual	O	ADJ	B
-	O	PUNCT	O
chamber	O	NOUN	B
(	O	PUNCT	O
DDDR	O	PROPN	B
)	O	PUNCT	O
devices	O	NOUN	B
will	O	AUX	O
be	O	AUX	O
used	O	VERB	O
in	O	ADP	O
a	O	DET	O
significant	O	ADJ	O
number	O	NOUN	O
of	O	ADP	O
these	O	DET	O
patients	O	NOUN	B
.	O	PUNCT	O
(	O	PUNCT	O
ABSTRACT	O	NOUN	B
TRUNCATED	O	VERB	I
AT	O	ADP	I
250	O	NUM	I
WORDS	O	NOUN	I
)	O	PUNCT	O


When	O	SCONJ	O
transiently	O	ADV	B
transfected	O	VERB	B
into	O	ADP	O
K562	O	NOUN	B
cells	O	NOUN	I
,	O	PUNCT	O
this	O	DET	O
Lg	B-GENE	X	B
genomic	O	ADJ	I
clone	O	NOUN	I
is	O	AUX	O
actively	O	ADV	O
transcribed	O	VERB	B
,	O	PUNCT	O
suggesting	O	VERB	O
that	O	SCONJ	O
,	O	PUNCT	O
although	O	SCONJ	O
it	O	PRON	O
possesses	O	VERB	O
the	O	DET	O
characteristics	O	NOUN	B
of	O	ADP	O
a	O	DET	O
processed	O	VERB	B
pseudogene	O	NOUN	B
,	O	PUNCT	O
it	O	PRON	O
is	O	AUX	O
likely	O	ADJ	O
to	O	PART	O
correspond	O	VERB	O
to	O	PART	O
the	O	DET	O
gene	O	NOUN	B
encoding	O	VERB	B
this	O	DET	O
new	O	ADJ	O
ferritin	B-GENE	NOUN	B
subunit	I-GENE	NOUN	I
.	O	PUNCT	O


The	O	DET	O
p130	B-GENE	NOUN	B
and	O	CCONJ	O
p62	B-GENE	NOUN	B
tyrosine	O	NOUN	B
-	O	PUNCT	O
phosphorylated	O	VERB	B
proteins	O	NOUN	I
that	O	PRON	O
complexed	O	VERB	B
v	B-GENE	X	O
-	I-GENE	PUNCT	O
Src	I-GENE	NOUN	B
SH2	B-GENE	NOUN	B
in	O	X	B
vitro	O	X	I
also	O	ADV	O
associated	O	VERB	B
with	O	ADP	I
v	B-GENE	NOUN	O
-	I-GENE	PUNCT	O
Src	I-GENE	NOUN	B
in	O	ADP	O
v	B-GENE	NOUN	O
-	I-GENE	PUNCT	O
src	I-GENE	NOUN	B
-	O	PUNCT	O
transformed	O	VERB	B
Rat	O	NOUN	B
-	O	PUNCT	O
2	O	NUM	O
cells	O	NOUN	B
;	O	PUNCT	O
this	O	DET	O
in	O	X	B
vivo	O	X	I
binding	O	NOUN	B
was	O	AUX	O
dependent	O	ADJ	B
on	O	ADP	O
the	O	DET	O
v	B-GENE	X	B
-	I-GENE	PUNCT	O
Src	I-GENE	NOUN	B
SH2	B-GENE	NOUN	B
domain	O	NOUN	I
.	O	PUNCT	O


These	O	DET	O
data	O	NOUN	B
support	O	VERB	O
a	O	DET	O
possible	O	ADJ	O
biological	O	ADJ	B
significance	O	NOUN	B
of	O	ADP	O
the	O	DET	O
frameshift	O	NOUN	B
to	O	PART	O
occur	O	VERB	O
at	O	ADP	O
this	O	DET	O
position	O	NOUN	O
of	O	ADP	O
the	O	DET	O
large	O	ADJ	O
overlap	O	NOUN	B
by	O	ADP	O
including	O	VERB	O
the	O	DET	O
putative	O	ADJ	O
RNA	O	NOUN	B
template	O	NOUN	B
-	O	PUNCT	O
binding	O	VERB	B
site	O	NOUN	O
of	O	ADP	O
the	O	DET	O
PLRV	B-GENE	NOUN	B
replicase	I-GENE	NOUN	B
in	O	ADP	O
the	O	DET	O
ORF2a	B-GENE	NOUN	B
/	I-GENE	PUNCT	O
ORF2b	I-GENE	NOUN	B
transframe	I-GENE	NOUN	B
protein	I-GENE	NOUN	I
.	O	PUNCT	O


The	O	DET	O
MET4	B-GENE	NOUN	B
gene	O	NOUN	I
was	O	AUX	O
cloned	O	VERB	B
,	O	PUNCT	O
and	O	CCONJ	O
its	O	PRON	O
sequence	O	NOUN	B
reveals	O	VERB	O
that	O	SCONJ	O
it	O	PRON	O
encodes	O	VERB	B
a	O	DET	O
protein	O	NOUN	B
related	O	ADJ	O
to	O	PART	O
the	O	DET	O
family	O	NOUN	B
of	O	ADP	O
the	O	DET	O
bZIP	B-GENE	NOUN	B
transcriptional	I-GENE	ADJ	O
activators	I-GENE	NOUN	O
.	O	PUNCT	O


It	O	PRON	O
is	O	AUX	O
believed	O	VERB	O
that	O	SCONJ	O
these	O	DET	O
domains	O	NOUN	B
are	O	AUX	O
important	O	ADJ	O
for	O	ADP	O
directing	O	VERB	O
specific	O	ADJ	O
protein	O	NOUN	B
-	O	PUNCT	O
protein	O	NOUN	B
interactions	O	NOUN	B
necessary	O	ADJ	O
for	O	ADP	O
the	O	DET	O
proper	O	ADJ	O
functioning	O	NOUN	B
of	O	ADP	O
Src	B-GENE	NOUN	B
.	O	PUNCT	O


The	O	DET	O
recently	O	ADV	O
developed	O	VERB	O
gamma	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
interferon	I-GENE	NOUN	B
(	O	PUNCT	O
IFN	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
gamma	I-GENE	NOUN	B
)	O	PUNCT	I
assay	O	NOUN	O
system	O	NOUN	O
for	O	ADP	O
the	O	DET	O
diagnosis	O	NOUN	B
of	O	ADP	O
bovine	O	ADJ	B
tuberculosis	O	NOUN	I
in	O	ADP	O
cattle	O	NOUN	B
has	O	AUX	O
been	O	AUX	O
accredited	O	VERB	B
by	O	ADP	O
the	O	DET	O
Standing	O	PROPN	B
Committee	O	PROPN	I
on	O	ADP	O
Agriculture	O	PROPN	B
for	O	ADP	O
use	O	NOUN	O
in	O	ADP	O
Australia	O	PROPN	B
.	O	PUNCT	O


Control	O	PROPN	B
Tmuscle	O	PROPN	B
was	O	AUX	O
35	O	NUM	O
.	O	PUNCT	O
8	O	NUM	O
+	O	CCONJ	O
/	O	SYM	O
-	O	PUNCT	O
0	O	NUM	O
.	O	PUNCT	O
7	O	NUM	O
degrees	O	NOUN	B
C	O	NOUN	I
,	O	PUNCT	O
with	O	ADP	O
control	O	ADJ	B
Wi	O	PROPN	O
,	O	PUNCT	O
max	O	X	O
being	O	AUX	O
51	O	NUM	O
.	O	PUNCT	O
6	O	NUM	O
(	O	PUNCT	O
SD	O	NOUN	B
8	O	NUM	O
.	O	PUNCT	O
7	O	NUM	O
)	O	PUNCT	O
W	O	NOUN	O
.	O	PUNCT	O
kg	O	NOUN	O
-	O	PUNCT	O
1	O	NUM	O
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
other	O	ADJ	O
regions	O	NOUN	B
of	O	ADP	O
the	O	DET	O
plasmid	O	NOUN	B
are	O	AUX	O
also	O	ADV	O
efficiently	O	ADV	O
repaired	O	VERB	B
.	O	PUNCT	O


Thus	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
human	B-GENE	ADJ	B
D1A	I-GENE	NOUN	B
gene	I-GENE	NOUN	I
belongs	O	VERB	O
to	O	PART	O
the	O	DET	O
category	O	NOUN	B
of	O	ADP	O
tissue	O	NOUN	B
-	O	PUNCT	O
specific	O	ADJ	B
,	O	PUNCT	O
regulated	O	VERB	B
genes	O	NOUN	I
that	O	PRON	O
have	O	AUX	O
housekeeping	O	ADJ	B
-	O	PUNCT	O
type	O	NOUN	B
promoters	O	NOUN	B
.	O	PUNCT	O


Computer	O	PROPN	B
-	O	PUNCT	O
aided	O	VERB	B
"	O	PUNCT	O
FRAME	O	NOUN	B
"	O	PUNCT	O
analysis	O	NOUN	B
revealed	O	VERB	O
four	O	NUM	O
possible	O	ADJ	O
open	O	ADJ	B
reading	O	NOUN	I
frames	O	NOUN	I
(	O	PUNCT	O
ORFs	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
three	O	NUM	O
in	O	ADP	O
one	O	NUM	O
direction	O	NOUN	B
and	O	CCONJ	O
one	O	NUM	O
in	O	ADP	O
the	O	DET	O
opposite	O	ADJ	O
direction	O	NOUN	B
.	O	PUNCT	O


Domain	O	NOUN	B
II	O	NUM	I
is	O	AUX	O
highly	O	ADV	O
homologous	O	ADJ	B
to	O	PART	O
the	O	DET	O
LDL	B-GENE	NOUN	B
receptor	I-GENE	NOUN	I
and	O	CCONJ	O
contains	O	VERB	O
four	O	NUM	O
repeats	O	NOUN	B
with	O	ADP	O
perfect	O	ADJ	O
conservation	O	NOUN	B
of	O	ADP	O
all	O	DET	O
6	O	NUM	O
consecutive	O	ADJ	B
cysteines	O	NOUN	B
.	O	PUNCT	O


Here	O	ADV	O
,	O	PUNCT	O
we	O	PRON	O
present	O	VERB	O
evidence	O	NOUN	B
for	O	ADP	O
a	O	DET	O
model	O	NOUN	B
in	O	ADP	O
which	O	DET	O
mRNA	O	NOUN	B
sequences	O	NOUN	I
up	O	ADV	O
to	O	PART	O
around	O	ADV	O
100	O	NUM	O
nucleotides	O	NOUN	B
downstream	O	ADJ	B
from	O	ADP	O
the	O	DET	O
start	O	NOUN	O
codon	O	NOUN	B
of	O	ADP	O
21K	O	NOUN	O
fold	O	ADV	O
back	O	ADV	O
and	O	CCONJ	O
base	O	NOUN	B
-	O	PUNCT	O
pair	O	NOUN	B
to	O	ADP	O
the	O	DET	O
21K	O	NOUN	O
translation	O	NOUN	O
initiation	O	NOUN	O
region	O	NOUN	O
,	O	PUNCT	O
thereby	O	ADV	O
decreasing	O	VERB	B
the	O	DET	O
translation	O	NOUN	B
initiation	O	NOUN	I
frequency	O	NOUN	O
.	O	PUNCT	O


In	O	ADP	O
the	O	DET	O
last	O	ADJ	O
20	O	NUM	O
years	O	NOUN	B
,	O	PUNCT	O
the	O	DET	O
therapeutic	O	ADJ	B
uses	O	NOUN	O
of	O	ADP	O
botulinum	B-GENE	NOUN	B
toxin	I-GENE	NOUN	I
,	O	PUNCT	O
a	O	DET	O
potent	O	ADJ	O
neurotoxin	O	NOUN	B
,	O	PUNCT	O
have	O	AUX	O
been	O	AUX	O
investigated	O	VERB	B
.	O	PUNCT	O


At	O	ADP	O
the	O	DET	O
C	O	NOUN	B
-	O	PUNCT	O
terminus	O	NOUN	B
of	O	ADP	O
the	O	DET	O
protein	O	NOUN	B
is	O	AUX	O
a	O	DET	O
domain	O	NOUN	B
that	O	PRON	O
contains	O	VERB	O
sequences	O	NOUN	B
very	O	ADV	O
similar	O	ADJ	O
to	O	PART	O
those	O	DET	O
found	O	VERB	O
in	O	ADP	O
the	O	DET	O
breakpoint	O	NOUN	B
cluster	O	NOUN	I
region	O	NOUN	I
gene	O	NOUN	B
product	O	NOUN	I
,	O	PUNCT	O
n	B-GENE	NOUN	O
-	I-GENE	PUNCT	O
chimerin	I-GENE	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
rho	B-GENE	ADJ	O
GAP	I-GENE	NOUN	B
,	O	PUNCT	O
all	O	DET	O
of	O	ADP	O
which	O	DET	O
have	O	AUX	O
been	O	AUX	O
shown	O	VERB	O
to	O	PART	O
possess	O	VERB	O
intrinsic	O	ADJ	B
GAP	B-GENE	NOUN	B
activity	O	NOUN	O
on	O	ADP	O
small	B-GENE	ADJ	O
GTPases	I-GENE	NOUN	B
.	O	PUNCT	O


The	O	DET	O
circadian	O	ADJ	B
rhythmicity	O	NOUN	I
of	O	ADP	I
sleep	O	NOUN	I
was	O	AUX	O
pronounced	O	ADJ	O
.	O	PUNCT	O


The	O	DET	O
sequence	O	NOUN	B
data	O	NOUN	B
now	O	ADV	O
permit	O	VERB	O
a	O	DET	O
detailed	O	ADJ	O
interpretation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
X	O	NOUN	B
-	O	PUNCT	O
ray	O	NOUN	B
crystallographic	O	ADJ	I
structure	O	NOUN	I
of	O	ADP	O
the	O	DET	O
enzyme	O	NOUN	B
and	O	CCONJ	O
the	O	DET	O
cloning	O	NOUN	B
and	O	CCONJ	O
expression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
clostridial	O	ADJ	B
gene	O	NOUN	I
will	O	AUX	O
facilitate	O	VERB	O
site	O	NOUN	B
-	O	PUNCT	O
directed	O	VERB	B
mutagenesis	O	NOUN	B
.	O	PUNCT	O


AgMNPV	O	NOUN	B
and	O	CCONJ	O
Orgyia	O	NOUN	B
pseudotsugata	O	NOUN	I
MNPV	O	NOUN	I
(	O	PUNCT	O
OpMNPV	O	NOUN	B
)	O	PUNCT	O
are	O	AUX	O
similar	O	ADJ	O
in	O	ADP	O
terms	O	NOUN	O
of	O	ADP	O
promoter	O	NOUN	B
structure	O	NOUN	I
and	O	CCONJ	O
polyhedrin	B-GENE	NOUN	B
primary	I-GENE	ADJ	O
sequence	I-GENE	NOUN	O
,	O	PUNCT	O
and	O	CCONJ	O
the	O	DET	O
polyhedrin	B-GENE	NOUN	B
gene	I-GENE	NOUN	I
of	O	ADP	O
both	O	DET	O
viruses	O	NOUN	B
is	O	AUX	O
transcribed	O	VERB	B
in	O	ADP	O
the	O	DET	O
anti	O	ADJ	B
-	O	PUNCT	O
clockwise	O	NOUN	B
direction	O	NOUN	B
in	O	ADP	O
relation	O	NOUN	O
to	O	ADP	O
their	O	PRON	O
physical	O	ADJ	B
maps	O	NOUN	I
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
are	O	AUX	O
consistent	O	ADJ	B
with	O	ADP	I
the	O	DET	O
roles	O	NOUN	O
that	O	PRON	O
CCK	B-GENE	NOUN	B
and	O	CCONJ	O
trypsin	B-GENE	NOUN	B
inhibitors	O	NOUN	I
are	O	AUX	O
believed	O	VERB	O
to	O	PART	O
play	O	VERB	O
in	O	ADP	O
the	O	DET	O
negative	O	ADJ	B
feedback	O	NOUN	O
control	O	NOUN	O
of	O	ADP	O
pancreatic	O	ADJ	B
exocrine	O	ADJ	I
function	O	NOUN	I
.	O	PUNCT	O


A	O	DET	O
724	O	NUM	O
-	O	PUNCT	O
bp	O	NOUN	B
segment	O	NOUN	B
of	O	ADP	O
the	O	DET	O
5	O	NUM	O
'	O	PART	O
-	O	PUNCT	O
flanking	O	ADJ	B
region	O	NOUN	I
consisting	O	VERB	O
of	O	ADP	O
the	O	DET	O
proximal	O	ADJ	B
E	O	PROPN	I
-	O	PUNCT	O
box	O	NOUN	B
flanked	O	VERB	I
upstream	O	ADV	O
by	O	ADP	O
a	O	DET	O
mammalian	O	ADJ	B
-	O	PUNCT	O
specific	O	ADJ	B
352	O	NUM	O
-	O	PUNCT	O
bp	O	NOUN	B
region	O	NOUN	B
was	O	AUX	O
sufficient	O	ADJ	O
for	O	ADP	O
maximal	O	ADJ	B
transcriptional	O	ADJ	B
activation	O	NOUN	I
in	O	ADP	O
postconfluent	O	ADJ	B
BC3H1	O	NOUN	B
myoblasts	O	NOUN	B
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
indicate	O	VERB	O
that	O	SCONJ	O
baculovirus	O	NOUN	B
-	O	PUNCT	O
expressed	O	VERB	B
TR	B-GENE	NOUN	B
mediates	O	VERB	O
transcriptional	O	ADJ	B
activation	O	NOUN	I
and	O	CCONJ	O
repression	O	NOUN	B
in	O	ADP	O
a	O	DET	O
promoter	O	NOUN	B
-	O	PUNCT	O
specific	O	ADJ	B
manner	O	NOUN	O
in	O	X	B
vitro	O	X	I
.	O	PUNCT	O


The	O	DET	O
serum	O	NOUN	B
erythropoietin	B-GENE	NOUN	I
(	O	PUNCT	O
EPO	B-GENE	NOUN	B
)	O	PUNCT	O
concentrations	O	NOUN	B
of	O	ADP	O
15	O	NUM	O
male	O	NOUN	B
triathletes	O	NOUN	B
(	O	PUNCT	O
26	O	NUM	O
.	O	PUNCT	O
3	O	NUM	O
U	O	NOUN	O
.	O	PUNCT	O
ml	O	NOUN	O
-	O	PUNCT	O
1	O	NUM	O
)	O	PUNCT	O
were	O	AUX	O
significantly	O	ADV	O
lower	O	ADJ	O
than	O	ADP	O
those	O	DET	O
of	O	ADP	O
45	O	NUM	O
male	O	NOUN	B
distance	O	NOUN	O
runners	O	NOUN	O
(	O	PUNCT	O
31	O	NUM	O
.	O	PUNCT	O
6	O	NUM	O
U	O	NOUN	B
.	O	PUNCT	O
ml	O	NOUN	O
-	O	PUNCT	O
1	O	NUM	O
;	O	PUNCT	O
P	O	NOUN	O
less	O	ADJ	O
than	O	ADP	O
0	O	NUM	O
.	O	PUNCT	O
05	O	NUM	O
)	O	PUNCT	O
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
support	O	VERB	O
the	O	DET	O
diagnostic	O	ADJ	B
validity	O	NOUN	I
of	O	ADP	O
NFPD	O	NOUN	B
in	O	ADP	O
CP	O	PROPN	B
/	O	SYM	O
NCA	O	NOUN	B
patients	O	NOUN	B
,	O	PUNCT	O
because	O	SCONJ	O
such	O	ADJ	O
patients	O	NOUN	B
had	O	AUX	O
a	O	DET	O
family	O	NOUN	B
history	O	NOUN	I
of	O	ADP	O
panic	O	NOUN	B
disorder	O	NOUN	I
similar	O	ADJ	O
to	O	PART	O
patients	O	NOUN	B
with	O	ADP	O
a	O	DET	O
more	O	ADV	O
classical	O	ADJ	O
panic	O	NOUN	B
disorder	O	NOUN	I
presentation	O	NOUN	B
.	O	PUNCT	O


FDA	O	PROPN	B
regulations	O	NOUN	B
for	O	ADP	O
growth	O	NOUN	B
factors	O	NOUN	I
and	O	CCONJ	O
related	O	ADJ	O
products	O	NOUN	B
.	O	PUNCT	O


DESIGN	O	NOUN	O
:	O	PUNCT	O
Serum	O	NOUN	B
aldosterone	O	NOUN	I
and	O	CCONJ	O
plasma	B-GENE	NOUN	B
renin	I-GENE	NOUN	B
activity	O	NOUN	B
were	O	AUX	O
measured	O	VERB	B
supine	O	NOUN	B
prior	O	ADJ	O
to	O	PART	O
and	O	CCONJ	O
60	O	NUM	O
,	O	PUNCT	O
90	O	NUM	O
,	O	PUNCT	O
120	O	NUM	O
minutes	O	NOUN	O
after	O	ADP	O
oral	O	ADJ	B
captopril	O	NOUN	B
,	O	PUNCT	O
25	O	NUM	O
mg	O	NOUN	O
.	O	PUNCT	O


Both	O	DET	O
parents	O	NOUN	B
are	O	AUX	O
clinically	O	ADV	B
normal	O	ADJ	I
and	O	CCONJ	O
unrelated	O	ADJ	B
.	O	PUNCT	O


UF	O	PROPN	B
-	O	PUNCT	O
021	O	NUM	O
ophthalmic	O	ADJ	B
solution	O	NOUN	I
(	O	PUNCT	O
0	O	NUM	O
.	O	PUNCT	O
03	O	NUM	O
to	O	PART	O
0	O	NUM	O
.	O	PUNCT	O
24	O	NUM	O
%	O	NOUN	O
)	O	PUNCT	O
,	O	PUNCT	O
when	O	SCONJ	O
topically	O	ADV	B
applied	O	VERB	O
to	O	ADP	O
the	O	DET	O
eyes	O	NOUN	B
of	O	ADP	O
rabbits	O	NOUN	B
,	O	PUNCT	O
caused	O	VERB	O
dose	O	NOUN	B
-	O	PUNCT	O
dependent	O	ADJ	B
IOP	O	NOUN	B
reduction	O	NOUN	B
(	O	PUNCT	O
2	O	NUM	O
.	O	PUNCT	O
8	O	NUM	O
to	O	PART	O
5	O	NUM	O
.	O	PUNCT	O
2	O	NUM	O
mmHg	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
without	O	ADP	O
transient	O	ADJ	B
IOP	O	NOUN	B
rise	O	NOUN	O
.	O	PUNCT	O


This	O	DET	O
is	O	AUX	O
in	O	ADP	O
contrast	O	NOUN	O
with	O	ADP	O
the	O	DET	O
classical	O	ADJ	O
'	O	PUNCT	O
oxygen	O	NOUN	B
debt	O	NOUN	I
hypothesis	O	NOUN	B
'	O	PUNCT	O
,	O	PUNCT	O
which	O	DET	O
states	O	VERB	B
that	O	SCONJ	O
the	O	DET	O
oxygen	O	NOUN	B
debt	O	NOUN	I
and	O	CCONJ	O
lactate	O	NOUN	B
clearance	O	NOUN	I
are	O	AUX	O
linked	O	VERB	O
.	O	PUNCT	O


In	O	ADP	O
addition	O	NOUN	O
a	O	DET	O
greater	O	ADJ	O
proportion	O	NOUN	B
of	O	ADP	O
women	O	NOUN	B
in	O	ADP	O
the	O	DET	O
sweeping	O	VERB	B
group	O	NOUN	I
had	O	AUX	O
a	O	DET	O
cervical	O	ADJ	B
dilatation	O	NOUN	I
of	O	ADP	O
4	O	NUM	O
cm	O	NOUN	O
or	O	CCONJ	O
more	O	ADJ	O
at	O	ADP	O
the	O	DET	O
first	O	ADJ	O
vaginal	O	ADJ	B
examination	O	NOUN	I
in	O	ADP	O
the	O	DET	O
labour	O	ADJ	B
ward	O	NOUN	I
(	O	PUNCT	O
16	O	NUM	O
/	O	SYM	O
33	O	NUM	O
(	O	PUNCT	O
49	O	NUM	O
%	O	NOUN	O
)	O	PUNCT	O
vs	O	CCONJ	O
5	O	NUM	O
/	O	SYM	O
32	O	NUM	O
(	O	PUNCT	O
16	O	NUM	O
%	O	NOUN	O
)	O	PUNCT	O
;	O	PUNCT	O
OR	O	CCONJ	B
4	O	NUM	O
.	O	PUNCT	O
39	O	NUM	O
;	O	PUNCT	O
95	O	NUM	O
%	O	NOUN	O
CI	O	NOUN	B
1	O	NUM	O
.	O	PUNCT	O
56	O	NUM	O
to	O	PART	O
12	O	NUM	O
.	O	PUNCT	O
32	O	NUM	O
;	O	PUNCT	O
P	O	NOUN	O
=	O	ADJ	O
0	O	NUM	O
.	O	PUNCT	O
005	O	NUM	O
)	O	PUNCT	O
.	O	PUNCT	O


A	O	DET	O
control	O	NOUN	B
group	O	NOUN	I
of	O	ADP	O
nine	O	NUM	O
women	O	NOUN	B
(	O	PUNCT	O
age	O	NOUN	B
23	O	NUM	O
-	O	SYM	O
40	O	NUM	O
years	O	NOUN	B
)	O	PUNCT	O
on	O	ADP	O
oral	O	ADJ	B
contraceptives	O	NOUN	I
(	O	PUNCT	O
Nordette	O	PROPN	B
-	O	PUNCT	O
28	O	NUM	O
)	O	PUNCT	O
was	O	AUX	O
also	O	ADV	O
studied	O	VERB	O
four	O	NUM	O
times	O	NOUN	O
during	O	ADP	O
a	O	DET	O
pill	O	NOUN	B
cycle	O	NOUN	I
.	O	PUNCT	O


Patients	O	NOUN	B
with	O	ADP	O
an	O	DET	O
enzymatic	O	ADJ	B
activity	O	NOUN	I
below	O	ADP	O
X	O	NOUN	B
-	O	PUNCT	O
-	O	PUNCT	O
1	O	NUM	O
manifested	O	VERB	O
a	O	DET	O
decrease	O	NOUN	B
of	O	ADP	O
the	O	DET	O
content	O	NOUN	B
of	O	ADP	O
IgA	B-GENE	NOUN	B
,	O	PUNCT	O
IgG	B-GENE	NOUN	B
,	O	PUNCT	O
IgM	B-GENE	NOUN	B
,	O	PUNCT	O
T	O	NOUN	B
and	O	CCONJ	O
B	O	NOUN	B
lymphocytes	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
of	O	ADP	O
phagocytic	O	ADJ	B
activity	O	NOUN	B
of	O	ADP	O
neutrophils	O	NOUN	B
as	O	ADP	O
compared	O	VERB	O
to	O	PART	O
patients	O	NOUN	B
exhibiting	O	VERB	O
a	O	DET	O
high	O	ADJ	O
enzymatic	O	ADJ	B
activity	O	NOUN	O
.	O	PUNCT	O


The	O	DET	O
relation	O	NOUN	O
between	O	ADP	O
myocardial	B-GENE	ADJ	B
beta	I-GENE	NOUN	I
-	I-GENE	PUNCT	O
adrenergic	I-GENE	ADJ	B
receptor	I-GENE	NOUN	I
and	O	CCONJ	O
left	O	VERB	B
ventricular	O	ADJ	I
(	O	PUNCT	I
LV	O	NOUN	O
)	O	PUNCT	O
function	O	NOUN	O
was	O	AUX	O
studied	O	VERB	O
in	O	ADP	O
10	O	NUM	O
patients	O	NOUN	B
,	O	PUNCT	O
aged	O	ADJ	B
41	O	NUM	O
to	O	PART	O
61	O	NUM	O
years	O	NOUN	B
(	O	PUNCT	O
average	O	NOUN	B
51	O	NUM	O
)	O	PUNCT	O
,	O	PUNCT	O
with	O	ADP	O
LV	O	NOUN	B
volume	O	NOUN	I
overload	O	NOUN	I
mainly	O	ADV	O
due	O	ADJ	O
to	O	PART	O
chronic	O	ADJ	B
mitral	O	ADJ	I
regurgitation	O	NOUN	I
.	O	PUNCT	O


axl	O	NOUN	B
,	O	PUNCT	O
a	O	DET	O
transforming	O	VERB	B
gene	O	NOUN	I
isolated	O	VERB	B
from	O	ADP	O
primary	O	ADJ	O
human	O	ADJ	B
myeloid	O	ADJ	O
leukemia	O	NOUN	O
cells	O	NOUN	B
,	O	PUNCT	O
encodes	O	VERB	B
a	O	DET	O
novel	O	ADJ	O
receptor	B-GENE	NOUN	B
tyrosine	I-GENE	NOUN	I
kinase	I-GENE	NOUN	I
.	O	PUNCT	O


The	O	DET	O
single	O	ADJ	O
most	O	ADV	O
important	O	ADJ	O
element	O	NOUN	B
,	O	PUNCT	O
by	O	ADP	O
linker	O	NOUN	B
-	O	PUNCT	O
scanning	O	NOUN	B
analysis	O	NOUN	O
,	O	PUNCT	O
is	O	AUX	O
a	O	DET	O
10	O	NUM	O
-	O	PUNCT	O
bp	O	NOUN	B
region	O	NOUN	O
that	O	PRON	O
contains	O	VERB	O
a	O	DET	O
CCAAT	O	NOUN	B
motif	O	NOUN	B
.	O	PUNCT	O


Capnography	O	NOUN	B
curves	O	NOUN	O
of	O	ADP	O
40	O	NUM	O
HVS	O	NOUN	B
patients	O	NOUN	B
,	O	PUNCT	O
40	O	NUM	O
non	O	NOUN	B
-	O	PUNCT	O
HVS	O	NOUN	B
patients	O	NOUN	B
with	O	ADP	O
psycho	O	NOUN	B
-	O	PUNCT	O
somatic	O	ADJ	B
complaints	O	NOUN	B
and	O	CCONJ	O
26	O	NUM	O
healthy	O	ADJ	B
controls	O	NOUN	I
were	O	AUX	O
analyzed	O	VERB	B
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
alterations	O	NOUN	B
in	O	ADP	O
electrostatic	O	ADJ	B
and	O	CCONJ	O
hydrophobic	O	ADJ	B
interactions	O	NOUN	B
created	O	VERB	O
by	O	ADP	O
the	O	DET	O
three	O	NUM	O
amino	O	NOUN	B
acid	O	NOUN	I
substitutions	O	NOUN	I
prevent	O	VERB	B
the	O	DET	O
conformational	O	ADJ	B
change	O	NOUN	I
in	O	ADP	O
the	O	DET	O
enzyme	O	NOUN	B
usually	O	ADV	O
produced	O	VERB	O
by	O	ADP	O
calmodulin	B-GENE	NOUN	B
binding	O	NOUN	I
.	O	PUNCT	O


Transfer	O	NOUN	O
RNA	O	NOUN	B
genes	O	NOUN	I
from	O	ADP	O
Dictyostelium	O	NOUN	B
discoideum	O	NOUN	I
are	O	AUX	O
frequently	O	ADV	O
associated	O	VERB	B
with	O	ADP	I
repetitive	O	ADJ	B
elements	O	NOUN	I
and	O	CCONJ	O
contain	O	VERB	O
consensus	O	NOUN	B
boxes	O	NOUN	I
in	O	ADP	O
their	O	PRON	O
5	O	NUM	O
'	O	PUNCT	O
and	O	CCONJ	O
3	O	NUM	O
'	O	PART	O
-	O	PUNCT	O
flanking	O	ADJ	B
regions	O	NOUN	O
.	O	PUNCT	O


Histamine	O	NOUN	B
-	O	PUNCT	O
2	O	NUM	O
blockade	O	NOUN	B
in	O	ADP	O
psoriasis	O	NOUN	B


A	O	DET	O
third	O	NOUN	O
is	O	AUX	O
a	O	DET	O
partial	O	ADJ	B
element	O	NOUN	B
terminating	O	VERB	O
at	O	ADP	O
a	O	DET	O
probable	O	ADJ	O
internal	O	ADJ	B
restriction	O	NOUN	I
site	O	NOUN	I
used	O	VERB	O
for	O	ADP	O
cloning	O	NOUN	B
.	O	PUNCT	O


No	O	DET	O
such	O	ADJ	O
benefits	O	NOUN	B
were	O	AUX	O
seen	O	VERB	O
for	O	ADP	O
children	O	NOUN	B
with	O	ADP	O
CD4	B-GENE	NOUN	B
+	I-GENE	CCONJ	O
counts	O	NOUN	B
below	O	ADP	O
0	O	NUM	O
.	O	PUNCT	O
2	O	NUM	O
x	O	NOUN	O
10	O	NUM	O
(	O	PUNCT	O
9	O	NUM	O
)	O	PUNCT	O
per	O	ADP	O
liter	O	NOUN	O
at	O	ADP	O
entry	O	NOUN	B
.	O	PUNCT	O


Because	O	SCONJ	O
the	O	DET	O
human	B-GENE	ADJ	B
Antp	I-GENE	NOUN	O
TATAA	I-GENE	NOUN	O
binding	I-GENE	NOUN	O
protein	I-GENE	NOUN	O
is	O	AUX	O
expressed	O	VERB	B
in	O	ADP	O
both	O	CCONJ	O
lymphoid	O	ADJ	B
and	O	CCONJ	O
non	O	ADJ	B
-	O	PUNCT	O
lymphoid	O	ADJ	B
cells	O	NOUN	O
,	O	PUNCT	O
we	O	PRON	O
suggest	O	VERB	O
that	O	SCONJ	O
this	O	DET	O
homeobox	B-GENE	NOUN	B
gene	I-GENE	NOUN	I
has	O	AUX	O
evolved	O	VERB	O
a	O	DET	O
more	O	ADV	O
general	O	ADJ	O
transcriptional	O	ADJ	B
regulatory	O	ADJ	O
function	O	NOUN	O
in	O	ADP	O
higher	O	ADJ	O
eukaryotic	O	ADJ	B
cells	O	NOUN	I
.	O	PUNCT	O


Venkatesan	O	PROPN	B
,	O	PUNCT	O
and	O	CCONJ	O
D	O	NOUN	B
.	O	PUNCT	O


Stable	O	ADJ	B
expression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
chimeric	O	ADJ	B
alpha	B-GENE	NOUN	I
i	I-GENE	NUM	I
(	I-GENE	PUNCT	O
54	I-GENE	NUM	O
)	I-GENE	PUNCT	O
/	I-GENE	PUNCT	O
s	I-GENE	NOUN	O
polypeptide	O	NOUN	B
in	O	ADP	O
Chinese	O	ADJ	B
hamster	O	NOUN	I
ovary	O	NOUN	I
(	O	PUNCT	O
CHO	O	NOUN	B
)	O	PUNCT	O
cells	O	NOUN	B
constitutively	O	ADV	B
increased	O	VERB	B
both	O	CCONJ	O
cAMP	O	NOUN	B
synthesis	O	NOUN	I
and	O	CCONJ	O
cAMP	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
dependent	I-GENE	ADJ	B
protein	I-GENE	NOUN	B
kinase	I-GENE	NOUN	I
activity	O	NOUN	O
.	O	PUNCT	O


Surprisingly	O	ADV	O
,	O	PUNCT	O
there	O	PRON	O
is	O	AUX	O
no	O	DET	O
sequence	O	NOUN	O
homology	O	NOUN	B
between	O	ADP	O
this	O	DET	O
region	O	NOUN	B
of	O	ADP	O
Ly	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
6E	I-GENE	PROPN	B
and	O	CCONJ	O
the	O	DET	O
established	O	ADJ	O
consensus	O	NOUN	B
for	O	ADP	O
the	O	DET	O
interferon	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
stimulated	I-GENE	VERB	B
response	I-GENE	NOUN	B
element	I-GENE	NOUN	I
,	O	PUNCT	O
which	O	DET	O
has	O	AUX	O
been	O	AUX	O
shown	O	VERB	O
functionally	O	ADV	O
important	O	ADJ	O
to	O	PART	O
all	O	DET	O
previously	O	ADV	O
characterized	O	VERB	B
alpha	B-GENE	NOUN	B
/	I-GENE	PUNCT	O
beta	I-GENE	NOUN	B
interferon	I-GENE	NOUN	I
-	O	PUNCT	O
inducible	O	ADJ	B
promoters	O	NOUN	B
.	O	PUNCT	O


Relatively	O	ADV	O
large	O	ADJ	O
DNA	O	NOUN	B
rearrangements	O	NOUN	I
spanning	O	VERB	O
the	O	DET	O
region	O	NOUN	B
with	O	ADP	O
tandem	O	ADJ	B
direct	O	ADJ	I
repeats	O	NOUN	I
encoding	O	VERB	B
the	O	DET	O
carboxy	O	NOUN	B
-	O	PUNCT	O
terminal	O	ADJ	B
histone	B-GENE	NOUN	B
H1	I-GENE	NOUN	I
-	I-GENE	PUNCT	O
like	I-GENE	ADJ	B
structure	O	NOUN	B
of	O	ADP	O
AlgP	B-GENE	NOUN	B
were	O	AUX	O
detected	O	VERB	B
in	O	ADP	O
several	O	ADJ	O
strains	O	NOUN	B
upon	O	SCONJ	O
conversion	O	NOUN	B
from	O	ADP	O
the	O	DET	O
mucoid	O	NOUN	B
to	O	PART	O
the	O	DET	O
nonmucoid	O	X	B
phenotype	O	NOUN	B
.	O	PUNCT	O


It	O	PRON	O
is	O	AUX	O
,	O	PUNCT	O
however	O	ADV	O
,	O	PUNCT	O
extremely	O	ADV	O
homologous	O	ADJ	B
to	O	PART	O
a	O	DET	O
third	O	ADJ	O
'	O	PUNCT	O
non	O	ADJ	B
-	O	PUNCT	O
classical	O	ADJ	B
'	O	PUNCT	O
gene	O	NOUN	B
,	O	PUNCT	O
HLA	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
5	I-GENE	NUM	O
.	I-GENE	PUNCT	O
4	I-GENE	NUM	O
,	O	PUNCT	O
and	O	CCONJ	O
to	O	PART	O
the	O	DET	O
chimpanzee	O	NOUN	B
gene	O	NOUN	I
,	O	PUNCT	O
Ch28	B-GENE	NOUN	B
.	O	PUNCT	O


Although	O	SCONJ	O
the	O	DET	O
N13	O	NOUN	B
-	O	PUNCT	O
N20	O	NOUN	B
interpeak	O	ADJ	B
interval	O	NOUN	I
remained	O	VERB	O
stable	O	ADJ	B
because	O	SCONJ	O
of	O	ADP	O
the	O	DET	O
parallel	O	ADJ	O
shift	O	NOUN	B
of	O	ADP	O
the	O	DET	O
2	O	NUM	O
peaks	O	NOUN	B
,	O	PUNCT	O
the	O	DET	O
central	O	ADJ	B
conduction	O	NOUN	I
time	O	NOUN	I
measured	O	VERB	O
from	O	ADP	O
onset	O	NOUN	O
latencies	O	NOUN	B
of	O	ADP	O
N11	O	NOUN	B
and	O	CCONJ	O
N20	O	NOUN	B
significantly	O	ADV	O
increased	O	VERB	B
.	O	PUNCT	O


Isolation	O	NOUN	B
and	O	CCONJ	O
characterization	O	NOUN	B
of	O	ADP	O
the	O	DET	O
rat	O	NOUN	B
chromosomal	O	ADJ	B
gene	O	NOUN	I
for	O	ADP	O
a	O	DET	O
polypeptide	O	NOUN	B
(	O	PUNCT	O
pS1	B-GENE	NOUN	B
)	O	PUNCT	O
antigenically	O	ADV	B
related	O	ADJ	O
to	O	PART	O
statin	B-GENE	NOUN	B
.	O	PUNCT	O


Chem	O	PROPN	O
.	O	PUNCT	O


This	O	DET	O
report	O	NOUN	O
substantiates	O	VERB	O
that	O	SCONJ	O
at	O	ADP	O
least	O	ADJ	O
two	O	NUM	O
of	O	ADP	O
the	O	DET	O
18	O	NUM	O
kDa	O	NOUN	O
hsps	B-GENE	NOUN	B
in	O	ADP	O
maize	O	NOUN	B
are	O	AUX	O
products	O	NOUN	B
of	O	ADP	O
different	O	ADJ	B
but	O	CCONJ	O
related	O	ADJ	O
genes	O	NOUN	B
.	O	PUNCT	O


Finally	O	ADV	O
,	O	PUNCT	O
some	O	DET	O
point	O	NOUN	O
mutations	O	NOUN	B
in	O	ADP	O
the	O	DET	O
Gag	B-GENE	NOUN	B
-	O	PUNCT	O
Pol	B-GENE	NOUN	B
PR	O	NOUN	B
domain	O	NOUN	B
inhibited	O	VERB	B
activation	O	NOUN	B
of	O	ADP	O
RT	B-GENE	NOUN	B
in	O	ADP	O
trans	O	NOUN	O
by	O	ADP	O
a	O	DET	O
wild	O	ADJ	B
-	O	PUNCT	O
type	O	NOUN	B
PR	B-GENE	NOUN	B
,	O	PUNCT	O
suggesting	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
correct	O	ADJ	B
conformation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
PR	B-GENE	NOUN	B
domain	O	NOUN	B
in	O	ADP	O
Gag	B-GENE	NOUN	B
-	O	PUNCT	O
Pol	B-GENE	PROPN	B
is	O	AUX	O
prerequisite	O	ADJ	O
for	O	ADP	O
activation	O	NOUN	B
of	O	ADP	O
RT	B-GENE	NOUN	B
.	O	PUNCT	O


Cloning	O	NOUN	B
of	O	ADP	O
a	O	DET	O
human	O	ADJ	B
cDNA	O	NOUN	B
encoding	O	VERB	B
a	O	DET	O
CDC2	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
related	I-GENE	VERB	B
kinase	I-GENE	NOUN	B
by	O	ADP	O
complementation	O	NOUN	B
of	O	ADP	O
a	O	DET	O
budding	B-GENE	ADJ	B
yeast	I-GENE	NOUN	B
cdc28	I-GENE	NOUN	B
mutation	O	NOUN	B
.	O	PUNCT	O


E	O	NOUN	B
.	O	PUNCT	O
,	O	PUNCT	O
Hession	O	PROPN	B
,	O	PUNCT	O
C	O	PROPN	B
.	O	PUNCT	O
,	O	PUNCT	O
Goff	O	PROPN	B
,	O	PUNCT	O
D	O	NOUN	B
.	O	PUNCT	O
,	O	PUNCT	O
Griffiths	O	PROPN	B
,	O	PUNCT	O
B	O	NOUN	B
.	O	PUNCT	O
,	O	PUNCT	O
Tizard	O	PROPN	B
,	O	PUNCT	O
R	O	PROPN	B
.	O	PUNCT	O
,	O	PUNCT	O
Newman	O	PROPN	B
,	O	PUNCT	O
B	O	NOUN	B
.	O	PUNCT	O
,	O	PUNCT	O
Chi	O	PROPN	B
-	O	PUNCT	O
Rosso	O	PROPN	B
,	O	PUNCT	O
G	O	NOUN	B
.	O	PUNCT	O
,	O	PUNCT	O
and	O	CCONJ	O
Lobb	O	PROPN	B
,	O	PUNCT	O
R	O	PROPN	B
.	O	PUNCT	O
,	O	PUNCT	O
(	O	PUNCT	O
1990	O	NUM	O
)	O	PUNCT	O
Cell	O	NOUN	O
63	O	NUM	O
,	O	PUNCT	O
1349	O	NUM	O
-	O	SYM	O
1356	O	NUM	O
)	O	PUNCT	O
.	O	PUNCT	O


The	O	DET	O
above	O	ADJ	O
results	O	NOUN	B
mean	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
increase	O	NOUN	B
in	O	ADP	O
alpha	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
adrenergic	I-GENE	ADJ	B
receptors	I-GENE	NOUN	I
makes	O	VERB	O
the	O	DET	O
prostate	O	NOUN	B
,	O	PUNCT	O
which	O	DET	O
has	O	AUX	O
been	O	AUX	O
already	O	ADV	O
hypertrophied	O	VERB	B
,	O	PUNCT	O
less	O	ADV	O
elastic	O	ADJ	B
,	O	PUNCT	O
inhibiting	O	VERB	B
external	O	ADJ	B
urinary	O	ADJ	B
sphincter	O	NOUN	O
function	O	NOUN	O
.	O	PUNCT	O


An	O	DET	O
approximately	O	ADV	B
2	B-GENE	NUM	O
-	I-GENE	PUNCT	O
kilobase	I-GENE	NOUN	B
B2	I-GENE	NOUN	I
transcript	I-GENE	NOUN	B
was	O	AUX	O
expressed	O	VERB	B
in	O	ADP	O
all	O	DET	O
alfalfa	O	NOUN	B
organs	O	NOUN	B
tested	O	VERB	B
.	O	PUNCT	O


In	O	ADP	O
some	O	DET	O
early	O	ADJ	O
B	O	NOUN	B
cells	O	NOUN	I
and	O	CCONJ	O
Abelson	O	NOUN	B
murine	O	ADJ	I
leukemia	O	NOUN	I
virus	O	NOUN	B
-	O	PUNCT	O
transformed	O	VERB	B
pre	O	NOUN	B
-	O	PUNCT	O
B	O	NOUN	B
-	O	PUNCT	O
cell	O	NOUN	B
lines	O	NOUN	I
,	O	PUNCT	O
LT	B-GENE	NOUN	B
mRNA	I-GENE	NOUN	B
is	O	AUX	O
constitutively	O	ADV	B
expressed	O	VERB	B
.	O	PUNCT	O


Testosterone	O	NOUN	B
,	O	PUNCT	O
free	O	ADJ	B
testosterone	O	NOUN	I
,	O	PUNCT	O
non	B-GENE	ADJ	B
-	I-GENE	PUNCT	O
sex	I-GENE	NOUN	B
hormone	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
binding	I-GENE	VERB	B
globulin	I-GENE	NOUN	I
-	O	PUNCT	O
bound	O	VERB	B
testosterone	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
free	O	ADJ	B
androgen	O	NOUN	I
index	O	NOUN	I
:	O	PUNCT	O
which	O	DET	O
testosterone	O	NOUN	B
measurement	O	NOUN	B
is	O	AUX	O
most	O	ADV	O
relevant	O	ADJ	B
to	O	ADP	O
reproductive	O	ADJ	B
and	O	CCONJ	O
sexual	O	ADJ	B
function	O	NOUN	I
in	O	ADP	O
men	O	NOUN	B
with	O	ADP	O
epilepsy	O	NOUN	B
?	O	PUNCT	O


One	O	NUM	O
patients	O	NOUN	B
had	O	AUX	O
plasma	B-GENE	NOUN	B
C	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
peptide	I-GENE	NOUN	B
greater	O	ADJ	O
than	O	ADP	O
3	O	NUM	O
pM	O	NOUN	B
and	O	CCONJ	O
was	O	AUX	O
therefore	O	ADV	O
excluded	O	VERB	O
from	O	ADP	O
analysis	O	NOUN	B
.	O	PUNCT	O


Complex	O	NOUN	B
repetitive	O	ADJ	B
discharges	O	NOUN	I
were	O	AUX	O
observed	O	VERB	O
in	O	ADP	O
muscles	O	NOUN	B
of	O	ADP	O
mdx	O	NOUN	B
mice	O	NOUN	I
but	O	CCONJ	O
no	O	DET	O
complex	O	ADJ	O
repetitive	O	ADJ	B
discharges	O	NOUN	I
or	O	CCONJ	O
other	O	ADJ	O
abnormalities	O	NOUN	B
were	O	AUX	O
observed	O	VERB	O
in	O	ADP	O
muscles	O	NOUN	B
of	O	ADP	O
normal	O	ADJ	O
control	O	NOUN	O
mice	O	NOUN	O
.	O	PUNCT	O


W	O	NOUN	O
.	O	PUNCT	O
G	O	NOUN	B
.	O	PUNCT	O


A	O	DET	O
mouse	B-GENE	NOUN	B
brain	I-GENE	NOUN	B
beta	I-GENE	NOUN	I
-	I-GENE	PUNCT	O
spectrin	I-GENE	NOUN	B
of	O	ADP	O
cDNA	O	NOUN	B
was	O	AUX	O
identified	O	VERB	B
within	O	ADP	O
a	O	DET	O
lambda	O	NOUN	B
Gt11	O	NOUN	B
expression	O	NOUN	I
library	O	NOUN	I
using	O	VERB	O
an	O	DET	O
antibody	O	NOUN	B
which	O	DET	O
specifically	O	ADV	O
binds	O	VERB	B
with	O	ADP	O
the	O	DET	O
235	B-GENE	NUM	O
kDa	I-GENE	NOUN	O
spectrin	I-GENE	NOUN	B
beta	I-GENE	NOUN	I
-	I-GENE	PUNCT	O
subunit	I-GENE	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
obtained	O	VERB	O
quantitative	O	ADJ	B
evidence	O	NOUN	B
on	O	ADP	O
the	O	DET	O
coding	O	NOUN	B
of	O	ADP	O
interaural	O	ADJ	B
time	O	NOUN	I
differences	O	NOUN	I
(	O	PUNCT	O
ITDs	O	NOUN	B
)	O	PUNCT	O
of	O	ADP	O
click	O	NOUN	B
stimuli	O	NOUN	I
by	O	ADP	O
40	O	NUM	O
single	O	ADJ	O
neurons	O	NOUN	B
in	O	ADP	O
the	O	DET	O
auditory	O	ADJ	B
cortex	O	NOUN	I
of	O	ADP	O
anesthetized	O	VERB	B
albino	O	ADJ	B
rats	O	NOUN	I
.	O	PUNCT	O


Pulmonary	O	ADJ	B
hypertension	O	NOUN	I
,	O	PUNCT	O
with	O	ADP	O
or	O	CCONJ	O
without	O	ADP	O
coronary	O	ADJ	B
arterial	O	ADJ	I
narrowing	O	NOUN	I
,	O	PUNCT	O
is	O	AUX	O
the	O	DET	O
major	O	ADJ	O
condition	O	NOUN	B
leading	O	VERB	O
to	O	PART	O
isolated	O	VERB	B
atrial	O	ADJ	B
infarction	O	NOUN	I
.	O	PUNCT	O


Diltiazem	O	NOUN	B
decreased	O	VERB	B
the	O	DET	O
total	O	ADJ	B
body	O	NOUN	I
clearance	O	NOUN	I
from	O	ADP	O
34	O	NUM	O
.	O	PUNCT	O
0	O	NUM	O
+	O	CCONJ	O
/	O	SYM	O
-	O	PUNCT	O
8	O	NUM	O
.	O	PUNCT	O
0	O	NUM	O
to	O	PART	O
28	O	NUM	O
.	O	PUNCT	O
6	O	NUM	O
+	O	CCONJ	O
/	O	SYM	O
-	O	PUNCT	O
6	O	NUM	O
.	O	PUNCT	O
1	O	NUM	O
mL	O	NOUN	O
/	O	PUNCT	O
min	O	NOUN	B
(	O	PUNCT	O
P	O	NOUN	O
less	O	ADJ	O
than	O	ADP	O
.	O	PUNCT	O
01	O	NUM	O
)	O	PUNCT	O
,	O	PUNCT	O
and	O	CCONJ	O
prolonged	O	VERB	B
the	O	DET	O
elimination	O	NOUN	B
half	O	NOUN	B
-	O	PUNCT	O
life	O	NOUN	B
from	O	ADP	O
12	O	NUM	O
.	O	PUNCT	O
6	O	NUM	O
+	O	CCONJ	O
/	O	SYM	O
-	O	PUNCT	O
3	O	NUM	O
.	O	PUNCT	O
0	O	NUM	O
to	O	PART	O
14	O	NUM	O
.	O	PUNCT	O
3	O	NUM	O
+	O	CCONJ	O
/	O	SYM	O
-	O	PUNCT	O
2	O	NUM	O
.	O	PUNCT	O
5	O	NUM	O
hours	O	NOUN	B
(	O	PUNCT	O
P	O	NOUN	O
less	O	ADJ	O
than	O	ADP	O
.	O	PUNCT	O
01	O	NUM	O
)	O	PUNCT	O
of	O	ADP	O
antipyrine	O	NOUN	B
without	O	ADP	O
any	O	DET	O
changes	O	NOUN	B
in	O	ADP	O
volume	O	NOUN	B
of	O	ADP	O
distribution	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
model	O	NOUN	B
is	O	AUX	O
able	O	ADJ	O
to	O	PART	O
anticipate	O	VERB	O
why	O	SCONJ	O
the	O	DET	O
effect	O	NOUN	B
of	O	ADP	O
water	O	NOUN	B
fluoridation	O	NOUN	B
on	O	ADP	O
caries	O	NOUN	B
prevalence	O	NOUN	B
is	O	AUX	O
most	O	ADV	O
pronounced	O	ADJ	O
when	O	SCONJ	O
caries	O	NOUN	B
is	O	AUX	O
diagnosed	O	VERB	B
at	O	ADP	O
cavity	O	NOUN	B
level	O	NOUN	B
.	O	PUNCT	O


An	O	DET	O
8	O	NUM	O
-	O	PUNCT	O
h	O	NOUN	B
exposure	O	NOUN	B
to	O	PART	I
10	O	NUM	O
mg	O	NOUN	O
DMEA	O	PROPN	B
/	O	PUNCT	O
m3	O	PROPN	B
corresponds	O	VERB	O
to	O	PART	O
a	O	DET	O
postexposure	O	ADJ	B
plasma	O	NOUN	B
concentration	O	NOUN	B
and	O	CCONJ	O
2	O	NUM	O
-	O	PUNCT	O
h	O	NOUN	O
postexposure	O	ADJ	B
urinary	O	ADJ	B
excretion	O	NOUN	B
of	O	ADP	O
4	O	NUM	O
.	O	PUNCT	O
9	O	NUM	O
mumol	O	NOUN	B
/	O	SYM	O
l	O	NOUN	O
and	O	CCONJ	O
75	O	NUM	O
mmol	O	NOUN	O
/	O	SYM	O
mol	O	NOUN	B
creatinine	O	NOUN	I
,	O	PUNCT	O
respectively	O	ADV	O
.	O	PUNCT	O


Marked	O	ADJ	O
thrombocytopenia	O	NOUN	B
,	O	PUNCT	O
depletion	O	NOUN	B
of	O	ADP	O
serum	B-GENE	NOUN	B
fibrinogen	I-GENE	NOUN	I
and	O	CCONJ	O
prolonged	O	ADJ	B
prothrombin	B-GENE	NOUN	B
and	O	CCONJ	O
activated	O	VERB	B
partial	O	ADJ	I
thromboplastin	B-GENE	NOUN	I
time	O	NOUN	I
,	O	PUNCT	O
were	O	AUX	O
recorded	O	VERB	O
at	O	ADP	O
5	O	NUM	O
to	O	PART	O
10	O	NUM	O
and	O	CCONJ	O
30	O	NUM	O
to	O	PART	O
40	O	NUM	O
minutes	O	NOUN	B
after	O	ADP	O
intravenous	O	ADJ	B
envenomation	O	NOUN	I
.	O	PUNCT	O


Auditory	O	ADJ	B
threshold	O	NOUN	O
shifts	O	NOUN	B
,	O	PUNCT	O
as	O	ADP	O
measured	O	VERB	B
by	O	ADP	O
the	O	DET	O
auditory	O	ADJ	B
evoked	O	VERB	O
brainstem	O	NOUN	B
response	O	NOUN	I
,	O	PUNCT	O
were	O	AUX	O
measured	O	VERB	B
at	O	ADP	O
2	O	NUM	O
,	O	PUNCT	O
4	O	NUM	O
,	O	PUNCT	O
8	O	NUM	O
,	O	PUNCT	O
12	O	NUM	O
,	O	PUNCT	O
16	O	NUM	O
,	O	PUNCT	O
20	O	NUM	O
and	O	CCONJ	O
24	O	NUM	O
kHz	O	NOUN	O
.	O	PUNCT	O


Interspecific	O	ADJ	B
backcross	O	NOUN	O
analysis	O	NOUN	O
using	O	VERB	O
progeny	O	NOUN	B
derived	O	VERB	O
from	O	ADP	O
matings	O	NOUN	B
of	O	ADP	O
(	O	PUNCT	O
C57BL	O	NOUN	B
/	O	SYM	O
6J	O	NOUN	B
x	O	CCONJ	O
Mus	O	NOUN	B
spretus	O	NOUN	I
)	O	PUNCT	O
F1	O	NOUN	B
x	O	NOUN	O
C57BL	O	NOUN	B
/	O	SYM	O
6J	O	NOUN	B
mice	O	NOUN	B
indicates	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
thrombospondin	B-GENE	NOUN	B
gene	I-GENE	NOUN	I
is	O	AUX	O
tightly	O	ADV	O
linked	O	VERB	O
to	O	PART	O
the	O	DET	O
Fshb	B-GENE	NOUN	B
,	O	PUNCT	O
Actcl	B-GENE	PROPN	B
,	O	PUNCT	O
Ltk	B-GENE	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
B2M	B-GENE	NOUN	B
loci	I-GENE	NOUN	I
on	O	ADP	O
murine	O	ADJ	B
chromosome	O	NOUN	B
2	O	NUM	I
.	O	PUNCT	O


If	O	SCONJ	O
delay	O	NOUN	B
has	O	AUX	O
occurred	O	VERB	O
between	O	ADP	O
centrifugation	O	NOUN	B
and	O	CCONJ	O
the	O	DET	O
measurement	O	NOUN	B
,	O	PUNCT	O
causing	O	VERB	O
substantial	O	ADJ	O
loss	O	NOUN	O
of	O	ADP	O
CO2	O	NOUN	B
,	O	PUNCT	O
equilibration	O	NOUN	B
of	O	ADP	O
the	O	DET	O
sample	O	NOUN	B
with	O	ADP	O
a	O	DET	O
gas	O	NOUN	B
mixture	O	NOUN	I
corresponding	O	VERB	O
to	O	PART	O
PCO2	O	NOUN	B
=	O	ADJ	O
5	O	NUM	O
.	O	PUNCT	O
3	O	NUM	O
kPa	O	NOUN	O
prior	O	ADV	O
to	O	PART	O
the	O	DET	O
measurement	O	NOUN	B
is	O	AUX	O
recommended	O	VERB	B
.	O	PUNCT	O


The	O	DET	O
EPO	B-GENE	NOUN	B
levels	O	NOUN	B
were	O	AUX	O
distinctly	O	ADV	O
increased	O	VERB	B
before	O	ADP	O
transfusion	O	NOUN	B
;	O	PUNCT	O
they	O	PRON	O
did	O	AUX	O
not	O	PART	O
significantly	O	ADV	O
change	O	VERB	O
just	O	ADV	O
after	O	ADP	O
transfusion	O	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
subsequently	O	ADV	O
decreased	O	VERB	B
.	O	PUNCT	O


Felodipine	O	NOUN	B
did	O	AUX	O
not	O	PART	O
alter	O	VERB	O
the	O	DET	O
baseline	O	NOUN	B
FEV1	O	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
showed	O	VERB	O
a	O	DET	O
small	O	ADJ	O
significant	O	ADJ	O
inhibitory	O	ADJ	B
effect	O	NOUN	O
upon	O	SCONJ	O
histamine	O	NOUN	B
and	O	CCONJ	O
AMP	O	NOUN	B
induced	O	VERB	B
bronchoconstriction	O	NOUN	B
.	O	PUNCT	O


Relatively	O	ADV	O
little	O	ADJ	O
is	O	AUX	O
known	O	VERB	O
regarding	O	VERB	O
the	O	DET	O
role	O	NOUN	O
of	O	ADP	O
5	B-GENE	NUM	O
-	I-GENE	PUNCT	O
HT2	I-GENE	NOUN	B
receptor	I-GENE	NOUN	I
activity	O	NOUN	B
in	O	ADP	O
male	O	NOUN	B
rat	O	NOUN	B
sexual	O	ADJ	B
behavior	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
present	O	ADJ	O
study	O	NOUN	B
reports	O	VERB	B
visual	O	ADJ	B
evoked	O	VERB	O
potential	O	ADJ	O
responses	O	NOUN	B
to	O	PART	O
pattern	O	NOUN	B
reversal	O	NOUN	I
(	O	PUNCT	O
VEP	O	NOUN	B
-	O	PUNCT	O
P	O	NOUN	B
)	O	PUNCT	O
in	O	ADP	O
ten	O	NUM	O
third	O	ADJ	O
trimester	O	NOUN	B
pregnant	O	ADJ	B
women	O	NOUN	I
and	O	CCONJ	O
changes	O	NOUN	B
in	O	ADP	O
latency	O	NOUN	B
of	O	ADP	O
NPN	O	NOUN	B
complex	O	NOUN	O
when	O	SCONJ	O
compared	O	VERB	B
with	O	ADP	O
these	O	DET	O
responses	O	NOUN	B
in	O	ADP	O
the	O	DET	O
non	O	ADJ	B
pregnant	O	ADJ	I
state	O	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
all	O	DET	O
instances	O	NOUN	O
the	O	DET	O
apparent	O	ADJ	B
alcohol	O	NOUN	B
responses	O	NOUN	I
were	O	AUX	O
very	O	ADV	O
small	O	ADJ	O
and	O	CCONJ	O
never	O	ADV	O
exceeded	O	VERB	O
a	O	DET	O
reading	O	NOUN	B
of	O	ADP	O
1	O	NUM	O
microgram	O	NOUN	B
/	O	SYM	O
100ml	O	NOUN	O
for	O	ADP	O
breath	O	NOUN	B
samples	O	NOUN	I
more	O	ADJ	O
than	O	ADP	O
10min	O	ADJ	O
post	O	NOUN	B
-	O	PUNCT	O
exposure	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
gene	O	NOUN	B
is	O	AUX	O
1	O	NUM	O
,	O	PUNCT	O
139	O	NUM	O
base	O	NOUN	B
pairs	O	NOUN	I
(	O	PUNCT	O
bp	O	NOUN	B
)	O	PUNCT	O
long	O	ADV	B
,	O	PUNCT	O
and	O	CCONJ	O
,	O	PUNCT	O
like	O	ADP	O
other	O	ADJ	O
members	O	NOUN	B
of	O	ADP	O
the	O	DET	O
SIG	B-GENE	NOUN	B
family	I-GENE	NOUN	I
,	O	PUNCT	O
the	O	DET	O
beta	B-GENE	NOUN	B
TG	I-GENE	NOUN	I
gene	I-GENE	NOUN	I
is	O	AUX	O
divided	O	VERB	O
into	O	ADP	O
3	O	NUM	O
exons	O	NOUN	B
.	O	PUNCT	O


Thus	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
positive	O	ADJ	B
effect	O	NOUN	B
of	O	ADP	O
NS1	B-GENE	NOUN	B
on	O	ADP	O
the	O	DET	O
steady	O	ADJ	B
-	O	PUNCT	O
state	O	NOUN	B
levels	O	NOUN	B
of	O	ADP	O
P4	B-GENE	NOUN	B
transcripts	I-GENE	NOUN	B
depends	O	VERB	O
on	O	ADP	O
the	O	DET	O
amplification	O	NOUN	B
of	O	ADP	O
gene	O	NOUN	O
copy	O	NOUN	B
number	O	NOUN	I
and	O	CCONJ	O
the	O	DET	O
integrity	O	NOUN	B
of	O	ADP	O
the	O	DET	O
terminal	O	ADJ	B
repeats	O	NOUN	B
.	O	PUNCT	O


It	O	PRON	O
is	O	AUX	O
transparent	O	ADJ	B
,	O	PUNCT	O
cheap	O	ADJ	O
to	O	PART	O
be	O	AUX	O
made	O	VERB	O
,	O	PUNCT	O
and	O	CCONJ	O
easy	O	ADJ	O
to	O	PART	O
empty	O	ADJ	B
and	O	CCONJ	O
was	O	AUX	O
tested	O	VERB	B
in	O	ADP	O
118	O	NUM	O
animals	O	NOUN	B
for	O	ADP	O
two	O	NUM	O
and	O	CCONJ	O
four	O	NUM	O
weeks	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
Thr161Val	O	NOUN	B
mutation	O	NOUN	B
causes	O	VERB	O
a	O	DET	O
lethal	O	ADJ	B
phenotype	O	NOUN	B
in	O	ADP	O
the	O	DET	O
fission	O	NOUN	B
yeast	O	NOUN	I
Schizosaccharomyces	O	X	I
pombe	O	X	I
,	O	PUNCT	O
while	O	SCONJ	O
replacement	O	NOUN	B
of	O	ADP	O
Thr161	O	NOUN	B
with	O	ADP	O
glutamic	O	ADJ	B
acid	O	NOUN	I
,	O	PUNCT	O
potentially	O	ADV	O
mimicking	O	VERB	O
phosphorylation	O	NOUN	B
,	O	PUNCT	O
causes	O	VERB	O
uncoordination	O	NOUN	B
of	O	ADP	O
mitosis	O	NOUN	B
and	O	CCONJ	O
multiple	O	ADJ	B
cytokinesis	O	NOUN	I
.	O	PUNCT	O


Deregulation	O	NOUN	B
of	O	ADP	O
their	O	PRON	O
expression	O	NOUN	B
may	O	AUX	O
contribute	O	VERB	O
to	O	PART	O
malignant	O	ADJ	B
transformation	O	NOUN	O
associated	O	VERB	B
with	O	ADP	I
HTLV	O	NOUN	B
-	O	PUNCT	O
1	O	NUM	O
infection	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
conclusion	O	NOUN	O
,	O	PUNCT	O
we	O	PRON	O
observed	O	VERB	O
a	O	DET	O
great	O	ADJ	O
regeneration	O	NOUN	B
ability	O	NOUN	B
following	O	VERB	O
mechanical	O	ADJ	B
injury	O	NOUN	I
in	O	ADP	O
the	O	DET	O
nasal	O	ADJ	B
mucosa	O	NOUN	I
.	O	PUNCT	O


There	O	PRON	O
occurred	O	VERB	O
a	O	DET	O
linear	O	ADJ	O
relationship	O	NOUN	B
between	O	ADP	O
the	O	DET	O
drop	O	NOUN	B
in	O	ADP	O
glucose	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
6	I-GENE	NUM	O
-	I-GENE	PUNCT	O
phosphatase	I-GENE	NOUN	B
dehydrogenase	I-GENE	NOUN	I
activity	O	NOUN	I
and	O	CCONJ	O
in	O	ADP	O
vitamin	O	NOUN	B
E	O	NOUN	I
level	O	NOUN	I
,	O	PUNCT	O
on	O	ADP	O
one	O	NUM	O
hand	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
the	O	DET	O
duration	O	NOUN	B
of	O	ADP	O
poisoning	O	NOUN	B
with	O	ADP	O
sodium	O	NOUN	B
nitrite	O	NOUN	I
.	O	PUNCT	O


A	O	DET	O
vector	O	NOUN	B
containing	O	VERB	O
a	O	DET	O
transcriptionally	O	ADV	B
inactive	O	ADJ	O
neomycin	B-GENE	NOUN	B
phosphotransferase	I-GENE	NOUN	I
II	I-GENE	NUM	I
gene	I-GENE	NOUN	I
was	O	AUX	O
used	O	VERB	O
to	O	PART	O
select	O	VERB	O
promoter	O	NOUN	B
sequences	O	NOUN	I
from	O	ADP	O
a	O	DET	O
pool	O	NOUN	B
of	O	ADP	O
random	O	ADJ	B
genomic	O	ADJ	B
DNA	O	NOUN	I
fragments	O	NOUN	I
.	O	PUNCT	O


Previous	O	ADJ	O
analysis	O	NOUN	B
of	O	ADP	O
the	O	DET	O
98	O	NUM	O
-	O	PUNCT	O
bp	O	NOUN	B
sequence	O	NOUN	B
has	O	AUX	O
delineated	O	VERB	O
several	O	ADJ	O
protein	O	NOUN	B
-	O	PUNCT	O
binding	O	VERB	B
domains	O	NOUN	O
that	O	PRON	O
are	O	AUX	O
recognized	O	VERB	O
by	O	ADP	O
nuclear	O	ADJ	B
factors	O	NOUN	I
present	O	ADJ	O
in	O	ADP	O
human	O	ADJ	B
brain	O	NOUN	B
cells	O	NOUN	I
.	O	PUNCT	O


Naturally	O	ADV	O
acquired	O	VERB	B
antibodies	O	NOUN	I
were	O	AUX	O
demonstrated	O	VERB	O
in	O	ADP	O
some	O	DET	O
rabbits	O	NOUN	B
kept	O	VERB	O
on	O	ADP	O
commercial	O	ADJ	B
farms	O	NOUN	B
.	O	PUNCT	O


Biol	O	NOUN	B
.	O	PUNCT	O


Nucleotide	O	NOUN	B
sequences	O	NOUN	I
between	O	ADP	O
the	O	DET	O
env	B-GENE	NOUN	B
gene	I-GENE	NOUN	I
and	O	CCONJ	O
the	O	DET	O
LTR	B-GENE	NOUN	B
of	I-GENE	ADP	O
SFV	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	O
were	O	AUX	O
determined	O	VERB	O
.	O	PUNCT	O


The	O	DET	O
human	O	ADJ	B
cDNA	O	NOUN	B
was	O	AUX	O
used	O	VERB	O
to	O	PART	O
demonstrate	O	VERB	O
that	O	SCONJ	O
tumor	B-GENE	NOUN	B
necrosis	I-GENE	NOUN	I
factor	I-GENE	NOUN	I
-	I-GENE	PUNCT	O
alpha	I-GENE	NOUN	B
could	O	AUX	O
rapidly	O	ADV	O
stimulate	O	VERB	B
MARCKS	B-GENE	NOUN	B
gene	I-GENE	NOUN	B
transcription	O	NOUN	I
in	O	ADP	O
the	O	DET	O
human	O	ADJ	B
promyelocytic	O	ADJ	I
leukemia	O	NOUN	I
cell	O	NOUN	B
line	O	NOUN	I
HL60	O	NOUN	B
.	O	PUNCT	O


Dd	B-GENE	NOUN	B
PK1	I-GENE	NOUN	B
RNA	I-GENE	NOUN	I
decreases	O	VERB	B
after	O	ADP	O
6	O	NUM	O
h	O	NOUN	O
of	O	ADP	O
starvation	O	NOUN	B
to	O	ADP	O
re	O	ADP	B
-	O	PUNCT	O
accumulate	O	NOUN	B
once	O	SCONJ	O
the	O	DET	O
cells	O	NOUN	B
have	O	AUX	O
aggregated	O	VERB	B
.	O	PUNCT	O


Young	O	ADJ	B
CD	O	PROPN	B
-	O	PUNCT	O
1	O	NUM	O
mice	O	NOUN	B
,	O	PUNCT	O
4	O	NUM	O
days	O	NOUN	B
old	O	ADJ	O
,	O	PUNCT	O
exposed	O	VERB	O
to	O	PART	O
0	O	NUM	O
.	O	PUNCT	O
1	O	NUM	O
%	O	NOUN	O
nicotine	O	NOUN	B
sulfate	O	NOUN	B
on	O	ADP	O
gestational	O	ADJ	B
days	O	NOUN	I
6	O	NUM	O
-	O	SYM	O
20	O	NUM	O
were	O	AUX	O
compared	O	VERB	B
with	O	ADP	O
untreated	O	ADJ	B
pups	O	NOUN	B
of	O	ADP	O
the	O	DET	O
same	O	ADJ	O
age	O	NOUN	B
to	O	PART	O
determine	O	VERB	O
its	O	PRON	O
effect	O	NOUN	B
on	O	ADP	O
the	O	DET	O
development	O	NOUN	B
of	O	ADP	O
mandibular	O	ADJ	B
first	O	ADJ	O
molars	O	NOUN	O
.	O	PUNCT	O


USF	B-GENE	NOUN	B
synthesized	O	VERB	B
in	O	ADP	O
an	O	DET	O
in	O	X	B
vitro	O	X	I
transcription	O	NOUN	B
and	O	CCONJ	O
translation	O	NOUN	B
system	O	NOUN	I
also	O	ADV	O
binds	O	VERB	B
to	O	PART	O
the	O	DET	O
ADH	B-GENE	NOUN	B
promoter	I-GENE	NOUN	B
as	O	ADV	O
well	O	ADV	O
as	O	ADP	O
to	O	ADP	O
the	O	DET	O
MLP	O	NOUN	B
.	O	PUNCT	O


Arterial	O	ADJ	B
radioactivity	O	NOUN	O
content	O	NOUN	B
after	O	ADP	O
the	O	DET	O
intravenous	O	ADJ	B
administration	O	NOUN	I
of	O	ADP	O
HMPAO	O	NOUN	B
in	O	ADP	O
seven	O	NUM	O
human	O	ADJ	B
subjects	O	NOUN	B
was	O	AUX	O
analyzed	O	VERB	B
.	O	PUNCT	O


Linear	O	ADJ	B
regression	O	NOUN	I
analysis	O	NOUN	I
was	O	AUX	O
performed	O	VERB	O
and	O	CCONJ	O
the	O	DET	O
following	O	VERB	O
result	O	NOUN	B
was	O	AUX	O
obtained	O	VERB	O
:	O	PUNCT	O
clearance	O	NOUN	B
(	O	PUNCT	O
HMPAO	O	NOUN	B
)	O	PUNCT	O
=	O	ADJ	O
0	O	NUM	O
.	O	PUNCT	O
07	O	NUM	O
+	O	CCONJ	O
0	O	NUM	O
.	O	PUNCT	O
43	O	NUM	O
.	O	PUNCT	O
rCBF	O	NOUN	B
with	O	ADP	O
a	O	DET	O
high	O	ADJ	O
significance	O	NOUN	B
(	O	PUNCT	O
p	O	NOUN	O
less	O	ADJ	O
than	O	ADP	O
0	O	NUM	O
.	O	PUNCT	O
001	O	NUM	O
)	O	PUNCT	O
.	O	PUNCT	O


Saccharomyces	O	X	B
cerevisiae	O	X	I
has	O	AUX	O
been	O	AUX	O
used	O	VERB	O
widely	O	ADV	O
both	O	CCONJ	O
as	O	ADP	O
a	O	DET	O
model	O	NOUN	B
system	O	NOUN	I
for	O	ADP	O
unraveling	O	VERB	O
the	O	DET	O
biochemical	O	ADJ	B
,	O	PUNCT	O
genetic	O	ADJ	B
,	O	PUNCT	O
and	O	CCONJ	O
molecular	O	ADJ	B
details	O	NOUN	I
of	O	ADP	O
gene	O	NOUN	B
expression	O	NOUN	I
and	O	CCONJ	O
the	O	DET	O
secretion	O	NOUN	B
process	O	NOUN	O
,	O	PUNCT	O
and	O	CCONJ	O
as	O	ADP	O
a	O	DET	O
host	O	NOUN	B
for	O	ADP	O
the	O	DET	O
production	O	NOUN	B
of	O	ADP	O
heterologous	O	ADJ	B
proteins	O	NOUN	B
of	O	ADP	O
biotechnological	O	ADJ	B
interest	O	NOUN	O
.	O	PUNCT	O


Formalin	O	NOUN	B
activated	O	VERB	B
both	O	CCONJ	O
SNO	O	NOUN	B
NS	O	NOUN	B
and	O	CCONJ	O
NnS	O	NOUN	B
neurones	O	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
,	O	PUNCT	O
when	O	SCONJ	O
they	O	PRON	O
responded	O	VERB	O
,	O	PUNCT	O
NS	O	NOUN	B
neurones	O	NOUN	B
(	O	PUNCT	O
n	O	NOUN	O
=	O	ADJ	O
5	O	NUM	O
)	O	PUNCT	O
showed	O	VERB	O
only	O	ADV	O
the	O	DET	O
first	O	ADJ	O
phase	O	NOUN	O
of	O	ADP	O
activity	O	NOUN	B
while	O	SCONJ	O
NnS	O	NOUN	B
neurones	O	NOUN	B
showed	O	VERB	O
either	O	DET	O
one	O	NUM	O
(	O	PUNCT	O
n	O	NOUN	O
=	O	ADJ	O
13	O	NUM	O
)	O	PUNCT	O
or	O	CCONJ	O
two	O	NUM	O
phases	O	NOUN	B
(	O	PUNCT	O
n	O	NOUN	O
=	O	ADJ	O
6	O	NUM	O
)	O	PUNCT	O
.	O	PUNCT	O


Uptake	O	NOUN	B
of	O	ADP	O
ofloxacin	O	NOUN	B
by	O	ADP	O
Escherichia	O	X	B
coli	O	X	I


A	O	DET	O
deletion	O	NOUN	B
series	O	NOUN	O
of	O	ADP	O
the	O	DET	O
5	O	NUM	O
'	O	PART	O
flanking	O	ADJ	B
region	O	NOUN	I
was	O	AUX	O
created	O	VERB	O
from	O	ADP	O
position	O	NOUN	B
-	O	PUNCT	O
1329	O	NUM	O
to	O	PART	O
-	O	PUNCT	O
74	O	NUM	O
relative	O	ADJ	O
to	O	PART	O
the	O	DET	O
transcriptional	O	ADJ	B
initiation	O	NOUN	I
site	O	NOUN	I
and	O	CCONJ	O
similarly	O	ADV	O
examined	O	VERB	O
in	O	ADP	O
transgenic	O	ADJ	B
tobacco	O	NOUN	I
.	O	PUNCT	O


Toxicity	O	NOUN	B
was	O	AUX	O
very	O	ADV	O
mild	O	ADJ	B
with	O	ADP	O
both	O	DET	O
regimens	O	NOUN	B
,	O	PUNCT	O
although	O	SCONJ	O
sedation	O	NOUN	B
was	O	AUX	O
significantly	O	ADV	O
higher	O	ADJ	O
in	O	ADP	O
arm	O	NOUN	B
B	O	NOUN	I
(	O	PUNCT	O
p	O	NOUN	O
less	O	ADJ	O
than	O	ADP	O
0	O	NUM	O
.	O	PUNCT	O
001	O	NUM	O
)	O	PUNCT	O
.	O	PUNCT	O


Limits	O	NOUN	B
of	O	ADP	O
energy	O	NOUN	B
turnover	O	NOUN	B
in	O	ADP	O
relation	O	NOUN	O
to	O	ADP	O
physical	O	ADJ	B
performance	O	NOUN	I
were	O	AUX	O
addressed	O	VERB	O
in	O	ADP	O
terms	O	NOUN	O
of	O	ADP	O
upper	O	ADJ	B
and	O	CCONJ	O
lower	O	ADJ	O
limit	O	NOUN	O
,	O	PUNCT	O
changes	O	NOUN	B
during	O	ADP	O
a	O	DET	O
training	O	NOUN	B
programme	O	NOUN	I
and	O	CCONJ	O
how	O	SCONJ	O
to	O	PART	O
regulate	O	VERB	B
energy	O	NOUN	O
balance	O	NOUN	O
at	O	ADP	O
a	O	DET	O
changing	O	VERB	B
energy	O	NOUN	B
turnover	O	NOUN	B
.	O	PUNCT	O


Moreover	O	ADV	O
,	O	PUNCT	O
promoters	O	NOUN	B
containing	O	VERB	O
a	O	DET	O
TATA	O	NOUN	B
box	O	NOUN	O
in	O	ADP	O
the	O	DET	O
absence	O	NOUN	B
of	O	ADP	O
Sp1	B-GENE	NOUN	B
sites	I-GENE	NOUN	O
or	O	CCONJ	O
Sp1	B-GENE	NOUN	B
sites	I-GENE	NOUN	B
in	O	ADP	O
the	O	DET	O
absence	O	NOUN	B
of	O	ADP	O
a	O	DET	O
TATA	O	NOUN	B
box	O	NOUN	I
were	O	AUX	O
equally	O	ADV	O
inducible	O	ADJ	B
in	O	X	B
vitro	O	X	I
,	O	PUNCT	O
as	O	ADP	O
was	O	AUX	O
an	O	DET	O
RNA	B-GENE	NOUN	B
polymerase	I-GENE	NOUN	I
III	I-GENE	NUM	I
promoter	I-GENE	NOUN	I
.	O	PUNCT	O


Ivermectin	O	NOUN	B
uptake	O	NOUN	B
and	O	CCONJ	O
distribution	O	NOUN	B
in	O	ADP	O
the	O	DET	O
plasma	O	NOUN	B
and	O	CCONJ	O
tissue	O	NOUN	B
of	O	ADP	O
Sudanese	O	ADJ	B
and	O	CCONJ	O
Mexican	O	ADJ	B
patients	O	NOUN	B
infected	O	VERB	B
with	O	ADP	O
Onchocerca	O	PROPN	B
volvulus	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
currently	O	ADV	O
proposed	O	VERB	O
extended	O	VERB	O
arch	O	ADJ	B
repair	O	NOUN	I
should	O	AUX	O
be	O	AUX	O
reserved	O	VERB	O
for	O	ADP	O
the	O	DET	O
small	O	ADJ	B
group	O	NOUN	I
of	O	ADP	O
infants	O	NOUN	B
with	O	ADP	O
transverse	O	ADJ	B
aortic	O	ADJ	I
arch	O	NOUN	I
to	O	PART	O
ascending	O	VERB	B
aorta	O	NOUN	B
diameter	O	NOUN	O
ratios	O	NOUN	O
(	O	PUNCT	O
arch	O	ADJ	B
indices	O	NOUN	I
)	O	PUNCT	O
of	O	ADP	O
less	O	ADJ	O
than	O	ADP	O
0	O	NUM	O
.	O	PUNCT	O
25	O	NUM	O
.	O	PUNCT	O


DNA	O	NOUN	B
hybridization	O	NOUN	I
analysis	O	NOUN	I
revealed	O	VERB	O
that	O	SCONJ	O
both	O	CCONJ	O
pigmented	O	ADJ	B
and	O	CCONJ	O
nonpigmented	O	ADJ	B
cells	O	NOUN	I
of	O	ADP	O
Y	O	NOUN	O
.	O	PUNCT	O
pestis	O	NOUN	B
possess	O	VERB	O
a	O	DET	O
DNA	O	NOUN	B
locus	O	NOUN	I
homologous	O	ADJ	I
to	O	PART	O
the	O	DET	O
Escherichia	B-GENE	X	B
coli	I-GENE	X	I
fur	I-GENE	NOUN	I
gene	I-GENE	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
report	O	VERB	O
two	O	NUM	O
patients	O	NOUN	B
receiving	O	VERB	O
maintenance	O	NOUN	B
valproate	O	NOUN	B
,	O	PUNCT	O
one	O	NUM	O
with	O	ADP	O
resolving	O	VERB	O
acute	O	ADJ	B
hepatitis	O	NOUN	I
C	O	NOUN	I
and	O	CCONJ	O
the	O	DET	O
other	O	ADJ	O
with	O	ADP	O
chronic	O	ADJ	B
persistent	O	ADJ	I
hepatitis	O	NOUN	I
C	O	NOUN	I
,	O	PUNCT	O
with	O	ADP	O
incidental	O	ADJ	B
microvesicular	O	ADJ	B
steatosis	O	NOUN	I
demonstrated	O	VERB	O
on	O	ADP	O
oil	O	NOUN	B
-	O	PUNCT	O
red	O	ADJ	B
O	O	NOUN	I
stains	O	NOUN	I
.	O	PUNCT	O


UDP	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
Gal	I-GENE	PROPN	B
:	I-GENE	PUNCT	O
Gal	I-GENE	NOUN	B
beta	I-GENE	NOUN	I
1	I-GENE	NUM	I
-	I-GENE	PUNCT	O
-	I-GENE	PUNCT	O
-	I-GENE	PUNCT	O
-	I-GENE	PUNCT	O
4GlcNAc	I-GENE	NOUN	B
alpha	I-GENE	NOUN	I
1	I-GENE	NUM	I
-	I-GENE	PUNCT	O
-	I-GENE	PUNCT	O
-	I-GENE	PUNCT	O
-	I-GENE	PUNCT	O
3	I-GENE	NUM	B
-	I-GENE	PUNCT	O
galactosyltransferase	I-GENE	NOUN	B
is	O	AUX	O
a	O	DET	O
terminal	B-GENE	ADJ	B
glycosyltransferase	I-GENE	NOUN	B
that	O	PRON	O
is	O	AUX	O
widely	O	ADV	O
expressed	O	VERB	B
in	O	ADP	O
a	O	DET	O
variety	O	NOUN	O
of	O	ADP	O
mammalian	O	ADJ	B
species	O	NOUN	B
,	O	PUNCT	O
with	O	ADP	O
the	O	DET	O
notable	O	ADJ	O
exception	O	NOUN	O
of	O	ADP	O
man	O	NOUN	B
,	O	PUNCT	O
apes	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
Old	O	PROPN	B
World	O	NOUN	I
monkeys	O	NOUN	I
.	O	PUNCT	O


A	O	DET	O
synthetic	O	ADJ	B
oligonucleotide	O	NOUN	I
containing	O	VERB	O
the	O	DET	O
SRE	O	NOUN	B
sequence	O	NOUN	B
from	O	ADP	O
the	O	DET	O
mouse	B-GENE	NOUN	B
c	I-GENE	NOUN	I
-	I-GENE	PUNCT	O
fos	I-GENE	NOUN	B
gene	I-GENE	NOUN	I
promoter	I-GENE	NOUN	O
(	O	PUNCT	O
-	O	PUNCT	O
299	O	NUM	O
to	O	ADP	O
-	O	PUNCT	O
322	O	NUM	O
)	O	PUNCT	O
was	O	AUX	O
radioactively	O	ADV	B
labeled	O	VERB	I
,	O	PUNCT	O
used	O	VERB	O
as	O	ADP	O
a	O	DET	O
probe	O	NOUN	B
for	O	ADP	O
the	O	DET	O
mobility	O	NOUN	B
shift	O	NOUN	I
assay	O	NOUN	I
and	O	CCONJ	O
Southwestern	O	NOUN	B
(	O	PUNCT	O
DNA	O	NOUN	B
-	O	PUNCT	O
protein	O	NOUN	B
)	O	PUNCT	O
blotting	O	NOUN	O
,	O	PUNCT	O
and	O	CCONJ	O
also	O	ADV	O
used	O	VERB	O
for	O	ADP	O
sequence	O	NOUN	B
-	O	PUNCT	O
specific	O	ADJ	B
affinity	O	NOUN	B
chromatography	O	NOUN	I
.	O	PUNCT	O


This	O	DET	O
study	O	NOUN	B
indicates	O	VERB	O
that	O	SCONJ	O
this	O	DET	O
dose	O	NOUN	B
-	O	PUNCT	O
intense	O	ADJ	B
regimen	O	NOUN	B
can	O	AUX	O
be	O	AUX	O
safely	O	ADV	O
administered	O	VERB	B
,	O	PUNCT	O
even	O	ADV	O
with	O	ADP	O
the	O	DET	O
use	O	NOUN	O
of	O	ADP	O
purged	O	ADJ	B
marrow	O	NOUN	I
,	O	PUNCT	O
with	O	ADP	O
an	O	DET	O
acceptable	O	ADJ	O
toxicity	O	NOUN	B
profile	O	NOUN	O
.	O	PUNCT	O


INTERVENTIONS	O	NOUN	B
:	O	PUNCT	O
Patients	O	NOUN	B
received	O	VERB	O
rt	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
PA	I-GENE	PROPN	B
,	O	PUNCT	O
heparin	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
aspirin	O	NOUN	B
.	O	PUNCT	O


Sequence	O	NOUN	B
analysis	O	NOUN	I
of	O	ADP	O
the	O	DET	O
sMtCK	B-GENE	NOUN	B
genomic	I-GENE	ADJ	B
upstream	I-GENE	ADJ	I
sequences	I-GENE	NOUN	I
reveals	O	VERB	O
a	O	DET	O
typical	O	ADJ	O
TATAA	O	NOUN	B
box	O	NOUN	B
within	O	ADP	O
the	O	DET	O
80	O	NUM	O
base	O	NOUN	B
pairs	O	NOUN	I
(	O	PUNCT	O
bp	O	NOUN	B
)	O	PUNCT	O
that	O	PRON	O
,	O	PUNCT	O
by	O	ADP	O
transfection	O	NOUN	B
experiments	O	NOUN	O
,	O	PUNCT	O
are	O	AUX	O
sufficient	O	ADJ	O
to	O	PART	O
promote	O	VERB	B
expression	O	NOUN	B
of	O	ADP	O
chimeric	O	ADJ	B
plasmids	O	NOUN	I
with	O	ADP	O
the	O	DET	O
chloramphenicol	B-GENE	NOUN	B
acetyltransferase	I-GENE	NOUN	I
reporter	I-GENE	NOUN	I
.	O	PUNCT	O


Sequence	O	NOUN	B
analysis	O	NOUN	I
of	O	ADP	O
the	O	DET	O
sMtCK	B-GENE	NOUN	B
genomic	I-GENE	ADJ	B
upstream	I-GENE	ADJ	I
sequences	I-GENE	NOUN	I
reveals	O	VERB	O
a	O	DET	O
typical	O	ADJ	O
TATAA	O	NOUN	B
box	O	NOUN	B
within	O	ADP	O
the	O	DET	O
80	O	NUM	O
base	O	NOUN	B
pairs	O	NOUN	I
(	O	PUNCT	O
bp	O	NOUN	B
)	O	PUNCT	O
that	O	PRON	O
,	O	PUNCT	O
by	O	ADP	O
transfection	O	NOUN	B
experiments	O	NOUN	O
,	O	PUNCT	O
are	O	AUX	O
sufficient	O	ADJ	O
to	O	PART	O
promote	O	VERB	B
expression	O	NOUN	B
of	O	ADP	O
chimeric	O	ADJ	B
plasmids	O	NOUN	I
with	O	ADP	O
the	O	DET	O
chloramphenicol	B-GENE	NOUN	B
acetyltransferase	I-GENE	NOUN	I
reporter	I-GENE	NOUN	I
.	O	PUNCT	O


The	O	DET	O
cDNA	O	NOUN	B
segment	O	NOUN	O
is	O	AUX	O
flanked	O	VERB	B
by	O	ADP	O
the	O	DET	O
immunoglobulin	B-GENE	NOUN	B
gene	I-GENE	NOUN	I
recombination	I-GENE	NOUN	I
signal	I-GENE	NOUN	I
sequences	I-GENE	NOUN	I
so	O	SCONJ	O
that	O	SCONJ	O
the	O	DET	O
cDNA	O	NOUN	B
segment	O	NOUN	O
can	O	AUX	O
invert	O	VERB	B
and	O	CCONJ	O
the	O	DET	O
human	B-GENE	ADJ	B
IL	I-GENE	NOUN	O
-	I-GENE	PUNCT	O
2R	I-GENE	NOUN	B
L	I-GENE	NOUN	I
chain	I-GENE	NOUN	I
is	O	AUX	O
subsequently	O	ADV	O
expressed	O	VERB	B
under	O	ADP	O
the	O	DET	O
control	O	NOUN	B
of	O	ADP	O
the	O	DET	O
SV40	B-GENE	NOUN	B
promoter	I-GENE	NOUN	B
.	O	PUNCT	O


Habituation	O	NOUN	B
of	O	ADP	O
completely	O	ADV	O
isolated	O	VERB	B
neurons	O	NOUN	B
of	O	ADP	O
the	O	DET	O
edible	O	ADJ	B
snail	O	NOUN	I
to	O	PART	O
electrical	O	ADJ	B
stimulation	O	NOUN	I
.	O	PUNCT	O


Insulin	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
like	I-GENE	ADJ	B
growth	I-GENE	NOUN	B
factor	I-GENE	NOUN	I
1	I-GENE	NUM	I
(	O	PUNCT	O
IGF	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	O
)	O	PUNCT	O
in	O	ADP	O
burn	O	NOUN	B
patients	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
suppression	O	NOUN	B
was	O	AUX	O
also	O	ADV	O
demonstrated	O	VERB	O
in	O	ADP	O
a	O	DET	O
transient	O	ADJ	B
expression	O	NOUN	O
assay	O	NOUN	O
in	O	X	B
vivo	O	X	I
using	O	VERB	O
isolated	O	VERB	B
barley	O	NOUN	B
endosperms	O	NOUN	I
.	O	PUNCT	O


RNA	O	NOUN	B
gel	O	NOUN	I
retardation	O	NOUN	I
and	O	CCONJ	O
competition	O	NOUN	B
analyses	O	NOUN	I
indicate	O	VERB	O
that	O	SCONJ	O
TRP	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
185	I-GENE	NUM	O
binding	O	NOUN	B
is	O	AUX	O
strongly	O	ADV	O
dependent	O	ADJ	O
on	O	ADP	O
the	O	DET	O
TAR	O	NOUN	B
RNA	O	NOUN	I
loop	O	NOUN	I
sequences	O	NOUN	I
.	O	PUNCT	O


This	O	DET	O
generalization	O	NOUN	B
of	O	ADP	O
MFP	O	PROPN	B
involves	O	VERB	O
defining	O	VERB	O
an	O	DET	O
appropriate	O	ADJ	O
high	O	ADJ	B
-	O	PUNCT	O
resolution	O	NOUN	B
cost	O	NOUN	B
function	O	NOUN	I
,	O	PUNCT	O
parametrizing	O	VERB	B
the	O	DET	O
search	O	NOUN	O
space	O	NOUN	O
of	O	ADP	O
the	O	DET	O
environment	O	NOUN	B
and	O	CCONJ	O
source	O	NOUN	B
,	O	PUNCT	O
constructing	O	VERB	B
solutions	O	NOUN	B
of	O	ADP	O
the	O	DET	O
wave	O	NOUN	B
equation	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
utilizing	O	VERB	O
a	O	DET	O
nonlinear	O	ADJ	B
optimization	O	NOUN	I
method	O	NOUN	I
to	O	PART	O
search	O	VERB	O
the	O	DET	O
parameter	O	NOUN	B
landscape	O	NOUN	B
for	O	ADP	O
the	O	DET	O
global	O	ADJ	B
minimum	O	NOUN	I
of	O	ADP	O
the	O	DET	O
cost	O	NOUN	B
function	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
original	O	ADJ	B
technique	O	NOUN	B
was	O	AUX	O
developed	O	VERB	O
in	O	ADP	O
the	O	DET	O
1960	O	NUM	O
'	O	PART	O
s	O	NOUN	O
to	O	PART	O
analyze	O	VERB	B
the	O	DET	O
inner	O	ADJ	B
ear	O	NOUN	I
fluid	O	NOUN	I
as	O	ADP	O
a	O	DET	O
diagnostic	O	ADJ	B
procedure	O	NOUN	I
(	O	PUNCT	O
i	O	X	O
.	O	PUNCT	O
e	O	X	O
.	O	PUNCT	O
,	O	PUNCT	O
diagnostic	O	ADJ	B
labyrinthotomy	O	NOUN	I
)	O	PUNCT	O
in	O	ADP	O
acoustic	O	ADJ	B
neuroma	O	NOUN	I
suspects	O	NOUN	I
.	O	PUNCT	O


Evolution	O	NOUN	B
of	O	ADP	O
lesions	O	NOUN	B
did	O	AUX	O
not	O	PART	O
necessarily	O	ADV	O
follow	O	VERB	O
a	O	DET	O
regular	O	ADJ	O
progression	O	NOUN	B
through	O	ADP	O
the	O	DET	O
later	O	ADJ	O
stages	O	NOUN	B
of	O	ADP	O
the	O	DET	O
vitelliform	O	NOUN	B
classification	O	NOUN	B
.	O	PUNCT	O


Urine	O	NOUN	B
specimens	O	NOUN	I
containing	O	VERB	O
either	O	CCONJ	O
phencyclidine	O	NOUN	B
(	O	PUNCT	O
PCP	O	NOUN	B
)	O	PUNCT	O
or	O	CCONJ	O
11	O	NUM	O
-	O	PUNCT	O
nor	O	CCONJ	B
-	O	PUNCT	O
delta	O	NOUN	B
9	O	NUM	I
-	O	PUNCT	O
tetrahydrocannabinol	O	NOUN	B
-	O	PUNCT	O
9	O	NUM	B
-	O	PUNCT	O
carboxylic	O	ADJ	B
acid	O	NOUN	I
(	O	PUNCT	O
9	O	NUM	B
-	O	PUNCT	O
THC	O	PROPN	B
-	O	PUNCT	O
COOH	O	NOUN	B
)	O	PUNCT	O
were	O	AUX	O
adulterated	O	VERB	B
with	O	ADP	O
sodium	O	NOUN	B
chloride	O	NOUN	I
,	O	PUNCT	O
bleach	O	NOUN	B
,	O	PUNCT	O
vinegar	O	NOUN	B
,	O	PUNCT	O
potassium	O	NOUN	B
hydroxide	O	NOUN	I
,	O	PUNCT	O
liquid	O	ADJ	B
soap	O	NOUN	I
,	O	PUNCT	O
2	O	NUM	B
-	O	PUNCT	O
propanol	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
ammonia	O	NOUN	B
.	O	PUNCT	O


Along	O	ADP	O
with	O	ADP	O
previously	O	ADV	O
mapped	O	VERB	B
genes	O	NOUN	I
including	O	VERB	O
Ly	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	B
and	O	CCONJ	O
CD20	B-GENE	NOUN	B
,	O	PUNCT	O
OSBP	B-GENE	NOUN	B
defines	O	VERB	O
a	O	DET	O
new	O	ADJ	O
conserved	O	VERB	O
syntenic	O	ADJ	B
group	O	NOUN	O
on	O	ADP	O
the	O	DET	O
long	O	ADJ	B
arm	O	NOUN	I
of	O	ADP	I
chromosome	O	NOUN	I
11	O	NUM	I
in	O	ADP	O
the	O	DET	O
human	O	ADJ	B
and	O	CCONJ	O
the	O	DET	O
proximal	O	ADJ	B
end	O	NOUN	O
of	O	ADP	O
chromosome	O	NOUN	O
19	O	NUM	O
in	O	ADP	O
the	O	DET	O
mouse	O	NOUN	B
.	O	PUNCT	O


Here	O	ADV	O
we	O	PRON	O
show	O	VERB	O
that	O	SCONJ	O
these	O	DET	O
synthetic	O	ADJ	B
binding	O	NOUN	I
sites	O	NOUN	I
have	O	AUX	O
a	O	DET	O
more	O	ADV	O
restricted	O	ADJ	B
and	O	CCONJ	O
specific	O	ADJ	O
ability	O	NOUN	O
to	O	PART	O
enhance	O	VERB	B
transcription	O	NOUN	B
when	O	SCONJ	O
assayed	O	VERB	B
in	O	ADP	O
transformed	O	VERB	B
embryos	O	NOUN	B
.	O	PUNCT	O


After	O	ADP	O
base	O	NOUN	B
-	O	PUNCT	O
line	O	NOUN	B
CBF	O	NOUN	B
was	O	AUX	O
established	O	VERB	O
,	O	PUNCT	O
hexamethonium	O	NOUN	B
bromide	O	NOUN	I
(	O	PUNCT	O
2	O	NUM	O
mg	O	NOUN	O
/	O	SYM	O
kg	O	NOUN	B
iv	O	NOUN	O
)	O	PUNCT	O
,	O	PUNCT	O
ipratropium	O	NOUN	B
bromide	O	NOUN	I
(	O	PUNCT	O
0	O	NUM	O
.	O	PUNCT	O
5	O	NUM	O
microgram	O	NOUN	B
/	O	SYM	O
kg	O	NOUN	B
iv	O	NOUN	O
)	O	PUNCT	O
,	O	PUNCT	O
indomethacin	O	NOUN	B
(	O	PUNCT	O
2	O	NUM	O
mg	O	NOUN	O
/	O	SYM	O
kg	O	NOUN	B
iv	O	NOUN	O
)	O	PUNCT	O
,	O	PUNCT	O
or	O	CCONJ	O
intravenous	O	ADJ	B
0	O	NUM	O
.	O	PUNCT	O
9	O	NUM	O
%	O	NOUN	O
saline	O	NOUN	B
was	O	AUX	O
administered	O	VERB	B
.	O	PUNCT	O


This	O	DET	O
study	O	NOUN	B
suggests	O	VERB	O
that	O	SCONJ	O
BSPMs	O	NOUN	B
are	O	AUX	O
useful	O	ADJ	O
in	O	ADP	O
the	O	DET	O
assessment	O	NOUN	B
of	O	ADP	O
AMI	O	NOUN	B
in	O	ADP	O
terms	O	NOUN	O
of	O	ADP	O
diagnosis	O	NOUN	B
,	O	PUNCT	O
location	O	NOUN	B
and	O	CCONJ	O
extent	O	NOUN	B
of	O	ADP	O
myocardial	O	ADJ	B
infarct	O	NOUN	I
.	O	PUNCT	O


Examination	O	NOUN	B
of	O	ADP	O
immediate	B-GENE	ADJ	B
-	I-GENE	PUNCT	O
early	I-GENE	ADJ	B
transcription	I-GENE	NOUN	B
factor	I-GENE	NOUN	I
expression	O	NOUN	I
during	O	ADP	O
the	O	DET	O
MDI	O	PROPN	B
regimen	O	NOUN	B
revealed	O	VERB	B
that	O	SCONJ	O
RA	O	NOUN	B
mediated	O	VERB	O
an	O	DET	O
elevated	O	ADJ	B
,	O	PUNCT	O
prolonged	O	ADJ	B
expression	O	NOUN	B
of	O	ADP	O
c	B-GENE	NOUN	O
-	I-GENE	PUNCT	O
Jun	I-GENE	NOUN	B
mRNA	I-GENE	NOUN	B
accompanied	O	VERB	O
by	O	ADP	O
diminished	O	VERB	B
expression	O	NOUN	B
of	O	ADP	O
c	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
Fos	I-GENE	NOUN	B
and	O	CCONJ	O
Jun	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
B	I-GENE	NOUN	B
mRNAs	I-GENE	NOUN	B
.	O	PUNCT	O


Although	O	SCONJ	O
heart	O	NOUN	B
rate	O	NOUN	I
and	O	CCONJ	O
diastolic	O	ADJ	B
pressure	O	NOUN	I
rose	O	VERB	O
in	O	ADP	O
some	O	DET	O
degree	O	NOUN	B
1	O	NUM	O
min	O	NOUN	O
after	O	ADP	O
intubation	O	NOUN	B
,	O	PUNCT	O
free	O	ADV	B
and	O	CCONJ	O
total	O	VERB	O
CA	O	NOUN	B
concentrations	O	NOUN	B
did	O	AUX	O
not	O	PART	O
increase	O	VERB	B
during	O	ADP	O
study	O	NOUN	B
period	O	NOUN	B
.	O	PUNCT	O


Processing	O	NOUN	B
,	O	PUNCT	O
secretion	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
immunoreactivity	O	NOUN	B
of	O	ADP	O
carboxy	B-GENE	NOUN	B
terminally	I-GENE	ADV	I
truncated	I-GENE	VERB	I
dengue	I-GENE	NOUN	I
-	I-GENE	PUNCT	O
2	I-GENE	NUM	B
virus	I-GENE	NOUN	I
envelope	I-GENE	NOUN	I
proteins	I-GENE	NOUN	I
expressed	O	VERB	B
in	O	ADP	O
insect	O	ADJ	B
cells	O	NOUN	I
by	O	ADP	O
recombinant	O	ADJ	B
baculoviruses	O	NOUN	I
.	O	PUNCT	O


Seven	O	NUM	B
clones	O	NOUN	B
encoding	O	VERB	O
interferon	B-GENE	NOUN	B
response	I-GENE	NOUN	I
element	I-GENE	NOUN	I
binding	I-GENE	NOUN	B
factors	I-GENE	NOUN	I
have	O	AUX	O
been	O	AUX	O
isolated	O	VERB	B
from	O	ADP	O
a	O	DET	O
mouse	O	NOUN	B
fibroblast	O	NOUN	B
lambda	O	NOUN	I
gt11	O	NOUN	I
cDNA	O	NOUN	B
library	O	NOUN	I
by	O	ADP	O
using	O	VERB	O
a	O	DET	O
32P	O	NOUN	B
end	O	NOUN	I
-	O	PUNCT	O
labeled	O	VERB	B
tandem	O	ADJ	B
trimer	O	NOUN	B
of	O	ADP	O
the	O	DET	O
mouse	B-GENE	NOUN	B
(	I-GENE	PUNCT	O
2	I-GENE	NUM	O
'	I-GENE	PUNCT	O
-	I-GENE	PUNCT	O
5	I-GENE	NUM	O
'	I-GENE	PUNCT	O
)	I-GENE	PUNCT	O
oligoadenylate	I-GENE	NOUN	B
synthetase	I-GENE	NOUN	I
gene	I-GENE	NOUN	O
interferon	O	NOUN	B
response	O	NOUN	I
element	O	NOUN	I
as	O	ADP	O
a	O	DET	O
probe	O	NOUN	B
.	O	PUNCT	O


DNA	O	NOUN	B
-	O	PUNCT	O
protein	O	NOUN	B
UV	O	NOUN	I
cross	O	NOUN	B
-	O	PUNCT	O
linking	O	VERB	B
studies	O	NOUN	B
indicated	O	VERB	O
that	O	SCONJ	O
UHF	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	O
has	O	AUX	O
an	O	DET	O
electrophoretic	O	ADJ	B
mobility	O	NOUN	I
on	O	ADP	O
sodium	O	NOUN	B
dodecyl	O	NOUN	I
sulfate	O	NOUN	I
-	O	PUNCT	O
acrylamide	O	NOUN	B
gels	O	NOUN	B
of	O	ADP	O
approximately	O	ADV	O
85	O	NUM	O
kDa	O	NOUN	O
and	O	CCONJ	O
suggested	O	VERB	O
that	O	SCONJ	O
additional	O	ADJ	O
proteins	O	NOUN	B
,	O	PUNCT	O
specific	O	ADJ	O
to	O	PART	O
each	O	DET	O
promoter	O	NOUN	B
,	O	PUNCT	O
bind	O	VERB	B
to	O	PART	O
each	O	DET	O
site	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
specific	O	ADJ	O
interaction	O	NOUN	B
between	O	ADP	O
a	O	DET	O
defined	O	VERB	O
structural	O	ADJ	B
element	O	NOUN	I
of	O	ADP	O
the	O	DET	O
human	O	ADJ	B
immunodeficiency	O	NOUN	I
virus	O	NOUN	I
mRNA	O	NOUN	B
(	O	PUNCT	O
RRE	B-GENE	NOUN	B
,	O	PUNCT	O
the	O	DET	O
Rev	B-GENE	NOUN	B
response	I-GENE	NOUN	O
element	I-GENE	NOUN	O
)	O	PUNCT	O
and	O	CCONJ	O
the	O	DET	O
virus	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
encoded	I-GENE	VERB	B
protein	I-GENE	NOUN	B
Rev	I-GENE	NOUN	I
has	O	AUX	O
been	O	AUX	O
implicated	O	VERB	O
in	O	ADP	O
the	O	DET	O
regulation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
export	O	NOUN	B
of	O	ADP	O
unspliced	O	ADJ	B
or	O	CCONJ	O
singly	O	ADV	O
spliced	O	VERB	B
mRNA	O	NOUN	B
from	O	ADP	O
the	O	DET	O
nucleus	O	NOUN	B
to	O	PART	O
the	O	DET	O
cytoplasm	O	NOUN	B
.	O	PUNCT	O


Radiation	O	NOUN	B
-	O	PUNCT	O
induced	O	VERB	B
changes	O	NOUN	B
in	O	ADP	O
the	O	DET	O
area	O	NOUN	B
of	O	ADP	O
alveoli	O	NOUN	B
and	O	CCONJ	O
septa	O	NOUN	B
as	O	ADV	O
well	O	ADV	O
as	O	ADP	O
collagen	B-GENE	NOUN	B
content	O	NOUN	B
were	O	AUX	O
seen	O	VERB	O
11	O	NUM	O
weeks	O	NOUN	B
after	O	ADP	O
irradiation	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
first	O	ADJ	O
follow	O	NOUN	B
-	O	PUNCT	O
up	O	ADP	O
was	O	AUX	O
at	O	ADP	O
a	O	DET	O
nearly	O	ADV	O
constant	O	ADJ	B
interval	O	NOUN	O
of	O	ADP	O
5	O	NUM	O
.	O	PUNCT	O
1	O	NUM	O
years	O	NOUN	B
in	O	ADP	O
Caerphilly	O	PROPN	B
and	O	CCONJ	O
3	O	NUM	O
.	O	PUNCT	O
2	O	NUM	O
years	O	NOUN	B
in	O	ADP	O
Speedwell	O	PROPN	B
;	O	PUNCT	O
251	O	NUM	O
major	O	ADJ	O
IHD	O	NOUN	B
events	O	NOUN	B
had	O	AUX	O
occurred	O	VERB	O
.	O	PUNCT	O


Once	O	SCONJ	O
the	O	DET	O
proliferation	O	NOUN	B
of	O	ADP	O
fibroblasts	O	NOUN	B
and	O	CCONJ	O
collagen	B-GENE	NOUN	B
synthesis	O	NOUN	B
had	O	AUX	O
led	O	VERB	O
to	O	PART	O
an	O	DET	O
increase	O	NOUN	B
of	O	ADP	O
mechanical	O	ADJ	B
strength	O	NOUN	I
,	O	PUNCT	O
no	O	DET	O
negative	O	ADJ	B
effect	O	NOUN	O
on	O	ADP	O
wound	O	NOUN	B
healing	O	NOUN	I
could	O	AUX	O
be	O	AUX	O
detected	O	VERB	B
applying	O	VERB	O
the	O	DET	O
same	O	ADJ	O
chemotherapeutic	O	ADJ	B
agents	O	NOUN	I
.	O	PUNCT	O


During	O	ADP	O
the	O	DET	O
years	O	NOUN	B
1980	O	NUM	O
-	O	SYM	O
87	O	NUM	O
a	O	DET	O
total	O	NOUN	O
of	O	ADP	O
287	O	NUM	O
persons	O	NOUN	B
received	O	VERB	O
disability	O	NOUN	B
pensions	O	NOUN	B
in	O	ADP	O
the	O	DET	O
municipality	O	NOUN	B
of	O	ADP	O
Nordreisa	O	PROPN	B
in	O	ADP	O
northern	O	ADJ	B
Norway	O	PROPN	I
.	O	PUNCT	O


HeLa	O	NOUN	B
and	O	CCONJ	O
Jurkat	O	NOUN	B
cell	O	NOUN	I
lines	O	NOUN	I
carrying	O	VERB	O
the	O	DET	O
nef	B-GENE	NOUN	B
gene	I-GENE	NOUN	I
linked	O	VERB	O
to	O	PART	O
the	O	DET	O
CMV	O	NOUN	B
promoter	O	NOUN	B
or	O	CCONJ	O
the	O	DET	O
HIV	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	O
LTR	I-GENE	NOUN	B
were	O	AUX	O
isolated	O	VERB	B
by	O	ADP	O
coselection	O	NOUN	B
for	O	ADP	O
neomycin	O	NOUN	B
resistance	O	NOUN	I
.	O	PUNCT	O


Two	O	NUM	O
patients	O	NOUN	B
had	O	AUX	O
immediate	O	ADJ	B
adverse	O	ADJ	B
effects	O	NOUN	I
from	O	ADP	O
NMF	O	PROPN	B
;	O	PUNCT	O
one	O	PRON	O
had	O	AUX	O
a	O	DET	O
grand	O	ADJ	O
mal	O	ADJ	B
seizure	O	NOUN	I
and	O	CCONJ	O
the	O	DET	O
other	O	ADJ	O
developed	O	VERB	O
severe	O	ADJ	O
abdominal	O	ADJ	B
pain	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
muscles	O	NOUN	B
from	O	ADP	O
the	O	DET	O
ischemic	O	ADJ	B
group	O	NOUN	I
had	O	AUX	O
significantly	O	ADV	O
lower	O	ADJ	O
(	O	PUNCT	O
P	O	NOUN	O
less	O	ADJ	O
than	O	ADP	O
.	O	PUNCT	O
05	O	NUM	O
)	O	PUNCT	O
values	O	NOUN	B
for	O	ADP	O
capillary	O	ADJ	B
density	O	NOUN	I
and	O	CCONJ	O
capillary	O	ADJ	B
to	O	PART	O
fiber	O	NOUN	O
ratio	O	NOUN	O
and	O	CCONJ	O
significantly	O	ADV	O
higher	O	ADJ	O
intercapillary	O	ADJ	B
distance	O	NOUN	B
than	O	ADP	O
those	O	DET	O
from	O	ADP	O
the	O	DET	O
normal	O	ADJ	B
group	O	NOUN	I
.	O	PUNCT	O


Serum	B-GENE	NOUN	B
TNF	I-GENE	NOUN	B
concentrations	O	NOUN	B
were	O	AUX	O
elevated	O	ADJ	B
at	O	ADP	O
diagnosis	O	NOUN	B
and	O	CCONJ	O
gradually	O	ADV	O
decreased	O	VERB	B
toward	O	ADP	O
the	O	DET	O
reference	O	NOUN	B
limits	O	NOUN	B
by	O	ADP	O
week	O	NOUN	B
16	O	NUM	O
.	O	PUNCT	O


Conclusion	O	NOUN	B
:	O	PUNCT	O
inlet	O	NOUN	B
type	O	NOUN	I
VSD	O	PROPN	I
and	O	CCONJ	O
perimembranous	O	ADJ	B
type	O	NOUN	I
TOF	O	NOUN	I
have	O	AUX	O
anatomic	O	ADJ	B
features	O	NOUN	B
in	O	ADP	O
which	O	DET	O
the	O	DET	O
proximal	O	ADJ	B
His	O	PRON	O
bundle	O	NOUN	B
tends	O	VERB	O
to	O	PART	O
be	O	AUX	O
jeopardized	O	VERB	B
by	O	ADP	O
suturing	O	VERB	B
for	O	ADP	O
VSD	O	PROPN	B
closure	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
remainder	O	NOUN	O
(	O	PUNCT	O
18	O	NUM	O
.	O	PUNCT	O
4	O	NUM	O
%	O	NOUN	O
)	O	PUNCT	O
was	O	AUX	O
with	O	ADP	O
IgA	B-GENE	NOUN	B
nephropathy	O	NOUN	I
,	O	PUNCT	O
which	O	DET	O
was	O	AUX	O
histologically	O	ADV	B
mild	O	ADJ	O
.	O	PUNCT	O


Grossly	O	ADV	B
,	O	PUNCT	O
the	O	DET	O
experimental	O	ADJ	B
vulvitis	O	NOUN	I
was	O	AUX	O
identical	O	ADJ	B
to	O	PART	O
the	O	DET	O
field	O	NOUN	B
condition	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
bacteria	O	NOUN	B
indistinguishable	O	ADJ	B
from	O	ADP	O
the	O	DET	O
inoculated	O	VERB	B
strains	O	NOUN	B
were	O	AUX	O
reisolated	O	VERB	B
.	O	PUNCT	O


3	O	X	O
.	O	PUNCT	O


Hemorrhagic	O	ADJ	B
shock	O	NOUN	I
and	O	CCONJ	O
bacterial	O	ADJ	B
translocation	O	NOUN	B
in	O	ADP	O
a	O	DET	O
swine	O	NOUN	B
model	O	NOUN	O
.	O	PUNCT	O


A	O	DET	O
method	O	NOUN	B
for	O	ADP	O
establishing	O	VERB	O
stimulus	O	NOUN	B
control	O	NOUN	B
of	O	ADP	O
ethanol	O	NOUN	B
responding	O	NOUN	B
was	O	AUX	O
developed	O	VERB	O
.	O	PUNCT	O


In	O	ADP	O
all	O	DET	O
cases	O	NOUN	B
,	O	PUNCT	O
high	O	ADJ	B
-	O	PUNCT	O
level	O	NOUN	B
expression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
truncated	B-GENE	VERB	B
avian	I-GENE	ADJ	O
integrins	I-GENE	NOUN	B
was	O	AUX	O
obtained	O	VERB	O
.	O	PUNCT	O


In	O	ADP	B
adulthood	O	NOUN	I
these	O	DET	O
rats	O	NOUN	B
were	O	AUX	O
hyperactive	O	ADJ	B
and	O	CCONJ	O
learned	O	VERB	B
the	O	DET	O
active	O	ADJ	B
avoidance	O	NOUN	O
response	O	NOUN	O
later	O	ADV	O
than	O	ADP	O
the	O	DET	O
controls	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
N	O	NOUN	B
-	O	PUNCT	O
terminal	O	ADJ	B
115	O	NUM	O
amino	O	NOUN	B
acids	O	NOUN	I
correspond	O	VERB	O
to	O	PART	O
a	O	DET	O
putative	O	ADJ	O
DNA	O	NOUN	B
-	O	PUNCT	O
binding	O	VERB	B
domain	O	NOUN	O
and	O	CCONJ	O
show	O	VERB	O
significant	O	ADJ	B
sequence	O	NOUN	B
similarity	O	NOUN	O
with	O	ADP	O
other	O	ADJ	O
cloned	O	VERB	B
IFN	B-GENE	NOUN	B
response	I-GENE	NOUN	I
factors	I-GENE	NOUN	I
(	O	PUNCT	O
IRF	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	B
and	O	CCONJ	O
IRF	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
2	I-GENE	NUM	O
)	O	PUNCT	O
.	O	PUNCT	O


The	O	DET	O
patients	O	NOUN	B
were	O	AUX	O
divided	O	VERB	O
into	O	ADP	O
3	O	NUM	O
subgroups	O	NOUN	B
:	O	PUNCT	O
1	O	X	O
)	O	PUNCT	O
13	O	NUM	O
N	O	NOUN	B
+	O	CCONJ	O
patients	O	NOUN	B
with	O	ADP	O
multiple	O	ADJ	B
hot	O	ADJ	I
spots	O	NOUN	I
(	O	PUNCT	O
greater	O	ADJ	O
than	O	ADP	O
2	O	NUM	O
)	O	PUNCT	O
(	O	PUNCT	O
N	O	NOUN	B
+	O	CCONJ	O
IM	O	NOUN	B
)	O	PUNCT	O
;	O	PUNCT	O
2	O	X	O
)	O	PUNCT	O
24	O	NUM	O
N	O	NOUN	B
+	O	CCONJ	O
patients	O	NOUN	B
with	O	ADP	O
single	O	ADJ	B
hot	O	ADJ	I
spots	O	NOUN	I
(	O	PUNCT	O
less	O	ADJ	O
than	O	ADP	O
or	O	CCONJ	O
equal	O	ADJ	O
to	O	PART	O
2	O	NUM	O
)	O	PUNCT	O
(	O	PUNCT	O
N	O	NOUN	B
+	O	CCONJ	O
IS	O	NOUN	B
)	O	PUNCT	O
;	O	PUNCT	O
3	O	X	O
)	O	PUNCT	O
12	O	NUM	O
N	O	NOUN	B
-	O	PUNCT	O
patients	O	NOUN	B
with	O	ADP	O
single	O	ADJ	B
hot	O	ADJ	I
spots	O	NOUN	I
(	O	PUNCT	O
less	O	ADJ	O
than	O	ADP	O
or	O	CCONJ	O
equal	O	ADJ	O
to	O	PART	O
2	O	NUM	O
)	O	PUNCT	O
(	O	PUNCT	O
N	O	NOUN	B
-	O	PUNCT	O
IS	O	PROPN	B
)	O	PUNCT	O
.	O	PUNCT	O


Further	O	ADV	O
,	O	PUNCT	O
they	O	PRON	O
are	O	AUX	O
consistent	O	ADJ	B
with	O	ADP	I
the	O	DET	O
suggestion	O	NOUN	O
that	O	SCONJ	O
sites	O	NOUN	B
homologous	O	ADJ	B
to	O	PART	O
the	O	DET	O
CAR1	B-GENE	NOUN	B
URS	I-GENE	PROPN	B
may	O	AUX	O
be	O	AUX	O
situated	O	VERB	O
in	O	ADP	O
the	O	DET	O
5	O	NUM	O
'	O	PART	O
-	O	PUNCT	O
flanking	O	VERB	B
regions	O	NOUN	O
of	O	ADP	O
multiple	O	ADJ	O
unrelated	O	ADJ	O
yeast	O	NOUN	B
genes	O	NOUN	I
.	O	PUNCT	O


Uses	O	NOUN	B
of	O	ADP	O
orthoclone	O	NOUN	B
OKT3	B-GENE	NOUN	B
for	O	ADP	O
prophylaxis	O	NOUN	B
of	O	ADP	O
rejection	O	NOUN	B
and	O	CCONJ	O
induction	O	NOUN	B
in	O	ADP	O
initial	O	ADJ	O
nonfunction	O	NOUN	B
in	O	ADP	O
kidney	O	NOUN	B
transplantation	O	NOUN	I
.	O	PUNCT	O


Uses	O	NOUN	B
of	O	ADP	O
orthoclone	O	NOUN	B
OKT3	O	NOUN	B
for	O	ADP	O
prophylaxis	O	NOUN	B
of	O	ADP	O
rejection	O	NOUN	B
and	O	CCONJ	O
induction	O	NOUN	B
in	O	ADP	O
initial	O	ADJ	O
nonfunction	O	NOUN	B
in	O	ADP	O
kidney	O	NOUN	B
transplantation	O	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
Denmark	O	PROPN	B
only	O	ADV	O
1	O	NUM	O
-	O	SYM	O
3	O	NUM	O
cases	O	NOUN	B
of	O	ADP	O
transfusion	O	NOUN	B
-	O	PUNCT	O
associated	O	VERB	B
hepatitis	O	NOUN	B
NANB	O	NOUN	I
(	O	PUNCT	O
TAH	O	PROPN	B
-	O	PUNCT	O
NANB	O	NOUN	B
)	O	PUNCT	O
are	O	AUX	O
registered	O	VERB	O
annually	O	ADV	B
or	O	CCONJ	O
about	O	ADV	O
1	O	NUM	O
case	O	NOUN	B
per	O	ADP	O
100	O	NUM	O
,	O	PUNCT	O
000	O	NUM	O
units	O	NOUN	O
transfused	O	VERB	B
.	O	PUNCT	O


Hence	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
replacement	O	NOUN	B
of	O	ADP	O
Phe	O	PROPN	B
-	O	PUNCT	O
62	O	NUM	O
with	O	ADP	O
Ser	O	NOUN	B
specifically	O	ADV	O
affects	O	VERB	O
a	O	DET	O
determinant	O	NOUN	B
on	O	ADP	O
the	O	DET	O
lambda	B-GENE	NOUN	B
I	I-GENE	NUM	I
light	I-GENE	ADJ	I
chain	I-GENE	NOUN	I
that	O	PRON	O
is	O	AUX	O
necessary	O	ADJ	O
for	O	ADP	O
the	O	DET	O
intracellular	O	ADJ	B
transport	O	NOUN	B
of	O	ADP	O
this	O	DET	O
molecule	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
deduced	O	VERB	O
amino	O	NOUN	B
acid	O	NOUN	I
sequence	O	NOUN	I
has	O	AUX	O
the	O	DET	O
greatest	O	ADJ	O
homology	O	NOUN	B
(	O	PUNCT	O
61	O	NUM	O
%	O	NOUN	O
)	O	PUNCT	O
to	O	PART	O
the	O	DET	O
green	B-GENE	ADJ	B
alga	I-GENE	NOUN	I
Scenedemus	I-GENE	NOUN	B
obliquus	I-GENE	NOUN	I
plastocyanin	I-GENE	NOUN	I
.	O	PUNCT	O


Higher	O	ADJ	B
fasting	O	ADJ	B
serum	O	NOUN	B
gastrin	B-GENE	NOUN	O
concentration	O	NOUN	B
(	O	PUNCT	O
102	O	NUM	O
.	O	PUNCT	O
0	O	NUM	O
+	O	CCONJ	O
/	O	SYM	O
-	O	PUNCT	O
21	O	NUM	O
.	O	PUNCT	O
1	O	NUM	O
vs	O	CCONJ	O
63	O	NUM	O
.	O	PUNCT	O
3	O	NUM	O
+	O	CCONJ	O
/	O	SYM	O
-	O	PUNCT	O
8	O	NUM	O
.	O	PUNCT	O
3	O	NUM	O
ng	O	NOUN	O
.	O	PUNCT	O
l	O	NOUN	O
-	O	PUNCT	O
1	O	NUM	O
)	O	PUNCT	O
,	O	PUNCT	O
and	O	CCONJ	O
greater	O	ADJ	O
postprandial	O	ADJ	B
gastrin	B-GENE	NOUN	B
release	O	NOUN	O
(	O	PUNCT	O
AUC0	O	NOUN	B
-	O	PUNCT	O
120	O	NUM	O
:	O	PUNCT	O
16690	O	NUM	O
+	O	CCONJ	O
/	O	SYM	O
-	O	PUNCT	O
2648	O	NUM	O
vs	O	CCONJ	O
10654	O	NUM	O
+	O	CCONJ	O
/	O	SYM	O
-	O	PUNCT	O
1283	O	NUM	O
ng	O	NOUN	O
.	O	PUNCT	O
l	O	NOUN	O
-	O	PUNCT	O
1	O	NUM	O
min	O	NOUN	O
)	O	PUNCT	O
were	O	AUX	O
observed	O	VERB	O
after	O	ADP	O
VTP	O	PROPN	B
-	O	PUNCT	O
HM	O	NOUN	B
than	O	ADP	O
after	O	ADP	O
VTP	O	PROPN	B
-	O	PUNCT	O
Cas	O	PROPN	B
.	O	PUNCT	O


The	O	DET	O
experimental	O	ADJ	B
group	O	NOUN	I
consisted	O	VERB	O
of	O	ADP	O
61	O	NUM	O
examinees	O	NOUN	B
class	O	NOUN	O
II	O	NUM	O
/	O	SYM	O
2	O	NUM	B
orthodontic	O	ADJ	B
anomalies	O	NOUN	I
.	O	PUNCT	O


Subjects	O	NOUN	B
were	O	AUX	O
16	O	NUM	O
male	O	NOUN	B
chronic	O	ADJ	B
schizophrenics	O	NOUN	B
consisting	O	VERB	O
of	O	ADP	O
8	O	NUM	O
DST	O	NOUN	B
suppressors	O	NOUN	B
and	O	CCONJ	O
8	O	NUM	O
nonsuppressors	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
this	O	DET	O
article	O	NOUN	O
we	O	PRON	O
propose	O	VERB	O
to	O	PART	O
find	O	VERB	O
out	O	ADP	O
the	O	DET	O
percentage	O	NOUN	B
of	O	ADP	O
normal	O	ADJ	B
occlusion	O	NOUN	I
and	O	CCONJ	O
the	O	DET	O
distribution	O	NOUN	B
of	O	ADP	O
maloclusions	O	NOUN	B
,	O	PUNCT	O
according	O	VERB	O
to	O	ADP	O
the	O	DET	O
anteroposterior	O	ADJ	B
relationship	O	NOUN	B
between	O	ADP	O
the	O	DET	O
dental	O	NOUN	B
archs	O	NOUN	I
(	O	PUNCT	O
following	O	VERB	O
the	O	DET	O
ANGLE3	O	NOUN	B
classification	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
previously	O	ADV	O
identified	O	VERB	B
,	O	PUNCT	O
by	O	ADP	O
screening	O	VERB	B
a	O	DET	O
lambda	O	NOUN	B
gt11	O	NOUN	I
expression	O	NOUN	B
library	O	NOUN	I
,	O	PUNCT	O
murine	B-GENE	ADJ	B
protein	I-GENE	NOUN	O
mXBP	I-GENE	NOUN	B
,	O	PUNCT	O
which	O	DET	O
binds	O	VERB	B
to	O	PART	O
a	O	DET	O
sequence	O	NOUN	B
which	O	DET	O
overlaps	O	VERB	O
the	O	DET	O
3	O	NUM	O
'	O	PART	O
end	O	NOUN	O
of	O	ADP	O
the	O	DET	O
murine	B-GENE	ADJ	B
class	I-GENE	NOUN	B
II	I-GENE	NUM	I
major	I-GENE	ADJ	I
histocompatibility	I-GENE	NOUN	I
complex	I-GENE	NOUN	I
A	I-GENE	NOUN	I
alpha	I-GENE	NOUN	I
gene	I-GENE	NOUN	I
X	I-GENE	NOUN	I
box	I-GENE	NOUN	I
,	O	PUNCT	O
a	O	DET	O
conserved	O	VERB	O
transcription	O	NOUN	B
element	O	NOUN	I
found	O	VERB	O
upstream	O	ADV	B
of	O	ADP	O
all	O	DET	O
class	O	NOUN	B
II	O	NUM	I
genes	O	NOUN	I
.	O	PUNCT	O


A	O	DET	O
contiguous	O	ADJ	B
and	O	CCONJ	O
sequentially	O	ADV	O
occupied	O	VERB	O
secondary	O	ADJ	O
Fur	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
binding	I-GENE	VERB	B
site	I-GENE	NOUN	O
in	O	ADP	O
entC	B-GENE	NOUN	B
was	O	AUX	O
protected	O	VERB	O
at	O	ADP	O
higher	O	ADJ	O
Fur	B-GENE	ADJ	B
concentrations	O	NOUN	B
,	O	PUNCT	O
extending	O	VERB	O
the	O	DET	O
protected	O	VERB	O
region	O	NOUN	O
to	O	PART	O
+	O	CCONJ	O
49	O	NUM	O
,	O	PUNCT	O
and	O	CCONJ	O
sequestering	O	VERB	B
the	O	DET	O
putative	O	ADJ	O
Shine	O	PROPN	B
-	O	PUNCT	O
Dalgarno	O	NOUN	B
sequence	O	NOUN	O
.	O	PUNCT	O


The	O	DET	O
major	O	ADJ	O
promoter	O	NOUN	B
responds	O	VERB	O
strongly	O	ADV	O
to	O	PART	O
virus	O	NOUN	B
-	O	PUNCT	O
encoded	O	VERB	B
trans	O	ADJ	B
activators	O	NOUN	I
EIA	B-GENE	NOUN	B
and	O	CCONJ	O
EIV	B-GENE	NOUN	B
and	O	CCONJ	O
contains	O	VERB	O
four	O	NUM	O
elements	O	NOUN	B
:	O	PUNCT	O
a	O	DET	O
TAGA	O	NOUN	B
motif	O	NOUN	B
analogous	O	ADJ	O
to	O	PART	O
the	O	DET	O
TATA	O	NOUN	B
box	O	NOUN	O
,	O	PUNCT	O
two	O	NUM	O
EIIF	B-GENE	NOUN	B
sites	I-GENE	NOUN	B
present	O	ADJ	O
in	O	ADP	O
an	O	DET	O
inverted	O	ADJ	B
orientation	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
an	O	DET	O
ATF	B-GENE	NOUN	B
/	O	SYM	O
CREB	B-GENE	NOUN	B
site	O	NOUN	B
.	O	PUNCT	O


Luteinizing	B-GENE	NOUN	B
hormone	I-GENE	NOUN	I
-	I-GENE	PUNCT	O
releasing	I-GENE	VERB	B
hormone	I-GENE	NOUN	B
analog	O	NOUN	I
therapy	O	NOUN	I
of	O	ADP	O
uterine	O	ADJ	B
fibroid	O	NOUN	I
:	O	PUNCT	O
analysis	O	NOUN	B
of	O	ADP	O
results	O	NOUN	B
obtained	O	VERB	O
with	O	ADP	O
buserelin	O	NOUN	B
administered	O	VERB	B
intranasally	O	ADV	B
and	O	CCONJ	O
goserelin	O	NOUN	B
administered	O	VERB	B
subcutaneously	O	ADV	B
as	O	ADP	O
a	O	DET	O
monthly	O	ADJ	B
depot	O	NOUN	B
.	O	PUNCT	O


Although	O	SCONJ	O
there	O	PRON	O
are	O	AUX	O
no	O	DET	O
octamer	O	NOUN	B
elements	O	NOUN	I
in	O	ADP	O
the	O	DET	O
adenovirus	O	NOUN	B
genome	O	NOUN	B
that	O	PRON	O
are	O	AUX	O
known	O	VERB	O
to	O	PART	O
be	O	AUX	O
important	O	ADJ	O
for	O	ADP	O
transcription	O	NOUN	B
,	O	PUNCT	O
there	O	PRON	O
are	O	AUX	O
octamer	O	NOUN	B
elements	O	NOUN	I
in	O	ADP	O
the	O	DET	O
viral	O	ADJ	B
terminal	O	ADJ	I
repeat	O	NOUN	I
sequences	O	NOUN	I
.	O	PUNCT	O


A	O	DET	O
4	O	NUM	O
.	O	PUNCT	O
8	O	NUM	O
-	O	PUNCT	O
kilobase	O	NOUN	B
BamHI	B-GENE	NOUN	B
-	O	PUNCT	O
HindIII	B-GENE	NOUN	B
fragment	O	NOUN	I
encoding	O	VERB	B
the	O	DET	O
entire	B-GENE	ADJ	O
Neurospora	I-GENE	NOUN	B
crassa	I-GENE	ADJ	I
CuZn	I-GENE	NOUN	B
superoxide	I-GENE	NOUN	I
dismutase	I-GENE	NOUN	I
gene	I-GENE	NOUN	I
(	O	PUNCT	O
herein	O	ADV	O
designated	O	VERB	O
sod	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	O
)	O	PUNCT	O
was	O	AUX	O
isolated	O	VERB	B
from	O	ADP	O
a	O	DET	O
genomic	O	ADJ	B
library	O	NOUN	I
using	O	VERB	O
two	O	NUM	O
60	O	NUM	O
-	O	PUNCT	O
base	O	NOUN	B
deoxyoligonucleotide	O	NOUN	I
probes	O	NOUN	B
corresponding	O	VERB	O
to	O	PART	O
the	O	DET	O
published	O	VERB	B
N	O	NOUN	I
.	O	PUNCT	O
crassa	O	ADJ	B
amino	O	NOUN	B
acid	O	NOUN	I
sequence	O	NOUN	I
.	O	PUNCT	O


Using	O	VERB	O
appropriate	O	ADJ	O
synthetic	O	ADJ	B
HSE	O	NOUN	B
oligonucleotides	O	NOUN	B
,	O	PUNCT	O
three	O	NUM	O
types	O	NOUN	O
of	O	ADP	O
clones	O	NOUN	B
with	O	ADP	O
potential	O	ADJ	B
HSE	O	NOUN	B
binding	O	NOUN	B
domains	O	NOUN	I
were	O	AUX	O
isolated	O	VERB	B
from	O	ADP	O
a	O	DET	O
tomato	O	NOUN	B
lambda	O	NOUN	I
gt11	O	NOUN	I
expression	O	NOUN	B
library	O	NOUN	I
by	O	ADP	O
DNA	O	NOUN	B
-	O	PUNCT	O
ligand	O	NOUN	B
screening	O	NOUN	B
.	O	PUNCT	O


This	O	DET	O
result	O	NOUN	O
indicates	O	VERB	O
that	O	SCONJ	O
separate	O	ADJ	O
complexes	O	NOUN	B
exist	O	VERB	O
containing	O	VERB	O
ankyrin	B-GENE	NOUN	B
and	O	CCONJ	O
fodrin	B-GENE	NOUN	B
with	O	ADP	O
either	O	CCONJ	O
uvomorulin	B-GENE	NOUN	B
or	O	CCONJ	O
Na	B-GENE	NOUN	B
+	I-GENE	CCONJ	O
,	I-GENE	PUNCT	O
K	I-GENE	PROPN	B
+	I-GENE	CCONJ	O
-	I-GENE	PUNCT	O
ATPase	I-GENE	NOUN	B
.	O	PUNCT	O


These	O	DET	O
genes	O	NOUN	B
are	O	AUX	O
expressed	O	VERB	B
within	O	ADP	O
a	O	DET	O
few	O	ADJ	O
hours	O	NOUN	O
of	O	ADP	O
the	O	DET	O
initiation	O	NOUN	B
of	O	ADP	O
development	O	NOUN	B
;	O	PUNCT	O
their	O	PRON	O
mRNAs	O	NOUN	B
accumulate	O	VERB	B
to	O	PART	O
a	O	DET	O
peak	O	NOUN	O
at	O	ADP	O
12	O	NUM	O
hr	O	NOUN	O
and	O	CCONJ	O
persist	O	VERB	O
until	O	ADP	O
culmination	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
transient	O	ADJ	B
cotransfection	O	NOUN	B
assays	O	NOUN	I
using	O	VERB	O
Chang	O	PROPN	B
liver	O	NOUN	I
cells	O	NOUN	I
(	O	PUNCT	O
CCL	O	NOUN	B
13	O	NUM	O
)	O	PUNCT	O
,	O	PUNCT	O
pM1	O	ADJ	B
DNA	O	NOUN	I
exerts	O	VERB	O
a	O	DET	O
6	O	NUM	O
-	O	PUNCT	O
to	O	PART	O
10	O	NUM	O
-	O	PUNCT	O
fold	O	ADJ	B
trans	O	ADJ	B
-	O	PUNCT	O
activating	O	VERB	B
effect	O	NOUN	B
on	O	ADP	O
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
pSV2CAT	O	NOUN	B
reporter	O	NOUN	I
plasmid	O	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
determined	O	VERB	O
the	O	DET	O
nucleotide	O	NOUN	B
(	O	PUNCT	O
nt	O	NOUN	O
)	O	PUNCT	O
sequence	O	NOUN	O
of	O	ADP	O
the	O	DET	O
7	B-GENE	NUM	O
.	I-GENE	PUNCT	O
5	I-GENE	NUM	O
-	I-GENE	PUNCT	O
kb	I-GENE	NOUN	B
COR	I-GENE	NOUN	B
segment	I-GENE	NOUN	B
that	O	PRON	O
encompasses	O	VERB	O
a	O	DET	O
cluster	O	NOUN	B
of	O	ADP	O
six	O	NUM	O
genes	O	NOUN	B
(	O	PUNCT	O
CYC1	B-GENE	NOUN	B
,	O	PUNCT	O
UTR1	B-GENE	NOUN	B
,	O	PUNCT	O
UTR3	B-GENE	NOUN	B
,	O	PUNCT	O
OSM1	B-GENE	NOUN	B
,	O	PUNCT	O
tRNA	B-GENE	NOUN	B
(	I-GENE	PUNCT	O
Gly	I-GENE	NOUN	B
)	I-GENE	PUNCT	O
and	O	CCONJ	O
RAD7	B-GENE	NOUN	B
)	O	PUNCT	O
located	O	ADJ	O
on	O	ADP	O
chromosome	O	NOUN	B
X	O	NOUN	I
of	O	ADP	O
the	O	DET	O
yeast	O	NOUN	B
Saccharomyces	O	X	B
cerevisiae	O	X	I
.	O	PUNCT	O


No	O	DET	O
recombination	O	NOUN	O
signal	O	NOUN	O
sequences	O	NOUN	O
have	O	AUX	O
been	O	AUX	O
found	O	VERB	O
contiguous	O	ADJ	B
to	O	PART	O
the	O	DET	O
recombination	O	NOUN	B
point	O	NOUN	O
.	O	PUNCT	O


The	O	DET	O
antinociceptive	O	ADJ	B
properties	O	NOUN	B
,	O	PUNCT	O
as	O	ADP	O
measured	O	VERB	B
by	O	ADP	O
the	O	DET	O
tail	O	NOUN	B
-	O	PUNCT	O
flick	O	NOUN	B
and	O	CCONJ	O
hot	O	ADJ	B
-	O	PUNCT	O
plate	O	NOUN	B
tests	O	NOUN	O
,	O	PUNCT	O
and	O	CCONJ	O
the	O	DET	O
motor	O	NOUN	B
effects	O	NOUN	I
of	O	ADP	O
an	O	DET	O
intrathecally	O	ADV	B
-	O	PUNCT	O
administered	O	VERB	B
benzodiazepine	O	NOUN	B
agonist	O	NOUN	B
midazolam	O	NOUN	B
,	O	PUNCT	O
alone	O	ADV	O
,	O	PUNCT	O
and	O	CCONJ	O
in	O	ADP	O
combination	O	NOUN	B
with	O	ADP	O
morphine	O	NOUN	B
,	O	PUNCT	O
was	O	AUX	O
examined	O	VERB	O
in	O	ADP	O
rats	O	NOUN	B
.	O	PUNCT	O


To	O	PART	O
identify	O	VERB	O
these	O	DET	O
sites	O	NOUN	B
,	O	PUNCT	O
the	O	DET	O
deduced	O	VERB	O
amino	O	NOUN	B
acid	O	NOUN	I
sequence	O	NOUN	I
of	O	ADP	O
the	O	DET	O
3T3	O	NOUN	B
-	O	PUNCT	O
L1	O	NOUN	B
adipocyte	B-GENE	NOUN	B
insulin	I-GENE	NOUN	B
receptor	I-GENE	NOUN	I
of	O	ADP	O
the	O	DET	O
mouse	O	NOUN	B
was	O	AUX	O
determined	O	VERB	O
.	O	PUNCT	O


PAO	O	NOUN	B
blocks	O	VERB	B
turnover	O	NOUN	B
of	O	ADP	O
the	O	DET	O
phosphoryl	O	NOUN	B
group	O	NOUN	I
of	O	ADP	O
pp15	B-GENE	NOUN	B
,	O	PUNCT	O
causing	O	VERB	O
its	O	PRON	O
accumulation	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
thereby	O	ADV	O
appears	O	VERB	O
to	O	PART	O
interrupt	O	VERB	O
signal	O	NOUN	B
transmission	O	NOUN	I
from	O	ADP	O
the	O	DET	O
receptor	O	NOUN	B
to	O	PART	O
the	O	DET	O
glucose	O	NOUN	B
-	O	PUNCT	O
transport	O	NOUN	B
system	O	NOUN	I
.	O	PUNCT	O


It	O	PRON	O
is	O	AUX	O
likely	O	ADJ	O
that	O	SCONJ	O
the	O	DET	O
sequence	O	NOUN	B
similarities	O	NOUN	B
reflect	O	VERB	O
a	O	DET	O
common	O	ADJ	O
molecular	O	ADJ	B
architecture	O	NOUN	I
of	O	ADP	O
the	O	DET	O
two	O	NUM	O
heme	O	NOUN	B
binding	O	NOUN	I
sites	O	NOUN	I
and	O	CCONJ	O
of	O	ADP	O
a	O	DET	O
copper	O	NOUN	B
binding	O	NOUN	O
site	O	NOUN	O
in	O	ADP	O
these	O	DET	O
enzymes	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
TraD	B-GENE	NOUN	B
protein	I-GENE	NOUN	I
(	I-GENE	PUNCT	O
83	I-GENE	NUM	O
,	I-GENE	PUNCT	O
899	I-GENE	NUM	O
Da	I-GENE	NOUN	O
)	I-GENE	PUNCT	O
contains	O	VERB	O
three	O	NUM	O
hydrophobic	O	ADJ	B
regions	O	NOUN	I
,	O	PUNCT	O
of	O	ADP	O
which	O	DET	O
two	O	NUM	O
are	O	AUX	O
located	O	ADJ	O
near	O	ADP	B
the	O	DET	O
amino	O	NOUN	B
-	O	PUNCT	O
terminal	O	ADJ	B
region	O	NOUN	O
.	O	PUNCT	O


The	O	DET	O
protein	O	NOUN	B
product	O	NOUN	I
of	O	ADP	O
orfD	B-GENE	NOUN	B
,	O	PUNCT	O
which	O	DET	O
is	O	AUX	O
probably	O	ADV	O
a	O	DET	O
new	O	ADJ	O
tra	B-GENE	NOUN	B
gene	I-GENE	NOUN	I
(	O	PUNCT	O
named	O	VERB	O
traX	B-GENE	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
contains	O	VERB	O
65	O	NUM	O
%	O	NOUN	O
hydrophobic	O	ADJ	B
amino	O	NOUN	B
acids	O	NOUN	I
,	O	PUNCT	O
especially	O	ADV	O
rich	O	ADJ	O
in	O	ADP	O
alanine	O	NOUN	B
and	O	CCONJ	O
leucine	O	NOUN	B
.	O	PUNCT	O


A	O	DET	O
gene	O	NOUN	B
in	O	ADP	O
Drosophila	O	X	B
melanogaster	O	NOUN	O
that	O	PRON	O
maps	O	VERB	B
cytologically	O	ADV	B
to	O	PART	O
2C1	O	PROPN	B
-	O	PUNCT	O
3	O	NUM	O
on	O	ADP	O
the	O	DET	O
distal	O	ADJ	B
portion	O	NOUN	O
of	O	ADP	O
the	O	DET	O
X	O	NOUN	B
-	O	PUNCT	O
chromosome	O	NOUN	B
encodes	O	VERB	B
a	O	DET	O
member	O	NOUN	B
of	O	ADP	O
the	O	DET	O
steroid	B-GENE	NOUN	B
/	I-GENE	SYM	O
thyroid	I-GENE	NOUN	B
hormone	I-GENE	NOUN	I
receptor	I-GENE	NOUN	I
superfamily	I-GENE	NOUN	B
.	O	PUNCT	O


A	O	DET	O
portion	O	NOUN	B
of	O	ADP	O
Region	O	PROPN	O
II	O	PROPN	O
also	O	ADV	O
resembles	O	VERB	O
part	O	NOUN	O
of	O	ADP	O
the	O	DET	O
human	O	ADJ	B
c	B-GENE	NOUN	O
-	I-GENE	PUNCT	O
jun	I-GENE	NOUN	B
oncoprotein	O	NOUN	I
'	O	PART	O
s	O	NOUN	O
leucine	O	NOUN	B
zipper	O	NOUN	I
,	O	PUNCT	O
which	O	DET	O
in	O	ADP	O
turn	O	NOUN	O
,	O	PUNCT	O
has	O	AUX	O
been	O	AUX	O
demonstrated	O	VERB	O
to	O	PART	O
be	O	AUX	O
the	O	DET	O
heterodimerization	O	NOUN	B
site	O	NOUN	I
between	O	ADP	O
the	O	DET	O
jun	B-GENE	NOUN	B
and	O	CCONJ	O
fos	B-GENE	NOUN	B
oncoproteins	I-GENE	NOUN	I
.	O	PUNCT	O


To	O	PART	O
determine	O	VERB	O
whether	O	SCONJ	O
vanadate	O	NOUN	B
could	O	AUX	O
inhibit	O	VERB	B
PEPCK	B-GENE	NOUN	B
gene	I-GENE	NOUN	B
transcription	O	NOUN	I
,	O	PUNCT	O
a	O	DET	O
series	O	NOUN	O
of	O	ADP	O
chimeric	O	ADJ	B
genes	O	NOUN	I
containing	O	VERB	O
several	O	ADJ	O
deletions	O	NOUN	B
in	O	ADP	O
the	O	DET	O
P	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
enolypyruvate	I-GENE	ADJ	B
carboxykinase	I-GENE	NOUN	B
promoter	I-GENE	NOUN	B
between	O	ADP	O
-	O	PUNCT	O
550	O	NUM	O
and	O	CCONJ	O
-	O	PUNCT	O
68	O	NUM	O
was	O	AUX	O
linked	O	VERB	O
to	O	PART	O
the	O	DET	O
structural	O	ADJ	B
genes	O	NOUN	I
for	O	ADP	O
either	O	CCONJ	O
amino	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
3	I-GENE	NUM	B
-	I-GENE	PUNCT	O
glycosyl	I-GENE	NOUN	B
phosphotransferase	I-GENE	NOUN	I
(	O	PUNCT	O
neo	B-GENE	NOUN	B
)	O	PUNCT	O
or	O	CCONJ	O
chloramphenicol	B-GENE	NOUN	B
acetyltransferase	I-GENE	NOUN	I
and	O	CCONJ	O
introduced	O	VERB	O
into	O	ADP	O
hepatoma	O	NOUN	B
cells	O	NOUN	I
using	O	VERB	O
three	O	NUM	O
methods	O	NOUN	B
:	O	PUNCT	O
(	O	PUNCT	O
a	O	X	O
)	O	PUNCT	O
infection	O	NOUN	B
with	O	ADP	O
a	O	DET	O
Moloney	O	NOUN	B
murine	O	ADJ	I
leukemia	O	NOUN	I
virus	O	NOUN	B
-	O	PUNCT	O
based	O	VERB	B
retrovirus	O	NOUN	B
,	O	PUNCT	O
(	O	PUNCT	O
b	O	X	O
)	O	PUNCT	O
transfection	O	NOUN	B
and	O	CCONJ	O
stable	O	ADJ	B
selection	O	NOUN	B
for	O	ADP	O
neo	B-GENE	NOUN	B
expression	O	NOUN	I
,	O	PUNCT	O
or	O	CCONJ	O
(	O	PUNCT	O
c	O	X	O
)	O	PUNCT	O
transient	O	ADJ	B
expression	O	NOUN	B
of	O	ADP	O
chloroamphenicol	B-GENE	NOUN	B
acetyltransferase	I-GENE	NOUN	I
.	O	PUNCT	O


Significant	O	ADJ	O
correlations	O	NOUN	B
were	O	AUX	O
obtained	O	VERB	O
between	O	ADP	O
changes	O	NOUN	B
in	O	ADP	O
SSEP	O	NOUN	B
in	O	ADP	O
response	O	NOUN	B
to	O	PART	O
AS	O	ADJ	B
and	O	CCONJ	O
the	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
not	O	PART	O
deep	O	ADJ	B
residual	O	ADJ	I
-	O	PUNCT	O
organic	O	ADJ	B
disturbances	O	NOUN	B
,	O	PUNCT	O
so	O	ADV	O
-	O	PUNCT	O
called	O	VERB	O
"	O	PUNCT	O
ground	O	NOUN	B
"	O	PUNCT	O
in	O	ADP	O
psychogenic	O	ADJ	B
disorders	O	NOUN	I
.	O	PUNCT	O


Both	O	DET	O
strains	O	NOUN	B
grew	O	VERB	B
very	O	ADV	O
poorly	O	ADV	O
,	O	PUNCT	O
or	O	CCONJ	O
not	O	PART	O
at	O	ADV	O
all	O	ADV	O
,	O	PUNCT	O
on	O	ADP	O
nonfermentable	O	ADJ	B
carbon	O	NOUN	B
sources	O	NOUN	B
and	O	CCONJ	O
exhibited	O	VERB	O
,	O	PUNCT	O
at	O	ADP	O
most	O	ADJ	O
,	O	PUNCT	O
only	O	ADV	O
5	O	NUM	O
%	O	NOUN	O
of	O	ADP	O
wild	B-GENE	ADJ	B
-	I-GENE	PUNCT	O
type	I-GENE	NOUN	B
ubiquinol	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
cytochrome	I-GENE	NOUN	B
c	I-GENE	NOUN	I
oxidoreductase	I-GENE	NOUN	I
activity	O	NOUN	O
.	O	PUNCT	O


Regulation	O	NOUN	B
of	O	ADP	O
irgA	B-GENE	NOUN	B
by	O	ADP	O
iron	O	NOUN	B
in	O	ADP	O
V	O	NOUN	B
.	O	PUNCT	O
cholerae	O	NOUN	B
occurs	O	VERB	B
at	O	ADP	O
the	O	DET	O
transcriptional	O	ADJ	B
level	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
there	O	PRON	O
is	O	AUX	O
an	O	DET	O
interrupted	O	ADJ	B
dyad	O	NOUN	O
symmetric	O	ADJ	O
sequence	O	NOUN	O
in	O	ADP	O
the	O	DET	O
vicinity	O	NOUN	O
of	O	ADP	O
the	O	DET	O
promoter	O	NOUN	B
that	O	PRON	O
is	O	AUX	O
homologous	O	ADJ	B
to	O	PART	O
Fur	B-GENE	NOUN	B
binding	I-GENE	NOUN	I
sites	I-GENE	NOUN	I
of	O	ADP	O
E	O	NOUN	B
.	O	PUNCT	O
coli	O	X	B
.	O	PUNCT	O


The	O	DET	O
recombinant	O	NOUN	B
contains	O	VERB	O
the	O	DET	O
normal	O	ADJ	O
beta	B-GENE	NOUN	B
A	I-GENE	NOUN	I
-	I-GENE	PUNCT	O
globin	I-GENE	NOUN	B
gene	I-GENE	NOUN	I
,	O	PUNCT	O
the	O	DET	O
mutant	O	ADJ	B
gene	O	NOUN	I
and	O	CCONJ	O
Ylp	O	NOUN	B
vector	O	NOUN	I
sequences	O	NOUN	O
between	O	ADP	O
the	O	DET	O
two	O	NUM	O
copies	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
characterized	O	VERB	B
Y	B-GENE	NOUN	O
'	I-GENE	PART	O
repeated	I-GENE	VERB	O
sequence	I-GENE	NOUN	B
families	I-GENE	NOUN	O
provide	O	VERB	O
an	O	DET	O
experimental	O	ADJ	B
system	O	NOUN	I
in	O	ADP	O
which	O	DET	O
repeated	O	VERB	O
sequence	O	NOUN	B
interactions	O	NOUN	O
and	O	CCONJ	O
subsequent	O	ADJ	O
evolution	O	NOUN	B
can	O	AUX	O
be	O	AUX	O
studied	O	VERB	O
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
primary	O	ADJ	O
transcripts	O	NOUN	B
of	O	ADP	O
a	O	DET	O
variant	B-GENE	ADJ	B
tRNA	I-GENE	NOUN	B
(	I-GENE	PUNCT	O
Val	I-GENE	NOUN	O
)	I-GENE	PUNCT	O
(	I-GENE	PUNCT	O
UAC	I-GENE	NOUN	B
)	I-GENE	PUNCT	O
gene	I-GENE	NOUN	O
are	O	AUX	O
processing	O	VERB	B
deficient	O	ADJ	B
under	O	ADP	O
standard	O	ADJ	B
growth	O	NOUN	B
conditions	O	NOUN	I
(	O	PUNCT	O
30	O	NUM	O
degrees	O	NOUN	B
C	O	NOUN	I
)	O	PUNCT	O
,	O	PUNCT	O
due	O	ADP	O
to	O	PART	O
a	O	DET	O
slightly	O	ADV	O
altered	O	ADJ	O
5	O	NUM	O
'	O	PART	O
flanking	O	ADJ	B
region	O	NOUN	I
.	O	PUNCT	O


Three	O	NUM	O
of	O	ADP	O
the	O	DET	O
short	O	ADJ	O
ORFs	O	NOUN	B
in	O	ADP	O
the	O	DET	O
central	O	ADJ	B
region	O	NOUN	I
of	O	ADP	O
BIV	O	NOUN	B
have	O	AUX	O
been	O	AUX	O
identified	O	VERB	B
by	O	ADP	O
location	O	NOUN	B
and	O	CCONJ	O
structural	O	ADJ	B
similarity	O	NOUN	I
to	O	PART	O
the	O	DET	O
nonstructural	O	ADJ	B
/	O	PUNCT	O
regulatory	O	ADJ	B
genes	O	NOUN	I
(	O	PUNCT	O
vif	B-GENE	NOUN	B
,	O	PUNCT	O
tat	B-GENE	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
rev	B-GENE	NOUN	B
)	O	PUNCT	O
of	O	ADP	O
other	O	ADJ	O
lentiviruses	O	NOUN	B
;	O	PUNCT	O
we	O	PRON	O
also	O	ADV	O
discovered	O	VERB	O
two	O	NUM	O
unique	O	ADJ	O
ORFs	O	NOUN	B
,	O	PUNCT	O
termed	O	VERB	O
W	O	NOUN	O
and	O	CCONJ	O
Y	O	NOUN	B
,	O	PUNCT	O
which	O	DET	O
may	O	AUX	O
serve	O	VERB	O
as	O	ADP	O
exons	O	NOUN	B
for	O	ADP	O
novel	O	ADJ	O
genes	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
contribution	O	NOUN	B
that	O	PRON	O
alternative	O	ADJ	B
splicing	O	NOUN	O
events	O	NOUN	O
in	O	ADP	O
c	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
myb	I-GENE	NOUN	B
expression	O	NOUN	B
may	O	AUX	O
make	O	VERB	O
on	O	ADP	O
c	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
myb	I-GENE	NOUN	B
function	O	NOUN	O
remains	O	VERB	O
to	O	PART	O
be	O	AUX	O
elucidated	O	VERB	O
.	O	PUNCT	O


IgG	B-GENE	NOUN	B
and	O	CCONJ	O
IgM	B-GENE	NOUN	B
antibody	O	NOUN	I
activity	O	NOUN	B
was	O	AUX	O
determined	O	VERB	O
by	O	ADP	O
adding	O	VERB	O
a	O	DET	O
1	O	NUM	O
:	O	PUNCT	O
100	O	NUM	O
dilution	O	NOUN	B
of	O	ADP	O
serum	O	NOUN	B
to	O	PART	O
plates	O	NOUN	B
coated	O	VERB	B
with	O	ADP	O
A60	B-GENE	NOUN	B
antigen	I-GENE	NOUN	I
.	O	PUNCT	O


1	O	NUM	O
,	O	PUNCT	O
among	O	ADP	O
which	O	DET	O
nine	O	NUM	O
have	O	AUX	O
been	O	AUX	O
cloned	O	VERB	B
and	O	CCONJ	O
two	O	NUM	O
(	O	PUNCT	O
potentially	O	ADV	O
functional	O	ADJ	B
)	O	PUNCT	O
sequenced	O	VERB	O
.	O	PUNCT	O


The	O	DET	O
urinary	O	ADJ	B
protein	O	NOUN	I
,	O	PUNCT	O
serum	O	NOUN	B
albumin	B-GENE	NOUN	I
,	O	PUNCT	O
BUN	O	NOUN	B
and	O	CCONJ	O
SCr	O	NOUN	B
all	O	DET	O
had	O	AUX	O
very	O	ADV	O
significant	O	ADJ	O
improvement	O	NOUN	B
.	O	PUNCT	O


Patients	O	NOUN	B
with	O	ADP	O
detectable	O	ADJ	B
serum	O	NOUN	B
TNF	B-GENE	NOUN	B
levels	O	NOUN	B
had	O	AUX	O
significantly	O	ADV	O
lower	O	ADJ	O
serum	O	NOUN	B
T3	O	NOUN	B
concentrations	O	NOUN	B
compared	O	VERB	B
to	O	PART	O
those	O	DET	O
with	O	ADP	O
undetectable	O	ADJ	B
levels	O	NOUN	O
[	O	PUNCT	O
1	O	X	O
.	O	PUNCT	O
072	O	NUM	O
+	O	CCONJ	O
/	O	SYM	O
-	O	PUNCT	O
0	O	NUM	O
.	O	PUNCT	O
588	O	NUM	O
vs	O	CCONJ	O
.	O	PUNCT	O


Rats	O	NOUN	B
with	O	ADP	O
one	O	NUM	O
olfactory	O	ADJ	B
bulb	O	NOUN	I
removed	O	VERB	B
and	O	CCONJ	O
the	O	DET	O
contralateral	O	ADJ	B
naris	O	NOUN	O
closed	O	VERB	O
can	O	AUX	O
detect	O	VERB	B
odors	O	NOUN	B
.	O	PUNCT	O


Expression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
human	O	ADJ	B
T	B-GENE	NOUN	O
cell	I-GENE	NOUN	O
receptor	I-GENE	NOUN	O
(	I-GENE	PUNCT	O
TCR	I-GENE	NOUN	B
)	I-GENE	PUNCT	O
alpha	I-GENE	NOUN	B
gene	I-GENE	NOUN	I
is	O	AUX	O
regulated	O	VERB	O
by	O	ADP	O
a	O	DET	O
T	O	NOUN	B
cell	O	NOUN	I
-	O	PUNCT	O
specific	O	ADJ	B
transcriptional	O	ADJ	B
enhancer	O	NOUN	I
that	O	PRON	O
is	O	AUX	O
located	O	ADJ	O
4	O	NUM	O
.	O	PUNCT	O
5	O	NUM	O
kilobases	O	NOUN	B
(	O	PUNCT	O
kb	O	NOUN	O
)	O	PUNCT	O
3	O	NUM	O
'	O	PUNCT	O
to	O	PART	O
the	O	DET	O
C	B-GENE	NOUN	B
alpha	I-GENE	NOUN	I
gene	I-GENE	NOUN	I
segment	I-GENE	NOUN	O
.	O	PUNCT	O


The	O	DET	O
Ets	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	B
binding	I-GENE	NOUN	B
site	I-GENE	NOUN	I
was	O	AUX	O
localized	O	ADJ	B
to	O	PART	O
a	O	DET	O
17	O	NUM	O
-	O	PUNCT	O
base	O	NOUN	B
pair	O	NOUN	I
(	O	PUNCT	O
bp	O	NOUN	O
)	O	PUNCT	O
region	O	NOUN	O
from	O	ADP	O
the	O	DET	O
3	O	NUM	O
'	O	PART	O
end	O	NOUN	O
of	O	ADP	O
T	B-GENE	NOUN	B
alpha	I-GENE	NOUN	I
2	I-GENE	NUM	I
.	O	PUNCT	O


Human	O	ADJ	B
T	O	NOUN	B
-	O	PUNCT	O
cell	O	NOUN	B
leukemia	O	NOUN	I
virus	O	NOUN	O
type	O	NOUN	O
I	O	NUM	O
(	O	PUNCT	O
HTLV	O	NOUN	B
-	O	PUNCT	O
I	O	NOUN	B
)	O	PUNCT	O
encodes	O	VERB	B
a	O	DET	O
40	O	NUM	O
-	O	PUNCT	O
kDa	O	NOUN	B
nuclear	O	ADJ	I
protein	O	NOUN	I
,	O	PUNCT	O
Tax	B-GENE	NOUN	B
,	O	PUNCT	O
which	O	DET	O
stimulates	O	VERB	B
transcription	O	NOUN	B
from	O	ADP	O
three	O	NUM	O
21	O	NUM	O
-	O	PUNCT	O
base	O	NOUN	B
pair	O	NOUN	I
(	O	PUNCT	O
bp	O	NOUN	O
)	O	PUNCT	O
repeats	O	NOUN	B
in	O	ADP	O
its	O	PRON	O
U3	O	NOUN	B
region	O	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
now	O	ADV	O
identified	O	VERB	B
,	O	PUNCT	O
after	O	ADP	O
21	O	NUM	O
serial	O	ADJ	O
undiluted	O	ADJ	O
passages	O	NOUN	B
of	O	ADP	O
MHV	O	NOUN	B
,	O	PUNCT	O
a	O	DET	O
small	B-GENE	ADJ	O
DI	I-GENE	NOUN	O
RNA	I-GENE	NOUN	O
,	O	PUNCT	O
DIssF	B-GENE	NOUN	B
,	O	PUNCT	O
which	O	DET	O
is	O	AUX	O
efficiently	O	ADV	O
packaged	O	VERB	O
into	O	ADP	O
virions	O	NOUN	B
.	O	PUNCT	O


This	O	DET	O
,	O	PUNCT	O
together	O	ADV	O
with	O	ADP	O
the	O	DET	O
data	O	NOUN	B
obtained	O	VERB	O
with	O	ADP	O
haloperidol	O	NOUN	B
,	O	PUNCT	O
suggests	O	VERB	O
that	O	SCONJ	O
a	O	DET	O
minimal	O	ADJ	O
increase	O	NOUN	B
in	O	ADP	O
the	O	DET	O
firing	O	NOUN	B
rate	O	NOUN	B
of	O	ADP	O
LC	O	NOUN	B
cells	O	NOUN	I
(	O	PUNCT	O
+	O	CCONJ	O
140	O	NUM	O
%	O	NOUN	O
)	O	PUNCT	O
is	O	AUX	O
required	O	VERB	O
before	O	ADP	O
it	O	PRON	O
could	O	AUX	O
influence	O	VERB	B
the	O	DET	O
turnover	O	NOUN	B
of	O	ADP	O
NA	O	PROPN	B
,	O	PUNCT	O
as	O	ADP	O
measured	O	VERB	B
by	O	ADP	O
DOPAC	O	NOUN	B
changes	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
Mauriceville	O	PROPN	B
and	O	CCONJ	O
Varkud	O	NOUN	B
mitochondrial	O	ADJ	I
plasmids	O	NOUN	I
are	O	AUX	O
closely	O	ADV	O
related	O	ADJ	O
,	O	PUNCT	O
closed	O	VERB	B
-	O	PUNCT	O
circular	O	ADJ	B
DNAs	O	NOUN	B
(	O	PUNCT	O
3	O	NUM	O
.	O	PUNCT	O
6	O	NUM	O
and	O	CCONJ	O
3	O	NUM	O
.	O	PUNCT	O
7	O	NUM	O
kb	O	NOUN	O
,	O	PUNCT	O
respectively	O	ADV	O
)	O	PUNCT	O
that	O	PRON	O
have	O	AUX	O
characteristics	O	NOUN	B
of	O	ADP	O
mtDNA	O	NOUN	B
introns	O	NOUN	B
and	O	CCONJ	O
retroid	O	ADJ	B
elements	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
circadian	O	ADJ	B
rhythm	O	NOUN	I
,	O	PUNCT	O
however	O	ADV	O
,	O	PUNCT	O
was	O	AUX	O
not	O	PART	O
affected	O	VERB	B
and	O	CCONJ	O
the	O	DET	O
difference	O	NOUN	O
between	O	ADP	O
minimum	O	NOUN	B
(	O	PUNCT	O
12	O	NUM	O
.	O	PUNCT	O
00	O	NUM	O
h	O	NOUN	O
)	O	PUNCT	O
and	O	CCONJ	O
maximum	O	NOUN	B
(	O	PUNCT	O
18	O	NUM	O
.	O	PUNCT	O
50	O	NUM	O
h	O	NOUN	O
)	O	PUNCT	O
serum	O	NOUN	B
concentrations	O	NOUN	B
was	O	AUX	O
31	O	NUM	O
.	O	PUNCT	O
3	O	NUM	O
%	O	NOUN	O
.	O	PUNCT	O


Most	O	ADJ	O
strains	O	NOUN	B
(	O	PUNCT	O
95	O	NUM	O
%	O	NOUN	O
)	O	PUNCT	O
of	O	ADP	O
S	O	NOUN	B
.	O	PUNCT	O
lugdunensis	O	NOUN	B
produced	O	VERB	O
a	O	DET	O
delta	B-GENE	NOUN	B
hemolysin	I-GENE	NOUN	I
like	O	ADP	O
that	O	DET	O
seen	O	VERB	O
with	O	ADP	O
nine	O	NUM	O
other	O	ADJ	O
species	O	NOUN	B
of	O	ADP	O
CNS	O	NOUN	B
.	O	PUNCT	O


Experiments	O	NOUN	B
showed	O	VERB	O
that	O	SCONJ	O
temporary	O	ADJ	B
arrest	O	NOUN	B
of	O	ADP	O
pulmonary	O	ADJ	B
circulation	O	NOUN	I
under	O	ADP	O
conditions	O	NOUN	B
of	O	ADP	O
extracorporeal	O	ADJ	B
circulation	O	NOUN	I
is	O	AUX	O
attended	O	VERB	B
by	O	ADP	O
the	O	DET	O
development	O	NOUN	B
of	O	ADP	O
ischemia	O	NOUN	B
of	O	ADP	O
the	O	DET	O
respiratory	O	ADJ	B
pulmonary	O	ADJ	I
tissue	O	NOUN	I
.	O	PUNCT	O


Taste	O	NOUN	B
reactivity	O	NOUN	I
tests	O	NOUN	I
were	O	AUX	O
used	O	VERB	O
to	O	PART	O
examine	O	VERB	O
the	O	DET	O
orofacial	O	ADJ	B
responses	O	NOUN	I
of	O	ADP	O
alcohol	O	NOUN	B
preferring	O	VERB	O
(	O	PUNCT	O
P	O	NOUN	O
)	O	PUNCT	O
rats	O	NOUN	B
and	O	CCONJ	O
alcohol	O	NOUN	B
nonpreferring	O	NOUN	I
(	O	PUNCT	O
NP	O	NOUN	B
)	O	PUNCT	O
rats	O	NOUN	B
to	O	ADP	O
the	O	DET	O
taste	O	NOUN	B
of	O	ADP	O
alcohol	O	NOUN	B
.	O	PUNCT	O


1	O	NUM	O
(	O	PUNCT	O
"	O	PUNCT	O
long	O	ADJ	B
method	O	NOUN	I
"	O	PUNCT	O
)	O	PUNCT	O
and	O	CCONJ	O
the	O	DET	O
HML	O	NOUN	B
method	O	NOUN	O
.	O	PUNCT	O


No	O	DET	O
causal	O	ADJ	O
relations	O	NOUN	O
may	O	AUX	O
be	O	AUX	O
inferred	O	VERB	O
from	O	ADP	O
the	O	DET	O
correlation	O	NOUN	B
between	O	ADP	O
the	O	DET	O
level	O	NOUN	B
of	O	ADP	O
trapezius	O	ADJ	B
activity	O	NOUN	I
and	O	CCONJ	O
complaints	O	NOUN	B
,	O	PUNCT	O
though	O	SCONJ	O
it	O	PRON	O
indicates	O	VERB	O
that	O	SCONJ	O
individual	O	NOUN	B
,	O	PUNCT	O
inexpedient	O	ADJ	B
muscle	O	NOUN	B
activity	O	NOUN	I
patterns	O	NOUN	O
may	O	AUX	O
constitute	O	VERB	O
an	O	DET	O
important	O	ADJ	O
risk	O	NOUN	B
factor	O	NOUN	I
for	O	ADP	O
development	O	NOUN	B
of	O	ADP	O
musculo	O	NOUN	B
-	O	PUNCT	O
skeletal	O	ADJ	B
complaints	O	NOUN	O
.	O	PUNCT	O


Analysis	O	NOUN	B
with	O	ADP	O
additional	O	ADJ	O
anti	O	ADJ	B
-	O	PUNCT	O
peptide	O	NOUN	B
antibodies	O	NOUN	I
specific	O	ADJ	B
for	O	ADP	O
alpha	B-GENE	NOUN	B
,	I-GENE	PUNCT	O
beta	I-GENE	NOUN	B
,	I-GENE	PUNCT	O
or	I-GENE	CCONJ	O
gamma	I-GENE	NOUN	B
PKC	I-GENE	NOUN	I
indicated	O	VERB	O
that	O	SCONJ	O
all	O	DET	O
three	O	NUM	O
types	O	NOUN	O
of	O	ADP	O
PKC	B-GENE	NOUN	B
are	O	AUX	O
expressed	O	VERB	B
in	O	ADP	O
JK	O	NOUN	B
cells	O	NOUN	I
;	O	PUNCT	O
however	O	ADV	O
,	O	PUNCT	O
JKPE	O	NOUN	B
cells	O	NOUN	O
lost	O	VERB	O
a	O	DET	O
major	O	ADJ	O
approximately	O	ADV	B
82	O	NUM	O
kDa	O	NOUN	O
immunoreactive	O	ADJ	B
cytosolic	O	ADJ	B
protein	O	NOUN	I
detectable	O	ADJ	B
with	O	ADP	O
anti	B-GENE	ADJ	B
-	I-GENE	PUNCT	O
PKC	I-GENE	NOUN	B
alpha	I-GENE	NOUN	B
antibody	I-GENE	NOUN	I
.	O	PUNCT	O


Erythrocyte	O	NOUN	B
protoporphyrin	O	NOUN	B
concentration	O	NOUN	B
increased	O	VERB	B
significantly	O	ADV	O
(	O	PUNCT	O
P	O	NOUN	O
less	O	ADJ	O
than	O	ADP	O
0	O	NUM	O
.	O	PUNCT	O
05	O	NUM	O
)	O	PUNCT	O
by	O	ADP	O
14	O	NUM	O
days	O	NOUN	B
in	O	ADP	O
dogs	O	NOUN	B
fed	O	VERB	B
the	O	DET	O
basal	O	ADJ	B
diet	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
remained	O	VERB	O
significantly	O	ADV	O
high	O	ADJ	O
relative	O	ADJ	O
to	O	PART	O
that	O	DET	O
in	O	ADP	O
dogs	O	NOUN	B
of	O	ADP	O
the	O	DET	O
other	O	ADJ	O
dietary	O	ADJ	B
groups	O	NOUN	I
for	O	ADP	O
the	O	DET	O
remainder	O	NOUN	O
of	O	ADP	O
the	O	DET	O
study	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
coding	O	VERB	B
sequences	O	NOUN	I
of	O	ADP	O
the	O	DET	O
Crry	B-GENE	NOUN	B
gene	I-GENE	NOUN	I
encompass	O	VERB	O
over	O	ADP	O
25	O	NUM	O
kb	O	NOUN	O
of	O	ADP	O
DNA	O	NOUN	B
,	O	PUNCT	O
whereas	O	SCONJ	O
the	O	DET	O
Crry	B-GENE	NOUN	B
-	O	PUNCT	O
ps	B-GENE	NOUN	B
sequences	O	NOUN	B
are	O	AUX	O
included	O	VERB	O
within	O	ADP	O
a	O	DET	O
single	O	ADJ	O
5	B-GENE	NUM	O
.	I-GENE	PUNCT	O
6	I-GENE	NUM	O
-	I-GENE	PUNCT	O
kb	I-GENE	NOUN	O
Eco	I-GENE	PROPN	B
-	I-GENE	PUNCT	O
R1	I-GENE	NOUN	B
fragment	I-GENE	NOUN	B
.	O	PUNCT	O


The	O	DET	O
genomic	O	ADJ	B
and	O	CCONJ	O
transcriptional	O	ADJ	B
complexity	O	NOUN	B
of	O	ADP	O
the	O	DET	O
Crry	B-GENE	NOUN	B
and	O	CCONJ	O
Crry	B-GENE	NOUN	B
-	O	PUNCT	O
ps	B-GENE	NOUN	B
genes	O	NOUN	I
.	O	PUNCT	O


Determination	O	NOUN	B
of	O	ADP	O
three	O	NUM	B
-	O	PUNCT	O
dimensional	O	ADJ	B
imaging	O	NOUN	B
properties	O	NOUN	B
of	O	ADP	O
a	O	DET	O
light	O	ADJ	B
microscope	O	NOUN	I
system	O	NOUN	I
.	O	PUNCT	O


Methods	O	NOUN	O
used	O	VERB	O
include	O	VERB	O
Cobb	O	PROPN	B
angle	O	NOUN	I
and	O	CCONJ	O
a	O	DET	O
segmental	O	ADJ	B
evaluation	O	NOUN	O
(	O	PUNCT	O
T7	O	NOUN	B
-	O	PUNCT	O
T12	O	NOUN	B
)	O	PUNCT	O
of	O	ADP	O
each	O	DET	O
of	O	ADP	O
convex	O	ADJ	B
and	O	CCONJ	O
concave	O	ADJ	B
rib	O	ADJ	B
-	O	PUNCT	O
vertebra	O	NOUN	B
angles	O	NOUN	I
(	O	PUNCT	O
RVAs	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
rib	O	ADJ	B
-	O	PUNCT	O
vertebra	O	NOUN	B
angle	O	NOUN	I
differences	O	NOUN	O
(	O	PUNCT	O
RVADs	O	PROPN	B
)	O	PUNCT	O
,	O	PUNCT	O
vertebral	O	ADJ	B
rotation	O	NOUN	I
,	O	PUNCT	O
tilt	O	NOUN	B
and	O	CCONJ	O
displacement	O	NOUN	B
.	O	PUNCT	O


Lars	O	PROPN	B
has	O	AUX	O
AIDS	O	PROPN	B
-	O	PUNCT	O
-	O	PUNCT	O
a	O	DET	O
more	O	ADV	O
dignified	O	ADJ	B
life	O	NOUN	I
with	O	ADP	I
care	O	NOUN	B
at	O	ADP	O
home	O	NOUN	B
.	O	PUNCT	O


Accumulations	O	NOUN	B
of	O	ADP	O
Tl	O	NOUN	B
+	O	CCONJ	O
1	O	NUM	O
(	O	PUNCT	O
202Tl	O	NUM	O
label	O	NOUN	B
)	O	PUNCT	O
were	O	AUX	O
6	O	NUM	O
times	O	NOUN	O
those	O	DET	O
for	O	ADP	O
Ga	O	PROPN	B
or	O	CCONJ	O
In	O	ADP	O
in	O	ADP	O
the	O	DET	O
brain	O	NOUN	B
and	O	CCONJ	O
muscles	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
.	O	PUNCT	O
1	O	NUM	O
times	O	NOUN	O
in	O	ADP	O
plasma	O	NOUN	B
.	O	PUNCT	O


A	O	DET	O
poor	O	ADJ	B
correlation	O	NOUN	I
was	O	AUX	O
also	O	ADV	O
observed	O	VERB	O
between	O	ADP	O
PbB	O	NOUN	B
and	O	CCONJ	O
ALAD	B-GENE	NOUN	B
activity	O	NOUN	B
of	O	ADP	O
the	O	DET	O
stearate	O	NOUN	B
workers	O	NOUN	I
.	O	PUNCT	O


Since	O	SCONJ	O
the	O	DET	O
UfAP	B-GENE	NOUN	B
and	O	CCONJ	O
UTMP	B-GENE	PROPN	B
share	O	VERB	O
many	O	ADJ	O
biosynthetic	O	ADJ	B
and	O	CCONJ	O
structural	O	ADJ	B
features	O	NOUN	I
that	O	PRON	O
include	O	VERB	O
site	O	NOUN	B
of	O	ADP	O
biosynthesis	O	NOUN	B
in	O	ADP	O
the	O	DET	O
endometrium	O	NOUN	B
,	O	PUNCT	O
P4	O	NOUN	B
-	O	PUNCT	O
responsiveness	O	NOUN	B
,	O	PUNCT	O
the	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
the	O	DET	O
mannose	O	NOUN	B
6	O	NUM	O
-	O	PUNCT	O
phosphate	O	NOUN	B
lysosomal	O	ADJ	B
recognition	O	NOUN	I
marker	O	NOUN	O
,	O	PUNCT	O
and	O	CCONJ	O
considerable	O	ADJ	O
sequence	O	NOUN	O
similarity	O	NOUN	O
,	O	PUNCT	O
the	O	DET	O
UfAP	B-GENE	NOUN	B
and	O	CCONJ	O
the	O	DET	O
UTMP	B-GENE	NOUN	B
may	O	AUX	O
have	O	AUX	O
homologous	O	ADJ	B
function	O	NOUN	I
which	O	DET	O
for	O	ADP	O
both	O	DET	O
still	O	ADV	O
remains	O	VERB	O
obscure	O	ADJ	B
.	O	PUNCT	O


Fifteen	O	NUM	O
light	O	NOUN	O
for	O	ADP	O
dates	O	NOUN	B
infants	O	NOUN	B
and	O	CCONJ	O
their	O	PRON	O
placentae	O	NOUN	B
were	O	AUX	O
compared	O	VERB	B
to	O	PART	O
15	O	NUM	O
well	O	ADV	O
-	O	PUNCT	O
grown	O	VERB	B
infants	O	NOUN	B
and	O	CCONJ	O
their	O	PRON	O
placentae	O	NOUN	B
.	O	PUNCT	O


Treating	O	VERB	B
renal	O	ADJ	B
anaemia	O	NOUN	I
with	O	ADP	O
recombinant	O	ADJ	B
human	O	ADJ	O
erythropoietin	B-GENE	NOUN	B
.	O	PUNCT	O


Basing	O	VERB	O
on	O	ADP	O
experimental	O	ADJ	B
toxicity	O	NOUN	B
research	O	NOUN	B
it	O	PRON	O
was	O	AUX	O
established	O	VERB	O
that	O	SCONJ	O
,	O	PUNCT	O
out	O	ADP	O
of	O	ADP	O
50	O	NUM	O
atmosphere	O	NOUN	B
metal	O	NOUN	B
corrosion	O	NOUN	B
inhibitors	O	NOUN	B
,	O	PUNCT	O
some	O	DET	O
14	O	NUM	O
per	O	ADP	O
cent	O	NOUN	O
were	O	AUX	O
found	O	VERB	O
extremely	O	ADV	O
hazardous	O	ADJ	B
,	O	PUNCT	O
42	O	NUM	O
per	O	ADP	O
cent	O	NOUN	O
-	O	PUNCT	O
-	O	PUNCT	O
of	O	ADP	O
high	O	ADJ	B
level	O	NOUN	B
hazardous	O	ADJ	B
,	O	PUNCT	O
33	O	NUM	O
percent	O	NOUN	B
-	O	PUNCT	O
-	O	PUNCT	O
of	O	ADP	O
moderate	O	ADJ	B
and	O	CCONJ	O
11	O	NUM	O
per	O	ADP	O
cent	O	NOUN	B
-	O	PUNCT	O
-	O	PUNCT	O
of	O	ADP	O
low	O	ADV	B
hazardous	O	ADJ	B
.	O	PUNCT	O


The	O	DET	O
effects	O	NOUN	B
on	O	ADP	O
reflex	O	ADJ	B
latencies	O	NOUN	B
but	O	CCONJ	O
not	O	PART	O
on	O	ADP	O
paCO2	O	NOUN	B
or	O	CCONJ	O
pHa	O	NOUN	B
were	O	AUX	O
blocked	O	VERB	B
by	O	ADP	O
naloxone	O	NOUN	B
(	O	PUNCT	O
2	O	NUM	O
mg	O	NOUN	O
/	O	SYM	O
kg	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
and	O	CCONJ	O
were	O	AUX	O
not	O	PART	O
present	O	ADJ	O
in	O	ADP	O
morphine	O	NOUN	B
-	O	PUNCT	O
tolerant	O	ADJ	B
animals	O	NOUN	B
.	O	PUNCT	O


Of	O	ADP	O
the	O	DET	O
remaining	O	VERB	O
seven	O	NUM	O
,	O	PUNCT	O
five	O	NUM	O
reacted	O	VERB	O
either	O	CCONJ	O
with	O	ADP	O
immediate	O	ADJ	B
and	O	CCONJ	O
strong	O	ADJ	B
symptoms	O	NOUN	B
or	O	CCONJ	O
had	O	AUX	O
spontaneously	O	ADV	B
reduced	O	VERB	B
gluten	B-GENE	NOUN	B
intake	O	NOUN	B
,	O	PUNCT	O
or	O	CCONJ	O
had	O	AUX	O
an	O	DET	O
acquired	O	VERB	B
IgA	B-GENE	NOUN	B
deficiency	O	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
addition	O	NOUN	O
serum	B-GENE	NOUN	B
IgE	I-GENE	NOUN	B
concentrations	O	NOUN	B
were	O	AUX	O
not	O	PART	O
statistically	O	ADV	O
different	O	ADJ	O
.	O	PUNCT	O


The	O	DET	O
findings	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
,	O	PUNCT	O
although	O	SCONJ	O
iodine	O	NOUN	B
deficiency	O	NOUN	I
is	O	AUX	O
the	O	DET	O
most	O	ADV	O
probable	O	ADJ	O
cause	O	NOUN	B
of	O	ADP	O
goiter	O	NOUN	B
among	O	ADP	O
immigrants	O	NOUN	B
of	O	ADP	O
the	O	DET	O
1928	O	NUM	O
cohort	O	NOUN	B
,	O	PUNCT	O
where	O	SCONJ	O
the	O	DET	O
native	O	ADJ	B
population	O	NOUN	B
is	O	AUX	O
concerned	O	ADJ	O
(	O	PUNCT	O
both	O	DET	O
men	O	NOUN	B
and	O	CCONJ	O
women	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
some	O	DET	O
other	O	ADJ	O
goitrogenic	O	ADJ	B
factor	O	NOUN	I
(	O	PUNCT	O
s	O	NOUN	O
)	O	PUNCT	O
must	O	AUX	O
be	O	AUX	O
involved	O	VERB	O
.	O	PUNCT	O


Co	O	PROPN	B
-	O	PUNCT	O
administration	O	NOUN	B
of	O	ADP	O
5FU	O	NOUN	B
,	O	PUNCT	O
angiotensin	B-GENE	NOUN	B
II	I-GENE	NUM	I
and	O	CCONJ	O
microspheres	O	NOUN	B
via	O	ADP	O
the	O	DET	O
hepatic	O	ADJ	B
artery	O	NOUN	I
may	O	AUX	O
reduce	O	VERB	B
drug	O	NOUN	B
exposure	O	NOUN	I
in	O	ADP	O
the	O	DET	O
systemic	O	ADJ	B
compartment	O	NOUN	I
and	O	CCONJ	O
therefore	O	ADV	O
may	O	AUX	O
increase	O	VERB	B
the	O	DET	O
therapeutic	O	ADJ	B
ratio	O	NOUN	I
of	O	ADP	O
5FU	O	NOUN	O
administration	O	NOUN	B
via	O	ADP	O
the	O	DET	O
hepatic	O	ADJ	B
artery	O	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
contrast	O	NOUN	O
,	O	PUNCT	O
2	O	NUM	O
,	O	PUNCT	O
397	O	NUM	O
(	O	PUNCT	O
74	O	NUM	O
%	O	NOUN	O
)	O	PUNCT	O
had	O	AUX	O
one	O	NUM	O
or	O	CCONJ	O
more	O	ADJ	O
risk	O	NOUN	B
factors	O	NOUN	I
(	O	PUNCT	O
not	O	PART	O
low	O	ADJ	B
risk	O	NOUN	I
)	O	PUNCT	O
;	O	PUNCT	O
of	O	ADP	O
these	O	DET	O
,	O	PUNCT	O
5	O	NUM	O
.	O	PUNCT	O
3	O	NUM	O
%	O	NOUN	O
died	O	VERB	B
in	O	ADP	O
6	O	NUM	O
weeks	O	NOUN	B
(	O	PUNCT	O
p	O	NOUN	O
less	O	ADJ	O
than	O	ADP	O
0	O	NUM	O
.	O	PUNCT	O
001	O	NUM	O
)	O	PUNCT	O
.	O	PUNCT	O


Comparison	O	NOUN	B
of	O	ADP	O
propofol	O	NOUN	B
and	O	CCONJ	O
thiopentone	O	NOUN	B
as	O	ADP	O
anaesthetic	O	ADJ	B
agents	O	NOUN	I
for	O	ADP	O
electroconvulsive	O	ADJ	B
therapy	O	NOUN	I
.	O	PUNCT	O


Nonvascular	O	ADJ	B
ophthalmic	O	ADJ	I
and	O	CCONJ	O
neurologic	O	ADJ	B
disorders	O	NOUN	I
that	O	PRON	O
can	O	AUX	O
be	O	AUX	O
confused	O	VERB	O
with	O	ADP	O
amaurosis	O	NOUN	B
fugax	O	NOUN	I
are	O	AUX	O
listed	O	VERB	O
,	O	PUNCT	O
and	O	CCONJ	O
an	O	DET	O
algorithm	O	NOUN	B
for	O	ADP	O
evaluation	O	NOUN	B
(	O	PUNCT	O
which	O	DET	O
includes	O	VERB	O
ophthalmic	O	ADJ	B
examination	O	NOUN	I
,	O	PUNCT	O
laboratory	O	ADJ	B
studies	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
noninvasive	O	ADJ	B
carotid	O	NOUN	I
artery	O	NOUN	I
studies	O	NOUN	I
)	O	PUNCT	O
is	O	AUX	O
given	O	VERB	O
.	O	PUNCT	O


These	O	DET	O
characteristics	O	NOUN	B
of	O	ADP	O
N22	O	NOUN	B
/	O	PUNCT	O
P22	O	NOUN	B
indicate	O	VERB	O
that	O	SCONJ	O
it	O	PRON	O
is	O	AUX	O
a	O	DET	O
localized	O	ADJ	B
synaptically	O	ADV	B
dependent	O	ADJ	I
event	O	NOUN	B
conforming	O	VERB	O
to	O	ADP	O
a	O	DET	O
transverse	O	ADJ	B
dipole	O	NOUN	B
with	O	ADP	O
dorsal	O	ADJ	B
negativity	O	NOUN	I
and	O	CCONJ	O
a	O	DET	O
simultaneous	O	ADJ	B
anterior	O	ADJ	B
positivity	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
evaluated	O	VERB	B
the	O	DET	O
likelihood	O	NOUN	B
of	O	ADP	O
tissues	O	NOUN	B
to	O	PART	O
be	O	AUX	O
positive	O	ADJ	B
for	O	ADP	O
carcinoembryonic	B-GENE	ADJ	B
antigen	I-GENE	NOUN	I
and	O	CCONJ	O
the	O	DET	O
intensity	O	NOUN	B
of	O	ADP	O
carcinoembryonic	B-GENE	ADJ	B
antigen	I-GENE	NOUN	I
staining	O	NOUN	O
in	O	ADP	O
specimens	O	NOUN	B
of	O	ADP	O
villous	O	ADJ	B
adenomas	O	NOUN	I
,	O	PUNCT	O
mixed	O	ADJ	B
polypoid	O	ADJ	I
villous	O	ADJ	B
adenomas	O	NOUN	I
,	O	PUNCT	O
polypoid	O	ADJ	B
adenomas	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
diverticulitis	O	NOUN	B
using	O	VERB	O
the	O	DET	O
peroxidase	B-GENE	NOUN	B
-	O	PUNCT	O
antiperoxidase	B-GENE	NOUN	B
technique	O	NOUN	I
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
support	O	VERB	O
the	O	DET	O
view	O	NOUN	O
that	O	SCONJ	O
clonidine	O	NOUN	B
and	O	CCONJ	O
6	O	NUM	O
-	O	PUNCT	O
OHDA	O	PROPN	B
,	O	PUNCT	O
but	O	CCONJ	O
not	O	PART	O
alpha	O	NOUN	B
-	O	PUNCT	O
MD	O	PROPN	B
,	O	PUNCT	O
have	O	AUX	O
central	O	ADJ	B
pressor	O	NOUN	I
actions	O	NOUN	B
in	O	ADP	O
the	O	DET	O
rat	O	NOUN	B
that	O	PRON	O
oppose	O	VERB	O
their	O	PRON	O
antihypertensive	O	ADJ	B
action	O	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
conclude	O	VERB	O
that	O	SCONJ	O
Hansel	O	PROPN	B
'	O	PART	O
s	O	NOUN	O
stain	O	NOUN	B
substantially	O	ADV	O
improves	O	VERB	B
the	O	DET	O
recognition	O	NOUN	B
of	O	ADP	O
eosinophiluria	O	NOUN	B
as	O	ADP	O
compared	O	VERB	B
with	O	ADP	O
Wright	O	NOUN	B
'	O	PART	I
s	O	NOUN	I
stain	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
study	O	NOUN	B
included	O	VERB	O
139	O	NUM	O
eyes	O	NOUN	B
with	O	ADP	O
presumed	O	VERB	O
ocular	O	ADJ	B
histoplasmosis	O	NOUN	I
syndrome	O	NOUN	I
(	O	PUNCT	O
POHS	O	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
age	O	NOUN	B
-	O	PUNCT	O
related	O	VERB	B
macular	O	NOUN	B
degeneration	O	NOUN	I
(	O	PUNCT	O
AMD	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Rarely	O	ADV	B
,	O	PUNCT	O
patients	O	NOUN	B
with	O	ADP	O
locally	O	ADV	B
advanced	O	ADJ	I
,	O	PUNCT	O
uncontrollable	O	ADJ	B
,	O	PUNCT	O
non	O	ADJ	B
-	O	PUNCT	O
metastatic	O	ADJ	B
prostatic	O	ADJ	B
cancer	O	NOUN	I
enjoy	O	VERB	O
prolonged	O	ADJ	B
survival	O	NOUN	B
.	O	PUNCT	O


ATP	O	NOUN	B
gamma	O	NOUN	B
S	O	NOUN	I
inhibition	O	NOUN	I
can	O	AUX	O
be	O	AUX	O
overcome	O	VERB	B
by	O	ADP	O
high	O	ADJ	O
concentrations	O	NOUN	B
of	O	ADP	O
ATP	O	NOUN	B
,	O	PUNCT	O
dATP	O	NOUN	B
,	O	PUNCT	O
araATP	O	ADJ	B
,	O	PUNCT	O
or	O	CCONJ	O
ddATP	O	NOUN	B
.	O	PUNCT	O


Enhancer	O	NOUN	B
and	O	CCONJ	O
promoter	O	NOUN	B
elements	O	NOUN	I
directing	O	VERB	O
activation	O	NOUN	B
and	O	CCONJ	O
glucocorticoid	O	NOUN	B
repression	O	NOUN	I
of	O	ADP	O
the	O	DET	O
alpha	B-GENE	NOUN	B
1	I-GENE	NUM	I
-	I-GENE	PUNCT	O
fetoprotein	I-GENE	NOUN	B
gene	I-GENE	NOUN	I
in	O	ADP	O
hepatocytes	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
gene	O	NOUN	B
is	O	AUX	O
contained	O	VERB	O
within	O	ADP	O
a	O	DET	O
1	O	NUM	O
.	O	PUNCT	O
8	O	NUM	O
-	O	PUNCT	O
kilobase	O	NOUN	B
AccI	B-GENE	NOUN	B
-	O	PUNCT	O
EcoRI	B-GENE	NOUN	B
restriction	O	NOUN	O
fragment	O	NOUN	O
mapping	O	NOUN	O
at	O	ADP	O
map	O	NOUN	B
coordinates	O	NOUN	B
0	O	NUM	O
.	O	PUNCT	O
136	O	NUM	O
to	O	PART	O
0	O	NUM	O
.	O	PUNCT	O
148	O	NUM	O
in	O	ADP	O
the	O	DET	O
UL	O	NOUN	B
region	O	NOUN	B
of	O	ADP	O
the	O	DET	O
EHV	O	PROPN	B
-	O	PUNCT	O
1	O	NUM	B
genome	O	NOUN	B
and	O	CCONJ	O
is	O	AUX	O
transcribed	O	VERB	B
from	O	ADP	O
right	O	ADJ	O
to	O	PART	O
left	O	VERB	O
.	O	PUNCT	O


Spontaneous	O	ADJ	B
sensitization	O	NOUN	B
to	O	PART	O
cross	O	VERB	B
-	O	PUNCT	O
reacting	O	VERB	B
chemicals	O	NOUN	B
in	O	ADP	O
a	O	DET	O
proportion	O	NOUN	B
of	O	ADP	O
control	O	ADJ	B
animals	O	NOUN	I
is	O	AUX	O
strongly	O	ADV	O
suggested	O	VERB	O
,	O	PUNCT	O
somewhat	O	ADV	O
akin	O	ADJ	O
to	O	PART	O
spontaneous	O	ADJ	B
sensitization	O	NOUN	O
in	O	ADP	O
patients	O	NOUN	B
with	O	ADP	O
anaphylactoid	O	ADJ	B
reactions	O	NOUN	I
to	O	PART	O
neuromuscular	O	ADJ	B
blockers	O	NOUN	I
on	O	ADP	O
first	O	ADJ	O
exposure	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
in	O	ADP	O
whom	O	PRON	O
IgE	B-GENE	NOUN	B
antibodies	I-GENE	NOUN	I
are	O	AUX	O
detected	O	VERB	B
.	O	PUNCT	O


The	O	DET	O
84	B-GENE	NUM	O
.	I-GENE	PUNCT	O
1C	I-GENE	NOUN	O
mAb	I-GENE	NOUN	B
recognizes	O	VERB	O
a	O	DET	O
site	O	NOUN	B
on	O	ADP	O
IgE	B-GENE	NOUN	B
which	O	DET	O
is	O	AUX	O
identical	O	ADJ	B
or	O	CCONJ	O
very	O	ADV	O
close	O	ADV	O
to	O	PART	O
the	O	DET	O
Fc	B-GENE	NOUN	B
epsilon	I-GENE	NOUN	I
R	I-GENE	NOUN	I
binding	I-GENE	NOUN	I
site	I-GENE	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
95	O	NUM	O
.	O	PUNCT	O
3	O	NUM	O
recognizes	O	VERB	O
a	O	DET	O
site	O	NOUN	B
on	O	ADP	O
IgE	B-GENE	NOUN	B
which	O	DET	O
is	O	AUX	O
related	O	ADJ	O
,	O	PUNCT	O
but	O	CCONJ	O
not	O	PART	O
identical	O	ADJ	O
to	O	PART	O
the	O	DET	O
Fc	B-GENE	NOUN	B
epsilon	I-GENE	NOUN	I
R	I-GENE	NOUN	I
binding	I-GENE	NOUN	I
site	I-GENE	NOUN	I
.	O	PUNCT	O


Endocrine	O	ADJ	B
cells	O	NOUN	I
were	O	AUX	O
studied	O	VERB	O
by	O	ADP	O
means	O	NOUN	O
of	O	ADP	O
Grimelius	O	PROPN	B
'	O	PART	I
silver	O	NOUN	B
staining	O	NOUN	I
and	O	CCONJ	O
immunostaining	O	NOUN	B
for	O	ADP	O
chromogranin	B-GENE	NOUN	B
,	O	PUNCT	O
a	O	DET	O
general	O	ADJ	O
marker	O	NOUN	B
of	O	ADP	O
endocrine	O	ADJ	B
cells	O	NOUN	I
.	O	PUNCT	O


A	O	DET	O
potential	O	ADJ	B
TATA	O	NOUN	B
box	O	NOUN	O
is	O	AUX	O
located	O	ADJ	O
29	O	NUM	O
base	O	NOUN	B
pairs	O	NOUN	I
upstream	O	ADJ	I
of	O	ADP	O
the	O	DET	O
first	O	ADJ	O
transcription	O	NOUN	B
initiation	O	NOUN	I
site	O	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
76	O	NUM	O
%	O	NOUN	O
of	O	ADP	O
59	O	NUM	O
lead	O	NOUN	B
-	O	PUNCT	O
toxic	O	ADJ	B
children	O	NOUN	B
,	O	PUNCT	O
bone	O	NOUN	B
lead	O	NOUN	B
values	O	NOUN	I
measured	O	VERB	B
by	O	ADP	O
LXRF	O	NOUN	B
were	O	AUX	O
equal	O	ADJ	O
to	O	PART	O
or	O	CCONJ	O
greater	O	ADJ	O
than	O	ADP	O
those	O	DET	O
measured	O	VERB	B
in	O	ADP	O
normal	O	ADJ	B
and	O	CCONJ	O
industrially	O	ADV	B
exposed	O	VERB	B
adults	O	NOUN	I
.	O	PUNCT	O


When	O	SCONJ	O
considered	O	VERB	O
with	O	ADP	O
the	O	DET	O
known	O	ADJ	O
neurotoxic	O	ADJ	B
effects	O	NOUN	O
on	O	ADP	O
children	O	NOUN	B
of	O	ADP	O
"	O	PUNCT	O
low	O	ADJ	B
levels	O	NOUN	B
"	O	PUNCT	O
of	O	ADP	O
exposure	O	NOUN	B
to	O	PART	I
lead	O	VERB	O
,	O	PUNCT	O
these	O	DET	O
results	O	NOUN	B
also	O	ADV	O
suggest	O	VERB	O
that	O	SCONJ	O
either	O	CCONJ	O
an	O	DET	O
excessively	O	ADV	O
narrow	O	ADJ	B
margin	O	NOUN	B
of	O	ADP	O
safety	O	NOUN	B
or	O	CCONJ	O
insufficient	O	ADJ	B
safety	O	NOUN	B
is	O	AUX	O
provided	O	VERB	O
by	O	ADP	O
present	O	ADJ	O
U	O	NOUN	B
.	O	PUNCT	O
S	O	NOUN	B
.	O	PUNCT	O
guidelines	O	NOUN	B
,	O	PUNCT	O
which	O	DET	O
classify	O	VERB	O
an	O	DET	O
elevated	O	ADJ	B
blood	O	NOUN	O
lead	O	NOUN	O
concentration	O	NOUN	B
as	O	ADP	O
25	O	NUM	O
micrograms	O	NOUN	B
/	O	PUNCT	O
dl	O	NOUN	B
or	O	CCONJ	O
greater	O	ADJ	B
.	O	PUNCT	O


In	O	ADP	O
resting	O	VERB	B
3T3	O	NOUN	I
cells	O	NOUN	I
,	O	PUNCT	O
jun	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
D	I-GENE	NOUN	B
is	O	AUX	O
expressed	O	VERB	B
at	O	ADP	O
a	O	DET	O
higher	O	ADJ	B
level	O	NOUN	B
compared	O	VERB	B
to	O	PART	O
c	B-GENE	NOUN	O
-	I-GENE	PUNCT	O
jun	I-GENE	NOUN	B
and	O	CCONJ	O
jun	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
B	I-GENE	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
its	O	PRON	O
transcription	O	NOUN	B
is	O	AUX	O
stimulated	O	VERB	B
only	O	ADV	O
slightly	O	ADV	O
by	O	ADP	O
serum	O	NOUN	B
growth	O	NOUN	I
factors	O	NOUN	I
.	O	PUNCT	O


Functional	O	ADJ	B
rearranged	O	ADJ	I
antibody	O	NOUN	I
genes	O	NOUN	I
were	O	AUX	O
detected	O	VERB	B
with	O	ADP	O
JH	B-GENE	NOUN	B
and	O	CCONJ	O
VH	B-GENE	NOUN	B
heavy	I-GENE	ADJ	I
chain	I-GENE	NOUN	I
probes	O	NOUN	I
and	O	CCONJ	O
with	O	ADP	O
Jk	B-GENE	NOUN	B
and	O	CCONJ	I
Vk	B-GENE	NOUN	I
light	I-GENE	ADJ	I
chain	I-GENE	NOUN	I
probes	O	NOUN	I
.	O	PUNCT	O


Isolation	O	NOUN	B
of	O	ADP	O
Weeksella	O	PROPN	B
virosa	O	X	I
(	O	PUNCT	O
formerly	O	ADV	O
CDC	O	NOUN	B
group	O	NOUN	B
IIf	O	NOUN	B
)	O	PUNCT	O
from	O	ADP	O
a	O	DET	O
vaginal	O	ADJ	B
sample	O	NOUN	I
.	O	PUNCT	O


Growth	O	NOUN	B
of	O	ADP	O
tracheal	O	ADJ	B
anastomoses	O	NOUN	I
in	O	ADP	O
growing	O	VERB	O
animals	O	NOUN	B


The	O	DET	O
ORF1	O	NOUN	B
product	O	NOUN	B
was	O	AUX	O
required	O	VERB	O
for	O	ADP	O
competence	O	NOUN	B
,	O	PUNCT	O
while	O	SCONJ	O
ORF2	O	NOUN	B
,	O	PUNCT	O
which	O	DET	O
was	O	AUX	O
cotranscribed	O	VERB	B
with	O	ADP	O
ORF1	O	NOUN	B
and	O	CCONJ	O
encoded	O	VERB	B
a	O	DET	O
predicted	O	VERB	O
protein	O	NOUN	B
of	O	ADP	O
126	O	NUM	O
amino	O	NOUN	B
acids	O	NOUN	I
,	O	PUNCT	O
was	O	AUX	O
not	O	PART	O
.	O	PUNCT	O


In	O	ADP	O
all	O	DET	O
sessions	O	NOUN	B
under	O	ADP	O
IFN	B-GENE	NOUN	B
,	O	PUNCT	O
the	O	DET	O
latency	O	NOUN	B
of	O	ADP	O
the	O	DET	O
P100	O	NOUN	B
component	O	NOUN	B
of	O	ADP	O
the	O	DET	O
VEP	O	PROPN	B
was	O	AUX	O
shortened	O	VERB	B
as	O	ADP	O
compared	O	VERB	B
to	O	PART	O
baseline	O	NOUN	B
conditions	O	NOUN	B
.	O	PUNCT	O


This	O	DET	O
paper	O	NOUN	O
presents	O	VERB	O
the	O	DET	O
reasons	O	NOUN	B
why	O	SCONJ	O
countries	O	NOUN	B
to	O	PART	O
which	O	DET	O
Chagas	O	PROPN	B
disease	O	NOUN	I
is	O	AUX	O
endemic	O	ADJ	B
should	O	AUX	O
carry	O	VERB	O
out	O	ADP	O
the	O	DET	O
relevant	O	ADJ	B
research	O	NOUN	B
themselves	O	PRON	O
.	O	PUNCT	O


The	O	DET	O
PETCO2	O	NOUN	B
measurement	O	NOUN	B
during	O	ADP	O
precordial	O	ADJ	B
compression	O	NOUN	I
predicted	O	VERB	B
the	O	DET	O
success	O	NOUN	B
of	O	ADP	O
defibrillation	O	NOUN	B
with	O	ADP	O
return	O	NOUN	B
of	O	ADP	I
spontaneous	O	ADJ	I
circulation	O	NOUN	I
.	O	PUNCT	O


Gastric	O	ADJ	B
CO2	O	NOUN	B
/	O	SYM	O
HCO3	O	NOUN	B
was	O	AUX	O
determined	O	VERB	O
in	O	ADP	O
absence	O	NOUN	B
of	O	ADP	O
simultaneous	O	ADJ	B
inhibition	O	NOUN	B
of	O	ADP	O
acid	O	NOUN	B
secretion	O	NOUN	I
by	O	ADP	O
intra	O	ADJ	B
-	O	PUNCT	O
and	O	CCONJ	O
extragastric	O	ADJ	B
pCO2	O	NOUN	B
/	O	SYM	O
pH	O	NOUN	B
measurements	O	NOUN	B
in	O	ADP	O
23	O	NUM	O
persons	O	NOUN	B
and	O	CCONJ	O
calculated	O	VERB	B
using	O	VERB	O
the	O	DET	O
equation	O	NOUN	B
of	O	ADP	O
Henderson	O	PROPN	B
-	O	PUNCT	O
Hasselbalch	O	PROPN	B
.	O	PUNCT	O
pCO2	O	NOUN	B
was	O	AUX	O
measured	O	VERB	B
with	O	ADP	O
use	O	NOUN	O
of	O	ADP	O
a	O	DET	O
new	O	ADJ	O
electrode	O	NOUN	B
.	O	PUNCT	O


Inefficacy	O	NOUN	B
of	O	ADP	O
phosphine	O	NOUN	B
fumigation	O	NOUN	I
against	O	ADP	O
ticks	O	NOUN	B
.	O	PUNCT	O


According	O	VERB	O
to	O	ADP	O
the	O	DET	O
published	O	VERB	B
sequence	O	NOUN	I
of	O	ADP	O
the	O	DET	O
CHS1	B-GENE	NOUN	B
gene	I-GENE	NOUN	I
,	O	PUNCT	O
this	O	DET	O
fragment	O	NOUN	B
contains	O	VERB	O
four	O	NUM	O
repeats	O	NOUN	B
of	O	ADP	O
a	O	DET	O
TGAAACA	O	NOUN	B
consensus	O	NOUN	B
sequence	O	NOUN	I
previously	O	ADV	O
identified	O	VERB	B
in	O	ADP	O
the	O	DET	O
alpha	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
factor	I-GENE	NOUN	B
-	O	PUNCT	O
inducible	O	ADJ	B
BAR1	B-GENE	NOUN	B
promoter	I-GENE	NOUN	I
[	O	PUNCT	O
Kronstad	O	PROPN	B
,	O	PUNCT	O
J	O	PROPN	O
.	O	PUNCT	O


Xenopus	B-GENE	NOUN	B
homolog	I-GENE	NOUN	I
of	I-GENE	ADP	O
the	I-GENE	DET	O
mos	I-GENE	NOUN	B
protooncogene	I-GENE	NOUN	I
transforms	O	VERB	I
mammalian	O	ADJ	B
fibroblasts	O	NOUN	B
and	O	CCONJ	O
induces	O	VERB	B
maturation	O	NOUN	B
of	O	ADP	O
Xenopus	O	NOUN	B
oocytes	O	NOUN	B
.	O	PUNCT	O


Southern	O	NOUN	B
blot	O	NOUN	I
analyses	O	NOUN	I
demonstrated	O	VERB	O
a	O	DET	O
low	O	ADJ	B
,	O	PUNCT	O
if	O	SCONJ	O
not	O	PART	O
single	O	ADJ	O
,	O	PUNCT	O
copy	O	NOUN	B
number	O	NOUN	I
for	O	ADP	O
this	O	DET	O
gene	O	NOUN	B
and	O	CCONJ	O
conservation	O	NOUN	B
of	O	ADP	O
this	O	DET	O
domain	O	NOUN	B
in	O	ADP	O
other	O	ADJ	O
vertebrates	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
conclude	O	VERB	O
that	O	SCONJ	O
(	O	PUNCT	O
a	O	X	O
)	O	PUNCT	O
the	O	DET	O
likelihood	O	NOUN	B
of	O	ADP	O
detecting	O	VERB	B
carcinoma	O	NOUN	B
or	O	CCONJ	O
atypical	O	ADJ	B
hyperplasia	O	NOUN	B
exclusively	O	ADV	O
in	O	ADP	O
the	O	DET	O
adipose	O	NOUN	B
tissue	O	NOUN	I
component	O	NOUN	O
of	O	ADP	O
grossly	O	ADV	B
benign	O	ADJ	I
breast	O	NOUN	B
biopsies	O	NOUN	I
is	O	AUX	O
extremely	O	ADV	O
low	O	ADJ	B
,	O	PUNCT	O
and	O	CCONJ	O
(	O	PUNCT	O
b	O	X	O
)	O	PUNCT	O
a	O	DET	O
possible	O	ADJ	O
cost	O	NOUN	B
-	O	PUNCT	O
effective	O	ADJ	B
method	O	NOUN	B
of	O	ADP	O
sampling	O	NOUN	B
grossly	O	ADV	O
benign	O	ADJ	B
breast	O	NOUN	B
biopsies	O	NOUN	I
consists	O	VERB	O
of	O	ADP	O
initially	O	ADV	O
submitting	O	VERB	O
a	O	DET	O
maximum	O	NOUN	B
of	O	ADP	O
10	O	NUM	O
blocks	O	NOUN	B
of	O	ADP	O
fibrous	O	ADJ	B
parenchyma	O	NOUN	I
for	O	ADP	O
each	O	DET	O
case	O	NOUN	B
,	O	PUNCT	O
then	O	ADV	O
examining	O	VERB	B
the	O	DET	O
remaining	O	VERB	O
tissue	O	NOUN	B
histologically	O	ADV	B
only	O	ADV	O
if	O	SCONJ	O
carcinoma	O	NOUN	B
or	O	CCONJ	O
atypical	O	ADJ	B
hyperplasia	O	NOUN	B
is	O	AUX	O
found	O	VERB	O
among	O	ADP	O
these	O	DET	O
blocks	O	NOUN	B
.	O	PUNCT	O


A	O	DET	O
brief	O	ADJ	O
account	O	NOUN	O
of	O	ADP	O
the	O	DET	O
1988	O	NUM	O
seminar	O	NOUN	B
in	O	ADP	O
Shanghai	O	PROPN	B
on	O	ADP	O
viral	O	ADJ	B
hepatitis	O	NOUN	I
A	O	NOUN	O


Erythrocytic	O	ADJ	B
stages	O	NOUN	I
of	O	ADP	O
mammalian	O	ADJ	B
malarial	O	ADJ	B
parasites	O	NOUN	B
contain	O	VERB	O
acristate	O	NOUN	B
mitochondria	O	NOUN	B
whose	O	DET	O
functions	O	NOUN	B
are	O	AUX	O
not	O	PART	O
well	O	ADV	O
understood	O	VERB	O
.	O	PUNCT	O


Restriction	O	NOUN	B
maps	O	NOUN	O
of	O	ADP	O
the	O	DET	O
cloned	O	VERB	B
plasmids	O	NOUN	B
revealed	O	VERB	B
that	O	SCONJ	O
their	O	PRON	O
chromosomal	O	ADJ	B
inserts	O	NOUN	I
consisted	O	VERB	O
of	O	ADP	O
overlapping	O	VERB	O
fragments	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
contrast	O	NOUN	O
,	O	PUNCT	O
a	O	DET	O
similar	O	ADJ	O
fragment	O	NOUN	B
lacking	O	VERB	B
the	O	DET	O
38	O	NUM	O
-	O	PUNCT	O
base	O	NOUN	B
-	O	PUNCT	O
pair	O	NOUN	B
region	O	NOUN	O
had	O	AUX	O
no	O	DET	O
such	O	ADJ	O
stabilizing	O	VERB	B
effect	O	NOUN	I
.	O	PUNCT	O


This	O	DET	O
TC	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
II	I-GENE	NUM	B
enhanson	I-GENE	NOUN	B
,	O	PUNCT	O
which	O	DET	O
is	O	AUX	O
identical	O	ADJ	B
to	O	PART	O
the	O	DET	O
kappa	B-GENE	NOUN	B
B	I-GENE	NOUN	I
motif	I-GENE	NOUN	B
from	O	ADP	O
the	O	DET	O
kappa	B-GENE	NOUN	B
chain	I-GENE	NOUN	I
enhancer	I-GENE	NOUN	I
,	O	PUNCT	O
was	O	AUX	O
active	O	ADJ	B
in	O	ADP	O
both	O	CCONJ	O
lymphoid	O	ADJ	B
and	O	CCONJ	O
non	O	ADJ	B
-	O	PUNCT	O
lymphoid	O	ADJ	B
cells	O	NOUN	O
,	O	PUNCT	O
which	O	DET	O
contrasts	O	VERB	O
with	O	ADP	O
the	O	DET	O
previously	O	ADV	O
reported	O	VERB	O
lymphoid	O	ADJ	B
cell	O	NOUN	I
specificity	O	NOUN	B
of	O	ADP	O
the	O	DET	O
kappa	B-GENE	NOUN	B
B	I-GENE	NOUN	I
motif	I-GENE	NOUN	B
.	O	PUNCT	O


The	O	DET	O
DNA	O	NOUN	B
sequences	O	NOUN	I
predict	O	VERB	O
proteins	O	NOUN	B
for	O	ADP	O
SRP54sc	B-GENE	NOUN	B
and	O	CCONJ	O
SRP54sp	B-GENE	NOUN	O
that	O	PRON	O
are	O	AUX	O
47	O	NUM	O
%	O	NOUN	O
and	O	CCONJ	O
52	O	NUM	O
%	O	NOUN	O
identical	O	ADJ	B
to	O	PART	O
SRP54mam	B-GENE	NOUN	B
,	O	PUNCT	O
respectively	O	ADV	O
.	O	PUNCT	O


Antihistamines	O	NOUN	B
in	O	ADP	O
asthma	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
therefore	O	ADV	O
evaluated	O	VERB	B
the	O	DET	O
efficacy	O	NOUN	B
and	O	CCONJ	O
safety	O	NOUN	B
of	O	ADP	O
doxazosin	O	NOUN	B
,	O	PUNCT	O
a	O	DET	O
new	O	ADJ	O
orally	O	ADV	B
active	O	ADJ	O
selective	O	ADJ	B
alpha	B-GENE	NOUN	I
1	I-GENE	NUM	I
blocker	O	NOUN	B
,	O	PUNCT	O
in	O	ADP	O
patients	O	NOUN	B
with	O	ADP	O
systemic	O	ADJ	B
hypertension	O	NOUN	I
with	O	ADP	O
concomitant	O	ADJ	B
airflow	O	NOUN	B
limitation	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
discussion	O	NOUN	B
focuses	O	VERB	O
primarily	O	ADV	O
on	O	ADP	O
the	O	DET	O
newer	O	ADJ	O
drugs	O	NOUN	B
like	O	ADP	O
angiotensin	B-GENE	NOUN	B
converting	I-GENE	NOUN	O
enzyme	I-GENE	NOUN	B
inhibitors	O	NOUN	I
,	O	PUNCT	O
alpha	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
adrenergic	I-GENE	ADJ	B
receptor	I-GENE	NOUN	I
blockers	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
calcium	O	NOUN	B
antagonists	O	NOUN	I
.	O	PUNCT	O


A	O	DET	O
736	O	NUM	O
-	O	PUNCT	O
bp	O	NOUN	B
sequence	O	NOUN	B
of	O	ADP	O
the	O	DET	O
5	O	NUM	O
'	O	PART	O
flanking	O	ADJ	B
region	O	NOUN	I
adjacent	O	ADJ	B
to	O	PART	O
the	O	DET	O
cap	O	NOUN	B
site	O	NOUN	I
of	O	ADP	O
the	O	DET	O
human	B-GENE	ADJ	B
AFP	I-GENE	NOUN	O
gene	I-GENE	NOUN	O
shows	O	VERB	O
a	O	DET	O
61	O	NUM	O
%	O	NOUN	O
similarity	O	NOUN	B
with	O	ADP	O
the	O	DET	O
corresponding	O	ADJ	O
region	O	NOUN	O
of	O	ADP	O
the	O	DET	O
mouse	B-GENE	NOUN	B
AFP	I-GENE	NOUN	B
gene	I-GENE	NOUN	O
.	O	PUNCT	O


Nodular	O	ADJ	B
involvement	O	NOUN	B
of	O	ADP	O
the	O	DET	O
left	O	ADJ	B
lung	O	NOUN	I
and	O	CCONJ	O
infiltration	O	NOUN	B
of	O	ADP	O
the	O	DET	O
mucosa	O	NOUN	B
of	O	ADP	O
the	O	DET	O
left	O	ADJ	B
lower	O	ADJ	I
lobe	O	ADJ	I
bronchus	O	NOUN	I
followed	O	VERB	O
very	O	ADV	O
gradually	O	ADV	O
and	O	CCONJ	O
a	O	DET	O
monoclonal	O	ADJ	B
gammopathy	O	NOUN	I
(	O	PUNCT	O
IgA	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
-	I-GENE	PUNCT	O
Type	I-GENE	NOUN	B
Kappa	I-GENE	NOUN	I
)	O	PUNCT	O
was	O	AUX	O
demonstrated	O	VERB	O
.	O	PUNCT	O


These	O	DET	O
data	O	NOUN	B
locate	O	VERB	O
the	O	DET	O
aniridia	B-GENE	NOUN	B
gene	I-GENE	NOUN	I
(	O	PUNCT	O
AN2	B-GENE	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
a	O	DET	O
recurrent	O	ADJ	B
T	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
cell	I-GENE	NOUN	B
leukemia	I-GENE	NOUN	I
breakpoint	I-GENE	NOUN	I
(	O	PUNCT	O
TCL2	B-GENE	NOUN	B
)	O	PUNCT	O
in	O	ADP	O
the	O	DET	O
marker	O	NOUN	B
sequence	O	NOUN	B
,	O	PUNCT	O
on	O	ADP	O
opposite	O	ADJ	O
sides	O	NOUN	O
of	O	ADP	O
MIC1	B-GENE	NOUN	B
.	O	PUNCT	O


A	O	DET	O
fine	O	ADJ	B
-	O	PUNCT	O
structure	O	NOUN	B
deletion	O	NOUN	O
map	O	NOUN	O
of	O	ADP	O
human	O	ADJ	B
chromosome	O	NOUN	O
11p	O	NOUN	O
:	O	PUNCT	O
analysis	O	NOUN	B
of	O	ADP	O
J1	O	NOUN	O
series	O	NOUN	O
hybrids	O	NOUN	O
.	O	PUNCT	O


Most	O	ADJ	O
of	O	ADP	O
them	O	PRON	O
were	O	AUX	O
situated	O	VERB	O
at	O	ADP	O
Sylvius	O	ADJ	B
fissure	O	NOUN	I
(	O	PUNCT	O
13	O	NUM	O
cases	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Intracellular	O	ADJ	B
activity	O	NOUN	O
studies	O	NOUN	O
indicated	O	VERB	O
that	O	SCONJ	O
,	O	PUNCT	O
at	O	ADP	O
ten	O	NUM	O
times	O	NOUN	O
MBC	O	NOUN	B
,	O	PUNCT	O
only	O	ADV	O
penicillin	O	NOUN	B
had	O	AUX	O
any	O	DET	O
significant	O	ADJ	O
activity	O	NOUN	B
against	O	ADP	O
intracellular	O	ADJ	B
staphylococci	O	NOUN	B
,	O	PUNCT	O
reducing	O	VERB	B
survival	O	NOUN	B
by	O	ADP	O
28	O	NUM	O
%	O	NOUN	O
.	O	PUNCT	O


The	O	DET	O
lowest	O	ADJ	O
detectable	O	ADJ	B
concentration	O	NOUN	B
was	O	AUX	O
1	O	NUM	O
.	O	PUNCT	O
0	O	NUM	O
ng	O	NOUN	O
/	O	PUNCT	O
ml	O	NOUN	O
in	O	ADP	O
the	O	DET	O
serum	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
antigen	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
specific	I-GENE	ADJ	B
IgG4	I-GENE	NOUN	B
antibody	I-GENE	NOUN	B
seems	O	VERB	O
to	O	PART	O
be	O	AUX	O
an	O	DET	O
index	O	NOUN	O
in	O	ADP	O
evaluating	O	VERB	B
immunotherapy	O	NOUN	B
objectively	O	ADV	B
.	O	PUNCT	O


The	O	DET	O
differential	O	ADJ	B
diagnosis	O	NOUN	I
of	O	ADP	O
both	O	DET	O
affections	O	NOUN	B
is	O	AUX	O
based	O	VERB	O
on	O	ADP	O
the	O	DET	O
clinical	O	ADJ	B
course	O	NOUN	I
,	O	PUNCT	O
sialography	O	NOUN	B
and	O	CCONJ	O
CT	O	NOUN	B
examination	O	NOUN	B
which	O	DET	O
along	O	ADP	O
with	O	ADP	O
modern	O	ADJ	O
ATB	O	NOUN	B
treatment	O	NOUN	B
significantly	O	ADV	O
modify	O	VERB	O
hitherto	O	ADV	O
used	O	VERB	O
surgical	O	ADJ	B
therapy	O	NOUN	I
.	O	PUNCT	O


An	O	DET	O
FP	B-GENE	NOUN	B
mutant	I-GENE	NOUN	I
,	O	PUNCT	O
AcFP875	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
2	I-GENE	NUM	B
,	O	PUNCT	O
had	O	AUX	O
a	O	DET	O
1	O	NUM	O
.	O	PUNCT	O
6	O	NUM	O
-	O	PUNCT	O
kbp	O	NOUN	B
insertion	O	NOUN	B
of	O	ADP	O
S	O	NOUN	B
.	O	PUNCT	O
frugiperda	O	X	O
DNA	O	NOUN	O
near	O	ADP	O
the	O	DET	O
5	O	NUM	O
'	O	PART	O
end	O	NOUN	O
of	O	ADP	O
these	O	DET	O
transcripts	O	NOUN	B
which	O	DET	O
by	O	ADP	O
S1	B-GENE	NOUN	B
analysis	O	NOUN	I
were	O	AUX	O
shown	O	VERB	O
to	O	PART	O
initiate	O	VERB	B
within	O	ADP	O
the	O	DET	O
host	O	NOUN	B
cell	O	NOUN	B
sequence	O	NOUN	I
.	O	PUNCT	O


Postcoital	O	ADJ	B
contraception	O	NOUN	I
:	O	PUNCT	O
a	O	DET	O
family	O	NOUN	B
planning	O	NOUN	I
study	O	NOUN	I
.	O	PUNCT	O


A	O	DET	O
0	O	NUM	O
.	O	PUNCT	O
5	O	NUM	O
rating	O	NOUN	B
was	O	AUX	O
intended	O	VERB	O
to	O	PART	O
characterize	O	VERB	O
subjects	O	NOUN	B
in	O	ADP	O
whom	O	PRON	O
mild	O	ADJ	B
cognitive	O	ADJ	B
impairment	O	NOUN	I
due	O	ADJ	O
to	O	PART	O
senile	O	ADJ	B
dementia	O	NOUN	I
of	O	ADP	O
the	O	DET	O
Alzheimer	O	NOUN	B
type	O	NOUN	I
was	O	AUX	O
suspected	O	VERB	B
but	O	CCONJ	O
was	O	AUX	O
insufficient	O	ADJ	B
in	O	ADP	O
degree	O	NOUN	B
to	O	PART	O
warrant	O	VERB	O
a	O	DET	O
diagnosis	O	NOUN	B
of	O	ADP	O
definite	O	ADJ	O
dementia	O	NOUN	B
.	O	PUNCT	O


An	O	DET	O
implant	O	NOUN	B
may	O	AUX	O
release	O	VERB	O
a	O	DET	O
drug	O	NOUN	B
either	O	CCONJ	O
by	O	ADP	O
diffusion	O	NOUN	B
concurrent	O	ADJ	B
with	O	ADP	O
dissolution	O	NOUN	B
of	O	ADP	O
the	O	DET	O
polymeric	O	ADJ	B
implant	O	ADJ	I
material	O	NOUN	I
without	O	ADP	O
depolymerization	O	NOUN	B
(	O	PUNCT	O
Type	O	NOUN	B
A	O	NOUN	I
)	O	PUNCT	O
or	O	CCONJ	O
by	O	ADP	O
bioerosion	O	NOUN	B
involving	O	VERB	O
depolymerization	O	NOUN	B
(	O	PUNCT	O
Type	O	NOUN	B
B	O	NOUN	I
)	O	PUNCT	O
.	O	PUNCT	O


Improved	O	ADJ	B
cosmesis	O	NOUN	B
,	O	PUNCT	O
extension	O	NOUN	B
of	O	ADP	O
the	O	DET	O
scope	O	NOUN	O
of	O	ADP	O
the	O	DET	O
problems	O	NOUN	B
that	O	PRON	O
can	O	AUX	O
be	O	AUX	O
addressed	O	VERB	O
with	O	ADP	O
this	O	DET	O
repair	O	NOUN	B
(	O	PUNCT	O
including	O	VERB	O
treatment	O	NOUN	B
of	O	ADP	O
a	O	DET	O
distal	O	ADJ	B
urethrocutaneous	O	ADJ	B
fistula	O	NOUN	I
)	O	PUNCT	O
and	O	CCONJ	O
the	O	DET	O
ease	O	NOUN	O
with	O	ADP	O
which	O	DET	O
the	O	DET	O
Arap	O	ADJ	B
procedure	O	NOUN	I
can	O	AUX	O
be	O	AUX	O
performed	O	VERB	B
are	O	AUX	O
the	O	DET	O
advantages	O	NOUN	O
that	O	SCONJ	O
this	O	DET	O
operation	O	NOUN	B
has	O	AUX	O
over	O	ADP	O
other	O	ADJ	O
1	O	NUM	O
-	O	PUNCT	O
stage	O	NOUN	B
distal	O	ADJ	B
hypospadias	O	NOUN	I
repairs	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
galactose	B-GENE	NOUN	B
transporter	I-GENE	NOUN	I
shows	O	VERB	O
both	O	CCONJ	O
sequence	O	NOUN	B
and	O	CCONJ	O
structural	O	ADJ	B
homology	O	NOUN	I
with	O	ADP	O
a	O	DET	O
superfamily	O	NOUN	B
of	O	ADP	O
sugar	B-GENE	NOUN	B
transporters	I-GENE	NOUN	O
which	O	DET	O
includes	O	VERB	O
the	O	DET	O
human	B-GENE	ADJ	B
HepG2	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
erythrocyte	I-GENE	NOUN	B
and	I-GENE	CCONJ	O
fetal	I-GENE	ADJ	B
muscle	I-GENE	NOUN	I
glucose	I-GENE	NOUN	B
transporters	I-GENE	NOUN	I
,	O	PUNCT	O
the	O	DET	O
rat	B-GENE	NOUN	B
brain	I-GENE	NOUN	B
and	I-GENE	CCONJ	O
liver	I-GENE	NOUN	B
glucose	I-GENE	NOUN	I
transporters	I-GENE	NOUN	I
,	O	PUNCT	O
the	O	DET	O
Escherichia	B-GENE	X	B
coli	I-GENE	X	I
xylose	I-GENE	NOUN	B
and	I-GENE	CCONJ	O
arabinose	I-GENE	NOUN	B
permeases	I-GENE	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
the	O	DET	O
S	B-GENE	NOUN	B
.	I-GENE	PUNCT	O
cerevisiae	I-GENE	X	B
glucose	I-GENE	NOUN	I
,	I-GENE	PUNCT	O
maltose	I-GENE	NOUN	B
,	I-GENE	PUNCT	O
and	I-GENE	CCONJ	O
galactose	I-GENE	NOUN	B
transporters	I-GENE	NOUN	I
.	O	PUNCT	O


The	O	DET	O
calcium	O	NOUN	B
requirement	O	NOUN	B
for	O	ADP	O
hypothermic	O	ADJ	B
storage	O	NOUN	B
of	O	ADP	O
the	O	DET	O
cardiac	O	ADJ	B
explant	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
seventh	O	ADJ	O
cysteine	O	NOUN	B
residue	O	NOUN	B
of	O	ADP	O
CTSE	B-GENE	NOUN	B
is	O	AUX	O
located	O	ADJ	O
within	O	ADP	O
the	O	DET	O
activation	O	NOUN	B
peptide	O	NOUN	B
region	O	NOUN	I
of	O	ADP	O
the	O	DET	O
proenzyme	O	NOUN	B
.	O	PUNCT	O


With	O	ADP	O
both	O	CCONJ	O
wild	O	ADJ	B
-	O	PUNCT	O
type	O	NOUN	B
and	O	CCONJ	O
the	O	DET	O
mutant	O	ADJ	B
enzymes	O	NOUN	O
,	O	PUNCT	O
ATP	O	NOUN	B
activates	O	VERB	B
both	O	DET	O
[	O	PUNCT	O
14C	O	NOUN	O
]	O	PUNCT	O
Asp	O	NOUN	B
in	O	ADP	O
equilibrium	O	X	B
N	O	NOUN	B
-	O	PUNCT	O
carbamyl	O	NOUN	B
-	O	PUNCT	O
L	O	PROPN	B
-	O	PUNCT	O
aspartate	O	NOUN	B
(	O	PUNCT	O
C	O	NOUN	B
-	O	PUNCT	O
Asp	O	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
the	O	DET	O
[	O	PUNCT	O
32P	O	NOUN	O
]	O	PUNCT	O
carbamyl	O	NOUN	O
phosphate	O	NOUN	O
(	O	PUNCT	O
C	O	NOUN	B
-	O	PUNCT	O
P	O	NOUN	B
)	O	PUNCT	O
in	O	ADP	O
equilibrium	O	X	B
Pi	O	NOUN	B
exchanges	O	NOUN	B
.	O	PUNCT	O


Mapping	O	NOUN	B
results	O	NOUN	I
suggested	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
complementation	O	NOUN	B
group	O	NOUN	I
identified	O	VERB	B
by	O	ADP	O
these	O	DET	O
mutants	O	NOUN	B
is	O	AUX	O
allelic	O	ADJ	B
to	O	PART	O
the	O	DET	O
ag	B-GENE	NOUN	O
alpha	I-GENE	NOUN	O
1	I-GENE	NUM	O
mutation	O	NOUN	B
identified	O	VERB	B
previously	O	ADV	O
.	O	PUNCT	O


Recently	O	ADV	O
,	O	PUNCT	O
an	O	DET	O
alternatively	O	ADV	O
spliced	O	VERB	B
form	O	NOUN	O
of	O	ADP	O
c	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
myb	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
encoded	I-GENE	VERB	B
mRNA	I-GENE	NOUN	B
has	O	AUX	O
been	O	AUX	O
identified	O	VERB	B
in	O	ADP	O
murine	O	ADJ	B
cells	O	NOUN	B
containing	O	VERB	O
either	O	CCONJ	O
normal	O	ADJ	B
or	O	CCONJ	O
rearranged	O	ADJ	B
c	B-GENE	NOUN	I
-	I-GENE	PUNCT	O
myb	I-GENE	NOUN	B
genes	I-GENE	NOUN	I
.	O	PUNCT	O


Metformin	O	NOUN	B
plasma	O	NOUN	B
concentrations	O	NOUN	B
remained	O	VERB	O
unchanged	O	ADJ	B
except	O	SCONJ	O
for	O	ADP	O
patients	O	NOUN	B
transferred	O	VERB	B
from	O	ADP	O
1	O	NUM	O
.	O	PUNCT	O
5	O	NUM	O
to	O	PART	O
2	O	NUM	O
.	O	PUNCT	O
0	O	NUM	O
g	O	NOUN	O
daily	O	ADV	B
to	O	PART	O
850	O	NUM	O
mg	O	NOUN	O
twice	O	ADV	O
daily	O	ADV	B
;	O	PUNCT	O
in	O	ADP	O
these	O	DET	O
patients	O	NOUN	B
plasma	O	NOUN	B
concentrations	O	NOUN	B
increased	O	VERB	B
from	O	ADP	O
1	O	NUM	O
.	O	PUNCT	O
83	O	NUM	O
+	O	CCONJ	O
/	O	SYM	O
-	O	PUNCT	O
0	O	NUM	O
.	O	PUNCT	O
87	O	NUM	O
to	O	PART	O
2	O	NUM	O
.	O	PUNCT	O
50	O	NUM	O
+	O	CCONJ	O
/	O	SYM	O
-	O	PUNCT	O
0	O	NUM	O
.	O	PUNCT	O
89	O	NUM	O
micrograms	O	NOUN	B
/	O	SYM	O
l	O	NOUN	B
(	O	PUNCT	O
p	O	NOUN	O
less	O	ADJ	O
than	O	ADP	O
0	O	NUM	O
.	O	PUNCT	O
01	O	NUM	O
)	O	PUNCT	O
.	O	PUNCT	O


A	O	DET	O
significant	O	ADJ	O
relationship	O	NOUN	B
existed	O	VERB	O
during	O	ADP	O
the	O	DET	O
evolution	O	NOUN	B
of	O	ADP	O
the	O	DET	O
disease	O	NOUN	B
between	O	ADP	O
CRS	O	PROPN	B
/	O	PUNCT	O
BW	O	PROPN	B
and	O	CCONJ	O
gas	O	NOUN	B
exchange	O	NOUN	I
parameters	O	NOUN	I
(	O	PUNCT	O
FIO2	O	NOUN	B
and	O	CCONJ	O
a	O	DET	O
/	O	SYM	O
AO2	O	NOUN	B
ratio	O	NOUN	I
)	O	PUNCT	O
(	O	PUNCT	O
P	O	NOUN	O
less	O	ADJ	O
than	O	ADP	O
0	O	NUM	O
.	O	PUNCT	O
01	O	NUM	O
)	O	PUNCT	O
,	O	PUNCT	O
but	O	CCONJ	O
gas	O	NOUN	B
exchange	O	NOUN	I
improved	O	VERB	O
earlier	O	ADV	O
than	O	ADP	O
lung	O	NOUN	B
mechanics	O	NOUN	B
.	O	PUNCT	O


Liquid	O	ADJ	B
chromatography	O	NOUN	I
with	O	ADP	O
amperometric	O	ADJ	B
detection	O	NOUN	I
(	O	PUNCT	O
LC	O	NOUN	B
/	O	SYM	O
AD	O	NOUN	B
)	O	PUNCT	O
is	O	AUX	O
used	O	VERB	O
to	O	PART	O
determine	O	VERB	O
fluazifop	O	ADJ	B
acid	O	NOUN	I
produced	O	VERB	O
from	O	ADP	O
the	O	DET	O
metabolism	O	NOUN	B
or	O	CCONJ	O
base	O	NOUN	B
hydrolysis	O	NOUN	I
of	O	ADP	O
fluazifop	O	ADJ	B
-	O	PUNCT	O
butyl	O	NOUN	B
in	O	ADP	O
soybeans	O	NOUN	B
and	O	CCONJ	O
soybean	O	NOUN	B
oil	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
dichloromethane	O	NOUN	B
is	O	AUX	O
removed	O	VERB	B
,	O	PUNCT	O
mobile	O	ADJ	B
phase	O	NOUN	I
solvent	O	NOUN	O
is	O	AUX	O
added	O	VERB	O
,	O	PUNCT	O
and	O	CCONJ	O
aliquots	O	NOUN	B
are	O	AUX	O
injected	O	VERB	B
onto	O	ADP	O
a	O	DET	O
PRP	O	NOUN	B
-	O	PUNCT	O
1	O	NUM	B
liquid	O	ADJ	I
chromatographic	O	ADJ	I
column	O	NOUN	I
;	O	PUNCT	O
fluazifop	O	ADJ	B
acid	O	NOUN	I
is	O	AUX	O
separated	O	VERB	O
from	O	ADP	O
coextracted	O	VERB	B
compounds	O	NOUN	I
and	O	CCONJ	O
detected	O	VERB	B
at	O	ADP	O
an	O	DET	O
applied	O	VERB	O
potential	O	NOUN	B
of	O	ADP	O
+	O	CCONJ	O
1	O	NUM	O
.	O	PUNCT	O
25	O	NUM	O
V	O	NOUN	O
,	O	PUNCT	O
using	O	VERB	O
an	O	DET	O
amperometric	O	ADJ	O
electrochemical	O	ADJ	O
detector	O	NOUN	O
in	O	ADP	O
the	O	DET	O
oxidation	O	NOUN	B
mode	O	NOUN	O
.	O	PUNCT	O


The	O	DET	O
titer	O	NOUN	B
of	O	ADP	O
anti	B-GENE	ADJ	B
HSV	I-GENE	NOUN	I
type	I-GENE	NOUN	I
1	I-GENE	NUM	I
and	O	CCONJ	O
anti	B-GENE	ADJ	B
HSV	I-GENE	NOUN	I
type	I-GENE	NOUN	I
2	I-GENE	NUM	I
antibodies	I-GENE	NOUN	I
in	O	ADP	O
the	O	DET	O
mothers	O	NOUN	B
'	O	PART	O
and	O	CCONJ	O
cord	O	NOUN	B
blood	O	NOUN	I
was	O	AUX	O
determined	O	VERB	O
and	O	CCONJ	O
compared	O	VERB	B
.	O	PUNCT	O


Kidney	O	NOUN	B
weight	O	NOUN	I
and	O	CCONJ	O
kidney	O	NOUN	B
-	O	PUNCT	O
to	O	ADP	O
-	O	PUNCT	O
body	O	NOUN	B
weight	O	NOUN	I
ratio	O	NOUN	O
were	O	AUX	O
significantly	O	ADV	O
elevated	O	ADJ	B
at	O	ADP	O
the	O	DET	O
highest	O	ADJ	B
dose	O	NOUN	B
level	O	NOUN	B
after	O	ADP	O
10	O	NUM	O
weeks	O	NOUN	B
and	O	CCONJ	O
at	O	ADP	O
the	O	DET	O
two	O	NUM	O
higher	O	ADJ	B
dose	O	NOUN	B
levels	O	NOUN	O
after	O	ADP	O
15	O	NUM	O
weeks	O	NOUN	B
of	O	ADP	O
exposure	O	NOUN	B
.	O	PUNCT	O


Swim	O	NOUN	B
-	O	PUNCT	O
over	O	ADP	O
:	O	PUNCT	O
an	O	DET	O
alternative	O	ADJ	B
method	O	NOUN	I
for	O	ADP	O
harvesting	O	VERB	B
motile	O	ADJ	B
spermatozoa	O	NOUN	B
.	O	PUNCT	O


A	O	DET	O
raised	O	VERB	B
amplitude	O	NOUN	B
of	O	ADP	O
the	O	DET	O
aggregation	O	NOUN	B
of	O	ADP	O
plates	O	NOUN	B
and	O	CCONJ	O
a	O	DET	O
decrease	O	NOUN	B
in	O	ADP	O
the	O	DET	O
threshold	O	NOUN	B
of	O	ADP	O
their	O	PRON	O
sensitivity	O	NOUN	B
to	O	PART	O
ADP	O	NOUN	B
were	O	AUX	O
established	O	VERB	O
in	O	ADP	O
the	O	DET	O
persons	O	NOUN	B
with	O	ADP	O
types	O	NOUN	O
IIa	O	NOUN	B
and	O	CCONJ	O
IIb	O	NOUN	B
HLP	O	NOUN	I
and	O	CCONJ	O
in	O	ADP	O
CHD	O	NOUN	B
without	O	ADP	O
HLP	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
Experiment	O	NOUN	B
2	O	NUM	O
,	O	PUNCT	O
we	O	PRON	O
again	O	ADV	O
used	O	VERB	O
classification	O	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
the	O	DET	O
fixed	O	ADJ	O
standard	O	NOUN	O
75	O	NUM	O
was	O	AUX	O
not	O	PART	O
at	O	ADP	O
the	O	DET	O
center	O	NOUN	B
of	O	ADP	O
the	O	DET	O
range	O	NOUN	B
of	O	ADP	O
target	O	NOUN	B
numbers	O	NOUN	B
(	O	PUNCT	O
20	O	NUM	O
,	O	PUNCT	O
21	O	NUM	O
,	O	PUNCT	O
.	O	PUNCT	O
.	O	PUNCT	O
.	O	PUNCT	O


Among	O	ADP	O
booked	O	VERB	B
patients	O	NOUN	B
the	O	DET	O
maternal	O	ADJ	B
mortality	O	NOUN	O
rate	O	NOUN	O
was	O	AUX	O
0	O	NUM	O
.	O	PUNCT	O
32	O	NUM	O
and	O	CCONJ	O
among	O	ADP	O
unbooked	O	ADJ	B
patients	O	NOUN	B
11	O	NUM	O
.	O	PUNCT	O
13	O	NUM	O
per	O	ADP	O
1000	O	NUM	O
deliveries	O	NOUN	B
.	O	PUNCT	O


Evidence	O	NOUN	B
from	O	ADP	O
the	O	DET	O
structure	O	NOUN	B
of	O	ADP	O
a	O	DET	O
number	O	NOUN	O
of	O	ADP	O
cDNA	O	NOUN	B
clones	O	NOUN	I
,	O	PUNCT	O
as	O	ADV	O
well	O	ADV	O
as	O	ADP	O
S1	B-GENE	NOUN	B
nuclease	I-GENE	NOUN	I
and	O	CCONJ	O
primer	O	NOUN	B
extension	O	NOUN	I
studies	O	NOUN	I
supports	O	VERB	O
the	O	DET	O
hypothesis	O	NOUN	B
that	O	SCONJ	O
the	O	DET	O
PTHrP	B-GENE	NOUN	B
gene	I-GENE	NOUN	I
contains	O	VERB	O
at	O	ADP	O
least	O	ADJ	O
two	O	NUM	O
mRNA	O	NOUN	B
transcription	O	NOUN	O
start	O	NOUN	O
points	O	NOUN	O
that	O	PRON	O
define	O	VERB	O
two	O	NUM	O
putative	O	ADJ	O
regulatory	O	ADJ	O
domains	O	NOUN	O
.	O	PUNCT	O


The	O	DET	O
transcription	O	NOUN	B
initiation	O	NOUN	I
site	O	NOUN	I
was	O	AUX	O
determined	O	VERB	O
by	O	ADP	O
S1	B-GENE	NOUN	B
nuclease	I-GENE	NOUN	I
mapping	O	NOUN	I
.	O	PUNCT	O


A	O	DET	O
larval	B-GENE	NOUN	B
albumin	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
like	I-GENE	ADJ	B
protein	I-GENE	NOUN	B
was	O	AUX	O
not	O	PART	O
detectable	O	ADJ	B
by	O	ADP	O
silver	O	ADJ	B
staining	O	NOUN	I
in	O	ADP	O
serum	O	NOUN	B
of	O	ADP	O
tadpoles	O	NOUN	B
before	O	ADP	O
the	O	DET	O
beginning	O	NOUN	O
of	O	ADP	O
metamorphosis	O	NOUN	B
at	O	ADP	O
stage	O	NOUN	B
48	O	NUM	O
.	O	PUNCT	O


Behaviorally	O	ADV	B
,	O	PUNCT	O
a	O	DET	O
pain	O	NOUN	B
-	O	PUNCT	O
tolerant	O	ADJ	B
group	O	NOUN	B
(	O	PUNCT	O
PT	O	NOUN	B
=	O	ADJ	O
29	O	NUM	O
Ss	O	NOUN	O
)	O	PUNCT	O
tolerated	O	VERB	B
the	O	DET	O
entire	O	ADJ	O
3	O	NUM	O
-	O	PUNCT	O
min	O	NOUN	B
test	O	NOUN	O
(	O	PUNCT	O
means	O	VERB	O
=	O	ADJ	O
180	O	NUM	O
+	O	CCONJ	O
/	O	SYM	O
-	O	PUNCT	O
0	O	NUM	O
sec	O	NOUN	O
)	O	PUNCT	O
,	O	PUNCT	O
while	O	SCONJ	O
a	O	DET	O
pain	O	NOUN	B
-	O	PUNCT	O
sensitive	O	ADJ	B
group	O	NOUN	B
(	O	PUNCT	O
PS	O	NOUN	B
=	O	ADJ	O
13	O	NUM	O
Ss	O	NOUN	O
)	O	PUNCT	O
averaged	O	VERB	O
only	O	ADV	O
50	O	NUM	O
.	O	PUNCT	O
31	O	NUM	O
+	O	CCONJ	O
/	O	SYM	O
-	O	PUNCT	O
20	O	NUM	O
.	O	PUNCT	O
81	O	NUM	O
sec	O	NOUN	O
of	O	ADP	O
the	O	DET	O
cold	O	ADJ	B
-	O	PUNCT	O
pressor	O	NOUN	B
test	O	NOUN	O
(	O	PUNCT	O
t	O	NOUN	O
=	O	ADJ	O
16	O	NUM	O
.	O	PUNCT	O
75	O	NUM	O
,	O	PUNCT	O
P	O	NOUN	O
less	O	ADJ	O
than	O	ADP	O
0	O	NUM	O
.	O	PUNCT	O
0001	O	NUM	O
)	O	PUNCT	O
,	O	PUNCT	O
replicating	O	VERB	B
our	O	PRON	O
earlier	O	ADJ	O
studies	O	NOUN	B
.	O	PUNCT	O


Isolated	O	ADJ	B
proteinuria	O	NOUN	I
(	O	PUNCT	O
i	O	X	O
.	O	PUNCT	O
e	O	X	O
.	O	PUNCT	O
without	O	ADP	O
hematuria	O	NOUN	B
and	O	CCONJ	O
/	O	SYM	B
or	O	CCONJ	O
pyuria	O	NOUN	B
)	O	PUNCT	O
is	O	AUX	O
a	O	DET	O
frequent	O	ADJ	O
finding	O	NOUN	B
.	O	PUNCT	O


Lithium	O	NOUN	B
delays	O	VERB	B
the	O	DET	O
circadian	O	ADJ	B
rhythm	O	NOUN	I
of	O	ADP	O
wheel	O	NOUN	B
-	O	PUNCT	O
running	O	NOUN	B
in	O	ADP	O
Syrian	O	ADJ	B
hamsters	O	NOUN	B
at	O	ADP	O
plasma	O	NOUN	B
concentrations	O	NOUN	B
(	O	PUNCT	O
0	O	NUM	O
.	O	PUNCT	O
59	O	NUM	O
-	O	SYM	O
0	O	NUM	O
.	O	PUNCT	O
74	O	NUM	O
mM	O	NOUN	O
)	O	PUNCT	O
that	O	PRON	O
also	O	ADV	O
cause	O	VERB	O
toxic	O	ADJ	B
weight	O	NOUN	O
loss	O	NOUN	O
.	O	PUNCT	O


When	O	SCONJ	O
two	O	NUM	O
-	O	PUNCT	O
dimensional	O	ADJ	B
polyacrylamide	O	NOUN	B
gel	O	NOUN	I
electrophoretic	O	ADJ	B
patterns	O	NOUN	I
of	O	ADP	O
[	O	PUNCT	O
35S	O	NOUN	O
]	O	PUNCT	O
methionine	O	NOUN	B
-	O	PUNCT	O
labeled	O	VERB	B
proteins	O	NOUN	B
secreted	O	VERB	B
from	O	ADP	O
cells	O	NOUN	B
infected	O	VERB	B
with	O	ADP	O
parental	O	ADJ	B
and	O	CCONJ	O
recombinant	O	ADJ	B
viruses	O	NOUN	I
were	O	AUX	O
compared	O	VERB	B
,	O	PUNCT	O
a	O	DET	O
spot	O	NOUN	O
missing	O	VERB	O
from	O	ADP	O
the	O	DET	O
latter	O	ADJ	O
corresponded	O	VERB	O
in	O	ADP	O
molecular	O	ADJ	B
weigh	O	ADJ	I
and	O	CCONJ	O
isoelectric	O	ADJ	B
point	O	NOUN	I
with	O	ADP	O
that	O	DET	O
predicted	O	VERB	B
from	O	ADP	O
the	O	DET	O
N1L	B-GENE	NOUN	B
ORF	I-GENE	NOUN	I
.	O	PUNCT	O


Buflomedil	O	NOUN	B
(	O	PUNCT	O
i	O	NOUN	O
.	O	PUNCT	O
v	O	X	O
.	O	PUNCT	O
)	O	PUNCT	O
induced	O	VERB	B
a	O	DET	O
dose	O	NOUN	B
-	O	PUNCT	O
dependent	O	ADJ	B
increase	O	NOUN	B
of	O	ADP	O
cardiac	O	ADJ	B
output	O	NOUN	I
at	O	ADP	O
0	O	NUM	O
.	O	PUNCT	O
16	O	NUM	O
-	O	SYM	O
0	O	NUM	O
.	O	PUNCT	O
64	O	NUM	O
mg	O	NOUN	O
/	O	SYM	O
kg	O	NOUN	B
,	O	PUNCT	O
biphasic	O	ADJ	B
changes	O	NOUN	I
at	O	ADP	O
1	O	NUM	O
.	O	PUNCT	O
28	O	NUM	O
and	O	CCONJ	O
2	O	NUM	O
.	O	PUNCT	O
56	O	NUM	O
mg	O	NOUN	O
/	O	SYM	O
kg	O	NOUN	B
and	O	CCONJ	O
a	O	DET	O
marked	O	ADJ	O
decrease	O	NOUN	B
and	O	CCONJ	O
subsequent	O	ADJ	O
slight	O	ADJ	O
increase	O	NOUN	B
at	O	ADP	O
a	O	DET	O
large	O	ADJ	O
dose	O	NOUN	B
of	O	ADP	O
5	O	NUM	O
.	O	PUNCT	O
12	O	NUM	O
mg	O	NOUN	O
/	O	SYM	O
kg	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
use	O	VERB	O
the	O	DET	O
term	O	NOUN	O
corticosteroid	O	NOUN	B
-	O	PUNCT	O
dependent	O	ADJ	B
IA	O	NOUN	B
to	O	PART	O
refer	O	VERB	O
to	O	ADP	O
the	O	DET	O
serious	O	ADJ	O
problem	O	NOUN	B
of	O	ADP	O
chronic	O	ADJ	B
IA	O	NOUN	I
requiring	O	VERB	O
maintenance	O	NOUN	O
prednisone	O	NOUN	B
therapy	O	NOUN	O
.	O	PUNCT	O


The	O	DET	O
two	O	NUM	O
IL6	B-GENE	NOUN	B
mRNA	I-GENE	NOUN	B
species	O	NOUN	I
are	O	AUX	O
generated	O	VERB	O
by	O	ADP	O
alternative	O	ADJ	B
polyadenylation	O	NOUN	B
at	O	ADP	O
sites	O	NOUN	B
separated	O	VERB	O
by	O	ADP	O
a	O	DET	O
distance	O	NOUN	B
of	O	ADP	O
1	O	NUM	O
.	O	PUNCT	O
2	O	NUM	O
kilobases	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
one	O	NUM	O
acromegalic	O	ADJ	B
patient	O	NOUN	B
visual	O	ADJ	B
improvement	O	NOUN	B
was	O	AUX	O
obtained	O	VERB	O
while	O	SCONJ	O
the	O	DET	O
abnormal	O	ADJ	B
GH	B-GENE	NOUN	B
secretion	O	NOUN	I
remained	O	VERB	O
unaltered	O	ADJ	B
.	O	PUNCT	O


In	O	ADP	O
contrast	O	NOUN	O
,	O	PUNCT	O
the	O	DET	O
PPSF	O	NOUN	B
+	O	CCONJ	O
DBP	O	NOUN	B
side	O	NOUN	O
showed	O	VERB	O
large	O	ADJ	O
amounts	O	NOUN	O
of	O	ADP	O
bone	O	NOUN	B
formation	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
bone	O	NOUN	B
almost	O	ADV	O
covered	O	VERB	O
the	O	DET	O
implant	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
44	O	NUM	O
evaluable	O	ADJ	O
patients	O	NOUN	B
the	O	DET	O
response	O	NOUN	B
rate	O	NOUN	I
was	O	AUX	O
50	O	NUM	O
%	O	NOUN	O
,	O	PUNCT	O
with	O	ADP	O
one	O	NUM	O
complete	O	ADJ	O
response	O	NOUN	B
.	O	PUNCT	O


Thus	O	ADV	O
,	O	PUNCT	O
multiple	O	ADJ	B
myogenic	O	ADJ	B
factors	O	NOUN	I
that	O	PRON	O
vary	O	VERB	O
qualitatively	O	ADV	B
and	O	CCONJ	O
quantitatively	O	ADV	B
may	O	AUX	O
be	O	AUX	O
responsible	O	ADJ	O
for	O	ADP	O
the	O	DET	O
different	O	ADJ	B
and	O	CCONJ	O
complex	O	ADJ	B
modulatory	O	ADJ	B
programs	O	NOUN	I
of	O	ADP	O
actin	B-GENE	NOUN	B
gene	I-GENE	NOUN	I
expression	O	NOUN	B
observed	O	VERB	O
during	O	ADP	O
in	O	X	B
vivo	O	X	I
muscle	O	NOUN	B
differentiation	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
effect	O	NOUN	B
of	O	ADP	O
acetazolamide	O	NOUN	B
(	O	PUNCT	O
ACZ	O	NOUN	B
)	O	PUNCT	O
on	O	ADP	O
HCO3	O	NOUN	B
-	O	PUNCT	O
and	O	CCONJ	O
Cl	O	NOUN	B
-	O	PUNCT	O
activities	O	NOUN	B
in	O	ADP	O
inner	O	ADJ	B
ear	O	NOUN	I
fluid	O	NOUN	I
was	O	AUX	O
investigated	O	VERB	B
by	O	ADP	O
ion	O	NOUN	B
-	O	PUNCT	O
selective	O	ADJ	B
microelectrode	O	ADJ	I
methods	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
predicted	O	VERB	B
L	B-GENE	NOUN	B
mRNA	I-GENE	NOUN	B
was	O	AUX	O
6398	O	NUM	O
nucleotides	O	NOUN	B
long	O	ADV	B
and	O	CCONJ	O
contained	O	VERB	O
a	O	DET	O
single	O	ADJ	O
open	O	ADJ	O
reading	O	NOUN	O
frame	O	NOUN	O
corresponding	O	VERB	O
to	O	PART	O
an	O	DET	O
L	B-GENE	NOUN	B
protein	I-GENE	NOUN	I
encompassing	I-GENE	VERB	O
2109	I-GENE	NUM	O
amino	I-GENE	NOUN	B
acids	I-GENE	NOUN	I
with	O	ADP	O
a	O	DET	O
MW	O	NOUN	B
of	O	ADP	O
241	O	NUM	O
,	O	PUNCT	O
546	O	NUM	O
.	O	PUNCT	O


Aplastic	O	ADJ	B
crisis	O	NOUN	I
in	O	ADP	O
sickle	O	ADJ	B
cell	O	NOUN	B
disorders	O	NOUN	I
:	O	PUNCT	O
bone	O	NOUN	B
marrow	O	NOUN	I
necrosis	O	NOUN	I
and	O	CCONJ	O
human	O	ADJ	B
parvovirus	O	NOUN	O
infection	O	NOUN	O
.	O	PUNCT	O


The	O	DET	O
bactericidal	O	ADJ	B
activity	O	NOUN	I
of	O	ADP	O
six	O	NUM	O
new	O	ADJ	O
rifamycin	O	NOUN	B
derivatives	O	NOUN	O
-	O	PUNCT	O
-	O	PUNCT	O
rifabutin	O	NOUN	B
(	O	PUNCT	O
RBU	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
FCE	O	NOUN	B
22250	O	NUM	O
(	O	PUNCT	O
F22	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
rifapentine	O	NOUN	B
(	O	PUNCT	O
RPE	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
CGP	O	NOUN	B
29861	O	NUM	O
(	O	PUNCT	O
C29	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
CGP	O	NOUN	B
7040	O	NUM	O
(	O	PUNCT	O
C70	O	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
CGP	O	NOUN	B
27557	O	NUM	O
(	O	PUNCT	O
C27	O	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
rifampicin	O	NOUN	B
(	O	PUNCT	O
RMP	O	NOUN	B
)	O	PUNCT	O
-	O	PUNCT	O
-	O	PUNCT	O
have	O	AUX	O
been	O	AUX	O
measured	O	VERB	O
against	O	ADP	O
log	O	NOUN	B
phase	O	NOUN	I
and	O	CCONJ	O
,	O	PUNCT	O
as	O	ADP	O
a	O	DET	O
better	O	ADJ	O
test	O	NOUN	O
of	O	ADP	O
sterilising	O	VERB	B
activity	O	NOUN	I
,	O	PUNCT	O
against	O	ADP	O
stationary	O	ADJ	O
phase	O	NOUN	B
cultures	O	NOUN	I
of	O	ADP	O
Mycobacterium	O	X	B
tuberculosis	O	NOUN	I
,	O	PUNCT	O
H37Rv	O	NOUN	B
.	O	PUNCT	O


Mo	O	NOUN	B
+	O	CCONJ	O
SV	O	PROPN	B
M	O	PROPN	I
-	O	PUNCT	O
MuLV	O	NOUN	B
-	O	PUNCT	O
inoculated	O	VERB	B
animals	O	NOUN	B
became	O	VERB	O
moribund	O	ADJ	B
at	O	ADP	O
3	O	NUM	O
to	O	PART	O
13	O	NUM	O
months	O	NOUN	B
postinoculation	O	NOUN	B
,	O	PUNCT	O
whereas	O	SCONJ	O
delta	O	NOUN	B
Mo	O	NOUN	B
+	O	CCONJ	O
SV	O	PROPN	B
M	O	PROPN	I
-	O	PUNCT	O
MuLV	O	NOUN	B
-	O	PUNCT	O
inoculated	O	VERB	B
animals	O	NOUN	B
became	O	VERB	O
moribund	O	ADJ	B
at	O	ADP	O
6	O	NUM	O
to	O	PART	O
24	O	NUM	O
months	O	NOUN	B
postinoculation	O	NOUN	B
.	O	PUNCT	O


RVEF	O	NOUN	B
and	O	CCONJ	O
LVEF	O	NOUN	B
both	O	CCONJ	O
increased	O	VERB	B
by	O	ADP	O
about	O	ADV	O
14	O	NUM	O
%	O	NOUN	O
(	O	PUNCT	O
p	O	NOUN	O
less	O	ADJ	O
than	O	ADP	O
0	O	NUM	O
.	O	PUNCT	O
05	O	NUM	O
and	O	CCONJ	O
p	O	NOUN	O
less	O	ADJ	O
than	O	ADP	O
0	O	NUM	O
.	O	PUNCT	O
01	O	NUM	O
)	O	PUNCT	O
.	O	PUNCT	O


The	O	DET	O
levels	O	NOUN	B
of	O	ADP	O
NPY	B-GENE	NOUN	B
-	O	PUNCT	O
ir	O	NOUN	B
in	O	ADP	O
the	O	DET	O
rat	O	NOUN	B
vas	O	NOUN	B
deferens	O	NOUN	I
were	O	AUX	O
not	O	PART	O
affected	O	VERB	O
by	O	ADP	O
either	O	CCONJ	O
surgical	O	ADJ	B
or	O	CCONJ	O
pharmacological	O	ADJ	B
treatment	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
primary	O	ADJ	B
structure	O	NOUN	I
and	O	CCONJ	O
cotranscription	O	NOUN	B
of	O	ADP	O
the	O	DET	O
petCA	B-GENE	NOUN	B
genes	I-GENE	NOUN	I
encoding	O	VERB	B
the	O	DET	O
Rieske	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
FeS	I-GENE	PROPN	B
(	O	PUNCT	O
nuclear	B-GENE	ADJ	B
encoded	I-GENE	VERB	O
in	I-GENE	ADP	O
plants	I-GENE	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
apocytochrome	B-GENE	NOUN	B
f	I-GENE	NOUN	I
proteins	I-GENE	NOUN	I
has	O	AUX	O
been	O	AUX	O
described	O	VERB	O
previously	O	ADV	O
(	O	PUNCT	O
Kallas	O	PROPN	B
,	O	PUNCT	O
T	O	NOUN	B
.	O	PUNCT	O
,	O	PUNCT	O
Spiller	O	PROPN	B
,	O	PUNCT	O
S	O	PROPN	B
.	O	PUNCT	O
,	O	PUNCT	O
and	O	CCONJ	O
Malkin	O	PROPN	B
,	O	PUNCT	O
R	O	PROPN	B
.	O	PUNCT	O


The	O	DET	O
Nostoc	O	NOUN	B
petBD	B-GENE	NOUN	I
genes	I-GENE	NOUN	I
are	O	AUX	O
not	O	PART	O
closely	O	ADV	O
linked	O	VERB	O
to	O	PART	O
the	O	DET	O
psbB	B-GENE	NOUN	B
gene	I-GENE	NOUN	I
(	O	PUNCT	O
encoding	O	VERB	B
the	O	DET	O
51	O	NUM	O
-	O	PUNCT	O
kDa	O	NOUN	B
photosystem	B-GENE	NOUN	I
II	I-GENE	NUM	I
polypeptide	I-GENE	NOUN	I
)	O	PUNCT	O
and	O	CCONJ	O
do	O	AUX	O
not	O	PART	O
contain	O	VERB	O
introns	O	NOUN	B
as	O	ADP	O
do	O	AUX	O
the	O	DET	O
closely	O	ADV	O
related	O	ADJ	O
chloroplast	O	NOUN	B
genes	O	NOUN	I
.	O	PUNCT	O


RNA	O	NOUN	B
blot	O	NOUN	I
hybridizations	O	NOUN	I
identified	O	VERB	B
an	O	DET	O
1	O	NUM	O
.	O	PUNCT	O
8	O	NUM	O
-	O	PUNCT	O
kb	O	NOUN	O
mRNA	O	NOUN	B
common	O	ADJ	O
to	O	PART	O
cytochrome	B-GENE	NOUN	B
b6	I-GENE	NOUN	I
and	O	CCONJ	O
subunit	O	NOUN	B
IV	O	NUM	I
,	O	PUNCT	O
and	O	CCONJ	O
an	O	DET	O
intensely	O	ADV	B
hybridizing	O	VERB	B
0	O	NUM	O
.	O	PUNCT	O
8	O	NUM	O
-	O	PUNCT	O
kb	O	NOUN	O
mRNA	O	NOUN	B
specific	O	ADJ	O
to	O	PART	O
the	O	DET	O
subunit	O	NOUN	B
IV	O	NUM	I
gene	O	NOUN	I
probe	O	NOUN	I
.	O	PUNCT	O


All	O	DET	O
of	O	ADP	O
the	O	DET	O
indigo	O	ADV	B
-	O	PUNCT	O
producing	O	VERB	B
bacteria	O	NOUN	B
had	O	AUX	O
an	O	DET	O
indoxyl	B-GENE	NOUN	B
phosphatase	I-GENE	NOUN	I
with	O	ADP	O
a	O	DET	O
pI	O	NOUN	B
of	O	ADP	O
6	O	NUM	O
.	O	PUNCT	O
4	O	NUM	O
.	O	PUNCT	O


The	O	DET	O
number	O	NOUN	O
of	O	ADP	O
polymerases	O	NOUN	B
active	O	ADJ	B
in	O	X	B
vitro	O	X	I
at	O	ADP	O
the	O	DET	O
E	O	NOUN	B
strand	O	NOUN	I
promoter	O	NOUN	B
was	O	AUX	O
similar	O	ADJ	O
to	O	ADP	O
the	O	DET	O
number	O	NOUN	O
of	O	ADP	O
polymerases	O	NOUN	B
at	O	ADP	O
the	O	DET	O
L	O	NOUN	B
strand	O	NOUN	I
promoter	O	NOUN	O
.	O	PUNCT	O


A	O	DET	O
family	O	NOUN	B
of	O	ADP	O
RNA	O	NOUN	B
molecules	O	NOUN	I
in	O	ADP	O
the	O	DET	O
2	O	NUM	O
.	O	PUNCT	O
0	O	NUM	O
-	O	SYM	O
2	O	NUM	O
.	O	PUNCT	O
2	O	NUM	O
-	O	PUNCT	O
kilobase	O	NOUN	B
range	O	NOUN	B
identified	O	VERB	B
with	O	ADP	O
a	O	DET	O
probe	O	NOUN	B
from	O	ADP	O
this	O	DET	O
gene	O	NOUN	B
was	O	AUX	O
overexpressed	O	VERB	B
in	O	ADP	O
the	O	DET	O
resistant	O	ADJ	B
cells	O	NOUN	I
.	O	PUNCT	O


Intravesical	O	ADJ	B
chemotherapy	O	NOUN	I
.	O	PUNCT	O


Studies	O	NOUN	B
were	O	AUX	O
performed	O	VERB	O
on	O	ADP	O
several	O	ADJ	O
superficial	O	ADJ	B
veins	O	NOUN	I
from	O	ADP	O
the	O	DET	O
rabbit	O	NOUN	B
face	O	NOUN	O
to	O	PART	O
examine	O	VERB	O
the	O	DET	O
relationship	O	NOUN	B
between	O	ADP	O
beta	B-GENE	NOUN	B
adrenoceptor	I-GENE	NOUN	I
subtype	I-GENE	NOUN	B
distribution	O	NOUN	B
,	O	PUNCT	O
intrinsic	O	ADJ	B
myogenic	O	ADJ	I
tone	O	NOUN	I
and	O	CCONJ	O
sympathetic	O	ADJ	B
nerve	O	NOUN	I
innervation	O	NOUN	B
.	O	PUNCT	O


Two	O	NUM	O
polyadenylation	O	NOUN	B
sites	O	NOUN	I
were	O	AUX	O
used	O	VERB	O
,	O	PUNCT	O
one	O	NUM	O
at	O	ADP	O
the	O	DET	O
end	O	NOUN	O
of	O	ADP	O
the	O	DET	O
early	B-GENE	ADJ	B
(	I-GENE	PUNCT	O
E	I-GENE	NOUN	B
)	I-GENE	PUNCT	O
region	I-GENE	NOUN	O
of	O	ADP	O
the	O	DET	O
viral	O	ADJ	B
DNA	O	NOUN	I
,	O	PUNCT	O
the	O	DET	O
other	O	ADJ	O
at	O	ADP	O
the	O	DET	O
end	O	NOUN	O
of	O	ADP	O
the	O	DET	O
late	B-GENE	ADJ	B
(	I-GENE	PUNCT	O
L	I-GENE	NOUN	O
)	I-GENE	PUNCT	O
region	I-GENE	NOUN	O
.	O	PUNCT	O


We	O	PRON	O
propose	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
technique	O	NOUN	B
of	O	ADP	O
low	O	ADJ	B
-	O	PUNCT	O
frequency	O	NOUN	B
kindling	O	NOUN	B
is	O	AUX	O
a	O	DET	O
useful	O	ADJ	O
experimental	O	ADJ	B
model	O	NOUN	I
in	O	ADP	O
assessing	O	VERB	O
the	O	DET	O
effects	O	NOUN	B
of	O	ADP	O
antipsychotic	O	ADJ	B
or	O	CCONJ	O
antiepileptic	O	ADJ	B
drugs	O	NOUN	I
on	O	ADP	O
the	O	DET	O
excitability	O	NOUN	B
of	O	ADP	O
the	O	DET	O
limbic	O	ADJ	B
regions	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
biosynthesis	O	NOUN	B
and	O	CCONJ	O
stability	O	NOUN	B
of	O	ADP	O
the	O	DET	O
three	O	NUM	O
mutant	O	ADJ	B
proteins	O	NOUN	I
were	O	AUX	O
similar	O	ADJ	O
to	O	PART	O
those	O	DET	O
of	O	ADP	O
the	O	DET	O
wild	B-GENE	ADJ	B
-	I-GENE	PUNCT	O
type	I-GENE	NOUN	B
erbB	I-GENE	NOUN	B
protein	I-GENE	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
all	O	DET	O
three	O	NUM	O
retained	O	VERB	B
the	O	DET	O
ability	O	NOUN	O
to	O	PART	O
transform	O	VERB	B
chicken	O	NOUN	B
embryo	O	NOUN	B
fibroblasts	O	NOUN	B
.	O	PUNCT	O


Codon	O	NOUN	B
usage	O	NOUN	B
in	O	ADP	O
C	O	NOUN	B
.	O	PUNCT	O
reinhardtii	O	NOUN	B
mitochondria	O	NOUN	B
is	O	AUX	O
highly	O	ADV	O
biased	O	ADJ	B
,	O	PUNCT	O
with	O	ADP	O
eight	O	NUM	O
codons	O	NOUN	B
entirely	O	ADV	O
absent	O	ADJ	B
from	O	ADP	O
all	O	DET	O
protein	O	NOUN	B
-	O	PUNCT	O
coding	O	VERB	B
genes	O	NOUN	I
;	O	PUNCT	O
however	O	ADV	O
,	O	PUNCT	O
even	O	ADV	O
though	O	SCONJ	O
codon	O	NOUN	B
usage	O	NOUN	B
is	O	AUX	O
restricted	O	ADJ	B
,	O	PUNCT	O
it	O	PRON	O
appears	O	VERB	O
that	O	SCONJ	O
C	O	NOUN	B
.	O	PUNCT	O
reinhardtii	O	NOUN	B
mtDNA	O	NOUN	B
cannot	O	PART	O
encode	O	VERB	B
the	O	DET	O
minimum	O	ADJ	O
number	O	NOUN	O
of	O	ADP	O
tRNAs	O	NOUN	B
needed	O	VERB	O
to	O	PART	O
support	O	VERB	O
mitochondrial	O	ADJ	B
protein	O	NOUN	I
synthesis	O	NOUN	O
.	O	PUNCT	O


Like	O	ADP	O
scrotal	O	ADJ	B
testes	O	NOUN	I
,	O	PUNCT	O
undescended	O	ADJ	B
testes	O	NOUN	I
were	O	AUX	O
hypointense	O	ADJ	B
to	O	PART	O
fat	O	VERB	O
on	O	ADP	O
sequences	O	NOUN	B
with	O	ADP	O
a	O	DET	O
short	O	ADJ	B
repetition	O	NOUN	I
time	O	NOUN	I
(	O	PUNCT	O
TR	O	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
echo	O	ADJ	B
time	O	NOUN	I
(	O	PUNCT	O
TE	O	NOUN	B
)	O	PUNCT	O
in	O	ADP	O
all	O	DET	O
cases	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
hyperintense	O	ADJ	B
or	O	CCONJ	O
isointense	O	ADJ	B
to	O	PART	O
fat	O	VERB	B
on	O	ADP	O
long	O	ADJ	B
TR	O	NOUN	B
/	O	SYM	O
TE	O	NOUN	B
sequences	O	NOUN	B
in	O	ADP	O
all	O	DET	O
but	O	CCONJ	O
two	O	NUM	O
cases	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
East	O	ADJ	B
African	O	ADJ	I
dik	O	NOUN	I
-	O	PUNCT	O
dik	O	NOUN	B
antelope	O	NOUN	I
represents	O	VERB	O
a	O	DET	O
miniature	O	ADJ	B
model	O	NOUN	I
ruminant	O	NOUN	I
for	O	ADP	O
comparative	O	ADJ	B
studies	O	NOUN	I
.	O	PUNCT	O


Efficacy	O	NOUN	B
and	O	CCONJ	O
field	O	NOUN	B
evaluation	O	NOUN	I
of	O	ADP	O
Bacillus	O	X	B
thuringiensis	O	X	I
(	O	PUNCT	O
H	O	NOUN	B
-	O	PUNCT	O
14	O	NUM	O
)	O	PUNCT	O
and	O	CCONJ	O
B	O	NOUN	B
.	O	PUNCT	O
sphaericus	O	NOUN	B
against	O	ADP	O
floodwater	O	NOUN	B
mosquitoes	O	NOUN	I
in	O	ADP	O
California	O	PROPN	B
.	O	PUNCT	O


2	O	NUM	O
cases	O	NOUN	B
of	O	ADP	O
type	O	NOUN	B
II	O	NUM	I
tyrosinosis	O	NOUN	I
(	O	PUNCT	O
Richner	O	PROPN	B
-	O	PUNCT	O
Hanhart	O	PROPN	B
syndrome	O	NOUN	I
)	O	PUNCT	O


This	O	DET	O
loss	O	NOUN	B
was	O	AUX	O
independent	O	ADJ	B
of	O	ADP	O
drug	O	NOUN	B
concentration	O	NOUN	I
and	O	CCONJ	O
a	O	DET	O
correction	O	NOUN	B
factor	O	NOUN	I
was	O	AUX	O
employed	O	VERB	O
to	O	PART	O
calculate	O	VERB	B
the	O	DET	O
true	O	ADJ	O
free	O	ADJ	O
diazepam	O	NOUN	B
concentration	O	NOUN	B
.	O	PUNCT	O


Effects	O	NOUN	B
of	O	ADP	I
a	O	DET	O
perfluorochemical	O	ADJ	B
blood	O	NOUN	I
substitute	O	NOUN	I
on	O	ADP	O
diazepam	O	NOUN	B
binding	O	NOUN	B
by	O	ADP	O
human	B-GENE	ADJ	B
albumin	I-GENE	NOUN	O
.	O	PUNCT	O


A	O	DET	O
second	O	ADJ	O
promoter	O	NOUN	B
activity	O	NOUN	I
was	O	AUX	O
identified	O	VERB	B
in	O	ADP	O
the	O	DET	O
region	O	NOUN	B
between	O	ADP	O
the	O	DET	O
two	O	NUM	O
major	O	ADJ	O
transcriptional	O	ADJ	B
start	O	NOUN	O
sites	O	NOUN	O
.	O	PUNCT	O


Computer	O	NOUN	B
analysis	O	NOUN	I
included	O	VERB	O
digital	O	ADJ	B
averaging	O	NOUN	O
,	O	PUNCT	O
followed	O	VERB	O
by	O	ADP	O
digital	O	ADJ	B
filtering	O	NOUN	I
in	O	ADP	O
different	O	ADJ	O
frequency	O	NOUN	B
bands	O	NOUN	I
in	O	ADP	O
order	O	NOUN	O
to	O	PART	O
determine	O	VERB	O
the	O	DET	O
frequency	O	NOUN	B
range	O	NOUN	O
corresponding	O	VERB	O
to	O	ADP	O
notches	O	NOUN	B
and	O	CCONJ	O
slurs	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
also	O	ADV	O
examined	O	VERB	O
the	O	DET	O
relationship	O	NOUN	B
between	O	ADP	O
the	O	DET	O
side	O	NOUN	O
of	O	ADP	O
sinusitis	O	NOUN	B
and	O	CCONJ	O
the	O	DET	O
cleft	O	NOUN	B
side	O	NOUN	O
in	O	ADP	O
patients	O	NOUN	B
with	O	ADP	O
unilateral	O	ADJ	B
cleft	O	ADJ	I
palate	O	NOUN	I
.	O	PUNCT	O


Successful	O	ADJ	O
use	O	NOUN	O
of	O	ADP	O
transureteroureterostomy	O	NOUN	B
to	O	ADP	O
salvage	O	NOUN	B
ureterosigmoidostomy	O	NOUN	O
after	O	ADP	O
anastomotic	O	ADJ	B
failure	O	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
identified	O	VERB	B
and	O	CCONJ	O
characterized	O	VERB	B
the	O	DET	O
structure	O	NOUN	B
of	O	ADP	O
the	O	DET	O
Spec1	B-GENE	NOUN	B
gene	I-GENE	NOUN	I
in	O	ADP	O
the	O	DET	O
sea	O	NOUN	B
urchin	O	NOUN	I
Strongylocentrotus	O	NOUN	I
purpuratus	O	NOUN	I
.	O	PUNCT	O


Functional	O	ADJ	B
flow	O	NOUN	I
was	O	AUX	O
evaluated	O	VERB	B
using	O	VERB	O
laser	O	NOUN	B
Doppler	O	PROPN	I
flowmetry	O	NOUN	I
(	O	PUNCT	O
LDF	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
for	O	ADP	O
which	O	DET	O
the	O	DET	O
output	O	NOUN	B
signal	O	NOUN	I
,	O	PUNCT	O
blood	O	NOUN	B
cell	O	NOUN	I
flux	O	NOUN	I
(	O	PUNCT	O
BCF	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
is	O	AUX	O
expressed	O	VERB	B
in	O	ADP	O
terms	O	NOUN	O
of	O	ADP	O
volts	O	NOUN	O
.	O	PUNCT	O


Our	O	PRON	O
data	O	NOUN	B
,	O	PUNCT	O
however	O	ADV	O
,	O	PUNCT	O
did	O	AUX	O
not	O	PART	O
suggest	O	VERB	O
the	O	DET	O
existence	O	NOUN	O
of	O	ADP	O
a	O	DET	O
conversion	O	NOUN	B
factor	O	NOUN	I
for	O	ADP	O
LDF	O	NOUN	B
signal	O	NOUN	B
to	O	PART	O
absolute	O	ADJ	B
flow	O	NOUN	B
values	O	NOUN	I
from	O	ADP	O
experiment	O	NOUN	B
to	O	PART	O
experiment	O	NOUN	B
.	O	PUNCT	O


Quantitative	O	ADJ	B
analysis	O	NOUN	I
of	O	ADP	O
the	O	DET	O
coronary	O	ADJ	B
stenosis	O	NOUN	I
was	O	AUX	O
assessed	O	VERB	B
before	O	ADP	O
and	O	CCONJ	O
after	O	ADP	O
PTCA	O	PROPN	B
,	O	PUNCT	O
and	O	CCONJ	O
the	O	DET	O
dilatation	O	NOUN	B
resulted	O	VERB	O
in	O	ADP	O
an	O	DET	O
increase	O	NOUN	B
in	O	ADP	O
minimal	O	ADJ	B
luminal	O	ADJ	B
cross	O	NOUN	O
-	O	PUNCT	O
sectional	O	ADJ	B
area	O	NOUN	I
from	O	ADP	O
1	O	NUM	O
.	O	PUNCT	O
1	O	NUM	O
+	O	CCONJ	O
/	O	SYM	O
-	O	PUNCT	O
0	O	NUM	O
.	O	PUNCT	O
8	O	NUM	O
to	O	PART	O
2	O	NUM	O
.	O	PUNCT	O
7	O	NUM	O
+	O	CCONJ	O
/	O	SYM	O
-	O	PUNCT	O
1	O	NUM	O
.	O	PUNCT	O
2	O	NUM	O
mm2	O	NUM	O
.	O	PUNCT	O


In	O	ADP	O
a	O	DET	O
previous	O	ADJ	O
study	O	NOUN	B
(	O	PUNCT	O
Brandl	O	PROPN	O
,	O	PUNCT	O
C	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
seco	O	ADJ	B
-	O	PUNCT	O
steroid	O	NOUN	B
hormone	O	NOUN	O
1	O	NUM	O
,	O	PUNCT	O
25	O	NUM	O
-	O	PUNCT	O
dihydroxyvitamin	O	NOUN	B
D3	O	NOUN	I
is	O	AUX	O
known	O	VERB	O
to	O	PART	O
induce	O	VERB	B
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
a	O	DET	O
calcium	O	NOUN	B
binding	O	NOUN	I
protein	O	NOUN	I
termed	O	VERB	O
calbindin	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
D28K	I-GENE	NOUN	B
in	O	ADP	O
a	O	DET	O
variety	O	NOUN	O
of	O	ADP	O
target	O	NOUN	B
tissues	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
addition	O	NOUN	O
,	O	PUNCT	O
the	O	DET	O
calbindin	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
D28K	I-GENE	NOUN	B
promoter	I-GENE	NOUN	B
is	O	AUX	O
composed	O	VERB	O
of	O	ADP	O
a	O	DET	O
variety	O	NOUN	O
of	O	ADP	O
simple	O	ADJ	O
repeated	O	ADJ	O
sequences	O	NOUN	B
,	O	PUNCT	O
some	O	DET	O
of	O	ADP	O
which	O	DET	O
are	O	AUX	O
components	O	NOUN	B
of	O	ADP	O
putative	O	ADJ	B
regulatory	O	ADJ	I
signals	O	NOUN	I
.	O	PUNCT	O


Organ	O	NOUN	B
transplantation	O	NOUN	I
in	O	ADP	O
Denmark	O	PROPN	B
.	O	PUNCT	O


A	O	DET	O
114	O	NUM	O
-	O	PUNCT	O
base	O	NOUN	B
pair	O	NOUN	I
sequence	O	NOUN	I
of	O	ADP	O
predominantly	O	ADV	O
repeating	O	VERB	O
purine	O	NOUN	B
-	O	PUNCT	O
pyrimidine	O	NOUN	B
nucleotides	O	NOUN	B
separates	O	VERB	O
these	O	DET	O
two	O	NUM	O
d	O	NOUN	O
(	O	PUNCT	O
AC	O	NOUN	B
)	O	PUNCT	O
repeats	O	NOUN	O
.	O	PUNCT	O


Evidence	O	NOUN	B
for	O	ADP	O
a	O	DET	O
role	O	NOUN	O
of	O	ADP	O
endogenous	B-GENE	ADJ	B
corticotropin	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
releasing	I-GENE	VERB	B
factor	I-GENE	NOUN	O
in	O	ADP	O
cold	O	ADJ	B
,	O	PUNCT	O
ether	O	ADJ	B
,	O	PUNCT	O
immobilization	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
traumatic	O	ADJ	B
stress	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
210	O	NUM	O
kDa	O	NOUN	O
precursor	O	NOUN	B
is	O	AUX	O
converted	O	VERB	O
slowly	O	ADV	O
(	O	PUNCT	O
t	O	NOUN	O
1	O	NUM	O
/	O	SYM	O
2	O	NUM	O
=	O	ADJ	O
2	O	NUM	O
h	O	NOUN	O
)	O	PUNCT	O
by	O	ADP	O
proteolytic	O	ADJ	B
processing	O	NOUN	I
into	O	ADP	O
a	O	DET	O
125	O	NUM	O
kDa	O	NOUN	O
(	O	PUNCT	O
alpha	O	NOUN	B
'	O	PUNCT	O
)	O	PUNCT	O
and	O	CCONJ	O
83	O	NUM	O
kDa	O	NOUN	O
(	O	PUNCT	O
beta	O	NOUN	B
'	O	PART	I
)	O	PUNCT	O
species	O	NOUN	B
.	O	PUNCT	O


Its	O	PRON	O
predicted	O	VERB	O
amino	O	NOUN	B
acid	O	NOUN	I
sequence	O	NOUN	I
shows	O	VERB	O
extensive	O	ADJ	O
homology	O	NOUN	B
to	O	PART	O
those	O	DET	O
of	O	ADP	O
Drosophila	B-GENE	X	B
hsp70	I-GENE	NOUN	B
,	O	PUNCT	O
trout	B-GENE	NOUN	B
hsp70	I-GENE	NOUN	B
,	O	PUNCT	O
Xenopus	B-GENE	NOUN	B
hsp70	I-GENE	NOUN	B
,	O	PUNCT	O
yeast	B-GENE	NOUN	B
hsp70	I-GENE	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
some	O	DET	O
homology	O	NOUN	B
to	O	PART	O
the	O	DET	O
heat	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
inducible	I-GENE	ADJ	B
dnaK	I-GENE	NOUN	B
gene	I-GENE	NOUN	I
product	I-GENE	NOUN	O
of	O	ADP	O
Escherichia	O	X	B
coli	O	X	I
.	O	PUNCT	O


At	O	ADP	O
temperatures	O	NOUN	B
permissive	O	ADJ	B
for	O	ADP	O
transformation	O	NOUN	B
,	O	PUNCT	O
6m2	O	ADJ	B
cells	O	NOUN	I
contain	O	VERB	O
P58gag	B-GENE	NOUN	B
produced	O	VERB	O
from	O	ADP	O
the	O	DET	O
4	O	NUM	O
.	O	PUNCT	O
0	O	NUM	O
-	O	PUNCT	O
kilobase	O	NOUN	B
(	O	PUNCT	O
kb	O	NOUN	O
)	O	PUNCT	O
viral	O	ADJ	B
RNA	O	NOUN	I
genome	O	NOUN	O
and	O	CCONJ	O
P85gag	B-GENE	NOUN	B
-	O	PUNCT	O
mos	B-GENE	NOUN	B
translated	O	VERB	B
from	O	ADP	O
a	O	DET	O
3	O	NUM	O
.	O	PUNCT	O
5	O	NUM	O
-	O	PUNCT	O
kb	O	NOUN	O
spliced	O	ADJ	B
mRNA	O	NOUN	B
.	O	PUNCT	O


Multistep	O	ADJ	B
transformation	O	NOUN	I
by	O	ADP	O
defined	O	VERB	O
fragments	O	NOUN	B
of	O	ADP	O
herpes	O	NOUN	B
simplex	O	NOUN	I
virus	O	NOUN	I
type	O	NOUN	I
2	O	NUM	I
DNA	O	NOUN	I
:	O	PUNCT	O
oncogenic	O	ADJ	B
region	O	NOUN	I
and	O	CCONJ	O
its	O	PRON	O
gene	O	NOUN	B
product	O	NOUN	I
.	O	PUNCT	O


One	O	NUM	O
group	O	NOUN	B
(	O	PUNCT	O
n	O	NOUN	O
=	O	ADJ	O
9	O	NUM	O
)	O	PUNCT	O
was	O	AUX	O
premedicated	O	VERB	B
with	O	ADP	O
midazolam	O	NOUN	B
,	O	PUNCT	O
0	O	NUM	O
.	O	PUNCT	O
1	O	NUM	O
mg	O	NOUN	O
kg	O	NOUN	O
-	O	PUNCT	O
1	O	NUM	O
,	O	PUNCT	O
and	O	CCONJ	O
atropine	O	NOUN	B
0	O	NUM	O
.	O	PUNCT	O
2	O	NUM	O
-	O	SYM	O
0	O	NUM	O
.	O	PUNCT	O
4	O	NUM	O
mg	O	NOUN	O
i	O	NUM	O
.	O	PUNCT	O
m	O	NOUN	O
.	O	PUNCT	O


In	O	ADP	O
order	O	NOUN	O
to	O	PART	O
study	O	VERB	B
the	O	DET	O
influence	O	NOUN	B
of	O	ADP	O
iron	O	NOUN	B
overload	O	NOUN	I
on	O	ADP	O
the	O	DET	O
polymorphonuclear	O	ADJ	B
leucocyte	O	NOUN	B
(	O	PUNCT	O
PMN	O	NOUN	B
)	O	PUNCT	O
metabolism	O	NOUN	B
of	O	ADP	O
patients	O	NOUN	B
on	O	ADP	O
chronic	O	ADJ	B
hemodialysis	O	NOUN	I
,	O	PUNCT	O
generation	O	NOUN	O
of	O	ADP	O
superoxide	O	NOUN	B
anion	O	NOUN	I
(	O	PUNCT	O
O2	O	NOUN	B
-	O	PUNCT	O
)	O	PUNCT	O
by	O	ADP	O
PMN	O	NOUN	B
in	O	ADP	O
whole	O	ADJ	B
blood	O	NOUN	I
was	O	AUX	O
compared	O	VERB	B
in	O	ADP	O
two	O	NUM	O
groups	O	NOUN	B
of	O	ADP	O
hemodialyzed	O	ADJ	B
patients	O	NOUN	B
:	O	PUNCT	O
group	O	NOUN	B
A	O	NOUN	O
consisted	O	VERB	O
of	O	ADP	O
twenty	O	NUM	B
-	O	PUNCT	O
one	O	NUM	O
individuals	O	NOUN	B
with	O	ADP	O
serum	O	NOUN	B
ferritin	B-GENE	NOUN	I
levels	O	NOUN	I
above	O	ADP	O
1000	O	NUM	O
ng	O	NOUN	O
/	O	PUNCT	O
ml	O	NOUN	O
and	O	CCONJ	O
group	O	NOUN	B
B	O	NOUN	I
of	O	ADP	O
nineteen	O	NUM	O
individuals	O	NOUN	B
with	O	ADP	O
serum	O	NOUN	B
ferritin	B-GENE	NOUN	I
levels	O	NOUN	I
below	O	ADP	O
1000	O	NUM	O
ng	O	NOUN	O
/	O	PUNCT	O
ml	O	NOUN	O
.	O	PUNCT	O


Diazepam	O	NOUN	B
(	O	PUNCT	O
3	O	NUM	O
mg	O	NOUN	O
/	O	SYM	O
kg	O	NOUN	B
)	O	PUNCT	O
generalized	O	VERB	O
to	O	PART	O
Ro	O	NOUN	B
11	O	NUM	O
-	O	SYM	O
6896	O	NUM	O
whereas	O	SCONJ	O
the	O	DET	O
structurally	O	ADV	B
related	O	ADJ	O
Ro	O	NOUN	B
5	O	NUM	O
-	O	SYM	O
4864	O	NUM	O
(	O	PUNCT	O
3	O	NUM	O
mg	O	NOUN	O
/	O	SYM	O
kg	O	NOUN	B
and	O	CCONJ	O
30	O	NUM	O
mg	O	NOUN	O
/	O	SYM	O
kg	O	NOUN	B
)	O	PUNCT	O
did	O	AUX	O
not	O	PART	O
.	O	PUNCT	O


Five	O	NUM	O
patients	O	NOUN	B
developed	O	VERB	O
metastatic	O	ADJ	B
spread	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
all	O	DET	O
of	O	ADP	O
them	O	PRON	O
died	O	VERB	B
of	O	ADP	O
tumor	O	NOUN	B
.	O	PUNCT	O


There	O	PRON	O
were	O	AUX	O
no	O	DET	O
interfering	O	VERB	O
peaks	O	NOUN	O
in	O	ADP	O
the	O	DET	O
quantitation	O	NOUN	B
of	O	ADP	O
sulbactam	O	NOUN	B
.	O	PUNCT	O


Translation	O	NOUN	B
of	O	ADP	O
specific	O	ADJ	O
cellular	O	ADJ	B
genes	O	NOUN	I
from	O	ADP	O
the	O	DET	O
chimeric	O	ADJ	B
viral	O	ADJ	B
-	O	PUNCT	O
cellular	O	ADJ	B
transcripts	O	NOUN	B
seems	O	VERB	O
to	O	PART	O
be	O	AUX	O
unlikely	O	ADJ	O
.	O	PUNCT	O


Two	O	NUM	O
mutants	O	NOUN	B
,	O	PUNCT	O
each	O	DET	O
representative	O	NOUN	O
of	O	ADP	O
a	O	DET	O
separate	O	ADJ	O
pet	B-GENE	ADJ	B
complementation	O	NOUN	B
group	O	NOUN	I
,	O	PUNCT	O
have	O	AUX	O
been	O	AUX	O
analyzed	O	VERB	B
.	O	PUNCT	O


A	O	DET	O
centromere	O	NOUN	B
in	O	ADP	O
S	O	NOUN	B
.	O	PUNCT	O
cerevisiae	O	X	B
consists	O	VERB	O
of	O	ADP	O
a	O	DET	O
region	O	NOUN	B
of	O	ADP	O
DNA	O	NOUN	B
,	O	PUNCT	O
approximately	O	ADV	O
150	O	NUM	O
bp	O	NOUN	O
in	O	ADP	O
length	O	NOUN	B
,	O	PUNCT	O
containing	O	VERB	O
three	O	NUM	O
important	O	ADJ	O
sequence	O	NOUN	B
elements	O	NOUN	I
,	O	PUNCT	O
which	O	DET	O
are	O	AUX	O
folded	O	VERB	B
with	O	ADP	I
proteins	O	NOUN	B
into	O	ADP	O
a	O	DET	O
specific	O	ADJ	O
conformation	O	NOUN	B
in	O	ADP	O
the	O	DET	O
chromatin	O	NOUN	B
(	O	PUNCT	O
the	O	DET	O
yeast	O	NOUN	B
kinetochore	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Two	O	NUM	O
separate	O	ADJ	O
NF1	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
binding	I-GENE	VERB	B
loci	I-GENE	NOUN	I
were	O	AUX	O
also	O	ADV	O
found	O	VERB	O
in	O	ADP	O
the	O	DET	O
equivalent	O	ADJ	O
IE68	B-GENE	NOUN	B
gene	I-GENE	NOUN	I
of	O	ADP	O
HCMV	O	NOUN	B
(	O	PUNCT	O
Towne	O	NOUN	B
)	O	PUNCT	O
DNA	O	NOUN	O
,	O	PUNCT	O
but	O	CCONJ	O
in	O	ADP	O
this	O	DET	O
case	O	NOUN	B
the	O	DET	O
DNA	O	NOUN	B
sequence	O	NOUN	I
and	O	CCONJ	O
competition	O	NOUN	B
filter	O	NOUN	O
binding	O	NOUN	O
experiments	O	NOUN	O
indicated	O	VERB	O
a	O	DET	O
maximum	O	NOUN	B
of	O	ADP	O
only	O	ADV	O
four	O	NUM	O
to	O	PART	O
five	O	NUM	O
consensus	O	NOUN	B
binding	O	NOUN	I
sites	O	NOUN	I
encompassing	O	VERB	O
the	O	DET	O
promoter	O	NOUN	B
-	O	PUNCT	O
enhancer	O	NOUN	B
region	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
previously	O	ADV	O
described	O	VERB	O
four	O	NUM	O
sets	O	NOUN	B
of	O	ADP	O
13	O	NUM	O
-	O	PUNCT	O
to	O	ADP	O
18	O	NUM	O
-	O	PUNCT	O
base	O	NOUN	B
-	O	PUNCT	O
pair	O	NOUN	B
interspersed	O	ADJ	O
repeat	O	NOUN	O
elements	O	NOUN	O
between	O	ADP	O
-	O	PUNCT	O
55	O	NUM	O
and	O	CCONJ	O
-	O	PUNCT	O
580	O	NUM	O
provide	O	VERB	O
most	O	ADJ	O
of	O	ADP	O
the	O	DET	O
high	O	ADJ	B
basal	O	ADJ	B
transcriptional	O	ADJ	I
strength	O	NOUN	I
,	O	PUNCT	O
whereas	O	SCONJ	O
the	O	DET	O
arrangement	O	NOUN	B
of	O	ADP	O
further	O	ADJ	O
upstream	O	ADJ	B
tandemly	O	ADJ	I
repeated	O	VERB	O
NF1	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
binding	I-GENE	VERB	B
sites	I-GENE	NOUN	O
may	O	AUX	O
contribute	O	VERB	O
significantly	O	ADV	O
to	O	PART	O
the	O	DET	O
expanded	O	ADJ	O
biological	O	ADJ	B
host	O	NOUN	B
range	O	NOUN	O
for	O	ADP	O
expression	O	NOUN	B
of	O	ADP	O
SCMV	B-GENE	NOUN	B
IE94	I-GENE	NOUN	B
compared	O	VERB	O
with	O	ADP	O
HCMV	B-GENE	NOUN	B
IE68	I-GENE	NOUN	B
.	O	PUNCT	O


Active	O	ADJ	B
lambda	B-GENE	NOUN	I
and	I-GENE	CCONJ	O
kappa	I-GENE	NOUN	B
antibody	I-GENE	NOUN	I
gene	I-GENE	NOUN	B
rearrangement	O	NOUN	I
in	O	ADP	O
Abelson	O	NOUN	B
murine	O	ADJ	I
leukemia	O	NOUN	I
virus	O	NOUN	B
-	O	PUNCT	O
transformed	O	VERB	B
pre	O	NOUN	B
-	O	PUNCT	O
B	O	NOUN	B
cell	O	NOUN	I
lines	O	NOUN	I
.	O	PUNCT	O


Influence	O	NOUN	B
of	O	ADP	O
cyclo	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
oxygenase	I-GENE	NOUN	B
inhibition	O	NOUN	B
and	O	CCONJ	O
of	O	ADP	O
leukotriene	B-GENE	NOUN	B
receptor	I-GENE	NOUN	I
blockade	O	NOUN	B
on	O	ADP	O
pulmonary	O	ADJ	B
vascular	O	ADJ	I
pressure	O	NOUN	I
/	O	SYM	O
cardiac	O	ADJ	B
index	O	NOUN	I
relationships	O	NOUN	B
in	O	ADP	O
hyperoxic	O	NOUN	B
and	O	CCONJ	O
in	O	ADP	O
hypoxic	O	ADJ	B
dogs	O	NOUN	I
.	O	PUNCT	O


Northern	O	NOUN	B
analyses	O	NOUN	I
of	O	ADP	O
RNAs	O	NOUN	B
from	O	ADP	O
mouse	O	NOUN	B
tissues	O	NOUN	I
and	O	CCONJ	O
cell	O	NOUN	B
lines	O	NOUN	I
indicated	O	VERB	O
that	O	SCONJ	O
p11	B-GENE	NOUN	B
mRNA	I-GENE	NOUN	B
levels	O	NOUN	O
vary	O	VERB	O
widely	O	ADV	O
.	O	PUNCT	O


Morphine	O	NOUN	B
produced	O	VERB	O
a	O	DET	O
dose	O	NOUN	B
-	O	PUNCT	O
dependent	O	ADJ	B
bradycardia	O	NOUN	B
followed	O	VERB	O
by	O	ADP	O
tachycardia	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
PSS	B-GENE	NOUN	B
gene	I-GENE	NOUN	I
was	O	AUX	O
subcloned	O	VERB	B
into	O	ADP	O
a	O	DET	O
1	O	NUM	O
.	O	PUNCT	O
1	O	NUM	O
-	O	PUNCT	O
kb	O	NOUN	O
fragment	O	NOUN	O
of	O	ADP	O
the	O	DET	O
yeast	O	NOUN	B
DNA	O	NOUN	B
on	O	ADP	O
the	O	DET	O
YEp13	O	NOUN	B
vector	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
gene	O	NOUN	B
is	O	AUX	O
essential	O	ADJ	O
for	O	ADP	O
yeast	O	NOUN	B
vegetative	O	ADJ	B
growth	O	NOUN	I
.	O	PUNCT	O


Bacteriologic	O	ADJ	B
culture	O	NOUN	I
of	O	ADP	O
pancreatic	O	ADJ	B
tissue	O	NOUN	I
was	O	AUX	O
positive	O	ADJ	B
in	O	ADP	O
6	O	NUM	O
/	O	SYM	O
8	O	NUM	B
IB	O	NOUN	B
and	O	CCONJ	O
3	O	NUM	O
/	O	SYM	O
17	O	NUM	B
NIB	O	NOUN	B
rats	O	NOUN	B
(	O	PUNCT	O
p	O	NOUN	O
less	O	ADJ	O
than	O	ADP	O
0	O	NUM	O
.	O	PUNCT	O
01	O	NUM	O
)	O	PUNCT	O
.	O	PUNCT	O


These	O	DET	O
similarities	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
these	O	DET	O
E2	B-GENE	NOUN	B
proteins	I-GENE	NOUN	I
are	O	AUX	O
structurally	O	ADV	B
and	O	CCONJ	O
evolutionarily	O	ADV	B
related	O	ADJ	O
.	O	PUNCT	O


Histological	O	ADJ	B
examination	O	NOUN	O
revealed	O	VERB	O
a	O	DET	O
small	O	ADJ	O
simple	O	ADJ	B
renal	O	ADJ	I
cyst	O	NOUN	I
associated	O	VERB	B
with	O	ADP	I
renal	O	ADJ	B
cell	O	NOUN	I
carcinoma	O	NOUN	I
.	O	PUNCT	O


Thus	O	ADV	O
,	O	PUNCT	O
prostacyclin	O	NOUN	B
enhanced	O	VERB	B
the	O	DET	O
autoregulative	O	ADJ	B
property	O	NOUN	B
of	O	ADP	O
the	O	DET	O
inner	O	ADJ	B
ear	O	NOUN	I
vessels	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
method	O	NOUN	B
is	O	AUX	O
accurate	O	ADJ	B
,	O	PUNCT	O
with	O	ADP	O
good	O	ADJ	O
precision	O	NOUN	B
and	O	CCONJ	O
adequate	O	ADJ	B
sensitivity	O	NOUN	B
.	O	PUNCT	O


Factors	O	NOUN	B
influencing	O	VERB	B
the	O	DET	O
bond	O	NOUN	B
strength	O	NOUN	I
between	O	ADP	O
glass	O	NOUN	B
polyalkenoate	O	NOUN	I
(	O	PUNCT	O
ionomer	O	NOUN	B
)	O	PUNCT	O
cements	O	NOUN	B
and	O	CCONJ	O
dentine	O	NOUN	B
.	O	PUNCT	O


Van	O	PROPN	O
der	O	NOUN	O
Ende	O	PROPN	O
,	O	PUNCT	O
R	O	PROPN	B
.	O	PUNCT	O


Clinical	O	ADJ	B
findings	O	NOUN	I
were	O	AUX	O
:	O	PUNCT	O
height	O	NOUN	B
183	O	NUM	O
cm	O	NOUN	O
,	O	PUNCT	O
weight	O	NOUN	B
62	O	NUM	O
kg	O	NOUN	O
,	O	PUNCT	O
increased	O	VERB	B
length	O	NOUN	B
of	O	ADP	O
lower	O	ADJ	B
limbs	O	NOUN	I
,	O	PUNCT	O
P2	O	NOUN	B
-	O	PUNCT	O
A2	O	NOUN	B
pilosity	O	ADJ	B
and	O	CCONJ	O
micropenis	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
8	O	NUM	O
patients	O	NOUN	B
receiving	O	VERB	O
Ir192	O	NOUN	B
implant	O	NOUN	B
in	O	ADP	O
addition	O	NOUN	O
to	O	ADP	O
external	O	ADJ	B
radiation	O	NOUN	B
showed	O	VERB	O
improved	O	VERB	B
(	O	PUNCT	O
p	O	NOUN	O
=	O	ADJ	O
0	O	NUM	O
.	O	PUNCT	O
06	O	NUM	O
)	O	PUNCT	O
survival	O	NOUN	B
compared	O	VERB	O
to	O	PART	O
the	O	DET	O
9	O	NUM	O
receiving	O	VERB	B
external	O	ADJ	B
only	O	ADV	O
:	O	PUNCT	O
median	O	ADJ	B
15	O	NUM	O
months	O	NOUN	B
(	O	PUNCT	O
range	O	NOUN	O
1	O	NUM	O
.	O	PUNCT	O
5	O	NUM	O
-	O	SYM	O
34	O	NUM	O
+	O	CCONJ	O
months	O	NOUN	B
)	O	PUNCT	O
versus	O	CCONJ	O
7	O	NUM	O
months	O	NOUN	B
(	O	PUNCT	O
range	O	NOUN	O
2	O	NUM	O
.	O	PUNCT	O
5	O	NUM	O
-	O	SYM	O
21	O	NUM	O
months	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


No	O	DET	B
effect	O	NOUN	I
was	O	AUX	O
found	O	VERB	O
on	O	ADP	O
grooming	O	NOUN	B
behavior	O	NOUN	I
.	O	PUNCT	O


Clinical	O	ADJ	B
and	O	CCONJ	O
biological	O	ADJ	B
correlates	O	NOUN	B
of	O	ADP	O
panic	O	NOUN	B
states	O	NOUN	I
.	O	PUNCT	O


Effects	O	NOUN	B
of	O	ADP	I
long	O	ADJ	B
-	O	PUNCT	O
term	O	NOUN	B
parenteral	O	ADJ	B
nutrition	O	NOUN	I
on	O	ADP	O
gastrin	B-GENE	NOUN	B
release	O	NOUN	B
in	O	ADP	O
dogs	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
mean	O	ADJ	O
weight	O	NOUN	O
and	O	CCONJ	O
height	O	NOUN	B
velocities	O	NOUN	B
were	O	AUX	O
148	O	NUM	O
%	O	NOUN	O
and	O	CCONJ	O
122	O	NUM	O
%	O	NOUN	O
of	O	ADP	O
the	O	DET	O
standard	O	NOUN	B
,	O	PUNCT	O
respectively	O	ADV	O
.	O	PUNCT	O


In	O	ADP	O
64	O	NUM	O
%	O	NOUN	O
a	O	DET	O
small	O	ADJ	B
cardiac	O	ADJ	I
vein	O	NOUN	I
does	O	AUX	O
not	O	PART	O
exist	O	VERB	O
,	O	PUNCT	O
but	O	CCONJ	O
its	O	PRON	O
origin	O	NOUN	B
,	O	PUNCT	O
the	O	DET	O
right	O	ADJ	B
marginal	O	ADJ	I
vein	O	NOUN	I
,	O	PUNCT	O
joins	O	VERB	O
the	O	DET	O
system	O	NOUN	B
of	O	ADP	O
anterior	O	ADJ	B
cardiac	O	ADJ	O
veins	O	NOUN	O
.	O	PUNCT	O


The	O	DET	O
results	O	NOUN	B
of	O	ADP	O
these	O	DET	O
experiments	O	NOUN	B
indicate	O	VERB	O
that	O	SCONJ	O
at	O	ADP	O
least	O	ADJ	O
two	O	NUM	O
upstream	O	ADJ	B
activator	O	NOUN	I
sequences	O	NOUN	I
(	O	PUNCT	O
UAS	O	NOUN	B
)	O	PUNCT	O
mediate	O	VERB	O
maximum	O	ADJ	B
induction	O	NOUN	B
by	O	ADP	O
galactose	O	NOUN	B
.	O	PUNCT	O


Reversal	O	NOUN	B
of	O	ADP	O
the	O	DET	O
increase	O	NOUN	B
in	O	ADP	O
apomorphine	O	NOUN	B
-	O	PUNCT	O
induced	O	VERB	B
stereotypy	O	NOUN	B
and	O	CCONJ	O
aggression	O	NOUN	B
in	O	ADP	O
REM	O	NOUN	B
sleep	O	NOUN	I
deprived	O	ADJ	O
rats	O	NOUN	B
by	O	ADP	O
dopamine	O	NOUN	B
agonist	O	NOUN	B
pretreatments	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
genetic	O	ADJ	B
basis	O	NOUN	O
for	O	ADP	O
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
a	O	DET	O
latent	O	ADJ	O
VH	B-GENE	NOUN	B
allotype	I-GENE	NOUN	B
in	O	ADP	O
the	O	DET	O
rabbit	O	NOUN	B
was	O	AUX	O
investigated	O	VERB	B
.	O	PUNCT	O


Potentiation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
thrombolytic	O	ADJ	B
efficacy	O	NOUN	B
of	O	ADP	O
single	B-GENE	ADJ	B
-	I-GENE	PUNCT	O
chain	I-GENE	NOUN	B
urokinase	I-GENE	NOUN	I
(	O	PUNCT	O
Pro	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
urokinase	I-GENE	NOUN	B
)	O	PUNCT	O
by	O	ADP	O
heparin	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
variability	O	NOUN	B
is	O	AUX	O
most	O	ADV	O
likely	O	ADV	O
a	O	DET	O
result	O	NOUN	O
of	O	ADP	O
alternative	O	ADJ	B
splicing	O	NOUN	B
of	O	ADP	O
exons	O	NOUN	B
from	O	ADP	O
the	O	DET	O
primary	O	ADJ	O
elastin	B-GENE	NOUN	B
transcripts	I-GENE	NOUN	B
.	O	PUNCT	O


This	O	DET	O
led	O	VERB	O
to	O	ADP	O
the	O	DET	O
conclusion	O	NOUN	O
that	O	SCONJ	O
the	O	DET	O
metatarsal	O	ADJ	B
artery	O	NOUN	I
should	O	AUX	O
be	O	AUX	O
used	O	VERB	O
for	O	ADP	O
toe	O	NOUN	B
MP	O	NOUN	I
joint	O	ADJ	I
grafts	O	NOUN	I
,	O	PUNCT	O
while	O	SCONJ	O
the	O	DET	O
unilateral	O	ADJ	B
proper	O	ADJ	O
digital	O	ADJ	B
artery	O	NOUN	I
is	O	AUX	O
suitable	O	ADJ	O
for	O	ADP	O
toe	O	NOUN	B
PIP	O	NOUN	B
joint	O	NOUN	I
grafts	O	NOUN	O
,	O	PUNCT	O
together	O	ADV	O
with	O	ADP	O
concomitant	O	ADJ	B
or	O	CCONJ	O
dorsal	O	ADJ	B
cutaneous	O	ADJ	I
vein	O	NOUN	I
.	O	PUNCT	O


Factors	O	NOUN	B
involved	O	VERB	O
in	O	ADP	O
specific	O	ADJ	O
transcription	O	NOUN	B
by	O	ADP	O
mammalian	O	ADJ	B
RNA	B-GENE	NOUN	B
polymerase	I-GENE	NOUN	I
II	I-GENE	NUM	I
:	O	PUNCT	O
purification	O	NOUN	B
,	O	PUNCT	O
genetic	O	ADJ	B
specificity	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
TATA	O	NOUN	B
box	O	NOUN	O
-	O	PUNCT	O
promoter	O	NOUN	B
interactions	O	NOUN	B
of	O	ADP	O
TFIID	B-GENE	NOUN	B
.	O	PUNCT	O


You	O	PRON	O
make	O	VERB	O
the	O	DET	O
diagnosis	O	NOUN	B
.	O	PUNCT	O


Conservative	O	ADJ	B
treatment	O	NOUN	I
of	O	ADP	O
bladder	O	NOUN	B
carcinoma	O	NOUN	I
by	O	ADP	O
partial	O	ADJ	B
cystectomy	O	NOUN	I
and	O	CCONJ	O
interstitial	O	ADJ	B
iridium	O	NOUN	I
192	O	NUM	O
.	O	PUNCT	O


The	O	DET	O
results	O	NOUN	B
presented	O	VERB	O
suggest	O	VERB	O
that	O	SCONJ	O
TIQ	O	NOUN	B
reduces	O	VERB	B
the	O	DET	O
turnover	O	NOUN	B
rate	O	NOUN	B
of	O	ADP	O
the	O	DET	O
nigrostriatal	O	ADJ	B
dopamine	O	NOUN	B
neurons	O	NOUN	B
after	O	ADP	O
repeated	O	VERB	O
administration	O	NOUN	B
for	O	ADP	O
a	O	DET	O
long	O	ADJ	O
period	O	NOUN	B
in	O	ADP	O
mice	O	NOUN	B
.	O	PUNCT	O


During	O	ADP	O
a	O	DET	O
28	O	NUM	O
-	O	PUNCT	O
week	O	NOUN	B
promotion	O	NOUN	B
bioassay	O	NOUN	I
,	O	PUNCT	O
groups	O	NOUN	B
of	O	ADP	O
30	O	NUM	O
male	O	ADJ	B
CD	O	PROPN	B
-	O	PUNCT	O
1	O	NUM	O
mice	O	NOUN	B
were	O	AUX	O
treated	O	VERB	B
once	O	ADV	B
with	O	ADP	I
50	O	NUM	O
microliter	O	NOUN	O
of	O	ADP	O
either	O	CCONJ	O
DMBA	O	NOUN	B
(	O	PUNCT	O
1	O	NUM	O
.	O	PUNCT	O
0	O	NUM	O
mg	O	NOUN	O
/	O	PUNCT	O
ml	O	NOUN	O
)	O	PUNCT	O
or	O	CCONJ	O
acetone	O	NOUN	B
,	O	PUNCT	O
rested	O	VERB	O
for	O	ADP	O
2	O	NUM	O
weeks	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
then	O	ADV	O
treated	O	VERB	B
twice	O	ADV	O
per	O	ADP	O
week	O	NOUN	B
with	O	ADP	O
test	O	NOUN	B
material	O	NOUN	I
for	O	ADP	O
the	O	DET	O
remaining	O	VERB	O
25	O	NUM	O
weeks	O	NOUN	B
.	O	PUNCT	O


An	O	DET	O
11	O	NUM	O
-	O	PUNCT	O
month	O	NOUN	B
-	O	PUNCT	O
old	O	ADJ	B
girl	O	NOUN	I
suffering	O	VERB	O
from	O	ADP	O
Dandy	O	PROPN	B
-	O	PUNCT	O
Walker	O	PROPN	B
malformation	O	NOUN	I
(	O	PUNCT	O
DWM	O	NOUN	B
)	O	PUNCT	O
associated	O	VERB	B
with	O	ADP	I
tetralogy	O	NOUN	B
of	O	ADP	I
Fallot	O	PROPN	I
(	O	PUNCT	O
TOF	O	NOUN	B
)	O	PUNCT	O
is	O	AUX	O
presented	O	VERB	O
.	O	PUNCT	O


The	O	DET	O
median	O	ADJ	B
survival	O	NOUN	I
is	O	AUX	O
not	O	PART	O
reached	O	VERB	O
with	O	ADP	O
a	O	DET	O
median	O	ADJ	B
follow	O	NOUN	B
-	O	PUNCT	O
up	O	ADP	O
time	O	NOUN	O
of	O	ADP	O
9	O	NUM	O
.	O	PUNCT	O
6	O	NUM	O
years	O	NOUN	B
.	O	PUNCT	O


Critical	O	ADJ	B
evaluation	O	NOUN	B
of	O	ADP	O
various	O	ADJ	O
methods	O	NOUN	B
of	O	ADP	O
determining	O	VERB	O
markers	O	NOUN	B
of	O	ADP	O
fetal	O	ADJ	B
maturity	O	NOUN	I
in	O	ADP	O
amniotic	O	ADJ	B
fluid	O	NOUN	I


Neuromyelitis	O	NOUN	B
optica	O	NOUN	I
(	O	PUNCT	O
Devic	O	NOUN	O
'	O	PART	O
s	O	NOUN	O
syndrome	O	NOUN	B
)	O	PUNCT	O
:	O	PUNCT	O
not	O	PART	O
always	O	ADV	O
multiple	O	ADJ	B
sclerosis	O	NOUN	I
.	O	PUNCT	O


Effect	O	NOUN	B
of	O	ADP	O
the	O	DET	O
methods	O	NOUN	B
of	O	ADP	O
cutaneous	O	ADJ	B
administration	O	NOUN	I
of	O	ADP	O
methyl	O	NOUN	B
isobutyl	O	NOUN	I
ketone	O	NOUN	B
on	O	ADP	O
its	O	PRON	O
toxicity	O	NOUN	B


The	O	DET	O
temporal	O	ADJ	B
and	O	CCONJ	O
static	O	ADJ	B
plasma	O	NOUN	I
concentration	O	NOUN	B
-	O	PUNCT	O
effect	O	NOUN	B
relationships	O	NOUN	B
were	O	AUX	O
evaluated	O	VERB	B
by	O	ADP	O
pharmacodynamic	O	ADJ	B
modeling	O	NOUN	I
and	O	CCONJ	O
linear	O	ADJ	B
regression	O	NOUN	I
.	O	PUNCT	O


Fourteen	O	NUM	O
patients	O	NOUN	B
were	O	AUX	O
in	O	ADP	O
the	O	DET	O
multifocal	O	ADJ	B
disease	O	NOUN	I
group	O	NOUN	O
;	O	PUNCT	O
13	O	NUM	O
were	O	AUX	O
detected	O	VERB	B
by	O	ADP	O
SPECT	O	NOUN	B
and	O	CCONJ	O
10	O	NUM	O
by	O	ADP	O
TCT	O	PROPN	B
.	O	PUNCT	O


The	O	DET	O
SSB	B-GENE	PROPN	B
-	O	PUNCT	O
poly	O	NOUN	B
(	O	PUNCT	O
dT	O	NOUN	B
)	O	PUNCT	O
affinity	O	NOUN	B
is	O	AUX	O
too	O	ADV	O
high	O	ADJ	O
to	O	PART	O
measure	O	VERB	B
in	O	ADP	O
buffers	O	NOUN	B
containing	O	VERB	O
even	O	ADV	O
5	O	NUM	O
M	O	NOUN	B
NaCl	O	NOUN	I
;	O	PUNCT	O
however	O	ADV	O
,	O	PUNCT	O
in	O	ADP	O
1	O	NUM	O
.	O	PUNCT	O
8	O	NUM	O
-	O	SYM	O
2	O	NUM	O
.	O	PUNCT	O
5	O	NUM	O
M	O	NOUN	O
NaBr	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
measure	O	VERB	B
alpha	O	NOUN	O
log	O	NOUN	O
Kobsd	O	PROPN	B
/	O	SYM	O
alpha	O	NOUN	B
log	O	NOUN	I
[	O	PUNCT	O
NaBr	O	NOUN	B
]	O	PUNCT	O
=	O	ADJ	O
-	O	SYM	O
5	O	NUM	O
.	O	PUNCT	O
7	O	NUM	O
+	O	CCONJ	O
/	O	SYM	O
-	O	PUNCT	O
0	O	NUM	O
.	O	PUNCT	O
7	O	NUM	O
,	O	PUNCT	O
with	O	ADP	O
a	O	DET	O
lower	O	ADJ	O
value	O	NOUN	O
of	O	ADP	O
omega	O	NOUN	B
T	O	NOUN	I
/	O	SYM	O
O	O	NOUN	B
=	O	ADJ	O
130	O	NUM	O
+	O	CCONJ	O
/	O	SYM	O
-	O	PUNCT	O
70	O	NUM	O
.	O	PUNCT	O


Minor	O	ADJ	B
differences	O	NOUN	B
were	O	AUX	O
noted	O	VERB	O
with	O	ADP	O
latamoxef	O	NOUN	B
producing	O	VERB	O
mild	O	ADJ	B
persistant	O	ADJ	B
elevation	O	NOUN	O
of	O	ADP	O
prothrombin	B-GENE	NOUN	B
time	O	NOUN	I
(	O	PUNCT	O
0	O	NUM	O
.	O	PUNCT	O
7	O	NUM	O
second	O	ADJ	O
)	O	PUNCT	O
associated	O	VERB	B
with	O	ADP	I
depression	O	NOUN	B
of	O	ADP	O
factor	B-GENE	NOUN	B
II	I-GENE	NUM	I
and	O	CCONJ	O
factor	B-GENE	NOUN	B
VII	I-GENE	NOUN	I
.	O	PUNCT	O


Plasma	B-GENE	NOUN	B
renin	I-GENE	NOUN	B
activity	O	NOUN	B
does	O	AUX	O
not	O	PART	O
predict	O	VERB	O
the	O	DET	O
antihypertensive	O	ADJ	B
efficacy	O	NOUN	B
of	O	ADP	O
chlorthalidone	O	NOUN	B
.	O	PUNCT	O


Cephradine	O	NOUN	B
250	O	NUM	O
mg	O	NOUN	O
at	O	ADP	O
night	O	NOUN	B
for	O	ADP	O
12	O	NUM	O
months	O	NOUN	B
was	O	AUX	O
given	O	VERB	O
as	O	ADP	O
a	O	DET	O
prophylactic	O	ADJ	B
measure	O	NOUN	I
to	O	ADP	O
33	O	NUM	O
female	O	ADJ	B
patients	O	NOUN	B
of	O	ADP	O
mean	O	ADJ	O
age	O	NOUN	B
41	O	NUM	O
.	O	PUNCT	O
6	O	NUM	O
years	O	NOUN	B
,	O	PUNCT	O
who	O	PRON	O
had	O	AUX	O
a	O	DET	O
history	O	NOUN	B
in	O	ADP	O
the	O	DET	O
preceding	O	VERB	O
12	O	NUM	O
months	O	NOUN	B
of	O	ADP	O
between	O	ADP	O
three	O	NUM	O
and	O	CCONJ	O
24	O	NUM	O
(	O	PUNCT	O
median	O	NOUN	B
=	O	ADJ	O
7	O	NUM	O
)	O	PUNCT	O
episodes	O	NOUN	B
of	O	ADP	O
frequency	O	NOUN	B
and	O	CCONJ	O
/	O	SYM	O
or	O	CCONJ	O
dysuria	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
activity	O	NOUN	B
of	O	ADP	O
the	O	DET	O
EGF	B-GENE	NOUN	B
receptor	I-GENE	NOUN	I
promoter	I-GENE	NOUN	B
can	O	AUX	O
be	O	AUX	O
modulated	O	VERB	B
by	O	ADP	O
E1A	B-GENE	NOUN	B
protein	I-GENE	NOUN	I
and	O	CCONJ	O
receptor	O	NOUN	B
RNA	O	NOUN	I
levels	O	NOUN	B
increased	O	VERB	B
by	O	ADP	O
stimulation	O	NOUN	B
with	O	ADP	O
phorbol	O	NOUN	B
ester	O	NOUN	I
or	O	CCONJ	O
fetal	O	ADJ	B
calf	O	NOUN	O
serum	O	NOUN	B
.	O	PUNCT	O


By	O	ADP	O
Felix	O	PROPN	B
Lagrange	O	PROPN	I
,	O	PUNCT	O
1918	O	NUM	O
.	O	PUNCT	O


The	O	DET	O
epidermal	B-GENE	ADJ	B
growth	I-GENE	NOUN	I
factor	I-GENE	NOUN	I
(	I-GENE	PUNCT	O
EGF	I-GENE	NOUN	B
)	I-GENE	PUNCT	O
receptor	I-GENE	NOUN	O
,	O	PUNCT	O
which	O	DET	O
exhibits	O	VERB	O
intrinsic	O	ADJ	B
protein	B-GENE	NOUN	I
tyrosine	I-GENE	NOUN	I
kinase	I-GENE	NOUN	I
activity	O	NOUN	O
,	O	PUNCT	O
undergoes	O	VERB	O
a	O	DET	O
rapid	O	ADJ	B
,	O	PUNCT	O
intramolecular	O	ADJ	B
self	O	NOUN	O
-	O	PUNCT	O
phosphorylation	O	NOUN	B
reaction	O	NOUN	B
following	O	VERB	O
EGF	B-GENE	NOUN	B
activation	O	NOUN	I
.	O	PUNCT	O


A	O	DET	O
case	O	NOUN	B
of	O	ADP	O
AIDS	O	PROPN	B
-	O	PUNCT	O
related	O	VERB	B
complex	O	NOUN	B
(	O	PUNCT	O
ARC	O	NOUN	B
/	O	SYM	O
LAS	O	PROPN	B
)	O	PUNCT	O
in	O	ADP	O
a	O	DET	O
health	O	NOUN	B
worker	O	NOUN	I


Vimentin	B-GENE	NOUN	B
positivity	O	NOUN	B
was	O	AUX	O
noted	O	VERB	O
in	O	ADP	O
the	O	DET	O
undifferentiated	O	ADJ	B
and	O	CCONJ	O
fibroblastic	O	ADJ	B
components	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
spermicide	O	NOUN	B
nonoxynol	O	NOUN	B
-	O	PUNCT	O
9	O	NUM	B
is	O	AUX	O
a	O	DET	O
member	O	NOUN	O
of	O	ADP	O
a	O	DET	O
homologous	O	ADJ	B
series	O	NOUN	O
of	O	ADP	O
alkylphenol	O	NOUN	B
-	O	PUNCT	O
ethoxylates	O	NOUN	B
(	O	PUNCT	O
polyethoxyethanols	O	NOUN	B
)	O	PUNCT	O
of	O	ADP	O
general	O	ADJ	B
formula	O	NOUN	I
C9H19	O	PROPN	B
-	O	PUNCT	O
C6H6	O	PROPN	B
-	O	PUNCT	O
O	O	PROPN	B
-	O	PUNCT	O
(	O	PUNCT	O
CH2CH2O	O	NOUN	O
)	O	PUNCT	O
n	O	NOUN	O
-	O	PUNCT	O
1	O	NUM	O
CH2CH2OH	O	NOUN	B
.	O	PUNCT	O


Depending	O	VERB	O
on	O	ADP	O
the	O	DET	O
location	O	NOUN	B
and	O	CCONJ	O
size	O	NOUN	B
of	O	ADP	O
the	O	DET	O
mass	O	NOUN	B
,	O	PUNCT	O
a	O	DET	O
wide	O	ADJ	O
range	O	NOUN	O
of	O	ADP	O
clinical	O	ADJ	B
presentations	O	NOUN	I
is	O	AUX	O
associated	O	VERB	B
with	O	ADP	I
the	O	DET	O
lesion	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
development	O	NOUN	B
and	O	CCONJ	O
distribution	O	NOUN	B
of	O	ADP	O
Trypanosoma	O	X	B
congolense	O	NOUN	I
,	O	PUNCT	O
T	O	NOUN	B
vivax	O	NOUN	I
and	O	CCONJ	O
T	O	NOUN	B
brucei	O	X	I
in	O	ADP	O
the	O	DET	O
skin	O	NOUN	B
of	O	ADP	O
goats	O	NOUN	B
was	O	AUX	O
examined	O	VERB	O
after	O	ADP	O
the	O	DET	O
animals	O	NOUN	B
were	O	AUX	O
bitten	O	VERB	B
by	O	ADP	O
infected	O	ADJ	B
Glossina	O	NOUN	B
morsitans	O	X	I
centralis	O	NOUN	I
.	O	PUNCT	O


During	O	ADP	O
the	O	DET	O
observation	O	NOUN	B
period	O	NOUN	B
of	O	ADP	O
0	O	NUM	O
.	O	PUNCT	O
4	O	NUM	O
-	O	SYM	O
30	O	NUM	O
weeks	O	NOUN	B
,	O	PUNCT	O
cardiac	O	ADJ	B
white	O	ADJ	I
spots	O	NOUN	I
on	O	ADP	O
the	O	DET	O
right	O	ADJ	B
ventricle	O	NOUN	I
of	O	ADP	O
BALB	O	PROPN	B
/	O	SYM	O
c	O	NOUN	B
mice	O	NOUN	B
were	O	AUX	O
first	O	ADV	O
detected	O	VERB	B
at	O	ADP	O
three	O	NUM	O
weeks	O	NOUN	B
(	O	PUNCT	O
6	O	NUM	O
of	O	ADP	O
20	O	NUM	O
mice	O	NOUN	B
;	O	PUNCT	O
30	O	NUM	O
%	O	NOUN	O
)	O	PUNCT	O
,	O	PUNCT	O
and	O	CCONJ	O
the	O	DET	O
maximal	O	ADJ	B
incidence	O	NOUN	B
of	O	ADP	O
cardiac	O	ADJ	B
white	O	ADJ	I
spots	O	NOUN	I
was	O	AUX	O
obtained	O	VERB	O
at	O	ADP	O
nine	O	NUM	O
weeks	O	NOUN	B
(	O	PUNCT	O
39	O	NUM	O
of	O	ADP	O
44	O	NUM	O
mice	O	NOUN	B
;	O	PUNCT	O
88	O	NUM	O
%	O	NOUN	O
)	O	PUNCT	O
.	O	PUNCT	O


Increasing	O	VERB	B
the	O	DET	O
RH	O	NOUN	B
beyond	O	ADP	O
32	O	NUM	O
%	O	NOUN	O
resulted	O	VERB	O
in	O	ADP	O
solvation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
peroxy	O	ADJ	B
radical	O	NOUN	I
,	O	PUNCT	O
sterically	O	ADV	B
hindering	O	VERB	O
the	O	DET	O
radical	O	NOUN	B
from	O	ADP	O
entering	O	VERB	O
the	O	DET	O
propagation	O	NOUN	B
transition	O	NOUN	O
state	O	NOUN	O
.	O	PUNCT	O


PATIENTS	O	NOUN	B
and	O	CCONJ	O
METHODS	O	NOUN	B
:	O	PUNCT	O
Thallium	O	PROPN	B
-	O	PUNCT	O
201	O	NUM	O
myocardial	O	ADJ	B
scintigraphy	O	NOUN	I
was	O	AUX	O
performed	O	VERB	O
at	O	ADP	O
rest	O	NOUN	B
and	O	CCONJ	O
after	O	ADP	O
0	O	NUM	O
.	O	PUNCT	O
56	O	NUM	O
mg	O	NOUN	O
/	O	SYM	O
kg	O	NOUN	O
intravenous	O	ADJ	B
dipyridamole	O	NOUN	O
during	O	ADP	O
four	O	NUM	O
minutes	O	NOUN	B
in	O	ADP	O
16	O	NUM	O
patients	O	NOUN	B
with	O	ADP	O
sarcoidosis	O	NOUN	B
.	O	PUNCT	O


Which	O	DET	O
cineangiographically	O	ADV	B
assessed	O	VERB	B
anatomic	O	ADJ	B
variable	O	ADJ	B
correlates	O	VERB	O
best	O	ADJ	O
with	O	ADP	O
functional	O	ADJ	B
measurements	O	NOUN	I
of	O	ADP	O
stenosis	O	NOUN	B
severity	O	NOUN	B
?	O	PUNCT	O
A	O	DET	O
comparison	O	NOUN	B
of	O	ADP	O
quantitative	O	ADJ	B
analysis	O	NOUN	I
of	O	ADP	O
the	O	DET	O
coronary	O	ADJ	B
cineangiogram	O	NOUN	I
with	O	ADP	O
measured	O	VERB	B
coronary	O	ADJ	B
flow	O	NOUN	I
reserve	O	NOUN	O
and	O	CCONJ	O
exercise	O	VERB	B
/	O	SYM	O
redistribution	O	NOUN	B
thallium	O	NOUN	B
-	O	PUNCT	O
201	O	NUM	O
scintigraphy	O	NOUN	B
.	O	PUNCT	O


Water	O	NOUN	B
content	O	NOUN	B
and	O	CCONJ	O
equilibrium	O	NOUN	B
water	O	NOUN	O
partition	O	NOUN	B
in	O	ADP	O
immature	O	ADJ	B
cartilage	O	NOUN	B
.	O	PUNCT	O


Ischemic	O	ADJ	B
heart	O	NOUN	I
disease	O	NOUN	I
,	O	PUNCT	O
age	O	NOUN	B
of	O	ADP	O
more	O	ADJ	O
than	O	ADP	O
75	O	NUM	O
years	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
the	O	DET	O
fact	O	NOUN	O
that	O	SCONJ	O
the	O	DET	O
patient	O	NOUN	B
was	O	AUX	O
a	O	DET	O
woman	O	NOUN	B
were	O	AUX	O
independent	O	ADJ	O
predictors	O	NOUN	B
of	O	ADP	O
poor	O	ADJ	B
cardiac	O	ADJ	I
function	O	NOUN	I
.	O	PUNCT	O


Liquid	O	ADJ	B
chromatographic	O	ADJ	I
method	O	NOUN	I
for	O	ADP	O
determination	O	NOUN	B
of	O	ADP	O
citreoviridin	O	NOUN	B
in	O	ADP	O
corn	O	NOUN	B
and	O	CCONJ	O
rice	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
incidence	O	NOUN	B
of	O	ADP	O
cryptosporidiosis	O	NOUN	B
in	O	ADP	O
young	O	ADJ	B
children	O	NOUN	B
was	O	AUX	O
determined	O	VERB	O
by	O	ADP	O
staining	O	NOUN	B
of	O	ADP	O
faecal	O	ADJ	B
specimens	O	NOUN	I
with	O	ADP	O
a	O	DET	O
modified	O	VERB	B
Kinyoun	O	PROPN	B
stain	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
4	O	NUM	O
degrees	O	NOUN	B
stimuli	O	NOUN	B
were	O	AUX	O
found	O	VERB	O
to	O	PART	O
elicit	O	VERB	O
scalp	O	NOUN	B
distributions	O	NOUN	B
for	O	ADP	O
the	O	DET	O
pattern	O	NOUN	B
reversal	O	VERB	O
P100	O	NOUN	B
and	O	CCONJ	O
the	O	DET	O
pattern	O	NOUN	B
onset	O	NOUN	I
C1	O	NOUN	B
consistent	O	ADJ	B
with	O	ADP	I
striate	O	ADJ	B
and	O	CCONJ	O
extrastriate	O	ADJ	B
visual	O	ADJ	B
cortical	O	ADJ	B
origins	O	NOUN	I
respectively	O	ADV	O
.	O	PUNCT	O


A	O	DET	O
Golgi	O	NOUN	B
study	O	NOUN	I
of	O	ADP	O
the	O	DET	O
sixth	O	ADJ	O
layer	O	NOUN	B
of	O	ADP	O
the	O	DET	O
cerebral	O	ADJ	B
cortex	O	NOUN	I
.	O	PUNCT	O


Man	O	PROPN	B
and	O	CCONJ	O
insect	O	NOUN	B
,	O	PUNCT	O
past	O	NOUN	O
,	O	PUNCT	O
present	O	ADJ	O
,	O	PUNCT	O
future	O	ADJ	O


Mean	O	VERB	O
fluorosis	O	NOUN	B
scores	O	NOUN	B
,	O	PUNCT	O
however	O	ADV	O
,	O	PUNCT	O
were	O	AUX	O
similar	O	ADJ	O
.	O	PUNCT	O


Autonomic	O	ADJ	B
dysfunctions	O	NOUN	I
were	O	AUX	O
restricted	O	ADJ	O
to	O	PART	O
tonic	O	ADJ	B
pupils	O	NOUN	I
.	O	PUNCT	O


On	O	ADP	O
the	O	DET	O
other	O	ADJ	O
hand	O	NOUN	B
,	O	PUNCT	O
if	O	SCONJ	O
the	O	DET	O
measured	O	VERB	B
angle	O	NOUN	B
ANB	O	PROPN	B
is	O	AUX	O
smaller	O	ADJ	O
than	O	ADP	O
the	O	DET	O
calculated	O	VERB	B
angle	O	NOUN	B
,	O	PUNCT	O
the	O	DET	O
skeletal	O	ADJ	B
relation	O	NOUN	O
is	O	AUX	O
Class	O	PROPN	B
III	O	NUM	I
.	O	PUNCT	O


These	O	DET	O
data	O	NOUN	B
should	O	AUX	O
be	O	AUX	O
useful	O	ADJ	O
in	O	ADP	O
developing	O	VERB	O
reagents	O	NOUN	B
for	O	ADP	O
heterozygote	O	NOUN	B
detection	O	NOUN	B
and	O	CCONJ	O
prenatal	O	ADJ	B
diagnosis	O	NOUN	I
of	O	ADP	O
11	B-GENE	NUM	O
beta	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
hydroxylase	I-GENE	NOUN	B
deficiency	O	NOUN	B
,	O	PUNCT	O
the	O	DET	O
second	O	ADJ	O
most	O	ADV	O
frequent	O	ADJ	B
cause	O	NOUN	B
of	O	ADP	O
congenital	O	ADJ	B
adrenal	O	ADJ	I
hyperplasia	O	NOUN	I
.	O	PUNCT	O


Neither	O	CCONJ	O
ethanol	O	NOUN	B
nor	O	CCONJ	O
estrogen	O	NOUN	B
has	O	AUX	O
been	O	AUX	O
shown	O	VERB	O
to	O	PART	O
cause	O	VERB	O
UROD	B-GENE	PROPN	B
-	O	PUNCT	O
deficiency	O	NOUN	B
in	O	ADP	O
animals	O	NOUN	B
.	O	PUNCT	O


Although	O	SCONJ	O
not	O	PART	O
common	O	ADJ	O
,	O	PUNCT	O
the	O	DET	O
disorder	O	NOUN	B
is	O	AUX	O
the	O	DET	O
most	O	ADV	O
frequently	O	ADV	O
diagnosed	O	VERB	B
disturbance	O	NOUN	B
of	O	ADP	O
porphyrin	O	NOUN	B
metabolism	O	NOUN	I
in	O	ADP	O
many	O	ADJ	O
countries	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
further	O	ADV	O
insight	O	NOUN	O
into	O	ADP	O
its	O	PRON	O
unusual	O	ADJ	O
pathogenesis	O	NOUN	B
may	O	AUX	O
clarify	O	VERB	O
the	O	DET	O
hepatotoxic	O	ADJ	B
effects	O	NOUN	B
of	O	ADP	O
the	O	DET	O
4	O	NUM	O
etiologic	O	ADJ	B
agents	O	NOUN	I
.	O	PUNCT	O


This	O	DET	O
means	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
loss	O	NOUN	B
of	O	ADP	O
recessives	O	NOUN	B
must	O	AUX	O
be	O	AUX	O
calculated	O	VERB	B
by	O	ADP	O
using	O	VERB	O
a	O	DET	O
hypergeometric	O	NOUN	B
and	O	CCONJ	O
not	O	PART	O
a	O	DET	O
binomial	O	ADJ	B
model	O	NOUN	I
as	O	ADP	O
Fisher	O	PROPN	B
did	O	AUX	O
.	O	PUNCT	O


The	O	DET	O
poly	O	NOUN	B
(	O	PUNCT	I
A	O	NOUN	I
)	O	PUNCT	I
segment	O	NOUN	O
of	O	ADP	O
the	O	DET	O
RNA	O	NOUN	B
was	O	AUX	O
selectively	O	ADV	O
cross	O	VERB	B
-	O	PUNCT	O
linked	O	VERB	O
to	O	PART	O
the	O	DET	O
72	O	NUM	O
,	O	PUNCT	O
000	O	NUM	O
-	O	PUNCT	O
molecular	O	ADJ	B
-	O	PUNCT	O
weight	O	NOUN	B
protein	O	NOUN	I
(	O	PUNCT	O
72K	O	NOUN	B
protein	O	NOUN	I
)	O	PUNCT	O
.	O	PUNCT	O


Possible	O	ADJ	O
pathogenetic	O	ADJ	B
mechanisms	O	NOUN	I
of	O	ADP	O
hemopoietic	O	ADJ	B
changes	O	NOUN	B
in	O	ADP	O
response	O	NOUN	B
to	O	PART	O
space	O	NOUN	O
flight	O	NOUN	B
effects	O	NOUN	I
are	O	AUX	O
described	O	VERB	O
.	O	PUNCT	O


Development	O	NOUN	B
of	O	ADP	O
a	O	DET	O
yeast	O	NOUN	B
system	O	NOUN	I
to	O	PART	O
assay	O	VERB	B
mutational	O	ADJ	B
specificity	O	NOUN	I
.	O	PUNCT	O


As	O	ADP	O
a	O	DET	O
last	O	ADJ	O
resort	O	NOUN	B
,	O	PUNCT	O
it	O	PRON	O
may	O	AUX	O
be	O	AUX	O
possible	O	ADJ	O
to	O	PART	O
maintain	O	VERB	O
a	O	DET	O
patient	O	NOUN	B
on	O	ADP	O
dialysis	O	NOUN	B
in	O	ADP	O
reasonable	O	ADJ	O
health	O	NOUN	B
with	O	ADP	O
a	O	DET	O
DiaTAP	O	PROPN	B
button	O	NOUN	I
graft	O	NOUN	I
complex	O	NOUN	I
infected	O	VERB	B
with	O	ADP	O
Staphylococcus	O	NOUN	B
epidermidis	O	NOUN	I
and	O	CCONJ	O
intermittent	O	ADJ	B
positive	O	ADJ	I
blood	O	NOUN	B
cultures	O	NOUN	I
using	O	VERB	O
long	O	ADJ	B
term	O	NOUN	I
vancomycin	O	NOUN	B
therapy	O	NOUN	I
.	O	PUNCT	O


Reward	O	NOUN	B
value	O	NOUN	I
of	O	ADP	O
prosodic	O	ADJ	B
features	O	NOUN	I
of	O	ADP	O
language	O	NOUN	B
for	O	ADP	O
autistic	O	ADJ	B
,	O	PUNCT	O
mentally	O	ADV	B
retarded	O	VERB	B
,	O	PUNCT	O
and	O	CCONJ	O
normal	O	ADJ	B
children	O	NOUN	I
.	O	PUNCT	O


Due	O	ADP	O
to	O	ADP	O
its	O	PRON	O
relatively	O	ADV	O
soluble	O	ADJ	B
chemical	O	NOUN	B
form	O	NOUN	I
,	O	PUNCT	O
90Sr	O	NOUN	O
was	O	AUX	O
rapidly	O	ADV	O
translocated	O	VERB	B
from	O	ADP	O
lung	O	NOUN	B
to	O	ADP	O
bone	O	NOUN	B
where	O	SCONJ	O
a	O	DET	O
substantial	O	ADJ	O
portion	O	NOUN	O
was	O	AUX	O
retained	O	VERB	O
for	O	ADP	O
a	O	DET	O
long	O	ADJ	O
period	O	NOUN	O
of	O	ADP	O
time	O	NOUN	O
.	O	PUNCT	O


Artificial	O	ADJ	B
ventilation	O	NOUN	I
was	O	AUX	O
conducted	O	VERB	O
using	O	VERB	O
a	O	DET	O
tidal	O	ADJ	B
volume	O	NOUN	I
of	O	ADP	O
10	O	NUM	O
ml	O	NOUN	O
X	O	NOUN	O
kg	O	NOUN	O
-	O	PUNCT	O
1	O	NUM	O
and	O	CCONJ	O
a	O	DET	O
rate	O	NOUN	B
of	O	ADP	O
10	O	NUM	O
to	O	PART	O
12	O	NUM	O
c	O	NOUN	O
X	O	NOUN	O
min	O	NOUN	B
-	O	PUNCT	O
1	O	NUM	O
.	O	PUNCT	O


Significantly	O	ADV	O
lower	O	ADJ	O
heart	O	NOUN	O
rate	O	NOUN	O
reactivity	O	NOUN	O
and	O	CCONJ	O
significantly	O	ADV	O
less	O	ADV	O
pronounced	O	ADJ	O
left	O	ADJ	B
temporal	O	ADJ	I
artery	O	NOUN	I
pulse	O	NOUN	B
amplitude	O	NOUN	I
responses	O	NOUN	I
were	O	AUX	O
found	O	VERB	O
in	O	ADP	O
non	O	ADJ	B
-	O	PUNCT	O
medicated	O	VERB	B
TH	O	NOUN	B
subjects	O	NOUN	B
than	O	ADP	O
in	O	ADP	O
controls	O	NOUN	B
.	O	PUNCT	O


An	O	DET	O
epidemiological	O	ADJ	B
survey	O	NOUN	I
of	O	ADP	O
rheumatic	O	ADJ	B
valve	O	NOUN	I
disease	O	NOUN	I
and	O	CCONJ	O
rheumatic	O	ADJ	B
fever	O	NOUN	I
in	O	ADP	O
primary	O	ADJ	B
and	O	CCONJ	O
secondary	O	ADJ	B
school	O	NOUN	I
students	O	NOUN	I
in	O	ADP	O
Jiangxi	O	PROPN	B
Province	O	PROPN	I


Heat	O	NOUN	B
-	O	PUNCT	O
labile	O	ADJ	B
-	O	PUNCT	O
like	O	ADJ	B
enterotoxin	O	NOUN	B
(	O	PUNCT	O
LT	B-GENE	NOUN	B
)	O	PUNCT	O
was	O	AUX	O
produced	O	VERB	O
by	O	ADP	O
26	O	NUM	O
of	O	ADP	O
42	O	NUM	O
stool	O	NOUN	B
isolates	O	NOUN	I
(	O	PUNCT	O
62	O	NUM	O
%	O	NOUN	O
)	O	PUNCT	O
,	O	PUNCT	O
while	O	SCONJ	O
only	O	ADV	O
1	O	NUM	O
of	O	ADP	O
the	O	DET	O
42	O	NUM	O
isolates	O	NOUN	B
(	O	PUNCT	O
2	O	NUM	O
%	O	NOUN	O
)	O	PUNCT	O
produced	O	VERB	O
enterotoxinlike	O	ADJ	B
activity	O	NOUN	I
in	O	ADP	O
suckling	O	VERB	B
mice	O	NOUN	I
;	O	PUNCT	O
65	O	NUM	O
%	O	NOUN	O
of	O	ADP	O
the	O	DET	O
cytotoxin	O	NOUN	B
-	O	PUNCT	O
producing	O	VERB	B
strains	O	NOUN	B
also	O	ADV	O
produced	O	VERB	O
an	O	DET	O
LT	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
like	I-GENE	ADJ	B
material	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
nucleotide	O	NOUN	B
sequences	O	NOUN	I
of	O	ADP	O
the	O	DET	O
human	B-GENE	ADJ	B
and	I-GENE	CCONJ	O
murine	I-GENE	ADJ	B
ornithine	I-GENE	NOUN	B
decarboxylase	I-GENE	NOUN	I
mRNAs	I-GENE	NOUN	B
share	O	VERB	O
an	O	DET	O
85	O	NUM	O
%	O	NOUN	O
homology	O	NOUN	B
,	O	PUNCT	O
even	O	ADV	O
in	O	ADP	O
their	O	PRON	O
3	O	NUM	O
'	O	PART	O
-	O	PUNCT	O
noncoding	O	ADJ	B
regions	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
absolute	O	ADJ	B
concentrations	O	NOUN	B
of	O	ADP	O
alpha	B-GENE	NOUN	B
2	I-GENE	NUM	I
-	I-GENE	PUNCT	O
plasmin	I-GENE	NOUN	B
inhibitor	O	NOUN	B
,	O	PUNCT	O
alpha	B-GENE	NOUN	B
2	I-GENE	NUM	I
-	I-GENE	PUNCT	O
macroglobulin	I-GENE	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
antithrombin	B-GENE	NOUN	B
III	I-GENE	NUM	I
increased	O	VERB	B
with	O	ADP	O
exercise	O	NOUN	B
(	O	PUNCT	O
all	O	DET	O
P	O	NOUN	O
less	O	ADJ	O
than	O	ADP	O
0	O	NUM	O
.	O	PUNCT	O
005	O	NUM	O
)	O	PUNCT	O
,	O	PUNCT	O
but	O	CCONJ	O
when	O	SCONJ	O
concentrations	O	NOUN	B
were	O	AUX	O
corrected	O	VERB	O
for	O	ADP	O
acute	O	ADJ	B
shifts	O	NOUN	O
of	O	ADP	O
plasma	O	NOUN	B
water	O	NOUN	O
during	O	ADP	O
exercise	O	NOUN	B
,	O	PUNCT	O
the	O	DET	O
quantity	O	NOUN	B
of	O	ADP	O
these	O	DET	O
inhibitors	O	NOUN	B
actually	O	ADV	O
decreased	O	VERB	B
(	O	PUNCT	O
all	O	DET	O
P	O	NOUN	O
less	O	ADJ	O
than	O	ADP	O
0	O	NUM	O
.	O	PUNCT	O
005	O	NUM	O
)	O	PUNCT	O
.	O	PUNCT	O


In	O	ADP	O
the	O	DET	O
normal	O	ADJ	B
,	O	PUNCT	O
basal	O	ADJ	B
(	O	PUNCT	O
unstimulated	O	ADJ	B
)	O	PUNCT	O
condition	O	NOUN	O
there	O	PRON	O
were	O	AUX	O
no	O	DET	O
significant	O	ADJ	O
correlations	O	NOUN	B
(	O	PUNCT	O
p	O	NOUN	O
greater	O	ADJ	O
than	O	ADP	O
0	O	NUM	O
.	O	PUNCT	O
05	O	NUM	O
)	O	PUNCT	O
between	O	ADP	O
the	O	DET	O
systolic	O	NOUN	B
blood	O	NOUN	I
pressure	O	NOUN	I
and	O	CCONJ	O
dopamine	O	NOUN	B
(	O	PUNCT	O
r	O	NOUN	O
=	O	ADJ	O
0	O	NUM	O
.	O	PUNCT	O
09	O	NUM	O
)	O	PUNCT	O
,	O	PUNCT	O
norepinephrine	O	NOUN	B
(	O	PUNCT	O
r	O	NOUN	O
=	O	ADJ	O
0	O	NUM	O
.	O	PUNCT	O
26	O	NUM	O
)	O	PUNCT	O
,	O	PUNCT	O
or	O	CCONJ	O
epinephrine	O	NOUN	B
(	O	PUNCT	O
r	O	NOUN	O
=	O	ADJ	O
0	O	NUM	O
.	O	PUNCT	O
27	O	NUM	O
)	O	PUNCT	O
,	O	PUNCT	O
nor	O	CCONJ	O
were	O	AUX	O
there	O	PRON	O
significant	O	ADJ	O
correlations	O	NOUN	B
between	O	ADP	O
melatonin	O	NOUN	B
and	O	CCONJ	O
dopamine	O	NOUN	B
(	O	PUNCT	O
r	O	NOUN	O
=	O	ADJ	O
-	O	PUNCT	O
0	O	NUM	O
.	O	PUNCT	O
01	O	NUM	O
)	O	PUNCT	O
,	O	PUNCT	O
norepinephrine	O	NOUN	B
(	O	PUNCT	O
r	O	NOUN	O
=	O	ADJ	O
-	O	PUNCT	O
0	O	NUM	O
.	O	PUNCT	O
26	O	NUM	O
)	O	PUNCT	O
,	O	PUNCT	O
or	O	CCONJ	O
growth	B-GENE	NOUN	B
hormone	I-GENE	NOUN	I
(	O	PUNCT	O
r	O	NOUN	O
=	O	ADJ	O
0	O	NUM	O
.	O	PUNCT	O
17	O	NUM	O
)	O	PUNCT	O
.	O	PUNCT	O


In	O	ADP	O
cases	O	NOUN	B
of	O	ADP	O
1	O	NUM	O
degrees	O	NOUN	B
HPT	O	NOUN	B
,	O	PUNCT	O
the	O	DET	O
plasma	O	NOUN	B
1	O	NUM	O
,	O	PUNCT	O
25	O	NUM	O
-	O	PUNCT	O
(	O	PUNCT	O
OH	O	NOUN	B
)	O	PUNCT	O
2D	O	NOUN	B
level	O	NOUN	B
rose	O	VERB	O
significantly	O	ADV	O
in	O	ADP	O
all	O	DET	O
cases	O	NOUN	B
(	O	PUNCT	O
P	O	NOUN	O
less	O	ADJ	O
than	O	ADP	O
0	O	NUM	O
.	O	PUNCT	O
05	O	NUM	O
)	O	PUNCT	O
,	O	PUNCT	O
although	O	SCONJ	O
the	O	DET	O
pattern	O	NOUN	B
of	O	ADP	O
the	O	DET	O
increase	O	NOUN	B
was	O	AUX	O
not	O	PART	O
uniform	O	ADJ	O
.	O	PUNCT	O


It	O	PRON	O
is	O	AUX	O
largely	O	ADV	O
predicted	O	VERB	B
by	O	ADP	O
lupus	O	NOUN	B
anticoagulant	O	NOUN	I
(	O	PUNCT	O
estimated	O	VERB	O
by	O	ADP	O
activated	O	VERB	B
partial	O	ADJ	I
thromboplastin	B-GENE	NOUN	I
time	O	NOUN	I
)	O	PUNCT	O
and	O	CCONJ	O
/	O	SYM	O
or	O	CCONJ	O
antibody	O	NOUN	B
to	O	PART	O
cardiolipin	O	NOUN	B
.	O	PUNCT	O


Data	O	NOUN	B
from	O	ADP	O
119	O	NUM	O
men	O	NOUN	B
and	O	CCONJ	O
40	O	NUM	O
women	O	NOUN	B
undergoing	O	VERB	O
coronary	O	ADJ	B
angiography	O	NOUN	I
provide	O	VERB	O
an	O	DET	O
opportunity	O	NOUN	O
to	O	PART	O
compare	O	VERB	B
these	O	DET	O
associations	O	NOUN	B
in	O	ADP	O
relation	O	NOUN	O
to	O	PART	O
a	O	DET	O
direct	O	ADJ	O
and	O	CCONJ	O
continuous	O	ADJ	B
measure	O	NOUN	B
of	O	ADP	O
atherosclerosis	O	NOUN	B
while	O	SCONJ	O
controlling	O	VERB	B
for	O	ADP	O
age	O	NOUN	B
,	O	PUNCT	O
sex	O	NOUN	B
,	O	PUNCT	O
income	O	NOUN	B
,	O	PUNCT	O
hypertension	O	NOUN	B
,	O	PUNCT	O
serum	O	NOUN	B
cholesterol	O	NOUN	I
,	O	PUNCT	O
smoking	O	NOUN	B
,	O	PUNCT	O
angina	O	ADJ	B
,	O	PUNCT	O
diabetes	O	NOUN	B
,	O	PUNCT	O
family	O	NOUN	B
history	O	NOUN	I
of	O	ADP	I
heart	O	NOUN	I
disease	O	NOUN	I
,	O	PUNCT	O
Type	O	NOUN	B
A	O	NOUN	I
behavior	O	NOUN	I
pattern	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
hostility	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
presence	O	NOUN	B
in	O	ADP	O
such	O	ADJ	O
patients	O	NOUN	B
of	O	ADP	O
antibodies	O	NOUN	B
to	O	PART	O
adrenaline	O	NOUN	B
and	O	CCONJ	O
noradrenaline	O	NOUN	B
is	O	AUX	O
indicative	O	ADJ	O
of	O	ADP	O
considerable	O	ADJ	O
disruption	O	NOUN	B
of	O	ADP	O
catecholamine	O	NOUN	B
biotransformation	O	NOUN	B
.	O	PUNCT	O


Effects	O	NOUN	B
of	O	ADP	I
a	O	DET	O
low	O	ADJ	B
-	O	PUNCT	O
energy	O	NOUN	B
laser	O	NOUN	I
beam	O	NOUN	O
on	O	ADP	O
the	O	DET	O
cells	O	NOUN	B
of	O	ADP	O
the	O	DET	O
newt	O	NOUN	B
embryo	O	NOUN	O


Samples	O	NOUN	B
from	O	ADP	O
1415	O	NUM	O
neurological	O	ADJ	B
patients	O	NOUN	B
were	O	AUX	O
used	O	VERB	O
to	O	PART	O
study	O	VERB	B
the	O	DET	O
diagnostic	O	ADJ	B
value	O	NOUN	I
of	O	ADP	O
acid	B-GENE	NOUN	B
alpha	I-GENE	NOUN	I
1	I-GENE	NUM	I
-	I-GENE	PUNCT	O
glycoprotein	I-GENE	NOUN	B
in	O	ADP	O
the	O	DET	O
lumbar	O	ADJ	B
cerebrospinal	O	ADJ	I
fluid	O	NOUN	I
.	O	PUNCT	O


Comparison	O	NOUN	B
of	O	ADP	O
the	O	DET	O
amino	O	NOUN	B
acid	O	NOUN	I
sequence	O	NOUN	I
of	O	ADP	O
the	O	DET	O
M	B-GENE	NOUN	B
RNA	I-GENE	NOUN	I
product	I-GENE	NOUN	O
of	I-GENE	ADP	O
Uukuniemi	I-GENE	NOUN	B
virus	I-GENE	NOUN	I
with	O	ADP	O
that	O	DET	O
of	O	ADP	O
Punta	O	PROPN	B
Toro	O	PROPN	I
and	O	CCONJ	O
Rift	O	PROPN	B
Valley	O	PROPN	I
fever	O	NOUN	B
viruses	O	NOUN	I
showed	O	VERB	O
in	O	ADP	O
both	O	DET	O
cases	O	NOUN	B
a	O	DET	O
weak	O	ADJ	B
homology	O	NOUN	B
that	O	PRON	O
was	O	AUX	O
more	O	ADV	O
pronounced	O	ADJ	O
for	O	ADP	O
the	O	DET	O
proteins	O	NOUN	B
located	O	ADJ	O
at	O	ADP	O
the	O	DET	O
COOH	O	NOUN	B
-	O	PUNCT	O
terminal	O	ADJ	B
end	O	NOUN	O
of	O	ADP	O
the	O	DET	O
precursor	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
purpose	O	NOUN	O
of	O	ADP	O
this	O	DET	O
study	O	NOUN	B
is	O	AUX	O
twofold	O	ADV	O
:	O	PUNCT	O
(	O	PUNCT	O
1	O	X	O
)	O	PUNCT	O
to	O	PART	O
present	O	VERB	O
a	O	DET	O
parallel	O	ADJ	O
form	O	NOUN	O
of	O	ADP	O
the	O	DET	O
Gudjonsson	O	PROPN	B
Suggestibility	O	PROPN	I
Scale	O	PROPN	I
(	O	PUNCT	O
GSS	O	PROPN	B
,	O	PUNCT	O
Form	O	NOUN	B
1	O	NUM	I
)	O	PUNCT	O
;	O	PUNCT	O
(	O	PUNCT	O
2	O	X	O
)	O	PUNCT	O
to	O	PART	O
study	O	VERB	B
test	O	NOUN	I
-	O	PUNCT	O
retest	O	NOUN	B
reliabilities	O	NOUN	B
of	O	ADP	O
interrogative	O	ADJ	B
suggestibility	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
average	O	ADJ	B
deviations	O	NOUN	B
in	O	ADP	O
the	O	DET	O
X	O	NOUN	B
-	O	PUNCT	O
ray	O	NOUN	B
counts	O	NOUN	B
of	O	ADP	O
the	O	DET	O
constant	O	ADJ	B
elements	O	NOUN	B
from	O	ADP	O
the	O	DET	O
series	O	NOUN	O
means	O	VERB	O
were	O	AUX	O
used	O	VERB	O
to	O	PART	O
correct	O	VERB	O
the	O	DET	O
recorded	O	VERB	O
count	O	NOUN	B
of	O	ADP	O
the	O	DET	O
variable	O	ADJ	B
element	O	NOUN	I
in	O	ADP	O
each	O	DET	O
block	O	NOUN	B
.	O	PUNCT	O


To	O	PART	O
evaluate	O	VERB	B
the	O	DET	O
relative	O	ADJ	O
accuracy	O	NOUN	B
of	O	ADP	O
continuous	O	ADJ	B
wave	O	NOUN	I
(	O	PUNCT	O
CW	O	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
high	O	ADJ	B
pulse	O	NOUN	B
repetition	O	NOUN	I
frequency	O	NOUN	I
(	O	PUNCT	O
HPRF	O	NOUN	B
)	O	PUNCT	O
Doppler	O	PROPN	B
for	O	ADP	O
estimating	O	VERB	O
aortic	O	ADJ	B
transvalvular	O	NOUN	I
pressure	O	NOUN	I
gradients	O	NOUN	I
,	O	PUNCT	O
Doppler	O	NOUN	B
examinations	O	NOUN	I
with	O	ADP	O
both	O	DET	O
devices	O	NOUN	B
were	O	AUX	O
obtained	O	VERB	O
in	O	ADP	O
87	O	NUM	O
consecutive	O	ADJ	B
patients	O	NOUN	B
with	O	ADP	O
aortic	O	ADJ	B
valve	O	NOUN	I
disease	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
number	O	NOUN	O
of	O	ADP	O
fecal	O	ADJ	B
pellets	O	NOUN	B
ingested	O	VERB	B
peaked	O	VERB	O
at	O	ADP	O
5	O	NUM	O
to	O	PART	O
6	O	NUM	O
weeks	O	NOUN	B
old	O	ADJ	O
(	O	PUNCT	O
13	O	NUM	O
pellets	O	NOUN	B
/	O	SYM	O
day	O	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
gradually	O	ADV	O
decreased	O	VERB	B
,	O	PUNCT	O
thereafter	O	ADV	O
(	O	PUNCT	O
2	O	NUM	O
.	O	PUNCT	O
1	O	NUM	O
pellets	O	NOUN	B
at	O	ADP	O
78	O	NUM	O
weeks	O	NOUN	B
old	O	ADJ	O
,	O	PUNCT	O
1	O	NUM	O
.	O	PUNCT	O
5	O	NUM	O
pellets	O	NOUN	B
at	O	ADP	O
104	O	NUM	O
weeks	O	NOUN	B
old	O	ADJ	O
)	O	PUNCT	O
.	O	PUNCT	O


Two	O	NUM	O
of	O	ADP	O
these	O	DET	O
six	O	NUM	O
cases	O	NOUN	B
showed	O	VERB	O
mucosal	O	ADJ	B
spread	O	NOUN	O
without	O	ADP	O
stromal	O	ADJ	B
invasion	O	NOUN	I
(	O	PUNCT	O
type	O	NOUN	O
A	O	NOUN	O
)	O	PUNCT	O
;	O	PUNCT	O
the	O	DET	O
remaining	O	VERB	O
four	O	NUM	O
cases	O	NOUN	B
presented	O	VERB	O
a	O	DET	O
direct	O	ADJ	O
extension	O	NOUN	O
(	O	PUNCT	O
type	O	NOUN	B
B	O	NOUN	I
)	O	PUNCT	O
from	O	ADP	O
muscle	O	NOUN	B
-	O	PUNCT	O
invasive	O	ADJ	B
carcinomas	O	NOUN	I
of	O	ADP	O
the	O	DET	O
bladder	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
development	O	NOUN	B
of	O	ADP	O
a	O	DET	O
data	O	NOUN	B
base	O	NOUN	I
is	O	AUX	O
described	O	VERB	O
which	O	DET	O
can	O	AUX	O
be	O	AUX	O
used	O	VERB	O
as	O	ADP	O
common	O	ADJ	O
reference	O	NOUN	O
for	O	ADP	O
ECG	O	PROPN	B
computer	O	NOUN	I
programs	O	NOUN	I
analyzing	O	VERB	O
12	O	NUM	O
or	O	CCONJ	O
15	O	NUM	O
simultaneously	O	ADV	B
recorded	O	VERB	O
leads	O	NOUN	O
.	O	PUNCT	O


Contraction	O	NOUN	B
of	O	ADP	O
the	O	DET	O
tracheal	O	ADJ	B
muscle	O	NOUN	I
and	O	CCONJ	O
the	O	DET	O
activity	O	NOUN	B
of	O	ADP	O
stretch	O	NOUN	B
receptors	O	NOUN	I
in	O	ADP	O
the	O	DET	O
trachea	O	NOUN	B


The	O	DET	O
selenium	O	NOUN	B
level	O	NOUN	B
and	O	CCONJ	O
glutathione	B-GENE	NOUN	B
peroxidase	I-GENE	NOUN	I
activity	O	NOUN	B
in	O	ADP	O
the	O	DET	O
blood	O	NOUN	B
,	O	PUNCT	O
liver	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
stomach	O	NOUN	B
mucosa	O	NOUN	I
were	O	AUX	O
significantly	O	ADV	O
higher	O	ADJ	O
in	O	ADP	O
the	O	DET	O
high	O	ADJ	B
-	O	PUNCT	O
selenium	O	NOUN	B
diet	O	NOUN	B
group	O	NOUN	I
than	O	ADP	O
in	O	ADP	O
the	O	DET	O
low	O	ADJ	B
-	O	PUNCT	O
selenium	O	NOUN	B
diet	O	NOUN	B
group	O	NOUN	I
.	O	PUNCT	O


Amikacin	O	NOUN	B
was	O	AUX	O
the	O	DET	O
most	O	ADV	O
stable	O	ADJ	B
and	O	CCONJ	O
tobramycin	O	NOUN	B
was	O	AUX	O
the	O	DET	O
least	O	ADV	O
stable	O	ADJ	O
aminoglycoside	O	NOUN	B
under	O	ADP	O
the	O	DET	O
conditions	O	NOUN	B
tested	O	VERB	B
.	O	PUNCT	O


This	O	DET	O
may	O	AUX	O
explain	O	VERB	O
in	O	ADP	O
part	O	NOUN	O
a	O	DET	O
secular	O	ADJ	B
trend	O	NOUN	O
towards	O	ADP	O
reduced	O	VERB	B
birthweight	O	NOUN	I
for	O	ADP	O
gestation	O	NOUN	B
in	O	ADP	O
preterm	O	NOUN	B
infants	O	NOUN	I
.	O	PUNCT	O


Nickel	O	NOUN	B
is	O	AUX	O
the	O	DET	O
most	O	ADV	O
common	O	ADJ	O
cause	O	NOUN	B
of	O	ADP	O
allergic	O	ADJ	B
contact	O	NOUN	I
dermatitis	O	NOUN	I
in	O	ADP	O
Singapore	O	PROPN	B
,	O	PUNCT	O
resulting	O	VERB	O
in	O	ADP	O
positive	O	ADJ	B
reactions	O	NOUN	I
in	O	ADP	O
patch	O	NOUN	B
tests	O	NOUN	I
between	O	ADP	O
7	O	NUM	O
and	O	CCONJ	O
14	O	NUM	O
%	O	NOUN	O
.	O	PUNCT	O


Findings	O	NOUN	B
of	O	ADP	O
positive	O	ADJ	B
potentials	O	NOUN	B
showed	O	VERB	O
that	O	SCONJ	O
N1	O	NOUN	B
originated	O	VERB	O
in	O	ADP	O
the	O	DET	O
area	O	NOUN	B
of	O	ADP	O
ventral	O	ADJ	B
gray	O	ADJ	I
matter	O	NOUN	I
through	O	ADP	O
the	O	DET	O
ventro	O	NOUN	B
-	O	PUNCT	O
lateral	O	ADJ	B
column	O	NOUN	O
and	O	CCONJ	O
N2	O	NOUN	B
through	O	ADP	O
the	O	DET	O
dorsal	O	ADJ	B
column	O	NOUN	I
.	O	PUNCT	O


Splenectomized	O	VERB	B
patients	O	NOUN	B
are	O	AUX	O
predisposed	O	VERB	B
toward	O	ADP	O
developing	O	VERB	O
overwhelming	O	ADJ	O
bacterial	O	ADJ	B
infections	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
rats	O	NOUN	B
were	O	AUX	O
used	O	VERB	O
for	O	ADP	O
the	O	DET	O
study	O	NOUN	B
of	O	ADP	O
the	O	DET	O
effects	O	NOUN	B
of	O	ADP	I
sepsis	O	NOUN	B
on	O	ADP	O
the	O	DET	O
utilization	O	NOUN	B
of	O	ADP	O
exogenous	O	ADJ	B
fat	O	ADJ	B
emulsion	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
possibility	O	NOUN	O
of	O	ADP	O
a	O	DET	O
hereditary	O	ADJ	B
disorder	O	NOUN	I
leading	O	VERB	O
to	O	PART	O
a	O	DET	O
minor	O	ADJ	O
defect	O	NOUN	B
in	O	ADP	O
elastic	O	ADJ	B
fibre	O	NOUN	I
structure	O	NOUN	I
which	O	DET	O
could	O	AUX	O
be	O	AUX	O
responsible	O	ADJ	O
for	O	ADP	O
the	O	DET	O
spontaneous	O	ADJ	B
lesions	O	NOUN	B
is	O	AUX	O
discussed	O	VERB	O
.	O	PUNCT	O


N	O	NOUN	B
-	O	PUNCT	O
Substituted	O	VERB	B
trimethylsilylcarbamates	O	NOUN	I
were	O	AUX	O
tested	O	VERB	O
as	O	ADP	O
derivatizing	O	VERB	B
reagents	O	NOUN	I
for	O	ADP	O
gas	O	NOUN	B
chromatographic	O	ADJ	I
analysis	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
growing	O	VERB	O
drug	O	NOUN	B
problem	O	NOUN	I
is	O	AUX	O
also	O	ADV	O
reflected	O	VERB	O
in	O	ADP	O
the	O	DET	O
increasing	O	VERB	B
number	O	NOUN	O
of	O	ADP	O
cases	O	NOUN	B
of	O	ADP	O
hepatitis	O	NOUN	B
B	O	NOUN	I
and	O	CCONJ	O
of	O	ADP	O
drug	O	NOUN	B
-	O	PUNCT	O
related	O	VERB	B
deaths	O	NOUN	B
.	O	PUNCT	O


Under	O	ADP	O
the	O	DET	O
same	O	ADJ	O
hematocrit	O	NOUN	B
and	O	CCONJ	O
flow	O	NOUN	B
conditions	O	NOUN	I
,	O	PUNCT	O
the	O	DET	O
rate	O	NOUN	B
of	O	ADP	O
oxygen	O	NOUN	B
saturation	O	NOUN	I
decrease	O	NOUN	B
was	O	AUX	O
significantly	O	ADV	O
higher	O	ADJ	O
for	O	ADP	O
the	O	DET	O
sickle	O	ADJ	B
cells	O	NOUN	I
than	O	ADP	O
for	O	ADP	O
normal	O	ADJ	B
cells	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
risk	O	NOUN	B
for	O	ADP	O
these	O	DET	O
complications	O	NOUN	B
is	O	AUX	O
increased	O	VERB	B
by	O	ADP	O
the	O	DET	O
following	O	VERB	O
factors	O	NOUN	B
:	O	PUNCT	O
multiple	O	ADJ	B
gestation	O	NOUN	B
,	O	PUNCT	O
the	O	DET	O
combination	O	NOUN	B
of	O	ADP	O
magnesium	O	NOUN	B
sulfate	O	NOUN	I
and	O	CCONJ	O
beta	O	NOUN	B
-	O	PUNCT	O
adrenergic	O	ADJ	B
agonist	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
the	O	DET	O
use	O	NOUN	O
of	O	ADP	O
adrenocortico	O	NOUN	B
-	O	PUNCT	O
steroids	O	NOUN	B
to	O	PART	O
hasten	O	VERB	O
fetal	O	ADJ	B
pulmonary	O	ADJ	O
maturity	O	NOUN	O
.	O	PUNCT	O


Intensification	O	NOUN	B
of	O	ADP	O
human	O	ADJ	B
myocardial	O	ADJ	O
contractile	O	NOUN	O
activity	O	NOUN	O
as	O	ADP	O
affected	O	VERB	B
by	O	ADP	O
blood	O	NOUN	B
serum	O	NOUN	I


Inhibition	O	NOUN	B
of	O	ADP	O
histalog	O	NOUN	B
-	O	PUNCT	O
stimulated	O	VERB	B
gastric	O	ADJ	B
secretion	O	NOUN	I
by	O	ADP	O
40	O	NUM	O
749	O	NUM	O
RP	O	NOUN	B
,	O	PUNCT	O
a	O	DET	O
new	O	ADJ	O
long	O	ADV	B
-	O	PUNCT	O
acting	O	VERB	B
gastric	O	ADJ	B
antisecretory	O	ADJ	I
agent	O	NOUN	I
.	O	PUNCT	O


Five	O	NUM	B
-	O	PUNCT	O
year	O	NOUN	B
prospective	O	ADJ	B
study	O	NOUN	I
of	O	ADP	O
peripheral	O	ADJ	B
white	O	ADJ	I
blood	O	NOUN	I
cells	O	NOUN	I
in	O	ADP	O
infectious	O	ADJ	B
mononucleosis	O	NOUN	I
.	O	PUNCT	O


Novel	O	ADJ	B
multigene	O	NOUN	B
families	O	NOUN	I
encoding	O	VERB	B
highly	O	ADV	O
repetitive	O	ADJ	O
peptide	O	NOUN	O
sequences	O	NOUN	O
.	O	PUNCT	O


The	O	DET	O
M	O	PROPN	B
-	O	PUNCT	O
3	O	NUM	B
subtype	O	NOUN	B
was	O	AUX	O
an	O	DET	O
adverse	O	ADJ	B
prognostic	O	ADJ	I
factor	O	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
addition	O	NOUN	O
,	O	PUNCT	O
marked	O	ADJ	O
hypertension	O	NOUN	B
accompanied	O	VERB	O
this	O	DET	O
disorder	O	NOUN	B
and	O	CCONJ	O
all	O	DET	O
abnormalities	O	NOUN	B
,	O	PUNCT	O
including	O	VERB	O
the	O	DET	O
hypertension	O	NOUN	B
,	O	PUNCT	O
responded	O	VERB	O
to	O	ADP	O
1	B-GENE	NUM	O
-	I-GENE	PUNCT	O
desamino	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
8	I-GENE	NUM	B
-	I-GENE	PUNCT	O
D	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
arginine	I-GENE	NOUN	B
vasopressin	I-GENE	NOUN	B
therapy	O	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
19	O	NUM	O
patients	O	NOUN	B
vagotomy	O	NOUN	B
not	O	PART	O
only	O	ADV	O
curbed	O	VERB	B
the	O	DET	O
bleeding	O	NOUN	B
but	O	CCONJ	O
provided	O	VERB	O
definitive	O	ADJ	O
therapy	O	NOUN	B
(	O	PUNCT	O
Visick	O	PROPN	B
I	O	NUM	I
-	O	PUNCT	O
II	O	PROPN	B
)	O	PUNCT	O
;	O	PUNCT	O
4	O	NUM	O
patients	O	NOUN	B
died	O	VERB	B
(	O	PUNCT	O
mortality	O	NOUN	B
rate	O	NOUN	I
16	O	NUM	O
%	O	NOUN	O
)	O	PUNCT	O
.	O	PUNCT	O


A	O	DET	O
yeast	O	NOUN	B
DNA	O	NOUN	B
fragment	O	NOUN	I
carrying	O	VERB	O
the	O	DET	O
gene	B-GENE	NOUN	B
CP	I-GENE	NOUN	I
A1	I-GENE	NOUN	I
encoding	O	VERB	B
the	O	DET	O
small	O	ADJ	O
subunit	O	NOUN	B
of	O	ADP	O
the	O	DET	O
arginine	O	NOUN	B
pathway	O	NOUN	O
carbamoyl	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
phosphate	I-GENE	NOUN	B
synthetase	I-GENE	NOUN	I
has	O	AUX	O
been	O	AUX	O
sequenced	O	VERB	B
.	O	PUNCT	O


The	O	DET	O
H2	B-GENE	NOUN	B
receptor	I-GENE	NOUN	I
antagonists	O	NOUN	I
and	O	CCONJ	O
sucralfate	O	NOUN	B
cost	O	NOUN	B
about	O	ADP	O
the	O	DET	O
same	O	ADJ	O
and	O	CCONJ	O
have	O	AUX	O
few	O	ADJ	O
side	O	NOUN	B
effects	O	NOUN	I
.	O	PUNCT	O


Such	O	ADJ	O
studied	O	VERB	O
acquired	O	VERB	O
with	O	ADP	O
low	O	ADJ	B
energy	O	NOUN	I
or	O	CCONJ	O
medium	O	NOUN	O
energy	O	NOUN	O
collimation	O	NOUN	O
and	O	CCONJ	O
a	O	DET	O
window	O	NOUN	B
centered	O	VERB	O
on	O	ADP	O
the	O	DET	O
159	O	NUM	O
keV	O	NOUN	B
123I	O	NOUN	I
photopeak	O	NOUN	B
contain	O	VERB	O
appreciable	O	ADJ	O
septal	O	ADJ	B
breakthrough	O	NOUN	O
signals	O	NOUN	O
originating	O	VERB	O
from	O	ADP	O
Compton	O	PROPN	B
scatter	O	NOUN	I
of	O	ADP	O
high	O	ADJ	B
energy	O	NOUN	I
photons	O	NOUN	I
primarily	O	ADV	O
from	O	ADP	O
124I	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
concentrations	O	NOUN	B
of	O	ADP	O
apo	B-GENE	NOUN	B
A	I-GENE	NOUN	I
-	I-GENE	PUNCT	O
I	I-GENE	NOUN	B
and	O	CCONJ	O
apo	B-GENE	NOUN	B
A	I-GENE	NOUN	I
-	I-GENE	PUNCT	O
II	I-GENE	PROPN	B
of	O	ADP	O
abstainers	O	NOUN	B
decreased	O	VERB	B
significantly	O	ADV	O
compared	O	VERB	B
with	O	ADP	O
the	O	DET	O
corresponding	O	ADJ	O
changes	O	NOUN	B
in	O	ADP	O
controls	O	NOUN	B
.	O	PUNCT	O


Thyrotropin	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
releasing	I-GENE	VERB	B
hormone	I-GENE	NOUN	B
-	O	PUNCT	O
induced	O	VERB	B
contraction	O	NOUN	B
of	O	ADP	O
urethral	O	ADJ	B
and	O	CCONJ	O
vaginal	O	ADJ	B
muscle	O	NOUN	I
.	O	PUNCT	O


Results	O	NOUN	B
of	O	ADP	O
this	O	DET	O
study	O	NOUN	B
indicate	O	VERB	O
that	O	SCONJ	O
GLC	O	NOUN	B
of	O	ADP	O
short	O	ADJ	B
chain	O	NOUN	I
fatty	O	NOUN	I
acids	O	NOUN	I
produced	O	VERB	O
on	O	ADP	O
agar	O	NOUN	B
medium	O	NOUN	I
by	O	ADP	O
anaerobes	O	NOUN	B
,	O	PUNCT	O
combined	O	VERB	O
with	O	ADP	O
simple	O	ADJ	O
tests	O	NOUN	O
such	O	ADJ	O
as	O	ADP	O
Gram	O	PROPN	B
'	O	PART	O
s	O	NOUN	O
stain	O	NOUN	B
and	O	CCONJ	O
colonial	O	ADJ	B
morphology	O	NOUN	B
,	O	PUNCT	O
may	O	AUX	O
allow	O	VERB	O
fir	O	NOUN	B
direct	O	ADJ	O
presumptive	O	ADJ	O
genus	O	NOUN	B
identification	O	NOUN	B
from	O	ADP	O
an	O	DET	O
initial	O	ADJ	O
pure	O	ADJ	O
agar	O	NOUN	B
culture	O	NOUN	O
.	O	PUNCT	O


Tissue	O	NOUN	B
pressure	O	NOUN	I
,	O	PUNCT	O
rCBF	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
water	O	NOUN	B
content	O	NOUN	B
were	O	AUX	O
measured	O	VERB	B
from	O	ADP	O
gray	O	ADJ	B
matter	O	NOUN	I
in	O	ADP	O
the	O	DET	O
central	O	ADJ	B
core	O	NOUN	I
and	O	CCONJ	O
the	O	DET	O
peripheral	O	ADJ	B
margin	O	NOUN	I
of	O	ADP	O
the	O	DET	O
MCA	O	PROPN	B
territory	O	NOUN	B
over	O	ADP	O
6	O	NUM	O
h	O	NOUN	O
after	O	ADP	O
MCAO	O	NOUN	B
.	O	PUNCT	O


Dissolution	O	NOUN	B
of	O	ADP	O
the	O	DET	O
Pt	O	PROPN	B
-	O	PUNCT	O
30	O	NUM	O
%	O	NOUN	O
Ir	O	NOUN	O
microelectrode	O	ADJ	O
tip	O	NOUN	O
was	O	AUX	O
observed	O	VERB	O
by	O	ADP	O
scanning	O	VERB	B
electron	O	NOUN	I
microscopy	O	NOUN	I
at	O	ADP	O
charge	O	NOUN	O
densities	O	NOUN	B
as	O	ADV	O
low	O	ADJ	O
as	O	ADP	O
200	O	NUM	O
microC	O	NOUN	B
/	O	SYM	O
cm2	O	NUM	B
X	O	NOUN	O
ph	O	NOUN	O
(	O	PUNCT	O
1	O	NUM	O
A	O	PROPN	O
/	O	SYM	O
cm2	O	NUM	B
)	O	PUNCT	O
,	O	PUNCT	O
whereas	O	SCONJ	O
erosion	O	NOUN	B
of	O	ADP	O
activated	O	VERB	B
iridium	O	NOUN	O
microelectrodes	O	NOUN	O
occurred	O	VERB	O
only	O	ADV	O
at	O	ADP	O
the	O	DET	O
highest	O	ADJ	B
charge	O	NOUN	B
and	O	CCONJ	O
current	O	ADJ	O
densities	O	NOUN	B
(	O	PUNCT	O
3200	O	NUM	O
microC	O	NOUN	O
/	O	SYM	O
cm2	O	NUM	B
X	O	NOUN	O
ph	O	NOUN	O
,	O	PUNCT	O
16	O	NUM	O
A	O	DET	B
/	O	SYM	O
cm2	O	NUM	B
)	O	PUNCT	O
.	O	PUNCT	O


The	O	DET	O
results	O	NOUN	B
from	O	ADP	O
the	O	DET	O
first	O	ADJ	O
five	O	NUM	O
years	O	NOUN	B
of	O	ADP	O
follow	O	VERB	B
up	O	ADP	I
in	O	ADP	O
1972	O	NUM	O
showed	O	VERB	O
a	O	DET	O
4	O	NUM	O
.	O	PUNCT	O
7	O	NUM	O
-	O	PUNCT	O
fold	O	ADJ	B
excess	O	ADJ	B
mortality	O	NOUN	B
for	O	ADP	O
ischaemic	O	ADJ	B
and	O	CCONJ	O
other	O	ADJ	O
heart	O	NOUN	B
diseases	O	NOUN	I
(	O	PUNCT	O
ICD	O	PROPN	B
A83	O	PROPN	I
-	O	PUNCT	O
A84	O	NOUN	B
)	O	PUNCT	O
compared	O	VERB	B
with	O	ADP	O
a	O	DET	O
comparable	O	ADJ	O
reference	O	NOUN	O
cohort	O	NOUN	B
of	O	ADP	O
paper	O	NOUN	B
mill	O	NOUN	B
workers	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
primary	O	ADJ	B
CT	O	NOUN	B
findings	O	NOUN	B
were	O	AUX	O
misinterpreted	O	VERB	O
as	O	ADP	O
a	O	DET	O
brain	O	NOUN	B
infarct	O	NOUN	I
or	O	CCONJ	O
possibly	O	ADV	O
a	O	DET	O
tumour	O	NOUN	B
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
kidneys	O	NOUN	B
perfused	O	VERB	B
for	O	ADP	O
72	O	NUM	O
hr	O	NOUN	O
demonstrated	O	VERB	O
more	O	ADV	O
similar	O	ADJ	O
renal	O	ADJ	B
functions	O	NOUN	I
when	O	SCONJ	O
tested	O	VERB	B
by	O	ADP	O
either	O	CCONJ	O
IMPK	O	NOUN	B
or	O	CCONJ	O
IBPK	O	NOUN	B
.	O	PUNCT	O


It	O	PRON	O
has	O	AUX	O
been	O	AUX	O
reported	O	VERB	O
that	O	SCONJ	O
rat	O	NOUN	B
blood	O	NOUN	B
chloroform	O	NOUN	B
levels	O	NOUN	B
were	O	AUX	O
significantly	O	ADV	O
decreased	O	VERB	B
after	O	ADP	O
treatment	O	NOUN	B
with	O	ADP	O
ClO2	O	NOUN	B
.	O	PUNCT	O


For	O	ADP	O
this	O	DET	O
purpose	O	NOUN	O
,	O	PUNCT	O
a	O	DET	O
simple	O	ADJ	O
respiration	O	NOUN	B
-	O	PUNCT	O
control	O	NOUN	B
device	O	NOUN	I
has	O	AUX	O
been	O	AUX	O
developed	O	VERB	O
that	O	PRON	O
enables	O	VERB	O
the	O	DET	O
patient	O	NOUN	B
to	O	PART	O
monitor	O	VERB	B
breath	O	NOUN	B
-	O	PUNCT	O
holding	O	VERB	B
during	O	ADP	O
successive	O	ADJ	O
scans	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
the	O	DET	O
10	O	NUM	O
patients	O	NOUN	B
with	O	ADP	O
a	O	DET	O
more	O	ADV	O
severe	O	ADJ	B
degree	O	NOUN	B
of	O	ADP	O
steatorrhea	O	NOUN	B
the	O	DET	O
decrease	O	NOUN	B
in	O	ADP	O
fat	O	ADJ	B
loss	O	NOUN	I
approached	O	VERB	O
20	O	NUM	O
%	O	NOUN	O
and	O	CCONJ	O
a	O	DET	O
close	O	ADJ	O
relationship	O	NOUN	B
was	O	AUX	O
found	O	VERB	O
(	O	PUNCT	O
r	O	NOUN	O
=	O	ADJ	O
0	O	NUM	O
.	O	PUNCT	O
84	O	NUM	O
,	O	PUNCT	O
p	O	NOUN	O
less	O	ADJ	O
than	O	ADP	O
0	O	NUM	O
.	O	PUNCT	O
01	O	NUM	O
)	O	PUNCT	O
between	O	ADP	O
the	O	DET	O
extent	O	NOUN	O
of	O	ADP	O
the	O	DET	O
fatty	O	ADJ	B
acid	O	NOUN	I
loss	O	NOUN	I
on	O	ADP	O
placebo	O	NOUN	B
and	O	CCONJ	O
the	O	DET	O
decrease	O	NOUN	B
of	O	ADP	O
this	O	DET	O
loss	O	NOUN	B
on	O	ADP	O
taurine	O	NOUN	B
.	O	PUNCT	O


Polysorbate	O	NOUN	B
80	O	NUM	O
did	O	AUX	O
not	O	PART	O
have	O	AUX	O
a	O	DET	O
direct	O	ADJ	O
stimulant	O	NOUN	B
or	O	CCONJ	O
relaxant	O	ADJ	B
effect	O	NOUN	I
on	O	ADP	O
either	O	CCONJ	O
guinea	O	NOUN	B
pig	O	NOUN	B
ileum	O	NOUN	B
or	O	CCONJ	O
rat	O	NOUN	B
uterus	O	NOUN	B
,	O	PUNCT	O
however	O	ADV	O
,	O	PUNCT	O
it	O	PRON	O
antagonised	O	VERB	B
the	O	DET	O
contractions	O	NOUN	B
induced	O	VERB	B
by	O	ADP	O
acetylcholine	O	NOUN	B
,	O	PUNCT	O
histamine	O	NOUN	B
,	O	PUNCT	O
barium	O	NOUN	B
,	O	PUNCT	O
5	O	NUM	O
-	O	PUNCT	O
hydroxytryptamine	O	NOUN	B
and	O	CCONJ	O
carbachol	O	NOUN	B
in	O	ADP	O
a	O	DET	O
dose	O	NOUN	B
-	O	PUNCT	O
dependent	O	ADJ	B
manner	O	NOUN	O
.	O	PUNCT	O


Either	O	CCONJ	O
a	O	DET	O
UV	O	NOUN	B
detector	O	NOUN	I
set	O	VERB	I
at	O	ADP	O
268	O	NUM	O
nm	O	NOUN	O
or	O	CCONJ	O
an	O	DET	O
electrochemical	O	ADJ	B
(	O	PUNCT	O
EC	O	NOUN	O
)	O	PUNCT	O
detector	O	NOUN	O
set	O	VERB	O
at	O	ADP	O
a	O	DET	O
potential	O	NOUN	B
of	O	ADP	O
+	O	CCONJ	O
0	O	NUM	O
.	O	PUNCT	O
9	O	NUM	O
V	O	NOUN	O
(	O	PUNCT	O
versus	O	CCONJ	O
Ag	O	PROPN	B
/	O	SYM	O
AgCl	O	PROPN	B
/	O	SYM	O
3	O	NUM	B
M	O	NOUN	I
NaCl	O	NOUN	I
)	O	PUNCT	O
was	O	AUX	O
used	O	VERB	O
to	O	PART	O
monitor	O	VERB	B
the	O	DET	O
drug	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
mean	O	ADJ	O
transfer	O	NOUN	O
ratios	O	NOUN	O
of	O	ADP	O
the	O	DET	O
drug	O	NOUN	B
into	O	ADP	O
the	O	DET	O
genital	O	ADJ	B
tissues	O	NOUN	I
to	O	PART	O
the	O	DET	O
concentration	O	NOUN	B
in	O	ADP	O
the	O	DET	O
uterine	O	ADJ	B
arterial	O	ADJ	I
blood	O	NOUN	O
were	O	AUX	O
such	O	ADJ	O
that	O	SCONJ	O
the	O	DET	O
transfer	O	NOUN	B
ratio	O	NOUN	I
into	O	ADP	O
the	O	DET	O
portio	O	NOUN	B
vaginalis	O	X	I
was	O	AUX	O
the	O	DET	O
highest	O	ADJ	B
,	O	PUNCT	O
followed	O	VERB	O
by	O	ADP	O
the	O	DET	O
uterine	O	NOUN	B
cervix	O	NOUN	I
and	O	CCONJ	O
the	O	DET	O
myometrium	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
that	O	DET	O
into	O	ADP	O
the	O	DET	O
oviduct	O	NOUN	B
was	O	AUX	O
the	O	DET	O
lowest	O	ADJ	B
with	O	ADP	O
about	O	ADV	O
1	O	NUM	O
/	O	SYM	O
2	O	NUM	O
that	O	PRON	O
into	O	ADP	O
the	O	DET	O
portio	O	NOUN	B
vaginalis	O	X	I
.	O	PUNCT	O


Lower	O	ADJ	B
extremity	O	NOUN	I
weight	O	NOUN	I
bearing	O	VERB	O
under	O	ADP	O
various	O	ADJ	O
standing	O	NOUN	B
conditions	O	NOUN	O
in	O	ADP	O
independently	O	ADV	O
ambulatory	O	ADJ	B
patients	O	NOUN	B
with	O	ADP	O
hemiparesis	O	NOUN	B
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
were	O	AUX	O
compared	O	VERB	B
with	O	ADP	O
those	O	DET	O
obtained	O	VERB	O
in	O	ADP	O
-	O	PUNCT	O
D	O	NOUN	B
mothers	O	NOUN	B
and	O	CCONJ	O
pups	O	NOUN	B
,	O	PUNCT	O
after	O	ADP	O
giving	O	VERB	O
the	O	DET	O
mothers	O	NOUN	B
an	O	DET	O
oral	O	ADJ	B
supplement	O	NOUN	I
(	O	PUNCT	O
10	O	NUM	O
i	O	X	O
.	O	PUNCT	O
u	O	INTJ	O
.	O	PUNCT	O
vitamin	O	NOUN	B
D3	O	NOUN	I
/	O	PUNCT	O
day	O	NOUN	B
)	O	PUNCT	O
during	O	ADP	O
the	O	DET	O
period	O	NOUN	B
of	O	ADP	O
lactation	O	NOUN	B
(	O	PUNCT	O
20	O	NUM	O
days	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Treatment	O	NOUN	B
with	O	ADP	O
oxyphenylbutazone	O	NOUN	B
and	O	CCONJ	O
hydrocortisone	O	NOUN	B
failed	O	VERB	B
to	O	PART	O
inhibit	O	VERB	B
the	O	DET	O
raised	O	VERB	B
serum	B-GENE	NOUN	B
CPN	I-GENE	NOUN	B
levels	O	NOUN	B
.	O	PUNCT	O


40	O	NUM	O
,	O	PUNCT	O
000	O	NUM	O
)	O	PUNCT	O
.	O	PUNCT	O


Duration	O	NOUN	B
of	O	ADP	O
remission	O	NOUN	B
in	O	ADP	O
advanced	O	ADJ	B
gastric	O	ADJ	I
cancer	O	NOUN	I
patients	O	NOUN	B
responding	O	VERB	B
to	O	PART	O
sequential	O	ADJ	B
dose	O	NOUN	B
of	O	ADP	O
MTX	O	NOUN	B
and	O	CCONJ	O
5	O	NUM	B
-	O	PUNCT	O
FU	O	PROPN	B


The	O	DET	O
fast	O	ADJ	B
real	O	ADJ	I
-	O	PUNCT	O
time	O	NOUN	B
digital	O	ADJ	O
processing	O	NOUN	O
of	O	ADP	O
the	O	DET	O
N2	O	ADJ	B
and	O	CCONJ	O
flow	O	NOUN	B
signals	O	NOUN	I
incorporated	O	VERB	O
filtering	O	NOUN	B
,	O	PUNCT	O
delay	O	NOUN	B
compensation	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
corrections	O	NOUN	B
for	O	ADP	O
the	O	DET	O
effects	O	NOUN	B
of	O	ADP	I
changes	O	NOUN	B
in	O	ADP	O
gas	O	NOUN	B
composition	O	NOUN	I
and	O	CCONJ	O
temperature	O	NOUN	B
.	O	PUNCT	O


National	O	PROPN	B
Institutes	O	PROPN	I
of	O	ADP	I
Health	O	PROPN	I
Consensus	O	PROPN	I
Development	O	PROPN	I
Conference	O	PROPN	I
Statement	O	PROPN	I
.	O	PUNCT	O


Diagnosis	O	NOUN	B
:	O	PUNCT	O
progressive	O	ADJ	B
multifocal	O	ADJ	B
leukoencephalopathy	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
imino	O	ADJ	B
proton	O	NOUN	I
of	O	ADP	O
T3	O	NOUN	B
in	O	ADP	O
the	O	DET	O
O6meG	O	NOUN	B
.	O	PUNCT	O
T	O	NOUN	O
12	O	NUM	O
-	O	PUNCT	O
mer	O	NOUN	B
and	O	CCONJ	O
G3	O	NOUN	B
in	O	ADP	O
the	O	DET	O
O6meG	O	NOUN	B
.	O	PUNCT	O
N	O	NOUN	O
12	O	NUM	O
-	O	PUNCT	O
mer	O	NOUN	B
helix	O	NOUN	B
,	O	PUNCT	O
which	O	DET	O
are	O	AUX	O
associated	O	VERB	B
with	O	ADP	I
the	O	DET	O
modification	O	NOUN	B
site	O	NOUN	I
,	O	PUNCT	O
resonate	O	VERB	O
at	O	ADP	O
unusually	O	ADV	O
high	O	ADJ	B
field	O	NOUN	I
(	O	PUNCT	O
8	O	NUM	O
.	O	PUNCT	O
5	O	NUM	O
to	O	PART	O
9	O	NUM	O
.	O	PUNCT	O
0	O	NUM	O
ppm	O	NOUN	O
)	O	PUNCT	O
compared	O	VERB	O
to	O	PART	O
imino	O	ADJ	B
protons	O	NOUN	I
in	O	ADP	O
Watson	O	PROPN	B
-	O	PUNCT	O
Crick	O	PROPN	B
base	O	NOUN	I
pairs	O	NOUN	I
(	O	PUNCT	O
12	O	NUM	O
.	O	PUNCT	O
5	O	NUM	O
to	O	PART	O
14	O	NUM	O
.	O	PUNCT	O
5	O	NUM	O
ppm	O	NOUN	O
)	O	PUNCT	O
.	O	PUNCT	O


Postnatal	O	ADJ	B
volumetric	O	ADJ	B
development	O	NOUN	B
of	O	ADP	O
the	O	DET	O
prefrontal	O	ADJ	B
cortex	O	NOUN	I
in	O	ADP	O
the	O	DET	O
rat	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
also	O	ADV	O
observed	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
predictive	O	ADJ	B
ability	O	NOUN	O
of	O	ADP	O
the	O	DET	O
selected	O	VERB	O
attitudes	O	NOUN	B
and	O	CCONJ	O
orientations	O	NOUN	B
increased	O	VERB	B
considerably	O	ADV	O
from	O	ADP	O
1975	O	NUM	O
to	O	ADP	O
1982	O	NUM	O
.	O	PUNCT	O


They	O	PRON	O
also	O	ADV	O
discuss	O	VERB	O
the	O	DET	O
existing	O	VERB	O
nomenclature	O	NOUN	B
.	O	PUNCT	O


Estral	O	ADJ	B
cycle	O	NOUN	I
in	O	ADP	O
white	O	ADJ	B
rats	O	NOUN	I
in	O	ADP	O
the	O	DET	O
low	O	ADJ	B
and	O	CCONJ	O
high	O	ADJ	B
mountains	O	NOUN	B
of	O	ADP	O
Kirghizia	O	PROPN	B


Studies	O	NOUN	B
on	O	ADP	O
the	O	DET	O
organic	O	ADJ	B
matrix	O	NOUN	I
of	O	ADP	O
human	O	ADJ	B
ear	O	NOUN	O
ossicles	O	NOUN	O


Sensitization	O	NOUN	B
to	O	PART	O
hyperlactatemia	O	NOUN	B
induced	O	VERB	B
by	O	ADP	O
phenformin	O	NOUN	B
after	O	ADP	O
subtotal	O	ADJ	B
ablation	O	NOUN	I
of	O	ADP	O
the	O	DET	O
pancreas	O	NOUN	B
.	O	PUNCT	O


Effect	O	NOUN	B
of	O	ADP	O
variations	O	NOUN	B
in	O	ADP	O
time	O	NOUN	B
interval	O	NOUN	I
between	O	ADP	O
treatment	O	NOUN	B
with	O	ADP	O
BCG	O	NOUN	B
and	O	CCONJ	O
quartz	O	NOUN	B
dust	O	NOUN	I
on	O	ADP	O
translocation	O	NOUN	B
of	O	ADP	O
quartz	O	NOUN	B
dust	O	NOUN	I
from	O	ADP	O
the	O	DET	O
lungs	O	NOUN	B
to	O	ADP	O
their	O	PRON	O
regional	O	ADJ	B
lymph	O	NOUN	B
nodes	O	NOUN	I
.	O	PUNCT	O


Metastasis	O	NOUN	B
of	O	ADP	O
colon	O	NOUN	B
carcinoma	O	NOUN	I
to	O	ADP	O
the	O	DET	O
lip	O	NOUN	B
.	O	PUNCT	O


Pre	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
beta	I-GENE	PROPN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	O
lipoprotein	I-GENE	NOUN	B
and	O	CCONJ	O
early	O	ADJ	B
detection	O	NOUN	B
of	O	ADP	O
risk	O	NOUN	B
factors	O	NOUN	I
for	O	ADP	O
coronary	O	ADJ	B
heart	O	NOUN	I
disease	O	NOUN	I
.	O	PUNCT	O


I	O	PRON	O
.	O	PUNCT	O


A	O	DET	O
study	O	NOUN	B
in	O	X	B
vivo	O	X	I
of	O	ADP	O
adrenergic	B-GENE	ADJ	B
receptors	I-GENE	NOUN	I
in	O	ADP	O
the	O	DET	O
rectum	O	NOUN	B
and	O	CCONJ	O
in	O	ADP	O
the	O	DET	O
internal	O	ADJ	B
and	O	CCONJ	O
sphincter	O	NOUN	B
of	O	ADP	O
the	O	DET	O
cat	O	NOUN	B
.	O	PUNCT	O


Problems	O	NOUN	B
common	O	ADJ	O
to	O	ADP	O
pediatrics	O	NOUN	B
and	O	CCONJ	O
anesthesiology	O	NOUN	B


Clinical	O	ADJ	B
course	O	NOUN	I
and	O	CCONJ	O
nursing	O	NOUN	B
care	O	NOUN	I
of	O	ADP	O
patients	O	NOUN	B
with	O	ADP	O
decubitus	O	NOUN	B
ulcer	O	NOUN	I
-	O	PUNCT	O
-	O	PUNCT	O
use	O	NOUN	B
of	O	ADP	I
pillows	O	NOUN	B
stuffed	O	VERB	B
with	O	ADP	O
buckwheat	O	NOUN	B
chaff	O	NOUN	I


Re	O	NOUN	B
-	O	PUNCT	O
examining	O	VERB	B
methylbenzene	O	NOUN	B
(	O	PUNCT	O
toluene	O	NOUN	B
)	O	PUNCT	O
as	O	ADP	O
a	O	DET	O
treatment	O	NOUN	B
for	O	ADP	O
Ancylostomum	O	PROPN	B
caninum	O	PROPN	I
.	O	PUNCT	O


Teratological	O	ADJ	B
studies	O	NOUN	I
on	O	ADP	O
SF	O	PROPN	B
-	O	PUNCT	O
837	O	NUM	O
.	O	PUNCT	O


60th	O	ADJ	O
birthday	O	NOUN	B
of	O	ADP	O
colonel	O	NOUN	B
prof	O	NOUN	I
.	O	PUNCT	O
e	O	X	O
.	O	PUNCT	O
cerny	O	NOUN	O
m	O	NOUN	O
.	O	PUNCT	O
d	O	X	O
.	O	PUNCT	O


Morphology	O	NOUN	B
of	O	ADP	O
bacteriophages	O	NOUN	B
of	O	ADP	O
Klebsiella	O	X	B
bacilli	O	NOUN	I
.	O	PUNCT	O


Benign	O	ADJ	B
intramural	O	ADJ	O
tumors	O	NOUN	O
of	O	ADP	O
the	O	DET	O
esophagus	O	NOUN	B


Methyl	O	NOUN	B
mercury	O	NOUN	B
intoxication	O	NOUN	B
in	O	ADP	O
rat	O	NOUN	B
kidneys	O	NOUN	B
.	O	PUNCT	O


Disability	O	NOUN	B
insurance	O	NOUN	O
under	O	ADP	O
social	O	ADJ	B
security	O	NOUN	I
.	O	PUNCT	O


Polycythemia	O	NOUN	B
-	O	PUNCT	O
1973	O	NUM	O
.	O	PUNCT	O


Analysis	O	NOUN	B
of	O	ADP	O
clearance	O	NOUN	B
curve	O	NOUN	I
of	O	ADP	O
rose	O	VERB	O
bengal	O	NOUN	B
-	O	PUNCT	O
I	O	PROPN	B
-	O	PUNCT	O
131	O	NUM	O


VII	O	NOUN	B
.	O	PUNCT	O


Effect	O	NOUN	B
of	O	ADP	O
a	O	DET	O
high	O	ADJ	B
-	O	PUNCT	O
intensity	O	NOUN	B
SHF	O	NOUN	B
field	O	NOUN	O
on	O	ADP	O
the	O	DET	O
blood	O	NOUN	B
coagulation	O	NOUN	I
system	O	NOUN	I


Plastic	O	ADJ	B
solution	O	NOUN	I
of	O	ADP	O
elbow	O	NOUN	B
joint	O	ADJ	I
ankylosis	O	NOUN	I
with	O	ADP	O
a	O	DET	O
decorticated	O	ADJ	B
cylindrical	O	ADJ	B
flap	O	NOUN	O


Effects	O	NOUN	B
of	O	ADP	I
ionizing	O	VERB	B
radiation	O	NOUN	I
in	O	ADP	O
the	O	DET	O
human	O	ADJ	B
oral	O	ADJ	B
cavity	O	NOUN	I
and	O	CCONJ	O
oropharynx	O	NOUN	B
:	O	PUNCT	O
results	O	NOUN	B
of	O	ADP	O
a	O	DET	O
survey	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
Twentieth	O	PROPN	B
Anniversary	O	PROPN	I
of	O	ADP	I
the	O	DET	I
Pomeranian	O	PROPN	I
Medical	O	PROPN	I
Academy	O	PROPN	I
.	O	PUNCT	O


Study	O	NOUN	B
of	O	ADP	O
antinuclear	O	ADJ	B
autoantibodies	O	NOUN	I
by	O	ADP	O
immunofluorescence	O	NOUN	B
technic	O	NOUN	I
in	O	ADP	O
collagen	B-GENE	NOUN	B
diseases	O	NOUN	I


Some	O	DET	O
reflexions	O	NOUN	B
apropos	O	NOUN	O
of	O	ADP	O
a	O	DET	O
personal	O	ADJ	B
statistical	O	ADJ	I
study	O	NOUN	I
of	O	ADP	O
513	O	NUM	O
arterial	O	ADJ	B
embolisms	O	NOUN	B


Reactivities	O	NOUN	B
to	O	PART	O
horse	B-GENE	NOUN	B
anti	I-GENE	ADJ	B
-	I-GENE	PUNCT	O
lymphocyte	I-GENE	NOUN	B
globulin	I-GENE	NOUN	I
.	O	PUNCT	O


The	O	DET	O
effect	O	NOUN	B
of	O	ADP	O
osmotic	O	ADJ	B
flow	O	NOUN	I
on	O	ADP	O
the	O	DET	O
distribution	O	NOUN	B
of	O	ADP	O
horseradish	B-GENE	ADJ	B
peroxidase	I-GENE	NOUN	I
within	O	ADP	O
the	O	DET	O
intercellular	O	ADJ	B
spaces	O	NOUN	B
of	O	ADP	O
toad	O	ADJ	B
bladder	O	NOUN	B
epithelium	O	NOUN	I
.	O	PUNCT	O


Nitrogen	O	NOUN	B
-	O	PUNCT	O
hydrogen	O	NOUN	B
tautomerism	O	NOUN	I
in	O	ADP	O
porphyrins	O	NOUN	B
and	O	CCONJ	O
chlorins	O	NOUN	B
.	O	PUNCT	O


A	O	DET	O
possible	O	ADJ	O
role	O	NOUN	O
for	O	ADP	O
the	O	DET	O
mixed	O	ADJ	B
function	O	NOUN	I
oxidase	B-GENE	NOUN	I
enzyme	O	NOUN	B
system	O	NOUN	I
in	O	ADP	O
the	O	DET	O
requirement	O	NOUN	B
for	O	ADP	O
selenium	O	NOUN	B
in	O	ADP	O
the	O	DET	O
rat	O	NOUN	B
.	O	PUNCT	O


Periodic	O	ADJ	B
breathing	O	NOUN	O
and	O	CCONJ	O
apnea	O	NOUN	B
in	O	ADP	O
preterm	O	NOUN	B
infants	O	NOUN	I
.	O	PUNCT	O


Working	O	NOUN	B
session	O	NOUN	I
report	O	NOUN	B
:	O	PUNCT	O
in	O	X	B
vivo	O	X	I
-	O	PUNCT	O
in	O	X	B
vitro	O	X	I
screening	O	NOUN	B
.	O	PUNCT	O


Dynamics	O	NOUN	B
of	O	ADP	O
hospital	O	NOUN	B
stay	O	NOUN	I
in	O	ADP	O
peptic	O	ADJ	B
ulcer	O	NOUN	I
patients	O	NOUN	B


A	O	DET	O
case	O	NOUN	B
of	O	ADP	O
M	O	NOUN	B
hemoglobinosis	O	NOUN	I


Results	O	NOUN	B
of	O	ADP	O
the	O	DET	O
official	O	ADJ	B
inspection	O	NOUN	B
of	O	ADP	O
the	O	DET	O
commercial	O	ADJ	B
anti	O	ADJ	B
-	O	PUNCT	O
inflammatory	O	ADJ	B
enzyme	O	NOUN	B
preparations	O	NOUN	I
containing	O	VERB	O
chymotrypsin	B-GENE	NOUN	B
and	O	CCONJ	O
trypsin	B-GENE	NOUN	B
by	O	ADP	O
means	O	NOUN	O
of	O	ADP	O
modified	O	VERB	B
NF	O	NOUN	B
13	O	NUM	O
methods	O	NOUN	B


The	O	DET	O
content	O	NOUN	B
of	O	ADP	O
glucosamine	O	NOUN	B
and	O	CCONJ	O
galactosamine	O	NOUN	B
in	O	ADP	O
tartar	O	NOUN	B


The	O	DET	O
non	O	ADJ	B
-	O	PUNCT	O
role	O	NOUN	B
of	O	ADP	O
fluoride	O	NOUN	B
in	O	ADP	O
the	O	DET	O
control	O	NOUN	B
of	O	ADP	O
plasma	O	NOUN	B
calcium	O	NOUN	O
in	O	ADP	O
the	O	DET	O
parathyroidectomized	O	VERB	B
rat	O	NOUN	B
.	O	PUNCT	O


Modification	O	NOUN	B
of	O	ADP	O
the	O	DET	O
growth	O	NOUN	B
of	O	ADP	O
Tetrahymena	O	PROPN	B
by	O	ADP	O
compounds	O	NOUN	B
which	O	DET	O
affect	O	VERB	O
the	O	DET	O
adrenergic	O	ADJ	B
mechanism	O	NOUN	B
.	O	PUNCT	O


Factors	O	NOUN	B
influencing	O	VERB	B
in	O	X	B
vitro	O	X	I
skin	B-GENE	NOUN	B
permeability	I-GENE	NOUN	B
factor	I-GENE	NOUN	I
production	O	NOUN	O
by	O	ADP	O
Vibrio	O	PROPN	B
cholerae	O	NOUN	I
.	O	PUNCT	O


Midge	O	NOUN	B
control	O	NOUN	B
in	O	ADP	O
flood	O	NOUN	B
channels	O	NOUN	I
.	O	PUNCT	O


Tolerance	O	NOUN	B
test	O	NOUN	I
of	O	ADP	O
HB	O	NOUN	B
419	O	NUM	O
in	O	ADP	O
animal	O	NOUN	B
experiments	O	NOUN	I


The	O	DET	O
distribution	O	NOUN	B
of	O	ADP	O
body	O	NOUN	B
fluids	O	NOUN	I
following	O	VERB	O
hemorrhage	O	NOUN	B
and	O	CCONJ	O
resuscitation	O	NOUN	B
in	O	ADP	O
combat	O	NOUN	B
casualties	O	NOUN	B
.	O	PUNCT	O


Once	O	ADV	O
more	O	ADJ	O
Hong	O	PROPN	O
Kong	O	PROPN	O
influenza	O	NOUN	B
in	O	ADP	O
the	O	DET	O
Netherlands	O	PROPN	B


Early	O	ADJ	B
disagnosis	O	NOUN	I
of	O	ADP	O
cancer	O	NOUN	B
-	O	PUNCT	O
-	O	PUNCT	O
50	O	NUM	O
per	O	ADP	O
cent	O	NOUN	O
of	O	ADP	O
all	O	DET	O
patients	O	NOUN	B
could	O	AUX	O
be	O	AUX	O
cured	O	VERB	B


Difficulties	O	NOUN	B
bound	O	VERB	O
to	O	PART	O
measuring	O	NOUN	B
of	O	ADP	O
sputum	O	NOUN	B
viscosity	O	NOUN	I


The	O	DET	O
absolute	O	ADJ	B
configuration	O	NOUN	B
at	O	ADP	O
C	O	NOUN	B
-	O	PUNCT	O
2	O	NUM	O
in	O	ADP	O
monocrotalic	O	ADJ	B
acid	O	NOUN	I
.	O	PUNCT	O


CO2	O	NOUN	B
assimilation	O	NOUN	B
by	O	ADP	O
chloroplasts	O	NOUN	B
illuminated	O	VERB	O
on	O	ADP	O
filter	O	NOUN	B
paper	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
effect	O	NOUN	B
of	O	ADP	O
low	O	ADJ	B
dosage	O	NOUN	B
radiation	O	NOUN	B
on	O	ADP	O
metabolism	O	NOUN	B
and	O	CCONJ	O
function	O	NOUN	B
of	O	ADP	O
the	O	DET	O
rat	O	NOUN	B
kidney	O	NOUN	B
damaged	O	VERB	B
by	O	ADP	O
ischemia	O	NOUN	B


Quantitation	O	NOUN	B
of	O	ADP	O
exocrine	B-GENE	ADJ	B
IgA	I-GENE	NOUN	B
in	O	ADP	O
human	O	ADJ	B
serum	O	NOUN	B
in	O	ADP	O
health	O	NOUN	B
and	O	CCONJ	O
disease	O	NOUN	B
.	O	PUNCT	O


Iodine	O	NOUN	B
metabolism	O	NOUN	I
in	O	ADP	O
chronic	O	ADJ	B
thyroiditis	O	NOUN	I
.	O	PUNCT	O


Propagation	O	NOUN	B
and	O	CCONJ	O
hormone	O	NOUN	B
production	O	NOUN	B
by	O	ADP	O
human	O	ADJ	B
normal	O	ADJ	B
and	O	CCONJ	O
malignant	O	ADJ	B
trophoblast	O	NOUN	O
in	O	ADP	O
rats	O	NOUN	B
.	O	PUNCT	O


Morphogenesis	O	NOUN	B
of	O	ADP	O
the	O	DET	O
trochanter	O	NOUN	B
produced	O	VERB	O
by	O	ADP	O
femoral	O	ADJ	B
regeneration	O	NOUN	I
in	O	ADP	O
the	O	DET	O
phasmid	O	PROPN	B
Carausius	O	PROPN	B
morosus	O	PROPN	I
Br	O	PROPN	O


3	O	X	O
.	O	PUNCT	O


Nephrectomy	O	NOUN	B
applied	O	VERB	O
to	O	ADP	O
cattle	O	NOUN	B


Evaluation	O	NOUN	B
of	O	ADP	O
automatic	O	ADJ	B
blood	O	NOUN	I
cell	O	NOUN	I
counters	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
effect	O	NOUN	B
of	O	ADP	O
a	O	DET	O
constant	O	ADJ	B
magnetic	O	ADJ	B
field	O	NOUN	I
on	O	ADP	O
the	O	DET	O
phagocytic	O	ADJ	B
activity	O	NOUN	B
of	O	ADP	O
Paramecia	O	PROPN	B


Relations	O	NOUN	B
between	O	ADP	O
adrenergic	O	ADJ	B
mechanisms	O	NOUN	B
and	O	CCONJ	O
analgesic	O	NOUN	B
effects	O	NOUN	I


The	O	DET	O
bearing	O	NOUN	O
of	O	ADP	O
season	O	NOUN	B
and	O	CCONJ	O
sequence	O	NOUN	B
of	O	ADP	O
calving	O	NOUN	B
on	O	ADP	O
frequency	O	NOUN	B
of	O	ADP	O
male	O	NOUN	B
,	O	PUNCT	O
female	O	NOUN	B
and	O	CCONJ	O
total	O	ADJ	O
calvings	O	NOUN	B
in	O	ADP	O
Hariana	O	PROPN	B
cows	O	NOUN	B
.	O	PUNCT	O


Effect	O	NOUN	B
of	O	ADP	O
castration	O	NOUN	B
on	O	ADP	O
pituitary	B-GENE	ADJ	B
and	I-GENE	CCONJ	O
serum	I-GENE	NOUN	B
LH	I-GENE	NOUN	B
and	O	CCONJ	O
FSH	B-GENE	NOUN	B
in	O	ADP	O
testosterone	O	NOUN	B
-	O	PUNCT	O
sterilized	O	VERB	B
rats	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
significance	O	NOUN	B
of	O	ADP	O
the	O	DET	O
phenolphthalein	B-GENE	NOUN	B
sulphatase	I-GENE	NOUN	I
test	O	NOUN	I
for	O	ADP	O
the	O	DET	O
differentiation	O	NOUN	B
and	O	CCONJ	O
identification	O	NOUN	B
of	O	ADP	O
Nocardia	O	NOUN	B
species	O	NOUN	I
.	O	PUNCT	O


Effect	O	NOUN	B
of	O	ADP	O
heparin	O	NOUN	B
on	O	ADP	O
the	O	DET	O
inactivation	O	NOUN	B
of	O	ADP	O
serum	B-GENE	NOUN	B
lipoprotein	I-GENE	NOUN	I
lipase	I-GENE	NOUN	I
by	O	ADP	O
the	O	DET	O
liver	O	NOUN	B
in	O	ADP	O
unanesthetized	O	ADJ	B
dogs	O	NOUN	I
.	O	PUNCT	O


Experimental	O	ADJ	B
chlorpromazine	O	NOUN	B
cataracts	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
need	O	NOUN	O
in	O	ADP	O
the	O	DET	O
small	O	ADJ	B
hospital	O	NOUN	I
.	O	PUNCT	O


Statistics	O	NOUN	B
of	O	ADP	O
the	O	DET	O
past	O	ADJ	O
5	O	NUM	O
years	O	NOUN	B


Naphthalene	O	NOUN	B
and	O	CCONJ	O
paradichlorobenzene	O	NOUN	B
in	O	ADP	O
clinical	O	ADJ	B
toxicology	O	NOUN	I


Story	O	NOUN	B
of	O	ADP	O
a	O	DET	O
hospital	O	NOUN	B
that	O	PRON	O
filmed	O	VERB	B
its	O	PRON	O
employee	O	NOUN	B
orientation	O	NOUN	B
program	O	NOUN	O
.	O	PUNCT	O


Value	O	NOUN	B
of	O	ADP	O
the	O	DET	O
method	O	NOUN	B
of	O	ADP	O
passive	O	ADJ	B
hemagglutination	O	NOUN	I
with	O	ADP	O
polysaccharide	O	NOUN	B
C	O	NOUN	I
in	O	ADP	O
detecting	O	VERB	B
C	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
reactive	I-GENE	ADJ	B
protein	I-GENE	NOUN	I
as	O	ADP	O
compared	O	VERB	O
to	O	ADP	O
precipitation	O	NOUN	B
in	O	ADP	O
capillaries	O	NOUN	B
and	O	CCONJ	O
slide	O	NOUN	B
latex	O	NOUN	I
test	O	NOUN	I
with	O	ADP	O
anti	B-GENE	ADJ	B
-	I-GENE	PUNCT	O
CRP	I-GENE	NOUN	B
serum	O	NOUN	O


Antimicrobial	O	ADJ	B
substance	O	NOUN	I
isolated	O	VERB	B
from	O	ADP	O
an	O	DET	O
acorn	O	ADJ	B
extract	O	NOUN	I
.	O	PUNCT	O


On	O	ADP	O
the	O	DET	O
amount	O	NOUN	B
and	O	CCONJ	O
significance	O	NOUN	B
of	O	ADP	O
the	O	DET	O
effective	O	ADJ	B
glucose	O	NOUN	B
level	O	NOUN	I
in	O	ADP	O
tumors	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
immuno	O	NOUN	B
-	O	PUNCT	O
purified	O	VERB	B
mRNA	O	NOUN	B
in	O	ADP	O
the	O	DET	O
polysome	O	NOUN	B
complex	O	NOUN	O
was	O	AUX	O
used	O	VERB	O
to	O	PART	O
prepare	O	VERB	O
cDNA	O	NOUN	B
with	O	ADP	O
which	O	DET	O
to	O	PART	O
probe	O	VERB	B
a	O	DET	O
D	O	NOUN	B
.	O	PUNCT	O
melanogaster	O	X	B
genomic	O	ADJ	B
library	O	NOUN	I
.	O	PUNCT	O


Eight	O	NUM	O
recombinant	O	ADJ	B
DNA	O	NOUN	B
clones	O	NOUN	I
of	O	ADP	O
endogenous	O	ADJ	B
murine	O	ADJ	O
leukemia	O	NOUN	O
virus	O	NOUN	O
(	O	PUNCT	O
MuLV	O	NOUN	B
)	O	PUNCT	O
-	O	PUNCT	O
related	O	VERB	B
DNA	O	NOUN	B
sequences	O	NOUN	I
have	O	AUX	O
been	O	AUX	O
isolated	O	VERB	B
from	O	ADP	O
a	O	DET	O
lambdaphage	O	NOUN	B
genomic	O	ADJ	B
library	O	NOUN	I
of	O	ADP	O
Balb	O	NOUN	B
/	O	SYM	O
c	O	X	O
mouse	O	NOUN	B
DNA	O	NOUN	I
.	O	PUNCT	O


Mature	O	ADJ	B
mRNA	O	NOUN	B
for	O	ADP	O
cytosolic	B-GENE	ADJ	B
phosphoenolpyruvate	I-GENE	NOUN	I
carboxykinase	I-GENE	NOUN	I
of	I-GENE	ADP	O
the	I-GENE	DET	O
chicken	I-GENE	NOUN	B
is	O	AUX	O
2	O	NUM	O
.	O	PUNCT	O
8	O	NUM	O
kilobases	O	NOUN	B
in	O	ADP	O
length	O	NOUN	B
,	O	PUNCT	O
similar	O	ADJ	O
to	O	PART	O
that	O	DET	O
previously	O	ADV	O
noted	O	VERB	O
for	O	ADP	O
mRNA	O	NOUN	B
coding	O	VERB	I
for	O	ADP	O
the	O	DET	O
same	O	ADJ	O
enzyme	O	NOUN	B
in	O	ADP	O
the	O	DET	O
rat	O	NOUN	B
.	O	PUNCT	O


Upstream	O	ADJ	B
activation	O	NOUN	B
sites	O	NOUN	I
of	O	ADP	O
the	O	DET	O
CYC1	B-GENE	NOUN	B
gene	I-GENE	NOUN	I
of	O	ADP	O
Saccharomyces	O	X	B
cerevisiae	O	X	I
are	O	AUX	O
active	O	ADJ	B
when	O	SCONJ	O
inverted	O	VERB	B
but	O	CCONJ	O
not	O	PART	O
when	O	SCONJ	O
placed	O	VERB	O
downstream	O	ADV	B
of	O	ADP	O
the	O	DET	O
"	O	PUNCT	O
TATA	O	NOUN	B
box	O	NOUN	I
"	O	PUNCT	O
.	O	PUNCT	O


Plasma	O	NOUN	B
and	O	CCONJ	O
erthrocyte	O	NOUN	B
lipid	O	NOUN	O
profile	O	NOUN	O
and	O	CCONJ	O
lipoprotein	B-GENE	NOUN	B
lipase	I-GENE	NOUN	I
activity	O	NOUN	B
in	O	ADP	O
postheparin	O	NOUN	B
plasma	O	NOUN	B
on	O	ADP	O
vasectomized	O	ADJ	B
rabbits	O	NOUN	B
were	O	AUX	O
studied	O	VERB	O
and	O	CCONJ	O
also	O	ADV	O
the	O	DET	O
incidence	O	NOUN	B
of	O	ADP	O
atherosclerosis	O	NOUN	B
in	O	ADP	O
different	O	ADJ	O
arterial	O	ADJ	B
beds	O	NOUN	I
.	O	PUNCT	O


Propranolol	O	NOUN	B
also	O	ADV	O
effectively	O	ADV	O
controlled	O	VERB	B
her	O	PRON	O
familial	O	ADJ	B
tremor	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
distribution	O	NOUN	B
phase	O	NOUN	O
is	O	AUX	O
followed	O	VERB	O
by	O	ADP	O
an	O	DET	O
elimination	O	NOUN	B
phase	O	NOUN	B
with	O	ADP	O
a	O	DET	O
much	O	ADV	O
longer	O	ADJ	O
half	O	NOUN	B
-	O	PUNCT	O
life	O	NOUN	B
(	O	PUNCT	O
mean	O	NOUN	B
value	O	NOUN	I
375	O	NUM	O
min	O	NOUN	O
)	O	PUNCT	O
and	O	CCONJ	O
a	O	DET	O
volume	O	NOUN	B
of	O	ADP	O
distribution	O	NOUN	B
of	O	ADP	O
approximately	O	ADV	B
200	O	NUM	O
-	O	PUNCT	O
400	O	NUM	O
l	O	NOUN	O
.	O	PUNCT	O


Plasma	B-GENE	NOUN	B
secretin	I-GENE	NOUN	B
,	O	PUNCT	O
pancreozymin	B-GENE	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
somatostatin	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
like	I-GENE	ADJ	B
hormone	I-GENE	NOUN	B
in	O	ADP	O
chronic	O	ADJ	B
renal	O	ADJ	I
failure	O	NOUN	I
patients	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
followed	O	VERB	O
37	O	NUM	O
phenytoin	O	NOUN	B
-	O	PUNCT	O
treated	O	VERB	B
patients	O	NOUN	B
with	O	ADP	O
reduced	O	VERB	B
serum	B-GENE	NOUN	B
IgA	I-GENE	NOUN	O
concentrations	O	NOUN	B
for	O	ADP	O
2	O	NUM	O
-	O	SYM	O
7	O	NUM	O
years	O	NOUN	B
.	O	PUNCT	O


Unusual	O	ADJ	B
course	O	NOUN	B
of	O	ADP	O
plasmocytosis	O	NOUN	B
.	O	PUNCT	O


Toxicity	O	NOUN	B
was	O	AUX	O
significant	O	ADJ	O
in	O	ADP	O
selected	O	VERB	O
cases	O	NOUN	B
;	O	PUNCT	O
three	O	NUM	O
patients	O	NOUN	B
developed	O	VERB	O
WBC	O	NOUN	B
counts	O	VERB	O
less	O	ADJ	O
than	O	ADP	O
1	O	NUM	O
,	O	PUNCT	O
000	O	NUM	O
/	O	SYM	O
mm3	O	NUM	B
and	O	CCONJ	O
one	O	NUM	O
of	O	ADP	O
these	O	DET	O
patients	O	NOUN	B
died	O	VERB	B
with	O	ADP	O
sepsis	O	NOUN	B
.	O	PUNCT	O


At	O	ADP	O
Cabras	O	PROPN	B
(	O	PUNCT	O
Oristano	O	PROPN	B
)	O	PUNCT	O
,	O	PUNCT	O
a	O	DET	O
town	O	NOUN	B
characterized	O	VERB	B
by	O	ADP	O
a	O	DET	O
high	O	ADJ	O
incidence	O	NOUN	B
of	O	ADP	O
thalassaemia	O	NOUN	B
and	O	CCONJ	O
G6PD	B-GENE	NOUN	B
deficiency	O	NOUN	I
less	O	ADJ	O
than	O	ADP	O
half	O	DET	O
the	O	DET	O
people	O	NOUN	B
between	O	ADP	O
18	O	NUM	O
and	O	CCONJ	O
35	O	NUM	O
have	O	AUX	O
a	O	DET	O
fair	O	ADJ	O
knowledge	O	NOUN	B
of	O	ADP	O
genetic	O	ADJ	B
diseases	O	NOUN	I
and	O	CCONJ	O
of	O	ADP	O
their	O	PRON	O
prevention	O	NOUN	B
.	O	PUNCT	O


Experience	O	NOUN	B
with	O	ADP	O
the	O	DET	O
tensor	O	NOUN	B
fasciae	O	NOUN	I
latae	O	ADJ	I
free	O	ADJ	I
flap	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
abluminal	O	ADJ	B
surface	O	NOUN	O
is	O	AUX	O
often	O	ADV	O
almost	O	ADV	O
entirely	O	ADV	O
encircled	O	VERB	B
by	O	ADP	O
a	O	DET	O
thick	O	ADJ	O
layer	O	NOUN	B
of	O	ADP	O
fibrillary	O	ADJ	B
connective	O	ADJ	B
tissue	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
customary	O	ADJ	O
coupling	O	NOUN	O
reagent	O	NOUN	B
sulfanilic	O	ADJ	I
acid	O	NOUN	I
has	O	AUX	O
been	O	AUX	O
replaced	O	VERB	O
by	O	ADP	O
1	O	NUM	O
,	O	PUNCT	O
3	O	NUM	O
-	O	PUNCT	O
dimethylbarbituric	O	ADJ	B
acid	O	NOUN	I
;	O	PUNCT	O
CNCl	O	NOUN	B
is	O	AUX	O
produced	O	VERB	O
in	O	ADP	O
the	O	DET	O
flow	O	NOUN	B
through	O	ADP	O
system	O	NOUN	B
directly	O	ADV	O
from	O	ADP	O
KCN	O	NOUN	B
and	O	CCONJ	O
chloramine	O	NOUN	B
T	O	NOUN	I
.	O	PUNCT	O


Among	O	ADP	O
six	O	NUM	O
different	O	ADJ	O
library	O	NOUN	B
isolates	O	NOUN	B
containing	O	VERB	O
6	B-GENE	NUM	O
.	I-GENE	PUNCT	O
5	I-GENE	NUM	O
-	I-GENE	PUNCT	O
to	I-GENE	PART	O
7	I-GENE	NUM	O
-	I-GENE	PUNCT	O
kb	I-GENE	NOUN	B
IAP	I-GENE	NOUN	B
units	I-GENE	NOUN	B
,	O	PUNCT	O
some	O	DET	O
restriction	O	NOUN	B
sites	O	NOUN	I
were	O	AUX	O
highly	O	ADV	O
conserved	O	VERB	O
whereas	O	SCONJ	O
others	O	NOUN	O
varied	O	VERB	O
in	O	ADP	O
both	O	CCONJ	O
occurrence	O	NOUN	B
and	O	CCONJ	O
position	O	NOUN	B
.	O	PUNCT	O


During	O	ADP	O
the	O	DET	O
period	O	NOUN	B
from	O	ADP	O
May	O	PROPN	O
to	O	ADP	O
August	O	PROPN	O
,	O	PUNCT	O
1978	O	NUM	O
,	O	PUNCT	O
an	O	DET	O
epidemic	O	NOUN	B
of	O	ADP	O
hand	O	NOUN	B
,	O	PUNCT	O
foot	O	NOUN	B
and	O	CCONJ	O
mouth	O	NOUN	O
disease	O	NOUN	O
(	O	PUNCT	O
HFMD	O	NOUN	B
)	O	PUNCT	O
occurred	O	VERB	O
in	O	ADP	O
Gifu	O	PROPN	B
prefecture	O	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
investigated	O	VERB	B
the	O	DET	O
requirements	O	NOUN	B
of	O	ADP	O
the	O	DET	O
CH	B-GENE	NOUN	B
gene	I-GENE	NOUN	I
switch	O	NOUN	O
by	O	ADP	O
characterizing	O	VERB	O
two	O	NUM	O
rearranged	B-GENE	VERB	B
gamma	I-GENE	NOUN	I
2b	I-GENE	NOUN	I
genes	I-GENE	NOUN	I
from	O	ADP	O
a	O	DET	O
gamma	B-GENE	NOUN	B
2b	I-GENE	NOUN	I
producing	O	VERB	O
mouse	O	NOUN	B
myeloma	O	NOUN	I
(	O	PUNCT	O
MPC	O	PROPN	B
-	O	PUNCT	O
11	O	NUM	O
)	O	PUNCT	O
.	O	PUNCT	O


WR	O	PROPN	B
-	O	PUNCT	O
2721	O	NUM	O
(	O	PUNCT	O
S	O	PROPN	B
-	O	PUNCT	O
2	O	NUM	B
-	O	PUNCT	O
(	O	PUNCT	O
3	O	NUM	O
aminopropylamino	O	NOUN	B
)	O	PUNCT	O
ethylphosphorothioic	O	ADJ	B
acid	O	NOUN	I
)	O	PUNCT	O
has	O	AUX	O
been	O	AUX	O
investigated	O	VERB	B
for	O	ADP	O
its	O	PRON	O
ability	O	NOUN	O
to	O	PART	O
protect	O	VERB	B
gut	O	NOUN	B
,	O	PUNCT	O
lung	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
testis	O	NOUN	B
,	O	PUNCT	O
as	O	ADV	O
well	O	ADV	O
as	O	ADP	O
fibrosarcoma	O	NOUN	B
(	O	PUNCT	O
FSa	O	NOUN	B
)	O	PUNCT	O
tumor	O	NOUN	B
nodules	O	NOUN	I
,	O	PUNCT	O
in	O	ADP	O
the	O	DET	O
lungs	O	NOUN	B
of	O	ADP	O
mice	O	NOUN	B
from	O	ADP	O
gamma	O	NOUN	B
-	O	PUNCT	O
radiation	O	NOUN	B
injury	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
ensembles	O	NOUN	B
are	O	AUX	O
considered	O	VERB	O
to	O	PART	O
be	O	AUX	O
one	O	NUM	O
of	O	ADP	O
the	O	DET	O
forms	O	NOUN	O
of	O	ADP	O
activity	O	NOUN	B
of	O	ADP	O
the	O	DET	O
structured	O	ADJ	B
morphofunctional	O	ADJ	B
cortical	O	ADJ	I
units	O	NOUN	I
,	O	PUNCT	O
i	O	X	O
.	O	PUNCT	O
e	O	X	O
.	O	PUNCT	O
the	O	DET	O
columns	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
strong	O	ADJ	O
conservation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
inverted	O	ADJ	B
terminal	O	ADJ	I
repeat	O	NOUN	I
sequence	O	NOUN	I
may	O	AUX	O
reflect	O	VERB	O
a	O	DET	O
common	O	ADJ	O
integration	O	NOUN	B
mechanism	O	NOUN	B
for	O	ADP	O
VL30	B-GENE	NOUN	B
elements	I-GENE	NOUN	I
and	O	CCONJ	O
MuLV	O	NOUN	B
proviruses	O	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
conclusion	O	NOUN	O
,	O	PUNCT	O
these	O	DET	O
studies	O	NOUN	B
indicate	O	VERB	O
that	O	SCONJ	O
LiCl	O	NOUN	B
(	O	PUNCT	O
1	O	NUM	O
)	O	PUNCT	O
decreases	O	VERB	B
histamine	O	NOUN	B
-	O	PUNCT	O
stimulated	O	VERB	B
gastric	O	ADJ	B
acid	O	NOUN	I
secretion	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
(	O	PUNCT	O
2	O	X	O
)	O	PUNCT	O
diminishes	O	VERB	O
bile	O	NOUN	B
-	O	PUNCT	O
induced	O	VERB	B
disruption	O	NOUN	B
of	O	ADP	O
the	O	DET	O
gastric	O	ADJ	B
mucosal	O	ADJ	I
barrier	O	NOUN	I
in	O	ADP	O
the	O	DET	O
canine	O	ADJ	B
Heidenhain	O	PROPN	B
pouch	O	NOUN	I
.	O	PUNCT	O


Gel	O	NOUN	B
route	O	NOUN	I
preparation	O	NOUN	I
of	O	ADP	O
low	O	ADJ	B
fusing	O	VERB	O
dental	O	NOUN	O
porcelain	O	NOUN	O
frit	O	NOUN	O
.	O	PUNCT	O


The	O	DET	O
dnaQ	B-GENE	NOUN	B
-	O	PUNCT	O
lacZ	B-GENE	NOUN	B
and	O	CCONJ	O
the	O	DET	O
rnh	B-GENE	NOUN	B
-	O	PUNCT	O
lacZ	B-GENE	NOUN	B
fused	O	VERB	B
genes	O	NOUN	I
were	O	AUX	O
constructed	O	VERB	O
and	O	CCONJ	O
hybrid	O	NOUN	B
proteins	O	NOUN	I
with	O	ADP	O
beta	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
galactosidase	I-GENE	NOUN	B
activity	O	NOUN	B
were	O	AUX	O
produced	O	VERB	O
.	O	PUNCT	O


The	O	DET	O
primary	O	ADJ	B
structure	O	NOUN	I
of	O	ADP	O
the	O	DET	O
GAL7	B-GENE	NOUN	B
5	I-GENE	NUM	O
'	I-GENE	PART	O
flanking	I-GENE	ADJ	B
region	I-GENE	NOUN	I
has	O	AUX	O
many	O	ADJ	O
features	O	NOUN	B
common	O	ADJ	O
to	O	PART	O
those	O	DET	O
of	O	ADP	O
multicellular	O	ADJ	B
eukaryotic	O	ADJ	B
genes	O	NOUN	I
.	O	PUNCT	O


Sweet	O	NOUN	B
oranges	O	NOUN	I
,	O	PUNCT	O
mandarin	O	NOUN	B
,	O	PUNCT	O
grapefruit	O	NOUN	B
,	O	PUNCT	O
lemon	O	ADJ	B
,	O	PUNCT	O
and	O	CCONJ	O
lime	O	NOUN	B
are	O	AUX	O
generally	O	ADV	O
used	O	VERB	O
for	O	ADP	O
processing	O	NOUN	B
.	O	PUNCT	O


Bepridil	O	NOUN	B
,	O	PUNCT	O
a	O	DET	O
calcium	O	NOUN	B
antagonist	O	NOUN	I
with	O	ADP	O
a	O	DET	O
half	O	NOUN	B
-	O	PUNCT	O
life	O	NOUN	B
of	O	ADP	O
approximately	O	ADV	B
42	O	NUM	O
hours	O	NOUN	B
,	O	PUNCT	O
was	O	AUX	O
compared	O	VERB	O
with	O	ADP	O
placebo	O	NOUN	B
in	O	ADP	O
a	O	DET	O
double	O	ADJ	B
-	O	PUNCT	O
blind	O	NOUN	B
,	O	PUNCT	O
randomized	O	ADJ	B
,	O	PUNCT	O
crossover	O	NOUN	B
trial	O	NOUN	I
.	O	PUNCT	O


Climatic	O	ADJ	B
treatment	O	NOUN	I
of	O	ADP	O
children	O	NOUN	B
with	O	ADP	O
respiratory	O	ADJ	B
allergy	O	NOUN	I


The	O	DET	O
susceptibility	O	NOUN	B
of	O	ADP	O
the	O	DET	O
PPNG	O	NOUN	B
strains	O	NOUN	B
to	O	PART	O
clinically	O	ADV	B
relevant	O	ADJ	B
antibiotics	O	NOUN	B
varied	O	VERB	O
with	O	ADP	O
the	O	DET	O
plasmid	O	NOUN	B
pattern	O	NOUN	B
;	O	PUNCT	O
this	O	DET	O
stresses	O	VERB	B
the	O	DET	O
necessity	O	NOUN	O
of	O	ADP	O
permanent	O	ADJ	B
surveillance	O	NOUN	B
of	O	ADP	O
gonococcal	O	ADJ	B
infections	O	NOUN	I
and	O	CCONJ	O
of	O	ADP	O
regular	O	ADJ	O
evaluation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
recommendations	O	NOUN	B
for	O	ADP	O
antimicrobial	O	ADJ	B
treatment	O	NOUN	I
.	O	PUNCT	O


If	O	SCONJ	O
facilities	O	NOUN	B
for	O	ADP	O
measurements	O	NOUN	B
of	O	ADP	O
O2	O	NOUN	B
consumption	O	NOUN	I
and	O	CCONJ	O
hence	O	ADV	O
metabolic	O	ADJ	B
rate	O	NOUN	O
are	O	AUX	O
available	O	ADJ	O
,	O	PUNCT	O
these	O	DET	O
should	O	AUX	O
be	O	AUX	O
utilized	O	VERB	O
.	O	PUNCT	O


This	O	DET	O
generally	O	ADV	O
means	O	VERB	O
an	O	DET	O
energy	O	NOUN	B
intake	O	NOUN	I
of	O	ADP	O
1	O	NUM	O
.	O	PUNCT	O
4	O	NUM	O
to	O	PART	O
1	O	NUM	O
.	O	PUNCT	O
6	O	NUM	O
times	O	NOUN	O
the	O	DET	O
energy	O	NOUN	B
expenditure	O	NOUN	I
,	O	PUNCT	O
with	O	ADP	O
a	O	DET	O
N	O	NOUN	B
intake	O	NOUN	I
of	O	ADP	O
250	O	NUM	O
to	O	PART	O
400	O	NUM	O
mg	O	NOUN	O
/	O	SYM	O
kg	O	NOUN	B
/	O	SYM	O
day	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
statistical	O	ADJ	B
analysis	O	NOUN	I
of	O	ADP	O
data	O	NOUN	B
of	O	ADP	O
TRH	B-GENE	NOUN	B
test	O	NOUN	O
on	O	ADP	O
a	O	DET	O
sample	O	NOUN	B
of	O	ADP	O
57	O	NUM	O
healthy	O	ADJ	B
volunteers	O	NOUN	I
has	O	AUX	O
permitted	O	VERB	O
an	O	DET	O
evaluation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
upper	O	ADJ	B
limits	O	NOUN	I
of	O	ADP	O
the	O	DET	O
normal	O	ADJ	O
thyrotropin	B-GENE	NOUN	B
response	O	NOUN	I
;	O	PUNCT	O
the	O	DET	O
secretory	O	ADJ	B
area	O	NOUN	I
(	O	PUNCT	O
As	O	ADP	O
)	O	PUNCT	O
was	O	AUX	O
shown	O	VERB	O
to	O	PART	O
be	O	AUX	O
more	O	ADV	O
discriminating	O	ADJ	B
.	O	PUNCT	O


Transitory	O	ADJ	B
subclinical	O	ADJ	I
and	O	CCONJ	O
permanent	O	ADJ	B
hypothyroidism	O	NOUN	I
in	O	ADP	O
the	O	DET	O
course	O	NOUN	B
of	O	ADP	O
subacute	O	ADJ	B
thyroiditis	O	NOUN	I
(	O	PUNCT	O
de	O	PROPN	O
Quervain	O	PROPN	O
)	O	PUNCT	O
.	O	PUNCT	O


It	O	PRON	O
is	O	AUX	O
concluded	O	VERB	O
that	O	SCONJ	O
axillo	O	NOUN	B
-	O	PUNCT	O
axillary	O	NOUN	B
by	O	ADP	O
-	O	PUNCT	O
pass	O	NOUN	B
is	O	AUX	O
a	O	DET	O
simple	O	ADJ	O
solution	O	NOUN	B
for	O	ADP	O
a	O	DET	O
complex	O	ADJ	B
haemodynamic	O	ADJ	B
,	O	PUNCT	O
clinical	O	ADJ	B
and	O	CCONJ	O
therapeutic	O	ADJ	B
problem	O	NOUN	I
.	O	PUNCT	O


Endothelium	O	NOUN	B
of	O	ADP	O
the	O	DET	O
central	O	ADJ	B
ear	O	NOUN	I
artery	O	NOUN	I
of	O	ADP	O
an	O	DET	O
anesthetized	O	VERB	B
rabbit	O	NOUN	B
is	O	AUX	O
damaged	O	VERB	B
by	O	ADP	O
placing	O	VERB	O
artery	O	NOUN	B
forceps	O	NOUN	I
on	O	ADP	O
the	O	DET	O
ear	O	NOUN	B
directly	O	ADV	O
over	O	ADP	O
the	O	DET	O
vessel	O	NOUN	B
.	O	PUNCT	O


Hydrocortisone	O	NOUN	B
seems	O	VERB	O
to	O	PART	O
be	O	AUX	O
unable	O	ADJ	O
to	O	PART	O
hinder	O	VERB	O
the	O	DET	O
postdenervation	O	NOUN	B
changes	O	NOUN	B
in	O	ADP	O
the	O	DET	O
muscle	O	NOUN	B
membrane	O	NOUN	I
whereas	O	SCONJ	O
high	O	ADJ	B
doses	O	NOUN	I
of	O	ADP	O
the	O	DET	O
hormone	O	NOUN	B
are	O	AUX	O
able	O	ADJ	O
to	O	PART	O
induce	O	VERB	B
changes	O	NOUN	B
in	O	ADP	O
the	O	DET	O
muscle	O	NOUN	B
membrane	O	NOUN	I
.	O	PUNCT	O


Significant	O	ADJ	O
clinical	O	ADJ	B
differences	O	NOUN	I
between	O	ADP	O
the	O	DET	O
patients	O	NOUN	B
treated	O	VERB	B
with	O	ADP	I
and	O	CCONJ	O
without	O	ADP	O
AMB	O	PROPN	B
were	O	AUX	O
longer	O	ADJ	B
survival	O	NOUN	I
time	O	NOUN	I
following	O	VERB	O
diagnosis	O	NOUN	B
of	O	ADP	O
illness	O	NOUN	B
(	O	PUNCT	O
P	O	NOUN	O
less	O	ADJ	O
than	O	ADP	O
0	O	NUM	O
.	O	PUNCT	O
05	O	NUM	O
)	O	PUNCT	O
and	O	CCONJ	O
more	O	ADV	O
frequent	O	ADJ	B
cranial	O	ADJ	B
nerve	O	NOUN	I
signs	O	NOUN	B
in	O	ADP	O
the	O	DET	O
treated	O	VERB	B
patients	O	NOUN	B
(	O	PUNCT	O
P	O	NOUN	O
=	O	ADJ	O
0	O	NUM	O
.	O	PUNCT	O
089	O	NUM	O
)	O	PUNCT	O
.	O	PUNCT	O


Catch	O	NOUN	B
-	O	PUNCT	O
up	O	ADP	B
growth	O	NOUN	B
was	O	AUX	O
observed	O	VERB	O
only	O	ADV	O
for	O	ADP	O
a	O	DET	O
12	O	NUM	O
-	O	PUNCT	O
month	O	NOUN	B
period	O	NOUN	B
in	O	ADP	O
4	O	NUM	O
children	O	NOUN	B
with	O	ADP	O
a	O	DET	O
bone	O	NOUN	B
age	O	NOUN	B
of	O	ADP	O
7	O	NUM	O
to	O	PART	O
8	O	NUM	O
years	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
present	O	ADJ	O
paper	O	NOUN	O
elucidates	O	VERB	O
the	O	DET	O
existing	O	VERB	O
discrepancies	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
offers	O	VERB	O
a	O	DET	O
consistent	O	ADJ	O
terminology	O	NOUN	B
incorporating	O	VERB	B
also	O	ADV	O
such	O	ADJ	O
terms	O	NOUN	O
as	O	ADP	O
"	O	PUNCT	O
additivity	O	NOUN	B
"	O	PUNCT	O
,	O	PUNCT	O
"	O	PUNCT	O
potentiation	O	NOUN	B
"	O	PUNCT	O
,	O	PUNCT	O
and	O	CCONJ	O
"	O	PUNCT	O
simple	O	ADJ	O
similarity	O	NOUN	B
"	O	PUNCT	O
.	O	PUNCT	O


Brainstem	O	NOUN	B
auditory	O	ADJ	O
evoked	O	ADJ	O
responses	O	NOUN	O
(	O	PUNCT	O
BAERs	O	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
quantitative	O	ADJ	B
saccadic	O	ADJ	B
eye	O	NOUN	I
movement	O	NOUN	I
studies	O	NOUN	B
provide	O	VERB	O
information	O	NOUN	B
on	O	ADP	O
the	O	DET	O
integrity	O	NOUN	B
of	O	ADP	O
pathways	O	NOUN	B
traversing	O	VERB	O
the	O	DET	O
brainstem	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
salient	O	ADJ	O
clinical	O	ADJ	B
features	O	NOUN	I
,	O	PUNCT	O
the	O	DET	O
problems	O	NOUN	B
of	O	ADP	O
management	O	NOUN	B
and	O	CCONJ	O
the	O	DET	O
modern	O	ADJ	B
approaches	O	NOUN	I
to	O	ADP	O
the	O	DET	O
reconstruction	O	NOUN	B
of	O	ADP	O
facial	O	ADJ	B
deformities	O	NOUN	I
seen	O	VERB	O
in	O	ADP	O
this	O	DET	O
disease	O	NOUN	B
are	O	AUX	O
described	O	VERB	O
.	O	PUNCT	O


The	O	DET	O
rational	O	ADJ	B
for	O	ADP	O
the	O	DET	O
prophylactic	O	ADJ	B
treatment	O	NOUN	I
,	O	PUNCT	O
the	O	DET	O
therapy	O	NOUN	B
of	O	ADP	O
the	O	DET	O
meningopathy	O	ADJ	B
and	O	CCONJ	O
AIL	O	NOUN	B
-	O	PUNCT	O
AIEOP	O	PROPN	B
protocols	O	NOUN	B
are	O	AUX	O
exposed	O	VERB	B
.	O	PUNCT	O


Hepatitis	O	NOUN	B
B	O	NOUN	I
vaccine	O	NOUN	I


The	O	DET	O
Sarns	O	PROPN	B
51F	O	NOUN	I
cavoatrial	O	NOUN	B
cannula	O	NOUN	I
decompressed	O	VERB	B
the	O	DET	O
venous	O	ADJ	B
system	O	NOUN	I
as	O	ADV	O
efficiently	O	ADV	O
as	O	ADP	O
the	O	DET	O
double	O	ADJ	O
caval	O	ADJ	B
cannulas	O	NOUN	I
.	O	PUNCT	O


Three	O	NUM	O
experiments	O	NOUN	B
contrasted	O	VERB	O
the	O	DET	O
effects	O	NOUN	B
of	O	ADP	O
6	O	NUM	O
-	O	PUNCT	O
hydroxydopamine	O	NOUN	B
-	O	PUNCT	O
induced	O	VERB	B
lesions	O	NOUN	B
of	O	ADP	O
the	O	DET	O
ventral	O	ADJ	B
noradrenergic	O	ADJ	I
and	O	CCONJ	O
dorsal	O	ADJ	B
noradrenergic	O	ADJ	I
projections	O	NOUN	B
,	O	PUNCT	O
predominantly	O	ADV	O
to	O	PART	O
hypothalamus	O	NOUN	B
and	O	CCONJ	O
cortex	O	NOUN	B
,	O	PUNCT	O
respectively	O	ADV	O
,	O	PUNCT	O
upon	O	SCONJ	O
body	O	NOUN	B
weight	O	NOUN	I
changes	O	NOUN	B
and	O	CCONJ	O
food	O	NOUN	B
-	O	PUNCT	O
related	O	VERB	B
behaviour	O	NOUN	B
in	O	ADP	O
the	O	DET	O
rat	O	NOUN	B
.	O	PUNCT	O


Female	O	ADJ	B
Wistar	O	PROPN	B
rats	O	NOUN	I
were	O	AUX	O
fed	O	VERB	O
a	O	DET	O
liquid	O	ADJ	B
diet	O	NOUN	I
,	O	PUNCT	O
Sustacal	O	PROPN	B
,	O	PUNCT	O
which	O	DET	O
contained	O	VERB	O
ethanol	O	NOUN	B
(	O	PUNCT	O
40	O	NUM	O
%	O	NOUN	O
of	O	ADP	O
calories	O	NOUN	B
)	O	PUNCT	O
or	O	CCONJ	O
isocaloric	O	ADJ	B
sucrose	O	NOUN	I
.	O	PUNCT	O


Introductory	O	ADJ	B
remarks	O	NOUN	I
.	O	PUNCT	O


Combination	O	NOUN	B
of	O	ADP	O
a	O	DET	O
Shwachman	O	ADJ	B
syndrome	O	NOUN	I
and	O	CCONJ	O
a	O	DET	O
complex	O	ADJ	B
granulocyte	O	NOUN	I
function	O	NOUN	I
disorder	O	NOUN	I
in	O	ADP	O
a	O	DET	O
girl	O	NOUN	B


Trial	O	NOUN	B
3	O	NUM	O
broiler	O	NOUN	B
chickens	O	NOUN	I
were	O	AUX	O
maintained	O	VERB	B
on	O	ADP	O
control	O	ADJ	B
feed	O	NOUN	I
until	O	ADP	O
they	O	PRON	O
reached	O	VERB	O
3	O	NUM	O
weeks	O	NOUN	B
of	O	ADP	O
age	O	NOUN	B
at	O	ADP	O
which	O	DET	O
time	O	NOUN	O
they	O	PRON	O
were	O	AUX	O
taken	O	VERB	O
off	O	ADP	O
of	O	ADP	O
feed	O	NOUN	B
for	O	ADP	O
2	O	NUM	O
.	O	PUNCT	O
5	O	NUM	O
hr	O	NOUN	O
and	O	CCONJ	O
then	O	ADV	O
placed	O	VERB	O
on	O	ADP	O
either	O	DET	O
control	O	ADJ	B
feed	O	NOUN	I
or	O	CCONJ	O
feed	O	VERB	B
containing	O	VERB	O
4	O	NUM	O
.	O	PUNCT	O
0	O	NUM	O
ppm	O	NOUN	O
ochratoxin	O	NOUN	B
A	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
heart	O	NOUN	B
rate	O	NOUN	I
and	O	CCONJ	O
blood	O	NOUN	B
pressure	O	NOUN	I
were	O	AUX	O
measured	O	VERB	B
every	O	DET	O
half	O	NOUN	O
hour	O	NOUN	B
through	O	ADP	O
7	O	NUM	O
hr	O	NOUN	O
.	O	PUNCT	O


While	O	SCONJ	O
these	O	DET	O
findings	O	NOUN	B
may	O	AUX	O
reflect	O	VERB	O
the	O	DET	O
sensitivity	O	NOUN	B
of	O	ADP	O
a	O	DET	O
thick	O	ADJ	O
myocardial	O	ADJ	B
wall	O	NOUN	I
to	O	ADP	O
ischaemia	O	NOUN	B
during	O	ADP	O
surgery	O	NOUN	B
,	O	PUNCT	O
the	O	DET	O
postoperative	O	ADJ	B
recovery	O	NOUN	B
was	O	AUX	O
not	O	PART	O
related	O	ADJ	O
to	O	PART	O
the	O	DET	O
serum	B-GENE	NOUN	B
CK	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
MB	I-GENE	PROPN	B
level	O	NOUN	B
.	O	PUNCT	O


Using	O	VERB	O
a	O	DET	O
MOS	O	PROPN	B
-	O	PUNCT	O
Hypersil	O	PROPN	B
reversed	O	VERB	B
-	O	PUNCT	O
phase	O	NOUN	B
column	O	NOUN	I
with	O	ADP	O
a	O	DET	O
phosphate	O	NOUN	B
buffer	O	NOUN	I
-	O	PUNCT	O
-	O	PUNCT	O
acetonitrile	O	NOUN	B
mobile	O	ADJ	I
phase	O	NOUN	I
,	O	PUNCT	O
baseline	O	NOUN	B
separation	O	NOUN	B
of	O	ADP	O
antipyrine	O	NOUN	B
,	O	PUNCT	O
its	O	PRON	O
metabolites	O	NOUN	B
3	O	NUM	O
-	O	PUNCT	O
hydroxymethylantipyrine	O	NOUN	B
,	O	PUNCT	O
norantipyrine	O	NOUN	B
and	O	CCONJ	O
4	O	NUM	B
-	O	PUNCT	O
hydroxyantipyrine	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
the	O	DET	O
internal	O	ADJ	B
standard	O	NOUN	I
,	O	PUNCT	O
phenacetin	O	NOUN	B
,	O	PUNCT	O
was	O	AUX	O
achieved	O	VERB	O
within	O	ADP	O
6	O	NUM	O
min	O	NOUN	O
.	O	PUNCT	O


Serum	O	NOUN	B
lipids	O	NOUN	I
and	O	CCONJ	O
lipoproteins	O	NOUN	B
of	O	ADP	O
29	O	NUM	O
insulin	B-GENE	NOUN	B
dependent	O	ADJ	O
diabetic	O	ADJ	B
children	O	NOUN	B
have	O	AUX	O
been	O	AUX	O
determined	O	VERB	O
and	O	CCONJ	O
related	O	ADJ	O
to	O	PART	O
the	O	DET	O
metabolic	O	ADJ	B
status	O	NOUN	I
of	O	ADP	O
the	O	DET	O
patients	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
AD	O	NOUN	B
components	O	NOUN	B
were	O	AUX	O
markedly	O	ADV	O
more	O	ADV	O
dependent	O	ADJ	B
on	O	ADP	O
the	O	DET	O
affective	O	ADJ	B
state	O	NOUN	I
of	O	ADP	O
the	O	DET	O
rat	O	NOUN	B
then	O	ADV	O
was	O	AUX	O
the	O	DET	O
V1	O	NOUN	B
component	O	NOUN	I
.	O	PUNCT	O


HBB	O	NOUN	B
concentration	O	NOUN	B
in	O	ADP	O
the	O	DET	O
fetuses	O	NOUN	B
indicated	O	VERB	O
little	O	ADJ	O
,	O	PUNCT	O
if	O	SCONJ	O
any	O	DET	O
accumulation	O	NOUN	B
.	O	PUNCT	O


All	O	DET	O
samples	O	NOUN	B
exhibited	O	VERB	O
a	O	DET	O
decline	O	NOUN	B
in	O	ADP	O
ethanol	O	NOUN	B
concentration	O	NOUN	B
,	O	PUNCT	O
with	O	ADP	O
most	O	ADJ	O
losses	O	NOUN	B
falling	O	VERB	B
within	O	ADP	O
the	O	DET	O
expected	O	VERB	O
20	O	NUM	O
to	O	PART	O
40	O	NUM	O
mg	O	NOUN	O
%	O	NOUN	O
range	O	NOUN	B
.	O	PUNCT	O


Pilot	O	ADJ	B
study	O	NOUN	I
of	O	ADP	O
blood	O	NOUN	B
coagulation	O	NOUN	I
in	O	ADP	O
gout	O	NOUN	B
patients	O	NOUN	B
.	O	PUNCT	O


Further	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
reduction	O	NOUN	B
in	O	ADP	O
5	O	NUM	O
-	O	PUNCT	O
hydroxytryptophan	O	NOUN	B
(	O	PUNCT	O
5	O	NUM	O
-	O	PUNCT	O
HTP	O	NOUN	B
)	O	PUNCT	O
accumulation	O	NOUN	B
by	O	ADP	O
LSD	O	NOUN	B
showed	O	VERB	O
regional	O	ADJ	B
differences	O	NOUN	I
in	O	ADP	O
inhibition	O	NOUN	B
by	O	ADP	O
methiothepin	O	NOUN	B
(	O	PUNCT	O
hypothalamus	O	NOUN	B
greater	O	ADJ	O
than	O	ADP	O
cortex	O	NOUN	B
greater	O	ADJ	O
than	O	ADP	O
striatum	O	NOUN	B
)	O	PUNCT	O
which	O	DET	O
paralleled	O	VERB	O
the	O	DET	O
autoreceptor	O	NOUN	B
antagonist	O	NOUN	B
activity	O	NOUN	B
of	O	ADP	O
methiothepin	O	NOUN	B
in	O	X	B
vitro	O	X	I
.	O	PUNCT	O
(	O	PUNCT	O
ABSTRACT	O	NOUN	B
TRUNCATED	O	VERB	I
AT	O	ADP	I
250	O	NUM	I
WORDS	O	NOUN	I
)	O	PUNCT	O


Effects	O	NOUN	B
of	O	ADP	I
methiothepin	O	NOUN	B
and	O	CCONJ	O
lysergic	O	ADJ	B
acid	O	NOUN	I
diethylamide	O	NOUN	I
on	O	ADP	O
serotonin	O	NOUN	B
release	O	NOUN	B
in	O	X	B
vitro	O	X	I
and	O	CCONJ	O
serotonin	O	NOUN	B
synthesis	O	NOUN	B
in	O	X	B
vivo	O	X	I
:	O	PUNCT	O
possible	O	ADJ	O
relation	O	NOUN	O
to	O	PART	O
serotonin	B-GENE	NOUN	B
autoreceptor	I-GENE	NOUN	I
function	O	NOUN	O
.	O	PUNCT	O


In	O	ADP	O
a	O	DET	O
recent	O	ADJ	O
measles	O	NOUN	B
epidemic	O	NOUN	B
in	O	ADP	O
El	O	PROPN	B
Paso	O	PROPN	I
,	O	PUNCT	O
TX	O	PROPN	B
,	O	PUNCT	O
120	O	NUM	O
,	O	PUNCT	O
000	O	NUM	O
records	O	NOUN	B
were	O	AUX	O
screened	O	VERB	B
using	O	VERB	O
these	O	DET	O
criteria	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
as	O	ADP	O
a	O	DET	O
result	O	NOUN	O
13	O	NUM	O
,	O	PUNCT	O
000	O	NUM	O
students	O	NOUN	B
were	O	AUX	O
vaccinated	O	VERB	B
.	O	PUNCT	O


Twenty	O	NUM	B
-	O	PUNCT	O
one	O	NUM	O
percent	O	NOUN	O
of	O	ADP	O
these	O	DET	O
patients	O	NOUN	B
had	O	AUX	O
neurologic	O	ADJ	B
disease	O	NOUN	I
that	O	PRON	O
appeared	O	VERB	O
to	O	PART	O
be	O	AUX	O
responsible	O	ADJ	O
for	O	ADP	O
the	O	DET	O
tinnitus	O	NOUN	B
.	O	PUNCT	O


Bullous	O	ADJ	B
angiolymphoid	O	ADJ	I
hyperplasia	O	NOUN	I
with	O	ADP	O
eosinophilia	O	NOUN	B


The	O	DET	O
hypertension	O	NOUN	B
with	O	ADP	O
elevated	O	ADJ	B
PRA	O	NOUN	B
,	O	PUNCT	O
however	O	ADV	O
,	O	PUNCT	O
was	O	AUX	O
resistant	O	ADJ	B
to	O	PART	O
the	O	DET	O
angiotensin	B-GENE	NOUN	B
II	I-GENE	NUM	I
(	O	PUNCT	O
AII	B-GENE	NOUN	B
)	O	PUNCT	O
analog	O	NOUN	O
[	O	PUNCT	O
Sar1	O	PROPN	B
,	O	PUNCT	O
Ile8	O	NOUN	B
]	O	PUNCT	O
ALL	O	NOUN	B
.	O	PUNCT	O


Volume	O	NOUN	B
of	O	ADP	O
distribution	O	NOUN	B
of	O	ADP	O
total	O	ADJ	O
DMDZ	O	NOUN	B
(	O	PUNCT	O
range	O	NOUN	B
,	O	PUNCT	O
1	O	X	O
.	O	PUNCT	O
33	O	NUM	O
to	O	PART	O
6	O	NUM	O
.	O	PUNCT	O
30	O	NUM	O
l	O	NOUN	O
/	O	SYM	O
kg	O	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
of	O	ADP	O
unbound	O	ADJ	B
DMDZ	O	NOUN	B
after	O	ADP	O
correction	O	NOUN	B
for	O	ADP	O
protein	O	NOUN	B
binding	O	NOUN	I
(	O	PUNCT	O
range	O	NOUN	B
,	O	PUNCT	O
43	O	NUM	O
to	O	PART	O
243	O	NUM	O
l	O	X	O
/	O	SYM	O
kg	O	NOUN	B
)	O	PUNCT	O
was	O	AUX	O
larger	O	ADJ	O
in	O	ADP	O
women	O	NOUN	B
than	O	ADP	O
in	O	ADP	O
men	O	NOUN	B
of	O	ADP	O
all	O	DET	O
ages	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
in	O	ADP	O
the	O	DET	O
elderly	O	ADJ	B
as	O	ADP	O
opposed	O	VERB	O
to	O	ADP	O
the	O	DET	O
young	O	NOUN	B
.	O	PUNCT	O


Effects	O	NOUN	B
of	O	ADP	I
dopamine	O	NOUN	B
and	O	CCONJ	O
of	O	ADP	O
a	O	DET	O
dopaminergic	O	ADJ	B
blocker	O	NOUN	I
,	O	PUNCT	O
haloperidol	O	NOUN	B
,	O	PUNCT	O
on	O	ADP	O
the	O	DET	O
responses	O	NOUN	B
of	O	ADP	O
carotid	O	NOUN	B
body	O	NOUN	I
chemoreceptors	O	NOUN	I
to	O	PART	O
hypoxia	O	NOUN	B
and	O	CCONJ	O
hypercapnia	O	NOUN	B
were	O	AUX	O
investigated	O	VERB	B
in	O	ADP	O
16	O	NUM	O
anesthetized	O	VERB	B
cats	O	NOUN	B
.	O	PUNCT	O


1	O	X	O
.	O	PUNCT	O


The	O	DET	O
alterations	O	NOUN	B
in	O	ADP	O
differentiation	O	NOUN	B
of	O	ADP	O
osteoprogenitor	O	NOUN	B
cells	O	NOUN	I
,	O	PUNCT	O
together	O	ADV	O
with	O	ADP	O
the	O	DET	O
failure	O	NOUN	B
of	O	ADP	O
mineralization	O	NOUN	B
,	O	PUNCT	O
resulted	O	VERB	O
in	O	ADP	O
significantly	O	ADV	O
lower	O	ADJ	O
rates	O	NOUN	B
of	O	ADP	O
bone	O	NOUN	B
formation	O	NOUN	I
(	O	PUNCT	O
as	O	ADP	O
measured	O	VERB	B
by	O	ADP	O
fluorochrome	O	NOUN	B
labeling	O	NOUN	I
)	O	PUNCT	O
in	O	ADP	O
the	O	DET	O
magnesium	O	NOUN	B
-	O	PUNCT	O
deficient	O	ADJ	B
rats	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
role	O	NOUN	O
of	O	ADP	O
DNA	O	NOUN	B
rearrangement	O	NOUN	I
and	O	CCONJ	O
alternative	O	ADJ	B
RNA	O	NOUN	B
processing	O	NOUN	I
in	O	ADP	O
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
immunoglobulin	B-GENE	NOUN	B
delta	I-GENE	NOUN	I
genes	I-GENE	NOUN	I
.	O	PUNCT	O


There	O	PRON	O
is	O	AUX	O
now	O	ADV	O
a	O	DET	O
significative	O	ADJ	O
difference	O	NOUN	O
between	O	ADP	O
age	O	NOUN	B
group	O	NOUN	I
1	O	NUM	I
-	O	SYM	O
5	O	NUM	O
and	O	CCONJ	O
the	O	DET	O
others	O	NOUN	O
(	O	PUNCT	O
p	O	NOUN	O
Less	O	ADJ	O
Than	O	ADV	O
0	O	NUM	O
,	O	PUNCT	O
02	O	NUM	O
)	O	PUNCT	O
.	O	PUNCT	O


Factor	B-GENE	NOUN	B
VIII	I-GENE	NOUN	I
procoagulant	O	ADJ	O
activity	O	NOUN	O
,	O	PUNCT	O
antigen	O	NOUN	B
concentration	O	NOUN	B
and	O	CCONJ	O
von	B-GENE	NOUN	B
Willebrand	I-GENE	NOUN	I
activity	O	NOUN	I
as	O	ADP	O
ristocetin	B-GENE	NOUN	B
cofactor	I-GENE	NOUN	I
were	O	AUX	O
determined	O	VERB	O
several	O	ADJ	O
times	O	NOUN	O
in	O	ADP	O
10	O	NUM	O
patients	O	NOUN	B
with	O	ADP	O
DIC	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
silicosis	O	NOUN	B
,	O	PUNCT	O
significant	O	ADJ	B
relationships	O	NOUN	B
between	O	ADP	O
patients	O	NOUN	B
and	O	CCONJ	O
sons	O	NOUN	B
were	O	AUX	O
not	O	PART	O
seen	O	VERB	O
with	O	ADP	O
respect	O	NOUN	O
to	O	PART	O
arterial	O	ADJ	B
blood	O	NOUN	I
gas	O	NOUN	I
determinations	O	NOUN	I
and	O	CCONJ	O
ventilatory	O	ADJ	B
responses	O	NOUN	I
except	O	SCONJ	O
for	O	ADP	O
Paco2	O	NOUN	B
of	O	ADP	O
patients	O	NOUN	B
and	O	CCONJ	O
hypercapnic	O	ADJ	B
ventilatory	O	ADJ	B
responses	O	NOUN	I
of	O	ADP	O
sons	O	NOUN	B
.	O	PUNCT	O


For	O	ADP	O
steers	O	NOUN	B
the	O	DET	O
urinary	O	ADJ	B
N	O	NOUN	I
values	O	NOUN	I
were	O	AUX	O
403	O	NUM	O
and	O	CCONJ	O
295	O	NUM	O
mg	O	NOUN	O
/	O	SYM	O
kg	O	NOUN	B
W0	O	NOUN	I
.	O	PUNCT	O
75	O	NUM	O
at	O	ADP	O
200	O	NUM	O
and	O	CCONJ	O
350	O	NUM	O
kg	O	NOUN	O
live	O	ADJ	B
weight	O	NOUN	I
respectively	O	ADV	O
and	O	CCONJ	O
total	O	ADJ	O
N	O	NOUN	O
excretion	O	NOUN	B
including	O	VERB	O
faecal	O	ADJ	B
N	O	NOUN	I
was	O	AUX	O
408	O	NUM	O
and	O	CCONJ	O
320	O	NUM	O
mg	O	NOUN	O
/	O	SYM	O
kg	O	NOUN	O
W0	O	NOUN	B
.	O	PUNCT	O
75	O	NUM	O
.	O	PUNCT	O


TEMTU	O	NOUN	B
and	O	CCONJ	O
DPTU	O	NOUN	B
were	O	AUX	O
the	O	DET	O
most	O	ADV	O
potent	O	ADJ	O
teratogens	O	NOUN	B
.	O	PUNCT	O


Similar	O	ADJ	O
observations	O	NOUN	B
were	O	AUX	O
made	O	VERB	O
with	O	ADP	O
unilateral	O	ADJ	B
pneumothorax	O	NOUN	B
of	O	ADP	O
15	O	NUM	O
cmH2O	O	NOUN	O
for	O	ADP	O
30	O	NUM	O
min	O	NOUN	O
.	O	PUNCT	O


Fibromuscular	O	ADJ	B
intimal	O	ADJ	B
thickening	O	NOUN	I
was	O	AUX	O
seen	O	VERB	O
in	O	ADP	O
the	O	DET	O
ascending	O	NOUN	B
and	O	CCONJ	O
thoracic	O	NOUN	B
aorta	O	NOUN	I
of	O	ADP	O
the	O	DET	O
swine	O	NOUN	B
fed	O	VERB	B
62	O	NUM	O
,	O	PUNCT	O
500	O	NUM	O
IU	O	NOUN	B
of	O	ADP	O
vitamin	O	NOUN	B
D3	O	NOUN	I
/	O	PUNCT	O
kg	O	NOUN	B
of	O	ADP	O
diet	O	NOUN	B
for	O	ADP	O
three	O	NUM	O
months	O	NOUN	B
duration	O	NOUN	B
;	O	PUNCT	O
and	O	CCONJ	O
after	O	ADP	O
3	O	NUM	O
months	O	NOUN	B
of	O	ADP	O
vitamin	O	NOUN	B
D3	O	NOUN	I
withdrawal	O	NOUN	B
,	O	PUNCT	O
atherosclerotic	O	ADJ	B
lesions	O	NOUN	I
were	O	AUX	O
found	O	VERB	O
.	O	PUNCT	O


Detection	O	NOUN	B
of	O	ADP	O
exercise	O	NOUN	B
-	O	PUNCT	O
induced	O	VERB	B
asynergy	O	NOUN	B
by	O	ADP	O
M	O	NOUN	B
-	O	PUNCT	O
mode	O	NOUN	B
echocardiography	O	NOUN	B
.	O	PUNCT	O


Both	O	DET	O
groups	O	NOUN	B
were	O	AUX	O
subjected	O	VERB	O
to	O	ADP	O
tests	O	NOUN	B
of	O	ADP	O
delayed	O	VERB	B
hypersensitivity	O	NOUN	I
with	O	ADP	O
Candidin	B-GENE	PROPN	B
,	O	PUNCT	O
Trycophytin	B-GENE	PROPN	B
and	O	CCONJ	O
Tuberculin	B-GENE	PROPN	B
.	O	PUNCT	O


Efficacy	O	NOUN	B
of	O	ADP	O
cervical	O	ADJ	B
spine	O	NOUN	I
immobilization	O	NOUN	I
methods	O	NOUN	I
.	O	PUNCT	O


Circulating	O	VERB	B
platelets	O	NOUN	O
may	O	AUX	O
be	O	AUX	O
activated	O	VERB	B
by	O	ADP	O
exposed	O	VERB	O
triple	O	ADJ	B
-	O	PUNCT	O
helical	O	ADJ	B
collagen	B-GENE	NOUN	B
in	O	ADP	O
atherosclerotic	O	ADJ	B
lesions	O	NOUN	I
in	O	ADP	O
Mg	O	NOUN	B
-	O	PUNCT	O
deficient	O	ADJ	B
ruminants	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
the	O	DET	O
ultramarathon	O	NOUN	B
runner	O	NOUN	I
the	O	DET	O
testosterone	O	NOUN	B
levels	O	NOUN	B
sharply	O	ADV	O
rose	O	VERB	O
at	O	ADP	O
the	O	DET	O
beginning	O	NOUN	O
of	O	ADP	O
the	O	DET	O
training	O	NOUN	B
session	O	NOUN	B
(	O	PUNCT	O
from	O	ADP	O
the	O	DET	O
7	O	NUM	O
,	O	PUNCT	O
20	O	NUM	O
ng	O	NOUN	O
/	O	PUNCT	O
ml	O	NOUN	O
to	O	ADP	O
11	O	NUM	O
,	O	PUNCT	O
50	O	NUM	O
ng	O	NOUN	O
/	O	PUNCT	O
ml	O	NOUN	O
after	O	ADP	O
20	O	NUM	O
'	O	PUNCT	O
training	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
and	O	CCONJ	O
subsequently	O	ADV	O
decrease	O	VERB	B
after	O	ADP	O
3	O	NUM	O
hours	O	NOUN	B
(	O	PUNCT	O
9	O	NUM	O
,	O	PUNCT	O
20	O	NUM	O
ng	O	NOUN	O
/	O	PUNCT	O
ml	O	NOUN	O
)	O	PUNCT	O
and	O	CCONJ	O
at	O	ADP	O
the	O	DET	O
end	O	NOUN	O
of	O	ADP	O
the	O	DET	O
6	O	NUM	O
hours	O	NOUN	B
training	O	NOUN	B
(	O	PUNCT	O
4	O	NUM	O
,	O	PUNCT	O
60	O	NUM	O
ng	O	NOUN	O
/	O	PUNCT	O
ml	O	NOUN	O
)	O	PUNCT	O
.	O	PUNCT	O


Terbutaline	O	NOUN	B
;	O	PUNCT	O
a	O	DET	O
beta2	O	NOUN	B
-	O	PUNCT	O
adrenergic	O	ADJ	B
agonist	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
aminophyllin	O	NOUN	B
,	O	PUNCT	O
a	O	DET	O
phosphodiesterase	O	NOUN	B
inhibitor	O	NOUN	I
,	O	PUNCT	O
were	O	AUX	O
given	O	VERB	O
separately	O	ADV	B
,	O	PUNCT	O
or	O	CCONJ	O
in	O	ADP	O
combination	O	NOUN	B
,	O	PUNCT	O
to	O	PART	O
rabbit	O	NOUN	B
fetuses	O	NOUN	B
on	O	ADP	O
the	O	DET	O
28th	O	ADJ	O
day	O	NOUN	B
of	O	ADP	O
gestation	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
hyperacute	O	ADJ	B
phase	O	NOUN	I
of	O	ADP	O
posterolateral	O	ADJ	B
myocardial	O	ADJ	I
infarction	O	NOUN	I
.	O	PUNCT	O


After	O	ADP	O
a	O	DET	O
year	O	NOUN	B
of	O	ADP	O
planning	O	NOUN	B
in	O	ADP	O
the	O	DET	O
Laboratory	O	PROPN	B
Assistants	O	PROPN	I
'	O	PART	I
School	O	PROPN	I
in	O	ADP	O
Stockholm	O	PROPN	O
:	O	PUNCT	O
new	O	ADJ	O
education	O	NOUN	B
for	O	ADP	O
laboratory	O	NOUN	B
assistants	O	NOUN	I
is	O	AUX	O
now	O	ADV	O
arranged	O	VERB	O


The	O	DET	O
electrocardiogram	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
Authors	O	NOUN	B
have	O	AUX	O
proposed	O	VERB	O
to	O	PART	O
develop	O	VERB	O
this	O	DET	O
research	O	NOUN	B
employing	O	VERB	O
a	O	DET	O
preparation	O	NOUN	B
containing	O	VERB	O
exclusively	O	ADV	O
a	O	DET	O
cortisonic	O	NOUN	B
,	O	PUNCT	O
the	O	DET	O
desametazone	O	NOUN	B
,	O	PUNCT	O
in	O	ADP	O
order	O	NOUN	O
to	O	PART	O
evaluate	O	VERB	B
the	O	DET	O
alterations	O	NOUN	B
of	O	ADP	O
the	O	DET	O
dentinogenesis	O	NOUN	B
to	O	PART	O
be	O	AUX	O
attributed	O	VERB	O
to	O	PART	O
such	O	ADJ	O
component	O	NOUN	B
.	O	PUNCT	O


Secretory	B-GENE	ADJ	B
IgA	I-GENE	NOUN	I
and	O	CCONJ	O
serum	B-GENE	NOUN	B
immunoglobulins	I-GENE	NOUN	I
as	O	ADP	O
indices	O	NOUN	B
of	O	ADP	O
the	O	DET	O
local	O	ADJ	B
immunity	O	NOUN	B
of	O	ADP	O
the	O	DET	O
intestinal	O	ADJ	B
mucosa	O	NOUN	I
in	O	ADP	O
acute	O	ADJ	B
leukemias	O	NOUN	I


Fluorometric	O	ADJ	B
methods	O	NOUN	I
can	O	AUX	O
also	O	ADV	O
provide	O	VERB	O
information	O	NOUN	B
about	O	ADP	O
porphyrin	O	NOUN	B
binding	O	NOUN	I
sites	O	NOUN	I
that	O	PRON	O
is	O	AUX	O
useful	O	ADJ	O
in	O	ADP	O
understanding	O	VERB	O
porphyrin	O	NOUN	B
transport	O	NOUN	I
and	O	CCONJ	O
clearance	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
monoexponential	O	ADJ	B
rate	O	NOUN	B
of	O	ADP	O
clearance	O	NOUN	B
of	O	ADP	O
tracer	O	NOUN	B
-	O	PUNCT	O
-	O	PUNCT	O
obtained	O	VERB	B
from	O	ADP	O
the	O	DET	O
portion	O	NOUN	B
of	O	ADP	O
the	O	DET	O
residue	O	NOUN	B
-	O	PUNCT	O
detection	O	NOUN	B
curve	O	NOUN	O
reflecting	O	VERB	O
metabolism	O	NOUN	B
of	O	ADP	O
fatty	O	ADJ	B
acid	O	NOUN	I
incorporated	O	VERB	O
into	O	ADP	O
neutral	O	ADJ	B
lipids	O	NOUN	B
-	O	PUNCT	O
-	O	PUNCT	O
correlated	O	VERB	B
directly	O	ADV	O
with	O	ADP	O
induced	O	VERB	B
changes	O	NOUN	B
in	O	ADP	O
tension	O	NOUN	B
-	O	PUNCT	O
time	O	NOUN	B
index	O	NOUN	I
after	O	ADP	O
injections	O	NOUN	B
into	O	ADP	O
the	O	DET	O
left	O	ADJ	B
atrium	O	NOUN	I
(	O	PUNCT	O
r	O	NOUN	O
=	O	ADJ	O
0	O	NUM	O
.	O	PUNCT	O
96	O	NUM	O
,	O	PUNCT	O
n	O	NOUN	O
=	O	ADJ	O
12	O	NUM	O
)	O	PUNCT	O
,	O	PUNCT	O
right	O	ADJ	B
atrium	O	NOUN	I
(	O	PUNCT	O
r	O	NOUN	O
=	O	ADJ	O
0	O	NUM	O
.	O	PUNCT	O
86	O	NUM	O
,	O	PUNCT	O
n	O	NOUN	O
=	O	ADJ	O
14	O	NUM	O
)	O	PUNCT	O
,	O	PUNCT	O
and	O	CCONJ	O
ear	O	NOUN	B
vein	O	NOUN	I
(	O	PUNCT	O
r	O	NOUN	O
=	O	ADJ	O
0	O	NUM	O
.	O	PUNCT	O
93	O	NUM	O
,	O	PUNCT	O
n	O	NOUN	O
=	O	ADJ	O
14	O	NUM	O
)	O	PUNCT	O
.	O	PUNCT	O


Specific	O	ADJ	O
IgE	B-GENE	NOUN	B
levels	O	NOUN	B
decreased	O	VERB	B
slightly	O	ADV	O
,	O	PUNCT	O
but	O	CCONJ	O
always	O	ADV	O
remained	O	VERB	O
within	O	ADP	O
the	O	DET	O
pathological	O	ADJ	B
range	O	NOUN	O
.	O	PUNCT	O


Correlation	O	NOUN	B
between	O	ADP	O
intraocular	O	ADJ	B
involvement	O	NOUN	B
and	O	CCONJ	O
systemic	O	ADJ	B
outcome	O	NOUN	I
was	O	AUX	O
poor	O	ADJ	B
.	O	PUNCT	O


The	O	DET	O
results	O	NOUN	B
indicate	O	VERB	O
that	O	SCONJ	O
folate	O	NOUN	B
compounds	O	NOUN	I
decrease	O	VERB	B
formate	O	NOUN	B
accumulation	O	NOUN	B
after	O	ADP	O
methanol	O	NOUN	B
by	O	ADP	O
stimulating	O	VERB	O
formate	O	NOUN	B
oxidation	O	NOUN	I
or	O	CCONJ	O
utilization	O	NOUN	B
and	O	CCONJ	O
suggest	O	VERB	O
a	O	DET	O
possible	O	ADJ	O
use	O	NOUN	O
for	O	ADP	O
folates	O	NOUN	B
in	O	ADP	O
the	O	DET	O
treatment	O	NOUN	B
of	O	ADP	O
certain	O	ADJ	O
cases	O	NOUN	B
of	O	ADP	O
human	O	ADJ	B
methanol	O	NOUN	B
poisoning	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
"	O	PUNCT	O
cracked	O	VERB	B
-	O	PUNCT	O
tooth	O	NOUN	B
"	O	PUNCT	O
syndrome	O	NOUN	O
.	O	PUNCT	O


The	O	DET	O
foregoing	O	ADJ	O
results	O	NOUN	B
show	O	VERB	O
that	O	SCONJ	O
CXD	O	PROPN	B
has	O	AUX	O
high	O	ADJ	O
efficacy	O	NOUN	B
and	O	CCONJ	O
safety	O	NOUN	B
and	O	CCONJ	O
it	O	PRON	O
can	O	AUX	O
be	O	AUX	O
said	O	VERB	O
that	O	SCONJ	O
it	O	PRON	O
is	O	AUX	O
a	O	DET	O
drug	O	NOUN	B
required	O	VERB	O
in	O	ADP	O
the	O	DET	O
pediatric	O	ADJ	B
field	O	NOUN	I
.	O	PUNCT	O


Based	O	VERB	O
on	O	ADP	O
peptide	O	NOUN	B
map	O	NOUN	I
similarities	O	NOUN	B
,	O	PUNCT	O
partial	O	ADJ	B
amino	O	NOUN	B
-	O	PUNCT	O
terminal	O	ADJ	B
sequence	O	NOUN	B
data	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
common	O	ADJ	O
genetic	O	ADJ	B
origin	O	NOUN	I
,	O	PUNCT	O
it	O	PRON	O
is	O	AUX	O
suggested	O	VERB	O
that	O	SCONJ	O
p60	B-GENE	NOUN	B
and	O	CCONJ	O
p62	B-GENE	NOUN	B
have	O	AUX	O
identical	O	ADJ	B
amino	O	NOUN	B
acid	O	NOUN	I
sequences	O	NOUN	I
carboxy	O	NOUN	B
-	O	PUNCT	O
terminal	O	ADJ	B
to	O	PART	O
the	O	DET	O
p60	B-GENE	NOUN	B
initiator	O	NOUN	I
methionine	O	NOUN	I
(	O	PUNCT	O
residue	O	NOUN	B
21	O	NUM	O
of	O	ADP	O
p62	B-GENE	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Diagnosis	O	NOUN	B
of	O	ADP	O
phenylalanine	B-GENE	NOUN	B
hydroxylase	I-GENE	NOUN	I
deficiency	O	NOUN	I
(	O	PUNCT	O
phenylketonuria	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


The	O	DET	O
uncomplicated	O	ADJ	O
cases	O	NOUN	B
of	O	ADP	O
typhoid	O	NOUN	B
fever	O	NOUN	I
were	O	AUX	O
found	O	VERB	O
to	O	PART	O
have	O	AUX	O
an	O	DET	O
intact	O	ADJ	B
CMIR	O	NOUN	B
as	O	ADP	O
compared	O	VERB	O
to	O	PART	O
the	O	DET	O
complicated	O	ADJ	B
cases	O	NOUN	B
.	O	PUNCT	O


There	O	PRON	O
was	O	AUX	O
a	O	DET	O
significant	O	ADJ	O
correlation	O	NOUN	B
between	O	ADP	O
tubular	O	ADJ	B
diameter	O	NOUN	B
and	O	CCONJ	O
spg	O	NOUN	B
(	O	PUNCT	O
r	O	NOUN	O
=	O	ADJ	O
0	O	NUM	O
.	O	PUNCT	O
68	O	NUM	O
,	O	PUNCT	O
P	O	NOUN	O
less	O	ADJ	O
than	O	ADP	O
0	O	NUM	O
.	O	PUNCT	O
001	O	NUM	O
)	O	PUNCT	O
suggesting	O	VERB	O
that	O	SCONJ	O
tubular	O	ADJ	B
diameter	O	NOUN	I
measurements	O	NOUN	I
in	O	ADP	O
histological	O	ADJ	B
sections	O	NOUN	I
could	O	AUX	O
be	O	AUX	O
used	O	VERB	O
to	O	PART	O
predict	O	VERB	O
sperm	O	NOUN	B
production	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
differential	O	ADJ	O
investigation	O	NOUN	B
of	O	ADP	O
lipoproteins	O	NOUN	B
,	O	PUNCT	O
however	O	ADV	O
,	O	PUNCT	O
showed	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
high	B-GENE	ADJ	B
-	I-GENE	PUNCT	O
density	I-GENE	NOUN	B
lipoprotein	I-GENE	NOUN	I
(	O	PUNCT	I
HDL	B-GENE	NOUN	O
)	O	PUNCT	O
fractions	O	NOUN	B
are	O	AUX	O
absolutely	O	ADV	O
or	O	CCONJ	O
relatively	O	ADV	O
decreased	O	VERB	B
with	O	ADP	O
respect	O	NOUN	O
to	O	PART	O
low	B-GENE	ADJ	B
-	I-GENE	PUNCT	O
density	I-GENE	NOUN	B
lipoproteins	I-GENE	NOUN	I
(	O	PUNCT	O
LDL	B-GENE	NOUN	B
)	O	PUNCT	O
in	O	ADP	O
cerebral	O	ADJ	B
infarcts	O	NOUN	I
and	O	CCONJ	O
in	O	ADP	O
transient	O	ADJ	B
ischaemic	O	ADJ	O
attacks	O	NOUN	O
.	O	PUNCT	O


A	O	DET	O
note	O	NOUN	O
on	O	ADP	O
some	O	DET	O
consequences	O	NOUN	B
of	O	ADP	I
UV	O	NOUN	B
vision	O	NOUN	B
in	O	ADP	O
birds	O	NOUN	B
.	O	PUNCT	O


Parasitological	O	ADJ	B
and	O	CCONJ	O
pathological	O	ADJ	B
findings	O	NOUN	B
in	O	ADP	O
capuchin	O	NOUN	B
monkeys	O	NOUN	I
infected	O	VERB	B
with	O	ADP	O
Schistosoma	O	X	B
japonicum	O	PROPN	I
or	O	CCONJ	O
Schistosoma	O	X	B
mansoni	O	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
the	O	DET	O
past	O	NOUN	O
,	O	PUNCT	O
immunology	O	NOUN	B
in	O	ADP	O
Singapore	O	PROPN	B
was	O	AUX	O
mainly	O	ADV	O
confined	O	VERB	O
to	O	PART	O
serology	O	VERB	B
for	O	ADP	O
the	O	DET	O
diagnosis	O	NOUN	B
of	O	ADP	O
certain	O	ADJ	O
infectious	O	ADJ	B
diseases	O	NOUN	I
.	O	PUNCT	O


Modification	O	NOUN	B
of	O	ADP	O
enteral	O	ADJ	B
resorption	O	NOUN	I
by	O	ADP	O
cytostatic	O	ADJ	B
therapy	O	NOUN	I


In	O	X	B
vitro	O	X	I
penetration	O	NOUN	B
tests	O	NOUN	O
of	O	ADP	O
human	O	ADJ	B
sperm	O	NOUN	B
into	O	ADP	O
cervical	O	ADJ	B
mucus	O	NOUN	I
were	O	AUX	O
introduced	O	VERB	O
in	O	ADP	O
order	O	NOUN	O
to	O	PART	O
study	O	VERB	B
the	O	DET	O
interaction	O	NOUN	B
between	O	ADP	O
sperm	O	NOUN	B
and	O	CCONJ	O
cervical	O	ADJ	B
mucus	O	NOUN	I
.	O	PUNCT	O


Vibrio	O	PROPN	B
fluvialis	O	X	I
(	O	PUNCT	O
group	O	NOUN	B
F	O	NOUN	I
vibrio	O	NOUN	I
)	O	PUNCT	O
in	O	ADP	O
Maharashtra	O	PROPN	B
.	O	PUNCT	O


The	O	DET	O
hormonal	O	ADJ	B
response	O	NOUN	I
to	O	PART	O
a	O	DET	O
standardized	O	ADJ	B
bicycle	O	NOUN	I
exercise	O	NOUN	I
test	O	NOUN	I
was	O	AUX	O
studied	O	VERB	O
in	O	ADP	O
11	O	NUM	O
male	O	NOUN	B
cadets	O	NOUN	B
exposed	O	VERB	B
to	O	ADP	O
a	O	DET	O
course	O	NOUN	B
of	O	ADP	O
107	O	NUM	O
h	O	NOUN	O
of	O	ADP	O
continuous	O	ADJ	B
activity	O	NOUN	B
with	O	ADP	O
less	O	ADJ	O
than	O	ADP	O
2	O	NUM	O
h	O	NOUN	O
sleep	O	NOUN	B
.	O	PUNCT	O


At	O	ADP	O
an	O	DET	O
ambient	O	ADJ	B
temperature	O	NOUN	B
of	O	ADP	O
25	O	NUM	O
degrees	O	NOUN	B
C	O	NOUN	I
,	O	PUNCT	O
the	O	DET	O
responses	O	NOUN	B
to	O	PART	O
spinal	O	ADJ	B
cooling	O	NOUN	B
are	O	AUX	O
reduced	O	VERB	B
during	O	ADP	O
the	O	DET	O
dark	O	ADJ	B
phase	O	NOUN	I
.	O	PUNCT	O


Ulcer	O	NOUN	B
appeared	O	VERB	O
on	O	ADP	O
the	O	DET	O
angulus	O	NOUN	B
of	O	ADP	O
the	O	DET	O
stomach	O	NOUN	B
at	O	ADP	O
the	O	DET	O
28th	O	ADJ	O
week	O	NOUN	B
and	O	CCONJ	O
resulted	O	VERB	O
in	O	ADP	O
ulcer	O	NOUN	B
scar	O	NOUN	I
at	O	ADP	O
the	O	DET	O
42nd	O	ADJ	O
week	O	NOUN	B
.	O	PUNCT	O


Results	O	NOUN	B
of	O	ADP	O
the	O	DET	O
recognition	O	NOUN	B
task	O	NOUN	I
revealed	O	VERB	O
significant	O	ADJ	O
effects	O	NOUN	B
of	O	ADP	O
consonant	O	ADJ	B
voicing	O	NOUN	B
,	O	PUNCT	O
position	O	NOUN	B
and	O	CCONJ	O
vowel	O	NOUN	B
context	O	NOUN	I
on	O	ADP	O
syllable	O	ADJ	B
recognition	O	NOUN	I
.	O	PUNCT	O


Visual	O	ADJ	B
response	O	NOUN	I
properties	O	NOUN	B
of	O	ADP	O
neurons	O	NOUN	B
in	O	ADP	O
four	O	NUM	O
extrastriate	O	ADJ	B
visual	O	ADJ	B
areas	O	NOUN	I
of	O	ADP	O
the	O	DET	O
owl	O	ADJ	B
monkey	O	NOUN	I
(	O	PUNCT	O
Aotus	O	NOUN	B
trivirgatus	O	NOUN	I
)	O	PUNCT	O
:	O	PUNCT	O
a	O	DET	O
quantitative	O	ADJ	B
comparison	O	NOUN	B
of	O	ADP	O
medial	O	ADJ	B
,	O	PUNCT	O
dorsomedial	O	ADJ	B
,	O	PUNCT	O
dorsolateral	O	ADJ	B
,	O	PUNCT	O
and	O	CCONJ	O
middle	O	ADJ	B
temporal	O	ADJ	I
areas	O	NOUN	I
.	O	PUNCT	O


A	O	DET	O
unified	O	ADJ	O
approach	O	NOUN	O
to	O	ADP	O
the	O	DET	O
standardization	O	NOUN	B
of	O	ADP	O
allergens	O	NOUN	B
.	O	PUNCT	O


A	O	DET	O
dose	O	NOUN	B
-	O	PUNCT	O
dependent	O	ADJ	B
fall	O	NOUN	B
in	O	ADP	O
GABA	O	NOUN	B
content	O	NOUN	B
was	O	AUX	O
observed	O	VERB	O
;	O	PUNCT	O
GABA	O	NOUN	B
decrease	O	NOUN	B
was	O	AUX	O
evident	O	ADJ	O
15	O	NUM	O
min	O	NOUN	O
after	O	ADP	O
the	O	DET	O
administration	O	NOUN	B
,	O	PUNCT	O
reached	O	VERB	O
its	O	PRON	O
nadir	O	NOUN	B
at	O	ADP	O
60	O	NUM	O
min	O	NOUN	O
and	O	CCONJ	O
disappeared	O	VERB	O
at	O	ADP	O
120	O	NUM	O
minutes	O	NOUN	B
.	O	PUNCT	O


For	O	ADP	O
monocytes	O	NOUN	B
,	O	PUNCT	O
as	O	ADP	O
measured	O	VERB	B
on	O	ADP	O
the	O	DET	O
Hematrak	O	PROPN	B
,	O	PUNCT	O
it	O	PRON	O
was	O	AUX	O
13	O	NUM	O
.	O	PUNCT	O
4	O	NUM	O
%	O	NOUN	O
.	O	PUNCT	O


Evoked	O	VERB	B
potential	O	ADJ	B
and	O	CCONJ	O
single	O	ADJ	O
unit	O	NOUN	O
responses	O	NOUN	B
to	O	PART	O
olfactory	O	ADJ	B
nerve	O	NOUN	I
volleys	O	NOUN	B
in	O	ADP	O
the	O	DET	O
isolated	O	VERB	B
turtle	O	NOUN	B
olfactory	O	ADJ	B
bulb	O	NOUN	I
.	O	PUNCT	O


While	O	SCONJ	O
all	O	DET	O
deletions	O	NOUN	B
within	O	ADP	O
the	O	DET	O
sequence	O	NOUN	B
coding	O	VERB	I
for	O	ADP	O
the	O	DET	O
mature	O	ADJ	B
tRNA	O	NOUN	B
led	O	VERB	O
to	O	ADP	O
inactivity	O	NOUN	B
of	O	ADP	O
the	O	DET	O
mutated	O	VERB	B
genes	O	NOUN	I
,	O	PUNCT	O
substitution	O	NOUN	B
of	O	ADP	O
the	O	DET	O
central	O	ADJ	B
portion	O	NOUN	I
by	O	ADP	O
concatenated	B-GENE	VERB	B
Hind	I-GENE	NOUN	B
III	I-GENE	NUM	I
linkers	I-GENE	NOUN	I
produced	O	VERB	O
gene	O	NOUN	B
units	O	NOUN	I
active	O	ADJ	B
in	O	ADP	O
transcription	O	NOUN	B
.	O	PUNCT	O


Survival	O	NOUN	B
was	O	AUX	O
calculated	O	VERB	O
both	O	CCONJ	O
from	O	ADP	O
the	O	DET	O
date	O	NOUN	O
of	O	ADP	O
onset	O	NOUN	B
and	O	CCONJ	O
from	O	ADP	O
the	O	DET	O
date	O	NOUN	B
of	O	ADP	O
diagnosis	O	NOUN	B
.	O	PUNCT	O


With	O	ADP	O
Sair	O	PROPN	B
and	O	CCONJ	O
So2	O	PROPN	B
,	O	PUNCT	O
mean	O	VERB	O
vital	O	ADJ	O
capacity	O	NOUN	O
was	O	AUX	O
reduced	O	VERB	B
by	O	ADP	O
44	O	NUM	O
%	O	NOUN	O
from	O	ADP	O
control	O	NOUN	B
.	O	PUNCT	O


Of	O	ADP	O
the	O	DET	O
117	O	NUM	O
patients	O	NOUN	B
(	O	PUNCT	O
out	O	ADP	O
of	O	ADP	O
the	O	DET	O
136	O	NUM	O
)	O	PUNCT	O
with	O	ADP	O
serologic	O	ADJ	B
evidence	O	NOUN	B
of	O	ADP	O
chronic	O	ADJ	B
thyroiditis	O	NOUN	I
who	O	PRON	O
could	O	AUX	O
be	O	AUX	O
studied	O	VERB	O
,	O	PUNCT	O
eight	O	NUM	O
(	O	PUNCT	O
7	O	NUM	O
%	O	NOUN	O
)	O	PUNCT	O
had	O	AUX	O
hyperthyroidism	O	NOUN	B
and	O	CCONJ	O
45	O	NUM	O
(	O	PUNCT	O
38	O	NUM	O
%	O	NOUN	O
)	O	PUNCT	O
were	O	AUX	O
hypothyroid	O	ADJ	B
.	O	PUNCT	O


The	O	DET	O
new	O	ADJ	O
semi	O	ADJ	B
-	O	PUNCT	O
synthetic	O	ADJ	B
oral	O	ADJ	O
cephalosporin	O	NOUN	B
,	O	PUNCT	O
CGP	O	NOUN	B
9	O	NUM	O
,	O	PUNCT	O
000	O	NUM	O
,	O	PUNCT	O
has	O	AUX	O
been	O	AUX	O
evaluated	O	VERB	B
in	O	ADP	O
a	O	DET	O
large	O	ADJ	O
number	O	NOUN	O
of	O	ADP	O
hospitalized	O	VERB	B
patients	O	NOUN	B
with	O	ADP	O
urinary	O	ADJ	B
infections	O	NOUN	I
.	O	PUNCT	O


Current	O	ADJ	O
status	O	NOUN	B
of	O	ADP	O
chemotherapy	O	NOUN	B
for	O	ADP	O
Hodgkin	O	NOUN	B
'	O	PART	I
s	O	NOUN	I
disease	O	NOUN	B


Over	O	ADP	O
a	O	DET	O
period	O	NOUN	B
of	O	ADP	O
15	O	NUM	O
days	O	NOUN	B
16	O	NUM	O
%	O	NOUN	O
of	O	ADP	O
the	O	DET	O
dose	O	NOUN	B
administered	O	VERB	B
was	O	AUX	O
excreted	O	VERB	B
with	O	ADP	O
faeces	O	NOUN	B
and	O	CCONJ	O
0	O	NUM	O
.	O	PUNCT	O
9	O	NUM	O
%	O	NOUN	O
in	O	ADP	O
the	O	DET	O
urine	O	NOUN	B
.	O	PUNCT	O


Electron	O	NOUN	B
microscopic	O	ADJ	I
picture	O	NOUN	I
of	O	ADP	O
the	O	DET	O
cerebral	O	ADJ	B
cortex	O	NOUN	I
in	O	ADP	O
rats	O	NOUN	B
cooled	O	VERB	B
to	O	ADP	O
22	O	NUM	O
degrees	O	NOUN	B
C	O	NOUN	I


Thirty	O	NUM	B
-	O	PUNCT	O
one	O	NUM	O
age	O	NOUN	B
-	O	PUNCT	O
matched	O	VERB	B
,	O	PUNCT	O
conscious	O	ADJ	B
,	O	PUNCT	O
virgin	O	ADJ	B
,	O	PUNCT	O
male	O	ADJ	B
Sprague	O	PROPN	B
-	O	PUNCT	O
Dawley	O	PROPN	B
rats	O	NOUN	B
and	O	CCONJ	O
spontaneously	O	ADV	B
hypertensive	O	ADJ	I
rats	O	NOUN	B
(	O	PUNCT	O
SHRs	O	NOUN	B
)	O	PUNCT	O
were	O	AUX	O
individually	O	ADV	O
injected	O	VERB	B
with	O	ADP	O
a	O	DET	O
single	O	ADJ	O
subcutaneous	O	ADJ	B
dose	O	NOUN	I
of	O	ADP	O
85	O	NUM	O
mg	O	NOUN	O
/	O	SYM	O
kg	O	NOUN	B
dl	O	PROPN	O
-	O	PUNCT	O
isoproterenol	O	NOUN	B
to	O	PART	O
determine	O	VERB	O
the	O	DET	O
degree	O	NOUN	B
and	O	CCONJ	O
time	O	NOUN	B
course	O	NOUN	I
of	O	ADP	O
drug	O	NOUN	B
-	O	PUNCT	O
induced	O	VERB	B
cardiac	O	ADJ	B
failure	O	NOUN	I
and	O	CCONJ	O
functional	O	ADJ	B
recovery	O	NOUN	I
.	O	PUNCT	O


Prevention	O	NOUN	B
of	O	ADP	O
transfusion	O	NOUN	B
reactions	O	NOUN	I
by	O	ADP	O
the	O	DET	O
use	O	NOUN	O
of	O	ADP	O
saline	O	NOUN	B
washed	O	VERB	O
red	O	ADJ	B
blood	O	NOUN	I
cells	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
geometric	O	ADJ	B
mean	O	NOUN	O
hemagglutination	O	NOUN	B
-	O	PUNCT	O
inhibition	O	NOUN	B
antibody	O	NOUN	O
titers	O	NOUN	B
(	O	PUNCT	O
GMT	O	NOUN	B
)	O	PUNCT	O
of	O	ADP	O
non	O	ADV	B
-	O	PUNCT	O
immunized	O	VERB	B
,	O	PUNCT	O
once	O	ADV	B
-	O	PUNCT	O
immunized	O	VERB	B
,	O	PUNCT	O
and	O	CCONJ	O
twice	O	ADV	B
-	O	PUNCT	O
immunized	O	VERB	B
chickens	O	NOUN	B
were	O	AUX	O
compared	O	VERB	B
at	O	ADP	O
2	O	NUM	O
-	O	PUNCT	O
week	O	NOUN	B
intervals	O	NOUN	B
following	O	VERB	O
primary	O	ADJ	B
immunization	O	NOUN	I
,	O	PUNCT	O
secondary	O	ADJ	B
immunization	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
challenge	O	NOUN	O
.	O	PUNCT	O


100	O	NUM	O
more	O	ADJ	O
than	O	ADP	O
in	O	ADP	O
the	O	DET	O
summer	O	NOUN	B
coat	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Two	O	NUM	O
new	O	ADJ	O
artifacts	O	NOUN	B
in	O	ADP	O
automated	O	VERB	B
coagulation	O	NOUN	I
testing	O	NOUN	I
.	O	PUNCT	O


This	O	DET	O
relatively	O	ADV	O
simple	O	ADJ	O
and	O	CCONJ	O
easily	O	ADV	O
performed	O	VERB	O
technique	O	NOUN	B
of	O	ADP	O
measuring	O	VERB	B
deep	O	ADJ	B
muscle	O	NOUN	I
temperature	O	NOUN	B
appears	O	VERB	O
to	O	PART	O
be	O	AUX	O
a	O	DET	O
useful	O	ADJ	O
adjunct	O	NOUN	B
in	O	ADP	O
choosing	O	VERB	O
the	O	DET	O
amputation	O	NOUN	B
level	O	NOUN	B
.	O	PUNCT	O


Changes	O	NOUN	B
in	O	ADP	O
immunologic	O	ADJ	B
reactivity	O	NOUN	I
in	O	ADP	O
subjects	O	NOUN	B
receiving	O	VERB	O
transfer	B-GENE	NOUN	B
factor	I-GENE	NOUN	I
could	O	AUX	O
not	O	PART	O
be	O	AUX	O
distinguished	O	VERB	O
from	O	ADP	O
those	O	DET	O
in	O	ADP	O
subjects	O	NOUN	B
receiving	O	VERB	O
placebo	O	NOUN	B
.	O	PUNCT	O


Charcoal	O	NOUN	B
-	O	PUNCT	O
facilitated	O	VERB	B
dialysis	O	NOUN	B
.	O	PUNCT	O


Retinal	O	ADJ	B
changes	O	NOUN	B
in	O	ADP	O
pigmentary	O	ADJ	B
retinopathy	O	NOUN	I
in	O	ADP	O
children	O	NOUN	B


As	O	ADP	O
a	O	DET	O
result	O	NOUN	B
,	O	PUNCT	O
beta	O	NOUN	B
-	O	PUNCT	O
apo	O	NOUN	B
-	O	PUNCT	O
8	O	NUM	O
'	O	PUNCT	O
-	O	PUNCT	O
carotenoic	O	ADJ	B
acid	O	NOUN	I
ethyl	O	NOUN	I
ester	O	NOUN	I
(	O	PUNCT	O
apo	O	NOUN	B
-	O	PUNCT	O
EE	O	NOUN	B
)	O	PUNCT	O
was	O	AUX	O
used	O	VERB	O
as	O	ADP	O
a	O	DET	O
reference	O	NOUN	O
standard	O	NOUN	O
in	O	ADP	O
Experiments	O	NOUN	B
4	O	NUM	O
to	O	PART	O
6	O	NUM	O
.	O	PUNCT	O


Six	O	NUM	B
hours	O	NOUN	I
after	O	ADP	O
the	O	DET	O
last	O	ADJ	O
administration	O	NOUN	B
,	O	PUNCT	O
uterus	O	NOUN	B
of	O	ADP	O
Gf	O	NOUN	B
and	O	CCONJ	O
Cv	O	NOUN	B
mice	O	NOUN	I
were	O	AUX	O
weight	O	NOUN	O
337	O	NUM	O
.	O	PUNCT	O
6	O	NUM	O
mg	O	NOUN	O
%	O	NOUN	O
and	O	CCONJ	O
423	O	NUM	O
.	O	PUNCT	O
5	O	NUM	O
mg	O	NOUN	O
%	O	NOUN	O
respectively	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
difference	O	NOUN	B
was	O	AUX	O
statistically	O	ADV	B
significant	O	ADJ	I
(	O	PUNCT	O
p	O	NOUN	O
less	O	ADJ	O
than	O	ADP	O
0	O	NUM	O
.	O	PUNCT	O
01	O	NUM	O
)	O	PUNCT	O
.	O	PUNCT	O


Analysis	O	NOUN	B
of	O	ADP	O
an	O	DET	O
autopsy	O	NOUN	B
population	O	NOUN	B
.	O	PUNCT	O


Autoradiographic	O	ADJ	B
localisation	O	NOUN	B
of	O	ADP	O
its	O	PRON	O
cellular	O	ADJ	B
distribution	O	NOUN	I
in	O	ADP	O
the	O	DET	O
kidney	O	NOUN	B
.	O	PUNCT	O


Microscopic	O	ADJ	B
anatomy	O	NOUN	B
and	O	CCONJ	O
cell	O	NOUN	B
population	O	NOUN	I
dynamics	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
11	O	NUM	O
patients	O	NOUN	B
with	O	ADP	O
Horton	O	NOUN	B
'	O	PART	I
s	O	NOUN	I
headache	O	NOUN	B
morphological	O	ADJ	B
investigations	O	NOUN	B
(	O	PUNCT	O
differential	O	ADJ	B
white	O	ADJ	I
blood	O	NOUN	I
cell	O	NOUN	I
count	O	NOUN	I
)	O	PUNCT	O
,	O	PUNCT	O
cytoenzymatic	O	ADJ	B
determinations	O	NOUN	I
(	O	PUNCT	O
alkaline	B-GENE	NOUN	B
and	I-GENE	CCONJ	O
acid	I-GENE	NOUN	B
phosphatase	I-GENE	NOUN	I
,	O	PUNCT	O
non	B-GENE	ADJ	B
-	I-GENE	PUNCT	O
specific	I-GENE	ADJ	B
esterase	I-GENE	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
cytoimmunological	O	ADJ	B
tests	O	NOUN	I
(	O	PUNCT	O
IgM	B-GENE	NOUN	B
and	O	CCONJ	O
IgG	B-GENE	NOUN	B
binding	O	NOUN	O
)	O	PUNCT	O
were	O	AUX	O
carried	O	VERB	O
out	O	ADP	O
on	O	ADP	O
capillary	O	ADJ	B
blood	O	NOUN	I
neutrophils	O	NOUN	I
obtained	O	VERB	O
from	O	ADP	O
the	O	DET	O
area	O	NOUN	B
of	O	ADP	I
pain	O	NOUN	B
,	O	PUNCT	O
non	O	ADJ	B
-	O	PUNCT	O
painful	O	ADJ	B
area	O	NOUN	B
of	O	ADP	I
the	O	DET	O
skin	O	NOUN	B
on	O	ADP	O
the	O	DET	O
head	O	NOUN	B
on	O	ADP	O
the	O	DET	O
contralateral	O	ADJ	B
side	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
from	O	ADP	O
the	O	DET	O
finger	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
resulting	O	VERB	O
R	B-GENE	NOUN	B
protein	I-GENE	NOUN	I
terminates	O	VERB	O
five	O	NUM	O
codons	O	NOUN	B
downstream	O	ADJ	B
of	O	ADP	O
the	O	DET	O
frameshift	O	NOUN	B
site	O	NOUN	I
at	O	ADP	O
the	O	DET	O
V	B-GENE	NOUN	B
protein	I-GENE	NOUN	I
stop	O	VERB	I
codon	O	NOUN	B
.	O	PUNCT	O


BSE	O	PROPN	B
and	O	CCONJ	O
farmworkers	O	NOUN	B
.	O	PUNCT	O


Peroxisome	B-GENE	NOUN	B
proliferator	I-GENE	NOUN	I
-	I-GENE	PUNCT	O
activated	I-GENE	VERB	B
receptors	I-GENE	NOUN	I
(	O	PUNCT	O
PPARs	B-GENE	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
retinoid	B-GENE	NOUN	B
X	I-GENE	NOUN	I
receptors	I-GENE	NOUN	I
(	O	PUNCT	O
RXRs	B-GENE	NOUN	B
)	O	PUNCT	O
are	O	AUX	O
nuclear	B-GENE	ADJ	B
hormone	I-GENE	NOUN	I
receptors	I-GENE	NOUN	I
that	O	PRON	O
are	O	AUX	O
activated	O	VERB	B
by	O	ADP	O
fatty	O	ADJ	B
acids	O	NOUN	I
and	O	CCONJ	O
9	O	NUM	B
-	O	PUNCT	O
cis	O	NOUN	B
-	O	PUNCT	O
retinoic	O	ADJ	B
acid	O	NOUN	I
,	O	PUNCT	O
respectively	O	ADV	O
.	O	PUNCT	O


The	O	DET	O
number	O	NOUN	O
of	O	ADP	O
lactotropes	O	NOUN	B
,	O	PUNCT	O
somatotropes	O	NOUN	B
,	O	PUNCT	O
thyrotropes	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
gonadotropes	O	NOUN	B
was	O	AUX	O
not	O	PART	O
altered	O	VERB	O
compared	O	VERB	B
with	O	ADP	O
controls	O	NOUN	B
,	O	PUNCT	O
indicating	O	VERB	O
that	O	SCONJ	O
in	O	ADP	O
the	O	DET	O
adult	O	ADJ	B
pituitary	O	NOUN	B
,	O	PUNCT	O
POMC	B-GENE	NOUN	B
products	I-GENE	NOUN	B
are	O	AUX	O
not	O	PART	O
required	O	VERB	O
to	O	PART	O
maintain	O	VERB	O
the	O	DET	O
distribution	O	NOUN	B
of	O	ADP	O
cell	O	NOUN	B
types	O	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
electrophoretic	O	ADJ	B
mobility	O	NOUN	I
shift	O	NOUN	I
assays	O	NOUN	I
,	O	PUNCT	O
the	O	DET	O
PERE	B-GENE	NOUN	B
formed	O	VERB	O
three	O	NUM	O
major	O	ADJ	O
complexes	O	NOUN	B
(	O	PUNCT	O
P1	O	NOUN	B
,	O	PUNCT	O
P2	O	NOUN	B
and	O	CCONJ	O
P3	O	NOUN	B
)	O	PUNCT	O
with	O	ADP	O
proteins	O	NOUN	B
in	O	ADP	O
nuclear	O	ADJ	B
extracts	O	NOUN	I
from	O	ADP	O
HeLa	O	NOUN	B
or	O	CCONJ	O
293	O	NUM	O
cells	O	NOUN	B
.	O	PUNCT	O


That	O	DET	O
sequence	O	NOUN	B
strongly	O	ADV	O
promoted	O	VERB	O
the	O	DET	O
transcription	O	NOUN	B
of	O	ADP	O
the	O	DET	O
promotorless	O	NOUN	B
chloramphenicol	B-GENE	NOUN	I
acetyltranferase	I-GENE	NOUN	I
(	O	PUNCT	O
CAT	B-GENE	NOUN	O
)	O	PUNCT	O
gene	O	NOUN	O
in	O	ADP	O
cells	O	NOUN	B
of	O	ADP	O
pancreatic	O	ADJ	B
origin	O	NOUN	I
(	O	PUNCT	O
AR	O	PROPN	B
-	O	PUNCT	O
42J	O	PROPN	B
)	O	PUNCT	O
but	O	CCONJ	O
not	O	PART	O
in	O	ADP	O
cells	O	NOUN	B
of	O	ADP	O
non	O	ADJ	B
-	O	PUNCT	O
pancreatic	O	ADJ	B
origin	O	NOUN	B
(	O	PUNCT	O
Rat	O	NOUN	B
2	O	NUM	I
and	O	CCONJ	O
IEC	O	NOUN	B
6	O	NUM	O
)	O	PUNCT	O
.	O	PUNCT	O


In	O	ADP	O
the	O	DET	O
absence	O	NOUN	B
of	O	ADP	O
E1A243	B-GENE	NOUN	B
,	O	PUNCT	O
YY1	B-GENE	NOUN	B
represses	O	VERB	B
CRE	O	NOUN	B
-	O	PUNCT	O
dependent	O	ADJ	B
transcription	O	NOUN	B
of	O	ADP	O
c	B-GENE	NOUN	O
-	I-GENE	PUNCT	O
fos	I-GENE	NOUN	B
by	O	ADP	O
physically	O	ADV	B
interacting	O	VERB	I
with	O	ADP	O
ATF	B-GENE	NOUN	B
/	O	SYM	O
CREB	B-GENE	NOUN	B
proteins	O	NOUN	B
bound	O	VERB	O
to	O	PART	O
the	O	DET	O
-	O	PUNCT	O
67	O	NUM	O
CRE	O	NOUN	B
.	O	PUNCT	O


TPBF	B-GENE	NOUN	B
has	O	AUX	O
two	O	NUM	O
potential	O	ADJ	B
coiled	O	VERB	B
-	O	PUNCT	O
coil	O	NOUN	B
regions	O	NOUN	B
,	O	PUNCT	O
a	O	DET	O
basic	O	ADJ	O
region	O	NOUN	O
,	O	PUNCT	O
a	O	DET	O
proline	O	NOUN	B
-	O	PUNCT	O
rich	O	ADJ	B
region	O	NOUN	I
,	O	PUNCT	O
a	O	DET	O
histidine	O	NOUN	B
-	O	PUNCT	O
rich	O	ADJ	B
N	O	NOUN	O
terminus	O	NOUN	O
,	O	PUNCT	O
and	O	CCONJ	O
a	O	DET	O
nuclear	O	ADJ	B
targeting	O	NOUN	I
sequence	O	NOUN	I
.	O	PUNCT	O


To	O	PART	O
confirm	O	VERB	O
the	O	DET	O
GapIII	B-GENE	NOUN	B
protein	I-GENE	NOUN	I
activity	O	NOUN	I
,	O	PUNCT	O
constructs	O	NOUN	B
containing	O	VERB	O
different	O	ADJ	O
GapIII	B-GENE	NOUN	B
-	O	PUNCT	O
GRD	B-GENE	NOUN	B
domains	O	NOUN	B
were	O	AUX	O
transformed	O	VERB	O
into	O	ADP	O
iral	B-GENE	ADJ	B
mutant	O	ADJ	B
yeast	O	NOUN	O
to	O	PART	O
determine	O	VERB	O
their	O	PRON	O
relative	O	ADJ	O
ability	O	NOUN	O
to	O	PART	O
replace	O	VERB	O
IRA1	B-GENE	NOUN	B
functionally	O	ADV	B
.	O	PUNCT	O


A	O	DET	O
water	O	NOUN	B
-	O	PUNCT	O
vapour	O	NOUN	B
giga	O	NOUN	B
-	O	PUNCT	O
maser	O	NOUN	B
in	O	ADP	O
the	O	DET	O
active	O	ADJ	B
galaxy	O	NOUN	I
TXFS2226	O	NOUN	B
-	O	PUNCT	O
184	O	NUM	O
.	O	PUNCT	O


These	O	DET	O
incisors	O	NOUN	B
were	O	AUX	O
studied	O	VERB	O
by	O	ADP	O
scanning	O	VERB	B
electron	O	NOUN	I
microscopy	O	NOUN	I
-	O	PUNCT	O
energy	O	NOUN	B
dispersive	O	ADJ	I
spectroscopy	O	NOUN	I
analysis	O	NOUN	I
(	O	PUNCT	O
SEM	O	PROPN	B
-	O	PUNCT	O
EDS	O	PROPN	B
)	O	PUNCT	O
and	O	CCONJ	O
light	O	ADJ	B
microscopy	O	NOUN	I
to	O	PART	O
examine	O	VERB	O
the	O	DET	O
calciotraumatic	O	ADJ	B
lines	O	NOUN	I
of	O	ADP	O
strontium	O	NOUN	B
in	O	ADP	O
the	O	DET	O
rat	O	NOUN	B
incisor	O	NOUN	B
labial	O	ADJ	O
dentin	O	NOUN	O
.	O	PUNCT	O


Mechanism	O	NOUN	B
of	O	ADP	O
enhancement	O	NOUN	B
of	O	ADP	O
DNA	O	NOUN	B
expression	O	NOUN	I
consequent	O	ADJ	O
to	O	PART	O
cointernalization	O	NOUN	B
of	O	ADP	O
a	O	DET	O
replication	O	NOUN	B
-	O	PUNCT	O
deficient	O	ADJ	B
adenovirus	O	NOUN	B
and	O	CCONJ	O
unmodified	O	ADJ	O
plasmid	O	NOUN	B
DNA	O	NOUN	B
.	O	PUNCT	O


Hepatitis	B-GENE	NOUN	B
B	I-GENE	NOUN	I
surface	I-GENE	NOUN	I
antigen	I-GENE	NOUN	I
was	O	AUX	O
detected	O	VERB	B
in	O	ADP	O
2	O	NUM	O
patients	O	NOUN	B
,	O	PUNCT	O
with	O	ADP	O
negative	O	ADJ	B
hepatitis	B-GENE	NOUN	B
C	I-GENE	NOUN	I
virus	I-GENE	NOUN	I
antibody	I-GENE	NOUN	I
.	O	PUNCT	O


Liver	O	NOUN	B
transplantation	O	NOUN	I
in	O	ADP	O
one	O	NUM	O
patient	O	NOUN	B
resolved	O	VERB	B
metabolic	O	ADJ	B
complications	O	NOUN	B
but	O	CCONJ	O
did	O	AUX	O
not	O	PART	O
improve	O	VERB	O
PMN	O	NOUN	B
count	O	NOUN	O
or	O	CCONJ	O
the	O	DET	O
infectious	O	ADJ	B
status	O	NOUN	I
,	O	PUNCT	O
while	O	SCONJ	O
neutropenia	O	NOUN	B
was	O	AUX	O
corrected	O	VERB	O
by	O	ADP	O
G	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
CSF	I-GENE	PROPN	B
.	O	PUNCT	O


Joys	O	NOUN	B
and	O	CCONJ	O
F	O	PROPN	B
.	O	PUNCT	O


Tyrosine	O	NOUN	B
phosphorylation	O	NOUN	B
of	O	ADP	O
cellular	O	ADJ	B
proteins	O	NOUN	I
is	O	AUX	O
the	O	DET	O
earliest	O	ADV	O
identifiable	O	ADJ	O
event	O	NOUN	B
following	O	VERB	O
T	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
cell	I-GENE	NOUN	B
antigen	I-GENE	NOUN	I
receptor	I-GENE	NOUN	I
(	O	PUNCT	O
TCR	B-GENE	NOUN	B
)	O	PUNCT	O
stimulation	O	NOUN	B
and	O	CCONJ	O
is	O	AUX	O
essential	O	ADJ	O
for	O	ADP	O
activating	O	VERB	B
downstream	O	ADJ	B
signaling	O	NOUN	O
machinery	O	NOUN	O
.	O	PUNCT	O


The	O	DET	O
interferon	B-GENE	NOUN	B
-	O	PUNCT	O
induced	O	VERB	B
RNA	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
dependent	I-GENE	ADJ	B
protein	I-GENE	NOUN	B
kinase	I-GENE	NOUN	I
(	O	PUNCT	O
PKR	B-GENE	NOUN	B
)	O	PUNCT	O
is	O	AUX	O
considered	O	VERB	O
to	O	PART	O
play	O	VERB	O
an	O	DET	O
important	O	ADJ	O
role	O	NOUN	O
in	O	ADP	O
the	O	DET	O
cellular	O	ADJ	B
defense	O	NOUN	I
against	O	ADP	O
viral	O	ADJ	B
infection	O	NOUN	I
and	O	CCONJ	O
,	O	PUNCT	O
in	O	ADP	O
addition	O	NOUN	O
,	O	PUNCT	O
has	O	AUX	O
been	O	AUX	O
suggested	O	VERB	O
to	O	PART	O
be	O	AUX	O
a	O	DET	O
tumor	O	NOUN	B
suppressor	O	NOUN	I
gene	O	NOUN	I
because	O	SCONJ	O
of	O	ADP	O
its	O	PRON	O
growth	O	NOUN	B
-	O	PUNCT	O
suppressive	O	ADJ	B
properties	O	NOUN	B
.	O	PUNCT	O


Moreover	O	ADV	O
,	O	PUNCT	O
Lck	B-GENE	NOUN	B
was	O	AUX	O
reversibly	O	ADV	O
co	O	ADV	B
-	O	PUNCT	O
immunoprecipitated	O	VERB	B
with	O	ADP	O
p95Vav	B-GENE	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
the	O	DET	O
stoichiometry	O	NOUN	B
of	O	ADP	O
binding	O	NOUN	B
increased	O	VERB	B
in	O	ADP	O
anti	B-GENE	ADJ	B
-	I-GENE	PUNCT	O
CD3	I-GENE	NOUN	B
-	O	PUNCT	O
treated	O	VERB	B
Jurkat	O	NOUN	B
cells	O	NOUN	I
.	O	PUNCT	O


Interleukin	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
8	I-GENE	NUM	O
(	O	PUNCT	O
IL	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
8	I-GENE	NUM	O
)	O	PUNCT	O
is	O	AUX	O
a	O	DET	O
potent	O	ADJ	O
inflammatory	O	ADJ	B
mediator	O	NOUN	O
that	O	PRON	O
belongs	O	VERB	O
to	O	PART	O
the	O	DET	O
family	O	NOUN	B
of	O	ADP	O
C	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
X	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
C	I-GENE	NOUN	B
chemokines	I-GENE	NOUN	B
.	O	PUNCT	O


Three	O	NUM	O
mutants	O	NOUN	B
(	O	PUNCT	O
pms1	B-GENE	NOUN	B
,	O	PUNCT	O
pms2	B-GENE	NOUN	B
and	O	CCONJ	O
pms3	B-GENE	NOUN	B
)	O	PUNCT	O
isolated	O	VERB	B
earlier	O	ADV	O
from	O	ADP	O
MW104	O	PROPN	B
-	O	PUNCT	O
1B	O	PROPN	B
were	O	AUX	O
shown	O	VERB	O
to	O	PART	O
correct	O	VERB	O
in	O	X	B
vitro	O	X	I
constructed	O	VERB	B
plasmids	O	NOUN	B
with	O	ADP	O
defined	O	VERB	O
DNA	O	NOUN	B
mismatches	O	NOUN	I
(	O	PUNCT	O
G	O	NOUN	B
/	O	SYM	O
T	O	NOUN	B
,	O	PUNCT	O
A	O	DET	B
/	O	SYM	O
C	O	NOUN	B
,	O	PUNCT	O
G	O	NOUN	B
/	O	PUNCT	O
G	O	NOUN	B
,	O	PUNCT	O
etc	O	X	O
.	O	PUNCT	O
)	O	PUNCT	O
poorly	O	ADV	O
(	O	PUNCT	O
Kramer	O	PROPN	O
et	O	X	O
al	O	X	O
.	O	PUNCT	O
,	O	PUNCT	O
1989a	O	NUM	O
)	O	PUNCT	O
.	O	PUNCT	O


Hematopoietic	B-GENE	ADJ	B
growth	I-GENE	NOUN	I
factors	I-GENE	NOUN	I
are	O	AUX	O
being	O	AUX	O
used	O	VERB	O
to	O	PART	O
accelerate	O	VERB	B
the	O	DET	O
recovery	O	NOUN	B
of	O	ADP	O
myelopoiesis	O	NOUN	B
following	O	VERB	O
high	O	ADJ	B
-	O	PUNCT	O
dose	O	NOUN	B
chemotherapy	O	NOUN	B
in	O	ADP	O
cancer	O	NOUN	B
patients	O	NOUN	I
.	O	PUNCT	O


A	O	DET	O
particularly	O	ADV	O
striking	O	ADJ	O
HpaII	B-GENE	NOUN	B
tiny	O	ADJ	O
fragment	O	NOUN	O
island	O	NOUN	O
,	O	PUNCT	O
extending	O	VERB	O
over	O	ADP	O
nearly	O	ADV	O
2	O	NUM	O
,	O	PUNCT	O
000	O	NUM	O
base	O	NOUN	B
pairs	O	NOUN	I
,	O	PUNCT	O
surrounds	O	VERB	O
the	O	DET	O
USF2	B-GENE	NOUN	B
translation	I-GENE	NOUN	O
initiation	I-GENE	NOUN	O
site	I-GENE	NOUN	O
.	O	PUNCT	O


Dilutions	O	NOUN	B
of	O	ADP	O
H	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
2b	I-GENE	NOUN	B
or	I-GENE	CCONJ	O
H	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
2d	I-GENE	NOUN	B
NP	I-GENE	PROPN	B
peptides	I-GENE	NOUN	B
indicated	O	VERB	O
that	O	SCONJ	O
3	O	NUM	O
-	O	SYM	O
4	O	NUM	O
logs	O	VERB	O
less	O	ADJ	O
H	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
2b	I-GENE	NOUN	B
NP	I-GENE	NOUN	B
peptide	I-GENE	NOUN	B
was	O	AUX	O
required	O	VERB	O
to	O	PART	O
sensitize	O	VERB	B
syngeneic	O	ADJ	B
target	O	NOUN	I
cells	O	NOUN	I
for	O	ADP	O
CTL	O	NOUN	B
-	O	PUNCT	O
specific	O	ADJ	B
lysis	O	NOUN	B
,	O	PUNCT	O
suggesting	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
differing	O	VERB	O
affinities	O	NOUN	B
of	O	ADP	O
H	O	NOUN	B
-	O	PUNCT	O
2b	O	NOUN	B
and	O	CCONJ	O
H	O	NOUN	B
-	O	PUNCT	O
2d	O	NOUN	O
major	B-GENE	ADJ	O
histocompatibility	I-GENE	NOUN	O
complex	I-GENE	NOUN	O
molecules	I-GENE	NOUN	O
for	O	ADP	O
their	O	PRON	O
peptides	O	NOUN	B
likely	O	ADV	O
account	O	VERB	O
for	O	ADP	O
the	O	DET	O
total	O	ADJ	O
removal	O	NOUN	B
of	O	ADP	O
NP	O	NOUN	B
CTL	O	NOUN	B
in	O	ADP	O
the	O	DET	O
H	O	NOUN	B
-	O	PUNCT	O
2b	O	NOUN	B
mice	O	NOUN	B
but	O	CCONJ	O
only	O	ADV	O
partial	O	ADJ	B
removal	O	NOUN	B
in	O	ADP	O
H	O	NOUN	B
-	O	PUNCT	O
2d	O	NOUN	B
mice	O	NOUN	B
made	O	VERB	O
to	O	PART	O
express	O	VERB	O
thymic	O	ADJ	B
NP	O	PROPN	B
.	O	PUNCT	O


Although	O	SCONJ	O
both	O	DET	O
transfected	O	VERB	B
cell	O	NOUN	O
lines	O	NOUN	O
contain	O	VERB	O
FGF	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	B
cell	I-GENE	NOUN	I
surface	I-GENE	NOUN	O
receptors	I-GENE	NOUN	O
as	O	ADP	O
judged	O	VERB	O
by	O	ADP	O
crosslinking	O	NOUN	B
studies	O	NOUN	O
,	O	PUNCT	O
the	O	DET	O
wild	O	ADJ	B
-	O	PUNCT	O
type	O	NOUN	B
transfectants	O	NOUN	B
are	O	AUX	O
refractory	O	ADJ	B
to	O	PART	O
exogenous	O	ADJ	B
FGF	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	B
,	O	PUNCT	O
whereas	O	SCONJ	O
the	O	DET	O
mutant	O	ADJ	B
transfectants	O	NOUN	B
respond	O	VERB	O
normally	O	ADV	O
.	O	PUNCT	O
(	O	PUNCT	O
ABSTRACT	O	NOUN	B
TRUNCATED	O	VERB	I
AT	O	ADP	I
250	O	NUM	I
WORDS	O	NOUN	I
)	O	PUNCT	O


The	O	DET	O
median	O	ADJ	B
post	O	NOUN	B
-	O	PUNCT	O
treatment	O	NOUN	B
,	O	PUNCT	O
pre	O	ADJ	B
-	O	PUNCT	O
operative	O	ADJ	B
serum	B-GENE	NOUN	O
PSA	I-GENE	NOUN	O
was	O	AUX	O
0	O	NUM	O
.	O	PUNCT	O
4	O	NUM	O
ng	O	NOUN	O
/	O	PUNCT	O
ml	O	NOUN	O
.	O	PUNCT	O


The	O	DET	O
amino	O	NOUN	B
acid	O	NOUN	I
sequences	O	NOUN	I
of	O	ADP	O
the	O	DET	O
predicted	O	VERB	B
RfbA	B-GENE	NOUN	B
and	O	CCONJ	O
RfbB	B-GENE	NOUN	B
homologs	I-GENE	NOUN	B
showed	O	VERB	O
identities	O	NOUN	B
of	O	ADP	O
75	O	NUM	O
.	O	PUNCT	O
7	O	NUM	O
%	O	NOUN	O
(	O	PUNCT	O
87	O	NUM	O
.	O	PUNCT	O
9	O	NUM	O
%	O	NOUN	O
total	O	ADJ	O
similarity	O	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
78	O	NUM	O
.	O	PUNCT	O
0	O	NUM	O
%	O	NOUN	O
(	O	PUNCT	O
86	O	NUM	O
.	O	PUNCT	O
5	O	NUM	O
%	O	NOUN	O
total	O	ADJ	O
similarity	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
respectively	O	ADV	O
.	O	PUNCT	O


In	O	ADP	O
this	O	DET	O
paper	O	NOUN	O
we	O	PRON	O
report	O	VERB	O
that	O	SCONJ	O
ligand	O	NOUN	B
binding	O	NOUN	B
induced	O	VERB	B
tyrosine	O	NOUN	B
phosphorylation	O	NOUN	I
in	O	ADP	O
BaF3	O	NOUN	B
cells	O	NOUN	I
engineered	O	VERB	B
to	O	PART	O
express	O	VERB	B
the	O	DET	O
murine	B-GENE	ADJ	B
Mpl	I-GENE	NOUN	B
receptor	I-GENE	NOUN	I
(	O	PUNCT	O
BaF3	O	NOUN	B
/	O	PUNCT	O
mMpl	B-GENE	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


A	O	DET	O
chicken	B-GENE	NOUN	B
paxillin	I-GENE	NOUN	B
cDNA	I-GENE	NOUN	B
was	O	AUX	O
also	O	ADV	O
cloned	O	VERB	B
and	O	CCONJ	O
is	O	AUX	O
predicted	O	VERB	O
to	O	PART	O
encode	O	VERB	B
a	O	DET	O
protein	O	NOUN	B
approximately	O	ADV	O
90	O	NUM	O
%	O	NOUN	O
identical	O	ADJ	B
to	O	PART	O
human	B-GENE	ADJ	B
paxil	I-GENE	ADJ	B
-	I-GENE	PUNCT	O
lin	I-GENE	NOUN	B
.	O	PUNCT	O


In	O	X	B
vivo	O	X	I
association	O	NOUN	B
between	O	ADP	O
Shb	B-GENE	NOUN	B
-	O	PUNCT	O
SH3	B-GENE	NOUN	B
domain	O	NOUN	B
proteins	O	NOUN	I
v	B-GENE	X	O
-	I-GENE	PUNCT	O
Src	I-GENE	NOUN	B
and	O	CCONJ	O
Eps8	B-GENE	NOUN	B
was	O	AUX	O
detected	O	VERB	B
by	O	ADP	O
coimmunoprecipitation	O	NOUN	B
.	O	PUNCT	O


As	O	ADP	O
expected	O	VERB	O
,	O	PUNCT	O
the	O	DET	O
insulin	B-GENE	NOUN	B
effect	O	NOUN	O
to	O	PART	O
increase	O	VERB	B
ras	B-GENE	NOUN	B
GTP	I-GENE	NOUN	O
formation	O	NOUN	B
and	O	CCONJ	O
MAP	B-GENE	NOUN	B
kinase	I-GENE	NOUN	I
activity	O	NOUN	B
was	O	AUX	O
negligible	O	ADJ	O
in	O	ADP	O
A	O	DET	B
/	O	SYM	O
K1018	O	NOUN	B
cells	O	NOUN	I
but	O	CCONJ	O
normal	O	ADJ	B
,	O	PUNCT	O
or	O	CCONJ	O
supernormal	O	ADJ	B
,	O	PUNCT	O
in	O	ADP	O
Y	O	NOUN	B
/	O	SYM	O
F2	O	NOUN	B
cells	O	NOUN	B
.	O	PUNCT	O


Appropriate	O	ADJ	O
restriction	O	NOUN	B
sites	O	NOUN	I
allow	O	VERB	O
one	O	NUM	O
to	O	PART	O
insert	O	VERB	B
virtually	O	ADV	O
any	O	DET	O
desired	O	VERB	O
cDNA	O	NOUN	B
fragment	O	NOUN	B
directly	O	ADV	O
behind	O	ADP	O
the	O	DET	O
epitope	O	NOUN	B
-	O	PUNCT	O
specific	O	ADJ	B
sequence	O	NOUN	B
and	O	CCONJ	O
before	O	ADP	O
a	O	DET	O
long	O	ADJ	O
poly	O	NOUN	B
(	O	PUNCT	I
A	O	NOUN	I
)	O	PUNCT	I
tail	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
gene	O	NOUN	B
product	O	NOUN	I
of	O	ADP	O
cotS	B-GENE	NOUN	B
was	O	AUX	O
confirmed	O	VERB	O
to	O	PART	O
be	O	AUX	O
identical	O	ADJ	B
to	O	PART	O
Cot40	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
2	I-GENE	NUM	O
by	O	ADP	O
SDS	O	NOUN	B
-	O	PUNCT	O
PAGE	O	NOUN	B
and	O	CCONJ	O
immunoblotting	O	NOUN	B
from	O	ADP	O
Escherichia	O	X	B
coli	O	X	I
transformed	O	VERB	B
with	O	ADP	I
a	O	DET	O
plasmid	O	NOUN	B
containing	O	VERB	O
the	O	DET	O
cotS	B-GENE	NOUN	B
region	I-GENE	NOUN	I
.	O	PUNCT	O


The	O	DET	O
optimal	O	ADJ	B
care	O	NOUN	B
of	O	ADP	O
CHF	O	NOUN	B
patient	O	NOUN	B
includes	O	VERB	O
the	O	DET	O
recognition	O	NOUN	B
and	O	CCONJ	O
management	O	NOUN	B
of	O	ADP	O
these	O	DET	O
electrolyte	O	NOUN	B
disturbances	O	NOUN	I
.	O	PUNCT	O


METHODS	O	NOUN	O
:	O	PUNCT	O
rHb1	B-GENE	NOUN	B
.	I-GENE	PUNCT	O
1	I-GENE	NUM	O
or	O	CCONJ	O
human	B-GENE	ADJ	B
serum	I-GENE	NOUN	O
albumin	I-GENE	NOUN	O
was	O	AUX	O
administered	O	VERB	B
intravenously	O	ADV	B
to	O	PART	O
fasting	O	VERB	B
male	O	NOUN	B
volunteers	O	NOUN	O
.	O	PUNCT	O


A	O	DET	O
mutant	O	ADJ	B
(	O	PUNCT	O
residues	O	NOUN	B
1	O	NUM	O
-	O	SYM	O
332	O	NUM	O
)	O	PUNCT	O
showed	O	VERB	O
complete	O	ADJ	B
Ca2	O	NOUN	B
+	O	CCONJ	O
/	O	SYM	O
CaM	B-GENE	NOUN	B
-	O	PUNCT	O
dependent	O	ADJ	B
activity	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
two	O	NUM	O
bases	O	NOUN	B
immediately	O	ADV	O
flanking	O	VERB	B
the	O	DET	O
5	O	NUM	O
'	O	PART	O
end	O	NOUN	O
of	O	ADP	O
the	O	DET	O
element	O	NOUN	B
proved	O	VERB	O
to	O	PART	O
be	O	AUX	O
very	O	ADV	O
important	O	ADJ	O
to	O	ADP	O
its	O	PRON	O
function	O	NOUN	B
as	O	ADP	O
a	O	DET	O
UAS	O	NOUN	B
element	O	NOUN	B
as	O	ADP	O
did	O	AUX	O
the	O	DET	O
two	O	NUM	O
bases	O	NOUN	B
immediately	O	ADV	O
3	O	NUM	O
'	O	PUNCT	O
of	O	ADP	O
the	O	DET	O
bHLH	O	ADJ	B
core	O	NOUN	I
motif	O	NOUN	I
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
indicate	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
PCNA	B-GENE	NOUN	B
gene	I-GENE	NOUN	I
is	O	AUX	O
a	O	DET	O
likely	O	ADJ	O
target	O	NOUN	B
gene	O	NOUN	O
of	O	ADP	O
E2F	B-GENE	NOUN	B
.	O	PUNCT	O


Differential	O	ADJ	B
sensitivity	O	NOUN	I
of	O	ADP	O
the	O	DET	O
MMPI	O	PROPN	B
-	O	PUNCT	O
2	O	NUM	B
depression	O	NOUN	B
scales	O	NOUN	B
and	O	CCONJ	O
subscales	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
chloramphenicol	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
resistance	I-GENE	NOUN	B
transposon	I-GENE	NOUN	B
Tn4451	B-GENE	NOUN	B
undergoes	O	VERB	O
precise	O	ADJ	O
conjugative	O	ADJ	B
deletion	O	NOUN	I
from	O	ADP	O
its	O	PRON	O
parent	O	NOUN	B
plasmid	O	NOUN	B
plP401	O	NOUN	B
in	O	ADP	O
Clostridium	O	NOUN	B
perfringens	O	NOUN	I
and	O	CCONJ	O
precise	O	ADJ	O
spontaneous	O	ADJ	B
excision	O	NOUN	B
from	O	ADP	O
multicopy	O	ADJ	B
plasmids	O	NOUN	I
in	O	ADP	O
Escherichia	O	X	B
coli	O	X	I
.	O	PUNCT	O


A	O	DET	O
general	O	ADJ	B
model	O	NOUN	I
for	O	ADP	O
ARE	O	NOUN	B
-	O	PUNCT	O
mediated	O	VERB	B
mRNA	O	NOUN	B
degradation	O	NOUN	I
involving	O	VERB	O
a	O	DET	O
potential	O	ADJ	O
role	O	NOUN	O
for	O	ADP	O
certain	O	ADJ	O
heterogeneous	O	ADJ	B
nuclear	O	ADJ	B
ribonucleoproteins	O	NOUN	I
and	O	CCONJ	O
ARE	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
binding	I-GENE	VERB	B
proteins	I-GENE	NOUN	I
is	O	AUX	O
proposed	O	VERB	O
.	O	PUNCT	O


Individual	O	ADJ	B
mutations	O	NOUN	B
in	O	ADP	O
motifs	O	NOUN	B
III	O	NUM	I
,	O	PUNCT	O
IV	O	NUM	B
,	O	PUNCT	O
and	O	CCONJ	O
V	O	NOUN	B
had	O	AUX	O
distinctive	O	ADJ	O
effects	O	NOUN	B
on	O	ADP	O
the	O	DET	O
affinity	O	NOUN	B
of	O	ADP	O
enzyme	O	NOUN	B
for	O	ADP	O
GTP	O	NOUN	B
,	O	PUNCT	O
the	O	DET	O
rate	O	NOUN	B
of	O	ADP	O
covalent	O	ADJ	B
catalysis	O	NOUN	I
(	O	PUNCT	O
EpG	O	NOUN	B
formation	O	NOUN	I
)	O	PUNCT	O
,	O	PUNCT	O
or	O	CCONJ	O
the	O	DET	O
transfer	O	NOUN	B
of	O	ADP	O
GMP	O	NOUN	B
from	O	ADP	O
enzyme	O	NOUN	B
to	O	PART	O
RNA	O	NOUN	B
.	O	PUNCT	O


Mutational	O	ADJ	B
analysis	O	NOUN	I
of	O	ADP	O
mRNA	B-GENE	NOUN	B
capping	I-GENE	NOUN	I
enzyme	I-GENE	NOUN	I
identifies	O	VERB	O
amino	O	NOUN	B
acids	O	NOUN	I
involved	O	VERB	O
in	O	ADP	O
GTP	O	NOUN	B
binding	O	NOUN	O
,	O	PUNCT	O
enzyme	O	NOUN	B
-	O	PUNCT	O
guanylate	O	NOUN	B
formation	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
GMP	O	NOUN	B
transfer	O	NOUN	I
to	O	PART	O
RNA	O	NOUN	B
.	O	PUNCT	O


Staphylococcal	B-GENE	ADJ	B
enterotoxin	I-GENE	NOUN	I
A	I-GENE	NOUN	O
involvement	O	NOUN	B
in	O	ADP	O
the	O	DET	O
illness	O	NOUN	B
of	O	ADP	O
a	O	DET	O
20	O	NUM	O
-	O	PUNCT	O
month	O	NOUN	B
-	O	PUNCT	O
old	O	ADJ	B
burn	O	NOUN	B
patient	O	NOUN	B
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
G	B-GENE	NOUN	B
beta	I-GENE	NOUN	I
gamma	I-GENE	NOUN	I
-	O	PUNCT	O
stimulated	O	VERB	B
Shc	B-GENE	NOUN	B
phosphorylation	O	NOUN	B
represents	O	VERB	O
an	O	DET	O
early	O	ADJ	B
step	O	NOUN	O
in	O	ADP	O
the	O	DET	O
pathway	O	NOUN	B
leading	O	VERB	O
to	O	PART	O
p21ras	B-GENE	NOUN	B
activation	O	NOUN	I
,	O	PUNCT	O
similar	O	ADJ	O
to	O	PART	O
the	O	DET	O
mechanism	O	NOUN	B
utilized	O	VERB	O
by	O	ADP	O
growth	B-GENE	NOUN	B
factor	I-GENE	NOUN	I
tyrosine	I-GENE	NOUN	I
kinase	I-GENE	NOUN	I
receptors	I-GENE	NOUN	I
.	O	PUNCT	O


Negative	O	ADJ	B
-	O	PUNCT	O
staining	O	NOUN	B
,	O	PUNCT	O
refractile	O	ADJ	B
mycobacteria	O	NOUN	I
in	O	ADP	O
Romanowsky	O	NOUN	B
-	O	PUNCT	O
stained	O	VERB	B
smears	O	NOUN	B
.	O	PUNCT	O


Here	O	ADV	O
we	O	PRON	O
focused	O	VERB	O
on	O	ADP	O
the	O	DET	O
role	O	NOUN	O
of	O	ADP	O
the	O	DET	O
5	O	NUM	O
'	O	PART	O
proximal	O	ADJ	B
regulatory	O	ADJ	O
cassette	O	NOUN	O
(	O	PUNCT	O
-	O	PUNCT	O
190	O	NUM	O
;	O	PUNCT	O
+	O	CCONJ	O
53	O	NUM	O
bp	O	NOUN	O
)	O	PUNCT	O
of	O	ADP	O
the	O	DET	O
rat	B-GENE	NOUN	B
enkephalin	I-GENE	NOUN	B
(	O	PUNCT	O
rENK	B-GENE	NOUN	B
)	O	PUNCT	O
gene	O	NOUN	O
in	O	ADP	O
the	O	DET	O
developmental	O	ADJ	B
regulation	O	NOUN	I
of	O	ADP	O
the	O	DET	O
enkephalin	B-GENE	NOUN	B
phenotype	O	NOUN	B
.	O	PUNCT	O


Unexpectedly	O	ADV	O
,	O	PUNCT	O
all	O	DET	O
ENK	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
specific	I-GENE	ADJ	B
motifs	I-GENE	NOUN	B
formed	O	VERB	O
specific	O	ADJ	B
and	O	CCONJ	O
highly	O	ADV	O
abundant	O	ADJ	B
protein	O	NOUN	B
-	O	PUNCT	O
DNA	O	NOUN	B
complexes	O	NOUN	I
when	O	SCONJ	O
nuclear	O	ADJ	B
extracts	O	NOUN	I
from	O	ADP	O
the	O	DET	O
human	O	ADJ	B
tumor	O	NOUN	O
cell	O	NOUN	O
line	O	NOUN	O
(	O	PUNCT	O
HeLa	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
which	O	DET	O
does	O	AUX	O
not	O	PART	O
express	O	VERB	O
ENK	B-GENE	NOUN	B
,	O	PUNCT	O
were	O	AUX	O
used	O	VERB	O
.	O	PUNCT	O


Infant	O	NOUN	B
aged	O	ADJ	B
3	O	NUM	O
.	O	PUNCT	O
5	O	NUM	O
years	O	NOUN	B
presents	O	VERB	O
persistence	O	NOUN	B
of	O	ADP	O
primordial	O	ADJ	B
vitreous	O	ADJ	B
body	O	NOUN	I
with	O	ADP	O
crystalline	O	ADJ	B
dislocation	O	NOUN	B
in	O	ADP	O
the	O	DET	O
camera	O	NOUN	B
aquosa	O	NOUN	O
and	O	CCONJ	O
secondary	O	ADJ	B
buphthalmos	O	NOUN	I
of	O	ADP	O
the	O	DET	O
left	O	VERB	B
eye	O	NOUN	I
and	O	CCONJ	O
microphthalmos	O	NOUN	B
with	O	ADP	O
dislocation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
crystalline	O	NOUN	B
in	O	ADP	O
the	O	DET	O
vitreous	O	ADJ	B
body	O	NOUN	I
of	O	ADP	O
the	O	DET	O
right	O	ADJ	B
eye	O	NOUN	I
.	O	PUNCT	O


Imaging	O	NOUN	B
features	O	NOUN	B
of	O	ADP	O
splenic	O	ADJ	B
epidermoid	O	ADJ	I
cyst	O	NOUN	I
with	O	ADP	O
pathologic	O	ADJ	B
correlation	O	NOUN	I
.	O	PUNCT	O


SL1	B-GENE	NOUN	B
trans	O	ADJ	B
-	O	PUNCT	O
splicing	O	NOUN	B
specified	O	VERB	O
by	O	ADP	O
AU	O	PROPN	B
-	O	PUNCT	O
rich	O	ADJ	B
synthetic	O	ADJ	O
RNA	O	NOUN	O
inserted	O	VERB	B
at	O	ADP	O
the	O	DET	O
5	O	NUM	O
'	O	PART	O
end	O	NOUN	O
of	O	ADP	O
Caenorhabditis	O	NOUN	B
elegans	O	X	I
pre	O	NOUN	B
-	O	PUNCT	O
mRNA	O	NOUN	B
.	O	PUNCT	O


Overexpression	O	NOUN	B
of	O	ADP	O
wild	B-GENE	ADJ	B
-	I-GENE	PUNCT	O
type	I-GENE	NOUN	B
p53	I-GENE	NOUN	B
also	O	ADV	O
induces	O	VERB	O
apoptosis	O	NOUN	B
in	O	ADP	O
an	O	DET	O
LCL	O	NOUN	B
.	O	PUNCT	O


These	O	DET	O
observations	O	NOUN	B
lead	O	VERB	O
to	O	PART	O
the	O	DET	O
proposal	O	NOUN	B
that	O	SCONJ	O
the	O	DET	O
RNAP	B-GENE	NOUN	B
II	I-GENE	NUM	I
CTD	I-GENE	PROPN	B
might	O	AUX	O
be	O	AUX	O
an	O	DET	O
in	O	X	B
vivo	O	X	I
target	O	NOUN	B
for	O	ADP	O
the	O	DET	O
activated	O	VERB	B
p42mapk	B-GENE	NOUN	B
and	O	CCONJ	O
p44mapk	B-GENE	ADJ	B
MAP	I-GENE	NOUN	B
kinases	I-GENE	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
also	O	ADV	O
isolated	O	VERB	B
two	O	NUM	O
alternatively	O	ADV	O
spliced	O	VERB	B
forms	O	NOUN	O
of	O	ADP	O
human	B-GENE	ADJ	B
CD6	I-GENE	NOUN	B
cDNA	I-GENE	NOUN	B
lacking	O	NOUN	B
sequences	O	NOUN	I
encoding	O	VERB	B
membrane	O	NOUN	B
-	O	PUNCT	O
proximal	O	ADJ	B
regions	O	NOUN	B
of	O	ADP	O
the	O	DET	O
cytoplasmic	O	ADJ	B
domain	O	NOUN	I
which	O	DET	O
maintain	O	VERB	O
the	O	DET	O
same	O	ADJ	O
reading	O	NOUN	B
frame	O	NOUN	I
as	O	ADP	O
CD6	B-GENE	NOUN	B
-	O	PUNCT	O
PB1	B-GENE	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
isolated	O	VERB	B
a	O	DET	O
Drosophila	O	X	B
melanogaster	O	X	I
(	O	PUNCT	O
Dm	O	NOUN	B
)	O	PUNCT	O
cDNA	O	NOUN	B
encoding	O	VERB	B
a	O	DET	O
polypeptide	O	NOUN	B
that	O	PRON	O
has	O	AUX	O
extensive	O	ADJ	O
sequence	O	NOUN	B
similarity	O	NOUN	O
to	O	PART	O
the	O	DET	O
mammalian	B-GENE	ADJ	B
MAPKAPK	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
2	I-GENE	NUM	B
.	O	PUNCT	O


A	O	DET	O
2	B-GENE	NUM	O
.	I-GENE	PUNCT	O
4	I-GENE	NUM	O
-	I-GENE	PUNCT	O
kb	I-GENE	NOUN	O
MAPKAPK	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
2	I-GENE	NUM	O
message	I-GENE	NOUN	B
is	O	AUX	O
expressed	O	VERB	B
throughout	O	ADP	O
development	O	NOUN	B
,	O	PUNCT	O
while	O	SCONJ	O
two	O	NUM	O
shorter	O	ADJ	B
transcripts	O	NOUN	B
of	O	ADP	O
2	O	NUM	O
.	O	PUNCT	O
3	O	NUM	O
and	O	CCONJ	O
1	O	NUM	O
.	O	PUNCT	O
8	O	NUM	O
kb	O	NOUN	O
appear	O	VERB	O
to	O	PART	O
be	O	AUX	O
specifically	O	ADV	O
expressed	O	VERB	B
in	O	ADP	O
the	O	DET	O
germline	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
integrity	O	NOUN	B
of	O	ADP	O
the	O	DET	O
cDNA	O	NOUN	B
sequence	O	NOUN	I
was	O	AUX	O
confirmed	O	VERB	O
by	O	ADP	O
analysis	O	NOUN	B
of	O	ADP	O
several	O	ADJ	O
overlapping	O	VERB	O
genomic	O	ADJ	B
clones	O	NOUN	I
that	O	PRON	O
span	O	VERB	O
the	O	DET	O
GAR1	B-GENE	NOUN	B
gene	I-GENE	NOUN	I
.	O	PUNCT	O


Phorbol	O	NOUN	B
esters	O	NOUN	I
stimulated	O	VERB	B
phosphorylation	O	NOUN	B
of	O	ADP	O
CSK	B-GENE	NOUN	B
35H	I-GENE	NOUN	O
proteins	I-GENE	NOUN	B
,	O	PUNCT	O
thus	O	ADV	O
emphasizing	O	VERB	O
that	O	SCONJ	O
sequences	O	NOUN	B
isolated	O	VERB	B
according	O	VERB	O
to	O	PART	O
PKC	B-GENE	NOUN	B
binding	O	NOUN	B
activity	O	NOUN	I
in	O	X	B
vitro	O	X	I
are	O	AUX	O
also	O	ADV	O
PKC	B-GENE	NOUN	B
substrates	O	NOUN	B
in	O	X	B
vivo	O	X	I
.	O	PUNCT	O


One	O	NUM	O
of	O	ADP	O
these	O	DET	O
is	O	AUX	O
surrounded	O	VERB	B
by	O	ADP	O
an	O	DET	O
adenine	O	NOUN	B
-	O	PUNCT	O
uridine	O	NOUN	B
rich	O	ADJ	B
region	O	NOUN	I
that	O	PRON	O
can	O	AUX	O
form	O	VERB	O
an	O	DET	O
11	O	NUM	O
-	O	PUNCT	O
base	O	NOUN	B
pair	O	NOUN	I
stem	O	NOUN	I
structure	O	NOUN	I
.	O	PUNCT	O


Additionally	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
enzyme	O	NOUN	B
shows	O	VERB	O
activity	O	NOUN	B
towards	O	ADP	O
triglycerides	O	NOUN	B
such	O	ADJ	O
as	O	ADP	O
olive	O	NOUN	B
oil	O	NOUN	I
and	O	CCONJ	O
tributyrin	O	NOUN	B
and	O	CCONJ	O
towards	O	ADP	O
egg	O	NOUN	B
-	O	PUNCT	O
yolk	O	NOUN	B
emulsions	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
nucleotide	O	NOUN	B
sequence	O	NOUN	I
directly	O	ADV	O
upstream	O	ADV	B
of	O	ADP	O
fimA	B-GENE	NOUN	B
contains	O	VERB	O
two	O	NUM	O
open	O	ADJ	O
reading	O	NOUN	O
frames	O	NOUN	O
,	O	PUNCT	O
ORF5	O	NOUN	B
and	O	CCONJ	O
ORF1	O	NOUN	B
,	O	PUNCT	O
whose	O	DET	O
deduced	O	VERB	B
protein	O	NOUN	I
products	O	NOUN	I
are	O	AUX	O
homologous	O	ADJ	B
to	O	PART	O
members	O	NOUN	B
of	O	ADP	O
a	O	DET	O
superfamily	O	NOUN	B
of	O	ADP	O
ATP	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
binding	I-GENE	VERB	B
cassette	I-GENE	NOUN	B
membrane	I-GENE	NOUN	I
transport	I-GENE	NOUN	O
proteins	I-GENE	NOUN	O
,	O	PUNCT	O
including	O	VERB	O
both	O	CCONJ	O
prokaryotic	O	ADJ	B
and	O	CCONJ	O
eukaryotic	O	ADJ	B
uptake	O	NOUN	I
and	O	CCONJ	O
export	O	NOUN	B
systems	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
ORF3	O	NOUN	B
probe	O	NOUN	I
also	O	ADV	O
hybridized	O	VERB	B
to	O	PART	O
a	O	DET	O
540	O	NUM	O
bp	O	NOUN	O
transcript	O	NOUN	B
consistent	O	ADJ	B
with	O	ADP	I
the	O	DET	O
size	O	NOUN	B
of	O	ADP	O
ORF3	O	NOUN	B
alone	O	ADV	O
and	O	CCONJ	O
supportive	O	ADJ	B
of	O	ADP	O
the	O	DET	O
mutagenesis	O	NOUN	B
data	O	NOUN	B
of	O	ADP	O
non	O	ADJ	B
-	O	PUNCT	O
linkage	O	NOUN	B
.	O	PUNCT	O


Mean	O	VERB	B
growth	O	NOUN	B
changes	O	NOUN	I
in	O	ADP	O
this	O	DET	O
Class	O	NOUN	B
II	O	NUM	I
sample	O	NOUN	B
were	O	AUX	O
comparable	O	ADJ	O
to	O	PART	O
those	O	DET	O
previously	O	ADV	O
reported	O	VERB	O
for	O	ADP	O
male	O	ADJ	B
subjects	O	NOUN	B
with	O	ADP	O
Class	O	NOUN	B
I	O	NUM	I
malocclusions	O	NOUN	B
over	O	ADP	O
the	O	DET	O
same	O	ADJ	O
age	O	NOUN	B
period	O	NOUN	B
,	O	PUNCT	O
suggesting	O	VERB	O
a	O	DET	O
similarity	O	NOUN	B
in	O	ADP	O
postpubertal	O	ADJ	B
development	O	NOUN	B
between	O	ADP	O
these	O	DET	O
two	O	NUM	O
groups	O	NOUN	B
.	O	PUNCT	O


By	O	ADP	O
in	O	X	B
vitro	O	X	I
immunoprecipitations	O	NOUN	B
and	O	CCONJ	O
gel	O	NOUN	B
shift	O	NOUN	I
assays	O	NOUN	I
,	O	PUNCT	O
we	O	PRON	O
identified	O	VERB	B
two	O	NUM	O
classes	O	NOUN	B
of	O	ADP	O
high	O	ADJ	B
affinity	O	NOUN	B
Engrailed	B-GENE	VERB	B
-	I-GENE	PUNCT	O
binding	I-GENE	VERB	B
sites	I-GENE	NOUN	I
upstream	O	ADJ	B
of	O	ADP	O
each	O	DET	O
of	O	ADP	O
the	O	DET	O
two	O	NUM	O
polyhomeotic	O	ADJ	B
transcription	O	NOUN	I
units	O	NOUN	I
.	O	PUNCT	O


Subjects	O	NOUN	B
with	O	ADP	O
a	O	DET	O
short	O	ADJ	O
postexposure	O	ADJ	B
time	O	NOUN	O
and	O	CCONJ	O
a	O	DET	O
dioxin	O	NOUN	B
burden	O	NOUN	B
>	O	NOUN	O
0	O	NUM	O
.	O	PUNCT	O
6	O	NUM	O
pg	O	NOUN	O
/	O	SYM	O
m3	O	NOUN	B
had	O	AUX	O
a	O	DET	O
significantly	O	ADV	O
higher	O	ADJ	O
risk	O	NOUN	B
of	O	ADP	O
hypoergy	O	NOUN	B
than	O	ADP	O
unexposed	O	ADJ	B
subjects	O	NOUN	I
(	O	PUNCT	O
hypoergy	O	NOUN	B
I	O	NUM	I
:	O	PUNCT	O
OR	O	CCONJ	B
=	O	ADJ	O
9	O	NUM	O
.	O	PUNCT	O
51	O	NUM	O
,	O	PUNCT	O
95	O	NUM	O
%	O	NOUN	O
CI	O	NOUN	B
=	O	ADJ	O
1	O	NUM	O
.	O	PUNCT	O
96	O	NUM	O
-	O	SYM	O
42	O	NUM	O
.	O	PUNCT	O
02	O	NUM	O
;	O	PUNCT	O
hypoergy	O	NOUN	B
II	O	NUM	I
:	O	PUNCT	O
OR	O	CCONJ	B
=	O	ADJ	O
2	O	NUM	O
.	O	PUNCT	O
92	O	NUM	O
,	O	PUNCT	O
95	O	NUM	O
%	O	NOUN	O
CI	O	NOUN	B
=	O	ADJ	O
1	O	NUM	O
.	O	PUNCT	O
14	O	NUM	O
-	O	SYM	O
7	O	NUM	O
.	O	PUNCT	O
5	O	NUM	O
)	O	PUNCT	O
.	O	PUNCT	O


Analysis	O	NOUN	B
of	O	ADP	O
this	O	DET	O
sequence	O	NOUN	B
combined	O	VERB	B
with	O	ADP	O
that	O	DET	O
previously	O	ADV	O
reported	O	VERB	O
for	O	ADP	O
the	O	DET	O
5	O	NUM	O
'	O	PART	O
-	O	PUNCT	O
flanking	O	ADJ	B
region	O	NOUN	I
directly	O	ADV	O
proximal	O	ADJ	B
to	O	PART	O
the	O	DET	O
start	O	NOUN	O
of	O	ADP	O
transcription	O	NOUN	B
revealed	O	VERB	B
several	O	ADJ	O
putative	O	ADJ	O
regulatory	O	ADJ	O
sequences	O	NOUN	O
.	O	PUNCT	O


The	O	DET	O
experimental	O	ADJ	B
design	O	NOUN	I
represents	O	VERB	O
a	O	DET	O
2	O	NUM	O
x	O	NOUN	O
3	O	NUM	O
factorial	O	ADJ	B
arrangement	O	NOUN	B
of	O	ADP	O
treatments	O	NOUN	B
with	O	ADP	O
three	O	NUM	O
dietary	O	ADJ	B
levels	O	NOUN	O
of	O	ADP	O
incorporation	O	NOUN	B
of	O	ADP	O
RSB	O	NOUN	B
(	O	PUNCT	O
0	O	NUM	O
,	O	PUNCT	O
50	O	NUM	O
,	O	PUNCT	O
and	O	CCONJ	O
100	O	NUM	O
%	O	NOUN	O
)	O	PUNCT	O
,	O	PUNCT	O
and	O	CCONJ	O
chickens	O	NOUN	B
either	O	CCONJ	O
infected	O	ADJ	B
or	O	CCONJ	O
uninfected	O	ADJ	B
.	O	PUNCT	O


A	O	DET	O
cDNA	O	NOUN	B
clone	O	NOUN	B
corresponding	O	VERB	O
to	O	PART	O
the	O	DET	O
putative	O	ADJ	O
GA	B-GENE	NOUN	B
20	I-GENE	NUM	O
-	O	PUNCT	O
oxidase	B-GENE	NOUN	B
genomic	O	ADJ	B
sequence	O	NOUN	I
was	O	AUX	O
constructed	O	VERB	O
with	O	ADP	O
the	O	DET	O
reverse	O	ADJ	B
transcription	O	NOUN	I
-	O	PUNCT	O
PCR	O	NOUN	B
method	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
the	O	DET	O
identity	O	NOUN	B
of	O	ADP	O
the	O	DET	O
cDNA	O	NOUN	B
clone	O	NOUN	B
was	O	AUX	O
confirmed	O	VERB	O
by	O	ADP	O
analyzing	O	VERB	B
the	O	DET	O
capability	O	NOUN	B
of	O	ADP	O
the	O	DET	O
fusion	O	NOUN	B
protein	O	NOUN	I
expressed	O	VERB	B
in	O	ADP	O
Escherichia	O	X	B
coli	O	X	I
to	O	PART	O
convert	O	VERB	O
GA53	B-GENE	NOUN	B
to	O	PART	O
GA44	B-GENE	NOUN	B
and	O	CCONJ	O
GA19	B-GENE	NOUN	B
to	O	PART	O
GA20	B-GENE	NOUN	B
.	O	PUNCT	O


Total	O	ADJ	B
cholesterol	O	NOUN	I
was	O	AUX	O
also	O	ADV	O
reduced	O	VERB	B
at	O	ADP	O
week	O	NOUN	B
12	O	NUM	O
by	O	ADP	O
17	O	NUM	O
.	O	PUNCT	O
0	O	NUM	O
%	O	NOUN	O
(	O	PUNCT	O
20	O	NUM	O
mg	O	NOUN	O
/	O	SYM	O
day	O	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
15	O	NUM	O
.	O	PUNCT	O
7	O	NUM	O
%	O	NOUN	O
(	O	PUNCT	O
20	O	NUM	O
-	O	SYM	O
30	O	NUM	O
mg	O	NOUN	O
/	O	PUNCT	O
day	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
and	O	CCONJ	O
at	O	ADP	O
week	O	NOUN	B
52	O	NUM	O
by	O	ADP	O
20	O	NUM	O
.	O	PUNCT	O
4	O	NUM	O
%	O	NOUN	O
(	O	PUNCT	O
<	O	X	O
or	O	CCONJ	O
=	O	ADJ	O
20	O	NUM	O
mg	O	NOUN	O
/	O	SYM	O
day	O	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
19	O	NUM	O
.	O	PUNCT	O
2	O	NUM	O
%	O	NOUN	O
(	O	PUNCT	O
>	O	NOUN	O
or	O	CCONJ	O
=	O	ADJ	O
30	O	NUM	O
mg	O	NOUN	O
/	O	SYM	O
day	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Piperacillin	O	NOUN	B
-	O	PUNCT	O
tazobactam	O	NOUN	B
can	O	AUX	O
be	O	AUX	O
used	O	VERB	O
for	O	ADP	O
the	O	DET	O
treatment	O	NOUN	B
of	O	ADP	O
infections	O	NOUN	B
caused	O	VERB	O
by	O	ADP	O
gram	O	X	B
-	O	PUNCT	O
negative	O	ADJ	B
,	O	PUNCT	O
gram	O	X	B
-	O	PUNCT	O
positive	O	ADJ	B
,	O	PUNCT	O
aerobic	O	ADJ	B
,	O	PUNCT	O
and	O	CCONJ	O
anaerobic	O	ADJ	B
bacteria	O	NOUN	I
.	O	PUNCT	O


This	O	DET	O
apparently	O	ADV	O
anomalous	O	ADJ	B
structure	O	NOUN	B
/	O	SYM	O
activity	O	NOUN	B
relationship	O	NOUN	B
raises	O	VERB	O
important	O	ADJ	O
issues	O	NOUN	B
for	O	ADP	O
understanding	O	VERB	O
the	O	DET	O
evolution	O	NOUN	B
of	O	ADP	O
regulatory	O	ADJ	B
peptides	O	NOUN	I
and	O	CCONJ	O
the	O	DET	O
mechanisms	O	NOUN	B
that	O	PRON	O
control	O	VERB	B
their	O	PRON	O
expression	O	NOUN	B
.	O	PUNCT	O


This	O	DET	O
paper	O	NOUN	O
summarises	O	VERB	O
the	O	DET	O
experimental	O	ADJ	B
evidence	O	NOUN	B
upon	O	SCONJ	O
which	O	DET	O
the	O	DET	O
clinical	O	ADJ	B
trials	O	NOUN	I
of	O	ADP	O
aldose	B-GENE	NOUN	B
reductase	I-GENE	NOUN	I
inhibitors	O	NOUN	B
in	O	ADP	O
diabetic	O	ADJ	B
patients	O	NOUN	B
have	O	AUX	O
been	O	AUX	O
initiated	O	VERB	B
and	O	CCONJ	O
the	O	DET	O
results	O	NOUN	B
of	O	ADP	O
published	O	VERB	B
drug	O	NOUN	I
trials	O	NOUN	I
in	O	ADP	O
these	O	DET	O
patients	O	NOUN	B
.	O	PUNCT	O


Increase	O	NOUN	B
in	O	ADP	O
urinary	O	ADJ	B
calcium	O	NOUN	I
and	O	CCONJ	O
oxalate	O	NOUN	B
after	O	ADP	O
fructose	O	NOUN	B
infusion	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
Babcock	O	PROPN	B
Surgical	O	PROPN	I
Clinic	O	PROPN	I
.	O	PUNCT	O


Histopathological	O	ADJ	B
features	O	NOUN	B
of	O	ADP	O
relapsed	O	ADJ	B
leprosy	O	NOUN	B
.	O	PUNCT	O


One	O	NUM	O
of	O	ADP	O
these	O	DET	O
factors	O	NOUN	B
,	O	PUNCT	O
HRF	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	O
,	O	PUNCT	O
recognizes	O	VERB	O
a	O	DET	O
cis	O	NOUN	B
element	O	NOUN	I
consisting	O	VERB	O
of	O	ADP	O
an	O	DET	O
inverted	O	ADJ	B
palindromic	O	ADJ	I
motif	O	NOUN	I
.	O	PUNCT	O


Regulation	O	NOUN	B
of	O	ADP	O
Gax	B-GENE	ADJ	B
homeobox	B-GENE	NOUN	I
gene	I-GENE	NOUN	I
transcription	O	NOUN	O
by	O	ADP	O
a	O	DET	O
combination	O	NOUN	B
of	O	ADP	O
positive	O	ADJ	B
factors	O	NOUN	I
including	O	VERB	O
myocyte	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
specific	I-GENE	ADJ	B
enhancer	I-GENE	NOUN	B
factor	I-GENE	NOUN	I
2	I-GENE	NUM	I
.	O	PUNCT	O


The	O	DET	O
carboxyl	O	NOUN	B
-	O	PUNCT	O
terminal	O	ADJ	B
transactivation	O	NOUN	B
domain	O	NOUN	I
of	O	ADP	O
heat	B-GENE	NOUN	B
shock	I-GENE	NOUN	I
factor	I-GENE	NOUN	I
1	I-GENE	NUM	I
is	O	AUX	O
negatively	O	ADV	O
regulated	O	VERB	O
and	O	CCONJ	O
stress	O	NOUN	B
responsive	O	ADJ	I
.	O	PUNCT	O


The	O	DET	O
RAT3	B-GENE	NOUN	B
gene	I-GENE	NOUN	B
encodes	O	VERB	B
an	O	DET	O
1157	O	NUM	O
-	O	PUNCT	O
amino	O	NOUN	B
acid	O	NOUN	I
protein	O	NOUN	I
without	O	ADP	O
similarity	O	NOUN	B
to	O	PART	O
other	O	ADJ	O
known	O	ADJ	O
proteins	O	NOUN	B
.	O	PUNCT	O


CCAAT	B-GENE	NOUN	B
/	I-GENE	PUNCT	O
enhancer	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
binding	I-GENE	VERB	B
protein	I-GENE	NOUN	I
isoforms	I-GENE	NOUN	O
beta	I-GENE	NOUN	B
and	I-GENE	CCONJ	I
delta	I-GENE	NOUN	I
are	O	AUX	O
expressed	O	VERB	B
in	O	ADP	O
mammary	O	ADJ	B
epithelial	O	ADJ	B
cells	O	NOUN	I
and	O	CCONJ	O
bind	O	VERB	B
to	O	PART	O
multiple	O	ADJ	O
sites	O	NOUN	B
in	O	ADP	O
the	O	DET	O
beta	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
casein	I-GENE	NOUN	B
gene	I-GENE	NOUN	I
promoter	I-GENE	NOUN	O
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
found	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
GTPase	B-GENE	NOUN	B
-	O	PUNCT	O
deficient	O	ADJ	B
mutants	O	NOUN	B
of	O	ADP	O
alpha	B-GENE	NOUN	B
12	I-GENE	NUM	I
(	O	PUNCT	O
alpha	B-GENE	NOUN	B
12Q229L	I-GENE	NUM	O
)	O	PUNCT	O
or	O	CCONJ	O
alpha	B-GENE	NOUN	B
13	I-GENE	NUM	I
(	O	PUNCT	O
alpha	B-GENE	NOUN	B
13Q226L	I-GENE	NOUN	I
)	O	PUNCT	O
leads	O	VERB	O
to	O	PART	O
robust	O	ADJ	O
activation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
Jun	B-GENE	NOUN	B
kinase	I-GENE	NOUN	I
/	O	SYM	O
stress	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
activated	I-GENE	VERB	B
protein	I-GENE	NOUN	O
kinase	I-GENE	NOUN	O
(	O	PUNCT	O
JNK	B-GENE	NOUN	B
/	O	PUNCT	O
SAPK	B-GENE	NOUN	B
)	O	PUNCT	O
pathway	O	NOUN	O
.	O	PUNCT	O


Using	O	VERB	O
mutagenesis	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
have	O	AUX	O
identified	O	VERB	B
two	O	NUM	O
mutations	O	NOUN	B
of	O	ADP	O
the	O	DET	O
second	O	ADJ	O
actin	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
binding	I-GENE	VERB	B
domain	I-GENE	NOUN	O
that	O	PRON	O
can	O	AUX	O
also	O	ADV	O
suppress	O	VERB	B
the	O	DET	O
act1	B-GENE	NOUN	B
mutations	O	NOUN	I
of	O	ADP	O
interest	O	NOUN	O
.	O	PUNCT	O


The	O	DET	O
normal	O	ADJ	B
cell	O	NOUN	I
cycle	O	NOUN	I
is	O	AUX	O
regulated	O	VERB	O
by	O	ADP	O
several	O	ADJ	O
molecules	O	NOUN	B
,	O	PUNCT	O
such	O	ADJ	O
as	O	ADP	O
the	O	DET	O
tumor	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
suppressor	I-GENE	NOUN	B
protein	I-GENE	NOUN	I
pRb	I-GENE	NOUN	B
,	O	PUNCT	O
the	O	DET	O
G1	B-GENE	NOUN	B
cyclins	I-GENE	NOUN	I
,	O	PUNCT	O
the	O	DET	O
cyclin	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
dependent	I-GENE	ADJ	B
kinases	I-GENE	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
their	O	PRON	O
inhibitors	O	NOUN	B
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
are	O	AUX	O
very	O	ADV	O
useful	O	ADJ	O
for	O	ADP	O
deciding	O	VERB	O
on	O	ADP	O
the	O	DET	O
doses	O	NOUN	B
of	O	ADP	O
hormones	O	NOUN	B
and	O	CCONJ	O
the	O	DET	O
expected	O	ADJ	O
serum	O	NOUN	B
estradiol	O	NOUN	O
level	O	NOUN	O
in	O	ADP	O
HRT	O	NOUN	B
for	O	ADP	O
Japanese	O	ADJ	B
women	O	NOUN	B
.	O	PUNCT	O


Comparison	O	NOUN	B
of	O	ADP	O
1	O	NUM	O
.	O	PUNCT	O
5	O	NUM	O
Tesla	O	PROPN	B
and	O	CCONJ	O
0	O	NUM	O
.	O	PUNCT	O
35	O	NUM	O
Tesla	O	PROPN	B
field	O	NOUN	I
strength	O	NOUN	I
magnetic	O	ADJ	B
resonance	O	NOUN	I
imaging	O	NOUN	I
scans	O	NOUN	I
in	O	ADP	O
the	O	DET	O
morphometric	O	ADJ	B
evaluation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
lumbar	O	ADJ	B
intervertebral	O	ADJ	I
foramina	O	NOUN	I
.	O	PUNCT	O


A	O	DET	O
new	O	ADJ	O
vector	O	NOUN	B
,	O	PUNCT	O
pHBK280	O	NOUN	B
,	O	PUNCT	O
was	O	AUX	O
designed	O	VERB	O
to	O	PART	O
facilitate	O	VERB	O
this	O	DET	O
analysis	O	NOUN	B
.	O	PUNCT	O


Here	O	ADV	O
we	O	PRON	O
describe	O	VERB	O
an	O	DET	O
in	O	X	B
vitro	O	X	I
assay	O	NOUN	B
where	O	SCONJ	O
the	O	DET	O
NS3	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
4A	I-GENE	NOUN	B
polyprotein	I-GENE	NOUN	B
,	O	PUNCT	O
NS3	B-GENE	NOUN	B
,	O	PUNCT	O
the	O	DET	O
serine	B-GENE	NOUN	B
proteinase	I-GENE	NOUN	I
domain	I-GENE	NOUN	I
(	I-GENE	PUNCT	O
the	I-GENE	DET	O
N	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
terminal	I-GENE	ADJ	B
181	I-GENE	NUM	O
residues	I-GENE	NOUN	B
of	I-GENE	ADP	O
NS3	I-GENE	NOUN	B
)	I-GENE	PUNCT	O
,	O	PUNCT	O
and	O	CCONJ	O
the	O	DET	O
NS4A	B-GENE	NOUN	B
cofactor	I-GENE	NOUN	B
were	O	AUX	O
produced	O	VERB	O
by	O	ADP	O
cell	O	NOUN	B
-	O	PUNCT	O
free	O	ADJ	B
translation	O	NOUN	B
and	O	CCONJ	O
tested	O	VERB	B
for	O	ADP	O
trans	O	ADJ	B
-	O	PUNCT	O
processing	O	NOUN	B
of	O	ADP	O
radiolabeled	O	VERB	B
substrates	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
contrast	O	NOUN	O
,	O	PUNCT	O
over	O	ADP	B
-	O	PUNCT	O
expression	O	NOUN	B
of	O	ADP	O
RAR	B-GENE	NOUN	B
beta	I-GENE	NOUN	B
only	O	ADV	O
poorly	O	ADV	O
restored	O	VERB	B
differentiation	O	NOUN	B
,	O	PUNCT	O
although	O	SCONJ	O
it	O	PRON	O
could	O	AUX	O
replace	O	VERB	O
RAR	B-GENE	NOUN	B
gamma	I-GENE	NOUN	O
for	O	ADP	O
the	O	DET	O
activation	O	NOUN	B
of	O	ADP	O
target	O	NOUN	B
genes	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
5	O	NUM	O
'	O	PART	O
-	O	PUNCT	O
terminus	O	NOUN	B
of	O	ADP	O
the	O	DET	O
p	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
gvpF	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
M	I-GENE	NOUN	B
mRNA	I-GENE	NOUN	B
was	O	AUX	O
located	O	ADJ	O
169	O	NUM	O
nucleotides	O	NOUN	B
upstream	O	ADJ	B
of	O	ADP	O
p	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
gvpF	I-GENE	NOUN	B
within	O	ADP	O
p	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
gvpE	I-GENE	NOUN	B
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
relative	O	ADJ	O
binding	O	NOUN	O
affinity	O	NOUN	B
for	O	ADP	O
the	O	DET	O
motifs	O	NOUN	B
is	O	AUX	O
different	O	ADJ	O
.	O	PUNCT	O


The	O	DET	O
transport	O	NOUN	B
of	O	ADP	O
a	O	DET	O
genetically	O	ADV	B
engineered	O	VERB	I
chimeric	O	ADJ	B
transmembrane	O	ADJ	I
protein	O	NOUN	I
connected	O	VERB	O
to	O	PART	O
this	O	DET	O
ER	O	NOUN	B
leader	O	NOUN	O
sequence	O	NOUN	O
was	O	AUX	O
as	O	ADV	O
efficient	O	ADJ	B
as	O	ADP	O
that	O	DET	O
of	O	ADP	O
the	O	DET	O
original	O	ADJ	B
protein	O	NOUN	B
from	O	ADP	O
which	O	DET	O
the	O	DET	O
ER	O	NOUN	B
sequence	O	NOUN	O
has	O	AUX	O
been	O	AUX	O
derived	O	VERB	O
.	O	PUNCT	O


A	O	DET	O
polymorphic	O	ADJ	B
bipartite	O	ADJ	I
motif	O	NOUN	O
signals	O	NOUN	O
nuclear	O	ADJ	B
targeting	O	NOUN	B
of	O	ADP	O
early	O	ADJ	O
auxin	O	NOUN	B
-	O	PUNCT	O
inducible	O	ADJ	B
proteins	O	NOUN	B
related	O	VERB	O
to	O	PART	O
PS	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
IAA4	I-GENE	PROPN	B
from	I-GENE	ADP	O
pea	I-GENE	NOUN	B
(	I-GENE	PUNCT	O
Pisum	I-GENE	NOUN	B
sativum	I-GENE	NOUN	I
)	I-GENE	PUNCT	O
.	O	PUNCT	O


The	O	DET	O
plant	O	NOUN	B
hormone	O	NOUN	I
auxin	O	NOUN	B
transcriptionally	O	ADV	B
activates	O	VERB	B
early	B-GENE	ADJ	B
genes	I-GENE	NOUN	I
.	O	PUNCT	O


A	O	DET	O
new	O	ADJ	O
non	O	ADJ	B
-	O	PUNCT	O
LTR	O	NOUN	B
retrotransposon	O	NOUN	O
provides	O	VERB	O
evidence	O	NOUN	B
for	O	ADP	O
multiple	O	ADJ	B
distinct	O	ADJ	O
site	O	NOUN	B
-	O	PUNCT	O
specific	O	ADJ	B
elements	O	NOUN	B
in	O	ADP	O
Crithidia	O	NOUN	B
fasciculata	O	X	I
miniexon	O	ADJ	I
arrays	O	NOUN	O
.	O	PUNCT	O


The	O	DET	O
CVA16	B-GENE	NOUN	B
.	I-GENE	PUNCT	O
4	I-GENE	NUM	O
proteolipid	I-GENE	NOUN	B
transcript	I-GENE	NOUN	I
is	O	AUX	O
the	O	DET	O
most	O	ADV	O
prevalent	O	ADJ	B
of	O	ADP	O
the	O	DET	O
two	O	NUM	O
proteolipid	O	NOUN	B
messages	O	NOUN	B
in	O	ADP	O
expanding	O	VERB	O
ovules	O	NOUN	B
harvested	O	VERB	B
10	O	NUM	O
d	O	NOUN	O
post	O	NOUN	B
-	O	PUNCT	O
anthesis	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
synthetic	O	ADJ	B
DNA	O	NOUN	O
sequence	O	NOUN	O
was	O	AUX	O
constructed	O	VERB	O
to	O	PART	O
achieve	O	VERB	O
efficient	O	ADJ	B
base	O	NOUN	B
pairing	O	NOUN	I
with	O	ADP	O
Escherichia	B-GENE	X	B
coli	I-GENE	X	I
16S	I-GENE	NOUN	B
ribosomal	I-GENE	ADJ	I
RNA	I-GENE	NOUN	I
,	O	PUNCT	O
avoidance	O	NOUN	B
of	O	ADP	O
internal	O	ADJ	B
secondary	O	ADJ	I
structure	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
optimal	O	ADJ	B
codon	O	NOUN	B
usage	O	NOUN	B
for	O	ADP	O
high	O	ADJ	B
-	O	PUNCT	O
level	O	NOUN	B
protein	O	NOUN	B
expression	O	NOUN	I
in	O	ADP	O
accord	O	NOUN	O
with	O	ADP	O
the	O	DET	O
known	O	ADJ	O
preferences	O	NOUN	B
in	O	ADP	O
E	O	NOUN	B
.	O	PUNCT	O
coli	O	X	B
.	O	PUNCT	O


Transcription	O	NOUN	B
factors	O	NOUN	I
containing	O	VERB	O
a	O	DET	O
basic	O	ADJ	O
helix	O	NOUN	B
-	O	PUNCT	O
loop	O	NOUN	B
-	O	PUNCT	O
helix	O	NOUN	B
(	O	PUNCT	O
bHLH	O	ADJ	B
)	O	PUNCT	O
motif	O	NOUN	O
regulate	O	VERB	O
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
tissue	O	NOUN	B
-	O	PUNCT	O
specific	O	ADJ	B
genes	O	NOUN	B
in	O	ADP	O
a	O	DET	O
number	O	NOUN	O
of	O	ADP	O
mammalian	O	ADJ	B
and	O	CCONJ	O
insect	O	ADJ	B
systems	O	NOUN	I
.	O	PUNCT	O


EsaR	B-GENE	NOUN	B
can	O	AUX	O
repress	O	VERB	B
its	O	PRON	O
own	O	ADJ	O
expression	O	NOUN	B
but	O	CCONJ	O
seems	O	VERB	O
not	O	PART	O
to	O	PART	O
regulate	O	VERB	B
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
esaI	B-GENE	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
conclude	O	VERB	O
that	O	SCONJ	O
,	O	PUNCT	O
in	O	ADP	O
comparison	O	NOUN	B
to	O	PART	O
reports	O	NOUN	B
from	O	ADP	O
other	O	ADJ	O
regions	O	NOUN	B
,	O	PUNCT	O
Scandinavian	O	ADJ	B
renal	O	ADJ	I
transplant	O	NOUN	I
recipients	O	NOUN	B
are	O	AUX	O
at	O	ADP	O
high	O	ADJ	O
risk	O	NOUN	B
of	O	ADP	O
dying	O	NOUN	B
of	O	ADP	O
IHD	O	NOUN	B
.	O	PUNCT	O


Veterinary	O	ADJ	B
certification	O	NOUN	B
for	O	ADP	O
livestock	O	NOUN	B
export	O	NOUN	B
.	O	PUNCT	O


Diffuse	O	ADJ	B
white	O	ADJ	I
matter	O	NOUN	I
injury	O	NOUN	I
can	O	AUX	O
be	O	AUX	O
attributed	O	VERB	O
to	O	ADP	O
radiation	O	NOUN	B
and	O	CCONJ	O
associated	O	VERB	B
with	O	ADP	I
neurological	O	ADJ	B
deficits	O	NOUN	I
,	O	PUNCT	O
but	O	CCONJ	O
leukoencephalopathy	O	NOUN	B
is	O	AUX	O
rarely	O	ADV	O
observed	O	VERB	B
in	O	ADP	O
the	O	DET	O
absence	O	NOUN	B
of	O	ADP	O
chemotherapy	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
ectopic	O	ADJ	B
expression	O	NOUN	B
of	O	ADP	O
Oct	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
3	I-GENE	NUM	O
/	I-GENE	SYM	O
4	I-GENE	NUM	B
in	O	ADP	O
hybrid	O	NOUN	B
cells	O	NOUN	I
under	O	ADP	O
a	O	DET	O
constitutive	O	ADJ	O
promoter	O	NOUN	B
is	O	AUX	O
sufficient	O	ADJ	O
for	O	ADP	O
transcriptional	O	ADJ	B
activation	O	NOUN	I
of	O	ADP	O
an	O	DET	O
octamer	O	NOUN	B
-	O	PUNCT	O
dependent	O	ADJ	B
promoter	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
here	O	ADV	O
demonstrate	O	VERB	O
that	O	SCONJ	O
a	O	DET	O
temperature	O	NOUN	B
-	O	PUNCT	O
sensitive	O	ADJ	B
fission	O	NOUN	B
yeast	O	NOUN	O
mutant	O	NOUN	O
which	O	DET	O
has	O	AUX	O
a	O	DET	O
mutation	O	NOUN	B
in	O	ADP	O
a	O	DET	O
homologous	O	ADJ	B
gene	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
two	O	NUM	O
of	O	ADP	O
three	O	NUM	O
additional	O	ADJ	O
(	O	PUNCT	O
mtr1	B-GENE	NOUN	B
/	O	SYM	O
prp20	B-GENE	PROPN	B
/	O	PUNCT	O
srm1	B-GENE	NOUN	B
)	O	PUNCT	O
mutants	O	NOUN	B
accumulate	O	VERB	B
nuclear	O	ADJ	B
poly	O	NOUN	I
(	O	PUNCT	I
A	O	NOUN	I
)	O	PUNCT	I
+	O	CCONJ	O
RNA	O	NOUN	B
at	O	ADP	O
37	O	NUM	O
degrees	O	NOUN	B
C	O	NOUN	I
.	O	PUNCT	O


Since	O	SCONJ	O
RCC1p	B-GENE	NOUN	B
acts	O	VERB	O
as	O	ADP	O
GNRP	B-GENE	NOUN	B
for	O	ADP	O
Ran	B-GENE	NOUN	B
,	O	PUNCT	O
a	O	DET	O
small	B-GENE	ADJ	O
nuclear	I-GENE	ADJ	B
GTPase	I-GENE	NOUN	I
of	O	ADP	O
the	O	DET	O
ras	B-GENE	NOUN	B
superfamily	I-GENE	NOUN	I
,	O	PUNCT	O
we	O	PRON	O
have	O	AUX	O
identified	O	VERB	B
two	O	NUM	O
homologs	O	NOUN	B
of	O	ADP	O
Ran	B-GENE	NOUN	B
in	O	ADP	O
S	O	NOUN	B
.	O	PUNCT	O
cerevisiae	O	X	B
(	O	PUNCT	O
CNR1	B-GENE	NOUN	B
and	O	CCONJ	O
CNR2	B-GENE	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Prostate	B-GENE	NOUN	B
specific	I-GENE	ADJ	I
antigen	I-GENE	NOUN	I
shows	O	VERB	O
the	O	DET	O
metastatic	O	ADJ	B
cases	O	NOUN	B
better	O	ADV	O
[	O	PUNCT	O
correction	O	NOUN	B
of	O	ADP	O
worse	O	ADJ	B
]	O	PUNCT	O
than	O	ADP	O
prostatic	B-GENE	ADJ	B
acid	I-GENE	NOUN	I
phosphatase	I-GENE	NOUN	I
.	O	PUNCT	O


Of	O	ADP	O
these	O	DET	O
carriers	O	NOUN	B
149	O	NUM	O
were	O	AUX	O
diagnosed	O	VERB	B
to	O	PART	O
be	O	AUX	O
asymptomatic	O	ADJ	B
clinically	O	ADV	B
,	O	PUNCT	O
biochemically	O	ADV	B
and	O	CCONJ	O
echographically	O	ADV	B
.	O	PUNCT	O


Identification	O	NOUN	B
of	O	ADP	O
mutations	O	NOUN	B
in	O	ADP	O
the	O	DET	O
coding	O	VERB	B
sequence	O	NOUN	I
of	O	ADP	O
the	O	DET	O
proto	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
oncogene	I-GENE	NOUN	B
c	I-GENE	NOUN	I
-	I-GENE	PUNCT	O
kit	I-GENE	NOUN	B
in	O	ADP	O
a	O	DET	O
human	O	ADJ	B
mast	O	NOUN	O
cell	O	NOUN	O
leukemia	O	NOUN	O
cell	O	NOUN	B
line	O	NOUN	I
causing	O	VERB	O
ligand	O	NOUN	B
-	O	PUNCT	O
independent	O	ADJ	B
activation	O	NOUN	B
of	O	ADP	O
c	B-GENE	NOUN	O
-	I-GENE	PUNCT	O
kit	I-GENE	NOUN	B
product	I-GENE	NOUN	B
.	O	PUNCT	O


Insulin	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
like	I-GENE	ADJ	B
growth	I-GENE	NOUN	B
factor	I-GENE	NOUN	I
-	I-GENE	PUNCT	O
binding	I-GENE	VERB	B
protein	I-GENE	NOUN	I
-	I-GENE	PUNCT	O
2	I-GENE	NUM	B
(	O	PUNCT	O
IGF	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
BP	I-GENE	PROPN	B
-	I-GENE	PUNCT	O
2	I-GENE	NUM	O
)	O	PUNCT	O
transcription	O	NOUN	B
in	O	ADP	O
rat	O	NOUN	B
liver	O	NOUN	B
varies	O	VERB	O
with	O	ADP	O
developmental	O	ADJ	B
age	O	NOUN	I
and	O	CCONJ	O
fasting	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
the	O	DET	O
RV	O	PROPN	B
5	O	NUM	I
'	O	PUNCT	O
(	O	PUNCT	O
+	O	CCONJ	O
)	O	PUNCT	O
SL	O	NOUN	B
sequence	O	NOUN	O
had	O	AUX	O
the	O	DET	O
primary	O	ADJ	B
enhancing	O	NOUN	B
effect	O	NOUN	O
on	O	ADP	O
translation	O	NOUN	B
.	O	PUNCT	O


By	O	ADP	O
contrast	O	NOUN	O
,	O	PUNCT	O
all	O	DET	O
proteins	O	NOUN	B
initiated	O	VERB	O
with	O	ADP	O
a	O	DET	O
methionine	O	NOUN	B
placed	O	VERB	O
one	O	NUM	O
residue	O	NOUN	B
upstream	O	ADJ	B
of	O	ADP	O
the	O	DET	O
natural	O	ADJ	B
N	O	NOUN	B
terminus	O	NOUN	I
of	O	ADP	O
PR	B-GENE	NOUN	B
failed	O	VERB	B
to	O	PART	O
show	O	VERB	O
specific	O	ADJ	O
proteolysis	O	NOUN	B
.	O	PUNCT	O


Reverse	B-GENE	VERB	B
transcriptase	I-GENE	NOUN	I
and	O	CCONJ	O
protease	O	NOUN	B
activities	O	NOUN	I
of	O	ADP	O
avian	O	ADJ	B
leukosis	O	NOUN	B
virus	O	NOUN	I
Gag	B-GENE	NOUN	B
-	O	PUNCT	O
Pol	B-GENE	NOUN	B
fusion	O	NOUN	I
proteins	O	NOUN	I
expressed	O	VERB	B
in	O	ADP	O
insect	O	ADJ	B
cells	O	NOUN	I
.	O	PUNCT	O


PATIENTS	O	NOUN	B
AND	O	CCONJ	O
METHODS	O	NOUN	O
:	O	PUNCT	O
We	O	PRON	O
report	O	VERB	O
our	O	PRON	O
experience	O	NOUN	B
with	O	ADP	O
seven	O	NUM	O
children	O	NOUN	B
with	O	ADP	O
active	O	ADJ	B
small	O	ADJ	I
bowel	O	NOUN	I
Crohn	O	NOUN	I
'	O	PART	I
s	O	NOUN	I
disease	O	NOUN	B
given	O	VERB	O
a	O	DET	O
casein	B-GENE	NOUN	B
-	O	PUNCT	O
based	O	VERB	B
,	O	PUNCT	O
polymeric	O	ADJ	B
feed	O	VERB	I
rich	O	ADJ	O
in	O	ADP	O
TGF	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
beta	I-GENE	NOUN	B
2	I-GENE	NUM	I
(	O	PUNCT	O
Specific	O	ADJ	O
Polymeric	O	PROPN	B
Diet	O	PROPN	I
;	O	PUNCT	O
Nestle	O	PROPN	B
-	O	PUNCT	O
Clintec	O	PROPN	B
;	O	PUNCT	O
Vevey	O	PROPN	B
,	O	PUNCT	O
Switzerland	O	PROPN	B
)	O	PUNCT	O
as	O	ADP	O
complete	O	ADJ	B
nutrition	O	NOUN	B
for	O	ADP	O
8	O	NUM	O
weeks	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
leader	O	NOUN	B
sequence	O	NOUN	I
of	O	ADP	O
the	O	DET	O
isolated	O	VERB	B
cDNA	O	NOUN	B
clone	O	NOUN	O
contains	O	VERB	O
several	O	ADJ	O
small	O	ADJ	O
open	O	ADJ	O
reading	O	NOUN	O
frames	O	NOUN	O
upstream	O	ADJ	O
of	O	ADP	O
the	O	DET	O
initiation	O	NOUN	B
codon	O	NOUN	B
of	O	ADP	O
the	O	DET	O
largest	O	ADJ	O
open	O	ADJ	B
reading	O	NOUN	I
frame	O	NOUN	I
coding	O	VERB	I
for	O	ADP	O
the	O	DET	O
homeodomain	B-GENE	NOUN	B
protein	I-GENE	NOUN	I
.	O	PUNCT	O


Experimental	O	ADJ	B
adhesion	O	NOUN	O
prophylaxis	O	NOUN	B
with	O	ADP	O
recombinant	B-GENE	ADJ	B
tissue	I-GENE	NOUN	I
plasminogen	I-GENE	NOUN	I
activator	I-GENE	NOUN	I
.	O	PUNCT	O


To	O	PART	O
determine	O	VERB	O
which	O	DET	O
sequences	O	NOUN	B
in	O	ADP	O
the	O	DET	O
rat	B-GENE	NOUN	B
P450c17	I-GENE	NOUN	B
promoter	I-GENE	NOUN	B
may	O	AUX	O
be	O	AUX	O
responsible	O	ADJ	O
for	O	ADP	O
basal	O	ADJ	B
and	O	CCONJ	O
cAMP	O	NOUN	B
-	O	PUNCT	O
stimulated	O	VERB	B
gene	O	NOUN	B
transcription	O	NOUN	I
,	O	PUNCT	O
deletion	O	NOUN	B
constructs	O	NOUN	I
containing	O	VERB	O
between	O	ADP	O
-	O	PUNCT	O
1	O	NUM	O
,	O	PUNCT	O
560	O	NUM	O
and	O	CCONJ	O
-	O	PUNCT	O
53	O	NUM	O
base	O	NOUN	B
pairs	O	NOUN	I
of	O	ADP	O
5	O	NUM	O
'	O	PUNCT	O
-	O	PUNCT	O
flanking	O	ADJ	B
DNA	O	NOUN	B
from	O	ADP	O
the	O	DET	O
rat	B-GENE	NOUN	B
P450c17	I-GENE	NOUN	B
gene	I-GENE	NOUN	I
were	O	AUX	O
ligated	O	VERB	B
to	O	PART	O
plasmids	O	NOUN	B
expressing	O	VERB	B
the	O	DET	O
reporter	O	NOUN	B
gene	O	NOUN	I
luciferase	B-GENE	NOUN	I
and	O	CCONJ	O
transfected	O	VERB	B
into	O	ADP	O
two	O	NUM	O
mouse	O	NOUN	B
cell	O	NOUN	B
lines	O	NOUN	I
,	O	PUNCT	O
adrenal	O	ADJ	B
Y	O	NOUN	I
-	O	PUNCT	O
1	O	NUM	O
cells	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
testicular	O	VERB	B
Leydig	O	PROPN	B
MA	O	PROPN	I
-	O	PUNCT	O
10	O	NUM	O
cells	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
cloned	O	VERB	B
and	O	CCONJ	O
sequenced	O	VERB	B
the	O	DET	O
mouse	B-GENE	NOUN	B
NMO1	I-GENE	NOUN	B
cDNA	I-GENE	NOUN	B
,	O	PUNCT	O
which	O	DET	O
encodes	O	VERB	B
the	O	DET	O
NAD	B-GENE	NOUN	B
(	I-GENE	PUNCT	O
P	I-GENE	NOUN	O
)	I-GENE	PUNCT	O
H	I-GENE	NOUN	O
:	I-GENE	PUNCT	O
menadione	I-GENE	NOUN	B
oxidoreductase	I-GENE	NOUN	I
[	O	PUNCT	O
also	O	ADV	O
called	O	VERB	O
NAD	B-GENE	NOUN	B
(	I-GENE	PUNCT	O
P	I-GENE	NOUN	O
)	I-GENE	PUNCT	O
H	I-GENE	NOUN	O
:	I-GENE	PUNCT	O
(	I-GENE	PUNCT	O
quinone	I-GENE	NOUN	B
acceptor	I-GENE	NOUN	I
)	I-GENE	PUNCT	O
oxidoreductase	I-GENE	NOUN	O
;	O	PUNCT	O
quinone	B-GENE	ADJ	B
reductase	I-GENE	NOUN	I
;	O	PUNCT	O
azo	B-GENE	NOUN	B
dye	I-GENE	NOUN	I
reductase	I-GENE	NOUN	I
;	O	PUNCT	O
DT	B-GENE	NOUN	B
diaphorase	I-GENE	NOUN	I
;	O	PUNCT	O
EC	B-GENE	NOUN	B
1	I-GENE	NUM	I
.	I-GENE	PUNCT	O
6	I-GENE	NUM	O
.	I-GENE	PUNCT	O
99	I-GENE	NUM	O
.	I-GENE	PUNCT	O
2	I-GENE	NUM	O
]	O	PUNCT	O
.	O	PUNCT	O


Mutations	O	NOUN	B
in	O	ADP	O
the	O	DET	O
VPS45	B-GENE	NOUN	B
gene	I-GENE	NOUN	I
,	O	PUNCT	O
a	O	DET	O
SEC1	B-GENE	NOUN	B
homologue	O	NOUN	B
,	O	PUNCT	O
result	O	VERB	O
in	O	ADP	O
vacuolar	O	ADJ	B
protein	O	NOUN	I
sorting	O	NOUN	O
defects	O	NOUN	B
and	O	CCONJ	O
accumulation	O	NOUN	B
of	O	ADP	O
membrane	O	NOUN	B
vesicles	O	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
293	O	NUM	O
cells	O	NOUN	B
,	O	PUNCT	O
expression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
NF	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
kappa	I-GENE	NOUN	B
B	I-GENE	NOUN	I
inhibitor	O	NOUN	I
,	O	PUNCT	O
I	B-GENE	NOUN	B
kappa	I-GENE	NOUN	I
B	I-GENE	NOUN	I
-	I-GENE	PUNCT	O
alpha	I-GENE	NOUN	B
,	O	PUNCT	O
reduced	O	VERB	B
the	O	DET	O
stimulatory	O	ADJ	B
activity	O	NOUN	I
of	O	ADP	O
LMP	B-GENE	NOUN	B
.	O	PUNCT	O


Binding	O	NOUN	B
of	O	ADP	O
meAda	B-GENE	NOUN	B
is	O	AUX	O
necessary	O	ADJ	O
to	O	PART	O
activate	O	VERB	B
transcription	O	NOUN	B
of	O	ADP	O
the	O	DET	O
adaptive	O	ADJ	B
response	O	NOUN	I
genes	O	NOUN	I
;	O	PUNCT	O
accordingly	O	ADV	O
,	O	PUNCT	O
in	O	X	B
vitro	O	X	I
transcription	O	NOUN	B
of	O	ADP	O
aidB	B-GENE	NOUN	B
is	O	AUX	O
dependent	O	ADJ	B
on	O	ADP	O
the	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
meAda	B-GENE	NOUN	B
.	O	PUNCT	O


No	O	DET	B
significant	O	ADJ	I
differences	O	NOUN	O
were	O	AUX	O
identified	O	VERB	B
between	O	ADP	O
groups	O	NOUN	B
for	O	ADP	O
pH	O	NOUN	B
,	O	PUNCT	O
PaCO2	O	NOUN	B
,	O	PUNCT	O
intracranial	O	ADJ	B
pressure	O	NOUN	I
,	O	PUNCT	O
heart	O	NOUN	B
rate	O	NOUN	I
,	O	PUNCT	O
brain	O	NOUN	B
temperature	O	NOUN	I
,	O	PUNCT	O
or	O	CCONJ	O
glucose	O	NOUN	B
levels	O	NOUN	I
.	O	PUNCT	O


Weak	O	ADJ	B
allergenicity	O	NOUN	B
of	O	ADP	O
recombinant	B-GENE	ADJ	B
hirudin	I-GENE	NOUN	O
CGP	I-GENE	NOUN	B
39393	I-GENE	NUM	O
(	O	PUNCT	O
REVASC	O	NOUN	B
)	O	PUNCT	O
in	O	ADP	O
immunocompetent	O	ADJ	B
volunteers	O	NOUN	B
.	O	PUNCT	O


Each	O	DET	O
dietary	O	ADJ	B
treatment	O	NOUN	I
was	O	AUX	O
fed	O	VERB	O
to	O	ADP	O
six	O	NUM	O
pen	O	NOUN	B
replicates	O	NOUN	B
of	O	ADP	O
five	O	NUM	O
chicks	O	NOUN	B
per	O	ADP	O
pen	O	NOUN	B
for	O	ADP	O
21	O	NUM	O
d	O	NOUN	O
.	O	PUNCT	O


The	O	DET	O
NarX	B-GENE	NOUN	B
and	O	CCONJ	O
NarQ	B-GENE	NOUN	B
proteins	I-GENE	NOUN	I
with	O	ADP	O
amino	O	NOUN	B
acid	O	NOUN	I
substitutions	O	NOUN	I
at	O	ADP	O
the	O	DET	O
first	O	ADJ	O
conserved	O	VERB	O
histidine	O	NOUN	B
position	O	NOUN	I
were	O	AUX	O
also	O	ADV	O
unable	O	ADJ	O
to	O	PART	O
dephosphorylate	O	VERB	B
NarL	B-GENE	NOUN	B
-	O	PUNCT	O
phosphate	O	NOUN	B
in	O	X	B
vitro	O	X	I
.	O	PUNCT	O


The	O	DET	O
Ng	B-GENE	PROPN	B
/	I-GENE	SYM	O
RC3	I-GENE	PROPN	B
and	O	CCONJ	O
PKC	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
gamma	I-GENE	NOUN	B
genes	I-GENE	NOUN	I
have	O	AUX	O
a	O	DET	O
similar	O	ADJ	O
expression	O	NOUN	B
pattern	O	NOUN	I
in	O	ADP	O
the	O	DET	O
brain	O	NOUN	B
during	O	ADP	O
development	O	NOUN	B
.	O	PUNCT	O


Structure	O	NOUN	B
and	O	CCONJ	O
regulation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
gene	O	NOUN	B
encoding	O	VERB	B
the	O	DET	O
neuron	O	NOUN	B
-	O	PUNCT	O
specific	O	ADJ	B
protein	B-GENE	NOUN	B
kinase	I-GENE	NOUN	I
C	I-GENE	NOUN	I
substrate	O	NOUN	O
neurogranin	B-GENE	NOUN	B
(	O	PUNCT	O
RC3	B-GENE	NOUN	B
protein	I-GENE	NOUN	I
)	O	PUNCT	O
.	O	PUNCT	O


As	O	ADP	O
in	O	ADP	O
Tb	O	NOUN	B
,	O	PUNCT	O
U6	B-GENE	NOUN	B
is	O	AUX	O
a	O	DET	O
single	O	ADJ	B
-	O	PUNCT	O
copy	O	NOUN	B
gene	O	NOUN	I
and	O	CCONJ	O
two	O	NUM	O
tRNA	O	NOUN	B
genes	O	NOUN	I
,	O	PUNCT	O
tRNAGln	B-GENE	NOUN	B
and	O	CCONJ	O
tRNAIle	B-GENE	NOUN	B
,	O	PUNCT	O
are	O	AUX	O
found	O	VERB	O
upstream	O	ADJ	B
to	O	PART	O
the	O	DET	O
gene	O	NOUN	B
.	O	PUNCT	O


2	O	X	O
.	O	PUNCT	O


Two	O	NUM	O
mammalian	O	ADJ	B
enzymes	O	NOUN	B
,	O	PUNCT	O
the	O	DET	O
haem	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
controlled	I-GENE	VERB	B
repressor	I-GENE	NOUN	I
(	O	PUNCT	O
HCR	B-GENE	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
the	O	DET	O
double	B-GENE	ADJ	B
-	I-GENE	PUNCT	O
stranded	I-GENE	VERB	B
RNA	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
activated	I-GENE	VERB	B
inhibitor	I-GENE	NOUN	B
(	O	PUNCT	O
dsI	B-GENE	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
phosphorylate	O	VERB	B
Ser	O	NOUN	B
-	O	PUNCT	O
51	O	NUM	O
of	O	ADP	O
the	O	DET	O
alpha	O	NOUN	B
subunit	O	NOUN	I
,	O	PUNCT	O
thereby	O	ADV	O
inhibiting	O	VERB	B
the	O	DET	O
exchange	O	NOUN	B
of	O	ADP	O
bound	O	VERB	B
nucleotides	O	NOUN	B
on	O	ADP	O
,	O	PUNCT	O
and	O	CCONJ	O
thus	O	ADV	O
the	O	DET	O
recycling	O	NOUN	B
of	O	ADP	O
,	O	PUNCT	O
eIF	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
2	I-GENE	NUM	B
.	O	PUNCT	O


A	O	DET	O
triple	O	ADJ	B
Ser	O	NOUN	B
-	O	PUNCT	O
-	O	PUNCT	O
>	O	X	O
Ala	O	NOUN	B
mutant	O	ADJ	I
form	O	NOUN	O
of	O	ADP	O
yeast	O	NOUN	B
eIF	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
2	I-GENE	NUM	B
alpha	I-GENE	NOUN	I
was	O	AUX	O
found	O	VERB	O
to	O	PART	O
be	O	AUX	O
no	O	DET	O
longer	O	ADV	O
phosphorylated	O	VERB	B
by	O	ADP	O
either	O	DET	O
of	O	ADP	O
the	O	DET	O
yeast	O	NOUN	B
(	O	PUNCT	O
or	O	CCONJ	O
mammalian	O	ADJ	B
)	O	PUNCT	O
casein	B-GENE	NOUN	B
kinase	I-GENE	NOUN	I
activities	O	NOUN	O
in	O	X	B
vitro	O	X	I
.	O	PUNCT	O


Binding	O	NOUN	B
activity	O	NOUN	I
in	O	ADP	O
rat	O	NOUN	B
liver	O	NOUN	B
nuclear	O	ADJ	I
extracts	O	NOUN	I
includes	O	VERB	O
these	O	DET	O
orphan	O	NOUN	B
receptors	O	NOUN	I
as	O	ADP	O
judged	O	VERB	O
from	O	ADP	O
electromobility	O	NOUN	B
supershift	O	NOUN	I
experiments	O	NOUN	I
and	O	CCONJ	O
from	O	ADP	O
results	O	NOUN	B
obtained	O	VERB	O
with	O	ADP	O
expressed	O	VERB	B
receptors	O	NOUN	I
,	O	PUNCT	O
although	O	SCONJ	O
the	O	DET	O
element	O	NOUN	B
in	O	ADP	O
CYP2C11	B-GENE	NOUN	B
did	O	AUX	O
not	O	PART	O
bind	O	VERB	B
HNF	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
4	I-GENE	NUM	O
.	O	PUNCT	O


Transcript	O	NOUN	B
analysis	O	NOUN	B
reveals	O	VERB	O
that	O	SCONJ	O
lethal	O	ADJ	B
B	B-GENE	NOUN	I
block	I-GENE	NOUN	I
substitutions	O	NOUN	I
reduce	O	VERB	O
U6	B-GENE	NOUN	B
RNA	I-GENE	NOUN	I
synthesis	O	NOUN	B
at	O	ADP	O
least	O	ADJ	O
10	O	NUM	O
-	O	PUNCT	O
fold	O	ADJ	B
in	O	X	B
vivo	O	X	I
and	O	CCONJ	O
20	O	NUM	O
-	O	PUNCT	O
fold	O	ADJ	B
in	O	X	B
vitro	O	X	I
.	O	PUNCT	O


Lung	O	NOUN	B
function	O	NOUN	I
tests	O	NOUN	I
(	O	PUNCT	O
EFR	O	NOUN	B
)	O	PUNCT	O
were	O	AUX	O
performed	O	VERB	O
on	O	ADP	O
these	O	DET	O
patients	O	NOUN	B
for	O	ADP	O
a	O	DET	O
period	O	NOUN	B
of	O	ADP	O
19	O	NUM	O
.	O	PUNCT	O
2	O	NUM	O
+	O	CCONJ	O
/	O	SYM	O
-	O	PUNCT	O
3	O	NUM	O
.	O	PUNCT	O
4	O	NUM	O
months	O	NOUN	B
.	O	PUNCT	O


Staphylococcus	O	X	B
aureus	O	X	I
and	O	CCONJ	O
CNS	O	NOUN	B
showed	O	VERB	O
high	O	ADJ	B
or	O	CCONJ	O
moderate	O	ADJ	B
resistance	O	NOUN	B
rates	O	NOUN	O
to	O	PART	O
methicillin	O	NOUN	B
(	O	PUNCT	O
DMPPC	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Hybridization	O	NOUN	B
signals	O	NOUN	B
were	O	AUX	O
also	O	ADV	O
detected	O	VERB	B
with	O	ADP	O
total	O	ADJ	O
DNAs	O	NOUN	B
of	O	ADP	O
Rhizobium	O	NOUN	B
leguminosarum	O	X	I
bv	O	NOUN	I
.	O	PUNCT	O
phaseoli	O	NOUN	B
,	O	PUNCT	O
Rhodobacter	O	NOUN	B
capsulatus	O	X	I
and	O	CCONJ	O
Escherichia	O	X	B
coli	O	X	I
,	O	PUNCT	O
but	O	CCONJ	O
not	O	PART	O
those	O	DET	O
of	O	ADP	O
Xanthomonas	O	X	B
campestris	O	X	I
pv	O	X	I
.	O	PUNCT	O
campestris	O	X	B
and	O	CCONJ	O
Pseudomonas	O	X	B
putida	O	NOUN	I
.	O	PUNCT	O


Serum	O	NOUN	B
induction	O	NOUN	B
of	O	ADP	O
a	O	DET	O
MEF2	B-GENE	NOUN	B
reporter	I-GENE	NOUN	I
gene	I-GENE	NOUN	I
was	O	AUX	O
not	O	PART	O
observed	O	VERB	O
in	O	ADP	O
a	O	DET	O
line	O	NOUN	O
of	O	ADP	O
NIH	O	NOUN	B
3T3	O	NOUN	I
cells	O	NOUN	I
which	O	DET	O
contain	O	VERB	O
low	O	ADJ	B
MEF2	B-GENE	NOUN	B
site	I-GENE	NOUN	I
binding	O	NOUN	B
activity	O	NOUN	I
.	O	PUNCT	O


Since	O	SCONJ	O
AP	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	O
is	O	AUX	O
an	O	DET	O
important	O	ADJ	O
mediator	O	NOUN	O
of	O	ADP	O
tumor	O	NOUN	B
promoter	O	NOUN	O
action	O	NOUN	O
,	O	PUNCT	O
these	O	DET	O
findings	O	NOUN	B
may	O	AUX	O
explain	O	VERB	O
the	O	DET	O
anti	O	ADJ	B
-	O	PUNCT	O
tumor	O	NOUN	B
-	O	PUNCT	O
promoting	O	VERB	B
activity	O	NOUN	B
of	O	ADP	O
phenolic	O	ADJ	B
antioxidants	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
second	O	ADJ	O
complex	O	NOUN	B
,	O	PUNCT	O
when	O	SCONJ	O
purified	O	VERB	B
,	O	PUNCT	O
contained	O	VERB	O
four	O	NUM	O
protein	O	NOUN	B
components	O	NOUN	I
including	O	VERB	O
the	O	DET	O
36	O	NUM	O
-	O	PUNCT	O
kDa	O	NOUN	B
protein	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
study	O	NOUN	B
was	O	AUX	O
repeated	O	VERB	O
after	O	ADP	O
administration	O	NOUN	B
of	O	ADP	O
oral	O	ADJ	B
amiodarone	O	NOUN	I
,	O	PUNCT	O
50	O	NUM	O
mg	O	NOUN	O
/	O	SYM	O
kg	O	NOUN	B
/	O	SYM	O
day	O	NOUN	B
for	O	ADP	O
2	O	NUM	O
days	O	NOUN	B
in	O	ADP	O
8	O	NUM	O
divided	O	ADJ	B
doses	O	NOUN	I
(	O	PUNCT	O
mean	O	NOUN	B
dose	O	NOUN	I
6	O	NUM	O
.	O	PUNCT	O
9	O	NUM	O
+	O	CCONJ	O
/	O	SYM	O
-	O	PUNCT	O
0	O	NUM	O
.	O	PUNCT	O
4	O	NUM	O
g	O	NOUN	O
)	O	PUNCT	O
.	O	PUNCT	O


The	O	DET	O
other	O	ADJ	O
two	O	NUM	O
clones	O	NOUN	B
,	O	PUNCT	O
Ash	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
m	I-GENE	PROPN	B
and	I-GENE	CCONJ	O
-	I-GENE	PUNCT	O
s	I-GENE	PROPN	O
,	O	PUNCT	O
had	O	AUX	O
nucleotide	O	NOUN	B
sequences	O	NOUN	I
identical	O	ADJ	B
with	O	ADP	O
Ash	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
l	I-GENE	NOUN	O
cDNA	O	NOUN	B
in	O	ADP	O
the	O	DET	O
amino	O	NOUN	B
-	O	PUNCT	O
terminal	O	ADJ	B
region	O	NOUN	O
.	O	PUNCT	O


MATERIAL	O	NOUN	B
AND	O	CCONJ	O
METHODS	O	NOUN	O
:	O	PUNCT	O
Of	O	ADP	O
the	O	DET	O
17	O	NUM	O
men	O	NOUN	B
and	O	CCONJ	O
17	O	NUM	O
women	O	NOUN	B
,	O	PUNCT	O
who	O	PRON	O
were	O	AUX	O
21	O	NUM	O
to	O	PART	O
80	O	NUM	O
years	O	NOUN	B
of	O	ADP	O
age	O	NOUN	B
,	O	PUNCT	O
27	O	NUM	O
had	O	AUX	O
hereditary	O	ADJ	B
motor	O	NOUN	I
and	O	CCONJ	O
sensory	O	ADJ	B
neuropathy	O	NOUN	I
type	O	NOUN	I
I	O	NUM	I
and	O	CCONJ	O
7	O	NUM	O
had	O	AUX	O
acquired	O	VERB	B
demyelinating	O	VERB	B
polyneuropathy	O	NOUN	I
.	O	PUNCT	O


Muscle	B-GENE	PROPN	B
GSH	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
Px	I-GENE	NOUN	B
activity	O	NOUN	B
after	O	ADP	O
prolonged	O	ADJ	B
exercise	O	NOUN	B
,	O	PUNCT	O
training	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
selenium	O	NOUN	B
supplementation	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
found	O	VERB	O
that	O	SCONJ	O
PML	B-GENE	NOUN	B
was	O	AUX	O
expressed	O	VERB	B
at	O	ADP	O
a	O	DET	O
lower	O	ADJ	O
level	O	NOUN	B
in	O	ADP	O
S	O	NOUN	B
,	O	PUNCT	O
G2	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
M	O	NOUN	B
phases	O	NOUN	I
and	O	CCONJ	O
at	O	ADP	O
a	O	DET	O
significantly	O	ADV	O
higher	O	ADJ	O
level	O	NOUN	B
in	O	ADP	O
G1	O	NOUN	B
phase	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
roxithromycin	O	NOUN	B
doses	O	NOUN	B
that	O	PRON	O
were	O	AUX	O
chosen	O	VERB	O
for	O	ADP	O
these	O	DET	O
studies	O	NOUN	B
were	O	AUX	O
less	O	ADJ	O
than	O	ADP	O
achievable	O	ADJ	O
blood	O	NOUN	B
levels	O	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
demonstrate	O	VERB	O
here	O	ADV	O
that	O	SCONJ	O
the	O	DET	O
-	O	PUNCT	O
DEDDDL	O	NOUN	B
sequence	O	NOUN	B
stabilizes	O	VERB	B
GDP	O	NOUN	B
binding	O	NOUN	B
to	O	PART	O
Ran	B-GENE	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
that	O	SCONJ	O
the	O	DET	O
domain	O	NOUN	B
is	O	AUX	O
required	O	VERB	O
for	O	ADP	O
high	O	ADJ	O
affinity	O	NOUN	B
interaction	O	NOUN	B
with	O	ADP	O
a	O	DET	O
Ran	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
binding	I-GENE	VERB	B
protein	I-GENE	NOUN	I
,	O	PUNCT	O
HTF9A	B-GENE	NOUN	B
/	O	SYM	O
RanBP1	B-GENE	NOUN	B
.	O	PUNCT	O


Serial	O	ADJ	O
followup	O	NOUN	B
strength	O	NOUN	O
data	O	NOUN	B
for	O	ADP	O
2	O	NUM	O
patients	O	NOUN	B
were	O	AUX	O
compared	O	VERB	O
to	O	PART	O
change	O	VERB	O
in	O	ADP	O
creatinine	B-GENE	NOUN	B
kinase	I-GENE	NOUN	I
(	O	PUNCT	O
CK	B-GENE	NOUN	B
)	O	PUNCT	O
levels	O	NOUN	B
.	O	PUNCT	O


Transfection	O	NOUN	B
of	O	ADP	O
non	O	ADJ	B
-	O	PUNCT	O
deleted	O	VERB	B
expression	O	NOUN	B
vector	O	NOUN	I
into	O	ADP	O
NIH3T3	O	NOUN	B
cells	O	NOUN	I
results	O	VERB	B
in	O	ADP	O
acquisition	O	NOUN	B
of	O	ADP	O
focus	O	NOUN	B
-	O	PUNCT	O
forming	O	VERB	B
activity	O	NOUN	B
while	O	SCONJ	O
a	O	DET	O
deleted	O	ADJ	O
form	O	NOUN	O
of	O	ADP	O
expression	O	NOUN	B
vector	O	NOUN	I
fails	O	VERB	B
to	O	PART	O
show	O	VERB	O
this	O	DET	O
activity	O	NOUN	B
even	O	ADV	O
in	O	ADP	O
the	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
basic	B-GENE	ADJ	O
FGF	I-GENE	NOUN	B
.	O	PUNCT	O


All	O	DET	O
ribosomal	B-GENE	ADJ	B
protein	I-GENE	NOUN	I
(	O	PUNCT	O
rp	B-GENE	NOUN	O
)	O	PUNCT	O
gene	O	NOUN	B
promoters	O	NOUN	I
from	O	ADP	O
Saccharomyces	O	X	B
cerevisiae	O	X	I
studied	O	VERB	O
so	O	ADV	O
far	O	ADV	O
contain	O	VERB	O
either	O	CCONJ	O
(	O	PUNCT	O
usually	O	ADV	O
two	O	NUM	O
)	O	PUNCT	O
binding	O	NOUN	B
sites	O	NOUN	I
for	O	ADP	O
the	O	DET	O
global	O	ADJ	B
gene	O	NOUN	I
regulator	O	NOUN	I
Rap1p	B-GENE	NOUN	B
or	O	CCONJ	O
one	O	NUM	O
binding	O	VERB	B
site	O	NOUN	I
for	O	ADP	O
another	O	DET	O
global	O	ADJ	B
factor	O	NOUN	I
,	O	PUNCT	O
Abf1p	B-GENE	NOUN	B
.	O	PUNCT	O


CONCLUSION	O	NOUN	O
:	O	PUNCT	O
The	O	DET	O
MTD	O	NOUN	B
for	O	ADP	O
CPT	O	PROPN	B
-	O	PUNCT	O
11	O	NUM	O
administered	O	VERB	B
in	O	ADP	O
a	O	DET	O
3	O	NUM	O
consecutive	O	ADJ	B
-	O	PUNCT	O
days	O	NOUN	B
-	O	PUNCT	O
every	O	DET	B
-	O	PUNCT	O
3	O	NUM	O
weeks	O	NOUN	B
schedule	O	NOUN	B
in	O	ADP	O
this	O	DET	O
patient	O	NOUN	B
population	O	NOUN	I
is	O	AUX	O
115	O	NUM	O
mg	O	NOUN	O
/	O	SYM	O
m2	O	PROPN	B
/	O	SYM	O
day	O	NOUN	B
.	O	PUNCT	O


Otte	O	PROPN	B
,	O	PUNCT	O
Mol	O	PROPN	O
.	O	PUNCT	O


A	O	DET	O
secondary	O	ADJ	B
phosphorylation	O	NOUN	B
of	O	ADP	O
CREB341	B-GENE	NOUN	B
at	O	ADP	O
Ser129	O	NOUN	B
is	O	AUX	O
required	O	VERB	O
for	O	ADP	O
the	O	DET	O
cAMP	O	NOUN	B
-	O	PUNCT	O
mediated	O	VERB	B
control	O	NOUN	I
of	O	ADP	O
gene	O	NOUN	B
expression	O	NOUN	I
.	O	PUNCT	O


A	O	DET	O
role	O	NOUN	O
for	O	ADP	O
glycogen	B-GENE	NOUN	B
synthase	I-GENE	NOUN	I
kinase	I-GENE	NOUN	I
-	I-GENE	PUNCT	O
3	I-GENE	NUM	O
in	O	ADP	O
the	O	DET	O
control	O	NOUN	B
of	O	ADP	O
gene	O	NOUN	B
expression	O	NOUN	I
.	O	PUNCT	O


Reconstitution	O	NOUN	B
of	O	ADP	O
complexes	O	NOUN	B
containing	O	VERB	O
p62	B-GENE	NOUN	B
and	O	CCONJ	O
the	O	DET	O
src	B-GENE	NOUN	B
family	I-GENE	NOUN	I
kinase	I-GENE	NOUN	I
p59fyn	B-GENE	NOUN	I
in	O	ADP	O
HeLa	O	NOUN	B
cells	O	NOUN	I
demonstrated	O	VERB	O
that	O	SCONJ	O
complex	O	NOUN	B
formation	O	NOUN	B
resulted	O	VERB	O
in	O	ADP	O
tyrosine	O	NOUN	B
phosphorylation	O	NOUN	B
of	O	ADP	O
p62	B-GENE	NOUN	B
and	O	CCONJ	O
was	O	AUX	O
mediated	O	VERB	O
by	O	ADP	O
both	O	CCONJ	O
the	O	DET	O
SH3	B-GENE	NOUN	B
and	O	CCONJ	O
SH2	B-GENE	NOUN	B
domains	I-GENE	NOUN	I
of	O	ADP	O
p59fyn	B-GENE	NOUN	B
.	O	PUNCT	O


Protein	B-GENE	NOUN	B
cHMGI	I-GENE	NOUN	I
binds	O	VERB	B
preferentially	O	ADV	O
to	O	ADP	O
AT	O	ADP	B
-	O	PUNCT	O
rich	O	ADJ	B
DNA	O	NOUN	B
with	O	ADP	O
a	O	DET	O
half	O	NOUN	B
-	O	PUNCT	O
saturation	O	NOUN	B
value	O	NOUN	O
of	O	ADP	O
1	O	NUM	O
.	O	PUNCT	O
1	O	NUM	O
nM	O	NOUN	O
.	O	PUNCT	O


The	O	DET	O
U14	B-GENE	NOUN	B
genes	I-GENE	NOUN	I
of	O	ADP	O
mouse	O	NOUN	B
as	O	ADV	O
well	O	ADV	O
as	O	ADP	O
rat	O	NOUN	B
,	O	PUNCT	O
hamster	O	NOUN	B
,	O	PUNCT	O
human	O	ADJ	B
,	O	PUNCT	O
Xenopus	O	NOUN	B
and	O	CCONJ	O
trout	O	NOUN	B
are	O	AUX	O
encoded	O	VERB	B
within	O	ADP	O
introns	O	NOUN	B
of	O	ADP	O
the	O	DET	O
constitutively	O	ADV	B
expressed	O	VERB	B
70	B-GENE	NUM	O
-	I-GENE	PUNCT	O
kDa	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
cognate	I-GENE	ADJ	B
-	I-GENE	PUNCT	O
heat	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
shock	I-GENE	NOUN	B
protein	I-GENE	NOUN	I
gene	I-GENE	NOUN	I
(	O	PUNCT	O
hsc70	B-GENE	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Inclusion	O	NOUN	B
in	O	ADP	O
this	O	DET	O
family	O	NOUN	B
of	O	ADP	O
proteins	O	NOUN	B
suggests	O	VERB	O
that	O	SCONJ	O
FliQ	B-GENE	NOUN	B
and	O	CCONJ	O
FliR	B-GENE	NOUN	B
may	O	AUX	O
participate	O	VERB	B
in	O	ADP	O
an	O	DET	O
export	O	NOUN	B
pathway	O	NOUN	I
required	O	VERB	O
for	O	ADP	O
flagellum	O	NOUN	B
assembly	O	NOUN	B
.	O	PUNCT	O


Coronary	O	ADJ	B
vasoconstriction	O	NOUN	I
caused	O	VERB	O
by	O	ADP	O
endothelin	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	O
is	O	AUX	O
enhanced	O	VERB	B
by	O	ADP	O
ischemia	O	NOUN	B
-	O	PUNCT	O
reperfusion	O	NOUN	B
and	O	CCONJ	O
by	O	ADP	O
norepinephrine	O	NOUN	B
present	O	ADJ	O
in	O	ADP	O
concentrations	O	NOUN	B
typically	O	ADV	O
observed	O	VERB	O
after	O	ADP	O
neonatal	O	ADJ	B
cardiopulmonary	O	NOUN	B
bypass	O	NOUN	I
.	O	PUNCT	O


Atcys1	B-GENE	NOUN	B
,	O	PUNCT	O
Athyp1	B-GENE	NOUN	B
,	O	PUNCT	O
AKin10	B-GENE	NOUN	B
and	O	CCONJ	O
the	O	DET	O
ORF	O	NOUN	B
are	O	AUX	O
very	O	ADV	O
close	O	ADJ	O
to	O	ADP	O
each	O	DET	O
other	O	ADJ	O
and	O	CCONJ	O
organized	O	VERB	B
in	O	ADP	O
the	O	DET	O
same	O	ADJ	O
polarity	O	NOUN	B
;	O	PUNCT	O
hence	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
intergenic	O	ADJ	B
regions	O	NOUN	I
probably	O	ADV	O
contain	O	VERB	O
,	O	PUNCT	O
within	O	ADP	O
less	O	ADJ	O
than	O	ADP	O
0	O	NUM	O
.	O	PUNCT	O
5	O	NUM	O
kb	O	NOUN	O
,	O	PUNCT	O
all	O	DET	O
the	O	DET	O
regulatory	O	ADJ	B
elements	O	NOUN	I
necessary	O	ADJ	O
to	O	PART	O
govern	O	VERB	O
initiation	O	NOUN	B
and	O	CCONJ	O
termination	O	NOUN	B
of	O	ADP	O
transcription	O	NOUN	B
.	O	PUNCT	O


Southern	O	NOUN	B
blot	O	NOUN	I
hybridization	O	NOUN	I
experiments	O	NOUN	B
suggest	O	VERB	O
the	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
one	O	NUM	O
copy	O	NOUN	B
of	O	ADP	O
Atcys1	B-GENE	NOUN	B
,	O	PUNCT	O
Athyp1	B-GENE	NOUN	B
and	O	CCONJ	O
AKin10	B-GENE	NOUN	B
per	O	ADP	O
haploid	O	NOUN	B
genome	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
Northern	O	NOUN	B
blot	O	NOUN	I
analysis	O	NOUN	I
demonstrates	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
three	O	NUM	O
genes	O	NOUN	B
are	O	AUX	O
differentially	O	ADV	O
expressed	O	VERB	B
in	O	ADP	O
roots	O	NOUN	B
,	O	PUNCT	O
shoots	O	NOUN	B
and	O	CCONJ	O
leaves	O	NOUN	B
.	O	PUNCT	O


Between	O	ADP	O
the	O	DET	O
subgroups	O	NOUN	B
of	O	ADP	O
dementia	O	NOUN	B
disorders	O	NOUN	I
there	O	PRON	O
were	O	AUX	O
no	O	DET	O
significant	O	ADJ	O
differences	O	NOUN	O
in	O	ADP	O
basal	O	ADJ	B
cortisol	O	NOUN	I
levels	O	NOUN	I
.	O	PUNCT	O


Basal	O	ADJ	B
components	O	NOUN	I
of	O	ADP	O
the	O	DET	O
transcription	O	NOUN	B
apparatus	O	NOUN	I
(	O	PUNCT	O
RNA	B-GENE	NOUN	B
polymerase	I-GENE	NOUN	I
II	I-GENE	NUM	I
,	O	PUNCT	O
TATA	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
binding	I-GENE	VERB	B
protein	I-GENE	NOUN	I
)	O	PUNCT	O
contain	O	VERB	O
activation	O	NOUN	B
domains	O	NOUN	I
:	O	PUNCT	O
is	O	AUX	O
the	O	DET	O
repetitive	O	ADJ	B
C	O	NOUN	I
-	O	PUNCT	O
terminal	O	ADJ	B
domain	O	NOUN	I
(	O	PUNCT	O
CTD	O	NOUN	B
)	O	PUNCT	O
of	O	ADP	O
RNA	B-GENE	NOUN	B
polymerase	I-GENE	NOUN	I
II	I-GENE	NUM	I
a	O	DET	O
"	O	PUNCT	O
portable	O	ADJ	B
enhancer	O	NOUN	I
domain	O	NOUN	I
"	O	PUNCT	O
?	O	PUNCT	O
Regions	O	NOUN	B
rich	O	ADJ	O
in	O	ADP	O
serine	O	NOUN	B
,	O	PUNCT	O
threonine	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
proline	O	NOUN	B
residues	O	NOUN	I
can	O	AUX	O
be	O	AUX	O
found	O	VERB	O
in	O	ADP	O
transcriptional	O	ADJ	B
activation	O	NOUN	I
domains	O	NOUN	O
,	O	PUNCT	O
as	O	ADV	O
well	O	ADV	O
as	O	ADP	O
in	O	ADP	O
the	O	DET	O
N	O	NOUN	B
-	O	PUNCT	O
terminal	O	ADJ	B
parts	O	NOUN	B
of	O	ADP	O
mammalian	B-GENE	ADJ	B
TATA	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
binding	I-GENE	VERB	B
proteins	I-GENE	NOUN	I
,	O	PUNCT	O
where	O	SCONJ	O
they	O	PRON	O
are	O	AUX	O
interrupted	O	VERB	B
by	O	ADP	O
polyglutamine	O	NOUN	B
stretches	O	NOUN	O
.	O	PUNCT	O


Mutagenesis	O	NOUN	B
of	O	ADP	O
IM1	B-GENE	NOUN	B
enhances	O	VERB	B
the	O	DET	O
ability	O	NOUN	O
of	O	ADP	O
c	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
Fos	I-GENE	NOUN	B
to	O	PART	O
activate	O	VERB	B
an	O	DET	O
AP1	B-GENE	NOUN	B
bearing	I-GENE	NOUN	O
promoter	I-GENE	NOUN	B
.	O	PUNCT	O


Self	O	NOUN	B
or	O	CCONJ	O
foreign	O	ADJ	B
cellular	O	ADJ	I
proteins	O	NOUN	I
provide	O	VERB	O
peptides	O	NOUN	B
for	O	ADP	O
presentation	O	NOUN	B
by	O	ADP	O
major	B-GENE	ADJ	O
histocompatibility	I-GENE	NOUN	O
complex	I-GENE	NOUN	O
(	I-GENE	PUNCT	O
MHC	I-GENE	NOUN	B
)	I-GENE	PUNCT	O
class	I-GENE	NOUN	B
I	I-GENE	NUM	I
molecules	I-GENE	NOUN	B
on	O	ADP	O
the	O	DET	O
surface	O	NOUN	B
of	O	ADP	O
antigen	O	NOUN	O
presenting	O	NOUN	O
cells	O	NOUN	O
(	O	PUNCT	O
APC	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
cotransfection	O	NOUN	B
studies	O	NOUN	I
indicate	O	VERB	O
that	O	SCONJ	O
RVR	B-GENE	NOUN	B
does	O	AUX	O
not	O	PART	O
activate	O	VERB	B
transcription	O	NOUN	B
when	O	SCONJ	O
this	O	DET	O
hormone	O	NOUN	B
response	O	NOUN	I
element	O	NOUN	I
is	O	AUX	O
linked	O	VERB	O
to	O	PART	O
a	O	DET	O
reporter	O	NOUN	B
gene	O	NOUN	I
but	O	CCONJ	O
rather	O	ADV	O
acts	O	VERB	O
as	O	ADP	O
a	O	DET	O
potent	O	ADJ	O
competitive	O	ADJ	B
repressor	O	NOUN	B
of	O	ADP	O
ROR	B-GENE	NOUN	B
alpha	I-GENE	NOUN	I
function	O	NOUN	I
.	O	PUNCT	O


Molecular	O	ADJ	B
cloning	O	NOUN	I
and	O	CCONJ	O
sequencing	O	NOUN	B
of	O	ADP	O
a	O	DET	O
cDNA	O	NOUN	B
encoding	O	NOUN	O
SR	B-GENE	ADJ	B
beta	I-GENE	NOUN	O
revealed	O	VERB	O
that	O	SCONJ	O
SR	B-GENE	ADJ	B
beta	I-GENE	NOUN	O
is	O	AUX	O
a	O	DET	O
transmembrane	O	ADJ	B
protein	O	NOUN	I
and	O	CCONJ	O
,	O	PUNCT	O
like	O	ADP	O
SR	B-GENE	ADJ	B
alpha	I-GENE	NOUN	I
and	O	CCONJ	O
SRP54	B-GENE	NOUN	B
,	O	PUNCT	O
is	O	AUX	O
a	O	DET	O
member	O	NOUN	B
of	O	ADP	O
the	O	DET	O
GTPase	B-GENE	NOUN	B
superfamily	I-GENE	NOUN	B
.	O	PUNCT	O


To	O	PART	O
understand	O	VERB	O
the	O	DET	O
function	O	NOUN	B
of	O	ADP	O
receptor	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
linked	I-GENE	VERB	B
tyrosine	I-GENE	NOUN	B
phosphatases	I-GENE	NOUN	I
in	O	ADP	O
neural	O	ADJ	B
development	O	NOUN	I
,	O	PUNCT	O
we	O	PRON	O
sought	O	VERB	O
to	O	PART	O
identify	O	VERB	O
LAR	B-GENE	NOUN	B
isoforms	I-GENE	NOUN	B
preferentially	O	ADV	O
expressed	O	VERB	B
in	O	ADP	O
the	O	DET	O
nervous	O	ADJ	B
system	O	NOUN	I
and	O	CCONJ	O
cellular	O	ADJ	B
processes	O	NOUN	I
regulating	O	VERB	O
LAR	B-GENE	NOUN	B
alternative	O	ADJ	B
splicing	O	NOUN	I
.	O	PUNCT	O


135	O	NUM	O
students	O	NOUN	B
had	O	AUX	O
a	O	DET	O
count	O	NOUN	B
of	O	ADP	O
less	O	ADJ	O
than	O	ADP	O
50	O	NUM	O
eggs	O	NOUN	B
/	O	SYM	O
10	O	NUM	O
ml	O	NOUN	O
.	O	PUNCT	O
urine	O	NOUN	B
and	O	CCONJ	O
56	O	NUM	O
had	O	AUX	O
more	O	ADJ	O
than	O	ADP	O
50	O	NUM	O
eggs	O	NOUN	B
/	O	SYM	O
10ml	O	ADJ	B
.	O	PUNCT	O


Chrispeels	O	PROPN	B
[	O	PUNCT	O
1993	O	NUM	O
]	O	PUNCT	O
EMBO	O	PROPN	O
J	O	PROPN	O
12	O	NUM	O
:	O	PUNCT	O
2241	O	NUM	O
-	O	SYM	O
2247	O	NUM	O
)	O	PUNCT	O
.	O	PUNCT	O


The	O	DET	O
mRNAs	O	NOUN	B
of	O	ADP	O
the	O	DET	O
GRF	B-GENE	NOUN	B
genes	I-GENE	NOUN	O
are	O	AUX	O
encoded	O	VERB	B
by	O	ADP	O
six	O	NUM	O
exons	O	NOUN	B
interrupted	O	VERB	B
by	O	ADP	O
five	O	NUM	O
introns	O	NOUN	B
.	O	PUNCT	O


A	O	DET	O
major	O	ADJ	O
task	O	NOUN	O
for	O	ADP	O
sports	O	NOUN	B
scientists	O	NOUN	B
may	O	AUX	O
be	O	AUX	O
to	O	PART	O
verify	O	VERB	O
empirically	O	ADV	O
the	O	DET	O
nature	O	NOUN	B
of	O	ADP	O
an	O	DET	O
integrated	O	ADJ	B
model	O	NOUN	I
of	O	ADP	O
the	O	DET	O
sport	O	NOUN	B
performer	O	NOUN	I
.	O	PUNCT	O


Removal	O	NOUN	B
of	O	ADP	O
the	O	DET	O
GST	B-GENE	NOUN	B
domain	I-GENE	NOUN	O
from	O	ADP	O
GST	B-GENE	NOUN	B
-	O	PUNCT	O
Tax	B-GENE	NOUN	B
by	O	ADP	O
thrombin	B-GENE	NOUN	B
restores	O	VERB	B
Tax	B-GENE	NOUN	B
'	O	PART	O
s	O	NOUN	O
ability	O	NOUN	O
to	O	PART	O
assemble	O	VERB	B
a	O	DET	O
ternary	O	ADJ	B
Tax	B-GENE	NOUN	B
-	O	PUNCT	O
CREB	B-GENE	PROPN	B
-	O	PUNCT	O
21	O	NUM	B
-	O	PUNCT	O
bp	O	NOUN	B
-	O	PUNCT	O
repeat	O	NOUN	B
complex	O	NOUN	B
.	O	PUNCT	O
(	O	PUNCT	O
ABSTRACT	O	NOUN	B
TRUNCATED	O	VERB	I
AT	O	ADP	I
400	O	NUM	I
WORDS	O	NOUN	I
)	O	PUNCT	O


Specific	O	ADJ	O
binding	O	NOUN	B
was	O	AUX	O
not	O	PART	O
observed	O	VERB	O
with	O	ADP	O
either	O	CCONJ	O
the	O	DET	O
orthologous	O	ADJ	B
rat	O	NOUN	B
or	O	CCONJ	O
mouse	O	NOUN	B
fragments	O	NOUN	I
using	O	VERB	O
human	O	ADJ	B
or	O	CCONJ	O
rodent	O	ADJ	B
extracts	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
attempted	O	VERB	O
to	O	PART	O
clone	O	NOUN	B
two	O	NUM	O
recessive	O	ADJ	B
extragenic	O	ADJ	I
suppressors	O	NOUN	I
of	O	ADP	O
such	O	ADJ	O
ts	O	NOUN	B
mutants	O	NOUN	B
(	O	PUNCT	O
sdp1	B-GENE	NOUN	B
for	O	ADP	O
mutation	B-GENE	NOUN	B
pol3	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
14	I-GENE	NUM	B
and	O	CCONJ	O
sdp5	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	O
for	O	ADP	O
mutation	B-GENE	NOUN	B
pol3	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
11	I-GENE	NUM	O
)	O	PUNCT	O
by	O	ADP	O
transforming	O	VERB	B
thermoresistant	O	ADJ	I
haploid	O	NOUN	I
strains	O	NOUN	I
pol3	B-GENE	NOUN	O
-	I-GENE	PUNCT	O
14	I-GENE	NUM	O
sdp1	I-GENE	NOUN	B
and	O	CCONJ	O
pol3	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
11	I-GENE	NUM	O
sdp5	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	O
with	O	ADP	O
wild	O	ADJ	B
-	O	PUNCT	O
type	O	NOUN	B
genomic	O	ADJ	B
libraries	O	NOUN	I
in	O	ADP	O
singlecopy	O	NOUN	B
or	O	CCONJ	O
multicopy	O	ADJ	B
vectors	O	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
acute	O	ADJ	B
-	O	PUNCT	O
phase	O	NOUN	B
livers	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
observed	O	VERB	O
a	O	DET	O
dramatic	O	ADJ	O
reduction	O	NOUN	B
in	O	ADP	O
HNF	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
3	I-GENE	NUM	O
alpha	I-GENE	NOUN	B
expression	O	NOUN	I
which	O	DET	O
correlates	O	VERB	O
with	O	ADP	O
a	O	DET	O
decrease	O	NOUN	B
in	O	ADP	O
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
its	O	PRON	O
target	O	NOUN	B
gene	O	NOUN	O
,	O	PUNCT	O
the	O	DET	O
TTR	B-GENE	NOUN	B
gene	I-GENE	NOUN	I
.	O	PUNCT	O


Similarly	O	ADV	O
,	O	PUNCT	O
in	O	ADP	O
mammalian	O	ADJ	B
cells	O	NOUN	I
PBP74	B-GENE	NOUN	B
is	O	AUX	O
synthesized	O	VERB	B
as	O	ADP	O
a	O	DET	O
pre	O	ADJ	B
-	O	PUNCT	O
protein	O	NOUN	B
that	O	PRON	O
requires	O	VERB	O
membrane	O	NOUN	B
potential	O	ADJ	B
-	O	PUNCT	O
dependent	O	ADJ	B
import	O	NOUN	B
into	O	ADP	O
mitochondria	O	NOUN	B
for	O	ADP	O
its	O	PRON	O
maturation	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
first	O	ADJ	O
open	O	ADJ	O
reading	O	NOUN	O
frame	O	NOUN	O
of	O	ADP	O
the	O	DET	O
blueberry	O	NOUN	B
scorch	O	NOUN	I
carlavirus	O	NOUN	I
(	O	PUNCT	O
BBScV	O	NOUN	B
)	O	PUNCT	O
genome	O	NOUN	B
encodes	O	VERB	B
a	O	DET	O
putative	O	ADJ	O
replication	O	NOUN	B
-	O	PUNCT	O
associated	O	VERB	B
protein	O	NOUN	B
of	O	ADP	O
223	O	NUM	O
kDa	O	NOUN	O
(	O	PUNCT	O
p223	B-GENE	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


From	O	ADP	O
sequence	O	NOUN	B
alignments	O	NOUN	I
with	O	ADP	O
phylogenetically	O	ADV	B
related	O	ADJ	I
viruses	O	NOUN	I
,	O	PUNCT	O
including	O	VERB	O
tymoviruses	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
predicted	O	VERB	O
that	O	SCONJ	O
p223	B-GENE	NOUN	B
contained	O	VERB	O
a	O	DET	O
papain	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
like	I-GENE	ADJ	B
proteinase	I-GENE	ADJ	B
domain	I-GENE	NOUN	I
with	O	ADP	O
a	O	DET	O
putative	O	ADJ	O
catalytic	O	ADJ	O
cysteine994	O	NOUN	O
and	O	CCONJ	O
histidine1075	O	PROPN	B
.	O	PUNCT	O


The	O	DET	O
p97	B-GENE	NOUN	B
-	O	PUNCT	O
depleted	O	VERB	B
nuclei	O	NOUN	B
remained	O	VERB	O
largely	O	ADV	O
competent	O	ADJ	B
for	O	ADP	O
nuclear	O	ADJ	B
protein	O	NOUN	I
import	O	NOUN	I
.	O	PUNCT	O


Using	O	VERB	O
gel	O	NOUN	B
retardation	O	NOUN	I
assays	O	NOUN	I
with	O	ADP	O
HepG2	O	NOUN	B
nuclear	O	ADJ	B
extract	O	NOUN	I
,	O	PUNCT	O
we	O	PRON	O
demonstrated	O	VERB	O
the	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
a	O	DET	O
specific	O	ADJ	O
protein	O	NOUN	B
which	O	DET	O
bound	O	VERB	O
to	O	PART	O
the	O	DET	O
NRE	O	NOUN	B
fragment	O	NOUN	B
.	O	PUNCT	O


Twenty	O	NUM	B
-	O	PUNCT	O
two	O	NUM	O
consecutive	O	ADJ	B
patients	O	NOUN	B
with	O	ADP	O
ischaemic	O	ADJ	B
ulcers	O	NOUN	I
had	O	AUX	O
tcPO2	O	NOUN	B
measured	O	VERB	B
and	O	CCONJ	O
the	O	DET	O
ankle	O	NOUN	B
/	O	SYM	O
brachial	O	ADJ	B
(	O	PUNCT	O
ABI	O	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
toe	O	NOUN	B
/	O	SYM	O
brachial	O	ADJ	B
(	O	PUNCT	O
TBI	O	NOUN	B
)	O	PUNCT	O
indices	O	NOUN	O
calculated	O	VERB	O
.	O	PUNCT	O


TcPO2	O	NOUN	B
measurement	O	NOUN	B
appears	O	VERB	O
to	O	PART	O
be	O	AUX	O
a	O	DET	O
reliable	O	ADJ	O
technique	O	NOUN	B
that	O	PRON	O
can	O	AUX	O
influence	O	VERB	B
ischaemic	O	ADJ	B
ulcer	O	NOUN	I
management	O	NOUN	B
.	O	PUNCT	O


Expression	O	NOUN	B
of	O	ADP	O
h6	O	NOUN	B
.	O	PUNCT	O
1	O	NUM	O
in	O	ADP	O
COS	O	NOUN	B
-	O	PUNCT	O
1	O	NUM	O
cells	O	NOUN	B
led	O	VERB	O
to	O	PART	O
the	O	DET	O
production	O	NOUN	B
of	O	ADP	O
a	O	DET	O
typical	O	ADJ	O
type	B-GENE	NOUN	B
IV	I-GENE	NUM	I
PDE	I-GENE	NOUN	I
activity	O	NOUN	B
in	O	ADP	O
that	O	DET	O
cAMP	O	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
not	O	PART	O
cGMP	O	NOUN	B
,	O	PUNCT	O
served	O	VERB	O
as	O	ADP	O
substrate	O	NOUN	B
and	O	CCONJ	O
its	O	PRON	O
activity	O	NOUN	B
was	O	AUX	O
insensitive	O	ADJ	O
to	O	PART	O
either	O	CCONJ	O
Ca2	O	NOUN	B
+	O	CCONJ	O
/	O	SYM	O
CaM	B-GENE	NOUN	B
or	O	CCONJ	O
cGMP	O	NOUN	B
but	O	CCONJ	O
was	O	AUX	O
inhibited	O	VERB	B
by	O	ADP	O
low	O	ADJ	B
concentrations	O	NOUN	B
of	O	ADP	O
rolipram	O	NOUN	B
.	O	PUNCT	O
(	O	PUNCT	O
ABSTRACT	O	NOUN	B
TRUNCATED	O	VERB	I
AT	O	ADP	I
400	O	NUM	I
WORDS	O	NOUN	I
)	O	PUNCT	O


The	O	DET	O
PSD2	B-GENE	NOUN	B
gene	I-GENE	NOUN	I
was	O	AUX	O
heterologously	O	ADV	B
expressed	O	VERB	B
by	O	ADP	O
infection	O	NOUN	B
of	O	ADP	O
Sf	O	PROPN	B
-	O	PUNCT	O
9	O	NUM	B
insect	O	NOUN	B
cells	O	NOUN	I
with	O	ADP	O
recombinant	O	ADJ	B
baculovirus	O	NOUN	I
,	O	PUNCT	O
resulting	O	VERB	O
in	O	ADP	O
a	O	DET	O
10	O	NUM	O
-	O	PUNCT	O
fold	O	ADJ	B
increase	O	NOUN	B
in	O	ADP	O
PSD	B-GENE	NOUN	B
activity	O	NOUN	B
.	O	PUNCT	O


Like	O	ADP	O
Epo	B-GENE	NOUN	B
,	O	PUNCT	O
HNF	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
4	I-GENE	NUM	O
is	O	AUX	O
expressed	O	VERB	B
in	O	ADP	O
kidney	O	NOUN	B
,	O	PUNCT	O
liver	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
Hep3B	O	NOUN	B
cells	O	NOUN	I
but	O	CCONJ	O
not	O	PART	O
in	O	ADP	O
HeLa	O	NOUN	B
cells	O	NOUN	I
.	O	PUNCT	O


Moreover	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
hypoxia	O	NOUN	B
-	O	PUNCT	O
induced	O	VERB	B
expression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
endogenous	O	ADJ	B
Epo	B-GENE	NOUN	B
gene	I-GENE	NOUN	I
was	O	AUX	O
significantly	O	ADV	O
inhibited	O	VERB	B
in	O	ADP	O
Hep3B	O	NOUN	B
cells	O	NOUN	I
stably	O	ADV	B
transfected	O	VERB	B
with	O	ADP	O
HNF	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
4	I-GENE	NUM	B
delta	I-GENE	NOUN	I
C	I-GENE	NOUN	I
.	O	PUNCT	O


These	O	DET	O
observations	O	NOUN	B
indicate	O	VERB	O
that	O	SCONJ	O
there	O	PRON	O
are	O	AUX	O
multiple	O	ADJ	O
mechanisms	O	NOUN	B
by	O	ADP	O
which	O	DET	O
an	O	DET	O
individual	O	ADJ	B
transcript	O	NOUN	B
can	O	AUX	O
be	O	AUX	O
degraded	O	VERB	B
following	O	VERB	O
deadenylation	O	NOUN	B
.	O	PUNCT	O


Small	B-GENE	ADJ	B
Maf	I-GENE	NOUN	B
proteins	I-GENE	NOUN	I
heterodimerize	O	VERB	B
with	O	ADP	O
Fos	B-GENE	NOUN	B
and	O	CCONJ	O
may	O	AUX	O
act	O	VERB	O
as	O	ADP	O
competitive	O	ADJ	B
repressors	O	NOUN	B
of	O	ADP	O
the	O	DET	O
NF	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
E2	I-GENE	NOUN	B
transcription	I-GENE	NOUN	B
factor	I-GENE	NOUN	I
.	O	PUNCT	O


Both	O	DET	O
factors	O	NOUN	B
demonstrated	O	VERB	O
significant	O	ADJ	O
correlations	O	NOUN	B
with	O	ADP	O
rCBF	O	NOUN	B
in	O	ADP	O
the	O	DET	O
medial	O	ADJ	B
prefrontal	O	ADJ	B
cortex	O	NOUN	I
and	O	CCONJ	O
frontal	O	ADJ	B
polar	O	ADJ	I
cortex	O	NOUN	I
while	O	SCONJ	O
for	O	ADP	O
each	O	DET	O
factor	O	NOUN	B
there	O	PRON	O
were	O	AUX	O
also	O	ADV	O
unique	O	ADJ	O
patterns	O	NOUN	B
of	O	ADP	O
correlations	O	NOUN	B
with	O	ADP	O
posterior	O	ADJ	B
brain	O	NOUN	I
regions	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
resulting	O	VERB	O
integrated	O	ADJ	B
physical	O	ADJ	I
,	O	PUNCT	O
genetic	O	ADJ	B
,	O	PUNCT	O
and	O	CCONJ	O
cytogenetic	O	ADJ	B
map	O	NOUN	I
constitutes	O	VERB	O
a	O	DET	O
resource	O	NOUN	B
for	O	ADP	O
the	O	DET	O
characterization	O	NOUN	B
of	O	ADP	O
genes	O	NOUN	B
that	O	PRON	O
may	O	AUX	O
be	O	AUX	O
involved	O	VERB	O
in	O	ADP	O
the	O	DET	O
WAGR	O	NOUN	B
syndrome	O	NOUN	I
.	O	PUNCT	O


Three	O	NUM	O
classes	O	NOUN	B
of	O	ADP	O
test	O	NOUN	B
objects	O	NOUN	I
were	O	AUX	O
considered	O	VERB	O
:	O	PUNCT	O
(	O	PUNCT	O
1	O	X	O
)	O	PUNCT	O
a	O	DET	O
multicompartment	O	ADJ	B
test	O	NOUN	I
object	O	NOUN	B
for	O	ADP	O
31P	O	ADJ	B
MRS	O	NOUN	I
measurements	O	NOUN	B
performed	O	VERB	O
with	O	ADP	O
slice	O	NOUN	B
-	O	PUNCT	O
selective	O	ADJ	B
sequences	O	NOUN	I
;	O	PUNCT	O
(	O	PUNCT	O
2	O	X	O
)	O	PUNCT	O
a	O	DET	O
two	O	NUM	O
-	O	PUNCT	O
compartment	O	NOUN	B
test	O	NOUN	O
object	O	NOUN	B
for	O	ADP	O
volume	O	NOUN	B
-	O	PUNCT	O
selection	O	NOUN	B
1H	O	NOUN	O
MRS	O	PROPN	B
;	O	PUNCT	O
and	O	CCONJ	O
(	O	PUNCT	O
3	O	X	O
)	O	PUNCT	O
two	O	NUM	O
-	O	PUNCT	O
compartment	O	NOUN	B
test	O	NOUN	O
objects	O	NOUN	O
for	O	ADP	O
assessing	O	VERB	B
the	O	DET	O
performance	O	NOUN	B
of	O	ADP	O
experimental	O	ADJ	B
systems	O	NOUN	I
using	O	VERB	O
ISIS	O	NOUN	B
as	O	ADP	O
volume	O	NOUN	B
localization	O	NOUN	I
sequence	O	NOUN	I
in	O	ADP	O
31P	O	ADJ	B
MRS	O	PROPN	B
.	O	PUNCT	O


Pregnancy	O	NOUN	B
screening	O	NOUN	I
by	O	ADP	O
uterine	O	ADJ	B
artery	O	NOUN	I
Doppler	O	PROPN	B
velocimetry	O	NOUN	I
-	O	PUNCT	O
-	O	PUNCT	O
which	O	DET	O
criterion	O	NOUN	B
performs	O	VERB	O
best	O	ADV	O
?	O	PUNCT	O
OBJECTIVE	O	NOUN	O
:	O	PUNCT	O
To	O	PART	O
test	O	VERB	O
whether	O	SCONJ	O
repeating	O	VERB	O
Doppler	O	NOUN	B
studies	O	NOUN	I
of	O	ADP	O
the	O	DET	O
uteroplacental	O	ADJ	B
circulation	O	NOUN	B
late	O	ADJ	O
in	O	ADP	O
gestation	O	NOUN	B
will	O	AUX	O
improve	O	VERB	B
the	O	DET	O
test	O	NOUN	B
'	O	PART	O
s	O	NOUN	O
power	O	NOUN	O
for	O	ADP	O
predicting	O	VERB	B
pregnancy	O	NOUN	B
-	O	PUNCT	O
induced	O	VERB	B
hypertension	O	NOUN	B
and	O	CCONJ	O
fetal	O	ADJ	B
growth	O	NOUN	I
restriction	O	NOUN	I
(	O	PUNCT	O
FGR	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
and	O	CCONJ	O
whether	O	SCONJ	O
analysis	O	NOUN	B
based	O	VERB	O
on	O	ADP	O
a	O	DET	O
combination	O	NOUN	B
of	O	ADP	O
quantitative	O	ADJ	B
and	O	CCONJ	O
qualitative	O	ADJ	B
assessments	O	NOUN	B
of	O	ADP	O
the	O	DET	O
uterine	O	ADJ	B
arterial	O	ADJ	I
waveforms	O	NOUN	B
will	O	AUX	O
yield	O	VERB	O
better	O	ADJ	O
results	O	NOUN	B
than	O	ADP	O
analysis	O	NOUN	B
based	O	VERB	O
on	O	ADP	O
either	O	CCONJ	O
alone	O	ADV	O
.	O	PUNCT	O


Analysis	O	NOUN	B
of	O	ADP	O
disassociation	O	NOUN	B
rates	O	NOUN	O
indicates	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
Grf10	B-GENE	NOUN	B
-	O	PUNCT	O
Swi5	B-GENE	NOUN	B
-	O	PUNCT	O
DNA	O	NOUN	B
complex	O	NOUN	I
has	O	AUX	O
a	O	DET	O
longer	O	ADV	O
half	O	NOUN	B
-	O	PUNCT	O
life	O	NOUN	B
than	O	ADP	O
protein	O	NOUN	B
-	O	PUNCT	O
DNA	O	NOUN	B
complexes	O	NOUN	I
that	O	PRON	O
contain	O	VERB	O
only	O	ADV	O
Swi5	B-GENE	NOUN	B
or	O	CCONJ	O
Grf10	B-GENE	NOUN	B
.	O	PUNCT	O


The	O	DET	O
mutant	O	ADJ	B
allele	O	NOUN	O
of	O	ADP	O
the	O	DET	O
alpha	B-GENE	NOUN	B
1	I-GENE	NUM	I
-	I-GENE	PUNCT	O
tubulin	I-GENE	NOUN	B
gene	I-GENE	NOUN	O
was	O	AUX	O
designated	O	VERB	O
tua1	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	O
.	O	PUNCT	O


Analysis	O	NOUN	B
of	O	ADP	O
a	O	DET	O
set	O	NOUN	O
of	O	ADP	O
deletion	O	NOUN	B
constructs	O	NOUN	O
in	O	ADP	O
transient	O	ADJ	B
transfection	O	NOUN	O
assays	O	NOUN	O
measuring	O	VERB	O
heterologous	O	ADJ	B
reporter	O	NOUN	O
gene	O	NOUN	O
(	O	PUNCT	O
luciferase	B-GENE	NOUN	B
)	O	PUNCT	O
activity	O	NOUN	O
demonstrated	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
182	O	NUM	O
-	O	PUNCT	O
bp	O	NOUN	B
5	O	NUM	O
'	O	PUNCT	O
-	O	PUNCT	O
flanking	O	ADJ	B
region	O	NOUN	I
provides	O	VERB	O
full	O	ADJ	O
promoter	O	NOUN	B
activity	O	NOUN	I
in	O	ADP	O
IL	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
2	I-GENE	NUM	B
-	O	PUNCT	O
stimulated	O	VERB	B
L2	O	NOUN	B
cells	O	NOUN	I
.	O	PUNCT	O


Northern	O	ADJ	B
analysis	O	NOUN	I
of	O	ADP	O
RNA	O	NOUN	B
samples	O	NOUN	O
isolated	O	VERB	B
from	O	ADP	O
ammonium	O	NOUN	B
-	O	PUNCT	O
grown	O	VERB	B
cultures	O	NOUN	B
of	O	ADP	O
the	O	DET	O
ntcA	B-GENE	NOUN	B
mutant	I-GENE	NOUN	B
showed	O	VERB	O
reduced	O	VERB	B
amounts	O	NOUN	O
of	O	ADP	O
glnA	B-GENE	NOUN	B
message	I-GENE	NOUN	B
and	O	CCONJ	O
the	O	DET	O
absence	O	NOUN	B
of	O	ADP	O
a	O	DET	O
1	O	NUM	O
.	O	PUNCT	O
7	O	NUM	O
-	O	PUNCT	O
kb	O	NOUN	O
transcript	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
order	O	NOUN	O
to	O	PART	O
define	O	VERB	O
potential	O	ADJ	O
candidate	O	NOUN	B
genes	O	NOUN	I
for	O	ADP	O
inherited	O	VERB	B
disorders	O	NOUN	I
characterized	O	VERB	B
by	O	ADP	O
aberrant	O	ADJ	B
gene	O	NOUN	B
expression	O	NOUN	I
,	O	PUNCT	O
we	O	PRON	O
utilized	O	VERB	O
Kruppel	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
related	I-GENE	VERB	B
sequences	I-GENE	NOUN	B
to	O	PART	O
isolate	O	VERB	B
zinc	O	NOUN	B
finger	O	NOUN	I
-	O	PUNCT	O
containing	O	VERB	B
cDNAs	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
isolated	O	VERB	B
POT1	B-GENE	NOUN	B
clones	O	NOUN	B
hybridized	O	VERB	B
to	O	PART	O
a	O	DET	O
1	O	NUM	O
.	O	PUNCT	O
4	O	NUM	O
kb	O	NOUN	O
RNA	O	NOUN	B
species	O	NOUN	I
,	O	PUNCT	O
which	O	DET	O
was	O	AUX	O
induced	O	VERB	B
approximately	O	ADV	O
30	O	NUM	O
-	O	PUNCT	O
fold	O	NOUN	B
when	O	SCONJ	O
oleate	O	NOUN	B
was	O	AUX	O
the	O	DET	O
carbon	O	NOUN	B
source	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
Y	O	NOUN	B
.	O	PUNCT	O
lipolytica	O	X	B
genomic	O	ADJ	B
POT1	B-GENE	NOUN	I
gene	O	NOUN	I
was	O	AUX	O
disrupted	O	VERB	B
by	O	ADP	O
replacing	O	VERB	O
120	O	NUM	O
bp	O	NOUN	O
of	O	ADP	O
its	O	PRON	O
coding	O	VERB	B
sequence	O	NOUN	I
with	O	ADP	O
2	O	NUM	O
.	O	PUNCT	O
7	O	NUM	O
kbp	O	NOUN	O
of	O	ADP	O
DNA	O	NOUN	B
including	O	VERB	O
the	O	DET	O
Y	O	NOUN	B
.	O	PUNCT	O
lipolytica	O	X	B
LEU2	B-GENE	NOUN	I
gene	I-GENE	NOUN	I
.	O	PUNCT	O


The	O	DET	O
novel	O	ADJ	O
Notch	B-GENE	NOUN	B
homologue	I-GENE	NOUN	I
mouse	B-GENE	NOUN	O
Notch	I-GENE	NOUN	B
3	I-GENE	NUM	I
lacks	O	VERB	O
specific	O	ADJ	O
epidermal	B-GENE	ADJ	B
growth	I-GENE	NOUN	I
factor	I-GENE	NOUN	I
-	I-GENE	PUNCT	O
repeats	I-GENE	NOUN	B
and	O	CCONJ	O
is	O	AUX	O
expressed	O	VERB	B
in	O	ADP	O
proliferating	O	VERB	B
neuroepithelium	O	NOUN	I
.	O	PUNCT	O


Immunoreactive	O	ADJ	B
AR	B-GENE	NOUN	B
content	O	NOUN	B
in	O	ADP	O
transfected	O	VERB	B
COS	O	NOUN	B
-	O	PUNCT	O
1	O	NUM	O
cells	O	NOUN	B
was	O	AUX	O
not	O	PART	O
influenced	O	VERB	O
by	O	ADP	O
exposure	O	NOUN	B
to	O	PART	I
8	O	NUM	O
-	O	PUNCT	O
Br	O	PROPN	B
-	O	PUNCT	O
cAMP	O	NOUN	B
.	O	PUNCT	O


Internal	O	ADJ	B
biliary	O	ADJ	I
drainage	O	NOUN	I
,	O	PUNCT	O
unlike	O	ADP	O
external	O	ADJ	B
drainage	O	NOUN	B
,	O	PUNCT	O
does	O	AUX	O
not	O	PART	O
suppress	O	VERB	B
the	O	DET	O
regeneration	O	NOUN	B
of	O	ADP	O
cholestatic	O	ADJ	B
rat	O	NOUN	B
liver	O	NOUN	B
after	O	ADP	O
partial	O	ADJ	B
hepatectomy	O	NOUN	B
.	O	PUNCT	O


ORF	O	NOUN	B
2	O	NUM	O
potentially	O	ADV	O
encoded	O	VERB	B
a	O	DET	O
hydrophobic	O	ADJ	B
protein	O	NOUN	I
of	O	ADP	O
29	O	NUM	O
,	O	PUNCT	O
705	O	NUM	O
Da	O	NOUN	O
with	O	ADP	O
six	O	NUM	O
potential	O	ADJ	B
membrane	O	NOUN	B
-	O	PUNCT	O
spanning	O	VERB	B
regions	O	NOUN	B
.	O	PUNCT	O


Plasmids	O	NOUN	B
were	O	AUX	O
constructed	O	VERB	O
with	O	ADP	O
the	O	DET	O
mouse	O	NOUN	B
promoter	O	NOUN	B
region	O	NOUN	I
linked	O	VERB	O
to	O	PART	O
the	O	DET	O
reporter	B-GENE	NOUN	B
gene	I-GENE	NOUN	I
chloramphenicol	I-GENE	NOUN	I
acetyltransferase	I-GENE	NOUN	I
(	O	PUNCT	O
CAT	B-GENE	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
and	O	CCONJ	O
transiently	O	ADV	B
and	O	CCONJ	O
stably	O	ADV	B
transfected	O	VERB	B
in	O	ADP	O
the	O	DET	O
INS	O	PROPN	B
-	O	PUNCT	O
1	O	NUM	O
cells	O	NOUN	B
.	O	PUNCT	O


Specifically	O	ADV	O
,	O	PUNCT	O
this	O	DET	O
study	O	NOUN	B
determined	O	VERB	O
the	O	DET	O
influence	O	NOUN	B
of	O	ADP	O
:	O	PUNCT	O
(	O	PUNCT	O
1	O	X	O
)	O	PUNCT	O
an	O	DET	O
awareness	O	NOUN	B
strategy	O	NOUN	O
,	O	PUNCT	O
(	O	PUNCT	O
2	O	X	O
)	O	PUNCT	O
a	O	DET	O
non	O	ADJ	B
-	O	PUNCT	O
awareness	O	NOUN	B
strategy	O	NOUN	B
,	O	PUNCT	O
(	O	PUNCT	O
3	O	X	O
)	O	PUNCT	O
a	O	DET	O
Five	O	NUM	B
-	O	PUNCT	O
Step	O	PROPN	B
Approach	O	PROPN	I
strategy	O	NOUN	O
and	O	CCONJ	O
(	O	PUNCT	O
4	O	X	O
)	O	PUNCT	O
a	O	DET	O
control	O	NOUN	B
condition	O	NOUN	I
.	O	PUNCT	O


Mutually	O	ADV	B
exclusive	O	ADJ	O
interaction	O	NOUN	B
of	O	ADP	O
the	O	DET	O
adenovirus	B-GENE	NOUN	B
E4	I-GENE	NOUN	I
-	I-GENE	PUNCT	O
6	I-GENE	NUM	O
/	I-GENE	SYM	O
7	I-GENE	NUM	B
protein	I-GENE	NOUN	B
and	O	CCONJ	O
the	O	DET	O
retinoblastoma	B-GENE	NOUN	B
gene	I-GENE	NOUN	I
product	I-GENE	NOUN	O
with	O	ADP	O
internal	O	ADJ	B
domains	O	NOUN	I
of	O	ADP	O
E2F	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	B
and	O	CCONJ	O
DP	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	O
.	O	PUNCT	O


The	O	DET	O
transverse	O	ADJ	B
magnetization	O	NOUN	B
decays	O	NOUN	B
mentioned	O	VERB	O
above	O	ADP	O
exhibited	O	VERB	O
two	O	NUM	O
components	O	NOUN	B
,	O	PUNCT	O
a	O	DET	O
T2	O	NOUN	B
fast	O	ADV	I
(	O	PUNCT	O
T2f	O	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
a	O	DET	O
T2	O	NOUN	B
slow	O	ADJ	O
(	O	PUNCT	O
T2s	O	ADJ	B
)	O	PUNCT	O
component	O	NOUN	O
.	O	PUNCT	O


Expression	O	NOUN	B
of	O	ADP	O
a	O	DET	O
dominant	B-GENE	ADJ	B
-	I-GENE	PUNCT	O
negative	I-GENE	ADJ	B
ras	I-GENE	NOUN	B
gene	I-GENE	NOUN	I
also	O	ADV	O
blocks	O	VERB	O
TIS10	B-GENE	PROPN	B
/	O	SYM	O
PGS2	B-GENE	NOUN	B
induction	O	NOUN	B
by	O	ADP	O
v	B-GENE	NOUN	O
-	I-GENE	PUNCT	O
src	I-GENE	NOUN	B
.	O	PUNCT	O


Human	O	ADJ	B
T	O	NOUN	B
-	O	PUNCT	O
cell	O	NOUN	B
leukemia	O	NOUN	I
virus	O	NOUN	O
type	O	NOUN	O
I	O	NUM	O
Tax	B-GENE	NOUN	B
activation	O	NOUN	B
of	O	ADP	O
NF	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
kappa	I-GENE	NOUN	B
B	I-GENE	NOUN	I
/	O	SYM	O
Rel	B-GENE	NOUN	B
involves	O	VERB	O
phosphorylation	O	NOUN	B
and	O	CCONJ	O
degradation	O	NOUN	B
of	O	ADP	O
I	B-GENE	NOUN	O
kappa	I-GENE	NOUN	O
B	I-GENE	NOUN	O
alpha	I-GENE	NOUN	O
and	O	CCONJ	O
RelA	B-GENE	NOUN	B
(	I-GENE	PUNCT	O
p65	I-GENE	NOUN	B
)	I-GENE	PUNCT	O
-	O	PUNCT	O
mediated	O	VERB	B
induction	O	NOUN	B
of	O	ADP	O
the	O	DET	O
c	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
rel	I-GENE	NOUN	B
gene	I-GENE	NOUN	I
.	O	PUNCT	O


These	O	DET	O
RZR	B-GENE	NOUN	B
subtypes	O	NOUN	B
represent	O	VERB	O
members	O	NOUN	B
of	O	ADP	O
a	O	DET	O
new	O	ADJ	O
family	O	NOUN	B
of	O	ADP	O
orphan	B-GENE	NOUN	B
nuclear	I-GENE	ADJ	I
receptors	I-GENE	NOUN	I
that	O	PRON	O
most	O	ADV	O
likely	O	ADV	O
regulate	O	VERB	B
specific	O	ADJ	O
gene	O	NOUN	B
expression	O	NOUN	I
.	O	PUNCT	O


Interestingly	O	ADV	O
,	O	PUNCT	O
these	O	DET	O
response	O	NOUN	B
elements	O	NOUN	I
display	O	VERB	O
dramatically	O	ADV	O
reduced	O	VERB	B
affinity	O	NOUN	B
for	O	ADP	O
retinoic	B-GENE	ADJ	B
acid	I-GENE	NOUN	I
receptor	I-GENE	NOUN	I
-	O	PUNCT	O
retinoid	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
X	I-GENE	NOUN	B
receptor	I-GENE	NOUN	I
heterodimers	O	NOUN	I
.	O	PUNCT	O


Remarkably	O	ADV	O
,	O	PUNCT	O
U21	B-GENE	NOUN	O
contains	O	VERB	O
a	O	DET	O
long	O	ADJ	B
stretch	O	NOUN	I
(	O	PUNCT	O
13	O	NUM	O
nt	O	NOUN	O
.	O	PUNCT	O
)	O	PUNCT	O
of	O	ADP	O
complementarity	O	NOUN	B
to	O	PART	O
a	O	DET	O
highly	O	ADV	O
conserved	O	VERB	O
sequence	O	NOUN	O
in	O	ADP	O
28S	B-GENE	ADJ	B
rRNA	I-GENE	NOUN	I
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
provide	O	VERB	O
evidence	O	NOUN	B
of	O	ADP	O
a	O	DET	O
bypass	O	NOUN	B
of	O	ADP	O
p53	B-GENE	NOUN	B
-	O	PUNCT	O
induced	O	VERB	B
Waf1	B-GENE	NOUN	B
/	O	PUNCT	O
Cip1	B-GENE	NOUN	B
-	O	PUNCT	O
mediated	O	VERB	B
cell	O	NOUN	B
cycle	O	NOUN	I
regulatory	O	ADJ	O
pathways	O	NOUN	O
by	O	ADP	O
a	O	DET	O
member	O	NOUN	B
of	O	ADP	O
the	O	DET	O
myb	B-GENE	NOUN	B
oncogene	I-GENE	NOUN	I
family	I-GENE	NOUN	O
.	O	PUNCT	O


All	O	DET	O
groups	O	NOUN	B
were	O	AUX	O
challenged	O	VERB	O
subsequently	O	ADV	O
with	O	ADP	O
naloxone	O	NOUN	B
(	O	PUNCT	O
0	O	NUM	O
.	O	PUNCT	O
4	O	NUM	O
mg	O	NOUN	O
/	O	SYM	O
kg	O	NOUN	B
)	O	PUNCT	O
in	O	ADP	O
the	O	DET	O
distinctive	O	ADJ	O
environment	O	NOUN	B
and	O	CCONJ	O
then	O	ADV	O
observed	O	VERB	B
for	O	ADP	O
signs	O	NOUN	B
of	O	ADP	O
opiate	O	ADJ	B
withdrawal	O	NOUN	O
.	O	PUNCT	O


There	O	PRON	O
were	O	AUX	O
9	O	NUM	O
patients	O	NOUN	B
in	O	ADP	O
NYHA	O	NOUN	B
class	O	NOUN	I
III	O	NUM	I
and	O	CCONJ	O
8	O	NUM	O
in	O	ADP	O
class	O	NOUN	B
IV	O	NUM	I
.	O	PUNCT	O
(	O	PUNCT	O
ABSTRACT	O	NOUN	B
TRUNCATED	O	VERB	I
AT	O	ADP	I
250	O	NUM	I
WORDS	O	NOUN	I
)	O	PUNCT	O


TG	O	NOUN	B
-	O	PUNCT	O
day	O	NOUN	B
and	O	CCONJ	O
TG	O	NOUN	B
-	O	PUNCT	O
night	O	NOUN	B
were	O	AUX	O
19	O	NUM	O
.	O	PUNCT	O
4	O	NUM	O
+	O	CCONJ	O
/	O	SYM	O
-	O	PUNCT	O
6	O	NUM	O
.	O	PUNCT	O
1	O	NUM	O
%	O	NOUN	O
,	O	PUNCT	O
26	O	NUM	O
.	O	PUNCT	O
6	O	NUM	O
+	O	CCONJ	O
/	O	SYM	O
-	O	PUNCT	O
5	O	NUM	O
.	O	PUNCT	O
3	O	NUM	O
%	O	NOUN	O
,	O	PUNCT	O
(	O	PUNCT	O
750	O	NUM	O
mm3	O	NUM	O
<	O	X	O
T	O	NOUN	B
.	O	PUNCT	O


Ten	O	NUM	B
volunteers	O	NOUN	I
were	O	AUX	O
tested	O	VERB	B
at	O	ADP	O
18	O	NUM	O
,	O	PUNCT	O
000	O	NUM	O
ft	O	NOUN	O
(	O	PUNCT	O
5	O	NUM	O
,	O	PUNCT	O
486	O	NUM	O
m	O	NOUN	O
)	O	PUNCT	O
,	O	PUNCT	O
and	O	CCONJ	O
through	O	ADP	O
12	O	NUM	O
,	O	PUNCT	O
000	O	NUM	O
,	O	PUNCT	O
8	O	NUM	O
,	O	PUNCT	O
000	O	NUM	O
,	O	PUNCT	O
and	O	CCONJ	O
5	O	NUM	O
,	O	PUNCT	O
000	O	NUM	O
ft	O	NOUN	O
(	O	PUNCT	O
3	O	NUM	O
,	O	PUNCT	O
657	O	NUM	O
,	O	PUNCT	O
2	O	NUM	O
,	O	PUNCT	O
438	O	NUM	O
,	O	PUNCT	O
and	O	CCONJ	O
1	O	NUM	O
,	O	PUNCT	O
524	O	NUM	O
m	O	NOUN	O
)	O	PUNCT	O
with	O	ADP	O
directional	O	ADJ	B
sounds	O	NOUN	I
recorded	O	VERB	O
via	O	ADP	O
a	O	DET	O
dummy	O	ADJ	O
head	O	NOUN	B
microphone	O	NOUN	I
and	O	CCONJ	O
presented	O	VERB	O
binaurally	O	ADV	B
.	O	PUNCT	O


Upon	O	SCONJ	O
differentiation	O	NOUN	B
with	O	ADP	O
retinoic	O	ADJ	B
acid	O	NOUN	I
(	O	PUNCT	O
RA	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
transcription	O	NOUN	B
of	O	ADP	O
the	O	DET	O
Rex	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	O
gene	I-GENE	NOUN	B
decreases	O	VERB	B
rapidly	O	ADV	O
.	O	PUNCT	O


In	O	ADP	O
general	O	ADJ	O
,	O	PUNCT	O
the	O	DET	O
filtration	O	NOUN	B
rate	O	NOUN	I
in	O	ADP	O
relevant	O	ADJ	B
areas	O	NOUN	B
appears	O	VERB	O
to	O	PART	O
be	O	AUX	O
an	O	DET	O
integrative	O	ADJ	B
and	O	CCONJ	O
easily	O	ADV	O
determined	O	VERB	O
parameter	O	NOUN	B
,	O	PUNCT	O
reflecting	O	VERB	O
hormonal	O	ADJ	B
and	O	CCONJ	O
neurogenic	O	ADJ	B
vascular	O	ADJ	I
as	O	ADV	O
well	O	ADV	O
as	O	ADP	O
local	O	ADJ	B
interstitial	O	ADJ	I
control	O	NOUN	I
of	O	ADP	O
the	O	DET	O
Starling	O	NOUN	B
forces	O	NOUN	I
.	O	PUNCT	O


Homozygous	O	ADJ	B
null	O	ADJ	B
embryos	O	NOUN	I
also	O	ADV	O
displayed	O	VERB	O
abnormalities	O	NOUN	B
in	O	ADP	O
heart	O	NOUN	B
development	O	NOUN	I
,	O	PUNCT	O
consistent	O	ADJ	B
with	O	ADP	I
the	O	DET	O
conclusion	O	NOUN	O
that	O	SCONJ	O
Tek	B-GENE	PROPN	B
is	O	AUX	O
necessary	O	ADJ	O
for	O	ADP	O
endocardial	O	ADJ	B
/	O	SYM	O
myocardial	O	ADJ	B
interactions	O	NOUN	B
during	O	ADP	O
development	O	NOUN	B
.	O	PUNCT	O


A	O	DET	O
strong	O	ADJ	O
trithorax	B-GENE	ADJ	B
binding	I-GENE	NOUN	I
site	I-GENE	NOUN	I
was	O	AUX	O
found	O	VERB	O
at	O	ADP	O
the	O	DET	O
cytological	O	ADJ	B
location	O	NOUN	B
of	O	ADP	O
the	O	DET	O
fork	B-GENE	NOUN	B
head	I-GENE	NOUN	I
gene	I-GENE	NOUN	I
,	O	PUNCT	O
a	O	DET	O
region	O	NOUN	B
-	O	PUNCT	O
specific	O	ADJ	B
homeotic	B-GENE	ADJ	B
gene	I-GENE	NOUN	I
not	O	PART	O
located	O	ADJ	O
within	O	ADP	O
a	O	DET	O
homeotic	B-GENE	ADJ	B
complex	I-GENE	NOUN	I
.	O	PUNCT	O


C	B-GENE	NOUN	B
/	I-GENE	SYM	O
EBP	I-GENE	NOUN	B
alpha	I-GENE	NOUN	I
also	O	ADV	O
activates	O	VERB	B
the	O	DET	O
promoter	O	NOUN	B
of	O	ADP	O
the	O	DET	O
rat	B-GENE	NOUN	B
class	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
I	I-GENE	NOUN	B
ADH	I-GENE	NOUN	B
gene	I-GENE	NOUN	I
in	O	ADP	O
a	O	DET	O
sequence	O	NOUN	B
-	O	PUNCT	O
specific	O	ADJ	B
manner	O	NOUN	O
[	O	PUNCT	O
Potter	O	PROPN	O
et	O	X	O
al	O	X	O
.	O	PUNCT	O
,	O	PUNCT	O
Arch	O	NOUN	B
.	O	PUNCT	O


C	B-GENE	NOUN	B
/	I-GENE	SYM	O
EBP	I-GENE	NOUN	B
alpha	I-GENE	NOUN	I
also	O	ADV	O
activates	O	VERB	B
the	O	DET	O
promoter	O	NOUN	B
of	O	ADP	O
the	O	DET	O
rat	B-GENE	NOUN	B
class	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
I	I-GENE	NOUN	B
ADH	I-GENE	NOUN	B
gene	I-GENE	NOUN	I
in	O	ADP	O
a	O	DET	O
sequence	O	NOUN	B
-	O	PUNCT	O
specific	O	ADJ	B
manner	O	NOUN	O
[	O	PUNCT	O
Potter	O	PROPN	O
et	O	X	O
al	O	X	O
.	O	PUNCT	O
,	O	PUNCT	O
Arch	O	NOUN	B
.	O	PUNCT	O


Segments	O	NOUN	B
with	O	ADP	O
more	O	ADV	O
reduced	O	VERB	B
BMIPP	O	NOUN	B
uptake	O	NOUN	B
than	O	ADP	O
MIBI	O	NOUN	B
uptake	O	NOUN	B
(	O	PUNCT	O
mismatching	O	NOUN	B
)	O	PUNCT	O
showed	O	VERB	O
either	O	CCONJ	O
normal	O	ADJ	B
wall	O	NOUN	I
motion	O	NOUN	I
or	O	CCONJ	O
demonstrated	O	VERB	O
inotropic	O	ADJ	B
reserve	O	NOUN	I
during	O	ADP	O
dobutamine	O	NOUN	B
stimulation	O	NOUN	O
.	O	PUNCT	O


The	O	DET	O
present	O	ADJ	O
data	O	NOUN	B
also	O	ADV	O
indicate	O	VERB	O
that	O	SCONJ	O
patients	O	NOUN	B
with	O	ADP	O
TGBM	O	NOUN	B
nephropathy	O	NOUN	B
often	O	ADV	O
have	O	AUX	O
concomitant	O	ADJ	B
IgA	B-GENE	NOUN	B
nephropathy	O	NOUN	I
and	O	CCONJ	O
mesangial	O	ADJ	B
proliferative	O	ADJ	I
glomerulonephritis	O	NOUN	I
.	O	PUNCT	O


A	O	DET	O
full	O	ADJ	B
-	O	PUNCT	O
length	O	NOUN	B
cDNA	O	NOUN	B
clone	O	NOUN	O
isolated	O	VERB	B
from	O	ADP	O
a	O	DET	O
rat	O	NOUN	B
lung	O	NOUN	B
library	O	NOUN	I
was	O	AUX	O
predicted	O	VERB	O
to	O	PART	O
encode	O	VERB	B
a	O	DET	O
55	O	NUM	O
-	O	PUNCT	O
kDa	O	NOUN	B
protein	O	NOUN	I
containing	O	VERB	O
at	O	ADP	O
its	O	PRON	O
amino	O	NOUN	B
terminus	O	NOUN	I
a	O	DET	O
targeting	O	NOUN	B
domain	O	NOUN	B
that	O	PRON	O
binds	O	VERB	B
to	O	PART	O
the	O	DET	O
ANP	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
receptor	I-GENE	NOUN	B
kinase	I-GENE	NOUN	I
-	I-GENE	PUNCT	O
like	I-GENE	ADJ	B
domain	I-GENE	NOUN	B
and	O	CCONJ	O
containing	O	VERB	O
at	O	ADP	O
its	O	PRON	O
carboxyl	O	NOUN	B
terminus	O	NOUN	I
a	O	DET	O
putative	O	ADJ	B
protein	B-GENE	NOUN	I
-	I-GENE	PUNCT	O
serine	I-GENE	NOUN	B
phosphatase	I-GENE	NOUN	I
domain	O	NOUN	I
.	O	PUNCT	O


A	O	DET	O
high	O	ADJ	B
-	O	PUNCT	O
resolution	O	NOUN	B
restriction	O	NOUN	B
map	O	NOUN	I
of	O	ADP	O
over	O	ADP	O
200	O	NUM	O
kb	O	NOUN	O
of	O	ADP	O
contiguous	O	ADJ	B
DNA	O	NOUN	I
containing	O	VERB	O
N	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
myc	I-GENE	NOUN	B
has	O	AUX	O
been	O	AUX	O
generated	O	VERB	O
by	O	ADP	O
subcloning	O	VERB	B
YACs	O	NOUN	B
into	O	ADP	O
cosmids	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
the	O	DET	O
present	O	ADJ	O
article	O	NOUN	B
,	O	PUNCT	O
the	O	DET	O
causes	O	NOUN	O
of	O	ADP	O
death	O	NOUN	B
or	O	CCONJ	O
ill	O	ADV	B
-	O	PUNCT	O
being	O	AUX	O
as	O	ADP	O
found	O	VERB	O
in	O	ADP	O
10	O	NUM	O
consecutive	O	ADJ	B
carcinogenicity	O	NOUN	B
studies	O	NOUN	I
-	O	PUNCT	O
-	O	PUNCT	O
5	O	NUM	O
studies	O	NOUN	B
with	O	ADP	O
2400	O	NUM	O
OFA	O	PROPN	B
(	O	PUNCT	O
Sprague	O	PROPN	B
-	O	PUNCT	O
Dawley	O	PROPN	B
-	O	PUNCT	O
derived	O	VERB	B
)	O	PUNCT	O
and	O	CCONJ	O
Wistar	O	NOUN	B
rats	O	NOUN	I
and	O	CCONJ	O
5	O	NUM	O
studies	O	NOUN	B
with	O	ADP	O
2400	O	NUM	O
OF1	O	NOUN	B
and	O	CCONJ	O
NMRI	O	NOUN	B
mice	O	NOUN	O
-	O	PUNCT	O
-	O	PUNCT	O
were	O	AUX	O
re	O	ADP	B
-	O	PUNCT	O
examined	O	VERB	B
.	O	PUNCT	O


Surprisingly	O	ADV	O
,	O	PUNCT	O
Northern	O	NOUN	B
(	O	PUNCT	O
RNA	O	NOUN	B
)	O	PUNCT	O
blot	O	NOUN	B
analysis	O	NOUN	I
and	O	CCONJ	O
reverse	B-GENE	ADJ	B
transcriptase	I-GENE	NOUN	I
-	O	PUNCT	O
PCRs	O	PROPN	B
performed	O	VERB	O
after	O	ADP	O
transfection	O	NOUN	B
of	O	ADP	O
COS	O	NOUN	B
-	O	PUNCT	O
7	O	NUM	B
or	O	CCONJ	O
HeLa	O	NOUN	B
cells	O	NOUN	I
with	O	ADP	O
these	O	DET	O
viral	O	ADJ	B
RNAs	O	NOUN	I
revealed	O	VERB	O
that	O	SCONJ	O
Y88S	B-GENE	NOUN	O
and	O	CCONJ	O
Y88L	B-GENE	NOUN	B
RNAs	I-GENE	NOUN	I
replicated	O	VERB	O
at	O	ADP	O
only	O	ADV	O
very	O	ADV	O
low	O	ADJ	O
levels	O	NOUN	B
.	O	PUNCT	O


Moreover	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
ability	O	NOUN	O
to	O	PART	O
selectivity	O	NOUN	O
arrest	O	NOUN	B
elongation	O	NOUN	I
by	O	ADP	O
polIII	B-GENE	PROPN	B
at	O	ADP	O
defined	O	VERB	O
positions	O	NOUN	B
within	O	ADP	O
the	O	DET	O
tRNA	O	NOUN	B
gene	O	NOUN	I
transcription	O	NOUN	O
unit	O	NOUN	O
has	O	AUX	O
permitted	O	VERB	O
the	O	DET	O
identification	O	NOUN	B
of	O	ADP	O
discrete	O	ADJ	O
functional	O	ADJ	B
properties	O	NOUN	B
of	O	ADP	O
paused	O	ADJ	B
mammalian	B-GENE	ADJ	I
polIII	I-GENE	ADJ	B
ternary	I-GENE	ADJ	I
complexes	I-GENE	NOUN	I
.	O	PUNCT	O


A	O	DET	O
recent	O	ADJ	B
index	O	NOUN	I
(	O	PUNCT	O
Fluorosis	O	PROPN	B
Risk	O	NOUN	I
Index	O	PROPN	I
)	O	PUNCT	O
developed	O	VERB	O
by	O	ADP	O
Pendrys	O	PROPN	B
(	O	PUNCT	O
1990	O	NUM	O
)	O	PUNCT	O
is	O	AUX	O
also	O	ADV	O
included	O	VERB	O
in	O	ADP	O
this	O	DET	O
review	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
role	O	NOUN	O
of	O	ADP	O
HIV	B-GENE	NOUN	B
tat	I-GENE	NOUN	B
,	O	PUNCT	O
which	O	DET	O
is	O	AUX	O
the	O	DET	O
main	O	ADJ	O
enhancing	O	NOUN	B
factor	O	NOUN	B
for	O	ADP	O
viral	B-GENE	ADJ	B
LTR	I-GENE	NOUN	I
,	O	PUNCT	O
in	O	ADP	O
the	O	DET	O
regulation	O	NOUN	B
of	O	ADP	O
IL	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
2	I-GENE	NUM	O
gene	I-GENE	NOUN	B
transcription	O	NOUN	I
has	O	AUX	O
been	O	AUX	O
studied	O	VERB	O
following	O	VERB	O
transient	O	ADJ	B
expression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
tat	B-GENE	NOUN	B
gene	I-GENE	NOUN	I
in	O	ADP	O
phorbol	O	NOUN	B
ester	O	NOUN	I
and	O	CCONJ	O
calcium	O	NOUN	B
ionophore	O	NOUN	I
-	O	PUNCT	O
activated	O	VERB	B
Jurkat	O	NOUN	B
cells	O	NOUN	I
transfected	O	VERB	B
with	O	ADP	O
IL	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
2	I-GENE	NUM	O
promoter	O	NOUN	B
-	O	PUNCT	O
chloramphenicol	B-GENE	NOUN	B
acetyltransferase	I-GENE	NOUN	B
reporter	O	NOUN	I
constructs	O	NOUN	O
.	O	PUNCT	O


Splice	O	NOUN	B
variations	O	NOUN	I
in	O	ADP	O
genes	O	NOUN	B
coding	O	VERB	I
for	O	ADP	O
the	O	DET	O
transmembrane	B-GENE	ADJ	B
FGF	I-GENE	NOUN	I
receptor	I-GENE	NOUN	I
(	O	PUNCT	O
FGFR	B-GENE	NOUN	B
)	O	PUNCT	O
result	O	VERB	O
in	O	ADP	O
isoforms	O	NOUN	B
that	O	PRON	O
vary	O	VERB	O
in	O	ADP	O
the	O	DET	O
ectodomain	O	NOUN	B
,	O	PUNCT	O
intracellular	O	ADJ	B
juxtamembrane	O	NOUN	B
domain	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
the	O	DET	O
intracellular	O	ADJ	B
kinase	O	NOUN	O
domain	O	NOUN	O
.	O	PUNCT	O


The	O	DET	O
git1	B-GENE	NOUN	B
,	O	PUNCT	O
git3	B-GENE	NOUN	B
,	O	PUNCT	O
git5	B-GENE	NOUN	B
,	O	PUNCT	O
git7	B-GENE	NOUN	B
,	O	PUNCT	O
git8	B-GENE	NOUN	B
and	O	CCONJ	O
git10	B-GENE	NOUN	B
genes	I-GENE	NOUN	I
act	O	VERB	O
upstream	O	ADJ	B
of	O	ADP	O
adenylate	B-GENE	ADJ	B
cyclase	I-GENE	NOUN	I
,	O	PUNCT	O
presumably	O	ADV	O
encoding	O	VERB	B
an	O	DET	O
adenylate	B-GENE	ADJ	B
cyclase	I-GENE	NOUN	I
activation	O	NOUN	O
pathway	O	NOUN	O
.	O	PUNCT	O


Deletion	O	NOUN	B
studies	O	NOUN	I
identified	O	VERB	O
a	O	DET	O
distal	O	ADJ	B
response	O	NOUN	I
element	O	NOUN	I
that	O	PRON	O
is	O	AUX	O
responsible	O	ADJ	O
for	O	ADP	O
the	O	DET	O
cytokine	O	NOUN	B
response	O	NOUN	I
and	O	CCONJ	O
has	O	AUX	O
properties	O	NOUN	B
of	O	ADP	O
an	O	DET	O
inducible	O	ADJ	B
transcriptional	O	ADJ	B
enhancer	O	NOUN	I
.	O	PUNCT	O


No	O	DET	O
drop	O	NOUN	O
in	O	ADP	O
oxygen	O	NOUN	B
saturation	O	NOUN	I
(	O	PUNCT	O
SaO2	O	NOUN	B
)	O	PUNCT	O
or	O	CCONJ	O
visual	O	ADJ	B
evidence	O	NOUN	B
of	O	ADP	O
transient	O	ADJ	B
electroencephalographic	O	ADJ	I
(	O	PUNCT	O
EEG	O	PROPN	B
)	O	PUNCT	O
arousals	O	NOUN	B
can	O	AUX	O
be	O	AUX	O
found	O	VERB	O
at	O	ADP	O
repeat	O	NOUN	O
polysomnography	O	NOUN	B
.	O	PUNCT	O


This	O	DET	O
sequenced	O	VERB	B
region	O	NOUN	I
of	O	ADP	O
the	O	DET	O
V	O	NOUN	B
beta	O	NOUN	I
locus	O	NOUN	I
contains	O	VERB	O
an	O	DET	O
average	O	ADJ	O
number	O	NOUN	O
of	O	ADP	O
repetitive	O	ADJ	B
DNA	O	NOUN	I
elements	O	NOUN	I
(	O	PUNCT	O
21	O	NUM	O
Alu	B-GENE	NOUN	B
,	O	PUNCT	O
three	O	NUM	O
L1	B-GENE	NOUN	O
,	O	PUNCT	O
three	O	NUM	O
MER	O	PROPN	B
,	O	PUNCT	O
and	O	CCONJ	O
three	O	NUM	O
retrovirus	O	NOUN	B
-	O	PUNCT	O
related	O	VERB	B
elements	O	NOUN	B
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
by	O	ADP	O
an	O	DET	O
NS35	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
specific	I-GENE	ADJ	B
RNA	I-GENE	NOUN	B
capture	O	NOUN	I
assay	O	NOUN	I
,	O	PUNCT	O
the	O	DET	O
multimers	O	NOUN	B
were	O	AUX	O
shown	O	VERB	O
to	O	PART	O
possess	O	VERB	B
the	O	DET	O
RNA	O	NOUN	B
-	O	PUNCT	O
binding	O	NOUN	B
activity	O	NOUN	B
previously	O	ADV	O
demonstrated	O	VERB	O
for	O	ADP	O
NS35	B-GENE	NOUN	B
.	O	PUNCT	O


Ketamine	O	NOUN	B
in	O	ADP	O
the	O	DET	O
treatment	O	NOUN	B
of	O	ADP	O
bronchospasm	O	NOUN	B
during	O	ADP	O
mechanical	O	ADJ	B
ventilation	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
molecular	O	ADJ	B
basis	O	NOUN	I
for	O	ADP	O
commitment	O	NOUN	B
of	O	ADP	O
progenitors	O	NOUN	B
to	O	PART	O
the	O	DET	O
eosinophil	O	NOUN	B
lineage	O	NOUN	B
and	O	CCONJ	O
mechanisms	O	NOUN	B
by	O	ADP	O
which	O	DET	O
eosinophil	O	NOUN	B
-	O	PUNCT	O
specific	O	ADJ	B
genes	O	NOUN	B
are	O	AUX	O
expressed	O	VERB	B
and	O	CCONJ	O
regulated	O	VERB	B
during	O	ADP	O
differentiation	O	NOUN	B
is	O	AUX	O
unknown	O	ADJ	O
.	O	PUNCT	O


Thus	O	ADV	O
,	O	PUNCT	O
YMIP	B-GENE	NOUN	B
is	O	AUX	O
a	O	DET	O
functional	O	ADJ	B
homolog	O	NOUN	B
of	O	ADP	O
RMIP	B-GENE	NOUN	B
and	O	CCONJ	O
represents	O	VERB	O
a	O	DET	O
new	O	ADJ	O
component	O	NOUN	O
of	O	ADP	O
the	O	DET	O
yeast	O	NOUN	B
mitochondrial	O	ADJ	B
import	O	NOUN	O
machinery	O	NOUN	O
.	O	PUNCT	O


Tryptic	O	ADJ	B
cleavage	O	NOUN	I
and	O	CCONJ	O
peptide	O	NOUN	B
sequence	O	NOUN	I
analysis	O	NOUN	I
demonstrated	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
98	O	NUM	O
-	O	PUNCT	O
kD	O	NOUN	B
protein	O	NOUN	I
is	O	AUX	O
identical	O	ADJ	B
to	O	PART	O
a	O	DET	O
recently	O	ADV	O
cloned	O	VERB	B
protein	O	NOUN	I
,	O	PUNCT	O
special	B-GENE	ADJ	O
A	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
T	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
rich	I-GENE	ADJ	B
binding	I-GENE	NOUN	I
protein	I-GENE	NOUN	I
1	I-GENE	NUM	I
(	O	PUNCT	O
SATB1	B-GENE	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
that	O	PRON	O
binds	O	VERB	B
selectively	O	ADV	O
to	O	PART	O
nuclear	O	ADJ	B
matrix	O	NOUN	I
/	O	SYM	O
scaffold	O	NOUN	B
-	O	PUNCT	O
associated	O	VERB	B
regions	O	NOUN	O
of	O	ADP	O
DNA	O	NOUN	O
(	O	PUNCT	O
MARs	O	NOUN	B
/	O	SYM	O
SARs	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Heparin	O	NOUN	B
had	O	AUX	O
no	O	DET	B
effect	O	NOUN	I
on	O	ADP	O
rAC	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
st	I-GENE	X	B
myosin	I-GENE	ADJ	B
light	I-GENE	ADJ	I
chain	I-GENE	NOUN	I
phosphatase	I-GENE	NOUN	I
activity	O	NOUN	I
,	O	PUNCT	O
while	O	SCONJ	O
the	O	DET	O
B	O	NOUN	B
subunit	O	NOUN	I
-	O	PUNCT	O
containing	O	VERB	B
forms	O	NOUN	O
were	O	AUX	O
stimulated	O	VERB	B
2	O	NUM	O
-	O	SYM	O
3	O	NUM	B
-	O	PUNCT	O
fold	O	NOUN	B
.	O	PUNCT	O


BACKGROUND	O	NOUN	B
AND	O	CCONJ	O
DESIGN	O	NOUN	O
:	O	PUNCT	O
Fifty	O	NUM	B
-	O	PUNCT	O
nine	O	NUM	B
melanocytic	O	ADJ	B
nevi	O	NOUN	O
with	O	ADP	O
eccentric	O	ADJ	B
foci	O	NOUN	I
of	O	ADP	O
hyperpigmentation	O	NOUN	B
(	O	PUNCT	O
"	O	PUNCT	O
small	O	ADJ	B
dark	O	ADJ	I
dots	O	NOUN	I
"	O	PUNCT	O
)	O	PUNCT	O
that	O	PRON	O
measured	O	VERB	B
primarily	O	ADV	O
1	O	NUM	O
to	O	PART	O
2	O	NUM	O
mm	O	NOUN	O
in	O	ADP	O
diameter	O	NOUN	B
were	O	AUX	O
prospectively	O	ADV	O
examined	O	VERB	O
to	O	PART	O
determine	O	VERB	O
the	O	DET	O
histologic	O	ADJ	B
correlates	O	NOUN	B
of	O	ADP	O
the	O	DET	O
dark	O	ADJ	B
dots	O	NOUN	I
.	O	PUNCT	O


A	O	DET	O
single	O	ADJ	O
NMSC	O	NOUN	B
was	O	AUX	O
present	O	ADJ	O
in	O	ADP	O
69	O	NUM	O
.	O	PUNCT	O
4	O	NUM	O
%	O	NOUN	O
,	O	PUNCT	O
two	O	NUM	O
in	O	ADP	O
16	O	NUM	O
%	O	NOUN	O
,	O	PUNCT	O
three	O	NUM	O
in	O	ADP	O
6	O	NUM	O
.	O	PUNCT	O
4	O	NUM	O
%	O	NOUN	O
,	O	PUNCT	O
four	O	NUM	O
in	O	ADP	O
3	O	NUM	O
.	O	PUNCT	O
5	O	NUM	O
%	O	NOUN	O
,	O	PUNCT	O
five	O	NUM	O
to	O	PART	O
nine	O	NUM	O
in	O	ADP	O
4	O	NUM	O
.	O	PUNCT	O
2	O	NUM	O
%	O	NOUN	O
,	O	PUNCT	O
and	O	CCONJ	O
0	O	NUM	O
.	O	PUNCT	O
5	O	NUM	O
%	O	NOUN	O
had	O	AUX	O
ten	O	NUM	O
or	O	CCONJ	O
more	O	ADJ	O
.	O	PUNCT	O


The	O	DET	O
two	O	NUM	O
ParA	B-GENE	NOUN	B
proteins	I-GENE	NOUN	I
that	O	PRON	O
are	O	AUX	O
produced	O	VERB	O
as	O	ADP	O
a	O	DET	O
result	O	NOUN	O
of	O	ADP	O
independent	O	ADJ	B
translation	O	NOUN	B
initiation	O	NOUN	O
at	O	ADP	O
two	O	NUM	O
different	O	ADJ	O
start	O	NOUN	O
codons	O	NOUN	B
within	O	ADP	O
the	O	DET	O
same	O	ADJ	O
open	O	ADJ	B
reading	O	NOUN	I
frame	O	NOUN	I
were	O	AUX	O
overexpressed	O	VERB	B
in	O	ADP	O
Escherichia	O	X	B
coli	O	X	I
and	O	CCONJ	O
partially	O	ADV	O
purified	O	VERB	B
.	O	PUNCT	O


To	O	PART	O
get	O	VERB	O
further	O	ADJ	O
insights	O	NOUN	O
into	O	ADP	O
the	O	DET	O
molecular	O	ADJ	B
mechanisms	O	NOUN	I
that	O	PRON	O
control	O	VERB	B
tal	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	O
expression	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
have	O	AUX	O
isolated	O	VERB	B
5	O	NUM	O
'	O	PART	O
sequences	O	NOUN	B
of	O	ADP	O
the	O	DET	O
murine	O	ADJ	B
gene	O	NOUN	O
and	O	CCONJ	O
compared	O	VERB	B
them	O	PRON	O
to	O	ADP	O
their	O	PRON	O
human	O	ADJ	B
counterparts	O	NOUN	B
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
demonstrate	O	VERB	O
that	O	SCONJ	O
a	O	DET	O
diverse	O	ADJ	B
set	O	NOUN	O
of	O	ADP	O
carboxyl	O	NOUN	B
-	O	PUNCT	O
terminal	O	ADJ	B
sequence	O	NOUN	B
motifs	O	NOUN	B
and	O	CCONJ	O
posttranslational	O	ADJ	B
modifications	O	NOUN	B
lead	O	VERB	O
to	O	PART	O
functional	O	ADJ	B
Ras	B-GENE	NOUN	B
proteins	I-GENE	NOUN	I
in	O	ADP	O
yeast	O	NOUN	B
.	O	PUNCT	O


Binding	O	NOUN	B
of	O	ADP	O
U2	B-GENE	NOUN	O
small	I-GENE	ADJ	O
nuclear	I-GENE	ADJ	O
ribonucleoprotein	I-GENE	NOUN	O
(	O	PUNCT	O
snRNP	O	NOUN	B
)	O	PUNCT	O
to	O	PART	O
the	O	DET	O
pre	O	ADJ	B
-	O	PUNCT	O
mRNA	O	NOUN	B
is	O	AUX	O
an	O	DET	O
early	O	ADJ	B
and	O	CCONJ	O
important	O	ADJ	O
step	O	NOUN	O
in	O	ADP	O
spliceosome	O	NOUN	B
assembly	O	NOUN	I
.	O	PUNCT	O


Our	O	PRON	O
results	O	NOUN	B
indicate	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
KRAB	B-GENE	NOUN	B
domain	I-GENE	NOUN	I
present	O	ADJ	O
in	O	ADP	O
the	O	DET	O
non	O	ADJ	B
-	O	PUNCT	O
finger	O	NOUN	B
region	O	NOUN	B
of	O	ADP	O
many	O	ADJ	O
ZFP	B-GENE	NOUN	B
genes	I-GENE	NOUN	I
quenches	O	VERB	B
transcription	O	NOUN	I
possibly	O	ADV	O
due	O	ADJ	O
to	O	PART	O
specific	O	ADJ	O
protein	O	NOUN	B
-	O	PUNCT	O
protein	O	NOUN	B
interactions	O	NOUN	B
between	O	ADP	O
the	O	DET	O
KRAB	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
A	I-GENE	NOUN	B
domain	I-GENE	NOUN	B
and	O	CCONJ	O
components	O	NOUN	B
of	O	ADP	O
the	O	DET	O
proximal	O	ADJ	B
transcriptional	O	ADJ	O
apparatus	O	NOUN	O
.	O	PUNCT	O


Marine	O	ADJ	B
oils	O	NOUN	I
and	O	CCONJ	O
cardiovascular	O	ADJ	B
reactivity	O	NOUN	I
.	O	PUNCT	O


Significant	O	ADJ	O
alterations	O	NOUN	B
in	O	ADP	O
CBC	O	NOUN	B
results	O	NOUN	B
and	O	CCONJ	O
serum	B-GENE	NOUN	B
CRP	I-GENE	NOUN	O
concentration	O	NOUN	O
,	O	PUNCT	O
compared	O	VERB	B
with	O	ADP	O
baseline	O	NOUN	B
values	O	NOUN	O
,	O	PUNCT	O
were	O	AUX	O
lacking	O	VERB	B
in	O	ADP	O
dogs	O	NOUN	B
of	O	ADP	O
the	O	DET	O
control	O	NOUN	B
group	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
newly	O	ADV	O
recognised	O	VERB	O
skeletogenital	O	ADJ	B
syndrome	O	NOUN	I
.	O	PUNCT	O


Ras	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
and	I-GENE	CCONJ	O
ultra	I-GENE	ADJ	B
-	I-GENE	PUNCT	O
violet	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
responsive	I-GENE	ADJ	B
protein	I-GENE	NOUN	B
kinases	I-GENE	NOUN	I
that	O	PRON	O
phosphorylate	O	VERB	B
c	B-GENE	X	O
-	I-GENE	PUNCT	O
Jun	I-GENE	NOUN	B
on	O	ADP	O
serine	O	NOUN	B
residues	O	NOUN	I
at	O	ADP	O
positions	O	NOUN	B
63	O	NUM	O
and	O	CCONJ	O
73	O	NUM	O
and	O	CCONJ	O
stimulate	O	VERB	B
its	O	PRON	O
transcriptional	O	ADJ	B
activity	O	NOUN	I
have	O	AUX	O
been	O	AUX	O
identified	O	VERB	B
.	O	PUNCT	O


A	O	DET	O
short	O	ADJ	B
sequence	O	NOUN	I
surrounding	O	VERB	O
the	O	DET	O
major	O	ADJ	O
JNK	B-GENE	NOUN	B
phosphorylation	O	NOUN	B
site	O	NOUN	O
of	O	ADP	O
c	B-GENE	NOUN	O
-	I-GENE	PUNCT	O
Jun	I-GENE	NOUN	B
is	O	AUX	O
conserved	O	VERB	O
in	O	ADP	O
c	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
Fos	I-GENE	NOUN	B
and	O	CCONJ	O
is	O	AUX	O
part	O	NOUN	O
of	O	ADP	O
its	O	PRON	O
activation	O	NOUN	B
domain	O	NOUN	I
,	O	PUNCT	O
suggesting	O	VERB	O
that	O	SCONJ	O
c	B-GENE	X	B
-	I-GENE	PUNCT	O
Fos	I-GENE	NOUN	B
may	O	AUX	O
be	O	AUX	O
similarly	O	ADV	O
regulated	O	VERB	O
.	O	PUNCT	O


c	B-GENE	X	O
-	I-GENE	PUNCT	O
Fos	I-GENE	NOUN	B
transcriptional	O	ADJ	B
activity	O	NOUN	I
stimulated	O	VERB	B
by	O	ADP	O
H	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
Ras	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
activated	I-GENE	VERB	B
protein	I-GENE	NOUN	B
kinase	I-GENE	NOUN	I
distinct	O	ADJ	O
from	O	ADP	O
JNK	B-GENE	NOUN	B
and	O	CCONJ	O
ERK	B-GENE	NOUN	B
.	O	PUNCT	O


Essential	O	ADJ	B
features	O	NOUN	O
of	O	ADP	O
this	O	DET	O
model	O	NOUN	B
are	O	AUX	O
bending	O	VERB	B
of	O	ADP	O
the	O	DET	O
DNA	O	NOUN	B
double	O	ADJ	O
helix	O	NOUN	O
and	O	CCONJ	O
contact	O	NOUN	B
of	O	ADP	O
operator	O	NOUN	B
sites	O	NOUN	I
with	O	ADP	O
repressor	O	NOUN	B
domains	O	NOUN	I
bearing	O	VERB	O
sequence	O	NOUN	B
homologies	O	NOUN	B
with	O	ADP	O
the	O	DET	O
helix	O	NOUN	B
-	O	PUNCT	O
turn	O	NOUN	B
-	O	PUNCT	O
helix	O	NOUN	B
(	O	PUNCT	O
HTH	O	NOUN	B
)	O	PUNCT	O
motifs	O	NOUN	B
of	O	ADP	O
other	O	ADJ	O
DNA	O	NOUN	B
-	O	PUNCT	O
binding	O	VERB	B
proteins	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
binding	O	NOUN	B
of	O	ADP	O
transcription	O	NOUN	B
factor	O	NOUN	I
AP	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	B
and	O	CCONJ	O
vitamin	B-GENE	NOUN	B
D	I-GENE	NOUN	I
receptor	I-GENE	NOUN	I
(	O	PUNCT	O
VDR	B-GENE	NOUN	B
)	O	PUNCT	O
to	O	PART	O
the	O	DET	O
composite	O	ADJ	B
AP	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	O
plus	I-GENE	CCONJ	O
vitamin	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
D	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
responsive	I-GENE	ADJ	B
promoter	I-GENE	NOUN	B
region	O	NOUN	I
(	O	PUNCT	O
AP	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	B
+	I-GENE	CCONJ	O
VDRE	I-GENE	NOUN	B
)	O	PUNCT	O
of	O	ADP	O
the	O	DET	O
human	B-GENE	ADJ	B
osteocalcin	I-GENE	NOUN	O
gene	I-GENE	NOUN	O
was	O	AUX	O
characterized	O	VERB	B
in	O	ADP	O
osteocalcin	B-GENE	NOUN	B
-	O	PUNCT	O
producing	O	VERB	B
(	O	PUNCT	O
MG	O	PROPN	B
-	O	PUNCT	O
63	O	NUM	O
)	O	PUNCT	O
and	O	CCONJ	O
non	O	NOUN	B
-	O	PUNCT	O
producing	O	VERB	B
(	O	PUNCT	O
U2	O	NOUN	B
-	O	PUNCT	O
Os	O	PROPN	B
,	O	PUNCT	O
SaOs	O	NOUN	B
-	O	PUNCT	O
2	O	NUM	O
)	O	PUNCT	O
human	O	ADJ	B
osteosarcoma	O	NOUN	B
cell	O	NOUN	B
lines	O	NOUN	I
.	O	PUNCT	O


2	O	X	O
.	O	PUNCT	O


The	O	DET	O
LTR	O	NOUN	B
-	O	PUNCT	O
binding	O	NOUN	B
activities	O	NOUN	B
of	O	ADP	O
VBP	B-GENE	PROPN	B
,	O	PUNCT	O
a1	B-GENE	PROPN	B
/	I-GENE	SYM	O
EBP	I-GENE	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
B	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
cell	I-GENE	NOUN	B
nuclear	I-GENE	ADJ	I
extract	I-GENE	NOUN	I
protein	I-GENE	NOUN	I
were	O	AUX	O
compared	O	VERB	B
and	O	CCONJ	O
mapped	O	VERB	B
by	O	ADP	O
gel	O	NOUN	B
shift	O	NOUN	B
,	O	PUNCT	O
DNase	B-GENE	NOUN	B
I	I-GENE	NUM	I
footprinting	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
methylation	O	NOUN	B
interference	O	NOUN	O
assays	O	NOUN	O
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
leader	O	NOUN	B
-	O	PUNCT	O
mRNA	O	NOUN	B
fusion	O	NOUN	B
in	O	ADP	O
coronavirus	O	NOUN	B
transcription	O	NOUN	B
does	O	AUX	O
not	O	PART	O
require	O	VERB	O
direct	O	ADJ	O
RNA	O	NOUN	B
-	O	PUNCT	O
RNA	O	NOUN	B
interaction	O	NOUN	B
between	O	ADP	O
complementary	O	ADJ	B
sequences	O	NOUN	I
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
leader	O	NOUN	B
-	O	PUNCT	O
mRNA	O	NOUN	B
fusion	O	NOUN	B
in	O	ADP	O
coronavirus	O	NOUN	B
transcription	O	NOUN	B
does	O	AUX	O
not	O	PART	O
require	O	VERB	O
direct	O	ADJ	O
RNA	O	NOUN	B
-	O	PUNCT	O
RNA	O	NOUN	B
interaction	O	NOUN	B
between	O	ADP	O
complementary	O	ADJ	B
sequences	O	NOUN	I
.	O	PUNCT	O


To	O	PART	O
determine	O	VERB	O
whether	O	SCONJ	O
P35	B-GENE	NOUN	B
could	O	AUX	O
activate	O	VERB	B
the	O	DET	O
39k	O	NOUN	O
promoter	O	NOUN	B
in	O	ADP	O
the	O	DET	O
absence	O	NOUN	B
of	O	ADP	O
IE1	B-GENE	NOUN	B
,	O	PUNCT	O
the	O	DET	O
p35	B-GENE	NOUN	B
open	O	ADJ	O
reading	O	NOUN	O
frame	O	NOUN	O
was	O	AUX	O
cloned	O	VERB	B
under	O	ADP	O
the	O	DET	O
control	O	NOUN	B
of	O	ADP	O
the	O	DET	O
ie1	B-GENE	NOUN	B
promoter	I-GENE	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
addition	O	NOUN	O
,	O	PUNCT	O
a	O	DET	O
microsatellite	O	NOUN	B
repeat	O	NOUN	I
polymorphism	O	NOUN	B
with	O	ADP	O
a	O	DET	O
heterozygosity	O	NOUN	B
of	O	ADP	O
71	O	NUM	O
%	O	NOUN	O
at	O	ADP	O
the	O	DET	O
RET	B-GENE	NOUN	B
locus	I-GENE	NOUN	B
and	O	CCONJ	O
a	O	DET	O
restriction	O	NOUN	B
fragment	O	NOUN	I
length	O	NOUN	I
polymorphism	O	NOUN	I
with	O	ADP	O
a	O	DET	O
heterozygosity	O	NOUN	B
of	O	ADP	O
42	O	NUM	O
%	O	NOUN	O
detected	O	VERB	B
by	O	ADP	O
a	O	DET	O
lambda	O	NOUN	B
clone	O	NOUN	I
from	O	ADP	O
the	O	DET	O
D10S94	B-GENE	NOUN	B
locus	I-GENE	NOUN	I
have	O	AUX	O
been	O	AUX	O
developed	O	VERB	O
for	O	ADP	O
high	O	ADJ	B
-	O	PUNCT	O
resolution	O	NOUN	B
genetic	O	ADJ	B
linkage	O	NOUN	I
mapping	O	NOUN	I
and	O	CCONJ	O
predictive	O	ADJ	B
diagnostic	O	ADJ	B
testing	O	NOUN	I
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
tyrA	B-GENE	NOUN	B
can	O	AUX	O
be	O	AUX	O
expressed	O	VERB	B
efficiently	O	ADV	B
from	O	ADP	O
an	O	DET	O
internal	O	ADJ	B
promoter	O	NOUN	I
which	O	DET	O
appears	O	VERB	O
to	O	PART	O
lie	O	VERB	O
within	O	ADP	O
the	O	DET	O
3	O	NUM	O
'	O	PART	O
portion	O	NOUN	B
of	O	ADP	O
aroF	B-GENE	NOUN	B
.	O	PUNCT	O


Within	O	ADP	O
the	O	DET	O
span	O	NOUN	O
of	O	ADP	O
attenuator	O	NOUN	B
region	O	NOUN	I
encoding	O	VERB	B
the	O	DET	O
three	O	NUM	O
stem	O	NOUN	B
-	O	PUNCT	O
loop	O	NOUN	B
structures	O	NOUN	B
of	O	ADP	O
mRNA	O	NOUN	B
secondary	O	ADJ	O
configuration	O	NOUN	O
,	O	PUNCT	O
hot	O	ADJ	B
spots	O	NOUN	I
of	O	ADP	O
base	O	NOUN	B
-	O	PUNCT	O
residue	O	NOUN	B
divergence	O	NOUN	B
were	O	AUX	O
localized	O	ADJ	B
to	O	PART	O
looped	O	VERB	B
-	O	PUNCT	O
out	O	ADP	O
regions	O	NOUN	B
.	O	PUNCT	O


Previous	O	ADJ	O
studies	O	NOUN	B
showed	O	VERB	O
that	O	SCONJ	O
mutations	O	NOUN	B
in	O	ADP	O
the	O	DET	O
6K	O	NOUN	B
protein	O	NOUN	I
led	O	VERB	O
to	O	PART	O
the	O	DET	O
slow	O	ADJ	B
release	O	NOUN	I
of	O	ADP	O
aberrant	O	ADJ	B
,	O	PUNCT	O
multi	O	ADJ	B
-	O	PUNCT	O
cored	O	VERB	B
infectious	O	ADJ	B
virions	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
RFLP	O	NOUN	B
patterns	O	NOUN	B
of	O	ADP	O
the	O	DET	O
isolates	O	NOUN	B
from	O	ADP	O
six	O	NUM	O
of	O	ADP	O
these	O	DET	O
patients	O	NOUN	B
remained	O	VERB	O
essentially	O	ADV	O
unchanged	O	ADJ	B
(	O	PUNCT	O
two	O	NUM	O
strains	O	NOUN	B
showed	O	VERB	O
one	O	NUM	O
additional	O	ADJ	O
band	O	NOUN	B
)	O	PUNCT	O
despite	O	SCONJ	O
the	O	DET	O
development	O	NOUN	B
of	O	ADP	O
drug	O	NOUN	B
resistance	O	NOUN	I
.	O	PUNCT	O


Southern	O	NOUN	B
analysis	O	NOUN	O
on	O	ADP	O
genomic	O	ADJ	B
DNA	O	NOUN	I
isolated	O	VERB	B
from	O	ADP	O
tissues	O	NOUN	B
and	O	CCONJ	O
cell	O	NOUN	B
lines	O	NOUN	I
from	O	ADP	O
several	O	ADJ	O
mouse	O	NOUN	B
strains	O	NOUN	I
using	O	VERB	O
mCD22	B-GENE	NOUN	B
cDNA	I-GENE	NOUN	B
demonstrated	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
Cd22	B-GENE	NOUN	B
locus	I-GENE	NOUN	I
encoding	O	NOUN	B
mCD22	B-GENE	NOUN	B
is	O	AUX	O
a	O	DET	O
single	O	ADJ	O
copy	O	NOUN	B
gene	O	NOUN	I
of	O	ADP	O
<	O	X	O
or	O	CCONJ	O
=	O	ADJ	O
30	O	NUM	O
kb	O	NOUN	O
.	O	PUNCT	O


The	O	DET	O
tyrosine	B-GENE	NOUN	B
hydroxylase	I-GENE	NOUN	I
gene	I-GENE	NOUN	I
(	O	PUNCT	O
TH	B-GENE	NOUN	B
)	O	PUNCT	O
contains	O	VERB	O
a	O	DET	O
single	O	ADJ	O
copy	O	NOUN	B
of	O	ADP	I
a	O	DET	O
consensus	O	NOUN	B
CRE	O	NOUN	B
at	O	ADP	O
-	O	PUNCT	O
45	O	NUM	O
to	O	PART	O
-	O	PUNCT	O
38	O	NUM	O
base	O	NOUN	B
pair	O	NOUN	I
(	O	PUNCT	O
bp	O	NOUN	O
)	O	PUNCT	O
upstream	O	ADJ	B
of	O	ADP	O
the	O	DET	O
transcription	O	NOUN	B
initiation	O	NOUN	I
site	O	NOUN	I
.	O	PUNCT	O


Fenoldopam	O	NOUN	B
,	O	PUNCT	O
a	O	DET	O
dopamine	B-GENE	NOUN	B
receptor	I-GENE	NOUN	I
agonist	O	NOUN	B
,	O	PUNCT	O
has	O	AUX	O
been	O	AUX	O
shown	O	VERB	O
,	O	PUNCT	O
in	O	ADP	O
animal	O	NOUN	B
experiments	O	NOUN	I
,	O	PUNCT	O
to	O	PART	O
improve	O	VERB	O
renal	O	ADJ	B
perfusion	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
results	O	NOUN	B
indicate	O	VERB	O
that	O	SCONJ	O
hrpRS	B-GENE	NOUN	B
and	O	CCONJ	O
hrpL	B-GENE	NOUN	B
are	O	AUX	O
part	O	NOUN	O
of	O	ADP	O
a	O	DET	O
regulatory	O	ADJ	B
cascade	O	NOUN	I
in	O	ADP	O
which	O	DET	O
HrpR	B-GENE	NOUN	B
and	O	CCONJ	O
HrpS	B-GENE	NOUN	B
activate	O	VERB	B
expression	O	NOUN	B
of	O	ADP	O
hrpL	B-GENE	NOUN	B
and	O	CCONJ	O
HrpL	B-GENE	NOUN	B
,	O	PUNCT	O
a	O	DET	O
putative	O	ADJ	B
sigma	B-GENE	NOUN	I
factor	I-GENE	NOUN	I
,	O	PUNCT	O
induces	O	VERB	B
expression	O	NOUN	B
of	O	ADP	O
HrpL	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
responsive	I-GENE	ADJ	B
genes	I-GENE	NOUN	B
.	O	PUNCT	O


All	O	DET	O
other	O	ADJ	O
normal	O	ADJ	B
and	O	CCONJ	O
transformed	O	VERB	B
lymphoid	O	ADJ	B
and	O	CCONJ	O
nonlymphoid	O	ADJ	B
cell	O	NOUN	B
lines	O	NOUN	I
and	O	CCONJ	O
normal	O	ADJ	B
tissues	O	NOUN	I
were	O	AUX	O
negative	O	ADJ	B
for	O	ADP	O
PANG	B-GENE	NOUN	B
expression	O	NOUN	B
except	O	SCONJ	O
for	O	ADP	O
the	O	DET	O
brain	O	NOUN	B
,	O	PUNCT	O
wherein	O	ADP	O
unique	O	ADJ	O
4	O	NUM	O
.	O	PUNCT	O
0	O	NUM	O
-	O	PUNCT	O
and	O	CCONJ	O
6	O	NUM	O
.	O	PUNCT	O
1	O	NUM	O
-	O	PUNCT	O
kb	O	NOUN	B
transcripts	O	NOUN	B
were	O	AUX	O
detected	O	VERB	B
.	O	PUNCT	O


L	O	NOUN	B
.	O	PUNCT	O
,	O	PUNCT	O
Greer	O	PROPN	B
,	O	PUNCT	O
J	O	PROPN	O
.	O	PUNCT	O
&	O	CCONJ	O
Carter	O	PROPN	O
,	O	PUNCT	O
G	O	NOUN	B
.	O	PUNCT	O


Western	O	NOUN	B
blotting	O	NOUN	I
(	O	PUNCT	O
immunoblotting	O	NOUN	B
)	O	PUNCT	O
with	O	ADP	O
an	O	DET	O
antiserum	O	NOUN	B
to	O	PART	O
a	O	DET	O
partial	O	ADJ	B
SOD	B-GENE	NOUN	B
expressed	O	VERB	B
in	O	ADP	O
Escherichia	O	X	B
coli	O	X	I
revealed	O	VERB	O
two	O	NUM	O
proteins	O	NOUN	B
with	O	ADP	O
estimated	O	VERB	O
molecular	O	ADJ	B
masses	O	NOUN	I
of	O	ADP	O
19	O	NUM	O
and	O	CCONJ	O
29	O	NUM	O
kDa	O	NOUN	O
.	O	PUNCT	O


Members	O	NOUN	O
of	O	ADP	O
the	O	DET	O
myocyte	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
specific	I-GENE	ADJ	B
enhancer	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
binding	I-GENE	VERB	B
factor	I-GENE	NOUN	I
2	I-GENE	NUM	I
(	O	PUNCT	O
MEF2	B-GENE	NOUN	B
)	O	PUNCT	O
family	O	NOUN	B
of	O	ADP	O
transcription	O	NOUN	B
factors	O	NOUN	I
bind	O	VERB	B
a	O	DET	O
conserved	O	VERB	O
A	O	PROPN	B
/	O	SYM	O
T	O	NOUN	B
-	O	PUNCT	O
rich	O	ADJ	B
sequence	O	NOUN	B
in	O	ADP	O
the	O	DET	O
control	O	NOUN	B
regions	O	NOUN	I
of	O	ADP	O
numerous	O	ADJ	O
muscle	O	NOUN	B
-	O	PUNCT	O
specific	O	ADJ	B
genes	O	NOUN	B
.	O	PUNCT	O


Seven	O	NUM	O
of	O	ADP	O
these	O	DET	O
had	O	AUX	O
counterparts	O	NOUN	O
in	O	ADP	O
the	O	DET	O
US	O	PROPN	B
of	O	ADP	O
herpes	O	NOUN	B
simplex	O	NOUN	I
type	O	NOUN	I
1	O	NUM	I
(	O	PUNCT	O
HSV	O	NOUN	B
-	O	PUNCT	O
1	O	NUM	O
)	O	PUNCT	O
,	O	PUNCT	O
pseudorabies	O	NOUN	B
virus	O	NOUN	I
(	O	PUNCT	O
PRV	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
and	O	CCONJ	O
equine	O	NOUN	B
herpesvirus	O	NOUN	B
type	O	NOUN	I
1	O	NUM	I
(	O	PUNCT	O
EHV	O	PROPN	B
-	O	PUNCT	O
1	O	NUM	O
)	O	PUNCT	O
.	O	PUNCT	O


The	O	DET	O
previously	O	ADV	O
described	O	VERB	O
enhanced	O	VERB	B
translation	O	NOUN	B
of	O	ADP	O
spinach	O	NOUN	B
L12	B-GENE	NOUN	I
mRNA	I-GENE	NOUN	B
from	O	ADP	O
its	O	PRON	O
two	O	NUM	O
tandem	O	ADJ	O
AUG	O	NOUN	B
codons	O	NOUN	I
and	O	CCONJ	O
the	O	DET	O
two	O	NUM	O
functional	O	ADJ	O
rpl12	B-GENE	NOUN	B
genes	I-GENE	NOUN	I
in	O	ADP	O
Arabidopsis	O	NOUN	B
probably	O	ADV	O
provide	O	VERB	O
two	O	NUM	O
mechanisms	O	NOUN	B
for	O	ADP	O
generating	O	VERB	O
the	O	DET	O
four	O	NUM	O
copies	O	NOUN	B
of	O	ADP	O
L12	B-GENE	NOUN	B
/	I-GENE	PUNCT	O
chloroplast	I-GENE	NOUN	B
ribosome	I-GENE	NOUN	B
,	O	PUNCT	O
qualitatively	O	ADV	B
different	O	ADJ	O
from	O	ADP	O
those	O	DET	O
attempted	O	VERB	O
in	O	ADP	O
eubacteria	O	NOUN	B
.	O	PUNCT	O


Genomic	O	ADJ	B
DNA	O	NOUN	I
clones	O	NOUN	I
containing	O	VERB	O
the	O	DET	O
T	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
cell	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
specific	I-GENE	ADJ	B
human	I-GENE	ADJ	B
MAL	I-GENE	NOUN	B
gene	I-GENE	NOUN	I
were	O	AUX	O
isolated	O	VERB	B
.	O	PUNCT	O


Expression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
dibasic	O	ADJ	B
proprotein	O	NOUN	I
processing	O	NOUN	O
enzyme	O	NOUN	B
furin	B-GENE	NOUN	I
is	O	AUX	O
directed	O	VERB	O
by	O	ADP	O
multiple	O	ADJ	B
promoters	O	NOUN	I
.	O	PUNCT	O


Certain	O	ADJ	O
spt10	B-GENE	ADJ	B
spontaneous	O	ADJ	B
alleles	O	NOUN	B
are	O	AUX	O
good	O	ADJ	O
suppressors	O	NOUN	B
but	O	CCONJ	O
have	O	AUX	O
a	O	DET	O
normal	O	ADJ	B
growth	O	NOUN	I
rate	O	NOUN	O
,	O	PUNCT	O
suggesting	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
SPT10	B-GENE	NOUN	B
protein	I-GENE	NOUN	I
may	O	AUX	O
have	O	AUX	O
two	O	NUM	O
distinct	O	ADJ	O
functions	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
Rat	O	NOUN	B
1a	O	NOUN	I
cells	O	NOUN	I
,	O	PUNCT	O
m1R	B-GENE	ADJ	B
stimulation	O	NOUN	B
of	O	ADP	O
phospholipase	B-GENE	NOUN	B
C	I-GENE	NOUN	I
beta	I-GENE	NOUN	I
and	O	CCONJ	O
the	O	DET	O
marked	O	ADJ	O
rise	O	NOUN	O
in	O	ADP	O
intracellular	O	ADJ	B
calcium	O	NOUN	B
stimulated	O	VERB	O
cyclic	O	ADJ	B
AMP	O	NOUN	I
(	O	PUNCT	O
cAMP	O	NOUN	B
)	O	PUNCT	O
synthesis	O	NOUN	B
,	O	PUNCT	O
resulting	O	VERB	O
in	O	ADP	O
the	O	DET	O
activation	O	NOUN	B
of	O	ADP	O
protein	B-GENE	NOUN	B
kinase	I-GENE	NOUN	I
A	I-GENE	NOUN	I
.	O	PUNCT	O


The	O	DET	O
mutations	O	NOUN	B
did	O	AUX	O
not	O	PART	O
affect	O	VERB	O
the	O	DET	O
repression	O	NOUN	B
of	O	ADP	O
CPA1	B-GENE	NOUN	B
by	O	ADP	O
arginine	O	NOUN	B
.	O	PUNCT	O


A	O	DET	O
segment	O	NOUN	B
of	O	ADP	O
mRNA	O	NOUN	B
encoding	O	VERB	B
the	O	DET	O
leader	O	NOUN	B
peptide	O	NOUN	I
of	O	ADP	O
the	O	DET	O
CPA1	B-GENE	NOUN	B
gene	I-GENE	NOUN	I
confers	O	VERB	O
repression	O	NOUN	B
by	O	ADP	O
arginine	O	NOUN	B
on	O	ADP	O
a	O	DET	O
heterologous	O	ADJ	B
yeast	O	NOUN	B
gene	O	NOUN	O
transcript	O	NOUN	O
.	O	PUNCT	O


Structure	O	NOUN	B
and	O	CCONJ	O
expression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
alternative	O	ADJ	B
sigma	B-GENE	NOUN	I
factor	I-GENE	NOUN	I
,	O	PUNCT	O
RpoN	B-GENE	NOUN	B
,	O	PUNCT	O
in	O	ADP	O
Rhodobacter	O	NOUN	B
capsulatus	O	NOUN	I
;	O	PUNCT	O
physiological	O	ADJ	B
relevance	O	NOUN	B
of	O	ADP	O
an	O	DET	O
autoactivated	O	ADJ	B
nifU2	B-GENE	NOUN	B
-	O	PUNCT	O
rpoN	B-GENE	NOUN	B
superoperon	O	NOUN	B
.	O	PUNCT	O


Insertion	O	NOUN	B
of	O	ADP	O
short	O	ADJ	B
oligonucleotides	O	NOUN	I
encoding	O	VERB	B
the	O	DET	O
basic	O	ADJ	O
amino	O	NOUN	B
acid	O	NOUN	I
motifs	O	NOUN	O
726	O	NUM	O
-	O	PUNCT	O
GRKRKSP	O	PROPN	B
-	O	PUNCT	O
732	O	NUM	O
from	O	ADP	O
IE175	B-GENE	NOUN	B
and	O	CCONJ	O
500	O	NUM	O
-	O	PUNCT	O
VRPRKRR	O	PROPN	B
-	O	PUNCT	O
506	O	NUM	O
from	O	ADP	O
IE110	B-GENE	NOUN	B
into	O	ADP	O
deleted	O	VERB	B
cytoplasmic	O	ADJ	B
forms	O	NOUN	O
of	O	ADP	O
the	O	DET	O
two	O	NUM	O
proteins	O	NOUN	B
restored	O	VERB	B
the	O	DET	O
karyophilic	O	ADJ	B
phenotype	O	NOUN	B
and	O	CCONJ	O
confirmed	O	VERB	O
that	O	SCONJ	O
these	O	DET	O
motifs	O	NOUN	B
are	O	AUX	O
both	O	CCONJ	O
necessary	O	ADJ	O
and	O	CCONJ	O
sufficient	O	ADJ	B
for	O	ADP	O
proper	O	ADJ	O
nuclear	O	ADJ	B
localization	O	NOUN	I
.	O	PUNCT	O


Mapping	O	NOUN	B
of	O	ADP	O
intracellular	O	ADJ	B
localization	O	NOUN	B
domains	O	NOUN	O
and	O	CCONJ	O
evidence	O	NOUN	B
for	O	ADP	O
colocalization	O	NOUN	B
interactions	O	NOUN	B
between	O	ADP	O
the	O	DET	O
IE110	B-GENE	NOUN	B
and	O	CCONJ	O
IE175	B-GENE	NOUN	O
nuclear	O	ADJ	O
transactivator	O	NOUN	O
proteins	O	NOUN	O
of	O	ADP	O
herpes	O	NOUN	B
simplex	O	NOUN	I
virus	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
revertant	O	ADJ	B
TATA	O	NOUN	B
boxes	O	NOUN	I
accelerated	O	VERB	B
the	O	DET	O
kinetics	O	NOUN	B
of	O	ADP	O
HIV	O	NOUN	B
replication	O	NOUN	B
when	O	SCONJ	O
present	O	ADJ	O
in	O	ADP	O
the	O	DET	O
context	O	NOUN	B
of	O	ADP	O
an	O	DET	O
LTR	O	NOUN	B
containing	O	VERB	O
a	O	DET	O
Sp1	B-GENE	NOUN	B
mutation	O	NOUN	B
(	O	PUNCT	O
deletion	O	NOUN	B
or	O	CCONJ	O
site	O	NOUN	B
specific	O	ADJ	B
)	O	PUNCT	O
;	O	PUNCT	O
no	O	DET	B
effect	O	NOUN	I
was	O	AUX	O
observed	O	VERB	O
on	O	ADP	O
the	O	DET	O
infectivity	O	NOUN	B
of	O	ADP	O
wild	O	ADJ	B
-	O	PUNCT	O
type	O	NOUN	B
HIV	O	NOUN	B
.	O	PUNCT	O


Mitochondrial	B-GENE	ADJ	B
Mas70p	I-GENE	NOUN	I
signal	I-GENE	NOUN	O
anchor	I-GENE	NOUN	O
sequence	I-GENE	NOUN	O
.	O	PUNCT	O


Response	O	NOUN	B
to	O	PART	O
treatment	O	NOUN	B
was	O	AUX	O
better	O	ADJ	O
in	O	ADP	O
patients	O	NOUN	B
with	O	ADP	O
less	O	ADJ	O
pretreatment	O	NOUN	B
(	O	PUNCT	O
one	O	NUM	O
-	O	PUNCT	O
two	O	NUM	O
prior	O	ADJ	O
treatments	O	NOUN	B
)	O	PUNCT	O
than	O	ADP	O
in	O	ADP	O
heavily	O	ADV	O
pretreated	O	ADJ	B
ones	O	NOUN	O
(	O	PUNCT	O
more	O	ADJ	O
than	O	ADP	O
three	O	NUM	O
)	O	PUNCT	O
and	O	CCONJ	O
this	O	DET	O
relation	O	NOUN	O
was	O	AUX	O
found	O	VERB	O
to	O	PART	O
be	O	AUX	O
statistically	O	ADV	B
significant	O	ADJ	I
(	O	PUNCT	O
p	O	NOUN	O
<	O	X	O
0	O	NUM	O
.	O	PUNCT	O
05	O	NUM	O
)	O	PUNCT	O
.	O	PUNCT	O


The	O	DET	O
class	B-GENE	NOUN	B
II	I-GENE	NUM	I
Escherichia	I-GENE	X	B
coli	I-GENE	X	I
alanine	I-GENE	NOUN	B
tRNA	I-GENE	NOUN	I
synthetase	I-GENE	NOUN	I
aminoacylates	I-GENE	VERB	O
RNA	I-GENE	NOUN	O
miniduplexes	I-GENE	NOUN	O
,	O	PUNCT	O
which	O	DET	O
reconstruct	O	VERB	O
the	O	DET	O
acceptor	O	NOUN	B
end	O	NOUN	O
of	O	ADP	O
alanine	B-GENE	NOUN	B
tRNA	I-GENE	NOUN	I
with	O	ADP	O
the	O	DET	O
critical	O	ADJ	O
G3	O	NOUN	O
:	O	PUNCT	O
U70	O	NOUN	B
base	O	NOUN	I
pair	O	NOUN	I
.	O	PUNCT	O


A	O	DET	O
second	O	ADJ	O
study	O	NOUN	B
group	O	NOUN	I
,	O	PUNCT	O
with	O	ADP	O
intact	O	ADJ	B
cardiac	O	ADJ	B
innervation	O	NOUN	I
,	O	PUNCT	O
consisted	O	VERB	O
of	O	ADP	O
19	O	NUM	O
patients	O	NOUN	B
with	O	ADP	O
stable	O	ADJ	B
angina	O	ADJ	I
pectoris	O	NOUN	I
class	O	NOUN	I
I	O	NUM	I
to	O	PART	O
III	O	NUM	O
.	O	PUNCT	O


Thus	O	ADV	O
,	O	PUNCT	O
we	O	PRON	O
have	O	AUX	O
separated	O	VERB	O
the	O	DET	O
signal	O	NOUN	B
function	O	NOUN	I
from	O	ADP	O
the	O	DET	O
anchor	O	ADJ	B
function	O	NOUN	I
of	O	ADP	O
the	O	DET	O
6	O	NUM	O
.	O	PUNCT	O
7K	O	NOUN	O
SA	O	NOUN	B
domain	O	NOUN	B
.	O	PUNCT	O


Exposure	O	NOUN	B
to	O	PART	I
higher	O	ADJ	O
TPA	O	NOUN	B
concentrations	O	NOUN	B
decreased	O	VERB	B
the	O	DET	O
content	O	NOUN	B
of	O	ADP	O
these	O	DET	O
transcripts	O	NOUN	B
.	O	PUNCT	O


Our	O	PRON	O
results	O	NOUN	B
indicate	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
minimal	O	ADJ	B
requirements	O	NOUN	B
for	O	ADP	O
induction	O	NOUN	B
of	O	ADP	O
PEPCK	B-GENE	NOUN	B
by	O	ADP	O
PKA	B-GENE	NOUN	B
and	O	CCONJ	O
inhibition	O	NOUN	B
by	O	ADP	O
insulin	B-GENE	NOUN	B
include	O	VERB	O
:	O	PUNCT	O
1	O	X	O
)	O	PUNCT	O
the	O	DET	O
CREB	B-GENE	NOUN	B
activation	I-GENE	NOUN	B
domain	I-GENE	NOUN	I
,	O	PUNCT	O
2	O	X	O
)	O	PUNCT	O
the	O	DET	O
PEPCK	B-GENE	NOUN	B
TATA	I-GENE	NOUN	B
sequence	I-GENE	NOUN	O
,	O	PUNCT	O
and	O	CCONJ	O
3	O	X	O
)	O	PUNCT	O
insulin	B-GENE	NOUN	B
-	O	PUNCT	O
responsive	O	ADJ	B
hepatoma	O	NOUN	B
cells	O	NOUN	I
.	O	PUNCT	O


Topical	O	PROPN	B
L	O	PROPN	B
-	O	PUNCT	O
NNA	O	PROPN	B
attenuated	O	VERB	B
the	O	DET	O
hypercapnic	O	ADJ	B
increase	O	NOUN	B
of	O	ADP	O
CoBF	O	NOUN	B
by	O	ADP	O
52	O	NUM	O
+	O	CCONJ	O
/	O	SYM	O
-	O	PUNCT	O
6	O	NUM	O
%	O	NOUN	O
and	O	CCONJ	O
CeBF	O	NOUN	B
by	O	ADP	O
29	O	NUM	O
+	O	CCONJ	O
/	O	SYM	O
-	O	PUNCT	O
5	O	NUM	O
%	O	NOUN	O
after	O	ADP	O
45	O	NUM	O
-	O	PUNCT	O
min	O	NOUN	B
exposure	O	NOUN	B
.	O	PUNCT	O


Restriction	O	NOUN	B
analysis	O	NOUN	I
and	O	CCONJ	O
Southern	O	NOUN	B
hybridization	O	NOUN	I
revealed	O	VERB	O
the	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
Tn5422	B-GENE	NOUN	B
in	O	ADP	O
all	O	DET	O
the	O	DET	O
plasmid	O	NOUN	B
-	O	PUNCT	O
mediated	O	VERB	B
cadmium	O	NOUN	B
-	O	PUNCT	O
resistant	O	ADJ	B
L	O	NOUN	B
.	O	PUNCT	O
monocytogenes	O	NOUN	B
strains	O	NOUN	I
tested	O	VERB	B
but	O	CCONJ	O
not	O	PART	O
in	O	ADP	O
strains	O	NOUN	B
encoding	O	VERB	B
cadmium	O	NOUN	B
resistance	O	NOUN	I
on	O	ADP	O
the	O	DET	O
chromosome	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
7	O	NUM	O
-	O	PUNCT	O
day	O	NOUN	B
treatment	O	NOUN	B
resulted	O	VERB	O
in	O	ADP	O
a	O	DET	O
decrease	O	NOUN	B
in	O	ADP	O
mitochondrial	O	ADJ	B
uptake	O	NOUN	B
of	O	ADP	O
Rh123	O	NOUN	B
and	O	CCONJ	O
an	O	DET	O
increase	O	NOUN	B
in	O	ADP	O
NAO	O	NOUN	B
uptake	O	NOUN	B
.	O	PUNCT	O


Thrombotic	O	ADJ	B
thrombocytopenic	O	ADJ	I
purpura	O	NOUN	I
in	O	ADP	O
systemic	O	ADJ	B
lupus	O	NOUN	I
erythematosus	O	NOUN	I
.	O	PUNCT	O


Women	O	PROPN	B
'	O	PART	O
s	O	PROPN	O
opportunities	O	NOUN	B
for	O	ADP	O
paid	O	VERB	O
work	O	NOUN	O
outside	O	ADP	O
the	O	DET	O
home	O	NOUN	B
are	O	AUX	O
constrained	O	VERB	O
by	O	ADP	O
their	O	PRON	O
role	O	NOUN	O
as	O	ADP	O
primary	O	ADJ	B
carer	O	NOUN	I
within	O	ADP	O
the	O	DET	O
family	O	NOUN	B
,	O	PUNCT	O
writes	O	VERB	O
Trudy	O	PROPN	B
Wynne	O	PROPN	I
.	O	PUNCT	O


Interestingly	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
interaction	O	NOUN	B
of	O	ADP	O
ZAP	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
70	I-GENE	NUM	O
with	O	ADP	O
the	O	DET	O
motif	O	NOUN	B
was	O	AUX	O
dependent	O	ADJ	B
on	O	ADP	O
the	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
both	O	CCONJ	O
ZAP	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
70	I-GENE	NUM	O
SH2	B-GENE	NOUN	B
domains	I-GENE	NOUN	I
and	O	CCONJ	O
both	O	DET	O
of	O	ADP	O
the	O	DET	O
tyrosine	O	NOUN	B
residues	O	NOUN	I
in	O	ADP	O
the	O	DET	O
motif	O	NOUN	B
,	O	PUNCT	O
suggesting	O	VERB	O
that	O	SCONJ	O
ZAP	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
70	I-GENE	NUM	O
interacts	O	VERB	O
with	O	ADP	O
two	O	NUM	O
phosphotyrosine	O	NOUN	B
residues	O	NOUN	I
and	O	CCONJ	O
that	O	SCONJ	O
the	O	DET	O
binding	O	NOUN	B
of	O	ADP	O
the	O	DET	O
two	O	NUM	O
SH2	B-GENE	NOUN	B
domains	I-GENE	NOUN	I
is	O	AUX	O
cooperative	O	ADJ	O
.	O	PUNCT	O


PRL	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	O
is	O	AUX	O
able	O	ADJ	O
to	O	PART	O
dephosphorylate	O	VERB	B
phosphotyrosine	O	NOUN	I
substrates	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
mutation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
active	O	ADJ	B
-	O	PUNCT	O
site	O	NOUN	B
cysteine	O	NOUN	B
residue	O	NOUN	B
abolishes	O	VERB	O
this	O	DET	O
activity	O	NOUN	B
.	O	PUNCT	O


50	O	NUM	O
kDa	O	NOUN	O
and	O	CCONJ	O
130	O	NUM	O
-	O	PUNCT	O
170	O	NUM	O
kDa	O	NOUN	O
were	O	AUX	O
detected	O	VERB	B
.	O	PUNCT	O


This	O	DET	O
strategy	O	NOUN	O
was	O	AUX	O
used	O	VERB	O
to	O	PART	O
place	O	VERB	O
both	O	CCONJ	O
the	O	DET	O
Tn903	B-GENE	NOUN	B
neo	I-GENE	NOUN	I
gene	I-GENE	NOUN	I
and	O	CCONJ	O
the	O	DET	O
Rhodosporidium	B-GENE	NOUN	B
toruloides	I-GENE	NOUN	I
phenylalanine	I-GENE	NOUN	B
ammonia	I-GENE	NOUN	I
lyase	I-GENE	NOUN	I
(	O	PUNCT	O
PAL	B-GENE	NOUN	B
)	O	PUNCT	O
-	O	PUNCT	O
encoding	O	VERB	B
gene	O	NOUN	B
under	O	ADP	O
the	O	DET	O
transcriptional	O	ADJ	B
control	O	NOUN	I
of	O	ADP	O
pPGK	B-GENE	NOUN	B
:	O	PUNCT	O
:	O	PUNCT	O
REP2	B-GENE	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
the	O	DET	O
case	O	NOUN	B
of	O	ADP	O
congenital	O	ADJ	B
protein	B-GENE	NOUN	I
C	I-GENE	NOUN	I
deficiency	O	NOUN	I
,	O	PUNCT	O
vitamin	O	NOUN	B
K	O	NOUN	I
antagonists	O	NOUN	I
must	O	AUX	O
be	O	AUX	O
started	O	VERB	O
cautiously	O	ADV	O
due	O	ADJ	O
to	O	PART	O
the	O	DET	O
risk	O	NOUN	B
of	O	ADP	O
skin	O	NOUN	B
necrosis	O	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
addition	O	NOUN	O
,	O	PUNCT	O
we	O	PRON	O
observe	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
hUBF	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
promoter	I-GENE	NOUN	B
interaction	O	NOUN	B
is	O	AUX	O
highly	O	ADV	O
sensitive	O	ADJ	B
to	O	PART	O
the	O	DET	O
antagonistic	O	ADJ	B
effects	O	NOUN	I
of	O	ADP	O
cisplatin	O	NOUN	B
-	O	PUNCT	O
DNA	O	NOUN	B
adducts	O	NOUN	B
.	O	PUNCT	O


Simultaneous	O	ADJ	B
,	O	PUNCT	O
bilateral	O	ADJ	B
and	O	CCONJ	O
permanent	O	ADJ	B
ventilation	O	NOUN	I
with	O	ADP	O
a	O	DET	O
diaphragm	O	ADJ	B
pacing	O	NOUN	I
in	O	ADP	O
childhood	O	NOUN	B
:	O	PUNCT	O
the	O	DET	O
implantation	O	NOUN	B
technique	O	NOUN	I
and	O	CCONJ	O
indications	O	NOUN	B


The	O	DET	O
pyrR	B-GENE	NOUN	B
and	O	CCONJ	O
pyrP	B-GENE	NOUN	B
genes	I-GENE	NOUN	I
encoded	O	VERB	B
polypeptides	O	NOUN	B
with	O	ADP	O
calculated	O	VERB	O
molecular	O	ADJ	B
masses	O	NOUN	I
of	O	ADP	O
19	O	NUM	O
.	O	PUNCT	O
9	O	NUM	O
and	O	CCONJ	O
45	O	NUM	O
.	O	PUNCT	O
2	O	NUM	O
kDa	O	NOUN	O
,	O	PUNCT	O
respectively	O	ADV	O
.	O	PUNCT	O


To	O	PART	O
identify	O	VERB	O
the	O	DET	O
precise	O	ADJ	O
location	O	NOUN	B
of	O	ADP	O
the	O	DET	O
phosphorylation	O	NOUN	B
site	O	NOUN	O
on	O	ADP	O
the	O	DET	O
64	O	NUM	O
-	O	PUNCT	O
kDa	O	NOUN	O
protein	O	NOUN	O
,	O	PUNCT	O
a	O	DET	O
step	O	NOUN	B
-	O	PUNCT	O
by	O	ADP	O
-	O	PUNCT	O
step	O	NOUN	B
mutagenesis	O	NOUN	B
procedures	O	NOUN	I
was	O	AUX	O
followed	O	VERB	O
.	O	PUNCT	O


Co	O	PROPN	B
-	O	PUNCT	O
transfection	O	NOUN	B
of	O	ADP	O
a	O	DET	O
tat	B-GENE	NOUN	B
expressing	O	NOUN	B
plasmid	O	NOUN	B
with	O	ADP	O
these	O	DET	O
viruses	O	NOUN	B
containing	O	VERB	O
the	O	DET	O
tat	B-GENE	NOUN	B
ORF	I-GENE	NOUN	I
mutations	O	NOUN	B
resulted	O	VERB	O
in	O	ADP	O
higher	O	ADJ	O
levels	O	NOUN	B
of	O	ADP	O
virus	O	NOUN	B
production	O	NOUN	B
demonstrating	O	NOUN	O
that	O	SCONJ	O
the	O	DET	O
effects	O	NOUN	B
of	O	ADP	O
both	O	DET	O
mutants	O	NOUN	B
are	O	AUX	O
tat	B-GENE	NOUN	B
specific	O	ADJ	B
.	O	PUNCT	O


Analysis	O	NOUN	B
of	O	ADP	O
the	O	DET	O
gag	B-GENE	NOUN	B
and	O	CCONJ	O
rev	B-GENE	NOUN	B
proteins	I-GENE	NOUN	I
in	O	ADP	O
the	O	DET	O
transfected	O	VERB	B
cells	O	NOUN	I
demonstrated	O	VERB	O
that	O	SCONJ	O
these	O	DET	O
proteins	O	NOUN	B
were	O	AUX	O
not	O	PART	O
detectable	O	ADJ	B
in	O	ADP	O
cells	O	NOUN	B
transfected	O	VERB	B
with	O	ADP	O
the	O	DET	O
tat	B-GENE	NOUN	B
mutants	I-GENE	NOUN	I
but	O	CCONJ	O
could	O	AUX	O
be	O	AUX	O
readily	O	ADV	O
detected	O	VERB	B
when	O	SCONJ	O
the	O	DET	O
mutations	O	NOUN	B
were	O	AUX	O
complemented	O	VERB	B
in	O	ADP	O
trans	O	NOUN	O
with	O	ADP	O
a	O	DET	O
tat	B-GENE	NOUN	O
expression	O	NOUN	B
vector	O	NOUN	I
.	O	PUNCT	O


SIN	O	PROPN	B
-	O	PUNCT	O
1	O	NUM	O
had	O	AUX	O
no	O	DET	O
influence	O	NOUN	B
on	O	ADP	O
either	O	CCONJ	O
the	O	DET	O
ischemic	O	ADJ	B
parameters	O	NOUN	B
in	O	ADP	O
the	O	DET	O
surface	O	NOUN	B
electrocardiogram	O	NOUN	I
(	O	PUNCT	O
ECG	O	PROPN	B
)	O	PUNCT	O
or	O	CCONJ	O
the	O	DET	O
intracoronary	O	ADJ	B
ECG	O	PROPN	B
.	O	PUNCT	O


Stimulation	O	NOUN	B
of	O	ADP	O
[	O	PUNCT	O
3H	O	NOUN	B
]	O	PUNCT	O
PA	O	NOUN	B
production	O	NOUN	O
upon	O	SCONJ	O
CD3	B-GENE	NOUN	B
cross	O	NOUN	I
-	O	PUNCT	O
linking	O	VERB	B
was	O	AUX	O
77	O	NUM	O
%	O	NOUN	O
lower	O	ADJ	B
in	O	ADP	O
permeabilized	O	ADJ	B
CD45	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
cells	O	NOUN	B
than	O	ADP	O
in	O	ADP	O
CD45	B-GENE	NOUN	B
+	I-GENE	CCONJ	I
cells	O	NOUN	B
,	O	PUNCT	O
consistent	O	ADJ	B
with	O	ADP	I
the	O	DET	O
reduced	O	VERB	B
activity	O	NOUN	B
of	O	ADP	O
p59fyn	B-GENE	NOUN	B
in	O	ADP	O
CD45	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
cells	O	NOUN	B
.	O	PUNCT	O


A	O	DET	O
Dictyostelium	O	NOUN	B
transformant	O	NOUN	I
overexpressing	O	VERB	B
DdPTPa	B-GENE	NOUN	B
does	O	AUX	O
not	O	PART	O
develop	O	VERB	O
normally	O	ADV	O
.	O	PUNCT	O


We	O	PRON	O
postulate	O	VERB	O
that	O	SCONJ	O
CaM	B-GENE	NOUN	B
binding	O	NOUN	O
by	O	ADP	O
HIV	B-GENE	NOUN	B
envelope	I-GENE	NOUN	I
proteins	I-GENE	NOUN	I
is	O	AUX	O
likely	O	ADJ	O
to	O	PART	O
exert	O	VERB	O
diverse	O	ADJ	O
modulatory	O	ADJ	B
effects	O	NOUN	O
,	O	PUNCT	O
and	O	CCONJ	O
the	O	DET	O
mechanism	O	NOUN	B
for	O	ADP	O
HIV	O	NOUN	B
-	O	PUNCT	O
induced	O	VERB	B
cytotoxicity	O	NOUN	B
may	O	AUX	O
involve	O	VERB	O
,	O	PUNCT	O
in	O	ADP	O
part	O	NOUN	O
,	O	PUNCT	O
inhibition	O	NOUN	B
of	O	ADP	O
CaM	B-GENE	NOUN	B
-	O	PUNCT	O
regulated	O	VERB	B
cellular	O	ADJ	B
functions	O	NOUN	I
.	O	PUNCT	O


There	O	PRON	O
was	O	AUX	O
no	O	DET	O
apparent	O	ADJ	O
effect	O	NOUN	O
of	O	ADP	O
growth	O	NOUN	B
temperature	O	NOUN	I
on	O	ADP	O
the	O	DET	O
steady	O	ADJ	B
-	O	PUNCT	O
state	O	NOUN	B
levels	O	NOUN	B
of	O	ADP	O
fad7	B-GENE	NOUN	B
mRNA	I-GENE	NOUN	B
in	O	ADP	O
wild	O	ADJ	B
type	O	NOUN	I
plants	O	NOUN	I
.	O	PUNCT	O


A	O	DET	O
second	O	ADJ	O
important	O	ADJ	O
molecule	O	NOUN	B
in	O	ADP	O
TCR	B-GENE	NOUN	B
signal	O	NOUN	B
transduction	O	NOUN	I
is	O	AUX	O
the	O	DET	O
guanine	B-GENE	NOUN	B
nucleotide	I-GENE	NOUN	I
binding	I-GENE	NOUN	I
protein	I-GENE	NOUN	I
,	O	PUNCT	O
p21ras	B-GENE	NOUN	B
,	O	PUNCT	O
which	O	DET	O
is	O	AUX	O
coupled	O	VERB	O
to	O	PART	O
the	O	DET	O
TCR	B-GENE	NOUN	B
by	O	ADP	O
a	O	DET	O
protein	B-GENE	NOUN	B
tyrosine	I-GENE	NOUN	I
kinase	I-GENE	NOUN	I
dependent	O	ADJ	O
mechanism	O	NOUN	B
.	O	PUNCT	O


A	O	DET	O
series	O	NOUN	B
of	O	ADP	O
5	O	NUM	O
'	O	PUNCT	O
-	O	PUNCT	O
deletions	O	NOUN	B
revealed	O	VERB	B
that	O	SCONJ	O
the	O	DET	O
fragment	O	NOUN	B
-	O	PUNCT	O
218	O	NUM	O
to	O	PART	O
+	O	CCONJ	O
4	O	NUM	O
from	O	ADP	O
the	O	DET	O
TSS	O	NOUN	B
had	O	AUX	O
the	O	DET	O
highest	O	ADJ	O
promoter	O	NOUN	B
activity	O	NOUN	I
,	O	PUNCT	O
nearly	O	ADV	O
1000	O	NUM	O
-	O	PUNCT	O
fold	O	NOUN	B
greater	O	ADJ	B
than	O	ADP	O
the	O	DET	O
promoterless	O	NOUN	B
chloramphenicol	B-GENE	NOUN	I
acetyltransferase	I-GENE	NOUN	I
construct	I-GENE	NOUN	I
.	O	PUNCT	O


The	O	DET	O
lemdr1	B-GENE	NOUN	B
gene	I-GENE	NOUN	I
was	O	AUX	O
cloned	O	VERB	B
in	O	ADP	O
the	O	DET	O
expression	O	NOUN	B
vector	O	NOUN	I
pALTNEO	O	NUM	B
and	O	CCONJ	O
transfected	O	VERB	B
into	O	ADP	O
wild	O	ADJ	B
-	O	PUNCT	O
type	O	NOUN	B
L	O	NOUN	B
.	O	PUNCT	O
enriettii	O	NOUN	B
and	O	CCONJ	O
the	O	DET	O
resulting	O	VERB	O
transfected	O	VERB	B
cells	O	NOUN	I
were	O	AUX	O
resistant	O	ADJ	B
to	O	PART	O
vinblastine	O	NOUN	B
but	O	CCONJ	O
at	O	ADP	O
lower	O	ADJ	O
levels	O	NOUN	B
than	O	ADP	O
in	O	ADP	O
the	O	DET	O
selected	O	VERB	O
mutant	O	ADJ	B
cells	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
bioavailability	O	NOUN	B
of	O	ADP	O
etodolac	O	NOUN	B
from	O	ADP	O
capsules	O	NOUN	B
exposed	O	VERB	B
to	O	ADP	I
stressed	O	ADJ	B
conditions	O	NOUN	B
was	O	AUX	O
compared	O	VERB	B
in	O	ADP	O
both	O	CCONJ	O
dogs	O	NOUN	B
and	O	CCONJ	O
humans	O	NOUN	B
to	O	PART	O
capsules	O	NOUN	B
stored	O	VERB	B
at	O	ADP	O
RT	O	NOUN	B
conditions	O	NOUN	O
.	O	PUNCT	O


As	O	ADP	O
regards	O	NOUN	O
lipid	O	NOUN	B
metabolism	O	NOUN	I
,	O	PUNCT	O
the	O	DET	O
mean	O	ADJ	O
values	O	NOUN	O
for	O	ADP	O
total	O	ADJ	O
triglycerides	O	NOUN	B
,	O	PUNCT	O
cholesterol	O	NOUN	B
,	O	PUNCT	O
LDL	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
cholesterol	I-GENE	NOUN	B
and	O	CCONJ	O
HDL	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
cholesterol	I-GENE	NOUN	B
seen	O	VERB	O
at	O	ADP	O
the	O	DET	O
end	O	NOUN	O
of	O	ADP	O
five	O	NUM	O
years	O	NOUN	B
of	O	ADP	O
Norplant	O	PROPN	B
-	O	PUNCT	O
2	O	NUM	O
rod	O	NOUN	O
use	O	NOUN	O
and	O	CCONJ	O
six	O	NUM	O
months	O	NOUN	B
postremoval	O	NOUN	B
were	O	AUX	O
similar	O	ADJ	O
to	O	PART	O
the	O	DET	O
preinsertion	O	NOUN	B
mean	O	NOUN	O
.	O	PUNCT	O


To	O	ADP	O
our	O	PRON	O
knowledge	O	NOUN	B
this	O	DET	O
is	O	AUX	O
the	O	DET	O
first	O	ADJ	O
case	O	NOUN	B
in	O	ADP	O
which	O	DET	O
a	O	DET	O
probable	O	ADJ	O
association	O	NOUN	B
between	O	ADP	O
cholelithiasis	O	NOUN	B
and	O	CCONJ	O
Wildervanck	O	NOUN	B
'	O	PART	I
s	O	NOUN	I
syndrome	O	NOUN	B
has	O	AUX	O
been	O	AUX	O
recorded	O	VERB	O
.	O	PUNCT	O


Addition	O	NOUN	B
of	O	ADP	O
phalloidin	O	NOUN	B
-	O	PUNCT	O
stabilized	O	VERB	B
F	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
actin	I-GENE	NOUN	B
nuclei	O	NOUN	I
and	O	CCONJ	O
phalloidin	O	NOUN	B
restored	O	VERB	O
L266D	O	NOUN	B
actin	B-GENE	NOUN	I
'	O	PART	O
s	O	NOUN	O
ability	O	NOUN	O
to	O	PART	O
polymerize	O	VERB	B
at	O	ADP	O
4	O	NUM	O
degrees	O	NOUN	B
C	O	NOUN	I
.	O	PUNCT	O


Northern	O	NOUN	B
(	O	PUNCT	O
RNA	O	NOUN	B
)	O	PUNCT	O
analysis	O	NOUN	O
demonstrated	O	VERB	O
expression	O	NOUN	B
of	O	ADP	O
human	O	ADJ	B
PI	B-GENE	NOUN	O
3	I-GENE	NUM	O
-	I-GENE	PUNCT	O
kinase	I-GENE	NOUN	B
in	O	ADP	O
all	O	DET	O
tissues	O	NOUN	B
and	O	CCONJ	O
cell	O	NOUN	B
lines	O	NOUN	I
tested	O	VERB	B
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
demonstrate	O	VERB	O
the	O	DET	O
existence	O	NOUN	O
of	O	ADP	O
different	O	ADJ	O
PI	B-GENE	NOUN	B
3	I-GENE	NUM	O
-	I-GENE	PUNCT	O
kinase	I-GENE	NOUN	B
isoforms	I-GENE	NOUN	B
and	O	CCONJ	O
define	O	VERB	O
a	O	DET	O
family	O	NOUN	B
of	O	ADP	O
genes	O	NOUN	B
encoding	O	VERB	B
distinct	O	ADJ	O
PI	B-GENE	NOUN	B
3	I-GENE	NUM	O
-	I-GENE	PUNCT	O
kinase	I-GENE	NOUN	B
catalytic	I-GENE	ADJ	B
subunits	I-GENE	NOUN	I
that	O	PRON	O
can	O	AUX	O
associate	O	VERB	B
with	O	ADP	I
p85	B-GENE	NOUN	B
.	O	PUNCT	O


One	O	NUM	O
complex	O	NOUN	B
most	O	ADV	O
likely	O	ADV	O
contained	O	VERB	O
Sp1	B-GENE	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
another	O	DET	O
complex	O	NOUN	B
showed	O	VERB	O
S	O	NOUN	B
-	O	PUNCT	O
phase	O	NOUN	B
-	O	PUNCT	O
specific	O	ADJ	B
binding	O	NOUN	B
,	O	PUNCT	O
suggesting	O	VERB	O
a	O	DET	O
direct	O	ADJ	O
role	O	NOUN	O
in	O	ADP	O
the	O	DET	O
cell	O	NOUN	B
-	O	PUNCT	O
cycle	O	NOUN	B
-	O	PUNCT	O
dependent	O	ADJ	B
R1	B-GENE	NOUN	B
gene	I-GENE	NOUN	B
expression	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
rate	O	NOUN	B
of	O	ADP	O
enzymic	O	ADJ	B
stimulation	O	NOUN	I
induced	O	VERB	B
by	O	ADP	O
a	O	DET	O
given	O	VERB	O
nitrate	O	NOUN	B
correlates	O	VERB	O
closely	O	ADV	O
with	O	ADP	O
the	O	DET	O
rate	O	NOUN	B
of	O	ADP	O
measured	O	VERB	B
NO	O	NOUN	B
production	O	NOUN	B
from	O	ADP	O
the	O	DET	O
nitrate	O	NOUN	B
molecule	O	NOUN	I
.	O	PUNCT	O


Two	O	NUM	O
patients	O	NOUN	B
were	O	AUX	O
treated	O	VERB	B
successfully	O	ADV	O
with	O	ADP	O
a	O	DET	O
combination	O	NOUN	B
of	O	ADP	O
metronidazole	O	NOUN	B
(	O	PUNCT	O
a	O	DET	O
tissue	O	NOUN	B
amoebicide	O	NOUN	O
)	O	PUNCT	O
and	O	CCONJ	O
diloxanide	O	NOUN	B
(	O	PUNCT	O
a	O	DET	O
lumenal	O	ADJ	B
amoebicide	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
identified	O	VERB	B
in	O	ADP	O
the	O	DET	O
5	O	NUM	O
'	O	PART	O
untranslated	O	ADJ	B
region	O	NOUN	I
of	O	ADP	O
the	O	DET	O
Drosophila	B-GENE	X	B
copia	I-GENE	NOUN	B
retrotransposon	I-GENE	NOUN	I
,	O	PUNCT	O
3	O	NUM	O
'	O	PUNCT	O
to	O	ADP	O
the	O	DET	O
left	O	ADJ	B
LTR	O	NOUN	I
,	O	PUNCT	O
a	O	DET	O
sequence	O	NOUN	B
for	O	ADP	O
transcriptional	O	ADJ	B
regulation	O	NOUN	I
by	O	ADP	O
homeoproteins	O	NOUN	B
.	O	PUNCT	O


By	O	ADP	O
using	O	VERB	O
the	O	DET	O
full	O	ADJ	B
-	O	PUNCT	O
length	O	NOUN	B
cytoplasmic	O	ADJ	O
domain	O	NOUN	O
and	O	CCONJ	O
mutants	O	NOUN	B
with	O	ADP	O
progressive	O	ADJ	B
carboxy	O	NOUN	B
-	O	PUNCT	O
terminal	O	ADJ	B
deletions	O	NOUN	B
,	O	PUNCT	O
internal	O	ADJ	B
deletions	O	NOUN	I
,	O	PUNCT	O
or	O	CCONJ	O
point	O	NOUN	B
mutations	O	NOUN	I
,	O	PUNCT	O
we	O	PRON	O
identified	O	VERB	B
the	O	DET	O
first	O	ADJ	O
150	O	NUM	O
amino	O	NOUN	B
acid	O	NOUN	I
residues	O	NOUN	I
of	O	ADP	O
LIFR	B-GENE	NOUN	B
as	O	ADP	O
the	O	DET	O
minimal	O	ADJ	B
region	O	NOUN	I
necessary	O	ADJ	O
for	O	ADP	O
signaling	O	NOUN	B
.	O	PUNCT	O


Oligonucleotide	O	NOUN	B
competitors	O	NOUN	I
were	O	AUX	O
used	O	VERB	O
to	O	PART	O
evaluate	O	VERB	B
the	O	DET	O
accessibility	O	NOUN	B
of	O	ADP	O
the	O	DET	O
TATA	O	NOUN	B
-	O	PUNCT	O
binding	O	VERB	B
site	O	NOUN	I
in	O	ADP	O
TIF	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
IB	I-GENE	NOUN	B
,	O	PUNCT	O
TFIID	B-GENE	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
TFIIIB	B-GENE	NOUN	B
.	O	PUNCT	O


The	O	DET	O
227	O	NUM	O
-	O	PUNCT	O
to	O	ADP	O
-	O	PUNCT	O
239	O	NUM	O
region	O	NOUN	O
blocked	O	VERB	B
ADR1	B-GENE	NOUN	B
activity	O	NOUN	O
independently	O	ADV	O
of	O	ADP	O
the	O	DET	O
TAD	B-GENE	NOUN	B
present	O	ADJ	O
on	O	ADP	O
ADR1	B-GENE	NOUN	B
,	O	PUNCT	O
ADR1	B-GENE	NOUN	B
DNA	O	NOUN	B
binding	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
specific	O	ADJ	O
ADH2	B-GENE	NOUN	B
promoter	I-GENE	NOUN	B
sequences	I-GENE	NOUN	I
.	O	PUNCT	O


TGF	B-GENE	NOUN	B
beta	I-GENE	NOUN	O
1	I-GENE	NUM	O
expression	O	NOUN	B
is	O	AUX	O
largely	O	ADV	O
governed	O	VERB	O
by	O	ADP	O
three	O	NUM	O
AP	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	B
binding	I-GENE	NOUN	B
sites	I-GENE	NOUN	I
located	O	ADJ	O
in	O	ADP	O
two	O	NUM	O
different	O	ADJ	O
promoters	O	NOUN	B
of	O	ADP	O
this	O	DET	O
gene	O	NOUN	B
.	O	PUNCT	O


Repeated	O	VERB	B
administration	O	NOUN	B
of	O	ADP	O
GRg2	O	NOUN	B
20	O	NUM	O
mg	O	NOUN	O
/	O	SYM	O
kg	O	NOUN	O
i	O	X	O
.	O	PUNCT	O
p	O	NOUN	O
.	O	PUNCT	O
significantly	O	ADV	O
improved	O	VERB	O
the	O	DET	O
CYP	O	PROPN	B
-	O	PUNCT	O
induced	O	VERB	B
recognitional	O	ADJ	B
deficits	O	NOUN	I
by	O	ADP	O
increasing	O	VERB	B
the	O	DET	O
CYP	O	PROPN	B
-	O	PUNCT	O
decreased	O	VERB	B
rate	O	NOUN	B
from	O	ADP	O
55	O	NUM	O
.	O	PUNCT	O
8	O	NUM	O
+	O	CCONJ	O
/	O	SYM	O
-	O	PUNCT	O
9	O	NUM	B
.	O	PUNCT	O
6	O	NUM	O
to	O	PART	O
80	O	NUM	O
.	O	PUNCT	O
8	O	NUM	O
+	O	CCONJ	O
/	O	SYM	O
-	O	PUNCT	O
4	O	NUM	O
.	O	PUNCT	O
2	O	NUM	O
in	O	ADP	O
d	O	NOUN	O
3	O	NUM	O
learning	O	NOUN	B
acquisition	O	NOUN	I
(	O	PUNCT	O
F	O	NOUN	B
(	O	PUNCT	O
1	O	NUM	O
,	O	PUNCT	O
14	O	NUM	O
)	O	PUNCT	O
=	O	ADJ	O
5	O	NUM	O
.	O	PUNCT	O
6	O	NUM	O
,	O	PUNCT	O
p	O	X	O
<	O	X	O
0	O	NUM	O
.	O	PUNCT	O
05	O	NUM	O
)	O	PUNCT	O
,	O	PUNCT	O
from	O	ADP	O
53	O	NUM	O
.	O	PUNCT	O
4	O	NUM	O
+	O	CCONJ	O
/	O	SYM	O
-	O	PUNCT	O
8	O	NUM	O
.	O	PUNCT	O
4	O	NUM	O
to	O	PART	O
60	O	NUM	O
.	O	PUNCT	O
0	O	NUM	O
+	O	CCONJ	O
/	O	SYM	O
-	O	PUNCT	O
8	O	NUM	O
.	O	PUNCT	O
2	O	NUM	O
in	O	ADP	O
48	O	NUM	O
h	O	NOUN	O
memory	O	NOUN	B
acquisition	O	NOUN	I
(	O	PUNCT	O
F	O	NOUN	B
(	O	PUNCT	O
1	O	NUM	O
,	O	PUNCT	O
14	O	NUM	O
)	O	PUNCT	O
=	O	ADJ	O
7	O	NUM	O
.	O	PUNCT	O
5	O	NUM	O
,	O	PUNCT	O
p	O	X	O
<	O	X	O
0	O	NUM	O
.	O	PUNCT	O
05	O	NUM	O
)	O	PUNCT	O
and	O	CCONJ	O
from	O	ADP	O
55	O	NUM	O
.	O	PUNCT	O
0	O	NUM	O
+	O	CCONJ	O
/	O	SYM	O
-	O	PUNCT	O
5	O	NUM	O
.	O	PUNCT	O
5	O	NUM	O
to	O	PART	O
88	O	NUM	O
.	O	PUNCT	O
3	O	NUM	O
+	O	CCONJ	O
/	O	SYM	O
-	O	PUNCT	O
2	O	NUM	O
.	O	PUNCT	O
5	O	NUM	O
in	O	ADP	O
24	O	NUM	O
h	O	NOUN	O
memory	O	NOUN	B
retention	O	NOUN	I
(	O	PUNCT	O
F	O	NOUN	B
(	O	PUNCT	O
1	O	NUM	O
,	O	PUNCT	O
12	O	NUM	O
)	O	PUNCT	O
27	O	NUM	O
.	O	PUNCT	O
5	O	NUM	O
,	O	PUNCT	O
p	O	X	O
<	O	X	O
0	O	NUM	O
.	O	PUNCT	O
01	O	NUM	O
)	O	PUNCT	O
as	O	ADV	O
well	O	ADV	O
as	O	ADP	O
from	O	ADP	O
60	O	NUM	O
.	O	PUNCT	O
0	O	NUM	O
+	O	CCONJ	O
/	O	SYM	O
-	O	PUNCT	O
6	O	NUM	O
.	O	PUNCT	O
8	O	NUM	O
to	O	PART	O
85	O	NUM	O
.	O	PUNCT	O
6	O	NUM	O
+	O	CCONJ	O
/	O	SYM	O
-	O	PUNCT	O
6	O	NUM	O
.	O	PUNCT	O
9	O	NUM	O
in	O	ADP	O
48	O	NUM	O
h	O	NOUN	O
memory	O	NOUN	B
retrieval	O	NOUN	I
(	O	PUNCT	O
F	O	NOUN	B
(	O	PUNCT	O
1	O	NUM	O
,	O	PUNCT	O
12	O	NUM	O
)	O	PUNCT	O
=	O	ADJ	O
5	O	NUM	O
.	O	PUNCT	O
2	O	NUM	O
,	O	PUNCT	O
p	O	X	O
<	O	X	O
0	O	NUM	O
.	O	PUNCT	O
05	O	NUM	O
)	O	PUNCT	O
,	O	PUNCT	O
respectively	O	ADV	O
.	O	PUNCT	O


The	O	DET	O
therapeutic	O	ADJ	B
action	O	NOUN	I
of	O	ADP	O
cyclosporin	O	NOUN	B
A	O	NOUN	I
(	O	PUNCT	O
Sandimmun	O	NOUN	B
)	O	PUNCT	O
:	O	PUNCT	O
its	O	PRON	O
application	O	NOUN	O
in	O	ADP	O
rheumatoid	O	ADJ	B
arthritis	O	NOUN	I
.	O	PUNCT	O


Pentazocine	O	NOUN	B
analgesia	O	NOUN	I
:	O	PUNCT	O
is	O	AUX	O
there	O	PRON	O
a	O	DET	O
niche	O	NOUN	B
for	O	ADP	O
Talwin	O	PROPN	B
Nx	O	PROPN	O
?	O	PUNCT	O
Pentazocine	O	NOUN	B
can	O	AUX	O
be	O	AUX	O
a	O	DET	O
useful	O	ADJ	O
analgesic	O	NOUN	B
agent	O	NOUN	I
for	O	ADP	O
the	O	DET	O
management	O	NOUN	B
of	O	ADP	O
acute	O	ADJ	B
dental	O	NOUN	I
pain	O	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
addition	O	NOUN	O
,	O	PUNCT	O
REP21	O	NOUN	B
plants	O	NOUN	I
were	O	AUX	O
resistant	O	ADJ	B
to	O	PART	O
an	O	DET	O
unusually	O	ADV	O
broad	O	ADJ	O
range	O	NOUN	O
of	O	ADP	O
tobamoviruses	O	NOUN	B
including	O	VERB	O
tomato	O	NOUN	B
mosaic	O	ADJ	I
virus	O	NOUN	I
,	O	PUNCT	O
tobacco	O	NOUN	B
mild	O	ADJ	I
green	O	ADJ	I
mosaic	O	ADJ	I
virus	O	NOUN	I
,	O	PUNCT	O
TMV	O	NOUN	B
-	O	PUNCT	O
U5	O	NOUN	B
,	O	PUNCT	O
green	O	ADJ	B
tomato	O	NOUN	I
atypical	O	ADJ	B
mosaic	O	ADJ	B
virus	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
ribgrass	O	NOUN	B
mosaic	O	ADJ	I
virus	O	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
our	O	PRON	O
studies	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
utilized	O	VERB	O
HIV	O	NOUN	B
-	O	PUNCT	O
1	O	NUM	B
HXB2	B-GENE	NOUN	B
and	O	CCONJ	O
HIV	O	NOUN	B
-	O	PUNCT	O
1	O	NUM	O
Z2Z6	B-GENE	NOUN	B
core	I-GENE	NOUN	I
enhancers	I-GENE	NOUN	I
because	O	SCONJ	O
the	O	DET	O
Z2Z6	B-GENE	NOUN	B
strain	O	NOUN	I
has	O	AUX	O
a	O	DET	O
single	O	ADJ	O
point	O	NOUN	O
mutation	O	NOUN	O
flanking	O	VERB	O
the	O	DET	O
right	O	ADJ	B
ETS	B-GENE	NOUN	I
-	I-GENE	PUNCT	O
binding	I-GENE	VERB	B
site	I-GENE	NOUN	I
.	O	PUNCT	O


Because	O	SCONJ	O
of	O	ADP	O
the	O	DET	O
small	O	ADJ	O
number	O	NOUN	O
of	O	ADP	O
visceral	O	ADJ	B
angiography	O	NOUN	I
procedures	O	NOUN	B
performed	O	VERB	O
(	O	PUNCT	O
38	O	NUM	O
)	O	PUNCT	O
,	O	PUNCT	O
no	O	DET	O
definitive	O	ADJ	O
conclusions	O	NOUN	B
could	O	AUX	O
be	O	AUX	O
drawn	O	VERB	O
as	O	ADP	O
to	O	ADP	O
the	O	DET	O
differences	O	NOUN	B
between	O	ADP	O
ionic	O	ADJ	B
and	O	CCONJ	O
nonionic	O	ADJ	B
agents	O	NOUN	I
regarding	O	VERB	O
grade	O	NOUN	B
-	O	PUNCT	O
2	O	NUM	O
and	O	CCONJ	O
grade	O	NOUN	B
-	O	PUNCT	O
3	O	NUM	O
adverse	O	ADJ	B
events	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
Stryker	O	PROPN	B
frame	O	NOUN	I
modification	O	NOUN	B
to	O	ADP	O
the	O	DET	O
standard	O	ADJ	B
Dornier	O	PROPN	B
HM3	O	PROPN	I
lithotriptor	O	NOUN	I
allows	O	VERB	O
for	O	ADP	O
improved	O	VERB	B
visualization	O	NOUN	B
and	O	CCONJ	O
easier	O	ADJ	O
localization	O	NOUN	B
of	O	ADP	O
distal	O	ADJ	B
ureteral	O	ADJ	B
calculi	O	NOUN	I
compared	O	VERB	O
to	O	PART	O
the	O	DET	O
standard	O	ADJ	B
gantry	O	NOUN	I
.	O	PUNCT	O


Glomerular	O	ADJ	B
mesangial	O	ADJ	I
cells	O	NOUN	I
expressed	O	VERB	B
an	O	DET	O
abundant	O	ADJ	B
1	O	NUM	O
.	O	PUNCT	O
1	O	NUM	O
kb	O	NOUN	O
mRNA	O	NOUN	B
transcript	O	NOUN	O
for	O	ADP	O
Id1	B-GENE	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
in	O	ADP	O
contrast	O	NOUN	O
to	O	PART	O
other	O	ADJ	O
cell	O	NOUN	B
types	O	NOUN	I
Id1	B-GENE	NOUN	B
mRNA	I-GENE	NOUN	B
was	O	AUX	O
expressed	O	VERB	B
in	O	ADP	O
both	O	CCONJ	O
randomly	O	ADJ	O
cycling	O	NOUN	B
cells	O	NOUN	I
and	O	CCONJ	O
in	O	ADP	O
serum	O	NOUN	B
-	O	PUNCT	O
deprived	O	VERB	B
,	O	PUNCT	O
quiescent	O	ADJ	B
cultures	O	NOUN	I
.	O	PUNCT	O


A	O	DET	O
single	O	ADJ	O
1	O	NUM	O
.	O	PUNCT	O
8	O	NUM	O
-	O	PUNCT	O
kb	O	NOUN	O
transcript	O	NOUN	B
mRNA	O	NOUN	B
was	O	AUX	O
detected	O	VERB	B
by	O	ADP	O
Northern	O	NOUN	B
(	O	PUNCT	O
RNA	O	NOUN	B
)	O	PUNCT	O
blot	O	NOUN	B
analysis	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
its	O	PRON	O
5	O	NUM	O
'	O	PART	O
end	O	NOUN	O
maps	O	NOUN	O
to	O	PART	O
a	O	DET	O
position	O	NOUN	O
51	O	NUM	O
bp	O	NOUN	O
upstream	O	ADJ	O
from	O	ADP	O
the	O	DET	O
site	O	NOUN	B
of	O	ADP	O
initiation	O	NOUN	B
of	O	ADP	O
protein	O	NOUN	B
synthesis	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
sequence	O	NOUN	B
similarity	O	NOUN	I
has	O	AUX	O
suggested	O	VERB	O
that	O	SCONJ	O
SCG10	B-GENE	NOUN	B
and	O	CCONJ	O
stathmin	B-GENE	NOUN	B
have	O	AUX	O
been	O	AUX	O
derived	O	VERB	O
from	O	ADP	O
structurally	O	ADV	B
and	O	CCONJ	O
evolutionarily	O	ADV	B
related	O	ADJ	O
genes	O	NOUN	B
.	O	PUNCT	O


These	O	DET	O
data	O	NOUN	B
are	O	AUX	O
consistent	O	ADJ	B
with	O	ADP	I
the	O	DET	O
idea	O	NOUN	O
that	O	SCONJ	O
the	O	DET	O
neuron	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
specific	I-GENE	ADJ	B
SCG10	I-GENE	NOUN	B
gene	I-GENE	NOUN	B
evolved	O	VERB	O
by	O	ADP	O
duplication	O	NOUN	B
and	O	CCONJ	O
modification	O	NOUN	B
of	O	ADP	O
the	O	DET	O
more	O	ADV	O
broadly	O	ADV	O
expressed	O	VERB	B
stathmin	B-GENE	NOUN	B
/	O	PUNCT	O
Lap18	B-GENE	NOUN	B
gene	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
found	O	VERB	O
that	O	SCONJ	O
T3	O	NOUN	B
(	O	PUNCT	O
10	O	NUM	O
(	O	PUNCT	O
-	O	PUNCT	O
8	O	NUM	O
)	O	PUNCT	O
M	O	NOUN	B
)	O	PUNCT	O
selectively	O	ADV	O
stimulates	O	VERB	B
transcription	O	NOUN	B
from	O	ADP	O
rGH	B-GENE	NOUN	B
-	O	PUNCT	O
TRE	O	PROPN	B
-	O	PUNCT	O
and	O	CCONJ	O
TREpal	O	NOUN	B
-	O	PUNCT	O
,	O	PUNCT	O
but	O	CCONJ	O
not	O	PART	O
ME	O	NOUN	B
-	O	PUNCT	O
TRE	O	PROPN	B
-	O	PUNCT	O
and	O	CCONJ	O
F2	O	PROPN	B
-	O	PUNCT	O
TRE	O	PROPN	B
-	O	PUNCT	O
,	O	PUNCT	O
containing	O	VERB	O
templates	O	NOUN	B
in	O	ADP	O
which	O	DET	O
these	O	DET	O
TREs	O	NOUN	B
are	O	AUX	O
linked	O	VERB	O
in	O	ADP	O
front	O	NOUN	O
of	O	ADP	O
the	O	DET	O
rGH	B-GENE	NOUN	B
minimal	I-GENE	ADJ	B
promoter	I-GENE	NOUN	B
containing	O	VERB	O
only	O	ADV	O
the	O	DET	O
TATA	B-GENE	NOUN	B
box	I-GENE	NOUN	O
binding	I-GENE	NOUN	O
protein	I-GENE	NOUN	O
,	O	PUNCT	O
but	O	CCONJ	O
not	O	PART	O
any	O	DET	O
other	O	ADJ	O
proximal	O	ADJ	B
binding	O	NOUN	I
protein	O	NOUN	I
,	O	PUNCT	O
sequence	O	NOUN	B
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
artificially	O	ADV	B
ventilated	O	VERB	I
rats	O	NOUN	B
,	O	PUNCT	O
pretreated	O	VERB	B
with	O	ADP	O
MK	O	PROPN	B
-	O	PUNCT	O
801	O	NUM	O
,	O	PUNCT	O
were	O	AUX	O
more	O	ADV	O
sensitive	O	ADJ	B
(	O	PUNCT	O
lethal	O	ADJ	B
cocaine	O	NOUN	B
dose	O	NOUN	I
,	O	PUNCT	O
76	O	NUM	O
.	O	PUNCT	O
6	O	NUM	O
+	O	CCONJ	O
/	O	SYM	O
-	O	PUNCT	O
8	O	NUM	O
.	O	PUNCT	O
0	O	NUM	O
mg	O	NOUN	O
/	O	SYM	O
kg	O	NOUN	B
,	O	PUNCT	O
n	O	NOUN	O
=	O	ADJ	O
5	O	NUM	O
)	O	PUNCT	O
than	O	ADP	O
vehicle	O	NOUN	B
pretreated	O	ADJ	B
rats	O	NOUN	B
(	O	PUNCT	O
129	O	NUM	O
.	O	PUNCT	O
4	O	NUM	O
+	O	CCONJ	O
/	O	SYM	O
-	O	PUNCT	O
15	O	NUM	O
.	O	PUNCT	O
8	O	NUM	O
mg	O	NOUN	O
/	O	SYM	O
kg	O	NOUN	B
,	O	PUNCT	O
n	O	NOUN	O
=	O	ADJ	O
6	O	NUM	O
)	O	PUNCT	O
,	O	PUNCT	O
indicating	O	VERB	O
that	O	SCONJ	O
MK	O	PROPN	B
-	O	PUNCT	O
801	O	NUM	O
may	O	AUX	O
increase	O	VERB	B
both	O	CCONJ	O
the	O	DET	O
respiratory	O	ADJ	B
and	O	CCONJ	O
the	O	DET	O
cardiac	O	ADJ	B
toxicity	O	NOUN	B
of	O	ADP	O
cocaine	O	NOUN	B
in	O	ADP	O
urethane	O	NOUN	B
anesthetized	O	ADJ	B
rats	O	NOUN	B
.	O	PUNCT	O


ENV	B-GENE	NOUN	B
also	O	ADV	O
was	O	AUX	O
secreted	O	VERB	B
from	O	ADP	O
P	O	NOUN	O
.	O	PUNCT	O
pastoris	O	NOUN	B
using	O	VERB	O
the	O	DET	O
S	B-GENE	NOUN	B
.	I-GENE	PUNCT	O
cerevisiae	I-GENE	X	B
alpha	I-GENE	NOUN	I
-	I-GENE	PUNCT	O
factor	I-GENE	NOUN	B
prepro	I-GENE	NOUN	I
secretion	I-GENE	NOUN	I
leader	I-GENE	NOUN	O
and	O	CCONJ	O
the	O	DET	O
S	B-GENE	NOUN	B
.	I-GENE	PUNCT	O
cerevisiae	I-GENE	X	B
invertase	I-GENE	NOUN	I
signal	I-GENE	NOUN	I
sequence	I-GENE	NOUN	I
.	O	PUNCT	O


The	O	DET	O
following	O	VERB	O
evidence	O	NOUN	B
indicates	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
69	O	NUM	O
-	O	PUNCT	O
kD	O	NOUN	B
protein	O	NOUN	I
is	O	AUX	O
a	O	DET	O
common	O	ADJ	O
,	O	PUNCT	O
rather	O	ADV	O
than	O	ADP	O
a	O	DET	O
U1	B-GENE	NOUN	B
-	O	PUNCT	O
specific	O	ADJ	B
,	O	PUNCT	O
protein	O	NOUN	B
,	O	PUNCT	O
possibly	O	ADV	O
associating	O	VERB	O
with	O	ADP	O
the	O	DET	O
snRNP	O	NOUN	B
core	O	NOUN	B
particles	O	NOUN	I
by	O	ADP	O
protein	O	NOUN	B
-	O	PUNCT	O
protein	O	NOUN	B
interaction	O	NOUN	B
.	O	PUNCT	O


Praziquantel	O	PROPN	B
and	O	CCONJ	O
Albendazole	O	PROPN	B
were	O	AUX	O
found	O	VERB	O
effective	O	ADJ	B
in	O	ADP	O
the	O	DET	O
treatment	O	NOUN	B
of	O	ADP	O
neurocysticercosis	O	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
because	O	SCONJ	O
of	O	ADP	O
serious	O	ADJ	O
side	O	NOUN	B
effects	O	NOUN	I
encountered	O	VERB	O
in	O	ADP	O
some	O	DET	O
cases	O	NOUN	B
,	O	PUNCT	O
the	O	DET	O
drugs	O	NOUN	B
should	O	AUX	O
be	O	AUX	O
used	O	VERB	O
cautiously	O	ADV	O
in	O	ADP	O
selected	O	VERB	O
cases	O	NOUN	B
only	O	ADV	O
.	O	PUNCT	O


Transcriptional	O	ADJ	B
analysis	O	NOUN	I
of	O	ADP	O
a	O	DET	O
series	O	NOUN	O
of	O	ADP	O
deletion	O	NOUN	B
mutants	O	NOUN	I
of	O	ADP	O
the	O	DET	O
gene	O	NOUN	B
in	O	ADP	O
the	O	DET	O
nuclear	O	ADJ	B
extracts	O	NOUN	I
prepared	O	VERB	O
from	O	ADP	O
the	O	DET	O
middle	O	ADJ	B
silk	O	NOUN	I
gland	O	NOUN	I
of	O	ADP	O
2	O	NUM	B
-	O	PUNCT	O
day	O	NOUN	B
-	O	PUNCT	O
old	O	ADJ	B
fifth	O	ADJ	O
instar	O	NOUN	B
larvae	O	NOUN	I
revealed	O	VERB	O
the	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
multiple	O	ADJ	B
cis	O	NOUN	B
-	O	PUNCT	O
regulatory	O	ADJ	B
elements	O	NOUN	I
located	O	ADJ	O
both	O	CCONJ	O
upstream	O	ADJ	B
and	O	CCONJ	O
downstream	O	ADJ	B
of	O	ADP	O
the	O	DET	O
initiation	O	NOUN	B
site	O	NOUN	I
.	O	PUNCT	O


One	O	NUM	O
of	O	ADP	O
these	O	DET	O
elements	O	NOUN	B
,	O	PUNCT	O
the	O	DET	O
homeodomain	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
binding	I-GENE	VERB	B
element	I-GENE	NOUN	B
,	O	PUNCT	O
was	O	AUX	O
identified	O	VERB	O
to	O	PART	O
mediate	O	VERB	O
negative	O	ADJ	B
regulation	O	NOUN	O
.	O	PUNCT	O


Monospecific	O	ADJ	B
antibodies	O	NOUN	I
raised	O	VERB	O
against	O	ADP	O
rat	B-GENE	NOUN	B
cytochrome	I-GENE	NOUN	B
P	I-GENE	NOUN	I
-	I-GENE	PUNCT	O
450	I-GENE	NUM	O
1A1	I-GENE	NOUN	O
recognized	O	VERB	O
a	O	DET	O
protein	O	NOUN	B
in	O	ADP	O
the	O	DET	O
hepatic	O	ADJ	B
microsomes	O	NOUN	I
of	O	ADP	O
the	O	DET	O
double	O	ADV	B
-	O	PUNCT	O
crested	O	ADJ	B
cormorant	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
also	O	ADV	O
in	O	ADP	O
those	O	DET	O
of	O	ADP	O
the	O	DET	O
great	O	ADJ	B
blue	O	ADJ	I
heron	O	NOUN	I
(	O	PUNCT	O
Ardea	O	PROPN	B
herodias	O	NOUN	I
)	O	PUNCT	O
,	O	PUNCT	O
using	O	VERB	O
immunoblotting	O	NOUN	B
.	O	PUNCT	O


Mutations	O	NOUN	B
in	O	ADP	O
the	O	DET	O
nuclear	B-GENE	ADJ	B
gene	I-GENE	NOUN	I
CBP1	I-GENE	NOUN	B
of	I-GENE	ADP	O
Saccharomyces	I-GENE	X	B
cerevisiae	I-GENE	X	I
result	O	VERB	O
in	O	ADP	O
degradation	O	NOUN	B
of	O	ADP	O
mitochondrially	B-GENE	ADV	B
encoded	I-GENE	VERB	O
cytochrome	I-GENE	NOUN	O
b	I-GENE	NOUN	O
(	O	PUNCT	O
cob	B-GENE	NOUN	O
)	O	PUNCT	O
RNA	O	NOUN	O
;	O	PUNCT	O
thus	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
cells	O	NOUN	B
are	O	AUX	O
unable	O	ADJ	O
to	O	PART	O
respire	O	VERB	B
.	O	PUNCT	O


The	O	DET	O
5	O	NUM	O
'	O	PUNCT	O
ends	O	NOUN	B
of	O	ADP	O
F3R	B-GENE	NOUN	B
late	O	ADJ	O
transcripts	O	NOUN	B
were	O	AUX	O
located	O	ADJ	O
to	O	PART	O
an	O	DET	O
A	O	NOUN	O
within	O	ADP	O
the	O	DET	O
sequence	O	NOUN	B
5	O	NUM	O
'	O	PUNCT	O
-	O	PUNCT	O
TAAAG	O	NOUN	B
,	O	PUNCT	O
41	O	NUM	O
nt	O	NOUN	O
downstream	O	ADJ	B
from	O	ADP	O
the	O	DET	O
early	O	ADJ	O
promoter	O	NOUN	B
and	O	CCONJ	O
17	O	NUM	O
nt	O	NOUN	O
upstream	O	ADJ	O
from	O	ADP	O
the	O	DET	O
initiation	O	NOUN	B
codon	O	NOUN	B
.	O	PUNCT	O


NF	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
kappa	I-GENE	NOUN	B
B	I-GENE	NOUN	I
p65	B-GENE	NOUN	I
,	O	PUNCT	O
p50	B-GENE	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
Rel	B-GENE	NOUN	B
functionally	O	ADV	O
synergize	O	VERB	B
with	O	ADP	O
C	B-GENE	NOUN	B
/	I-GENE	SYM	O
EBP	I-GENE	NOUN	B
alpha	I-GENE	NOUN	I
,	O	PUNCT	O
C	B-GENE	PROPN	B
/	I-GENE	SYM	O
EBP	I-GENE	NOUN	B
beta	I-GENE	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
C	B-GENE	NOUN	B
/	I-GENE	SYM	O
EBP	I-GENE	NOUN	B
delta	I-GENE	NOUN	O
.	O	PUNCT	O


It	O	PRON	O
could	O	AUX	O
be	O	AUX	O
detected	O	VERB	B
exclusively	O	ADV	O
in	O	ADP	O
the	O	DET	O
culture	O	NOUN	B
medium	O	NOUN	I
of	O	ADP	O
cDNA	O	NOUN	B
-	O	PUNCT	O
transfected	O	VERB	B
COS	O	NOUN	B
cells	O	NOUN	O
.	O	PUNCT	O


The	O	DET	O
first	O	ADJ	O
group	O	NOUN	B
of	O	ADP	O
sequential	O	ADJ	B
BMB	O	NOUN	B
showed	O	VERB	O
a	O	DET	O
significant	O	ADJ	O
progress	O	NOUN	B
to	O	PART	O
myelofibrosis	O	NOUN	B
in	O	ADP	O
so	O	ADV	O
-	O	PUNCT	O
called	O	VERB	O
"	O	PUNCT	O
Chronic	O	ADJ	B
Megakaryocytic	O	ADJ	B
-	O	PUNCT	O
Granulocytic	O	ADJ	B
Myelosis	O	NOUN	B
"	O	PUNCT	O
-	O	PUNCT	O
-	O	PUNCT	O
CMGM	O	PROPN	B
-	O	PUNCT	O
,	O	PUNCT	O
which	O	DET	O
corresponds	O	VERB	O
to	O	PART	O
Agnogenic	O	ADJ	B
Myeloid	O	ADJ	I
Metaplasia	O	PROPN	I
-	O	PUNCT	O
AMM	O	PROPN	B
-	O	PUNCT	O
in	O	ADP	O
72	O	NUM	O
.	O	PUNCT	O
4	O	NUM	O
%	O	NOUN	O
(	O	PUNCT	O
21	O	NUM	O
/	O	SYM	O
29	O	NUM	O
patients	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
as	O	ADV	O
well	O	ADV	O
as	O	ADP	O
in	O	ADP	O
CML	O	NOUN	B
with	O	ADP	O
megakaryocytic	O	ADJ	B
increase	O	NOUN	B
-	O	PUNCT	O
CML	O	NOUN	B
.	O	PUNCT	O
MI	O	NOUN	B
-	O	PUNCT	O
in	O	ADP	O
39	O	NUM	O
.	O	PUNCT	O
2	O	NUM	O
%	O	NOUN	O
(	O	PUNCT	O
20	O	NUM	O
/	O	SYM	O
51	O	NUM	O
)	O	PUNCT	O
.	O	PUNCT	O


These	O	DET	O
lesions	O	NOUN	B
were	O	AUX	O
asymptomatic	O	ADJ	B
,	O	PUNCT	O
but	O	CCONJ	O
both	O	DET	O
were	O	AUX	O
characterized	O	VERB	B
clinically	O	ADV	B
by	O	ADP	O
central	O	ADJ	B
ulceration	O	NOUN	I
.	O	PUNCT	O


Release	O	NOUN	B
of	O	ADP	O
this	O	DET	O
selective	O	ADJ	O
pressure	O	NOUN	O
,	O	PUNCT	O
however	O	ADV	O
,	O	PUNCT	O
gave	O	VERB	O
way	O	NOUN	O
to	O	PART	O
homologous	O	ADJ	B
resolution	O	NOUN	I
of	O	ADP	O
the	O	DET	O
cointegrate	O	NOUN	B
structures	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
equivalent	O	NOUN	B
of	O	ADP	O
the	O	DET	O
third	O	ADJ	O
ligand	O	NOUN	B
,	O	PUNCT	O
H	O	NOUN	B
-	O	PUNCT	O
87	O	NUM	O
,	O	PUNCT	O
is	O	AUX	O
T	O	NOUN	B
-	O	PUNCT	O
47	O	NUM	O
in	O	ADP	O
the	O	DET	O
PSTAIRE	O	NOUN	B
sequence	O	NOUN	O
motif	O	NOUN	O
.	O	PUNCT	O


Botulinum	B-GENE	NOUN	B
toxin	I-GENE	NOUN	I
:	O	PUNCT	O
preferred	O	ADJ	O
treatment	O	NOUN	B
for	O	ADP	O
hemifacial	O	ADJ	B
spasm	O	NOUN	I
.	O	PUNCT	O


2	O	NUM	O
-	O	PUNCT	O
AP	O	PROPN	B
induced	O	VERB	B
marked	O	ADJ	O
,	O	PUNCT	O
steady	O	ADJ	B
rises	O	NOUN	O
in	O	ADP	O
mRNA	O	NOUN	B
accumulation	O	NOUN	B
from	O	ADP	O
both	O	CCONJ	O
transfected	O	VERB	B
and	O	CCONJ	O
chromosomally	O	ADV	B
integrated	O	VERB	O
HIV	O	NOUN	B
-	O	PUNCT	O
1	O	NUM	O
constructs	O	NOUN	B
but	O	CCONJ	O
no	O	DET	O
increases	O	NOUN	B
from	O	ADP	O
an	O	DET	O
endogenous	O	ADJ	B
gene	O	NOUN	B
encoding	O	VERB	B
gamma	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
actin	I-GENE	NOUN	B
or	O	CCONJ	O
glucose	B-GENE	NOUN	B
6	I-GENE	NUM	I
-	I-GENE	PUNCT	O
phosphate	I-GENE	NOUN	B
dehydrogenase	I-GENE	NOUN	I
.	O	PUNCT	O


On	O	ADP	O
the	O	DET	O
other	O	ADJ	O
hand	O	NOUN	B
,	O	PUNCT	O
the	O	DET	O
structures	O	NOUN	B
of	O	ADP	O
the	O	DET	O
b	O	NOUN	O
-	O	PUNCT	O
Zip	O	NOUN	B
domain	O	NOUN	I
are	O	AUX	O
well	O	ADV	O
conserved	O	VERB	O
among	O	ADP	O
these	O	DET	O
Maf	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
related	I-GENE	VERB	B
proteins	I-GENE	NOUN	B
.	O	PUNCT	O


The	O	DET	O
Functional	O	PROPN	B
Independence	O	PROPN	I
Measure	O	PROPN	I
:	O	PUNCT	O
a	O	DET	O
comparative	O	ADJ	B
study	O	NOUN	I
of	O	ADP	O
clinician	O	NOUN	B
and	O	CCONJ	O
self	O	NOUN	B
ratings	O	NOUN	I
.	O	PUNCT	O


Polymyxin	O	NOUN	B
B	O	NOUN	I
was	O	AUX	O
given	O	VERB	O
intravenously	O	ADV	B
for	O	ADP	O
1	O	NUM	O
week	O	NOUN	B
postburn	O	NOUN	B
in	O	ADP	O
doses	O	NOUN	B
designed	O	VERB	O
to	O	PART	O
neutralize	O	VERB	B
circulating	O	VERB	O
endotoxemia	O	NOUN	B
.	O	PUNCT	O


SvO2	O	NOUN	B
can	O	AUX	O
be	O	AUX	O
determined	O	VERB	O
in	O	X	B
vitro	O	X	I
and	O	CCONJ	O
in	O	X	B
vivo	O	X	I
.	O	PUNCT	O


The	O	DET	O
transverse	O	ADJ	B
relaxation	O	NOUN	O
time	O	NOUN	O
(	O	PUNCT	O
T2	O	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
apparent	O	ADJ	B
diffusion	O	NOUN	I
coefficient	O	NOUN	I
of	O	ADP	O
water	O	NOUN	B
were	O	AUX	O
determined	O	VERB	O
.	O	PUNCT	O


These	O	DET	O
findings	O	NOUN	B
suggest	O	VERB	O
a	O	DET	O
functional	O	ADJ	B
cross	O	NOUN	B
-	O	PUNCT	O
talk	O	NOUN	B
between	O	ADP	O
RB	B-GENE	NOUN	B
protein	I-GENE	NOUN	I
and	O	CCONJ	O
p21ras	B-GENE	NOUN	B
,	O	PUNCT	O
which	O	DET	O
balances	O	VERB	B
the	O	DET	O
cell	O	NOUN	B
phenotype	O	NOUN	I
between	O	ADP	O
normal	O	ADJ	B
and	O	CCONJ	O
transformed	O	VERB	B
states	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
other	O	ADJ	O
transmembrane	O	ADJ	B
regions	O	NOUN	I
as	O	ADV	O
well	O	ADV	O
as	O	ADP	O
the	O	DET	O
nucleoplasmic	O	ADJ	B
domain	O	NOUN	I
are	O	AUX	O
not	O	PART	O
required	O	VERB	O
for	O	ADP	O
sorting	O	NOUN	B
.	O	PUNCT	O


These	O	DET	O
cell	O	NOUN	B
lines	O	NOUN	I
,	O	PUNCT	O
selected	O	VERB	O
for	O	ADP	O
the	O	DET	O
ability	O	NOUN	O
to	O	PART	O
support	O	VERB	O
the	O	DET	O
replication	O	NOUN	B
of	O	ADP	O
a	O	DET	O
temperature	O	NOUN	B
-	O	PUNCT	O
sensitive	O	ADJ	B
VP5	B-GENE	NOUN	B
mutant	I-GENE	NOUN	O
,	O	PUNCT	O
were	O	AUX	O
used	O	VERB	O
to	O	PART	O
isolate	O	VERB	B
VP5	B-GENE	NOUN	B
and	O	CCONJ	O
VP23	B-GENE	NOUN	B
null	O	ADJ	O
mutants	O	NOUN	O
.	O	PUNCT	O


The	O	DET	O
E1	B-GENE	NOUN	B
nuclear	I-GENE	ADJ	O
transport	I-GENE	NOUN	O
motif	I-GENE	NOUN	O
is	O	AUX	O
highly	O	ADV	O
conserved	O	VERB	O
in	O	ADP	O
the	O	DET	O
animal	O	NOUN	B
and	O	CCONJ	O
human	O	ADJ	B
papillomaviruses	O	NOUN	I
and	O	CCONJ	O
is	O	AUX	O
encoded	O	VERB	B
in	O	ADP	O
a	O	DET	O
similar	O	ADJ	O
region	O	NOUN	B
in	O	ADP	O
the	O	DET	O
related	O	ADJ	O
E1	B-GENE	NOUN	B
genes	I-GENE	NOUN	I
.	O	PUNCT	O


The	O	DET	O
E1	B-GENE	NOUN	B
replication	I-GENE	NOUN	O
protein	I-GENE	NOUN	O
of	O	ADP	O
bovine	O	ADJ	B
papillomavirus	O	NOUN	I
type	O	NOUN	I
1	O	NUM	O
contains	O	VERB	O
an	O	DET	O
extended	O	VERB	O
nuclear	O	ADJ	B
localization	O	NOUN	I
signal	O	NOUN	O
that	O	PRON	O
includes	O	VERB	O
a	O	DET	O
p34cdc2	B-GENE	NOUN	B
phosphorylation	O	NOUN	B
site	O	NOUN	O
.	O	PUNCT	O


In	O	ADP	O
the	O	DET	O
present	O	ADJ	O
study	O	NOUN	B
,	O	PUNCT	O
beta	O	NOUN	B
-	O	PUNCT	O
funaltrexamine	O	NOUN	B
(	O	PUNCT	O
beta	O	NOUN	B
-	O	PUNCT	O
FNA	O	PROPN	B
)	O	PUNCT	O
and	O	CCONJ	O
naltrindole	O	NOUN	B
(	O	PUNCT	O
NTI	O	NOUN	B
)	O	PUNCT	O
(	O	PUNCT	O
nonequilibrium	O	NOUN	B
mu	O	NOUN	O
-	O	PUNCT	O
and	O	CCONJ	O
delta	O	NOUN	B
-	O	PUNCT	O
antagonist	O	NOUN	B
,	O	PUNCT	O
respectively	O	ADV	O
)	O	PUNCT	O
were	O	AUX	O
used	O	VERB	O
to	O	PART	O
precipitate	O	VERB	B
withdrawal	O	NOUN	B
in	O	ADP	O
butorphanol	O	NOUN	B
-	O	PUNCT	O
dependent	O	ADJ	B
rats	O	NOUN	B
.	O	PUNCT	O


Mutations	O	NOUN	B
at	O	ADP	O
the	O	DET	O
extreme	O	ADJ	O
C	O	NOUN	B
-	O	PUNCT	O
terminus	O	NOUN	B
of	O	ADP	O
EIAV	B-GENE	NOUN	B
Tat	I-GENE	NOUN	B
impaired	O	VERB	B
both	O	CCONJ	O
RNA	O	NOUN	B
binding	O	NOUN	I
and	O	CCONJ	O
activation	O	NOUN	B
domain	O	NOUN	I
functions	O	NOUN	I
,	O	PUNCT	O
suggesting	O	VERB	O
effects	O	NOUN	B
on	O	ADP	O
secondary	O	ADJ	B
or	O	CCONJ	O
tertiary	O	ADJ	B
structure	O	NOUN	I
.	O	PUNCT	O


This	O	DET	O
observation	O	NOUN	B
suggests	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
methyl	O	NOUN	B
-	O	PUNCT	O
directed	O	VERB	B
repair	O	NOUN	B
system	O	NOUN	I
utilizes	O	VERB	O
the	O	DET	O
proximal	O	ADJ	B
d	O	NOUN	O
(	O	PUNCT	O
GATC	O	NOUN	B
)	O	PUNCT	O
sequence	O	NOUN	O
to	O	PART	O
direct	O	VERB	O
correction	O	NOUN	B
.	O	PUNCT	O


Lithium	O	NOUN	B
phthalocyanine	O	NOUN	I
(	O	PUNCT	O
LiPc	O	NOUN	B
)	O	PUNCT	O
is	O	AUX	O
a	O	DET	O
prototype	O	NOUN	B
of	O	ADP	O
another	O	DET	O
generation	O	NOUN	B
of	O	ADP	O
synthetic	O	ADJ	B
,	O	PUNCT	O
metallic	O	ADJ	B
-	O	PUNCT	O
organic	O	ADJ	B
,	O	PUNCT	O
paramagnetic	O	ADJ	B
crystallites	O	NOUN	I
that	O	PRON	O
appear	O	VERB	O
very	O	ADV	O
useful	O	ADJ	O
for	O	ADP	O
in	O	X	B
vitro	O	X	I
and	O	CCONJ	O
in	O	X	B
vivo	O	X	I
electron	O	NOUN	B
paramagnetic	O	ADJ	I
resonance	O	NOUN	I
oximetry	O	NOUN	I
.	O	PUNCT	O


IE2	B-GENE	NOUN	B
-	O	PUNCT	O
IE2	B-GENE	NOUN	B
interactions	O	NOUN	B
were	O	AUX	O
mapped	O	VERB	B
to	O	PART	O
a	O	DET	O
domain	O	NOUN	B
containing	O	VERB	O
a	O	DET	O
putative	O	ADJ	O
helix	O	NOUN	B
-	O	PUNCT	O
turn	O	NOUN	B
-	O	PUNCT	O
helix	O	NOUN	B
motif	O	NOUN	B
located	O	ADJ	O
near	O	ADP	B
the	O	DET	O
C	O	NOUN	O
terminus	O	NOUN	B
of	O	ADP	O
IE2	B-GENE	NOUN	B
,	O	PUNCT	O
between	O	ADP	O
amino	O	NOUN	B
acids	O	NOUN	I
456	O	NUM	O
and	O	CCONJ	O
539	O	NUM	O
.	O	PUNCT	O


Precipitation	O	NOUN	B
using	O	VERB	O
GST	B-GENE	NOUN	B
fusion	I-GENE	NOUN	I
proteins	I-GENE	NOUN	I
containing	O	VERB	O
Fyn	B-GENE	NOUN	B
SH2	B-GENE	NOUN	B
,	O	PUNCT	O
SH3	B-GENE	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
SH2	B-GENE	NOUN	B
/	O	PUNCT	O
SH3	B-GENE	NOUN	B
domains	O	NOUN	I
revealed	O	VERB	B
that	O	SCONJ	O
PI	B-GENE	NOUN	B
3	I-GENE	NUM	O
-	I-GENE	PUNCT	O
kinase	I-GENE	NOUN	B
bound	O	VERB	B
principally	O	ADV	O
to	O	PART	O
the	O	DET	O
SH3	B-GENE	NOUN	B
domain	I-GENE	NOUN	I
of	O	ADP	O
Fyn	B-GENE	NOUN	B
.	O	PUNCT	O


A	O	DET	O
sheep	O	NOUN	B
testicular	O	NOUN	B
cDNA	O	NOUN	B
library	O	NOUN	I
constructed	O	VERB	O
in	O	ADP	O
pcDNA1	O	NOUN	B
vector	O	NOUN	I
was	O	AUX	O
screened	O	VERB	B
with	O	ADP	O
a	O	DET	O
probe	O	NOUN	B
generated	O	VERB	O
by	O	ADP	O
polymerase	O	NOUN	B
chain	O	NOUN	I
reaction	O	NOUN	I
(	O	PUNCT	O
PCR	O	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
corresponding	O	VERB	O
to	O	PART	O
a	O	DET	O
1	O	NUM	O
.	O	PUNCT	O
6	O	NUM	O
kb	O	NOUN	O
fragment	O	NOUN	O
of	O	ADP	O
the	O	DET	O
rat	B-GENE	NOUN	B
luteinizing	I-GENE	NOUN	O
hormone	I-GENE	NOUN	O
receptor	I-GENE	NOUN	O
cDNA	I-GENE	NOUN	B
.	O	PUNCT	O


Two	O	NUM	O
putative	O	ADJ	O
Rev	B-GENE	NOUN	B
proteins	I-GENE	NOUN	I
with	O	ADP	O
apparent	O	ADJ	B
molecular	O	ADJ	B
masses	O	NOUN	I
of	O	ADP	O
18	O	NUM	O
and	O	CCONJ	O
16	O	NUM	O
kDa	O	NOUN	O
were	O	AUX	O
expressed	O	VERB	B
by	O	ADP	O
p2	B-GENE	PROPN	B
/	I-GENE	SYM	O
2	I-GENE	NUM	B
and	O	CCONJ	O
p176	B-GENE	NOUN	B
,	O	PUNCT	O
while	O	SCONJ	O
p20	B-GENE	NOUN	B
expressed	O	VERB	B
only	O	ADV	O
a	O	DET	O
16	O	NUM	O
-	O	PUNCT	O
kDa	O	NOUN	B
species	O	NOUN	B
.	O	PUNCT	O


Defects	O	NOUN	B
of	O	ADP	O
fibrillin	B-GENE	NOUN	B
(	O	PUNCT	O
FBN1	B-GENE	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
a	O	DET	O
glycoprotein	O	NOUN	B
component	O	NOUN	I
of	O	ADP	O
the	O	DET	O
extracellular	O	ADJ	B
microfibril	O	NOUN	O
,	O	PUNCT	O
cause	O	VERB	O
Marfan	O	NOUN	B
syndrome	O	NOUN	I
.	O	PUNCT	O


A	O	DET	O
region	O	NOUN	O
approximately	O	ADV	O
100	O	NUM	O
bp	O	NOUN	O
upstream	O	ADJ	B
from	O	ADP	O
the	O	DET	O
transcription	O	NOUN	B
start	O	NOUN	O
point	O	NOUN	O
of	O	ADP	O
virB	B-GENE	NOUN	B
was	O	AUX	O
identified	O	VERB	O
as	O	ADP	O
being	O	AUX	O
necessary	O	ADJ	O
for	O	ADP	O
full	O	ADJ	O
activation	O	NOUN	B
of	O	ADP	O
this	O	DET	O
promoter	O	NOUN	B
by	O	ADP	O
VirF	B-GENE	NOUN	B
.	O	PUNCT	O


METHODS	O	NOUN	O
:	O	PUNCT	O
Fifty	O	NUM	B
-	O	PUNCT	O
one	O	NUM	O
healthy	O	ADJ	B
eyes	O	NOUN	B
,	O	PUNCT	O
169	O	NUM	O
ocular	O	ADJ	B
hypertensive	O	ADJ	I
eyes	O	NOUN	B
with	O	ADP	O
normal	O	ADJ	O
visual	O	ADJ	B
fields	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
132	O	NUM	O
glaucomatous	O	ADJ	B
eyes	O	NOUN	O
with	O	ADP	O
early	O	ADJ	B
visual	O	ADJ	B
field	O	NOUN	I
defects	O	NOUN	O
were	O	AUX	O
evaluated	O	VERB	B
with	O	ADP	O
qualitative	O	ADJ	B
and	O	CCONJ	O
quantitative	O	ADJ	B
measures	O	NOUN	B
of	O	ADP	O
structural	O	ADJ	B
damage	O	NOUN	I
to	O	ADP	O
the	O	DET	O
optic	O	ADJ	B
nerve	O	NOUN	I
and	O	CCONJ	O
nerve	O	NOUN	B
fiber	O	NOUN	I
layer	O	NOUN	I
.	O	PUNCT	O


Consistent	O	ADJ	B
with	O	ADP	I
the	O	DET	O
hypothesis	O	NOUN	B
that	O	SCONJ	O
it	O	PRON	O
acts	O	VERB	O
as	O	ADP	O
transcriptional	O	ADJ	B
regulator	O	NOUN	I
,	O	PUNCT	O
wild	B-GENE	ADJ	B
-	I-GENE	PUNCT	O
type	I-GENE	NOUN	B
p53	I-GENE	NOUN	I
protein	I-GENE	NOUN	I
binds	O	VERB	B
DNA	O	NOUN	B
and	O	CCONJ	O
activates	O	VERB	B
transcription	O	NOUN	B
of	O	ADP	O
several	O	ADJ	O
promoters	O	NOUN	B
.	O	PUNCT	O


Instead	O	ADV	O
,	O	PUNCT	O
mRNA	O	NOUN	B
of	O	ADP	O
2	O	NUM	O
.	O	PUNCT	O
0	O	NUM	O
and	O	CCONJ	O
2	O	NUM	O
.	O	PUNCT	O
8	O	NUM	O
kb	O	NOUN	O
are	O	AUX	O
detected	O	VERB	B
in	O	ADP	O
varying	O	VERB	O
abundance	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
sequence	O	NOUN	B
of	O	ADP	O
the	O	DET	O
HIR1	B-GENE	NOUN	B
gene	I-GENE	NOUN	I
predicts	O	VERB	O
an	O	DET	O
88	O	NUM	O
-	O	PUNCT	O
kDa	O	NOUN	B
protein	O	NOUN	I
with	O	ADP	O
three	O	NUM	O
repeats	O	NOUN	B
of	O	ADP	O
a	O	DET	O
motif	O	NOUN	B
found	O	VERB	O
in	O	ADP	O
the	O	DET	O
G	B-GENE	NOUN	B
beta	I-GENE	NOUN	I
subunit	I-GENE	NOUN	I
of	O	ADP	O
retinal	B-GENE	ADJ	B
transducin	I-GENE	NOUN	B
and	O	CCONJ	O
in	O	ADP	O
a	O	DET	O
yeast	O	NOUN	B
transcriptional	O	ADJ	O
repressor	O	NOUN	O
,	O	PUNCT	O
Tup1	B-GENE	NOUN	B
.	O	PUNCT	O


All	O	DET	O
of	O	ADP	O
these	O	DET	O
data	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
replication	O	NOUN	B
of	O	ADP	O
UV	O	NOUN	B
-	O	PUNCT	O
damaged	O	VERB	B
templates	O	NOUN	B
occurs	O	VERB	O
in	O	X	B
vitro	O	X	I
as	O	ADP	O
it	O	PRON	O
does	O	AUX	O
in	O	X	B
vivo	O	X	I
and	O	CCONJ	O
that	O	SCONJ	O
this	O	DET	O
replication	O	NOUN	B
results	O	VERB	B
in	O	ADP	O
mutation	O	NOUN	B
fixation	O	NOUN	I
.	O	PUNCT	O


Biol	O	NOUN	B
.	O	PUNCT	O


265	O	NUM	O
,	O	PUNCT	O
1102	O	NUM	O
-	O	SYM	O
1110	O	NUM	O
)	O	PUNCT	O
.	O	PUNCT	O


The	O	DET	O
use	O	NOUN	O
of	O	ADP	O
this	O	DET	O
model	O	NOUN	B
for	O	ADP	O
investigating	O	VERB	B
pathophysiologically	O	ADV	B
significant	O	ADJ	I
issues	O	NOUN	B
in	O	ADP	O
denervating	O	NOUN	B
diseases	O	NOUN	I
is	O	AUX	O
illustrated	O	VERB	O
with	O	ADP	O
five	O	NUM	O
different	O	ADJ	O
sets	O	NOUN	B
of	O	ADP	O
parameters	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
describe	O	VERB	O
a	O	DET	O
novel	O	ADJ	O
cytoplasmic	B-GENE	ADJ	B
tyrosine	I-GENE	NOUN	O
kinase	I-GENE	NOUN	O
,	O	PUNCT	O
termed	O	VERB	O
BPK	B-GENE	PROPN	B
(	O	PUNCT	O
B	B-GENE	NOUN	B
cell	I-GENE	NOUN	I
progenitor	I-GENE	NOUN	I
kinase	I-GENE	NOUN	I
)	O	PUNCT	O
,	O	PUNCT	O
which	O	DET	O
is	O	AUX	O
expressed	O	VERB	B
in	O	ADP	O
all	O	DET	O
stages	O	NOUN	B
of	O	ADP	O
the	O	DET	O
B	O	NOUN	B
lineage	O	NOUN	I
and	O	CCONJ	O
in	O	ADP	O
myeloid	O	ADJ	B
cells	O	NOUN	I
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
L	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
plastin	I-GENE	PROPN	B
has	O	AUX	O
been	O	AUX	O
found	O	VERB	O
in	O	ADP	O
many	O	ADJ	O
types	O	NOUN	O
of	O	ADP	O
malignant	O	ADJ	B
human	O	ADJ	B
cells	O	NOUN	I
of	O	ADP	O
non	O	ADJ	B
-	O	PUNCT	O
hemopoietic	O	ADJ	B
origin	O	NOUN	B
suggesting	O	VERB	O
that	O	SCONJ	O
its	O	PRON	O
expression	O	NOUN	B
is	O	AUX	O
induced	O	VERB	B
accompanying	O	VERB	O
tumorigenesis	O	NOUN	B
in	O	ADP	O
solid	O	ADJ	B
tissues	O	NOUN	I
.	O	PUNCT	O


Finally	O	ADV	O
,	O	PUNCT	O
we	O	PRON	O
present	O	VERB	O
evidence	O	NOUN	B
that	O	SCONJ	O
fimbrin	B-GENE	NOUN	B
is	O	AUX	O
a	O	DET	O
third	O	ADJ	O
distinct	O	ADJ	O
plastin	B-GENE	NOUN	B
isoform	I-GENE	NOUN	B
which	O	DET	O
is	O	AUX	O
specifically	O	ADV	O
expressed	O	VERB	B
at	O	ADP	O
high	O	ADJ	O
levels	O	NOUN	B
in	O	ADP	O
the	O	DET	O
small	O	ADJ	B
intestine	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
DNase	B-GENE	NOUN	B
I	I-GENE	NUM	I
footprint	O	NOUN	I
extended	O	VERB	B
5	O	NUM	O
'	O	PUNCT	O
in	O	ADP	O
the	O	DET	O
silencer	O	NOUN	B
region	O	NOUN	I
to	O	PART	O
include	O	VERB	O
an	O	DET	O
inverted	O	ADJ	O
repeat	O	NOUN	O
of	O	ADP	O
a	O	DET	O
six	O	NUM	B
-	O	PUNCT	O
nucleotide	O	NOUN	B
motif	O	NOUN	I
(	O	PUNCT	O
epsilon	O	NOUN	B
-	O	PUNCT	O
267	O	NUM	O
to	O	PART	O
-	O	PUNCT	O
278	O	NUM	O
bp	O	NOUN	O
)	O	PUNCT	O
which	O	DET	O
shares	O	VERB	O
5	O	NUM	O
of	O	ADP	O
6	O	NUM	O
bases	O	NOUN	B
with	O	ADP	O
the	O	DET	O
GATA	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	O
consensus	I-GENE	NOUN	B
sequence	I-GENE	NOUN	I
.	O	PUNCT	O


Furthermore	O	ADV	O
,	O	PUNCT	O
competitor	O	NOUN	B
containing	O	VERB	O
the	O	DET	O
YY1	B-GENE	NOUN	B
consensus	I-GENE	NOUN	B
sequence	I-GENE	NOUN	I
competed	O	VERB	O
for	O	ADP	O
protein	B-GENE	NOUN	B
B	I-GENE	NOUN	I
binding	O	NOUN	I
,	O	PUNCT	O
whereas	O	SCONJ	O
competitor	O	NOUN	B
containing	O	VERB	O
a	O	DET	O
perfect	O	ADJ	O
yeast	B-GENE	NOUN	B
ABF	I-GENE	PROPN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	O
consensus	I-GENE	NOUN	B
sequence	I-GENE	NOUN	I
did	O	AUX	O
not	O	PART	O
.	O	PUNCT	O
(	O	PUNCT	O
ABSTRACT	O	NOUN	B
TRUNCATED	O	VERB	I
AT	O	ADP	I
400	O	NUM	I
WORDS	O	NOUN	I
)	O	PUNCT	O


Naval	O	ADJ	B
personnel	O	NOUN	I
who	O	PRON	O
exceed	O	VERB	O
standards	O	NOUN	B
for	O	ADP	O
%	O	NOUN	O
BF	O	NOUN	B
can	O	AUX	O
be	O	AUX	O
separated	O	VERB	O
from	O	ADP	O
active	O	ADJ	B
duty	O	NOUN	I
.	O	PUNCT	O


Weak	O	ADJ	B
promoter	O	NOUN	B
activity	O	NOUN	I
was	O	AUX	O
observed	O	VERB	O
for	O	ADP	O
the	O	DET	O
promoter	O	NOUN	B
of	O	ADP	O
the	O	DET	O
C1	B-GENE	NOUN	B
and	O	CCONJ	O
C2	B-GENE	NOUN	O
ORFs	O	NOUN	O
(	O	PUNCT	O
C1	B-GENE	NOUN	B
-	O	PUNCT	O
C2	B-GENE	NOUN	B
gene	O	NOUN	I
)	O	PUNCT	O
and	O	CCONJ	O
for	O	ADP	O
the	O	DET	O
promoter	O	NOUN	B
of	O	ADP	O
the	O	DET	O
V1	B-GENE	NOUN	B
ORF	I-GENE	NOUN	I
.	O	PUNCT	O


The	O	DET	O
activity	O	NOUN	B
of	O	ADP	O
the	O	DET	O
coat	B-GENE	NOUN	B
protein	I-GENE	NOUN	I
promoter	I-GENE	NOUN	B
of	O	ADP	O
chloris	O	NOUN	B
striate	O	ADJ	I
mosaic	O	ADJ	I
virus	O	NOUN	I
is	O	AUX	O
enhanced	O	VERB	B
by	O	ADP	O
its	O	PRON	O
own	O	ADJ	O
and	O	CCONJ	O
C1	B-GENE	NOUN	B
-	O	PUNCT	O
C2	B-GENE	NOUN	B
gene	O	NOUN	I
products	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
amino	O	NOUN	B
acid	O	NOUN	I
sequence	O	NOUN	I
alignment	O	NOUN	B
of	O	ADP	O
TC	B-GENE	NOUN	B
II	I-GENE	NUM	I
with	O	ADP	O
that	O	DET	O
of	O	ADP	O
other	O	ADJ	O
Cbl	B-GENE	NOUN	B
binding	I-GENE	NOUN	I
proteins	I-GENE	NOUN	I
(	O	PUNCT	O
rat	B-GENE	NOUN	B
intrinsic	I-GENE	ADJ	B
factor	I-GENE	NOUN	I
,	O	PUNCT	O
human	B-GENE	ADJ	B
transcobalamin	I-GENE	NOUN	B
I	I-GENE	NUM	I
and	O	CCONJ	O
porcine	B-GENE	NOUN	B
haptocorrin	I-GENE	NOUN	B
)	O	PUNCT	O
revealed	O	VERB	O
only	O	ADV	O
33	O	NUM	O
%	O	NOUN	O
overall	O	ADJ	O
homology	O	NOUN	B
.	O	PUNCT	O


This	O	DET	O
short	O	ADJ	O
communication	O	NOUN	B
compares	O	VERB	O
a	O	DET	O
novel	O	ADJ	O
fluorimetric	O	ADJ	B
microplate	O	NOUN	I
enzyme	O	NOUN	I
immunoassay	O	NOUN	I
(	O	PUNCT	O
FEIA	O	NOUN	B
)	O	PUNCT	O
with	O	ADP	O
a	O	DET	O
commercial	O	ADJ	B
time	O	NOUN	B
-	O	PUNCT	O
resolved	O	VERB	B
fluoroimmunoassay	O	NOUN	B
for	O	ADP	O
the	O	DET	O
determination	O	NOUN	B
of	O	ADP	O
thyrotropin	B-GENE	NOUN	B
in	O	ADP	O
dried	O	VERB	B
blood	O	NOUN	I
spots	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
evaluation	O	NOUN	B
was	O	AUX	O
performed	O	VERB	O
using	O	VERB	O
a	O	DET	O
retrospective	O	ADJ	B
study	O	NOUN	I
design	O	NOUN	I
with	O	ADP	O
newborn	O	ADJ	B
blood	O	NOUN	I
samples	O	NOUN	I
from	O	ADP	O
three	O	NUM	O
screening	O	VERB	B
centres	O	NOUN	I
.	O	PUNCT	O


When	O	SCONJ	O
ligated	O	VERB	B
to	O	PART	O
the	O	DET	O
proIL	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	O
beta	I-GENE	NOUN	B
cap	I-GENE	NOUN	I
site	I-GENE	NOUN	I
-	I-GENE	PUNCT	O
proximal	I-GENE	ADJ	B
region	I-GENE	NOUN	O
(	O	PUNCT	O
located	O	ADJ	O
between	O	ADP	O
-	O	PUNCT	O
131	O	NUM	O
to	O	PART	O
+	O	CCONJ	O
12	O	NUM	O
)	O	PUNCT	O
,	O	PUNCT	O
both	O	CCONJ	O
the	O	DET	O
proIL	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	O
beta	I-GENE	NOUN	B
and	O	CCONJ	O
the	O	DET	O
simian	B-GENE	ADJ	B
virus	I-GENE	NOUN	I
40	I-GENE	NUM	O
enhancer	I-GENE	NOUN	B
elements	I-GENE	NOUN	I
functioned	O	VERB	O
more	O	ADV	O
efficiently	O	ADV	B
in	O	ADP	O
monocytes	O	NOUN	B
than	O	ADP	O
in	O	ADP	O
HeLa	O	NOUN	B
cells	O	NOUN	I
,	O	PUNCT	O
which	O	DET	O
are	O	AUX	O
not	O	PART	O
normally	O	ADV	O
competent	O	ADJ	B
for	O	ADP	O
IL	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	O
beta	I-GENE	NOUN	B
expression	O	NOUN	I
.	O	PUNCT	O


Therefore	O	ADV	O
,	O	PUNCT	O
PC	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
PLC	I-GENE	PROPN	B
is	O	AUX	O
a	O	DET	O
component	O	NOUN	B
of	O	ADP	O
a	O	DET	O
signal	O	NOUN	B
transduction	O	NOUN	I
pathway	O	NOUN	O
leading	O	VERB	O
to	O	PART	O
transcription	O	NOUN	B
of	O	ADP	O
c	B-GENE	NOUN	O
-	I-GENE	PUNCT	O
fos	I-GENE	NOUN	B
and	O	CCONJ	O
junB	B-GENE	NOUN	B
that	O	PRON	O
collaborates	O	VERB	B
with	O	ADP	O
c	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
myc	I-GENE	NOUN	B
and	O	CCONJ	O
is	O	AUX	O
independent	O	ADJ	O
of	O	ADP	O
PKC	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
delta	I-GENE	NOUN	B
and	O	CCONJ	O
Ras	B-GENE	NOUN	B
activation	O	NOUN	B
.	O	PUNCT	O


Southern	O	NOUN	B
blot	O	NOUN	I
analysis	O	NOUN	I
using	O	VERB	O
probes	O	NOUN	B
from	O	ADP	O
the	O	DET	O
3	O	NUM	O
'	O	PART	O
portions	O	NOUN	B
of	O	ADP	O
the	O	DET	O
genomic	O	ADJ	B
and	O	CCONJ	O
B	B-GENE	NOUN	B
.	I-GENE	PUNCT	O
napus	I-GENE	NOUN	B
MA	I-GENE	NOUN	I
and	O	CCONJ	O
MB	B-GENE	NOUN	B
cDNA	I-GENE	NOUN	B
clones	O	NOUN	I
showed	O	VERB	O
that	O	SCONJ	O
MA	B-GENE	NOUN	B
type	I-GENE	NOUN	I
myrosinases	B-GENE	NOUN	B
are	O	AUX	O
encoded	O	VERB	B
by	O	ADP	O
approximately	O	ADV	O
4	O	NUM	O
genes	O	NOUN	B
,	O	PUNCT	O
while	O	SCONJ	O
MB	B-GENE	NOUN	B
type	I-GENE	NOUN	I
myrosinases	B-GENE	NOUN	I
are	O	AUX	O
encoded	O	VERB	B
by	O	ADP	O
more	O	ADJ	O
than	O	ADP	O
10	O	NUM	O
genes	O	NOUN	B
in	O	ADP	O
B	O	NOUN	B
.	O	PUNCT	O
napus	O	NOUN	B
.	O	PUNCT	O


Type	O	NOUN	B
II	O	NUM	I
could	O	AUX	O
be	O	AUX	O
divided	O	VERB	O
further	O	ADV	O
into	O	ADP	O
two	O	NUM	O
forms	O	NOUN	O
(	O	PUNCT	O
IIA	O	NOUN	B
and	O	CCONJ	O
IIB	O	NOUN	B
)	O	PUNCT	O
that	O	PRON	O
may	O	AUX	O
represent	O	VERB	O
two	O	NUM	O
underscribed	O	ADJ	B
species	O	NOUN	I
or	O	CCONJ	O
developmental	O	ADJ	B
stages	O	NOUN	I
of	O	ADP	O
the	O	DET	O
same	O	ADJ	O
species	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
the	O	DET	O
present	O	ADJ	O
study	O	NOUN	B
we	O	PRON	O
demonstrated	O	VERB	O
a	O	DET	O
unique	O	ADJ	O
mechanism	O	NOUN	B
of	O	ADP	O
action	O	NOUN	B
of	O	ADP	O
8	O	NUM	O
-	O	PUNCT	O
Cl	O	NOUN	B
-	O	PUNCT	O
cAMP	O	NOUN	B
in	O	ADP	O
the	O	DET	O
regulation	O	NOUN	B
of	O	ADP	O
these	O	DET	O
kinase	O	NOUN	B
isozymes	O	NOUN	I
in	O	ADP	O
HL	O	NOUN	B
-	O	PUNCT	O
60	O	NUM	O
human	O	ADJ	B
promyelocytic	O	ADJ	I
leukemia	O	NOUN	I
cells	O	NOUN	B
.	O	PUNCT	O


There	O	PRON	O
are	O	AUX	O
,	O	PUNCT	O
however	O	ADV	O
,	O	PUNCT	O
several	O	ADJ	O
differences	O	NOUN	O
between	O	ADP	O
the	O	DET	O
two	O	NUM	O
new	O	ADJ	O
ars	O	NOUN	B
sequences	O	NOUN	I
.	O	PUNCT	O


Pokeweed	B-GENE	NOUN	B
mitogen	I-GENE	NOUN	I
(	O	PUNCT	I
PWM	B-GENE	NOUN	B
)	O	PUNCT	O
or	O	CCONJ	O
anti	B-GENE	ADJ	B
-	I-GENE	PUNCT	O
CD3	I-GENE	NOUN	B
significantly	O	ADV	O
increases	O	VERB	B
c	B-GENE	X	O
-	I-GENE	PUNCT	O
jun	I-GENE	NOUN	B
messenger	I-GENE	NOUN	I
RNA	I-GENE	NOUN	I
(	I-GENE	PUNCT	O
mRNA	I-GENE	NOUN	B
)	I-GENE	PUNCT	O
levels	O	NOUN	B
in	O	ADP	O
T	O	NOUN	B
cells	O	NOUN	I
.	O	PUNCT	O


Following	O	VERB	O
seizure	O	NOUN	B
induction	O	NOUN	B
,	O	PUNCT	O
MABP	O	NOUN	B
increased	O	VERB	B
to	O	PART	O
105	O	NUM	O
mm	O	X	B
Hg	O	NOUN	I
and	O	CCONJ	O
brain	O	NOUN	B
pHi	O	NOUN	B
fell	O	VERB	O
to	O	ADP	O
6	O	NUM	O
.	O	PUNCT	O
79	O	NUM	O
+	O	CCONJ	O
/	O	SYM	O
-	O	PUNCT	O
0	O	NUM	O
.	O	PUNCT	O
03	O	NUM	O
within	O	ADP	O
15	O	NUM	O
min	O	NOUN	B
and	O	CCONJ	O
remained	O	VERB	O
at	O	ADP	O
this	O	DET	O
level	O	NOUN	B
for	O	ADP	O
1	O	NUM	O
h	O	NOUN	O
(	O	PUNCT	O
P	O	NOUN	O
<	O	X	O
0	O	NUM	O
.	O	PUNCT	O
001	O	NUM	O
)	O	PUNCT	O
.	O	PUNCT	O


Sterile	O	ADJ	B
mutants	O	NOUN	I
of	O	ADP	O
Saccharomyces	O	X	B
cerevisiae	O	X	I
were	O	AUX	O
isolated	O	VERB	B
from	O	ADP	O
alpha	O	NOUN	B
*	O	PUNCT	I
cells	O	NOUN	I
having	O	VERB	O
the	O	DET	O
a	B-GENE	DET	O
/	I-GENE	SYM	O
alpha	I-GENE	NOUN	B
aar1	I-GENE	NOUN	I
-	I-GENE	PUNCT	O
6	I-GENE	NUM	O
genotype	O	NOUN	B
(	O	PUNCT	O
exhibiting	O	VERB	O
alpha	O	NOUN	B
mating	O	NOUN	I
ability	O	NOUN	O
and	O	CCONJ	O
weak	O	ADJ	B
a	O	DET	O
mating	O	ADJ	B
ability	O	NOUN	O
as	O	ADP	O
a	O	DET	O
result	O	NOUN	O
of	O	ADP	O
a	O	DET	O
defect	O	NOUN	B
in	O	ADP	O
a1	B-GENE	ADJ	B
-	I-GENE	PUNCT	O
alpha	I-GENE	NOUN	B
2	I-GENE	NUM	I
repression	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


OBJECTIVE	O	NOUN	O
:	O	PUNCT	O
Our	O	PRON	O
purpose	O	NOUN	O
was	O	AUX	O
to	O	PART	O
determine	O	VERB	O
the	O	DET	O
simultaneous	O	ADJ	B
concentrations	O	NOUN	B
of	O	ADP	O
serum	O	NOUN	B
cotinine	O	NOUN	B
in	O	ADP	O
both	O	CCONJ	O
fetal	O	ADJ	B
and	O	CCONJ	O
maternal	O	ADJ	B
blood	O	NOUN	I
.	O	PUNCT	O


5	O	NUM	O
micrograms	O	NOUN	B
/	O	PUNCT	O
l	O	NOUN	O
was	O	AUX	O
detected	O	VERB	B
in	O	ADP	O
urine	O	NOUN	B
from	O	ADP	O
some	O	DET	O
non	O	ADJ	B
-	O	PUNCT	O
occupationally	O	ADV	B
exposed	O	VERB	B
persons	O	NOUN	B
.	O	PUNCT	O


Finger	B-GENE	PROPN	B
associated	I-GENE	VERB	O
box	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
zinc	I-GENE	NOUN	B
finger	I-GENE	NOUN	I
proteins	I-GENE	NOUN	I
(	O	PUNCT	O
FAX	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
ZFPs	I-GENE	PROPN	B
)	O	PUNCT	O
constitute	O	VERB	O
a	O	DET	O
subfamily	O	NOUN	B
of	O	ADP	O
the	O	DET	O
many	O	ADJ	O
C2H2	B-GENE	NOUN	B
type	I-GENE	NOUN	I
ZFPs	I-GENE	NOUN	B
in	O	ADP	O
Xenopus	O	NOUN	B
laevis	O	NOUN	I
.	O	PUNCT	O


Further	O	ADJ	O
evidence	O	NOUN	B
for	O	ADP	O
a	O	DET	O
clustered	O	ADJ	B
organization	O	NOUN	I
of	O	ADP	O
FAX	B-GENE	PROPN	B
-	O	PUNCT	O
ZFP	B-GENE	NOUN	B
transcription	O	NOUN	B
units	O	NOUN	I
is	O	AUX	O
provided	O	VERB	O
by	O	ADP	O
Southern	O	NOUN	B
blot	O	NOUN	I
analysis	O	NOUN	I
of	O	ADP	O
large	O	ADJ	O
genomic	O	ADJ	B
restriction	O	NOUN	I
fragments	O	NOUN	O
separated	O	VERB	O
by	O	ADP	O
transverse	O	ADJ	B
field	O	NOUN	I
gel	O	NOUN	I
electrophoresis	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
by	O	ADP	O
in	O	X	B
situ	O	X	I
hybridization	O	NOUN	I
on	O	ADP	O
intact	O	ADJ	B
chromosomes	O	NOUN	B
.	O	PUNCT	O


Mutational	O	ADJ	B
analyses	O	NOUN	I
have	O	AUX	O
demonstrated	O	VERB	O
the	O	DET	O
importance	O	NOUN	O
of	O	ADP	O
sequences	O	NOUN	B
within	O	ADP	O
the	O	DET	O
327	O	NUM	O
bp	O	NOUN	O
segment	O	NOUN	B
that	O	PRON	O
contain	O	VERB	O
a	O	DET	O
putative	O	ADJ	B
cyclic	B-GENE	ADJ	I
AMP	I-GENE	NOUN	I
responsive	I-GENE	ADJ	O
element	I-GENE	NOUN	O
binding	I-GENE	NOUN	O
protein	I-GENE	NOUN	O
(	O	PUNCT	O
CREB	B-GENE	NOUN	B
)	O	PUNCT	O
binding	O	NOUN	B
site	O	NOUN	I
for	O	ADP	O
TGF	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
beta	I-GENE	NOUN	B
1	I-GENE	NUM	I
and	O	CCONJ	O
PMA	O	NOUN	B
responsiveness	O	NOUN	B
and	O	CCONJ	O
putative	O	ADJ	O
PU	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	B
and	O	CCONJ	O
Sp1	B-GENE	NOUN	B
binding	I-GENE	NOUN	B
sites	I-GENE	NOUN	I
for	O	ADP	O
basal	O	ADJ	B
promoter	O	NOUN	I
activity	O	NOUN	I
.	O	PUNCT	O


(	O	PUNCT	O
1992	O	NUM	O
)	O	PUNCT	O
J	O	NOUN	O
.	O	PUNCT	O


We	O	PRON	O
obtained	O	VERB	O
the	O	DET	O
prevalence	O	NOUN	B
of	O	ADP	O
IgG	B-GENE	NOUN	B
antibodies	I-GENE	NOUN	I
against	O	ADP	O
Trypanosoma	O	X	B
cruzi	O	X	I
among	O	ADP	O
1076	O	NUM	O
blood	O	NOUN	B
donors	O	NOUN	I
at	O	ADP	O
the	O	DET	O
Instituto	O	PROPN	B
Nacional	O	PROPN	I
de	O	PROPN	I
Cardiologia	O	PROPN	I
"	O	PUNCT	I
Ignacio	O	PROPN	I
Chavez	O	PROPN	I
"	O	PUNCT	O
in	O	ADP	O
Mexico	O	PROPN	B
City	O	PROPN	I
.	O	PUNCT	O


Examination	O	NOUN	B
of	O	ADP	O
the	O	DET	O
immediate	O	ADJ	O
sequence	O	NOUN	B
5	O	NUM	O
'	O	PUNCT	O
to	O	PART	O
the	O	DET	O
mRNA	O	NOUN	B
start	O	NOUN	O
site	O	NOUN	B
reveals	O	VERB	O
no	O	DET	O
TATA	O	NOUN	B
box	O	NOUN	I
and	O	CCONJ	O
multiple	O	ADJ	O
known	O	ADJ	O
enhancer	O	NOUN	B
sequences	O	NOUN	I
.	O	PUNCT	O


Pseudosubstrate	O	NOUN	B
(	O	PUNCT	O
19	O	NUM	O
-	O	SYM	O
36	O	NUM	O
)	O	PUNCT	O
,	O	PUNCT	O
derived	O	VERB	O
from	O	ADP	O
the	O	DET	O
C	O	NOUN	B
-	O	PUNCT	O
terminus	O	NOUN	B
of	O	ADP	O
Ca	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
dependent	I-GENE	ADJ	B
PKC	I-GENE	NOUN	B
isotypes	I-GENE	NOUN	B
,	O	PUNCT	O
inhibited	O	VERB	B
beta	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
PKC	I-GENE	NOUN	B
but	O	CCONJ	O
not	O	PART	O
nPKC	B-GENE	NOUN	B
activity	O	NOUN	B
using	O	VERB	O
either	O	CCONJ	O
Histone	B-GENE	NOUN	B
IIIS	I-GENE	NOUN	I
or	O	CCONJ	O
peptide	O	NOUN	B
(	O	PUNCT	O
19	O	NUM	O
-	O	SYM	O
31	O	NUM	O
)	O	PUNCT	O
as	O	ADP	O
substrate	O	NOUN	B
.	O	PUNCT	O


This	O	DET	O
may	O	AUX	O
account	O	VERB	O
,	O	PUNCT	O
at	O	ADP	O
least	O	ADJ	O
in	O	ADP	O
part	O	NOUN	O
,	O	PUNCT	O
for	O	ADP	O
the	O	DET	O
ability	O	NOUN	B
of	O	ADP	O
excess	O	ADJ	B
wt	B-GENE	NOUN	O
p53	I-GENE	NOUN	B
to	O	PART	O
inhibit	O	VERB	B
cell	O	NOUN	B
proliferation	O	NOUN	I
and	O	CCONJ	O
to	O	PART	O
interfere	O	VERB	B
with	O	ADP	I
neoplastic	O	ADJ	B
processes	O	NOUN	I
.	O	PUNCT	O


Northern	O	NOUN	B
blot	O	NOUN	I
analysis	O	NOUN	I
of	O	ADP	O
total	O	ADJ	O
cellular	O	ADJ	O
RNA	O	NOUN	O
indicated	O	VERB	O
that	O	SCONJ	O
xylP	B-GENE	NOUN	B
encodes	O	VERB	B
a	O	DET	O
1	O	NUM	O
.	O	PUNCT	O
3	O	NUM	O
-	O	PUNCT	O
kb	O	NOUN	O
transcript	O	NOUN	B
which	O	DET	O
is	O	AUX	O
induced	O	VERB	B
by	O	ADP	O
xylan	O	NOUN	B
.	O	PUNCT	O


These	O	DET	O
data	O	NOUN	B
show	O	VERB	O
that	O	SCONJ	O
PTH	B-GENE	NOUN	B
and	O	CCONJ	O
cAMP	O	NOUN	B
can	O	AUX	O
repress	O	VERB	B
collagen	B-GENE	NOUN	B
promoter	I-GENE	NOUN	B
activity	O	NOUN	I
in	O	ADP	O
calvariae	O	NOUN	B
from	O	ADP	O
transgenic	O	ADJ	B
mice	O	NOUN	I
,	O	PUNCT	O
suggesting	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
alpha	B-GENE	NOUN	B
1	I-GENE	NUM	I
(	I-GENE	PUNCT	O
I	I-GENE	NOUN	B
)	I-GENE	PUNCT	O
collagen	I-GENE	NOUN	B
promoter	I-GENE	NOUN	B
may	O	AUX	O
contain	O	VERB	O
cis	O	NOUN	O
elements	O	NOUN	O
down	O	ADP	B
-	O	PUNCT	O
stream	O	NOUN	B
of	O	ADP	O
-	O	PUNCT	O
2	O	NUM	O
.	O	PUNCT	O
3	O	NUM	O
kilobases	O	NOUN	B
that	O	PRON	O
mediate	O	VERB	O
PTH	B-GENE	NOUN	B
and	O	CCONJ	O
cAMP	O	NOUN	B
repression	O	NOUN	I
of	O	ADP	O
collagen	B-GENE	NOUN	B
gene	I-GENE	NOUN	B
expression	O	NOUN	I
in	O	ADP	O
bone	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
yeast	O	NOUN	B
gene	O	NOUN	I
that	O	PRON	O
encodes	O	VERB	B
eIF	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
5	I-GENE	NUM	O
,	O	PUNCT	O
designated	O	VERB	O
TIF5	B-GENE	NOUN	B
,	O	PUNCT	O
has	O	AUX	O
been	O	AUX	O
isolated	O	VERB	B
and	O	CCONJ	O
expressed	O	VERB	B
in	O	ADP	O
Escherichia	O	X	B
coli	O	X	I
to	O	PART	O
yield	O	VERB	O
a	O	DET	O
catalytically	O	ADV	B
active	O	ADJ	O
eIF	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
5	I-GENE	NUM	O
protein	I-GENE	NOUN	B
.	O	PUNCT	O


Xylose	O	NOUN	B
-	O	PUNCT	O
and	O	CCONJ	O
arabinose	O	NOUN	B
-	O	PUNCT	O
containing	O	VERB	B
polymers	O	NOUN	B
were	O	AUX	O
better	O	ADV	O
digested	O	VERB	B
than	O	ADP	O
was	O	AUX	O
cellulose	O	NOUN	B
for	O	ADP	O
both	O	DET	O
breads	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
alpha	O	NOUN	B
-	O	PUNCT	O
subunit	O	NOUN	B
by	O	ADP	O
itself	O	PRON	O
binds	O	VERB	B
to	O	PART	O
telomeric	O	ADJ	B
DNA	O	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
conclude	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
alpha	O	NOUN	B
-	O	PUNCT	O
subunit	O	NOUN	B
of	O	ADP	O
the	O	DET	O
telomere	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
binding	I-GENE	VERB	B
protein	I-GENE	NOUN	I
,	O	PUNCT	O
like	O	ADP	O
many	O	ADJ	O
transcription	O	NOUN	B
factors	O	NOUN	I
,	O	PUNCT	O
has	O	AUX	O
separable	O	ADJ	O
DNA	O	NOUN	B
-	O	PUNCT	O
binding	O	NOUN	B
and	O	CCONJ	O
protein	O	NOUN	B
-	O	PUNCT	O
protein	O	NOUN	B
interaction	O	NOUN	O
domains	O	NOUN	O
.	O	PUNCT	O


Calcification	O	NOUN	B
of	O	ADP	O
a	O	DET	O
cariogenic	O	ADJ	B
Streptococcus	O	PROPN	I
and	O	CCONJ	O
of	O	ADP	O
Corynebacterium	O	X	B
(	O	PUNCT	O
Bacterionema	O	NOUN	O
)	O	PUNCT	O
matruchotii	O	NOUN	O
.	O	PUNCT	O


A	O	DET	O
comparison	O	NOUN	B
of	O	ADP	O
the	O	DET	O
promoters	O	NOUN	B
for	O	ADP	O
muMIP	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	O
beta	I-GENE	NOUN	B
and	O	CCONJ	O
muMIP	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	O
alpha	I-GENE	NOUN	B
reveals	O	VERB	O
a	O	DET	O
conserved	O	VERB	O
CK	O	NOUN	B
-	O	PUNCT	O
1	O	NUM	O
element	O	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
transient	O	ADJ	B
expression	O	NOUN	B
studies	O	NOUN	I
in	O	ADP	O
RAW	O	NOUN	B
264	O	NUM	I
.	O	PUNCT	O
7	O	NUM	O
macrophages	O	NOUN	B
with	O	ADP	O
proximal	O	ADJ	B
fragments	O	NOUN	B
of	O	ADP	O
either	O	CCONJ	O
the	O	DET	O
muMIP	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	O
beta	I-GENE	NOUN	B
or	O	CCONJ	O
the	O	DET	O
muMIP	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	O
alpha	I-GENE	NOUN	O
5	I-GENE	NUM	O
'	I-GENE	PART	O
promoter	I-GENE	NOUN	B
fused	O	VERB	I
to	O	PART	O
a	O	DET	O
human	B-GENE	ADJ	B
growth	I-GENE	NOUN	O
hormone	I-GENE	NOUN	O
reporter	I-GENE	NOUN	O
gene	I-GENE	NOUN	O
link	O	VERB	O
LPS	O	NOUN	B
-	O	PUNCT	O
inducibility	O	NOUN	B
in	O	ADP	O
both	O	DET	O
to	O	PART	O
promoter	O	NOUN	B
segments	O	NOUN	I
near	O	ADJ	O
to	O	PART	O
,	O	PUNCT	O
but	O	CCONJ	O
not	O	PART	O
identical	O	ADJ	B
with	O	ADP	O
,	O	PUNCT	O
the	O	DET	O
consensus	O	NOUN	B
CK	O	NOUN	B
-	O	PUNCT	O
1	O	NUM	O
sequence	O	NOUN	B
.	O	PUNCT	O


Sequence	O	NOUN	B
analysis	O	NOUN	I
and	O	CCONJ	O
identification	O	NOUN	B
of	O	ADP	O
two	O	NUM	O
hyp	B-GENE	NOUN	B
regulatory	I-GENE	ADJ	B
mutants	I-GENE	NOUN	I
.	O	PUNCT	O


The	O	DET	O
gene	O	NOUN	B
encoding	O	VERB	B
the	O	DET	O
receptor	O	NOUN	B
for	O	ADP	O
macrophage	B-GENE	NOUN	B
colony	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
stimulating	I-GENE	VERB	B
factor	I-GENE	NOUN	O
1	I-GENE	NUM	O
(	O	PUNCT	O
CSF	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	O
)	O	PUNCT	O
,	O	PUNCT	O
the	O	DET	O
c	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
fms	I-GENE	NOUN	B
protooncogene	I-GENE	NOUN	I
,	O	PUNCT	O
is	O	AUX	O
selectively	O	ADV	O
expressed	O	VERB	B
in	O	ADP	O
immature	O	ADJ	B
and	O	CCONJ	O
mature	O	ADJ	B
mononuclear	O	ADJ	B
phagocytes	O	NOUN	B
and	O	CCONJ	O
trophoblasts	O	NOUN	B
.	O	PUNCT	O


Since	O	SCONJ	O
the	O	DET	O
regulation	O	NOUN	B
of	O	ADP	O
SWI4	B-GENE	NOUN	B
is	O	AUX	O
required	O	VERB	O
for	O	ADP	O
normal	O	ADJ	B
cell	O	NOUN	I
cycle	O	NOUN	I
progression	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
have	O	AUX	O
characterized	O	VERB	B
cis	O	ADV	B
-	O	PUNCT	O
and	O	CCONJ	O
trans	O	ADJ	B
-	O	PUNCT	O
acting	O	VERB	B
regulators	O	NOUN	B
of	O	ADP	O
SWI4	B-GENE	NOUN	B
transcription	O	NOUN	B
.	O	PUNCT	O


It	O	PRON	O
also	O	ADV	O
suggests	O	VERB	O
that	O	SCONJ	O
there	O	PRON	O
is	O	AUX	O
another	O	DET	O
pathway	O	NOUN	B
which	O	DET	O
can	O	AUX	O
activate	O	VERB	B
SWI4	B-GENE	NOUN	B
transcription	O	NOUN	B
in	O	ADP	O
the	O	DET	O
absence	O	NOUN	B
of	O	ADP	O
SWI6	B-GENE	NOUN	B
.	O	PUNCT	O


Multiple	O	ADJ	B
SWI6	B-GENE	NOUN	B
-	O	PUNCT	O
dependent	O	ADJ	B
cis	O	ADV	B
-	O	PUNCT	O
acting	O	VERB	B
elements	O	NOUN	I
control	O	VERB	O
SWI4	B-GENE	NOUN	B
transcription	O	NOUN	B
through	O	ADP	O
the	O	DET	O
cell	O	NOUN	B
cycle	O	NOUN	I
.	O	PUNCT	O


Biol	O	NOUN	B
.	O	PUNCT	O


Patient	O	ADJ	B
characteristics	O	NOUN	B
associated	O	VERB	B
with	O	ADP	I
deep	O	ADJ	B
wounds	O	NOUN	I
as	O	ADV	O
well	O	ADV	O
as	O	ADP	O
patient	O	NOUN	B
and	O	CCONJ	O
wound	O	NOUN	B
characteristics	O	NOUN	I
predictive	O	ADJ	B
of	O	ADP	O
the	O	DET	O
extent	O	NOUN	B
of	O	ADP	O
healing	O	NOUN	B
and	O	CCONJ	O
time	O	NOUN	B
required	O	VERB	O
for	O	ADP	O
healing	O	NOUN	B
were	O	AUX	O
identified	O	VERB	B
.	O	PUNCT	O


Yeast	O	NOUN	B
mutants	O	NOUN	I
lacking	O	VERB	O
a	O	DET	O
functional	O	ADJ	B
NOP1	B-GENE	NOUN	B
gene	I-GENE	NOUN	I
can	O	AUX	O
be	O	AUX	O
complemented	O	VERB	B
by	O	ADP	O
human	B-GENE	ADJ	B
fibrillarin	I-GENE	NOUN	B
but	O	CCONJ	O
are	O	AUX	O
temperature	O	NOUN	B
sensitive	O	ADJ	B
for	O	ADP	O
growth	O	NOUN	B
and	O	CCONJ	O
impaired	O	ADJ	B
in	O	ADP	O
pre	O	ADJ	B
-	O	PUNCT	O
rRNA	O	NOUN	B
processing	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
patients	O	NOUN	B
were	O	AUX	O
divided	O	VERB	O
into	O	ADP	O
ischaemia	O	NOUN	B
and	O	CCONJ	O
non	O	ADJ	B
-	O	PUNCT	O
ischaemia	O	NOUN	B
groups	O	NOUN	B
on	O	ADP	O
the	O	DET	O
basis	O	NOUN	O
of	O	ADP	O
the	O	DET	O
change	O	NOUN	B
in	O	ADP	O
lactate	O	NOUN	B
extraction	O	NOUN	I
ratio	O	NOUN	I
during	O	ADP	O
balloon	O	NOUN	B
inflation	O	NOUN	B
.	O	PUNCT	O


Both	O	DET	O
immunophilins	B-GENE	NOUN	B
may	O	AUX	O
have	O	AUX	O
important	O	ADJ	O
roles	O	NOUN	O
in	O	ADP	O
receptor	O	NOUN	B
assembly	O	NOUN	I
and	O	CCONJ	O
may	O	AUX	O
represent	O	VERB	O
a	O	DET	O
new	O	ADJ	O
category	O	NOUN	O
of	O	ADP	O
ligand	O	NOUN	B
-	O	PUNCT	O
and	O	CCONJ	O
calcium	O	NOUN	B
-	O	PUNCT	O
dependent	O	ADJ	B
modulators	O	NOUN	B
of	O	ADP	O
protein	O	NOUN	B
function	O	NOUN	I
.	O	PUNCT	O


Umweltchem	O	PRON	B
.	O	PUNCT	O


Contrary	O	ADJ	O
to	O	ADP	O
expectations	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
find	O	VERB	O
a	O	DET	O
relatively	O	ADV	O
high	O	ADJ	O
level	O	NOUN	B
of	O	ADP	O
variation	O	NOUN	B
in	O	ADP	O
the	O	DET	O
stripe	B-GENE	NOUN	B
2	I-GENE	NUM	I
enhancer	O	NOUN	I
region	O	NOUN	I
,	O	PUNCT	O
including	O	VERB	O
point	O	NOUN	B
substitutions	O	NOUN	I
and	O	CCONJ	O
insertion	O	NOUN	B
/	O	SYM	O
deletions	O	NOUN	B
in	O	ADP	O
binding	O	VERB	B
sites	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
a	O	DET	O
comparable	O	ADJ	O
level	O	NOUN	B
of	O	ADP	O
variation	O	NOUN	B
in	O	ADP	O
the	O	DET	O
other	O	ADJ	O
noncoding	O	ADJ	B
regions	O	NOUN	I
.	O	PUNCT	O


I	O	PRON	O
report	O	VERB	B
here	O	ADV	O
that	O	SCONJ	O
induction	O	NOUN	B
of	O	ADP	O
HSP82	B-GENE	NOUN	B
is	O	AUX	O
regulated	O	VERB	O
by	O	ADP	O
the	O	DET	O
early	O	ADJ	O
meiotic	O	ADJ	B
IME1	B-GENE	NOUN	B
-	O	PUNCT	O
IME2	B-GENE	NOUN	B
transcriptional	O	ADJ	B
cascade	O	NOUN	I
.	O	PUNCT	O


Refugees	O	NOUN	B
living	O	VERB	B
in	O	ADP	O
Lund	O	PROPN	B
and	O	CCONJ	O
repatriated	O	VERB	B
to	O	ADP	O
Chile	O	PROPN	B
considered	O	VERB	O
their	O	PRON	O
health	O	NOUN	B
as	O	ADV	O
bad	O	ADJ	O
in	O	ADP	O
a	O	DET	O
higher	O	ADJ	O
proportion	O	NOUN	B
than	O	ADP	O
their	O	PRON	O
Swedish	O	ADJ	B
counterparts	O	NOUN	B
,	O	PUNCT	O
with	O	ADP	O
an	O	DET	O
odds	O	NOUN	B
ratio	O	NOUN	I
of	O	ADP	O
3	O	NUM	O
.	O	PUNCT	O
48	O	NUM	O
(	O	PUNCT	O
2	O	NUM	O
.	O	PUNCT	O
03	O	NUM	O
-	O	SYM	O
5	O	NUM	O
.	O	PUNCT	O
66	O	NUM	O
)	O	PUNCT	O
and	O	CCONJ	O
4	O	NUM	O
.	O	PUNCT	O
78	O	NUM	O
(	O	PUNCT	O
2	O	NUM	O
.	O	PUNCT	O
1	O	NUM	O
-	O	SYM	O
10	O	NUM	O
.	O	PUNCT	O
25	O	NUM	O
)	O	PUNCT	O
respectively	O	ADV	O
.	O	PUNCT	O


This	O	DET	O
study	O	NOUN	B
underlines	O	VERB	O
the	O	DET	O
importance	O	NOUN	O
of	O	ADP	O
terminal	O	ADJ	B
SC5b	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
9	I-GENE	NUM	B
complement	I-GENE	NOUN	B
complex	I-GENE	NOUN	I
as	O	ADP	O
a	O	DET	O
suitable	O	ADJ	O
marker	O	NOUN	B
in	O	ADP	O
the	O	DET	O
evaluation	O	NOUN	B
of	O	ADP	O
complement	O	NOUN	B
activation	O	NOUN	I
during	O	ADP	O
cardiopulmonary	O	NOUN	B
bypass	O	NOUN	I
.	O	PUNCT	O


Striking	O	VERB	B
sequence	O	NOUN	I
similarities	O	NOUN	B
(	O	PUNCT	O
57	O	NUM	O
and	O	CCONJ	O
53	O	NUM	O
%	O	NOUN	O
)	O	PUNCT	O
were	O	AUX	O
observed	O	VERB	O
with	O	ADP	O
yeast	O	NOUN	B
mitochondrial	O	ADJ	B
proteins	O	NOUN	I
,	O	PUNCT	O
SMF1	B-GENE	NOUN	B
and	O	CCONJ	O
SMF2	B-GENE	NOUN	B
,	O	PUNCT	O
especially	O	ADV	O
within	O	ADP	O
putative	O	ADJ	O
functional	O	ADJ	O
domains	O	NOUN	O
:	O	PUNCT	O
exon	O	NOUN	B
6	O	NUM	O
encoding	O	VERB	B
the	O	DET	O
second	O	ADJ	O
transmembrane	O	ADJ	B
spanning	O	NOUN	I
domain	O	NOUN	I
,	O	PUNCT	O
site	O	NOUN	B
of	O	ADP	O
the	O	DET	O
murine	B-GENE	NOUN	B
susceptibility	I-GENE	NOUN	B
mutation	O	NOUN	O
;	O	PUNCT	O
and	O	CCONJ	O
exon	O	NOUN	B
11	O	NUM	O
encoding	O	VERB	B
a	O	DET	O
conserved	O	VERB	O
transport	O	NOUN	B
motif	O	NOUN	O
.	O	PUNCT	O


Furthermore	O	ADV	O
,	O	PUNCT	O
we	O	PRON	O
have	O	AUX	O
identified	O	VERB	B
a	O	DET	O
soluble	O	ADJ	B
form	O	NOUN	O
of	O	ADP	O
ERp57	B-GENE	NOUN	B
/	O	PUNCT	O
GRP58	B-GENE	NOUN	B
by	O	ADP	O
Western	O	NOUN	B
blotting	O	NOUN	I
and	O	CCONJ	O
biosynthetic	O	ADJ	B
labeling	O	NOUN	I
.	O	PUNCT	O


Consistent	O	ADJ	B
with	O	ADP	I
the	O	DET	O
hepatic	O	ADJ	B
and	O	CCONJ	O
epidermal	O	ADJ	B
expression	O	NOUN	I
of	O	ADP	O
histidase	B-GENE	NOUN	B
,	O	PUNCT	O
this	O	DET	O
finding	O	NOUN	O
suggests	O	VERB	O
that	O	SCONJ	O
histidase	B-GENE	NOUN	B
transcription	O	NOUN	I
may	O	AUX	O
be	O	AUX	O
regulated	O	VERB	O
by	O	ADP	O
these	O	DET	O
factors	O	NOUN	B
.	O	PUNCT	O


Unlike	O	ADP	O
ARF	B-GENE	PROPN	B
,	O	PUNCT	O
the	O	DET	O
ARP	B-GENE	PROPN	B
immunoreactivity	O	NOUN	B
was	O	AUX	O
detected	O	VERB	B
in	O	ADP	O
plasma	O	NOUN	B
membranes	O	NOUN	I
but	O	CCONJ	O
not	O	PART	O
in	O	ADP	O
cytosol	O	NOUN	B
of	O	ADP	O
fractionated	O	VERB	B
3T3	O	NOUN	I
-	O	PUNCT	O
L1	O	NOUN	B
cells	O	NOUN	I
.	O	PUNCT	O


An	O	DET	O
infectious	O	ADJ	B
origin	O	NOUN	I
should	O	AUX	O
always	O	ADV	O
be	O	AUX	O
excluded	O	VERB	O
since	O	SCONJ	O
specific	O	ADJ	O
etiologic	O	ADJ	B
therapy	O	NOUN	I
may	O	AUX	O
be	O	AUX	O
implemented	O	VERB	B
.	O	PUNCT	O


All	O	DET	O
three	O	NUM	O
NR	B-GENE	NOUN	B
isoforms	I-GENE	NOUN	B
are	O	AUX	O
expressed	O	VERB	B
in	O	ADP	O
cv	O	NOUN	B
.	O	PUNCT	O


All	O	DET	O
three	O	NUM	O
NR	B-GENE	NOUN	B
isoforms	O	NOUN	B
are	O	AUX	O
expressed	O	VERB	B
in	O	ADP	O
cv	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
Arabidopsis	B-GENE	NOUN	B
FAD7	I-GENE	NOUN	B
gene	I-GENE	NOUN	O
encodes	O	VERB	O
a	O	DET	O
chloroplast	B-GENE	NOUN	B
omega	I-GENE	NOUN	O
-	I-GENE	PUNCT	O
3	I-GENE	NUM	O
fatty	I-GENE	ADJ	B
acid	I-GENE	NOUN	I
desaturase	I-GENE	NOUN	I
that	O	PRON	O
catalyzes	O	VERB	B
the	O	DET	O
desaturation	O	NOUN	B
of	O	ADP	O
lipid	O	NOUN	B
-	O	PUNCT	O
linked	O	VERB	B
dienoic	O	ADJ	B
fatty	O	ADJ	I
acids	O	NOUN	I
(	O	PUNCT	O
18	O	NUM	O
:	O	PUNCT	O
2	O	NUM	O
and	O	CCONJ	O
16	O	NUM	O
:	O	PUNCT	O
2	O	NUM	O
)	O	PUNCT	O
.	O	PUNCT	O


Certain	O	ADJ	O
transcript	O	NOUN	B
patterns	O	NOUN	B
in	O	ADP	O
Epifagus	O	NOUN	B
plastids	O	NOUN	I
are	O	AUX	O
highly	O	ADV	O
complex	O	ADJ	B
and	O	CCONJ	O
similar	O	ADJ	O
to	O	PART	O
those	O	DET	O
of	O	ADP	O
tobacco	O	NOUN	B
operons	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
XS2	B-GENE	NOUN	B
gene	I-GENE	NOUN	I
down	O	ADV	I
-	O	PUNCT	O
regulates	O	VERB	B
but	O	CCONJ	O
does	O	AUX	O
not	O	PART	O
abolish	O	VERB	O
expression	O	NOUN	B
of	O	ADP	O
LU	B-GENE	NOUN	B
genes	I-GENE	NOUN	B
and	O	CCONJ	O
does	O	AUX	O
not	O	PART	O
affect	O	VERB	O
expression	O	NOUN	B
of	O	ADP	O
CD44	B-GENE	NOUN	B
.	O	PUNCT	O


Diabetes	O	NOUN	B
care	O	NOUN	I
:	O	PUNCT	O
a	O	DET	O
guideline	O	NOUN	B
to	O	ADP	O
the	O	DET	O
facilities	O	NOUN	B
needed	O	VERB	O
to	O	PART	O
support	O	VERB	O
internationally	O	ADV	B
endorsed	O	VERB	I
standards	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
gene	O	NOUN	B
was	O	AUX	O
uniquely	O	ADV	O
mapped	O	VERB	B
with	O	ADP	O
odds	O	NOUN	B
>	O	X	O
1	O	NUM	O
,	O	PUNCT	O
000	O	NUM	O
:	O	PUNCT	O
1	O	NUM	O
on	O	ADP	O
chromosome	O	NOUN	B
3p	O	NOUN	I
in	O	ADP	O
Centre	O	NOUN	O
d	O	X	O
'	O	PART	O
Etude	O	NOUN	O
du	O	X	O
Polymorphisme	O	PROPN	O
Humain	O	PROPN	O
pedigrees	O	NOUN	O
.	O	PUNCT	O


Human	B-GENE	ADJ	B
LAF	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
4	I-GENE	NUM	O
readily	O	ADV	O
hybridized	O	VERB	B
with	O	ADP	O
genes	O	NOUN	B
in	O	ADP	O
mouse	O	NOUN	B
and	O	CCONJ	O
chicken	O	NOUN	B
,	O	PUNCT	O
thus	O	ADV	O
showing	O	VERB	O
that	O	SCONJ	O
this	O	DET	O
gene	O	NOUN	B
family	O	NOUN	I
has	O	AUX	O
been	O	AUX	O
highly	O	ADV	O
conserved	O	VERB	O
during	O	ADP	O
vertebrate	O	NOUN	B
evolution	O	NOUN	B
.	O	PUNCT	O


Cycles	O	NOUN	B
were	O	AUX	O
repeated	O	VERB	O
every	O	DET	O
3	O	NUM	O
weeks	O	NOUN	B
.	O	PUNCT	O


Upstream	O	ADJ	B
of	O	ADP	O
-	O	PUNCT	O
37	O	NUM	O
,	O	PUNCT	O
the	O	DET	O
5	O	NUM	O
'	O	PART	O
untranslated	O	ADJ	B
sequences	O	NOUN	I
of	O	ADP	O
the	O	DET	O
isolates	O	NOUN	B
differ	O	VERB	O
in	O	ADP	O
both	O	CCONJ	O
length	O	NOUN	B
and	O	CCONJ	O
sequence	O	NOUN	B
.	O	PUNCT	O


SBF	B-GENE	NOUN	B
binds	O	VERB	B
to	O	PART	O
the	O	DET	O
promoter	O	NOUN	B
prior	O	ADV	O
to	O	PART	O
the	O	DET	O
activation	O	NOUN	B
of	O	ADP	O
transcription	O	NOUN	B
in	O	ADP	O
late	O	ADJ	O
G1	O	NOUN	O
,	O	PUNCT	O
suggesting	O	VERB	O
that	O	SCONJ	O
Cln	B-GENE	NOUN	B
/	O	PUNCT	O
Cdc28	B-GENE	NOUN	B
kinase	O	NOUN	I
regulates	O	VERB	B
the	O	DET	O
ability	O	NOUN	O
of	O	ADP	O
previously	O	ADV	O
bound	O	VERB	B
SBF	B-GENE	NOUN	B
to	O	PART	O
activate	O	VERB	B
transcription	O	NOUN	B
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
it	O	PRON	O
remains	O	VERB	O
an	O	DET	O
open	O	ADJ	O
question	O	NOUN	O
whether	O	SCONJ	O
vertebrate	B-GENE	ADJ	B
Hox	I-GENE	NOUN	B
genes	I-GENE	NOUN	I
expressed	O	VERB	B
under	O	ADP	O
the	O	DET	O
control	O	NOUN	B
of	O	ADP	O
Drosophila	O	X	B
regulatory	O	ADJ	B
sequences	O	NOUN	I
can	O	AUX	O
substitute	O	VERB	O
the	O	DET	O
function	O	NOUN	B
of	O	ADP	O
Drosophila	B-GENE	X	B
Hox	I-GENE	NOUN	B
genes	I-GENE	NOUN	I
.	O	PUNCT	O


This	O	DET	O
approach	O	NOUN	O
places	O	NOUN	O
gHoxb	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	O
into	O	ADP	O
the	O	DET	O
normal	O	ADJ	O
embryonic	O	ADJ	O
spatiotemporal	O	ADJ	O
context	O	NOUN	O
in	O	ADP	O
which	O	DET	O
lab	O	NOUN	B
acts	O	VERB	O
.	O	PUNCT	O


We	O	PRON	O
propose	O	VERB	O
that	O	SCONJ	O
CTS1	B-GENE	NOUN	B
and	I-GENE	CCONJ	O
CTS2	I-GENE	NOUN	B
of	I-GENE	ADP	O
Ci	I-GENE	NOUN	B
are	O	AUX	O
members	O	NOUN	B
of	O	ADP	O
two	O	NUM	O
distinct	O	ADJ	O
classes	O	NOUN	B
of	O	ADP	O
fungal	B-GENE	ADJ	B
chitinases	I-GENE	NOUN	I
,	O	PUNCT	O
an	O	DET	O
observation	O	NOUN	B
not	O	PART	O
previously	O	ADV	O
reported	O	VERB	O
for	O	ADP	O
a	O	DET	O
single	O	ADJ	O
fungus	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
purpose	O	NOUN	O
of	O	ADP	O
the	O	DET	O
study	O	NOUN	B
reported	O	VERB	O
here	O	ADV	O
was	O	AUX	O
to	O	PART	O
investigate	O	VERB	B
whether	O	SCONJ	O
differences	O	NOUN	B
in	O	ADP	O
T1	O	NOUN	B
and	O	CCONJ	O
T2	O	NOUN	B
between	O	ADP	O
tumors	O	NOUN	B
are	O	AUX	O
mainly	O	ADV	O
a	O	DET	O
consequence	O	NOUN	B
of	O	ADP	I
differences	O	NOUN	B
in	O	ADP	O
the	O	DET	O
fractional	O	ADJ	B
volume	O	NOUN	I
of	O	ADP	O
the	O	DET	O
extracellular	O	ADJ	B
compartment	O	NOUN	B
.	O	PUNCT	O


A	O	DET	O
mutant	B-GENE	ADJ	B
areA	I-GENE	NOUN	B
product	I-GENE	NOUN	I
truncated	O	VERB	I
immediately	O	ADV	O
after	O	ADP	O
the	O	DET	O
last	O	ADJ	O
residue	O	NOUN	B
of	O	ADP	O
the	O	DET	O
highly	O	ADV	O
conserved	O	VERB	O
GATA	B-GENE	NOUN	B
(	I-GENE	PUNCT	O
DNA	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
binding	I-GENE	VERB	B
)	I-GENE	PUNCT	O
domain	I-GENE	NOUN	O
retains	O	VERB	O
partial	O	ADJ	B
function	O	NOUN	I
.	O	PUNCT	O


This	O	DET	O
region	O	NOUN	B
contains	O	VERB	O
a	O	DET	O
motif	O	NOUN	B
with	O	ADP	O
partial	O	ADJ	B
identity	O	NOUN	B
with	O	ADP	O
the	O	DET	O
binding	O	VERB	B
site	O	NOUN	I
for	O	ADP	O
the	O	DET	O
ubiquitous	O	ADJ	O
transcription	O	NOUN	O
factor	O	NOUN	O
upstream	B-GENE	ADJ	O
stimulatory	I-GENE	ADJ	O
factor	I-GENE	NOUN	O
(	O	PUNCT	O
USF	B-GENE	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
which	O	DET	O
binds	O	VERB	B
to	O	PART	O
the	O	DET	O
human	B-GENE	ADJ	B
insulin	I-GENE	NOUN	O
promoter	I-GENE	NOUN	O
.	O	PUNCT	O


The	O	DET	O
Clb5	B-GENE	NOUN	B
kinase	I-GENE	NOUN	I
,	O	PUNCT	O
which	O	DET	O
promotes	O	VERB	B
S	O	NOUN	B
phase	O	NOUN	I
,	O	PUNCT	O
remains	O	VERB	O
active	O	ADJ	B
during	O	ADP	O
the	O	DET	O
G2	O	NOUN	B
-	O	PUNCT	O
phase	O	NOUN	B
arrest	O	NOUN	I
of	O	ADP	O
cells	O	NOUN	O
of	O	ADP	O
the	O	DET	O
parental	O	ADJ	B
strain	O	NOUN	I
,	O	PUNCT	O
but	O	CCONJ	O
its	O	PRON	O
activity	O	NOUN	B
declines	O	VERB	O
rapidly	O	ADV	O
in	O	ADP	O
sim	B-GENE	NOUN	B
mutants	I-GENE	NOUN	I
.	O	PUNCT	O


The	O	DET	O
C	O	PROPN	B
/	O	SYM	O
D	O	NOUN	B
ratio	O	NOUN	B
was	O	AUX	O
equal	O	ADJ	O
to	O	PART	O
or	O	CCONJ	O
over	O	ADP	O
0	O	NUM	O
.	O	PUNCT	O
6	O	NUM	O
in	O	ADP	O
9	O	NUM	O
cases	O	NOUN	B
(	O	PUNCT	O
16	O	NUM	O
eyes	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
and	O	CCONJ	O
the	O	DET	O
values	O	NOUN	B
were	O	AUX	O
inconsistent	O	ADJ	B
between	O	ADP	O
both	O	DET	O
eyes	O	NOUN	B
in	O	ADP	O
55	O	NUM	O
%	O	NOUN	O
of	O	ADP	O
the	O	DET	O
patients	O	NOUN	B
.	O	PUNCT	O


(	O	PUNCT	O
1989	O	NUM	O
)	O	PUNCT	O
,	O	PUNCT	O
which	O	DET	O
is	O	AUX	O
identical	O	ADJ	B
to	O	PART	O
the	O	DET	O
SSC1	B-GENE	NOUN	B
gene	I-GENE	NOUN	I
(	O	PUNCT	O
Smith	O	NOUN	O
et	O	X	O
al	O	X	O
.	O	PUNCT	O
,	O	PUNCT	O
1988	O	NUM	O
)	O	PUNCT	O
.	O	PUNCT	O


This	O	DET	O
region	O	NOUN	B
also	O	ADV	O
contains	O	VERB	O
a	O	DET	O
gene	O	NOUN	B
specifying	O	VERB	O
a	O	DET	O
Leu	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
tRNA	I-GENE	NOUN	B
precursor	I-GENE	NOUN	B
and	O	CCONJ	O
a	O	DET	O
remnant	O	NOUN	B
of	O	ADP	O
a	O	DET	O
tau	O	NOUN	B
element	O	NOUN	B
.	O	PUNCT	O


Occupational	O	ADJ	B
exposure	O	NOUN	O
to	O	PART	O
hepatitis	O	NOUN	B
B	O	NOUN	I
virus	O	NOUN	I
and	O	CCONJ	O
human	O	ADJ	B
immunodeficiency	O	NOUN	I
virus	O	NOUN	I
:	O	PUNCT	O
a	O	DET	O
comparative	O	ADJ	B
risk	O	NOUN	I
analysis	O	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
these	O	DET	O
constructs	O	NOUN	B
,	O	PUNCT	O
GUS	B-GENE	NOUN	B
expression	O	NOUN	B
was	O	AUX	O
driven	O	VERB	O
by	O	ADP	O
promoter	O	NOUN	B
regions	O	NOUN	I
derived	O	VERB	O
from	O	ADP	O
the	O	DET	O
Arabidopsis	B-GENE	NOUN	B
alcohol	I-GENE	NOUN	B
dehydrogenase	I-GENE	NOUN	I
(	O	PUNCT	O
Adh1	B-GENE	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
maize	B-GENE	NOUN	B
ubiquitin	I-GENE	NOUN	B
(	O	PUNCT	O
Ubi1	B-GENE	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
rice	B-GENE	NOUN	B
actin	I-GENE	NOUN	I
(	O	PUNCT	O
Act1	B-GENE	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
CaMV	B-GENE	NOUN	B
35S	I-GENE	NOUN	I
genes	I-GENE	NOUN	I
.	O	PUNCT	O


Its	O	PRON	O
organization	O	NOUN	B
and	O	CCONJ	O
regulation	O	NOUN	B
indicate	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
S	B-GENE	NOUN	B
.	I-GENE	PUNCT	O
pombe	I-GENE	X	B
URA1	I-GENE	NOUN	I
gene	I-GENE	NOUN	I
product	I-GENE	NOUN	O
appears	O	VERB	O
very	O	ADV	O
similar	O	ADJ	O
to	O	ADP	O
the	O	DET	O
S	B-GENE	NOUN	B
.	I-GENE	PUNCT	O
cerevisiae	I-GENE	X	B
URA2	I-GENE	NOUN	B
gene	I-GENE	NOUN	I
product	I-GENE	NOUN	O
.	O	PUNCT	O


(	O	PUNCT	O
ii	O	X	O
)	O	PUNCT	O
opening	O	NOUN	B
of	O	ADP	O
KATP	O	NOUN	B
attenuates	O	VERB	B
,	O	PUNCT	O
inhibition	O	NOUN	B
of	O	ADP	O
the	O	DET	O
channel	O	NOUN	B
exacerbates	O	VERB	O
functional	O	ADJ	B
consequences	O	NOUN	B
of	O	ADP	O
coronary	O	ADJ	B
occlusion	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
(	O	PUNCT	O
iii	O	X	O
)	O	PUNCT	O
KATP	O	NOUN	B
opening	O	NOUN	O
attenuates	O	VERB	B
reperfusion	O	NOUN	B
-	O	PUNCT	O
induced	O	VERB	B
VF	O	PROPN	B
,	O	PUNCT	O
but	O	CCONJ	O
it	O	PRON	O
triggers	O	VERB	O
ischemia	O	NOUN	B
-	O	PUNCT	O
induced	O	VERB	B
VF	O	PROPN	B
.	O	PUNCT	O


Effects	O	NOUN	B
of	O	ADP	I
repeated	O	VERB	O
exposures	O	NOUN	B
of	O	ADP	O
hydrogen	O	NOUN	B
sulphide	O	NOUN	I
on	O	ADP	O
rat	O	NOUN	B
hippocampal	O	NOUN	B
EEG	O	NOUN	B
.	O	PUNCT	O


Pseudomembranous	O	ADJ	B
conjunctivitis	O	NOUN	I
following	O	VERB	O
bone	O	NOUN	B
marrow	O	NOUN	I
transplantation	O	NOUN	I
:	O	PUNCT	O
immunopathological	O	ADJ	B
and	O	CCONJ	O
ultrastructural	O	ADJ	B
study	O	NOUN	I
of	O	ADP	O
one	O	NUM	O
case	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
view	O	NOUN	O
of	O	ADP	O
the	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
SECIS	O	NOUN	B
elements	O	NOUN	B
in	O	ADP	O
the	O	DET	O
open	O	ADJ	B
reading	O	NOUN	I
frames	O	NOUN	I
(	O	PUNCT	O
ORFs	O	NOUN	B
)	O	PUNCT	O
of	O	ADP	O
bacterial	B-GENE	ADJ	B
selenoproteins	I-GENE	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
examine	O	VERB	O
the	O	DET	O
effects	O	NOUN	B
in	O	ADP	O
the	O	DET	O
type	B-GENE	NOUN	B
1	I-GENE	NUM	I
deiodinase	I-GENE	NOUN	I
of	O	ADP	O
extending	O	VERB	O
the	O	DET	O
ORF	O	NOUN	B
into	O	ADP	O
the	O	DET	O
SECIS	O	NOUN	B
element	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
find	O	VERB	O
that	O	SCONJ	O
this	O	DET	O
dramatically	O	ADV	O
inhibits	O	VERB	B
SECIS	O	NOUN	B
function	O	NOUN	O
.	O	PUNCT	O


This	O	DET	O
spindle	O	NOUN	B
defect	O	NOUN	I
of	O	ADP	O
pds1	B-GENE	NOUN	B
mutants	I-GENE	NOUN	B
results	O	VERB	B
from	O	ADP	O
a	O	DET	O
temperature	O	NOUN	B
-	O	PUNCT	O
sensitive	O	ADJ	B
step	O	NOUN	O
that	O	PRON	O
occurs	O	VERB	O
around	O	ADP	O
the	O	DET	O
G1	O	NOUN	B
/	O	SYM	O
S	O	NOUN	B
boundary	O	NOUN	B
about	O	ADP	O
the	O	DET	O
time	O	NOUN	B
of	O	ADP	O
spindle	O	NOUN	B
assembly	O	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
the	O	DET	O
point	O	NOUN	B
mutant	O	NOUN	I
we	O	PRON	O
observed	O	VERB	O
normal	O	ADJ	O
repair	O	NOUN	O
of	O	ADP	O
endonuclease	B-GENE	NOUN	O
III	I-GENE	NUM	O
site	I-GENE	NOUN	O
(	O	PUNCT	O
i	O	X	O
.	O	PUNCT	O
e	O	X	O
.	O	PUNCT	O
as	O	ADP	O
wild	O	ADJ	B
type	O	NOUN	I
)	O	PUNCT	O
,	O	PUNCT	O
but	O	CCONJ	O
no	O	DET	O
removal	O	NOUN	B
of	O	ADP	O
CPDs	O	NOUN	B
at	O	ADP	O
the	O	DET	O
MAT	B-GENE	PROPN	B
alpha	I-GENE	NOUN	I
and	O	CCONJ	O
HML	B-GENE	NOUN	B
alpha	I-GENE	NOUN	I
loci	I-GENE	NOUN	I
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
for	O	ADP	O
the	O	DET	O
evaluable	O	ADJ	O
cases	O	NOUN	B
,	O	PUNCT	O
the	O	DET	O
performances	O	NOUN	B
of	O	ADP	O
the	O	DET	O
CD3500	O	NOUN	B
and	O	CCONJ	O
the	O	DET	O
STKS	O	NOUN	B
were	O	AUX	O
broadly	O	ADV	O
similar	O	ADJ	O
and	O	CCONJ	O
generally	O	ADV	O
correlated	O	VERB	B
well	O	ADV	O
with	O	ADP	O
the	O	DET	O
manual	O	ADJ	B
reference	O	NOUN	O
procedure	O	NOUN	O
.	O	PUNCT	O


In	O	ADP	O
conclusion	O	NOUN	O
,	O	PUNCT	O
IgM	B-GENE	NOUN	B
class	O	NOUN	O
CIC	O	NOUN	B
is	O	AUX	O
the	O	DET	O
predominant	O	ADJ	B
CIC	O	NOUN	B
in	O	ADP	O
acute	O	ADJ	B
hepatitis	O	NOUN	I
A	O	NOUN	I
and	O	CCONJ	O
correlated	O	VERB	B
with	O	ADP	O
disease	O	NOUN	B
activity	O	NOUN	I
.	O	PUNCT	O


Left	O	ADJ	B
atrial	O	ADJ	I
volumes	O	NOUN	I
were	O	AUX	O
greater	O	ADJ	O
in	O	ADP	O
old	O	ADJ	O
compared	O	VERB	B
with	O	ADP	O
young	O	ADJ	B
subjects	O	NOUN	I
(	O	PUNCT	O
maximal	O	ADJ	B
:	O	PUNCT	O
31	O	NUM	O
+	O	CCONJ	O
/	O	SYM	O
-	O	PUNCT	O
10	O	NUM	O
cm3	O	PROPN	B
/	O	SYM	O
m2	O	NOUN	B
vs	O	CCONJ	O
24	O	NUM	O
+	O	CCONJ	O
/	O	SYM	O
-	O	PUNCT	O
8	O	NUM	O
cm3	O	PROPN	B
/	O	SYM	O
m2	O	NOUN	B
,	O	PUNCT	O
p	O	NOUN	O
=	O	ADJ	O
0	O	NUM	O
.	O	PUNCT	O
02	O	NUM	O
;	O	PUNCT	O
at	O	ADP	O
onset	O	NOUN	O
of	O	ADP	O
atrial	O	ADJ	B
systole	O	NOUN	I
:	O	PUNCT	O
23	O	NUM	O
+	O	CCONJ	O
/	O	SYM	O
-	O	PUNCT	O
8	O	NUM	O
cm3	O	PROPN	B
/	O	SYM	O
m2	O	NOUN	B
vs	O	CCONJ	O
15	O	NUM	O
+	O	CCONJ	O
/	O	SYM	O
-	O	PUNCT	O
5	O	NUM	O
cm3	O	PROPN	B
/	O	SYM	O
m2	O	NOUN	B
,	O	PUNCT	O
p	O	NOUN	O
=	O	ADJ	O
0	O	NUM	O
.	O	PUNCT	O
0002	O	NUM	O
;	O	PUNCT	O
minimal	O	ADJ	B
:	O	PUNCT	O
13	O	NUM	O
+	O	CCONJ	O
/	O	SYM	O
-	O	PUNCT	O
5	O	NUM	O
cm3	O	PROPN	B
/	O	SYM	O
m2	O	NOUN	B
vs	O	CCONJ	O
9	O	NUM	O
+	O	CCONJ	O
/	O	SYM	O
-	O	PUNCT	O
4	O	NUM	O
cm3	O	PROPN	B
/	O	SYM	O
m2	O	NOUN	B
,	O	PUNCT	O
p	O	NOUN	O
=	O	ADJ	O
0	O	NUM	O
.	O	PUNCT	O
001	O	NUM	O
)	O	PUNCT	O
.	O	PUNCT	O


We	O	PRON	O
observed	O	VERB	O
abundant	O	ADJ	B
levels	O	NOUN	B
of	O	ADP	O
Rev	B-GENE	NOUN	B
-	O	PUNCT	O
erbA	B-GENE	NOUN	B
alpha	I-GENE	NOUN	O
mRNA	O	NOUN	B
in	O	ADP	O
dividing	O	VERB	O
C2C12	O	NOUN	B
myoblasts	O	NOUN	B
,	O	PUNCT	O
which	O	DET	O
were	O	AUX	O
suppressed	O	VERB	B
when	O	SCONJ	O
the	O	DET	O
cells	O	NOUN	B
differentiated	O	VERB	O
into	O	ADP	O
postmitotic	O	ADJ	B
multinucleated	O	ADJ	B
myotubes	O	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
then	O	ADV	O
demonstrated	O	VERB	O
that	O	SCONJ	O
1	O	X	O
)	O	PUNCT	O
GAL4	B-GENE	NOUN	B
-	O	PUNCT	O
REV	B-GENE	PROPN	B
-	O	PUNCT	O
erbA	B-GENE	NOUN	B
alpha	I-GENE	NOUN	B
chimeras	O	NOUN	I
that	O	PRON	O
contain	O	VERB	O
the	O	DET	O
'	O	PUNCT	O
AB	O	NOUN	O
'	O	PART	O
region	O	NOUN	O
and	O	CCONJ	O
lack	O	VERB	B
the	O	DET	O
'	O	PUNCT	O
E	O	PROPN	O
'	O	PART	O
region	O	NOUN	O
activated	O	VERB	B
transcription	O	NOUN	B
of	O	ADP	O
GAL4	B-GENE	NOUN	B
response	I-GENE	NOUN	O
elements	I-GENE	NOUN	O
in	O	ADP	O
the	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
8	O	NUM	O
-	O	PUNCT	O
Br	O	PROPN	B
-	O	PUNCT	O
cAMP	O	NOUN	B
and	O	CCONJ	O
2	O	NUM	O
)	O	PUNCT	O
the	O	DET	O
ligand	O	NOUN	B
-	O	PUNCT	O
binding	O	VERB	B
domain	O	NOUN	I
(	O	PUNCT	O
LBD	O	NOUN	B
)	O	PUNCT	O
contains	O	VERB	O
an	O	DET	O
active	O	ADJ	O
transcriptional	O	ADJ	B
silencer	O	NOUN	I
.	O	PUNCT	O


TNF	B-GENE	NOUN	B
Treatment	O	NOUN	B
of	O	ADP	O
cell	O	NOUN	B
activated	O	VERB	I
the	O	DET	O
p38	B-GENE	NOUN	B
MAP	I-GENE	NOUN	I
kinase	I-GENE	NOUN	I
pathway	O	NOUN	I
,	O	PUNCT	O
as	O	ADP	O
revealed	O	VERB	O
by	O	ADP	O
increased	O	VERB	B
phosphorylation	O	NOUN	B
of	O	ADP	O
p38	B-GENE	NOUN	B
MAP	I-GENE	NOUN	I
kinase	I-GENE	NOUN	I
itself	O	PRON	O
,	O	PUNCT	O
activation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
substrate	O	ADJ	B
protein	O	NOUN	I
MAPKAP	B-GENE	NOUN	B
kinase	I-GENE	NOUN	I
-	I-GENE	PUNCT	O
2	I-GENE	NUM	B
,	O	PUNCT	O
and	O	CCONJ	O
culminating	O	VERB	O
in	O	ADP	O
the	O	DET	O
phosphorylation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
heat	B-GENE	NOUN	B
shock	I-GENE	NOUN	I
protein	I-GENE	NOUN	I
27	I-GENE	NUM	I
(	O	PUNCT	O
hsp27	B-GENE	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
while	O	SCONJ	O
the	O	DET	O
sequence	O	NOUN	B
similarity	O	NOUN	B
between	O	ADP	O
the	O	DET	O
membrane	O	NOUN	B
exons	O	NOUN	I
of	O	ADP	O
avian	B-GENE	ADJ	B
mIgY	I-GENE	PROPN	B
and	O	CCONJ	O
mammalian	B-GENE	ADJ	B
mIgG	I-GENE	NOUN	B
and	I-GENE	CCONJ	O
IgE	I-GENE	NOUN	B
is	O	AUX	O
striking	O	ADJ	O
,	O	PUNCT	O
the	O	DET	O
overall	O	ADJ	O
similarity	O	NOUN	B
with	O	ADP	O
Xenopus	B-GENE	NOUN	B
mIgY	I-GENE	PROPN	I
is	O	AUX	O
very	O	ADV	O
low	O	ADJ	O
.	O	PUNCT	O


The	O	DET	O
novel	O	ADJ	O
hematopoietic	B-GENE	ADJ	B
growth	I-GENE	NOUN	I
factor	I-GENE	NOUN	I
FLT3	I-GENE	NOUN	B
ligand	I-GENE	NOUN	B
(	O	PUNCT	O
FL	B-GENE	NOUN	B
)	O	PUNCT	O
is	O	AUX	O
the	O	DET	O
cognate	O	ADJ	B
ligand	O	NOUN	B
for	O	ADP	O
the	O	DET	O
FLT3	B-GENE	NOUN	B
,	O	PUNCT	O
tyrosine	B-GENE	NOUN	B
kinase	I-GENE	NOUN	I
receptor	I-GENE	NOUN	I
(	O	PUNCT	O
R	B-GENE	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
also	O	ADV	O
referred	O	VERB	O
to	O	PART	O
as	O	ADP	O
FLK	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
2	I-GENE	NUM	B
and	O	CCONJ	O
STK	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	O
.	O	PUNCT	O


In	O	ADP	O
contrast	O	NOUN	O
to	O	PART	O
the	O	DET	O
selective	O	ADJ	O
expression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
receptor	O	NOUN	B
,	O	PUNCT	O
FL	B-GENE	NOUN	B
expression	O	NOUN	B
was	O	AUX	O
detected	O	VERB	B
in	O	ADP	O
90	O	NUM	O
-	O	SYM	O
100	O	NUM	O
%	O	NOUN	O
of	O	ADP	O
the	O	DET	O
various	O	ADJ	O
cell	O	NOUN	B
types	O	NOUN	I
of	O	ADP	O
leukemia	O	NOUN	B
cell	O	NOUN	B
lines	O	NOUN	I
from	O	ADP	O
all	O	DET	O
hematopoietic	O	ADJ	B
cell	O	NOUN	I
lineages	O	NOUN	O
.	O	PUNCT	O


LY290181	O	NOUN	B
appears	O	VERB	O
to	O	PART	O
inhibit	O	VERB	B
uPA	B-GENE	NOUN	B
promoter	I-GENE	NOUN	B
activation	O	NOUN	I
by	O	ADP	O
blocking	O	VERB	B
phorbol	O	NOUN	B
ester	O	NOUN	I
-	O	PUNCT	O
stimulated	O	VERB	B
binding	O	NOUN	B
of	O	ADP	O
nuclear	O	ADJ	B
proteins	O	NOUN	I
to	O	PART	O
the	O	DET	O
uPA	B-GENE	NOUN	B
PEA3	B-GENE	NOUN	B
/	O	SYM	O
12	O	NUM	B
-	O	PUNCT	O
0	O	NUM	O
-	O	PUNCT	O
tetradecanoylphorbol	O	NOUN	B
13	O	NUM	I
-	O	PUNCT	O
acetate	O	NOUN	B
responsive	O	ADJ	I
element	O	NOUN	I
(	O	PUNCT	O
TRE	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


The	O	DET	O
protein	O	NOUN	B
folds	O	VERB	I
correctly	O	ADV	O
with	O	ADP	O
two	O	NUM	O
disulfide	O	NOUN	B
bonds	O	NOUN	I
and	O	CCONJ	O
a	O	DET	O
free	O	ADJ	B
thiol	O	NOUN	O
group	O	NOUN	O
at	O	ADP	O
Cys25	O	NOUN	B
.	O	PUNCT	O


No	O	DET	B
significant	O	ADJ	I
differences	O	NOUN	O
existed	O	VERB	O
between	O	ADP	O
the	O	DET	O
two	O	NUM	O
age	O	NOUN	B
groups	O	NOUN	I
in	O	ADP	O
baseline	O	NOUN	B
characteristics	O	NOUN	B
,	O	PUNCT	O
including	O	VERB	O
treatment	O	NOUN	B
protocol	O	NOUN	I
,	O	PUNCT	O
performance	O	NOUN	B
status	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
serum	B-GENE	NOUN	B
lactate	I-GENE	NOUN	I
dehydrogenase	I-GENE	NOUN	I
(	O	PUNCT	O
LDH	B-GENE	NOUN	B
)	O	PUNCT	O
level	O	NOUN	B
.	O	PUNCT	O


Conversely	O	ADV	O
,	O	PUNCT	O
when	O	SCONJ	O
VDR	B-GENE	NOUN	B
is	O	AUX	O
overexpressed	O	VERB	B
,	O	PUNCT	O
vitamin	O	NOUN	B
D3	O	NOUN	I
attenuates	O	VERB	B
9	O	NUM	O
-	O	PUNCT	O
cis	O	NOUN	B
RA	O	NOUN	B
induction	O	NOUN	B
from	O	ADP	O
an	O	DET	O
RXR	B-GENE	NOUN	B
-	O	PUNCT	O
responsive	O	ADJ	B
element	O	NOUN	B
.	O	PUNCT	O


Mutations	O	NOUN	B
within	O	ADP	O
conserved	O	VERB	B
region	O	NOUN	I
2	O	NUM	I
(	O	PUNCT	O
CR2	O	NOUN	B
)	O	PUNCT	O
of	O	ADP	O
E1A	B-GENE	NOUN	B
that	O	PRON	O
inhibit	O	VERB	B
the	O	DET	O
binding	O	NOUN	B
of	O	ADP	O
E1A	B-GENE	NOUN	B
to	O	PART	O
the	O	DET	O
retinoblastoma	B-GENE	NOUN	B
gene	I-GENE	NOUN	I
product	I-GENE	NOUN	I
(	O	PUNCT	O
pRb	B-GENE	NOUN	B
)	O	PUNCT	O
further	O	ADV	O
enhanced	O	VERB	B
the	O	DET	O
stimulation	O	NOUN	B
of	O	ADP	O
transcription	O	NOUN	B
from	O	ADP	O
the	O	DET	O
PEPCK	B-GENE	NOUN	B
promoter	I-GENE	NOUN	B
by	O	ADP	O
2	O	NUM	O
3	O	NUM	O
-	O	PUNCT	O
fold	O	NOUN	B
compared	O	VERB	B
with	O	ADP	O
wild	B-GENE	ADJ	B
type	I-GENE	NOUN	I
E1A	I-GENE	NOUN	B
.	O	PUNCT	O


Using	O	VERB	O
autoantibodies	O	NOUN	B
from	O	ADP	O
a	O	DET	O
Sjogren	O	NOUN	B
'	O	PART	O
s	O	NOUN	O
syndrome	O	NOUN	B
patient	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
have	O	AUX	O
previously	O	ADV	O
identified	O	VERB	B
a	O	DET	O
230	O	NUM	O
-	O	PUNCT	O
kDa	O	NOUN	B
peripheral	O	ADJ	B
membrane	O	NOUN	I
protein	O	NOUN	I
associated	O	VERB	B
with	O	ADP	I
the	O	DET	O
cytosolic	O	ADJ	B
face	O	NOUN	O
of	O	ADP	O
the	O	DET	O
trans	O	ADJ	B
-	O	PUNCT	O
Golgi	O	PROPN	B
(	O	PUNCT	O
Kooy	O	PROPN	O
,	O	PUNCT	O
J	O	PROPN	O
.	O	PUNCT	O
,	O	PUNCT	O
Toh	O	NOUN	B
,	O	PUNCT	O
B	O	NOUN	B
.	O	PUNCT	O


Apart	O	ADV	O
from	O	ADP	O
two	O	NUM	O
proline	O	NOUN	B
-	O	PUNCT	O
rich	O	ADJ	B
regions	O	NOUN	I
(	O	PUNCT	O
amino	O	NOUN	B
acids	O	NOUN	I
1	O	NUM	I
-	O	SYM	O
117	O	NUM	O
and	O	CCONJ	O
239	O	NUM	O
-	O	SYM	O
270	O	NUM	O
)	O	PUNCT	O
,	O	PUNCT	O
p230	B-GENE	NOUN	B
contains	O	VERB	O
a	O	DET	O
very	O	ADV	O
high	O	ADJ	O
frequency	O	NOUN	B
of	O	ADP	O
heptad	O	NOUN	B
repeats	O	NOUN	I
,	O	PUNCT	O
characteristic	O	ADJ	O
of	O	ADP	O
alpha	O	NOUN	B
-	O	PUNCT	O
helices	O	NOUN	B
that	O	PRON	O
form	O	VERB	O
dimeric	O	ADJ	B
coiled	O	VERB	B
-	O	PUNCT	O
coil	O	NOUN	B
structures	O	NOUN	B
.	O	PUNCT	O
p230	B-GENE	NOUN	B
also	O	ADV	O
includes	O	VERB	O
the	O	DET	O
sequence	O	NOUN	B
ESLALEELEL	O	NOUN	I
(	O	PUNCT	O
amino	O	NOUN	B
acids	O	NOUN	I
538	O	NUM	O
-	O	SYM	O
546	O	NUM	O
)	O	PUNCT	O
,	O	PUNCT	O
a	O	DET	O
motif	O	NOUN	B
found	O	VERB	O
in	O	ADP	O
the	O	DET	O
granin	B-GENE	NOUN	B
family	I-GENE	NOUN	B
of	O	ADP	O
acidic	O	ADJ	B
proteins	O	NOUN	I
present	O	ADJ	O
in	O	ADP	O
secretory	O	ADJ	B
granules	O	NOUN	I
of	O	ADP	O
neuroendocrine	O	ADJ	B
cells	O	NOUN	I
.	O	PUNCT	O


They	O	PRON	O
were	O	AUX	O
found	O	VERB	O
to	O	PART	O
stimulate	O	VERB	B
at	O	ADP	O
nanomolar	O	ADJ	B
concentrations	O	NOUN	B
the	O	DET	O
turnover	O	NOUN	B
of	O	ADP	O
biosynthetically	O	ADV	B
labeled	O	VERB	O
ceramide	O	NOUN	B
,	O	PUNCT	O
glucosylceramide	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
lactosylceramide	O	NOUN	B
.	O	PUNCT	O


These	O	DET	O
findings	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
increase	O	NOUN	B
in	O	ADP	O
V	O	NOUN	B
O2	O	NOUN	B
may	O	AUX	O
have	O	AUX	O
been	O	AUX	O
a	O	DET	O
consequence	O	NOUN	B
of	O	ADP	I
the	O	DET	O
increase	O	NOUN	B
in	O	ADP	O
Q	O	NOUN	B
O2	O	NOUN	I
rather	O	ADV	O
than	O	ADP	O
a	O	DET	O
response	O	NOUN	B
to	O	ADP	O
the	O	DET	O
procedure	O	NOUN	B
itself	O	PRON	O
.	O	PUNCT	O


Consistent	O	ADJ	B
with	O	ADP	I
ErbB	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
2	I-GENE	NUM	O
being	O	AUX	O
a	O	DET	O
shared	O	VERB	O
receptor	O	NOUN	O
subunit	O	NOUN	O
,	O	PUNCT	O
its	O	PRON	O
tyrosine	O	NOUN	B
phosphorylation	O	NOUN	B
was	O	AUX	O
increased	O	VERB	B
by	O	ADP	O
both	O	CCONJ	O
heterologous	O	ADJ	B
ligands	O	NOUN	B
and	O	CCONJ	O
it	O	PRON	O
mediated	O	VERB	O
a	O	DET	O
trans	O	ADJ	B
-	O	PUNCT	O
inhibitory	O	ADJ	B
effect	O	NOUN	B
of	O	ADP	O
NDF	B-GENE	NOUN	B
on	O	ADP	O
EGF	B-GENE	NOUN	B
binding	O	NOUN	I
.	O	PUNCT	O


Identification	O	NOUN	B
of	O	ADP	O
a	O	DET	O
consensus	O	NOUN	B
cyclin	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
dependent	I-GENE	ADJ	B
kinase	I-GENE	NOUN	B
phosphorylation	I-GENE	NOUN	B
site	I-GENE	NOUN	O
unique	O	ADJ	B
to	O	PART	O
the	O	DET	O
nuclear	O	ADJ	B
form	O	NOUN	I
of	O	ADP	O
human	B-GENE	ADJ	B
deoxyuridine	I-GENE	NOUN	B
triphosphate	I-GENE	NOUN	I
nucleotidohydrolase	I-GENE	NOUN	I
.	O	PUNCT	O


VDR	B-GENE	NOUN	B
/	O	SYM	O
RXR	B-GENE	NOUN	B
bound	O	VERB	B
well	O	ADV	O
to	O	ADP	O
the	O	DET	O
VDREs	O	NOUN	B
and	O	CCONJ	O
to	O	PART	O
DR4	O	NOUN	B
and	O	CCONJ	O
DR5	O	NOUN	B
using	O	VERB	O
the	O	DET	O
electrophoretic	O	ADJ	B
mobility	O	NOUN	I
shift	O	NOUN	I
assay	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
sequence	O	NOUN	B
and	O	CCONJ	O
isolated	O	VERB	B
cDNAs	O	NOUN	B
will	O	AUX	O
provide	O	VERB	O
useful	O	ADJ	O
reagents	O	NOUN	B
for	O	ADP	O
studying	O	VERB	O
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
Brca1	B-GENE	NOUN	B
in	O	ADP	O
the	O	DET	O
mouse	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
for	O	ADP	O
testing	O	VERB	B
the	O	DET	O
importance	O	NOUN	O
of	O	ADP	O
the	O	DET	O
evolutionarily	O	ADV	O
conserved	O	VERB	O
domains	O	NOUN	O
.	O	PUNCT	O


A	O	DET	O
study	O	NOUN	B
was	O	AUX	O
performed	O	VERB	O
to	O	PART	O
compare	O	VERB	B
the	O	DET	O
ONLINE	O	PROPN	B
and	O	CCONJ	O
EMIT	O	NOUN	B
II	O	NUM	I
immunoassays	O	NOUN	I
with	O	ADP	O
gas	O	NOUN	B
chromatographic	O	ADJ	I
/	O	SYM	O
mass	O	ADJ	B
spectrometric	O	ADJ	I
(	O	PUNCT	O
GC	O	NOUN	B
/	O	SYM	O
MS	O	NOUN	B
)	O	PUNCT	O
analysis	O	NOUN	B
of	O	ADP	O
methaqualone	O	NOUN	B
metabolites	O	NOUN	B
on	O	ADP	O
urine	O	NOUN	B
using	O	VERB	O
samples	O	NOUN	B
obtained	O	VERB	O
from	O	ADP	O
a	O	DET	O
clinical	O	ADJ	B
study	O	NOUN	I
.	O	PUNCT	O


Isolation	O	NOUN	B
by	O	ADP	O
PCR	O	NOUN	B
of	O	ADP	O
a	O	DET	O
cDNA	O	NOUN	B
clone	O	NOUN	B
from	O	ADP	O
pea	O	NOUN	B
petals	O	NOUN	I
with	O	ADP	O
similarity	O	NOUN	B
to	O	PART	O
petunia	O	NOUN	B
and	O	CCONJ	O
wheat	B-GENE	NOUN	B
zinc	I-GENE	NOUN	B
finger	I-GENE	NOUN	I
proteins	I-GENE	NOUN	I
.	O	PUNCT	O


Exposure	O	NOUN	B
of	O	ADP	O
peripheral	O	ADJ	B
blood	O	NOUN	I
T	O	NOUN	I
cells	O	NOUN	I
from	O	ADP	O
young	O	ADJ	B
subjects	O	NOUN	I
to	O	PART	O
PHA	B-GENE	NOUN	B
or	O	CCONJ	O
cross	O	NOUN	B
-	O	PUNCT	O
linked	O	VERB	B
anti	B-GENE	ADJ	B
-	I-GENE	PUNCT	O
CD3	I-GENE	NOUN	B
monoclonal	I-GENE	ADJ	B
antibodies	I-GENE	NOUN	I
stimulated	O	VERB	O
rapid	O	ADJ	O
increases	O	NOUN	B
in	O	ADP	O
MAPK	B-GENE	NOUN	B
and	O	CCONJ	O
MEK	B-GENE	NOUN	B
enzymatic	O	ADJ	B
activity	O	NOUN	I
.	O	PUNCT	O


Deletion	O	NOUN	B
analysis	O	NOUN	I
of	O	ADP	O
rOC	B-GENE	NOUN	B
promoter	I-GENE	NOUN	B
-	O	PUNCT	O
chloramphenicol	B-GENE	NOUN	B
acetyltransferase	I-GENE	NOUN	B
constructs	O	NOUN	O
demonstrates	O	VERB	O
that	O	SCONJ	O
an	O	DET	O
AML	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	B
-	I-GENE	PUNCT	O
binding	I-GENE	VERB	B
sequence	I-GENE	NOUN	O
within	O	ADP	O
the	O	DET	O
proximal	O	ADJ	B
promoter	O	NOUN	O
(	O	PUNCT	O
-	O	PUNCT	O
138	O	NUM	O
to	O	ADP	O
-	O	PUNCT	O
130	O	NUM	O
nt	O	NOUN	O
)	O	PUNCT	O
contributes	O	VERB	O
to	O	PART	O
75	O	NUM	O
%	O	NOUN	O
of	O	ADP	O
the	O	DET	O
level	O	NOUN	B
of	O	ADP	O
osteocalcin	B-GENE	NOUN	B
gene	I-GENE	NOUN	B
expression	O	NOUN	I
.	O	PUNCT	O


Escherichia	O	X	B
coli	O	X	I
BL21	O	X	I
(	O	PUNCT	O
DE3	O	NOUN	O
)	O	PUNCT	O
plysS	O	NOUN	O
,	O	PUNCT	O
harbouring	O	VERB	O
a	O	DET	O
recombinant	O	ADJ	B
plasmid	O	NOUN	I
containing	O	VERB	O
the	O	DET	O
catalase	B-GENE	NOUN	B
-	O	PUNCT	O
peroxidase	B-GENE	NOUN	B
gene	O	NOUN	I
,	O	PUNCT	O
produced	O	VERB	O
a	O	DET	O
large	O	ADJ	O
amount	O	NOUN	O
of	O	ADP	O
proteins	O	NOUN	B
that	O	PRON	O
co	O	ADV	B
-	O	PUNCT	O
migrated	O	VERB	B
on	O	ADP	O
SDS	O	NOUN	B
/	O	SYM	O
PAGE	O	NOUN	B
with	O	ADP	O
the	O	DET	O
native	O	ADJ	B
enzyme	O	NOUN	B
.	O	PUNCT	O


Cdk2	B-GENE	NOUN	B
formed	O	VERB	O
a	O	DET	O
complex	O	NOUN	B
with	O	ADP	O
cyclin	B-GENE	NOUN	B
D1	I-GENE	NOUN	I
in	O	ADP	O
this	O	DET	O
system	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
Cdk2	B-GENE	NOUN	B
-	O	PUNCT	O
cyclin	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
D1	I-GENE	NOUN	B
complex	O	NOUN	B
did	O	AUX	O
not	O	PART	O
phosphorylate	O	VERB	B
any	O	DET	O
tested	O	VERB	B
substrates	O	NOUN	B
,	O	PUNCT	O
such	O	ADJ	O
as	O	ADP	O
H1	B-GENE	NOUN	B
histone	I-GENE	NOUN	B
,	O	PUNCT	O
pRB	B-GENE	NOUN	B
,	O	PUNCT	O
SV40	B-GENE	NOUN	B
large	I-GENE	ADJ	O
T	I-GENE	NOUN	O
antigen	I-GENE	NOUN	O
,	O	PUNCT	O
p53	B-GENE	NOUN	B
,	O	PUNCT	O
E2F	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	O
or	O	CCONJ	O
a	O	DET	O
preparation	O	NOUN	B
of	O	ADP	O
nuclear	O	ADJ	B
proteins	O	NOUN	I
from	O	ADP	O
HeLa	O	NOUN	B
cells	O	NOUN	I
;	O	PUNCT	O
in	O	ADP	O
contrast	O	NOUN	O
,	O	PUNCT	O
Cdk2	B-GENE	NOUN	B
-	O	PUNCT	O
cyclin	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
E	I-GENE	NOUN	B
and	O	CCONJ	O
Cdk2	B-GENE	NOUN	B
-	O	PUNCT	O
cyclin	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
A	I-GENE	NOUN	B
phosphorylated	O	ADJ	B
these	O	DET	O
proteins	O	NOUN	B
.	O	PUNCT	O


Cyclin	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
dependent	I-GENE	ADJ	B
kinase	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
2	I-GENE	NUM	B
(	O	PUNCT	O
Cdk2	B-GENE	NOUN	B
)	O	PUNCT	O
forms	O	VERB	O
an	O	DET	O
inactive	O	ADJ	B
complex	O	NOUN	B
with	O	ADP	O
cyclin	B-GENE	NOUN	B
D1	I-GENE	NOUN	I
since	O	SCONJ	O
Cdk2	B-GENE	NOUN	B
associated	O	VERB	B
with	O	ADP	I
cyclin	B-GENE	NOUN	B
D1	I-GENE	NOUN	I
is	O	AUX	O
not	O	PART	O
phosphorylated	O	VERB	B
by	O	ADP	O
Cdk7	B-GENE	NOUN	B
-	O	PUNCT	O
cyclin	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
H	I-GENE	NOUN	B
.	O	PUNCT	O


A	O	DET	O
human	O	ADJ	B
cytoplasmic	O	ADJ	O
signaling	O	NOUN	O
protein	O	NOUN	O
has	O	AUX	O
been	O	AUX	O
cloned	O	VERB	B
that	O	PRON	O
possesses	O	VERB	O
the	O	DET	O
same	O	ADJ	O
structural	O	ADJ	B
arrangement	O	NOUN	I
of	O	ADP	O
SH3	B-GENE	NOUN	B
-	O	PUNCT	O
SH2	B-GENE	NOUN	B
-	O	PUNCT	O
SH3	B-GENE	NOUN	B
domains	O	NOUN	O
as	O	ADP	O
Grb2	B-GENE	NOUN	B
.	O	PUNCT	O


Cloning	O	NOUN	B
of	O	ADP	O
individual	O	ADJ	B
ZI	O	NOUN	B
domains	O	NOUN	I
upstream	O	ADJ	B
of	O	ADP	O
a	O	DET	O
minimal	O	ADJ	B
promoter	O	NOUN	B
demonstrated	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
ZIA	O	NOUN	B
,	O	PUNCT	O
ZIC	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
ZID	O	NOUN	B
domains	O	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
not	O	PART	O
the	O	DET	O
ZIB	O	NOUN	B
domain	O	NOUN	I
,	O	PUNCT	O
are	O	AUX	O
TPA	O	NOUN	B
responsive	O	ADJ	B
.	O	PUNCT	O


Sp1	B-GENE	NOUN	B
binds	O	VERB	B
two	O	NUM	O
sites	O	NOUN	B
in	O	ADP	O
the	O	DET	O
CD11c	B-GENE	NOUN	B
promoter	I-GENE	NOUN	B
in	O	X	B
vivo	O	X	I
specifically	O	ADV	O
in	O	ADP	O
myeloid	O	ADJ	B
cells	O	NOUN	I
and	O	CCONJ	O
cooperates	O	VERB	B
with	O	ADP	O
AP1	B-GENE	NOUN	B
to	O	PART	O
activate	O	VERB	B
transcription	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
found	O	VERB	O
that	O	SCONJ	O
120	O	NUM	O
bp	O	NOUN	O
of	O	ADP	O
the	O	DET	O
enhancer	O	NOUN	B
'	O	PART	O
s	O	NOUN	O
transcriptional	O	ADJ	B
core	O	NOUN	I
becomes	O	VERB	O
DNase	B-GENE	NOUN	B
I	I-GENE	NUM	I
hypersensitive	O	ADJ	B
early	O	ADV	B
in	O	ADP	O
B	O	NOUN	B
-	O	PUNCT	O
cell	O	NOUN	B
development	O	NOUN	B
.	O	PUNCT	O


A	O	DET	O
developmentally	O	ADV	O
modulated	O	VERB	B
chromatin	O	NOUN	B
structure	O	NOUN	I
at	O	ADP	O
the	O	DET	O
mouse	B-GENE	NOUN	B
immunoglobulin	I-GENE	NOUN	O
kappa	I-GENE	NOUN	O
3	I-GENE	NUM	O
'	I-GENE	PART	O
enhancer	I-GENE	NOUN	B
.	O	PUNCT	O


Heme	B-GENE	NOUN	B
oxygenase	I-GENE	NOUN	I
1	I-GENE	NUM	I
is	O	AUX	O
an	O	DET	O
essential	O	ADJ	O
enzyme	O	NOUN	B
in	O	ADP	O
heme	O	NOUN	B
catabolism	O	NOUN	I
that	O	PRON	O
cleaves	O	VERB	B
heme	O	NOUN	B
to	O	PART	O
form	O	VERB	O
biliverdin	O	NOUN	B
,	O	PUNCT	O
iron	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
carbon	O	NOUN	B
monoxide	O	NOUN	I
.	O	PUNCT	O


An	O	DET	O
inactive	O	ADJ	B
analog	O	NOUN	B
of	O	ADP	O
wortmannin	O	NOUN	B
,	O	PUNCT	O
WM12	O	NOUN	B
,	O	PUNCT	O
did	O	AUX	O
not	O	PART	O
affect	O	VERB	O
TCR	B-GENE	NOUN	B
/	O	PUNCT	O
CD3	B-GENE	NOUN	B
-	O	PUNCT	O
induced	O	VERB	B
Erk2	B-GENE	NOUN	B
activation	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
wortmannin	O	NOUN	B
had	O	AUX	O
no	O	DET	B
effect	O	NOUN	I
on	O	ADP	O
the	O	DET	O
activity	O	NOUN	B
of	O	ADP	O
Erk2	B-GENE	NOUN	B
when	O	SCONJ	O
added	O	VERB	O
directly	O	ADV	O
to	O	ADP	O
the	O	DET	O
in	O	X	B
vitro	O	X	I
assays	O	NOUN	I
.	O	PUNCT	O


Defects	O	NOUN	B
in	O	ADP	O
the	O	DET	O
Schizosaccharomyces	O	X	B
pombe	O	X	I
(	O	PUNCT	O
Sp	O	NOUN	O
)	O	PUNCT	O
cell	O	NOUN	O
cycle	O	NOUN	O
-	O	PUNCT	O
controlling	O	VERB	B
genes	O	NOUN	B
prevent	O	VERB	B
the	O	DET	O
cell	O	NOUN	B
cycle	O	NOUN	I
progression	O	NOUN	I
.	O	PUNCT	O


To	O	PART	O
determine	O	VERB	O
the	O	DET	O
signal	B-GENE	NOUN	B
recognition	I-GENE	NOUN	I
particle	I-GENE	NOUN	I
(	O	PUNCT	O
SRP	B-GENE	NOUN	B
)	O	PUNCT	O
-	O	PUNCT	O
SRP	B-GENE	NOUN	B
receptor	I-GENE	NOUN	I
(	O	PUNCT	O
Srb	B-GENE	NOUN	B
)	O	PUNCT	O
system	O	NOUN	O
in	O	ADP	O
Bacillus	O	X	B
subtilis	O	X	I
(	O	PUNCT	O
Bs	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
we	O	PRON	O
cloned	O	VERB	B
the	O	DET	O
Bs	B-GENE	NOUN	B
srb	I-GENE	NOUN	I
gene	I-GENE	NOUN	I
,	O	PUNCT	O
which	O	DET	O
encodes	O	VERB	B
a	O	DET	O
homologue	O	NOUN	B
of	O	ADP	O
the	O	DET	O
mammalian	B-GENE	ADJ	B
SRP	I-GENE	NOUN	B
receptor	I-GENE	NOUN	I
alpha	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
subunit	I-GENE	NOUN	B
[	O	PUNCT	O
Oguro	O	PROPN	O
et	O	X	O
al	O	X	O
.	O	PUNCT	O
,	O	PUNCT	O
DNA	O	NOUN	B
Res	O	NOUN	I
.	O	PUNCT	O


Promoter	O	NOUN	B
activity	O	NOUN	I
was	O	AUX	O
high	O	ADJ	O
in	O	ADP	O
cell	O	NOUN	B
lines	O	NOUN	I
that	O	PRON	O
expressed	O	VERB	B
high	O	ADJ	O
levels	O	NOUN	B
of	O	ADP	O
endogenous	O	ADJ	B
D3	B-GENE	NOUN	B
mRNA	I-GENE	NOUN	B
,	O	PUNCT	O
as	O	ADP	O
indicated	O	VERB	O
by	O	ADP	O
Northern	O	NOUN	B
blot	O	NOUN	I
analyses	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
was	O	AUX	O
significantly	O	ADV	O
reduced	O	VERB	B
when	O	SCONJ	O
the	O	DET	O
promoter	O	NOUN	B
was	O	AUX	O
truncated	O	VERB	B
to	O	PART	O
-	O	PUNCT	O
122	O	NUM	O
bp	O	NOUN	B
.	O	PUNCT	O


This	O	DET	O
phenomenon	O	NOUN	B
did	O	AUX	O
not	O	PART	O
require	O	VERB	O
DNA	O	NOUN	B
binding	O	NOUN	I
by	O	ADP	O
the	O	DET	O
"	O	PUNCT	O
interfering	O	VERB	B
"	O	PUNCT	O
receptor	O	NOUN	B
but	O	CCONJ	O
required	O	VERB	O
it	O	PRON	O
to	O	PART	O
be	O	AUX	O
hormone	O	NOUN	B
-	O	PUNCT	O
bound	O	VERB	B
,	O	PUNCT	O
indicating	O	VERB	O
that	O	SCONJ	O
a	O	DET	O
transcriptionally	O	ADV	B
active	O	ADJ	O
form	O	NOUN	O
of	O	ADP	O
the	O	DET	O
interfering	O	VERB	B
receptor	O	NOUN	I
is	O	AUX	O
essential	O	ADJ	O
for	O	ADP	O
the	O	DET	O
interfering	O	VERB	B
effect	O	NOUN	I
.	O	PUNCT	O


A	O	DET	O
cis	O	ADV	B
-	O	PUNCT	O
acting	O	VERB	B
DNA	O	NOUN	B
element	O	NOUN	I
located	O	ADJ	O
between	O	ADP	O
TATA	O	NOUN	B
box	O	NOUN	O
and	O	CCONJ	O
transcription	O	NOUN	B
initiation	O	NOUN	I
site	O	NOUN	I
is	O	AUX	O
critical	O	ADJ	O
in	O	ADP	O
response	O	NOUN	B
to	O	PART	O
regulatory	O	ADJ	B
sequences	O	NOUN	I
in	O	ADP	O
human	O	ADJ	B
angiotensinogen	B-GENE	NOUN	B
gene	I-GENE	NOUN	I
.	O	PUNCT	O


The	O	DET	O
promoter	O	NOUN	B
of	O	ADP	O
the	O	DET	O
rat	B-GENE	NOUN	B
PGS	I-GENE	PROPN	B
-	I-GENE	PUNCT	O
2	I-GENE	NUM	O
gene	I-GENE	NOUN	B
contains	O	VERB	O
a	O	DET	O
CAAT	B-GENE	NOUN	B
enhancer	I-GENE	NOUN	I
-	I-GENE	PUNCT	O
binding	I-GENE	VERB	B
protein	I-GENE	NOUN	I
consensus	I-GENE	NOUN	O
site	I-GENE	NOUN	O
(	I-GENE	PUNCT	O
CAAT	I-GENE	NOUN	B
box	I-GENE	NOUN	I
)	I-GENE	PUNCT	O
which	O	DET	O
can	O	AUX	O
confer	O	VERB	O
hormone	O	NOUN	B
inducibility	O	NOUN	B
to	O	PART	O
a	O	DET	O
PGS	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
2	I-GENE	NUM	B
.	O	PUNCT	O
CAT	B-GENE	NOUN	B
reporter	O	NOUN	I
gene	O	NOUN	I
,	O	PUNCT	O
as	O	ADV	O
well	O	ADV	O
as	O	ADP	O
a	O	DET	O
putative	O	ADJ	B
E	O	NOUN	I
-	O	PUNCT	O
box	O	NOUN	B
region	O	NOUN	I
.	O	PUNCT	O


SETTING	O	NOUN	B
-	O	PUNCT	O
-	O	PUNCT	O
Delhi	O	PROPN	B
,	O	PUNCT	O
urban	O	ADJ	B
India	O	PROPN	I
,	O	PUNCT	O
1985	O	NUM	O
-	O	SYM	O
6	O	NUM	O
.	O	PUNCT	O


Selective	O	ADJ	O
translation	O	NOUN	O
initiation	O	NOUN	O
by	O	ADP	O
ribosome	O	NOUN	B
jumping	O	NOUN	I
in	O	ADP	O
adenovirus	O	NOUN	B
-	O	PUNCT	O
infected	O	ADJ	B
and	O	CCONJ	O
heat	O	NOUN	B
-	O	PUNCT	O
shocked	O	ADJ	B
cells	O	NOUN	B
.	O	PUNCT	O


Furthermore	O	ADV	O
,	O	PUNCT	O
we	O	PRON	O
have	O	AUX	O
identified	O	VERB	B
a	O	DET	O
43	O	NUM	O
-	O	PUNCT	O
bp	O	NOUN	B
region	O	NOUN	B
of	O	ADP	O
the	O	DET	O
24p3	B-GENE	NOUN	B
promoter	I-GENE	NOUN	B
required	O	VERB	O
for	O	ADP	O
the	O	DET	O
Dex	O	NOUN	B
responsiveness	O	NOUN	B
.	O	PUNCT	O


Our	O	PRON	O
data	O	NOUN	B
demonstrate	O	VERB	O
directly	O	ADV	O
that	O	SCONJ	O
Rpm1r	B-GENE	NOUN	B
is	O	AUX	O
transcribed	O	VERB	B
with	O	ADP	O
its	O	PRON	O
substrates	O	NOUN	B
,	O	PUNCT	O
tRNA	B-GENE	NOUN	B
met	I-GENE	VERB	O
f	I-GENE	X	O
and	O	CCONJ	O
tRNAPro	B-GENE	NOUN	B
,	O	PUNCT	O
from	O	ADP	O
a	O	DET	O
promoter	O	NOUN	B
located	O	ADJ	O
upstream	O	ADV	B
of	O	ADP	O
the	O	DET	O
tRNA	B-GENE	NOUN	B
met	I-GENE	VERB	O
f	I-GENE	NOUN	O
gene	I-GENE	NOUN	B
and	O	CCONJ	O
suggest	O	VERB	O
that	O	SCONJ	O
a	O	DET	O
portion	O	NOUN	B
also	O	ADV	O
originates	O	VERB	O
from	O	ADP	O
a	O	DET	O
second	O	ADJ	O
promoter	O	NOUN	B
,	O	PUNCT	O
located	O	ADJ	O
between	O	ADP	O
the	O	DET	O
tRNA	B-GENE	NOUN	B
met	I-GENE	VERB	O
f	I-GENE	NOUN	O
gene	I-GENE	NOUN	B
and	O	CCONJ	O
RPM1	B-GENE	NOUN	B
.	O	PUNCT	O


Furthermore	O	ADV	O
,	O	PUNCT	O
strains	O	NOUN	B
with	O	ADP	O
mutant	B-GENE	ADJ	B
RPM1	I-GENE	NOUN	O
genes	I-GENE	NOUN	O
also	O	ADV	O
accumulate	O	VERB	B
precursor	B-GENE	NOUN	B
Rpm1r	I-GENE	NOUN	I
,	O	PUNCT	O
suggesting	O	VERB	O
that	O	SCONJ	O
mutations	O	NOUN	B
in	O	ADP	O
either	O	DET	O
gene	O	NOUN	B
can	O	AUX	O
lead	O	VERB	O
to	O	PART	O
similar	O	ADJ	O
biogenesis	O	NOUN	B
defects	O	NOUN	B
.	O	PUNCT	O


Merlie	O	PROPN	B
,	O	PUNCT	O
Cold	O	PROPN	B
Spring	O	PROPN	I
Harbor	O	PROPN	I
Symp	O	PROPN	I
.	O	PUNCT	O


Substantial	O	ADJ	O
evidence	O	NOUN	O
supports	O	VERB	O
a	O	DET	O
critical	O	ADJ	O
role	O	NOUN	O
for	O	ADP	O
the	O	DET	O
activation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
Raf	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	B
/	O	SYM	O
MEK	B-GENE	NOUN	B
/	O	SYM	O
mitogen	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
activated	I-GENE	VERB	B
protein	I-GENE	NOUN	B
kinase	I-GENE	NOUN	I
pathway	O	NOUN	I
in	O	ADP	O
oncogenic	O	ADJ	B
Ras	B-GENE	NOUN	B
-	O	PUNCT	O
mediated	O	VERB	B
transformation	O	NOUN	B
.	O	PUNCT	O


Stylohyoid	O	NOUN	B
chain	O	NOUN	I
ossification	O	NOUN	I
:	O	PUNCT	O
choice	O	NOUN	O
of	O	ADP	O
the	O	DET	O
surgical	O	ADJ	B
approach	O	NOUN	I
.	O	PUNCT	O


63	O	NUM	O
.	O	PUNCT	O
3	O	NUM	O
micromol	O	NOUN	O
/	O	SYM	O
1	O	NUM	O
,	O	PUNCT	O
p	O	X	O
<	O	X	O
0	O	NUM	O
.	O	PUNCT	O
01	O	NUM	O
)	O	PUNCT	O
and	O	CCONJ	O
area	O	NOUN	B
under	O	ADP	O
the	O	DET	O
plasma	O	NOUN	B
concentration	O	NOUN	B
-	O	PUNCT	O
time	O	NOUN	B
curve	O	NOUN	I
extrapolated	O	VERB	O
to	O	PART	O
infinity	O	VERB	O
AUC	O	PROPN	B
9	O	NUM	O
(	O	PUNCT	O
0	O	NUM	O
-	O	PUNCT	O
infinity	O	NOUN	B
)	O	PUNCT	O
(	O	PUNCT	O
518	O	NUM	O
.	O	PUNCT	O
7	O	NUM	O
vs	O	CCONJ	O
.	O	PUNCT	O


Mean	O	VERB	O
increase	O	NOUN	B
of	O	ADP	O
milk	O	NOUN	B
protein	O	NOUN	I
yield	O	NOUN	O
was	O	AUX	O
46	O	NUM	O
g	O	NOUN	O
/	O	SYM	O
d	O	NOUN	B
with	O	ADP	O
Met	O	NOUN	B
plus	O	CCONJ	O
Lys	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
mean	O	VERB	O
increase	O	NOUN	B
of	O	ADP	O
true	O	ADJ	O
protein	O	NOUN	B
content	O	NOUN	B
was	O	AUX	O
1	O	NUM	O
.	O	PUNCT	O
1	O	NUM	O
g	O	NOUN	O
/	O	PUNCT	O
kg	O	NOUN	B
of	O	ADP	O
milk	O	NOUN	B
.	O	PUNCT	O


A	O	DET	O
chimeric	O	ADJ	B
VP16	B-GENE	NOUN	B
-	O	PUNCT	O
Tat	B-GENE	NOUN	B
construct	O	NOUN	B
containing	O	VERB	O
the	O	DET	O
leucine	O	NOUN	B
mutations	O	NOUN	I
showed	O	VERB	O
no	O	DET	O
increased	O	VERB	B
AP	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	O
responsiveness	O	NOUN	B
in	O	ADP	O
comparison	O	NOUN	B
with	O	ADP	O
that	O	DET	O
of	O	ADP	O
the	O	DET	O
VP16	B-GENE	NOUN	B
activation	I-GENE	NOUN	B
domain	I-GENE	NOUN	I
alone	O	ADV	O
.	O	PUNCT	O


Despite	O	SCONJ	O
significant	O	ADJ	O
lethality	O	NOUN	B
and	O	CCONJ	O
cardiovascular	O	ADJ	B
dysfunction	O	NOUN	I
,	O	PUNCT	O
in	O	ADP	O
the	O	DET	O
septic	O	ADJ	B
group	O	NOUN	I
on	O	ADP	O
Days	O	NOUN	B
1	O	NUM	I
and	O	CCONJ	O
2	O	NUM	O
,	O	PUNCT	O
septic	O	ADJ	B
versus	O	CCONJ	O
control	O	NOUN	B
animals	O	NOUN	I
had	O	AUX	O
no	O	DET	B
significant	O	ADJ	I
differences	O	NOUN	O
in	O	ADP	O
mean	O	ADJ	O
metabolic	O	ADJ	B
cart	O	NOUN	I
measured	O	VERB	O
(	O	PUNCT	O
Vo2DIR	O	NOUN	B
,	O	PUNCT	O
ml	O	NOUN	O
/	O	SYM	O
kg	O	NOUN	B
/	O	PUNCT	O
min	O	NOUN	B
;	O	PUNCT	O
Day	O	PROPN	O
1	O	NUM	O
:	O	PUNCT	O
11	O	NUM	O
.	O	PUNCT	O
9	O	NUM	O
versus	O	CCONJ	O
12	O	NUM	O
.	O	PUNCT	O
4	O	NUM	O
,	O	PUNCT	O
p	O	NOUN	O
=	O	ADJ	O
0	O	NUM	O
.	O	PUNCT	O
81	O	NUM	O
;	O	PUNCT	O
Day	O	PROPN	O
2	O	NUM	O
:	O	PUNCT	O
14	O	NUM	O
.	O	PUNCT	O
2	O	NUM	O
versus	O	CCONJ	O
13	O	NUM	O
.	O	PUNCT	O
5	O	NUM	O
,	O	PUNCT	O
p	O	NOUN	O
=	O	ADJ	O
0	O	NUM	O
.	O	PUNCT	O
72	O	NUM	O
,	O	PUNCT	O
respectively	O	ADV	O
)	O	PUNCT	O
and	O	CCONJ	O
intravascular	O	ADJ	B
catheter	O	NOUN	I
calculated	O	VERB	I
(	O	PUNCT	O
Vo2INDIR	O	NOUN	B
,	O	PUNCT	O
ml	O	NOUN	O
/	O	SYM	O
kg	O	NOUN	B
/	O	PUNCT	O
min	O	NOUN	B
;	O	PUNCT	O
Day	O	PROPN	O
1	O	NUM	O
:	O	PUNCT	O
11	O	NUM	O
.	O	PUNCT	O
2	O	NUM	O
versus	O	CCONJ	O
11	O	NUM	O
.	O	PUNCT	O
2	O	NUM	O
,	O	PUNCT	O
p	O	NOUN	O
=	O	ADJ	O
0	O	NUM	O
.	O	PUNCT	O
99	O	NUM	O
;	O	PUNCT	O
Day	O	PROPN	O
2	O	NUM	O
:	O	PUNCT	O
12	O	NUM	O
.	O	PUNCT	O
8	O	NUM	O
versus	O	CCONJ	O
15	O	NUM	O
.	O	PUNCT	O
4	O	NUM	O
,	O	PUNCT	O
p	O	NOUN	O
=	O	ADJ	O
0	O	NUM	O
.	O	PUNCT	O
49	O	NUM	O
,	O	PUNCT	O
respectively	O	ADV	O
)	O	PUNCT	O
.	O	PUNCT	O


Although	O	SCONJ	O
IL	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
2	I-GENE	NUM	B
and	O	CCONJ	O
IFN	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
alpha	I-GENE	NOUN	B
activated	O	VERB	B
STAT1	B-GENE	NOUN	B
alpha	I-GENE	NOUN	I
and	O	CCONJ	O
STAT5	B-GENE	NOUN	B
,	O	PUNCT	O
IL	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
2	I-GENE	NUM	O
predominantly	O	ADV	O
activated	O	VERB	B
STAT5	B-GENE	NOUN	B
,	O	PUNCT	O
while	O	SCONJ	O
IFN	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
alpha	I-GENE	NOUN	B
predominantly	O	ADV	O
activated	O	VERB	B
STAT1	B-GENE	NOUN	B
alpha	I-GENE	NOUN	I
.	O	PUNCT	O


One	O	NUM	O
complex	O	NOUN	B
containing	O	VERB	O
a	O	DET	O
70	O	NUM	O
D	O	NOUN	B
protein	O	NOUN	I
was	O	AUX	O
found	O	VERB	O
to	O	PART	O
be	O	AUX	O
associated	O	VERB	B
specifically	O	ADV	I
with	O	ADP	O
transcriptionally	O	ADV	B
active	O	ADJ	O
leukemia	O	NOUN	O
cells	O	NOUN	B
.	O	PUNCT	O


Our	O	PRON	O
results	O	NOUN	O
confirm	O	VERB	O
the	O	DET	O
participation	O	NOUN	B
of	O	ADP	O
intron	O	NOUN	B
1	O	NUM	O
in	O	ADP	O
transcriptional	O	ADJ	B
regulation	O	NOUN	I
of	O	ADP	O
the	O	DET	O
c	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
myb	I-GENE	NOUN	B
gene	I-GENE	NOUN	I
(	O	PUNCT	O
in	O	ADP	O
mouse	O	NOUN	B
and	O	CCONJ	O
human	O	ADJ	B
)	O	PUNCT	O
and	O	CCONJ	O
implicate	O	VERB	O
multiple	O	ADJ	B
and	O	CCONJ	O
complex	O	ADJ	B
regulatory	O	ADJ	B
mechanisms	O	NOUN	I
of	O	ADP	O
activation	O	NOUN	B
during	O	ADP	O
myelomonocytic	O	ADJ	B
differentiation	O	NOUN	I
and	O	CCONJ	O
leukemic	O	ADJ	B
cell	O	NOUN	I
growth	O	NOUN	I
control	O	NOUN	I
.	O	PUNCT	O


Limited	O	ADJ	O
role	O	NOUN	O
for	O	ADP	O
PCR	O	NOUN	B
-	O	PUNCT	O
based	O	VERB	B
diagnosis	O	NOUN	B
of	O	ADP	O
Whipple	O	PROPN	B
'	O	PART	O
s	O	NOUN	O
disease	O	NOUN	B
from	O	ADP	O
peripheral	O	ADJ	B
blood	O	NOUN	I
mononuclear	O	ADJ	I
cells	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
Pro	O	PROPN	B
-	O	PUNCT	O
258	O	NUM	O
-	O	PUNCT	O
-	O	PUNCT	O
>	O	X	O
Leu	O	NOUN	B
(	O	PUNCT	O
P258L	O	NOUN	O
)	O	PUNCT	O
mutation	O	NOUN	B
caused	O	VERB	O
constitutive	O	ADJ	B
receptor	O	NOUN	I
signaling	O	NOUN	O
that	O	PRON	O
was	O	AUX	O
equivalent	O	ADJ	O
to	O	ADP	O
about	O	ADP	O
45	O	NUM	O
%	O	NOUN	O
of	O	ADP	O
the	O	DET	O
maximum	O	ADJ	B
level	O	NOUN	B
observed	O	VERB	B
in	O	ADP	O
wild	O	ADJ	B
-	O	PUNCT	O
type	O	NOUN	B
cells	O	NOUN	I
stimulated	O	VERB	B
with	O	ADP	O
alpha	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
factor	I-GENE	NOUN	B
.	O	PUNCT	O


CONCLUSIONS	O	NOUN	O
:	O	PUNCT	O
Our	O	PRON	O
findings	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
pre	O	ADJ	B
-	O	PUNCT	O
treatment	O	NOUN	B
with	O	ADP	O
coenzyme	O	ADJ	B
Q10	O	NOUN	I
may	O	AUX	O
play	O	VERB	O
a	O	DET	O
protective	O	ADJ	O
role	O	NOUN	O
during	O	ADP	O
routine	O	ADJ	O
vascular	O	ADJ	B
procedures	O	NOUN	I
requiring	O	VERB	O
abdominal	O	ADJ	B
aortic	O	ADJ	I
cross	O	NOUN	I
clamping	O	NOUN	I
by	O	ADP	O
attenuating	O	VERB	B
the	O	DET	O
degree	O	NOUN	B
of	O	ADP	O
peroxidative	O	ADJ	B
damage	O	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
a	O	DET	O
screen	O	NOUN	B
for	O	ADP	O
genes	O	NOUN	B
with	O	ADP	O
oncogenic	O	ADJ	B
potential	O	NOUN	B
expressed	O	VERB	B
by	O	ADP	O
the	O	DET	O
murine	O	ADJ	B
B6SUtA1	O	NOUN	B
myeloid	O	ADJ	I
progenitor	O	NOUN	I
cell	O	NOUN	I
line	O	NOUN	I
,	O	PUNCT	O
we	O	PRON	O
isolated	O	VERB	B
a	O	DET	O
2	O	NUM	O
.	O	PUNCT	O


The	O	DET	O
mechanism	O	NOUN	B
involves	O	VERB	O
Gbetagamma	B-GENE	NOUN	B
subunit	O	NOUN	I
-	O	PUNCT	O
mediated	O	VERB	B
increases	O	NOUN	B
in	O	ADP	O
tyrosine	O	NOUN	B
phosphorylation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
Shc	B-GENE	NOUN	B
adapter	I-GENE	NOUN	I
protein	I-GENE	NOUN	I
,	O	PUNCT	O
Shc	B-GENE	NOUN	B
*	O	PUNCT	O
Grb2	B-GENE	NOUN	B
complex	O	NOUN	B
formation	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
recruitment	O	NOUN	B
of	O	ADP	O
Ras	B-GENE	NOUN	B
guanine	I-GENE	NOUN	I
nucleotide	I-GENE	NOUN	I
exchange	I-GENE	NOUN	I
factor	I-GENE	NOUN	I
activity	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
cis	O	ADV	B
-	O	PUNCT	O
acting	O	VERB	B
elements	O	NOUN	O
that	O	PRON	O
control	O	VERB	O
promoter	O	NOUN	B
activity	O	NOUN	I
include	O	VERB	O
binding	O	VERB	B
sites	O	NOUN	I
for	O	ADP	O
transcription	O	NOUN	B
factors	O	NOUN	I
Sp1	B-GENE	NOUN	B
and	O	CCONJ	O
alphaCbf	B-GENE	NOUN	B
,	O	PUNCT	O
a	O	DET	O
60	B-GENE	NUM	O
-	I-GENE	PUNCT	O
kDa	I-GENE	NOUN	B
CCAAT	I-GENE	NOUN	O
box	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
binding	I-GENE	VERB	B
protein	I-GENE	NOUN	I
.	O	PUNCT	O


There	O	PRON	O
was	O	AUX	O
a	O	DET	O
general	O	ADJ	O
broadening	O	NOUN	O
of	O	ADP	O
proton	O	NOUN	B
resonances	O	NOUN	I
for	O	ADP	O
a	O	DET	O
three	O	NUM	B
-	O	PUNCT	O
nucleotide	O	NOUN	B
segment	O	NOUN	B
centered	O	VERB	O
about	O	ADP	O
the	O	DET	O
lesion	O	NOUN	B
site	O	NOUN	I
which	O	DET	O
resulted	O	VERB	O
in	O	ADP	O
a	O	DET	O
tentative	O	ADJ	O
assignment	O	NOUN	B
for	O	ADP	O
the	O	DET	O
sugar	O	NOUN	B
protons	O	NOUN	B
of	O	ADP	O
the	O	DET	O
C7	O	NOUN	B
residue	O	NOUN	B
in	O	ADP	O
the	O	DET	O
spectrum	O	NOUN	B
of	O	ADP	O
the	O	DET	O
adduct	O	NOUN	B
duplex	O	NOUN	O
.	O	PUNCT	O


Using	O	VERB	O
immunogold	O	ADJ	B
electron	O	NOUN	I
microscopy	O	NOUN	I
,	O	PUNCT	O
we	O	PRON	O
found	O	VERB	O
that	O	SCONJ	O
p58	B-GENE	NOUN	B
/	O	SYM	O
p45	B-GENE	NOUN	B
and	O	CCONJ	O
p54	B-GENE	NOUN	B
are	O	AUX	O
localized	O	ADJ	B
on	O	ADP	O
both	O	DET	O
sides	O	NOUN	O
of	O	ADP	O
the	O	DET	O
nuclear	O	ADJ	B
pore	O	NOUN	I
complex	O	NOUN	I
,	O	PUNCT	O
like	O	ADP	O
p62	B-GENE	NOUN	B
.	O	PUNCT	O


Transcription	O	NOUN	B
initiation	O	NOUN	B
sites	O	NOUN	I
of	O	ADP	O
the	O	DET	O
rat	O	NOUN	B
II	B-GENE	NUM	O
beta	I-GENE	PROPN	B
-	I-GENE	PUNCT	O
,	I-GENE	PUNCT	O
III	I-GENE	NUM	B
beta	I-GENE	NOUN	I
,	I-GENE	PUNCT	O
and	I-GENE	CCONJ	O
O	I-GENE	NOUN	O
beta	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
globin	I-GENE	NOUN	B
genes	O	NOUN	I
were	O	AUX	O
determined	O	VERB	O
to	O	PART	O
be	O	AUX	O
52	O	NUM	O
base	O	NOUN	B
pairs	O	NOUN	I
(	O	PUNCT	O
bp	O	NOUN	B
)	O	PUNCT	O
5	O	NUM	O
'	O	PUNCT	O
-	O	PUNCT	O
upstream	O	ADJ	B
of	O	ADP	O
the	O	DET	O
translation	O	NOUN	B
initiation	O	NOUN	I
codon	O	NOUN	O
(	O	PUNCT	O
ATG	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
in	O	ADP	O
each	O	DET	O
gene	O	NOUN	B
by	O	ADP	O
primer	O	NOUN	B
extension	O	NOUN	I
analysis	O	NOUN	I
.	O	PUNCT	O


Aggravating	O	ADJ	B
process	O	NOUN	I
induced	O	VERB	B
by	O	ADP	O
indomethacin	O	NOUN	B
on	O	ADP	O
chronic	O	ADJ	B
gastric	O	ADJ	I
lesion	O	NOUN	I
in	O	ADP	O
rat	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
been	O	AUX	O
studying	O	VERB	O
the	O	DET	O
interaction	O	NOUN	B
of	O	ADP	O
the	O	DET	O
oncogenic	O	ADJ	B
human	O	ADJ	O
polyomavirus	O	NOUN	O
BK	O	NOUN	B
(	O	PUNCT	O
BKV	O	NOUN	B
)	O	PUNCT	O
with	O	ADP	O
the	O	DET	O
tumor	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
suppressor	I-GENE	NOUN	B
protein	I-GENE	NOUN	I
p53	I-GENE	NOUN	I
to	O	PART	O
understand	O	VERB	O
the	O	DET	O
biology	O	NOUN	B
of	O	ADP	O
this	O	DET	O
virus	O	NOUN	B
as	O	ADV	O
well	O	ADV	O
as	O	ADP	O
to	O	PART	O
understand	O	VERB	O
the	O	DET	O
basic	O	ADJ	O
mechanisms	O	NOUN	B
of	O	ADP	O
p53	B-GENE	NOUN	B
transactivation	O	NOUN	B
.	O	PUNCT	O


Site	O	NOUN	B
S	O	PROPN	I
-	O	PUNCT	O
II	O	PROPN	B
also	O	ADV	O
spans	O	VERB	O
a	O	DET	O
23	O	NUM	O
bp	O	NOUN	O
sequence	O	NOUN	B
containing	O	VERB	O
two	O	NUM	O
tandem	O	ADJ	B
consensus	O	NOUN	B
binding	O	NOUN	I
sites	O	NOUN	I
with	O	ADP	O
three	O	NUM	O
base	O	NOUN	B
pair	O	NOUN	I
mismatches	O	NOUN	O
in	O	ADP	O
each	O	DET	O
and	O	CCONJ	O
a	O	DET	O
one	O	NUM	O
base	O	NOUN	B
pair	O	NOUN	I
deletion	O	NOUN	B
.	O	PUNCT	O


Unaided	O	ADJ	B
attempts	O	NOUN	O
to	O	PART	O
quit	O	VERB	B
smoking	O	NOUN	I
are	O	AUX	O
generally	O	ADV	O
unsuccessful	O	ADJ	O
.	O	PUNCT	O


The	O	DET	O
experience	O	NOUN	B
of	O	ADP	O
the	O	DET	O
lateral	O	ADJ	B
rhinotomy	O	NOUN	I
approach	O	NOUN	O
in	O	ADP	O
transsphenoidal	O	ADJ	B
surgery	O	NOUN	I
of	O	ADP	O
acromegaly	O	NOUN	B
has	O	AUX	O
been	O	AUX	O
favourable	O	ADJ	O
.	O	PUNCT	O


Possible	O	ADJ	O
relationship	O	NOUN	B
between	O	ADP	O
hyperinsulinemia	O	NOUN	B
and	O	CCONJ	O
glomerular	O	ADJ	B
hypertrophy	O	NOUN	I
in	O	ADP	O
nephrosclerosis	O	NOUN	B
.	O	PUNCT	O


Blood	O	NOUN	B
GSH	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
Px	I-GENE	PROPN	B
activity	O	NOUN	B
was	O	AUX	O
measured	O	VERB	B
with	O	ADP	O
a	O	DET	O
spectrophotometer	O	NOUN	B
,	O	PUNCT	O
using	O	VERB	O
a	O	DET	O
modification	O	NOUN	B
of	O	ADP	O
a	O	DET	O
previously	O	ADV	O
described	O	VERB	O
assay	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
concentrations	O	NOUN	B
of	O	ADP	O
vitamin	O	NOUN	B
A	O	NOUN	I
precursors	O	NOUN	B
and	O	CCONJ	O
vitamin	O	NOUN	B
E	O	NOUN	I
in	O	ADP	O
the	O	DET	O
hay	O	NOUN	B
were	O	AUX	O
below	O	ADP	O
currently	O	ADV	O
recommended	O	VERB	B
dietary	O	ADJ	B
levels	O	NOUN	I
for	O	ADP	O
llamas	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
alfalfa	O	NOUN	B
hay	O	NOUN	B
appears	O	VERB	O
to	O	PART	O
provide	O	VERB	O
an	O	DET	O
unreliable	O	ADJ	O
source	O	NOUN	B
of	O	ADP	O
vitamins	O	NOUN	B
A	O	NOUN	I
and	O	CCONJ	O
E	O	NOUN	B
in	O	ADP	O
this	O	DET	O
species	O	NOUN	B
.	O	PUNCT	O


Eight	O	NUM	O
cats	O	NOUN	B
infected	O	VERB	B
with	O	ADP	O
H	O	NOUN	B
.	O	PUNCT	O
pylori	O	NOUN	B
were	O	AUX	O
used	O	VERB	O
in	O	ADP	O
the	O	DET	O
study	O	NOUN	B
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
as	O	ADP	O
determined	O	VERB	O
by	O	ADP	O
PCR	O	NOUN	B
with	O	ADP	O
primers	O	NOUN	B
specific	O	ADJ	B
for	O	ADP	O
the	O	DET	O
26	O	NUM	O
-	O	PUNCT	O
kDa	O	NOUN	O
product	O	NOUN	B
,	O	PUNCT	O
the	O	DET	O
majority	O	NOUN	O
of	O	ADP	O
cats	O	NOUN	B
at	O	ADP	O
2	O	NUM	O
and	O	CCONJ	O
4	O	NUM	O
weeks	O	NOUN	B
p	O	NOUN	O
.	O	PUNCT	O
t	O	NOUN	O
.	O	PUNCT	O
had	O	AUX	O
gastric	O	ADJ	B
fluid	O	ADJ	I
samples	O	NOUN	O
which	O	DET	O
were	O	AUX	O
positive	O	ADJ	B
for	O	ADP	O
H	O	NOUN	O
.	O	PUNCT	O
pylori	O	NOUN	B
and	O	CCONJ	O
three	O	NUM	O
of	O	ADP	O
three	O	NUM	O
cats	O	NOUN	B
at	O	ADP	O
2	O	NUM	O
weeks	O	NOUN	B
p	O	NOUN	O
.	O	PUNCT	O
t	O	NOUN	O
.	O	PUNCT	O
had	O	AUX	O
dental	O	NOUN	B
plaque	O	NOUN	I
which	O	DET	O
was	O	AUX	O
positive	O	ADJ	B
for	O	ADP	O
H	O	NOUN	O
.	O	PUNCT	O
pylori	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
most	O	ADV	O
frequent	O	ADJ	B
causes	O	NOUN	O
of	O	ADP	O
the	O	DET	O
meningitis	O	NOUN	B
was	O	AUX	O
the	O	DET	O
external	O	ADJ	B
ventricular	O	ADJ	I
drainage	O	NOUN	I
(	O	PUNCT	O
14	O	NUM	O
.	O	PUNCT	O
8	O	NUM	O
%	O	NOUN	O
)	O	PUNCT	O
,	O	PUNCT	O
post	O	NOUN	B
-	O	PUNCT	O
neurosurgical	O	ADJ	B
(	O	PUNCT	O
0	O	NUM	O
.	O	PUNCT	O
8	O	NUM	O
%	O	NOUN	O
)	O	PUNCT	O
and	O	CCONJ	O
head	O	NOUN	B
injury	O	NOUN	I
(	O	PUNCT	O
0	O	NUM	O
.	O	PUNCT	O
0007	O	NUM	O
%	O	NOUN	O
)	O	PUNCT	O
.	O	PUNCT	O


In	O	X	B
vitro	O	X	I
interaction	O	NOUN	B
studies	O	NOUN	O
,	O	PUNCT	O
using	O	VERB	O
proteins	O	NOUN	B
fused	O	VERB	O
to	O	PART	O
glutathione	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
S	I-GENE	PROPN	B
-	I-GENE	PUNCT	O
transferase	I-GENE	NOUN	B
,	O	PUNCT	O
showed	O	VERB	O
that	O	SCONJ	O
RBP	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
J	I-GENE	NOUN	B
kappa	I-GENE	NOUN	I
and	O	CCONJ	O
Su	B-GENE	PROPN	B
(	I-GENE	PUNCT	I
H	I-GENE	NOUN	I
)	I-GENE	PUNCT	I
bind	O	VERB	B
directly	O	ADV	O
to	O	PART	O
the	O	DET	O
RAM23	B-GENE	NOUN	B
regions	I-GENE	NOUN	B
of	O	ADP	O
mouse	B-GENE	NOUN	B
Notch1	I-GENE	NOUN	B
and	O	CCONJ	O
Drosophila	B-GENE	NOUN	B
Notch	I-GENE	NOUN	B
,	O	PUNCT	O
respectively	O	ADV	O
.	O	PUNCT	O


Twelve	O	NUM	O
genomic	O	ADJ	B
fragments	O	NOUN	I
containing	O	VERB	O
novel	O	ADJ	O
response	O	NOUN	B
elements	O	NOUN	I
are	O	AUX	O
described	O	VERB	O
,	O	PUNCT	O
and	O	CCONJ	O
the	O	DET	O
transcription	O	NOUN	B
unit	O	NOUN	I
associated	O	VERB	B
with	O	ADP	I
one	O	NUM	O
of	O	ADP	O
them	O	PRON	O
,	O	PUNCT	O
NN	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
84AG	I-GENE	PROPN	B
,	O	PUNCT	O
was	O	AUX	O
characterized	O	VERB	B
in	O	ADP	O
detail	O	NOUN	O
.	O	PUNCT	O


Members	O	NOUN	O
of	O	ADP	O
the	O	DET	O
Ras	B-GENE	NOUN	B
subfamily	I-GENE	NOUN	O
of	O	ADP	O
small	B-GENE	ADJ	B
GTP	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
binding	I-GENE	VERB	B
proteins	I-GENE	NOUN	I
have	O	AUX	O
been	O	AUX	O
shown	O	VERB	O
to	O	PART	O
be	O	AUX	O
promiscuous	O	ADJ	B
towards	O	ADP	O
a	O	DET	O
variety	O	NOUN	O
of	O	ADP	O
putative	O	ADJ	B
effector	O	NOUN	I
molecules	O	NOUN	I
such	O	ADJ	O
as	O	ADP	O
the	O	DET	O
protein	B-GENE	NOUN	B
kinase	I-GENE	NOUN	I
c	I-GENE	NOUN	I
-	I-GENE	PUNCT	O
Raf	I-GENE	NOUN	B
and	O	CCONJ	O
the	O	DET	O
Ral	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
specific	I-GENE	ADJ	B
guanine	I-GENE	NOUN	B
nucleotide	I-GENE	NOUN	I
exchange	I-GENE	NOUN	I
factor	I-GENE	NOUN	I
(	O	PUNCT	O
Ral	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
GEF	I-GENE	PROPN	B
)	O	PUNCT	O
.	O	PUNCT	O


The	O	DET	O
cDNA	O	NOUN	B
encoded	O	VERB	O
a	O	DET	O
mature	O	ADJ	B
protein	O	NOUN	B
of	O	ADP	O
240	O	NUM	O
amino	O	NOUN	B
acids	O	NOUN	I
,	O	PUNCT	O
including	O	VERB	O
a	O	DET	O
29	O	NUM	O
-	O	PUNCT	O
amino	O	NOUN	B
acid	O	NOUN	I
signal	O	NOUN	I
sequence	O	NOUN	I
.	O	PUNCT	O


Biol	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
effect	O	NOUN	B
of	O	ADP	O
ligustrazine	O	NOUN	B
hydrochloride	O	NOUN	I
(	O	PUNCT	O
LTH	O	NOUN	B
)	O	PUNCT	O
on	O	ADP	O
depressing	O	VERB	B
pulmonary	O	ADJ	B
artery	O	NOUN	I
hypertension	O	NOUN	I
has	O	AUX	O
been	O	AUX	O
proved	O	VERB	O
in	O	ADP	O
recent	O	ADJ	O
studies	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
the	O	DET	O
same	O	ADJ	O
period	O	NOUN	B
we	O	PRON	O
pointed	O	VERB	O
out	O	ADP	O
an	O	DET	O
increase	O	NOUN	B
of	O	ADP	O
hematocrit	O	NOUN	B
(	O	PUNCT	O
from	O	ADP	O
29	O	NUM	O
%	O	NOUN	O
to	O	PART	O
35	O	NUM	O
%	O	NOUN	O
)	O	PUNCT	O
and	O	CCONJ	O
of	O	ADP	O
the	O	DET	O
Hb	B-GENE	NOUN	B
(	O	PUNCT	O
from	O	ADP	O
9	O	NUM	O
.	O	PUNCT	O
3	O	NUM	O
to	O	PART	O
11	O	NUM	O
.	O	PUNCT	O
2	O	NUM	O
g	O	NOUN	O
/	O	SYM	O
dl	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


The	O	DET	O
structure	O	NOUN	B
of	O	ADP	O
these	O	DET	O
genes	O	NOUN	B
suggests	O	VERB	O
a	O	DET	O
common	O	ADJ	O
ancestor	O	NOUN	B
for	O	ADP	O
all	O	DET	O
viperid	B-GENE	NOUN	B
PLA2	I-GENE	NOUN	B
genes	I-GENE	NOUN	I
.	O	PUNCT	O


Chloroplast	B-GENE	NOUN	B
mutator	I-GENE	NOUN	O
(	O	PUNCT	O
chm	B-GENE	NOUN	B
)	O	PUNCT	O
of	O	ADP	O
Arabidopsis	O	NOUN	B
is	O	AUX	O
a	O	DET	O
recessive	O	ADJ	B
nuclear	O	ADJ	B
mutation	O	NOUN	I
that	O	PRON	O
causes	O	VERB	O
green	O	ADJ	B
and	O	CCONJ	O
white	O	ADJ	B
variegation	O	NOUN	I
in	O	ADP	O
leaves	O	NOUN	B
and	O	CCONJ	O
is	O	AUX	O
inherited	O	VERB	B
in	O	ADP	O
a	O	DET	O
non	O	ADJ	B
-	O	PUNCT	O
Mendelian	O	ADJ	B
fashion	O	NOUN	O
.	O	PUNCT	O


Also	O	ADV	O
like	O	ADP	O
the	O	DET	O
thrombin	B-GENE	NOUN	B
receptor	I-GENE	NOUN	I
,	O	PUNCT	O
PAR2	B-GENE	NOUN	B
can	O	AUX	O
be	O	AUX	O
activated	O	VERB	B
by	O	ADP	O
the	O	DET	O
hexapeptide	O	NOUN	B
corresponding	O	VERB	O
to	O	PART	O
its	O	PRON	O
tethered	O	VERB	B
ligand	O	NOUN	B
sequence	O	NOUN	I
independent	O	ADJ	B
of	O	ADP	O
receptor	O	NOUN	B
cleavage	O	NOUN	I
.	O	PUNCT	O


Such	O	DET	O
an	O	DET	O
increase	O	NOUN	B
in	O	ADP	O
the	O	DET	O
steady	O	ADJ	B
-	O	PUNCT	O
state	O	NOUN	B
testicular	B-GENE	NOUN	B
TIMP	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
2	I-GENE	NUM	O
mRNA	I-GENE	NOUN	B
level	O	NOUN	B
apparently	O	ADV	O
is	O	AUX	O
not	O	PART	O
the	O	DET	O
result	O	NOUN	B
of	O	ADP	O
an	O	DET	O
up	O	ADV	B
-	O	PUNCT	O
regulation	O	NOUN	B
by	O	ADP	O
germ	O	NOUN	B
cells	O	NOUN	I
because	O	SCONJ	O
germ	O	NOUN	B
cells	O	NOUN	I
cocultured	O	VERB	B
with	O	ADP	O
Sertoli	O	NOUN	B
cells	O	NOUN	I
failed	O	VERB	B
to	O	PART	O
elicit	O	VERB	O
an	O	DET	O
increase	O	NOUN	B
in	O	ADP	O
the	O	DET	O
Sertoli	O	NOUN	B
cell	O	NOUN	I
steady	O	ADJ	B
-	O	PUNCT	O
state	O	NOUN	B
TIMP	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
2	I-GENE	NUM	O
mRNA	I-GENE	NOUN	B
level	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
the	O	DET	O
SPK	O	NOUN	B
and	O	CCONJ	O
PTA	O	PROPN	B
category	O	NOUN	B
,	O	PUNCT	O
anti	O	ADJ	B
-	O	PUNCT	O
T	O	NOUN	B
-	O	PUNCT	O
cell	O	NOUN	B
therapy	O	NOUN	I
significantly	O	ADV	O
lowered	O	VERB	B
the	O	DET	O
risk	O	NOUN	B
of	O	ADP	O
graft	O	NOUN	B
loss	O	NOUN	I
.	O	PUNCT	O


Five	O	NUM	B
-	O	PUNCT	O
year	O	NOUN	B
survivals	O	NOUN	B
amounted	O	VERB	O
to	O	ADP	O
100	O	NUM	O
%	O	NOUN	O
,	O	PUNCT	O
86	O	NUM	O
.	O	PUNCT	O
2	O	NUM	O
%	O	NOUN	O
,	O	PUNCT	O
59	O	NUM	O
.	O	PUNCT	O
4	O	NUM	O
%	O	NOUN	O
,	O	PUNCT	O
29	O	NUM	O
.	O	PUNCT	O
8	O	NUM	O
%	O	NOUN	O
,	O	PUNCT	O
and	O	CCONJ	O
20	O	NUM	O
%	O	NOUN	O
for	O	ADP	O
stages	O	NOUN	B
I	O	NUM	I
,	O	PUNCT	O
II	O	NUM	B
,	O	PUNCT	O
III	O	NUM	B
,	O	PUNCT	O
IVA	O	NOUN	B
and	O	CCONJ	O
IVB	O	NOUN	B
respectively	O	ADV	O
.	O	PUNCT	O


Targeted	O	VERB	B
disruption	O	NOUN	B
of	O	ADP	O
the	O	DET	O
OGG1	B-GENE	NOUN	B
gene	I-GENE	NOUN	I
in	O	ADP	O
yeast	O	NOUN	B
revealed	O	VERB	O
a	O	DET	O
second	O	ADJ	O
OG	B-GENE	NOUN	B
glycosylase	I-GENE	NOUN	I
/	I-GENE	SYM	O
lyase	I-GENE	NOUN	B
protein	I-GENE	NOUN	I
,	O	PUNCT	O
tentatively	O	ADV	O
named	O	VERB	O
Ogg2	B-GENE	NOUN	B
,	O	PUNCT	O
which	O	DET	O
differs	O	VERB	O
from	O	ADP	O
Ogg1	B-GENE	NOUN	B
in	O	ADP	O
that	O	SCONJ	O
it	O	PRON	O
preferentially	O	ADV	O
acts	O	VERB	O
on	O	ADP	O
OG	O	NOUN	B
:	O	PUNCT	O
G	O	NOUN	B
.	O	PUNCT	O


Sequence	O	NOUN	B
analysis	O	NOUN	I
of	O	ADP	O
the	O	DET	O
isolated	O	VERB	B
genomic	O	ADJ	B
clone	O	NOUN	I
revealed	O	VERB	B
that	O	SCONJ	O
the	O	DET	O
DNA	O	NOUN	B
binding	O	NOUN	I
domain	O	NOUN	I
of	O	ADP	O
this	O	DET	O
orphan	O	NOUN	B
receptor	O	NOUN	I
is	O	AUX	O
most	O	ADV	O
homologous	O	ADJ	B
to	O	PART	O
the	O	DET	O
human	B-GENE	ADJ	B
TR2	I-GENE	NOUN	B
receptor	I-GENE	NOUN	I
.	O	PUNCT	O


Genomic	O	ADJ	B
DNA	O	NOUN	I
hybridization	O	NOUN	I
suggests	O	VERB	O
that	O	SCONJ	O
SpSHR2	B-GENE	PROPN	B
is	O	AUX	O
a	O	DET	O
single	O	ADJ	B
-	O	PUNCT	O
copy	O	NOUN	B
gene	O	NOUN	I
in	O	ADP	O
the	O	DET	O
S	O	NOUN	B
.	O	PUNCT	O
purpuratus	O	NOUN	O
genome	O	NOUN	B
.	O	PUNCT	O


Its	O	PRON	O
hydropathy	O	ADJ	B
profile	O	NOUN	O
predicts	O	VERB	O
seven	O	NUM	O
transmembrane	O	NOUN	B
spans	O	NOUN	I
and	O	CCONJ	O
a	O	DET	O
hydrophilic	O	ADJ	B
amino	O	NOUN	B
terminus	O	NOUN	I
of	O	ADP	O
approximately	O	ADV	B
100	O	NUM	O
residues	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
it	O	PRON	O
suggests	O	VERB	O
the	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
an	O	DET	O
amphiphilic	O	ADJ	B
alpha	O	NOUN	I
-	O	PUNCT	O
helix	O	NOUN	B
(	O	PUNCT	O
L	O	NOUN	B
-	O	PUNCT	O
61	O	NUM	O
to	O	PART	O
F	O	PROPN	B
-	O	PUNCT	O
97	O	NUM	O
)	O	PUNCT	O
in	O	ADP	O
close	O	ADJ	O
proximity	O	NOUN	B
to	O	PART	O
the	O	DET	O
first	O	ADJ	O
strongly	O	ADV	O
hydrophobic	O	ADJ	B
segment	O	NOUN	O
of	O	ADP	O
ProW	B-GENE	NOUN	B
.	O	PUNCT	O


There	O	PRON	O
are	O	AUX	O
four	O	NUM	O
polyglutamine	O	NOUN	B
motifs	O	NOUN	I
interspersed	O	VERB	B
with	O	ADP	O
histidine	O	NOUN	B
-	O	PUNCT	O
rich	O	ADJ	B
regions	O	NOUN	O
.	O	PUNCT	O


Quantitative	O	ADJ	B
analysis	O	NOUN	I
of	O	ADP	O
plasmid	O	NOUN	B
loss	O	NOUN	B
rates	O	NOUN	I
in	O	ADP	O
cdc28	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
1N	I-GENE	PROPN	B
strains	O	NOUN	B
carrying	O	VERB	O
plasmids	O	NOUN	B
with	O	ADP	O
multiple	O	ADJ	B
replication	O	NOUN	B
origins	O	NOUN	B
suggests	O	VERB	O
that	O	SCONJ	O
a	O	DET	O
defect	O	NOUN	B
in	O	ADP	O
initiating	O	VERB	O
DNA	O	NOUN	B
replication	O	NOUN	I
probably	O	ADV	O
causes	O	VERB	O
this	O	DET	O
plasmid	O	NOUN	B
loss	O	NOUN	B
phenotype	O	NOUN	B
.	O	PUNCT	O


Platelet	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
derived	I-GENE	VERB	B
growth	I-GENE	NOUN	B
factor	I-GENE	NOUN	I
-	O	PUNCT	O
dependent	O	ADJ	B
activation	O	NOUN	B
of	O	ADP	O
phosphatidylinositol	B-GENE	NOUN	B
3	I-GENE	NUM	I
-	I-GENE	PUNCT	O
kinase	I-GENE	NOUN	B
is	O	AUX	O
regulated	O	VERB	O
by	O	ADP	O
receptor	O	NOUN	B
binding	O	NOUN	I
of	O	ADP	O
SH2	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
domain	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
containing	I-GENE	VERB	B
proteins	I-GENE	NOUN	B
which	O	DET	O
influence	O	VERB	B
Ras	B-GENE	NOUN	B
activity	O	NOUN	B
.	O	PUNCT	O


Almost	O	ADV	O
complete	O	ADJ	O
sequence	O	NOUN	O
identity	O	NOUN	B
was	O	AUX	O
found	O	VERB	O
between	O	ADP	O
the	O	DET	O
3	O	NUM	O
'	O	PART	O
end	O	NOUN	O
of	O	ADP	O
the	O	DET	O
DXS6673E	B-GENE	NOUN	B
gene	I-GENE	NOUN	I
and	O	CCONJ	O
two	O	NUM	O
expressed	O	VERB	B
sequence	O	NOUN	O
tags	O	NOUN	O
(	O	PUNCT	O
ESTs	O	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
between	O	ADP	O
the	O	DET	O
5	O	NUM	O
'	O	PART	O
end	O	NOUN	O
of	O	ADP	O
the	O	DET	O
DXS6673E	B-GENE	NOUN	B
gene	I-GENE	NOUN	I
and	O	CCONJ	O
a	O	DET	O
third	O	ADJ	O
EST	O	PROPN	B
.	O	PUNCT	O


Several	O	ADJ	O
of	O	ADP	O
the	O	DET	O
exon	O	NOUN	B
boundaries	O	NOUN	I
correspond	O	VERB	O
to	O	PART	O
the	O	DET	O
boundaries	O	NOUN	B
of	O	ADP	O
functional	O	ADJ	B
domains	O	NOUN	I
in	O	ADP	O
the	O	DET	O
p55	B-GENE	NOUN	B
protein	I-GENE	NOUN	I
.	O	PUNCT	O


Tristetraprolin	B-GENE	NOUN	B
(	O	PUNCT	O
TTP	B-GENE	NOUN	B
)	O	PUNCT	O
is	O	AUX	O
the	O	DET	O
prototype	O	NOUN	B
of	O	ADP	O
a	O	DET	O
group	O	NOUN	B
of	O	ADP	O
potential	O	ADJ	B
transcription	O	NOUN	B
factors	O	NOUN	I
that	O	PRON	O
contain	O	VERB	O
two	O	NUM	O
or	O	CCONJ	O
more	O	ADV	O
unusual	O	ADJ	B
CCCH	O	NOUN	B
zinc	O	NOUN	B
fingers	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
ewes	O	NOUN	B
were	O	AUX	O
returned	O	VERB	O
to	O	ADP	O
normoxia	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
monitoring	O	NOUN	B
was	O	AUX	O
continued	O	VERB	O
for	O	ADP	O
1	O	NUM	O
h	O	NOUN	O
.	O	PUNCT	O


Feline	O	ADJ	B
leukemia	O	NOUN	I
viruses	O	NOUN	B
(	O	PUNCT	O
FeLVs	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
which	O	DET	O
are	O	AUX	O
replication	O	NOUN	B
-	O	PUNCT	O
competent	O	ADJ	B
oncoretroviruses	O	NOUN	B
of	O	ADP	O
the	O	DET	O
domestic	O	ADJ	B
cat	O	NOUN	B
species	O	NOUN	I
,	O	PUNCT	O
are	O	AUX	O
contagiously	O	ADV	B
transmitted	O	VERB	B
in	O	ADP	O
natural	O	ADJ	B
environments	O	NOUN	I
.	O	PUNCT	O


Both	O	CCONJ	O
verapamil	O	NOUN	B
and	O	CCONJ	O
propranolol	O	NOUN	B
can	O	AUX	O
exhibit	O	VERB	O
additive	O	ADJ	B
effects	O	NOUN	I
with	O	ADP	O
adenosine	O	NOUN	B
in	O	ADP	O
prolonging	O	VERB	B
AV	O	NOUN	B
nodal	O	NOUN	I
conduction	O	NOUN	I
time	O	NOUN	I
;	O	PUNCT	O
however	O	ADV	O
,	O	PUNCT	O
only	O	ADV	O
verapamil	O	NOUN	B
can	O	AUX	O
reduce	O	VERB	B
the	O	DET	O
dose	O	NOUN	B
of	O	ADP	O
adenosine	O	NOUN	B
required	O	VERB	O
to	O	PART	O
produce	O	VERB	O
AV	O	NOUN	B
nodal	O	ADJ	O
block	O	NOUN	O
.	O	PUNCT	O


RVR	B-GENE	NOUN	B
'	O	PART	O
loss	O	NOUN	B
of	O	ADP	I
function	O	NOUN	I
'	O	PART	O
studies	O	NOUN	B
by	O	ADP	O
constitutive	O	ADJ	B
over	O	ADP	B
-	O	PUNCT	O
expression	O	NOUN	B
of	O	ADP	O
a	O	DET	O
dominant	O	ADJ	B
negative	O	ADJ	B
RVR	B-GENE	NOUN	B
delta	I-GENE	NOUN	B
E	I-GENE	NOUN	I
resulted	O	VERB	O
in	O	ADP	O
increased	O	VERB	B
levels	O	NOUN	B
of	O	ADP	O
p21Cip1	B-GENE	NOUN	B
/	O	PUNCT	O
Waf1	B-GENE	NOUN	B
and	O	CCONJ	O
myogenin	B-GENE	NOUN	B
mRNAs	I-GENE	NOUN	B
after	O	ADP	O
serum	O	NOUN	B
withdrawal	O	NOUN	B
.	O	PUNCT	O


These	O	DET	O
two	O	NUM	O
repeat	O	NOUN	O
motifs	O	NOUN	B
are	O	AUX	O
organized	O	VERB	B
in	O	ADP	O
an	O	DET	O
extremely	O	ADV	O
well	O	ADV	O
-	O	PUNCT	O
ordered	O	VERB	B
pattern	O	NOUN	B
in	O	ADP	O
each	O	DET	O
domain	O	NOUN	B
,	O	PUNCT	O
which	O	DET	O
suggests	O	VERB	O
that	O	SCONJ	O
SbHRGP3	B-GENE	NOUN	B
belongs	O	VERB	O
to	O	PART	O
a	O	DET	O
new	O	ADJ	O
group	O	NOUN	B
of	O	ADP	O
proteins	O	NOUN	B
having	O	VERB	O
the	O	DET	O
repeat	O	NOUN	O
motifs	O	NOUN	B
of	O	ADP	O
two	O	NUM	O
distinct	O	ADJ	O
groups	O	NOUN	B
of	O	ADP	O
dicot	B-GENE	NOUN	B
extensins	I-GENE	NOUN	B
.	O	PUNCT	O


Two	O	NUM	O
classes	O	NOUN	B
of	O	ADP	O
inactive	O	ADJ	B
receptors	O	NOUN	I
were	O	AUX	O
identified	O	VERB	B
:	O	PUNCT	O
one	O	NUM	O
in	O	ADP	O
which	O	DET	O
both	O	CCONJ	O
transcriptional	O	ADJ	B
activation	O	NOUN	I
and	O	CCONJ	O
dimerization	O	NOUN	B
were	O	AUX	O
compromised	O	VERB	B
and	O	CCONJ	O
a	O	DET	O
second	O	NOUN	O
in	O	ADP	O
which	O	DET	O
only	O	ADV	O
transcriptional	O	ADJ	B
activation	O	NOUN	I
was	O	AUX	O
abolished	O	VERB	O
.	O	PUNCT	O


Here	O	ADV	O
we	O	PRON	O
localize	O	VERB	B
a	O	DET	O
transferable	O	ADJ	O
40	O	NUM	O
-	O	PUNCT	O
amino	O	NOUN	B
acid	O	NOUN	I
region	O	NOUN	I
within	O	ADP	O
the	O	DET	O
LBDs	B-GENE	NOUN	B
of	O	ADP	O
RXR	B-GENE	NOUN	B
,	O	PUNCT	O
RAR	B-GENE	NOUN	B
,	O	PUNCT	O
TR	B-GENE	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
chicken	B-GENE	NOUN	B
ovalbumin	I-GENE	NOUN	B
upstream	I-GENE	ADJ	I
promoter	I-GENE	NOUN	B
transcription	I-GENE	NOUN	I
factor	I-GENE	NOUN	I
that	O	PRON	O
is	O	AUX	O
critical	O	ADJ	O
for	O	ADP	O
determining	O	VERB	O
identity	O	NOUN	B
in	O	ADP	O
the	O	DET	O
heterodimeric	O	ADJ	B
interaction	O	NOUN	I
and	O	CCONJ	O
for	O	ADP	O
high	O	ADJ	B
-	O	PUNCT	O
affinity	O	NOUN	B
DNA	O	NOUN	B
binding	O	NOUN	I
.	O	PUNCT	O


OKA	O	NOUN	B
and	O	CCONJ	O
calyculin	O	NOUN	B
A	O	NOUN	O
do	O	AUX	O
not	O	PART	O
decrease	O	VERB	B
OCFRE	B-GENE	NOUN	B
DNA	O	NOUN	B
-	O	PUNCT	O
protein	O	NOUN	B
interactions	O	NOUN	B
,	O	PUNCT	O
suggesting	O	VERB	O
that	O	SCONJ	O
important	O	ADJ	O
protein	O	NOUN	B
-	O	PUNCT	O
protein	O	NOUN	B
interactions	O	NOUN	B
are	O	AUX	O
phosphatase	O	NOUN	B
regulated	O	VERB	B
.	O	PUNCT	O


IMPLICATIONS	O	NOUN	B
:	O	PUNCT	O
Given	O	VERB	O
the	O	DET	O
small	O	ADJ	B
size	O	NOUN	I
of	O	ADP	O
this	O	DET	O
study	O	NOUN	B
and	O	CCONJ	O
the	O	DET	O
inconsistency	O	NOUN	B
of	O	ADP	O
results	O	NOUN	B
among	O	ADP	O
the	O	DET	O
few	O	ADJ	O
prospective	O	ADJ	B
studies	O	NOUN	I
of	O	ADP	O
ovarian	O	ADJ	B
cancer	O	NOUN	I
conducted	O	VERB	O
to	O	PART	O
test	O	VERB	O
these	O	DET	O
associations	O	NOUN	B
,	O	PUNCT	O
replications	O	NOUN	B
of	O	ADP	O
these	O	DET	O
findings	O	NOUN	B
are	O	AUX	O
highly	O	ADV	O
desirable	O	ADJ	O
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
performed	O	VERB	O
toeprinting	O	NOUN	B
analyses	O	NOUN	I
on	O	ADP	O
repA	B-GENE	NOUN	B
mRNA	I-GENE	NOUN	B
of	O	ADP	O
plasmid	O	NOUN	B
R1	O	NOUN	B
,	O	PUNCT	O
both	O	CCONJ	O
free	O	ADJ	B
and	O	CCONJ	O
in	O	ADP	O
duplex	O	NOUN	B
with	O	ADP	O
the	O	DET	O
antisense	O	ADJ	B
RNA	O	NOUN	I
,	O	PUNCT	O
CopA	B-GENE	NOUN	B
.	O	PUNCT	O


Previous	O	ADJ	O
work	O	NOUN	O
showed	O	VERB	O
that	O	SCONJ	O
repA	B-GENE	NOUN	B
(	O	PUNCT	O
initiator	O	NOUN	B
protein	O	NOUN	I
)	O	PUNCT	O
expression	O	NOUN	B
requires	O	VERB	O
tap	B-GENE	NOUN	B
(	O	PUNCT	O
leader	O	NOUN	B
peptide	O	NOUN	I
)	O	PUNCT	O
translation	O	NOUN	B
.	O	PUNCT	O


Tonsillectomy	O	NOUN	B
is	O	AUX	O
an	O	DET	O
effective	O	ADJ	B
means	O	NOUN	O
of	O	ADP	O
prophylaxis	O	NOUN	B
for	O	ADP	O
upper	O	ADJ	B
respiratory	O	ADJ	I
infection	O	NOUN	I
in	O	ADP	O
habitual	O	ADJ	B
angina	O	ADJ	I
patients	O	NOUN	B
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
were	O	AUX	O
corroborated	O	VERB	O
in	O	ADP	O
a	O	DET	O
subsequent	O	ADJ	O
study	O	NOUN	B
in	O	ADP	O
which	O	DET	O
30	O	NUM	O
hypogonadal	O	ADJ	B
men	O	NOUN	B
were	O	AUX	O
supplemented	O	VERB	B
with	O	ADP	O
SLT	O	NOUN	B
5	O	NUM	O
mg	O	NOUN	O
three	O	NUM	O
times	O	NOUN	O
daily	O	ADV	B
for	O	ADP	O
6	O	NUM	O
months	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
elevations	O	NOUN	B
achieved	O	VERB	O
by	O	ADP	O
LDEE	O	NOUN	B
given	O	VERB	O
s	O	NOUN	O
.	O	PUNCT	O
c	O	X	O
.	O	PUNCT	O
were	O	AUX	O
higher	O	ADJ	O
than	O	ADP	O
those	O	DET	O
achieved	O	VERB	O
after	O	ADP	O
i	O	PRON	O
.	O	PUNCT	O
p	O	NOUN	O
.	O	PUNCT	O
administration	O	NOUN	B
and	O	CCONJ	O
lasted	O	VERB	O
for	O	ADP	O
longer	O	ADJ	B
periods	O	NOUN	B
.	O	PUNCT	O


Many	O	ADJ	O
human	O	ADJ	B
viruses	O	NOUN	I
are	O	AUX	O
able	O	ADJ	O
to	O	PART	O
develop	O	VERB	O
suitable	O	ADJ	O
strategies	O	NOUN	O
for	O	ADP	O
modifying	O	VERB	O
apoptosis	O	NOUN	B
in	O	ADP	O
virus	O	NOUN	B
-	O	PUNCT	O
infected	O	VERB	B
cells	O	NOUN	B
and	O	CCONJ	O
in	O	ADP	O
virus	O	NOUN	B
-	O	PUNCT	O
primed	O	VERB	B
T	O	NOUN	B
cells	O	NOUN	I
.	O	PUNCT	O


Taken	O	VERB	O
together	O	ADV	O
,	O	PUNCT	O
these	O	DET	O
observations	O	NOUN	B
indicate	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
C	O	PROPN	B
-	O	PUNCT	O
terminal	O	ADJ	B
24	O	NUM	O
amino	O	NOUN	B
acids	O	NOUN	I
are	O	AUX	O
sufficient	O	ADJ	O
for	O	ADP	O
NodO	B-GENE	NOUN	B
secretion	O	NOUN	B
although	O	SCONJ	O
the	O	DET	O
region	O	NOUN	B
adjacent	O	ADJ	B
to	O	PART	O
this	O	DET	O
domain	O	NOUN	B
appears	O	VERB	O
to	O	PART	O
affect	O	VERB	O
secretion	O	NOUN	B
efficiency	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
model	O	NOUN	B
also	O	ADV	O
predicts	O	VERB	O
that	O	SCONJ	O
blood	O	NOUN	B
flow	O	NOUN	I
shunt	O	NOUN	I
fraction	O	NOUN	I
(	O	PUNCT	O
Qs	O	PROPN	B
/	O	SYM	O
QT	O	PROPN	B
)	O	PUNCT	O
is	O	AUX	O
directly	O	ADV	O
related	O	VERB	O
to	O	PART	O
the	O	DET	O
oxygen	O	NOUN	B
sine	O	NOUN	I
-	O	PUNCT	O
wave	O	NOUN	B
amplitude	O	NOUN	O
perturbations	O	NOUN	O
transmitted	O	VERB	B
to	O	PART	O
end	O	VERB	B
-	O	PUNCT	O
expired	O	VERB	B
air	O	NOUN	B
and	O	CCONJ	O
arterial	O	ADJ	B
and	O	CCONJ	O
mixed	O	ADJ	B
-	O	PUNCT	O
venous	O	ADJ	B
blood	O	NOUN	I
through	O	ADP	O
two	O	NUM	O
simple	O	ADJ	O
equations	O	NOUN	B
.	O	PUNCT	O


Discrimination	O	NOUN	B
between	O	ADP	O
HIV	O	NOUN	B
-	O	PUNCT	O
1	O	NUM	B
and	O	CCONJ	O
HIV	O	NOUN	B
-	O	PUNCT	O
2	O	NUM	B
showed	O	VERB	O
evidence	O	NOUN	B
for	O	ADP	O
the	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
HIV	O	NOUN	B
-	O	PUNCT	O
1	O	NUM	O
only	O	ADV	O
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
an	O	DET	O
intrinsic	O	ADJ	B
DNA	O	NOUN	B
-	O	PUNCT	O
binding	O	VERB	B
subunit	O	NOUN	I
for	O	ADP	O
HiNF	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
D	I-GENE	NOUN	B
was	O	AUX	O
not	O	PART	O
identified	O	VERB	B
.	O	PUNCT	O


The	O	DET	O
HiNF	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
D	I-GENE	NOUN	B
(	O	PUNCT	O
CDP	B-GENE	PROPN	B
/	O	SYM	O
cut	B-GENE	VERB	B
)	O	PUNCT	O
complex	O	NOUN	O
with	O	ADP	O
the	O	DET	O
H4	B-GENE	NOUN	B
promoter	I-GENE	NOUN	I
is	O	AUX	O
immunoreactive	O	ADJ	B
with	O	ADP	O
antibodies	O	NOUN	B
against	O	ADP	O
CDP	B-GENE	PROPN	B
/	O	PUNCT	O
cut	B-GENE	NOUN	B
and	O	CCONJ	O
pRB	B-GENE	NOUN	B
but	O	CCONJ	O
not	O	PART	O
p107	B-GENE	NOUN	B
,	O	PUNCT	O
whereas	O	SCONJ	O
the	O	DET	O
CDP	B-GENE	PROPN	B
/	O	SYM	O
cut	B-GENE	VERB	B
complex	O	NOUN	I
with	O	ADP	O
a	O	DET	O
nonhistone	O	ADJ	B
promoter	O	NOUN	I
(	O	PUNCT	O
gp91	B-GENE	NOUN	B
-	O	PUNCT	O
phox	B-GENE	NOUN	B
)	O	PUNCT	O
reacts	O	VERB	O
only	O	ADV	O
with	O	ADP	O
CDP	B-GENE	NOUN	B
and	O	CCONJ	O
p107	B-GENE	NOUN	B
antibodies	O	NOUN	I
.	O	PUNCT	O


Eight	O	NUM	O
-	O	PUNCT	O
four	O	NUM	B
ACOAs	O	PROPN	B
were	O	AUX	O
tested	O	VERB	B
in	O	ADP	O
order	O	NOUN	O
to	O	PART	O
examine	O	VERB	O
the	O	DET	O
fit	O	NOUN	B
of	O	ADP	O
the	O	DET	O
model	O	NOUN	B
to	O	ADP	O
the	O	DET	O
data	O	NOUN	B
by	O	ADP	O
path	O	NOUN	B
analysis	O	NOUN	B
with	O	ADP	O
LISREL	O	NOUN	B
VII	O	PROPN	I
.	O	PUNCT	O


Using	O	VERB	O
anchored	O	VERB	B
PCR	O	NOUN	B
,	O	PUNCT	O
a	O	DET	O
VL	B-GENE	NOUN	B
element	I-GENE	NOUN	B
rearranged	O	VERB	O
to	O	PART	O
CL2	B-GENE	NOUN	B
was	O	AUX	O
isolated	O	VERB	B
.	O	PUNCT	O


A	O	DET	O
subset	O	NOUN	O
of	O	ADP	O
these	O	DET	O
DMP1	B-GENE	NOUN	B
recognition	I-GENE	NOUN	B
sequences	I-GENE	NOUN	I
containing	O	VERB	O
a	O	DET	O
GGA	O	NOUN	B
trinucleotide	O	NOUN	I
core	O	NOUN	I
can	O	AUX	O
also	O	ADV	O
function	O	VERB	B
as	O	ADP	O
Ets	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
responsive	I-GENE	ADJ	B
elements	I-GENE	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
both	O	DET	O
settings	O	NOUN	O
,	O	PUNCT	O
it	O	PRON	O
can	O	AUX	O
be	O	AUX	O
phosphorylated	O	VERB	B
by	O	ADP	O
cyclin	B-GENE	NOUN	B
D	I-GENE	NOUN	I
-	I-GENE	PUNCT	O
dependent	I-GENE	ADJ	B
kinases	I-GENE	NOUN	B
,	O	PUNCT	O
suggesting	O	VERB	O
that	O	SCONJ	O
its	O	PRON	O
transcriptional	O	ADJ	B
activity	O	NOUN	I
may	O	AUX	O
normally	O	ADV	O
be	O	AUX	O
regulated	O	VERB	B
through	O	ADP	O
such	O	ADJ	O
mechanisms	O	NOUN	B
.	O	PUNCT	O


Enterococcus	O	X	B
faecium	O	NOUN	I
strains	O	NOUN	B
with	O	ADP	O
vanA	O	NOUN	B
-	O	PUNCT	O
mediated	O	VERB	B
glycopeptide	O	NOUN	B
resistance	O	NOUN	B
were	O	AUX	O
isolated	O	VERB	B
by	O	ADP	O
enrichment	O	NOUN	O
culture	O	NOUN	B
from	O	ADP	O
the	O	DET	O
intestines	O	NOUN	B
and	O	CCONJ	O
feces	O	NOUN	B
of	O	ADP	O
several	O	ADJ	O
animal	O	ADJ	B
species	O	NOUN	I
,	O	PUNCT	O
mainly	O	ADV	O
horses	O	NOUN	B
and	O	CCONJ	O
dogs	O	NOUN	B
(	O	PUNCT	O
8	O	NUM	O
%	O	NOUN	O
positive	O	ADJ	B
)	O	PUNCT	O
,	O	PUNCT	O
chickens	O	NOUN	B
(	O	PUNCT	O
7	O	NUM	O
%	O	NOUN	O
positive	O	ADJ	B
)	O	PUNCT	O
,	O	PUNCT	O
and	O	CCONJ	O
pigs	O	NOUN	B
(	O	PUNCT	O
6	O	NUM	O
%	O	NOUN	O
positive	O	ADJ	B
)	O	PUNCT	O
.	O	PUNCT	O


Oncogenic	O	ADJ	B
activation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
tyrosine	B-GENE	NOUN	B
kinase	I-GENE	NOUN	I
domain	I-GENE	NOUN	I
of	O	ADP	O
the	O	DET	O
human	B-GENE	ADJ	B
trk	I-GENE	NOUN	O
proto	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
oncogene	I-GENE	NOUN	B
by	O	ADP	O
fusion	O	NOUN	B
to	O	PART	O
a	O	DET	O
cell	O	NOUN	B
adhesion	O	NOUN	I
molecule	O	NOUN	I
.	O	PUNCT	O


Physiol	O	NOUN	B
.	O	PUNCT	O


They	O	PRON	O
suggest	O	VERB	O
that	O	SCONJ	O
decreased	O	VERB	B
steady	O	ADJ	B
-	O	PUNCT	O
state	O	NOUN	B
levels	O	NOUN	B
of	O	ADP	O
IME1	B-GENE	NOUN	B
and	O	CCONJ	O
IME2	B-GENE	NOUN	B
mRNA	I-GENE	NOUN	B
were	O	AUX	O
not	O	PART	O
merely	O	ADV	O
the	O	DET	O
result	O	NOUN	B
of	O	ADP	O
non	O	ADJ	B
-	O	PUNCT	O
specific	O	ADJ	B
adverse	O	NOUN	B
affects	O	NOUN	O
on	O	ADP	O
nucleic	O	ADJ	B
acid	O	NOUN	I
metabolism	O	NOUN	I
caused	O	VERB	O
by	O	ADP	O
the	O	DET	O
yvh1	B-GENE	NOUN	B
disruption	O	NOUN	B
.	O	PUNCT	O


RNase	B-GENE	NOUN	B
protection	O	NOUN	B
analysis	O	NOUN	I
of	O	ADP	O
two	O	NUM	O
rRNA	O	NOUN	B
fragments	O	NOUN	B
whose	O	DET	O
genes	O	NOUN	B
are	O	AUX	O
adjacent	O	ADJ	B
provided	O	VERB	O
evidence	O	NOUN	B
for	O	ADP	O
a	O	DET	O
polycistronic	O	ADJ	B
transcript	O	NOUN	B
containing	O	VERB	O
sequences	O	NOUN	O
from	O	ADP	O
both	O	DET	O
,	O	PUNCT	O
as	O	ADV	O
well	O	ADV	O
as	O	ADP	O
separate	O	ADJ	O
small	O	ADJ	B
RNAs	O	NOUN	I
.	O	PUNCT	O


These	O	DET	O
two	O	NUM	O
contigs	O	NOUN	B
contain	O	VERB	O
a	O	DET	O
total	O	NOUN	O
of	O	ADP	O
163	O	NUM	O
open	O	ADJ	B
reading	O	NOUN	I
frames	O	NOUN	I
(	O	PUNCT	O
ORFs	O	NOUN	B
)	O	PUNCT	O
in	O	ADP	O
26	O	NUM	O
-	O	SYM	O
29	O	NUM	O
putative	O	ADJ	B
operons	O	NOUN	I
;	O	PUNCT	O
56	O	NUM	O
ORFs	O	NOUN	B
could	O	AUX	O
be	O	AUX	O
identified	O	VERB	B
with	O	ADP	O
reasonable	O	ADJ	O
certainty	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
evidence	O	NOUN	B
in	O	ADP	O
support	O	NOUN	O
of	O	ADP	O
this	O	DET	O
was	O	AUX	O
derived	O	VERB	O
from	O	ADP	O
the	O	DET	O
fact	O	NOUN	O
that	O	SCONJ	O
the	O	DET	O
affinity	O	NOUN	B
or	O	CCONJ	O
interaction	O	NOUN	B
between	O	ADP	O
the	O	DET	O
two	O	NUM	O
subunits	O	NOUN	B
was	O	AUX	O
impaired	O	VERB	B
as	O	ADP	O
indicated	O	VERB	O
by	O	ADP	O
the	O	DET	O
first	O	ADJ	O
order	O	NOUN	O
rate	O	NOUN	B
constant	O	NOUN	O
of	O	ADP	O
hCG	B-GENE	NOUN	B
alpha	I-GENE	NOUN	I
1	I-GENE	NUM	I
beta	I-GENE	NOUN	I
(	O	PUNCT	O
km	O	NOUN	O
=	O	ADJ	O
4	O	NUM	O
.	O	PUNCT	O
1	O	NUM	O
x	O	NOUN	O
10	O	NUM	O
(	O	PUNCT	O
-	O	PUNCT	O
2	O	NUM	O
)	O	PUNCT	O
min	O	NOUN	B
-	O	PUNCT	O
1	O	NUM	O
)	O	PUNCT	O
at	O	ADP	O
pH	O	NOUN	B
3	O	NUM	I
.	O	PUNCT	O
0	O	NUM	O
at	O	ADP	O
23	O	NUM	O
degrees	O	NOUN	B
C	O	NOUN	O
which	O	DET	O
is	O	AUX	O
one	O	NUM	O
order	O	NOUN	O
of	O	ADP	O
magnitude	O	NOUN	B
greater	O	ADJ	O
relative	O	ADJ	O
to	O	PART	O
rehCG	B-GENE	NOUN	O
(	O	PUNCT	O
kw	O	NOUN	O
=	O	ADJ	O
4	O	NUM	O
.	O	PUNCT	O
6	O	NUM	O
x	O	NOUN	O
10	O	NUM	O
(	O	PUNCT	O
-	O	PUNCT	O
3	O	NUM	O
)	O	PUNCT	O
min	O	NOUN	B
-	O	PUNCT	O
1	O	NUM	O
)	O	PUNCT	O
.	O	PUNCT	O


Rifabutin	O	NOUN	B
has	O	AUX	O
substantial	O	ADJ	O
efficacy	O	NOUN	B
when	O	SCONJ	O
combined	O	VERB	B
with	O	ADP	O
other	O	ADJ	O
agents	O	NOUN	B
.	O	PUNCT	O


Leukemia	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
inhibitory	I-GENE	ADJ	B
factor	I-GENE	NOUN	I
(	O	PUNCT	O
LIF	B-GENE	NOUN	B
)	O	PUNCT	O
is	O	AUX	O
a	O	DET	O
neuropoietin	B-GENE	NOUN	B
able	O	ADJ	O
to	O	PART	O
regulate	O	VERB	B
the	O	DET	O
differentiation	O	NOUN	B
and	O	CCONJ	O
the	O	DET	O
survival	O	NOUN	B
of	O	ADP	O
many	O	ADJ	O
cell	O	NOUN	B
types	O	NOUN	I
,	O	PUNCT	O
which	O	DET	O
include	O	VERB	O
some	O	DET	O
neuronal	O	ADJ	B
populations	O	NOUN	I
.	O	PUNCT	O


Paracrine	O	NOUN	B
activation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
HIV	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	O
LTR	I-GENE	NOUN	B
promoter	I-GENE	NOUN	B
by	O	ADP	O
the	O	DET	O
viral	B-GENE	ADJ	B
Tat	I-GENE	NOUN	I
protein	I-GENE	NOUN	I
is	O	AUX	O
mechanistically	O	ADV	O
similar	O	ADJ	O
to	O	PART	O
trans	O	ADJ	B
-	O	PUNCT	O
activation	O	NOUN	B
within	O	ADP	O
a	O	DET	O
cell	O	NOUN	B
.	O	PUNCT	O


RUSH	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	O
beta	I-GENE	NOUN	B
is	O	AUX	O
a	O	DET	O
95	O	NUM	O
-	O	PUNCT	O
kDa	O	NOUN	B
truncated	O	VERB	B
version	O	NOUN	O
of	O	ADP	O
RUSH	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	O
alpha	I-GENE	NOUN	B
that	O	PRON	O
results	O	VERB	B
from	O	ADP	O
alternative	O	ADJ	B
splicing	O	NOUN	B
of	O	ADP	O
a	O	DET	O
57	O	NUM	O
-	O	PUNCT	O
bp	O	NOUN	B
exon	O	NOUN	B
as	O	ADP	O
confirmed	O	VERB	O
by	O	ADP	O
genomic	O	ADJ	B
cloning	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
mobility	O	NOUN	B
shift	O	NOUN	I
assay	O	NOUN	I
of	O	ADP	O
the	O	DET	O
65	O	NUM	O
bp	O	NOUN	O
(	O	PUNCT	O
-	O	PUNCT	O
318	O	NUM	O
/	O	SYM	O
-	O	PUNCT	O
254	O	NUM	O
)	O	PUNCT	O
fragment	O	NOUN	O
with	O	ADP	O
nuclear	O	ADJ	B
extract	O	NOUN	I
from	O	ADP	O
the	O	DET	O
dark	O	NOUN	B
-	O	PUNCT	O
adapted	O	VERB	B
sample	O	NOUN	B
showed	O	VERB	O
an	O	DET	O
additional	O	ADJ	O
band	O	NOUN	B
,	O	PUNCT	O
not	O	PART	O
seen	O	VERB	O
with	O	ADP	O
the	O	DET	O
light	O	ADJ	B
-	O	PUNCT	O
grown	O	VERB	B
sample	O	NOUN	B
.	O	PUNCT	O


Moreover	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
same	O	ADJ	O
mutations	O	NOUN	B
alter	O	VERB	O
the	O	DET	O
structure	O	NOUN	B
of	O	ADP	O
junB	B-GENE	NOUN	B
5	O	NUM	I
'	O	PART	I
flanking	O	ADJ	I
DNA	O	NOUN	I
within	O	ADP	O
chromatin	O	NOUN	B
.	O	PUNCT	O


RESULTS	O	NOUN	B
:	O	PUNCT	O
The	O	DET	O
age	O	NOUN	B
distribution	O	NOUN	B
was	O	AUX	O
28	O	NUM	O
to	O	PART	O
83	O	NUM	O
years	O	NOUN	O
old	O	ADJ	O
(	O	PUNCT	O
mean	O	NOUN	B
was	O	AUX	O
54	O	NUM	O
.	O	PUNCT	O
1	O	NUM	O
years	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


The	O	DET	O
ERH	B-GENE	NOUN	B
expression	O	NOUN	B
profile	O	NOUN	O
is	O	AUX	O
similar	O	ADJ	O
,	O	PUNCT	O
to	O	PART	O
that	O	DET	O
of	O	ADP	O
An3	B-GENE	NOUN	B
,	O	PUNCT	O
which	O	DET	O
localizes	O	VERB	B
to	O	PART	O
the	O	DET	O
animal	O	ADJ	B
hemisphere	O	NOUN	I
of	O	ADP	O
oocytes	O	NOUN	B
and	O	CCONJ	O
is	O	AUX	O
abundantly	O	ADV	O
expressed	O	VERB	B
in	O	ADP	O
the	O	DET	O
embryo	O	NOUN	B
.	O	PUNCT	O


When	O	SCONJ	O
the	O	DET	O
degree	O	NOUN	B
of	O	ADP	O
exercise	O	NOUN	B
was	O	AUX	O
maximal	O	ADJ	B
,	O	PUNCT	O
mPAP	O	NOUN	B
was	O	AUX	O
maintained	O	VERB	B
,	O	PUNCT	O
SVI	O	PROPN	B
decreased	O	VERB	B
,	O	PUNCT	O
HR	O	NOUN	B
was	O	AUX	O
unchanged	O	ADJ	B
,	O	PUNCT	O
and	O	CCONJ	O
CO	O	NOUN	B
and	O	CCONJ	O
VO2	O	NOUN	B
decreased	O	VERB	B
.	O	PUNCT	O


327	O	NUM	O
and	O	CCONJ	O
736	O	NUM	O
protocols	O	NOUN	B
of	O	ADP	O
postmortem	O	NOUN	B
examinations	O	NOUN	B
from	O	ADP	O
Moscow	O	PROPN	B
hospitals	O	NOUN	I
N	O	NOUN	O
31	O	NUM	O
and	O	CCONJ	O
57	O	NUM	O
,	O	PUNCT	O
respectively	O	ADV	O
,	O	PUNCT	O
were	O	AUX	O
evaluated	O	VERB	B
statistically	O	ADV	B
.	O	PUNCT	O


The	O	DET	O
effect	O	NOUN	B
of	O	ADP	O
six	O	NUM	O
arginine	O	NOUN	B
mutations	O	NOUN	B
of	O	ADP	O
oxidative	O	ADJ	B
phosphorylation	O	NOUN	I
and	O	CCONJ	O
AAC	B-GENE	NOUN	B
expression	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
RI	B-GENE	NOUN	B
alpha	I-GENE	NOUN	I
gene	I-GENE	NOUN	I
is	O	AUX	O
composed	O	VERB	O
of	O	ADP	O
nine	O	NUM	O
coding	O	VERB	B
exons	O	NOUN	I
of	O	ADP	O
varying	O	VERB	O
lengths	O	NOUN	B
,	O	PUNCT	O
separated	O	VERB	O
by	O	ADP	O
introns	O	NOUN	B
,	O	PUNCT	O
giving	O	VERB	O
the	O	DET	O
gene	O	NOUN	B
a	O	DET	O
total	O	ADJ	O
length	O	NOUN	B
of	O	ADP	O
at	O	ADP	O
least	O	ADJ	O
21	O	NUM	O
kb	O	NOUN	O
.	O	PUNCT	O
our	O	PRON	O
recent	O	ADJ	O
cloning	O	NOUN	B
of	O	ADP	O
a	O	DET	O
processed	O	VERB	O
RI	B-GENE	NOUN	B
alpha	I-GENE	NOUN	O
pseudogene	I-GENE	NOUN	O
with	O	ADP	O
a	O	DET	O
5	O	NUM	O
'	O	PART	O
-	O	PUNCT	O
noncoding	O	ADJ	B
region	O	NOUN	I
different	O	ADJ	O
from	O	ADP	O
the	O	DET	O
previously	O	ADV	O
reported	O	VERB	O
RI	B-GENE	NOUN	B
alpha	I-GENE	NOUN	O
complementary	I-GENE	ADJ	O
RNA	I-GENE	NOUN	O
indicated	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
RI	B-GENE	NOUN	B
alpha	I-GENE	NOUN	I
gene	I-GENE	NOUN	I
may	O	AUX	O
have	O	AUX	O
multiple	O	ADJ	O
leader	O	NOUN	B
exons	O	NOUN	I
giving	O	VERB	O
rise	O	NOUN	O
to	O	ADP	O
alternately	O	ADV	O
spliced	O	VERB	B
messenger	O	NOUN	O
RNAs	O	NOUN	O
(	O	PUNCT	O
mRNAs	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


This	O	DET	O
establishes	O	VERB	O
Rad3	B-GENE	NOUN	B
/	O	SYM	O
Mec1	B-GENE	NOUN	B
as	O	ADP	O
the	O	DET	O
only	O	ADV	O
conserved	O	VERB	B
protein	O	NOUN	I
which	O	DET	O
is	O	AUX	O
required	O	VERB	O
for	O	ADP	O
all	O	DET	O
the	O	DET	O
DNA	O	NOUN	B
structure	O	NOUN	I
checkpoints	O	NOUN	I
in	O	ADP	O
both	O	DET	O
yeast	O	NOUN	B
model	O	NOUN	O
systems	O	NOUN	O
.	O	PUNCT	O


The	O	DET	O
identification	O	NOUN	B
of	O	ADP	O
the	O	DET	O
hepatitis	O	NOUN	B
C	O	NOUN	I
virus	O	NOUN	I
as	O	ADP	O
the	O	DET	O
major	O	ADJ	O
cause	O	NOUN	O
of	O	ADP	O
liver	O	NOUN	B
disease	O	NOUN	I
both	O	CCONJ	O
in	O	ADP	O
dialysis	O	NOUN	B
patients	O	NOUN	B
and	O	CCONJ	O
in	O	ADP	O
transplant	O	NOUN	B
patients	O	NOUN	B
has	O	AUX	O
focused	O	VERB	O
attention	O	NOUN	O
on	O	ADP	O
the	O	DET	O
epidemiology	O	NOUN	B
and	O	CCONJ	O
the	O	DET	O
impact	O	NOUN	B
of	O	ADP	O
continuing	O	VERB	B
infection	O	NOUN	I
in	O	ADP	O
these	O	DET	O
patient	O	NOUN	B
groups	O	NOUN	I
.	O	PUNCT	O


Stable	O	ADJ	B
transfection	O	NOUN	B
of	O	ADP	O
the	O	DET	O
BL	O	NOUN	B
cell	O	NOUN	I
line	O	NOUN	I
Raji	O	NOUN	I
with	O	ADP	O
constructs	O	NOUN	B
containing	O	VERB	O
core	O	NOUN	O
promoter	O	NOUN	B
mutations	O	NOUN	I
confirmed	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
proximal	O	ADJ	B
Sp1	B-GENE	NOUN	B
site	I-GENE	NOUN	O
and	O	CCONJ	O
the	O	DET	O
TATA	O	NOUN	B
box	O	NOUN	O
are	O	AUX	O
essential	O	ADJ	B
for	O	ADP	O
the	O	DET	O
activation	O	NOUN	B
of	O	ADP	O
promoter	O	NOUN	B
P1	O	NOUN	I
by	O	ADP	O
the	O	DET	O
Ig	B-GENE	NOUN	B
kappa	I-GENE	NOUN	I
enhancers	I-GENE	NOUN	B
.	O	PUNCT	O


The	O	DET	O
first	O	ADJ	O
identification	O	NOUN	B
of	O	ADP	O
the	O	DET	O
active	O	ADJ	B
37LRP	B-GENE	NOUN	B
/	O	SYM	O
p40	B-GENE	NOUN	B
gene	O	NOUN	O
presented	O	VERB	O
in	O	ADP	O
this	O	DET	O
study	O	NOUN	B
is	O	AUX	O
a	O	DET	O
critical	O	ADJ	O
step	O	NOUN	O
toward	O	ADP	O
the	O	DET	O
isolation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
corresponding	O	ADJ	O
human	O	ADJ	B
gene	O	NOUN	O
and	O	CCONJ	O
the	O	DET	O
understanding	O	NOUN	O
of	O	ADP	O
the	O	DET	O
molecular	O	ADJ	B
mechanisms	O	NOUN	I
involved	O	VERB	O
in	O	ADP	O
the	O	DET	O
up	O	ADJ	B
-	O	PUNCT	O
regulation	O	NOUN	B
of	O	ADP	O
its	O	PRON	O
expression	O	NOUN	B
during	O	ADP	O
tumor	O	NOUN	B
invasion	O	NOUN	I
and	O	CCONJ	O
metastasis	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
promoter	O	NOUN	B
region	O	NOUN	I
(	O	PUNCT	O
P1	O	NOUN	B
)	O	PUNCT	O
corresponding	O	VERB	O
to	O	PART	O
the	O	DET	O
main	O	ADJ	O
group	O	NOUN	B
of	O	ADP	O
transcription	O	NOUN	B
initiation	O	NOUN	I
sites	O	NOUN	I
is	O	AUX	O
devoid	O	ADJ	O
of	O	ADP	O
TATA	O	NOUN	B
and	O	CCONJ	O
CAAT	O	NOUN	B
boxes	O	NOUN	I
but	O	CCONJ	O
has	O	AUX	O
putative	O	ADJ	O
binding	O	VERB	O
sites	O	NOUN	O
for	O	ADP	O
the	O	DET	O
transcription	B-GENE	NOUN	B
factor	I-GENE	NOUN	I
SP1	I-GENE	NOUN	I
and	O	CCONJ	O
is	O	AUX	O
embedded	O	ADJ	O
in	O	ADP	O
a	O	DET	O
large	O	ADJ	O
G	O	NOUN	B
+	O	CCONJ	O
C	O	NOUN	B
-	O	PUNCT	O
rich	O	ADJ	B
domain	O	NOUN	B
of	O	ADP	O
a	O	DET	O
CpG	O	NOUN	B
island	O	NOUN	I
,	O	PUNCT	O
features	O	NOUN	B
shared	O	VERB	O
by	O	ADP	O
the	O	DET	O
promoters	O	NOUN	B
of	O	ADP	O
constitutively	O	ADV	B
expressed	O	VERB	O
housekeeping	O	ADJ	B
genes	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
STAT	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	B
signaling	O	NOUN	B
pathway	O	NOUN	I
provides	O	VERB	O
at	O	ADP	O
least	O	ADJ	O
one	O	NUM	O
mechanism	O	NOUN	B
for	O	ADP	O
activation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
CAEV	B-GENE	NOUN	B
LTR	I-GENE	NOUN	B
by	O	ADP	O
IFN	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
gamma	I-GENE	NOUN	B
in	O	ADP	O
monocytes	O	NOUN	B
.	O	PUNCT	O


Unlike	O	ADP	O
wild	B-GENE	ADJ	B
-	I-GENE	PUNCT	O
type	I-GENE	NOUN	B
p53	I-GENE	NOUN	B
,	O	PUNCT	O
the	O	DET	O
delta	B-GENE	NOUN	B
proAE	I-GENE	NOUN	I
mutant	I-GENE	ADJ	B
cDNA	I-GENE	NOUN	B
can	O	AUX	O
be	O	AUX	O
stably	O	ADV	B
expressed	O	VERB	B
in	O	ADP	O
tumor	O	NOUN	B
derived	O	ADJ	O
cell	O	NOUN	B
lines	O	NOUN	I
with	O	ADP	O
few	O	ADJ	O
immediate	O	ADJ	O
detrimental	O	ADJ	B
effects	O	NOUN	I
.	O	PUNCT	O


Several	O	ADJ	O
artifacts	O	NOUN	B
occurred	O	VERB	O
that	O	PRON	O
interfered	O	VERB	B
with	O	ADP	O
visualization	O	NOUN	B
of	O	ADP	O
the	O	DET	O
diaphragm	O	NOUN	B
.	O	PUNCT	O


During	O	ADP	O
skeletal	O	ADJ	B
muscle	O	NOUN	I
development	O	NOUN	B
,	O	PUNCT	O
different	O	ADJ	O
types	O	NOUN	O
of	O	ADP	O
muscle	O	NOUN	B
fibers	O	NOUN	I
are	O	AUX	O
generated	O	VERB	O
,	O	PUNCT	O
which	O	DET	O
express	O	VERB	O
different	O	ADJ	O
combinations	O	NOUN	B
of	O	ADP	O
muscle	O	NOUN	B
-	O	PUNCT	O
specific	O	ADJ	B
gene	O	NOUN	B
products	O	NOUN	I
.	O	PUNCT	O


Its	O	PRON	O
transcription	O	NOUN	B
product	O	NOUN	I
,	O	PUNCT	O
a	O	DET	O
1	O	NUM	O
.	O	PUNCT	O
3	O	NUM	O
kb	O	NOUN	O
mRNA	O	NOUN	B
,	O	PUNCT	O
is	O	AUX	O
polyadenylated	O	VERB	B
at	O	ADP	O
a	O	DET	O
site	O	NOUN	B
containing	O	VERB	O
consensus	O	NOUN	B
eukaryotic	O	ADJ	O
polyadenylation	O	NOUN	O
signals	O	NOUN	O
and	O	CCONJ	O
mapping	O	VERB	B
87	O	NUM	O
bp	O	NOUN	O
downstream	O	ADJ	B
of	O	ADP	O
the	O	DET	O
translation	O	NOUN	B
termination	O	NOUN	I
codon	O	NOUN	B
for	O	ADP	O
CG30	B-GENE	NOUN	B
.	O	PUNCT	O


BCL	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
2	I-GENE	NUM	O
,	O	PUNCT	O
an	O	DET	O
inhibitor	O	NOUN	B
of	O	ADP	O
apoptosis	O	NOUN	B
in	O	ADP	O
a	O	DET	O
wide	O	ADJ	O
variety	O	NOUN	O
of	O	ADP	O
cell	O	NOUN	B
types	O	NOUN	I
,	O	PUNCT	O
has	O	AUX	O
been	O	AUX	O
reported	O	VERB	O
to	O	PART	O
prevent	O	VERB	B
oxidative	O	ADJ	B
stress	O	NOUN	I
-	O	PUNCT	O
induced	O	VERB	B
cell	O	NOUN	B
death	O	NOUN	I
.	O	PUNCT	O


Full	B-GENE	ADJ	B
-	I-GENE	PUNCT	O
length	I-GENE	NOUN	B
AT	I-GENE	ADP	B
-	I-GENE	PUNCT	O
PHH1	I-GENE	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
both	O	CCONJ	O
AT	B-GENE	ADP	B
-	I-GENE	PUNCT	O
PHH1	I-GENE	NOUN	B
and	O	CCONJ	O
AT	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
PHH1	I-GENE	NOUN	B
delta	I-GENE	NOUN	B
C	I-GENE	NOUN	I
-	I-GENE	PUNCT	O
513	I-GENE	NUM	O
(	O	PUNCT	O
truncated	O	VERB	B
to	O	PART	O
be	O	AUX	O
approximately	O	ADV	O
the	O	DET	O
size	O	NOUN	B
of	O	ADP	O
microbial	B-GENE	ADJ	B
photolyase	I-GENE	NOUN	O
genes	I-GENE	NOUN	O
)	O	PUNCT	O
cDNAs	O	NOUN	B
,	O	PUNCT	O
were	O	AUX	O
overexpressed	O	VERB	B
,	O	PUNCT	O
respectively	O	ADV	O
,	O	PUNCT	O
in	O	ADP	O
yeast	O	NOUN	B
and	O	CCONJ	O
Escherichia	O	X	B
coli	O	X	I
mutants	O	NOUN	B
hypersensitive	O	ADJ	B
to	O	PART	O
ultraviolet	O	ADJ	B
light	O	NOUN	I
.	O	PUNCT	O


Serotonin	O	NOUN	B
concentration	O	NOUN	B
in	O	ADP	O
the	O	DET	O
blood	O	NOUN	B
of	O	ADP	O
patients	O	NOUN	B
with	O	ADP	O
hemorrhagic	O	ADJ	B
fever	O	NOUN	I
with	O	ADP	O
renal	O	ADJ	B
syndrome	O	NOUN	I


Control	O	NOUN	B
examination	O	NOUN	I
was	O	AUX	O
performed	O	VERB	O
at	O	ADP	O
the	O	DET	O
end	O	NOUN	O
of	O	ADP	O
each	O	DET	O
period	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
total	O	ADJ	O
number	O	NOUN	O
of	O	ADP	O
specimens	O	NOUN	B
was	O	AUX	O
131	O	NUM	O
with	O	ADP	O
78	O	NUM	O
nonsmokers	O	NOUN	B
and	O	CCONJ	O
53	O	NUM	O
smokers	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
Experiment	O	NOUN	B
1	O	NUM	O
,	O	PUNCT	O
pups	O	NOUN	B
that	O	PRON	O
had	O	AUX	O
received	O	VERB	O
an	O	DET	O
injection	O	NOUN	B
of	O	ADP	O
the	O	DET	O
noncompetitive	O	ADJ	B
N	B-GENE	NOUN	I
-	I-GENE	PUNCT	O
methyl	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
D	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
aspartate	I-GENE	NOUN	B
receptor	I-GENE	NOUN	I
antagonist	O	NOUN	B
MK	O	PROPN	B
-	O	PUNCT	O
801	O	NUM	O
(	O	PUNCT	O
0	O	NUM	O
.	O	PUNCT	O
1	O	NUM	O
mg	O	NOUN	O
/	O	SYM	O
kg	O	NOUN	B
,	O	PUNCT	O
i	O	X	O
.	O	PUNCT	O
p	O	NOUN	O
.	O	PUNCT	O
)	O	PUNCT	O
either	O	CCONJ	O
30	O	NUM	O
min	O	NOUN	O
before	O	ADP	O
or	O	CCONJ	O
immediately	O	ADV	O
after	O	ADP	O
conditioning	O	NOUN	B
spent	O	VERB	O
less	O	ADJ	O
time	O	NOUN	O
over	O	ADP	O
the	O	DET	O
conditioned	O	ADJ	B
odor	O	NOUN	I
than	O	ADP	O
saline	O	NOUN	B
-	O	PUNCT	O
treated	O	VERB	B
controls	O	NOUN	B
.	O	PUNCT	O


Serotonin	B-GENE	NOUN	B
receptors	I-GENE	NOUN	I
in	O	ADP	O
suicide	O	NOUN	B
victims	O	NOUN	I
with	O	ADP	O
major	O	ADJ	O
depression	O	NOUN	B
.	O	PUNCT	O


Experimental	O	ADJ	B
data	O	NOUN	O
showed	O	VERB	O
that	O	SCONJ	O
these	O	DET	O
abnormal	O	ADJ	B
proteins	O	NOUN	I
are	O	AUX	O
constitutively	O	ADV	B
localized	O	ADJ	I
in	O	ADP	O
the	O	DET	O
nucleus	O	NOUN	B
,	O	PUNCT	O
have	O	AUX	O
lost	O	VERB	O
the	O	DET	O
transcriptional	O	ADJ	B
repressor	O	NOUN	O
functions	O	NOUN	B
typical	O	ADJ	O
of	O	ADP	O
normal	O	ADJ	O
NF	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
kappa	I-GENE	NOUN	B
B2p52	I-GENE	PROPN	B
and	O	CCONJ	O
may	O	AUX	O
be	O	AUX	O
capable	O	ADJ	O
of	O	ADP	O
transactivation	O	NOUN	B
activity	O	NOUN	O
.	O	PUNCT	O


Because	O	SCONJ	O
L	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
plastin	I-GENE	NOUN	B
expression	O	NOUN	B
in	O	ADP	O
tissue	O	NOUN	B
-	O	PUNCT	O
specifically	O	ADV	B
regulated	O	VERB	O
in	O	ADP	O
both	O	CCONJ	O
humans	O	NOUN	B
and	O	CCONJ	O
rodents	O	NOUN	B
,	O	PUNCT	O
it	O	PRON	O
is	O	AUX	O
likely	O	ADJ	O
that	O	SCONJ	O
similar	O	ADJ	O
mechanisms	O	NOUN	B
regulate	O	VERB	B
L	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
plastin	I-GENE	NOUN	B
gene	I-GENE	NOUN	B
expression	O	NOUN	I
in	O	ADP	O
human	O	ADJ	B
and	O	CCONJ	O
rodent	O	ADJ	B
cells	O	NOUN	I
and	O	CCONJ	O
that	O	SCONJ	O
they	O	PRON	O
could	O	AUX	O
be	O	AUX	O
identified	O	VERB	B
by	O	ADP	O
comparing	O	VERB	B
the	O	DET	O
function	O	NOUN	B
and	O	CCONJ	O
nucleotide	O	NOUN	B
sequences	O	NOUN	I
of	O	ADP	O
the	O	DET	O
human	O	ADJ	B
and	O	CCONJ	O
murine	O	ADJ	B
L	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
plastin	I-GENE	NOUN	B
gene	O	NOUN	B
promoters	O	NOUN	I
.	O	PUNCT	O


How	O	SCONJ	O
does	O	AUX	O
a	O	DET	O
nurse	O	NOUN	B
go	O	VERB	O
about	O	ADP	O
maintaining	O	VERB	O
her	O	PRON	O
level	O	NOUN	B
of	O	ADP	O
competence	O	NOUN	B
when	O	SCONJ	O
she	O	PRON	O
is	O	AUX	O
one	O	NUM	O
of	O	ADP	O
the	O	DET	O
few	O	ADJ	O
local	O	ADJ	B
practitioners	O	NOUN	B
in	O	ADP	O
her	O	PRON	O
field	O	NOUN	B
?	O	PUNCT	O
Vancouver	O	PROPN	B
sex	O	NOUN	O
therapist	O	NOUN	O
Bianca	O	PROPN	B
Rucker	O	PROPN	I
is	O	AUX	O
doing	O	VERB	O
it	O	PRON	O
by	O	ADP	O
cultivating	O	VERB	O
a	O	DET	O
network	O	NOUN	B
of	O	ADP	O
colleagues	O	NOUN	B
and	O	CCONJ	O
mentors	O	NOUN	B
in	O	ADP	O
related	O	ADJ	O
fields	O	NOUN	B
both	O	CCONJ	O
at	O	ADP	O
home	O	NOUN	B
and	O	CCONJ	O
across	O	ADP	O
the	O	DET	O
continent	O	NOUN	B
.	O	PUNCT	O


Finally	O	ADV	O
,	O	PUNCT	O
antibody	O	NOUN	B
binding	O	VERB	I
to	O	PART	I
site	O	NOUN	I
IIIa	O	NOUN	I
on	O	ADP	O
the	O	DET	O
hCG	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
ectodomain	I-GENE	NOUN	B
complex	I-GENE	NOUN	O
was	O	AUX	O
also	O	ADV	O
hindered	O	VERB	O
by	O	ADP	O
an	O	DET	O
anti	O	ADJ	B
-	O	PUNCT	O
peptide	O	NOUN	B
mAb	O	NOUN	B
directed	O	VERB	O
against	O	ADP	O
a	O	DET	O
peptide	O	NOUN	B
encoded	O	VERB	B
by	O	ADP	O
the	O	DET	O
eighth	O	ADJ	O
exon	O	NOUN	B
(	O	PUNCT	O
pE	O	NOUN	B
x	O	NOUN	O
8	O	NUM	O
)	O	PUNCT	O
of	O	ADP	O
the	O	DET	O
LHR	B-GENE	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
rlf2	B-GENE	NOUN	B
mutants	I-GENE	NOUN	B
,	O	PUNCT	O
telomeric	O	ADJ	B
chromatin	O	NOUN	I
is	O	AUX	O
perturbed	O	VERB	O
:	O	PUNCT	O
Telomeric	O	ADJ	B
silencing	O	NOUN	I
is	O	AUX	O
reduced	O	VERB	B
and	O	CCONJ	O
Rap1p	B-GENE	NOUN	B
localization	O	NOUN	B
is	O	AUX	O
altered	O	VERB	O
.	O	PUNCT	O


This	O	DET	O
0	O	NUM	O
.	O	PUNCT	O
74	O	NUM	O
kb	O	NOUN	O
cDNA	O	NOUN	B
contains	O	VERB	O
an	O	DET	O
open	O	ADJ	B
reading	O	NOUN	I
frame	O	NOUN	I
(	O	PUNCT	O
ORF	O	NOUN	B
)	O	PUNCT	O
of	O	ADP	O
477	O	NUM	O
bp	O	NOUN	O
encoding	O	VERB	B
a	O	DET	O
polypeptide	O	NOUN	B
of	O	ADP	O
159	O	NUM	O
amino	O	NOUN	B
acids	O	NOUN	I
(	O	PUNCT	O
aa	O	NOUN	B
)	O	PUNCT	O
which	O	DET	O
differs	O	VERB	O
at	O	ADP	O
only	O	ADV	O
one	O	NUM	O
position	O	NOUN	B
(	O	PUNCT	O
position	O	NOUN	O
65	O	NUM	O
)	O	PUNCT	O
from	O	ADP	O
the	O	DET	O
human	B-GENE	ADJ	B
U1	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
C	I-GENE	NOUN	B
protein	I-GENE	NOUN	I
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
action	O	NOUN	B
of	O	ADP	O
each	O	DET	O
cognate	O	ADJ	B
ligand	O	NOUN	B
and	O	CCONJ	O
the	O	DET	O
accessory	O	ADJ	B
cellular	O	ADJ	I
factors	O	NOUN	I
that	O	PRON	O
can	O	AUX	O
differentially	O	ADV	O
regulate	O	VERB	B
the	O	DET	O
transcriptional	O	ADJ	B
responses	O	NOUN	I
of	O	ADP	O
a	O	DET	O
heterodimer	O	NOUN	B
-	O	PUNCT	O
DNA	O	NOUN	B
complex	O	NOUN	I
are	O	AUX	O
not	O	PART	O
well	O	ADV	O
understood	O	VERB	O
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
measured	O	VERB	B
the	O	DET	O
MBF	O	NOUN	B
on	O	ADP	O
incisors	O	NOUN	B
and	O	CCONJ	O
its	O	PRON	O
direction	O	NOUN	B
in	O	ADP	O
three	O	NUM	O
dimensions	O	NOUN	B
for	O	ADP	O
different	O	ADJ	O
jaw	O	NOUN	B
openings	O	NOUN	I
in	O	ADP	O
ten	O	NUM	O
subjects	O	NOUN	B
.	O	PUNCT	O


Clinically	O	ADV	O
meaningful	O	ADJ	O
decreases	O	NOUN	B
due	O	ADP	O
to	O	PART	O
alkalinization	O	NOUN	B
alone	O	ADV	O
within	O	ADP	O
30	O	NUM	O
minutes	O	NOUN	B
are	O	AUX	O
unlikely	O	ADJ	O
.	O	PUNCT	O


In	O	ADP	O
co	O	ADJ	B
-	O	PUNCT	O
transfection	O	NOUN	B
studies	O	NOUN	B
,	O	PUNCT	O
an	O	DET	O
AP	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
2	I-GENE	NUM	B
but	O	CCONJ	O
not	O	PART	O
an	O	DET	O
Egr	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	O
expression	O	NOUN	B
vector	O	NOUN	I
activated	O	VERB	B
VPF	B-GENE	NOUN	B
/	O	SYM	O
VEGF	B-GENE	NOUN	B
transcription	O	NOUN	B
,	O	PUNCT	O
thus	O	ADV	O
indicating	O	VERB	O
that	O	SCONJ	O
AP	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
2	I-GENE	NUM	O
protein	I-GENE	NOUN	B
is	O	AUX	O
functionally	O	ADV	O
important	O	ADJ	O
in	O	ADP	O
TGF	B-GENE	NOUN	B
alpha	I-GENE	NOUN	I
-	O	PUNCT	O
induced	O	VERB	B
VPF	B-GENE	NOUN	B
/	O	SYM	O
VEGF	B-GENE	NOUN	B
gene	O	NOUN	B
expression	O	NOUN	I
.	O	PUNCT	O


Cytohesin	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	O
,	O	PUNCT	O
a	O	DET	O
protein	O	NOUN	B
abundant	O	ADJ	B
in	O	ADP	O
cells	O	NOUN	B
of	O	ADP	O
the	O	DET	O
immune	O	ADJ	B
system	O	NOUN	I
,	O	PUNCT	O
has	O	AUX	O
been	O	AUX	O
proposed	O	VERB	O
to	O	PART	O
be	O	AUX	O
a	O	DET	O
human	O	ADJ	B
homolog	O	NOUN	B
of	O	ADP	O
the	O	DET	O
Saccharomyces	B-GENE	X	B
cerevisiae	I-GENE	X	I
Sec7	I-GENE	NOUN	B
gene	I-GENE	NOUN	I
product	I-GENE	NOUN	O
,	O	PUNCT	O
which	O	DET	O
is	O	AUX	O
crucial	O	ADJ	O
in	O	ADP	O
protein	O	NOUN	B
transport	O	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
this	O	DET	O
regard	O	NOUN	O
,	O	PUNCT	O
it	O	PRON	O
differs	O	VERB	O
from	O	ADP	O
a	O	DET	O
recently	O	ADV	O
reported	O	VERB	O
BFA	O	NOUN	B
-	O	PUNCT	O
sensitive	O	ADJ	B
ARF	B-GENE	PROPN	B
-	O	PUNCT	O
GEP	B-GENE	PROPN	B
that	O	PRON	O
contains	O	VERB	O
a	O	DET	O
Sec7	B-GENE	NOUN	B
domain	I-GENE	NOUN	O
.	O	PUNCT	O


The	O	DET	O
recombinant	O	ADJ	B
protein	O	NOUN	I
was	O	AUX	O
purified	O	VERB	O
to	O	PART	O
homogeneity	O	NOUN	B
by	O	ADP	O
(	O	PUNCT	O
NH4	O	NOUN	B
)	O	PUNCT	O
2SO4	O	NOUN	B
-	O	PUNCT	O
precipitation	O	NOUN	B
and	O	CCONJ	O
affinity	O	NOUN	B
chromatography	O	NOUN	I
on	O	ADP	O
5	O	NUM	O
'	O	PART	O
AMP	O	NOUN	B
-	O	PUNCT	O
Sepharose	O	PROPN	B
.	O	PUNCT	O


Derepression	O	NOUN	B
of	O	ADP	O
gene	O	NOUN	B
expression	O	NOUN	I
mediated	O	VERB	O
by	O	ADP	O
the	O	DET	O
5	O	NUM	O
'	O	PART	O
upstream	O	ADJ	B
region	O	NOUN	I
of	O	ADP	O
the	O	DET	O
isocitrate	B-GENE	ADJ	B
lyase	I-GENE	NOUN	I
gene	I-GENE	NOUN	I
of	I-GENE	ADP	O
Candida	I-GENE	NOUN	B
tropicalis	I-GENE	NOUN	I
is	O	AUX	O
controlled	O	VERB	B
by	O	ADP	O
two	O	NUM	O
distinct	O	ADJ	O
regulatory	O	ADJ	B
pathways	O	NOUN	I
in	O	ADP	O
Saccharomyces	O	X	B
cerevisiae	O	X	I
.	O	PUNCT	O


99mTc	O	ADJ	B
-	O	PUNCT	O
HMPAO	O	NOUN	B
was	O	AUX	O
distributed	O	VERB	B
in	O	ADP	O
the	O	DET	O
territories	O	NOUN	B
of	O	ADP	O
the	O	DET	O
ACA	O	NOUN	B
and	O	CCONJ	O
MCA	O	PROPN	B
in	O	ADP	O
the	O	DET	O
two	O	NUM	O
patients	O	NOUN	B
who	O	PRON	O
were	O	AUX	O
treated	O	VERB	B
with	O	ADP	I
intraarterial	O	ADJ	B
infusion	O	NOUN	B
of	O	ADP	O
papaverine	O	NOUN	B
from	O	ADP	O
the	O	DET	O
C4	O	NOUN	B
segment	O	NOUN	I
,	O	PUNCT	O
but	O	CCONJ	O
was	O	AUX	O
distributed	O	VERB	O
only	O	ADV	O
to	O	ADP	O
the	O	DET	O
territory	O	NOUN	B
of	O	ADP	O
the	O	DET	O
ACA	O	NOUN	B
in	O	ADP	O
four	O	NUM	O
patients	O	NOUN	B
who	O	PRON	O
were	O	AUX	O
treated	O	VERB	B
with	O	ADP	I
intraarterial	O	ADJ	B
infusion	O	NOUN	B
of	O	ADP	O
papaverine	O	NOUN	B
from	O	ADP	O
the	O	DET	O
C1	O	NOUN	B
segment	O	NOUN	B
at	O	ADP	O
1	O	NUM	O
ml	O	NOUN	O
/	O	SYM	O
min	O	NOUN	B
.	O	PUNCT	O


This	O	DET	O
brief	O	ADJ	O
review	O	NOUN	O
analyses	O	VERB	O
these	O	DET	O
interactions	O	NOUN	B
and	O	CCONJ	O
defines	O	VERB	O
clinical	O	ADJ	B
settings	O	NOUN	I
where	O	SCONJ	O
antibiotic	O	ADJ	B
-	O	PUNCT	O
induced	O	VERB	B
endotoxin	O	NOUN	B
release	O	NOUN	B
may	O	AUX	O
prove	O	VERB	O
to	O	PART	O
be	O	AUX	O
clinically	O	ADV	B
relevant	O	ADJ	O
.	O	PUNCT	O


These	O	DET	O
changes	O	NOUN	B
in	O	ADP	O
virus	O	NOUN	B
entry	O	NOUN	O
features	O	NOUN	B
may	O	AUX	O
result	O	VERB	O
in	O	ADP	O
coronaviruses	O	NOUN	B
with	O	ADP	O
novel	O	ADJ	O
pathogenic	O	ADJ	B
properties	O	NOUN	B
.	O	PUNCT	O


Effect	O	NOUN	B
of	O	ADP	O
Azadirachta	O	X	B
indica	O	X	I
hydroalcoholic	O	ADJ	B
leaf	O	NOUN	B
extract	O	NOUN	B
on	O	ADP	O
the	O	DET	O
cardiovascular	O	ADJ	B
system	O	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
cellular	O	ADJ	B
supernatant	O	ADJ	I
fraction	O	NOUN	I
,	O	PUNCT	O
SHRSP	O	NOUN	B
showed	O	VERB	O
a	O	DET	O
decrease	O	NOUN	B
of	O	ADP	O
magnesium	O	NOUN	B
in	O	ADP	O
many	O	ADJ	O
tissues	O	NOUN	B
and	O	CCONJ	O
an	O	DET	O
elevation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
calcium	O	NOUN	B
to	O	PART	O
magnesium	O	NOUN	B
ratio	O	NOUN	I
when	O	SCONJ	O
compared	O	VERB	B
to	O	ADP	O
age	O	NOUN	B
-	O	PUNCT	O
matched	O	VERB	B
WKY	O	NOUN	B
and	O	CCONJ	O
SHRSR	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
reduced	O	VERB	B
NO	O	NOUN	B
production	O	NOUN	B
in	O	ADP	O
these	O	DET	O
cells	O	NOUN	B
was	O	AUX	O
associated	O	VERB	B
with	O	ADP	I
low	O	ADJ	B
levels	O	NOUN	B
of	O	ADP	O
mRNA	O	NOUN	B
of	O	ADP	O
inducible	B-GENE	ADJ	B
NO	I-GENE	NOUN	B
synthetase	I-GENE	NOUN	I
.	O	PUNCT	O


Apart	O	ADV	O
from	O	ADP	O
iron	O	NOUN	B
regulation	O	NOUN	I
,	O	PUNCT	O
sodA	B-GENE	NOUN	B
expression	O	NOUN	B
was	O	AUX	O
affected	O	VERB	B
by	O	ADP	O
changes	O	NOUN	B
in	O	ADP	O
DNA	O	NOUN	B
topology	O	NOUN	I
induced	O	VERB	B
by	O	ADP	O
coumermycin	O	NOUN	B
A	O	NOUN	O
but	O	CCONJ	O
not	O	PART	O
by	O	ADP	O
the	O	DET	O
global	O	ADJ	B
virulence	O	NOUN	I
regulatory	O	ADJ	O
Bvg	B-GENE	ADJ	O
system	I-GENE	NOUN	O
.	O	PUNCT	O


In	O	ADP	O
the	O	DET	O
present	O	ADJ	O
study	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
have	O	AUX	O
isolated	O	VERB	B
and	O	CCONJ	O
sequenced	O	VERB	B
several	O	ADJ	O
p15E	B-GENE	NOUN	B
cDNA	I-GENE	NOUN	B
gene	I-GENE	NOUN	B
fragments	I-GENE	NOUN	I
amplified	O	VERB	B
by	O	ADP	O
means	O	NOUN	O
of	O	ADP	O
polymerase	O	NOUN	B
chain	O	NOUN	I
reaction	O	NOUN	I
(	O	PUNCT	O
PCR	O	NOUN	B
)	O	PUNCT	O
from	O	ADP	O
parental	O	ADJ	B
(	O	PUNCT	O
P815	O	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
xenogenized	O	VERB	B
(	O	PUNCT	O
P815	O	NOUN	B
/	O	SYM	O
DTIC	O	NOUN	B
)	O	PUNCT	O
tumour	O	NOUN	B
cells	O	NOUN	I
.	O	PUNCT	O


Transcriptional	O	ADJ	B
activity	O	NOUN	I
was	O	AUX	O
measured	O	VERB	O
by	O	ADP	O
slot	O	NOUN	B
-	O	PUNCT	O
blot	O	NOUN	B
hybridization	O	NOUN	I
with	O	ADP	O
steady	O	ADJ	B
-	O	PUNCT	O
state	O	NOUN	B
RNA	O	NOUN	B
isolated	O	VERB	B
from	O	ADP	O
lacZ	B-GENE	NOUN	B
+	I-GENE	CCONJ	O
M	I-GENE	NOUN	B
.	I-GENE	PUNCT	O
smegmatis	I-GENE	X	B
clones	O	NOUN	I
.	O	PUNCT	O


Movement	O	ADJ	B
time	O	NOUN	I
and	O	CCONJ	O
kinematic	O	ADJ	B
characteristics	O	NOUN	I
were	O	AUX	O
analyzed	O	VERB	B
together	O	ADV	O
with	O	ADP	O
the	O	DET	O
magnitude	O	NOUN	B
of	O	ADP	O
cerebral	O	ADJ	B
blood	O	NOUN	I
flow	O	NOUN	I
to	O	PART	O
identify	O	VERB	O
areas	O	NOUN	O
of	O	ADP	O
brain	O	NOUN	B
activity	O	NOUN	I
proportionate	O	ADJ	B
to	O	ADP	O
task	O	NOUN	B
and	O	CCONJ	O
movement	O	NOUN	B
variables	O	NOUN	B
.	O	PUNCT	O


Areas	O	NOUN	B
with	O	ADP	O
significantly	O	ADV	O
greater	O	ADJ	O
rCBF	O	NOUN	B
for	O	ADP	O
targeting	O	NOUN	B
were	O	AUX	O
the	O	DET	O
left	O	ADJ	B
motor	O	NOUN	I
cortex	O	NOUN	I
,	O	PUNCT	O
left	O	VERB	B
intraparietal	O	ADJ	I
sulcus	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
left	O	VERB	B
caudate	O	NOUN	I
.	O	PUNCT	O


Recent	O	ADJ	O
studies	O	NOUN	B
have	O	AUX	O
demonstrated	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
U1	B-GENE	NOUN	B
snRNP	I-GENE	NOUN	B
is	O	AUX	O
recruited	O	VERB	O
to	O	PART	O
the	O	DET	O
5	O	NUM	O
'	O	PART	O
splice	O	NOUN	B
site	O	NOUN	I
by	O	ADP	O
protein	O	NOUN	B
/	O	SYM	O
protein	O	NOUN	B
interactions	O	NOUN	B
involving	O	VERB	O
the	O	DET	O
SR	B-GENE	ADJ	B
domains	O	NOUN	B
of	O	ADP	O
the	O	DET	O
U1	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
70K	I-GENE	NOUN	B
protein	I-GENE	NOUN	I
and	O	CCONJ	O
SF2	B-GENE	NOUN	B
/	O	SYM	O
ASF	B-GENE	PROPN	B
.	O	PUNCT	O


Thus	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
tri	O	NOUN	B
-	O	PUNCT	O
snRNP	O	NOUN	B
-	O	PUNCT	O
specific	O	ADJ	B
27K	O	NOUN	B
protein	O	NOUN	I
could	O	AUX	O
potentially	O	ADV	O
be	O	AUX	O
involved	O	VERB	O
in	O	ADP	O
SR	B-GENE	ADJ	B
protein	O	NOUN	I
-	O	PUNCT	O
mediated	O	VERB	B
protein	O	NOUN	B
/	O	SYM	O
protein	O	NOUN	B
interactions	O	NOUN	B
and	O	CCONJ	O
,	O	PUNCT	O
additionally	O	ADV	B
,	O	PUNCT	O
its	O	PRON	O
phosphorylation	O	NOUN	B
state	O	NOUN	O
could	O	AUX	O
modulate	O	VERB	B
pre	O	ADJ	B
-	O	PUNCT	O
mRNA	O	NOUN	B
splicing	O	NOUN	B
.	O	PUNCT	O


Although	O	SCONJ	O
methods	O	NOUN	B
to	O	PART	O
align	O	VERB	O
the	O	DET	O
control	O	NOUN	B
and	O	CCONJ	O
activation	O	NOUN	B
fMR	O	NOUN	B
images	O	NOUN	B
may	O	AUX	O
correct	O	VERB	O
for	O	ADP	O
some	O	DET	O
of	O	ADP	O
this	O	DET	O
motional	O	ADJ	B
error	O	NOUN	I
,	O	PUNCT	O
they	O	PRON	O
will	O	AUX	O
be	O	AUX	O
incomplete	O	ADJ	B
in	O	ADP	O
correcting	O	VERB	B
for	O	ADP	O
those	O	DET	O
that	O	PRON	O
depend	O	VERB	O
on	O	ADP	O
spatial	O	ADJ	B
orientation	O	NOUN	I
.	O	PUNCT	O


Three	O	NUM	O
women	O	NOUN	B
have	O	AUX	O
had	O	AUX	O
abnormal	O	ADJ	B
endocervical	O	ADJ	B
follow	O	NOUN	B
up	O	ADP	I
cytology	O	NOUN	B
suggestive	O	ADJ	O
of	O	ADP	O
residual	O	ADJ	B
disease	O	NOUN	I
.	O	PUNCT	O


This	O	DET	O
site	O	NOUN	B
is	O	AUX	O
upstream	O	ADJ	B
from	O	ADP	O
the	O	DET	O
TATA	O	NOUN	B
box	O	NOUN	O
used	O	VERB	O
in	O	ADP	O
somatic	O	ADJ	B
cells	O	NOUN	I
.	O	PUNCT	O


An	O	DET	O
aromatic	O	ADJ	B
stacking	O	NOUN	I
interaction	O	NOUN	B
between	O	ADP	O
subunits	O	NOUN	B
helps	O	VERB	O
mediate	O	VERB	O
DNA	O	NOUN	B
sequence	O	NOUN	I
specificity	O	NOUN	B
:	O	PUNCT	O
operator	O	NOUN	B
site	O	NOUN	I
discrimination	O	NOUN	B
by	O	ADP	O
phage	B-GENE	NOUN	B
lambda	I-GENE	NOUN	I
cI	I-GENE	NOUN	I
repressor	I-GENE	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
characterized	O	VERB	B
a	O	DET	O
panel	O	NOUN	O
of	O	ADP	O
6	O	NUM	O
monoclonal	O	ADJ	B
antibodies	O	NOUN	I
raised	O	VERB	O
against	O	ADP	O
human	B-GENE	ADJ	B
platelet	I-GENE	NOUN	O
talin	I-GENE	NOUN	O
by	O	ADP	O
Western	O	NOUN	B
blotting	O	NOUN	I
,	O	PUNCT	O
immune	O	ADJ	B
precipitation	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
immunofluorescence	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
shown	O	VERB	O
that	O	SCONJ	O
antibodies	B-GENE	NOUN	B
TA205	I-GENE	NOUN	I
and	O	CCONJ	O
TD77	B-GENE	NOUN	B
disrupt	O	VERB	B
actin	B-GENE	NOUN	B
stress	O	NOUN	I
fibers	O	NOUN	I
and	O	CCONJ	O
focal	O	ADJ	B
adhesions	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
inhibit	O	VERB	B
cell	O	NOUN	B
motility	O	NOUN	I
when	O	SCONJ	O
microinjected	O	VERB	B
into	O	ADP	O
human	O	ADJ	B
fibroblasts	O	NOUN	B
.	O	PUNCT	O


Here	O	ADV	O
we	O	PRON	O
report	O	VERB	O
the	O	DET	O
purification	O	NOUN	B
of	O	ADP	O
this	O	DET	O
larger	O	ADJ	O
form	O	NOUN	O
as	O	ADP	O
an	O	DET	O
approximately	O	ADV	O
320	O	NUM	O
-	O	PUNCT	O
kDa	O	NOUN	B
particle	O	NOUN	B
that	O	PRON	O
contains	O	VERB	O
mRNP3	B-GENE	NOUN	B
+	I-GENE	CCONJ	O
4	I-GENE	NUM	O
and	O	CCONJ	O
nine	O	NUM	O
additional	O	ADJ	O
polypeptides	O	NOUN	B
,	O	PUNCT	O
including	O	VERB	O
mRNA	O	NOUN	B
-	O	PUNCT	O
binding	O	VERB	B
polypeptides	O	NOUN	B
of	O	ADP	O
34	O	NUM	O
and	O	CCONJ	O
36	O	NUM	O
kDa	O	NOUN	O
and	O	CCONJ	O
a	O	DET	O
doublet	O	NOUN	B
of	O	ADP	O
110	O	NUM	O
/	O	SYM	O
105	O	NUM	O
kDa	O	NOUN	O
that	O	PRON	O
proved	O	VERB	O
to	O	PART	O
be	O	AUX	O
nucleolin	B-GENE	NOUN	B
.	O	PUNCT	O


This	O	DET	O
study	O	NOUN	B
indicates	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
phenotype	O	NOUN	B
of	O	ADP	O
myofibrillar	O	ADJ	B
disarray	O	NOUN	I
seen	O	VERB	O
in	O	ADP	O
HCM	O	NOUN	B
patients	O	NOUN	B
which	O	DET	O
harbor	O	VERB	O
either	O	DET	O
of	O	ADP	O
these	O	DET	O
two	O	NUM	O
mutations	O	NOUN	B
may	O	AUX	O
not	O	PART	O
be	O	AUX	O
directly	O	ADV	O
due	O	ADJ	O
to	O	PART	O
the	O	DET	O
failure	O	NOUN	B
of	O	ADP	O
the	O	DET	O
mutant	B-GENE	ADJ	B
myosin	I-GENE	NOUN	O
heavy	I-GENE	ADJ	O
chain	I-GENE	NOUN	O
protein	I-GENE	NOUN	O
to	O	PART	O
assemble	O	VERB	B
and	O	CCONJ	O
form	O	VERB	O
normal	O	ADJ	O
sarcomeres	O	NOUN	O
,	O	PUNCT	O
but	O	CCONJ	O
may	O	AUX	O
rather	O	ADV	O
be	O	AUX	O
a	O	DET	O
secondary	O	ADJ	B
effect	O	NOUN	I
possibly	O	ADV	O
resulting	O	VERB	O
from	O	ADP	O
the	O	DET	O
chronic	O	ADJ	B
stress	O	NOUN	I
of	O	ADP	O
decreased	O	VERB	B
beta	B-GENE	NOUN	B
MHC	I-GENE	NOUN	I
function	O	NOUN	B
.	O	PUNCT	O


A	O	DET	O
method	O	NOUN	B
for	O	ADP	O
the	O	DET	O
simultaneous	O	ADJ	B
determination	O	NOUN	B
of	O	ADP	O
de	O	X	O
(	O	PUNCT	O
N	O	NOUN	B
-	O	PUNCT	O
methyl	O	NOUN	B
)	O	PUNCT	O
-	O	PUNCT	O
N	O	NOUN	B
-	O	PUNCT	O
ethyl	O	NOUN	B
-	O	PUNCT	O
8	O	NUM	O
,	O	PUNCT	O
9	O	NUM	B
-	O	PUNCT	O
anhydroerythromycin	O	NOUN	B
A	O	NOUN	O
6	O	NUM	O
,	O	PUNCT	O
9	O	NUM	B
-	O	PUNCT	O
hemiacetal	O	NOUN	B
(	O	PUNCT	O
EM523	O	NOUN	B
,	O	PUNCT	O
I	O	NUM	B
)	O	PUNCT	O
and	O	CCONJ	O
its	O	PRON	O
three	O	NUM	O
metabolites	O	NOUN	B
in	O	ADP	O
human	O	ADJ	B
plasma	O	NOUN	B
and	O	CCONJ	O
urine	O	NOUN	B
has	O	AUX	O
been	O	AUX	O
developed	O	VERB	O
using	O	VERB	O
high	O	ADJ	B
-	O	PUNCT	O
performance	O	NOUN	B
liquid	O	ADJ	O
chromatography	O	NOUN	O
(	O	PUNCT	O
HPLC	O	NOUN	B
)	O	PUNCT	O
with	O	ADP	O
chemiluminescence	O	NOUN	B
(	O	PUNCT	O
CL	O	NOUN	B
)	O	PUNCT	O
detection	O	NOUN	B
.	O	PUNCT	O


Cotransfection	O	NOUN	B
of	O	ADP	O
Ets	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
2	I-GENE	NUM	B
and	O	CCONJ	O
p44	B-GENE	NOUN	B
mitogen	B-GENE	NOUN	I
-	I-GENE	PUNCT	O
activated	I-GENE	VERB	B
protein	I-GENE	NOUN	I
(	I-GENE	PUNCT	O
MAP	I-GENE	NOUN	B
)	I-GENE	PUNCT	O
kinase	I-GENE	NOUN	B
expression	O	NOUN	I
vectors	O	NOUN	I
strongly	O	ADV	O
potentiated	O	VERB	B
HB	B-GENE	PROPN	B
-	O	PUNCT	O
EGF	B-GENE	NOUN	B
promoter	O	NOUN	B
activation	O	NOUN	I
in	O	ADP	O
response	O	NOUN	B
to	O	PART	O
deltaRaf	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	O
:	O	PUNCT	O
ER	B-GENE	NOUN	B
.	O	PUNCT	O


The	O	DET	O
Rlm1	B-GENE	NOUN	B
protein	I-GENE	NOUN	I
,	O	PUNCT	O
a	O	DET	O
member	O	NOUN	B
of	O	ADP	O
the	O	DET	O
MADS	B-GENE	NOUN	B
box	I-GENE	NOUN	O
family	I-GENE	NOUN	O
of	O	ADP	O
transcription	O	NOUN	B
factors	O	NOUN	I
,	O	PUNCT	O
functions	O	VERB	B
downstream	O	ADV	B
of	O	ADP	O
Mpk1	B-GENE	NOUN	B
in	O	ADP	O
the	O	DET	O
pathway	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
likelihood	O	NOUN	B
that	O	PRON	O
a	O	DET	O
common	O	ADJ	O
region	O	NOUN	O
of	O	ADP	O
deletions	O	NOUN	B
would	O	AUX	O
contain	O	VERB	O
a	O	DET	O
tumor	O	NOUN	B
suppressor	O	NOUN	I
is	O	AUX	O
strongly	O	ADV	O
enhanced	O	VERB	B
by	O	ADP	O
coincidence	O	NOUN	O
of	O	ADP	O
that	O	DET	O
region	O	NOUN	B
with	O	ADP	O
a	O	DET	O
chromosome	O	NOUN	B
fragment	O	NOUN	I
suppressing	O	NOUN	B
tumorigenicity	O	NOUN	B
upon	O	SCONJ	O
introduction	O	NOUN	B
in	O	ADP	O
tumor	O	NOUN	B
cells	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
carboxyl	O	ADJ	B
-	O	PUNCT	O
terminal	O	ADJ	B
CCCC	O	NOUN	B
module	O	NOUN	I
is	O	AUX	O
structurally	O	ADV	O
related	O	ADJ	O
to	O	PART	O
the	O	DET	O
DNA	O	NOUN	B
-	O	PUNCT	O
binding	O	VERB	B
domain	O	NOUN	O
of	O	ADP	O
the	O	DET	O
erythroid	B-GENE	ADJ	B
transcription	I-GENE	NOUN	I
factor	I-GENE	NOUN	I
GATA	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	O
.	O	PUNCT	O


The	O	DET	O
different	O	ADJ	O
holoenzyme	B-GENE	NOUN	B
RNA	I-GENE	NOUN	O
polymerases	I-GENE	NOUN	O
generated	O	VERB	O
upon	O	SCONJ	O
reconstituting	O	VERB	B
these	O	DET	O
mutants	O	NOUN	B
independently	O	ADV	O
with	O	ADP	O
core	B-GENE	NOUN	B
RNA	I-GENE	NOUN	I
polymerase	I-GENE	NOUN	I
(	O	PUNCT	O
alpha2beta	B-GENE	NOUN	B
beta	I-GENE	NOUN	I
'	I-GENE	PUNCT	I
)	O	PUNCT	O
have	O	AUX	O
shown	O	VERB	O
reduced	O	VERB	O
transcriptional	O	ADJ	B
activity	O	NOUN	I
in	O	ADP	O
comparison	O	NOUN	B
to	O	PART	O
the	O	DET	O
enzyme	O	NOUN	B
containing	O	VERB	O
wild	B-GENE	ADJ	B
-	I-GENE	PUNCT	O
type	I-GENE	NOUN	B
sigma	I-GENE	NOUN	I
factor	I-GENE	NOUN	I
.	O	PUNCT	O


These	O	DET	O
data	O	NOUN	B
are	O	AUX	O
consistent	O	ADJ	B
with	O	ADP	I
a	O	DET	O
model	O	NOUN	B
in	O	ADP	O
which	O	DET	O
GATA	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
5	I-GENE	NUM	O
performs	O	VERB	O
a	O	DET	O
unique	O	ADJ	B
temporally	O	ADV	B
and	O	CCONJ	O
spatially	O	ADV	B
restricted	O	ADJ	I
function	O	NOUN	I
in	O	ADP	O
the	O	DET	O
embryonic	O	ADJ	B
heart	O	NOUN	I
and	O	CCONJ	O
lung	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
similar	O	ADJ	O
phenotypes	O	NOUN	B
of	O	ADP	O
bur6	B-GENE	NOUN	B
and	O	CCONJ	O
bur3	B-GENE	NOUN	B
(	O	PUNCT	O
mot1	B-GENE	NOUN	B
)	O	PUNCT	O
mutations	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
Bur6p	B-GENE	NOUN	B
and	O	CCONJ	O
Mot1p	B-GENE	NOUN	B
have	O	AUX	O
related	O	VERB	O
,	O	PUNCT	O
but	O	CCONJ	O
not	O	PART	O
identical	O	ADJ	B
,	O	PUNCT	O
functions	O	NOUN	B
in	O	ADP	O
modulating	O	VERB	B
the	O	DET	O
activity	O	NOUN	B
of	O	ADP	O
the	O	DET	O
general	O	ADJ	B
transcription	O	NOUN	I
machinery	O	NOUN	I
in	O	X	B
vivo	O	X	I
.	O	PUNCT	O


A	O	DET	O
genetic	O	ADJ	B
screen	O	NOUN	I
applied	O	VERB	O
to	O	ADP	O
mutants	O	NOUN	B
in	O	ADP	O
the	O	DET	O
branch	O	NOUN	B
site	O	NOUN	I
region	O	NOUN	I
shows	O	VERB	O
that	O	SCONJ	O
all	O	DET	O
positions	O	NOUN	B
in	O	ADP	O
the	O	DET	O
conserved	O	VERB	O
TACTAAC	O	NOUN	B
sequence	O	NOUN	O
are	O	AUX	O
important	O	ADJ	O
for	O	ADP	O
intron	O	NOUN	B
recognition	O	NOUN	O
.	O	PUNCT	O


Implication	O	NOUN	B
of	O	ADP	O
PAF	B-GENE	NOUN	B
and	O	CCONJ	O
acetylhydrolase	B-GENE	NOUN	B
(	O	PUNCT	O
PAF	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
AH	I-GENE	PROPN	B
)	O	PUNCT	O
activity	O	NOUN	B
in	O	ADP	O
periodontal	O	ADJ	B
disease	O	NOUN	I
.	O	PUNCT	O


A	O	DET	O
polypeptide	O	NOUN	B
encoded	O	VERB	B
by	O	ADP	O
the	O	DET	O
NTS	O	PROPN	B
16	O	NUM	O
open	O	ADJ	B
reading	O	NOUN	I
frame	O	NOUN	I
has	O	AUX	O
sequence	O	NOUN	B
similarity	O	NOUN	B
to	O	PART	O
the	O	DET	O
catalytic	O	ADJ	B
domain	O	NOUN	I
of	O	ADP	O
several	O	ADJ	O
receptor	B-GENE	NOUN	B
protein	I-GENE	NOUN	I
kinases	I-GENE	NOUN	I
from	I-GENE	ADP	O
plants	I-GENE	NOUN	B
including	O	VERB	O
the	O	DET	O
S	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
receptor	I-GENE	NOUN	B
kinases	I-GENE	NOUN	I
implicated	O	VERB	O
in	O	ADP	O
the	O	DET	O
rejection	O	NOUN	B
of	O	ADP	O
self	O	NOUN	B
-	O	PUNCT	O
pollen	O	NOUN	B
in	O	ADP	O
Brassica	O	PROPN	B
species	O	NOUN	I
and	O	CCONJ	O
the	O	DET	O
Pto	B-GENE	NOUN	B
gene	I-GENE	NOUN	I
product	I-GENE	NOUN	O
of	I-GENE	ADP	O
tomato	I-GENE	NOUN	B
which	O	DET	O
confers	O	VERB	O
resistance	O	NOUN	B
to	O	PART	O
a	O	DET	O
bacterial	O	ADJ	B
pathogen	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
atp	B-GENE	NOUN	B
1	I-GENE	NUM	I
and	O	CCONJ	O
atp	B-GENE	ADJ	B
2	I-GENE	NUM	I
types	O	NOUN	I
of	O	ADP	O
cDNA	O	NOUN	B
sequences	O	NOUN	I
were	O	AUX	O
the	O	DET	O
most	O	ADV	O
redundant	O	ADJ	O
among	O	ADP	O
the	O	DET	O
28	O	NUM	O
different	O	ADJ	O
isoperoxidases	B-GENE	NOUN	B
identified	O	VERB	B
among	O	ADP	O
about	O	ADV	O
200	O	NUM	O
peroxidase	B-GENE	NOUN	B
encoding	I-GENE	NOUN	B
ESTs	I-GENE	NOUN	B
.	O	PUNCT	O


Glycemic	O	ADJ	B
response	O	NOUN	I
to	O	ADP	O
malted	O	VERB	B
,	O	PUNCT	O
popped	O	VERB	B
and	O	CCONJ	O
roller	O	NOUN	B
dried	O	VERB	O
wheat	O	NOUN	B
-	O	PUNCT	O
legume	O	NOUN	B
based	O	VERB	O
foods	O	NOUN	B
in	O	ADP	O
normal	O	ADJ	B
subjects	O	NOUN	I
.	O	PUNCT	O


4	O	X	O
.	O	PUNCT	O
26	O	NUM	O
+	O	CCONJ	O
/	O	SYM	O
-	O	PUNCT	O
1	O	NUM	O
.	O	PUNCT	O
54	O	NUM	O
mmol	O	NOUN	O
/	O	SYM	O
l	O	NOUN	O
,	O	PUNCT	O
P	O	NOUN	O
<	O	X	O
0	O	NUM	O
.	O	PUNCT	O
01	O	NUM	O
)	O	PUNCT	O
,	O	PUNCT	O
and	O	CCONJ	O
systolic	O	NOUN	B
BP	O	NOUN	I
responses	O	NOUN	B
to	O	PART	O
intravenous	O	ADJ	B
norepinephrine	O	NOUN	B
and	O	CCONJ	O
angiotensin	B-GENE	NOUN	B
II	I-GENE	NUM	I
were	O	AUX	O
significantly	O	ADV	O
higher	O	ADJ	O
on	O	ADP	O
glibenclamide	O	NOUN	B
than	O	ADP	O
on	O	ADP	O
metformin	O	NOUN	B
(	O	PUNCT	O
P	O	NOUN	O
<	O	X	O
0	O	NUM	O
.	O	PUNCT	O
02	O	NUM	O
and	O	CCONJ	O
P	O	NOUN	O
<	O	X	O
0	O	NUM	O
.	O	PUNCT	O
05	O	NUM	O
,	O	PUNCT	O
respectively	O	ADV	O
)	O	PUNCT	O
.	O	PUNCT	O


Is	O	AUX	O
leishmaniasis	O	NOUN	B
endemic	O	ADJ	B
on	O	ADP	O
the	O	DET	O
island	O	NOUN	B
of	O	ADP	O
Minorca	O	PROPN	B
(	O	PUNCT	O
Spain	O	PROPN	B
)	O	PUNCT	O
?	O	PUNCT	O
A	O	DET	O
human	O	ADJ	B
visceral	O	ADJ	B
case	O	NOUN	O
after	O	ADP	O
living	O	VERB	B
13	O	NUM	O
years	O	NOUN	B
in	O	ADP	O
Minorca	O	PROPN	B
.	O	PUNCT	O


RESULTS	O	NOUN	B
:	O	PUNCT	O
Surprisingly	O	ADV	O
,	O	PUNCT	O
PAF	B-GENE	NOUN	B
blockade	O	VERB	B
increased	O	VERB	B
mortality	O	NOUN	B
after	O	ADP	O
trauma	O	NOUN	B
(	O	PUNCT	O
5	O	NUM	O
of	O	ADP	O
11	O	NUM	O
WEB	O	NOUN	B
-	O	PUNCT	O
2086	O	NUM	B
animals	O	NOUN	B
versus	O	CCONJ	O
1	O	NUM	O
of	O	ADP	O
9	O	NUM	O
vehicle	O	NOUN	B
animals	O	NOUN	B
;	O	PUNCT	O
p	O	NOUN	O
=	O	ADJ	O
0	O	NUM	O
.	O	PUNCT	O
15	O	NUM	O
)	O	PUNCT	O
and	O	CCONJ	O
depressed	O	ADJ	B
cardiac	O	ADJ	I
index	O	NOUN	I
and	O	CCONJ	O
O2	O	NOUN	B
delivery	O	NOUN	I
at	O	ADP	O
72	O	NUM	O
hours	O	NOUN	B
(	O	PUNCT	O
p	O	NOUN	O
<	O	X	O
0	O	NUM	O
.	O	PUNCT	O
05	O	NUM	O
)	O	PUNCT	O
.	O	PUNCT	O


This	O	DET	O
finding	O	NOUN	B
is	O	AUX	O
the	O	DET	O
first	O	ADJ	O
example	O	NOUN	O
of	O	ADP	O
utilization	O	NOUN	B
of	O	ADP	O
noncomplementary	O	ADJ	B
dinucleotide	O	NOUN	I
primer	O	NOUN	I
by	O	ADP	O
an	O	DET	O
RNA	B-GENE	NOUN	B
polymerase	I-GENE	NOUN	I
.	O	PUNCT	O


Pure	O	ADJ	B
T1	O	NOUN	I
and	O	CCONJ	O
dual	O	ADJ	B
-	O	PUNCT	O
T1	O	NOUN	B
images	O	NOUN	B
were	O	AUX	O
visually	O	ADV	B
evaluated	O	VERB	B
for	O	ADP	O
image	O	NOUN	B
quality	O	NOUN	I
(	O	PUNCT	O
IQ	O	NOUN	B
)	O	PUNCT	O
on	O	ADP	O
a	O	DET	O
five	O	NUM	B
-	O	PUNCT	O
point	O	NOUN	B
scale	O	NOUN	I
(	O	PUNCT	O
0	O	NUM	O
=	O	ADJ	O
unacceptable	O	ADJ	O
to	O	PART	O
4	O	NUM	O
=	O	ADJ	O
excellent	O	ADJ	B
)	O	PUNCT	O
.	O	PUNCT	O


This	O	DET	O
conformer	O	NOUN	B
features	O	NOUN	B
a	O	DET	O
Type	O	NOUN	B
I	O	NUM	I
beta	O	NOUN	I
-	O	PUNCT	O
turn	O	NOUN	B
and	O	CCONJ	O
has	O	AUX	O
extensive	O	ADJ	O
hydrophobic	O	ADJ	B
contacts	O	NOUN	O
with	O	ADP	O
the	O	DET	O
FKBP12	B-GENE	NOUN	B
binding	O	NOUN	O
surface	O	NOUN	O
.	O	PUNCT	O


Children	O	NOUN	B
'	O	PART	O
s	O	NOUN	O
temperament	O	NOUN	B
and	O	CCONJ	O
maternal	O	ADJ	B
socialization	O	NOUN	B
at	O	ADP	O
Time	O	NOUN	B
1	O	NUM	I
(	O	PUNCT	O
n	O	NOUN	O
=	O	ADJ	O
103	O	NUM	O
,	O	PUNCT	O
aged	O	ADJ	B
2	O	NUM	O
-	O	SYM	O
3	O	NUM	O
years	O	NOUN	B
)	O	PUNCT	O
were	O	AUX	O
considered	O	VERB	O
predictors	O	NOUN	B
of	O	ADP	O
future	O	ADJ	B
conscience	O	NOUN	B
,	O	PUNCT	O
assessed	O	VERB	B
using	O	VERB	O
new	O	ADJ	O
observational	O	ADJ	B
and	O	CCONJ	O
narrative	O	ADJ	B
measures	O	NOUN	I
.	O	PUNCT	O


One	O	NUM	O
P1	O	NOUN	O
genomic	O	ADJ	B
clone	O	NOUN	I
and	O	CCONJ	O
six	O	NUM	O
subsequent	O	ADJ	O
plasmid	O	NOUN	B
subclones	O	NOUN	B
were	O	AUX	O
isolated	O	VERB	B
and	O	CCONJ	O
analyzed	O	VERB	B
for	O	ADP	O
the	O	DET	O
exon	O	NOUN	B
-	O	PUNCT	O
intron	O	NOUN	B
organization	O	NOUN	B
of	O	ADP	O
the	O	DET	O
Ctpct	B-GENE	NOUN	B
gene	I-GENE	NOUN	I
.	O	PUNCT	O


Congruent	O	ADJ	B
with	O	ADP	O
empirical	O	ADJ	B
predictions	O	NOUN	B
,	O	PUNCT	O
the	O	DET	O
most	O	ADV	O
homesick	O	ADJ	B
children	O	NOUN	B
perceived	O	VERB	O
low	O	ADJ	B
control	O	NOUN	I
over	O	ADP	O
homesickness	O	NOUN	B
and	O	CCONJ	O
separation	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
coped	O	VERB	O
by	O	ADP	O
relinquishing	O	VERB	B
control	O	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
also	O	ADV	O
review	O	VERB	B
the	O	DET	O
role	O	NOUN	O
of	O	ADP	O
grains	O	NOUN	B
in	O	ADP	O
the	O	DET	O
formation	O	NOUN	B
of	O	ADP	O
complex	O	ADJ	B
molecules	O	NOUN	B
in	O	ADP	O
interstellar	O	ADJ	B
molecular	O	ADJ	I
clouds	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
C	O	PROPN	B
-	O	PUNCT	O
LIP	O	PROPN	B
also	O	ADV	O
was	O	AUX	O
compared	O	VERB	B
with	O	ADP	O
transcather	O	ADJ	B
arterial	O	ADJ	I
embolization	O	NOUN	I
(	O	PUNCT	O
TAE	O	NOUN	B
;	O	PUNCT	O
C	O	NOUN	B
-	O	PUNCT	O
LIP	O	NOUN	B
followed	O	VERB	O
by	O	ADP	O
gelatin	O	NOUN	B
sponge	O	NOUN	O
)	O	PUNCT	O
and	O	CCONJ	O
percutaneous	O	ADJ	B
ethanol	O	NOUN	I
injection	O	NOUN	I
therapy	O	NOUN	I
(	O	PUNCT	O
PEIT	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


We	O	PRON	O
also	O	ADV	O
demonstrate	O	VERB	O
that	O	SCONJ	O
preformed	O	ADJ	B
triplexes	O	NOUN	B
are	O	AUX	O
quite	O	ADV	O
stable	O	ADJ	B
when	O	SCONJ	O
precipitated	O	VERB	B
with	O	ADP	I
ethanol	O	NOUN	B
and	O	CCONJ	O
resuspended	O	VERB	B
in	O	ADP	O
water	O	NOUN	B
.	O	PUNCT	O


Transfection	O	NOUN	B
experiments	O	NOUN	B
using	O	VERB	O
preformed	O	ADJ	B
triplexes	O	NOUN	B
with	O	ADP	O
a	O	DET	O
reporter	O	NOUN	B
plasmid	O	NOUN	I
containing	O	VERB	O
the	O	DET	O
collagen	B-GENE	NOUN	B
promoter	I-GENE	NOUN	B
sequence	I-GENE	NOUN	I
showed	O	VERB	O
significant	O	ADJ	O
inhibition	O	NOUN	B
of	O	ADP	O
transcription	O	NOUN	B
when	O	SCONJ	O
compared	O	VERB	B
with	O	ADP	O
a	O	DET	O
control	O	ADJ	B
phosphorothioate	O	NOUN	B
ODN	O	NOUN	B
.	O	PUNCT	O


Thus	O	ADV	O
,	O	PUNCT	O
an	O	DET	O
increase	O	NOUN	B
in	O	ADP	O
plasma	B-GENE	NOUN	B
TBG	I-GENE	NOUN	B
and	O	CCONJ	O
a	O	DET	O
shift	O	NOUN	B
from	O	ADP	O
adrenal	O	ADJ	B
androgen	O	NOUN	I
and	O	CCONJ	O
mineralocorticoid	O	NOUN	B
steroid	O	NOUN	B
secretion	O	NOUN	I
towards	O	ADP	O
cortisol	O	NOUN	B
secretion	O	NOUN	I
may	O	AUX	O
be	O	AUX	O
endocrine	O	ADJ	B
markers	O	NOUN	B
for	O	ADP	O
progression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
disease	O	NOUN	B
in	O	ADP	O
patients	O	NOUN	B
with	O	ADP	O
HIV	O	NOUN	B
-	O	PUNCT	O
infection	O	NOUN	B
.	O	PUNCT	O


Latanoprost	O	NOUN	B
produces	O	VERB	O
an	O	DET	O
additional	O	ADJ	O
reduction	O	NOUN	B
of	O	ADP	O
intraocular	O	ADJ	B
pressure	O	NOUN	I
(	O	PUNCT	O
IOP	O	NOUN	B
)	O	PUNCT	O
when	O	SCONJ	O
used	O	VERB	O
in	O	ADP	O
combination	O	NOUN	B
with	O	ADP	O
timolol	O	NOUN	B
,	O	PUNCT	O
pilocarpine	O	NOUN	B
,	O	PUNCT	O
acetazolamide	O	NOUN	B
and	O	CCONJ	O
dipivefrin	O	NOUN	B
.	O	PUNCT	O


Transient	O	ADJ	B
overexpression	O	NOUN	B
of	O	ADP	O
c	B-GENE	NOUN	O
-	I-GENE	PUNCT	O
Jun	I-GENE	NOUN	B
induced	O	VERB	B
tenascin	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
C	I-GENE	NOUN	B
expression	O	NOUN	B
in	O	ADP	O
primary	O	ADJ	B
REF	O	NOUN	B
and	O	CCONJ	O
in	O	ADP	O
FR3T3	O	NOUN	B
,	O	PUNCT	O
an	O	DET	O
established	O	ADJ	O
fibroblast	O	NOUN	B
cell	O	NOUN	I
line	O	NOUN	I
.	O	PUNCT	O


Selected	O	ADJ	O
parameters	O	NOUN	B
:	O	PUNCT	O
heart	O	NOUN	B
rate	O	NOUN	I
(	O	PUNCT	O
HR	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
arterial	O	ADJ	B
blood	O	NOUN	I
pressure	O	NOUN	I
(	O	PUNCT	O
ABP	O	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
arterial	O	ADJ	B
O2	O	NOUN	B
saturation	O	NOUN	I
(	O	PUNCT	O
SaO2	O	NOUN	B
)	O	PUNCT	O
monitored	O	VERB	O
by	O	ADP	O
pulsoximetry	O	NOUN	B
were	O	AUX	O
measured	O	VERB	B
during	O	ADP	O
the	O	DET	O
procedure	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
tested	O	VERB	B
this	O	DET	O
proposal	O	NOUN	B
by	O	ADP	O
carrying	O	VERB	O
out	O	ADP	O
circular	O	ADJ	B
dichroism	O	NOUN	I
(	O	PUNCT	O
CD	O	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
NMR	O	NOUN	B
experiments	O	NOUN	O
on	O	ADP	O
the	O	DET	O
Skn	B-GENE	NOUN	B
domain	I-GENE	NOUN	I
and	O	CCONJ	O
five	O	NUM	O
truncated	O	VERB	B
proteins	O	NOUN	I
.	O	PUNCT	O


Genes	O	NOUN	B
for	O	ADP	O
ocs	B-GENE	NOUN	B
element	I-GENE	NOUN	I
binding	I-GENE	NOUN	O
factors	I-GENE	NOUN	O
(	O	PUNCT	O
OBFs	B-GENE	X	B
)	O	PUNCT	O
,	O	PUNCT	O
belonging	O	VERB	O
to	O	PART	O
a	O	DET	O
specific	O	ADJ	O
class	O	NOUN	O
of	O	ADP	O
basic	B-GENE	ADJ	B
-	I-GENE	PUNCT	O
region	I-GENE	NOUN	B
leucine	I-GENE	NOUN	B
zipper	I-GENE	NOUN	I
(	I-GENE	PUNCT	O
bZIP	I-GENE	NOUN	B
)	I-GENE	PUNCT	O
transcription	I-GENE	NOUN	B
factors	I-GENE	NOUN	I
,	O	PUNCT	O
have	O	AUX	O
been	O	AUX	O
isolated	O	VERB	B
in	O	ADP	O
a	O	DET	O
number	O	NOUN	O
of	O	ADP	O
plants	O	NOUN	B
.	O	PUNCT	O


SRE	O	NOUN	B
activity	O	NOUN	B
is	O	AUX	O
dependent	O	ADJ	O
upon	O	SCONJ	O
the	O	DET	O
activation	O	NOUN	B
by	O	ADP	O
phosphorylation	O	NOUN	B
of	O	ADP	O
a	O	DET	O
ternary	O	ADJ	B
complex	O	NOUN	I
factor	O	NOUN	I
;	O	PUNCT	O
included	O	VERB	O
among	O	ADP	O
the	O	DET	O
ternary	O	ADJ	B
complex	O	NOUN	I
factors	O	NOUN	I
is	O	AUX	O
Elk	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	O
.	O	PUNCT	O


A	O	DET	O
xylE	B-GENE	NOUN	B
transcriptional	I-GENE	ADJ	B
fusion	I-GENE	NOUN	I
to	O	PART	O
the	O	DET	O
putative	O	ADJ	O
mxbD	B-GENE	NOUN	B
promoter	I-GENE	NOUN	B
showed	O	VERB	O
low	O	ADJ	B
-	O	PUNCT	O
level	O	NOUN	B
expression	O	NOUN	B
in	O	ADP	O
wild	O	ADJ	B
-	O	PUNCT	O
type	O	NOUN	B
cells	O	NOUN	B
grown	O	VERB	O
on	O	ADP	O
one	O	NUM	O
-	O	PUNCT	O
carbon	O	NOUN	B
(	O	PUNCT	O
C1	O	NOUN	B
)	O	PUNCT	O
compounds	O	NOUN	O
and	O	CCONJ	O
no	O	DET	O
detectable	O	ADJ	B
expression	O	NOUN	B
in	O	ADP	O
cells	O	NOUN	B
grown	O	VERB	O
on	O	ADP	O
succinate	O	NOUN	B
.	O	PUNCT	O


Pax	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
3	I-GENE	NUM	O
is	O	AUX	O
a	O	DET	O
paired	B-GENE	ADJ	B
-	I-GENE	PUNCT	O
type	I-GENE	NOUN	B
homeobox	I-GENE	NOUN	I
gene	I-GENE	NOUN	I
that	O	PRON	O
is	O	AUX	O
specifically	O	ADV	O
expressed	O	VERB	B
in	O	ADP	O
the	O	DET	O
dorsal	O	NOUN	B
and	O	CCONJ	O
posterior	O	ADJ	B
neural	O	ADJ	O
tube	O	NOUN	O
.	O	PUNCT	O


Instead	O	ADV	O
,	O	PUNCT	O
they	O	PRON	O
contained	O	VERB	O
dendritic	O	ADJ	B
cells	O	NOUN	I
that	O	PRON	O
express	O	VERB	O
melanogenic	O	ADJ	B
marker	O	NOUN	O
proteins	O	NOUN	O
such	O	ADJ	O
as	O	ADP	O
tyrosinase	B-GENE	NOUN	B
and	O	CCONJ	O
tyrosinase	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
related	I-GENE	VERB	B
protein	I-GENE	NOUN	B
1	I-GENE	NUM	I
.	O	PUNCT	O


These	O	DET	O
mutations	O	NOUN	B
create	O	VERB	O
stop	O	VERB	O
codons	O	NOUN	O
in	O	ADP	O
exon	O	NOUN	B
7	O	NUM	I
and	O	CCONJ	O
8	O	NUM	O
,	O	PUNCT	O
respectively	O	ADV	O
,	O	PUNCT	O
and	O	CCONJ	O
probably	O	ADV	O
result	O	VERB	O
in	O	ADP	O
truncated	O	VERB	B
proteins	O	NOUN	I
lacking	O	VERB	O
HLH	O	ADJ	B
-	O	PUNCT	O
Zip	O	NOUN	B
or	O	CCONJ	O
Zip	O	NOUN	B
structure	O	NOUN	I
.	O	PUNCT	O


These	O	DET	O
six	O	NUM	O
amino	O	NOUN	B
acids	O	NOUN	I
are	O	AUX	O
part	O	NOUN	O
of	O	ADP	O
an	O	DET	O
amphipathic	O	ADJ	B
helix	O	NOUN	I
that	O	PRON	O
is	O	AUX	O
highly	O	ADV	O
conserved	O	VERB	O
among	O	ADP	O
nuclear	B-GENE	ADJ	B
hormone	I-GENE	NOUN	I
receptors	I-GENE	NOUN	I
and	O	CCONJ	O
contains	O	VERB	O
the	O	DET	O
core	O	NOUN	B
domain	O	NOUN	I
of	O	ADP	O
the	O	DET	O
ligand	O	NOUN	B
-	O	PUNCT	O
dependent	O	ADJ	B
transactivation	O	NOUN	B
function	O	NOUN	I
,	O	PUNCT	O
AF	O	PROPN	B
-	O	PUNCT	O
2	O	NUM	B
.	O	PUNCT	O


Surprisingly	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
RXR	B-GENE	NOUN	B
-	O	PUNCT	O
specific	O	ADJ	B
ligand	O	NOUN	B
9	O	NUM	O
-	O	PUNCT	O
cis	O	NOUN	B
-	O	PUNCT	O
retinoic	O	ADJ	B
acid	O	NOUN	I
induced	O	VERB	B
binding	O	NOUN	B
of	O	ADP	O
SRC	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	O
to	O	PART	O
the	O	DET	O
RXR	B-GENE	NOUN	B
component	I-GENE	NOUN	B
of	O	ADP	O
the	O	DET	O
TRE	O	NOUN	B
-	O	PUNCT	O
bound	O	VERB	B
heterodimer	O	NOUN	B
.	O	PUNCT	O


Using	O	VERB	O
PRL	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
R	I-GENE	NOUN	B
tagged	O	VERB	B
both	O	CCONJ	O
in	O	ADP	O
the	O	DET	O
N	O	NOUN	B
-	O	PUNCT	O
terminal	O	ADJ	B
or	O	CCONJ	O
C	O	NOUN	B
-	O	PUNCT	O
terminal	O	ADJ	B
regions	O	NOUN	B
of	O	ADP	O
the	O	DET	O
mature	O	ADJ	B
receptor	O	NOUN	I
excludes	O	VERB	O
the	O	DET	O
possibility	O	NOUN	O
of	O	ADP	O
a	O	DET	O
cleaved	O	VERB	B
fragment	O	NOUN	O
which	O	DET	O
could	O	AUX	O
have	O	AUX	O
been	O	AUX	O
subsequently	O	ADV	O
imported	O	VERB	B
into	O	ADP	O
the	O	DET	O
nucleus	O	NOUN	B
.	O	PUNCT	O


Transcription	O	NOUN	B
of	O	ADP	O
these	O	DET	O
genes	O	NOUN	B
was	O	AUX	O
also	O	ADV	O
elevated	O	VERB	B
in	O	ADP	O
gut	O	NOUN	B
and	O	CCONJ	O
lung	O	NOUN	B
during	O	ADP	O
freezing	O	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
mRNA	O	NOUN	B
levels	O	NOUN	O
in	O	ADP	O
these	O	DET	O
tissues	O	NOUN	B
were	O	AUX	O
lower	O	ADJ	O
than	O	ADP	O
in	O	ADP	O
liver	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
most	O	ADV	O
important	O	ADJ	O
one	O	NUM	O
among	O	ADP	O
them	O	PRON	O
is	O	AUX	O
Cyclosporin	O	NOUN	B
A	O	NOUN	I
,	O	PUNCT	O
which	O	DET	O
is	O	AUX	O
a	O	DET	O
selective	O	ADJ	O
immunosuppressive	O	ADJ	B
drug	O	NOUN	I
.	O	PUNCT	O


Using	O	VERB	O
a	O	DET	O
conditional	O	ADJ	B
-	O	PUNCT	O
lethal	O	ADJ	B
mutant	O	ADJ	B
allele	O	NOUN	O
of	O	ADP	O
SUP45	B-GENE	NOUN	B
(	O	PUNCT	O
sup45	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
2	I-GENE	NUM	O
)	O	PUNCT	O
and	O	CCONJ	O
a	O	DET	O
combination	O	NOUN	B
of	O	ADP	O
in	O	X	B
vivo	O	X	I
and	O	CCONJ	O
in	O	X	B
vitro	O	X	I
approaches	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
demonstrate	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
product	O	NOUN	B
of	O	ADP	O
the	O	DET	O
SUP45	B-GENE	NOUN	B
gene	I-GENE	NOUN	I
(	O	PUNCT	O
Sup45p	B-GENE	NOUN	B
or	O	CCONJ	O
eRF1	B-GENE	NOUN	B
)	O	PUNCT	O
is	O	AUX	O
a	O	DET	O
factor	O	NOUN	B
required	O	VERB	O
for	O	ADP	O
translation	O	NOUN	B
termination	O	NOUN	I
in	O	ADP	O
yeast	O	NOUN	B
.	O	PUNCT	O


She	O	PRON	O
was	O	AUX	O
able	O	ADJ	O
to	O	PART	O
stand	O	VERB	O
unaided	O	ADJ	B
by	O	ADP	O
3	O	NUM	O
years	O	NOUN	B
of	O	ADP	O
age	O	NOUN	B
with	O	ADP	O
then	O	ADV	O
progressive	O	ADJ	B
worsening	O	NOUN	B
of	O	ADP	O
motor	O	NOUN	B
abilities	O	NOUN	I
.	O	PUNCT	O


Merosin	B-GENE	NOUN	B
positive	O	ADJ	B
congenital	O	ADJ	B
muscular	O	ADJ	I
dystrophy	O	NOUN	I
with	O	ADP	O
mental	O	ADJ	B
deficiency	O	NOUN	I
,	O	PUNCT	O
epilepsy	O	NOUN	B
and	O	CCONJ	O
MRI	O	NOUN	B
changes	O	NOUN	B
in	O	ADP	O
the	O	DET	O
cerebral	O	ADJ	B
white	O	ADJ	I
matter	O	NOUN	I
.	O	PUNCT	O


Also	O	ADV	O
,	O	PUNCT	O
transient	O	ADJ	B
overexpression	O	NOUN	B
of	O	ADP	O
this	O	DET	O
protein	O	NOUN	B
in	O	ADP	O
C2C12	O	NOUN	B
cells	O	NOUN	I
reduced	O	VERB	B
the	O	DET	O
transcription	O	NOUN	B
of	O	ADP	O
a	O	DET	O
CAT	B-GENE	NOUN	B
-	O	PUNCT	O
reporter	O	NOUN	B
regulated	O	VERB	B
by	O	ADP	O
an	O	DET	O
E12	B-GENE	NOUN	B
/	O	SYM	O
MyoD	B-GENE	NOUN	B
driven	O	ADJ	O
enhancer	O	NOUN	B
.	O	PUNCT	O


Type	O	NOUN	B
I	O	NUM	I
position	O	NOUN	I
-	O	PUNCT	O
vestibular	O	ADJ	B
-	O	PUNCT	O
pause	O	NOUN	B
(	O	PUNCT	O
PVP	O	NOUN	B
I	O	NUM	I
)	O	PUNCT	O
and	O	CCONJ	O
vestibular	O	ADJ	B
-	O	PUNCT	O
only	O	ADJ	O
(	O	PUNCT	O
V	O	NOUN	B
I	O	NUM	I
)	O	PUNCT	O
neurons	O	NOUN	B
,	O	PUNCT	O
as	O	ADV	O
well	O	ADV	O
as	O	ADP	O
a	O	DET	O
smaller	O	ADJ	O
number	O	NOUN	O
of	O	ADP	O
other	O	ADJ	O
type	O	NOUN	B
I	O	NUM	I
and	O	CCONJ	O
type	O	NOUN	B
II	O	NUM	I
eye	O	NOUN	I
-	O	PUNCT	O
plus	O	CCONJ	B
-	O	PUNCT	O
vestibular	O	ADJ	B
neurons	O	NOUN	B
were	O	AUX	O
studied	O	VERB	O
.	O	PUNCT	O


Using	O	VERB	O
mouse	O	NOUN	B
-	O	PUNCT	O
human	O	ADJ	B
somatic	O	ADJ	B
hybrids	O	NOUN	I
and	O	CCONJ	O
FISH	O	NOUN	B
analysis	O	NOUN	I
,	O	PUNCT	O
the	O	DET	O
PE	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
2	I-GENE	NUM	O
gene	I-GENE	NOUN	B
is	O	AUX	O
localized	O	ADJ	B
to	O	PART	O
human	O	ADJ	B
chromosome	O	NOUN	O
19q13	O	NOUN	O
.	O	PUNCT	O
2	O	X	O
,	O	PUNCT	O
a	O	DET	O
region	O	NOUN	B
involved	O	VERB	O
in	O	ADP	O
translocations	O	NOUN	B
and	O	CCONJ	O
deletions	O	NOUN	B
in	O	ADP	O
leukemias	O	NOUN	B
and	O	CCONJ	O
several	O	ADJ	O
solid	O	ADJ	B
tumors	O	NOUN	I
,	O	PUNCT	O
suggesting	O	VERB	O
that	O	SCONJ	O
this	O	DET	O
novel	O	ADJ	O
ETS	B-GENE	NOUN	B
factor	I-GENE	NOUN	I
may	O	AUX	O
play	O	VERB	O
a	O	DET	O
role	O	NOUN	O
in	O	ADP	O
carcinogenesis	O	NOUN	B
.	O	PUNCT	O


Sequence	O	NOUN	B
divergence	O	NOUN	B
is	O	AUX	O
observed	O	VERB	O
in	O	ADP	O
untranslated	O	ADJ	B
regions	O	NOUN	I
which	O	DET	O
allows	O	VERB	O
the	O	DET	O
definition	O	NOUN	B
of	O	ADP	O
gene	O	NOUN	B
-	O	PUNCT	O
specific	O	ADJ	B
probes	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
adherent	O	ADJ	B
macrophages	O	NOUN	B
,	O	PUNCT	O
absence	O	NOUN	B
of	O	ADP	O
CD45	B-GENE	NOUN	B
led	O	VERB	O
to	O	PART	O
the	O	DET	O
hyperphosphorylation	O	NOUN	B
and	O	CCONJ	O
hyperactivation	O	NOUN	B
of	O	ADP	O
p56	B-GENE	NOUN	B
/	I-GENE	SYM	O
59	I-GENE	NUM	B
(	O	PUNCT	O
hck	B-GENE	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
p53	B-GENE	NOUN	B
/	I-GENE	SYM	O
56	I-GENE	NUM	B
(	O	PUNCT	O
lyn	B-GENE	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
but	O	CCONJ	O
not	O	PART	O
of	O	ADP	O
p58	B-GENE	NOUN	B
(	O	PUNCT	O
c	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
fgr	I-GENE	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Secretion	O	NOUN	B
in	O	ADP	O
milk	O	NOUN	B
and	O	CCONJ	O
transplacental	O	ADJ	B
transfer	O	NOUN	I
of	O	ADP	O
two	O	NUM	O
iodized	O	ADJ	B
oils	O	NOUN	I
,	O	PUNCT	O
Lipiodol	O	PROPN	B
UF	O	PROPN	I
and	O	CCONJ	O
Oriodol	O	PROPN	B
,	O	PUNCT	O
in	O	ADP	O
rabbits	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
RNA	O	NOUN	B
-	O	PUNCT	O
binding	O	NOUN	B
and	O	CCONJ	O
RNA	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
DNA	I-GENE	NOUN	B
helicase	I-GENE	NOUN	I
activities	O	NOUN	O
of	O	ADP	O
the	O	DET	O
Escherichia	B-GENE	X	B
coli	I-GENE	X	I
transcription	I-GENE	NOUN	O
termination	I-GENE	NOUN	O
factor	I-GENE	NOUN	O
rho	I-GENE	NOUN	O
have	O	AUX	O
been	O	AUX	O
investigated	O	VERB	B
using	O	VERB	O
natural	O	ADJ	B
RNA	O	NOUN	O
molecules	O	NOUN	O
that	O	PRON	O
are	O	AUX	O
255	O	NUM	O
and	O	CCONJ	O
391	O	NUM	O
nucleotide	O	NOUN	B
residues	O	NOUN	I
in	O	ADP	O
length	O	NOUN	B
and	O	CCONJ	O
that	O	PRON	O
contain	O	VERB	O
the	O	DET	O
trp	B-GENE	NOUN	B
t	I-GENE	NOUN	I
'	I-GENE	PART	O
rho	I-GENE	ADJ	B
-	I-GENE	PUNCT	O
dependent	I-GENE	ADJ	B
termination	I-GENE	NOUN	B
sequence	I-GENE	NOUN	I
of	O	ADP	O
E	O	NOUN	B
.	O	PUNCT	O
coli	O	X	B
.	O	PUNCT	O


The	O	DET	O
serum	O	NOUN	B
levels	O	NOUN	B
of	O	ADP	O
beta	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
human	I-GENE	ADJ	B
chorionic	I-GENE	ADJ	B
gonadotropin	I-GENE	NOUN	I
(	O	PUNCT	O
HCG	B-GENE	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
placental	B-GENE	ADJ	B
alkaline	I-GENE	NOUN	B
phosphatase	I-GENE	NOUN	I
(	O	PUNCT	O
PLAP	B-GENE	NOUN	B
)	O	PUNCT	O
were	O	AUX	O
not	O	PART	O
elevated	O	ADJ	B
.	O	PUNCT	O


Thus	O	ADV	O
E14	O	NOUN	B
.	O	PUNCT	O
1TG3B1	O	NUM	O
is	O	AUX	O
a	O	DET	O
useful	O	ADJ	O
ES	O	NOUN	B
cell	O	NOUN	I
line	O	NOUN	I
for	O	ADP	O
modifying	O	VERB	O
the	O	DET	O
mouse	O	NOUN	B
genome	O	NOUN	I
using	O	VERB	O
the	O	DET	O
HPRT	B-GENE	NOUN	B
gene	I-GENE	NOUN	I
as	O	ADP	O
a	O	DET	O
selection	O	NOUN	B
marker	O	NOUN	I
and	O	CCONJ	O
for	O	ADP	O
transmission	O	NOUN	B
at	O	ADP	O
a	O	DET	O
high	O	ADJ	O
frequency	O	NOUN	B
into	O	ADP	O
the	O	DET	O
mouse	O	NOUN	B
germ	O	NOUN	B
line	O	NOUN	I
.	O	PUNCT	O


OBJECTIVE	O	NOUN	O
:	O	PUNCT	O
This	O	DET	O
study	O	NOUN	B
was	O	AUX	O
designed	O	VERB	O
to	O	PART	O
analyze	O	VERB	B
the	O	DET	O
common	O	ADJ	O
cause	O	NOUN	B
of	O	ADP	O
asthenopia	O	NOUN	B
,	O	PUNCT	O
mixed	O	ADJ	B
astigmatism	O	NOUN	I
.	O	PUNCT	O


One	O	NUM	O
RNA	O	NOUN	B
construct	O	NOUN	I
which	O	DET	O
consisted	O	VERB	O
of	O	ADP	O
112	O	NUM	O
nucleotides	O	NOUN	B
(	O	PUNCT	O
nt	O	NOUN	O
)	O	PUNCT	O
from	O	ADP	O
nt	O	NOUN	O
639	O	NUM	O
to	O	PART	O
nt	O	NOUN	O
750	O	NUM	O
formed	O	VERB	O
a	O	DET	O
heterodimeric	O	ADJ	B
complex	O	NOUN	I
with	O	ADP	O
the	O	DET	O
RNA	O	NOUN	B
which	O	DET	O
consisted	O	VERB	O
of	O	ADP	O
200	O	NUM	O
nucleotides	O	NOUN	B
from	O	ADP	O
nt	O	NOUN	O
551	O	NUM	O
to	O	PART	O
nt	O	NOUN	O
750	O	NUM	O
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
we	O	PRON	O
could	O	AUX	O
not	O	PART	O
find	O	VERB	O
the	O	DET	O
homologous	O	ADJ	B
regions	O	NOUN	I
with	O	ADP	O
guanine	B-GENE	NOUN	B
nucleotide	I-GENE	NOUN	I
exchange	I-GENE	NOUN	I
factors	I-GENE	NOUN	I
or	O	CCONJ	O
GTPase	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
activating	I-GENE	VERB	B
proteins	I-GENE	NOUN	B
in	O	ADP	O
the	O	DET	O
c	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
cbl	I-GENE	NOUN	B
gene	I-GENE	NOUN	I
.	O	PUNCT	O


Aryl	B-GENE	ADJ	B
hydrocarbon	I-GENE	NOUN	I
receptor	I-GENE	NOUN	I
nuclear	I-GENE	ADJ	I
translocator	I-GENE	NOUN	I
(	O	PUNCT	O
ARNT	B-GENE	NOUN	B
)	O	PUNCT	O
is	O	AUX	O
a	O	DET	O
component	O	NOUN	B
of	O	ADP	O
the	O	DET	O
transcription	O	NOUN	B
factors	O	NOUN	I
,	O	PUNCT	O
aryl	B-GENE	NOUN	B
hydrocarbon	I-GENE	NOUN	I
receptor	I-GENE	NOUN	I
(	O	PUNCT	O
AhR	B-GENE	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
hypoxia	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
inducible	I-GENE	ADJ	B
factor	I-GENE	NOUN	I
1	I-GENE	NUM	I
,	O	PUNCT	O
which	O	DET	O
transactivate	O	VERB	B
their	O	PRON	O
target	O	NOUN	B
genes	O	NOUN	I
,	O	PUNCT	O
such	O	ADJ	O
as	O	ADP	O
CYP1A1	B-GENE	NOUN	B
and	O	CCONJ	O
erythropoietin	B-GENE	NOUN	B
,	O	PUNCT	O
in	O	ADP	O
response	O	NOUN	B
to	O	PART	O
xenobiotic	O	ADJ	B
aromatic	O	ADJ	B
hydrocarbons	O	NOUN	I
and	O	CCONJ	O
to	O	PART	O
low	O	ADJ	B
O2	O	NOUN	B
concentration	O	NOUN	B
,	O	PUNCT	O
respectively	O	ADV	O
.	O	PUNCT	O


We	O	PRON	O
also	O	ADV	O
provide	O	VERB	O
evidence	O	NOUN	B
that	O	SCONJ	O
gar2	B-GENE	NOUN	B
is	O	AUX	O
phosphorylated	O	VERB	B
in	O	X	B
vitro	O	X	I
by	O	ADP	O
a	O	DET	O
p13	B-GENE	NOUN	B
(	O	PUNCT	O
suc1	B-GENE	NOUN	B
)	O	PUNCT	O
-	O	PUNCT	O
Sepharose	O	PROPN	B
-	O	PUNCT	O
bound	O	VERB	B
kinase	O	NOUN	O
from	O	ADP	O
Schizosaccharomyces	O	X	B
pombe	O	X	I
extracts	O	NOUN	O
that	O	PRON	O
displays	O	VERB	O
cell	O	NOUN	B
cycle	O	NOUN	I
-	O	PUNCT	O
regulated	O	VERB	B
activity	O	NOUN	B
similar	O	ADJ	O
to	O	PART	O
that	O	DET	O
of	O	ADP	O
the	O	DET	O
p34	B-GENE	NOUN	B
(	O	PUNCT	O
cdc2	B-GENE	NOUN	B
(	O	PUNCT	O
kinase	O	NOUN	B
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
by	O	ADP	O
immobilized	O	VERB	B
metal	O	NOUN	B
affinity	O	NOUN	O
chromatography	O	NOUN	O
assay	O	NOUN	O
,	O	PUNCT	O
self	O	NOUN	B
-	O	PUNCT	O
association	O	NOUN	B
of	O	ADP	O
PR	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
A	I-GENE	PROPN	B
was	O	AUX	O
3	O	NUM	O
.	O	PUNCT	O
5	O	NUM	O
-	O	PUNCT	O
fold	O	VERB	B
more	O	ADV	O
efficient	O	ADJ	B
than	O	ADP	O
that	O	DET	O
of	O	ADP	O
either	O	CCONJ	O
the	O	DET	O
DhLBD	O	NOUN	B
or	O	CCONJ	O
hLBD	O	NOUN	B
constructs	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
overall	O	ADJ	O
results	O	NOUN	B
of	O	ADP	O
this	O	DET	O
paper	O	NOUN	O
are	O	AUX	O
consistent	O	ADJ	B
with	O	ADP	I
the	O	DET	O
conclusion	O	NOUN	O
that	O	SCONJ	O
the	O	DET	O
carboxyl	O	NOUN	B
-	O	PUNCT	O
terminal	O	ADJ	B
LBD	O	NOUN	B
is	O	AUX	O
not	O	PART	O
sufficient	O	ADJ	O
for	O	ADP	O
mediating	O	VERB	O
PR	B-GENE	NOUN	B
dimerization	O	NOUN	B
and	O	CCONJ	O
that	O	SCONJ	O
multiple	O	ADJ	B
regions	O	NOUN	I
,	O	PUNCT	O
including	O	VERB	O
the	O	DET	O
hinge	O	NOUN	B
and	O	CCONJ	O
amino	O	NOUN	B
-	O	PUNCT	O
terminal	O	ADJ	B
sequences	O	NOUN	B
,	O	PUNCT	O
contribute	O	VERB	O
either	O	CCONJ	O
directly	O	ADV	O
or	O	CCONJ	O
indirectly	O	ADV	O
to	O	PART	O
homodimerization	O	NOUN	B
of	O	ADP	O
PR	B-GENE	NOUN	B
.	O	PUNCT	O


Colorectal	O	NOUN	B
carcinoma	O	NOUN	I
:	O	PUNCT	O
therapeutic	O	ADJ	B
approach	O	NOUN	I
in	O	ADP	O
patients	O	NOUN	B
already	O	ADV	O
treated	O	VERB	B
with	O	ADP	I
metastasis	O	NOUN	B
resection	O	NOUN	I


Alternative	O	ADJ	B
splicing	O	NOUN	I
of	O	ADP	O
ClC	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
6	I-GENE	NUM	O
(	O	PUNCT	O
a	O	DET	O
member	O	NOUN	O
of	O	ADP	O
the	O	DET	O
CIC	B-GENE	PROPN	B
chloride	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
channel	I-GENE	NOUN	B
family	I-GENE	NOUN	O
)	O	PUNCT	O
transcripts	O	NOUN	B
generates	O	VERB	O
three	O	NUM	O
truncated	O	VERB	B
isoforms	O	NOUN	B
one	O	NUM	O
of	O	ADP	O
which	O	DET	O
,	O	PUNCT	O
ClC	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
6c	I-GENE	NOUN	B
,	O	PUNCT	O
is	O	AUX	O
kidney	O	NOUN	B
-	O	PUNCT	O
specific	O	ADJ	B
.	O	PUNCT	O


The	O	DET	O
frequency	O	NOUN	B
of	O	ADP	O
positive	O	ADJ	B
anti	B-GENE	ADJ	B
-	I-GENE	PUNCT	O
GM1	I-GENE	NOUN	B
antibody	I-GENE	NOUN	B
titers	O	NOUN	B
in	O	ADP	O
the	O	DET	O
Guillain	O	PROPN	B
-	O	PUNCT	O
Barre	O	PROPN	B
syndrome	O	NOUN	I
patients	O	NOUN	B
with	O	ADP	O
PEN	O	NOUN	B
19	O	NUM	O
isolates	O	NOUN	B
was	O	AUX	O
higher	O	ADJ	O
than	O	ADP	O
that	O	DET	O
in	O	ADP	O
the	O	DET	O
Guillain	O	PROPN	B
-	O	PUNCT	O
Barre	O	PROPN	B
syndrome	O	NOUN	I
and	O	CCONJ	O
Fisher	O	PROPN	B
'	O	PART	I
s	O	NOUN	I
syndrome	O	NOUN	B
patients	O	NOUN	B
without	O	ADP	O
PEN	O	NOUN	B
19	O	NUM	O
isolates	O	NOUN	B
.	O	PUNCT	O


NF	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
kappa	I-GENE	NOUN	B
B	I-GENE	NOUN	I
/	O	SYM	O
Rel	B-GENE	NOUN	B
transcription	O	NOUN	I
factors	O	NOUN	I
participate	O	VERB	B
in	O	ADP	O
the	O	DET	O
activation	O	NOUN	B
of	O	ADP	O
numerous	O	ADJ	B
genes	O	NOUN	B
involved	O	VERB	O
in	O	ADP	O
immune	O	ADJ	B
regulation	O	NOUN	I
/	O	PUNCT	O
inflammation	O	NOUN	B
including	O	VERB	O
cytokines	O	NOUN	B
,	O	PUNCT	O
cell	O	NOUN	B
surface	O	NOUN	I
receptors	O	NOUN	I
,	O	PUNCT	O
adhesion	O	NOUN	B
molecules	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
acute	O	ADJ	B
phase	O	NOUN	I
proteins	O	NOUN	I
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
mean	O	VERB	B
food	O	NOUN	I
intake	O	NOUN	I
in	O	ADP	O
the	O	DET	O
40	O	NUM	O
%	O	NOUN	O
group	O	NOUN	B
was	O	AUX	O
half	O	NOUN	O
that	O	DET	O
of	O	ADP	O
the	O	DET	O
ACT	O	NOUN	B
group	O	NOUN	B
(	O	PUNCT	O
p	O	NOUN	O
<	O	X	O
0	O	NUM	O
.	O	PUNCT	O
001	O	NUM	O
)	O	PUNCT	O
and	O	CCONJ	O
significantly	O	ADV	B
less	O	ADJ	I
(	O	PUNCT	O
p	O	NOUN	O
<	O	X	O
0	O	NUM	O
.	O	PUNCT	O
01	O	NUM	O
)	O	PUNCT	O
than	O	ADP	O
the	O	DET	O
SEP	O	PROPN	B
group	O	NOUN	B
,	O	PUNCT	O
which	O	DET	O
consumed	O	VERB	O
amounts	O	NOUN	B
equivalent	O	ADJ	O
to	O	PART	O
65	O	NUM	O
%	O	NOUN	O
of	O	ADP	O
daily	O	ADJ	B
requirement	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
separated	O	VERB	O
a	O	DET	O
dermatan	O	NOUN	B
sulfate	O	NOUN	I
proteoglycan	O	NOUN	I
,	O	PUNCT	O
epiphycan	O	NOUN	B
,	O	PUNCT	O
from	O	ADP	O
decorin	B-GENE	NOUN	B
and	O	CCONJ	O
biglycan	O	NOUN	B
by	O	ADP	O
using	O	VERB	O
dissociative	O	ADJ	B
extraction	O	NOUN	I
of	O	ADP	O
bovine	O	ADJ	B
fetal	O	ADJ	B
epiphyseal	O	ADJ	B
cartilage	O	NOUN	I
,	O	PUNCT	O
followed	O	VERB	O
by	O	ADP	O
sequential	O	ADJ	B
ion	O	NOUN	B
-	O	PUNCT	O
exchange	O	NOUN	B
,	O	PUNCT	O
gel	O	NOUN	B
permeation	O	NOUN	B
,	O	PUNCT	O
hydrophobic	O	ADJ	B
,	O	PUNCT	O
and	O	CCONJ	O
Zn2	O	NOUN	B
+	O	CCONJ	O
chelate	O	VERB	B
chromatographic	O	ADJ	I
steps	O	NOUN	O
.	O	PUNCT	O


The	O	DET	O
mean	O	ADJ	O
times	O	NOUN	O
to	O	PART	O
detection	O	NOUN	B
of	O	ADP	O
all	O	DET	O
mycobacteria	O	NOUN	B
with	O	ADP	O
BACTEC	O	NOUN	B
9000	O	NUM	O
MB	O	NOUN	B
and	O	CCONJ	O
BACTEC	O	PROPN	B
460	O	NUM	O
TB	O	NOUN	B
were	O	AUX	O
similar	O	ADJ	O
(	O	PUNCT	O
10	O	NUM	O
.	O	PUNCT	O
3	O	NUM	O
and	O	CCONJ	O
10	O	NUM	O
.	O	PUNCT	O
0	O	NUM	O
days	O	NOUN	B
,	O	PUNCT	O
respectively	O	ADV	O
)	O	PUNCT	O
.	O	PUNCT	O


Though	O	SCONJ	O
the	O	DET	O
BACTEC	O	NOUN	B
9000	O	NUM	O
MB	O	NOUN	O
system	O	NOUN	O
is	O	AUX	O
recommended	O	VERB	O
for	O	ADP	O
respiratory	O	ADJ	B
specimens	O	NOUN	I
,	O	PUNCT	O
we	O	PRON	O
demonstrated	O	VERB	O
that	O	SCONJ	O
it	O	PRON	O
can	O	AUX	O
be	O	AUX	O
successfully	O	ADV	O
used	O	VERB	O
also	O	ADV	O
for	O	ADP	O
recovery	O	NOUN	B
of	O	ADP	O
mycobacteria	O	NOUN	B
from	O	ADP	O
clinical	O	ADJ	B
specimens	O	NOUN	I
from	O	ADP	O
various	O	ADJ	O
extrapulmonary	O	ADJ	B
sites	O	NOUN	I
.	O	PUNCT	O


A	O	DET	O
pre	O	NOUN	B
-	O	PUNCT	O
boutonniere	O	ADJ	B
deformity	O	NOUN	I
was	O	AUX	O
simulated	O	VERB	B
by	O	ADP	O
dividing	O	VERB	O
the	O	DET	O
central	O	ADJ	B
slip	O	NOUN	I
.	O	PUNCT	O


This	O	DET	O
regulation	O	NOUN	B
requires	O	VERB	O
two	O	NUM	O
HMG	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
box	I-GENE	NOUN	B
proteins	I-GENE	NOUN	I
:	O	PUNCT	O
the	O	DET	O
ubiquitous	O	ADJ	O
Ste11	B-GENE	NOUN	B
transcription	I-GENE	NOUN	B
factor	I-GENE	NOUN	I
and	O	CCONJ	O
the	O	DET	O
M	O	NOUN	B
cell	O	NOUN	I
-	O	PUNCT	O
controlling	O	VERB	B
protein	O	NOUN	B
Mat1	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
Mc	I-GENE	PROPN	B
.	O	PUNCT	O


Neither	O	DET	O
of	O	ADP	O
these	O	DET	O
proteins	O	NOUN	B
,	O	PUNCT	O
individually	O	ADV	O
or	O	CCONJ	O
as	O	ADP	O
a	O	DET	O
pair	O	NOUN	B
,	O	PUNCT	O
can	O	AUX	O
bind	O	VERB	B
the	O	DET	O
alpha	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
globin	I-GENE	NOUN	B
3	I-GENE	NUM	I
'	I-GENE	PART	I
UTR	I-GENE	NOUN	B
unless	O	SCONJ	O
they	O	PRON	O
are	O	AUX	O
complexed	O	VERB	B
with	O	ADP	O
the	O	DET	O
remaining	O	VERB	O
non	O	NOUN	B
-	O	PUNCT	O
poly	O	NOUN	B
(	O	PUNCT	I
C	O	NOUN	I
)	O	PUNCT	I
binding	O	NOUN	I
proteins	O	NOUN	I
of	O	ADP	O
the	O	DET	O
alpha	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
complex	I-GENE	NOUN	B
.	O	PUNCT	O


(	O	PUNCT	O
1996a	O	NUM	O
)	O	PUNCT	O
Biochemistry	O	PROPN	O
35	O	NUM	O
,	O	PUNCT	O
1589	O	NUM	O
-	O	SYM	O
1598	O	NUM	O
]	O	PUNCT	O
.	O	PUNCT	O


A	O	DET	O
prospective	O	ADJ	B
observational	O	ADJ	I
study	O	NOUN	I
was	O	AUX	O
conducted	O	VERB	O
to	O	PART	O
identify	O	VERB	O
early	O	ADJ	B
indicators	O	NOUN	B
of	O	ADP	O
acute	O	ADJ	B
dengue	O	NOUN	I
virus	O	NOUN	I
infection	O	NOUN	I
.	O	PUNCT	O


It	O	PRON	O
is	O	AUX	O
present	O	ADJ	O
in	O	ADP	O
the	O	DET	O
nucleus	O	NOUN	B
of	O	ADP	O
the	O	DET	O
cells	O	NOUN	B
in	O	ADP	O
which	O	DET	O
it	O	PRON	O
is	O	AUX	O
expressed	O	VERB	B
and	O	CCONJ	O
can	O	AUX	O
phosphorylate	O	VERB	B
and	O	CCONJ	O
activate	O	VERB	B
the	O	DET	O
cyclic	B-GENE	ADJ	B
AMP	I-GENE	NOUN	O
response	I-GENE	NOUN	O
element	I-GENE	NOUN	O
binding	I-GENE	NOUN	O
proteins	I-GENE	NOUN	O
CREB	B-GENE	NOUN	B
and	O	CCONJ	O
CREM	B-GENE	NOUN	B
tau	I-GENE	NOUN	B
in	O	ADP	O
a	O	DET	O
manner	O	NOUN	O
analogous	O	ADJ	O
to	O	PART	O
protein	B-GENE	NOUN	B
kinase	I-GENE	NOUN	I
A	I-GENE	NOUN	I
.	O	PUNCT	O


These	O	DET	O
cells	O	NOUN	B
fail	O	VERB	O
to	O	PART	O
generate	O	VERB	O
the	O	DET	O
signals	O	NOUN	B
to	O	PART	O
phosphorylate	O	VERB	B
CREB	B-GENE	NOUN	B
and	O	CCONJ	O
produce	O	VERB	O
significantly	O	ADV	O
less	O	ADJ	O
of	O	ADP	O
the	O	DET	O
cytokine	O	NOUN	B
Interleukin	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
2	I-GENE	NUM	O
(	O	PUNCT	O
IL	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
2	I-GENE	NUM	O
)	O	PUNCT	O
in	O	ADP	O
response	O	NOUN	B
to	O	PART	O
agents	O	NOUN	B
that	O	SCONJ	O
either	O	CCONJ	O
increase	O	VERB	B
intracellular	O	ADJ	B
Ca2	O	NOUN	B
+	O	CCONJ	O
and	O	CCONJ	O
/	O	SYM	O
or	O	CCONJ	O
activate	O	VERB	B
protein	B-GENE	NOUN	B
kinase	I-GENE	NOUN	I
C	I-GENE	NOUN	I
.	O	PUNCT	O


Both	O	DET	O
of	O	ADP	O
these	O	DET	O
dogs	O	NOUN	B
had	O	AUX	O
low	O	ADJ	B
serum	O	NOUN	B
IgG	B-GENE	NOUN	I
(	O	PUNCT	O
3	O	NUM	O
.	O	PUNCT	O
5	O	NUM	O
to	O	PART	O
7	O	NUM	O
.	O	PUNCT	O
2	O	NUM	O
mg	O	NOUN	O
/	O	PUNCT	O
ml	O	NOUN	O
)	O	PUNCT	O
and	O	CCONJ	O
the	O	DET	O
second	O	ADJ	O
littermate	O	NOUN	B
also	O	ADV	O
had	O	AUX	O
reduced	O	VERB	B
serum	O	NOUN	B
IgA	B-GENE	NOUN	I
(	O	PUNCT	O
<	O	X	O
0	O	NUM	O
.	O	PUNCT	O
1	O	NUM	O
to	O	PART	O
0	O	NUM	O
.	O	PUNCT	O
15	O	NUM	O
mg	O	NOUN	O
/	O	PUNCT	O
ml	O	NOUN	O
)	O	PUNCT	O
.	O	PUNCT	O


CONCLUSIONS	O	NOUN	O
:	O	PUNCT	O
Valproate	O	NOUN	B
appears	O	VERB	O
to	O	PART	O
inhibit	O	VERB	B
the	O	DET	O
glucuronidation	O	NOUN	B
of	O	ADP	O
carbamazepine	O	NOUN	B
-	O	PUNCT	O
10	O	NUM	O
,	O	PUNCT	O
11	O	NUM	O
-	O	PUNCT	O
trans	O	ADJ	B
-	O	PUNCT	O
diol	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
probably	O	ADV	O
also	O	ADV	O
inhibits	O	VERB	B
the	O	DET	O
conversion	O	NOUN	B
of	O	ADP	O
carbamazepine	O	NOUN	B
-	O	PUNCT	O
10	O	NUM	O
,	O	PUNCT	O
11	O	NUM	O
-	O	PUNCT	O
epoxide	O	NOUN	B
to	O	PART	O
this	O	DET	O
trans	O	ADJ	B
-	O	PUNCT	O
diol	O	NOUN	B
derivative	O	NOUN	I
,	O	PUNCT	O
rather	O	ADV	O
than	O	ADP	O
simply	O	ADV	O
inhibiting	O	VERB	B
the	O	DET	O
latter	O	ADJ	O
reaction	O	NOUN	B
only	O	ADV	O
.	O	PUNCT	O


Proteinuria	O	NOUN	B
in	O	ADP	O
a	O	DET	O
young	O	ADJ	B
man	O	NOUN	B
.	O	PUNCT	O


Neural	O	ADJ	B
blockade	O	NOUN	I
in	O	ADP	O
chronic	O	ADJ	B
and	O	CCONJ	O
cancer	O	NOUN	B
pain	O	NOUN	I
.	O	PUNCT	O


Five	O	NUM	O
cell	O	NOUN	B
strains	O	NOUN	I
of	O	ADP	O
human	O	ADJ	B
dermal	O	ADJ	B
fibroblasts	O	NOUN	B
were	O	AUX	O
each	O	DET	O
treated	O	VERB	B
with	O	ADP	I
three	O	NUM	O
samples	O	NOUN	B
of	O	ADP	O
burn	O	NOUN	B
blister	O	NOUN	B
fluid	O	NOUN	B
and	O	CCONJ	O
the	O	DET	O
effect	O	NOUN	B
compared	O	VERB	B
with	O	ADP	O
the	O	DET	O
rate	O	NOUN	B
of	O	ADP	O
contraction	O	NOUN	B
of	O	ADP	O
free	O	ADJ	B
floating	O	VERB	O
fibroblast	O	NOUN	O
populated	O	ADJ	O
collagen	B-GENE	NOUN	O
lattices	O	NOUN	B
(	O	PUNCT	O
FPCL	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


It	O	PRON	O
is	O	AUX	O
thus	O	ADV	O
one	O	NUM	O
of	O	ADP	O
the	O	DET	O
key	O	ADJ	O
enzymes	O	NOUN	B
involved	O	VERB	O
in	O	ADP	O
the	O	DET	O
triiodothyronine	O	NOUN	B
-	O	PUNCT	O
mediated	O	VERB	B
control	O	NOUN	I
of	O	ADP	O
growth	O	NOUN	O
,	O	PUNCT	O
differentiation	O	NOUN	B
and	O	CCONJ	O
basal	O	ADJ	B
metabolism	O	NOUN	I
in	O	ADP	O
vertebrates	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
had	O	AUX	O
previously	O	ADV	O
analyzed	O	VERB	B
repair	O	NOUN	B
rates	O	NOUN	I
of	O	ADP	O
cyclobutane	O	NOUN	B
pyrimidine	O	NOUN	I
dimers	O	NOUN	I
at	O	ADP	O
nucleotide	O	NOUN	B
resolution	O	NOUN	I
along	O	ADP	O
the	O	DET	O
human	B-GENE	ADJ	B
JUN	I-GENE	NOUN	O
gene	I-GENE	NOUN	O
in	O	ADP	O
normal	O	ADJ	O
fibroblasts	O	NOUN	B
and	O	CCONJ	O
found	O	VERB	O
very	O	ADV	O
efficient	O	ADJ	B
repair	O	NOUN	B
of	O	ADP	I
sequences	O	NOUN	I
near	O	ADP	O
the	O	DET	O
transcription	O	NOUN	B
initiation	O	NOUN	I
site	O	NOUN	I
but	O	CCONJ	O
slow	O	ADJ	B
repair	O	NOUN	I
along	O	ADP	O
the	O	DET	O
promoter	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
used	O	VERB	O
expression	O	NOUN	B
system	O	NOUN	I
could	O	AUX	O
allow	O	VERB	O
to	O	PART	O
produce	O	VERB	O
mutated	O	VERB	B
forms	O	NOUN	O
of	O	ADP	O
SsEF	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
2	I-GENE	NUM	O
obtained	O	VERB	O
by	O	ADP	O
mutagenesis	O	NOUN	B
of	O	ADP	O
the	O	DET	O
corresponding	O	ADJ	O
gene	O	NOUN	B
.	O	PUNCT	O


Crosstalk	O	NOUN	B
among	O	ADP	O
the	O	DET	O
pathways	O	NOUN	B
may	O	AUX	O
explain	O	VERB	O
how	O	SCONJ	O
some	O	DET	O
forms	O	NOUN	O
of	O	ADP	O
stress	O	NOUN	B
can	O	AUX	O
contribute	O	VERB	O
to	O	PART	O
the	O	DET	O
development	O	NOUN	B
of	O	ADP	O
a	O	DET	O
malignancy	O	NOUN	B
.	O	PUNCT	O


MEASUREMENTS	O	NOUN	O
AND	O	CCONJ	O
MAIN	O	NOUN	O
RESULTS	O	NOUN	O
:	O	PUNCT	O
Lung	O	NOUN	B
elastance	O	NOUN	I
(	O	PUNCT	O
EL	O	PROPN	B
)	O	PUNCT	O
and	O	CCONJ	O
resistance	O	NOUN	B
(	O	PUNCT	O
RL	O	NOUN	B
)	O	PUNCT	O
were	O	AUX	O
calculated	O	VERB	B
from	O	ADP	O
measurements	O	NOUN	B
of	O	ADP	O
airway	O	NOUN	B
pressure	O	NOUN	I
,	O	PUNCT	O
esophageal	O	ADJ	B
pressure	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
airway	O	NOUN	B
flow	O	NOUN	I
in	O	ADP	O
five	O	NUM	O
anesthetized	O	VERB	B
,	O	PUNCT	O
paralyzed	O	ADJ	B
dogs	O	NOUN	I
during	O	ADP	O
sinusoidal	O	ADJ	B
forcing	O	VERB	B
at	O	ADP	O
a	O	DET	O
constant	O	ADJ	B
mean	O	NOUN	O
airway	O	NOUN	O
pressure	O	NOUN	O
of	O	ADP	O
10	O	NUM	O
cmH2O	O	NOUN	O
in	O	ADP	O
a	O	DET	O
wide	O	ADJ	O
range	O	NOUN	O
of	O	ADP	O
breathing	O	NOUN	B
frequencies	O	NOUN	I
(	O	PUNCT	O
0	O	NUM	O
.	O	PUNCT	O
2	O	NUM	O
to	O	PART	O
1	O	NUM	O
.	O	PUNCT	O
0	O	NUM	O
Hz	O	NOUN	O
in	O	ADP	O
intervals	O	NOUN	B
of	O	ADP	O
0	O	NUM	O
.	O	PUNCT	O
2	O	NUM	O
)	O	PUNCT	O
and	O	CCONJ	O
tidal	O	ADJ	B
volumes	O	NOUN	I
(	O	PUNCT	O
50	O	NUM	O
,	O	PUNCT	O
100	O	NUM	O
,	O	PUNCT	O
200	O	NUM	O
,	O	PUNCT	O
and	O	CCONJ	O
to	O	PART	O
300	O	NUM	O
mL	O	NOUN	O
)	O	PUNCT	O
.	O	PUNCT	O


Because	O	SCONJ	O
the	O	DET	O
biosynthetic	O	ADJ	B
pathway	O	NOUN	I
to	O	PART	O
the	O	DET	O
vacuole	O	NOUN	B
intersects	O	VERB	O
with	O	ADP	O
the	O	DET	O
endocytic	O	ADJ	B
pathway	O	NOUN	I
,	O	PUNCT	O
internalization	O	NOUN	B
of	O	ADP	O
a	O	DET	O
bulk	O	ADJ	O
membrane	O	NOUN	B
endocytic	O	ADJ	O
marker	O	NOUN	O
FM	O	NOUN	B
4	O	NUM	O
-	O	SYM	O
64	O	NUM	O
was	O	AUX	O
assayed	O	VERB	B
in	O	ADP	O
the	O	DET	O
sop	B-GENE	NOUN	B
mutants	I-GENE	NOUN	B
.	O	PUNCT	O


Naltrexone	O	NOUN	B
has	O	AUX	O
been	O	AUX	O
recently	O	ADV	O
approved	O	VERB	O
by	O	ADP	O
the	O	DET	O
Food	O	PROPN	B
and	O	CCONJ	I
Drug	O	PROPN	I
Administration	O	PROPN	I
for	O	ADP	O
the	O	DET	O
treatment	O	NOUN	B
of	O	ADP	O
alcohol	O	NOUN	B
dependence	O	NOUN	I
.	O	PUNCT	O


Consistent	O	ADJ	B
with	O	ADP	I
this	O	DET	O
model	O	NOUN	B
,	O	PUNCT	O
a	O	DET	O
synthetic	O	ADJ	B
construct	O	NOUN	I
containing	O	VERB	O
three	O	NUM	O
tandem	O	ADJ	B
copies	O	NOUN	B
of	O	ADP	O
the	O	DET	O
native	O	ADJ	B
LDL	B-GENE	NOUN	B
receptor	I-GENE	NOUN	I
SREBP	B-GENE	NOUN	O
site	O	NOUN	O
linked	O	VERB	O
to	O	PART	O
a	O	DET	O
single	O	ADJ	O
Sp1	B-GENE	NOUN	B
site	I-GENE	NOUN	B
was	O	AUX	O
also	O	ADV	O
significantly	O	ADV	O
activated	O	VERB	B
in	O	ADP	O
a	O	DET	O
buttonhead	B-GENE	NOUN	B
-	O	PUNCT	O
independent	O	ADJ	B
fashion	O	NOUN	B
.	O	PUNCT	O


Analysis	O	NOUN	B
of	O	ADP	O
the	O	DET	O
5	O	NUM	O
'	O	PART	O
flanking	O	ADJ	B
region	O	NOUN	I
of	O	ADP	O
the	O	DET	O
gene	O	NOUN	B
also	O	ADV	O
revealed	O	VERB	O
the	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
multiple	O	ADJ	B
TATA	O	NOUN	B
and	O	CCONJ	O
CAAT	O	NOUN	B
sequences	O	NOUN	I
.	O	PUNCT	O


Analysis	O	NOUN	B
of	O	ADP	O
the	O	DET	O
5	O	NUM	O
'	O	PART	O
flanking	O	ADJ	B
region	O	NOUN	I
of	O	ADP	O
the	O	DET	O
gene	O	NOUN	B
also	O	ADV	O
revealed	O	VERB	O
the	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
multiple	O	ADJ	B
TATA	O	NOUN	B
and	O	CCONJ	O
CAAT	O	NOUN	B
sequences	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
m7GpppN	O	ADJ	B
cap	O	NOUN	I
structure	O	NOUN	I
of	O	ADP	O
eukaryotic	O	ADJ	B
mRNA	O	NOUN	B
is	O	AUX	O
formed	O	VERB	O
cotranscriptionally	O	ADV	B
by	O	ADP	O
the	O	DET	O
sequential	O	ADJ	B
action	O	NOUN	B
of	O	ADP	O
three	O	NUM	O
enzymes	O	NOUN	B
:	O	PUNCT	O
RNA	B-GENE	NOUN	B
triphosphatase	I-GENE	NOUN	I
,	O	PUNCT	O
RNA	B-GENE	NOUN	B
guanylyltransferase	I-GENE	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
RNA	B-GENE	NOUN	B
(	I-GENE	PUNCT	O
guanine	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
7	I-GENE	NUM	B
)	I-GENE	PUNCT	O
-	I-GENE	PUNCT	O
methyltransferase	I-GENE	NOUN	B
.	O	PUNCT	O


CONCLUSION	O	NOUN	O
:	O	PUNCT	O
Patients	O	NOUN	B
wit	O	AUX	O
clinically	O	ADV	B
palpable	O	ADJ	I
neck	O	NOUN	O
disease	O	NOUN	O
(	O	PUNCT	O
N1	O	NOUN	B
-	O	PUNCT	O
3	O	NUM	O
)	O	PUNCT	O
,	O	PUNCT	O
histological	O	ADJ	B
evidence	O	NOUN	B
of	O	ADP	O
metastatic	O	ADJ	B
nodal	O	ADJ	I
disease	O	NOUN	I
,	O	PUNCT	O
extracapsular	O	ADJ	B
spread	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
three	O	NUM	O
or	O	CCONJ	O
more	O	ADV	O
positive	O	ADJ	B
lymph	O	NOUN	B
nodes	O	NOUN	I
are	O	AUX	O
at	O	ADP	O
greater	O	ADJ	O
risk	O	NOUN	B
of	O	ADP	O
developing	O	VERB	O
failure	O	NOUN	B
at	O	ADP	O
distant	O	ADJ	B
sites	O	NOUN	I
.	O	PUNCT	O


4	O	X	O
.	O	PUNCT	O


Area	O	NOUN	B
under	O	ADP	O
the	O	DET	O
drug	O	NOUN	B
concentration	O	NOUN	I
-	O	PUNCT	O
time	O	NOUN	B
curves	O	NOUN	I
(	O	PUNCT	O
AUC0	O	NOUN	B
-	O	PUNCT	O
24	O	NUM	O
hr	O	NOUN	O
)	O	PUNCT	O
for	O	ADP	O
MTX	O	NOUN	B
were	O	AUX	O
2379	O	NUM	O
and	O	CCONJ	O
3534	O	NUM	O
ng	O	NOUN	O
*	O	X	O
hr	O	NOUN	B
/	O	PUNCT	O
ml	O	NOUN	O
from	O	ADP	O
PG	O	PROPN	B
-	O	PUNCT	O
2	O	NUM	B
.	O	PUNCT	O
5	O	NUM	O
%	O	NOUN	O
Azone	O	NOUN	B
and	O	CCONJ	O
PG	O	PROPN	B
-	O	PUNCT	O
7	O	NUM	B
.	O	PUNCT	O
5	O	NUM	O
%	O	NOUN	O
Azone	O	NOUN	B
systems	O	NOUN	O
respectively	O	ADV	O
.	O	PUNCT	O


There	O	PRON	O
were	O	AUX	O
differences	O	NOUN	O
between	O	ADP	O
males	O	NOUN	B
(	O	PUNCT	O
p	O	NOUN	O
<	O	X	O
0	O	NUM	O
.	O	PUNCT	O
05	O	NUM	O
)	O	PUNCT	O
for	O	ADP	O
most	O	ADJ	O
of	O	ADP	O
the	O	DET	O
characteristics	O	NOUN	B
studied	O	VERB	O
.	O	PUNCT	O


Although	O	SCONJ	O
previous	O	ADJ	O
data	O	NOUN	B
have	O	AUX	O
suggested	O	VERB	O
that	O	SCONJ	O
Rev	B-GENE	NOUN	B
uses	O	VERB	O
the	O	DET	O
same	O	ADJ	O
export	O	NOUN	B
pathway	O	NOUN	I
as	O	ADP	O
uracil	O	NOUN	B
-	O	PUNCT	O
rich	O	ADJ	B
small	O	ADJ	O
nuclear	O	ADJ	O
RNAs	O	NOUN	O
and	O	CCONJ	O
5S	B-GENE	NOUN	B
ribosomal	I-GENE	ADJ	I
RNA	I-GENE	NOUN	I
,	O	PUNCT	O
the	O	DET	O
CTE	O	PROPN	B
seems	O	VERB	O
to	O	PART	O
interact	O	VERB	B
with	O	ADP	O
evolutionarily	O	ADV	O
conserved	O	VERB	O
factors	O	NOUN	O
that	O	PRON	O
are	O	AUX	O
essential	O	ADJ	B
for	O	ADP	O
cellular	O	ADJ	B
mRNA	O	NOUN	B
export	O	NOUN	O
.	O	PUNCT	O


S2F	B-GENE	NOUN	B
,	O	PUNCT	O
a	O	DET	O
leaf	O	NOUN	B
-	O	PUNCT	O
specific	O	ADJ	B
trans	O	ADJ	B
-	O	PUNCT	O
acting	O	VERB	B
factor	O	NOUN	B
,	O	PUNCT	O
binds	O	VERB	B
to	O	PART	O
a	O	DET	O
novel	O	ADJ	O
cis	O	NOUN	B
-	O	PUNCT	O
acting	O	VERB	B
element	O	NOUN	B
and	O	CCONJ	O
differentially	O	ADV	B
activates	O	VERB	B
the	O	DET	O
RPL21	B-GENE	NOUN	B
gene	I-GENE	NOUN	I
.	O	PUNCT	O


Polarised	O	VERB	B
expression	O	NOUN	B
of	O	ADP	O
human	O	ADJ	B
intestinal	O	ADJ	B
N	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
benzoyl	I-GENE	PROPN	B
-	I-GENE	PUNCT	O
L	I-GENE	PROPN	B
-	I-GENE	PUNCT	O
tyrosyl	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
p	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
aminobenzoic	I-GENE	ADJ	B
acid	I-GENE	NOUN	I
hydrolase	I-GENE	NOUN	I
(	O	PUNCT	O
human	B-GENE	ADJ	B
meprin	I-GENE	NOUN	I
)	O	PUNCT	O
alpha	O	NOUN	O
and	O	CCONJ	O
beta	O	NOUN	B
subunits	O	NOUN	I
in	O	ADP	O
Madin	O	PROPN	B
-	O	PUNCT	O
Darby	O	PROPN	B
canine	O	NOUN	B
kidney	O	NOUN	B
cells	O	NOUN	I
.	O	PUNCT	O


Neither	O	CCONJ	O
mutant	O	NOUN	B
exhibited	O	VERB	O
derepression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
silent	B-GENE	ADJ	B
mating	I-GENE	ADJ	B
type	I-GENE	NOUN	O
loci	I-GENE	NOUN	O
.	O	PUNCT	O


In	O	ADP	O
contrast	O	NOUN	O
to	O	PART	O
the	O	DET	O
wild	O	ADJ	B
-	O	PUNCT	O
type	O	NOUN	B
protein	O	NOUN	I
,	O	PUNCT	O
expression	O	NOUN	B
of	O	ADP	O
p45	B-GENE	NOUN	B
NF	B-GENE	NOUN	I
-	I-GENE	PUNCT	O
E2	I-GENE	NOUN	B
lacking	O	VERB	O
this	O	DET	O
activation	O	NOUN	B
domain	O	NOUN	I
in	O	ADP	O
an	O	DET	O
NF	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
E2	I-GENE	NOUN	B
null	O	ADJ	B
cell	O	NOUN	I
line	O	NOUN	I
fails	O	VERB	O
to	O	PART	O
support	O	VERB	O
enhancer	O	NOUN	B
-	O	PUNCT	O
dependent	O	ADJ	B
transcription	O	NOUN	B
in	O	ADP	O
transient	O	ADJ	B
assays	O	NOUN	I
.	O	PUNCT	O


These	O	DET	O
findings	O	NOUN	B
suggest	O	VERB	O
one	O	NUM	O
potential	O	ADJ	B
mechanism	O	NOUN	B
for	O	ADP	O
direct	O	ADJ	O
recruitment	O	NOUN	B
of	O	ADP	O
distal	O	ADJ	B
regulatory	O	ADJ	O
regions	O	NOUN	O
of	O	ADP	O
the	O	DET	O
globin	B-GENE	NOUN	B
loci	I-GENE	NOUN	I
to	O	PART	O
the	O	DET	O
individual	O	ADJ	B
promoters	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
promoter	O	NOUN	B
region	O	NOUN	I
showed	O	VERB	O
no	O	DET	O
consensus	O	NOUN	B
TATA	O	NOUN	I
box	O	NOUN	O
but	O	CCONJ	O
it	O	PRON	O
contains	O	VERB	O
CCAAT	O	NOUN	B
and	O	CCONJ	O
CreA	B-GENE	NOUN	B
boxes	O	NOUN	I
known	O	VERB	O
to	O	PART	O
be	O	AUX	O
involved	O	VERB	O
in	O	ADP	O
both	O	CCONJ	O
stress	O	NOUN	B
and	O	CCONJ	O
carbon	O	NOUN	B
-	O	PUNCT	O
catabolite	O	NOUN	B
regulation	O	NOUN	B
of	O	ADP	O
fungal	O	ADJ	B
promoters	O	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
support	O	NOUN	O
of	O	ADP	O
this	O	DET	O
interpretation	O	NOUN	B
we	O	PRON	O
demonstrate	O	VERB	O
that	O	SCONJ	O
MQ9b	B-GENE	NOUN	B
binds	O	VERB	B
strongly	O	ADV	O
5	O	NUM	O
of	O	ADP	O
17	O	NUM	O
motif	O	NOUN	B
-	O	PUNCT	O
positive	O	ADJ	B
,	O	PUNCT	O
pathogen	O	NOUN	B
-	O	PUNCT	O
derived	O	VERB	B
synthetic	O	ADJ	B
peptides	O	NOUN	I
.	O	PUNCT	O


These	O	DET	O
discoloration	O	NOUN	B
'	O	PART	O
s	O	NOUN	O
can	O	AUX	O
be	O	AUX	O
treated	O	VERB	B
in	O	ADP	O
several	O	ADJ	O
ways	O	NOUN	O
but	O	CCONJ	O
up	O	ADP	O
to	O	ADP	O
lately	O	ADV	O
tooth	O	NOUN	B
structure	O	NOUN	I
had	O	AUX	O
to	O	PART	O
be	O	AUX	O
removed	O	VERB	B
in	O	ADP	O
an	O	DET	O
irreversible	O	ADJ	B
manner	O	NOUN	O
in	O	ADP	O
order	O	NOUN	O
to	O	PART	O
provide	O	VERB	O
sufficient	O	ADJ	O
bulk	O	NOUN	O
for	O	ADP	O
the	O	DET	O
new	O	ADJ	O
restorative	O	ADJ	B
material	O	NOUN	I
.	O	PUNCT	O


Overexpression	O	NOUN	B
of	O	ADP	O
BAG	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	O
also	O	ADV	O
protected	O	VERB	O
certain	O	ADJ	O
cell	O	NOUN	B
lines	O	NOUN	I
from	O	ADP	O
heat	O	NOUN	B
shock	O	NOUN	I
-	O	PUNCT	O
induced	O	VERB	B
cell	O	NOUN	B
death	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
5	O	NUM	O
'	O	PART	O
flanking	O	ADJ	B
region	O	NOUN	I
contains	O	VERB	O
potential	O	ADJ	B
binding	O	NOUN	B
sites	O	NOUN	I
for	O	ADP	O
TATA	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
binding	I-GENE	VERB	B
protein	I-GENE	NOUN	I
,	O	PUNCT	O
Sp1	B-GENE	NOUN	B
,	O	PUNCT	O
nuclear	B-GENE	ADJ	B
factor	I-GENE	NOUN	I
1	I-GENE	NUM	I
(	O	PUNCT	O
NF1	B-GENE	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
CAAT	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
box	I-GENE	NOUN	B
binding	I-GENE	NOUN	I
protein	I-GENE	NOUN	I
(	O	PUNCT	O
C	B-GENE	NOUN	B
/	I-GENE	SYM	O
EBP	I-GENE	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
hepatocyte	B-GENE	NOUN	B
nuclear	I-GENE	ADJ	O
factors	I-GENE	NOUN	O
1	I-GENE	NUM	O
and	I-GENE	CCONJ	O
5	I-GENE	NUM	O
(	O	PUNCT	O
HNF1	B-GENE	NOUN	B
,	O	PUNCT	O
HNF5	B-GENE	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
activator	B-GENE	NOUN	B
proteins	I-GENE	NOUN	I
1	I-GENE	NUM	I
and	I-GENE	CCONJ	O
2	I-GENE	NUM	O
(	O	PUNCT	O
AP1	B-GENE	NOUN	B
,	O	PUNCT	O
AP2	B-GENE	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


The	O	DET	O
recognition	O	NOUN	B
specificity	O	NOUN	I
of	O	ADP	O
the	O	DET	O
p55	B-GENE	NOUN	B
PDZ	B-GENE	NOUN	I
domain	I-GENE	NOUN	O
appears	O	VERB	O
to	O	PART	O
be	O	AUX	O
unique	O	ADJ	B
,	O	PUNCT	O
since	O	SCONJ	O
the	O	DET	O
three	O	NUM	O
PDZ	B-GENE	NOUN	B
domains	I-GENE	NOUN	O
of	O	ADP	O
hDlg	B-GENE	NOUN	B
(	O	PUNCT	O
human	O	ADJ	B
lymphocyte	O	NOUN	O
homologue	O	NOUN	O
of	O	ADP	O
the	O	DET	O
Drosophila	B-GENE	NOUN	B
discs	I-GENE	NOUN	B
large	I-GENE	ADJ	O
tumor	I-GENE	NOUN	B
suppressor	I-GENE	NOUN	I
)	O	PUNCT	O
do	O	AUX	O
not	O	PART	O
bind	O	VERB	B
the	O	DET	O
cytoplasmic	O	ADJ	B
domain	O	NOUN	I
of	O	ADP	O
glycophorin	B-GENE	NOUN	B
C	I-GENE	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
the	O	DET	O
United	O	PROPN	B
States	O	PROPN	I
high	O	ADJ	B
-	O	PUNCT	O
MW	O	NOUN	B
HES	O	PROPN	B
480	O	NUM	O
which	O	DET	O
is	O	AUX	O
difficult	O	ADJ	O
to	O	PART	O
degrade	O	VERB	B
is	O	AUX	O
most	O	ADV	O
frequently	O	ADV	O
used	O	VERB	O
and	O	CCONJ	O
results	O	NOUN	B
in	O	ADP	O
a	O	DET	O
larger	O	ADJ	O
in	O	X	B
vivo	O	X	I
MW	O	NOUN	B
and	O	CCONJ	O
subsequent	O	ADJ	O
decrease	O	NOUN	B
in	O	ADP	O
factor	B-GENE	NOUN	B
VIII	I-GENE	NOUN	I
/	O	SYM	O
von	B-GENE	NOUN	B
Willebrand	I-GENE	NOUN	I
factor	I-GENE	NOUN	I
levels	O	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
our	O	PRON	O
previous	O	ADJ	O
studies	O	NOUN	B
,	O	PUNCT	O
transcriptional	O	ADJ	B
activation	O	NOUN	I
was	O	AUX	O
shown	O	VERB	O
to	O	PART	O
correlate	O	VERB	B
with	O	ADP	O
IEP86	B-GENE	NOUN	B
binding	O	NOUN	I
to	O	PART	O
both	O	CCONJ	O
the	O	DET	O
TATA	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
box	I-GENE	NOUN	B
binding	I-GENE	NOUN	I
protein	I-GENE	NOUN	I
(	O	PUNCT	O
TBP	B-GENE	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
the	O	DET	O
transcription	O	NOUN	B
factor	O	NOUN	I
bound	O	VERB	I
upstream	O	ADV	I
.	O	PUNCT	O


Previously	O	ADV	O
,	O	PUNCT	O
we	O	PRON	O
reported	O	VERB	O
that	O	SCONJ	O
scanthrough	O	ADJ	B
translation	O	NOUN	B
,	O	PUNCT	O
where	O	SCONJ	O
the	O	DET	O
initiating	O	VERB	O
AUG	O	NOUN	B
of	O	ADP	O
a	O	DET	O
primary	O	ADJ	B
open	O	ADJ	O
reading	O	NOUN	O
frame	O	NOUN	O
is	O	AUX	O
bypassed	O	VERB	O
,	O	PUNCT	O
is	O	AUX	O
most	O	ADV	O
likely	O	ADJ	O
to	O	PART	O
account	O	VERB	O
for	O	ADP	O
the	O	DET	O
presentation	O	NOUN	B
of	O	ADP	O
cryptic	O	ADJ	B
epitopes	O	NOUN	I
from	O	ADP	O
alternative	O	ADJ	B
reading	O	NOUN	I
frames	O	NOUN	I
within	O	ADP	O
the	O	DET	O
influenza	B-GENE	NOUN	B
A	I-GENE	NOUN	I
PR	I-GENE	NOUN	B
/	I-GENE	SYM	O
8	I-GENE	NUM	B
/	I-GENE	SYM	O
34	I-GENE	NUM	B
nucleoprotein	I-GENE	NOUN	I
gene	I-GENE	NOUN	I
.	O	PUNCT	O


The	O	DET	O
deduced	O	VERB	O
amino	O	NOUN	B
acid	O	NOUN	I
sequence	O	NOUN	I
of	O	ADP	O
the	O	DET	O
gene	O	NOUN	B
has	O	AUX	O
significant	O	ADJ	O
homology	O	NOUN	B
to	O	PART	O
the	O	DET	O
interferon	B-GENE	NOUN	B
regulatory	I-GENE	ADJ	I
factors	I-GENE	NOUN	I
(	O	PUNCT	O
IRFs	B-GENE	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


The	O	DET	O
pheromone	O	NOUN	B
response	O	NOUN	I
pathway	O	NOUN	I
activates	O	VERB	B
transcription	O	NOUN	B
of	O	ADP	O
Ty5	B-GENE	NOUN	B
retrotransposons	I-GENE	NOUN	B
located	O	ADJ	O
within	O	ADP	O
silent	O	ADJ	B
chromatin	O	NOUN	B
of	O	ADP	O
Saccharomyces	O	X	B
cerevisiae	O	X	I
.	O	PUNCT	O


The	O	DET	O
malate	B-GENE	ADJ	B
synthase	I-GENE	NOUN	I
gene	I-GENE	NOUN	I
,	O	PUNCT	O
MLS1	B-GENE	NOUN	B
,	O	PUNCT	O
of	O	ADP	O
the	O	DET	O
yeast	O	NOUN	B
Saccharomyces	O	X	B
cerevisiae	O	X	I
is	O	AUX	O
transcriptionally	O	ADV	B
regulated	O	VERB	I
by	O	ADP	O
the	O	DET	O
carbon	O	NOUN	B
source	O	NOUN	B
in	O	ADP	O
the	O	DET	O
growth	O	NOUN	B
medium	O	NOUN	I
.	O	PUNCT	O


By	O	ADP	O
deletion	O	NOUN	B
analysis	O	NOUN	I
of	O	ADP	O
the	O	DET	O
MLS1	B-GENE	NOUN	B
control	O	NOUN	B
region	O	NOUN	I
,	O	PUNCT	O
we	O	PRON	O
identified	O	VERB	B
two	O	NUM	O
sites	O	NOUN	B
,	O	PUNCT	O
UAS1	O	NOUN	B
and	O	CCONJ	O
UAS2	O	NOUN	B
,	O	PUNCT	O
as	O	ADP	O
important	O	ADJ	O
for	O	ADP	O
efficient	O	ADJ	B
derepression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
gene	O	NOUN	B
.	O	PUNCT	O


Prior	O	ADV	O
to	O	ADP	O
meals	O	NOUN	B
2	O	NUM	O
to	O	PART	O
3	O	NUM	O
times	O	NOUN	O
daily	O	ADV	B
,	O	PUNCT	O
1	O	NUM	O
-	O	SYM	O
2	O	NUM	O
tablespoons	O	NOUN	O
of	O	ADP	O
Alzoon	O	PROPN	B
are	O	AUX	O
recommended	O	VERB	B
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
UBP41	B-GENE	NOUN	B
may	O	AUX	O
play	O	VERB	O
an	O	DET	O
important	O	ADJ	O
role	O	NOUN	O
in	O	ADP	O
the	O	DET	O
recycling	O	NOUN	B
of	O	ADP	O
ubiquitin	B-GENE	NOUN	B
by	O	ADP	O
hydrolysis	O	NOUN	B
of	O	ADP	O
branched	B-GENE	ADJ	B
poly	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
ubiquitin	I-GENE	NOUN	B
chains	I-GENE	NOUN	I
generated	O	VERB	O
by	O	ADP	O
the	O	DET	O
action	O	NOUN	B
of	O	ADP	O
26	B-GENE	NUM	O
S	I-GENE	NOUN	B
proteasome	I-GENE	NOUN	I
on	O	ADP	O
poly	O	NOUN	B
-	O	PUNCT	O
ubiquitinated	O	VERB	B
protein	O	NOUN	O
substrates	O	NOUN	O
,	O	PUNCT	O
as	O	ADV	O
well	O	ADV	O
as	O	ADP	O
in	O	ADP	O
the	O	DET	O
production	O	NOUN	B
of	O	ADP	O
free	O	ADJ	B
ubiquitin	B-GENE	NOUN	I
from	O	ADP	O
linear	B-GENE	ADJ	O
poly	I-GENE	ADJ	B
-	I-GENE	PUNCT	O
ubiquitin	I-GENE	NOUN	B
chains	I-GENE	NOUN	I
and	O	CCONJ	O
of	O	ADP	O
certain	O	ADJ	O
ribosomal	O	ADJ	B
proteins	O	NOUN	I
from	O	ADP	O
ubiquitin	B-GENE	NOUN	B
fusion	I-GENE	NOUN	I
proteins	I-GENE	NOUN	I
.	O	PUNCT	O


The	O	DET	O
regurgitation	O	NOUN	B
of	O	ADP	O
large	O	ADJ	O
vitreous	O	ADJ	B
injections	O	NOUN	I
.	O	PUNCT	O


Attenuation	O	NOUN	B
from	O	ADP	O
the	O	DET	O
vit	B-GENE	NOUN	B
A2	I-GENE	NOUN	I
consensus	O	NOUN	I
ERE	O	NOUN	I
is	O	AUX	O
not	O	PART	O
necessarily	O	ADV	O
dependent	O	ADJ	O
on	O	ADP	O
DNA	O	NOUN	B
binding	O	NOUN	I
as	O	ADP	O
the	O	DET	O
TR	B-GENE	NOUN	B
alpha	I-GENE	NOUN	I
DNA	O	NOUN	B
binding	O	NOUN	I
mutant	O	NOUN	I
was	O	AUX	O
still	O	ADV	O
able	O	ADJ	O
to	O	PART	O
inhibit	O	VERB	B
E	O	NOUN	B
-	O	PUNCT	O
dependent	O	ADJ	B
transactivation	O	NOUN	B
.	O	PUNCT	O


Null	O	ADJ	B
mutations	O	NOUN	I
in	O	ADP	O
daf	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
3	I-GENE	NUM	O
suppress	O	VERB	B
mutations	O	NOUN	B
in	O	ADP	O
genes	O	NOUN	B
encoding	O	VERB	B
this	O	DET	O
TGF	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
beta	I-GENE	NOUN	B
signal	O	NOUN	I
,	O	PUNCT	O
its	O	PRON	O
receptors	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
associated	O	VERB	O
Smad	B-GENE	NOUN	B
signal	I-GENE	NOUN	I
transduction	I-GENE	NOUN	I
proteins	I-GENE	NOUN	I
.	O	PUNCT	O
daf	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
3	I-GENE	NUM	O
encodes	O	VERB	B
a	O	DET	O
Smad	B-GENE	NOUN	B
protein	I-GENE	NOUN	I
that	O	PRON	O
is	O	AUX	O
most	O	ADV	O
closely	O	ADV	O
related	O	ADJ	O
to	O	PART	O
mammalian	B-GENE	ADJ	B
DPC4	I-GENE	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
is	O	AUX	O
expressed	O	VERB	B
throughout	O	ADP	O
development	O	NOUN	B
in	O	ADP	O
many	O	ADJ	O
of	O	ADP	O
the	O	DET	O
tissues	O	NOUN	B
that	O	PRON	O
are	O	AUX	O
remodeled	O	VERB	B
during	O	ADP	O
dauer	O	NOUN	B
development	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
overexpressed	O	VERB	B
,	O	PUNCT	O
purified	O	VERB	B
,	O	PUNCT	O
characterized	O	VERB	B
,	O	PUNCT	O
and	O	CCONJ	O
crystallized	O	VERB	B
the	O	DET	O
BTB	B-GENE	PROPN	B
/	O	PUNCT	O
POZ	O	NOUN	B
domain	O	NOUN	B
from	O	ADP	O
PLZF	B-GENE	NOUN	B
(	O	PUNCT	O
PLZF	B-GENE	NOUN	B
-	O	PUNCT	O
BTB	B-GENE	PROPN	B
/	O	PUNCT	O
POZ	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Furthermore	O	ADV	O
,	O	PUNCT	O
deletion	O	NOUN	B
and	O	CCONJ	O
mutation	O	NOUN	B
analyses	O	NOUN	I
of	O	ADP	O
the	O	DET	O
VCAM	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	O
promoter	I-GENE	NOUN	B
performed	O	VERB	O
with	O	ADP	O
chloramphenicol	B-GENE	NOUN	B
acetyltransferase	I-GENE	NOUN	I
constructs	I-GENE	NOUN	O
revealed	O	VERB	O
that	O	SCONJ	O
Tax	B-GENE	NOUN	B
was	O	AUX	O
trans	O	ADJ	O
activating	O	VERB	O
the	O	DET	O
VCAM	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	O
promoter	I-GENE	NOUN	B
via	O	ADP	O
two	O	NUM	O
NF	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
kappaB	I-GENE	NOUN	B
sites	I-GENE	NOUN	I
present	O	ADJ	O
at	O	ADP	O
bp	O	NOUN	B
-	O	PUNCT	O
72	O	NUM	O
and	O	CCONJ	O
-	O	PUNCT	O
57	O	NUM	O
in	O	ADP	O
the	O	DET	O
VCAM	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	O
gene	I-GENE	NOUN	B
promoter	I-GENE	NOUN	I
,	O	PUNCT	O
with	O	ADP	O
both	O	DET	O
of	O	ADP	O
them	O	PRON	O
being	O	AUX	O
required	O	VERB	O
for	O	ADP	O
the	O	DET	O
Tax	B-GENE	NOUN	B
-	O	PUNCT	O
induced	O	VERB	B
expression	O	NOUN	B
of	O	ADP	O
this	O	DET	O
adhesion	O	NOUN	B
molecule	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
AGM	B-GENE	NOUN	B
and	I-GENE	CCONJ	O
NIH	I-GENE	PROPN	B
/	I-GENE	PUNCT	O
Swiss	I-GENE	ADJ	B
mouse	I-GENE	NOUN	B
CCR5	I-GENE	NOUN	B
proteins	I-GENE	NOUN	I
are	O	AUX	O
97	O	NUM	O
.	O	PUNCT	O
7	O	NUM	O
to	O	PART	O
98	O	NUM	O
.	O	PUNCT	O
3	O	NUM	O
%	O	NOUN	O
and	O	CCONJ	O
79	O	NUM	O
.	O	PUNCT	O
8	O	NUM	O
%	O	NOUN	O
identical	O	ADJ	B
to	O	PART	O
the	O	DET	O
human	O	ADJ	B
protein	O	NOUN	I
,	O	PUNCT	O
respectively	O	ADV	O
.	O	PUNCT	O


Recently	O	ADV	O
,	O	PUNCT	O
roles	O	NOUN	O
also	O	ADV	O
have	O	AUX	O
been	O	AUX	O
suggested	O	VERB	O
for	O	ADP	O
the	O	DET	O
nuclear	O	ADJ	B
trans	O	ADJ	I
-	O	PUNCT	O
factor	O	NOUN	B
GATA	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	O
in	O	ADP	O
regulating	O	VERB	B
progenitor	O	NOUN	I
cell	O	NOUN	I
proliferation	O	NOUN	I
.	O	PUNCT	O


(	O	PUNCT	O
ii	O	X	O
)	O	PUNCT	O
An	O	DET	O
AF	O	NOUN	B
G	B-GENE	NOUN	I
-	I-GENE	PUNCT	O
CSF	I-GENE	NOUN	B
level	O	NOUN	B
>	O	X	O
2000	O	NUM	O
pg	O	NOUN	O
/	O	SYM	O
ml	O	NOUN	O
is	O	AUX	O
a	O	DET	O
strong	O	ADJ	O
positive	O	ADJ	B
predictor	O	NOUN	B
of	O	ADP	O
CAM	O	PROPN	B
.	O	PUNCT	O


[	O	PUNCT	O
Pulmonary	O	ADJ	B
vascular	O	ADJ	I
resistance	O	NOUN	I
(	O	PUNCT	O
PVR	O	NOUN	B
)	O	PUNCT	O
during	O	ADP	O
10	O	NUM	O
%	O	NOUN	O
O2	O	NOUN	B
-	O	PUNCT	O
PVR	O	NOUN	B
during	O	ADP	O
21	O	NUM	O
%	O	NOUN	O
O2	O	NOUN	B
/	O	SYM	O
PVR	O	NOUN	B
during	O	ADP	O
21	O	NUM	O
%	O	NOUN	O
O2	O	NOUN	B
]	O	PUNCT	O
x	O	NOUN	O
100	O	NUM	O
was	O	AUX	O
termed	O	VERB	O
as	O	ADP	O
hypoxic	O	ADJ	B
pulmonary	O	ADJ	I
vasoconstriction	O	NOUN	I
(	O	PUNCT	O
HPV	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


An	O	DET	O
unusual	O	ADJ	B
cysteine	O	NOUN	B
triplet	O	NOUN	I
conserved	O	VERB	I
in	O	ADP	O
the	O	DET	O
sequences	O	NOUN	B
of	O	ADP	O
TB	B-GENE	NOUN	B
domains	I-GENE	NOUN	B
is	O	AUX	O
localized	O	ADJ	B
to	O	PART	O
the	O	DET	O
hydrophobic	O	ADJ	B
core	O	NOUN	B
,	O	PUNCT	O
at	O	ADP	O
the	O	DET	O
C	O	NOUN	B
-	O	PUNCT	O
terminus	O	NOUN	B
of	O	ADP	O
an	O	DET	O
alpha	O	NOUN	B
-	O	PUNCT	O
helix	O	NOUN	B
.	O	PUNCT	O


Protein	O	NOUN	B
phosphatases	O	NOUN	I
play	O	VERB	O
a	O	DET	O
critical	O	ADJ	O
role	O	NOUN	O
in	O	ADP	O
the	O	DET	O
regulation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
eukaryotic	O	ADJ	B
cell	O	NOUN	I
cycle	O	NOUN	I
and	O	CCONJ	O
signal	O	NOUN	B
transduction	O	NOUN	I
.	O	PUNCT	O


Re	O	VERB	B
:	O	PUNCT	O
"	O	PUNCT	O
Assessing	O	VERB	B
the	O	DET	O
direction	O	NOUN	B
of	O	ADP	O
causality	O	NOUN	B
in	O	ADP	O
cross	O	NOUN	B
-	O	PUNCT	O
sectional	O	ADJ	B
studies	O	NOUN	I
"	O	PUNCT	O
.	O	PUNCT	O


Restriction	O	NOUN	B
enzyme	O	NOUN	B
mapping	O	NOUN	I
,	O	PUNCT	O
subcloning	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
DNA	O	NOUN	B
sequencing	O	NOUN	I
analysis	O	NOUN	I
of	O	ADP	O
recombinant	O	ADJ	B
phage	O	NOUN	I
lambda	O	NOUN	I
and	O	CCONJ	O
P1	O	NOUN	B
clones	O	NOUN	I
revealed	O	VERB	O
that	O	SCONJ	O
exons	O	NOUN	B
encoding	O	VERB	B
the	O	DET	O
1	O	NUM	O
.	O	PUNCT	O
9	O	NUM	O
-	O	PUNCT	O
kb	O	NOUN	O
mouse	B-GENE	NOUN	B
TS	I-GENE	NOUN	B
mRNA	I-GENE	NOUN	B
are	O	AUX	O
dispersed	O	VERB	B
over	O	ADP	O
>	O	X	O
150	O	NUM	O
kb	O	NOUN	O
genomic	O	ADJ	B
DNA	O	NOUN	I
.	O	PUNCT	O


Transfection	O	NOUN	B
analyses	O	NOUN	I
indicated	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
Tbxas1	B-GENE	NOUN	B
is	O	AUX	O
controlled	O	VERB	B
by	O	ADP	O
a	O	DET	O
short	O	ADJ	O
(	O	PUNCT	O
70	O	NUM	O
-	O	PUNCT	O
bp	O	NOUN	B
)	O	PUNCT	O
positive	O	ADJ	B
regulatory	O	ADJ	B
sequence	O	NOUN	I
and	O	CCONJ	O
several	O	ADJ	O
upstream	O	ADJ	B
repressive	O	ADJ	O
elements	O	NOUN	O
.	O	PUNCT	O


Electromobility	O	NOUN	B
shift	O	NOUN	I
and	O	CCONJ	O
cotransfection	O	NOUN	B
assays	O	NOUN	I
demonstrated	O	VERB	O
that	O	SCONJ	O
HNF1alpha	B-GENE	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
not	O	PART	O
HNF4	B-GENE	NOUN	B
,	O	PUNCT	O
bound	O	VERB	O
to	O	PART	O
its	O	PRON	O
cognate	O	ADJ	B
site	O	NOUN	I
and	O	CCONJ	O
transactivated	O	VERB	B
G6Pase	B-GENE	NOUN	O
gene	I-GENE	NOUN	B
expression	O	NOUN	I
.	O	PUNCT	O


Differential	O	ADJ	B
regulation	O	NOUN	I
of	O	ADP	O
the	O	DET	O
pre	B-GENE	ADJ	B
-	I-GENE	PUNCT	O
C	I-GENE	NOUN	B
and	O	CCONJ	O
pregenomic	O	ADJ	B
promoters	O	NOUN	I
of	O	ADP	O
human	O	ADJ	B
hepatitis	O	NOUN	O
B	O	NOUN	O
virus	O	NOUN	O
by	O	ADP	O
members	O	NOUN	B
of	O	ADP	O
the	O	DET	O
nuclear	B-GENE	ADJ	B
receptor	I-GENE	NOUN	I
superfamily	I-GENE	NOUN	I
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
implicate	O	VERB	O
a	O	DET	O
precursor	O	NOUN	B
-	O	PUNCT	O
specific	O	ADJ	B
base	O	NOUN	B
-	O	PUNCT	O
paired	O	VERB	B
structure	O	NOUN	I
involving	O	VERB	O
sequences	O	NOUN	B
on	O	ADP	O
both	O	DET	O
sides	O	NOUN	O
of	O	ADP	O
the	O	DET	O
mature	O	ADJ	B
cleavage	O	NOUN	B
site	O	NOUN	I
in	O	ADP	O
the	O	DET	O
3	O	NUM	O
'	O	PART	O
processing	O	NOUN	B
of	O	ADP	O
human	B-GENE	ADJ	B
U2	I-GENE	NOUN	O
RNA	I-GENE	NOUN	O
.	O	PUNCT	O


The	O	DET	O
mouse	B-GENE	NOUN	B
M	I-GENE	NOUN	I
-	I-GENE	PUNCT	O
lysozyme	I-GENE	NOUN	B
downstream	I-GENE	ADJ	B
enhancer	I-GENE	NOUN	I
has	O	AUX	O
been	O	AUX	O
previously	O	ADV	O
characterized	O	VERB	B
on	O	ADP	O
several	O	ADJ	O
levels	O	NOUN	B
of	O	ADP	O
gene	O	NOUN	B
regulation	O	NOUN	I
.	O	PUNCT	O


Bitter	O	ADJ	B
cassava	O	NOUN	B
contains	O	VERB	O
cyanogenic	O	ADJ	B
glycosides	O	NOUN	I
;	O	PUNCT	O
processing	O	NOUN	B
breaks	O	VERB	I
them	O	PRON	O
down	O	ADP	O
to	O	ADP	O
acetone	O	NOUN	B
cyanohydrin	O	NOUN	I
and	O	CCONJ	O
hydrogen	O	NOUN	B
cyanide	O	NOUN	I
.	O	PUNCT	O


First	O	ADV	O
,	O	PUNCT	O
two	O	NUM	O
MCTs	O	NOUN	B
using	O	VERB	O
a	O	DET	O
long	O	ADJ	B
electrode	O	NOUN	I
,	O	PUNCT	O
3	O	NUM	O
cm	O	NOUN	O
in	O	ADP	O
size	O	NOUN	B
,	O	PUNCT	O
were	O	AUX	O
performed	O	VERB	O
in	O	ADP	O
the	O	DET	O
central	O	ADJ	B
area	O	NOUN	I
of	O	ADP	O
the	O	DET	O
tumor	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
eight	O	NUM	O
MCTs	O	NOUN	B
by	O	ADP	O
a	O	DET	O
short	O	ADJ	B
electrode	O	NOUN	I
,	O	PUNCT	O
2	O	NUM	O
cm	O	NOUN	O
in	O	ADP	O
size	O	NOUN	B
,	O	PUNCT	O
were	O	AUX	O
done	O	VERB	O
in	O	ADP	O
the	O	DET	O
peripheral	O	ADJ	B
and	O	CCONJ	O
surrounding	O	VERB	O
area	O	NOUN	O
of	O	ADP	O
the	O	DET	O
tumor	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
also	O	ADV	O
show	O	VERB	O
by	O	ADP	O
immunogold	O	ADJ	B
electron	O	NOUN	I
microscopy	O	NOUN	I
immunocytochemistry	O	NOUN	B
that	O	PRON	O
amphiphysin	B-GENE	NOUN	B
I	I-GENE	NUM	I
is	O	AUX	O
localized	O	ADJ	B
in	O	ADP	O
the	O	DET	O
nerve	O	NOUN	B
terminal	O	ADJ	B
cytomatrix	O	NOUN	B
and	O	CCONJ	O
is	O	AUX	O
partially	O	ADV	O
associated	O	VERB	B
with	O	ADP	I
endocytic	O	ADJ	B
intermediates	O	NOUN	O
.	O	PUNCT	O


The	O	DET	O
prescription	O	NOUN	B
for	O	ADP	O
apoplexy	O	NOUN	B
includes	O	VERB	O
C1	O	NOUN	B
-	O	PUNCT	O
7	O	NUM	B
,	O	PUNCT	O
T1	O	PROPN	B
-	O	PUNCT	O
9	O	NUM	B
and	O	CCONJ	O
L2	O	NOUN	B
-	O	PUNCT	O
4	O	NUM	O
.	O	PUNCT	O


Thus	O	ADV	O
,	O	PUNCT	O
dpp	B-GENE	NOUN	B
and	O	CCONJ	O
omb	B-GENE	NOUN	B
promote	O	VERB	B
both	O	CCONJ	O
dorsal	O	ADJ	B
leg	O	NOUN	I
cell	O	NOUN	I
fate	O	NOUN	O
as	O	ADV	O
well	O	ADV	O
as	O	ADP	O
transdetermination	O	NOUN	B
-	O	PUNCT	O
competent	O	ADJ	B
leg	O	NOUN	B
disc	O	NOUN	B
cells	O	NOUN	I
.	O	PUNCT	O


These	O	DET	O
observations	O	NOUN	B
provide	O	VERB	O
strong	O	ADJ	O
support	O	NOUN	O
for	O	ADP	O
the	O	DET	O
idea	O	NOUN	O
that	O	SCONJ	O
expression	O	NOUN	B
of	O	ADP	O
mutant	O	ADJ	B
tRNA	O	NOUN	B
can	O	AUX	O
confer	O	VERB	O
a	O	DET	O
mutator	O	NOUN	B
phenotype	O	NOUN	B
,	O	PUNCT	O
including	O	VERB	O
the	O	DET	O
UVM	O	PROPN	B
-	O	PUNCT	O
constitutive	O	ADJ	B
phenotype	O	NOUN	B
observed	O	VERB	B
in	O	ADP	O
mutA	B-GENE	NOUN	B
and	O	CCONJ	O
mutC	B-GENE	NOUN	B
cells	O	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
now	O	ADV	O
demonstrate	O	VERB	O
that	O	SCONJ	O
CCAAT	B-GENE	NOUN	B
/	I-GENE	PUNCT	O
enhancer	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
binding	I-GENE	VERB	B
protein	I-GENE	NOUN	I
(	I-GENE	PUNCT	O
C	I-GENE	NOUN	B
/	I-GENE	PUNCT	O
EBP	I-GENE	NOUN	B
)	I-GENE	PUNCT	O
delta	I-GENE	NOUN	O
is	O	AUX	O
a	O	DET	O
major	O	ADJ	O
component	O	NOUN	O
of	O	ADP	O
a	O	DET	O
PGE2	O	NOUN	B
-	O	PUNCT	O
stimulated	O	VERB	B
DNA	O	NOUN	B
-	O	PUNCT	O
protein	O	NOUN	B
complex	O	NOUN	I
involving	O	VERB	O
HS3D	B-GENE	NOUN	B
and	O	CCONJ	O
find	O	VERB	O
that	O	SCONJ	O
C	B-GENE	NOUN	B
/	I-GENE	SYM	O
EBPdelta	I-GENE	NOUN	B
transactivates	O	VERB	B
IGF	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
I	I-GENE	NOUN	B
promoter	I-GENE	NOUN	B
1	I-GENE	NUM	I
through	O	ADP	O
this	O	DET	O
site	O	NOUN	B
.	O	PUNCT	O


Interleukin	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	O
levels	O	NOUN	B
remained	O	VERB	O
low	O	ADJ	O
throughout	O	ADP	O
the	O	DET	O
course	O	NOUN	B
.	O	PUNCT	O


Southern	O	NOUN	B
blot	O	NOUN	I
analysis	O	NOUN	I
of	O	ADP	O
endonuclease	O	NOUN	B
-	O	PUNCT	O
digested	O	VERB	B
genomic	O	ADJ	B
DNA	O	NOUN	I
from	O	ADP	O
primary	O	ADJ	B
chick	O	NOUN	B
embryo	O	NOUN	B
fibroblasts	O	NOUN	B
(	O	PUNCT	O
CEF	O	NOUN	B
)	O	PUNCT	O
suggested	O	VERB	O
that	O	SCONJ	O
MEK2	B-GENE	NOUN	B
is	O	AUX	O
a	O	DET	O
single	O	ADJ	B
-	O	PUNCT	O
copy	O	NOUN	B
gene	O	NOUN	I
in	O	ADP	O
this	O	DET	O
vertebrate	O	NOUN	B
species	O	NOUN	B
.	O	PUNCT	O


SCID	O	NOUN	B
V	B-GENE	NOUN	I
(	O	PUNCT	O
D	B-GENE	NOUN	O
)	O	PUNCT	O
J	B-GENE	NOUN	O
recombination	O	NOUN	B
can	O	AUX	O
be	O	AUX	O
partly	O	ADV	O
rescued	O	VERB	B
in	O	ADP	O
T	O	NOUN	B
-	O	PUNCT	O
lymphocytes	O	NOUN	B
by	O	ADP	O
either	O	CCONJ	O
DNA	O	NOUN	B
-	O	PUNCT	O
damaging	O	NOUN	B
agents	O	NOUN	B
(	O	PUNCT	O
gamma	O	NOUN	B
-	O	PUNCT	O
irradiation	O	NOUN	B
and	O	CCONJ	O
bieomycin	O	ADJ	B
)	O	PUNCT	O
or	O	CCONJ	O
a	O	DET	O
null	O	ADJ	B
mutation	O	NOUN	I
of	O	ADP	O
the	O	DET	O
p53	B-GENE	NOUN	B
gene	I-GENE	NOUN	I
,	O	PUNCT	O
possibly	O	ADV	O
because	O	SCONJ	O
of	O	ADP	O
transiently	O	ADV	B
elevated	O	ADJ	B
DNA	O	NOUN	B
repair	O	NOUN	I
activity	O	NOUN	I
in	O	ADP	O
response	O	NOUN	B
to	O	PART	I
DNA	O	NOUN	B
damage	O	NOUN	I
or	O	CCONJ	O
to	O	PART	O
delayed	O	VERB	B
apoptosis	O	NOUN	B
in	O	ADP	O
the	O	DET	O
absence	O	NOUN	B
of	O	ADP	O
p53	B-GENE	NOUN	B
.	O	PUNCT	O


The	O	DET	O
existence	O	NOUN	O
of	O	ADP	O
these	O	DET	O
two	O	NUM	O
categories	O	NOUN	B
of	O	ADP	O
strains	O	NOUN	B
offers	O	VERB	O
a	O	DET	O
new	O	ADJ	O
genetic	O	ADJ	B
system	O	NOUN	I
in	O	ADP	O
which	O	DET	O
the	O	DET	O
properties	O	NOUN	B
of	O	ADP	O
a	O	DET	O
potential	O	ADJ	O
invertebrate	O	NOUN	B
retrovirus	O	NOUN	I
can	O	AUX	O
be	O	AUX	O
tested	O	VERB	B
.	O	PUNCT	O


TSA	O	NOUN	B
treatment	O	NOUN	B
,	O	PUNCT	O
however	O	ADV	O
,	O	PUNCT	O
did	O	AUX	O
not	O	PART	O
detectably	O	ADV	O
alter	O	VERB	O
enhancer	O	NOUN	B
factor	O	NOUN	I
binding	O	NOUN	I
or	O	CCONJ	O
the	O	DET	O
positioning	O	NOUN	B
of	O	ADP	O
nuc	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	O
on	O	ADP	O
the	O	DET	O
majority	O	NOUN	O
of	O	ADP	O
the	O	DET	O
chromatin	O	NOUN	B
templates	O	NOUN	B
indicating	O	VERB	O
that	O	SCONJ	O
protein	O	NOUN	B
acetylation	O	NOUN	I
and	O	CCONJ	O
chromatin	O	NOUN	B
remodeling	O	NOUN	I
may	O	AUX	O
be	O	AUX	O
limiting	O	VERB	O
steps	O	NOUN	O
that	O	PRON	O
occur	O	VERB	O
only	O	ADV	O
on	O	ADP	O
transcriptionally	O	ADV	B
competent	O	ADJ	O
templates	O	NOUN	B
,	O	PUNCT	O
or	O	CCONJ	O
that	O	SCONJ	O
remodeling	O	NOUN	B
of	O	ADP	O
nuc	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	O
requires	O	VERB	O
additional	O	ADJ	O
factors	O	NOUN	B
.	O	PUNCT	O


Y15170	B-GENE	NOUN	B
(	O	PUNCT	O
Surf	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
2	I-GENE	NUM	O
,	O	PUNCT	O
Surf	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
4	I-GENE	NUM	O
)	O	PUNCT	O
,	O	PUNCT	O
Y15171	B-GENE	NOUN	B
(	O	PUNCT	O
Surf	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
3	I-GENE	NUM	O
,	O	PUNCT	O
Surf	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	O
,	O	PUNCT	O
Surf	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
6	I-GENE	NUM	O
)	O	PUNCT	O
,	O	PUNCT	O
and	O	CCONJ	O
Y15172	B-GENE	NOUN	B
(	O	PUNCT	O
Surf	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
5	I-GENE	NUM	O
.	O	PUNCT	O
)	O	PUNCT	O
]	O	PUNCT	O


The	O	DET	O
mean	O	ADJ	O
values	O	NOUN	B
of	O	ADP	O
the	O	DET	O
first	O	ADJ	O
three	O	NUM	O
components	O	NOUN	B
were	O	AUX	O
not	O	PART	O
significantly	O	ADV	O
different	O	ADJ	O
in	O	ADP	O
ARVD	O	NOUN	B
patients	O	NOUN	B
and	O	CCONJ	O
control	O	ADJ	B
subjects	O	NOUN	I
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
signaling	O	NOUN	B
cascade	O	NOUN	I
utilized	O	VERB	O
by	O	ADP	O
the	O	DET	O
urokinase	B-GENE	NOUN	B
receptor	I-GENE	NOUN	I
is	O	AUX	O
only	O	ADV	O
incompletely	O	ADV	O
understood	O	VERB	O
.	O	PUNCT	O


The	O	DET	O
interaction	O	NOUN	B
between	O	ADP	O
DDB	B-GENE	NOUN	B
and	O	CCONJ	O
E2F1	B-GENE	NOUN	B
can	O	AUX	O
also	O	ADV	O
be	O	AUX	O
detected	O	VERB	B
by	O	ADP	O
coimmunoprecipitation	O	NOUN	B
experiments	O	NOUN	O
.	O	PUNCT	O


Lysine	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
ketoglutarate	I-GENE	NOUN	B
reductase	I-GENE	NOUN	I
and	O	CCONJ	O
saccharopine	B-GENE	NOUN	B
dehydrogenase	I-GENE	NOUN	I
from	O	ADP	O
Arabidopsis	O	NOUN	B
thaliana	O	NOUN	I
:	O	PUNCT	O
nucleotide	O	NOUN	B
sequence	O	NOUN	I
and	O	CCONJ	O
characterization	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
pel	B-GENE	NOUN	B
gene	I-GENE	NOUN	I
from	O	ADP	O
an	O	DET	O
Amycolata	O	NOUN	B
sp	O	NOUN	I
.	O	PUNCT	O
encoding	O	VERB	B
a	O	DET	O
pectate	B-GENE	NOUN	B
lyase	I-GENE	NOUN	I
(	O	PUNCT	O
EC	B-GENE	NOUN	B
4	I-GENE	NUM	O
.	I-GENE	PUNCT	O
2	I-GENE	NUM	O
.	I-GENE	PUNCT	O
2	I-GENE	NUM	O
.	I-GENE	PUNCT	O
2	I-GENE	NUM	O
)	O	PUNCT	O
was	O	AUX	O
isolated	O	VERB	B
by	O	ADP	O
activity	O	NOUN	B
screening	O	VERB	I
a	O	DET	O
genomic	O	ADJ	B
DNA	O	NOUN	I
library	O	NOUN	I
in	O	ADP	O
Streptomyces	O	X	B
lividans	O	X	I
TK24	O	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
the	O	DET	O
clinical	O	ADJ	B
study	O	NOUN	I
,	O	PUNCT	O
the	O	DET	O
defect	O	NOUN	B
size	O	NOUN	I
shown	O	VERB	O
by	O	ADP	O
BMIPP	O	NOUN	B
imaging	O	NOUN	O
was	O	AUX	O
greater	O	ADJ	O
in	O	ADP	O
anterior	O	ADJ	B
than	O	ADP	O
in	O	ADP	O
inferior	O	ADJ	B
infarcts	O	NOUN	I
(	O	PUNCT	O
p	O	NOUN	O
<	O	X	O
0	O	NUM	O
.	O	PUNCT	O
001	O	NUM	O
)	O	PUNCT	O
and	O	CCONJ	O
correlated	O	VERB	B
well	O	ADV	O
with	O	ADP	O
the	O	DET	O
risk	O	NOUN	B
area	O	NOUN	I
revealed	O	VERB	O
by	O	ADP	O
contrast	O	NOUN	B
ventriculography	O	NOUN	I
(	O	PUNCT	O
r	O	NOUN	O
=	O	ADJ	O
0	O	NUM	O
.	O	PUNCT	O
80	O	NUM	O
,	O	PUNCT	O
p	O	X	O
<	O	X	O
0	O	NUM	O
.	O	PUNCT	O
0001	O	NUM	O
)	O	PUNCT	O
CONCLUSION	O	NOUN	O
:	O	PUNCT	O
The	O	DET	O
above	O	ADJ	O
preliminary	O	ADJ	B
data	O	NOUN	B
,	O	PUNCT	O
admittedly	O	ADV	O
from	O	ADP	O
a	O	DET	O
small	O	ADJ	B
group	O	NOUN	I
of	O	ADP	O
patients	O	NOUN	B
,	O	PUNCT	O
suggest	O	VERB	O
that	O	SCONJ	O
tomographic	O	ADJ	B
BMIPP	O	NOUN	I
imaging	O	NOUN	I
provides	O	VERB	O
an	O	DET	O
accurate	O	ADJ	B
quantification	O	NOUN	B
of	O	ADP	O
defect	O	NOUN	B
size	O	NOUN	I
by	O	ADP	O
means	O	NOUN	O
of	O	ADP	O
a	O	DET	O
simple	O	ADJ	O
threshold	O	NOUN	B
technique	O	NOUN	B
and	O	CCONJ	O
,	O	PUNCT	O
in	O	ADP	O
the	O	DET	O
subacute	O	ADJ	B
phase	O	NOUN	I
,	O	PUNCT	O
permits	O	VERB	O
determination	O	NOUN	B
of	O	ADP	O
the	O	DET	O
amount	O	NOUN	B
of	O	ADP	O
myocardium	O	NOUN	B
at	O	ADP	O
risk	O	NOUN	B
after	O	ADP	O
acute	O	ADJ	B
myocardial	O	ADJ	I
infarction	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
promoter	O	NOUN	B
for	O	ADP	O
HMG	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
CoA	I-GENE	NOUN	B
synthase	I-GENE	NOUN	B
contains	O	VERB	O
two	O	NUM	O
binding	O	VERB	B
sites	O	NOUN	I
for	O	ADP	O
the	O	DET	O
sterol	B-GENE	NOUN	B
regulatory	I-GENE	ADJ	O
element	I-GENE	NOUN	O
-	I-GENE	PUNCT	O
binding	I-GENE	VERB	B
proteins	I-GENE	NOUN	I
(	O	PUNCT	O
SREBPs	B-GENE	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Although	O	SCONJ	O
RAD17	B-GENE	NOUN	B
,	O	PUNCT	O
RAD24	B-GENE	NOUN	B
and	O	CCONJ	O
MEC3	B-GENE	NOUN	B
are	O	AUX	O
not	O	PART	O
required	O	VERB	O
for	O	ADP	O
cell	O	NOUN	B
cycle	O	NOUN	I
arrest	O	NOUN	I
when	O	SCONJ	O
S	O	NOUN	B
phase	O	NOUN	I
is	O	AUX	O
inhibited	O	VERB	B
by	O	ADP	O
hydroxyurea	O	NOUN	B
(	O	PUNCT	O
HU	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
they	O	PRON	O
do	O	AUX	O
contribute	O	VERB	O
to	O	PART	O
the	O	DET	O
viability	O	NOUN	B
of	O	ADP	O
yeast	O	NOUN	B
cells	O	NOUN	I
grown	O	VERB	O
in	O	ADP	O
the	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
HU	O	NOUN	B
,	O	PUNCT	O
possibly	O	ADV	O
because	O	SCONJ	O
they	O	PRON	O
are	O	AUX	O
required	O	VERB	O
for	O	ADP	O
the	O	DET	O
repair	O	NOUN	B
of	O	ADP	O
HU	O	NOUN	B
-	O	PUNCT	O
induced	O	VERB	B
DNA	O	NOUN	B
damage	O	NOUN	I
.	O	PUNCT	O


Protein	B-GENE	NOUN	B
C	I-GENE	NOUN	I
deficiency	O	NOUN	I
or	O	CCONJ	O
protein	B-GENE	NOUN	B
S	I-GENE	NOUN	I
deficiency	O	NOUN	I
was	O	AUX	O
the	O	DET	O
only	O	ADV	O
identified	O	VERB	B
risk	O	NOUN	B
factor	O	NOUN	I
for	O	ADP	O
5	O	NUM	O
.	O	PUNCT	O
4	O	NUM	O
%	O	NOUN	O
(	O	PUNCT	O
2	O	NUM	O
patients	O	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
13	O	NUM	O
.	O	PUNCT	O
5	O	NUM	O
%	O	NOUN	O
(	O	PUNCT	O
5	O	NUM	O
patients	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
respectively	O	ADV	O
,	O	PUNCT	O
of	O	ADP	O
these	O	DET	O
37	O	NUM	O
children	O	NOUN	B
.	O	PUNCT	O


A	O	DET	O
reciprocal	O	ADJ	B
binding	O	NOUN	I
assay	O	NOUN	I
using	O	VERB	O
IM	O	NOUN	B
-	O	PUNCT	O
9	O	NUM	B
cells	O	NOUN	B
as	O	ADP	O
a	O	DET	O
source	O	NOUN	B
of	O	ADP	O
SHP	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	B
and	O	CCONJ	O
SHP	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
2	I-GENE	NUM	B
revealed	O	VERB	B
specific	O	ADJ	O
association	O	NOUN	B
of	O	ADP	O
SHP	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
2	I-GENE	NUM	B
(	O	PUNCT	O
but	O	CCONJ	O
not	O	PART	O
SHP	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	O
)	O	PUNCT	O
with	O	ADP	O
a	O	DET	O
glutathione	B-GENE	NOUN	B
S	I-GENE	NOUN	I
-	I-GENE	PUNCT	O
transferase	I-GENE	NOUN	B
fusion	I-GENE	NOUN	B
incorporating	O	VERB	O
GHR	B-GENE	NOUN	B
cytoplasmic	I-GENE	ADJ	B
domain	I-GENE	NOUN	I
residues	I-GENE	NOUN	I
485	I-GENE	NUM	O
-	I-GENE	SYM	O
620	I-GENE	NUM	O
,	O	PUNCT	O
but	O	CCONJ	O
only	O	ADV	O
if	O	SCONJ	O
the	O	DET	O
fusion	O	NOUN	B
was	O	AUX	O
first	O	ADV	O
rendered	O	VERB	O
tyrosine	O	NOUN	B
-	O	PUNCT	O
phosphorylated	O	VERB	B
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
used	O	VERB	O
mutation	O	NOUN	B
-	O	PUNCT	O
directed	O	VERB	B
chemical	O	NOUN	B
cross	O	NOUN	I
-	O	PUNCT	O
linking	O	VERB	B
with	O	ADP	I
bis	O	NOUN	B
(	O	PUNCT	I
sulfosuccinimidyl	O	NOUN	I
)	O	PUNCT	I
suberate	O	NOUN	I
(	O	PUNCT	O
BS3	O	NOUN	B
)	O	PUNCT	O
to	O	PART	O
investigate	O	VERB	B
the	O	DET	O
architecture	O	NOUN	B
of	O	ADP	O
the	O	DET	O
gp41	B-GENE	NOUN	B
oligomer	I-GENE	NOUN	B
.	O	PUNCT	O


Consistent	O	ADJ	B
with	O	ADP	I
previous	O	ADJ	O
reports	O	NOUN	B
,	O	PUNCT	O
addition	O	NOUN	O
of	O	ADP	O
a	O	DET	O
myristoylation	O	NOUN	B
signal	O	NOUN	O
to	O	PART	O
mSos1	B-GENE	NOUN	B
(	O	PUNCT	O
MyrSos1	B-GENE	NOUN	B
)	O	PUNCT	O
rendered	O	VERB	O
it	O	PRON	O
transforming	O	VERB	B
for	O	ADP	O
NIH	O	NOUN	B
3T3	O	NOUN	I
cells	O	NOUN	I
and	O	CCONJ	O
deletion	O	NOUN	B
of	O	ADP	O
the	O	DET	O
mSos	B-GENE	NOUN	B
C	I-GENE	NOUN	O
terminus	I-GENE	NOUN	B
(	O	PUNCT	O
MyrSos1	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
deltaC	I-GENE	NOUN	B
)	O	PUNCT	O
did	O	AUX	O
not	O	PART	O
interfere	O	VERB	B
with	O	ADP	I
this	O	DET	O
activity	O	NOUN	B
.	O	PUNCT	O


Demonstration	O	NOUN	B
of	O	ADP	O
tissue	O	NOUN	B
lesions	O	NOUN	I
after	O	ADP	O
intramuscular	O	ADJ	B
injection	O	NOUN	B
by	O	ADP	O
determination	O	NOUN	B
of	O	ADP	O
creatine	B-GENE	NOUN	B
kinase	I-GENE	NOUN	I
in	O	ADP	O
blood	O	NOUN	B


Levels	O	NOUN	B
of	O	ADP	O
the	O	DET	O
MEK	B-GENE	NOUN	B
inhibitor	O	NOUN	O
PD98059	O	NOUN	B
that	O	PRON	O
block	O	VERB	B
EGF	B-GENE	NOUN	B
-	O	PUNCT	O
induced	O	VERB	B
mitogenesis	O	NOUN	B
and	O	CCONJ	O
MAP	B-GENE	NOUN	B
kinase	I-GENE	NOUN	I
phosphorylation	O	NOUN	B
also	O	ADV	O
abrogate	O	VERB	O
EGF	B-GENE	NOUN	B
-	O	PUNCT	O
induced	O	VERB	B
focal	O	ADJ	B
adhesion	O	NOUN	I
disassembly	O	NOUN	B
and	O	CCONJ	O
cell	O	NOUN	B
motility	O	NOUN	I
.	O	PUNCT	O


Surprisingly	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
COOH	O	NOUN	B
-	O	PUNCT	O
terminal	O	ADJ	B
domain	O	NOUN	B
of	O	ADP	O
RanGAP1	B-GENE	NOUN	B
was	O	AUX	O
also	O	ADV	O
found	O	VERB	O
to	O	PART	O
harbor	O	VERB	O
a	O	DET	O
nuclear	O	ADJ	B
localization	O	NOUN	I
signal	O	NOUN	I
.	O	PUNCT	O


Here	O	ADV	O
,	O	PUNCT	O
we	O	PRON	O
present	O	VERB	O
evidence	O	NOUN	B
that	O	SCONJ	O
exposure	O	NOUN	B
of	O	ADP	I
DT40	O	NOUN	B
lymphoma	O	NOUN	I
B	O	NOUN	I
cells	O	NOUN	I
to	O	PART	O
low	O	ADJ	B
energy	O	NOUN	I
electromagnetic	O	ADJ	I
field	O	NOUN	I
(	O	PUNCT	O
EMF	O	NOUN	B
)	O	PUNCT	O
results	O	VERB	B
in	O	ADP	O
a	O	DET	O
tyrosine	B-GENE	NOUN	B
kinase	I-GENE	NOUN	I
-	O	PUNCT	O
dependent	O	ADJ	B
activation	O	NOUN	B
of	O	ADP	O
phospholipase	B-GENE	NOUN	B
Cgamma2	I-GENE	NOUN	I
(	O	PUNCT	O
PLC	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
gamma2	I-GENE	NOUN	B
)	O	PUNCT	O
leading	O	VERB	O
to	O	PART	O
increased	O	VERB	B
inositol	O	NOUN	B
phospholipid	O	ADJ	B
turnover	O	NOUN	B
.	O	PUNCT	O


PATIENTS	O	NOUN	B
AND	O	CCONJ	O
METHOD	O	NOUN	B
:	O	PUNCT	O
Since	O	SCONJ	O
1986	O	NUM	O
,	O	PUNCT	O
62	O	NUM	O
patients	O	NOUN	B
were	O	AUX	O
irradiated	O	VERB	B
stereotactically	O	ADV	B
.	O	PUNCT	O


Training	O	NOUN	B
for	O	ADP	O
audit	O	NOUN	B
.	O	PUNCT	O


Cytoskeletal	O	ADJ	B
polarization	O	NOUN	I
of	O	ADP	O
T	O	NOUN	B
cells	O	NOUN	I
is	O	AUX	O
regulated	O	VERB	O
by	O	ADP	O
an	O	DET	O
immunoreceptor	O	NOUN	B
tyrosine	O	NOUN	I
-	O	PUNCT	O
based	O	VERB	B
activation	O	NOUN	B
motif	O	NOUN	B
-	O	PUNCT	O
dependent	O	ADJ	B
mechanism	O	NOUN	B
.	O	PUNCT	O


Here	O	ADV	O
we	O	PRON	O
have	O	AUX	O
examined	O	VERB	B
the	O	DET	O
ability	O	NOUN	O
of	O	ADP	O
the	O	DET	O
cellular	O	ADJ	B
protein	O	NOUN	I
YB	B-GENE	NOUN	I
-	I-GENE	PUNCT	O
1	I-GENE	NUM	O
to	O	PART	O
modulate	O	VERB	B
transcription	O	NOUN	B
of	O	ADP	O
the	O	DET	O
HIV	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	O
promoter	I-GENE	NOUN	B
in	O	ADP	O
a	O	DET	O
human	O	ADJ	B
astrocytic	O	ADJ	B
cell	O	NOUN	I
line	O	NOUN	I
(	O	PUNCT	O
U	O	NOUN	B
-	O	PUNCT	O
87MG	O	PROPN	B
)	O	PUNCT	O
,	O	PUNCT	O
a	O	DET	O
neuronal	O	ADJ	B
cell	O	NOUN	I
line	O	NOUN	I
(	O	PUNCT	O
SK	O	PROPN	B
-	O	PUNCT	O
N	O	PROPN	B
-	O	PUNCT	O
MC	O	PROPN	B
)	O	PUNCT	O
and	O	CCONJ	O
lymphoid	O	ADJ	B
cells	O	NOUN	I
(	O	PUNCT	O
Jurkat	O	NOUN	B
)	O	PUNCT	O
by	O	ADP	O
transfection	O	NOUN	B
assay	O	NOUN	I
.	O	PUNCT	O


Substrates	O	NOUN	B
for	O	ADP	O
p210	B-GENE	NOUN	B
(	O	PUNCT	O
bcr	B-GENE	NOUN	B
-	O	PUNCT	O
abl	B-GENE	NOUN	B
)	O	PUNCT	O
are	O	AUX	O
likely	O	ADJ	O
to	O	PART	O
be	O	AUX	O
involved	O	VERB	O
in	O	ADP	O
the	O	DET	O
pathogenesis	O	NOUN	B
of	O	ADP	O
CML	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
COOH	O	NOUN	B
-	O	PUNCT	O
terminal	O	ADJ	B
region	O	NOUN	B
of	O	ADP	O
the	O	DET	O
transcripts	O	NOUN	B
contained	O	VERB	O
fifteen	O	NUM	O
triplet	O	NOUN	B
repeats	O	NOUN	I
(	O	PUNCT	O
GCT	O	NOUN	B
;	O	PUNCT	O
alanine	O	NOUN	B
)	O	PUNCT	O
at	O	ADP	O
nucleotide	O	NOUN	B
465	O	NUM	O
to	O	PART	O
509	O	NUM	O
,	O	PUNCT	O
which	O	DET	O
is	O	AUX	O
significantly	O	ADV	O
expanded	O	VERB	O
compared	O	VERB	O
to	O	PART	O
the	O	DET	O
rat	B-GENE	NOUN	B
RL14	I-GENE	NOUN	B
.	O	PUNCT	O


Control	O	NOUN	B
of	O	ADP	I
fatty	O	ADJ	I
liver	O	NOUN	I
syndrome	O	NOUN	I
in	O	ADP	O
a	O	DET	O
Jersey	O	PROPN	B
herd	O	NOUN	I
by	O	ADP	O
a	O	DET	O
change	O	NOUN	B
of	O	ADP	O
diet	O	NOUN	B
and	O	CCONJ	O
the	O	DET	O
use	O	NOUN	O
of	O	ADP	O
recombinant	O	ADJ	B
bovine	O	ADJ	I
somatotrophin	B-GENE	NOUN	B
.	O	PUNCT	O


During	O	ADP	O
organogenesis	O	NOUN	B
,	O	PUNCT	O
HFH	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
8	I-GENE	NUM	O
expression	O	NOUN	B
is	O	AUX	O
found	O	VERB	O
in	O	ADP	O
the	O	DET	O
splanchnic	O	ADJ	B
mesoderm	O	NOUN	I
in	O	ADP	O
close	O	ADJ	O
apposition	O	NOUN	B
of	O	ADP	O
the	O	DET	O
gut	O	NOUN	B
endoderm	O	NOUN	I
,	O	PUNCT	O
suggesting	O	VERB	O
a	O	DET	O
role	O	NOUN	O
in	O	ADP	O
mesenchymal	O	ADJ	B
-	O	PUNCT	O
epithelial	O	ADJ	B
induction	O	NOUN	B
of	O	ADP	O
lung	O	NOUN	B
and	O	CCONJ	O
gut	O	NOUN	B
morphogenesis	O	NOUN	I
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
laparoscopy	O	NOUN	B
failed	O	VERB	B
to	O	PART	O
establish	O	VERB	O
inoperability	O	NOUN	B
in	O	ADP	O
any	O	DET	O
cases	O	NOUN	B
of	O	ADP	O
carcinoma	O	NOUN	B
spread	O	VERB	B
to	O	ADP	O
areas	O	NOUN	O
not	O	PART	O
accessible	O	ADJ	O
to	O	ADP	O
laparoscopic	O	ADJ	B
visualization	O	NOUN	I
.	O	PUNCT	O


No	O	DET	B
difference	O	NOUN	I
in	O	ADP	O
telomere	O	NOUN	B
length	O	NOUN	B
was	O	AUX	O
seen	O	VERB	O
in	O	ADP	O
mutants	O	NOUN	B
affected	O	VERB	B
in	O	ADP	O
the	O	DET	O
regulation	O	NOUN	B
of	O	ADP	O
Cdc2	B-GENE	NOUN	B
,	O	PUNCT	O
whereas	O	SCONJ	O
some	O	DET	O
of	O	ADP	O
the	O	DET	O
DNA	O	NOUN	B
repair	O	NOUN	I
mutants	O	NOUN	B
examined	O	VERB	O
had	O	AUX	O
slightly	O	ADV	O
longer	O	ADJ	B
telomeres	O	NOUN	B
than	O	ADP	O
did	O	AUX	O
the	O	DET	O
wild	O	ADJ	B
type	O	NOUN	I
.	O	PUNCT	O


Sp1	B-GENE	NOUN	B
can	O	AUX	O
activate	O	VERB	B
transcription	O	NOUN	B
through	O	ADP	O
immunoglobulin	B-GENE	NOUN	B
kappa	I-GENE	NOUN	I
-	I-GENE	PUNCT	O
chain	I-GENE	NOUN	B
enhancer	I-GENE	NOUN	I
or	O	CCONJ	O
P	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
selectin	I-GENE	NOUN	B
promoter	I-GENE	NOUN	B
NF	B-GENE	NOUN	I
-	I-GENE	PUNCT	O
kappaB	I-GENE	NOUN	B
sites	I-GENE	NOUN	I
.	O	PUNCT	O
p50	B-GENE	NOUN	B
homodimers	I-GENE	NOUN	I
replace	O	VERB	O
Sp1	B-GENE	NOUN	B
from	O	ADP	O
the	O	DET	O
P	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
selectin	I-GENE	NOUN	B
promoter	I-GENE	NOUN	B
by	O	ADP	O
binding	O	VERB	B
site	O	NOUN	I
competition	O	NOUN	B
and	O	CCONJ	O
thereby	O	ADV	O
either	O	DET	O
inhibit	O	VERB	B
basal	O	ADJ	B
Sp1	B-GENE	NOUN	B
-	O	PUNCT	O
driven	O	VERB	B
expression	O	NOUN	B
or	O	CCONJ	O
,	O	PUNCT	O
in	O	ADP	O
concert	O	NOUN	O
with	O	ADP	O
Bcl	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
3	I-GENE	NUM	O
,	O	PUNCT	O
stimulate	O	VERB	B
expression	O	NOUN	B
.	O	PUNCT	O


For	O	ADP	O
the	O	DET	O
5HT5A	B-GENE	ADJ	B
receptor	I-GENE	NOUN	I
the	O	DET	O
addition	O	NOUN	O
of	O	ADP	O
yohimbine	O	NOUN	B
resulted	O	VERB	O
in	O	ADP	O
a	O	DET	O
similar	O	ADJ	O
but	O	CCONJ	O
smaller	O	ADJ	O
effect	O	NOUN	B
.	O	PUNCT	O


CONCLUSIONS	O	NOUN	B
:	O	PUNCT	O
XCoe2	B-GENE	NOUN	O
may	O	AUX	O
play	O	VERB	O
a	O	DET	O
pivotal	O	ADJ	O
role	O	NOUN	O
in	O	ADP	O
the	O	DET	O
transcriptional	O	ADJ	B
cascade	O	NOUN	I
that	O	PRON	O
specifies	O	VERB	O
primary	O	ADJ	B
neurons	O	NOUN	B
in	O	ADP	O
Xenopus	O	NOUN	B
embryos	O	NOUN	B
:	O	PUNCT	O
by	O	ADP	O
maintaining	O	VERB	O
Delta	B-GENE	PROPN	B
-	O	PUNCT	O
Notch	B-GENE	NOUN	B
signalling	O	NOUN	B
,	O	PUNCT	O
XCoe2	B-GENE	PRON	O
stabilises	O	VERB	B
the	O	DET	O
higher	O	ADJ	B
neural	O	ADJ	B
potential	O	NOUN	B
of	O	ADP	O
selected	O	VERB	O
progenitor	O	NOUN	B
cells	O	NOUN	I
that	O	PRON	O
express	O	VERB	B
X	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
ngnr	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	O
,	O	PUNCT	O
ensuring	O	VERB	O
the	O	DET	O
transition	O	NOUN	B
between	O	ADP	O
neural	O	ADJ	B
competence	O	NOUN	B
and	O	CCONJ	O
irreversible	O	ADJ	B
commitment	O	NOUN	B
to	O	PART	O
a	O	DET	O
neural	O	ADJ	B
fate	O	NOUN	I
;	O	PUNCT	O
and	O	CCONJ	O
it	O	PRON	O
promotes	O	VERB	O
neuronal	O	ADJ	B
differentiation	O	NOUN	I
by	O	ADP	O
activating	O	VERB	B
XNeuroD	B-GENE	ADJ	B
expression	O	NOUN	B
,	O	PUNCT	O
directly	O	ADV	O
or	O	CCONJ	O
indirectly	O	ADV	B
.	O	PUNCT	O


RESULTS	O	NOUN	B
:	O	PUNCT	O
Patients	O	NOUN	B
in	O	ADP	O
Group	O	PROPN	B
A	O	PROPN	O
had	O	AUX	O
a	O	DET	O
higher	O	ADJ	O
incidence	O	NOUN	B
of	O	ADP	O
posterolateral	O	ADJ	B
wall	O	NOUN	I
motion	O	NOUN	I
abnormalities	O	NOUN	I
(	O	PUNCT	O
p	O	NOUN	O
<	O	X	O
0	O	NUM	O
.	O	PUNCT	O
001	O	NUM	O
)	O	PUNCT	O
on	O	ADP	O
radionuclide	O	NOUN	B
ventriculography	O	NOUN	I
,	O	PUNCT	O
a	O	DET	O
larger	O	ADJ	O
infarct	O	NOUN	B
area	O	NOUN	I
(	O	PUNCT	O
as	O	ADP	O
evidenced	O	VERB	O
by	O	ADP	O
higher	O	ADJ	O
peak	O	NOUN	O
creatine	B-GENE	NOUN	B
kinase	I-GENE	NOUN	I
levels	O	NOUN	O
)	O	PUNCT	O
(	O	PUNCT	O
p	O	NOUN	O
<	O	X	O
0	O	NUM	O
.	O	PUNCT	O
02	O	NUM	O
)	O	PUNCT	O
and	O	CCONJ	O
a	O	DET	O
lower	O	ADJ	B
left	O	VERB	I
ventricular	O	ADJ	I
ejection	O	NOUN	I
fraction	O	NOUN	I
(	O	PUNCT	O
LVEF	O	NOUN	B
)	O	PUNCT	O
at	O	ADP	O
hospital	O	NOUN	B
discharge	O	NOUN	I
(	O	PUNCT	O
p	O	NOUN	O
<	O	X	O
0	O	NUM	O
.	O	PUNCT	O
008	O	NUM	O
)	O	PUNCT	O
than	O	ADP	O
those	O	DET	O
in	O	ADP	O
Group	O	PROPN	B
B	O	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
all	O	DET	O
cells	O	NOUN	B
,	O	PUNCT	O
the	O	DET	O
accumulation	O	NOUN	B
of	O	ADP	O
high	O	ADJ	O
Dsg	B-GENE	NOUN	B
protein	I-GENE	NOUN	I
levels	O	NOUN	O
required	O	VERB	O
calcium	O	NOUN	B
and	O	CCONJ	O
was	O	AUX	O
not	O	PART	O
observed	O	VERB	O
in	O	ADP	O
low	O	ADJ	B
calcium	O	NOUN	B
(	O	PUNCT	O
0	O	NUM	O
.	O	PUNCT	O
05	O	NUM	O
-	O	SYM	O
0	O	NUM	O
.	O	PUNCT	O
07	O	NUM	O
mM	O	NOUN	O
)	O	PUNCT	O
media	O	NOUN	O
.	O	PUNCT	O


RESULTS	O	NOUN	B
:	O	PUNCT	O
Using	O	VERB	O
information	O	NOUN	B
in	O	ADP	O
the	O	DET	O
dbEST	O	NOUN	B
database	O	NOUN	I
of	O	ADP	O
expressed	O	VERB	B
sequence	O	NOUN	B
tags	O	NOUN	O
,	O	PUNCT	O
we	O	PRON	O
isolated	O	VERB	B
an	O	DET	O
Arabidopsis	O	NOUN	B
thaliana	O	NOUN	I
gene	O	NOUN	I
(	O	PUNCT	O
GCR1	B-GENE	NOUN	B
)	O	PUNCT	O
that	O	PRON	O
encodes	O	VERB	B
a	O	DET	O
protein	O	NOUN	B
with	O	ADP	O
seven	O	NUM	O
predicted	O	VERB	B
membrane	O	NOUN	B
-	O	PUNCT	O
spanning	O	VERB	B
domains	O	NOUN	B
and	O	CCONJ	O
other	O	ADJ	O
features	O	NOUN	B
characteristic	O	ADJ	O
of	O	ADP	O
7TM	B-GENE	ADJ	B
receptors	I-GENE	NOUN	I
.	O	PUNCT	O


E1A	B-GENE	NOUN	B
represses	O	VERB	O
apolipoprotein	B-GENE	NOUN	B
AI	I-GENE	NOUN	I
enhancer	I-GENE	NOUN	I
activity	O	NOUN	O
in	O	ADP	O
liver	O	NOUN	B
cells	O	NOUN	I
through	O	ADP	O
a	O	DET	O
pRb	B-GENE	NOUN	B
-	O	PUNCT	O
and	O	CCONJ	O
CBP	B-GENE	PROPN	B
-	O	PUNCT	O
independent	O	ADJ	B
pathway	O	NOUN	B
.	O	PUNCT	O


M	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
66	I-GENE	NUM	O
identified	O	VERB	B
the	O	DET	O
14	O	NUM	O
-	O	PUNCT	O
kDa	O	NOUN	B
protein	O	NOUN	I
in	O	ADP	O
another	O	DET	O
MMTV	O	NOUN	B
bearing	O	VERB	O
T	O	NOUN	B
-	O	PUNCT	O
cell	O	NOUN	B
lymphoma	O	NOUN	I
,	O	PUNCT	O
EL	O	PROPN	B
-	O	PUNCT	O
4	O	NUM	B
.	O	PUNCT	O


RT	O	NOUN	B
-	O	PUNCT	O
PCR	O	NOUN	B
indicated	O	VERB	O
that	O	SCONJ	O
p21	B-GENE	NOUN	B
mRNA	I-GENE	NOUN	B
was	O	AUX	O
induced	O	VERB	B
1	O	NUM	O
.	O	PUNCT	O
4	O	NUM	O
-	O	PUNCT	O
,	O	PUNCT	O
2	O	NUM	O
.	O	PUNCT	O
0	O	NUM	O
-	O	PUNCT	O
,	O	PUNCT	O
and	O	CCONJ	O
3	O	NUM	O
.	O	PUNCT	O
1	O	NUM	O
-	O	PUNCT	O
fold	O	NOUN	B
in	O	ADP	O
the	O	DET	O
2	O	NUM	B
-	O	PUNCT	O
day	O	NOUN	B
neonatal	O	ADJ	B
,	O	PUNCT	O
7	O	NUM	O
-	O	PUNCT	O
day	O	NOUN	B
neonatal	O	ADJ	B
,	O	PUNCT	O
and	O	CCONJ	O
adult	O	ADJ	B
stages	O	NOUN	B
,	O	PUNCT	O
respectively	O	ADV	O
,	O	PUNCT	O
compared	O	VERB	O
to	O	ADP	O
the	O	DET	O
17	O	NUM	O
-	O	PUNCT	O
day	O	NOUN	B
fetal	O	ADJ	B
stage	O	NOUN	I
.	O	PUNCT	O


Ganciclovir	O	NOUN	B
and	O	CCONJ	O
foscarnet	O	NOUN	B
efficacy	O	NOUN	B
in	O	ADP	O
AIDS	O	PROPN	B
-	O	PUNCT	O
related	O	VERB	B
CMV	O	NOUN	B
polyradiculopathy	O	NOUN	I
.	O	PUNCT	O


BACKGROUND	O	NOUN	B
AND	O	CCONJ	O
OBJECTIVES	O	NOUN	O
:	O	PUNCT	O
The	O	DET	O
sexually	O	ADV	B
transmitted	O	VERB	I
diseases	O	NOUN	I
(	O	PUNCT	O
STD	O	NOUN	B
)	O	PUNCT	O
control	O	NOUN	B
program	O	NOUN	I
for	O	ADP	O
female	O	ADJ	B
sex	O	NOUN	O
workers	O	NOUN	O
(	O	PUNCT	O
FSW	O	PROPN	B
)	O	PUNCT	O
in	O	ADP	O
Lima	O	PROPN	B
,	O	PUNCT	O
Peru	O	PROPN	B
,	O	PUNCT	O
provided	O	VERB	O
periodic	O	ADJ	B
serological	O	ADJ	B
tests	O	NOUN	I
for	O	ADP	O
syphilis	O	NOUN	B
and	O	CCONJ	O
cervical	O	ADJ	B
smears	O	NOUN	I
for	O	ADP	O
gonococci	O	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
not	O	PART	O
medication	O	NOUN	B
for	O	ADP	O
STD	O	NOUN	B
or	O	CCONJ	O
condoms	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
order	O	NOUN	O
to	O	PART	O
examine	O	VERB	O
the	O	DET	O
potential	O	ADJ	O
role	O	NOUN	O
of	O	ADP	O
transcriptional	O	ADJ	B
silencing	O	NOUN	I
during	O	ADP	O
productive	O	ADJ	O
HSV	O	NOUN	B
-	O	PUNCT	O
1	O	NUM	O
infection	O	NOUN	B
,	O	PUNCT	O
recombinant	O	ADJ	B
viruses	O	NOUN	I
were	O	AUX	O
generated	O	VERB	O
in	O	ADP	O
which	O	DET	O
wild	B-GENE	ADJ	B
-	I-GENE	PUNCT	O
type	I-GENE	NOUN	B
or	I-GENE	CCONJ	O
mutant	I-GENE	ADJ	B
ICP34	I-GENE	NOUN	B
.	I-GENE	PUNCT	O
5	I-GENE	NUM	O
promoters	I-GENE	NOUN	B
controlling	O	VERB	B
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
a	O	DET	O
chloramphenicol	B-GENE	NOUN	B
acetyltransferase	I-GENE	NOUN	I
reporter	I-GENE	NOUN	I
gene	I-GENE	NOUN	I
were	O	AUX	O
inserted	O	VERB	O
into	O	ADP	O
the	O	DET	O
thymidine	B-GENE	NOUN	B
kinase	I-GENE	NOUN	I
gene	I-GENE	NOUN	I
of	O	ADP	O
the	O	DET	O
viral	O	ADJ	B
genome	O	NOUN	I
.	O	PUNCT	O


Members	O	NOUN	O
of	O	ADP	O
the	O	DET	O
meis1	B-GENE	NOUN	B
and	O	CCONJ	O
pbx	B-GENE	ADJ	B
homeodomain	I-GENE	NOUN	I
protein	I-GENE	NOUN	I
families	I-GENE	NOUN	B
cooperatively	O	ADV	O
bind	O	VERB	B
a	O	DET	O
cAMP	O	NOUN	B
-	O	PUNCT	O
responsive	O	ADJ	B
sequence	O	NOUN	O
(	O	PUNCT	O
CRS1	O	NOUN	B
)	O	PUNCT	O
from	O	ADP	O
bovine	B-GENE	ADJ	B
CYP17	I-GENE	NOUN	B
.	O	PUNCT	O


The	O	DET	O
RAS	B-GENE	NOUN	B
-	O	PUNCT	O
cyclic	B-GENE	ADJ	B
AMP	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
dependent	I-GENE	ADJ	B
protein	I-GENE	NOUN	B
kinase	I-GENE	NOUN	I
cAPK	B-GENE	NOUN	I
pathway	O	NOUN	O
prevents	O	VERB	B
the	O	DET	O
UAS	O	NOUN	B
activity	O	NOUN	B
of	O	ADP	O
IREu	B-GENE	NOUN	B
in	O	ADP	O
the	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
glucose	O	NOUN	B
as	O	ADP	O
the	O	DET	O
sole	O	ADJ	O
carbon	O	NOUN	B
source	O	NOUN	B
,	O	PUNCT	O
while	O	SCONJ	O
the	O	DET	O
transcriptional	O	ADJ	B
activators	O	NOUN	O
Msn2p	B-GENE	NOUN	B
and	O	CCONJ	O
Msn4p	B-GENE	NOUN	B
promote	O	VERB	B
the	O	DET	O
UAS	O	NOUN	B
activity	O	NOUN	B
of	O	ADP	O
this	O	DET	O
repeat	O	NOUN	O
in	O	ADP	O
the	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
acetate	O	NOUN	B
.	O	PUNCT	O


Alternative	O	ADJ	B
splicing	O	NOUN	I
of	O	ADP	O
fibroblast	B-GENE	NOUN	B
growth	I-GENE	NOUN	I
factor	I-GENE	NOUN	I
receptor	I-GENE	NOUN	I
2	I-GENE	NUM	I
(	O	PUNCT	O
FGF	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
R2	I-GENE	NOUN	B
)	O	PUNCT	O
is	O	AUX	O
an	O	DET	O
example	O	NOUN	O
of	O	ADP	O
highly	O	ADV	O
regulated	O	VERB	O
alternative	O	ADJ	O
splicing	O	NOUN	O
in	O	ADP	O
which	O	DET	O
exons	O	NOUN	B
IIIb	O	NOUN	I
and	O	CCONJ	O
IIIc	O	NOUN	B
are	O	AUX	O
utilized	O	VERB	O
in	O	ADP	O
a	O	DET	O
mutually	O	ADV	O
exclusive	O	ADJ	O
manner	O	NOUN	O
in	O	ADP	O
different	O	ADJ	O
cell	O	NOUN	B
types	O	NOUN	I
.	O	PUNCT	O


SNAC	O	NOUN	B
or	O	CCONJ	O
PBS	O	PROPN	B
was	O	AUX	O
infused	O	VERB	B
for	O	ADP	O
6	O	NUM	O
.	O	PUNCT	O
5	O	NUM	O
h	O	NOUN	O
,	O	PUNCT	O
beginning	O	VERB	O
30	O	NUM	O
min	O	NOUN	O
before	O	ADP	O
ischemia	O	NOUN	B
and	O	CCONJ	O
continuing	O	VERB	B
throughout	O	ADP	O
the	O	DET	O
duration	O	NOUN	B
of	O	ADP	O
reperfusion	O	NOUN	B
.	O	PUNCT	O


Moreover	O	ADV	O
,	O	PUNCT	O
it	O	PRON	O
is	O	AUX	O
the	O	DET	O
assumptions	O	NOUN	O
behind	O	ADP	O
steady	O	ADJ	B
-	O	PUNCT	O
state	O	NOUN	B
O2	O	NOUN	B
uptake	O	NOUN	B
that	O	PRON	O
do	O	AUX	O
not	O	PART	O
permit	O	VERB	O
proper	O	ADJ	O
interpretation	O	NOUN	B
of	O	ADP	O
energy	O	NOUN	B
expenditure	O	NOUN	I
during	O	ADP	O
EPOC	O	NOUN	B
;	O	PUNCT	O
1	O	NUM	O
l	O	X	O
O2	O	NOUN	B
not	O	PART	O
=	O	ADJ	O
20	O	NUM	O
.	O	PUNCT	O
9	O	NUM	O
kJ	O	NOUN	O
.	O	PUNCT	O


The	O	DET	O
predicted	O	VERB	O
amino	O	NOUN	B
acid	O	NOUN	I
sequence	O	NOUN	I
of	O	ADP	O
m	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
Staf	I-GENE	NOUN	B
is	O	AUX	O
highly	O	ADV	O
homologous	O	ADJ	B
to	O	PART	O
that	O	DET	O
of	O	ADP	O
Staf	B-GENE	NOUN	B
,	O	PUNCT	O
another	O	DET	O
selenocysteine	B-GENE	NOUN	B
tRNA	I-GENE	NOUN	I
gene	I-GENE	NOUN	B
transcription	I-GENE	NOUN	I
activating	I-GENE	NOUN	I
factor	I-GENE	NOUN	I
of	O	ADP	O
Xenopus	O	NOUN	B
laevis	O	NOUN	I
.	O	PUNCT	O


Recent	O	ADJ	O
studies	O	NOUN	B
have	O	AUX	O
revealed	O	VERB	O
unconventional	O	ADJ	B
myosin	B-GENE	NOUN	B
V	I-GENE	NOUN	I
to	O	PART	O
be	O	AUX	O
an	O	DET	O
important	O	ADJ	O
actin	B-GENE	NOUN	B
-	O	PUNCT	O
based	O	VERB	B
molecular	O	ADJ	B
motor	O	NOUN	I
involved	O	VERB	O
in	O	ADP	O
vesicular	O	ADJ	B
movement	O	NOUN	B
.	O	PUNCT	O


Furthermore	O	ADV	O
,	O	PUNCT	O
a	O	DET	O
minor	O	ADJ	O
start	O	NOUN	O
site	O	NOUN	B
was	O	AUX	O
localized	O	VERB	B
179	O	NUM	O
bp	O	NOUN	O
upstream	O	ADJ	B
of	O	ADP	O
the	O	DET	O
major	O	ADJ	O
site	O	NOUN	B
using	O	VERB	O
reverse	B-GENE	ADJ	B
transcriptase	I-GENE	NOUN	I
-	O	PUNCT	O
polymerase	O	NOUN	B
chain	O	NOUN	I
reaction	O	NOUN	I
with	O	ADP	O
various	O	ADJ	O
P1	O	NOUN	B
primers	O	NOUN	I
(	O	PUNCT	O
primer	O	NOUN	B
walking	O	NOUN	I
)	O	PUNCT	O
,	O	PUNCT	O
primer	O	NOUN	B
extension	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
cDNA	O	NOUN	B
cloning	O	NOUN	I
.	O	PUNCT	O


Analysis	O	NOUN	B
of	O	ADP	O
promoter	O	NOUN	B
and	O	CCONJ	O
androgen	O	NOUN	B
regulatory	O	ADJ	I
sequences	O	NOUN	I
required	O	VERB	O
for	O	ADP	O
optimal	O	ADJ	B
transcription	O	NOUN	B
of	O	ADP	O
the	O	DET	O
rat	O	NOUN	B
androgen	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
binding	I-GENE	VERB	B
protein	I-GENE	NOUN	I
gene	O	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
a	O	DET	O
gntR	B-GENE	NOUN	B
deletion	I-GENE	NOUN	B
mutant	I-GENE	NOUN	I
,	O	PUNCT	O
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
a	O	DET	O
chromosomal	O	ADJ	B
gntT	B-GENE	NOUN	I
:	O	PUNCT	O
:	O	PUNCT	O
lacZ	B-GENE	NOUN	B
fusion	O	NOUN	B
is	O	AUX	O
both	O	CCONJ	O
high	O	ADJ	B
and	O	CCONJ	O
constitutive	O	ADJ	B
,	O	PUNCT	O
confirming	O	VERB	O
that	O	SCONJ	O
GntR	B-GENE	NOUN	B
is	O	AUX	O
the	O	DET	O
negative	O	ADJ	B
regulator	O	NOUN	B
of	O	ADP	O
gntT	B-GENE	NOUN	B
.	O	PUNCT	O


Therefore	O	ADV	O
,	O	PUNCT	O
we	O	PRON	O
conclude	O	VERB	O
that	O	SCONJ	O
DnaA	B-GENE	NOUN	B
may	O	AUX	O
contact	O	VERB	B
the	O	DET	O
beta	O	NOUN	B
subunit	O	NOUN	I
of	O	ADP	O
RNA	B-GENE	NOUN	B
polymerase	I-GENE	NOUN	I
during	O	ADP	O
activation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
pR	B-GENE	NOUN	B
promoter	I-GENE	NOUN	B
.	O	PUNCT	O


Expression	O	NOUN	B
of	O	ADP	O
Bcl	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
XL	I-GENE	PROPN	B
inhibited	O	VERB	B
the	O	DET	O
association	O	NOUN	B
of	O	ADP	O
Apaf	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	O
with	O	ADP	O
caspase	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
9	I-GENE	NUM	B
in	O	ADP	O
mammalian	O	ADJ	B
cells	O	NOUN	I
.	O	PUNCT	O


Whole	O	ADJ	B
-	O	PUNCT	O
mount	O	NOUN	B
in	O	X	B
situ	O	X	I
hybridization	O	NOUN	I
to	O	PART	O
early	O	ADJ	O
mouse	O	NOUN	B
embryos	O	NOUN	B
of	O	ADP	O
9	O	NUM	O
.	O	PUNCT	O
5	O	NUM	O
-	O	SYM	O
10	O	NUM	O
.	O	PUNCT	O
5	O	NUM	O
days	O	NOUN	B
indicated	O	VERB	O
a	O	DET	O
complex	O	ADJ	B
pattern	O	NOUN	B
of	O	ADP	O
Arp1	B-GENE	NOUN	B
expression	O	NOUN	B
spatially	O	ADV	B
overlapping	O	VERB	I
with	O	ADP	O
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
All1	B-GENE	NOUN	B
.	O	PUNCT	O


Creatine	B-GENE	NOUN	B
kinase	I-GENE	NOUN	I
release	O	NOUN	B
after	O	ADP	O
hepatic	O	ADJ	B
artery	O	NOUN	I
embolization	O	NOUN	I
in	O	ADP	O
patients	O	NOUN	B
with	O	ADP	O
carcinoid	O	ADJ	B
tumors	O	NOUN	I
.	O	PUNCT	O


Our	O	PRON	O
observations	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
members	O	NOUN	B
of	O	ADP	O
the	O	DET	O
HMG	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
I	I-GENE	NOUN	B
family	I-GENE	NOUN	B
play	O	VERB	O
an	O	DET	O
important	O	ADJ	O
role	O	NOUN	O
in	O	ADP	O
SRF	B-GENE	NOUN	B
-	O	PUNCT	O
dependent	O	ADJ	B
transcription	O	NOUN	B
and	O	CCONJ	O
that	O	SCONJ	O
their	O	PRON	O
effect	O	NOUN	B
is	O	AUX	O
mediated	O	VERB	O
primarily	O	ADV	O
by	O	ADP	O
a	O	DET	O
protein	O	NOUN	B
-	O	PUNCT	O
protein	O	NOUN	B
interaction	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
recently	O	ADV	O
characterized	O	VERB	B
a	O	DET	O
single	O	ADJ	O
yeast	B-GENE	NOUN	B
hnRNP	I-GENE	NOUN	B
methyltransferase	I-GENE	NOUN	I
(	O	PUNCT	O
HMT1	B-GENE	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


We	O	PRON	O
recently	O	ADV	O
characterized	O	VERB	B
a	O	DET	O
single	O	ADJ	O
yeast	B-GENE	NOUN	B
hnRNP	I-GENE	NOUN	B
methyltransferase	I-GENE	NOUN	I
(	O	PUNCT	O
HMT1	B-GENE	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Recombinant	B-GENE	ADJ	B
HRMT1L2	I-GENE	NOUN	O
protein	I-GENE	NOUN	O
encoded	O	VERB	B
by	O	ADP	O
the	O	DET	O
most	O	ADV	O
common	O	ADJ	O
5	O	NUM	O
'	O	PUNCT	O
-	O	PUNCT	O
variant	O	NOUN	B
exhibited	O	VERB	O
methyltransferase	O	NOUN	B
activity	O	NOUN	O
in	O	X	B
vitro	O	X	I
.	O	PUNCT	O


The	O	DET	O
possible	O	ADJ	O
roles	O	NOUN	O
of	O	ADP	O
HRMT1L1	B-GENE	NOUN	B
and	O	CCONJ	O
HRMT1L2	B-GENE	NOUN	B
in	O	ADP	O
human	O	ADJ	B
disease	O	NOUN	I
are	O	AUX	O
currently	O	ADV	O
unknown	O	ADJ	O
.	O	PUNCT	O


Identification	O	NOUN	B
and	O	CCONJ	O
characterization	O	NOUN	B
of	O	ADP	O
two	O	NUM	O
putative	O	ADJ	O
human	B-GENE	ADJ	B
arginine	I-GENE	NOUN	O
methyltransferases	I-GENE	NOUN	O
(	O	PUNCT	O
HRMT1L1	B-GENE	NOUN	B
and	O	CCONJ	O
HRMT1L2	B-GENE	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


To	O	PART	O
identify	O	VERB	O
nuclear	O	ADJ	B
regulatory	O	ADJ	I
factors	O	NOUN	I
,	O	PUNCT	O
we	O	PRON	O
have	O	AUX	O
located	O	ADJ	B
and	O	CCONJ	O
functionally	O	ADV	O
characterized	O	VERB	B
the	O	DET	O
CCR5	B-GENE	NOUN	B
gene	I-GENE	NOUN	I
promoter	I-GENE	NOUN	B
.	O	PUNCT	O


The	O	DET	O
interaction	O	NOUN	B
between	O	ADP	O
piroxicam	O	NOUN	B
and	O	CCONJ	O
poloxamer	O	NOUN	B
was	O	AUX	O
studied	O	VERB	O
by	O	ADP	O
x	O	NOUN	B
-	O	PUNCT	O
ray	O	NOUN	B
diffractometry	O	NOUN	I
(	O	PUNCT	O
XRD	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
infrared	O	NOUN	B
(	O	PUNCT	O
IR	O	NOUN	O
)	O	PUNCT	O
spectroscopy	O	NOUN	O
and	O	CCONJ	O
differential	O	ADJ	B
thermal	O	ADJ	I
analysis	O	NOUN	I
(	O	PUNCT	O
DTA	O	PROPN	B
)	O	PUNCT	O
with	O	ADP	O
a	O	DET	O
solid	O	ADJ	B
dispersion	O	NOUN	I
,	O	PUNCT	O
coprecipitate	O	NOUN	B
,	O	PUNCT	O
or	O	CCONJ	O
physical	O	ADJ	B
mixture	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
results	O	NOUN	B
confirm	O	VERB	O
that	O	SCONJ	O
a	O	DET	O
single	O	ADJ	O
base	O	NOUN	O
change	O	NOUN	O
in	O	ADP	O
the	O	DET	O
branchpoint	O	ADJ	B
consensus	O	NOUN	O
sequence	O	NOUN	O
of	O	ADP	O
an	O	DET	O
intron	O	NOUN	B
can	O	AUX	O
cause	O	VERB	O
human	O	ADJ	B
disease	O	NOUN	O
although	O	SCONJ	O
this	O	DET	O
sequence	O	NOUN	B
is	O	AUX	O
poorly	O	ADV	O
conserved	O	VERB	O
in	O	ADP	O
mammals	O	NOUN	B
.	O	PUNCT	O


It	O	PRON	O
bound	O	VERB	O
to	O	PART	O
vitamin	B-GENE	NOUN	B
D	I-GENE	NOUN	I
receptor	I-GENE	NOUN	I
(	O	PUNCT	O
VDR	B-GENE	NOUN	B
)	O	PUNCT	O
but	O	CCONJ	O
not	O	PART	O
retinoic	B-GENE	ADJ	B
acid	I-GENE	NOUN	I
Xalpha	I-GENE	NOUN	I
receptor	I-GENE	NOUN	I
(	O	PUNCT	O
RXRalpha	B-GENE	NOUN	B
)	O	PUNCT	O
in	O	ADP	O
the	O	DET	O
human	O	ADJ	B
T	O	NOUN	O
cell	O	NOUN	O
line	O	NOUN	O
MT2	O	NOUN	B
cells	O	NOUN	I
.	O	PUNCT	O


Based	O	VERB	O
on	O	ADP	O
the	O	DET	O
current	O	ADJ	O
literature	O	NOUN	B
,	O	PUNCT	O
the	O	DET	O
mechanisms	O	NOUN	B
involved	O	VERB	O
in	O	ADP	O
the	O	DET	O
toxicity	O	NOUN	B
of	O	ADP	O
OA	B-GENE	NOUN	B
indicate	O	VERB	O
three	O	NUM	O
major	O	ADJ	O
effects	O	NOUN	B
:	O	PUNCT	O
(	O	PUNCT	O
1	O	X	O
)	O	PUNCT	O
inhibition	O	NOUN	B
of	O	ADP	O
mitochondrial	O	ADJ	B
respiration	O	NOUN	O
correlated	O	VERB	B
with	O	ADP	O
a	O	DET	O
depletion	O	NOUN	B
of	O	ADP	O
ATP	O	NOUN	B
;	O	PUNCT	O
(	O	PUNCT	O
2	O	X	O
)	O	PUNCT	O
inhibition	O	NOUN	B
of	O	ADP	O
tRNA	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
synthetase	I-GENE	NOUN	B
accompanied	O	VERB	O
by	O	ADP	O
a	O	DET	O
reduced	O	VERB	B
protein	O	NOUN	B
synthesis	O	NOUN	I
;	O	PUNCT	O
and	O	CCONJ	O
(	O	PUNCT	O
3	O	X	O
)	O	PUNCT	O
enhanced	O	VERB	B
lipid	O	NOUN	B
peroxidation	O	NOUN	I
.	O	PUNCT	O


Another	O	DET	O
stem	O	NOUN	B
-	O	PUNCT	O
loop	O	NOUN	B
called	O	VERB	O
structure	O	NOUN	B
III	O	NUM	I
near	O	ADP	I
the	O	DET	O
3	O	NUM	O
'	O	PART	O
-	O	PUNCT	O
end	O	NOUN	O
of	O	ADP	O
repY	B-GENE	NOUN	B
sequesters	O	VERB	B
both	O	CCONJ	O
the	O	DET	O
5	O	NUM	O
'	O	PUNCT	O
-	O	PUNCT	O
rCGCC	O	NOUN	B
-	O	PUNCT	O
3	O	NUM	B
'	O	PART	I
sequence	O	NOUN	I
and	O	CCONJ	O
the	O	DET	O
repZ	B-GENE	NOUN	B
ribosome	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
binding	I-GENE	VERB	B
site	I-GENE	NOUN	I
.	O	PUNCT	O


The	O	DET	O
general	O	ADJ	B
transcription	B-GENE	NOUN	I
factor	I-GENE	NOUN	I
IIA	I-GENE	NOUN	I
(	O	PUNCT	O
TFIIA	B-GENE	NOUN	B
)	O	PUNCT	O
interacts	O	VERB	O
with	O	ADP	O
the	O	DET	O
TATA	B-GENE	NOUN	B
binding	I-GENE	NOUN	I
protein	I-GENE	NOUN	I
(	O	PUNCT	O
TBP	B-GENE	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
promoter	O	NOUN	B
DNA	O	NOUN	I
to	O	PART	O
mediate	O	VERB	O
transcription	O	NOUN	B
activation	O	NOUN	I
in	O	X	B
vitro	O	X	I
.	O	PUNCT	O


Localization	O	NOUN	B
of	O	ADP	O
67	O	NUM	O
exons	O	NOUN	B
on	O	ADP	O
a	O	DET	O
YAC	O	NOUN	B
contig	O	NOUN	B
spanning	O	VERB	O
1	O	NUM	O
.	O	PUNCT	O
5	O	NUM	O
Mb	O	NOUN	O
around	O	ADP	O
the	O	DET	O
multidrug	B-GENE	ADJ	B
resistance	I-GENE	NOUN	I
gene	I-GENE	NOUN	I
region	I-GENE	NOUN	I
of	O	ADP	O
human	O	ADJ	B
chromosome	O	NOUN	O
7q21	O	NOUN	O
.	O	PUNCT	O
1	O	NUM	O
.	O	PUNCT	O


Using	O	VERB	O
Southern	O	NOUN	B
blot	O	NOUN	I
analysis	O	NOUN	I
and	O	CCONJ	O
restriction	O	NOUN	B
mapping	O	NOUN	I
of	O	ADP	O
genomic	O	ADJ	B
YAC	O	NOUN	I
(	O	PUNCT	O
yeast	O	NOUN	B
artificial	O	ADJ	O
chromosome	O	NOUN	O
)	O	PUNCT	O
and	O	CCONJ	O
cosmid	O	NOUN	B
clones	O	NOUN	I
,	O	PUNCT	O
we	O	PRON	O
located	O	VERB	O
the	O	DET	O
human	B-GENE	ADJ	B
RIL	I-GENE	NOUN	B
gene	I-GENE	NOUN	O
240	O	NUM	O
-	O	PUNCT	O
260	O	NUM	O
kb	O	NOUN	O
telomeric	O	ADJ	O
to	O	PART	O
the	O	DET	O
IRF1	B-GENE	NOUN	B
gene	I-GENE	NOUN	O
and	O	CCONJ	O
characterized	O	VERB	B
its	O	PRON	O
genomic	O	ADJ	B
structure	O	NOUN	I
.	O	PUNCT	O


U73	B-GENE	NOUN	O
contains	O	VERB	O
C	O	NOUN	O
,	O	PUNCT	O
D	O	NOUN	B
and	O	CCONJ	O
D	O	NOUN	B
'	O	PART	O
boxes	O	NOUN	B
and	O	CCONJ	O
a	O	DET	O
12	O	NUM	O
-	O	PUNCT	O
nucleotide	O	NOUN	B
antisense	O	ADJ	O
complementarity	O	NOUN	O
to	O	PART	O
the	O	DET	O
28S	B-GENE	ADJ	B
ribosomal	I-GENE	ADJ	I
RNA	I-GENE	NOUN	I
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
mandibular	O	ADJ	B
position	O	NOUN	I
(	O	PUNCT	O
S	O	PROPN	B
-	O	PUNCT	O
N	O	PROPN	B
-	O	PUNCT	O
B	O	NOUN	B
and	O	CCONJ	O
S	O	NOUN	B
-	O	PUNCT	O
N	O	PROPN	B
-	O	PUNCT	O
Pog	O	PROPN	B
)	O	PUNCT	O
was	O	AUX	O
found	O	VERB	O
to	O	PART	O
be	O	AUX	O
significantly	O	ADV	O
more	O	ADV	O
retrusive	O	ADJ	B
in	O	ADP	O
Class	O	NOUN	B
II	O	NUM	I
when	O	SCONJ	O
compared	O	VERB	B
with	O	ADP	O
Class	O	NOUN	B
I	O	NUM	I
subjects	O	NOUN	B
.	O	PUNCT	O


Echinostomiasis	O	NOUN	B
is	O	AUX	O
aggravated	O	VERB	B
by	O	ADP	O
socioeconomic	O	ADJ	B
factors	O	NOUN	I
such	O	ADJ	O
as	O	ADP	O
poverty	O	NOUN	B
,	O	PUNCT	O
malnutrition	O	NOUN	B
,	O	PUNCT	O
an	O	DET	O
explosively	O	ADV	O
growing	O	VERB	O
free	O	ADJ	B
-	O	PUNCT	O
food	O	NOUN	B
market	O	NOUN	I
,	O	PUNCT	O
a	O	DET	O
lack	O	NOUN	B
of	O	ADP	O
supervised	O	VERB	B
food	O	NOUN	B
inspection	O	NOUN	I
,	O	PUNCT	O
poor	O	ADJ	B
or	O	CCONJ	O
insufficient	O	ADJ	B
sanitation	O	NOUN	B
,	O	PUNCT	O
other	O	ADJ	O
helminthiases	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
declining	O	VERB	B
economic	O	ADJ	B
conditions	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
localization	O	NOUN	B
of	O	ADP	O
ZAP	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
70	I-GENE	NUM	O
to	O	PART	O
the	O	DET	O
cell	O	NOUN	B
cortex	O	NOUN	I
is	O	AUX	O
,	O	PUNCT	O
therefore	O	ADV	O
,	O	PUNCT	O
regulated	O	VERB	O
by	O	ADP	O
the	O	DET	O
activity	O	NOUN	B
of	O	ADP	O
SRC	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
family	I-GENE	NOUN	B
kinases	I-GENE	NOUN	I
,	O	PUNCT	O
independently	O	ADV	O
of	O	ADP	O
their	O	PRON	O
ability	O	NOUN	O
to	O	PART	O
phosphorylate	O	VERB	B
immunoreceptor	O	NOUN	B
tyrosine	O	NOUN	I
-	O	PUNCT	O
based	O	VERB	B
activation	O	NOUN	B
motifs	O	NOUN	B
of	O	ADP	O
the	O	DET	O
TCR	B-GENE	NOUN	B
.	O	PUNCT	O


The	O	DET	O
effect	O	NOUN	B
of	O	ADP	O
nitric	B-GENE	ADJ	B
oxide	I-GENE	NOUN	I
synthase	I-GENE	NOUN	I
inhibitor	O	NOUN	I
on	O	ADP	O
reperfusion	O	NOUN	B
injury	O	NOUN	I
of	O	ADP	O
the	O	DET	O
brain	O	NOUN	B
under	O	ADP	O
hypothermic	O	ADJ	B
circulatory	O	ADJ	B
arrest	O	NOUN	I
.	O	PUNCT	O


UDP	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
GlcNAc	I-GENE	NOUN	B
:	O	PUNCT	O
alpha	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
6	I-GENE	NUM	B
-	I-GENE	PUNCT	O
D	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
mannoside	I-GENE	NOUN	B
beta	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	O
,	I-GENE	PUNCT	O
2	I-GENE	NUM	O
-	I-GENE	PUNCT	O
N	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
acetylglucosaminyltransferase	I-GENE	PROPN	B
II	I-GENE	NUM	I
(	O	PUNCT	O
GnT	B-GENE	NOUN	B
II	I-GENE	NUM	I
;	O	PUNCT	O
EC	B-GENE	PROPN	B
2	I-GENE	NUM	I
.	I-GENE	PUNCT	O
4	I-GENE	NUM	O
.	I-GENE	PUNCT	O
1	I-GENE	NUM	O
.	I-GENE	PUNCT	O
143	I-GENE	NUM	O
)	O	PUNCT	O
is	O	AUX	O
essential	O	ADJ	B
for	O	ADP	O
the	O	DET	O
normal	O	ADJ	B
assembly	O	NOUN	I
of	O	ADP	O
complex	O	ADJ	B
Asn	O	NOUN	B
-	O	PUNCT	O
linked	O	VERB	B
glycans	O	NOUN	B
.	O	PUNCT	O


Taken	O	VERB	O
together	O	ADV	O
,	O	PUNCT	O
these	O	DET	O
results	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
silymarin	O	NOUN	B
may	O	AUX	O
exert	O	VERB	O
a	O	DET	O
strong	O	ADJ	O
anticarcinogenic	O	ADJ	B
effect	O	NOUN	I
against	O	ADP	O
PCA	O	NOUN	B
and	O	CCONJ	O
that	O	SCONJ	O
this	O	DET	O
effect	O	NOUN	B
is	O	AUX	O
likely	O	ADJ	O
to	O	PART	O
involve	O	VERB	O
impairment	O	NOUN	B
of	O	ADP	O
erbB1	B-GENE	NOUN	B
-	O	PUNCT	O
SHC	B-GENE	NOUN	B
-	O	PUNCT	O
mediated	O	VERB	B
signaling	O	NOUN	B
pathway	O	NOUN	I
,	O	PUNCT	O
induction	O	NOUN	B
of	O	ADP	O
CDKIs	B-GENE	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
a	O	DET	O
resultant	O	ADJ	O
G1	O	NOUN	B
arrest	O	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
connective	O	ADJ	B
tissue	O	NOUN	I
,	O	PUNCT	O
cell	O	NOUN	B
structure	O	NOUN	I
contributes	O	VERB	O
to	O	PART	O
type	B-GENE	NOUN	B
I	I-GENE	NUM	I
collagen	I-GENE	NOUN	I
expression	O	NOUN	B
.	O	PUNCT	O


A	O	DET	O
point	O	NOUN	O
mutation	O	NOUN	O
in	O	ADP	O
Galphao	B-GENE	NOUN	B
and	O	CCONJ	O
Galphai1	B-GENE	NOUN	B
blocks	O	VERB	B
interaction	O	NOUN	B
with	O	ADP	O
regulator	O	NOUN	B
of	O	ADP	O
G	B-GENE	NOUN	B
protein	I-GENE	NOUN	I
signaling	O	NOUN	I
proteins	O	NOUN	I
.	O	PUNCT	O


Indeed	O	ADV	O
,	O	PUNCT	O
it	O	PRON	O
is	O	AUX	O
shown	O	VERB	O
that	O	SCONJ	O
it	O	PRON	O
mediates	O	VERB	O
the	O	DET	O
formation	O	NOUN	B
of	O	ADP	O
disulfide	O	NOUN	B
-	O	PUNCT	O
linked	O	VERB	B
homodimers	O	NOUN	B
and	O	CCONJ	O
that	O	SCONJ	O
the	O	DET	O
formation	O	NOUN	B
of	O	ADP	O
homo	O	NOUN	B
-	O	PUNCT	O
and	O	CCONJ	O
heterodimers	O	NOUN	B
are	O	AUX	O
mutually	O	ADV	O
excluded	O	VERB	O
.	O	PUNCT	O


N	O	NOUN	B
.	O	PUNCT	O
,	O	PUNCT	O
and	O	CCONJ	O
Fanning	O	PROPN	B
,	O	PUNCT	O
E	O	PROPN	B
.	O	PUNCT	O


In	O	ADP	O
patients	O	NOUN	B
with	O	ADP	O
type	O	NOUN	B
IA	O	NUM	I
maple	O	VERB	I
syrup	O	NOUN	I
urine	O	NOUN	B
disease	O	NOUN	I
,	O	PUNCT	O
the	O	DET	O
E1alpha	B-GENE	NOUN	B
subunit	I-GENE	NOUN	I
is	O	AUX	O
affected	O	VERB	B
,	O	PUNCT	O
resulting	O	VERB	O
in	O	ADP	O
the	O	DET	O
loss	O	NOUN	B
of	O	ADP	O
E1	B-GENE	NOUN	B
and	O	CCONJ	O
branched	B-GENE	ADJ	B
-	I-GENE	PUNCT	O
chain	I-GENE	NOUN	B
ketoacid	I-GENE	NOUN	I
dehydrogenase	I-GENE	NOUN	I
catalytic	O	ADJ	B
activities	O	NOUN	I
.	O	PUNCT	O


All	O	DET	O
patients	O	NOUN	B
diagnosed	O	VERB	B
of	O	ADP	O
H	O	NOUN	B
.	O	PUNCT	O
influenza	O	NOUN	O
type	O	NOUN	O
b	O	NOUN	O
meningitis	O	NOUN	B
were	O	AUX	O
less	O	ADJ	O
than	O	ADP	O
3	O	NUM	O
years	O	NOUN	B
old	O	ADJ	O
.	O	PUNCT	O


Immunohistochemically	O	ADV	B
,	O	PUNCT	O
anticytokeratin	B-GENE	NOUN	B
19	I-GENE	NUM	O
antibody	I-GENE	NOUN	B
revealed	O	VERB	O
strong	O	ADJ	O
staining	O	NOUN	B
in	O	ADP	O
both	O	CCONJ	O
epithelial	O	ADJ	B
and	O	CCONJ	O
sarcomatous	O	ADJ	B
MPM	O	NOUN	B
tissues	O	NOUN	B
.	O	PUNCT	O


Combined	O	ADJ	B
expression	O	NOUN	B
of	O	ADP	O
c	B-GENE	NOUN	O
-	I-GENE	PUNCT	O
Jun	I-GENE	NOUN	B
and	O	CCONJ	O
p65	B-GENE	NOUN	B
induced	O	VERB	B
vigorous	O	ADJ	B
transcription	O	NOUN	I
of	O	ADP	O
IL	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
2	I-GENE	NUM	O
promoter	O	NOUN	B
-	O	PUNCT	O
and	O	CCONJ	O
CD28RE	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
driven	I-GENE	VERB	B
reporter	I-GENE	NOUN	O
constructs	I-GENE	NOUN	O
in	O	ADP	O
both	O	CCONJ	O
LFA	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
3	I-GENE	NUM	B
-	O	PUNCT	O
and	O	CCONJ	O
B7	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	B
-	O	PUNCT	O
costimulated	O	VERB	B
Jurkat	O	NOUN	B
cells	O	NOUN	I
.	O	PUNCT	O


Liquid	O	ADJ	B
chromatographic	O	ADJ	I
method	O	NOUN	I
for	O	ADP	O
analysis	O	NOUN	B
of	O	ADP	O
all	O	DET	O
-	O	PUNCT	O
rac	O	NOUN	B
-	O	PUNCT	O
alpha	O	NOUN	B
-	O	PUNCT	O
tocopheryl	O	NOUN	B
acetate	O	NOUN	I
and	O	CCONJ	O
retinyl	O	NOUN	B
palmitate	O	NOUN	I
in	O	ADP	O
milk	O	NOUN	B
-	O	PUNCT	O
based	O	VERB	B
infant	O	NOUN	B
formula	O	NOUN	I
using	O	VERB	O
matrix	O	ADJ	B
solid	O	ADJ	B
-	O	PUNCT	O
phase	O	NOUN	B
dispersion	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
ability	O	NOUN	O
to	O	PART	O
maintain	O	VERB	O
expression	O	NOUN	B
of	O	ADP	O
FAS1	B-GENE	NOUN	B
in	O	ADP	O
nmt1	B-GENE	NOUN	B
-	O	PUNCT	O
451Dino2	B-GENE	PROPN	B
Delta	O	NOUN	B
cells	O	NOUN	I
suggests	O	VERB	O
the	O	DET	O
existence	O	NOUN	O
of	O	ADP	O
another	O	DET	O
transcription	O	NOUN	B
factor	O	NOUN	I
,	O	PUNCT	O
or	O	CCONJ	O
factors	O	NOUN	B
,	O	PUNCT	O
whose	O	DET	O
expression	O	NOUN	B
/	O	PUNCT	O
activity	O	NOUN	B
is	O	AUX	O
inversely	O	ADV	O
related	O	ADJ	O
to	O	PART	O
overall	O	ADJ	B
levels	O	NOUN	B
of	O	ADP	O
cellular	O	ADJ	B
protein	O	NOUN	I
N	O	NOUN	I
-	O	PUNCT	O
myristoy	O	NOUN	B
-	O	PUNCT	O
lation	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
identified	O	VERB	O
isolates	O	NOUN	B
of	O	ADP	O
CSF	O	NOUN	B
(	O	PUNCT	O
20	O	NUM	O
of	O	ADP	O
29	O	NUM	O
)	O	PUNCT	O
were	O	AUX	O
:	O	PUNCT	O
ECHO	O	PROPN	B
30	O	NUM	O
(	O	PUNCT	O
9	O	NUM	O
)	O	PUNCT	O
,	O	PUNCT	O
ECHO	O	NOUN	B
11	O	NUM	O
(	O	PUNCT	O
7	O	NUM	O
)	O	PUNCT	O
,	O	PUNCT	O
ECHO	O	NOUN	B
9	O	NUM	O
(	O	PUNCT	O
3	O	NUM	O
)	O	PUNCT	O
and	O	CCONJ	O
ECHO	O	NOUN	B
7	O	NUM	O
(	O	PUNCT	O
1	O	NUM	O
)	O	PUNCT	O
.	O	PUNCT	O


There	O	PRON	O
was	O	AUX	O
no	O	DET	O
evidence	O	NOUN	B
of	O	ADP	O
any	O	DET	O
persistent	O	ADJ	B
oscillation	O	NOUN	B
within	O	ADP	O
the	O	DET	O
ULF	O	NOUN	B
band	O	NOUN	O
.	O	PUNCT	O


A	O	DET	O
large	O	ADJ	O
deletion	O	NOUN	B
in	O	ADP	O
the	O	DET	O
CTD	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
binding	I-GENE	VERB	B
motif	I-GENE	NOUN	B
blocks	O	VERB	I
down	O	ADP	B
-	O	PUNCT	O
regulation	O	NOUN	B
but	O	CCONJ	O
does	O	AUX	O
not	O	PART	O
affect	O	VERB	O
the	O	DET	O
essential	O	ADJ	B
function	O	NOUN	I
of	O	ADP	O
Nrd1	B-GENE	NOUN	B
.	O	PUNCT	O


Thus	O	ADV	O
,	O	PUNCT	O
included	O	VERB	O
in	O	ADP	O
the	O	DET	O
KG1a	O	NOUN	B
EST	O	NOUN	B
dataset	O	NOUN	B
are	O	AUX	O
candidates	O	NOUN	O
for	O	ADP	O
new	O	ADJ	O
human	O	ADJ	B
genes	O	NOUN	I
that	O	PRON	O
may	O	AUX	O
play	O	VERB	O
roles	O	NOUN	O
in	O	ADP	O
hematopoietic	O	ADJ	B
differentiative	O	ADJ	I
progression	O	NOUN	I
and	O	CCONJ	O
lineage	O	NOUN	B
commitment	O	NOUN	B
.	O	PUNCT	O


Sp1	B-GENE	NOUN	B
and	O	CCONJ	O
two	O	NUM	O
Sp3	B-GENE	NOUN	B
isoforms	I-GENE	NOUN	B
were	O	AUX	O
detected	O	VERB	B
as	O	ADP	O
the	O	DET	O
primary	O	ADJ	O
cellular	O	ADJ	B
constituents	O	NOUN	I
of	O	ADP	O
DNA	O	NOUN	B
-	O	PUNCT	O
protein	O	NOUN	B
complexes	O	NOUN	I
formed	O	VERB	O
with	O	ADP	O
the	O	DET	O
NF	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
kappaB	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
proximal	I-GENE	ADJ	B
site	I-GENE	NOUN	B
.	O	PUNCT	O


The	O	DET	O
second	O	ADJ	O
patient	O	NOUN	B
had	O	AUX	O
received	O	VERB	O
pituitary	B-GENE	ADJ	B
-	I-GENE	PUNCT	O
derived	I-GENE	VERB	B
growth	I-GENE	NOUN	B
hormone	I-GENE	NOUN	I
for	O	ADP	O
treatment	O	NOUN	B
of	O	ADP	O
growth	B-GENE	NOUN	B
hormone	I-GENE	NOUN	I
deficiency	O	NOUN	I
,	O	PUNCT	O
secondary	O	ADJ	B
to	O	PART	I
a	O	DET	O
third	O	ADJ	O
ventricle	O	NOUN	O
teratoma	O	NOUN	O
,	O	PUNCT	O
exised	O	ADJ	B
13	O	NUM	O
yr	O	NOUN	O
earlier	O	ADV	O
.	O	PUNCT	O


Binding	O	NOUN	B
affinities	O	NOUN	B
of	O	ADP	O
different	O	ADJ	O
nucleotide	O	NOUN	B
mono	O	NOUN	I
-	O	PUNCT	O
,	O	PUNCT	O
di	O	PROPN	O
-	O	PUNCT	O
and	O	CCONJ	O
triphosphates	O	NOUN	B
and	O	CCONJ	O
non	O	ADJ	B
-	O	PUNCT	O
hydrolyzable	O	ADJ	B
analogs	O	NOUN	B
indicate	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
beta	O	NOUN	B
-	O	PUNCT	O
phosphate	O	NOUN	B
moiety	O	NOUN	I
is	O	AUX	O
required	O	VERB	O
for	O	ADP	O
substrate	O	NOUN	B
binding	O	NOUN	B
.	O	PUNCT	O


[	O	PUNCT	O
Treatment	O	NOUN	B
of	O	ADP	O
early	O	ADJ	B
T1	O	NOUN	I
small	O	ADJ	B
T2N	O	NOUN	B
breast	O	NOUN	I
cancers	O	NOUN	I
.	O	PUNCT	O


Malaria	O	NOUN	B
had	O	AUX	O
diminished	O	VERB	B
significantly	O	ADV	O
by	O	ADP	O
the	O	DET	O
early	O	ADJ	B
1940s	O	NOUN	O
,	O	PUNCT	O
and	O	CCONJ	O
this	O	DET	O
paper	O	NOUN	O
queries	O	VERB	B
whether	O	SCONJ	O
that	O	DET	O
reduction	O	NOUN	B
was	O	AUX	O
due	O	ADJ	O
to	O	PART	O
the	O	DET	O
control	O	NOUN	B
projects	O	NOUN	I
of	O	ADP	O
the	O	DET	O
thirties	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
,	O	PUNCT	O
if	O	SCONJ	O
so	O	ADV	O
,	O	PUNCT	O
whether	O	SCONJ	O
such	O	ADJ	O
projects	O	NOUN	B
should	O	AUX	O
be	O	AUX	O
a	O	DET	O
model	O	NOUN	B
for	O	ADP	O
the	O	DET	O
current	O	ADJ	O
developing	O	VERB	B
world	O	NOUN	I
,	O	PUNCT	O
where	O	SCONJ	O
malaria	O	NOUN	B
is	O	AUX	O
a	O	DET	O
growing	O	VERB	O
problem	O	NOUN	B
today	O	NOUN	O
.	O	PUNCT	O


Fowlpox	O	ADJ	B
virus	O	NOUN	I
encodes	O	VERB	O
nonessential	O	ADJ	O
homologs	O	NOUN	B
of	O	ADP	O
cellular	B-GENE	ADJ	B
alpha	I-GENE	NOUN	I
-	I-GENE	PUNCT	O
SNAP	I-GENE	NOUN	B
,	O	PUNCT	O
PC	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	O
,	O	PUNCT	O
and	O	CCONJ	O
an	O	DET	O
orphan	O	NOUN	B
human	O	ADJ	I
homolog	O	NOUN	I
of	O	ADP	O
a	O	DET	O
secreted	O	VERB	B
nematode	O	NOUN	O
protein	O	NOUN	O
.	O	PUNCT	O


Further	O	ADV	O
,	O	PUNCT	O
Ser	O	NOUN	B
/	O	SYM	O
Thr	O	NOUN	B
phosphorylation	O	NOUN	B
of	O	ADP	O
downstream	O	ADJ	B
molecules	O	NOUN	I
Akt	B-GENE	NOUN	B
and	O	CCONJ	O
p70	B-GENE	NOUN	B
S6	I-GENE	NOUN	I
kinase	I-GENE	NOUN	I
was	O	AUX	O
inhibited	O	VERB	B
.	O	PUNCT	O


Quantitative	O	ADJ	B
evaluation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
steady	O	ADJ	B
state	O	NOUN	I
kinetics	O	NOUN	B
of	O	ADP	O
MEK	B-GENE	NOUN	B
inhibition	O	NOUN	B
by	O	ADP	O
these	O	DET	O
compounds	O	NOUN	B
reveals	O	VERB	O
that	O	SCONJ	O
U0126	O	NOUN	B
has	O	AUX	O
approximately	O	ADV	O
100	O	NUM	O
-	O	PUNCT	O
fold	O	ADJ	B
higher	O	ADJ	B
affinity	O	NOUN	B
for	O	ADP	O
deltaN3	B-GENE	ADJ	B
-	I-GENE	PUNCT	O
S218E	I-GENE	PROPN	B
/	I-GENE	SYM	O
S222D	I-GENE	NOUN	B
MEK	I-GENE	NOUN	B
than	O	ADP	O
does	O	AUX	O
PD098059	O	NOUN	B
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
little	O	ADJ	O
is	O	AUX	O
known	O	VERB	O
regarding	O	VERB	O
the	O	DET	O
genomic	O	ADJ	B
organization	O	NOUN	I
and	O	CCONJ	O
developmental	O	ADJ	B
expression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
caveolin	B-GENE	NOUN	B
gene	I-GENE	NOUN	I
family	I-GENE	NOUN	O
.	O	PUNCT	O


Tensile	O	NOUN	B
bond	O	NOUN	I
strengths	O	NOUN	I
between	O	ADP	O
resin	O	NOUN	B
composite	O	ADJ	I
and	O	CCONJ	O
bovine	O	ADJ	B
dentin	O	NOUN	I
using	O	VERB	O
dentin	O	NOUN	B
adhesive	O	ADJ	I
systems	O	NOUN	I
(	O	PUNCT	O
Clearfil	O	PROPN	B
Liner	O	PROPN	I
Bond	O	PROPN	I
II	O	NUM	I
:	O	PUNCT	O
LB	O	PROPN	B
II	O	NUM	I
;	O	PUNCT	O
Scotchbond	O	PROPN	B
Multi	O	PROPN	I
-	O	PUNCT	O
Purpose	O	PROPN	B
:	O	PUNCT	O
MP	O	NOUN	B
)	O	PUNCT	O
bonding	O	NOUN	B
systems	O	NOUN	I
showed	O	VERB	O
a	O	DET	O
large	O	ADJ	O
scatter	O	NOUN	B
among	O	ADP	O
students	O	NOUN	B
and	O	CCONJ	O
dentists	O	NOUN	B
.	O	PUNCT	O


To	O	PART	O
better	O	ADV	O
understand	O	VERB	O
the	O	DET	O
role	O	NOUN	O
of	O	ADP	O
Ets	B-GENE	NOUN	B
proteins	I-GENE	NOUN	I
in	O	ADP	O
Ras	B-GENE	NOUN	B
transformation	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
have	O	AUX	O
now	O	ADV	O
analyzed	O	VERB	B
the	O	DET	O
effects	O	NOUN	B
of	O	ADP	I
stably	O	ADV	B
expressing	O	VERB	B
a	O	DET	O
variety	O	NOUN	O
of	O	ADP	O
Ets2	B-GENE	NOUN	B
constructs	I-GENE	NOUN	B
in	O	ADP	O
Ras	B-GENE	NOUN	B
-	O	PUNCT	O
transformed	O	VERB	B
NIH3T3	O	NOUN	B
(	O	PUNCT	O
DT	O	NOUN	O
)	O	PUNCT	O
cells	O	NOUN	O
.	O	PUNCT	O


Manipulation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
checkpoint	O	NOUN	B
regulators	O	NOUN	I
involved	O	VERB	O
in	O	ADP	O
cell	O	NOUN	B
cycle	O	NOUN	I
arrest	O	NOUN	I
and	O	CCONJ	O
apoptosis	O	NOUN	B
may	O	AUX	O
thus	O	ADV	O
provide	O	VERB	O
a	O	DET	O
novel	O	ADJ	O
strategy	O	NOUN	O
to	O	ADP	O
cancer	O	NOUN	B
therapy	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
diagnostic	O	ADJ	B
accuracy	O	NOUN	I
of	O	ADP	O
serum	O	NOUN	B
PE	B-GENE	NOUN	I
-	I-GENE	PUNCT	O
1	I-GENE	NUM	O
was	O	AUX	O
0	O	NUM	O
.	O	PUNCT	O
80	O	NUM	O
,	O	PUNCT	O
and	O	CCONJ	O
that	O	DET	O
of	O	ADP	O
amylase	B-GENE	NOUN	B
0	O	NUM	O
.	O	PUNCT	O
97	O	NUM	O
.	O	PUNCT	O


We	O	PRON	O
demonstrate	O	VERB	O
that	O	SCONJ	O
Ddc1p	B-GENE	NOUN	B
interacts	O	VERB	O
physically	O	ADV	B
in	O	X	B
vivo	O	X	I
with	O	ADP	O
Mec3p	B-GENE	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
this	O	DET	O
interaction	O	NOUN	B
requires	O	VERB	O
Rad17p	B-GENE	NOUN	B
.	O	PUNCT	O


Deleting	O	VERB	B
SNF1	B-GENE	NOUN	B
repressed	O	VERB	B
meiosis	O	NOUN	B
at	O	ADP	O
the	O	DET	O
same	O	ADJ	O
three	O	NUM	O
steps	O	NOUN	B
that	O	PRON	O
were	O	AUX	O
inhibited	O	VERB	B
by	O	ADP	O
glucose	O	NOUN	B
,	O	PUNCT	O
suggesting	O	VERB	O
that	O	SCONJ	O
glucose	O	NOUN	B
blocks	O	VERB	I
meiosis	O	NOUN	B
by	O	ADP	O
inhibiting	O	VERB	B
Snf1	B-GENE	NOUN	B
.	O	PUNCT	O


Ligand	O	NOUN	B
-	O	PUNCT	O
independent	O	ADJ	B
activation	O	NOUN	B
of	O	ADP	O
platelet	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
derived	I-GENE	VERB	B
growth	I-GENE	NOUN	B
factor	I-GENE	NOUN	I
receptor	I-GENE	NOUN	I
is	O	AUX	O
a	O	DET	O
necessary	O	ADJ	O
intermediate	O	NOUN	B
in	O	ADP	O
lysophosphatidic	O	ADJ	B
,	O	PUNCT	O
acid	O	NOUN	B
-	O	PUNCT	O
stimulated	O	VERB	B
mitogenic	O	ADJ	B
activity	O	NOUN	I
in	O	ADP	O
L	O	NOUN	B
cells	O	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
canrenoate	O	NOUN	B
-	O	PUNCT	O
treated	O	VERB	B
rats	O	NOUN	B
,	O	PUNCT	O
ANP	B-GENE	NOUN	B
infusion	O	NOUN	B
caused	O	VERB	O
greater	O	ADJ	O
increases	O	NOUN	B
in	O	ADP	O
sodium	O	NOUN	B
excretion	O	NOUN	B
(	O	PUNCT	O
FENA	O	NOUN	B
from	O	ADP	O
3	O	NUM	O
.	O	PUNCT	O
05	O	NUM	O
+	O	CCONJ	O
/	O	SYM	O
-	O	PUNCT	O
0	O	NUM	O
.	O	PUNCT	O
71	O	NUM	O
to	O	PART	O
7	O	NUM	O
.	O	PUNCT	O
21	O	NUM	O
+	O	CCONJ	O
/	O	SYM	O
-	O	PUNCT	O
0	O	NUM	O
.	O	PUNCT	O
45	O	NUM	O
%	O	NOUN	O
;	O	PUNCT	O
P	O	NOUN	O
<	O	X	O
0	O	NUM	O
.	O	PUNCT	O
05	O	NUM	O
;	O	PUNCT	O
n	O	NOUN	O
=	O	ADJ	O
8	O	NUM	O
)	O	PUNCT	O
than	O	ADP	O
saline	O	NOUN	B
infusion	O	NOUN	I
(	O	PUNCT	O
FENA	O	NOUN	B
from	O	ADP	O
4	O	NUM	O
.	O	PUNCT	O
16	O	NUM	O
+	O	CCONJ	O
/	O	SYM	O
-	O	PUNCT	O
1	O	NUM	O
.	O	PUNCT	O
11	O	NUM	O
to	O	PART	O
5	O	NUM	O
.	O	PUNCT	O
47	O	NUM	O
+	O	CCONJ	O
/	O	SYM	O
-	O	PUNCT	O
0	O	NUM	O
.	O	PUNCT	O
66	O	NUM	O
%	O	NOUN	O
;	O	PUNCT	O
n	O	NOUN	O
=	O	ADJ	O
6	O	NUM	O
)	O	PUNCT	O
,	O	PUNCT	O
despite	O	SCONJ	O
the	O	DET	O
hypocapnia	O	NOUN	B
.	O	PUNCT	O


Identical	O	ADJ	O
c	B-GENE	NOUN	O
-	I-GENE	PUNCT	O
erbB3	I-GENE	NOUN	B
transcripts	I-GENE	NOUN	B
are	O	AUX	O
expressed	O	VERB	B
in	O	ADP	O
normal	O	ADJ	O
human	O	ADJ	B
placental	O	ADJ	B
tissues	O	NOUN	B
.	O	PUNCT	O


Downregulation	O	NOUN	B
of	O	ADP	O
FUS	B-GENE	NOUN	B
expression	O	NOUN	B
in	O	ADP	O
BCR	B-GENE	NOUN	B
/	O	SYM	O
ABL	B-GENE	NOUN	B
-	O	PUNCT	O
expressing	O	VERB	B
32Dcl3	O	NOUN	B
cells	O	NOUN	I
was	O	AUX	O
associated	O	VERB	B
with	O	ADP	I
suppression	O	NOUN	B
of	O	ADP	O
growth	O	NOUN	B
factor	O	NOUN	I
-	O	PUNCT	O
independent	O	ADJ	B
colony	O	NOUN	B
formation	O	NOUN	B
,	O	PUNCT	O
restoration	O	NOUN	B
of	O	ADP	O
G	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
CSF	I-GENE	PROPN	B
-	O	PUNCT	O
induced	O	VERB	B
granulocytic	O	ADJ	B
differentiation	O	NOUN	I
and	O	CCONJ	O
reduced	O	VERB	B
tumorigenic	O	ADJ	B
potential	O	NOUN	O
in	O	X	B
vivo	O	X	I
.	O	PUNCT	O


We	O	PRON	O
propose	O	VERB	O
a	O	DET	O
model	O	NOUN	B
in	O	ADP	O
which	O	DET	O
Sro7	B-GENE	NOUN	B
function	O	NOUN	B
is	O	AUX	O
involved	O	VERB	O
in	O	ADP	O
the	O	DET	O
targeting	O	NOUN	B
of	O	ADP	O
the	O	DET	O
myosin	B-GENE	NOUN	B
proteins	I-GENE	NOUN	I
to	O	PART	O
their	O	PRON	O
intrinsic	O	ADJ	B
pathways	O	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
experiments	O	NOUN	B
with	O	ADP	O
the	O	DET	O
D1	O	NOUN	B
antagonist	O	NOUN	O
SCH	O	NOUN	B
23390	O	NUM	O
,	O	PUNCT	O
buprenorphine	O	NOUN	B
-	O	PUNCT	O
induced	O	VERB	B
depression	O	NOUN	B
was	O	AUX	O
consistently	O	ADV	O
blocked	O	VERB	B
,	O	PUNCT	O
but	O	CCONJ	O
facilitation	O	NOUN	B
was	O	AUX	O
unaffected	O	ADJ	B
.	O	PUNCT	O


Acute	O	ADJ	B
idiopathic	O	ADJ	I
thrombocytopenic	O	ADJ	I
purpura	O	NOUN	I
presenting	O	VERB	O
a	O	DET	O
high	O	ADJ	O
serum	O	NOUN	B
level	O	NOUN	O
of	O	ADP	O
immunoglobulin	B-GENE	NOUN	B
E	I-GENE	NOUN	I
and	O	CCONJ	O
eosinophilia	O	NOUN	B
in	O	ADP	O
an	O	DET	O
elderly	O	ADJ	B
patient	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
purpose	O	NOUN	O
of	O	ADP	O
this	O	DET	O
article	O	NOUN	B
is	O	AUX	O
to	O	PART	O
discuss	O	VERB	O
the	O	DET	O
factors	O	NOUN	B
involved	O	VERB	O
in	O	ADP	O
the	O	DET	O
selection	O	NOUN	B
of	O	ADP	O
antibodies	O	NOUN	B
,	O	PUNCT	O
radionuclides	O	NOUN	B
and	O	CCONJ	O
labeling	O	NOUN	B
methods	O	NOUN	I
in	O	ADP	O
the	O	DET	O
development	O	NOUN	B
of	O	ADP	O
radioimmunotherapy	O	NOUN	B
(	O	PUNCT	O
RIT	O	NOUN	B
)	O	PUNCT	O
for	O	ADP	O
non	O	ADJ	B
-	O	PUNCT	O
Hodgkin	O	NOUN	B
'	O	PART	O
s	O	NOUN	O
lymphoma	O	NOUN	B
(	O	PUNCT	O
NHL	O	NOUN	B
)	O	PUNCT	O
from	O	ADP	O
a	O	DET	O
single	O	ADJ	O
clinical	O	ADJ	B
study	O	NOUN	I
site	O	NOUN	O
through	O	ADP	O
multicenter	O	ADJ	B
trials	O	NOUN	I
and	O	CCONJ	O
commercialization	O	NOUN	B
.	O	PUNCT	O


Transcriptional	O	ADJ	B
regulation	O	NOUN	I
of	O	ADP	O
the	O	DET	O
GluR2	B-GENE	NOUN	B
gene	I-GENE	NOUN	I
:	O	PUNCT	O
neural	O	ADJ	B
-	O	PUNCT	O
specific	O	ADJ	B
expression	O	NOUN	B
,	O	PUNCT	O
multiple	O	ADJ	B
promoters	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
regulatory	O	ADJ	B
elements	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
binding	O	NOUN	B
of	O	ADP	O
NF	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
ATp	I-GENE	NOUN	B
,	O	PUNCT	O
although	O	SCONJ	O
not	O	PART	O
NF	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
AT4	I-GENE	PROPN	B
,	O	PUNCT	O
to	O	PART	O
this	O	DET	O
enhancer	O	NOUN	B
also	O	ADV	O
occurs	O	VERB	O
along	O	ADP	O
with	O	ADP	O
HTLV	O	NOUN	B
-	O	PUNCT	O
I	O	NUM	B
-	O	PUNCT	O
mediated	O	VERB	B
infection	O	NOUN	B
of	O	ADP	O
human	O	ADJ	B
peripheral	O	ADJ	B
blood	O	NOUN	I
T	O	NOUN	I
-	O	PUNCT	O
cells	O	NOUN	B
.	O	PUNCT	O


Thus	O	ADV	O
,	O	PUNCT	O
TRAF2	B-GENE	NOUN	B
initiates	O	VERB	B
SAPK	B-GENE	NOUN	B
and	O	CCONJ	O
p38	B-GENE	NOUN	B
activation	O	NOUN	B
by	O	ADP	O
binding	O	VERB	B
two	O	NUM	O
proximal	O	ADJ	B
protein	O	NOUN	I
kinases	O	NOUN	I
:	O	PUNCT	O
GCK	B-GENE	NOUN	B
and	O	CCONJ	O
RIP	B-GENE	NOUN	B
.	O	PUNCT	O


Tumor	B-GENE	NOUN	B
necrosis	I-GENE	NOUN	I
factor	I-GENE	NOUN	I
signaling	O	VERB	I
to	O	PART	O
stress	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
activated	I-GENE	VERB	B
protein	I-GENE	NOUN	O
kinase	I-GENE	NOUN	O
(	O	PUNCT	O
SAPK	B-GENE	NOUN	B
)	O	PUNCT	O
/	O	SYM	O
Jun	B-GENE	NOUN	B
NH2	I-GENE	NOUN	I
-	I-GENE	PUNCT	O
terminal	I-GENE	ADJ	B
kinase	I-GENE	NOUN	O
(	O	PUNCT	O
JNK	B-GENE	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
p38	B-GENE	NOUN	B
.	O	PUNCT	O


The	O	DET	O
activity	O	NOUN	B
of	O	ADP	O
the	O	DET	O
minimal	O	ADJ	B
promoter	O	NOUN	B
was	O	AUX	O
found	O	VERB	O
to	O	PART	O
be	O	AUX	O
controlled	O	VERB	B
by	O	ADP	O
a	O	DET	O
combination	O	NOUN	B
of	O	ADP	O
the	O	DET	O
activities	O	NOUN	B
of	O	ADP	O
the	O	DET	O
transcription	O	NOUN	B
factors	O	NOUN	I
Sp1	B-GENE	NOUN	B
,	O	PUNCT	O
Sp3	B-GENE	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
NF	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
Y	I-GENE	NOUN	B
.	O	PUNCT	O


Pressure	O	NOUN	B
ulcers	O	NOUN	I
.	O	PUNCT	O


TBP	B-GENE	NOUN	B
can	O	AUX	O
be	O	AUX	O
phosphorylated	O	VERB	B
in	O	X	B
vitro	O	X	I
by	O	ADP	O
extracts	O	NOUN	B
of	O	ADP	O
U937	O	NOUN	B
cells	O	NOUN	I
or	O	CCONJ	O
by	O	ADP	O
bacterially	O	ADV	B
expressed	O	VERB	I
activated	O	VERB	B
ERK2	B-GENE	NOUN	B
;	O	PUNCT	O
the	O	DET	O
phosphorylation	O	NOUN	B
sites	O	NOUN	O
were	O	AUX	O
mapped	O	VERB	B
to	O	PART	O
ERK	B-GENE	NOUN	B
kinase	I-GENE	NOUN	O
consensus	I-GENE	NOUN	B
sites	I-GENE	NOUN	I
in	O	ADP	O
the	O	DET	O
TBP	B-GENE	NOUN	B
amino	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
terminal	I-GENE	ADJ	B
domain	I-GENE	NOUN	B
.	O	PUNCT	O


During	O	ADP	O
the	O	DET	O
CR	O	ADJ	B
/	O	SYM	O
PP	O	NOUN	B
diet	O	NOUN	O
only	O	ADV	O
the	O	DET	O
HS	O	NOUN	B
subjects	O	NOUN	B
did	O	AUX	O
not	O	PART	O
show	O	VERB	O
the	O	DET	O
stress	O	NOUN	B
-	O	PUNCT	O
induced	O	VERB	B
rise	O	NOUN	O
in	O	ADP	O
depression	O	NOUN	B
,	O	PUNCT	O
decline	O	NOUN	B
in	O	ADP	O
vigour	O	NOUN	B
and	O	CCONJ	O
cortisol	O	NOUN	B
elevation	O	NOUN	O
that	O	PRON	O
they	O	PRON	O
showed	O	VERB	O
after	O	ADP	O
the	O	DET	O
PR	O	NOUN	B
/	O	SYM	O
CP	O	NOUN	B
diet	O	NOUN	B
.	O	PUNCT	O


Evidence	O	NOUN	B
for	O	ADP	O
a	O	DET	O
novel	O	ADJ	O
MAPKKK	B-GENE	NOUN	B
-	O	PUNCT	O
independent	O	ADJ	B
pathway	O	NOUN	B
controlling	O	VERB	B
the	O	DET	O
stress	O	NOUN	B
activated	O	VERB	O
Sty1	B-GENE	NOUN	B
/	O	PUNCT	O
Spc1	B-GENE	NOUN	B
MAP	O	NOUN	B
kinase	O	NOUN	I
in	O	ADP	O
fission	O	NOUN	B
yeast	O	NOUN	I
.	O	PUNCT	O


Furthermore	O	ADV	O
,	O	PUNCT	O
we	O	PRON	O
demonstrated	O	VERB	O
that	O	SCONJ	O
Galpha11	B-GENE	NOUN	B
Q209L	I-GENE	NOUN	I
stimulated	O	VERB	B
Src	B-GENE	NOUN	B
family	I-GENE	NOUN	O
kinase	O	NOUN	O
activity	O	NOUN	O
and	O	CCONJ	O
induced	O	VERB	B
tyrosine	O	NOUN	B
phosphorylation	O	NOUN	B
of	O	ADP	O
several	O	ADJ	O
proteins	O	NOUN	B
in	O	ADP	O
HEK	O	NOUN	B
-	O	PUNCT	O
293	O	NUM	O
cells	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
micturition	O	NOUN	B
pressure	O	NOUN	I
was	O	AUX	O
significantly	O	ADV	O
decreased	O	VERB	B
only	O	ADV	O
after	O	ADP	O
injection	O	NOUN	B
with	O	ADP	O
BUP	O	NOUN	B
-	O	PUNCT	O
4	O	NUM	O
in	O	ADP	O
both	O	CCONJ	O
normal	O	ADJ	B
and	O	CCONJ	O
obstructed	O	ADJ	B
rats	O	NOUN	B
.	O	PUNCT	O


Peroxisome	B-GENE	NOUN	B
proliferator	I-GENE	NOUN	I
-	I-GENE	PUNCT	O
activated	I-GENE	VERB	B
receptors	I-GENE	NOUN	I
(	O	PUNCT	O
PPAR	B-GENE	NOUN	B
)	O	PUNCT	O
modulate	O	VERB	B
transcription	O	NOUN	B
by	O	ADP	O
binding	O	VERB	B
to	O	PART	O
specific	O	ADJ	O
peroxisome	O	NOUN	B
proliferator	O	NOUN	I
-	O	PUNCT	O
response	O	NOUN	B
elements	O	NOUN	I
(	O	PUNCT	O
PPRE	O	NOUN	B
)	O	PUNCT	O
through	O	ADP	O
heterodimerization	O	NOUN	B
with	O	ADP	O
the	O	DET	O
9	B-GENE	NUM	B
-	I-GENE	PUNCT	O
cis	I-GENE	NOUN	B
retinoic	I-GENE	ADJ	I
acid	I-GENE	NOUN	I
receptor	I-GENE	NOUN	I
(	O	PUNCT	O
RXR	B-GENE	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Molecular	O	ADJ	B
cloning	O	NOUN	I
and	O	CCONJ	O
functional	O	ADJ	B
characterization	O	NOUN	B
of	O	ADP	O
murine	B-GENE	ADJ	B
sphingosine	I-GENE	NOUN	B
kinase	I-GENE	NOUN	I
.	O	PUNCT	O


Our	O	PRON	O
results	O	NOUN	B
show	O	VERB	O
that	O	SCONJ	O
,	O	PUNCT	O
from	O	ADP	O
a	O	DET	O
thermodynamical	O	ADJ	B
standpoint	O	NOUN	O
,	O	PUNCT	O
melatonin	O	NOUN	B
may	O	AUX	O
directly	O	ADV	O
scavenge	O	VERB	B
hydroxyl	O	NOUN	B
radicals	O	NOUN	I
both	O	CCONJ	O
in	O	ADP	O
vacuum	O	NOUN	B
and	O	CCONJ	O
in	O	ADP	O
aqueous	O	ADJ	B
solution	O	NOUN	O
.	O	PUNCT	O


This	O	DET	O
sequence	O	NOUN	B
,	O	PUNCT	O
Thr	O	NOUN	B
-	O	PUNCT	O
Gly	O	PROPN	B
-	O	PUNCT	O
X	O	PROPN	B
-	O	PUNCT	O
X	O	PROPN	B
-	O	PUNCT	O
Gly	O	PROPN	B
-	O	PUNCT	O
Asp	O	PROPN	B
-	O	PUNCT	O
Gly	O	PROPN	B
-	O	PUNCT	O
Lys	O	PROPN	B
-	O	PUNCT	O
Ile	O	PROPN	B
-	O	PUNCT	O
Phe	O	PROPN	B
,	O	PUNCT	O
forms	O	NOUN	O
part	O	NOUN	O
of	O	ADP	O
the	O	DET	O
B	O	NOUN	B
-	O	PUNCT	O
loop	O	NOUN	B
and	O	CCONJ	O
is	O	AUX	O
conserved	O	VERB	O
in	O	ADP	O
a	O	DET	O
wide	O	ADJ	O
variety	O	NOUN	O
of	O	ADP	O
organisms	O	NOUN	B
that	O	PRON	O
include	O	VERB	O
bacteria	O	NOUN	B
,	O	PUNCT	O
algae	O	NOUN	B
and	O	CCONJ	O
archeabacteria	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
only	O	ADV	O
abundant	O	ADJ	B
viral	O	ADJ	B
transcript	O	NOUN	I
expressed	O	VERB	B
during	O	ADP	O
latency	O	NOUN	B
is	O	AUX	O
the	O	DET	O
latency	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
related	I-GENE	ADJ	B
(	O	PUNCT	O
LR	B-GENE	NOUN	B
)	O	PUNCT	O
RNA	O	NOUN	O
.	O	PUNCT	O


Expression	O	NOUN	B
of	O	ADP	O
constitutively	O	ADV	B
active	O	ADJ	O
MEK1	B-GENE	NOUN	B
,	O	PUNCT	O
the	O	DET	O
kinase	O	NOUN	B
that	O	PRON	O
activates	O	VERB	B
ERKs	B-GENE	NOUN	B
,	O	PUNCT	O
or	O	CCONJ	O
overexpression	O	NOUN	B
of	O	ADP	O
ERK2	B-GENE	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
not	O	PART	O
JNK1	B-GENE	NOUN	B
,	O	PUNCT	O
inhibited	O	VERB	B
Stat3	B-GENE	NOUN	B
activation	O	NOUN	B
.	O	PUNCT	O


MEKs	B-GENE	NOUN	B
and	O	CCONJ	O
ERKs	B-GENE	NOUN	B
inhibited	O	VERB	B
IL	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
6	I-GENE	NUM	O
activation	O	NOUN	B
of	O	ADP	O
Stat3	B-GENE	NOUN	B
harboring	O	VERB	O
a	O	DET	O
mutation	O	NOUN	B
at	O	ADP	O
serine	O	NOUN	B
-	O	PUNCT	O
727	O	NUM	O
,	O	PUNCT	O
the	O	DET	O
major	O	ADJ	O
site	O	NOUN	B
for	O	ADP	O
serine	O	NOUN	B
phosphorylation	O	NOUN	B
,	O	PUNCT	O
similar	O	ADJ	O
to	O	PART	O
inhibition	O	NOUN	B
of	O	ADP	O
wild	B-GENE	ADJ	B
-	I-GENE	PUNCT	O
type	I-GENE	NOUN	B
Stat3	I-GENE	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
inhibited	O	VERB	B
Janus	B-GENE	NOUN	B
kinases	I-GENE	NOUN	I
Jak1	B-GENE	NOUN	I
and	O	CCONJ	O
Jak2	B-GENE	NOUN	B
upstream	O	ADJ	B
of	O	ADP	O
Stat3	B-GENE	NOUN	B
in	O	ADP	O
the	O	DET	O
Jak	B-GENE	NOUN	B
-	O	PUNCT	O
STAT	B-GENE	NOUN	B
-	O	PUNCT	O
signaling	O	NOUN	B
pathway	O	NOUN	I
.	O	PUNCT	O


Genome	O	NOUN	B
plasticity	O	NOUN	B
in	O	ADP	O
the	O	DET	O
distal	O	ADJ	B
tail	O	NOUN	I
fiber	O	NOUN	I
locus	O	NOUN	I
of	O	ADP	O
the	O	DET	O
T	O	NOUN	B
-	O	PUNCT	O
even	O	ADV	O
bacteriophage	O	NOUN	B
:	O	PUNCT	O
recombination	O	NOUN	B
between	O	ADP	O
conserved	O	VERB	O
motifs	O	NOUN	B
swaps	O	NOUN	I
adhesin	B-GENE	NOUN	B
specificity	O	NOUN	B
.	O	PUNCT	O


Whereas	O	SCONJ	O
,	O	PUNCT	O
in	O	ADP	O
the	O	DET	O
single	O	ADJ	B
-	O	PUNCT	O
chambered	O	VERB	B
body	O	NOUN	I
box	O	NOUN	I
,	O	PUNCT	O
PenH	O	NOUN	B
units	O	NOUN	O
(	O	PUNCT	O
Enhanced	O	VERB	B
Pause	O	NOUN	B
)	O	PUNCT	O
reflect	O	VERB	O
"	O	PUNCT	O
effort	O	NOUN	O
of	O	ADP	O
breathing	O	NOUN	B
.	O	PUNCT	O
"	O	PUNCT	O
This	O	DET	O
is	O	AUX	O
measured	O	VERB	B
as	O	ADP	O
the	O	DET	O
pause	O	NOUN	B
between	O	ADP	O
inspiration	O	NOUN	B
and	O	CCONJ	O
expiration	O	NOUN	B
.	O	PUNCT	O


This	O	DET	O
suggests	O	VERB	O
that	O	SCONJ	O
while	O	SCONJ	O
underpredictions	O	NOUN	B
of	O	ADP	O
pain	O	NOUN	B
do	O	AUX	O
not	O	PART	O
hurt	O	VERB	O
more	O	ADV	O
,	O	PUNCT	O
disruption	O	NOUN	B
on	O	ADP	O
primary	O	ADJ	B
tasks	O	NOUN	I
and	O	CCONJ	O
physiological	O	ADJ	B
impact	O	NOUN	B
are	O	AUX	O
higher	O	ADJ	B
.	O	PUNCT	O


Badcock	O	PROPN	B
and	O	CCONJ	O
Westheimer	O	PROPN	B
(	O	PUNCT	O
Spatial	O	PROPN	B
Vision	O	PROPN	I
1	O	NUM	I
(	O	PUNCT	O
1	O	NUM	O
)	O	PUNCT	O
,	O	PUNCT	O
3	O	NUM	O
-	O	SYM	O
11	O	NUM	O
,	O	PUNCT	O
1985	O	NUM	O
)	O	PUNCT	O
showed	O	VERB	O
that	O	SCONJ	O
a	O	DET	O
thin	O	ADJ	B
vertical	O	ADJ	O
line	O	NOUN	O
induces	O	VERB	B
nearby	O	ADJ	O
zones	O	NOUN	B
of	O	ADP	O
attraction	O	NOUN	B
and	O	CCONJ	O
repulsion	O	NOUN	B
;	O	PUNCT	O
this	O	DET	O
study	O	NOUN	B
extends	O	VERB	O
those	O	DET	O
results	O	NOUN	B
by	O	ADP	O
more	O	ADV	O
closely	O	ADV	O
examining	O	VERB	B
the	O	DET	O
horizontal	O	ADJ	B
and	O	CCONJ	O
vertical	O	ADJ	B
extents	O	NOUN	B
of	O	ADP	O
the	O	DET	O
repulsion	O	NOUN	B
zone	O	NOUN	I
and	O	CCONJ	O
by	O	ADP	O
using	O	VERB	O
an	O	DET	O
illusory	O	ADJ	B
contour	O	NOUN	O
to	O	PART	O
induce	O	VERB	B
repulsion	O	NOUN	B
.	O	PUNCT	O


desmethyltrimebutine	O	NOUN	B
was	O	AUX	O
inactive	O	ADJ	B
.	O	PUNCT	O


A	O	DET	O
5	O	NUM	O
.	O	PUNCT	O
0	O	NUM	O
-	O	PUNCT	O
kb	O	NOUN	O
transcript	O	NOUN	B
detected	O	VERB	B
by	O	ADP	O
the	O	DET	O
differential	O	ADJ	B
display	O	NOUN	I
amplicon	O	NOUN	I
3G1	O	NOUN	I
was	O	AUX	O
found	O	VERB	O
to	O	PART	O
correlate	O	VERB	B
strongly	O	ADV	O
with	O	ADP	O
RAG1	B-GENE	NOUN	B
mRNA	I-GENE	NOUN	B
expression	O	NOUN	B
in	O	ADP	O
various	O	ADJ	O
human	O	ADJ	B
cell	O	NOUN	B
lines	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
hBRAG	B-GENE	NOUN	B
gene	I-GENE	NOUN	I
was	O	AUX	O
localized	O	ADJ	B
to	O	PART	O
the	O	DET	O
long	O	ADJ	B
arm	O	NOUN	I
of	O	ADP	I
chromosome	O	NOUN	I
10	O	NUM	I
(	O	PUNCT	O
10q26	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Genomic	O	ADJ	B
locus	O	NOUN	I
of	O	ADP	O
chCTCF	B-GENE	NOUN	B
contains	O	VERB	O
a	O	DET	O
GC	O	NOUN	B
-	O	PUNCT	O
rich	O	ADJ	B
untranslated	O	ADJ	O
exon	O	NOUN	O
separated	O	VERB	O
from	O	ADP	O
seven	O	NUM	O
coding	O	VERB	B
exons	O	NOUN	I
by	O	ADP	O
a	O	DET	O
long	O	ADJ	B
intron	O	NOUN	I
.	O	PUNCT	O


Small	B-GENE	ADJ	B
GTPases	I-GENE	NOUN	B
of	O	ADP	O
the	O	DET	O
Ypt	B-GENE	PROPN	B
/	O	SYM	O
Rab	B-GENE	NOUN	B
family	O	NOUN	O
are	O	AUX	O
involved	O	VERB	O
in	O	ADP	O
the	O	DET	O
regulation	O	NOUN	B
of	O	ADP	O
vesicular	O	ADJ	B
transport	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
GEF	B-GENE	NOUN	B
and	O	CCONJ	O
GAP	B-GENE	NOUN	B
activities	O	NOUN	B
for	O	ADP	O
Ypt1p	B-GENE	NOUN	B
localize	O	NOUN	O
to	O	PART	O
particulate	O	ADJ	B
cellular	O	ADJ	B
fractions	O	NOUN	I
.	O	PUNCT	O


Dopamine	B-GENE	NOUN	B
beta	I-GENE	NOUN	I
-	I-GENE	PUNCT	O
hydroxylase	I-GENE	NOUN	B
(	O	PUNCT	O
DBH	B-GENE	NOUN	B
)	O	PUNCT	O
catalyzes	O	VERB	B
the	O	DET	O
conversion	O	NOUN	B
of	O	ADP	O
dopamine	O	NOUN	B
to	O	PART	O
noradrenaline	O	NOUN	B
and	O	CCONJ	O
is	O	AUX	O
selectively	O	ADV	O
expressed	O	VERB	B
in	O	ADP	O
noradrenergic	O	ADJ	B
and	O	CCONJ	O
adrenergic	O	ADJ	B
neurons	O	NOUN	I
and	O	CCONJ	O
neuroendocrine	O	ADJ	B
cells	O	NOUN	I
.	O	PUNCT	O


Collectively	O	ADV	O
,	O	PUNCT	O
this	O	DET	O
study	O	NOUN	B
emphasizes	O	VERB	O
a	O	DET	O
critical	O	ADJ	O
role	O	NOUN	O
of	O	ADP	O
Phox2a	B-GENE	NOUN	B
as	O	ADV	O
well	O	ADV	O
as	O	ADP	O
its	O	PRON	O
functional	O	ADJ	B
synergism	O	NOUN	B
with	O	ADP	O
other	O	ADJ	O
transcription	O	NOUN	B
factors	O	NOUN	I
(	O	PUNCT	O
e	O	X	O
.	O	PUNCT	O
g	O	NOUN	O
.	O	PUNCT	O
,	O	PUNCT	O
CREB	B-GENE	NOUN	B
,	O	PUNCT	O
AP2	B-GENE	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
Sp1	B-GENE	NOUN	B
)	O	PUNCT	O
in	O	ADP	O
transcriptional	O	ADJ	B
activation	O	NOUN	I
of	O	ADP	O
the	O	DET	O
DBH	B-GENE	NOUN	B
gene	I-GENE	NOUN	I
.	O	PUNCT	O


Sequence	O	NOUN	B
comparisons	O	NOUN	B
strongly	O	ADV	O
suggest	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
S27a	B-GENE	NOUN	B
and	O	CCONJ	O
the	O	DET	O
ubiquitin	B-GENE	NOUN	B
coding	O	NOUN	I
sequences	O	NOUN	I
found	O	VERB	O
in	O	ADP	O
the	O	DET	O
genome	O	NOUN	B
of	O	ADP	O
CP	O	NOUN	B
Rit	O	PROPN	B
were	O	AUX	O
both	O	DET	O
derived	O	VERB	O
from	O	ADP	O
a	O	DET	O
bovine	O	ADJ	B
mRNA	O	NOUN	B
encoding	O	VERB	B
a	O	DET	O
hybrid	O	NOUN	B
protein	O	NOUN	I
with	O	ADP	O
the	O	DET	O
structure	O	NOUN	B
NH2	O	NOUN	B
-	O	PUNCT	O
ubiquitin	B-GENE	NOUN	B
-	O	PUNCT	O
S27a	B-GENE	PROPN	B
-	O	PUNCT	O
COOH	O	NOUN	B
.	O	PUNCT	O


J	O	NOUN	O
.	O	PUNCT	O


There	O	PRON	O
was	O	AUX	O
a	O	DET	O
trend	O	NOUN	O
in	O	ADP	O
all	O	DET	O
studies	O	NOUN	B
favouring	O	VERB	O
PVI	O	PROPN	B
.	O	PUNCT	O


This	O	DET	O
domain	O	NOUN	B
,	O	PUNCT	O
although	O	SCONJ	O
adjacent	O	ADJ	B
to	O	PART	O
the	O	DET	O
5	O	NUM	O
'	O	PART	O
edge	O	NOUN	O
of	O	ADP	O
the	O	DET	O
SD	O	NOUN	B
sequence	O	NOUN	B
,	O	PUNCT	O
does	O	AUX	O
not	O	PART	O
inhibit	O	VERB	B
ribosome	O	NOUN	B
binding	O	NOUN	I
as	O	ADV	O
long	O	ADV	O
as	O	ADP	O
the	O	DET	O
single	O	ADJ	B
-	O	PUNCT	O
stranded	O	VERB	B
region	O	NOUN	I
of	O	ADP	O
domain	O	NOUN	O
3	O	NUM	O
is	O	AUX	O
present	O	ADJ	O
.	O	PUNCT	O


Previous	O	ADJ	O
genetic	O	ADJ	B
studies	O	NOUN	I
led	O	VERB	O
to	O	PART	O
the	O	DET	O
conclusion	O	NOUN	O
that	O	SCONJ	O
nitrate	O	NOUN	B
and	O	CCONJ	O
nitrite	O	NOUN	B
induction	O	NOUN	B
of	O	ADP	O
nasF	B-GENE	NOUN	B
operon	I-GENE	NOUN	B
expression	O	NOUN	B
is	O	AUX	O
determined	O	VERB	O
by	O	ADP	O
a	O	DET	O
transcriptional	O	ADJ	B
antitermination	O	NOUN	B
mechanism	O	NOUN	B
.	O	PUNCT	O


EGFR	B-GENE	NOUN	B
levels	O	NOUN	B
were	O	AUX	O
found	O	VERB	O
to	O	PART	O
be	O	AUX	O
elevated	O	ADJ	B
5	O	NUM	O
-	O	PUNCT	O
,	O	PUNCT	O
3	O	NUM	O
.	O	PUNCT	O


Furthermore	O	ADV	O
,	O	PUNCT	O
LB1	B-GENE	NOUN	B
gene	I-GENE	NOUN	I
mapped	O	VERB	O
to	O	PART	O
chromosome	O	NOUN	B
13q14	O	NOUN	I
,	O	PUNCT	O
a	O	DET	O
region	O	NOUN	B
that	O	PRON	O
has	O	AUX	O
been	O	AUX	O
involved	O	VERB	O
as	O	ADP	O
a	O	DET	O
chromosomal	O	ADJ	B
breakpoint	O	NOUN	I
in	O	ADP	O
DLBL	O	NOUN	B
.	O	PUNCT	O


Wild	B-GENE	ADJ	B
-	I-GENE	PUNCT	O
type	I-GENE	NOUN	B
AT1A	I-GENE	NOUN	I
receptors	I-GENE	NOUN	I
,	O	PUNCT	O
expressed	O	VERB	B
in	O	ADP	O
Chinese	O	ADJ	B
hamster	O	NOUN	I
ovary	O	NOUN	I
cells	O	NOUN	I
,	O	PUNCT	O
rapidly	O	ADV	O
internalized	O	VERB	B
after	O	ADP	O
Ang	B-GENE	NOUN	B
II	I-GENE	NUM	I
stimulation	O	NOUN	O
[	O	PUNCT	O
t1	O	NOUN	B
/	O	SYM	O
2	O	NUM	O
2	O	NUM	O
.	O	PUNCT	O
3	O	NUM	O
min	O	NOUN	O
;	O	PUNCT	O
maximal	O	ADJ	B
level	O	NOUN	B
of	O	ADP	O
internalization	O	NOUN	B
(	O	PUNCT	O
Ymax	O	NOUN	B
)	O	PUNCT	O
78	O	NUM	O
.	O	PUNCT	O
2	O	NUM	O
%	O	NOUN	O
]	O	PUNCT	O
,	O	PUNCT	O
as	O	ADP	O
did	O	AUX	O
mutant	O	ADJ	B
receptors	O	NOUN	I
carrying	O	VERB	O
single	O	ADJ	O
acidic	O	ADJ	O
substitutions	O	NOUN	O
(	O	PUNCT	O
T332E	O	NOUN	O
,	O	PUNCT	O
t1	O	NOUN	B
/	O	SYM	O
2	O	NUM	O
2	O	NUM	O
.	O	PUNCT	O
7	O	NUM	O
min	O	NOUN	O
,	O	PUNCT	O
Ymax	O	PROPN	O
76	O	NUM	O
.	O	PUNCT	O
3	O	NUM	O
%	O	NOUN	O
;	O	PUNCT	O
S335D	O	NOUN	O
,	O	PUNCT	O
t1	O	NOUN	B
/	O	SYM	O
2	O	NUM	O
2	O	NUM	O
.	O	PUNCT	O
4	O	NUM	O
min	O	NOUN	O
,	O	PUNCT	O
Ymax	O	PROPN	O
76	O	NUM	O
.	O	PUNCT	O
7	O	NUM	O
%	O	NOUN	O
;	O	PUNCT	O
T336E	O	NOUN	O
,	O	PUNCT	O
t1	O	NOUN	B
/	O	SYM	O
2	O	NUM	O
2	O	NUM	O
.	O	PUNCT	O
5	O	NUM	O
min	O	NOUN	O
,	O	PUNCT	O
Ymax	O	PROPN	O
78	O	NUM	O
.	O	PUNCT	O
2	O	NUM	O
%	O	NOUN	O
;	O	PUNCT	O
S338D	O	NOUN	B
,	O	PUNCT	O
t1	O	NOUN	B
/	O	SYM	O
2	O	NUM	O
2	O	NUM	O
.	O	PUNCT	O
6	O	NUM	O
min	O	NOUN	O
,	O	PUNCT	O
Ymax	O	PROPN	O
78	O	NUM	O
.	O	PUNCT	O
4	O	NUM	O
%	O	NOUN	O
)	O	PUNCT	O
.	O	PUNCT	O


The	O	DET	O
activated	O	VERB	B
glucocorticoid	B-GENE	NOUN	B
receptor	I-GENE	NOUN	I
forms	O	VERB	O
a	O	DET	O
complex	O	NOUN	B
with	O	ADP	O
Stat5	B-GENE	NOUN	B
and	O	CCONJ	O
enhances	O	VERB	O
Stat5	B-GENE	NOUN	B
-	O	PUNCT	O
mediated	O	VERB	B
transcriptional	O	ADJ	B
induction	O	NOUN	O
.	O	PUNCT	O


T	O	NOUN	B
.	O	PUNCT	O
,	O	PUNCT	O
Mahasneh	O	PROPN	B
,	O	PUNCT	O
A	O	PROPN	O
.	O	PUNCT	O
,	O	PUNCT	O
and	O	CCONJ	O
Cote	O	PROPN	B
,	O	PUNCT	O
G	O	NOUN	B
.	O	PUNCT	O


RESULTS	O	NOUN	B
:	O	PUNCT	O
The	O	DET	O
binding	O	NOUN	B
of	O	ADP	O
99mTc	O	ADJ	O
d	O	NOUN	O
,	O	PUNCT	O
1	O	NUM	O
-	O	PUNCT	O
HMPAO	O	NOUN	B
to	O	PART	O
human	O	ADJ	B
placenta	O	NOUN	B
ranged	O	VERB	O
from	O	ADP	O
2	O	NUM	O
.	O	PUNCT	O
95	O	NUM	O
%	O	NOUN	O
+	O	CCONJ	O
/	O	SYM	O
-	O	PUNCT	O
1	O	NUM	O
.	O	PUNCT	O
5	O	NUM	O
%	O	NOUN	O
to	O	PART	O
5	O	NUM	O
.	O	PUNCT	O
82	O	NUM	O
%	O	NOUN	O
+	O	CCONJ	O
/	O	SYM	O
-	O	PUNCT	O
0	O	NUM	O
.	O	PUNCT	O
3	O	NUM	O
%	O	NOUN	O
per	O	ADP	O
1	O	NUM	O
ml	O	NOUN	O
standard	O	ADJ	B
solution	O	NOUN	I
.	O	PUNCT	O


CM	O	NOUN	B
reduced	O	VERB	B
the	O	DET	O
nuclear	O	ADJ	B
binding	O	NOUN	I
activity	O	NOUN	I
of	O	ADP	O
transcription	B-GENE	NOUN	B
factor	I-GENE	NOUN	I
AP	I-GENE	PROPN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	O
.	O	PUNCT	O


NF	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
kappaB	I-GENE	NOUN	B
,	O	PUNCT	O
which	O	DET	O
is	O	AUX	O
probably	O	ADV	O
important	O	ADJ	O
for	O	ADP	O
basal	O	ADJ	B
activity	O	NOUN	I
of	O	ADP	O
the	O	DET	O
human	B-GENE	ADJ	B
NOS	I-GENE	NOUN	O
II	I-GENE	NUM	O
promoter	I-GENE	NOUN	B
,	O	PUNCT	O
is	O	AUX	O
unlikely	O	ADJ	O
to	O	PART	O
function	O	VERB	B
as	O	ADP	O
a	O	DET	O
major	O	ADJ	O
effector	O	NOUN	B
of	O	ADP	O
CM	O	NOUN	B
in	O	ADP	O
DLD	O	PROPN	B
-	O	PUNCT	O
1	O	NUM	O
cells	O	NOUN	B
.	O	PUNCT	O


RESULTS	O	NOUN	B
:	O	PUNCT	O
The	O	DET	O
cardiac	O	ADJ	B
index	O	NOUN	I
significantly	O	ADV	O
changed	O	VERB	O
with	O	ADP	O
varying	O	VERB	O
PaCO2	O	NOUN	B
levels	O	NOUN	O
(	O	PUNCT	O
hypocapnia	O	NOUN	B
,	O	PUNCT	O
-	O	PUNCT	O
9	O	NUM	O
%	O	NOUN	O
;	O	PUNCT	O
hypercapnia	O	NOUN	B
,	O	PUNCT	O
13	O	NUM	O
%	O	NOUN	O
)	O	PUNCT	O
.	O	PUNCT	O


Sequencing	O	NOUN	B
of	O	ADP	O
a	O	DET	O
40	O	NUM	O
-	O	PUNCT	O
kb	O	NOUN	B
DNA	O	NOUN	I
segment	O	NOUN	I
of	O	ADP	O
the	O	DET	O
FK506	O	NOUN	B
gene	O	NOUN	I
cluster	O	NOUN	I
from	O	ADP	O
Streptomyces	O	X	B
sp	O	X	I
.	O	PUNCT	O


The	O	DET	O
predicted	O	VERB	B
domain	O	NOUN	B
structures	O	NOUN	I
of	O	ADP	O
FkbB	B-GENE	NOUN	B
and	O	CCONJ	O
FkbC	B-GENE	NOUN	B
are	O	AUX	O
analogous	O	ADJ	O
to	O	PART	O
that	O	DET	O
of	O	ADP	O
FkbA	B-GENE	NOUN	B
and	O	CCONJ	O
comprise	O	VERB	O
30	O	NUM	O
fatty	B-GENE	ADJ	B
-	I-GENE	PUNCT	O
acid	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
synthase	I-GENE	NOUN	B
(	O	PUNCT	O
FAS	B-GENE	NOUN	B
)	O	PUNCT	O
-	O	PUNCT	O
like	O	ADJ	O
domains	O	NOUN	B
arranged	O	VERB	O
in	O	ADP	O
6	O	NUM	O
modules	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
cwg2	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	O
mutation	I-GENE	NOUN	B
was	O	AUX	O
identified	O	VERB	O
as	O	ADP	O
a	O	DET	O
guanine	O	NOUN	B
to	O	PART	O
adenine	O	NOUN	B
substitution	O	NOUN	B
at	O	ADP	O
nucleotide	O	NOUN	B
604	O	NUM	O
of	O	ADP	O
the	O	DET	O
coding	O	VERB	B
region	O	NOUN	I
,	O	PUNCT	O
originating	O	VERB	O
the	O	DET	O
change	O	NOUN	O
A202T	O	NOUN	O
in	O	ADP	O
the	O	DET	O
cwg2p	B-GENE	NOUN	B
.	O	PUNCT	O


Handling	O	VERB	B
on	O	ADP	O
PND	O	PROPN	B
9	O	NUM	O
did	O	AUX	O
not	O	PART	O
result	O	VERB	O
in	O	ADP	O
elevated	O	ADJ	B
CORT	O	NOUN	B
levels	O	NOUN	B
in	O	ADP	O
any	O	DET	O
of	O	ADP	O
the	O	DET	O
groups	O	NOUN	B
.	O	PUNCT	O


633	O	NUM	O
+	O	CCONJ	O
/	O	SYM	O
-	O	PUNCT	O
258	O	NUM	O
aggregates	O	NOUN	B
/	O	PUNCT	O
ml	O	NOUN	O
at	O	ADP	O
0	O	NUM	O
rpm	O	NOUN	O
;	O	PUNCT	O
P	O	NOUN	O
<	O	X	O
0	O	NUM	O
.	O	PUNCT	O
001	O	NUM	O
)	O	PUNCT	O
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
indicate	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
total	O	ADJ	O
number	O	NOUN	O
of	O	ADP	O
subunit	O	NOUN	B
c	O	NOUN	I
in	O	ADP	O
F0	B-GENE	NOUN	B
should	O	AUX	O
be	O	AUX	O
a	O	DET	O
multiple	O	ADJ	B
of	O	ADP	O
2	O	NUM	O
and	O	CCONJ	O
3	O	NUM	O
.	O	PUNCT	O


BACKGROUND	O	NOUN	B
:	O	PUNCT	O
The	O	DET	O
c	B-GENE	X	B
-	I-GENE	PUNCT	O
myc	I-GENE	NOUN	B
proto	I-GENE	NOUN	I
-	I-GENE	PUNCT	O
oncogene	I-GENE	NOUN	B
has	O	AUX	O
been	O	AUX	O
suggested	O	VERB	O
to	O	PART	O
play	O	VERB	O
key	O	ADJ	O
roles	O	NOUN	O
in	O	ADP	O
cell	O	NOUN	B
proliferation	O	NOUN	I
,	O	PUNCT	O
differentiation	O	NOUN	B
,	O	PUNCT	O
transformation	O	NOUN	B
and	O	CCONJ	O
apoptosis	O	NOUN	B
.	O	PUNCT	O


AMY	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	O
was	O	AUX	O
localized	O	ADJ	B
in	O	ADP	O
the	O	DET	O
cytoplasm	O	NOUN	B
in	O	ADP	O
cells	O	NOUN	B
expressing	O	VERB	O
c	B-GENE	NOUN	O
-	I-GENE	PUNCT	O
myc	I-GENE	NOUN	B
at	O	ADP	O
low	O	ADJ	B
levels	O	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
in	O	ADP	O
the	O	DET	O
nucleus	O	NOUN	B
in	O	ADP	O
the	O	DET	O
cells	O	NOUN	B
of	O	ADP	O
a	O	DET	O
high	O	ADJ	O
c	B-GENE	NOUN	O
-	I-GENE	PUNCT	O
myc	I-GENE	NOUN	B
expression	O	NOUN	B
in	O	ADP	O
transiently	O	ADV	O
transfected	O	VERB	B
cells	O	NOUN	O
.	O	PUNCT	O


Antidepressant	O	ADJ	B
-	O	PUNCT	O
like	O	ADJ	B
properties	O	NOUN	B
of	O	ADP	O
some	O	DET	O
serotonin	B-GENE	NOUN	B
receptor	I-GENE	NOUN	I
ligands	O	NOUN	I
and	O	CCONJ	O
calcium	O	NOUN	B
channel	O	NOUN	I
antagonists	O	NOUN	I
measured	O	VERB	B
with	O	ADP	O
the	O	DET	O
forced	O	ADJ	B
swimming	O	NOUN	I
test	O	NOUN	I
in	O	ADP	O
mice	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
various	O	ADJ	O
available	O	ADJ	O
data	O	NOUN	B
strongly	O	ADV	O
suggesting	O	VERB	O
an	O	DET	O
environmental	O	ADJ	B
toxic	O	ADJ	I
origin	O	NOUN	I
for	O	ADP	O
the	O	DET	O
"	O	PUNCT	O
sperm	O	NOUN	B
fall	O	NOUN	B
"	O	PUNCT	O
will	O	AUX	O
be	O	AUX	O
presented	O	VERB	O
as	O	ADV	O
well	O	ADV	O
as	O	ADP	O
the	O	DET	O
most	O	ADV	O
frequently	O	ADV	O
suspected	O	VERB	B
class	O	NOUN	O
of	O	ADP	O
substances	O	NOUN	B
,	O	PUNCT	O
the	O	DET	O
xenoestrogens	O	NOUN	B
.	O	PUNCT	O


Examination	O	NOUN	B
of	O	ADP	O
DNA	O	NOUN	B
:	O	PUNCT	O
protein	O	NOUN	B
binding	O	NOUN	I
complexes	O	NOUN	I
by	O	ADP	O
gel	O	NOUN	B
-	O	PUNCT	O
shift	O	NOUN	B
analysis	O	NOUN	B
indicated	O	VERB	O
that	O	SCONJ	O
nuclear	O	ADJ	B
factors	O	NOUN	I
from	O	ADP	O
both	O	CCONJ	O
proliferative	O	ADJ	B
and	O	CCONJ	O
growth	O	NOUN	B
-	O	PUNCT	O
arrested	O	VERB	B
cells	O	NOUN	B
bound	O	VERB	O
to	O	PART	O
the	O	DET	O
DNA	O	NOUN	B
fragment	O	NOUN	I
spanning	O	VERB	B
-	O	PUNCT	O
949	O	NUM	O
-	O	PUNCT	O
-	O	PUNCT	O
722	O	NUM	O
bp	O	NOUN	O
.	O	PUNCT	O


RESULTS	O	NOUN	B
:	O	PUNCT	O
An	O	DET	O
herpetic	O	ADJ	B
seroconversion	O	NOUN	B
is	O	AUX	O
observed	O	VERB	O
with	O	ADP	O
presence	O	NOUN	B
of	O	ADP	O
type	O	NOUN	B
I	O	NUM	I
herpes	O	NOUN	I
simplex	O	NOUN	I
virus	O	NOUN	I
(	O	PUNCT	O
HSV	O	NOUN	B
I	O	NUM	I
)	O	PUNCT	O
nucleic	O	ADJ	B
acids	O	NOUN	I
in	O	ADP	O
the	O	DET	O
recipient	O	NOUN	B
'	O	PART	O
s	O	NOUN	O
aqueous	O	ADJ	B
humor	O	NOUN	B
.	O	PUNCT	O


GH	B-GENE	NOUN	B
failed	O	VERB	O
to	O	PART	O
stimulate	O	VERB	B
phosphorylation	O	NOUN	B
or	O	CCONJ	O
activation	O	NOUN	B
of	O	ADP	O
Jun	B-GENE	NOUN	B
N	I-GENE	NOUN	I
-	I-GENE	PUNCT	O
terminal	I-GENE	ADJ	B
kinase	I-GENE	NOUN	B
under	O	ADP	O
the	O	DET	O
conditions	O	NOUN	B
used	O	VERB	O
.	O	PUNCT	O


CD4	B-GENE	NOUN	B
lymphocyte	O	NOUN	I
and	O	CCONJ	O
viral	O	ADJ	B
load	O	NOUN	I
levels	O	NOUN	B
suggested	O	VERB	O
an	O	DET	O
optimal	O	ADJ	B
response	O	NOUN	B
to	O	PART	O
ARV	O	NOUN	B
therapy	O	NOUN	B
at	O	ADP	O
the	O	DET	O
time	O	NOUN	B
LD	O	NOUN	I
developed	O	VERB	O
.	O	PUNCT	O


By	O	ADP	O
DNase	B-GENE	NOUN	B
I	I-GENE	NUM	I
footprint	O	NOUN	I
analysis	O	NOUN	I
of	O	ADP	O
the	O	DET	O
PNR	O	NOUN	B
element	O	NOUN	B
,	O	PUNCT	O
a	O	DET	O
palindrome	O	NOUN	B
of	O	ADP	O
two	O	NUM	O
high	O	ADJ	B
-	O	PUNCT	O
affinity	O	NOUN	B
Ets	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
binding	I-GENE	VERB	B
sites	I-GENE	NOUN	I
(	O	PUNCT	O
CTTCCCTGGAAG	O	NOUN	B
)	O	PUNCT	O
was	O	AUX	O
identified	O	VERB	B
.	O	PUNCT	O


No	O	DET	O
mutations	O	NOUN	B
were	O	AUX	O
found	O	VERB	O
in	O	ADP	O
follicular	O	ADJ	B
adenomas	O	NOUN	I
.	O	PUNCT	O


Expression	O	NOUN	B
of	O	ADP	O
lacZ	B-GENE	NOUN	B
from	O	ADP	O
the	O	DET	O
promoter	O	NOUN	B
of	O	ADP	O
the	O	DET	O
Escherichia	B-GENE	X	B
coli	I-GENE	X	I
spc	I-GENE	NOUN	I
operon	I-GENE	NOUN	I
cloned	O	VERB	B
into	O	ADP	O
vectors	O	NOUN	B
carrying	O	VERB	O
the	O	DET	O
W205	O	PROPN	B
trp	B-GENE	NOUN	I
-	O	PUNCT	O
lac	B-GENE	NOUN	B
fusion	O	NOUN	B
.	O	PUNCT	O


RT	O	NOUN	B
-	O	PUNCT	O
PCR	O	NOUN	B
analysis	O	NOUN	B
showed	O	VERB	O
that	O	SCONJ	O
PLP	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
H	I-GENE	PROPN	B
as	O	ADV	O
well	O	ADV	O
as	O	ADP	O
PLP	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
C	I-GENE	PROPN	B
and	O	CCONJ	O
PLP	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
D	I-GENE	NOUN	B
are	O	AUX	O
expressed	O	VERB	B
in	O	ADP	O
all	O	DET	O
rat	O	NOUN	B
strains	O	NOUN	B
examined	O	VERB	B
,	O	PUNCT	O
confirming	O	VERB	O
that	O	SCONJ	O
PLP	B-GENE	NOUN	B
diversity	O	NOUN	B
is	O	AUX	O
not	O	PART	O
due	O	ADJ	O
to	O	PART	O
strain	O	NOUN	B
differences	O	NOUN	O
.	O	PUNCT	O


Molecular	O	ADJ	B
cloning	O	NOUN	I
and	O	CCONJ	O
characterization	O	NOUN	B
of	O	ADP	O
a	O	DET	O
new	O	ADJ	O
member	O	NOUN	O
of	O	ADP	O
the	O	DET	O
rat	B-GENE	NOUN	B
placental	I-GENE	ADJ	B
prolactin	I-GENE	NOUN	B
(	O	PUNCT	O
PRL	B-GENE	NOUN	B
)	O	PUNCT	O
family	O	NOUN	B
,	O	PUNCT	O
PRL	B-GENE	NOUN	B
-	O	PUNCT	O
like	O	ADJ	B
protein	B-GENE	NOUN	B
H	I-GENE	NOUN	I
.	O	PUNCT	O


Thus	O	ADV	O
,	O	PUNCT	O
we	O	PRON	O
have	O	AUX	O
identified	O	VERB	B
an	O	DET	O
activation	O	NOUN	B
target	O	NOUN	B
of	O	ADP	O
a	O	DET	O
human	O	ADJ	B
activator	O	NOUN	I
,	O	PUNCT	O
Oct	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	O
,	O	PUNCT	O
within	O	ADP	O
its	O	PRON	O
cognate	O	ADJ	B
basal	O	ADJ	B
transcription	O	NOUN	I
complex	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
results	O	NOUN	B
raise	O	VERB	O
the	O	DET	O
possibility	O	NOUN	O
that	O	SCONJ	O
pH	O	NOUN	B
induced	O	VERB	B
post	O	NOUN	B
-	O	PUNCT	O
translational	O	ADJ	B
modifications	O	NOUN	B
of	O	ADP	O
DdRPA	B-GENE	NOUN	B
are	O	AUX	O
involved	O	VERB	O
in	O	ADP	O
events	O	NOUN	B
that	O	PRON	O
halt	O	VERB	O
cell	O	NOUN	B
proliferation	O	NOUN	I
and	O	CCONJ	O
induce	O	VERB	B
differentiation	O	NOUN	B
in	O	ADP	O
Dictyostelium	O	NOUN	B
.	O	PUNCT	O


P	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
CIP1	I-GENE	NOUN	B
,	O	PUNCT	O
a	O	DET	O
novel	O	ADJ	O
protein	O	NOUN	B
that	O	PRON	O
interacts	O	VERB	O
with	O	ADP	O
the	O	DET	O
cytosolic	O	ADJ	B
domain	O	NOUN	I
of	O	ADP	O
peptidylglycine	B-GENE	NOUN	B
alpha	I-GENE	NOUN	I
-	I-GENE	PUNCT	O
amidating	I-GENE	VERB	B
monooxygenase	I-GENE	NOUN	B
,	O	PUNCT	O
is	O	AUX	O
associated	O	VERB	B
with	O	ADP	I
endosomes	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
this	O	DET	O
study	O	NOUN	B
we	O	PRON	O
provide	O	VERB	O
evidence	O	NOUN	B
that	O	SCONJ	O
B	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
Myb	I-GENE	PROPN	B
is	O	AUX	O
a	O	DET	O
direct	O	ADJ	O
physiological	O	ADJ	B
target	O	NOUN	B
for	O	ADP	O
cyclin	B-GENE	NOUN	B
A	I-GENE	NOUN	I
/	O	PUNCT	O
Cdk2	B-GENE	NOUN	B
.	O	PUNCT	O


The	O	DET	O
highly	O	ADV	O
amyloidogenic	O	ADJ	B
42	O	NUM	O
-	O	PUNCT	O
residue	O	NOUN	B
form	O	NOUN	O
of	O	ADP	O
Abeta	B-GENE	PROPN	B
(	O	PUNCT	O
Abeta42	B-GENE	NOUN	B
)	O	PUNCT	O
is	O	AUX	O
the	O	DET	O
first	O	ADJ	O
species	O	NOUN	B
to	O	PART	O
be	O	AUX	O
deposited	O	VERB	B
in	O	ADP	O
both	O	CCONJ	O
sporadic	O	ADJ	B
and	O	CCONJ	O
familial	O	ADJ	B
AD	O	NOUN	B
.	O	PUNCT	O


This	O	DET	O
model	O	NOUN	B
is	O	AUX	O
supported	O	VERB	O
by	O	ADP	O
experiments	O	NOUN	B
showing	O	VERB	O
that	O	SCONJ	O
Cdr2	B-GENE	NOUN	B
associates	O	VERB	B
with	O	ADP	I
the	O	DET	O
N	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
terminal	I-GENE	ADJ	B
regulatory	I-GENE	ADJ	B
domain	I-GENE	NOUN	I
of	I-GENE	ADP	O
Wee1	I-GENE	NOUN	B
in	O	ADP	O
cell	O	NOUN	B
lysates	O	NOUN	I
and	O	CCONJ	O
phosphorylates	O	VERB	B
Wee1	B-GENE	NOUN	B
in	O	X	B
vitro	O	X	I
.	O	PUNCT	O


RESULTS	O	NOUN	B
:	O	PUNCT	O
Significant	O	ADJ	O
changes	O	NOUN	B
from	O	ADP	O
pretreatment	O	NOUN	B
to	O	PART	O
posttreatment	O	NOUN	B
were	O	AUX	O
observed	O	VERB	O
(	O	PUNCT	O
p	O	NOUN	O
<	O	X	O
0	O	NUM	O
.	O	PUNCT	O
001	O	NUM	O
)	O	PUNCT	O
.	O	PUNCT	O


The	O	DET	O
tip	O	NOUN	B
of	O	ADP	O
the	O	DET	O
button	O	NOUN	B
caused	O	VERB	O
a	O	DET	O
perforation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
posterior	O	ADJ	B
stomach	O	NOUN	I
wall	O	NOUN	I
,	O	PUNCT	O
leading	O	VERB	O
to	O	ADP	O
death	O	NOUN	B
.	O	PUNCT	O


Also	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
amplitude	O	NOUN	B
of	O	ADP	O
the	O	DET	O
oscillatory	O	ADJ	B
potentials	O	NOUN	I
(	O	PUNCT	O
O1	O	NOUN	B
+	O	CCONJ	O
O2	O	NOUN	B
+	O	CCONJ	O
O3	O	NOUN	B
+	O	CCONJ	O
O4	O	NOUN	O
)	O	PUNCT	O
was	O	AUX	O
significantly	O	ADV	O
reduced	O	VERB	B
in	O	ADP	O
the	O	DET	O
early	O	ADJ	B
postoperative	O	ADJ	B
period	O	NOUN	B
.	O	PUNCT	O


Both	O	CCONJ	O
NUP98	B-GENE	NOUN	B
-	O	PUNCT	O
HOXA9	B-GENE	NOUN	B
chimeras	O	NOUN	B
transformed	O	VERB	O
NIH	O	NOUN	O
3T3	O	NOUN	O
fibroblasts	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
this	O	DET	O
transformation	O	NOUN	B
required	O	VERB	O
the	O	DET	O
HOXA9	B-GENE	NOUN	B
domains	I-GENE	NOUN	B
for	O	ADP	O
DNA	O	NOUN	B
binding	O	NOUN	I
and	O	CCONJ	O
PBX	B-GENE	NOUN	B
interaction	O	NOUN	B
.	O	PUNCT	O


Ethylene	O	NOUN	B
is	O	AUX	O
involved	O	VERB	O
in	O	ADP	O
endosperm	O	NOUN	B
rupture	O	NOUN	B
and	O	CCONJ	O
high	O	ADJ	B
-	O	PUNCT	O
level	O	NOUN	B
betaGLU	B-GENE	NOUN	B
I	I-GENE	NUM	I
expression	O	NOUN	B
;	O	PUNCT	O
but	O	CCONJ	O
,	O	PUNCT	O
it	O	PRON	O
does	O	AUX	O
not	O	PART	O
affect	O	VERB	O
the	O	DET	O
spatial	O	ADJ	B
and	O	CCONJ	O
temporal	O	ADJ	B
pattern	O	NOUN	O
of	O	ADP	O
betaGLU	B-GENE	NOUN	B
I	I-GENE	NUM	I
expression	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
divergence	O	NOUN	B
in	O	ADP	O
primary	O	ADJ	B
structure	O	NOUN	I
between	O	ADP	O
the	O	DET	O
sheep	O	NOUN	B
CRF1	B-GENE	NOUN	B
and	O	CCONJ	O
the	O	DET	O
other	O	ADJ	O
mammalian	B-GENE	ADJ	B
CRF1s	I-GENE	NOUN	B
is	O	AUX	O
primarily	O	ADV	O
localized	O	ADJ	B
to	O	PART	O
the	O	DET	O
extracellular	O	ADJ	B
amino	O	NOUN	O
terminal	O	ADJ	O
domain	O	NOUN	O
of	O	ADP	O
the	O	DET	O
receptor	O	NOUN	B
(	O	PUNCT	O
18	O	NUM	O
of	O	ADP	O
22	O	NUM	O
divergent	O	ADJ	B
residues	O	NOUN	I
,	O	PUNCT	O
ovine	O	NOUN	B
vs	O	CCONJ	O
human	B-GENE	ADJ	B
CRF1	I-GENE	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Agonist	O	NOUN	B
-	O	PUNCT	O
induced	O	VERB	B
receptor	O	NOUN	B
internalization	O	NOUN	I
,	O	PUNCT	O
determined	O	VERB	O
as	O	ADP	O
the	O	DET	O
percent	O	NOUN	O
of	O	ADP	O
total	O	NOUN	O
[	O	PUNCT	O
125I	O	NUM	O
]	O	PUNCT	O
Tyr0	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
oCRF	I-GENE	NOUN	B
bound	O	VERB	B
located	O	ADJ	O
in	O	ADP	O
the	O	DET	O
acid	O	NOUN	B
-	O	PUNCT	O
resistant	O	ADJ	B
fraction	O	NOUN	B
of	O	ADP	O
transfected	O	VERB	B
Cos	O	NOUN	O
7	O	NUM	O
cells	O	NOUN	B
,	O	PUNCT	O
increased	O	VERB	B
with	O	ADP	O
time	O	NOUN	B
(	O	PUNCT	O
0	O	NUM	O
-	O	PUNCT	O
60	O	NUM	O
min	O	NOUN	O
at	O	ADP	O
37	O	NUM	O
degrees	O	NOUN	B
C	O	NOUN	I
)	O	PUNCT	O
for	O	ADP	O
both	O	CCONJ	O
wild	O	ADJ	B
-	O	PUNCT	O
type	O	NOUN	B
and	O	CCONJ	O
variant	O	ADJ	B
oCRF1	B-GENE	NOUN	B
.	O	PUNCT	O


This	O	DET	O
c	B-GENE	NOUN	O
-	I-GENE	PUNCT	O
Jun	I-GENE	NOUN	B
activity	O	NOUN	O
is	O	AUX	O
inhibited	O	VERB	B
by	O	ADP	O
c	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
Fos	I-GENE	NOUN	B
,	O	PUNCT	O
another	O	DET	O
protooncoprotein	O	NOUN	B
that	O	PRON	O
can	O	AUX	O
dimerize	O	VERB	B
with	O	ADP	O
c	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
Jun	I-GENE	NOUN	B
to	O	PART	O
form	O	VERB	O
the	O	DET	O
transcription	O	NOUN	B
factor	O	NOUN	I
AP	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	O
.	O	PUNCT	O


CONCLUSION	O	NOUN	O
:	O	PUNCT	O
Our	O	PRON	O
study	O	NOUN	B
shows	O	VERB	O
that	O	SCONJ	O
(	O	PUNCT	O
1	O	X	O
)	O	PUNCT	O
total	O	ADJ	B
body	O	NOUN	I
BMD	O	NOUN	I
and	O	CCONJ	O
femoral	O	ADJ	B
neck	O	NOUN	I
BMD	O	NOUN	I
were	O	AUX	O
significantly	O	ADV	O
higher	O	ADJ	O
in	O	ADP	O
the	O	DET	O
study	O	NOUN	B
group	O	NOUN	I
that	O	PRON	O
performed	O	VERB	O
weight	O	NOUN	B
-	O	PUNCT	O
bearing	O	VERB	B
exercises	O	NOUN	B
than	O	ADP	O
in	O	ADP	O
control	O	ADJ	B
subjects	O	NOUN	I
,	O	PUNCT	O
(	O	PUNCT	O
2	O	X	O
)	O	PUNCT	O
swimming	O	NOUN	B
exercise	O	NOUN	B
had	O	AUX	O
no	O	DET	B
effect	O	NOUN	I
on	O	ADP	O
BMD	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
(	O	PUNCT	O
3	O	X	O
)	O	PUNCT	O
although	O	SCONJ	O
swimming	O	NOUN	B
is	O	AUX	O
not	O	PART	O
a	O	DET	O
bone	O	NOUN	B
-	O	PUNCT	O
building	O	NOUN	B
exercise	O	NOUN	B
,	O	PUNCT	O
it	O	PRON	O
can	O	AUX	O
significantly	O	ADV	O
improve	O	VERB	B
shoulder	O	NOUN	B
,	O	PUNCT	O
back	O	ADV	O
,	O	PUNCT	O
and	O	CCONJ	O
grip	O	VERB	B
muscle	O	NOUN	I
strength	O	NOUN	O
.	O	PUNCT	O


Comparisons	O	NOUN	B
with	O	ADP	O
other	O	ADJ	O
known	O	ADJ	O
germins	B-GENE	NOUN	B
and	O	CCONJ	O
germin	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
like	I-GENE	ADJ	B
proteins	I-GENE	NOUN	B
indicate	O	VERB	O
that	O	SCONJ	O
these	O	DET	O
Arabidopsis	O	NOUN	B
GLP	B-GENE	NOUN	B
subfamilies	O	NOUN	B
are	O	AUX	O
unique	O	ADJ	B
from	O	ADP	O
wheat	O	NOUN	B
germin	B-GENE	NOUN	I
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
there	O	PRON	O
has	O	AUX	O
not	O	PART	O
been	O	AUX	O
any	O	DET	O
evidence	O	NOUN	B
of	O	ADP	O
A	O	NOUN	B
.	O	PUNCT	O
salmonicida	O	NOUN	B
infections	O	NOUN	I
,	O	PUNCT	O
specifically	O	ADV	O
furunculosis	O	NOUN	B
,	O	PUNCT	O
associated	O	VERB	B
with	O	ADP	I
the	O	DET	O
fish	O	NOUN	B
in	O	ADP	O
this	O	DET	O
loch	O	NOUN	B
.	O	PUNCT	O


Improving	O	VERB	B
the	O	DET	O
evidence	O	NOUN	B
base	O	NOUN	O
for	O	ADP	O
anaesthesia	O	NOUN	B
.	O	PUNCT	O


Plasma	O	NOUN	B
CCK	B-GENE	NOUN	B
levels	O	NOUN	B
were	O	AUX	O
determined	O	VERB	O
at	O	ADP	O
regular	O	ADJ	O
intervals	O	NOUN	B
.	O	PUNCT	O


Consistent	O	ADJ	B
with	O	ADP	I
these	O	DET	O
findings	O	NOUN	B
,	O	PUNCT	O
relatively	O	ADV	O
weak	O	ADJ	B
transcriptional	O	ADJ	B
silencing	O	NOUN	O
by	O	ADP	O
the	O	DET	O
native	O	ADJ	B
VDR	B-GENE	NOUN	B
was	O	AUX	O
observed	O	VERB	O
using	O	VERB	O
the	O	DET	O
osteopontin	B-GENE	NOUN	B
VDRE	O	NOUN	O
.	O	PUNCT	O


A	O	DET	O
motif	O	NOUN	O
(	O	PUNCT	O
TGATGTCA	O	NOUN	B
)	O	PUNCT	O
which	O	DET	O
matches	O	VERB	O
a	O	DET	O
CREB	B-GENE	NOUN	B
site	I-GENE	NOUN	O
and	O	CCONJ	O
is	O	AUX	O
similar	O	ADJ	O
to	O	PART	O
an	O	DET	O
AP	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	O
site	I-GENE	NOUN	B
is	O	AUX	O
embedded	O	ADJ	O
within	O	ADP	O
ER2	B-GENE	NOUN	B
.	O	PUNCT	O


Conventionally	O	ADV	B
,	O	PUNCT	O
four	O	NUM	O
nominal	O	ADJ	B
allotypic	O	ADJ	I
variants	O	NOUN	I
,	O	PUNCT	O
b4	O	NOUN	B
,	O	PUNCT	O
b5	O	NOUN	B
,	O	PUNCT	O
b6	O	NOUN	B
and	O	CCONJ	O
b9	O	NOUN	B
have	O	AUX	O
been	O	AUX	O
shown	O	VERB	O
to	O	PART	O
be	O	AUX	O
co	O	X	B
-	O	PUNCT	O
dominantly	O	ADV	B
expressed	O	VERB	B
at	O	ADP	O
the	O	DET	O
Ckappa1	B-GENE	NOUN	B
gene	I-GENE	NOUN	I
locus	I-GENE	NOUN	I
.	O	PUNCT	O


Therefore	O	ADV	O
,	O	PUNCT	O
in	O	ADP	O
order	O	NOUN	O
to	O	PART	O
search	O	VERB	O
for	O	ADP	O
the	O	DET	O
latent	O	ADJ	B
genes	O	NOUN	I
,	O	PUNCT	O
we	O	PRON	O
used	O	VERB	O
allotype	O	NOUN	B
-	O	PUNCT	O
specific	O	ADJ	B
oligonucleotides	O	NOUN	B
for	O	ADP	O
b5	O	NOUN	B
,	O	PUNCT	O
b6	O	NOUN	B
and	O	CCONJ	O
b9	O	NOUN	O
to	O	PART	O
probe	O	NOUN	B
DNAs	O	NOUN	B
from	O	ADP	O
both	O	CCONJ	O
normal	O	ADJ	B
and	O	CCONJ	O
T	O	NOUN	B
.	O	PUNCT	O
brucei	O	X	B
-	O	PUNCT	O
infected	O	ADJ	B
rabbits	O	NOUN	B
by	O	ADP	O
Southern	O	NOUN	B
blotting	O	NOUN	I
.	O	PUNCT	O


TRAF2	B-GENE	NOUN	B
is	O	AUX	O
known	O	VERB	O
to	O	PART	O
associate	O	VERB	B
with	O	ADP	I
TRADD	B-GENE	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
expression	O	NOUN	B
of	O	ADP	O
a	O	DET	O
dominant	O	ADJ	B
-	O	PUNCT	O
negative	O	ADJ	B
N	O	NOUN	B
-	O	PUNCT	O
terminal	O	ADJ	B
deletion	O	NOUN	B
TRAF2	B-GENE	NOUN	O
mutant	I-GENE	NOUN	B
was	O	AUX	O
found	O	VERB	O
to	O	PART	O
partially	O	ADV	O
inhibit	O	VERB	B
LMP1	B-GENE	NOUN	B
-	O	PUNCT	O
induced	O	VERB	B
JNK	B-GENE	NOUN	B
activation	O	NOUN	B
in	O	ADP	O
293	O	NUM	O
cells	O	NOUN	B
.	O	PUNCT	O


These	O	DET	O
data	O	NOUN	B
further	O	ADV	O
define	O	VERB	O
a	O	DET	O
role	O	NOUN	O
for	O	ADP	O
TRADD	B-GENE	NOUN	B
and	O	CCONJ	O
TRAF2	B-GENE	NOUN	B
in	O	ADP	O
JNK	B-GENE	NOUN	B
activation	O	NOUN	B
and	O	CCONJ	O
confirm	O	VERB	O
that	O	SCONJ	O
LMP1	B-GENE	NOUN	B
utilizes	O	VERB	O
signalling	O	NOUN	B
mechanisms	O	NOUN	B
used	O	VERB	O
by	O	ADP	O
the	O	DET	O
TNF	B-GENE	NOUN	B
receptor	I-GENE	NOUN	I
/	O	PUNCT	O
CD40	B-GENE	NOUN	B
family	O	NOUN	B
to	O	PART	O
elicit	O	VERB	O
its	O	PRON	O
pleiotropic	O	ADJ	B
activities	O	NOUN	I
.	O	PUNCT	O


Epstein	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
Barr	I-GENE	PROPN	B
virus	I-GENE	NOUN	I
-	I-GENE	PUNCT	O
encoded	I-GENE	VERB	B
latent	I-GENE	ADJ	B
membrane	I-GENE	NOUN	I
protein	I-GENE	NOUN	I
1	I-GENE	NUM	I
activates	O	VERB	B
the	O	DET	O
JNK	B-GENE	NOUN	B
pathway	O	NOUN	I
through	O	ADP	O
its	O	PRON	O
extreme	O	ADJ	O
C	O	NOUN	B
terminus	O	NOUN	B
via	O	ADP	O
a	O	DET	O
mechanism	O	NOUN	B
involving	O	VERB	O
TRADD	B-GENE	NOUN	B
and	O	CCONJ	O
TRAF2	B-GENE	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
contrast	O	NOUN	O
,	O	PUNCT	O
transiently	O	ADV	O
transfected	O	VERB	B
cells	O	NOUN	O
expressing	O	VERB	B
EBNA	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
3	I-GENE	NUM	O
revealed	O	VERB	B
a	O	DET	O
sixfold	O	ADJ	O
increase	O	NOUN	B
in	O	ADP	O
EBNA	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
3	I-GENE	NUM	O
protein	I-GENE	NOUN	B
expression	O	NOUN	I
from	O	ADP	O
the	O	DET	O
genomic	O	ADJ	B
EBNA	B-GENE	NOUN	I
-	I-GENE	PUNCT	O
3	I-GENE	NUM	O
gene	I-GENE	NOUN	B
compared	O	VERB	O
to	O	PART	O
EBNA	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
3	I-GENE	NUM	B
cDNA	I-GENE	NOUN	B
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
serial	O	ADJ	O
passages	O	NOUN	B
of	O	ADP	O
fetal	O	ADJ	B
lamb	O	NOUN	I
kidney	O	NOUN	I
(	O	PUNCT	O
FLK	O	NOUN	B
)	O	PUNCT	O
cells	O	NOUN	O
,	O	PUNCT	O
which	O	DET	O
are	O	AUX	O
sensitive	O	ADJ	B
to	O	PART	O
infection	O	NOUN	B
with	O	ADP	O
BLV	O	NOUN	B
,	O	PUNCT	O
after	O	ADP	O
transient	O	ADJ	B
transfection	O	NOUN	B
revealed	O	VERB	O
that	O	SCONJ	O
mutation	O	NOUN	B
of	O	ADP	O
a	O	DET	O
second	O	ADJ	O
tyrosine	O	NOUN	B
residue	O	NOUN	B
in	O	ADP	O
the	O	DET	O
N	O	NOUN	B
-	O	PUNCT	O
terminal	O	ADJ	B
motif	O	NOUN	B
completely	O	ADV	O
prevented	O	VERB	B
the	O	DET	O
propagation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
virus	O	NOUN	B
.	O	PUNCT	O


To	O	PART	O
search	O	VERB	O
for	O	ADP	O
transcriptional	O	ADJ	B
regulators	O	NOUN	I
,	O	PUNCT	O
we	O	PRON	O
used	O	VERB	O
a	O	DET	O
fragment	O	NOUN	B
of	O	ADP	O
the	O	DET	O
SpHE	B-GENE	NOUN	B
promoter	I-GENE	NOUN	B
containing	O	VERB	O
several	O	ADJ	O
individual	O	ADJ	B
elements	O	NOUN	I
instead	O	ADV	O
of	O	ADP	O
the	O	DET	O
conventional	O	ADJ	B
bait	O	NOUN	B
that	O	PRON	O
contains	O	VERB	O
a	O	DET	O
multimerized	O	ADJ	B
cis	O	NOUN	I
element	O	NOUN	I
.	O	PUNCT	O


As	O	ADP	O
expected	O	VERB	O
for	O	ADP	O
a	O	DET	O
positive	O	ADJ	B
SpHE	B-GENE	NOUN	B
transcriptional	I-GENE	ADJ	B
regulator	I-GENE	NOUN	I
,	O	PUNCT	O
the	O	DET	O
timing	O	NOUN	B
of	O	ADP	O
SpEts4	B-GENE	NOUN	B
gene	I-GENE	NOUN	I
expression	O	NOUN	B
precedes	O	VERB	O
the	O	DET	O
transient	O	ADJ	B
expression	O	NOUN	B
of	O	ADP	O
SpHE	B-GENE	NOUN	B
in	O	ADP	O
the	O	DET	O
very	O	ADV	O
early	O	ADJ	O
sea	O	NOUN	B
urchin	O	NOUN	O
blastula	O	NOUN	O
.	O	PUNCT	O


Induction	O	NOUN	B
of	O	ADP	O
anaesthesia	O	NOUN	O
was	O	AUX	O
standardised	O	VERB	B
:	O	PUNCT	O
fentanyl	O	NOUN	B
(	O	PUNCT	O
3	O	NUM	O
micrograms	O	NOUN	B
/	O	SYM	O
kg	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
thiopentone	O	NOUN	B
(	O	PUNCT	O
5	O	NUM	O
mg	O	NOUN	O
/	O	SYM	O
kg	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
atracurium	O	NOUN	B
(	O	PUNCT	O
0	O	NUM	O
.	O	PUNCT	O
4	O	NUM	O
mg	O	NOUN	O
/	O	SYM	O
kg	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Conserved	O	VERB	B
and	O	CCONJ	O
distinct	O	ADJ	O
roles	O	NOUN	O
of	O	ADP	O
kreisler	B-GENE	NOUN	B
in	O	ADP	O
regulation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
paralogous	O	ADJ	B
Hoxa3	B-GENE	NOUN	B
and	O	CCONJ	O
Hoxb3	B-GENE	NOUN	B
genes	I-GENE	NOUN	I
.	O	PUNCT	O


Moreover	O	ADV	O
,	O	PUNCT	O
this	O	DET	O
enhancement	O	NOUN	B
of	O	ADP	O
transcriptional	O	ADJ	B
activation	O	NOUN	I
by	O	ADP	O
COUP	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
TFI	I-GENE	PROPN	B
requires	O	VERB	O
specifically	O	ADV	O
the	O	DET	O
AF	O	PROPN	B
-	O	PUNCT	O
1	O	NUM	B
transactivation	O	NOUN	B
function	O	NOUN	I
of	O	ADP	O
ER	B-GENE	NOUN	B
and	O	CCONJ	O
can	O	AUX	O
be	O	AUX	O
observed	O	VERB	B
in	O	ADP	O
the	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
E2	O	NOUN	B
or	O	CCONJ	O
4	O	NUM	B
-	O	PUNCT	O
hydroxytamoxifen	O	NOUN	B
but	O	CCONJ	O
not	O	PART	O
ICI	O	NOUN	B
164384	O	NUM	I
.	O	PUNCT	O


Recombinant	B-GENE	ADJ	B
Ffh	I-GENE	PROPN	B
has	O	AUX	O
a	O	DET	O
melting	O	ADJ	B
point	O	NOUN	I
of	O	ADP	O
tm	O	NOUN	O
=	O	ADJ	O
89	O	NUM	O
degreesC	O	NOUN	B
.	O	PUNCT	O


This	O	DET	O
region	O	NOUN	B
of	O	ADP	O
hsp90	B-GENE	NOUN	B
mediates	O	VERB	B
ATP	O	NOUN	B
-	O	PUNCT	O
independent	O	ADJ	B
chaperone	O	NOUN	B
activity	O	NOUN	B
,	O	PUNCT	O
overlaps	O	VERB	O
the	O	DET	O
hsp90	B-GENE	NOUN	B
dimerization	I-GENE	NOUN	B
domain	I-GENE	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
includes	O	VERB	O
structural	O	ADJ	B
elements	O	NOUN	I
important	O	ADJ	O
for	O	ADP	O
steroid	B-GENE	NOUN	B
receptor	I-GENE	NOUN	I
interaction	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
RNA	B-GENE	NOUN	B
polymerase	I-GENE	NOUN	I
III	I-GENE	NUM	I
-	I-GENE	PUNCT	O
recruiting	I-GENE	VERB	B
factor	I-GENE	NOUN	B
TFIIIB	I-GENE	NOUN	B
induces	O	VERB	O
a	O	DET	O
DNA	O	NOUN	B
bend	O	NOUN	I
between	O	ADP	O
the	O	DET	O
TATA	O	NOUN	B
box	O	NOUN	I
and	O	CCONJ	O
the	O	DET	O
transcriptional	O	ADJ	B
start	O	NOUN	O
site	O	NOUN	O
.	O	PUNCT	O


Analysis	O	NOUN	B
of	O	ADP	O
hematopoietic	B-GENE	ADJ	B
growth	I-GENE	NOUN	I
factor	I-GENE	NOUN	I
prescriptions	O	NOUN	I
in	O	ADP	O
19	O	NUM	O
french	O	ADJ	B
cancer	O	NOUN	I
centers	O	NOUN	I


Chem	O	PROPN	O
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
c	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
met	I-GENE	VERB	B
gene	I-GENE	NOUN	B
is	O	AUX	O
also	O	ADV	O
a	O	DET	O
target	O	NOUN	B
of	O	ADP	O
p53	B-GENE	NOUN	B
gene	I-GENE	NOUN	B
regulation	O	NOUN	I
.	O	PUNCT	O


Pokeweed	B-GENE	NOUN	B
antiviral	I-GENE	ADJ	I
protein	I-GENE	NOUN	I
(	O	PUNCT	O
PAP	B-GENE	NOUN	B
)	O	PUNCT	O
from	O	ADP	O
Phytolacca	O	PROPN	B
americana	O	X	I
is	O	AUX	O
a	O	DET	O
highly	O	ADV	O
specific	O	ADJ	B
N	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
glycosidase	I-GENE	NOUN	B
removing	O	VERB	O
adenine	O	NOUN	B
residues	O	NOUN	I
(	O	PUNCT	O
A4324	O	NOUN	B
in	O	ADP	O
28S	B-GENE	ADJ	B
rRNA	I-GENE	NOUN	I
and	O	CCONJ	O
A2660	O	NOUN	B
in	O	ADP	O
23S	B-GENE	ADJ	B
rRNA	I-GENE	NOUN	I
)	O	PUNCT	O
from	O	ADP	O
intact	O	ADJ	B
ribosomes	O	NOUN	B
of	O	ADP	O
both	O	DET	O
eukaryotes	O	NOUN	B
and	O	CCONJ	O
prokaryotes	O	NOUN	B
.	O	PUNCT	O


Among	O	ADP	O
these	O	DET	O
360	O	NUM	O
ZFPs	B-GENE	NOUN	B
,	O	PUNCT	O
a	O	DET	O
novel	O	ADJ	O
ZFP	B-GENE	NOUN	B
cDNA	I-GENE	NOUN	I
named	O	VERB	O
HFHZ	B-GENE	NOUN	B
(	O	PUNCT	O
human	B-GENE	ADJ	B
fetal	I-GENE	ADJ	I
heart	I-GENE	NOUN	I
ZFP	I-GENE	NOUN	B
)	O	PUNCT	O
with	O	ADP	O
sequence	O	NOUN	B
homology	O	NOUN	I
to	O	PART	O
a	O	DET	O
Kruppel	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
associated	I-GENE	VERB	B
box	I-GENE	NOUN	B
(	O	PUNCT	I
KRAB	B-GENE	NOUN	B
)	O	PUNCT	O
was	O	AUX	O
identified	O	VERB	B
.	O	PUNCT	O


The	O	DET	O
3	O	NUM	O
.	O	PUNCT	O
3	O	NUM	O
-	O	PUNCT	O
fold	O	ADJ	B
higher	O	ADJ	B
expression	O	NOUN	B
in	O	ADP	O
the	O	DET	O
fetal	O	ADJ	B
heart	O	NOUN	I
than	O	ADP	O
in	O	ADP	O
the	O	DET	O
adult	O	ADJ	B
heart	O	NOUN	B
suggests	O	VERB	O
that	O	SCONJ	O
HFHZ	B-GENE	NOUN	B
mRNA	I-GENE	NOUN	B
is	O	AUX	O
downregulated	O	VERB	B
in	O	ADP	O
the	O	DET	O
process	O	NOUN	B
of	O	ADP	O
development	O	NOUN	B
.	O	PUNCT	O


CONTEXT	O	NOUN	B
:	O	PUNCT	O
ThinPrep	O	PROPN	B
,	O	PUNCT	O
AutoPap	O	PROPN	B
,	O	PUNCT	O
and	O	CCONJ	O
Papnet	O	PROPN	B
are	O	AUX	O
3	O	NUM	O
new	O	ADJ	O
technologies	O	NOUN	B
that	O	PRON	O
increase	O	VERB	B
the	O	DET	O
sensitivity	O	NOUN	B
and	O	CCONJ	O
cost	O	NOUN	B
of	O	ADP	O
cervical	O	ADJ	B
cancer	O	NOUN	I
screening	O	NOUN	B
.	O	PUNCT	O


Experiments	O	NOUN	B
on	O	ADP	O
narcotized	O	VERB	B
cats	O	NOUN	B
demonstrated	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
derivatives	O	NOUN	O
of	O	ADP	O
2	O	NUM	O
-	O	PUNCT	O
mercaptobenzimidazole	O	NOUN	B
possessing	O	VERB	O
the	O	DET	O
properties	O	NOUN	B
of	O	ADP	O
specific	O	ADJ	O
bradycardic	O	ADJ	B
agents	O	NOUN	I
and	O	CCONJ	O
coded	O	VERB	O
as	O	ADP	O
CM	O	PROPN	B
-	O	PUNCT	O
251	O	NUM	O
,	O	PUNCT	O
CM	O	PROPN	B
-	O	PUNCT	O
266	O	NUM	O
,	O	PUNCT	O
and	O	CCONJ	O
CM	O	PROPN	B
-	O	PUNCT	O
345	O	NUM	O
,	O	PUNCT	O
reduce	O	VERB	B
the	O	DET	O
mean	O	ADJ	O
rise	O	NOUN	O
of	O	ADP	O
segment	O	NOUN	B
ST	O	NOUN	B
on	O	ADP	O
numerous	O	ADJ	O
leads	O	NOUN	O
of	O	ADP	O
the	O	DET	O
epicardial	O	ADJ	B
electrogram	O	NOUN	O
during	O	ADP	O
5	O	NUM	O
-	O	PUNCT	O
min	O	NOUN	B
occlusion	O	NOUN	B
of	O	ADP	O
the	O	DET	O
anterior	O	ADJ	B
descending	O	ADJ	I
branch	O	NOUN	I
of	O	ADP	O
the	O	DET	O
left	O	ADJ	B
coronary	O	ADJ	I
artery	O	NOUN	I
.	O	PUNCT	O


Expression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
second	O	ADJ	O
gene	O	NOUN	O
(	O	PUNCT	O
XT3	B-GENE	NOUN	B
)	O	PUNCT	O
was	O	AUX	O
found	O	VERB	O
to	O	PART	O
be	O	AUX	O
conserved	O	VERB	O
in	O	ADP	O
human	O	ADJ	B
kidney	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
partial	O	ADJ	B
sequence	O	NOUN	I
was	O	AUX	O
obtained	O	VERB	O
from	O	ADP	O
a	O	DET	O
human	O	ADJ	B
cDNA	O	NOUN	B
library	O	NOUN	I
.	O	PUNCT	O


Internal	O	ADJ	B
modes	O	NOUN	I
of	O	ADP	O
a	O	DET	O
soliton	O	NOUN	B
.	O	PUNCT	O


(	O	PUNCT	O
2	O	X	O
)	O	PUNCT	O
Erythroid	O	ADJ	B
32D	O	NOUN	I
Epo1	B-GENE	NOUN	O
cells	O	NOUN	O
showed	O	VERB	O
a	O	DET	O
lower	O	ADJ	O
level	O	NOUN	B
of	O	ADP	O
bulk	O	ADJ	O
PKC	B-GENE	NOUN	B
catalytic	O	ADJ	B
activity	O	NOUN	I
,	O	PUNCT	O
lacked	O	VERB	O
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
epsilon	B-GENE	NOUN	B
and	I-GENE	CCONJ	O
eta	I-GENE	NOUN	B
PKC	I-GENE	NOUN	I
isoforms	I-GENE	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
showed	O	VERB	O
a	O	DET	O
weak	O	ADJ	B
or	O	CCONJ	O
absent	O	ADJ	B
upregulation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
remaining	O	VERB	O
isoforms	O	NOUN	B
,	O	PUNCT	O
except	O	SCONJ	O
betaI	B-GENE	NOUN	B
,	O	PUNCT	O
upon	O	SCONJ	O
readdition	O	NOUN	B
of	O	ADP	O
Epo	B-GENE	NOUN	B
to	O	PART	O
growth	O	NOUN	B
factor	O	NOUN	I
-	O	PUNCT	O
starved	O	VERB	B
cells	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
used	O	VERB	O
expression	O	NOUN	B
cloning	O	VERB	I
to	O	PART	O
identify	O	VERB	O
interleukin	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
6	I-GENE	NUM	O
(	O	PUNCT	O
IL	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
6	I-GENE	NUM	O
)	O	PUNCT	O
as	O	ADP	O
one	O	NUM	O
factor	O	NOUN	B
that	O	PRON	O
suppressed	O	VERB	B
growth	O	NOUN	B
of	O	ADP	O
a	O	DET	O
pre	O	ADJ	B
-	O	PUNCT	O
B	O	NOUN	B
-	O	PUNCT	O
cell	O	NOUN	B
variant	O	ADJ	I
line	O	NOUN	I
,	O	PUNCT	O
1A9	O	NOUN	B
-	O	PUNCT	O
M	O	PROPN	B
.	O	PUNCT	O


Airflow	O	NOUN	B
through	O	ADP	O
the	O	DET	O
dust	O	NOUN	B
trap	O	NOUN	I
was	O	AUX	O
controlled	O	VERB	B
with	O	ADP	O
a	O	DET	O
vacuum	O	NOUN	B
pump	O	NOUN	I
.	O	PUNCT	O


Several	O	ADJ	O
mutations	O	NOUN	B
disrupted	O	VERB	B
the	O	DET	O
endonuclease	O	NOUN	B
and	O	CCONJ	O
helicase	B-GENE	NOUN	B
activities	O	NOUN	I
;	O	PUNCT	O
however	O	ADV	O
,	O	PUNCT	O
only	O	ADV	O
one	O	NUM	O
amino	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
terminal	I-GENE	ADJ	B
-	I-GENE	PUNCT	O
charge	I-GENE	NOUN	B
cluster	I-GENE	NOUN	O
mutant	I-GENE	ADJ	O
protein	I-GENE	NOUN	O
(	O	PUNCT	O
D40A	O	NOUN	B
-	O	PUNCT	O
D42A	O	NOUN	B
-	O	PUNCT	O
D44A	O	NOUN	B
)	O	PUNCT	O
completely	O	ADV	O
lost	O	VERB	O
AAV	O	NOUN	B
hairpin	O	NOUN	O
DNA	O	NOUN	B
binding	O	NOUN	I
activity	O	NOUN	I
.	O	PUNCT	O


Here	O	ADV	O
we	O	PRON	O
describe	O	VERB	O
the	O	DET	O
identification	O	NOUN	B
and	O	CCONJ	O
characterization	O	NOUN	B
of	O	ADP	O
several	O	ADJ	O
Sp100	B-GENE	NOUN	B
splice	I-GENE	NOUN	B
variant	I-GENE	ADJ	I
proteins	I-GENE	NOUN	O
and	O	CCONJ	O
support	O	VERB	O
their	O	PRON	O
existence	O	NOUN	O
by	O	ADP	O
elucidation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
3	O	NUM	O
'	O	PART	O
-	O	PUNCT	O
end	O	NOUN	O
of	O	ADP	O
the	O	DET	O
Sp100	B-GENE	NOUN	B
gene	I-GENE	NOUN	I
.	O	PUNCT	O


It	O	PRON	O
was	O	AUX	O
demonstrated	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
processing	O	NOUN	B
signals	O	NOUN	B
in	O	ADP	O
the	O	DET	O
transcript	O	NOUN	B
,	O	PUNCT	O
i	O	X	O
.	O	PUNCT	O
e	O	X	O
.	O	PUNCT	O
both	O	DET	O
donor	O	NOUN	B
splice	O	NOUN	B
sites	O	NOUN	I
and	O	CCONJ	O
the	O	DET	O
polyadenylation	O	NOUN	B
site	O	NOUN	I
located	O	ADJ	O
in	O	ADP	O
the	O	DET	O
muscle	O	NOUN	B
-	O	PUNCT	O
specific	O	ADJ	B
intron	O	NOUN	B
,	O	PUNCT	O
have	O	AUX	O
to	O	PART	O
be	O	AUX	O
weak	O	ADJ	B
.	O	PUNCT	O


Chirality	O	NOUN	B
-	O	PUNCT	O
glass	O	PROPN	B
and	O	CCONJ	O
spin	O	NOUN	B
-	O	PUNCT	O
glass	O	NOUN	B
correlations	O	NOUN	B
in	O	ADP	O
the	O	DET	O
two	O	NUM	O
-	O	PUNCT	O
dimensional	O	ADJ	B
random	O	ADJ	B
-	O	PUNCT	O
bond	O	NOUN	B
XY	O	NOUN	I
model	O	NOUN	B
.	O	PUNCT	O


Echo	O	NOUN	B
modulation	O	NOUN	I
in	O	ADP	O
Pr3	O	NOUN	B
+	O	CCONJ	O
:	O	PUNCT	O
YAlO3	O	ADJ	B
.	O	PUNCT	O


Mechanisms	O	NOUN	B
of	O	ADP	O
visible	O	ADJ	B
-	O	PUNCT	O
light	O	ADJ	B
emission	O	NOUN	B
from	O	ADP	O
electro	O	NOUN	B
-	O	PUNCT	O
oxidized	O	VERB	B
porous	O	ADJ	B
silicon	O	NOUN	B
.	O	PUNCT	O


Optically	O	ADV	B
detected	O	VERB	I
librons	O	NOUN	B
and	O	CCONJ	O
phonons	O	NOUN	B
in	O	ADP	O
crystalline	O	ADJ	B
C60	O	NOUN	B
.	O	PUNCT	O


Factors	O	NOUN	B
influencing	O	VERB	O
direct	O	ADJ	B
-	O	PUNCT	O
immersion	O	NOUN	B
(	O	PUNCT	O
DI	O	NOUN	B
)	O	PUNCT	O
-	O	PUNCT	O
SPME	O	NOUN	B
process	O	NOUN	B
were	O	AUX	O
also	O	ADV	O
checked	O	VERB	O
and	O	CCONJ	O
chosen	O	VERB	O
experimentally	O	ADV	B
.	O	PUNCT	O


In	O	ADP	O
contrast	O	NOUN	O
,	O	PUNCT	O
an	O	DET	O
amino	O	NOUN	B
-	O	PUNCT	O
terminal	O	ADJ	B
fragment	O	NOUN	B
containing	O	VERB	O
the	O	DET	O
C	O	PROPN	B
/	O	SYM	O
H1	O	NOUN	B
domain	O	NOUN	B
was	O	AUX	O
sufficient	O	ADJ	O
for	O	ADP	O
coactivation	O	NOUN	B
of	O	ADP	O
Zta	B-GENE	NOUN	B
transcription	O	NOUN	B
and	O	CCONJ	O
viral	O	ADJ	B
reactivation	O	NOUN	I
function	O	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
addition	O	NOUN	O
,	O	PUNCT	O
a	O	DET	O
potent	O	ADJ	O
splicing	O	NOUN	B
enhancer	O	NOUN	I
sequence	O	NOUN	I
isolated	O	VERB	B
in	O	ADP	O
the	O	DET	O
selection	O	NOUN	B
specifically	O	ADV	O
binds	O	VERB	B
a	O	DET	O
20	B-GENE	NUM	O
-	I-GENE	PUNCT	O
kDa	I-GENE	NOUN	B
SR	I-GENE	ADJ	I
protein	I-GENE	NOUN	I
.	O	PUNCT	O


These	O	DET	O
data	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
other	O	ADJ	O
Ras	B-GENE	NOUN	B
effectors	I-GENE	NOUN	B
can	O	AUX	O
collaborate	O	VERB	O
with	O	ADP	O
PI	B-GENE	NOUN	B
3	I-GENE	NUM	O
-	I-GENE	PUNCT	O
kinase	I-GENE	NOUN	B
and	O	CCONJ	O
with	O	ADP	O
each	O	DET	O
other	O	ADJ	O
to	O	PART	O
activate	O	VERB	B
Pak	B-GENE	PROPN	B
.	O	PUNCT	O


Electrophoretic	O	ADJ	B
mobility	O	NOUN	O
-	O	PUNCT	O
shift	O	NOUN	B
assays	O	NOUN	B
performed	O	VERB	O
with	O	ADP	O
the	O	DET	O
HNF	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
3	I-GENE	NUM	B
X	O	NOUN	I
and	O	CCONJ	O
Y	O	NOUN	O
sites	O	NOUN	O
demonstrated	O	VERB	O
that	O	SCONJ	O
both	O	DET	O
sites	O	NOUN	B
are	O	AUX	O
capable	O	ADJ	O
of	O	ADP	O
binding	O	VERB	B
HNF	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
3alpha	I-GENE	NOUN	B
and	O	CCONJ	O
HNF	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
3beta	I-GENE	NOUN	B
.	O	PUNCT	O


Proteins	O	NOUN	B
known	O	VERB	O
to	O	PART	O
bind	O	VERB	B
the	O	DET	O
PEPCK	B-GENE	NOUN	B
CRE	O	NOUN	B
include	O	VERB	O
the	O	DET	O
CRE	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
binding	I-GENE	VERB	B
protein	I-GENE	NOUN	I
(	O	PUNCT	O
CREB	B-GENE	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
members	O	NOUN	B
of	O	ADP	O
the	O	DET	O
CCAAT	B-GENE	NOUN	B
/	I-GENE	PUNCT	O
enhancer	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
binding	I-GENE	VERB	B
protein	I-GENE	NOUN	I
(	O	PUNCT	O
C	B-GENE	NOUN	B
/	I-GENE	PUNCT	O
EBP	I-GENE	NOUN	B
)	O	PUNCT	O
family	O	NOUN	B
.	O	PUNCT	O


This	O	DET	O
construct	O	NOUN	B
,	O	PUNCT	O
termed	O	VERB	O
pDeltaCREC	B-GENE	NOUN	B
/	O	SYM	O
EBP	B-GENE	PROPN	B
,	O	PUNCT	O
binds	O	VERB	B
C	B-GENE	NOUN	B
/	I-GENE	SYM	O
EBPalpha	I-GENE	NOUN	B
and	I-GENE	CCONJ	O
beta	I-GENE	NOUN	B
but	O	CCONJ	O
not	O	PART	O
CREB	B-GENE	NOUN	B
,	O	PUNCT	O
yet	O	CCONJ	O
it	O	PRON	O
confers	O	VERB	O
a	O	DET	O
nearly	O	ADV	O
complete	O	ADJ	O
glucocorticoid	O	NOUN	B
response	O	NOUN	I
when	O	SCONJ	O
transiently	O	ADV	O
transfected	O	VERB	B
into	O	ADP	O
H4IIE	O	NOUN	B
rat	O	NOUN	I
hepatoma	O	NOUN	B
cells	O	NOUN	I
.	O	PUNCT	O


Systematic	O	ADJ	B
functional	O	ADJ	I
analysis	O	NOUN	I
of	O	ADP	O
V1a	B-GENE	NOUN	B
/	I-GENE	SYM	O
V2	I-GENE	NOUN	B
hybrid	I-GENE	NOUN	I
receptors	I-GENE	NOUN	I
showed	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
second	O	ADJ	O
intracellular	O	ADJ	B
loop	O	NOUN	O
of	O	ADP	O
the	O	DET	O
V1a	B-GENE	NOUN	B
receptor	I-GENE	NOUN	I
is	O	AUX	O
required	O	VERB	O
and	O	CCONJ	O
sufficient	O	ADJ	B
for	O	ADP	O
efficient	O	ADJ	B
coupling	O	NOUN	B
to	O	PART	O
Gq	B-GENE	NOUN	B
/	I-GENE	SYM	O
11	I-GENE	NUM	O
,	O	PUNCT	O
whereas	O	SCONJ	O
the	O	DET	O
third	O	ADJ	O
intracellular	O	ADJ	B
loop	O	NOUN	O
of	O	ADP	O
the	O	DET	O
V2	B-GENE	NOUN	B
receptor	I-GENE	NOUN	I
is	O	AUX	O
required	O	VERB	O
and	O	CCONJ	O
sufficient	O	ADJ	B
for	O	ADP	O
coupling	O	NOUN	B
to	O	PART	O
Gs	B-GENE	VERB	B
.	O	PUNCT	O


The	O	DET	O
fatigue	O	NOUN	B
exercise	O	NOUN	B
showed	O	VERB	O
relatively	O	ADV	O
high	O	ADJ	O
blood	O	NOUN	B
lactate	O	NOUN	I
concentration	O	NOUN	I
[	O	PUNCT	O
12	O	NUM	O
.	O	PUNCT	O
5	O	NUM	O
(	O	PUNCT	O
SD	O	NOUN	B
2	O	NUM	O
.	O	PUNCT	O
6	O	NUM	O
)	O	PUNCT	O
mmol	O	NOUN	O
x	O	NOUN	O
l	O	NOUN	O
(	O	PUNCT	O
-	O	PUNCT	O
1	O	NUM	O
)	O	PUNCT	O
]	O	PUNCT	O
and	O	CCONJ	O
an	O	DET	O
increase	O	NOUN	B
of	O	ADP	O
serum	B-GENE	NOUN	B
creatine	I-GENE	NOUN	O
kinase	I-GENE	NOUN	O
(	O	PUNCT	O
CK	B-GENE	NOUN	B
)	O	PUNCT	O
activity	O	NOUN	B
delayed	O	VERB	B
by	O	ADP	O
2	O	NUM	O
days	O	NOUN	B
[	O	PUNCT	O
540	O	NUM	O
(	O	PUNCT	O
SD	O	NOUN	B
407	O	NUM	O
)	O	PUNCT	O
U	O	NOUN	O
x	O	NOUN	O
l	O	NOUN	O
(	O	PUNCT	O
-	O	PUNCT	O
1	O	NUM	O
)	O	PUNCT	O
]	O	PUNCT	O
.	O	PUNCT	O


New	O	ADJ	O
Langevin	O	PROPN	O
equations	O	NOUN	O
for	O	ADP	O
a	O	DET	O
translating	O	NOUN	B
and	O	CCONJ	O
simultaneously	O	ADV	B
rotating	O	VERB	B
asymmetric	O	ADJ	I
top	O	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
the	O	DET	O
brain	O	NOUN	B
,	O	PUNCT	O
muscarinic	B-GENE	ADJ	B
receptors	I-GENE	NOUN	I
mediate	O	VERB	O
motor	O	NOUN	B
and	O	CCONJ	O
memory	O	NOUN	B
function	O	NOUN	I
by	O	ADP	O
interaction	O	NOUN	B
with	O	ADP	O
their	O	PRON	O
ligand	O	NOUN	B
acetylcholine	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
this	O	DET	O
study	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
investigated	O	VERB	B
the	O	DET	O
signal	O	NOUN	B
transduction	O	NOUN	I
pathways	O	NOUN	I
that	O	PRON	O
are	O	AUX	O
involved	O	VERB	O
in	O	ADP	O
OM	B-GENE	NOUN	B
-	O	PUNCT	O
induced	O	VERB	B
LDLR	B-GENE	NOUN	B
transcription	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
Lp	B-GENE	NOUN	B
mouse	I-GENE	NOUN	O
mutant	I-GENE	NOUN	O
provides	O	VERB	O
a	O	DET	O
model	O	NOUN	B
for	O	ADP	O
the	O	DET	O
severe	O	ADJ	B
human	O	ADJ	B
neural	O	ADJ	B
tube	O	NOUN	I
defect	O	NOUN	I
(	O	PUNCT	O
NTD	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
cranio	O	NOUN	B
-	O	PUNCT	O
rachischisis	O	NOUN	B
.	O	PUNCT	O


Therefore	O	ADV	O
,	O	PUNCT	O
high	O	ADJ	O
set	O	NOUN	O
-	O	PUNCT	O
up	O	ADP	B
accuracy	O	NOUN	B
and	O	CCONJ	O
reproducibility	O	NOUN	B
are	O	AUX	O
mandatory	O	ADJ	O
.	O	PUNCT	O


CPDs	O	NOUN	B
at	O	ADP	O
these	O	DET	O
three	O	NUM	O
sites	O	NOUN	B
may	O	AUX	O
partially	O	ADV	O
displace	O	VERB	O
TFIIIA	B-GENE	NOUN	B
,	O	PUNCT	O
thereby	O	ADV	O
enabling	O	VERB	O
rapid	O	ADJ	O
repair	O	NOUN	B
.	O	PUNCT	O


There	O	PRON	O
was	O	AUX	O
no	O	DET	O
difference	O	NOUN	O
in	O	ADP	O
the	O	DET	O
hormone	O	NOUN	B
receptor	O	NOUN	I
status	O	NOUN	O
between	O	ADP	O
the	O	DET	O
cases	O	NOUN	B
without	O	ADP	O
lymph	O	NOUN	B
node	O	NOUN	I
metastases	O	NOUN	I
and	O	CCONJ	O
with	O	ADP	O
lymph	O	NOUN	B
node	O	NOUN	I
metastases	O	NOUN	I
,	O	PUNCT	O
'	O	PUNCT	O
clandestine	O	NOUN	B
'	O	PUNCT	O
or	O	CCONJ	O
macrometastases	O	NOUN	B
.	O	PUNCT	O


Gel	O	NOUN	B
filtration	O	NOUN	I
,	O	PUNCT	O
sedimentation	O	NOUN	B
velocity	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
immunoprecipitation	O	NOUN	B
experiments	O	NOUN	B
revealed	O	VERB	O
that	O	SCONJ	O
beta4	O	NOUN	B
is	O	AUX	O
a	O	DET	O
component	O	NOUN	B
of	O	ADP	O
a	O	DET	O
multisubunit	O	ADJ	B
complex	O	NOUN	I
(	O	PUNCT	O
AP	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
4	I-GENE	NUM	O
)	O	PUNCT	O
that	O	PRON	O
also	O	ADV	O
contains	O	VERB	O
the	O	DET	O
sigma4	O	NOUN	B
polypeptide	O	NOUN	I
and	O	CCONJ	O
two	O	NUM	O
additional	O	ADJ	O
adaptor	O	NOUN	B
subunit	O	NOUN	I
homologs	O	NOUN	B
named	O	VERB	O
mu4	O	NOUN	B
(	O	PUNCT	O
mu	O	NOUN	B
-	O	PUNCT	O
ARP2	O	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
epsilon	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
show	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
mouse	O	NOUN	B
genome	O	NOUN	O
contains	O	VERB	O
four	O	NUM	O
copies	O	NOUN	B
of	O	ADP	O
the	O	DET	O
ubc	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
9	I-GENE	NUM	B
gene	I-GENE	NOUN	B
.	O	PUNCT	O


Independent	O	ADJ	B
splicing	O	NOUN	I
events	O	NOUN	I
involve	O	VERB	O
three	O	NUM	O
previously	O	ADV	O
described	O	VERB	O
cassette	O	NOUN	B
exons	O	NOUN	I
,	O	PUNCT	O
which	O	DET	O
are	O	AUX	O
predicted	O	VERB	O
to	O	PART	O
encode	O	VERB	B
most	O	ADJ	O
of	O	ADP	O
the	O	DET	O
second	O	ADJ	O
transmembrane	O	ADJ	B
domain	O	NOUN	I
.	O	PUNCT	O


Each	O	DET	O
of	O	ADP	O
these	O	DET	O
genes	O	NOUN	B
contains	O	VERB	O
a	O	DET	O
putative	O	ADJ	O
upstream	O	ADJ	O
ORF	O	NOUN	O
,	O	PUNCT	O
while	O	SCONJ	O
STA2	B-GENE	NOUN	B
has	O	AUX	O
two	O	NUM	O
additional	O	ADJ	O
in	O	ADP	O
-	O	PUNCT	O
frame	O	NOUN	B
AUG	O	NOUN	B
codons	O	NOUN	O
5	O	NUM	O
'	O	PUNCT	O
to	O	ADP	O
the	O	DET	O
major	O	ADJ	O
cistron	O	NOUN	B
.	O	PUNCT	O


Primary	O	ADJ	B
and	O	CCONJ	O
secondary	O	ADJ	B
structural	O	ADJ	O
elements	O	NOUN	O
required	O	VERB	O
for	O	ADP	O
synthesis	O	NOUN	B
of	O	ADP	O
barley	O	NOUN	B
yellow	O	NOUN	I
dwarf	O	NOUN	I
virus	O	NOUN	I
subgenomic	O	ADJ	B
RNA1	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
H	O	PROPN	B
-	O	PUNCT	O
reflex	O	ADJ	B
recovery	O	NOUN	B
curve	O	NOUN	I
was	O	AUX	O
obtained	O	VERB	O
after	O	ADP	O
stimulation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
median	O	ADJ	B
nerve	O	NOUN	I
at	O	ADP	O
the	O	DET	O
elbow	O	NOUN	B
and	O	CCONJ	O
recording	O	NOUN	B
from	O	ADP	O
the	O	DET	O
flexor	O	ADJ	B
carpi	O	NOUN	I
radialis	O	NOUN	I
.	O	PUNCT	O


To	O	PART	O
identify	O	VERB	O
additional	O	ADJ	O
non	O	ADV	B
-	O	PUNCT	O
Sir	B-GENE	PROPN	B
factors	I-GENE	NOUN	I
that	O	PRON	O
affect	O	VERB	O
rDNA	O	NOUN	B
silencing	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
performed	O	VERB	O
a	O	DET	O
genetic	O	ADJ	B
screen	O	NOUN	I
designed	O	VERB	O
to	O	PART	O
isolate	O	VERB	B
mutations	O	NOUN	B
which	O	DET	O
alter	O	VERB	O
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
reporter	O	NOUN	B
genes	O	NOUN	I
integrated	O	VERB	B
within	O	ADP	O
the	O	DET	O
rDNA	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
this	O	DET	O
study	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
elucidate	O	VERB	O
signaling	O	NOUN	B
pathways	O	NOUN	I
induced	O	VERB	B
by	O	ADP	O
photodynamic	O	ADJ	B
therapy	O	NOUN	I
(	O	PUNCT	O
PDT	O	NOUN	B
)	O	PUNCT	O
with	O	ADP	O
hypericin	O	NOUN	B
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
indicate	O	VERB	O
that	O	SCONJ	O
ATF	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
2	I-GENE	NUM	B
plays	O	VERB	O
a	O	DET	O
central	O	ADJ	O
role	O	NOUN	O
in	O	ADP	O
TGF	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
beta	I-GENE	NOUN	B
signaling	O	NOUN	I
by	O	ADP	O
acting	O	VERB	O
as	O	ADP	O
a	O	DET	O
common	O	ADJ	O
nuclear	O	ADJ	B
target	O	NOUN	B
of	O	ADP	O
both	O	CCONJ	O
Smad	B-GENE	NOUN	B
and	O	CCONJ	O
TAK1	B-GENE	NOUN	B
pathways	O	NOUN	O
.	O	PUNCT	O


FASEB	O	PROPN	B
Federal	O	PROPN	I
Funding	O	PROPN	I
Consensus	O	PROPN	I
Conference	O	PROPN	I
FY	O	PROPN	B
2000	O	NUM	O
.	O	PUNCT	O


Analysis	O	NOUN	B
of	O	ADP	O
the	O	DET	O
protein	O	NOUN	B
sequences	O	NOUN	I
of	O	ADP	O
these	O	DET	O
two	O	NUM	O
replicases	B-GENE	NOUN	B
,	O	PUNCT	O
together	O	ADV	O
with	O	ADP	O
previously	O	ADV	O
characterized	O	VERB	B
H	B-GENE	NOUN	B
.	I-GENE	PUNCT	O
pylori	I-GENE	NOUN	B
plasmid	I-GENE	NOUN	I
replication	I-GENE	NOUN	B
proteins	I-GENE	NOUN	I
,	O	PUNCT	O
supports	O	VERB	O
the	O	DET	O
formation	O	NOUN	B
of	O	ADP	O
a	O	DET	O
distinct	O	ADJ	O
class	O	NOUN	O
of	O	ADP	O
H	B-GENE	NOUN	O
.	I-GENE	PUNCT	O
pylori	I-GENE	NOUN	B
plasmid	I-GENE	NOUN	I
proteins	I-GENE	NOUN	B
.	O	PUNCT	O


The	O	DET	O
algorithm	O	NOUN	B
also	O	ADV	O
limited	O	VERB	O
TG	O	NOUN	B
to	O	ADP	O
20	O	NUM	O
and	O	CCONJ	O
64	O	NUM	O
%	O	NOUN	O
,	O	PUNCT	O
apoB	B-GENE	NOUN	B
to	O	PART	O
6	O	NUM	O
and	O	CCONJ	O
20	O	NUM	O
%	O	NOUN	O
,	O	PUNCT	O
and	O	CCONJ	O
Lp	B-GENE	NOUN	B
(	I-GENE	PUNCT	O
a	I-GENE	X	O
)	I-GENE	PUNCT	O
to	O	PART	O
15	O	NUM	O
and	O	CCONJ	O
56	O	NUM	O
%	O	NOUN	O
,	O	PUNCT	O
of	O	ADP	O
low	O	ADJ	B
-	O	PUNCT	O
and	O	CCONJ	O
high	O	ADJ	B
-	O	PUNCT	O
risk	O	NOUN	B
groups	O	NOUN	B
,	O	PUNCT	O
respectively	O	ADV	O
.	O	PUNCT	O


Conformational	O	ADJ	B
studies	O	NOUN	I
combining	O	VERB	O
secondary	O	ADJ	B
structure	O	NOUN	I
predictions	O	NOUN	O
,	O	PUNCT	O
CD	O	NOUN	B
and	O	CCONJ	O
NMR	O	NOUN	B
spectroscopy	O	NOUN	I
together	O	ADV	O
with	O	ADP	O
ELISA	O	NOUN	B
assays	O	NOUN	I
,	O	PUNCT	O
showed	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
greater	O	ADJ	B
is	O	AUX	O
the	O	DET	O
propensity	O	NOUN	B
of	O	ADP	O
the	O	DET	O
epitope	O	NOUN	B
for	O	ADP	O
helix	O	NOUN	B
formation	O	NOUN	I
the	O	DET	O
higher	O	ADJ	B
is	O	AUX	O
the	O	DET	O
recognition	O	NOUN	B
by	O	ADP	O
anti	B-GENE	ADJ	B
-	I-GENE	PUNCT	O
K159	I-GENE	NOUN	B
.	O	PUNCT	O


Schwab	O	PROPN	B
and	O	CCONJ	O
England	O	PROPN	B
ADL	O	PROPN	O
scores	O	NOUN	B
in	O	ADP	O
the	O	DET	O
"	O	PUNCT	O
off	O	ADP	O
"	O	PUNCT	O
state	O	NOUN	B
were	O	AUX	O
improved	O	VERB	B
by	O	ADP	O
18	O	NUM	O
%	O	NOUN	O
and	O	CCONJ	O
in	O	ADP	O
the	O	DET	O
"	O	PUNCT	O
on	O	ADP	O
"	O	PUNCT	O
state	O	NOUN	B
the	O	DET	O
scores	O	NOUN	B
declined	O	VERB	B
by	O	ADP	O
2	O	NUM	O
%	O	NOUN	O
.	O	PUNCT	O


Sequence	O	NOUN	B
analysis	O	NOUN	I
revealed	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
MEMA	B-GENE	NOUN	B
protein	I-GENE	NOUN	I
is	O	AUX	O
identical	O	ADJ	B
with	O	ADP	O
a	O	DET	O
160	B-GENE	NUM	O
kDa	I-GENE	NOUN	O
nuclear	I-GENE	ADJ	O
'	I-GENE	PUNCT	O
domain	I-GENE	NOUN	O
rich	I-GENE	ADJ	O
in	I-GENE	ADP	O
serines	I-GENE	NOUN	B
'	I-GENE	PART	O
(	I-GENE	PUNCT	O
DRS	I-GENE	NOUN	B
)	I-GENE	PUNCT	O
protein	I-GENE	NOUN	O
occurring	O	VERB	O
free	O	ADJ	B
in	O	ADP	O
the	O	DET	O
nucleoplasm	O	NOUN	B
and	O	CCONJ	O
in	O	ADP	O
U2	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
ribonucleoprotein	I-GENE	NOUN	B
structures	I-GENE	NOUN	I
.	O	PUNCT	O


Dopaminergic	O	ADJ	B
modulation	O	NOUN	B
of	O	ADP	O
transcallosal	O	ADJ	B
activity	O	NOUN	I
of	O	ADP	O
cat	O	NOUN	B
motor	O	NOUN	I
cortical	O	ADJ	I
neurons	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
induced	O	VERB	B
respiratory	O	ADJ	B
burst	O	NOUN	I
was	O	AUX	O
investigated	O	VERB	B
by	O	ADP	O
the	O	DET	O
intracellular	O	ADJ	B
oxidative	O	ADJ	B
transformation	O	NOUN	I
of	O	ADP	O
dihydrorhodamine	O	NOUN	B
123	O	NUM	I
to	O	PART	O
the	O	DET	O
fluorescent	O	ADJ	B
dye	O	NOUN	I
rhodamine	O	NOUN	I
123	O	NUM	I
via	O	ADP	O
flow	O	NOUN	B
cytometry	O	NOUN	I
.	O	PUNCT	O


JCAHO	O	NOUN	B
asks	O	VERB	O
for	O	ADP	O
hospitals	O	NOUN	B
'	O	PART	O
patience	O	NOUN	B
.	O	PUNCT	O


25	O	NUM	O
-	O	PUNCT	O
OH	O	PROPN	B
-	O	PUNCT	O
D3	O	NOUN	B
did	O	AUX	O
not	O	PART	O
adversely	O	ADV	O
affect	O	VERB	O
animal	O	ADJ	B
health	O	NOUN	B
at	O	ADP	O
the	O	DET	O
proposed	O	VERB	O
use	O	NOUN	O
level	O	NOUN	B
of	O	ADP	O
99	O	NUM	O
micrograms	O	NOUN	B
/	O	PUNCT	O
kg	O	NOUN	B
feed	O	NOUN	B
when	O	SCONJ	O
replacing	O	VERB	O
vitamin	O	NOUN	B
D3	O	NOUN	I
in	O	ADP	O
turkey	O	NOUN	B
rations	O	NOUN	B
.	O	PUNCT	O


As	O	ADP	O
such	O	DET	O
the	O	DET	O
findings	O	NOUN	B
support	O	VERB	O
existing	O	VERB	O
studies	O	NOUN	B
that	O	PRON	O
have	O	AUX	O
identified	O	VERB	B
given	O	VERB	O
social	O	ADJ	B
characteristics	O	NOUN	I
of	O	ADP	O
drink	O	NOUN	B
drivers	O	NOUN	B
.	O	PUNCT	O


Analysis	O	NOUN	B
of	O	ADP	O
lacZ	B-GENE	NOUN	B
transcriptional	I-GENE	ADJ	B
fusions	I-GENE	NOUN	I
shows	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
KdgR	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
binding	I-GENE	VERB	B
sites	I-GENE	NOUN	O
negatively	O	ADV	B
affect	O	VERB	O
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
rsmB	B-GENE	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
the	O	DET	O
cell	O	NOUN	B
-	O	PUNCT	O
free	O	ADJ	B
import	O	NOUN	O
assay	O	NOUN	O
,	O	PUNCT	O
beta	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
catenin	I-GENE	NOUN	B
rapidly	O	ADV	O
migrates	O	VERB	B
into	O	ADP	O
the	O	DET	O
nucleus	O	NOUN	B
without	O	ADP	O
the	O	DET	O
exogenous	O	ADJ	B
addition	O	NOUN	O
of	O	ADP	O
cytosol	O	NOUN	B
,	O	PUNCT	O
Ran	B-GENE	NOUN	B
,	O	PUNCT	O
or	O	CCONJ	O
ATP	O	NOUN	B
/	O	SYM	O
GTP	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
ischemic	O	ADJ	B
and	O	CCONJ	O
hypoxic	O	ADJ	B
hypoxia	O	NOUN	I
,	O	PUNCT	O
a	O	DET	O
strong	O	ADJ	O
correlation	O	NOUN	B
was	O	AUX	O
found	O	VERB	O
between	O	ADP	O
cyt	O	NOUN	B
a	O	DET	O
,	O	PUNCT	O
a3	O	ADJ	B
oxidation	O	NOUN	I
level	O	NOUN	B
and	O	CCONJ	O
VO2	O	NOUN	B
in	O	ADP	O
both	O	CCONJ	O
ischemic	O	ADJ	B
and	O	CCONJ	O
hypoxic	O	ADJ	B
hypoxia	O	NOUN	I
(	O	PUNCT	O
r2	O	NOUN	O
=	O	ADJ	O
.	O	PUNCT	O
90	O	NUM	O
and	O	CCONJ	O
.	O	PUNCT	O
87	O	NUM	O
,	O	PUNCT	O
respectively	O	ADV	O
)	O	PUNCT	O
.	O	PUNCT	O


Each	O	DET	O
recombinant	O	ADJ	B
product	O	NOUN	I
was	O	AUX	O
a	O	DET	O
fusion	O	NOUN	B
protein	O	NOUN	I
with	O	ADP	O
a	O	DET	O
B	O	NOUN	B
domain	O	NOUN	I
of	O	ADP	O
Staphylococcal	B-GENE	ADJ	B
protein	I-GENE	NOUN	I
A	I-GENE	NOUN	I
(	O	PUNCT	O
SPA	B-GENE	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Polypyrimidine	O	NOUN	B
and	O	CCONJ	O
ssDNA	O	NOUN	B
binding	O	NOUN	I
by	O	ADP	O
the	O	DET	O
isolated	O	VERB	B
VH	B-GENE	NOUN	B
domain	I-GENE	NOUN	I
of	O	ADP	O
immunization	O	NOUN	B
-	O	PUNCT	O
induced	O	VERB	B
anti	O	ADJ	B
-	O	PUNCT	O
Z	O	NOUN	B
-	O	PUNCT	O
DNA	O	NOUN	B
Ab	O	NOUN	I
resembles	O	VERB	O
the	O	DET	O
activity	O	NOUN	B
of	O	ADP	O
natural	O	ADJ	B
autoantibodies	O	NOUN	I
and	O	CCONJ	O
suggests	O	VERB	O
that	O	SCONJ	O
VH	B-GENE	PROPN	B
-	O	PUNCT	O
dependent	O	ADJ	B
binding	O	NOUN	B
to	O	PART	O
a	O	DET	O
ligand	O	NOUN	B
mimicked	O	VERB	B
by	O	ADP	O
polypyrimidines	O	NOUN	B
may	O	AUX	O
play	O	VERB	O
a	O	DET	O
role	O	NOUN	O
in	O	ADP	O
B	O	NOUN	B
cell	O	NOUN	I
selection	O	NOUN	O
before	O	ADP	O
immunization	O	NOUN	B
with	O	ADP	O
Z	O	NOUN	B
-	O	PUNCT	O
DNA	O	NOUN	B
.	O	PUNCT	O


INTERVENTIONS	O	NOUN	B
:	O	PUNCT	O
Study	O	NOUN	B
patients	O	NOUN	B
were	O	AUX	O
randomly	O	ADV	O
divided	O	VERB	O
into	O	ADP	O
four	O	NUM	O
parallel	O	ADJ	O
groups	O	NOUN	B
to	O	PART	O
receive	O	VERB	O
either	O	CCONJ	O
terbinafine	O	NOUN	B
250	O	NUM	O
mg	O	NOUN	O
a	O	DET	O
day	O	NOUN	B
for	O	ADP	O
12	O	NUM	O
or	O	CCONJ	O
16	O	NUM	O
weeks	O	NOUN	B
(	O	PUNCT	O
groups	O	NOUN	B
T12	O	NOUN	O
and	O	CCONJ	O
T16	O	NOUN	B
)	O	PUNCT	O
or	O	CCONJ	O
itraconazole	O	NOUN	B
400	O	NUM	O
mg	O	NOUN	O
a	O	DET	O
day	O	NOUN	B
for	O	ADP	O
1	O	NUM	O
week	O	NOUN	B
in	O	ADP	O
every	O	DET	O
4	O	NUM	O
weeks	O	NOUN	B
for	O	ADP	O
12	O	NUM	O
or	O	CCONJ	O
16	O	NUM	O
weeks	O	NOUN	B
(	O	PUNCT	O
groups	O	NOUN	B
I3	O	NOUN	O
and	O	CCONJ	O
I4	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Bacteria	O	NOUN	B
can	O	AUX	O
also	O	ADV	O
cause	O	VERB	O
a	O	DET	O
labyrinthitis	O	NOUN	B
acting	O	VERB	O
directly	O	ADV	O
on	O	ADP	O
the	O	DET	O
inner	O	ADJ	B
ear	O	NOUN	I
:	O	PUNCT	O
among	O	ADP	O
these	O	DET	O
,	O	PUNCT	O
Treponemas	O	PROPN	O
Pallidum	O	PROPN	B
,	O	PUNCT	O
a	O	DET	O
spirochaete	O	NOUN	B
which	O	DET	O
causes	O	VERB	O
syphilis	O	NOUN	B
and	O	CCONJ	O
Borrelia	O	PROPN	B
Burgdorferi	O	PROPN	I
,	O	PUNCT	O
a	O	DET	O
spirochaete	O	NOUN	B
that	O	PRON	O
causes	O	VERB	O
Lyme	O	PROPN	B
Disease	O	PROPN	I
,	O	PUNCT	O
must	O	AUX	O
be	O	AUX	O
mentioned	O	VERB	O
.	O	PUNCT	O


Initial	O	ADJ	O
control	O	NOUN	B
of	O	ADP	I
bleeding	O	NOUN	B
is	O	AUX	O
similar	O	ADJ	O
,	O	PUNCT	O
but	O	CCONJ	O
eradication	O	NOUN	B
is	O	AUX	O
achieved	O	VERB	O
in	O	ADP	O
fewer	O	ADJ	O
sessions	O	NOUN	B
with	O	ADP	O
EVL	O	NOUN	B
.	O	PUNCT	O


Canalith	O	PROPN	B
repositioning	O	NOUN	I
is	O	AUX	O
the	O	DET	O
mainstay	O	ADJ	O
of	O	ADP	O
treatment	O	NOUN	B
.	O	PUNCT	O


Solution	O	NOUN	B
structure	O	NOUN	I
and	O	CCONJ	O
mechanism	O	NOUN	B
of	O	ADP	O
the	O	DET	O
MutT	B-GENE	NOUN	B
pyrophosphohydrolase	I-GENE	NOUN	I
.	O	PUNCT	O


The	O	DET	O
binding	O	NOUN	B
of	O	ADP	O
PH	B-GENE	NOUN	B
domains	I-GENE	NOUN	I
to	O	PART	O
Gbetagamma	B-GENE	NOUN	B
was	O	AUX	O
inhibited	O	VERB	B
by	O	ADP	O
preincubation	O	NOUN	B
of	O	ADP	O
Gbetagamma	B-GENE	NOUN	B
with	O	ADP	O
the	O	DET	O
GDP	O	PROPN	B
-	O	PUNCT	O
bound	O	VERB	B
but	O	CCONJ	O
not	O	PART	O
the	O	DET	O
GTP	O	NOUN	B
-	O	PUNCT	O
bound	O	VERB	B
form	O	NOUN	O
of	O	ADP	O
Gialpha	B-GENE	NOUN	B
.	O	PUNCT	O


Two	O	NUM	O
-	O	PUNCT	O
dimensional	O	ADJ	B
gel	O	NOUN	B
electrophoresis	O	NOUN	I
of	O	ADP	O
anti	B-GENE	ADJ	B
-	I-GENE	PUNCT	O
p59fyn	I-GENE	NOUN	B
immunoprecipitates	O	NOUN	B
obtained	O	VERB	O
from	O	ADP	O
non	O	ADV	B
-	O	PUNCT	O
transformed	O	VERB	B
resting	O	VERB	O
human	O	ADJ	O
T	O	NOUN	O
lymphocytes	O	NOUN	O
resulted	O	VERB	O
in	O	ADP	O
the	O	DET	O
identification	O	NOUN	B
of	O	ADP	O
an	O	DET	O
oligomeric	O	ADJ	B
protein	O	NOUN	I
complex	O	NOUN	I
which	O	DET	O
is	O	AUX	O
constitutively	O	ADV	B
formed	O	VERB	O
between	O	ADP	O
Fyn	B-GENE	NOUN	B
and	O	CCONJ	O
several	O	ADJ	O
additional	O	ADJ	O
phosphoproteins	O	NOUN	B
(	O	PUNCT	O
pp43	B-GENE	NOUN	B
,	O	PUNCT	O
pp72	B-GENE	NOUN	B
,	O	PUNCT	O
pp85	B-GENE	NOUN	B
,	O	PUNCT	O
the	O	DET	O
protein	B-GENE	NOUN	B
tyrosine	I-GENE	NOUN	I
kinase	I-GENE	NOUN	I
Pyk2	B-GENE	NOUN	B
,	O	PUNCT	O
as	O	ADV	O
well	O	ADV	O
as	O	ADP	O
the	O	DET	O
two	O	NUM	O
recently	O	ADV	O
cloned	O	VERB	B
adaptor	O	NOUN	O
proteins	O	NOUN	O
,	O	PUNCT	O
SKAP55	B-GENE	NOUN	B
and	O	CCONJ	O
SLAP	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
130	I-GENE	NUM	O
)	O	PUNCT	O
.	O	PUNCT	O


The	O	DET	O
gene	O	NOUN	B
structure	O	NOUN	I
of	O	ADP	O
Elk1	B-GENE	NOUN	B
spans	O	VERB	O
15	O	NUM	O
.	O	PUNCT	O
2	O	NUM	O
kb	O	NOUN	O
and	O	CCONJ	O
consists	O	VERB	O
of	O	ADP	O
seven	O	NUM	O
exons	O	NOUN	B
and	O	CCONJ	O
six	O	NUM	O
introns	O	NOUN	B
.	O	PUNCT	O


Sequence	O	NOUN	B
analysis	O	NOUN	I
suggests	O	VERB	O
that	O	SCONJ	O
TtrA	B-GENE	NOUN	B
contains	O	VERB	O
a	O	DET	O
molybdopterin	O	NOUN	B
guanine	O	NOUN	I
dinucleotide	O	NOUN	I
cofactor	O	NOUN	I
and	O	CCONJ	O
a	O	DET	O
[	O	PUNCT	O
4Fe	O	PROPN	B
-	O	PUNCT	O
4S	O	NOUN	B
]	O	PUNCT	O
cluster	O	NOUN	B
,	O	PUNCT	O
that	O	SCONJ	O
TtrB	B-GENE	NOUN	B
binds	O	VERB	B
four	O	NUM	O
[	O	PUNCT	O
4Fe	O	PROPN	B
-	O	PUNCT	O
4S	O	NOUN	B
]	O	PUNCT	O
clusters	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
that	O	SCONJ	O
TtrC	B-GENE	NOUN	B
is	O	AUX	O
an	O	DET	O
integral	O	ADJ	B
membrane	O	NOUN	I
protein	O	NOUN	I
containing	O	VERB	O
a	O	DET	O
quinol	O	NOUN	B
oxidation	O	NOUN	I
site	O	NOUN	O
.	O	PUNCT	O


Previous	O	ADJ	O
work	O	NOUN	O
has	O	AUX	O
shown	O	VERB	O
that	O	SCONJ	O
spleen	B-GENE	NOUN	B
necrosis	I-GENE	NOUN	I
virus	I-GENE	NOUN	I
(	I-GENE	PUNCT	O
SNV	I-GENE	NOUN	B
)	I-GENE	PUNCT	O
long	I-GENE	ADJ	B
terminal	I-GENE	ADJ	I
repeats	I-GENE	NOUN	I
(	O	PUNCT	O
LTRs	O	NOUN	B
)	O	PUNCT	O
are	O	AUX	O
associated	O	VERB	B
with	O	ADP	I
Rex	B-GENE	NOUN	B
/	O	SYM	O
Rex	B-GENE	PROPN	B
-	O	PUNCT	O
responsive	O	ADJ	B
element	O	NOUN	B
-	O	PUNCT	O
independent	O	ADJ	B
expression	O	NOUN	B
of	O	ADP	O
bovine	O	ADJ	B
leukemia	O	NOUN	I
virus	O	NOUN	O
RNA	O	NOUN	O
and	O	CCONJ	O
supports	O	VERB	O
the	O	DET	O
hypothesis	O	NOUN	B
that	O	SCONJ	O
SNV	O	NOUN	B
RNA	O	NOUN	I
contains	O	VERB	O
a	O	DET	O
cis	O	ADV	B
-	O	PUNCT	O
acting	O	VERB	B
element	O	NOUN	B
that	O	PRON	O
interacts	O	VERB	O
with	O	ADP	O
cellular	B-GENE	ADJ	B
Rex	I-GENE	NOUN	I
-	I-GENE	PUNCT	O
like	I-GENE	ADJ	B
proteins	I-GENE	NOUN	B
.	O	PUNCT	O


Online	O	NOUN	B
LATCH	O	NOUN	I
demonstrates	O	VERB	O
a	O	DET	O
shift	O	NOUN	B
in	O	ADP	O
identification	O	NOUN	B
of	O	ADP	O
the	O	DET	O
library	O	NOUN	B
as	O	ADP	O
an	O	DET	O
isolated	O	VERB	B
unit	O	NOUN	O
to	O	ADP	O
an	O	DET	O
interactive	O	ADJ	B
resource	O	NOUN	O
center	O	NOUN	O
.	O	PUNCT	O


We	O	PRON	O
calculated	O	VERB	O
differences	O	NOUN	B
in	O	ADP	O
late	O	ADJ	B
occlusion	O	NOUN	I
rates	O	NOUN	B
by	O	ADP	O
the	O	DET	O
chi2	O	NOUN	B
(	O	PUNCT	O
chi	O	NOUN	B
-	O	PUNCT	O
square	O	ADJ	B
)	O	PUNCT	O
test	O	NOUN	O
,	O	PUNCT	O
and	O	CCONJ	O
found	O	VERB	O
these	O	DET	O
differences	O	NOUN	B
were	O	AUX	O
significant	O	ADJ	B
(	O	PUNCT	O
P	O	NOUN	O
=	O	ADJ	O
.	O	PUNCT	O
04	O	NUM	O
)	O	PUNCT	O
.	O	PUNCT	O


We	O	PRON	O
describe	O	VERB	O
a	O	DET	O
genetic	O	ADJ	B
system	O	NOUN	I
for	O	ADP	O
further	O	ADV	O
characterizing	O	VERB	O
the	O	DET	O
role	O	NOUN	O
of	O	ADP	O
the	O	DET	O
extreme	O	ADJ	O
C	O	NOUN	B
-	O	PUNCT	O
terminus	O	NOUN	B
of	O	ADP	O
the	O	DET	O
beta	O	NOUN	B
subunit	O	NOUN	I
of	O	ADP	I
E	B-GENE	NOUN	I
.	I-GENE	PUNCT	O
coli	I-GENE	X	B
RNA	I-GENE	NOUN	I
polymerase	I-GENE	NOUN	I
.	O	PUNCT	O


The	O	DET	O
enhanced	O	VERB	B
binding	O	NOUN	B
of	O	ADP	O
c	B-GENE	NOUN	O
-	I-GENE	PUNCT	O
Abl	I-GENE	NOUN	B
to	O	PART	O
DNA	O	NOUN	B
containing	O	VERB	O
5	O	NUM	O
-	O	PUNCT	O
methylcytosine	O	NOUN	B
residues	O	NOUN	I
may	O	AUX	O
result	O	VERB	O
from	O	ADP	O
an	O	DET	O
increased	O	VERB	B
propensity	O	NOUN	B
of	O	ADP	O
the	O	DET	O
double	O	ADJ	B
helix	O	NOUN	I
to	O	PART	O
denature	O	VERB	B
locally	O	ADV	B
coupled	O	VERB	I
with	O	ADP	O
a	O	DET	O
protein	O	NOUN	B
-	O	PUNCT	O
induced	O	VERB	B
reduction	O	NOUN	B
in	O	ADP	O
the	O	DET	O
base	O	NOUN	B
stacking	O	NOUN	I
interaction	O	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
further	O	ADV	O
demonstrate	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
Stress	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
Activated	I-GENE	VERB	B
-	I-GENE	PUNCT	O
Protein	I-GENE	PROPN	B
-	I-GENE	PUNCT	O
Kinase	I-GENE	NOUN	B
(	O	PUNCT	O
SAPK	B-GENE	NOUN	B
)	O	PUNCT	O
target	O	NOUN	B
sites	O	NOUN	O
of	O	ADP	O
ATF2	B-GENE	NOUN	B
,	O	PUNCT	O
Thr69	O	NOUN	B
and	O	CCONJ	O
Thr71	O	NOUN	B
are	O	AUX	O
not	O	PART	O
required	O	VERB	O
for	O	ADP	O
the	O	DET	O
formation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
p300	B-GENE	NOUN	B
/	O	SYM	O
CBP	B-GENE	PROPN	B
-	O	PUNCT	O
ATF2	B-GENE	NOUN	B
multiprotein	O	ADJ	B
complex	O	NOUN	I
.	O	PUNCT	O


O	B-GENE	INTJ	B
.	I-GENE	PUNCT	O
novo	I-GENE	X	O
-	I-GENE	PUNCT	O
ulmi	I-GENE	X	B
RNA	I-GENE	NOUN	I
-	I-GENE	SYM	O
7	I-GENE	NUM	O
,	O	PUNCT	O
previously	O	ADV	O
believed	O	VERB	O
to	O	PART	O
be	O	AUX	O
a	O	DET	O
satellite	O	NOUN	B
-	O	PUNCT	O
like	O	ADJ	B
RNA	O	NOUN	B
,	O	PUNCT	O
is	O	AUX	O
shown	O	VERB	O
to	O	PART	O
be	O	AUX	O
a	O	DET	O
defective	O	ADJ	B
RNA	O	NOUN	B
,	O	PUNCT	O
derived	O	VERB	O
from	O	ADP	O
OnuMV4	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
Ld	I-GENE	NOUN	B
RNA	I-GENE	NOUN	I
by	O	ADP	O
multiple	O	ADJ	O
internal	O	ADJ	O
deletions	O	NOUN	O
.	O	PUNCT	O


The	O	DET	O
paramyxovirus	B-GENE	NOUN	B
fusion	I-GENE	NOUN	I
(	I-GENE	PUNCT	O
F	I-GENE	NOUN	O
)	I-GENE	PUNCT	O
protein	I-GENE	NOUN	O
mediates	O	VERB	O
membrane	O	NOUN	B
fusion	O	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
the	O	DET	O
present	O	ADJ	O
study	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
show	O	VERB	O
that	O	SCONJ	O
SRm160	B-GENE	ADV	B
/	I-GENE	SYM	O
300	I-GENE	NUM	O
is	O	AUX	O
required	O	VERB	O
for	O	ADP	O
a	O	DET	O
purine	O	NOUN	B
-	O	PUNCT	O
rich	O	ADJ	B
ESE	B-GENE	NOUN	B
to	O	PART	O
promote	O	VERB	B
the	O	DET	O
splicing	O	NOUN	B
of	O	ADP	O
a	O	DET	O
pre	O	ADJ	B
-	O	PUNCT	O
mRNA	O	NOUN	B
derived	O	VERB	O
from	O	ADP	O
the	O	DET	O
Drosophila	B-GENE	NOUN	B
doublesex	I-GENE	NOUN	B
gene	I-GENE	NOUN	I
.	O	PUNCT	O


The	O	DET	O
coefficient	O	NOUN	B
of	O	ADP	O
determination	O	NOUN	B
,	O	PUNCT	O
r2	O	NOUN	B
,	O	PUNCT	O
of	O	ADP	O
the	O	DET	O
other	O	ADJ	O
scores	O	NOUN	B
ranged	O	VERB	O
from	O	ADP	O
0	O	NUM	O
.	O	PUNCT	O
56	O	NUM	O
to	O	PART	O
0	O	NUM	O
.	O	PUNCT	O
61	O	NUM	O
.	O	PUNCT	O


While	O	SCONJ	O
determination	O	NOUN	B
of	O	ADP	O
the	O	DET	O
protein	O	NOUN	B
content	O	NOUN	B
of	O	ADP	O
the	O	DET	O
formulae	O	NOUN	B
gave	O	VERB	O
no	O	DET	O
valid	O	ADJ	O
information	O	NOUN	B
,	O	PUNCT	O
RAST	O	NOUN	B
/	O	PUNCT	O
EAST	O	NOUN	B
inhibition	O	NOUN	B
was	O	AUX	O
highest	O	ADJ	O
for	O	ADP	O
cow	O	NOUN	B
'	O	PART	O
s	O	NOUN	O
milk	O	NOUN	B
,	O	PUNCT	O
followed	O	VERB	O
by	O	ADP	O
the	O	DET	O
partially	O	ADV	B
hydrolysed	O	VERB	B
whey	O	NOUN	I
formula	O	NOUN	I
,	O	PUNCT	O
partially	O	ADV	O
hydrolysed	O	VERB	B
whey	O	NOUN	B
/	O	SYM	O
casein	B-GENE	NOUN	B
formula	O	NOUN	I
,	O	PUNCT	O
soy	B-GENE	NOUN	B
/	I-GENE	SYM	O
pork	I-GENE	NOUN	B
collagen	I-GENE	NOUN	I
formula	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
the	O	DET	O
amino	O	NOUN	B
acid	O	NOUN	I
formula	O	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
light	O	NOUN	O
of	O	ADP	O
the	O	DET	O
importance	O	NOUN	O
of	O	ADP	O
GnRHR	B-GENE	NOUN	B
,	O	PUNCT	O
the	O	DET	O
molecular	O	ADJ	B
mechanisms	O	NOUN	I
underlying	O	VERB	O
the	O	DET	O
transcriptional	O	ADJ	B
regulation	O	NOUN	I
of	O	ADP	O
the	O	DET	O
human	B-GENE	ADJ	B
GnRHR	I-GENE	NOUN	I
(	O	PUNCT	O
hGnRHR	B-GENE	NOUN	B
)	O	PUNCT	O
gene	O	NOUN	O
become	O	VERB	O
a	O	DET	O
key	O	ADJ	O
issue	O	NOUN	B
in	O	ADP	O
understanding	O	VERB	O
human	O	ADJ	B
reproduction	O	NOUN	B
.	O	PUNCT	O


Competitive	O	ADJ	B
mobility	O	NOUN	B
shift	O	NOUN	O
assays	O	NOUN	O
using	O	VERB	O
either	O	CCONJ	O
alphaT3	O	NOUN	B
-	O	PUNCT	O
1	O	NUM	O
nuclear	O	ADJ	B
extract	O	NOUN	I
or	O	CCONJ	O
recombinant	B-GENE	ADJ	B
SF	I-GENE	PROPN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	O
protein	I-GENE	NOUN	B
clearly	O	ADV	O
indicated	O	VERB	O
that	O	SCONJ	O
SF	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	O
is	O	AUX	O
able	O	ADJ	O
to	O	PART	O
interact	O	VERB	B
specifically	O	ADV	O
with	O	ADP	O
this	O	DET	O
GSE	B-GENE	NOUN	B
element	I-GENE	NOUN	B
positioned	O	ADJ	O
at	O	ADP	O
-	O	PUNCT	O
134	O	NUM	O
.	O	PUNCT	O


Grade	O	NOUN	B
3	O	NUM	I
mucositis	O	NOUN	I
was	O	AUX	O
reported	O	VERB	O
in	O	ADP	O
1	O	NUM	O
patient	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
a	O	DET	O
heterologous	O	ADJ	B
transcriptional	O	ADJ	B
system	O	NOUN	I
in	O	ADP	O
which	O	DET	O
the	O	DET	O
upstream	O	ADJ	B
regions	O	NOUN	I
of	O	ADP	O
oIFNtau	B-GENE	NOUN	B
were	O	AUX	O
inserted	O	VERB	B
in	O	ADP	O
front	O	NOUN	O
of	O	ADP	O
simian	B-GENE	ADJ	B
virus	I-GENE	NOUN	I
40	I-GENE	NUM	O
(	I-GENE	PUNCT	O
SV40	I-GENE	NOUN	B
)	I-GENE	PUNCT	O
promoter	I-GENE	NOUN	B
,	O	PUNCT	O
the	O	DET	O
regions	O	NOUN	B
between	O	ADP	O
bases	O	NOUN	B
-	O	PUNCT	O
654	O	NUM	O
and	O	CCONJ	O
-	O	PUNCT	O
555	O	NUM	O
were	O	AUX	O
determined	O	VERB	O
as	O	ADP	O
being	O	AUX	O
the	O	DET	O
enhancer	O	NOUN	B
region	O	NOUN	I
required	O	VERB	O
for	O	ADP	O
oIFNtau	B-GENE	NOUN	B
-	O	PUNCT	O
SV40	O	NOUN	B
-	O	PUNCT	O
CAT	B-GENE	NOUN	B
transactivation	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
co	O	ADJ	B
-	O	PUNCT	O
transfection	O	NOUN	B
studies	O	NOUN	B
,	O	PUNCT	O
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
c	B-GENE	NOUN	O
-	I-GENE	PUNCT	O
Jun	I-GENE	NOUN	B
plus	O	CCONJ	I
c	B-GENE	NOUN	I
-	I-GENE	PUNCT	O
Fos	I-GENE	NOUN	B
enhanced	O	VERB	B
the	O	DET	O
transactivation	O	NOUN	B
of	O	ADP	O
oIFNtau	B-GENE	NOUN	B
-	O	PUNCT	O
CAT	B-GENE	NOUN	B
but	O	CCONJ	O
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
GATA	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	O
,	O	PUNCT	O
GATA	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
2	I-GENE	NUM	B
or	O	CCONJ	O
GATA	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
3	I-GENE	NUM	O
did	O	AUX	O
not	O	PART	O
.	O	PUNCT	O


The	O	DET	O
relatively	O	ADV	O
mild	O	ADJ	B
defects	O	NOUN	B
observed	O	VERB	O
in	O	ADP	O
Rpd3	B-GENE	NOUN	B
mutants	I-GENE	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
recently	O	ADV	O
identified	O	VERB	O
Groucho	B-GENE	NOUN	B
and	O	CCONJ	O
dCtBP	B-GENE	NOUN	B
corepressor	I-GENE	NOUN	I
proteins	I-GENE	NOUN	I
do	O	AUX	O
not	O	PART	O
function	O	VERB	B
solely	O	ADV	O
through	O	ADP	O
the	O	DET	O
recruitment	O	NOUN	B
of	O	ADP	O
histone	B-GENE	NOUN	B
deacetylases	I-GENE	NOUN	I
.	O	PUNCT	O


Both	O	CCONJ	O
carbachol	O	NOUN	B
(	O	PUNCT	O
100	O	NUM	O
microM	O	NOUN	O
)	O	PUNCT	O
and	O	CCONJ	O
EGF	B-GENE	NOUN	B
(	O	PUNCT	O
10	O	NUM	O
nM	O	NOUN	O
)	O	PUNCT	O
induced	O	VERB	B
Ras	B-GENE	NOUN	B
activation	O	NOUN	B
.	O	PUNCT	O


Dominant	O	ADJ	B
negative	O	ADJ	I
Sos	B-GENE	NOUN	B
did	O	AUX	O
not	O	PART	O
affect	O	VERB	O
carbachol	O	NOUN	B
stimulation	O	NOUN	I
of	O	ADP	O
HA	B-GENE	NOUN	B
-	O	PUNCT	O
ERK2	B-GENE	NOUN	B
but	O	CCONJ	O
inhibited	O	VERB	B
the	O	DET	O
stimulatory	O	ADJ	B
effect	O	NOUN	I
of	O	ADP	O
EGF	B-GENE	NOUN	B
by	O	ADP	O
60	O	NUM	O
%	O	NOUN	O
.	O	PUNCT	O


Hrs	B-GENE	NOUN	B
has	O	AUX	O
a	O	DET	O
FYVE	O	NOUN	B
double	O	ADJ	O
zinc	O	NOUN	B
finger	O	NOUN	I
domain	O	NOUN	I
,	O	PUNCT	O
which	O	DET	O
specifically	O	ADV	O
binds	O	VERB	B
phosphatidylinositol	O	NOUN	I
(	O	PUNCT	O
3	O	NUM	O
)	O	PUNCT	O
-	O	PUNCT	O
phosphate	O	NOUN	B
and	O	CCONJ	O
is	O	AUX	O
conserved	O	VERB	O
in	O	ADP	O
several	O	ADJ	O
proteins	O	NOUN	B
involved	O	VERB	O
in	O	ADP	O
vesicular	O	ADJ	B
traffic	O	NOUN	B
.	O	PUNCT	O


Three	O	NUM	O
subgenomes	O	NOUN	B
also	O	ADV	O
comprised	O	VERB	O
15	O	NUM	O
to	O	PART	O
75	O	NUM	O
nucleotides	O	NOUN	B
derived	O	VERB	O
from	O	ADP	O
the	O	DET	O
5	O	NUM	O
'	O	PART	O
part	O	NOUN	O
of	O	ADP	O
the	O	DET	O
NS2	B-GENE	NOUN	B
gene	I-GENE	NOUN	I
.	O	PUNCT	O


The	O	DET	O
hybrid	O	NOUN	B
viruses	O	NOUN	I
were	O	AUX	O
found	O	VERB	O
to	O	PART	O
accumulate	O	VERB	B
to	O	ADP	O
high	O	ADJ	O
levels	O	NOUN	B
in	O	ADP	O
infected	O	ADJ	B
plants	O	NOUN	B
,	O	PUNCT	O
to	O	PART	O
form	O	VERB	O
stable	O	ADJ	B
virions	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
to	O	PART	O
be	O	AUX	O
mechanically	O	ADV	B
transmissible	O	ADJ	I
.	O	PUNCT	O


Nevertheless	O	ADV	O
cryopreservation	O	NOUN	B
of	O	ADP	O
spermatozoa	O	NOUN	B
in	O	ADP	O
a	O	DET	O
medium	O	NOUN	B
containing	O	VERB	O
neither	O	CCONJ	O
SP	O	NOUN	B
nor	O	CCONJ	O
biological	O	ADJ	B
substances	O	NOUN	I
could	O	AUX	O
offer	O	VERB	O
an	O	DET	O
acceptable	O	ADJ	O
cryoprotection	O	NOUN	B
of	O	ADP	O
spermatozoa	O	NOUN	B
to	O	PART	O
be	O	AUX	O
used	O	VERB	O
in	O	ADP	O
assisted	O	ADJ	B
fertilization	O	NOUN	I
procedures	O	NOUN	I
,	O	PUNCT	O
especially	O	ADV	O
for	O	ADP	O
intracytoplasmic	O	ADJ	B
sperm	O	NOUN	I
injection	O	NOUN	B
.	O	PUNCT	O


EMSA	O	NOUN	B
with	O	ADP	O
crude	O	ADJ	B
nuclear	O	ADJ	I
extracts	O	NOUN	I
demonstrated	O	VERB	O
that	O	SCONJ	O
stimulation	O	NOUN	B
with	O	ADP	O
CD40L	B-GENE	NOUN	B
results	O	VERB	B
in	O	ADP	O
the	O	DET	O
induction	O	NOUN	B
of	O	ADP	O
NF	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
kappaB	I-GENE	NOUN	B
complexes	I-GENE	NOUN	I
that	O	PRON	O
bind	O	VERB	B
to	O	PART	O
each	O	DET	O
of	O	ADP	O
the	O	DET	O
three	O	NUM	O
NF	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
kappaB	I-GENE	NOUN	B
sites	I-GENE	NOUN	I
and	O	CCONJ	O
are	O	AUX	O
composed	O	VERB	O
mainly	O	ADV	O
of	O	ADP	O
p50	B-GENE	NOUN	B
and	O	CCONJ	O
RelB	B-GENE	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
also	O	ADV	O
include	O	VERB	O
c	B-GENE	X	B
-	I-GENE	PUNCT	O
Rel	I-GENE	NOUN	B
and	O	CCONJ	O
p65	B-GENE	NOUN	B
.	O	PUNCT	O


The	O	DET	O
major	O	ADJ	O
transcription	O	NOUN	B
factors	O	NOUN	I
controlling	O	VERB	O
arginine	O	NOUN	B
metabolism	O	NOUN	B
in	O	ADP	O
Escherichia	O	X	B
coli	O	X	I
and	O	CCONJ	O
Bacillus	O	X	B
subtilis	O	X	I
,	O	PUNCT	O
ArgR	B-GENE	NOUN	B
and	O	CCONJ	O
AhrC	B-GENE	NOUN	B
,	O	PUNCT	O
respectively	O	ADV	O
,	O	PUNCT	O
are	O	AUX	O
homologous	O	ADJ	B
multimeric	O	ADJ	I
proteins	O	NOUN	I
that	O	PRON	O
form	O	VERB	O
l	O	NOUN	O
-	O	PUNCT	O
arginine	O	NOUN	B
-	O	PUNCT	O
dependent	O	ADJ	B
DNA	O	NOUN	B
-	O	PUNCT	O
binding	O	VERB	B
complexes	O	NOUN	B
capable	O	ADJ	O
of	O	ADP	O
repressing	O	VERB	B
transcription	O	NOUN	B
of	O	ADP	O
the	O	DET	O
biosynthetic	O	ADJ	B
genes	O	NOUN	I
(	O	PUNCT	O
both	O	DET	O
)	O	PUNCT	O
,	O	PUNCT	O
activating	O	VERB	B
transcription	O	NOUN	B
of	O	ADP	O
catabolic	O	ADJ	B
genes	O	NOUN	I
(	O	PUNCT	O
AhrC	B-GENE	NOUN	B
only	O	ADV	O
)	O	PUNCT	O
or	O	CCONJ	O
facilitating	O	VERB	O
plasmid	O	NOUN	B
dimer	O	NOUN	B
resolution	O	NOUN	I
(	O	PUNCT	O
both	O	DET	O
)	O	PUNCT	O
.	O	PUNCT	O


The	O	DET	O
studied	O	VERB	O
protein	O	NOUN	B
fragments	O	NOUN	I
consist	O	VERB	O
of	O	ADP	O
residues	O	NOUN	B
Arg183	O	NOUN	B
-	O	PUNCT	O
His267	O	NOUN	B
of	O	ADP	O
the	O	DET	O
human	B-GENE	ADJ	B
ER	I-GENE	NOUN	O
and	O	CCONJ	O
residues	O	NOUN	B
Lys438	O	PROPN	B
-	O	PUNCT	O
Gln520	O	NOUN	B
of	O	ADP	O
the	O	DET	O
rat	O	NOUN	B
GR	B-GENE	NOUN	B
.	O	PUNCT	O


CONCLUSIONS	O	NOUN	O
:	O	PUNCT	O
Turbutest	O	PROPN	B
is	O	AUX	O
a	O	DET	O
valuable	O	ADJ	O
tool	O	NOUN	O
in	O	ADP	O
asthmatic	O	ADJ	B
patients	O	NOUN	B
'	O	PART	O
training	O	NOUN	B
,	O	PUNCT	O
allowing	O	VERB	O
identification	O	NOUN	B
and	O	CCONJ	O
improvement	O	NOUN	B
of	O	ADP	O
an	O	DET	O
inadequate	O	ADJ	B
inhalation	O	NOUN	B
technique	O	NOUN	I
with	O	ADP	O
Turbuhaler	O	PROPN	B
.	O	PUNCT	O


The	O	DET	O
potency	O	NOUN	B
of	O	ADP	O
the	O	DET	O
effect	O	NOUN	B
of	O	ADP	O
Nim	O	NOUN	B
(	O	PUNCT	O
0	O	NUM	O
.	O	PUNCT	O
5	O	NUM	O
mg	O	NOUN	O
.	O	PUNCT	O
kg	O	NOUN	O
-	O	PUNCT	O
1	O	NUM	O
i	O	NUM	O
.	O	PUNCT	O
p	O	NOUN	O
.	O	PUNCT	O
)	O	PUNCT	O
was	O	AUX	O
similar	O	ADJ	O
to	O	PART	O
that	O	DET	O
of	O	ADP	O
NBP	O	PROPN	B
(	O	PUNCT	O
10	O	NUM	O
mg	O	NOUN	O
.	O	PUNCT	O
kg	O	NOUN	O
-	O	PUNCT	O
1	O	NUM	O
i	O	NUM	O
.	O	PUNCT	O
p	O	NOUN	O
.	O	PUNCT	O
)	O	PUNCT	O
.	O	PUNCT	O


CONCLUSION	O	NOUN	O
:	O	PUNCT	O
NBP	O	PROPN	B
pre	O	NOUN	B
-	O	PUNCT	O
treatment	O	NOUN	B
or	O	CCONJ	O
post	O	NOUN	B
-	O	PUNCT	O
treatment	O	NOUN	B
markedly	O	ADV	O
enhanced	O	VERB	B
the	O	DET	O
rCBF	O	NOUN	B
to	O	PART	O
striatum	O	NOUN	B
in	O	ADP	O
RMCAO	O	NOUN	B
rats	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
aim	O	NOUN	O
of	O	ADP	O
this	O	DET	O
study	O	NOUN	B
was	O	AUX	O
to	O	PART	O
investigate	O	VERB	B
the	O	DET	O
spontaneous	O	ADJ	B
reports	O	NOUN	O
of	O	ADP	O
suspected	O	VERB	B
adverse	O	ADJ	B
drug	O	NOUN	I
reactions	O	NOUN	I
,	O	PUNCT	O
observed	O	VERB	O
in	O	ADP	O
elderly	O	ADJ	B
patients	O	NOUN	B
(	O	PUNCT	O
over	O	ADV	O
65	O	NUM	O
years	O	NOUN	B
of	O	ADP	O
age	O	NOUN	B
)	O	PUNCT	O
in	O	ADP	O
Sicily	O	PROPN	B
(	O	PUNCT	O
Italy	O	PROPN	B
)	O	PUNCT	O
during	O	ADP	O
the	O	DET	O
period	O	NOUN	B
from	O	ADP	O
1	O	NUM	O
January	O	PROPN	O
1995	O	NUM	O
to	O	ADP	O
31	O	NUM	O
December	O	PROPN	O
1997	O	NUM	O
.	O	PUNCT	O


The	O	DET	O
high	B-GENE	ADJ	B
density	I-GENE	NOUN	I
lipoprotein	I-GENE	NOUN	I
(	I-GENE	PUNCT	I
HDL	I-GENE	NOUN	O
)	I-GENE	PUNCT	O
receptor	I-GENE	NOUN	O
mediates	O	VERB	O
the	O	DET	O
uptake	O	NOUN	B
of	O	ADP	O
cholesterol	O	NOUN	B
and	O	CCONJ	O
cholesteryl	O	NOUN	B
esters	O	NOUN	I
,	O	PUNCT	O
substrates	O	NOUN	B
for	O	ADP	O
steroidogenesis	O	NOUN	B
,	O	PUNCT	O
from	O	ADP	O
an	O	DET	O
HDL	B-GENE	NOUN	B
particle	O	NOUN	B
in	O	ADP	O
the	O	DET	O
adrenal	O	ADJ	B
gland	O	NOUN	I
and	O	CCONJ	O
gonads	O	NOUN	B
.	O	PUNCT	O


Ozagrel	O	NOUN	B
,	O	PUNCT	O
ifenprodil	O	NOUN	B
,	O	PUNCT	O
cinnarizine	O	NOUN	B
and	O	CCONJ	O
dilazep	O	NOUN	B
were	O	AUX	O
more	O	ADV	O
effective	O	ADJ	B
than	O	ADP	O
pentoxifylline	O	NOUN	B
in	O	ADP	O
increasing	O	VERB	B
rCBF	O	NOUN	B
at	O	ADP	O
the	O	DET	O
HPC	O	NOUN	B
.	O	PUNCT	O


Using	O	VERB	O
sequence	O	NOUN	B
information	O	NOUN	B
from	O	ADP	O
human	B-GENE	ADJ	B
BMAL1	I-GENE	NOUN	B
(	O	PUNCT	O
hBMAL1	B-GENE	NOUN	B
)	O	PUNCT	O
cDNAs	O	NOUN	B
previously	O	ADV	O
reported	O	VERB	O
by	O	ADP	O
our	O	PRON	O
laboratory	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
have	O	AUX	O
isolated	O	VERB	B
and	O	CCONJ	O
characterized	O	VERB	B
cDNAs	O	NOUN	B
encoding	O	VERB	B
three	O	NUM	O
splice	O	NOUN	B
variants	O	NOUN	I
of	O	ADP	O
the	O	DET	O
mouse	B-GENE	NOUN	B
BMAL1	I-GENE	NOUN	B
(	O	PUNCT	O
mBMAL1	B-GENE	NOUN	B
)	O	PUNCT	O
gene	O	NOUN	B
.	O	PUNCT	O


Comparison	O	NOUN	B
with	O	ADP	O
the	O	DET	O
bHLH	B-GENE	ADJ	B
/	O	SYM	O
PAS	B-GENE	NOUN	B
family	O	NOUN	B
genes	O	NOUN	I
revealed	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
intron	O	NOUN	B
/	O	SYM	O
exon	O	NOUN	B
splice	O	NOUN	I
pattern	O	NOUN	I
of	O	ADP	O
mBMAL1	B-GENE	NOUN	B
most	O	ADV	O
closely	O	ADV	O
matches	O	VERB	B
that	O	DET	O
of	O	ADP	O
the	O	DET	O
mAhr	B-GENE	PROPN	B
,	O	PUNCT	O
which	O	DET	O
suggests	O	VERB	O
that	O	SCONJ	O
BMAL1	B-GENE	NOUN	B
and	O	CCONJ	O
Ahr	B-GENE	NOUN	B
belong	O	VERB	O
to	O	PART	O
the	O	DET	O
same	O	ADJ	O
subclass	O	NOUN	B
and	O	CCONJ	O
may	O	AUX	O
be	O	AUX	O
derived	O	VERB	O
from	O	ADP	O
a	O	DET	O
common	O	ADJ	O
primordial	O	ADJ	B
gene	O	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
were	O	AUX	O
able	O	ADJ	O
to	O	PART	O
detect	O	VERB	B
significant	O	ADJ	O
differences	O	NOUN	O
in	O	ADP	O
functional	O	ADJ	B
residual	O	ADJ	I
capacity	O	NOUN	O
adjusted	O	VERB	O
for	O	ADP	O
weight	O	NOUN	B
or	O	CCONJ	O
height	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
compliance	O	NOUN	B
of	O	ADP	O
the	O	DET	O
respiratory	O	ADJ	B
system	O	NOUN	I
adjusted	O	VERB	O
for	O	ADP	O
weight	O	NOUN	B
or	O	CCONJ	O
lung	O	NOUN	B
volume	O	NOUN	I
in	O	ADP	O
the	O	DET	O
ILD	O	NOUN	B
infants	O	NOUN	B
compared	O	VERB	B
to	O	PART	O
the	O	DET	O
healthy	O	ADJ	B
controls	O	NOUN	I
or	O	CCONJ	O
infants	O	NOUN	B
who	O	PRON	O
had	O	AUX	O
PPHN	O	PROPN	B
,	O	PUNCT	O
indicating	O	VERB	O
that	O	SCONJ	O
these	O	DET	O
PFTs	O	NOUN	B
were	O	AUX	O
sensitive	O	ADJ	B
enough	O	ADV	O
to	O	PART	O
determine	O	VERB	O
abnormal	O	ADJ	B
lung	O	NOUN	B
function	O	NOUN	I
in	O	ADP	O
this	O	DET	O
age	O	NOUN	B
group	O	NOUN	I
.	O	PUNCT	O


Classical	O	ADJ	O
ligand	O	NOUN	B
-	O	PUNCT	O
activated	O	VERB	B
nuclear	O	ADJ	O
receptors	O	NOUN	O
(	O	PUNCT	O
e	O	X	O
.	O	PUNCT	O
g	O	NOUN	O
.	O	PUNCT	O
thyroid	B-GENE	NOUN	B
hormone	I-GENE	NOUN	I
receptor	I-GENE	NOUN	I
,	O	PUNCT	O
retinoic	B-GENE	ADJ	B
acid	I-GENE	NOUN	I
receptor	I-GENE	NOUN	I
)	O	PUNCT	O
,	O	PUNCT	O
orphan	B-GENE	VERB	B
nuclear	I-GENE	ADJ	I
receptors	I-GENE	NOUN	I
(	O	PUNCT	O
e	O	X	O
.	O	PUNCT	O
g	O	NOUN	O
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
shown	O	VERB	O
previously	O	ADV	O
that	O	SCONJ	O
in	O	ADP	O
contrast	O	NOUN	O
to	O	PART	O
other	O	ADJ	O
extracellular	O	ADJ	B
matrix	O	NOUN	I
molecules	O	NOUN	I
pepsin	B-GENE	NOUN	B
-	O	PUNCT	O
solubilized	O	VERB	B
collagen	B-GENE	NOUN	B
VI	I-GENE	PROPN	I
(	O	PUNCT	O
CVI	B-GENE	NOUN	B
)	O	PUNCT	O
can	O	AUX	O
stimulate	O	VERB	B
DNA	O	NOUN	B
synthesis	O	NOUN	I
of	O	ADP	O
various	O	ADJ	O
mesenchymal	O	ADJ	B
cell	O	NOUN	I
types	O	NOUN	I
,	O	PUNCT	O
apparently	O	ADV	O
independent	O	ADJ	B
of	O	ADP	O
integrin	B-GENE	NOUN	B
-	O	PUNCT	O
mediated	O	VERB	B
signal	O	NOUN	B
transduction	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
enzyme	O	NOUN	B
displays	O	VERB	O
optimal	O	ADJ	O
activity	O	NOUN	B
at	O	ADP	O
about	O	ADV	O
0	O	NUM	O
.	O	PUNCT	O
5	O	NUM	O
mM	O	NOUN	O
pantoate	O	NOUN	B
(	O	PUNCT	O
k	O	X	O
(	O	PUNCT	O
cat	O	NOUN	B
)	O	PUNCT	O
0	O	NUM	O
.	O	PUNCT	O
63	O	NUM	O
s	O	NOUN	O
(	O	PUNCT	O
-	O	PUNCT	O
1	O	NUM	O
)	O	PUNCT	O
)	O	PUNCT	O
and	O	CCONJ	O
at	O	ADP	O
pH	O	NOUN	B
7	O	NUM	O
.	O	PUNCT	O
8	O	NUM	O
.	O	PUNCT	O


Taken	O	VERB	O
together	O	ADV	O
,	O	PUNCT	O
these	O	DET	O
results	O	NOUN	B
demonstrate	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
RP	B-GENE	NOUN	B
,	O	PUNCT	O
like	O	ADP	O
the	O	DET	O
20S	B-GENE	NOUN	B
proteasome	I-GENE	NOUN	I
,	O	PUNCT	O
is	O	AUX	O
functionally	O	ADV	B
and	O	CCONJ	O
structurally	O	ADV	B
conserved	O	VERB	O
among	O	ADP	O
eukaryotes	O	NOUN	B
and	O	CCONJ	O
indicate	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
plant	B-GENE	NOUN	B
RPT	I-GENE	NOUN	B
subunits	I-GENE	NOUN	B
,	O	PUNCT	O
like	O	ADP	O
their	O	PRON	O
yeast	O	NOUN	B
counterparts	O	NOUN	B
,	O	PUNCT	O
have	O	AUX	O
non	O	NOUN	B
-	O	PUNCT	O
redundant	O	ADJ	B
functions	O	NOUN	B
.	O	PUNCT	O


Structure	O	NOUN	B
and	O	CCONJ	O
expression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
mouse	B-GENE	NOUN	B
growth	I-GENE	NOUN	I
hormone	I-GENE	NOUN	I
receptor	I-GENE	NOUN	I
/	O	PUNCT	O
growth	B-GENE	NOUN	B
hormone	I-GENE	NOUN	I
binding	I-GENE	NOUN	I
protein	I-GENE	NOUN	I
gene	I-GENE	NOUN	I
.	O	PUNCT	O


Repair	O	NOUN	B
of	O	ADP	O
double	O	ADJ	B
-	O	PUNCT	O
strand	O	NOUN	B
breaks	O	NOUN	I
(	O	PUNCT	O
DSBs	O	NOUN	B
)	O	PUNCT	O
in	O	ADP	O
chromosomal	O	ADJ	B
DNA	O	NOUN	I
by	O	ADP	O
nonhomologous	O	ADJ	B
end	O	NOUN	I
-	O	PUNCT	O
joining	O	NOUN	B
(	O	PUNCT	O
NHEJ	O	NOUN	B
)	O	PUNCT	O
is	O	AUX	O
not	O	PART	O
well	O	ADV	O
characterized	O	VERB	B
in	O	ADP	O
the	O	DET	O
yeast	O	NOUN	B
Saccharomyces	O	X	B
cerevisiae	O	X	I
.	O	PUNCT	O


Thus	O	ADV	O
,	O	PUNCT	O
elongin	B-GENE	NOUN	B
C	I-GENE	NOUN	I
is	O	AUX	O
found	O	VERB	O
to	O	PART	O
oligomerize	O	VERB	B
in	O	ADP	O
solution	O	NOUN	B
and	O	CCONJ	O
to	O	PART	O
undergo	O	VERB	O
significant	O	ADJ	B
structural	O	ADJ	B
rearrangements	O	NOUN	I
upon	O	SCONJ	O
binding	O	NOUN	B
of	O	ADP	O
two	O	NUM	O
different	O	ADJ	O
partner	O	NOUN	B
proteins	O	NOUN	I
.	O	PUNCT	O


Gel	O	NOUN	B
filtration	O	NOUN	I
and	O	CCONJ	O
co	O	X	B
-	O	PUNCT	O
immunoprecipitation	O	NOUN	B
analyses	O	NOUN	B
reveal	O	VERB	O
that	O	SCONJ	O
Mad2p	B-GENE	NOUN	B
tightly	O	ADV	O
associates	O	VERB	B
with	O	ADP	I
another	O	DET	O
spindle	O	NOUN	B
checkpoint	O	NOUN	I
component	O	NOUN	I
,	O	PUNCT	O
Mad1p	B-GENE	NOUN	B
.	O	PUNCT	O


John	O	PROPN	B
leonard	O	NOUN	I
dawson	O	NOUN	I


Microcirculatory	O	ADJ	B
oxygenation	O	NOUN	I
and	O	CCONJ	O
shunting	O	NOUN	B
in	O	ADP	O
sepsis	O	NOUN	B
and	O	CCONJ	O
shock	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
present	O	ADJ	O
investigation	O	NOUN	B
conducted	O	VERB	O
in	O	ADP	O
a	O	DET	O
population	O	NOUN	B
of	O	ADP	O
258	O	NUM	O
dentally	O	ADV	B
aware	O	ADJ	O
individuals	O	NOUN	B
in	O	ADP	O
the	O	DET	O
age	O	NOUN	B
range	O	NOUN	O
20	O	NUM	O
-	O	SYM	O
69	O	NUM	O
years	O	NOUN	B
,	O	PUNCT	O
was	O	AUX	O
initiated	O	VERB	O
to	O	PART	O
elucidate	O	VERB	O
the	O	DET	O
relationship	O	NOUN	B
between	O	ADP	O
tobacco	O	NOUN	B
smoking	O	NOUN	I
and	O	CCONJ	O
supragingival	O	NOUN	B
calculus	O	NOUN	I
,	O	PUNCT	O
taking	O	VERB	O
into	O	ADP	O
account	O	NOUN	O
possible	O	ADJ	O
confounding	O	NOUN	B
factors	O	NOUN	I
such	O	ADJ	O
as	O	ADP	O
age	O	NOUN	B
,	O	PUNCT	O
gender	O	NOUN	B
,	O	PUNCT	O
oral	O	ADJ	B
hygiene	O	NOUN	I
and	O	CCONJ	O
gingival	O	ADJ	B
inflammation	O	NOUN	I
.	O	PUNCT	O


Interaction	O	NOUN	B
of	O	ADP	O
HRI	B-GENE	NOUN	B
with	O	ADP	O
Hsc70	B-GENE	NOUN	B
was	O	AUX	O
required	O	VERB	O
for	O	ADP	O
the	O	DET	O
transformation	O	NOUN	B
of	O	ADP	O
HRI	B-GENE	NOUN	B
,	O	PUNCT	O
as	O	ADP	O
the	O	DET	O
Hsc70	B-GENE	NOUN	B
antagonist	O	NOUN	B
clofibric	O	ADJ	B
acid	O	NOUN	I
inhibited	O	VERB	B
the	O	DET	O
folding	O	NOUN	B
of	O	ADP	O
HRI	B-GENE	NOUN	B
into	O	ADP	O
a	O	DET	O
mature	O	ADJ	B
-	O	PUNCT	O
competent	O	ADJ	B
conformation	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
the	O	DET	O
budding	O	ADJ	B
yeast	O	NOUN	B
,	O	PUNCT	O
Saccharomyces	O	X	B
cerevisiae	O	X	I
,	O	PUNCT	O
replicators	O	NOUN	B
can	O	AUX	O
function	O	VERB	B
outside	O	ADP	O
the	O	DET	O
chromosome	O	NOUN	B
as	O	ADP	O
autonomously	O	ADV	B
replicating	O	VERB	I
sequence	O	NOUN	I
(	O	PUNCT	O
ARS	O	NOUN	B
)	O	PUNCT	O
elements	O	NOUN	O
;	O	PUNCT	O
however	O	ADV	O
,	O	PUNCT	O
within	O	ADP	O
chromosome	O	NOUN	B
III	O	NUM	I
,	O	PUNCT	O
certain	O	ADJ	O
ARSs	O	NOUN	B
near	O	ADP	B
the	O	DET	O
transcriptionally	O	ADV	B
silent	O	ADJ	O
HML	B-GENE	NOUN	B
locus	I-GENE	NOUN	I
show	O	VERB	O
no	O	DET	O
replication	O	NOUN	B
origin	O	NOUN	O
activity	O	NOUN	O
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
,	O	PUNCT	O
for	O	ADP	O
the	O	DET	O
HML	B-GENE	NOUN	B
ARS	O	NOUN	I
cluster	O	NOUN	I
(	O	PUNCT	O
ARS303	B-GENE	NOUN	B
,	O	PUNCT	O
ARS320	B-GENE	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
ARS302	B-GENE	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
inactivity	O	NOUN	B
of	O	ADP	O
origins	O	NOUN	B
is	O	AUX	O
independent	O	ADJ	O
of	O	ADP	O
local	O	ADJ	B
transcriptional	O	ADJ	O
silencing	O	NOUN	O
,	O	PUNCT	O
even	O	ADV	O
though	O	SCONJ	O
origins	O	NOUN	B
and	O	CCONJ	O
silencers	O	NOUN	B
share	O	VERB	O
key	O	ADJ	O
cis	O	NOUN	B
-	O	PUNCT	O
and	O	CCONJ	O
trans	O	ADJ	B
-	O	PUNCT	O
acting	O	VERB	B
components	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
report	O	VERB	O
the	O	DET	O
construction	O	NOUN	B
of	O	ADP	O
an	O	DET	O
approximately	O	ADV	O
1	O	NUM	O
.	O	PUNCT	O
7	O	NUM	O
-	O	PUNCT	O
Mb	O	NOUN	O
sequence	O	NOUN	B
-	O	PUNCT	O
ready	O	ADJ	B
YAC	O	NOUN	B
/	O	SYM	O
BAC	O	NOUN	B
clone	O	NOUN	B
contig	O	NOUN	B
of	O	ADP	O
8p22	O	NOUN	B
-	O	PUNCT	O
p23	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
recruitment	O	NOUN	B
of	O	ADP	O
constitutively	O	ADV	B
phosphorylated	O	VERB	O
p185	B-GENE	NOUN	O
(	O	PUNCT	O
neu	B-GENE	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
the	O	DET	O
activated	O	VERB	B
mitogenic	O	ADJ	B
pathway	O	NOUN	I
proteins	O	NOUN	O
to	O	PART	O
this	O	DET	O
membrane	O	NOUN	B
-	O	PUNCT	O
microfilament	O	NOUN	B
interaction	O	NOUN	B
site	O	NOUN	O
provides	O	VERB	O
a	O	DET	O
physical	O	ADJ	B
model	O	NOUN	I
for	O	ADP	O
integrating	O	VERB	O
the	O	DET	O
assembly	O	NOUN	B
of	O	ADP	O
the	O	DET	O
mitogenic	O	ADJ	B
pathway	O	NOUN	I
with	O	ADP	O
the	O	DET	O
transmission	O	NOUN	B
of	O	ADP	O
growth	O	NOUN	B
factor	O	NOUN	I
signal	O	NOUN	I
to	O	PART	O
the	O	DET	O
cytoskeleton	O	NOUN	B
.	O	PUNCT	O


ECG	O	PROPN	B
-	O	PUNCT	O
gated	O	VERB	B
myocardial	O	ADJ	B
Technetium	O	PROPN	B
-	O	PUNCT	O
99m	O	ADJ	B
sestamibi	O	NOUN	B
SPECT	O	PROPN	B
is	O	AUX	O
a	O	DET	O
useful	O	ADJ	O
technique	O	NOUN	B
to	O	PART	O
measure	O	VERB	B
myocardial	O	ADJ	B
perfusion	O	NOUN	I
and	O	CCONJ	O
function	O	NOUN	B
simultaneously	O	ADV	B
.	O	PUNCT	O


The	O	DET	O
controversy	O	NOUN	O
of	O	ADP	O
significance	O	NOUN	B
testing	O	NOUN	I
:	O	PUNCT	O
misconceptions	O	NOUN	B
and	O	CCONJ	O
alternatives	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
arrangement	O	NOUN	B
of	O	ADP	O
these	O	DET	O
cutoff	O	NOUN	B
-	O	PUNCT	O
levels	O	NOUN	B
leads	O	VERB	O
to	O	PART	O
a	O	DET	O
sensitivity	O	NOUN	B
of	O	ADP	O
85	O	NUM	O
%	O	NOUN	O
at	O	ADP	O
a	O	DET	O
specificity	O	NOUN	B
of	O	ADP	O
55	O	NUM	O
%	O	NOUN	O
for	O	ADP	O
Protein	B-GENE	NOUN	B
S100	I-GENE	NOUN	I
when	O	SCONJ	O
measured	O	VERB	B
by	O	ADP	O
RIA	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
to	O	PART	O
a	O	DET	O
sensitivity	O	NOUN	B
of	O	ADP	O
77	O	NUM	O
%	O	NOUN	O
at	O	ADP	O
a	O	DET	O
specificity	O	NOUN	B
of	O	ADP	O
61	O	NUM	O
%	O	NOUN	O
when	O	SCONJ	O
measured	O	VERB	B
by	O	ADP	O
LIA	O	NOUN	B
.	O	PUNCT	O


Null	O	ADJ	B
alleles	O	NOUN	I
of	O	ADP	O
SAS4	B-GENE	NOUN	B
and	O	CCONJ	O
SAS5	B-GENE	NOUN	B
bypassed	O	VERB	O
the	O	DET	O
role	O	NOUN	O
of	O	ADP	O
the	O	DET	O
Abf1p	B-GENE	NOUN	B
binding	I-GENE	NOUN	I
site	I-GENE	NOUN	I
of	O	ADP	O
the	O	DET	O
HMR	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
E	I-GENE	NOUN	B
silencer	I-GENE	NOUN	B
but	O	CCONJ	O
not	O	PART	O
the	O	DET	O
role	O	NOUN	O
of	O	ADP	O
the	O	DET	O
ACS	B-GENE	NOUN	B
or	O	CCONJ	O
Rap1p	B-GENE	NOUN	B
binding	I-GENE	NOUN	I
site	I-GENE	NOUN	I
.	O	PUNCT	O


RESULTS	O	NOUN	B
:	O	PUNCT	O
256	O	NUM	O
Periods	O	NOUN	B
of	O	ADP	O
TTP	O	NOUN	B
or	O	CCONJ	O
PUNP	O	NOUN	B
were	O	AUX	O
reported	O	VERB	O
by	O	ADP	O
men	O	NOUN	B
and	O	CCONJ	O
174	O	NUM	O
by	O	ADP	O
women	O	NOUN	B
.	O	PUNCT	O


Cytokine	O	NOUN	B
-	O	PUNCT	O
induced	O	VERB	B
NF	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
kappa	I-GENE	NOUN	B
B	I-GENE	NOUN	I
DNA	O	NOUN	B
binding	O	NOUN	I
activity	O	NOUN	I
,	O	PUNCT	O
RelA	B-GENE	NOUN	B
nuclear	O	ADJ	I
translocation	O	NOUN	I
,	O	PUNCT	O
I	B-GENE	NOUN	B
kappa	I-GENE	NOUN	I
B	I-GENE	NOUN	I
alpha	I-GENE	NOUN	I
degradation	O	NOUN	I
,	O	PUNCT	O
I	B-GENE	NOUN	B
kappa	I-GENE	NOUN	I
B	I-GENE	NOUN	I
serine	O	NOUN	I
32	O	NUM	I
phosphorylation	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
I	B-GENE	NOUN	B
kappa	I-GENE	NOUN	I
B	I-GENE	NOUN	I
kinase	I-GENE	NOUN	I
(	O	PUNCT	O
IKK	B-GENE	NOUN	B
)	O	PUNCT	O
activity	O	NOUN	B
were	O	AUX	O
blocked	O	VERB	B
by	O	ADP	O
curcumin	O	NOUN	B
treatment	O	NOUN	B
.	O	PUNCT	O


To	O	PART	O
estimate	O	VERB	B
the	O	DET	O
locations	O	NOUN	B
of	O	ADP	O
sources	O	NOUN	B
with	O	ADP	I
the	O	DET	O
TF	O	NOUN	B
-	O	PUNCT	O
MUSIC	O	NOUN	B
algorithm	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
first	O	ADV	O
set	O	VERB	O
the	O	DET	O
target	O	NOUN	B
region	O	NOUN	O
on	O	ADP	O
the	O	DET	O
spectrogram	O	NOUN	B
of	O	ADP	O
the	O	DET	O
somatosensory	O	ADJ	B
responses	O	NOUN	I
.	O	PUNCT	O


Immunohistochemical	O	ADJ	B
staining	O	NOUN	I
with	O	ADP	O
MIB	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	B
and	O	CCONJ	O
p53	B-GENE	NOUN	B
antibodies	I-GENE	NOUN	I
showed	O	VERB	O
low	O	ADJ	B
(	O	PUNCT	O
<	O	X	O
1	O	NUM	O
%	O	NOUN	O
)	O	PUNCT	O
and	O	CCONJ	O
negative	O	ADJ	B
reaction	O	NOUN	O
.	O	PUNCT	O


Two	O	NUM	O
patients	O	NOUN	B
with	O	ADP	O
recurrent	O	ADJ	B
tumors	O	NOUN	I
had	O	AUX	O
high	O	ADJ	B
S	O	NOUN	B
-	O	PUNCT	O
phase	O	NOUN	B
fractions	O	NOUN	B
both	O	CCONJ	O
on	O	ADP	O
the	O	DET	O
first	O	ADJ	O
resected	O	ADJ	B
specimens	O	NOUN	B
and	O	CCONJ	O
at	O	ADP	O
the	O	DET	O
time	O	NOUN	B
of	O	ADP	O
the	O	DET	O
second	O	ADJ	O
operation	O	NOUN	B
.	O	PUNCT	O


Treatment	O	NOUN	B
of	O	ADP	O
unstable	O	ADJ	B
angina	O	NOUN	I
:	O	PUNCT	O
role	O	NOUN	O
of	O	ADP	O
antithrombotic	O	ADJ	B
therapy	O	NOUN	I
.	O	PUNCT	O


Mutations	O	NOUN	B
of	O	ADP	O
the	O	DET	O
RET	B-GENE	NOUN	B
gene	I-GENE	NOUN	I
,	O	PUNCT	O
encoding	O	VERB	B
a	O	DET	O
receptor	B-GENE	NOUN	B
tyrosine	I-GENE	NOUN	I
kinase	I-GENE	NOUN	I
,	O	PUNCT	O
have	O	AUX	O
been	O	AUX	O
associated	O	VERB	B
with	O	ADP	I
the	O	DET	O
inherited	O	VERB	B
cancer	O	NOUN	B
syndromes	O	NOUN	I
MEN	O	NOUN	B
2A	O	NOUN	I
and	O	CCONJ	O
MEN	O	NOUN	B
2B	O	NOUN	I
.	O	PUNCT	O


Protein	B-GENE	NOUN	B
kinase	I-GENE	NOUN	I
A	I-GENE	PROPN	I
-	I-GENE	PUNCT	O
Ialpha	I-GENE	NOUN	B
subunit	O	NOUN	I
-	O	PUNCT	O
directed	O	VERB	B
antisense	O	ADJ	B
inhibition	O	NOUN	I
of	O	ADP	O
ovarian	O	ADJ	B
cancer	O	NOUN	I
cell	O	NOUN	B
growth	O	NOUN	I
:	O	PUNCT	O
crosstalk	O	NOUN	B
with	O	ADP	O
tyrosine	B-GENE	NOUN	B
kinase	I-GENE	NOUN	I
signaling	O	NOUN	I
pathway	O	NOUN	I
.	O	PUNCT	O


During	O	ADP	O
both	O	CCONJ	O
encephalopathy	O	NOUN	B
episodes	O	NOUN	B
,	O	PUNCT	O
CSF	O	NOUN	B
protein	O	NOUN	I
and	O	CCONJ	O
immunoglobulin	B-GENE	NOUN	B
G	I-GENE	NOUN	I
(	O	PUNCT	O
IgG	B-GENE	NOUN	B
)	O	PUNCT	O
levels	O	NOUN	B
were	O	AUX	O
elevated	O	ADJ	B
without	O	ADP	O
an	O	DET	O
increased	O	VERB	B
IgG	B-GENE	NOUN	B
index	O	NOUN	I
or	O	CCONJ	O
IgG	B-GENE	NOUN	B
synthesis	O	NOUN	O
rate	O	NOUN	B
.	O	PUNCT	O


SCOB	O	NOUN	B
testing	O	NOUN	O
of	O	ADP	O
food	O	NOUN	B
-	O	PUNCT	O
restricted	O	ADJ	B
animals	O	NOUN	B
,	O	PUNCT	O
using	O	VERB	O
a	O	DET	O
multiple	O	ADJ	O
fixed	O	ADJ	O
ratio	O	NOUN	O
(	O	PUNCT	O
FR	O	NOUN	B
)	O	PUNCT	O
/	O	SYM	O
fixed	O	VERB	B
interval	O	NOUN	I
(	O	PUNCT	O
FI	O	NOUN	B
)	O	PUNCT	O
schedule	O	NOUN	O
(	O	PUNCT	O
FR20	O	NOUN	B
:	O	PUNCT	O
FI120	O	PROPN	B
)	O	PUNCT	O
,	O	PUNCT	O
was	O	AUX	O
conducted	O	VERB	O
prior	O	ADV	O
to	O	PART	O
each	O	DET	O
exposure	O	NOUN	B
to	O	PART	I
maintain	O	VERB	O
the	O	DET	O
operant	O	NOUN	B
behavior	O	NOUN	I
;	O	PUNCT	O
the	O	DET	O
data	O	NOUN	B
from	O	ADP	O
Weeks	O	PROPN	B
-	O	PUNCT	O
1	O	NUM	O
,	O	PUNCT	O
4	O	NUM	O
,	O	PUNCT	O
8	O	NUM	O
,	O	PUNCT	O
and	O	CCONJ	O
13	O	NUM	O
were	O	AUX	O
evaluated	O	VERB	B
for	O	ADP	O
evidence	O	NOUN	B
of	O	ADP	O
neurotoxicity	O	NOUN	B
.	O	PUNCT	O


Differential	O	ADJ	B
expression	O	NOUN	B
was	O	AUX	O
confirmed	O	VERB	O
by	O	ADP	O
Northern	O	NOUN	B
blot	O	NOUN	I
analysis	O	NOUN	I
employing	O	VERB	O
multiple	O	ADJ	O
normal	O	ADJ	B
and	O	CCONJ	O
tumor	O	NOUN	B
cell	O	NOUN	I
lines	O	NOUN	I
.	O	PUNCT	O


Several	O	ADJ	O
genes	O	NOUN	B
or	O	CCONJ	O
transcriptional	O	ADJ	B
units	O	NOUN	I
were	O	AUX	O
identified	O	VERB	B
,	O	PUNCT	O
including	O	VERB	O
the	O	DET	O
3	O	NUM	O
'	O	PART	O
end	O	NOUN	O
of	O	ADP	O
ribosomal	B-GENE	ADJ	B
s6	I-GENE	NOUN	I
kinase	I-GENE	NOUN	I
(	O	PUNCT	O
Rsk3	B-GENE	NOUN	B
)	O	PUNCT	O
;	O	PUNCT	O
two	O	NUM	O
apparently	O	ADV	O
intronless	O	ADJ	B
and	O	CCONJ	O
ORF	O	NOUN	B
-	O	PUNCT	O
less	O	ADJ	B
genes	O	NOUN	B
;	O	PUNCT	O
and	O	CCONJ	O
Gpr31	B-GENE	NOUN	B
,	O	PUNCT	O
an	O	DET	O
intronless	O	NOUN	B
,	O	PUNCT	O
putative	O	ADJ	B
G	B-GENE	NOUN	I
-	I-GENE	PUNCT	O
protein	I-GENE	NOUN	B
coupled	I-GENE	ADJ	O
receptor	I-GENE	NOUN	O
.	O	PUNCT	O


The	O	DET	O
results	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
GATA	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
5	I-GENE	NUM	O
may	O	AUX	O
have	O	AUX	O
specific	O	ADJ	O
downstream	O	ADJ	B
targets	O	NOUN	B
and	O	CCONJ	O
that	O	SCONJ	O
GATA	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
4	I-GENE	NUM	O
,	I-GENE	PUNCT	O
-	I-GENE	PUNCT	O
5	I-GENE	NUM	O
,	I-GENE	PUNCT	O
and	I-GENE	CCONJ	O
-	I-GENE	PUNCT	O
6	I-GENE	NUM	O
can	O	AUX	O
only	O	ADV	O
partially	O	ADV	O
substitute	O	VERB	O
for	O	ADP	O
each	O	DET	O
other	O	ADJ	O
in	O	ADP	O
cardiogenesis	O	NOUN	B
.	O	PUNCT	O


This	O	DET	O
study	O	NOUN	B
was	O	AUX	O
designed	O	VERB	O
to	O	PART	O
compare	O	VERB	B
the	O	DET	O
efficacy	O	NOUN	B
of	O	ADP	O
efegatran	O	NOUN	B
plus	O	CCONJ	O
streptokinase	B-GENE	NOUN	B
versus	O	CCONJ	O
heparin	O	NOUN	B
plus	O	CCONJ	O
accelerated	O	VERB	B
tissue	B-GENE	NOUN	B
plasminogen	I-GENE	NOUN	O
activator	I-GENE	NOUN	O
(	O	PUNCT	O
TPA	B-GENE	NOUN	B
)	O	PUNCT	O
in	O	ADP	O
coronary	O	ADJ	B
reperfusion	O	NOUN	B
in	O	ADP	O
acute	O	ADJ	B
MI	O	PROPN	B
.	O	PUNCT	O


From	O	ADP	O
February	O	PROPN	O
1991	O	NUM	O
to	O	ADP	O
August	O	PROPN	O
1997	O	NUM	O
,	O	PUNCT	O
124	O	NUM	O
patients	O	NOUN	B
with	O	ADP	O
endometrial	O	ADJ	B
carcinoma	O	NOUN	I
were	O	AUX	O
treated	O	VERB	B
postoperatively	O	ADV	B
with	O	ADP	O
high	O	ADJ	B
-	O	PUNCT	O
dose	O	NOUN	B
-	O	PUNCT	O
rate	O	NOUN	B
vaginal	O	ADJ	B
vault	O	NOUN	B
brachytherapy	O	NOUN	I
as	O	ADP	O
the	O	DET	O
only	O	ADJ	O
adjuvant	O	ADJ	B
treatment	O	NOUN	B
.	O	PUNCT	O


Twelve	O	NUM	O
patients	O	NOUN	B
had	O	AUX	O
stage	O	NOUN	B
IBG3	O	NOUN	I
,	O	PUNCT	O
14	O	NUM	O
had	O	AUX	O
ICG1	O	PROPN	B
,	O	PUNCT	O
9	O	NUM	O
had	O	AUX	O
ICG2	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
3	O	NUM	O
had	O	AUX	O
ICG3	O	NOUN	B
disease	O	NOUN	B
.	O	PUNCT	O


For	O	ADP	O
EPV	O	PROPN	B
3	O	NUM	O
,	O	PUNCT	O
10	O	NUM	O
,	O	PUNCT	O
or	O	CCONJ	O
40	O	NUM	O
,	O	PUNCT	O
the	O	DET	O
bias	O	NOUN	B
exceeded	O	VERB	O
25	O	NUM	O
%	O	NOUN	O
for	O	ADP	O
7	O	NUM	O
,	O	PUNCT	O
3	O	NUM	O
,	O	PUNCT	O
and	O	CCONJ	O
1	O	NUM	O
in	O	ADP	O
the	O	DET	O
8	O	NUM	O
-	O	PUNCT	O
predictor	O	NOUN	B
model	O	NOUN	B
respectively	O	ADV	O
,	O	PUNCT	O
when	O	SCONJ	O
a	O	DET	O
conventional	O	ADJ	O
selection	O	NOUN	B
criterion	O	NOUN	I
was	O	AUX	O
used	O	VERB	O
(	O	PUNCT	O
alpha	O	NOUN	O
=	O	ADJ	O
0	O	NUM	O
.	O	PUNCT	O
05	O	NUM	O
)	O	PUNCT	O
.	O	PUNCT	O


Me	O	NOUN	B
(	O	PUNCT	I
2	O	NUM	I
)	O	PUNCT	I
SO	O	NOUN	B
-	O	PUNCT	O
induced	O	VERB	B
neuronal	O	ADJ	B
differentiation	O	NOUN	I
of	O	ADP	O
N1E	O	NOUN	B
-	O	PUNCT	O
115	O	NUM	O
neuroblastoma	O	NOUN	B
cells	O	NOUN	B
increased	O	VERB	B
both	O	CCONJ	O
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
endogenous	B-GENE	ADJ	B
Ntr	I-GENE	PROPN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	O
gene	I-GENE	NOUN	B
and	O	CCONJ	O
reporter	O	NOUN	B
genes	O	NOUN	I
driven	O	VERB	O
by	O	ADP	O
NTR	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	O
promoter	I-GENE	NOUN	B
sequences	I-GENE	NOUN	I
by	O	ADP	O
3	O	NUM	O
-	O	SYM	O
4	O	NUM	O
-	O	PUNCT	O
fold	O	ADJ	B
.	O	PUNCT	O


Although	O	SCONJ	O
the	O	DET	O
Src	B-GENE	NOUN	B
tyrosine	I-GENE	NOUN	I
kinase	I-GENE	NOUN	I
induces	O	VERB	O
constitutive	O	ADJ	B
Stat3	B-GENE	NOUN	B
phosphorylation	O	NOUN	B
on	O	ADP	O
tyrosine	O	NOUN	B
,	O	PUNCT	O
activation	O	NOUN	B
of	O	ADP	O
Stat3	B-GENE	NOUN	B
-	O	PUNCT	O
mediated	O	VERB	B
gene	O	NOUN	B
regulation	O	NOUN	I
requires	O	VERB	O
both	O	CCONJ	O
tyrosine	O	NOUN	B
and	O	CCONJ	O
serine	O	NOUN	B
phosphorylation	O	NOUN	B
of	O	ADP	O
Stat3	B-GENE	NOUN	B
.	O	PUNCT	O


RESULTS	O	NOUN	B
:	O	PUNCT	O
Factors	O	NOUN	B
associated	O	VERB	B
with	O	ADP	I
significantly	O	ADV	B
(	O	PUNCT	O
P	O	NOUN	O
<	O	X	O
.	O	PUNCT	O
05	O	NUM	O
)	O	PUNCT	O
increased	O	VERB	B
risk	O	NOUN	B
of	O	ADP	O
treatment	O	NOUN	B
failure	O	NOUN	I
in	O	ADP	O
a	O	DET	O
Cox	O	NOUN	B
multivariate	O	ADJ	I
analysis	O	NOUN	I
included	O	VERB	O
age	O	NOUN	B
older	O	ADJ	O
than	O	ADP	O
45	O	NUM	O
years	O	NOUN	B
(	O	PUNCT	O
relative	O	ADJ	O
hazard	O	NOUN	B
,	O	PUNCT	O
1	O	NUM	O
.	O	PUNCT	O
17	O	NUM	O
;	O	PUNCT	O
95	O	NUM	O
%	O	NOUN	O
confidence	O	NOUN	B
interval	O	NOUN	I
[	O	PUNCT	O
CI	O	NOUN	B
]	O	PUNCT	O
,	O	PUNCT	O
1	O	NUM	O
.	O	PUNCT	O
02	O	NUM	O
-	O	SYM	O
1	O	NUM	O
.	O	PUNCT	O
33	O	NUM	O
)	O	PUNCT	O
,	O	PUNCT	O
Karnofsky	O	PROPN	B
performance	O	NOUN	I
score	O	NOUN	I
less	O	ADJ	O
than	O	ADP	O
90	O	NUM	O
%	O	NOUN	O
(	O	PUNCT	O
1	O	NUM	O
.	O	PUNCT	O
27	O	NUM	O
;	O	PUNCT	O
95	O	NUM	O
%	O	NOUN	O
CI	O	NOUN	B
,	O	PUNCT	O
1	O	NUM	O
.	O	PUNCT	O
07	O	NUM	O
-	O	SYM	O
1	O	NUM	O
.	O	PUNCT	O
51	O	NUM	O
)	O	PUNCT	O
,	O	PUNCT	O
absence	O	NOUN	B
of	O	ADP	O
hormone	O	NOUN	B
receptors	O	NOUN	I
(	O	PUNCT	O
1	O	NUM	O
.	O	PUNCT	O
31	O	NUM	O
;	O	PUNCT	O
95	O	NUM	O
%	O	NOUN	O
CI	O	NOUN	B
,	O	PUNCT	O
1	O	NUM	O
.	O	PUNCT	O
15	O	NUM	O
-	O	SYM	O
1	O	NUM	O
.	O	PUNCT	O
51	O	NUM	O
)	O	PUNCT	O
,	O	PUNCT	O
prior	O	ADJ	O
use	O	NOUN	O
of	O	ADP	O
adjuvant	O	ADJ	B
chemotherapy	O	NOUN	I
(	O	PUNCT	O
1	O	NUM	O
.	O	PUNCT	O
31	O	NUM	O
;	O	PUNCT	O
95	O	NUM	O
%	O	NOUN	O
CI	O	NOUN	B
,	O	PUNCT	O
1	O	NUM	O
.	O	PUNCT	O
10	O	NUM	O
-	O	SYM	O
1	O	NUM	O
.	O	PUNCT	O
56	O	NUM	O
)	O	PUNCT	O
,	O	PUNCT	O
initial	O	ADJ	O
disease	O	NOUN	B
-	O	PUNCT	O
free	O	ADJ	B
survival	O	NOUN	B
interval	O	NOUN	I
after	O	ADP	O
adjuvant	O	ADJ	B
treatment	O	NOUN	B
of	O	ADP	O
no	O	DET	O
more	O	ADJ	O
than	O	ADP	O
18	O	NUM	O
months	O	NOUN	B
(	O	PUNCT	O
1	O	NUM	O
.	O	PUNCT	O
99	O	NUM	O
;	O	PUNCT	O
95	O	NUM	O
%	O	NOUN	O
CI	O	NOUN	B
,	O	PUNCT	O
1	O	NUM	O
.	O	PUNCT	O
62	O	NUM	O
-	O	SYM	O
2	O	NUM	O
.	O	PUNCT	O
43	O	NUM	O
)	O	PUNCT	O
,	O	PUNCT	O
metastases	O	NOUN	B
in	O	ADP	O
the	O	DET	O
liver	O	NOUN	B
(	O	PUNCT	O
1	O	NUM	O
.	O	PUNCT	O
47	O	NUM	O
;	O	PUNCT	O
95	O	NUM	O
%	O	NOUN	O
CI	O	NOUN	B
,	O	PUNCT	O
1	O	NUM	O
.	O	PUNCT	O
20	O	NUM	O
-	O	SYM	O
1	O	NUM	O
.	O	PUNCT	O
80	O	NUM	O
)	O	PUNCT	O
or	O	CCONJ	O
central	O	ADJ	B
nervous	O	ADJ	I
system	O	NOUN	I
(	O	PUNCT	O
1	O	NUM	O
.	O	PUNCT	O
56	O	NUM	O
;	O	PUNCT	O
95	O	NUM	O
%	O	NOUN	O
CI	O	NOUN	B
,	O	PUNCT	O
0	O	NUM	O
.	O	PUNCT	O
99	O	NUM	O
-	O	SYM	O
2	O	NUM	O
.	O	PUNCT	O
46	O	NUM	O
[	O	PUNCT	O
approaches	O	NOUN	B
significance	O	NOUN	I
]	O	PUNCT	O
)	O	PUNCT	O
vs	O	CCONJ	O
soft	O	ADJ	B
tissue	O	NOUN	I
,	O	PUNCT	O
bone	O	NOUN	B
,	O	PUNCT	O
or	O	CCONJ	O
lung	O	NOUN	B
,	O	PUNCT	O
3	O	NUM	O
or	O	CCONJ	O
more	O	ADJ	O
sites	O	NOUN	B
of	O	ADP	O
metastatic	O	ADJ	B
disease	O	NOUN	I
(	O	PUNCT	O
1	O	NUM	O
.	O	PUNCT	O
32	O	NUM	O
;	O	PUNCT	O
95	O	NUM	O
%	O	NOUN	O
CI	O	NOUN	B
,	O	PUNCT	O
1	O	NUM	O
.	O	PUNCT	O
13	O	NUM	O
-	O	SYM	O
1	O	NUM	O
.	O	PUNCT	O
54	O	NUM	O
)	O	PUNCT	O
,	O	PUNCT	O
and	O	CCONJ	O
incomplete	O	ADJ	B
response	O	NOUN	B
vs	O	CCONJ	O
complete	O	ADJ	O
response	O	NOUN	B
to	O	ADP	O
standard	O	ADJ	B
-	O	PUNCT	O
dose	O	NOUN	B
chemotherapy	O	NOUN	B
(	O	PUNCT	O
1	O	NUM	O
.	O	PUNCT	O
65	O	NUM	O
;	O	PUNCT	O
95	O	NUM	O
%	O	NOUN	O
CI	O	NOUN	B
,	O	PUNCT	O
1	O	NUM	O
.	O	PUNCT	O
36	O	NUM	O
-	O	SYM	O
1	O	NUM	O
.	O	PUNCT	O
99	O	NUM	O
)	O	PUNCT	O
.	O	PUNCT	O


The	O	DET	O
proteasome	O	NOUN	B
is	O	AUX	O
a	O	DET	O
large	O	ADJ	O
complex	O	NOUN	B
consisting	O	VERB	O
of	O	ADP	O
two	O	NUM	O
multisubunit	O	ADJ	B
structures	O	NOUN	O
,	O	PUNCT	O
the	O	DET	O
20S	B-GENE	NOUN	B
and	O	CCONJ	O
19S	B-GENE	NOUN	O
(	O	PUNCT	O
PA700	B-GENE	NOUN	B
)	O	PUNCT	O
or	O	CCONJ	O
P28	B-GENE	NOUN	B
complexes	I-GENE	NOUN	I
,	O	PUNCT	O
that	O	PRON	O
combine	O	VERB	O
to	O	PART	O
form	O	VERB	O
the	O	DET	O
26S	B-GENE	NOUN	B
particles	I-GENE	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
cloned	O	VERB	B
cDNA	O	NOUN	B
and	O	CCONJ	O
genomic	O	ADJ	B
DNA	O	NOUN	I
for	O	ADP	O
a	O	DET	O
mouse	O	NOUN	B
gene	O	NOUN	I
encoding	O	VERB	B
a	O	DET	O
protein	O	NOUN	B
with	O	ADP	O
significant	O	ADJ	O
sequence	O	NOUN	O
similarity	O	NOUN	O
to	O	PART	O
conserved	O	VERB	O
domains	O	NOUN	B
found	O	VERB	O
in	O	ADP	O
proteins	O	NOUN	B
of	O	ADP	O
the	O	DET	O
Spo11p	B-GENE	NOUN	B
family	I-GENE	NOUN	I
.	O	PUNCT	O


RT	O	NOUN	B
-	O	PUNCT	O
PCR	O	NOUN	B
and	O	CCONJ	O
in	O	X	B
situ	O	X	I
hybridization	O	NOUN	I
analyses	O	NOUN	B
of	O	ADP	O
a	O	DET	O
time	O	NOUN	B
course	O	NOUN	I
of	O	ADP	O
juvenile	O	ADJ	B
testis	O	NOUN	B
development	O	NOUN	B
indicate	O	VERB	O
that	O	SCONJ	O
Spo11	B-GENE	NOUN	B
expression	O	NOUN	B
begins	O	VERB	O
in	O	ADP	O
early	O	ADJ	O
meiotic	O	ADJ	B
Prophase	O	NOUN	B
I	O	NUM	I
,	O	PUNCT	O
prior	O	ADJ	O
to	O	PART	O
the	O	DET	O
pachytene	O	NOUN	B
stage	O	NOUN	I
,	O	PUNCT	O
with	O	ADP	O
increasing	O	VERB	O
accumulation	O	NOUN	B
of	O	ADP	O
mRNA	O	NOUN	B
through	O	ADP	O
the	O	DET	O
pachytene	O	NOUN	B
stage	O	NOUN	I
.	O	PUNCT	O


Animals	O	NOUN	B
were	O	AUX	O
put	O	VERB	O
to	O	ADP	O
death	O	NOUN	B
8	O	NUM	O
weeks	O	NOUN	B
later	O	ADV	O
and	O	CCONJ	O
the	O	DET	O
grafts	O	NOUN	B
were	O	AUX	O
sterilely	O	ADV	B
explanted	O	VERB	I
and	O	CCONJ	O
analyzed	O	VERB	B
via	O	ADP	O
microbiologic	O	ADJ	B
culture	O	NOUN	I
and	O	CCONJ	O
standard	O	ADJ	B
histologic	O	ADJ	B
procedures	O	NOUN	I
for	O	ADP	O
evidence	O	NOUN	B
of	O	ADP	O
infection	O	NOUN	B
.	O	PUNCT	O


Oseltamivir	O	NOUN	B
(	O	PUNCT	O
GS4104	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
which	O	DET	O
can	O	AUX	O
be	O	AUX	O
administered	O	VERB	B
orally	O	ADV	B
,	O	PUNCT	O
is	O	AUX	O
the	O	DET	O
prodrug	O	NOUN	B
of	O	ADP	O
GS4071	O	NOUN	B
,	O	PUNCT	O
a	O	DET	O
potent	O	ADJ	O
and	O	CCONJ	O
selective	O	ADJ	O
inhibitor	O	NOUN	B
of	O	ADP	O
influenzavirus	B-GENE	NOUN	B
neuraminidases	I-GENE	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
also	O	ADV	O
show	O	VERB	O
that	O	SCONJ	O
activation	O	NOUN	B
of	O	ADP	O
protein	B-GENE	NOUN	B
kinase	I-GENE	NOUN	I
A	I-GENE	NOUN	I
(	O	PUNCT	O
PKA	B-GENE	NOUN	B
)	O	PUNCT	O
signaling	O	NOUN	O
is	O	AUX	O
sufficient	O	ADJ	O
to	O	PART	O
down	O	ADV	B
-	O	PUNCT	O
regulate	O	VERB	B
caveolin	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	O
protein	I-GENE	NOUN	B
expression	O	NOUN	I
and	O	CCONJ	O
promoter	O	NOUN	B
activity	O	NOUN	I
.	O	PUNCT	O


Phosphatidylinositol	B-GENE	NOUN	B
3	I-GENE	NUM	I
-	I-GENE	PUNCT	O
kinase	I-GENE	NOUN	B
requirement	O	NOUN	B
in	O	ADP	O
activation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
ras	B-GENE	NOUN	B
/	O	SYM	O
C	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
raf	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	B
/	O	SYM	O
MEK	B-GENE	NOUN	B
/	O	PUNCT	O
ERK	B-GENE	NOUN	B
and	O	CCONJ	O
p70	B-GENE	NOUN	B
(	O	PUNCT	O
s6k	B-GENE	NOUN	B
)	O	PUNCT	O
signaling	O	NOUN	O
cascade	O	NOUN	O
by	O	ADP	O
the	O	DET	O
insulinomimetic	O	ADJ	B
agent	O	NOUN	I
vanadyl	O	ADJ	B
sulfate	O	NOUN	I
.	O	PUNCT	O


For	O	ADP	O
example	O	NOUN	O
,	O	PUNCT	O
introduction	O	NOUN	B
of	O	ADP	O
immunogenic	O	ADJ	B
and	O	CCONJ	O
purification	O	NOUN	B
tag	O	NOUN	O
sequences	O	NOUN	O
into	O	ADP	O
the	O	DET	O
C	O	NOUN	B
-	O	PUNCT	O
terminal	O	ADJ	B
coding	O	NOUN	B
region	O	NOUN	I
significantly	O	ADV	O
decreased	O	VERB	B
bop	B-GENE	NOUN	B
gene	I-GENE	NOUN	I
mRNA	I-GENE	NOUN	B
and	O	CCONJ	O
protein	O	NOUN	B
accumulation	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
recommend	O	VERB	O
that	O	SCONJ	O
paracervical	O	ADJ	B
block	O	NOUN	I
with	O	ADP	O
lignocaine	O	NOUN	B
should	O	AUX	O
be	O	AUX	O
used	O	VERB	O
in	O	ADP	O
conjunction	O	NOUN	B
with	O	ADP	O
i	O	PRON	O
.	O	PUNCT	O
v	O	X	O
.	O	PUNCT	O
sedation	O	NOUN	B
/	O	SYM	O
analgesia	O	NOUN	B
during	O	ADP	O
egg	O	NOUN	B
collection	O	NOUN	I
performed	O	VERB	O
through	O	ADP	O
the	O	DET	O
transvaginal	O	ADJ	B
route	O	NOUN	O
under	O	ADP	O
ultrasound	O	NOUN	B
guidance	O	NOUN	I
(	O	PUNCT	O
TUGOR	O	PROPN	B
)	O	PUNCT	O
to	O	PART	O
reduce	O	VERB	B
the	O	DET	O
pain	O	NOUN	B
of	O	ADP	O
the	O	DET	O
procedure	O	NOUN	B
.	O	PUNCT	O


This	O	DET	O
report	O	NOUN	B
describes	O	VERB	O
a	O	DET	O
patient	O	NOUN	B
with	O	ADP	O
a	O	DET	O
previous	O	ADJ	O
inferior	O	ADJ	B
acute	O	ADJ	I
myocardial	O	ADJ	I
infarction	O	NOUN	I
who	O	PRON	O
developed	O	VERB	O
right	O	ADJ	B
ventricular	O	ADJ	I
infarction	O	NOUN	I
with	O	ADP	O
significant	O	ADJ	B
anterior	O	ADJ	B
lead	O	NOUN	O
ST	O	ADJ	B
segment	O	NOUN	O
elevation	O	NOUN	O
(	O	PUNCT	O
V1	O	PROPN	B
-	O	PUNCT	O
V4	O	NOUN	B
)	O	PUNCT	O
caused	O	VERB	O
by	O	ADP	O
the	O	DET	O
loss	O	NOUN	B
of	O	ADP	O
two	O	NUM	O
large	O	ADJ	O
right	O	ADJ	B
ventricular	O	ADJ	I
branches	O	NOUN	I
during	O	ADP	O
a	O	DET	O
coronary	O	ADJ	B
angioplasty	O	NOUN	I
of	O	ADP	O
the	O	DET	O
right	O	ADJ	B
coronary	O	ADJ	I
artery	O	NOUN	I
.	O	PUNCT	O


PURPOSE	O	NOUN	B
:	O	PUNCT	O
Previous	O	ADJ	O
WR	O	PROPN	B
-	O	PUNCT	O
2721	O	NUM	O
human	O	ADJ	B
pharmacokinetic	O	ADJ	B
studies	O	NOUN	I
were	O	AUX	O
limited	O	ADJ	O
to	O	PART	O
plasma	O	NOUN	B
levels	O	NOUN	B
in	O	ADP	O
patients	O	NOUN	B
receiving	O	VERB	O
platinum	O	NOUN	B
-	O	PUNCT	O
based	O	VERB	B
compounds	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
none	O	NOUN	O
includes	O	VERB	O
the	O	DET	O
effects	O	NOUN	B
of	O	ADP	O
WR	O	PROPN	B
-	O	PUNCT	O
2721	O	NUM	O
on	O	ADP	O
endogenous	O	ADJ	B
thiols	O	NOUN	B
.	O	PUNCT	O


CONCLUSIONS	O	NOUN	O
:	O	PUNCT	O
In	O	ADP	O
addition	O	NOUN	O
to	O	PART	O
the	O	DET	O
superiority	O	NOUN	B
of	O	ADP	O
octafluoropropane	O	ADJ	B
-	O	PUNCT	O
filled	O	VERB	B
microspheres	O	NOUN	B
to	O	PART	O
air	O	NOUN	B
-	O	PUNCT	O
filled	O	VERB	B
microspheres	O	NOUN	B
for	O	ADP	O
LV	O	PROPN	B
opacification	O	NOUN	I
,	O	PUNCT	O
the	O	DET	O
efficacy	O	NOUN	B
of	O	ADP	O
OCTA	O	NOUN	B
is	O	AUX	O
relatively	O	ADV	O
unaffected	O	ADJ	O
by	O	ADP	O
impaired	O	ADJ	B
LV	O	NOUN	B
function	O	NOUN	I
and	O	CCONJ	O
is	O	AUX	O
less	O	ADV	O
susceptible	O	ADJ	B
to	O	PART	O
the	O	DET	O
effects	O	NOUN	B
of	O	ADP	I
poor	O	ADJ	B
echogenicity	O	NOUN	I
than	O	ADP	O
AIR	O	PROPN	B
.	O	PUNCT	O


These	O	DET	O
kinases	O	NOUN	B
belong	O	VERB	O
to	O	PART	O
a	O	DET	O
new	O	ADJ	O
subfamily	O	NOUN	B
related	O	ADJ	O
to	O	PART	O
the	O	DET	O
Trk	B-GENE	NOUN	B
subfamily	I-GENE	NOUN	B
.	O	PUNCT	O


The	O	DET	O
data	O	NOUN	B
indicate	O	VERB	O
that	O	SCONJ	O
etr	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	O
is	O	AUX	O
essential	O	ADJ	B
for	O	ADP	O
muscle	O	NOUN	B
development	O	NOUN	I
in	O	ADP	O
C	O	NOUN	B
.	O	PUNCT	O
elegans	O	NOUN	B
,	O	PUNCT	O
perhaps	O	ADV	O
by	O	ADP	O
playing	O	VERB	O
a	O	DET	O
role	O	NOUN	O
in	O	ADP	O
post	O	NOUN	B
-	O	PUNCT	O
transcriptional	O	ADJ	B
processing	O	NOUN	O
of	O	ADP	O
some	O	DET	O
muscle	O	NOUN	B
component	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
thus	O	ADV	O
suggesting	O	VERB	O
a	O	DET	O
possible	O	ADJ	O
conservation	O	NOUN	B
of	O	ADP	O
gene	O	NOUN	B
function	O	NOUN	I
with	O	ADP	O
human	B-GENE	ADJ	B
CUG	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
bp	I-GENE	NOUN	B
.	O	PUNCT	O


Detection	O	NOUN	B
of	O	ADP	O
poisoning	O	NOUN	B
by	O	ADP	O
Impila	O	PROPN	B
(	O	PUNCT	O
Callilepis	O	PROPN	B
laureola	O	NOUN	I
)	O	PUNCT	O
in	O	ADP	O
a	O	DET	O
mother	O	NOUN	B
and	O	CCONJ	O
child	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
HCMV	O	NOUN	B
(	O	PUNCT	O
Towne	O	NOUN	B
)	O	PUNCT	O
-	O	PUNCT	O
infected	O	VERB	B
HF	O	NOUN	B
cells	O	NOUN	B
at	O	ADP	O
24	O	NUM	O
to	O	PART	O
48	O	NUM	O
h	O	NOUN	O
,	O	PUNCT	O
IE2	B-GENE	NOUN	B
also	O	ADV	O
accumulated	O	VERB	O
in	O	ADP	O
newly	O	ADV	O
formed	O	VERB	O
viral	O	ADJ	B
DNA	O	NOUN	I
replication	O	NOUN	B
compartments	O	NOUN	I
containing	O	VERB	O
the	O	DET	O
polymerase	B-GENE	NOUN	B
processivity	I-GENE	NOUN	I
factor	I-GENE	NOUN	I
(	O	PUNCT	O
UL44	B-GENE	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
the	O	DET	O
single	B-GENE	ADJ	B
-	I-GENE	PUNCT	O
stranded	I-GENE	VERB	B
DNA	I-GENE	NOUN	B
binding	I-GENE	NOUN	I
protein	I-GENE	NOUN	I
(	O	PUNCT	O
SSB	B-GENE	NOUN	B
;	O	PUNCT	O
UL57	B-GENE	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
the	O	DET	O
UL112	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
113	I-GENE	NUM	O
accessory	I-GENE	NOUN	B
protein	I-GENE	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
newly	O	ADV	O
incorporated	O	VERB	O
bromodeoxyuridine	O	NOUN	B
(	O	PUNCT	O
BrdU	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Macroscopic	O	ADJ	B
researches	O	NOUN	I
on	O	ADP	O
heart	O	NOUN	B
vascularization	O	NOUN	I
have	O	AUX	O
indicated	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
angioarchitecture	O	NOUN	B
of	O	ADP	O
the	O	DET	O
conducting	O	VERB	B
system	O	NOUN	I
differs	O	VERB	O
from	O	ADP	O
that	O	DET	O
of	O	ADP	O
the	O	DET	O
normal	O	ADJ	B
myocardium	O	NOUN	I
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
reoperation	O	NOUN	B
for	O	ADP	O
bulky	O	ADJ	O
cervical	O	ADJ	O
disease	O	NOUN	O
(	O	PUNCT	O
group	O	NOUN	B
3	O	NUM	O
)	O	PUNCT	O
rarely	O	ADV	O
results	O	VERB	B
in	O	ADP	O
normal	O	ADJ	O
calcitonin	B-GENE	NOUN	B
levels	O	NOUN	B
and	O	CCONJ	O
is	O	AUX	O
associated	O	VERB	B
with	O	ADP	I
a	O	DET	O
high	O	ADJ	O
incidence	O	NOUN	B
of	O	ADP	O
permanent	O	ADJ	B
hypoparathyroidism	O	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
present	O	VERB	O
a	O	DET	O
case	O	NOUN	B
of	O	ADP	O
carcinoma	O	NOUN	B
of	O	ADP	O
the	O	DET	O
breast	O	NOUN	B
presenting	O	VERB	O
concurrently	O	ADV	O
with	O	ADP	O
SSc	O	NOUN	B
that	O	PRON	O
subsequently	O	ADV	O
progressed	O	VERB	O
to	O	PART	O
dialysis	O	NOUN	B
-	O	PUNCT	O
dependent	O	ADJ	B
renal	O	ADJ	B
failure	O	NOUN	I
in	O	ADP	O
just	O	ADV	O
1	O	NUM	O
month	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
GPI	O	NOUN	B
anchor	O	NOUN	I
moiety	O	NOUN	I
is	O	AUX	O
either	O	CCONJ	O
absent	O	ADJ	B
or	O	CCONJ	O
present	O	ADJ	O
at	O	ADP	O
a	O	DET	O
very	O	ADV	O
low	O	ADJ	O
level	O	NOUN	B
in	O	ADP	O
the	O	DET	O
polypeptide	O	NOUN	B
expressed	O	VERB	B
from	O	ADP	O
the	O	DET	O
cDNA	O	NOUN	B
that	O	PRON	O
contained	O	VERB	O
both	O	CCONJ	O
the	O	DET	O
signal	O	NOUN	B
peptide	O	NOUN	I
and	O	CCONJ	O
GPI	O	NOUN	B
signal	O	NOUN	I
sequences	O	NOUN	I
.	O	PUNCT	O


They	O	PRON	O
self	O	NOUN	B
-	O	PUNCT	O
completed	O	VERB	B
the	O	DET	O
SF	O	PROPN	B
-	O	PUNCT	O
36	O	NUM	O
questionnaire	O	NOUN	B
and	O	CCONJ	O
their	O	PRON	O
QoL	O	NOUN	B
was	O	AUX	O
described	O	VERB	O
and	O	CCONJ	O
retrospectively	O	ADV	B
compared	O	VERB	B
to	O	PART	O
that	O	DET	O
of	O	ADP	O
historical	O	ADJ	B
controls	O	NOUN	I
.	O	PUNCT	O


There	O	PRON	O
was	O	AUX	O
a	O	DET	O
trend	O	NOUN	O
toward	O	ADP	O
an	O	DET	O
association	O	NOUN	B
between	O	ADP	O
IENF	O	NOUN	B
and	O	CCONJ	O
sural	O	ADJ	B
nerve	O	NOUN	I
unmyelinated	O	ADJ	B
fiber	O	NOUN	O
densities	O	NOUN	B
(	O	PUNCT	O
r	O	NOUN	O
=	O	ADJ	O
0	O	NUM	O
.	O	PUNCT	O
32	O	NUM	O
,	O	PUNCT	O
p	O	NOUN	O
=	O	ADJ	O
0	O	NUM	O
.	O	PUNCT	O
054	O	NUM	O
)	O	PUNCT	O
.	O	PUNCT	O


FISH	O	NOUN	B
using	O	VERB	O
a	O	DET	O
whole	O	ADJ	B
chromosome	O	NOUN	I
4	O	NUM	I
paint	O	NOUN	I
demonstrated	O	VERB	O
multiple	O	ADJ	O
rearrangements	O	NOUN	B
involving	O	VERB	O
chromosome	O	NOUN	B
4	O	NUM	I
in	O	ADP	O
MCF	O	NOUN	B
-	O	PUNCT	O
7	O	NUM	B
AdVp3000	O	NOUN	B
and	O	CCONJ	O
MCF	O	NOUN	B
-	O	PUNCT	O
7	O	NUM	B
MX	O	PROPN	B
,	O	PUNCT	O
while	O	SCONJ	O
S1	O	PROPN	B
-	O	PUNCT	O
M1	O	PROPN	B
-	O	PUNCT	O
80	O	NUM	O
contained	O	VERB	O
only	O	ADV	O
a	O	DET	O
simple	O	ADJ	O
reciprocal	O	ADJ	B
translocation	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
MXR	B-GENE	NOUN	B
gene	I-GENE	NOUN	B
encodes	O	VERB	B
a	O	DET	O
half	O	ADJ	B
-	O	PUNCT	O
transporter	O	NOUN	B
and	O	CCONJ	O
the	O	DET	O
absence	O	NOUN	B
of	O	ADP	O
cytogenetic	O	ADJ	B
evidence	O	NOUN	B
of	O	ADP	O
coamplification	O	NOUN	B
of	O	ADP	O
other	O	ADJ	O
regions	O	NOUN	B
suggests	O	VERB	O
that	O	SCONJ	O
a	O	DET	O
partner	O	NOUN	O
may	O	AUX	O
not	O	PART	O
be	O	AUX	O
overexpressed	O	VERB	B
,	O	PUNCT	O
and	O	CCONJ	O
instead	O	ADV	O
the	O	DET	O
MXR	B-GENE	NOUN	B
half	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
transporter	I-GENE	NOUN	B
homodimerizes	O	VERB	B
to	O	PART	O
mediate	O	VERB	O
drug	O	NOUN	B
transport	O	NOUN	I
.	O	PUNCT	O


Serum	B-GENE	NOUN	B
insulin	I-GENE	NOUN	I
-	I-GENE	PUNCT	O
like	I-GENE	ADJ	B
growth	I-GENE	NOUN	B
factor	I-GENE	NOUN	I
I	I-GENE	NOUN	I
(	O	PUNCT	O
IGF	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
I	I-GENE	NOUN	B
)	O	PUNCT	O
SD	O	NOUN	B
score	O	NOUN	B
increased	O	VERB	B
from	O	ADP	O
-	O	PUNCT	O
2	O	NUM	O
.	O	PUNCT	O
2	O	NUM	O
and	O	CCONJ	O
-	O	PUNCT	O
4	O	NUM	O
.	O	PUNCT	O
2	O	NUM	O
in	O	ADP	O
men	O	NOUN	B
and	O	CCONJ	O
women	O	NOUN	B
,	O	PUNCT	O
respectively	O	ADV	O
,	O	PUNCT	O
to	O	PART	O
1	O	NUM	O
.	O	PUNCT	O
8	O	NUM	O
and	O	CCONJ	O
-	O	PUNCT	O
0	O	NUM	O
.	O	PUNCT	O
9	O	NUM	O
at	O	ADP	O
6	O	NUM	O
months	O	NOUN	B
and	O	CCONJ	O
0	O	NUM	O
.	O	PUNCT	O
8	O	NUM	O
and	O	CCONJ	O
-	O	PUNCT	O
0	O	NUM	O
.	O	PUNCT	O
7	O	NUM	O
at	O	ADP	O
12	O	NUM	O
months	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
level	O	NOUN	B
of	O	ADP	O
serum	B-GENE	NOUN	B
creatine	I-GENE	NOUN	O
kinase	I-GENE	NOUN	O
was	O	AUX	O
significantly	O	ADV	O
high	O	ADJ	O
2	O	NUM	O
days	O	NOUN	B
after	O	ADP	O
ESWIB	O	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
it	O	PRON	O
recovered	O	VERB	O
in	O	ADP	O
a	O	DET	O
week	O	NOUN	B
.	O	PUNCT	O


Several	O	ADJ	O
7SL	B-GENE	NOUN	B
RNA	I-GENE	NOUN	I
-	I-GENE	PUNCT	O
encoding	I-GENE	VERB	B
sequences	I-GENE	NOUN	B
and	O	CCONJ	O
various	O	ADJ	O
intergenic	O	ADJ	B
spacers	O	NOUN	I
were	O	AUX	O
amplified	O	VERB	B
from	O	ADP	O
the	O	DET	O
individual	O	ADJ	O
HindIII	B-GENE	NOUN	B
fragments	I-GENE	NOUN	I
of	O	ADP	O
about	O	ADV	O
1	O	NUM	O
.	O	PUNCT	O
3	O	NUM	O
and	O	CCONJ	O
2	O	NUM	O
.	O	PUNCT	O
8	O	NUM	O
kb	O	NOUN	O
.	O	PUNCT	O


Analysis	O	NOUN	B
of	O	ADP	O
its	O	PRON	O
genomic	O	ADJ	B
region	O	NOUN	I
revealed	O	VERB	B
that	O	SCONJ	O
the	O	DET	O
13	O	NUM	O
-	O	PUNCT	O
kb	O	NOUN	B
Cdc6	B-GENE	NOUN	B
gene	I-GENE	NOUN	I
is	O	AUX	O
divided	O	VERB	O
into	O	ADP	O
12	O	NUM	O
exons	O	NOUN	B
by	O	ADP	O
11	O	NUM	O
introns	O	NOUN	B
.	O	PUNCT	O


Phosphorylation	O	NOUN	B
of	O	ADP	O
myosin	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
binding	I-GENE	VERB	B
subunit	I-GENE	NOUN	I
(	O	PUNCT	O
MBS	B-GENE	NOUN	B
)	O	PUNCT	O
of	O	ADP	O
myosin	B-GENE	NOUN	B
phosphatase	I-GENE	NOUN	I
by	O	ADP	O
Rho	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
kinase	I-GENE	NOUN	B
in	O	X	B
vivo	O	X	I
.	O	PUNCT	O


Because	O	SCONJ	O
the	O	DET	O
Pit	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	O
sites	I-GENE	NOUN	B
in	O	ADP	O
the	O	DET	O
hGH	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
N	I-GENE	NOUN	B
gene	I-GENE	NOUN	I
promoter	I-GENE	NOUN	O
are	O	AUX	O
insufficient	O	ADJ	B
for	O	ADP	O
such	O	ADJ	O
gene	O	NOUN	B
activation	O	NOUN	I
in	O	X	B
vivo	O	X	I
,	O	PUNCT	O
these	O	DET	O
data	O	NOUN	B
suggested	O	VERB	O
a	O	DET	O
unique	O	ADJ	O
chromatin	O	NOUN	B
-	O	PUNCT	O
mediated	O	VERB	B
developmental	O	ADJ	B
role	O	NOUN	O
for	O	ADP	O
Pit	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	O
in	O	ADP	O
the	O	DET	O
hGH	B-GENE	NOUN	B
LCR	I-GENE	NOUN	B
.	O	PUNCT	O


Recombinant	B-GENE	ADJ	B
prenylcysteine	I-GENE	NOUN	B
lyase	I-GENE	NOUN	I
was	O	AUX	O
produced	O	VERB	O
in	O	ADP	O
a	O	DET	O
baculovirus	O	NOUN	B
-	O	PUNCT	O
Sf9	O	NOUN	B
expression	O	NOUN	B
system	O	NOUN	I
.	O	PUNCT	O


Mycoplasma	O	NOUN	B
hominis	O	NOUN	I
infections	O	NOUN	I
are	O	AUX	O
easily	O	ADV	O
missed	O	VERB	O
because	O	SCONJ	O
conventional	O	ADJ	B
methods	O	NOUN	B
for	O	ADP	O
bacterial	O	ADJ	B
detection	O	NOUN	I
may	O	AUX	O
fail	O	VERB	B
.	O	PUNCT	O


For	O	ADP	O
this	O	DET	O
purpose	O	NOUN	O
,	O	PUNCT	O
we	O	PRON	O
used	O	VERB	O
a	O	DET	O
series	O	NOUN	O
of	O	ADP	O
plasmid	O	NOUN	B
constructs	O	NOUN	B
encoding	O	VERB	B
different	O	ADJ	O
forms	O	NOUN	O
of	O	ADP	O
the	O	DET	O
envelope	B-GENE	NOUN	B
glycoprotein	I-GENE	NOUN	I
E	I-GENE	NOUN	I
of	I-GENE	ADP	O
the	I-GENE	DET	O
flavivirus	I-GENE	NOUN	B
tick	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
borne	I-GENE	VERB	B
encephalitis	I-GENE	NOUN	B
virus	I-GENE	NOUN	I
.	O	PUNCT	O


By	O	ADP	O
an	O	DET	O
induced	O	VERB	B
-	O	PUNCT	O
fit	O	NOUN	B
mechanism	O	NOUN	B
,	O	PUNCT	O
contacts	O	NOUN	B
with	O	ADP	O
the	O	DET	O
anticodon	O	NOUN	B
can	O	AUX	O
activate	O	VERB	B
formation	O	NOUN	B
of	O	ADP	O
a	O	DET	O
robust	O	ADJ	B
transition	O	NOUN	B
state	O	NOUN	O
at	O	ADP	O
a	O	DET	O
site	O	NOUN	B
over	O	ADP	O
70	O	NUM	O
A	O	DET	O
away	O	ADV	O
.	O	PUNCT	O


This	O	DET	O
revealed	O	VERB	O
a	O	DET	O
minimum	O	NOUN	B
of	O	ADP	O
six	O	NUM	O
novel	O	ADJ	O
OSBP	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
related	I-GENE	VERB	B
proteins	I-GENE	NOUN	B
,	O	PUNCT	O
designated	O	VERB	O
ORP	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	O
to	O	PART	O
ORP	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
6	I-GENE	NUM	O
.	O	PUNCT	O


In	O	ADP	O
conclusion	O	NOUN	O
:	O	PUNCT	O
(	O	PUNCT	O
i	O	X	O
)	O	PUNCT	O
TECRA	O	NOUN	B
kit	O	NOUN	I
is	O	AUX	O
suggested	O	VERB	O
to	O	PART	O
be	O	AUX	O
used	O	VERB	O
for	O	ADP	O
screening	O	VERB	B
SE	O	NOUN	I
producing	O	NOUN	O
strains	O	NOUN	B
;	O	PUNCT	O
(	O	PUNCT	O
ii	O	X	O
)	O	PUNCT	O
SET	O	PROPN	B
-	O	PUNCT	O
RPLA	O	NOUN	B
and	O	CCONJ	O
RIDASCREEN	O	NOUN	B
kits	O	NOUN	I
are	O	AUX	O
suitable	O	ADJ	O
for	O	ADP	O
epidemiological	O	ADJ	B
investigation	O	NOUN	B
of	O	ADP	O
SE	O	NOUN	B
types	O	NOUN	O
,	O	PUNCT	O
but	O	CCONJ	O
the	O	DET	O
lack	O	NOUN	B
of	O	ADP	O
ability	O	NOUN	O
for	O	ADP	O
detecting	O	VERB	B
SEE	O	PROPN	B
,	O	PUNCT	O
long	O	ADJ	B
time	O	NOUN	I
required	O	VERB	O
for	O	ADP	O
testing	O	NOUN	B
with	O	ADP	O
SET	O	NOUN	B
-	O	PUNCT	O
RPLA	O	PROPN	B
kit	O	NOUN	B
and	O	CCONJ	O
high	O	ADJ	O
background	O	NOUN	B
when	O	SCONJ	O
using	O	VERB	O
RIDASCREEN	O	PROPN	B
kit	O	NOUN	I
must	O	AUX	O
be	O	AUX	O
overcome	O	VERB	B
;	O	PUNCT	O
and	O	CCONJ	O
(	O	PUNCT	O
iii	O	X	O
)	O	PUNCT	O
because	O	SCONJ	O
of	O	ADP	O
the	O	DET	O
complicated	O	ADJ	B
test	O	NOUN	I
procedures	O	NOUN	I
and	O	CCONJ	O
the	O	DET	O
lack	O	NOUN	B
of	O	ADP	O
ability	O	NOUN	O
for	O	ADP	O
detecting	O	VERB	B
SEE	O	PROPN	B
,	O	PUNCT	O
the	O	DET	O
practicality	O	NOUN	B
of	O	ADP	O
SET	O	PROPN	B
-	O	PUNCT	O
EIA	O	PROPN	B
kit	O	NOUN	B
in	O	ADP	O
screening	O	NOUN	B
and	O	CCONJ	O
epidemiological	O	ADJ	B
research	O	NOUN	I
purposes	O	NOUN	O
is	O	AUX	O
low	O	ADJ	B
.	O	PUNCT	O


Comparison	O	NOUN	B
of	O	ADP	O
immunoassay	O	NOUN	B
kits	O	NOUN	I
for	O	ADP	O
detection	O	NOUN	B
of	O	ADP	O
staphylococcal	B-GENE	ADJ	B
enterotoxins	I-GENE	NOUN	I
produced	O	VERB	O
by	O	ADP	O
Staphylococcus	O	X	B
aureus	O	X	I


Sequence	O	NOUN	B
analysis	O	NOUN	I
of	O	ADP	O
the	O	DET	O
promoter	O	NOUN	B
region	O	NOUN	I
showed	O	VERB	O
no	O	DET	O
TATA	O	NOUN	B
box	O	NOUN	O
but	O	CCONJ	O
identified	O	VERB	O
consensus	O	NOUN	B
binding	O	NOUN	I
motifs	O	NOUN	O
for	O	ADP	O
Sp1	B-GENE	NOUN	B
,	O	PUNCT	O
CREB	B-GENE	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
half	O	NOUN	O
sites	O	NOUN	B
of	O	ADP	O
the	O	DET	O
estrogen	B-GENE	NOUN	B
receptor	I-GENE	NOUN	I
binding	I-GENE	NOUN	I
site	I-GENE	NOUN	I
.	O	PUNCT	O


Sak	B-GENE	NOUN	B
kinase	I-GENE	NOUN	I
gene	O	NOUN	B
structure	O	NOUN	I
and	O	CCONJ	O
transcriptional	O	ADJ	B
regulation	O	NOUN	I
.	O	PUNCT	O


Based	O	VERB	O
on	O	ADP	O
a	O	DET	O
type	O	NOUN	B
I	O	NUM	I
error	O	NOUN	I
of	O	ADP	O
0	O	NUM	O
.	O	PUNCT	O
05	O	NUM	O
,	O	PUNCT	O
our	O	PRON	O
study	O	NOUN	B
had	O	AUX	O
a	O	DET	O
power	O	NOUN	O
greater	O	ADJ	O
than	O	ADP	O
or	O	CCONJ	O
equal	O	ADJ	O
to	O	PART	O
75	O	NUM	O
%	O	NOUN	O
to	O	PART	O
detect	O	VERB	B
group	O	NOUN	B
differences	O	NOUN	B
in	O	ADP	O
treatment	O	NOUN	B
effect	O	NOUN	I
of	O	ADP	O
greater	O	ADJ	O
than	O	ADP	O
or	O	CCONJ	O
equal	O	ADJ	O
to	O	PART	O
15	O	NUM	O
%	O	NOUN	O
to	O	PART	O
20	O	NUM	O
%	O	NOUN	O
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
no	O	DET	O
genetic	O	ADJ	B
alteration	O	NOUN	I
was	O	AUX	O
detected	O	VERB	B
in	O	ADP	O
any	O	DET	O
of	O	ADP	O
the	O	DET	O
cancers	O	NOUN	B
examined	O	VERB	B
.	O	PUNCT	O


Statins	B-GENE	NOUN	B
:	O	PUNCT	O
lower	O	ADJ	B
lipids	O	NOUN	B
and	O	CCONJ	O
better	O	ADJ	O
bones	O	NOUN	B
?	O	PUNCT	O
Although	O	SCONJ	O
statins	O	NOUN	B
are	O	AUX	O
widely	O	ADV	O
used	O	VERB	O
as	O	ADP	O
cholesterol	O	NOUN	B
-	O	PUNCT	O
lowering	O	VERB	B
drugs	O	NOUN	B
,	O	PUNCT	O
a	O	DET	O
recent	O	ADJ	O
study	O	NOUN	B
suggests	O	VERB	O
that	O	SCONJ	O
these	O	DET	O
compounds	O	NOUN	B
have	O	AUX	O
anabolic	O	ADJ	B
effects	O	NOUN	I
on	O	ADP	O
bone	O	NOUN	B
and	O	CCONJ	O
could	O	AUX	O
be	O	AUX	O
developed	O	VERB	O
into	O	ADP	O
new	O	ADJ	O
treatments	O	NOUN	B
for	O	ADP	O
common	O	ADJ	O
metabolic	O	ADJ	B
bone	O	NOUN	O
diseases	O	NOUN	O
such	O	ADJ	O
as	O	ADP	O
osteoporosis	O	NOUN	B


Leukocyte	O	NOUN	B
cultures	O	NOUN	I
,	O	PUNCT	O
prepared	O	VERB	O
from	O	ADP	O
blood	O	NOUN	B
drawn	O	VERB	O
from	O	ADP	O
these	O	DET	O
18	O	NUM	O
children	O	NOUN	B
at	O	ADP	O
6	O	NUM	O
months	O	NOUN	B
of	O	ADP	O
age	O	NOUN	B
,	O	PUNCT	O
produced	O	VERB	O
lower	O	ADJ	O
yields	O	NOUN	O
of	O	ADP	O
IFN	B-GENE	NOUN	B
than	O	ADP	O
those	O	DET	O
of	O	ADP	O
the	O	DET	O
remaining	O	VERB	O
53	O	NUM	O
children	O	NOUN	B
,	O	PUNCT	O
when	O	SCONJ	O
stimulated	O	VERB	B
with	O	ADP	O
adenovirus	O	NOUN	B
(	O	PUNCT	O
P	O	NOUN	O
<	O	X	O
0	O	NUM	O
.	O	PUNCT	O
001	O	NUM	O
)	O	PUNCT	O
,	O	PUNCT	O
coronavirus	O	NOUN	B
(	O	PUNCT	O
P	O	NOUN	O
<	O	X	O
0	O	NUM	O
.	O	PUNCT	O
001	O	NUM	O
)	O	PUNCT	O
or	O	CCONJ	O
rhinovirus	O	NOUN	B
(	O	PUNCT	O
P	O	NOUN	O
=	O	ADJ	O
0	O	NUM	O
.	O	PUNCT	O
002	O	NUM	O
)	O	PUNCT	O
.	O	PUNCT	O


In	O	ADP	O
the	O	DET	O
BF	O	PROPN	B
ECT	O	PROPN	B
group	O	NOUN	B
the	O	DET	O
-	O	PUNCT	O
age	O	NOUN	B
based	O	VERB	O
dose	O	NOUN	B
would	O	AUX	O
have	O	AUX	O
been	O	AUX	O
similarly	O	ADV	O
dependent	O	ADJ	O
on	O	ADP	O
the	O	DET	O
initial	O	ADJ	O
seizure	O	NOUN	B
threshold	O	NOUN	B
level	O	NOUN	B
.	O	PUNCT	O


Haycocknema	O	X	B
perplexum	O	ADJ	I
n	O	NOUN	O
.	O	PUNCT	O
g	O	NOUN	O
.	O	PUNCT	O
,	O	PUNCT	O
n	O	NOUN	O
.	O	PUNCT	O
sp	O	NOUN	B
.	O	PUNCT	O


Hypothermia	O	NOUN	B
After	O	ADP	O
Cardiac	O	PROPN	B
Arrest	O	PROPN	I
(	O	PUNCT	O
HACA	O	NOUN	B
)	O	PUNCT	O
Study	O	PROPN	B
Group	O	PROPN	I
.	O	PUNCT	O


Two	O	NUM	O
US	O	PROPN	B
commercial	O	ADJ	B
cultivars	O	NOUN	O
(	O	PUNCT	O
Tehama	O	PROPN	B
and	O	CCONJ	O
Vina	O	PROPN	B
)	O	PUNCT	O
,	O	PUNCT	O
three	O	NUM	O
European	O	ADJ	B
commercial	O	ADJ	O
cultivars	O	NOUN	O
(	O	PUNCT	O
Esterhazy	O	PROPN	B
,	O	PUNCT	O
139	O	NUM	O
,	O	PUNCT	O
G120	O	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
five	O	NUM	O
New	O	PROPN	B
Zealand	O	PROPN	I
selections	O	NOUN	O
(	O	PUNCT	O
Rex	O	NOUN	B
,	O	PUNCT	O
Dublin	O	PROPN	B
'	O	PART	O
s	O	NOUN	O
Glory	O	NOUN	B
,	O	PUNCT	O
Meyric	O	PROPN	B
,	O	PUNCT	O
McKinster	O	PROPN	B
,	O	PUNCT	O
Stanley	O	PROPN	O
)	O	PUNCT	O
were	O	AUX	O
evaluated	O	VERB	B
.	O	PUNCT	O


Previously	O	ADV	O
,	O	PUNCT	O
we	O	PRON	O
showed	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
APRE	O	NOUN	B
is	O	AUX	O
a	O	DET	O
cytokine	O	NOUN	B
[	O	PUNCT	O
tumor	B-GENE	NOUN	B
necrosis	I-GENE	NOUN	I
factor	I-GENE	NOUN	I
-	I-GENE	PUNCT	O
alpha	I-GENE	NOUN	B
(	O	PUNCT	O
TNFalpha	B-GENE	NOUN	B
)	O	PUNCT	O
]	O	PUNCT	O
-	O	PUNCT	O
inducible	O	ADJ	B
enhancer	O	NOUN	B
by	O	ADP	O
binding	O	VERB	B
the	O	DET	O
heterodimeric	B-GENE	ADJ	B
nuclear	I-GENE	ADJ	I
factor	I-GENE	NOUN	I
-	I-GENE	PUNCT	O
kappaB	I-GENE	NOUN	B
(	O	PUNCT	O
NF	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
kappaB	I-GENE	NOUN	B
)	O	PUNCT	O
complex	O	NOUN	O
Rel	B-GENE	NOUN	B
A	I-GENE	NOUN	I
x	O	NOUN	O
NF	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
kappaB1	I-GENE	NOUN	B
.	O	PUNCT	O


Angiotensin	B-GENE	NOUN	B
II	I-GENE	NUM	I
induces	O	VERB	O
nuclear	B-GENE	ADJ	B
factor	I-GENE	NOUN	I
(	I-GENE	PUNCT	O
NF	I-GENE	NOUN	B
)	I-GENE	PUNCT	O
-	I-GENE	PUNCT	O
kappaB1	I-GENE	NOUN	B
isoforms	I-GENE	NOUN	B
to	O	PART	O
bind	O	VERB	B
the	O	DET	O
angiotensinogen	B-GENE	NOUN	B
gene	I-GENE	NOUN	I
acute	O	ADJ	B
-	O	PUNCT	O
phase	O	NOUN	B
response	O	NOUN	I
element	O	NOUN	I
:	O	PUNCT	O
a	O	DET	O
stimulus	O	NOUN	B
-	O	PUNCT	O
specific	O	ADJ	B
pathway	O	NOUN	B
for	O	ADP	O
NF	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
kappaB	I-GENE	NOUN	B
activation	O	NOUN	B
.	O	PUNCT	O


Arhythmacanthus	O	ADJ	B
Yamaguti	O	PROPN	I
,	O	PUNCT	O
1935	O	NUM	O
is	O	AUX	O
maintained	O	VERB	B
as	O	ADP	O
a	O	DET	O
synonym	O	NOUN	O
of	O	ADP	O
Heterosentis	O	PROPN	B
because	O	SCONJ	O
the	O	DET	O
distinction	O	NOUN	O
between	O	ADP	O
two	O	NUM	O
and	O	CCONJ	O
three	O	NUM	O
hook	O	NOUN	B
types	O	NOUN	I
is	O	AUX	O
made	O	VERB	O
equivocal	O	ADJ	B
when	O	SCONJ	O
the	O	DET	O
transition	O	NOUN	B
between	O	ADP	O
the	O	DET	O
apical	O	ADJ	B
and	O	CCONJ	O
subapical	O	ADJ	B
hooks	O	NOUN	I
is	O	AUX	O
gradual	O	ADJ	O
.	O	PUNCT	O


We	O	PRON	O
describe	O	VERB	O
a	O	DET	O
case	O	NOUN	B
of	O	ADP	O
acetaminophen	O	NOUN	B
overdose	O	NOUN	B
that	O	PRON	O
was	O	AUX	O
treated	O	VERB	B
with	O	ADP	I
both	O	CCONJ	O
hemodialysis	O	NOUN	B
(	O	PUNCT	O
HD	O	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
NAC	O	NOUN	B
due	O	ADP	O
to	O	PART	O
severe	O	ADJ	B
intoxication	O	NOUN	B
and	O	CCONJ	O
slow	O	ADJ	B
drug	O	NOUN	I
clearance	O	NOUN	I
.	O	PUNCT	O


Following	O	VERB	O
conditioning	O	NOUN	B
,	O	PUNCT	O
a	O	DET	O
single	O	ADJ	O
coat	O	NOUN	O
of	O	ADP	O
adhesive	O	ADJ	B
was	O	AUX	O
applied	O	VERB	O
and	O	CCONJ	O
light	O	ADJ	B
-	O	PUNCT	O
cured	O	VERB	B
.	O	PUNCT	O


Upon	O	SCONJ	O
tyrosine	O	NOUN	B
phosphorylation	O	NOUN	B
at	O	ADP	O
the	O	DET	O
ITIMs	O	NOUN	B
,	O	PUNCT	O
these	O	DET	O
molecules	O	NOUN	B
recruit	O	VERB	O
SH2	B-GENE	NOUN	B
domain	O	NOUN	I
-	O	PUNCT	O
containing	O	VERB	B
phosphatases	O	NOUN	B
such	O	ADJ	O
as	O	ADP	O
SH2	B-GENE	NOUN	B
-	O	PUNCT	O
containing	O	VERB	B
tyrosine	B-GENE	NOUN	B
phosphatase	I-GENE	NOUN	I
-	I-GENE	PUNCT	O
1	I-GENE	NUM	O
and	O	CCONJ	O
negatively	O	ADV	O
regulate	O	VERB	B
cell	O	NOUN	B
activity	O	NOUN	I
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
VP1	B-GENE	NOUN	B
was	O	AUX	O
efficiently	O	ADV	O
transported	O	VERB	B
to	O	PART	O
the	O	DET	O
nucleus	O	NOUN	B
and	O	CCONJ	O
localized	O	ADJ	B
in	O	ADP	O
the	O	DET	O
discrete	O	ADJ	O
subnuclear	O	ADJ	B
regions	O	NOUN	I
,	O	PUNCT	O
possibly	O	ADV	O
with	O	ADP	O
VP2	B-GENE	NOUN	B
and	O	CCONJ	O
VP3	B-GENE	NOUN	B
.	O	PUNCT	O


The	O	DET	O
case	O	NOUN	B
for	O	ADP	O
completing	O	VERB	O
the	O	DET	O
lymphadenectomy	O	NOUN	B
when	O	SCONJ	O
positive	O	ADJ	B
lymph	O	NOUN	B
nodes	O	NOUN	I
are	O	AUX	O
found	O	VERB	O
during	O	ADP	O
radical	O	ADJ	B
hysterectomy	O	NOUN	I
for	O	ADP	O
cervical	O	ADJ	B
carcinoma	O	NOUN	I
.	O	PUNCT	O


Isolation	O	NOUN	B
of	O	ADP	O
cDNAs	B-GENE	NOUN	B
encoding	I-GENE	VERB	B
gibbon	I-GENE	NOUN	B
and	I-GENE	CCONJ	O
monkey	I-GENE	NOUN	B
platelet	I-GENE	NOUN	B
and	I-GENE	CCONJ	O
T	I-GENE	NOUN	B
cell	I-GENE	NOUN	I
activation	I-GENE	NOUN	O
antigen	I-GENE	NOUN	O
1	I-GENE	NUM	O
(	O	PUNCT	O
PTA1	B-GENE	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


All	O	DET	O
clones	O	NOUN	B
and	O	CCONJ	O
strains	O	NOUN	B
produced	O	VERB	O
have	O	AUX	O
been	O	AUX	O
deposited	O	VERB	B
in	O	ADP	O
the	O	DET	O
EUROFAN	O	NOUN	B
genetic	O	ADJ	B
stock	O	NOUN	I
centre	O	NOUN	I
(	O	PUNCT	O
EUROSCARF	O	PROPN	B
,	O	PUNCT	O
Frankfurt	O	PROPN	B
)	O	PUNCT	O
.	O	PUNCT	O


High	O	ADJ	B
resolution	O	NOUN	I
computed	O	VERB	I
tomography	O	NOUN	I
of	O	ADP	O
the	O	DET	O
lungs	O	NOUN	B
in	O	ADP	O
patients	O	NOUN	B
with	O	ADP	O
rheumatoid	O	ADJ	B
arthritis	O	NOUN	I
.	O	PUNCT	O


Actins	B-GENE	NOUN	B
show	O	VERB	O
two	O	NUM	O
different	O	ADJ	O
forms	O	NOUN	O
of	O	ADP	O
N	O	NOUN	B
-	O	PUNCT	O
terminal	O	ADJ	B
processing	O	NOUN	B
dependent	O	ADJ	O
on	O	ADP	O
their	O	PRON	O
N	O	NOUN	B
-	O	PUNCT	O
terminal	O	ADJ	B
sequence	O	NOUN	B
.	O	PUNCT	O


All	O	DET	O
four	O	NUM	O
domains	O	NOUN	B
were	O	AUX	O
linked	O	VERB	O
via	O	ADP	O
proline	O	NOUN	B
-	O	PUNCT	O
threonine	O	NOUN	B
-	O	PUNCT	O
rich	O	ADJ	B
peptides	O	NOUN	B
.	O	PUNCT	O


METHODS	O	NOUN	O
:	O	PUNCT	O
The	O	DET	O
former	O	ADJ	B
group	O	NOUN	I
included	O	VERB	O
patients	O	NOUN	B
who	O	PRON	O
had	O	AUX	O
been	O	AUX	O
treated	O	VERB	B
with	O	ADP	I
at	O	ADP	O
least	O	ADJ	O
four	O	NUM	O
PGE1	O	NOUN	B
alpha	O	NOUN	B
-	O	PUNCT	O
ciclodestrina	O	NOUN	B
,	O	PUNCT	O
short	O	ADJ	B
-	O	PUNCT	O
term	O	NOUN	B
treatment	O	NOUN	B
cycles	O	NOUN	I
per	O	ADP	O
year	O	NOUN	B
while	O	SCONJ	O
the	O	DET	O
latter	O	ADJ	O
was	O	AUX	O
a	O	DET	O
historical	O	ADJ	B
reference	O	NOUN	O
group	O	NOUN	B
managed	O	VERB	O
without	O	ADP	O
prostaglandins	O	NOUN	B
.	O	PUNCT	O


Zebrafish	O	ADJ	B
cyclops	B-GENE	NOUN	B
(	O	PUNCT	O
cyc	B-GENE	NOUN	B
)	O	PUNCT	O
encodes	O	VERB	B
a	O	DET	O
Transforming	B-GENE	VERB	B
Growth	I-GENE	NOUN	I
Factor	I-GENE	NOUN	I
beta	I-GENE	NOUN	I
(	O	PUNCT	I
TGFbeta	B-GENE	NOUN	B
)	O	PUNCT	O
signaling	O	NOUN	B
factor	O	NOUN	I
closely	O	ADV	O
related	O	ADJ	O
to	O	PART	O
mouse	O	NOUN	B
Nodal	B-GENE	PROPN	B
.	O	PUNCT	O


The	O	DET	O
genome	O	NOUN	B
organization	O	NOUN	I
of	O	ADP	O
the	O	DET	O
mite	O	NOUN	B
-	O	PUNCT	O
transmitted	O	VERB	B
wheat	O	NOUN	B
streak	O	NOUN	B
mosaic	O	ADJ	I
virus	O	NOUN	I
(	O	PUNCT	O
WSMV	O	NOUN	B
)	O	PUNCT	O
appears	O	VERB	O
to	O	PART	O
parallel	O	VERB	O
that	O	DET	O
of	O	ADP	O
members	O	NOUN	B
of	O	ADP	O
the	O	DET	O
Potyviridae	O	PROPN	B
with	O	ADP	O
monopartite	O	ADJ	B
genomes	O	NOUN	I
,	O	PUNCT	O
but	O	CCONJ	O
there	O	PRON	O
are	O	AUX	O
substantial	O	ADJ	O
amino	O	NOUN	B
acid	O	NOUN	I
dissimilarities	O	NOUN	B
with	O	ADP	O
other	O	ADJ	O
potyviral	O	ADJ	B
polyproteins	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
two	O	NUM	O
-	O	PUNCT	O
hybrid	O	NOUN	B
assay	O	NOUN	B
was	O	AUX	O
then	O	ADV	O
performed	O	VERB	O
using	O	VERB	O
full	O	ADJ	B
-	O	PUNCT	O
length	O	NOUN	B
genes	O	NOUN	B
of	O	ADP	O
CI	B-GENE	NOUN	B
,	O	PUNCT	O
HC	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
Pro	I-GENE	NOUN	B
,	O	PUNCT	O
P1	B-GENE	NOUN	B
,	O	PUNCT	O
P3	B-GENE	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
CP	B-GENE	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
no	O	DET	O
heterologous	O	ADJ	B
interactions	O	NOUN	B
were	O	AUX	O
detected	O	VERB	B
.	O	PUNCT	O


Diverse	O	ADJ	B
endogenous	O	ADJ	B
light	O	ADJ	B
chains	O	NOUN	I
contribute	O	VERB	O
to	O	PART	O
basement	O	NOUN	B
membrane	O	NOUN	I
reactivity	O	NOUN	I
in	O	ADP	O
nonautoimmune	O	ADJ	B
mice	O	NOUN	I
transgenic	O	ADJ	B
for	O	ADP	O
an	O	DET	O
anti	B-GENE	ADJ	B
-	I-GENE	PUNCT	O
laminin	I-GENE	NOUN	B
Ig	B-GENE	NOUN	B
heavy	I-GENE	ADJ	I
chain	I-GENE	NOUN	I
.	O	PUNCT	O


Mechanisms	O	NOUN	B
of	O	ADP	O
tachyphylaxis	O	NOUN	B
in	O	ADP	O
regional	O	ADJ	B
anesthesia	O	NOUN	I
of	O	ADP	O
long	O	ADJ	B
duration	O	NOUN	I


Dermatology	O	NOUN	B
is	O	AUX	O
no	O	DET	O
exception	O	NOUN	O
.	O	PUNCT	O


Molecular	O	ADJ	B
cloning	O	NOUN	I
of	O	ADP	O
a	O	DET	O
novel	O	ADJ	O
human	B-GENE	ADJ	B
I	I-GENE	NUM	I
-	I-GENE	PUNCT	O
mfa	I-GENE	NOUN	B
domain	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
containing	I-GENE	VERB	B
protein	I-GENE	NOUN	B
that	O	PRON	O
differently	O	ADV	O
regulates	O	VERB	B
human	O	ADJ	B
T	O	NOUN	B
-	O	PUNCT	O
cell	O	NOUN	B
leukemia	O	NOUN	I
virus	O	NOUN	O
type	O	NOUN	O
I	O	NUM	O
and	O	CCONJ	O
HIV	O	NOUN	B
-	O	PUNCT	O
1	O	NUM	O
expression	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
central	O	ADJ	B
(	O	PUNCT	O
R	O	NOUN	O
)	O	PUNCT	O
domain	O	NOUN	O
is	O	AUX	O
responsible	O	ADJ	O
for	O	ADP	O
receptor	O	NOUN	B
-	O	PUNCT	O
binding	O	NOUN	B
activity	O	NOUN	O
whereas	O	SCONJ	O
the	O	DET	O
N	O	NOUN	B
-	O	PUNCT	O
terminal	O	ADJ	B
(	O	PUNCT	O
T	O	NOUN	O
)	O	PUNCT	O
domain	O	NOUN	O
mediates	O	VERB	O
translocation	O	NOUN	B
,	O	PUNCT	O
the	O	DET	O
process	O	NOUN	B
by	O	ADP	O
which	O	DET	O
the	O	DET	O
C	O	NOUN	B
-	O	PUNCT	O
terminal	O	ADJ	B
cytotoxic	O	ADJ	B
domain	O	NOUN	I
is	O	AUX	O
transported	O	VERB	B
from	O	ADP	O
the	O	DET	O
receptor	O	NOUN	B
to	O	PART	O
the	O	DET	O
site	O	NOUN	B
of	O	ADP	O
its	O	PRON	O
cytotoxicity	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
previously	O	ADV	O
demonstrated	O	VERB	O
that	O	SCONJ	O
expression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
gene	O	NOUN	B
for	O	ADP	O
the	O	DET	O
reproductive	O	ADJ	B
neuropeptide	O	NOUN	I
,	O	PUNCT	O
GnRH	B-GENE	NOUN	B
,	O	PUNCT	O
is	O	AUX	O
repressed	O	VERB	B
by	O	ADP	O
the	O	DET	O
glutamate	O	NOUN	B
/	O	SYM	O
NO	O	PROPN	B
/	O	PUNCT	O
cyclic	O	ADJ	B
GMP	O	NOUN	I
(	O	PUNCT	O
cGMP	O	NOUN	B
)	O	PUNCT	O
signal	O	NOUN	B
transduction	O	NOUN	I
pathway	O	NOUN	O
through	O	ADP	O
cGMP	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
dependent	I-GENE	ADJ	B
protein	I-GENE	NOUN	B
kinase	I-GENE	NOUN	I
in	O	ADP	O
the	O	DET	O
hypothalamic	O	ADJ	B
GnRH	B-GENE	NOUN	B
-	O	PUNCT	O
secreting	O	VERB	B
neuronal	O	ADJ	B
cell	O	NOUN	I
line	O	NOUN	I
GT1	O	NOUN	B
-	O	PUNCT	O
7	O	NUM	B
.	O	PUNCT	O


MSSPs	B-GENE	NOUN	B
are	O	AUX	O
believed	O	VERB	O
to	O	PART	O
regulate	O	VERB	B
DNA	O	NOUN	B
replication	O	NOUN	I
,	O	PUNCT	O
transcription	O	NOUN	B
,	O	PUNCT	O
apopotosis	O	NOUN	B
and	O	CCONJ	O
cell	O	NOUN	B
cycle	O	NOUN	I
progression	O	NOUN	I
by	O	ADP	O
interacting	O	VERB	B
with	O	ADP	O
the	O	DET	O
C	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
MYC	I-GENE	NOUN	B
protein	I-GENE	NOUN	B
.	O	PUNCT	O


As	O	ADP	O
no	O	DET	O
complete	O	ADJ	O
PPARgamma	B-GENE	NOUN	B
antagonists	O	NOUN	O
have	O	AUX	O
been	O	AUX	O
described	O	VERB	O
hitherto	O	ADV	O
,	O	PUNCT	O
we	O	PRON	O
have	O	AUX	O
constructed	O	VERB	O
a	O	DET	O
dominant	O	ADJ	B
-	O	PUNCT	O
negative	O	ADJ	B
mutant	O	ADJ	B
receptor	O	NOUN	I
to	O	PART	O
inhibit	O	VERB	B
wild	O	ADJ	B
-	O	PUNCT	O
type	O	NOUN	B
PPARgamma	B-GENE	NOUN	B
action	O	NOUN	B
.	O	PUNCT	O


Forty	O	NUM	O
4	O	NUM	O
-	O	PUNCT	O
month	O	NOUN	B
old	O	ADJ	B
SD	O	NOUN	I
female	O	NOUN	B
rats	O	NOUN	B
were	O	AUX	O
randomly	O	ADV	O
divided	O	VERB	O
into	O	ADP	O
four	O	NUM	O
groups	O	NOUN	B
,	O	PUNCT	O
namely	O	ADV	O
sham	O	NOUN	B
operation	O	NOUN	B
,	O	PUNCT	O
bilateral	O	ADJ	B
ovariectomy	O	NOUN	B
,	O	PUNCT	O
ovariectomy	O	NOUN	B
plus	O	CCONJ	O
supplementary	O	ADJ	O
ethinyl	O	NOUN	B
estradiol	O	NOUN	O
(	O	PUNCT	O
0	O	NUM	O
.	O	PUNCT	O
2	O	NUM	O
microgram	O	NOUN	B
/	O	SYM	O
100	O	NUM	O
g	O	NOUN	O
B	O	NOUN	O
.	O	PUNCT	O


The	O	DET	O
requirement	O	NOUN	O
of	O	ADP	O
3	O	NUM	O
'	O	PART	O
complementarity	O	NOUN	B
for	O	ADP	O
a	O	DET	O
ligation	O	NOUN	B
reaction	O	NOUN	I
is	O	AUX	O
reaffirmed	O	VERB	O
by	O	ADP	O
results	O	NOUN	B
from	O	ADP	O
1	O	NUM	O
nt	O	NOUN	O
insertions	O	NOUN	B
on	O	ADP	O
either	O	CCONJ	O
the	O	DET	O
3	O	NUM	O
'	O	PUNCT	O
-	O	PUNCT	O
or	O	CCONJ	O
5	O	NUM	O
'	O	PUNCT	O
-	O	PUNCT	O
side	O	NOUN	B
of	O	ADP	O
the	O	DET	O
nick	O	NOUN	B
.	O	PUNCT	O


Expression	O	NOUN	B
in	O	ADP	O
early	O	ADJ	O
postnatal	O	ADJ	B
pituitary	O	NOUN	B
and	O	CCONJ	O
in	O	ADP	O
pre	O	ADJ	B
-	O	PUNCT	O
somatotrophic	O	ADJ	B
cells	O	NOUN	I
suggests	O	VERB	O
that	O	SCONJ	O
Zn	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
16	I-GENE	NUM	O
could	O	AUX	O
play	O	VERB	O
a	O	DET	O
role	O	NOUN	O
in	O	ADP	O
pituitary	O	ADJ	B
development	O	NOUN	O
prior	O	ADJ	O
to	O	PART	O
somatotroph	O	NOUN	B
differentiation	O	NOUN	O
.	O	PUNCT	O


Mouse	B-GENE	NOUN	B
growth	I-GENE	NOUN	I
hormone	I-GENE	NOUN	O
transcription	I-GENE	NOUN	B
factor	I-GENE	NOUN	I
Zn	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
16	I-GENE	NUM	O
:	O	PUNCT	O
unique	O	ADJ	O
bipartite	O	ADJ	B
structure	O	NOUN	I
containing	O	VERB	O
tandemly	O	ADJ	B
repeated	O	ADJ	O
zinc	O	NOUN	B
finger	O	NOUN	I
domains	O	NOUN	O
not	O	PART	O
reported	O	VERB	O
in	O	ADP	O
rat	B-GENE	NOUN	B
Zn	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
15	I-GENE	NUM	O
.	O	PUNCT	O


The	O	DET	O
CCAAT	O	NOUN	B
core	O	NOUN	I
sequence	O	NOUN	I
mutants	O	NOUN	B
in	O	ADP	O
which	O	DET	O
both	O	CCONJ	O
CIII	O	NOUN	B
and	O	CCONJ	O
CI	O	NOUN	B
/	O	PUNCT	O
CII	O	NOUN	B
were	O	AUX	O
abolished	O	VERB	B
,	O	PUNCT	O
also	O	ADV	O
increased	O	VERB	B
the	O	DET	O
promoter	O	NOUN	B
activity	O	NOUN	I
.	O	PUNCT	O


Finally	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
mechanism	O	NOUN	B
of	O	ADP	O
ASK1	B-GENE	NOUN	B
activation	O	NOUN	B
involves	O	VERB	O
,	O	PUNCT	O
in	O	ADP	O
part	O	NOUN	O
,	O	PUNCT	O
homo	O	ADJ	B
-	O	PUNCT	O
oligomerization	O	NOUN	B
.	O	PUNCT	O


Two	O	NUM	O
other	O	ADJ	O
patients	O	NOUN	B
underwent	O	VERB	O
PRFR	O	PROPN	B
.	O	PUNCT	O


The	O	DET	O
variations	O	NOUN	B
were	O	AUX	O
caused	O	VERB	O
by	O	ADP	O
opposite	O	ADJ	O
shifts	O	NOUN	B
in	O	ADP	O
TSH	B-GENE	NOUN	B
frequency	O	NOUN	B
distribution	O	NOUN	B
in	O	ADP	O
mothers	O	NOUN	B
and	O	CCONJ	O
neonates	O	NOUN	B
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
such	O	DET	O
a	O	DET	O
mechanism	O	NOUN	B
was	O	AUX	O
not	O	PART	O
detected	O	VERB	B
in	O	ADP	O
preliminary	O	ADJ	B
observations	O	NOUN	B
on	O	ADP	O
M	O	NOUN	B
.	O	PUNCT	O
synoviae	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
yam8	B-GENE	NOUN	B
(	I-GENE	PUNCT	O
+	I-GENE	CCONJ	O
)	I-GENE	PUNCT	O
cDNA	I-GENE	NOUN	B
in	O	ADP	O
the	O	DET	O
mid1	B-GENE	NOUN	B
mutant	I-GENE	ADJ	I
cells	O	NOUN	I
partially	O	ADV	O
remediated	O	VERB	B
the	O	DET	O
mid	O	ADJ	O
phenotype	O	NOUN	B
and	O	CCONJ	O
resulted	O	VERB	O
in	O	ADP	O
a	O	DET	O
slight	O	ADJ	O
increase	O	NOUN	B
in	O	ADP	O
Ca	O	NOUN	B
(	O	PUNCT	O
2	O	NUM	O
+	O	CCONJ	O
)	O	PUNCT	O
uptake	O	NOUN	O
activity	O	NOUN	B
.	O	PUNCT	O


TIP30	B-GENE	NOUN	B
has	O	AUX	O
an	O	DET	O
intrinsic	O	ADJ	B
kinase	O	NOUN	I
activity	O	NOUN	O
required	O	VERB	O
for	O	ADP	O
up	O	ADV	B
-	O	PUNCT	O
regulation	O	NOUN	B
of	O	ADP	O
a	O	DET	O
subset	O	NOUN	O
of	O	ADP	O
apoptotic	O	ADJ	B
genes	O	NOUN	I
.	O	PUNCT	O


Alternatively	O	ADV	O
,	O	PUNCT	O
PC12	O	NOUN	B
-	O	PUNCT	O
E2	O	NOUN	B
cells	O	NOUN	B
were	O	AUX	O
submitted	O	VERB	O
to	O	PART	O
treatment	O	NOUN	B
with	O	ADP	O
antibodies	O	NOUN	B
to	O	PART	O
the	O	DET	O
fibroblast	B-GENE	NOUN	B
growth	I-GENE	NOUN	I
factor	I-GENE	NOUN	I
(	I-GENE	PUNCT	O
FGF	I-GENE	NOUN	B
)	I-GENE	PUNCT	O
receptor	I-GENE	NOUN	O
,	O	PUNCT	O
inhibitors	O	NOUN	B
of	O	ADP	O
the	O	DET	O
nonreceptor	B-GENE	ADJ	B
tyrosine	I-GENE	NOUN	I
kinase	I-GENE	NOUN	I
p59	B-GENE	NOUN	I
(	O	PUNCT	O
fyn	B-GENE	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
PLC	B-GENE	NOUN	B
,	O	PUNCT	O
PKC	B-GENE	NOUN	B
and	O	CCONJ	O
MEK	B-GENE	NOUN	B
and	O	CCONJ	O
an	O	DET	O
activator	O	NOUN	B
of	O	ADP	O
PKC	B-GENE	NOUN	B
,	O	PUNCT	O
phorbol	O	NOUN	B
-	O	PUNCT	O
12	O	NUM	O
-	O	PUNCT	O
myristate	O	NOUN	B
-	O	PUNCT	O
13	O	NUM	O
-	O	PUNCT	O
acetate	O	NOUN	B
(	O	PUNCT	O
PMA	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Approximately	O	ADV	O
20	O	NUM	O
%	O	NOUN	O
of	O	ADP	O
ALCLs	O	NOUN	B
that	O	PRON	O
express	O	VERB	B
ALK	B-GENE	NOUN	B
do	O	AUX	O
not	O	PART	O
contain	O	VERB	O
the	O	DET	O
t	O	NOUN	O
(	O	PUNCT	O
2	O	NUM	O
;	O	PUNCT	O
5	O	NUM	O
)	O	PUNCT	O
,	O	PUNCT	O
suggesting	O	VERB	O
that	O	SCONJ	O
other	O	ADJ	O
genetic	O	ADJ	B
abnormalities	O	NOUN	I
can	O	AUX	O
result	O	VERB	O
in	O	ADP	O
aberrant	O	ADJ	B
ALK	B-GENE	NOUN	B
expression	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
addition	O	NOUN	O
,	O	PUNCT	O
expected	O	VERB	O
decreases	O	NOUN	B
in	O	ADP	O
ATIC	B-GENE	NOUN	B
enzymatic	O	ADJ	B
function	O	NOUN	I
in	O	ADP	O
ATIC	B-GENE	NOUN	B
-	O	PUNCT	O
ALK	B-GENE	PROPN	B
-	O	PUNCT	O
containing	O	VERB	B
lymphomas	O	NOUN	B
may	O	AUX	O
render	O	VERB	O
these	O	DET	O
tumors	O	NOUN	B
more	O	ADV	O
sensitive	O	ADJ	B
to	O	PART	O
antifolate	O	VERB	B
drugs	O	NOUN	I
such	O	ADJ	O
as	O	ADP	O
methotrexate	O	NOUN	B
.	O	PUNCT	O


Manganese	O	NOUN	B
ions	O	NOUN	B
were	O	AUX	O
found	O	VERB	O
to	O	PART	O
be	O	AUX	O
essential	O	ADJ	B
for	O	ADP	O
autophosphorylation	O	NOUN	B
of	O	ADP	O
BGLF4	B-GENE	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
magnesium	O	NOUN	B
can	O	AUX	O
stimulate	O	VERB	B
the	O	DET	O
activity	O	NOUN	B
.	O	PUNCT	O


An	O	DET	O
amino	O	NOUN	B
-	O	PUNCT	O
acid	O	NOUN	B
sequence	O	NOUN	I
comparison	O	NOUN	B
revealed	O	VERB	O
that	O	SCONJ	O
Bacillus	B-GENE	PROPN	B
YM55	I-GENE	PROPN	I
-	I-GENE	PUNCT	O
1	I-GENE	NUM	O
aspartase	I-GENE	NOUN	B
shared	O	VERB	O
71	O	NUM	O
%	O	NOUN	O
homology	O	NOUN	B
with	O	ADP	O
Bacillus	B-GENE	X	B
subtilis	I-GENE	X	I
aspartase	I-GENE	NOUN	I
and	O	CCONJ	O
49	O	NUM	O
%	O	NOUN	O
with	O	ADP	O
Escherichia	O	X	B
coli	O	X	I
and	O	CCONJ	O
Pseudomonas	B-GENE	X	B
fluorescens	I-GENE	X	I
aspartases	I-GENE	NOUN	I
.	O	PUNCT	O


Unique	O	ADJ	O
to	O	ADP	O
this	O	DET	O
system	O	NOUN	B
,	O	PUNCT	O
the	O	DET	O
activity	O	NOUN	B
of	O	ADP	O
TraR	B-GENE	NOUN	B
is	O	AUX	O
negatively	O	ADV	O
modulated	O	VERB	B
by	O	ADP	O
an	O	DET	O
antiactivator	O	NOUN	B
called	O	VERB	O
TraM	B-GENE	NOUN	B
.	O	PUNCT	O


As	O	ADP	O
assessed	O	VERB	B
by	O	ADP	O
a	O	DET	O
genetic	O	ADJ	B
assay	O	NOUN	I
that	O	PRON	O
measures	O	VERB	B
AAI	O	PROPN	B
-	O	PUNCT	O
dependent	O	ADJ	B
DNA	O	NOUN	B
binding	O	NOUN	I
,	O	PUNCT	O
TraM	B-GENE	NOUN	B
inhibited	O	VERB	B
TraR	B-GENE	NOUN	B
function	O	NOUN	I
before	O	ADP	O
and	O	CCONJ	O
after	O	ADP	O
the	O	DET	O
transcription	O	NOUN	B
factor	O	NOUN	I
had	O	AUX	O
bound	O	VERB	O
to	O	PART	O
its	O	PRON	O
DNA	O	NOUN	B
recognition	O	NOUN	I
site	O	NOUN	I
.	O	PUNCT	O


Collectively	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
results	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
ARF	B-GENE	NOUN	B
binding	O	NOUN	B
to	O	PART	O
Mdm2	B-GENE	NOUN	B
induces	O	VERB	O
a	O	DET	O
conformational	O	ADJ	B
change	O	NOUN	I
that	O	PRON	O
facilitates	O	VERB	O
nucleolar	O	ADJ	B
import	O	NOUN	O
of	O	ADP	O
the	O	DET	O
ARF	B-GENE	PROPN	B
-	O	PUNCT	O
Mdm2	B-GENE	NOUN	B
complex	O	NOUN	B
and	O	CCONJ	O
p53	B-GENE	NOUN	B
-	O	PUNCT	O
dependent	O	ADJ	B
cell	O	NOUN	B
cycle	O	NOUN	I
arrest	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
AtERF	B-GENE	NOUN	B
genes	I-GENE	NOUN	B
were	O	AUX	O
differentially	O	ADV	O
regulated	O	VERB	O
by	O	ADP	O
ethylene	O	NOUN	B
and	O	CCONJ	O
by	O	ADP	O
abiotic	O	ADJ	B
stress	O	NOUN	I
conditions	O	NOUN	I
,	O	PUNCT	O
such	O	ADJ	O
as	O	ADP	O
wounding	O	NOUN	B
,	O	PUNCT	O
cold	O	ADJ	B
,	O	PUNCT	O
high	O	ADJ	B
salinity	O	NOUN	B
,	O	PUNCT	O
or	O	CCONJ	O
drought	O	NOUN	B
,	O	PUNCT	O
via	O	ADP	O
ETHYLENE	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
INSENSITIVE2	I-GENE	NOUN	B
(	O	PUNCT	O
EIN2	B-GENE	NOUN	B
)	O	PUNCT	O
-	O	PUNCT	O
dependent	O	ADJ	B
or	O	CCONJ	O
-	O	PUNCT	O
independent	O	ADJ	B
pathways	O	NOUN	B
.	O	PUNCT	O


Electrophoretic	O	ADJ	B
mobility	O	NOUN	I
shift	O	NOUN	I
assays	O	NOUN	I
revealed	O	VERB	O
that	O	SCONJ	O
Sp1	B-GENE	NOUN	B
binds	O	VERB	B
to	O	PART	O
two	O	NUM	O
different	O	ADJ	O
regions	O	NOUN	B
in	O	ADP	O
the	O	DET	O
proximal	O	ADJ	B
promoter	O	NOUN	B
,	O	PUNCT	O
a	O	DET	O
typical	O	ADJ	O
Sp1	B-GENE	NOUN	B
site	I-GENE	NOUN	B
located	O	ADJ	O
at	O	ADP	O
(	O	PUNCT	O
-	O	PUNCT	O
38	O	NUM	O
;	O	PUNCT	O
-	O	PUNCT	O
33	O	NUM	O
)	O	PUNCT	O
and	O	CCONJ	O
a	O	DET	O
G	O	NOUN	B
/	O	SYM	O
C	O	PROPN	B
-	O	PUNCT	O
rich	O	ADJ	B
region	O	NOUN	I
between	O	ADP	O
(	O	PUNCT	O
-	O	PUNCT	O
67	O	NUM	O
;	O	PUNCT	O
-	O	PUNCT	O
62	O	NUM	O
)	O	PUNCT	O
.	O	PUNCT	O


Eight	O	NUM	O
patients	O	NOUN	B
received	O	VERB	O
1	O	NUM	O
.	O	PUNCT	O
5	O	NUM	O
mg	O	NOUN	O
of	O	ADP	O
adefovir	O	NOUN	B
dipivoxil	O	NOUN	I
per	O	ADP	O
kg	O	NOUN	O
of	O	ADP	O
body	O	NOUN	B
weight	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
six	O	NUM	O
patients	O	NOUN	B
received	O	VERB	O
3	O	NUM	O
.	O	PUNCT	O
0	O	NUM	O
mg	O	NOUN	O
of	O	ADP	O
adefovir	O	NOUN	B
dipivoxil	O	NOUN	I
per	O	ADP	O
kg	O	NOUN	O
.	O	PUNCT	O


Most	O	ADV	O
likely	O	ADV	O
they	O	PRON	O
might	O	AUX	O
represent	O	VERB	O
regulatory	O	ADJ	B
RNAs	O	NOUN	I
or	O	CCONJ	O
transcribed	O	VERB	B
transposable	O	ADJ	I
elements	O	NOUN	I
.	O	PUNCT	O


Here	O	ADV	O
we	O	PRON	O
describe	O	VERB	O
the	O	DET	O
cloning	O	NOUN	B
,	O	PUNCT	O
tissue	O	NOUN	B
-	O	PUNCT	O
specific	O	ADJ	B
expression	O	NOUN	B
pattern	O	NOUN	O
,	O	PUNCT	O
and	O	CCONJ	O
functional	O	ADJ	B
characterization	O	NOUN	B
of	O	ADP	O
two	O	NUM	O
novel	O	ADJ	O
TEF	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	O
isoforms	I-GENE	NOUN	B
,	O	PUNCT	O
TEF	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
1beta	I-GENE	NOUN	B
and	O	CCONJ	O
TEF	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
1gamma	I-GENE	NOUN	B
.	O	PUNCT	O


The	O	DET	O
comparison	O	NOUN	B
of	O	ADP	O
the	O	DET	O
expression	O	NOUN	B
patterns	O	NOUN	O
of	O	ADP	O
the	O	DET	O
known	O	ADJ	O
Kv4	B-GENE	NOUN	B
family	I-GENE	NOUN	I
members	I-GENE	NOUN	I
shows	O	VERB	O
subtype	O	NOUN	B
specificity	O	NOUN	B
with	O	ADP	O
significant	O	ADJ	O
overlaps	O	NOUN	O
.	O	PUNCT	O


Preliminary	O	ADJ	B
use	O	NOUN	O
of	O	ADP	O
the	O	DET	O
Nottingham	O	PROPN	B
Eczema	O	PROPN	I
Severity	O	PROPN	I
Score	O	PROPN	I
would	O	AUX	O
support	O	VERB	O
further	O	ADJ	O
development	O	NOUN	B
as	O	ADP	O
a	O	DET	O
research	O	NOUN	B
tool	O	NOUN	I
for	O	ADP	O
a	O	DET	O
simple	O	ADJ	O
assessment	O	NOUN	B
of	O	ADP	O
disease	O	NOUN	B
severity	O	NOUN	B
that	O	PRON	O
could	O	AUX	O
be	O	AUX	O
used	O	VERB	O
in	O	ADP	O
epidemiological	O	ADJ	B
studies	O	NOUN	I
.	O	PUNCT	O


Advanced	O	ADJ	B
adenoma	O	NOUN	I
was	O	AUX	O
defined	O	VERB	O
as	O	ADP	O
an	O	DET	O
adenoma	O	NOUN	B
larger	O	ADJ	O
than	O	ADP	O
10	O	NUM	O
mm	O	NOUN	O
or	O	CCONJ	O
an	O	DET	O
adenoma	O	NOUN	B
of	O	ADP	O
any	O	DET	O
size	O	NOUN	B
with	O	ADP	O
villous	O	ADJ	B
component	O	NOUN	I
,	O	PUNCT	O
high	O	ADJ	B
-	O	PUNCT	O
grade	O	NOUN	B
dysplasia	O	NOUN	B
or	O	CCONJ	O
invasive	O	ADJ	B
carcinoma	O	NOUN	I
.	O	PUNCT	O


To	O	PART	O
understand	O	VERB	O
whether	O	SCONJ	O
Shc	B-GENE	NOUN	B
localization	O	NOUN	B
in	O	ADP	O
membrane	O	NOUN	B
rafts	O	NOUN	I
is	O	AUX	O
sufficient	O	ADJ	O
to	O	PART	O
regulate	O	VERB	B
Shc	B-GENE	NOUN	B
function	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
constructed	O	VERB	O
a	O	DET	O
Shc	B-GENE	NOUN	B
chimera	I-GENE	NOUN	B
containing	O	VERB	O
the	O	DET	O
Ras	B-GENE	NOUN	B
membrane	I-GENE	NOUN	I
localization	I-GENE	NOUN	B
motif	I-GENE	NOUN	B
at	O	ADP	O
the	O	DET	O
C	O	NOUN	B
-	O	PUNCT	O
terminus	O	NOUN	B
.	O	PUNCT	O


RegA	B-GENE	NOUN	B
is	O	AUX	O
a	O	DET	O
positive	O	ADJ	B
yet	O	ADV	O
nonessential	O	ADJ	O
regulator	O	NOUN	O
of	O	ADP	O
tol	B-GENE	NOUN	B
-	O	PUNCT	O
oprL	B-GENE	NOUN	B
expression	O	NOUN	B
.	O	PUNCT	O


Schlegel	O	PROPN	B
,	O	PUNCT	O
J	O	PROPN	O
.	O	PUNCT	O


The	O	DET	O
early	O	ADJ	B
dg	O	NOUN	O
.	O	PUNCT	O
of	O	ADP	O
rejection	O	NOUN	B
and	O	CCONJ	O
especially	O	ADV	O
acute	O	ADJ	B
rejection	O	NOUN	I
,	O	PUNCT	O
it	O	PRON	O
'	O	PUNCT	O
s	O	VERB	O
adequate	O	ADJ	B
management	O	NOUN	B
,	O	PUNCT	O
decreased	O	VERB	B
risk	O	NOUN	B
for	O	ADP	O
the	O	DET	O
future	O	ADJ	O
chronic	O	ADJ	B
rejection	O	NOUN	I
nephropathy	O	NOUN	I
.	O	PUNCT	O


Extracellular	B-GENE	ADJ	B
-	I-GENE	PUNCT	O
regulated	I-GENE	VERB	B
kinase	I-GENE	NOUN	O
(	O	PUNCT	O
ERK	B-GENE	NOUN	B
)	O	PUNCT	O
activation	O	NOUN	B
and	O	CCONJ	O
molecular	O	ADJ	B
coupling	O	NOUN	I
of	O	ADP	O
the	O	DET	O
adaptor	O	NOUN	B
proteins	O	NOUN	I
p130	B-GENE	NOUN	B
Crk	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
associated	I-GENE	VERB	B
substrate	I-GENE	NOUN	B
(	O	PUNCT	O
CAS	B-GENE	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
c	B-GENE	X	B
-	I-GENE	PUNCT	O
CrkII	I-GENE	NOUN	B
(	O	PUNCT	O
Crk	B-GENE	NOUN	B
)	O	PUNCT	O
represent	O	VERB	O
two	O	NUM	O
distinct	O	ADJ	O
pathways	O	NOUN	B
that	O	PRON	O
induce	O	VERB	B
cell	O	NOUN	B
invasion	O	NOUN	I
and	O	CCONJ	O
protect	O	VERB	B
cells	O	NOUN	I
from	O	ADP	O
apoptosis	O	NOUN	B
in	O	ADP	O
a	O	DET	O
three	O	NUM	B
-	O	PUNCT	O
dimensional	O	ADJ	B
collagen	B-GENE	NOUN	B
matrix	O	NOUN	O
.	O	PUNCT	O


The	O	DET	O
evolution	O	NOUN	B
of	O	ADP	O
the	O	DET	O
CCR5	B-GENE	NOUN	B
cis	I-GENE	NOUN	O
-	I-GENE	PUNCT	O
regulatory	I-GENE	ADJ	B
region	I-GENE	NOUN	I
versus	O	CCONJ	O
the	O	DET	O
open	O	ADJ	B
reading	O	NOUN	I
frame	O	NOUN	I
as	O	ADV	O
well	O	ADV	O
as	O	ADP	O
among	O	ADP	O
different	O	ADJ	O
domains	O	NOUN	B
of	O	ADP	O
the	O	DET	O
open	O	ADJ	B
reading	O	NOUN	I
frame	O	NOUN	I
differed	O	VERB	O
from	O	ADP	O
one	O	NUM	O
another	O	DET	O
.	O	PUNCT	O


Scanning	O	NOUN	B
mutations	O	NOUN	I
throughout	O	ADP	O
the	O	DET	O
AC	O	NOUN	B
element	O	NOUN	B
interfered	O	VERB	B
with	O	ADP	O
induction	O	NOUN	B
but	O	CCONJ	O
allowed	O	VERB	O
us	O	PRON	O
to	O	PART	O
define	O	VERB	O
five	O	NUM	O
overlapping	O	VERB	O
sites	O	NOUN	O
for	O	ADP	O
regulatory	O	ADJ	B
factors	O	NOUN	I
in	O	ADP	O
AC	O	NOUN	B
and	O	CCONJ	O
to	O	PART	O
design	O	VERB	B
probes	O	NOUN	B
binding	O	NOUN	B
just	O	ADV	O
one	O	NUM	O
or	O	CCONJ	O
two	O	NUM	O
factors	O	NOUN	B
.	O	PUNCT	O


Bites	O	NOUN	B
by	O	ADP	O
two	O	NUM	O
species	O	NOUN	B
of	O	ADP	O
adders	O	NOUN	B
(	O	PUNCT	O
Vipera	O	PROPN	B
aspis	O	NOUN	I
and	O	CCONJ	O
Vipera	O	PROPN	B
berus	O	NOUN	I
)	O	PUNCT	O
can	O	AUX	O
lead	O	VERB	O
to	O	ADP	O
extensive	O	ADJ	B
swelling	O	NOUN	B
with	O	ADP	O
multiorgan	O	ADJ	B
failure	O	NOUN	I
.	O	PUNCT	O


CONCLUSION	O	NOUN	B
:	O	PUNCT	O
Treatment	O	NOUN	B
of	O	ADP	O
sepsis	O	NOUN	B
with	O	ADP	O
the	O	DET	O
platelet	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
activating	I-GENE	VERB	B
factor	I-GENE	NOUN	O
antagonist	O	NOUN	O
BB	O	NOUN	B
-	O	PUNCT	O
882	O	NUM	O
offers	O	VERB	O
no	O	DET	O
advantage	O	NOUN	O
over	O	ADP	O
placebo	O	NOUN	B
on	O	ADP	O
survival	O	NOUN	B
,	O	PUNCT	O
hemodynamic	O	ADJ	B
status	O	NOUN	I
,	O	PUNCT	O
respiratory	O	ADJ	B
function	O	NOUN	I
,	O	PUNCT	O
or	O	CCONJ	O
organ	O	ADJ	B
failure	O	NOUN	I
scores	O	NOUN	B
.	O	PUNCT	O


In	O	X	B
vivo	O	X	I
dimethyl	O	ADJ	B
sulfate	O	NOUN	I
footprinting	O	NOUN	I
of	O	ADP	O
the	O	DET	O
cyclin	B-GENE	NOUN	B
E	I-GENE	NOUN	I
promoter	I-GENE	NOUN	O
revealed	O	VERB	O
several	O	ADJ	O
regions	O	NOUN	B
of	O	ADP	O
protection	O	NOUN	B
and	O	CCONJ	O
hypersensitivity	O	NOUN	B
that	O	PRON	O
were	O	AUX	O
unique	O	ADJ	O
to	O	PART	O
infected	O	ADJ	B
cells	O	NOUN	B
.	O	PUNCT	O


A	O	DET	O
total	O	NOUN	O
of	O	ADP	O
194	O	NUM	O
STSs	O	NOUN	B
map	O	NOUN	O
to	O	PART	O
this	O	DET	O
interval	O	NOUN	B
of	O	ADP	O
3	O	NUM	O
Mb	O	NOUN	O
,	O	PUNCT	O
giving	O	VERB	O
an	O	DET	O
average	O	ADJ	B
marker	O	NOUN	B
resolution	O	NOUN	B
of	O	ADP	O
approximately	O	ADV	O
one	O	NUM	O
per	O	ADP	O
15	O	NUM	O
kb	O	NOUN	O
.	O	PUNCT	O


Recently	O	ADV	O
,	O	PUNCT	O
a	O	DET	O
mutation	O	NOUN	B
in	O	ADP	O
the	O	DET	O
amino	O	NOUN	B
-	O	PUNCT	O
terminus	O	NOUN	B
of	O	ADP	O
IB1	B-GENE	NOUN	B
was	O	AUX	O
associated	O	VERB	B
with	O	ADP	I
diabetes	O	NOUN	B
.	O	PUNCT	O


Biol	O	NOUN	B
.	O	PUNCT	O


These	O	DET	O
data	O	NOUN	B
show	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
alpha	O	NOUN	B
-	O	PUNCT	O
helix	O	NOUN	B
domain	O	NOUN	O
of	O	ADP	O
p57	B-GENE	NOUN	B
(	O	PUNCT	O
Kip2	B-GENE	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
which	O	DET	O
is	O	AUX	O
conserved	O	VERB	O
in	O	ADP	O
the	O	DET	O
Cip	B-GENE	PROPN	B
/	O	SYM	O
Kip	B-GENE	NOUN	B
proteins	O	NOUN	I
,	O	PUNCT	O
is	O	AUX	O
implicated	O	VERB	O
in	O	ADP	O
protein	O	NOUN	B
-	O	PUNCT	O
protein	O	NOUN	B
interaction	O	NOUN	B
and	O	CCONJ	O
confers	O	VERB	O
a	O	DET	O
specific	O	ADJ	O
regulatory	O	ADJ	B
mechanism	O	NOUN	B
,	O	PUNCT	O
outside	O	ADP	O
of	O	ADP	O
their	O	PRON	O
Cdk	B-GENE	NOUN	B
-	O	PUNCT	O
inhibitory	O	ADJ	B
activity	O	NOUN	B
,	O	PUNCT	O
by	O	ADP	O
which	O	DET	O
the	O	DET	O
p57	B-GENE	NOUN	B
(	O	PUNCT	O
Kip2	B-GENE	NOUN	B
)	O	PUNCT	O
family	O	NOUN	B
members	O	NOUN	I
positively	O	ADV	O
act	O	VERB	O
on	O	ADP	O
myogenic	O	ADJ	B
differentiation	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
somatoform	O	NOUN	B
conundrum	O	NOUN	B
:	O	PUNCT	O
a	O	DET	O
question	O	NOUN	O
of	O	ADP	O
nosological	O	ADJ	B
valves	O	NOUN	I
.	O	PUNCT	O


Intra	O	NOUN	B
-	O	PUNCT	O
operative	O	ADJ	B
ultrasound	O	NOUN	I
(	O	PUNCT	O
IOUS	O	NOUN	B
)	O	PUNCT	O
has	O	AUX	O
been	O	AUX	O
widely	O	ADV	O
used	O	VERB	O
in	O	ADP	O
an	O	DET	O
attempt	O	NOUN	B
to	O	PART	O
overcome	O	VERB	B
these	O	DET	O
difficulties	O	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
is	O	AUX	O
limited	O	VERB	O
by	O	ADP	O
its	O	PRON	O
two	O	NUM	O
-	O	PUNCT	O
dimensional	O	ADJ	B
nature	O	NOUN	B
,	O	PUNCT	O
inter	O	ADJ	B
-	O	PUNCT	O
user	O	NOUN	B
variability	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
image	O	NOUN	B
obliteration	O	NOUN	I
with	O	ADP	O
ablative	O	ADJ	B
or	O	CCONJ	O
resectional	O	ADJ	B
techniques	O	NOUN	I
.	O	PUNCT	O


CONCLUSIONS	O	NOUN	O
:	O	PUNCT	O
This	O	DET	O
randomized	O	ADJ	B
study	O	NOUN	I
shows	O	VERB	O
that	O	SCONJ	O
Vivostat	O	PROPN	B
fibrin	B-GENE	NOUN	I
sealant	O	NOUN	I
is	O	AUX	O
effective	O	ADJ	B
in	O	ADP	O
preventing	O	VERB	B
air	O	NOUN	B
leakage	O	NOUN	B
after	O	ADP	O
small	O	ADJ	O
lung	O	NOUN	B
resections	O	NOUN	I
in	O	ADP	O
pigs	O	NOUN	B
,	O	PUNCT	O
even	O	ADV	O
at	O	ADP	O
high	O	ADJ	O
inspiratory	O	ADJ	B
pressures	O	NOUN	I
.	O	PUNCT	O


Hailey	O	PROPN	B
-	O	PUNCT	O
Hailey	O	PROPN	B
disease	O	NOUN	I
is	O	AUX	O
caused	O	VERB	O
by	O	ADP	O
mutations	O	NOUN	B
in	O	ADP	O
ATP2C1	B-GENE	NOUN	B
encoding	O	VERB	B
a	O	DET	O
novel	O	ADJ	B
Ca	O	NOUN	B
(	O	PUNCT	O
2	O	NUM	O
+	O	CCONJ	O
)	O	PUNCT	O
pump	O	VERB	B
.	O	PUNCT	O


A	O	DET	O
cause	O	NOUN	O
of	O	ADP	O
increase	O	NOUN	B
of	O	ADP	O
alkaline	B-GENE	NOUN	B
phosphatase	I-GENE	NOUN	I
in	O	ADP	O
children	O	NOUN	B


Significantly	O	ADV	O
,	O	PUNCT	O
two	O	NUM	O
proximal	O	ADJ	B
GATA	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	B
-	I-GENE	PUNCT	O
binding	I-GENE	VERB	B
sites	I-GENE	NOUN	I
(	O	PUNCT	O
-	O	PUNCT	O
118	O	NUM	O
/	O	SYM	O
-	O	PUNCT	O
113	O	NUM	O
and	O	CCONJ	O
-	O	PUNCT	O
98	O	NUM	B
/	O	SYM	O
-	O	PUNCT	O
93	O	NUM	O
)	O	PUNCT	O
and	O	CCONJ	O
a	O	DET	O
region	O	NOUN	B
located	O	ADJ	O
within	O	ADP	O
-	O	PUNCT	O
518	O	NUM	O
to	O	PART	O
-	O	PUNCT	O
315bp	O	NOUN	O
of	O	ADP	O
the	O	DET	O
mouse	B-GENE	NOUN	B
ALAS2	I-GENE	NOUN	I
promoter	I-GENE	NOUN	B
were	O	AUX	O
essential	O	ADJ	O
for	O	ADP	O
transcriptional	O	ADJ	B
activation	O	NOUN	I
during	O	ADP	O
chemically	O	ADV	B
induced	O	VERB	I
differentiation	O	NOUN	B
of	O	ADP	O
MEL	O	NOUN	B
cells	O	NOUN	O
,	O	PUNCT	O
implying	O	VERB	O
their	O	PRON	O
importance	O	NOUN	O
in	O	ADP	O
conferring	O	VERB	O
erythroid	O	ADJ	B
specificity	O	NOUN	B
to	O	PART	O
the	O	DET	O
ALAS2	B-GENE	NOUN	B
transcriptional	O	ADJ	B
activation	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
HMG	B-GENE	NOUN	B
domain	I-GENE	NOUN	I
of	O	ADP	O
both	O	CCONJ	O
HMG20	B-GENE	NOUN	B
proteins	I-GENE	NOUN	B
is	O	AUX	O
most	O	ADV	O
similar	O	ADJ	O
to	O	PART	O
that	O	DET	O
of	O	ADP	O
yeast	B-GENE	NOUN	B
NHP6A	I-GENE	NOUN	B
(	O	PUNCT	O
38	O	NUM	O
%	O	NOUN	O
to	O	PART	O
42	O	NUM	O
%	O	NOUN	O
)	O	PUNCT	O
.	O	PUNCT	O


IgM	B-GENE	NOUN	B
and	O	CCONJ	O
IgG	B-GENE	NOUN	B
anti	I-GENE	ADJ	B
A	I-GENE	NOUN	I
and	O	CCONJ	O
anti	B-GENE	ADJ	B
B	I-GENE	NOUN	I
antibody	I-GENE	NOUN	I
status	O	NOUN	O
of	O	ADP	O
100	O	NUM	O
antenatal	O	ADJ	B
O	O	NOUN	O
group	O	NOUN	O
mothers	O	NOUN	O
(	O	PUNCT	O
who	O	PRON	O
had	O	AUX	O
non	O	ADJ	B
O	O	NOUN	O
group	O	NOUN	B
husbands	O	NOUN	B
)	O	PUNCT	O
were	O	AUX	O
studied	O	VERB	O
.	O	PUNCT	O


In	O	ADP	O
an	O	DET	O
attempt	O	NOUN	O
to	O	PART	O
understand	O	VERB	O
Wee1	B-GENE	NOUN	B
regulation	O	NOUN	B
during	O	ADP	O
cell	O	NOUN	B
cycle	O	NOUN	I
,	O	PUNCT	O
yeast	O	NOUN	B
two	O	NUM	O
-	O	PUNCT	O
hybrid	O	NOUN	B
screening	O	NOUN	B
was	O	AUX	O
used	O	VERB	O
to	O	PART	O
identify	O	VERB	O
Wee1	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
binding	I-GENE	VERB	B
protein	I-GENE	NOUN	I
(	I-GENE	PUNCT	O
s	I-GENE	NOUN	O
)	I-GENE	PUNCT	O
.	O	PUNCT	O


Retroviral	O	ADJ	B
transduction	O	NOUN	I
of	O	ADP	O
T	B-GENE	NOUN	B
/	I-GENE	PUNCT	O
T	I-GENE	NOUN	B
(	I-GENE	PUNCT	O
L	I-GENE	NOUN	B
)	I-GENE	PUNCT	O
causes	O	VERB	O
a	O	DET	O
rapidly	O	ADV	O
fatal	O	ADJ	B
myeloproliferative	O	ADJ	B
disease	O	NOUN	I
in	O	ADP	O
a	O	DET	O
murine	O	ADJ	B
bone	O	NOUN	B
marrow	O	NOUN	I
transplant	O	NOUN	I
(	O	PUNCT	O
BMT	O	NOUN	B
)	O	PUNCT	O
model	O	NOUN	B
,	O	PUNCT	O
whereas	O	SCONJ	O
T	B-GENE	NOUN	B
/	I-GENE	PUNCT	O
T	I-GENE	NOUN	B
(	I-GENE	PUNCT	O
F	I-GENE	NOUN	B
)	I-GENE	PUNCT	O
causes	O	VERB	O
a	O	DET	O
long	O	ADJ	B
-	O	PUNCT	O
latency	O	NOUN	B
,	O	PUNCT	O
pre	O	ADJ	B
-	O	PUNCT	O
B	O	NOUN	B
-	O	PUNCT	O
cell	O	NOUN	B
lymphoblastic	O	ADJ	I
lymphoma	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
codon	O	NOUN	B
usage	O	NOUN	B
is	O	AUX	O
particularly	O	ADV	O
marked	O	VERB	O
for	O	ADP	O
the	O	DET	O
gag	B-GENE	NOUN	B
,	O	PUNCT	O
pol	B-GENE	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
env	B-GENE	NOUN	B
genes	I-GENE	NOUN	I
.	O	PUNCT	O


Slap	B-GENE	NOUN	O
negatively	O	ADV	O
regulates	O	VERB	B
Src	B-GENE	NOUN	B
mitogenic	O	ADJ	B
function	O	NOUN	I
but	O	CCONJ	O
does	O	AUX	O
not	O	PART	O
revert	O	VERB	O
Src	B-GENE	NOUN	B
-	O	PUNCT	O
induced	O	VERB	B
cell	O	NOUN	B
morphology	O	NOUN	B
changes	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
examine	O	VERB	O
current	O	ADJ	B
models	O	NOUN	B
of	O	ADP	O
the	O	DET	O
effects	O	NOUN	B
of	O	ADP	I
aging	O	NOUN	B
on	O	ADP	O
mean	O	ADJ	B
response	O	NOUN	I
time	O	NOUN	I
and	O	CCONJ	O
show	O	VERB	O
how	O	SCONJ	O
they	O	PRON	O
might	O	AUX	O
be	O	AUX	O
reinterpreted	O	VERB	O
.	O	PUNCT	O


The	O	DET	O
effects	O	NOUN	B
of	O	ADP	O
these	O	DET	O
mutations	O	NOUN	B
on	O	ADP	O
protein	O	NOUN	B
function	O	NOUN	I
require	O	VERB	O
further	O	ADJ	O
examination	O	NOUN	B
.	O	PUNCT	O


Kaposi	O	NOUN	B
'	O	PART	I
s	O	NOUN	O
sarcoma	O	NOUN	B
-	O	PUNCT	O
associated	O	VERB	B
herpesvirus	O	NOUN	B
viral	B-GENE	ADJ	B
interferon	I-GENE	NOUN	I
regulatory	I-GENE	ADJ	I
factor	I-GENE	NOUN	I
confers	O	VERB	O
resistance	O	NOUN	B
to	O	PART	O
the	O	DET	O
antiproliferative	O	ADJ	B
effect	O	NOUN	O
of	O	ADP	O
interferon	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
alpha	I-GENE	NOUN	B
.	O	PUNCT	O


AMDA	O	ADJ	B
white	O	ADJ	I
paper	O	NOUN	I
identifies	O	VERB	O
ways	O	NOUN	O
to	O	PART	O
improve	O	VERB	B
pharmaceutical	O	ADJ	B
care	O	NOUN	I
in	O	ADP	O
SNFs	O	NOUN	B
.	O	PUNCT	O


Because	O	SCONJ	O
the	O	DET	O
mutant	O	ADJ	B
defective	O	ADJ	B
in	O	ADP	O
DNA	O	NOUN	B
binding	O	NOUN	I
also	O	ADV	O
fails	O	VERB	O
to	O	PART	O
stimulate	O	VERB	B
Abf1	B-GENE	NOUN	B
ARS1	O	NOUN	O
DNA	O	NOUN	B
-	O	PUNCT	O
binding	O	NOUN	B
activity	O	NOUN	O
,	O	PUNCT	O
our	O	PRON	O
results	O	NOUN	O
suggest	O	VERB	O
that	O	SCONJ	O
Cdc6	B-GENE	NOUN	B
DNA	O	NOUN	B
-	O	PUNCT	O
binding	O	NOUN	B
activity	O	NOUN	O
may	O	AUX	O
play	O	VERB	O
a	O	DET	O
pivotal	O	ADJ	O
role	O	NOUN	O
in	O	ADP	O
the	O	DET	O
initiation	O	NOUN	B
of	O	ADP	O
DNA	O	NOUN	B
replication	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
structural	O	ADJ	B
study	O	NOUN	I
of	O	ADP	O
peptides	O	NOUN	B
belonging	O	VERB	O
to	O	PART	O
the	O	DET	O
terminal	O	ADJ	B
domains	O	NOUN	B
of	O	ADP	O
histone	B-GENE	NOUN	B
H1	I-GENE	NOUN	I
can	O	AUX	O
be	O	AUX	O
considered	O	VERB	O
as	O	ADP	O
a	O	DET	O
step	O	NOUN	O
toward	O	ADP	O
the	O	DET	O
understanding	O	NOUN	O
of	O	ADP	O
the	O	DET	O
function	O	NOUN	B
of	O	ADP	O
H1	B-GENE	NOUN	B
in	O	ADP	O
chromatin	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
recovery	O	NOUN	B
rates	O	NOUN	B
for	O	ADP	O
the	O	DET	O
MB	O	PROPN	B
/	O	SYM	O
BacT	O	PROPN	B
,	O	PUNCT	O
MGIT	O	PROPN	B
960	O	NUM	O
,	O	PUNCT	O
and	O	CCONJ	O
solid	O	ADJ	B
media	O	NOUN	I
were	O	AUX	O
91	O	NUM	O
.	O	PUNCT	O
6	O	NUM	O
,	O	PUNCT	O
87	O	NUM	O
.	O	PUNCT	O
4	O	NUM	O
,	O	PUNCT	O
and	O	CCONJ	O
54	O	NUM	O
.	O	PUNCT	O
7	O	NUM	O
%	O	NOUN	O
,	O	PUNCT	O
respectively	O	ADV	O
,	O	PUNCT	O
for	O	ADP	O
all	O	DET	O
mycobacteria	O	NOUN	B
;	O	PUNCT	O
the	O	DET	O
recovery	O	NOUN	B
rates	O	NOUN	I
were	O	AUX	O
93	O	NUM	O
.	O	PUNCT	O
6	O	NUM	O
,	O	PUNCT	O
88	O	NUM	O
.	O	PUNCT	O
9	O	NUM	O
,	O	PUNCT	O
and	O	CCONJ	O
63	O	NUM	O
.	O	PUNCT	O
4	O	NUM	O
%	O	NOUN	O
,	O	PUNCT	O
respectively	O	ADV	O
,	O	PUNCT	O
for	O	ADP	O
M	O	NOUN	B
.	O	PUNCT	O
tuberculosis	O	NOUN	B
complex	O	NOUN	I
alone	O	ADV	O
,	O	PUNCT	O
and	O	CCONJ	O
87	O	NUM	O
.	O	PUNCT	O
5	O	NUM	O
,	O	PUNCT	O
84	O	NUM	O
.	O	PUNCT	O
4	O	NUM	O
,	O	PUNCT	O
and	O	CCONJ	O
37	O	NUM	O
.	O	PUNCT	O
5	O	NUM	O
%	O	NOUN	O
,	O	PUNCT	O
respectively	O	ADV	O
,	O	PUNCT	O
for	O	ADP	O
all	O	DET	O
nontuberculous	O	ADJ	B
mycobacteria	O	NOUN	I
.	O	PUNCT	O


SELECTION	O	NOUN	B
CRITERIA	O	NOUN	I
:	O	PUNCT	O
Randomised	O	ADJ	B
and	O	CCONJ	O
possibly	O	ADV	O
randomised	O	VERB	B
trials	O	NOUN	I
using	O	VERB	O
acupuncture	O	NOUN	B
to	O	PART	O
treat	O	VERB	B
asthma	O	NOUN	B
and	O	CCONJ	O
asthma	O	NOUN	B
-	O	PUNCT	O
like	O	ADJ	B
symptoms	O	NOUN	B
.	O	PUNCT	O


SELECTION	O	NOUN	B
CRITERIA	O	NOUN	I
:	O	PUNCT	O
Randomised	O	ADJ	B
trials	O	NOUN	I
comparing	O	VERB	O
children	O	NOUN	B
undergoing	O	VERB	O
systematic	O	ADJ	B
therapy	O	NOUN	I
focusing	O	VERB	O
on	O	ADP	O
the	O	DET	O
family	O	NOUN	B
in	O	ADP	O
conjunction	O	NOUN	B
with	O	ADP	O
asthma	O	NOUN	B
medication	O	NOUN	I
,	O	PUNCT	O
with	O	ADP	O
children	O	NOUN	B
taking	O	VERB	O
asthma	O	NOUN	B
medication	O	NOUN	I
only	O	ADV	O
.	O	PUNCT	O


The	O	DET	O
models	O	NOUN	B
were	O	AUX	O
tested	O	VERB	B
by	O	ADP	O
studying	O	VERB	O
their	O	PRON	O
response	O	NOUN	B
to	O	ADP	O
disturbances	O	NOUN	B
of	O	ADP	O
the	O	DET	O
afferent	O	ADJ	B
signal	O	NOUN	B
from	O	ADP	O
the	O	DET	O
bladder	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
also	O	ADV	O
show	O	VERB	O
that	O	SCONJ	O
p65	B-GENE	NOUN	B
binds	O	VERB	B
to	O	PART	O
these	O	DET	O
targets	O	NOUN	B
with	O	ADP	O
almost	O	ADV	O
equal	O	ADJ	O
affinity	O	NOUN	B
and	O	CCONJ	O
that	O	SCONJ	O
different	O	ADJ	O
residues	O	NOUN	B
have	O	AUX	O
variable	O	ADJ	B
roles	O	NOUN	I
in	O	ADP	O
binding	O	VERB	B
different	O	ADJ	O
kappaB	B-GENE	NOUN	B
targets	I-GENE	NOUN	I
.	O	PUNCT	O


To	O	PART	O
illustrate	O	VERB	O
its	O	PRON	O
performance	O	NOUN	B
,	O	PUNCT	O
measurements	O	NOUN	B
of	O	ADP	O
photoluminescence	O	NOUN	B
in	O	ADP	O
GaAs	O	PROPN	B
/	O	SYM	O
AlGaAs	O	NOUN	B
heterostructures	O	NOUN	B
are	O	AUX	O
presented	O	VERB	O
.	O	PUNCT	O


D5	B-GENE	NOUN	B
/	I-GENE	PUNCT	O
D1	I-GENE	NOUN	B
(	I-GENE	PUNCT	O
CT	I-GENE	NOUN	B
)	I-GENE	PUNCT	O
or	O	CCONJ	O
D5	B-GENE	NOUN	B
/	I-GENE	PUNCT	O
D1D	I-GENE	NOUN	B
(	I-GENE	PUNCT	O
CT	I-GENE	NOUN	B
)	I-GENE	PUNCT	O
tail	O	NOUN	O
substitution	O	NOUN	O
mutants	O	NOUN	B
displayed	O	VERB	O
a	O	DET	O
rank	O	NOUN	O
order	O	NOUN	O
of	O	ADP	O
potency	O	NOUN	B
and	O	CCONJ	O
agonist	O	NOUN	B
affinities	O	NOUN	B
virtually	O	ADV	O
mimicking	O	VERB	O
wild	B-GENE	ADJ	B
-	I-GENE	PUNCT	O
type	I-GENE	NOUN	B
(	I-GENE	PUNCT	O
wt	I-GENE	NOUN	O
)	I-GENE	PUNCT	O
D1	I-GENE	NOUN	B
receptors	I-GENE	NOUN	I
,	O	PUNCT	O
as	O	ADP	O
indexed	O	VERB	O
by	O	ADP	O
both	O	DET	O
ligand	O	NOUN	B
binding	O	NOUN	I
and	O	CCONJ	O
dopamine	O	NOUN	B
-	O	PUNCT	O
stimulated	O	VERB	B
cAMP	O	NOUN	B
accumulation	O	NOUN	O
assays	O	NOUN	O
,	O	PUNCT	O
and	O	CCONJ	O
,	O	PUNCT	O
similar	O	ADJ	O
to	O	PART	O
wt	O	NOUN	O
D1	B-GENE	NOUN	B
receptors	I-GENE	NOUN	I
,	O	PUNCT	O
did	O	AUX	O
not	O	PART	O
exhibit	O	VERB	O
receptor	O	NOUN	B
constitutive	O	ADJ	I
activity	O	NOUN	O
or	O	CCONJ	O
responsiveness	O	NOUN	B
to	O	PART	O
inverse	O	ADJ	B
agonists	O	NOUN	B
.	O	PUNCT	O


Modeling	O	NOUN	B
also	O	ADV	O
revealed	O	VERB	O
a	O	DET	O
very	O	ADV	O
hydrophobic	O	ADJ	B
surface	O	NOUN	B
due	O	ADP	O
to	O	PART	O
the	O	DET	O
absence	O	NOUN	B
of	O	ADP	O
H12	O	NOUN	B
,	O	PUNCT	O
exposing	O	VERB	O
residues	O	NOUN	B
from	O	ADP	O
H3	O	NOUN	B
,	O	PUNCT	O
loop	O	NOUN	O
3	O	NUM	O
-	O	SYM	O
4	O	NUM	O
,	O	PUNCT	O
H4	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
H11	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
immune	O	ADJ	B
system	O	NOUN	I
is	O	AUX	O
closely	O	ADV	O
integrated	O	VERB	B
with	O	ADP	O
the	O	DET	O
neuroendocrine	O	ADJ	B
system	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
infection	O	NOUN	B
-	O	PUNCT	O
induced	O	VERB	B
increases	O	NOUN	B
in	O	ADP	O
cytokines	O	NOUN	B
such	O	ADJ	O
as	O	ADP	O
IL	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	O
,	O	PUNCT	O
IL	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
6	I-GENE	NUM	O
and	O	CCONJ	O
TNF	B-GENE	NOUN	B
have	O	AUX	O
numerous	O	ADJ	O
effects	O	NOUN	B
on	O	ADP	O
the	O	DET	O
central	O	ADJ	B
nervous	O	ADJ	I
system	O	NOUN	I
.	O	PUNCT	O


Flavonoids	O	NOUN	B
from	O	ADP	O
Brosimum	O	PROPN	B
acutifolium	O	NOUN	I
.	O	PUNCT	O


Although	O	SCONJ	O
the	O	DET	O
OC	B-GENE	NOUN	B
promoter	I-GENE	NOUN	B
is	O	AUX	O
activated	O	VERB	B
in	O	ADP	O
a	O	DET	O
C	O	NOUN	B
terminus	O	NOUN	I
dependent	O	ADJ	O
manner	O	NOUN	O
,	O	PUNCT	O
the	O	DET	O
MDR	B-GENE	NOUN	B
,	O	PUNCT	O
LTR	O	NOUN	B
and	O	CCONJ	O
BSP	B-GENE	NOUN	B
promoters	I-GENE	NOUN	B
are	O	AUX	O
repressed	O	VERB	B
by	O	ADP	O
three	O	NUM	O
distinct	O	ADJ	O
mechanisms	O	NOUN	B
,	O	PUNCT	O
either	O	CCONJ	O
independent	O	ADJ	B
of	O	ADP	O
or	O	CCONJ	O
involving	O	VERB	O
the	O	DET	O
AML	B-GENE	NOUN	B
C	I-GENE	NOUN	O
terminus	I-GENE	NOUN	B
,	O	PUNCT	O
or	O	CCONJ	O
requiring	O	VERB	O
only	O	ADV	O
the	O	DET	O
conserved	O	VERB	O
C	O	NOUN	B
-	O	PUNCT	O
terminal	O	ADJ	B
pentapeptide	O	NOUN	B
VWRPY	O	NOUN	B
.	O	PUNCT	O


Therefore	O	ADV	O
,	O	PUNCT	O
analogs	O	NOUN	B
of	O	ADP	O
vitamin	O	NOUN	B
D3	O	NOUN	I
have	O	AUX	O
been	O	AUX	O
investigated	O	VERB	B
in	O	ADP	O
a	O	DET	O
number	O	NOUN	O
of	O	ADP	O
trials	O	NOUN	B
showing	O	VERB	O
improvement	O	NOUN	B
of	O	ADP	O
psoriasis	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
network	O	NOUN	B
evolution	O	NOUN	B
was	O	AUX	O
interpreted	O	VERB	O
by	O	ADP	O
an	O	DET	O
approach	O	NOUN	O
based	O	VERB	O
on	O	ADP	O
the	O	DET	O
Flory	O	PROPN	B
model	O	NOUN	I
.	O	PUNCT	O


Biologically	O	ADV	B
significant	O	ADJ	I
amounts	O	NOUN	O
of	O	ADP	O
platelet	B-GENE	NOUN	B
activating	I-GENE	NOUN	I
factor	I-GENE	NOUN	I
were	O	AUX	O
eluted	O	VERB	B
from	O	ADP	O
the	O	DET	O
sorbent	O	NOUN	B
during	O	ADP	O
the	O	DET	O
entire	O	ADJ	O
treatment	O	NOUN	B
time	O	NOUN	I
.	O	PUNCT	O


Mucin	B-GENE	NOUN	B
gene	I-GENE	NOUN	B
expression	O	NOUN	I
has	O	AUX	O
been	O	AUX	O
shown	O	VERB	O
to	O	PART	O
be	O	AUX	O
altered	O	VERB	O
in	O	ADP	O
many	O	ADJ	O
intestinal	O	ADJ	B
diseases	O	NOUN	I
and	O	CCONJ	O
especially	O	ADV	O
cancers	O	NOUN	B
of	O	ADP	O
the	O	DET	O
gastrointestinal	O	ADJ	B
tract	O	NOUN	I
.	O	PUNCT	O


E2F	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	O
is	O	AUX	O
a	O	DET	O
transcription	O	NOUN	B
factor	O	NOUN	I
that	O	PRON	O
regulates	O	VERB	B
cell	O	NOUN	B
cycle	O	NOUN	I
progression	O	NOUN	B
into	O	ADP	O
S	O	NOUN	B
-	O	PUNCT	O
phase	O	NOUN	B
.	O	PUNCT	O


Taken	O	VERB	O
together	O	ADV	O
,	O	PUNCT	O
these	O	DET	O
results	O	NOUN	B
indicate	O	VERB	O
that	O	SCONJ	O
MAP	B-GENE	NOUN	B
kinase	I-GENE	NOUN	I
stimulates	O	VERB	B
the	O	DET	O
hPL	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
B	I-GENE	NOUN	B
enhancer	I-GENE	NOUN	B
by	O	ADP	O
an	O	DET	O
NF	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
IL	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
6	I-GENE	NUM	O
-	O	PUNCT	O
dependent	O	ADJ	B
pathway	O	NOUN	B
.	O	PUNCT	O


Using	O	VERB	O
adenoviral	O	ADJ	B
transfer	O	NOUN	I
of	O	ADP	O
IkappaBalpha	B-GENE	NOUN	B
(	O	PUNCT	O
IkappaBalpha	B-GENE	NOUN	B
overexpression	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
the	O	DET	O
production	O	NOUN	B
of	O	ADP	O
TNF	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
alpha	I-GENE	NOUN	B
induced	O	VERB	B
by	O	ADP	O
whole	O	ADJ	O
GBS	O	NOUN	B
was	O	AUX	O
inhibited	O	VERB	B
by	O	ADP	O
only	O	ADV	O
20	O	NUM	O
%	O	NOUN	O
.	O	PUNCT	O


The	O	DET	O
delta	B-GENE	NOUN	B
srb10	I-GENE	X	B
mutation	I-GENE	NOUN	B
also	O	ADV	O
influenced	O	VERB	B
on	O	ADP	O
the	O	DET	O
transcript	O	NOUN	B
levels	O	NOUN	B
of	O	ADP	O
meiosis	O	NOUN	B
-	O	PUNCT	O
inducing	O	VERB	B
genes	O	NOUN	B
called	O	VERB	O
IME1	B-GENE	NOUN	B
and	O	CCONJ	O
IME2	B-GENE	NOUN	B
:	O	PUNCT	O
the	O	DET	O
mutation	O	NOUN	B
elevated	O	VERB	B
the	O	DET	O
transcript	O	NOUN	B
level	O	NOUN	B
of	O	ADP	O
IME1	B-GENE	NOUN	B
but	O	CCONJ	O
reduced	O	VERB	B
that	O	DET	O
of	O	ADP	O
IME2	B-GENE	NOUN	B
,	O	PUNCT	O
resulting	O	VERB	O
in	O	ADP	O
partial	O	ADJ	B
defects	O	NOUN	B
in	O	ADP	O
premeiotic	O	ADJ	B
DNA	O	NOUN	B
synthesis	O	NOUN	I
and	O	CCONJ	O
meiosis	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
also	O	ADV	O
found	O	VERB	O
that	O	SCONJ	O
environmental	O	ADJ	B
conditions	O	NOUN	I
for	O	ADP	O
meiosis	O	NOUN	B
finely	O	ADV	B
regulate	O	VERB	B
the	O	DET	O
transcript	O	NOUN	B
levels	O	NOUN	B
of	O	ADP	O
KIN28	B-GENE	NOUN	B
and	O	CCONJ	O
CCL1	B-GENE	NOUN	B
,	O	PUNCT	O
such	O	ADJ	O
that	O	SCONJ	O
nitrogen	O	NOUN	B
starvation	O	NOUN	I
first	O	ADV	O
elevates	O	VERB	B
them	O	PRON	O
but	O	CCONJ	O
subsequent	O	ADJ	O
alkalization	O	NOUN	B
of	O	ADP	O
medium	O	NOUN	B
decreases	O	VERB	B
them	O	PRON	O
.	O	PUNCT	O


The	O	DET	O
effect	O	NOUN	B
of	O	ADP	O
acute	O	ADJ	B
,	O	PUNCT	O
mid	O	ADJ	B
-	O	PUNCT	O
cervical	O	ADJ	B
spinal	O	ADJ	B
cord	O	NOUN	I
lesions	O	NOUN	I
on	O	ADP	O
neuronal	O	ADJ	B
and	O	CCONJ	O
reflex	O	ADJ	B
activity	O	NOUN	B
evoked	O	VERB	O
by	O	ADP	O
the	O	DET	O
noxious	O	ADJ	B
visceral	O	ADJ	B
stimulus	O	NOUN	B
,	O	PUNCT	O
colorectal	O	ADJ	B
distension	O	NOUN	I
(	O	PUNCT	O
CRD	O	NOUN	B
;	O	PUNCT	O
80	O	NUM	O
mmHg	O	NOUN	B
,	O	PUNCT	O
20	O	NUM	O
s	O	NOUN	O
)	O	PUNCT	O
,	O	PUNCT	O
was	O	AUX	O
determined	O	VERB	O
in	O	ADP	O
halothane	O	NOUN	B
-	O	PUNCT	O
anesthetized	O	VERB	B
rats	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
results	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
role	O	NOUN	O
of	O	ADP	O
S	O	NOUN	B
.	O	PUNCT	O
argyrostoma	O	NOUN	B
in	O	ADP	O
the	O	DET	O
dissemination	O	NOUN	B
of	O	ADP	O
Trichinella	O	X	B
larvae	O	NOUN	I
in	O	ADP	O
nature	O	NOUN	B
is	O	AUX	O
limited	O	ADJ	O
in	O	ADP	O
comparison	O	NOUN	B
to	O	PART	O
the	O	DET	O
role	O	NOUN	O
played	O	VERB	O
by	O	ADP	O
mammals	O	NOUN	B
with	O	ADP	O
scavenger	O	NOUN	B
and	O	CCONJ	O
cannibalistic	O	ADJ	B
behavior	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
equilibrium	O	NOUN	B
dissociation	O	NOUN	O
binding	O	NOUN	B
constant	O	NOUN	I
for	O	ADP	O
the	O	DET	O
interaction	O	NOUN	B
of	O	ADP	O
TnrA	B-GENE	NOUN	B
with	O	ADP	O
the	O	DET	O
nrgAB	B-GENE	NOUN	B
promoter	I-GENE	NOUN	B
fragment	I-GENE	NOUN	I
was	O	AUX	O
7	O	NUM	O
.	O	PUNCT	O
7	O	NUM	O
nM	O	NOUN	O
under	O	ADP	O
the	O	DET	O
conditions	O	NOUN	B
used	O	VERB	O
here	O	ADV	O
.	O	PUNCT	O


Phd	B-GENE	NOUN	B
antibody	O	NOUN	I
-	O	PUNCT	O
immunoreactive	O	ADJ	B
peptides	O	NOUN	B
are	O	AUX	O
seen	O	VERB	O
in	O	ADP	O
light	O	ADJ	B
-	O	PUNCT	O
adapted	O	VERB	B
mouse	O	NOUN	B
retinal	O	ADJ	B
cytosolic	O	ADJ	B
and	O	CCONJ	O
nuclear	O	ADJ	B
extracts	O	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
contrast	O	NOUN	O
to	O	PART	O
the	O	DET	O
morphological	O	ADJ	B
criteria	O	NOUN	B
,	O	PUNCT	O
the	O	DET	O
few	O	ADJ	O
data	O	NOUN	B
available	O	ADJ	O
from	O	ADP	O
recent	O	ADJ	O
studies	O	NOUN	B
at	O	ADP	O
the	O	DET	O
genetic	O	ADJ	B
level	O	NOUN	I
have	O	AUX	O
suggested	O	VERB	O
that	O	SCONJ	O
EPVs	O	NOUN	B
infecting	O	VERB	B
different	O	ADJ	O
insect	O	NOUN	B
orders	O	NOUN	B
are	O	AUX	O
phylogenetically	O	ADV	B
distant	O	ADJ	I
.	O	PUNCT	O


Prevention	O	NOUN	B
,	O	PUNCT	O
differential	O	ADJ	B
diagnosis	O	NOUN	I
and	O	CCONJ	O
therapy	O	NOUN	B
of	O	ADP	O
travel	O	NOUN	B
diarrhea	O	NOUN	B


Mutation	O	NOUN	B
analysis	O	NOUN	I
demonstrates	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
motif	O	NOUN	B
TCCCCT	O	PROPN	I
is	O	AUX	O
critical	O	ADJ	O
for	O	ADP	O
PyRo1	B-GENE	ADJ	B
interaction	O	NOUN	B
.	O	PUNCT	O


Our	O	PRON	O
results	O	NOUN	O
suggest	O	VERB	O
that	O	SCONJ	O
proteasome	O	NOUN	B
inhibition	O	NOUN	B
leads	O	VERB	O
to	O	PART	O
upregulation	O	NOUN	B
of	O	ADP	O
specific	O	ADJ	O
members	O	NOUN	B
of	O	ADP	O
transcription	O	NOUN	B
factor	O	NOUN	I
families	O	NOUN	I
controlling	O	VERB	O
cellular	O	ADJ	B
stress	O	NOUN	I
response	O	NOUN	I
and	O	CCONJ	O
proliferation	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
hemodialyzed	O	ADJ	B
patients	O	NOUN	B
(	O	PUNCT	O
Epo	B-GENE	NOUN	B
and	O	CCONJ	O
Non	O	ADJ	B
-	O	PUNCT	O
Epo	B-GENE	NOUN	B
group	O	NOUN	B
)	O	PUNCT	O
leptin	B-GENE	NOUN	B
levels	O	NOUN	B
were	O	AUX	O
significantly	O	ADV	O
higher	O	ADJ	O
when	O	SCONJ	O
compared	O	VERB	B
to	O	PART	O
CAPD	O	NOUN	B
patients	O	NOUN	B
(	O	PUNCT	O
Epo	B-GENE	NOUN	B
and	O	CCONJ	O
Non	O	ADJ	B
-	O	PUNCT	O
Epo	B-GENE	NOUN	B
group	O	NOUN	B
,	O	PUNCT	O
respectively	O	ADV	O
)	O	PUNCT	O
.	O	PUNCT	O


ID	O	PROPN	B
-	O	PUNCT	O
PaGIA	O	PROPN	B
diphtheria	B-GENE	NOUN	B
toxin	I-GENE	NOUN	I
polymer	O	NOUN	B
particle	O	NOUN	B
diagnostic	O	ADJ	O
agent	O	NOUN	O
manufactured	O	VERB	B
by	O	ADP	O
DiaMed	O	NOUN	B
AG	O	PROPN	I
,	O	PUNCT	O
Switzerland	O	PROPN	B
,	O	PUNCT	O
was	O	AUX	O
tried	O	VERB	O
at	O	ADP	O
bacteriological	O	ADJ	B
laboratory	O	NOUN	I
of	O	ADP	O
Institute	O	PROPN	B
of	O	ADP	I
Childhood	O	PROPN	I
Infections	O	PROPN	I
in	O	ADP	O
St	O	PROPN	B
.	O	PUNCT	O


Topics	O	NOUN	B
reviewed	O	VERB	B
here	O	ADV	O
include	O	VERB	O
:	O	PUNCT	O
data	O	NOUN	B
supporting	O	VERB	O
the	O	DET	O
association	O	NOUN	B
of	O	ADP	O
myositis	O	NOUN	B
with	O	ADP	O
cancer	O	NOUN	B
and	O	CCONJ	O
the	O	DET	O
appropriate	O	ADJ	O
evaluations	O	NOUN	B
for	O	ADP	O
malignancy	O	NOUN	B
in	O	ADP	O
a	O	DET	O
myositis	O	NOUN	B
patient	O	NOUN	B
;	O	PUNCT	O
an	O	DET	O
approach	O	NOUN	O
to	O	ADP	O
the	O	DET	O
assessment	O	NOUN	B
of	O	ADP	O
patients	O	NOUN	B
with	O	ADP	O
dermatomyositis	O	NOUN	B
sine	O	NOUN	I
myositis	O	NOUN	I
;	O	PUNCT	O
the	O	DET	O
usefulness	O	NOUN	B
of	O	ADP	O
the	O	DET	O
clinicopathological	O	ADJ	B
and	O	CCONJ	O
serological	O	ADJ	B
classifications	O	NOUN	O
;	O	PUNCT	O
a	O	DET	O
discussion	O	NOUN	B
of	O	ADP	O
whether	O	SCONJ	O
childhood	O	NOUN	B
and	O	CCONJ	O
adult	O	ADJ	B
myositis	O	NOUN	B
are	O	AUX	O
the	O	DET	O
same	O	ADJ	O
or	O	CCONJ	O
different	O	ADJ	O
entities	O	NOUN	B
;	O	PUNCT	O
a	O	DET	O
review	O	NOUN	B
of	O	ADP	O
those	O	DET	O
prognostic	O	ADJ	B
factors	O	NOUN	I
to	O	PART	O
consider	O	VERB	O
in	O	ADP	O
the	O	DET	O
clinical	O	ADJ	B
management	O	NOUN	I
of	O	ADP	O
myositis	O	NOUN	B
patients	O	NOUN	B
;	O	PUNCT	O
current	O	ADJ	O
approaches	O	NOUN	B
and	O	CCONJ	O
their	O	PRON	O
limitations	O	NOUN	B
for	O	ADP	O
assessing	O	VERB	O
disease	O	NOUN	B
activity	O	NOUN	I
and	O	CCONJ	O
damage	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
outer	O	ADJ	B
diameter	O	NOUN	I
and	O	CCONJ	O
the	O	DET	O
thickness	O	NOUN	B
of	O	ADP	O
the	O	DET	O
rotor	O	NOUN	B
are	O	AUX	O
60	O	NUM	O
mm	O	NOUN	O
and	O	CCONJ	O
8	O	NUM	O
mm	O	NOUN	O
,	O	PUNCT	O
respectively	O	ADV	O
.	O	PUNCT	O


CONCLUSIONS	O	NOUN	O
:	O	PUNCT	O
There	O	PRON	O
is	O	AUX	O
a	O	DET	O
relation	O	NOUN	O
in	O	ADP	O
the	O	DET	O
topography	O	NOUN	B
of	O	ADP	O
some	O	DET	O
visual	O	ADJ	B
field	O	NOUN	I
areas	O	NOUN	I
assessed	O	VERB	B
by	O	ADP	O
SWAP	O	VERB	B
and	O	CCONJ	O
the	O	DET	O
inferotemporal	O	ADJ	B
neuroretinal	O	ADJ	I
rim	O	NOUN	I
area	O	NOUN	I
,	O	PUNCT	O
which	O	DET	O
may	O	AUX	O
play	O	VERB	O
a	O	DET	O
role	O	NOUN	O
in	O	ADP	O
the	O	DET	O
diagnosis	O	NOUN	B
and	O	CCONJ	O
follow	O	VERB	B
-	O	PUNCT	O
up	O	NOUN	O
of	O	ADP	O
suspected	O	VERB	B
glaucoma	O	NOUN	B
.	O	PUNCT	O


ACE	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
2	I-GENE	NUM	B
has	O	AUX	O
a	O	DET	O
hydrophobic	O	ADJ	B
C	O	NOUN	I
terminus	O	NOUN	B
of	O	ADP	O
H	O	NOUN	O
type	O	NOUN	O
.	O	PUNCT	O


We	O	PRON	O
concluded	O	VERB	O
that	O	SCONJ	O
activation	O	NOUN	B
of	O	ADP	O
c	B-GENE	NOUN	O
-	I-GENE	PUNCT	O
fosER	I-GENE	NOUN	B
mediated	O	ADJ	O
transcriptional	O	ADJ	B
inhibition	O	NOUN	I
of	O	ADP	O
p21	B-GENE	NOUN	B
(	O	PUNCT	O
Cip1	B-GENE	NOUN	B
/	O	SYM	O
WAF1	B-GENE	NOUN	B
)	O	PUNCT	O
through	O	ADP	O
a	O	DET	O
previously	O	ADV	O
uncharacterized	O	ADJ	B
AP	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	O
site	I-GENE	NOUN	B
,	O	PUNCT	O
revealing	O	VERB	O
an	O	DET	O
important	O	ADJ	O
role	O	NOUN	O
for	O	ADP	O
c	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
fos	I-GENE	NOUN	B
in	O	ADP	O
negative	O	ADJ	B
control	O	NOUN	O
of	O	ADP	O
cell	O	NOUN	B
cycle	O	NOUN	I
regulatory	O	ADJ	O
genes	O	NOUN	O
.	O	PUNCT	O


The	O	DET	O
first	O	ADJ	O
symptoms	O	NOUN	B
of	O	ADP	O
enzootic	O	ADJ	B
calcinosis	O	NOUN	I
were	O	AUX	O
noted	O	VERB	O
in	O	ADP	O
March	O	PROPN	O
1998	O	NUM	O
,	O	PUNCT	O
when	O	SCONJ	O
some	O	DET	O
of	O	ADP	O
the	O	DET	O
cows	O	NOUN	B
developed	O	VERB	O
locomotor	O	NOUN	B
abnormalities	O	NOUN	I
.	O	PUNCT	O


Screening	O	ADJ	B
,	O	PUNCT	O
counseling	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
treatment	O	NOUN	B
for	O	ADP	O
alcohol	O	NOUN	B
and	O	CCONJ	O
illicit	O	NOUN	B
drug	O	NOUN	I
use	O	NOUN	I
should	O	AUX	O
be	O	AUX	O
essential	O	ADJ	O
components	O	NOUN	O
in	O	ADP	O
comprehensive	O	ADJ	B
HBP	O	NOUN	B
care	O	NOUN	B
.	O	PUNCT	O


Transcriptional	O	ADJ	B
regulation	O	NOUN	I
of	O	ADP	O
the	O	DET	O
mouse	B-GENE	NOUN	B
cytosolic	I-GENE	ADJ	O
chaperonin	I-GENE	NOUN	O
subunit	I-GENE	NOUN	O
gene	I-GENE	NOUN	O
Ccta	B-GENE	PROPN	B
/	I-GENE	PUNCT	O
t	I-GENE	PROPN	B
-	I-GENE	PUNCT	O
complex	I-GENE	NOUN	B
polypeptide	I-GENE	NOUN	B
1	I-GENE	NUM	I
by	O	ADP	O
selenocysteine	B-GENE	NOUN	B
tRNA	I-GENE	NOUN	I
gene	I-GENE	NOUN	B
transcription	I-GENE	NOUN	I
activating	I-GENE	NOUN	I
factor	I-GENE	NOUN	I
family	I-GENE	NOUN	I
zinc	I-GENE	NOUN	B
finger	I-GENE	NOUN	I
proteins	I-GENE	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
shown	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
epidural	O	ADJ	B
(	O	PUNCT	O
EPI	O	NOUN	B
)	O	PUNCT	O
delivery	O	NOUN	B
of	O	ADP	O
morphine	O	NOUN	B
encapsulated	O	VERB	B
in	O	ADP	O
multivesicular	O	ADJ	B
liposomes	O	NOUN	B
(	O	PUNCT	O
DepoFoam	O	NOUN	B
drug	O	NOUN	I
delivery	O	NOUN	I
system	O	NOUN	I
)	O	PUNCT	O
produces	O	VERB	O
a	O	DET	O
sustained	O	ADJ	B
clearance	O	NOUN	B
of	O	ADP	O
morphine	O	NOUN	B
and	O	CCONJ	O
a	O	DET	O
prolonged	O	ADJ	B
analgesia	O	NOUN	B
.	O	PUNCT	O


Following	O	VERB	O
EPI	O	PROPN	B
-	O	PUNCT	O
C0401	O	PROPN	B
,	O	PUNCT	O
but	O	CCONJ	O
not	O	PART	O
saline	O	NOUN	B
or	O	CCONJ	O
DepoFoam	O	NOUN	B
vehicle	O	NOUN	I
,	O	PUNCT	O
there	O	PRON	O
were	O	AUX	O
transient	O	ADJ	B
(	O	PUNCT	O
<	O	X	O
72	O	NUM	O
hr	O	NOUN	O
)	O	PUNCT	O
decreases	O	VERB	B
in	O	ADP	O
food	O	NOUN	B
consumption	O	NOUN	I
,	O	PUNCT	O
arousal	O	NOUN	B
,	O	PUNCT	O
hindlimb	O	ADJ	B
muscle	O	NOUN	B
tone	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
body	O	NOUN	B
temperature	O	NOUN	I
.	O	PUNCT	O


Resistance	O	NOUN	B
ratios	O	NOUN	B
for	O	ADP	O
the	O	DET	O
other	O	ADJ	O
field	O	NOUN	B
strains	O	NOUN	I
obtained	O	VERB	O
by	O	ADP	O
comparison	O	NOUN	B
with	O	ADP	O
the	O	DET	O
R5	O	NOUN	B
strain	O	NOUN	I
ranged	O	VERB	O
from	O	ADP	O
24	O	NUM	O
.	O	PUNCT	O
5	O	NUM	O
to	O	PART	O
239	O	NUM	O
for	O	ADP	O
topical	O	ADJ	B
application	O	NOUN	B
and	O	CCONJ	O
from	O	ADP	O
1	O	NUM	O
.	O	PUNCT	O
2	O	NUM	O
to	O	PART	O
9	O	NUM	O
.	O	PUNCT	O
8	O	NUM	O
for	O	ADP	O
the	O	DET	O
glass	O	NOUN	B
jar	O	NOUN	I
method	O	NOUN	I
.	O	PUNCT	O


Reliability	O	NOUN	B
of	O	ADP	O
cervical	O	ADJ	B
range	O	NOUN	I
of	O	ADP	I
motion	O	NOUN	I
using	O	VERB	O
the	O	DET	O
OSI	O	PROPN	B
CA	O	PROPN	I
6000	O	NUM	I
spine	O	NOUN	O
motion	O	NOUN	O
analyser	O	NOUN	O
on	O	ADP	O
asymptomatic	O	ADJ	B
and	O	CCONJ	O
symptomatic	O	ADJ	B
subjects	O	NOUN	B
.	O	PUNCT	O


Activation	O	NOUN	B
of	O	ADP	O
PKA	B-GENE	NOUN	B
by	O	ADP	O
8	O	NUM	O
-	O	PUNCT	O
bromo	O	NOUN	B
-	O	PUNCT	O
cyclic	O	ADJ	B
AMP	O	NOUN	B
or	O	CCONJ	O
forskolin	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
inhibition	O	NOUN	B
of	O	ADP	O
PKC	B-GENE	NOUN	B
by	O	ADP	O
calphostin	O	NOUN	B
C	O	NOUN	I
,	O	PUNCT	O
resulted	O	VERB	O
in	O	ADP	O
a	O	DET	O
significant	O	ADJ	O
decrease	O	NOUN	B
in	O	ADP	O
3TP	B-GENE	NUM	O
activity	O	NOUN	B
as	O	ADV	O
well	O	ADV	O
as	O	ADP	O
in	O	X	B
vitro	O	X	I
ERK	B-GENE	NOUN	B
kinase	I-GENE	NOUN	B
activity	O	NOUN	I
in	O	ADP	O
CRAC	O	NOUN	B
.	O	PUNCT	O


Mus81p	B-GENE	NOUN	B
also	O	ADV	O
shares	O	VERB	O
homology	O	NOUN	B
with	O	ADP	O
motifs	O	NOUN	B
found	O	VERB	O
in	O	ADP	O
the	O	DET	O
XPF	B-GENE	NOUN	B
endonuclease	I-GENE	NOUN	I
superfamily	I-GENE	NOUN	O
.	O	PUNCT	O


Double	O	ADJ	B
mutant	O	ADJ	I
analysis	O	NOUN	I
suggests	O	VERB	O
that	O	SCONJ	O
Rad54p	B-GENE	NOUN	B
and	O	CCONJ	O
Mus81p	B-GENE	NOUN	B
act	O	VERB	O
in	O	ADP	O
one	O	NUM	O
pathway	O	NOUN	B
for	O	ADP	O
the	O	DET	O
repair	O	NOUN	B
of	O	ADP	O
,	O	PUNCT	O
or	O	CCONJ	O
tolerance	O	NOUN	B
to	O	PART	O
,	O	PUNCT	O
UV	O	NOUN	B
-	O	PUNCT	O
induced	O	VERB	B
DNA	O	NOUN	B
damage	O	NOUN	I
.	O	PUNCT	O


SELECTION	O	NOUN	B
CRITERIA	O	NOUN	I
:	O	PUNCT	O
All	O	DET	O
controlled	O	VERB	B
trials	O	NOUN	I
where	O	SCONJ	O
adults	O	NOUN	B
with	O	ADP	O
schizophrenia	O	NOUN	B
or	O	CCONJ	O
similar	O	ADJ	O
illnesses	O	NOUN	B
were	O	AUX	O
randomised	O	VERB	B
to	O	PART	O
quetiapine	O	NOUN	B
,	O	PUNCT	O
placebo	O	NOUN	B
or	O	CCONJ	O
other	O	ADJ	O
neuroleptic	O	ADJ	B
drugs	O	NOUN	I
and	O	CCONJ	O
where	O	SCONJ	O
clinically	O	ADV	B
relevant	O	ADJ	I
outcomes	O	NOUN	B
were	O	AUX	O
reported	O	VERB	O
.	O	PUNCT	O


Six	O	NUM	O
distinct	O	ADJ	O
Ets	B-GENE	NOUN	B
mRNAs	I-GENE	NOUN	B
were	O	AUX	O
identified	O	VERB	B
:	O	PUNCT	O
Ets2	B-GENE	NOUN	B
,	O	PUNCT	O
Fli1	B-GENE	NOUN	B
,	O	PUNCT	O
GABPalpha	B-GENE	NOUN	B
,	O	PUNCT	O
SAP1	B-GENE	NOUN	B
,	O	PUNCT	O
Elk1	B-GENE	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
PE1	B-GENE	NOUN	B
.	O	PUNCT	O


A	O	DET	O
2	O	NUM	O
kb	O	NOUN	O
transcript	O	NOUN	B
was	O	AUX	O
isolated	O	VERB	B
from	O	ADP	O
brain	O	NOUN	B
that	O	PRON	O
encodes	O	VERB	B
a	O	DET	O
approximately	O	ADV	B
57	O	NUM	O
kDa	O	NOUN	O
protein	O	NOUN	B
;	O	PUNCT	O
the	O	DET	O
predicted	O	VERB	O
protein	O	NOUN	B
contains	O	VERB	O
the	O	DET	O
known	O	VERB	O
N	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
terminal	I-GENE	ADJ	B
Ets	I-GENE	NOUN	B
domain	I-GENE	NOUN	I
of	O	ADP	O
PE1	B-GENE	NOUN	B
and	O	CCONJ	O
a	O	DET	O
novel	O	ADJ	B
C	O	NOUN	B
-	O	PUNCT	O
terminal	O	ADJ	B
domain	O	NOUN	B
with	O	ADP	O
signficant	O	ADJ	B
homology	O	NOUN	B
to	O	PART	O
murine	B-GENE	NOUN	B
ERF	I-GENE	NOUN	B
.	O	PUNCT	O


Twenty	O	NUM	O
eligible	O	ADJ	O
patients	O	NOUN	B
with	O	ADP	O
cirrhosis	O	NOUN	B
were	O	AUX	O
randomized	O	VERB	B
into	O	ADP	O
two	O	NUM	O
groups	O	NOUN	B
:	O	PUNCT	O
10	O	NUM	O
patients	O	NOUN	B
treated	O	VERB	B
with	O	ADP	I
6	O	NUM	O
million	O	NUM	O
units	O	NOUN	O
of	O	ADP	O
natural	O	ADJ	B
IFN	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
beta	I-GENE	NOUN	B
twice	O	ADV	O
a	O	DET	O
week	O	NOUN	B
for	O	ADP	O
36	O	NUM	O
months	O	NOUN	B
and	O	CCONJ	O
10	O	NUM	O
patients	O	NOUN	B
without	O	ADP	O
IFN	B-GENE	NOUN	B
therapy	O	NOUN	I
.	O	PUNCT	O


It	O	PRON	O
is	O	AUX	O
now	O	ADV	O
well	O	ADV	O
accepted	O	VERB	B
that	O	SCONJ	O
the	O	DET	O
p53	B-GENE	NOUN	B
C	I-GENE	NOUN	I
-	I-GENE	PUNCT	O
terminus	I-GENE	NOUN	B
plays	O	VERB	O
a	O	DET	O
central	O	ADJ	O
role	O	NOUN	O
in	O	ADP	O
controlling	O	VERB	B
the	O	DET	O
activity	O	NOUN	B
of	O	ADP	O
the	O	DET	O
wild	O	ADJ	B
-	O	PUNCT	O
type	O	NOUN	B
molecule	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
transcription	O	NOUN	B
factor	O	NOUN	I
Jun	B-GENE	NOUN	I
(	O	PUNCT	O
c	B-GENE	PROPN	O
-	I-GENE	PUNCT	O
Jun	I-GENE	NOUN	B
)	O	PUNCT	O
functions	O	VERB	B
as	O	ADP	O
a	O	DET	O
recipient	O	NOUN	B
of	O	ADP	O
extracellular	O	ADJ	B
growth	O	NOUN	I
signals	O	NOUN	O
and	O	CCONJ	O
converts	O	VERB	O
them	O	PRON	O
into	O	ADP	O
patterns	O	NOUN	B
of	O	ADP	O
gene	O	NOUN	B
expression	O	NOUN	I
.	O	PUNCT	O


This	O	DET	O
compound	O	NOUN	B
is	O	AUX	O
the	O	DET	O
main	O	ADJ	O
bioactive	O	ADJ	B
metabolite	O	NOUN	I
of	O	ADP	O
trimebutine	O	NOUN	B
II	O	NUM	I
(	O	PUNCT	O
Debridat	O	PROPN	B
,	O	PUNCT	O
CAS	O	PROPN	B
39133	O	NUM	O
-	O	PUNCT	O
31	O	NUM	O
-	O	SYM	O
8	O	NUM	O
)	O	PUNCT	O
,	O	PUNCT	O
an	O	DET	O
antispasmodic	O	NOUN	B
widely	O	ADV	O
used	O	VERB	O
for	O	ADP	O
intestinal	O	ADJ	B
diseases	O	NOUN	I
since	O	SCONJ	O
1969	O	NUM	O
.	O	PUNCT	O


This	O	DET	O
enabled	O	VERB	O
the	O	DET	O
formation	O	NOUN	B
of	O	ADP	O
stem	O	NOUN	B
-	O	PUNCT	O
loop	O	NOUN	B
templates	O	NOUN	B
with	O	ADP	O
the	O	DET	O
fusion	O	NOUN	B
point	O	NOUN	I
of	O	ADP	O
the	O	DET	O
chimeric	O	ADJ	B
transcript	O	NOUN	B
in	O	ADP	O
the	O	DET	O
loop	O	NOUN	B
and	O	CCONJ	O
the	O	DET	O
use	O	NOUN	O
of	O	ADP	O
MLL	B-GENE	NOUN	B
primers	O	NOUN	O
in	O	ADP	O
two	O	NUM	O
-	O	PUNCT	O
sided	O	ADJ	B
PCR	O	NOUN	B
.	O	PUNCT	O


It	O	PRON	O
contains	O	VERB	O
25	O	NUM	O
exons	O	NOUN	B
coding	O	VERB	B
for	O	ADP	O
a	O	DET	O
4	O	NUM	O
.	O	PUNCT	O
7kb	O	ADJ	O
transcript	O	NOUN	B
including	O	VERB	O
large	O	ADJ	O
5	O	NUM	O
'	O	PUNCT	O
-	O	PUNCT	O
and	O	CCONJ	O
3	O	NUM	O
'	O	PUNCT	O
-	O	PUNCT	O
(	O	PUNCT	O
1218bp	O	NUM	O
and	O	CCONJ	O
701bp	O	NOUN	O
,	O	PUNCT	O
respectively	O	ADV	O
)	O	PUNCT	O
untranslated	O	ADJ	O
regions	O	NOUN	O
(	O	PUNCT	O
UTRs	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


The	O	DET	O
limit	O	NOUN	O
between	O	ADP	O
the	O	DET	O
cecum	O	NOUN	B
and	O	CCONJ	O
the	O	DET	O
ascending	O	VERB	B
colon	O	NOUN	I
was	O	AUX	O
externally	O	ADV	B
marked	O	VERB	O
by	O	ADP	O
the	O	DET	O
sulcus	O	NOUN	B
cecocolicus	O	NOUN	I
dorsalis	O	X	I
and	O	CCONJ	O
ventralis	O	NOUN	B
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	O
further	O	ADV	O
support	O	VERB	O
an	O	DET	O
important	O	ADJ	O
role	O	NOUN	O
for	O	ADP	O
CBF2	B-GENE	NOUN	B
in	O	ADP	O
mediating	O	VERB	O
EBNA2	B-GENE	NOUN	B
transactivation	O	NOUN	B
;	O	PUNCT	O
they	O	PRON	O
identify	O	VERB	O
the	O	DET	O
hnRNP	B-GENE	NOUN	B
protein	I-GENE	NOUN	I
AUF1	I-GENE	NOUN	B
as	O	ADP	O
a	O	DET	O
major	O	ADJ	O
component	O	NOUN	O
of	O	ADP	O
CBF2	B-GENE	NOUN	B
and	O	CCONJ	O
are	O	AUX	O
also	O	ADV	O
the	O	DET	O
first	O	ADJ	O
evidence	O	NOUN	B
of	O	ADP	O
a	O	DET	O
cis	O	ADV	B
-	O	PUNCT	O
acting	O	VERB	B
sequence	O	NOUN	B
other	O	ADJ	O
than	O	ADP	O
a	O	DET	O
CBF1	B-GENE	NOUN	B
binding	I-GENE	NOUN	O
element	I-GENE	NOUN	O
that	O	PRON	O
is	O	AUX	O
able	O	ADJ	O
to	O	PART	O
confer	O	VERB	O
responsiveness	O	NOUN	B
to	O	PART	O
EBNA2	B-GENE	NOUN	B
.	O	PUNCT	O


Viruses	O	NOUN	B
were	O	AUX	O
isolated	O	VERB	B
from	O	ADP	O
9	O	NUM	O
lungs	O	NOUN	B
:	O	PUNCT	O
7	O	NUM	O
with	O	ADP	O
PI	O	NOUN	B
-	O	PUNCT	O
3V	O	PROPN	B
,	O	PUNCT	O
1	O	NUM	O
with	O	ADP	O
NCP	O	NOUN	B
BVDV	O	NOUN	B
type	O	NOUN	O
1	O	NUM	O
,	O	PUNCT	O
and	O	CCONJ	O
1	O	NUM	O
with	O	ADP	O
both	O	CCONJ	O
BVHV	O	ADJ	B
-	O	PUNCT	O
1	O	NUM	B
and	O	CCONJ	O
BVDV	O	NOUN	B
.	O	PUNCT	O


Splicing	O	NOUN	B
of	O	ADP	O
the	O	DET	O
K	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
SAM	I-GENE	PROPN	B
alternative	O	NOUN	B
exon	O	NOUN	O
of	O	ADP	O
the	O	DET	O
fibroblast	B-GENE	NOUN	B
growth	I-GENE	NOUN	I
factor	I-GENE	NOUN	I
receptor	I-GENE	NOUN	I
2	I-GENE	NUM	I
gene	I-GENE	NOUN	I
is	O	AUX	O
heavily	O	ADV	O
dependent	O	ADJ	O
on	O	ADP	O
the	O	DET	O
U	O	NOUN	B
-	O	PUNCT	O
rich	O	ADJ	B
sequence	O	NOUN	O
IAS1	B-GENE	NOUN	O
lying	O	VERB	O
immediately	O	ADV	O
downstream	O	ADV	B
from	O	ADP	O
its	O	PRON	O
5	O	NUM	O
'	O	PART	O
splice	O	NOUN	B
site	O	NOUN	I
.	O	PUNCT	O


During	O	ADP	O
treatment	O	NOUN	B
,	O	PUNCT	O
the	O	DET	O
phosphorylation	O	NOUN	B
state	O	NOUN	O
of	O	ADP	O
Rb	B-GENE	NOUN	B
shifted	O	VERB	O
to	O	PART	O
a	O	DET	O
hypophosphorylated	O	ADJ	B
form	O	NOUN	O
.	O	PUNCT	O
mRNA	O	NOUN	B
for	O	ADP	O
the	O	DET	O
HPV	O	NOUN	B
E6	B-GENE	NOUN	I
/	O	PUNCT	O
E7	B-GENE	NOUN	B
genes	O	NOUN	I
decreased	O	VERB	B
;	O	PUNCT	O
however	O	ADV	O
,	O	PUNCT	O
significant	O	ADJ	O
changes	O	NOUN	B
in	O	ADP	O
the	O	DET	O
E7	B-GENE	NOUN	B
protein	I-GENE	NOUN	I
were	O	AUX	O
not	O	PART	O
observed	O	VERB	O
,	O	PUNCT	O
while	O	SCONJ	O
increased	O	VERB	B
levels	O	NOUN	B
of	O	ADP	O
Rb	B-GENE	NOUN	B
immunoprecipitated	O	VERB	B
with	O	ADP	O
anti	B-GENE	ADJ	B
-	I-GENE	PUNCT	O
E7	I-GENE	NOUN	B
antibodies	I-GENE	NOUN	I
were	O	AUX	O
observed	O	VERB	B
.	O	PUNCT	O


Five	O	NUM	O
of	O	ADP	O
the	O	DET	O
Aeromonas	O	NOUN	B
strains	O	NOUN	I
and	O	CCONJ	O
one	O	NUM	O
of	O	ADP	O
V	O	NOUN	O
cholerae	O	NOUN	B
non	O	NOUN	B
-	O	PUNCT	O
O1	O	NOUN	B
were	O	AUX	O
positive	O	ADJ	B
for	O	ADP	O
enterotoxin	O	NOUN	B
activity	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
2	O	NUM	O
cDNAs	O	NOUN	B
differed	O	VERB	O
in	O	ADP	O
the	O	DET	O
length	O	NOUN	B
of	O	ADP	O
their	O	PRON	O
respective	O	ADJ	O
3	O	NUM	O
'	O	PART	O
untranslated	O	ADJ	B
regions	O	NOUN	I
,	O	PUNCT	O
of	O	ADP	O
577	O	NUM	O
bp	O	NOUN	O
in	O	ADP	O
Cp	B-GENE	NOUN	B
.	I-GENE	PUNCT	O
F6	I-GENE	NOUN	O
and	O	CCONJ	O
72	O	NUM	O
bp	O	NOUN	O
in	O	ADP	O
Cp	B-GENE	NOUN	B
.	I-GENE	PUNCT	O
F10	I-GENE	NOUN	O
,	O	PUNCT	O
in	O	ADP	O
both	O	DET	O
of	O	ADP	O
which	O	DET	O
a	O	DET	O
putative	O	ADJ	O
polyadenylation	O	NOUN	B
signal	O	NOUN	I
was	O	AUX	O
identified	O	VERB	B
.	O	PUNCT	O


Platelet	O	NOUN	B
counts	O	NOUN	I
and	O	CCONJ	O
function	O	VERB	B
as	O	ADV	O
well	O	ADV	O
as	O	ADP	O
fibrinogen	B-GENE	NOUN	B
and	O	CCONJ	O
von	B-GENE	NOUN	O
Willebrand	I-GENE	NOUN	O
factor	I-GENE	NOUN	O
(	O	PUNCT	O
vWF	B-GENE	NOUN	B
)	O	PUNCT	O
levels	O	NOUN	B
were	O	AUX	O
determined	O	VERB	O
in	O	ADP	O
each	O	DET	O
sample	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
aim	O	NOUN	O
of	O	ADP	O
our	O	PRON	O
study	O	NOUN	B
was	O	AUX	O
to	O	PART	O
evaluate	O	VERB	B
the	O	DET	O
level	O	NOUN	B
of	O	ADP	O
oxidative	O	ADJ	B
stress	O	NOUN	I
in	O	ADP	O
healthy	O	ADJ	B
controls	O	NOUN	I
(	O	PUNCT	O
CTL	O	NOUN	B
)	O	PUNCT	O
compared	O	VERB	O
with	O	ADP	O
CRF	O	NOUN	B
and	O	CCONJ	O
HD	O	NOUN	B
patients	O	NOUN	B
before	O	ADP	O
(	O	PUNCT	O
pre	O	ADJ	B
-	O	PUNCT	O
HD	O	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
after	O	ADP	O
(	O	PUNCT	O
post	O	NOUN	B
-	O	PUNCT	O
HD	O	NOUN	B
)	O	PUNCT	O
the	O	DET	O
dialysis	O	NOUN	B
session	O	NOUN	B
,	O	PUNCT	O
carried	O	VERB	O
out	O	ADP	O
on	O	ADP	O
a	O	DET	O
high	O	ADJ	O
biocompatible	O	ADJ	B
polyacrylonitrile	O	NOUN	B
membrane	O	NOUN	I
AN69	O	NOUN	I
.	O	PUNCT	O


Indirect	O	ADJ	B
plasma	O	NOUN	B
parameters	O	NOUN	B
such	O	ADJ	O
as	O	ADP	O
vitamin	O	NOUN	B
E	O	NOUN	I
,	O	PUNCT	O
thiol	O	NOUN	B
and	O	CCONJ	O
uric	O	ADJ	B
acid	O	NOUN	I
levels	O	NOUN	I
were	O	AUX	O
also	O	ADV	O
quantified	O	VERB	B
.	O	PUNCT	O


The	O	DET	O
results	O	NOUN	B
indicate	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
relationship	O	NOUN	B
between	O	ADP	O
comprehension	O	NOUN	B
and	O	CCONJ	O
production	O	NOUN	B
is	O	AUX	O
different	O	ADJ	O
at	O	ADP	O
different	O	ADJ	O
stages	O	NOUN	B
in	O	ADP	O
development	O	NOUN	B
.	O	PUNCT	O


On	O	ADP	O
long	O	ADJ	B
-	O	PUNCT	O
term	O	NOUN	B
follow	O	VERB	B
-	O	PUNCT	O
up	O	ADP	O
,	O	PUNCT	O
there	O	PRON	O
was	O	AUX	O
no	O	DET	B
significant	O	ADJ	I
difference	O	NOUN	O
in	O	ADP	O
the	O	DET	O
incidence	O	NOUN	B
of	O	ADP	O
hospitalizations	O	NOUN	B
(	O	PUNCT	O
1	O	NUM	O
per	O	ADP	O
2	O	NUM	O
.	O	PUNCT	O
1	O	NUM	O
vs	O	CCONJ	O
.	O	PUNCT	O


The	O	DET	O
tumor	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
suppressor	I-GENE	NOUN	B
protein	I-GENE	NOUN	I
p53	I-GENE	NOUN	I
is	O	AUX	O
involved	O	VERB	O
in	O	ADP	O
maintaining	O	VERB	O
genomic	O	ADJ	B
stability	O	NOUN	I
.	O	PUNCT	O


Abrogation	O	NOUN	B
of	O	ADP	O
p53	B-GENE	NOUN	B
function	O	NOUN	B
by	O	ADP	O
E6	B-GENE	NOUN	B
resulted	O	VERB	O
in	O	ADP	O
an	O	DET	O
increase	O	NOUN	B
in	O	ADP	O
the	O	DET	O
spontaneous	O	ADJ	B
mutation	O	NOUN	B
frequencies	O	NOUN	B
at	O	ADP	O
the	O	DET	O
heterozygous	O	ADJ	B
thymidine	B-GENE	NOUN	O
kinase	I-GENE	NOUN	O
(	O	PUNCT	O
TK	B-GENE	NOUN	B
)	O	PUNCT	O
locus	O	NOUN	B
but	O	CCONJ	O
not	O	PART	O
at	O	ADP	O
the	O	DET	O
hemizygous	O	ADJ	B
hypoxanthine	B-GENE	NOUN	I
phosphoribosyl	I-GENE	NOUN	I
transferase	I-GENE	NOUN	I
(	O	PUNCT	O
HPRT	B-GENE	NOUN	B
)	O	PUNCT	O
locus	O	NOUN	O
.	O	PUNCT	O


Cytogenetic	O	ADJ	B
analysis	O	NOUN	I
of	O	ADP	O
LOH	O	NOUN	B
mutants	O	NOUN	B
by	O	ADP	O
chromosome	O	NOUN	B
painting	O	NOUN	I
indicated	O	VERB	O
a	O	DET	O
mosaic	O	NOUN	B
of	O	ADP	O
chromosomal	O	ADJ	B
aberrations	O	NOUN	I
involving	O	VERB	O
chromosome	O	NOUN	B
17	O	NUM	I
,	O	PUNCT	O
in	O	ADP	O
which	O	DET	O
partial	O	ADJ	B
chromosome	O	NOUN	O
deletions	O	NOUN	O
,	O	PUNCT	O
amplifications	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
multiple	O	ADJ	B
translocations	O	NOUN	B
appeared	O	VERB	O
heterogeneously	O	ADV	B
in	O	ADP	O
a	O	DET	O
single	O	ADJ	O
mutant	O	NOUN	B
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
support	O	VERB	O
a	O	DET	O
model	O	NOUN	B
in	O	ADP	O
which	O	DET	O
p53	B-GENE	NOUN	B
protein	I-GENE	NOUN	I
contributes	O	VERB	O
to	O	PART	O
the	O	DET	O
maintenance	O	NOUN	B
of	O	ADP	O
genomic	O	ADJ	B
integrity	O	NOUN	I
through	O	ADP	O
recombinational	O	ADJ	B
repair	O	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
patients	O	NOUN	B
with	O	ADP	O
type	O	NOUN	B
II	O	NUM	I
tumors	O	NOUN	I
,	O	PUNCT	O
the	O	DET	O
pattern	O	NOUN	B
of	O	ADP	O
lymphatic	O	ADJ	B
spread	O	NOUN	B
was	O	AUX	O
primarily	O	ADV	O
directed	O	VERB	O
toward	O	ADP	O
the	O	DET	O
paracardial	O	ADJ	B
,	O	PUNCT	O
lesser	O	ADJ	B
curvature	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
left	O	VERB	B
gastric	O	ADJ	I
artery	O	NOUN	I
nodes	O	NOUN	I
;	O	PUNCT	O
esophagectomy	O	NOUN	B
offered	O	VERB	O
no	O	DET	B
survival	O	NOUN	I
benefit	O	NOUN	B
over	O	ADP	O
extended	O	VERB	O
gastrectomy	O	NOUN	B
in	O	ADP	O
these	O	DET	O
patients	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
muskox	O	NOUN	B
is	O	AUX	O
a	O	DET	O
new	O	ADJ	O
host	O	NOUN	B
record	O	NOUN	O
for	O	ADP	O
T	O	NOUN	B
.	O	PUNCT	O
gondii	O	NOUN	B
.	O	PUNCT	O


Mucosal	O	ADJ	B
application	O	NOUN	B
of	O	ADP	O
NCX	O	PROPN	B
-	O	PUNCT	O
4016	O	NUM	O
,	O	PUNCT	O
however	O	ADV	O
,	O	PUNCT	O
did	O	AUX	O
not	O	PART	O
cause	O	VERB	O
PD	O	NOUN	B
reduction	O	NOUN	B
and	O	CCONJ	O
luminal	O	ADJ	B
H	O	NOUN	I
+	O	CCONJ	I
loss	O	NOUN	I
,	O	PUNCT	O
but	O	CCONJ	O
produced	O	VERB	O
a	O	DET	O
marked	O	ADJ	O
hyperemia	O	NOUN	B
,	O	PUNCT	O
resulting	O	VERB	O
in	O	ADP	O
no	O	DET	O
damage	O	NOUN	B
in	O	ADP	O
the	O	DET	O
stomach	O	NOUN	B
of	O	ADP	O
both	O	CCONJ	O
normal	O	ADJ	B
and	O	CCONJ	O
STZ	O	NOUN	B
-	O	PUNCT	O
diabetic	O	ADJ	B
rats	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
amino	O	NOUN	B
acid	O	NOUN	I
sequence	O	NOUN	I
of	O	ADP	O
matrilysin	B-GENE	NOUN	B
-	I-GENE	SYM	O
2	I-GENE	NUM	O
also	O	ADV	O
contains	O	VERB	O
a	O	DET	O
threonine	O	NOUN	B
residue	O	NOUN	B
adjacent	O	ADJ	B
to	O	PART	O
the	O	DET	O
Zn	O	NOUN	B
-	O	PUNCT	O
binding	O	VERB	B
site	O	NOUN	O
that	O	PRON	O
has	O	AUX	O
been	O	AUX	O
defined	O	VERB	O
as	O	ADP	O
a	O	DET	O
specific	O	ADJ	O
feature	O	NOUN	O
of	O	ADP	O
matrilysin	B-GENE	NOUN	B
.	O	PUNCT	O


Regarding	O	VERB	O
"	O	PUNCT	O
the	O	DET	O
relation	O	NOUN	O
between	O	ADP	O
sexual	O	ADJ	B
orientation	O	NOUN	I
and	O	CCONJ	O
penile	O	ADJ	B
size	O	NOUN	I
,	O	PUNCT	O
"	O	PUNCT	O
by	O	ADP	O
A	O	NOUN	O
.	O	PUNCT	O


Analysis	O	NOUN	B
of	O	ADP	O
Standard	O	PROPN	B
Reference	O	PROPN	I
Material	O	PROPN	I
1846	O	NUM	I
,	O	PUNCT	O
Infant	O	PROPN	B
Formula	O	PROPN	I
,	O	PUNCT	O
gave	O	VERB	O
a	O	DET	O
mean	O	ADJ	O
value	O	NOUN	O
of	O	ADP	O
0	O	NUM	O
.	O	PUNCT	O
95	O	NUM	O
+	O	CCONJ	O
/	O	SYM	O
-	O	PUNCT	O
0	O	NUM	O
.	O	PUNCT	O
088	O	NUM	O
mg	O	NOUN	O
vitamin	O	NOUN	B
K	O	PROPN	I
/	O	SYM	O
kg	O	PROPN	B
(	O	PUNCT	O
K	O	NOUN	B
or	O	CCONJ	O
K1	O	NOUN	B
?	O	PUNCT	O
)	O	PUNCT	O
(	O	PUNCT	O
n	O	NOUN	O
=	O	ADJ	O
31	O	NUM	O
)	O	PUNCT	O
with	O	ADP	O
a	O	DET	O
coefficient	O	NOUN	B
of	O	ADP	O
variation	O	NOUN	B
of	O	ADP	O
9	O	NUM	O
.	O	PUNCT	O
26	O	NUM	O
.	O	PUNCT	O


The	O	DET	O
Spo0F	B-GENE	NOUN	B
residues	I-GENE	NOUN	I
making	O	VERB	O
up	O	ADP	O
the	O	DET	O
hydrophobic	O	ADJ	B
patch	O	NOUN	B
are	O	AUX	O
very	O	ADV	O
similar	O	ADJ	O
in	O	ADP	O
all	O	DET	O
response	O	NOUN	B
regulators	O	NOUN	I
suggesting	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
binding	O	NOUN	B
is	O	AUX	O
initiated	O	VERB	O
through	O	ADP	O
the	O	DET	O
same	O	ADJ	O
residues	O	NOUN	B
in	O	ADP	O
all	O	DET	O
interacting	O	VERB	B
response	O	NOUN	O
regulator	O	NOUN	O
-	O	PUNCT	O
kinase	O	NOUN	B
pairs	O	NOUN	B
.	O	PUNCT	O


While	O	SCONJ	O
mutations	O	NOUN	B
in	O	ADP	O
K	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
Rev	I-GENE	NOUN	B
that	O	PRON	O
inactivate	O	VERB	B
any	O	DET	O
one	O	NUM	O
of	O	ADP	O
these	O	DET	O
properties	O	NOUN	B
also	O	ADV	O
blocked	O	VERB	B
K	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
Rev	I-GENE	NOUN	B
-	O	PUNCT	O
dependent	O	ADJ	B
nuclear	O	ADJ	B
RNA	O	NOUN	I
export	O	NOUN	B
,	O	PUNCT	O
several	O	ADJ	O
K	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
Rev	I-GENE	NOUN	B
mutants	I-GENE	NOUN	B
were	O	AUX	O
comparable	O	ADJ	O
to	O	PART	O
wild	O	ADJ	B
type	O	NOUN	I
when	O	SCONJ	O
assayed	O	VERB	B
for	O	ADP	O
any	O	DET	O
of	O	ADP	O
these	O	DET	O
individual	O	ADJ	B
activities	O	NOUN	B
yet	O	ADV	O
nevertheless	O	ADV	O
defective	O	ADJ	B
for	O	ADP	O
RNA	O	NOUN	B
export	O	NOUN	B
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
Cdc42p	B-GENE	NOUN	B
is	O	AUX	O
in	O	ADP	O
fact	O	NOUN	O
required	O	VERB	O
for	O	ADP	O
pheromone	O	NOUN	B
response	O	NOUN	I
and	O	CCONJ	O
that	O	SCONJ	O
interaction	O	NOUN	B
with	O	ADP	O
the	O	DET	O
PAK	B-GENE	NOUN	B
Ste20p	B-GENE	NOUN	B
is	O	AUX	O
critical	O	ADJ	O
for	O	ADP	O
that	O	DET	O
role	O	NOUN	O
.	O	PUNCT	O


Symptoms	O	NOUN	B
,	O	PUNCT	O
however	O	ADV	O
,	O	PUNCT	O
appear	O	VERB	O
to	O	PART	O
correlate	O	VERB	O
poorly	O	ADV	B
with	O	ADP	O
oesophagitis	O	NOUN	B
;	O	PUNCT	O
hence	O	ADV	O
,	O	PUNCT	O
severe	O	ADJ	B
symptoms	O	NOUN	B
do	O	AUX	O
not	O	PART	O
indicate	O	VERB	O
there	O	PRON	O
is	O	AUX	O
greater	O	ADJ	O
oesophageal	O	ADJ	B
damage	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
variable	O	ADJ	B
phenotype	O	NOUN	B
of	O	ADP	O
the	O	DET	O
allotetraploids	O	NOUN	B
could	O	AUX	O
not	O	PART	O
be	O	AUX	O
explained	O	VERB	O
by	O	ADP	O
cytological	O	ADJ	B
abnormalities	O	NOUN	I
.	O	PUNCT	O


It	O	PRON	O
is	O	AUX	O
now	O	ADV	O
estimated	O	VERB	O
that	O	SCONJ	O
inactivation	O	NOUN	B
mutants	O	NOUN	B
of	O	ADP	O
PTEN	B-GENE	NOUN	B
exist	O	VERB	O
in	O	ADP	O
60	O	NUM	O
%	O	NOUN	O
of	O	ADP	O
all	O	DET	O
forms	O	NOUN	O
of	O	ADP	O
solid	O	ADJ	B
tumors	O	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
demonstrated	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
activity	O	NOUN	B
of	O	ADP	O
ILK	B-GENE	NOUN	B
is	O	AUX	O
constitutively	O	ADV	B
elevated	O	ADJ	B
in	O	ADP	O
PTEN	B-GENE	NOUN	B
mutant	I-GENE	ADJ	O
cells	O	NOUN	O
.	O	PUNCT	O


The	O	DET	O
detector	O	NOUN	B
has	O	AUX	O
the	O	DET	O
advantage	O	NOUN	O
of	O	ADP	O
finding	O	VERB	B
both	O	CCONJ	O
ST	O	ADJ	B
segment	O	NOUN	O
deviations	O	NOUN	O
and	O	CCONJ	O
entire	O	ADJ	O
ST	O	PROPN	B
-	O	PUNCT	O
T	O	NOUN	B
complex	O	NOUN	O
changes	O	NOUN	B
thereby	O	ADV	O
providing	O	VERB	O
a	O	DET	O
wider	O	ADJ	O
characterization	O	NOUN	B
of	O	ADP	O
the	O	DET	O
potential	O	ADJ	B
ischemic	O	ADJ	B
events	O	NOUN	I
.	O	PUNCT	O


Primary	O	ADJ	B
adrenal	O	ADJ	I
hypersensitivity	O	NOUN	I
to	O	PART	O
ACTH	B-GENE	NOUN	B
drive	O	NOUN	O
in	O	ADP	O
obesity	O	NOUN	B
has	O	AUX	O
also	O	ADV	O
been	O	AUX	O
suggested	O	VERB	O
.	O	PUNCT	O


In	O	ADP	O
addition	O	NOUN	O
,	O	PUNCT	O
a	O	DET	O
noncanonical	O	ADJ	B
C	B-GENE	NOUN	I
/	I-GENE	SYM	O
EBP	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
binding	I-GENE	VERB	B
site	I-GENE	NOUN	O
within	O	ADP	O
the	O	DET	O
Gadd45gamma	B-GENE	NOUN	B
promoter	I-GENE	NOUN	B
where	O	SCONJ	O
C	B-GENE	NOUN	B
/	I-GENE	SYM	O
EBPbeta	I-GENE	PROPN	B
and	O	CCONJ	O
C	B-GENE	PROPN	B
/	I-GENE	SYM	O
EBPdelta	I-GENE	PROPN	B
could	O	AUX	O
bind	O	VERB	B
,	O	PUNCT	O
was	O	AUX	O
identified	O	VERB	O
by	O	ADP	O
electrophoretic	O	ADJ	B
mobility	O	NOUN	I
shift	O	NOUN	I
assay	O	NOUN	I
(	O	PUNCT	O
EMSA	O	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
reporter	O	NOUN	B
gene	O	NOUN	I
analysis	O	NOUN	I
.	O	PUNCT	O


From	O	ADP	O
two	O	NUM	O
inhibitor	O	NOUN	B
scaffolds	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
have	O	AUX	O
identified	O	VERB	B
potent	O	ADJ	O
and	O	CCONJ	O
selective	O	ADJ	O
inhibitors	O	NOUN	B
for	O	ADP	O
sensitized	O	VERB	B
kinases	O	NOUN	I
from	O	ADP	O
five	O	NUM	O
distinct	O	ADJ	O
subfamilies	O	NOUN	B
.	O	PUNCT	O


By	O	ADP	O
progressive	O	ADJ	B
5	O	NUM	O
'	O	PUNCT	O
-	O	PUNCT	O
deletion	O	NOUN	B
studies	O	NOUN	O
,	O	PUNCT	O
we	O	PRON	O
have	O	AUX	O
identified	O	VERB	B
a	O	DET	O
248	O	NUM	O
-	O	PUNCT	O
bp	O	NOUN	B
DNA	O	NOUN	O
fragment	O	NOUN	O
(	O	PUNCT	O
-	O	PUNCT	O
1018	O	NUM	O
to	O	PART	O
-	O	PUNCT	O
771	O	NUM	O
,	O	PUNCT	O
relative	O	ADJ	O
to	O	PART	O
the	O	DET	O
translation	O	NOUN	B
start	O	NOUN	O
site	O	NOUN	B
)	O	PUNCT	O
at	O	ADP	O
the	O	DET	O
5	O	NUM	O
'	O	PART	O
-	O	PUNCT	O
flanking	O	ADJ	B
region	O	NOUN	I
of	O	ADP	O
the	O	DET	O
human	B-GENE	ADJ	B
GnRHR	I-GENE	NOUN	O
gene	I-GENE	NOUN	O
that	O	PRON	O
is	O	AUX	O
responsible	O	ADJ	O
for	O	ADP	O
the	O	DET	O
GnRHa	O	PROPN	B
-	O	PUNCT	O
mediated	O	VERB	B
down	O	NOUN	B
-	O	PUNCT	O
regulation	O	NOUN	B
of	O	ADP	O
human	B-GENE	ADJ	B
GnRHR	I-GENE	NOUN	O
promoter	I-GENE	NOUN	B
activity	O	NOUN	I
.	O	PUNCT	O


Intracellular	O	ADJ	B
localization	O	NOUN	B
studies	O	NOUN	I
using	O	VERB	O
the	O	DET	O
mDAP	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
3	I-GENE	NUM	B
/	O	SYM	O
EGFP	B-GENE	NOUN	B
fusion	O	NOUN	O
protein	O	NOUN	O
,	O	PUNCT	O
cell	O	NOUN	B
fractionation	O	NOUN	I
and	O	CCONJ	O
protease	O	NOUN	B
protection	O	NOUN	O
experiments	O	NOUN	O
localized	O	VERB	B
mDAP	B-GENE	NOUN	B
-	I-GENE	SYM	O
3	I-GENE	NUM	O
to	O	PART	O
the	O	DET	O
mitochondrial	O	ADJ	B
matrix	O	NOUN	I
.	O	PUNCT	O


Reporter	O	NOUN	B
gene	O	NOUN	I
expression	O	NOUN	I
analyses	O	NOUN	I
indicate	O	VERB	O
that	O	SCONJ	O
both	O	CCONJ	O
WASP	B-GENE	NOUN	B
promoters	I-GENE	NOUN	B
show	O	VERB	O
high	O	ADJ	O
levels	O	NOUN	B
of	O	ADP	O
expression	O	NOUN	B
in	O	ADP	O
different	O	ADJ	O
hematopoietic	O	ADJ	B
cell	O	NOUN	I
lines	O	NOUN	I
.	O	PUNCT	O


Altogether	O	ADV	O
these	O	DET	O
results	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
,	O	PUNCT	O
in	O	ADP	O
KG1a	O	NOUN	B
cells	O	NOUN	I
,	O	PUNCT	O
TNFalpha	B-GENE	NOUN	B
can	O	AUX	O
stimulate	O	VERB	B
in	O	ADP	O
parallel	O	ADJ	O
PC	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
PLC	I-GENE	PROPN	B
and	O	CCONJ	O
PLD	B-GENE	PROPN	B
,	O	PUNCT	O
whose	O	DET	O
lipid	O	NOUN	B
products	O	NOUN	I
activate	O	VERB	B
in	O	ADP	O
turn	O	NOUN	O
mitogen	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
activated	I-GENE	VERB	B
protein	I-GENE	NOUN	O
kinase	I-GENE	NOUN	O
(	O	PUNCT	O
MAP	B-GENE	NOUN	B
kinase	I-GENE	NOUN	I
)	O	PUNCT	O
and	O	CCONJ	O
NF	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
kappaB	I-GENE	NOUN	B
signalling	O	NOUN	B
respectively	O	ADV	O
.	O	PUNCT	O


Polysome	O	NOUN	B
and	O	CCONJ	O
40S	B-GENE	ADJ	B
ribosome	I-GENE	NOUN	I
fractions	O	NOUN	B
were	O	AUX	O
severely	O	ADV	O
decreased	O	VERB	B
in	O	ADP	O
the	O	DET	O
krr1	B-GENE	NOUN	B
mutant	I-GENE	NOUN	I
and	O	CCONJ	O
Kri1p	B-GENE	NOUN	B
-	O	PUNCT	O
depleted	O	VERB	B
cells	O	NOUN	O
.	O	PUNCT	O


They	O	PRON	O
also	O	ADV	O
negatively	O	ADV	O
modulate	O	VERB	B
the	O	DET	O
PI	B-GENE	NOUN	B
3	I-GENE	NUM	O
-	I-GENE	PUNCT	O
kinase	I-GENE	NOUN	B
catalytic	O	ADJ	B
activity	O	NOUN	I
but	O	CCONJ	O
to	O	PART	O
different	O	ADJ	O
extents	O	NOUN	B
,	O	PUNCT	O
dependent	O	ADJ	B
on	O	ADP	O
the	O	DET	O
unique	O	ADJ	B
N	O	NOUN	B
-	O	PUNCT	O
terminal	O	ADJ	B
structure	O	NOUN	B
of	O	ADP	O
each	O	DET	O
isoform	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
Drosophila	B-GENE	X	B
melanogaster	I-GENE	X	B
suppressor	I-GENE	NOUN	I
of	I-GENE	ADP	O
sable	I-GENE	ADJ	B
gene	I-GENE	NOUN	I
,	O	PUNCT	O
su	B-GENE	X	O
(	I-GENE	PUNCT	O
s	I-GENE	NOUN	O
)	I-GENE	PUNCT	O
,	O	PUNCT	O
encodes	O	VERB	B
a	O	DET	O
novel	O	ADJ	B
,	O	PUNCT	O
150	O	NUM	O
-	O	PUNCT	O
kDa	O	NOUN	B
nuclear	O	ADJ	B
RNA	O	NOUN	I
binding	O	NOUN	I
protein	O	NOUN	I
,	O	PUNCT	O
SU	B-GENE	NOUN	B
(	I-GENE	PUNCT	O
S	I-GENE	NOUN	B
)	I-GENE	PUNCT	O
,	O	PUNCT	O
that	O	PRON	O
negatively	O	ADV	O
regulates	O	VERB	B
RNA	O	NOUN	B
accumulation	O	NOUN	B
from	O	ADP	O
mutant	O	ADJ	B
alleles	O	NOUN	I
of	O	ADP	O
other	O	ADJ	O
genes	O	NOUN	B
that	O	PRON	O
have	O	AUX	O
transposon	O	NOUN	B
insertions	O	NOUN	I
in	O	ADP	O
the	O	DET	O
5	O	NUM	O
'	O	PART	O
transcribed	O	VERB	B
region	O	NOUN	I
.	O	PUNCT	O


As	O	ADP	O
a	O	DET	O
result	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
have	O	AUX	O
defined	O	VERB	O
two	O	NUM	O
arginine	O	NOUN	B
-	O	PUNCT	O
rich	O	ADJ	B
motifs	O	NOUN	O
(	O	PUNCT	O
ARM1	O	NOUN	B
and	O	CCONJ	O
ARM2	O	NOUN	B
)	O	PUNCT	O
that	O	PRON	O
mediate	O	VERB	O
the	O	DET	O
RNA	O	NOUN	B
binding	O	NOUN	I
activity	O	NOUN	I
of	O	ADP	O
SU	B-GENE	NOUN	B
(	I-GENE	PUNCT	O
S	I-GENE	NOUN	B
)	I-GENE	PUNCT	O
.	O	PUNCT	O


Vasoactive	B-GENE	ADJ	B
intestinal	I-GENE	ADJ	I
peptide	I-GENE	NOUN	I
and	O	CCONJ	O
pituitary	B-GENE	ADJ	B
adenylate	I-GENE	ADJ	I
cyclase	I-GENE	NOUN	I
-	I-GENE	PUNCT	O
activating	I-GENE	VERB	B
polypeptide	I-GENE	NOUN	B
inhibit	O	VERB	B
nuclear	B-GENE	ADJ	B
factor	I-GENE	NOUN	I
-	I-GENE	PUNCT	O
kappa	I-GENE	NOUN	B
B	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
dependent	I-GENE	ADJ	B
gene	I-GENE	NOUN	B
activation	O	NOUN	I
at	O	ADP	O
multiple	O	ADJ	O
levels	O	NOUN	B
in	O	ADP	O
the	O	DET	O
human	O	ADJ	B
monocytic	O	ADJ	I
cell	O	NOUN	I
line	O	NOUN	I
THP	O	NOUN	B
-	O	PUNCT	O
1	O	NUM	O
.	O	PUNCT	O


Overexpression	O	NOUN	B
of	O	ADP	O
Trdpm1	B-GENE	NOUN	B
in	O	ADP	O
a	O	DET	O
dpm1	B-GENE	NOUN	B
(	I-GENE	PUNCT	O
+	I-GENE	CCONJ	O
)	I-GENE	PUNCT	O
:	O	PUNCT	O
:	O	PUNCT	O
his7	B-GENE	NOUN	B
/	I-GENE	SYM	O
dpm1	I-GENE	NOUN	B
(	I-GENE	PUNCT	O
+	I-GENE	CCONJ	O
)	I-GENE	PUNCT	O
S	O	NOUN	O
.	O	PUNCT	O
pombe	O	X	B
diploid	O	NOUN	I
resulted	O	VERB	O
in	O	ADP	O
a	O	DET	O
4	O	NUM	O
-	O	PUNCT	O
fold	O	ADJ	B
increase	O	NOUN	B
in	O	ADP	O
specific	O	ADJ	O
DPM	B-GENE	NOUN	B
synthase	I-GENE	NOUN	O
activity	O	NOUN	O
.	O	PUNCT	O


The	O	DET	O
N	O	NOUN	B
-	O	PUNCT	O
terminal	O	ADJ	B
small	O	ADJ	B
segment	O	NOUN	I
of	O	ADP	O
yeast	B-GENE	NOUN	B
TAF145	I-GENE	NOUN	I
(	O	PUNCT	O
yTAF145	B-GENE	NOUN	B
)	O	PUNCT	O
binds	O	VERB	B
to	O	PART	O
TBP	B-GENE	NOUN	B
and	O	CCONJ	O
thereby	O	ADV	O
inhibits	O	VERB	B
TBP	B-GENE	NOUN	B
function	O	NOUN	O
.	O	PUNCT	O


These	O	DET	O
probable	O	ADJ	O
border	O	NOUN	B
sequences	O	NOUN	I
are	O	AUX	O
closely	O	ADV	O
related	O	ADJ	O
to	O	PART	O
those	O	DET	O
of	O	ADP	O
other	O	ADJ	O
known	O	ADJ	O
T	O	NOUN	B
-	O	PUNCT	O
regions	O	NOUN	B
and	O	CCONJ	O
define	O	VERB	O
a	O	DET	O
second	O	ADJ	O
T	O	NOUN	B
-	O	PUNCT	O
region	O	NOUN	B
of	O	ADP	O
pTiChry5	O	NOUN	B
,	O	PUNCT	O
called	O	VERB	O
T	O	NOUN	B
-	O	PUNCT	O
right	O	ADJ	B
(	O	PUNCT	O
TR	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
that	O	PRON	O
confers	O	VERB	O
production	O	NOUN	B
of	O	ADP	O
the	O	DET	O
Amadoriopines	O	PROPN	B
.	O	PUNCT	O


Another	O	DET	O
cis	O	ADV	B
-	O	PUNCT	O
acting	O	VERB	B
element	O	NOUN	B
,	O	PUNCT	O
exonic	O	ADJ	B
splicing	O	NOUN	I
suppressor	O	NOUN	I
1	O	NUM	I
(	O	PUNCT	O
ESS1	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
represses	O	VERB	B
use	O	NOUN	O
of	O	ADP	O
the	O	DET	O
nt	O	NOUN	O
3225	O	NUM	O
3	O	NUM	O
'	O	PART	O
splice	O	NOUN	B
site	O	NOUN	I
.	O	PUNCT	O


5	O	NUM	O
'	O	PUNCT	O
-	O	PUNCT	O
RACE	O	NOUN	B
analysis	O	NOUN	B
suggested	O	VERB	O
a	O	DET	O
single	O	ADJ	O
transcription	O	NOUN	O
initiation	O	NOUN	O
site	O	NOUN	O
187	O	NUM	O
bp	O	NOUN	O
upstream	O	ADJ	B
from	O	ADP	O
the	O	DET	O
translational	O	ADJ	B
start	O	NOUN	O
site	O	NOUN	O
.	O	PUNCT	O


Thromboelastography	O	NOUN	B
is	O	AUX	O
a	O	DET	O
test	O	NOUN	B
that	O	PRON	O
could	O	AUX	O
potentially	O	ADV	O
correlate	O	VERB	B
with	O	ADP	O
the	O	DET	O
degree	O	NOUN	B
of	O	ADP	O
anticoagulation	O	NOUN	B
produced	O	VERB	O
by	O	ADP	O
low	O	ADJ	O
molecular	O	ADJ	B
weight	O	NOUN	I
heparin	O	NOUN	B
.	O	PUNCT	O


Expression	O	NOUN	B
of	O	ADP	O
a	O	DET	O
hybrid	O	NOUN	B
protein	O	NOUN	I
containing	O	VERB	O
the	O	DET	O
cytoplasmic	O	ADJ	B
C	O	NOUN	O
-	O	PUNCT	O
terminal	O	ADJ	B
half	O	NOUN	B
of	O	ADP	O
UhpB	B-GENE	NOUN	B
fused	O	VERB	B
to	O	PART	O
glutathione	B-GENE	NOUN	B
S	I-GENE	NOUN	I
-	I-GENE	PUNCT	O
transferase	I-GENE	NOUN	B
(	O	PUNCT	O
GST	B-GENE	NOUN	B
)	O	PUNCT	O
also	O	ADV	O
interfered	O	VERB	B
with	O	ADP	O
Uhp	B-GENE	NOUN	B
signaling	O	NOUN	I
.	O	PUNCT	O


RESULTS	O	NOUN	B
:	O	PUNCT	O
Glaucoma	O	ADJ	B
suspects	O	NOUN	I
were	O	AUX	O
divided	O	VERB	O
into	O	ADP	O
two	O	NUM	O
groups	O	NOUN	B
according	O	VERB	O
to	O	ADP	O
their	O	PRON	O
SWAP	O	VERB	B
results	O	NOUN	B
:	O	PUNCT	O
high	O	ADJ	B
risk	O	NOUN	I
(	O	PUNCT	O
with	O	ADP	O
SWAP	O	VERB	B
abnormalities	O	NOUN	I
)	O	PUNCT	O
and	O	CCONJ	O
low	O	ADJ	B
risk	O	NOUN	I
(	O	PUNCT	O
with	O	ADP	O
normal	O	ADJ	O
SWAP	O	PROPN	B
result	O	NOUN	O
)	O	PUNCT	O
.	O	PUNCT	O


To	O	PART	O
begin	O	VERB	O
to	O	PART	O
understand	O	VERB	O
this	O	DET	O
role	O	NOUN	O
,	O	PUNCT	O
we	O	PRON	O
overexpressed	O	VERB	B
ATF	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
2	I-GENE	NUM	O
in	O	ADP	O
a	O	DET	O
human	O	ADJ	B
cancer	O	NOUN	I
cell	O	NOUN	O
line	O	NOUN	O
.	O	PUNCT	O


Botulinum	B-GENE	NOUN	B
toxin	I-GENE	NOUN	I
A	I-GENE	NOUN	I
in	O	ADP	O
the	O	DET	O
treatment	O	NOUN	B
of	O	ADP	O
hemiplegic	O	ADJ	B
spastic	O	ADJ	I
foot	O	NOUN	I
drop	O	NOUN	B
-	O	PUNCT	O
-	O	PUNCT	O
clinical	O	ADJ	B
and	O	CCONJ	O
functional	O	ADJ	B
outcomes	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
U17	B-GENE	PROPN	B
/	O	PUNCT	O
U16	B-GENE	PROPN	B
and	O	CCONJ	O
the	O	DET	O
U16	B-GENE	NOUN	B
+	I-GENE	CCONJ	O
gene	I-GENE	NOUN	B
products	I-GENE	NOUN	I
transactivated	O	VERB	B
the	O	DET	O
HIV	B-GENE	NOUN	B
LTR	I-GENE	NOUN	B
.	O	PUNCT	O


The	O	DET	O
Cili	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
2	I-GENE	NUM	O
sequences	I-GENE	NOUN	B
possess	O	VERB	O
similarity	O	NOUN	B
to	O	PART	O
the	O	DET	O
RNaseH	B-GENE	NOUN	B
domain	I-GENE	NOUN	I
of	O	ADP	O
Lian	B-GENE	PROPN	B
-	O	PUNCT	O
Aa1	B-GENE	PROPN	B
,	O	PUNCT	O
a	O	DET	O
mosquito	B-GENE	NOUN	B
non	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
LTR	I-GENE	NOUN	B
retrotransposon	I-GENE	NOUN	I
.	O	PUNCT	O


This	O	DET	O
dynamic	O	ADJ	B
response	O	NOUN	I
strongly	O	ADV	O
suggests	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
p53	B-GENE	NOUN	B
and	O	CCONJ	O
Rb	B-GENE	NOUN	B
tumor	O	NOUN	O
suppressor	O	NOUN	O
pathways	O	NOUN	O
are	O	AUX	O
intact	O	ADJ	B
in	O	ADP	O
HeLa	O	NOUN	B
cells	O	NOUN	I
and	O	CCONJ	O
that	O	SCONJ	O
repression	O	NOUN	B
of	O	ADP	O
HPV	B-GENE	NOUN	B
E6	I-GENE	NOUN	I
and	O	CCONJ	O
E7	B-GENE	NOUN	B
mobilizes	O	VERB	B
these	O	DET	O
pathways	O	NOUN	B
in	O	ADP	O
an	O	DET	O
orderly	O	ADJ	O
fashion	O	NOUN	O
to	O	PART	O
deliver	O	VERB	B
growth	O	NOUN	B
inhibitory	O	ADJ	I
signals	O	NOUN	O
to	O	PART	O
the	O	DET	O
cells	O	NOUN	B
.	O	PUNCT	O


Effects	O	NOUN	B
of	O	ADP	I
spatial	O	ADJ	B
and	O	CCONJ	O
temporal	O	ADJ	B
smoothing	O	NOUN	O
on	O	ADP	O
stimulated	O	VERB	B
brillouin	O	NOUN	B
scattering	O	NOUN	B
in	O	ADP	O
the	O	DET	O
independent	O	ADJ	B
-	O	PUNCT	O
hot	O	ADJ	B
-	O	PUNCT	O
spot	O	NOUN	B
model	O	NOUN	O
limit	O	VERB	O
The	O	DET	O
influence	O	NOUN	B
of	O	ADP	O
laser	O	NOUN	B
beam	O	NOUN	I
smoothing	O	NOUN	I
on	O	ADP	O
stimulated	O	VERB	B
Brillouin	O	NOUN	B
backscattering	O	NOUN	I
(	O	PUNCT	O
SBBS	O	NOUN	B
)	O	PUNCT	O
is	O	AUX	O
studied	O	VERB	O
analytically	O	ADV	B
in	O	ADP	O
the	O	DET	O
limit	O	NOUN	O
of	O	ADP	O
the	O	DET	O
independent	O	ADJ	B
hot	O	ADJ	B
spot	O	NOUN	I
model	O	NOUN	I
.	O	PUNCT	O


Association	O	NOUN	B
of	O	ADP	O
stress	O	NOUN	B
during	O	ADP	O
delivery	O	NOUN	B
with	O	ADP	O
increased	O	VERB	B
numbers	O	NOUN	O
of	O	ADP	O
nucleated	O	ADJ	B
cells	O	NOUN	I
and	O	CCONJ	O
hematopoietic	O	ADJ	B
progenitor	O	NOUN	I
cells	O	NOUN	I
in	O	ADP	O
umbilical	O	ADJ	B
cord	O	NOUN	I
blood	O	NOUN	I
.	O	PUNCT	O


Transformation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
sconC3	B-GENE	NOUN	B
mutant	I-GENE	NOUN	I
with	O	ADP	O
sconB	B-GENE	NOUN	B
+	I-GENE	CCONJ	O
restores	O	VERB	B
the	O	DET	O
wild	O	ADJ	B
-	O	PUNCT	O
type	O	NOUN	B
phenotype	O	NOUN	B
.	O	PUNCT	O


RESULTS	O	NOUN	B
:	O	PUNCT	O
The	O	DET	O
main	O	ADJ	O
effect	O	NOUN	B
of	O	ADP	O
muscle	O	NOUN	B
pain	O	NOUN	I
,	O	PUNCT	O
compared	O	VERB	O
to	O	PART	O
non	O	ADV	B
-	O	PUNCT	O
painful	O	ADJ	B
stimulation	O	NOUN	B
,	O	PUNCT	O
was	O	AUX	O
a	O	DET	O
significant	O	ADJ	B
and	O	CCONJ	O
long	O	ADJ	B
-	O	PUNCT	O
lasting	O	VERB	B
increase	O	NOUN	B
of	O	ADP	O
delta	O	NOUN	B
(	O	PUNCT	O
1	O	NUM	O
-	O	PUNCT	O
3	O	NUM	O
Hz	O	NOUN	O
)	O	PUNCT	O
power	O	NOUN	B
and	O	CCONJ	O
an	O	DET	O
alpha	O	NOUN	B
-	O	PUNCT	O
1	O	NUM	O
(	O	PUNCT	O
9	O	NUM	O
-	O	PUNCT	O
11	O	NUM	O
Hz	O	NOUN	O
)	O	PUNCT	O
power	O	NOUN	O
increase	O	NOUN	B
over	O	ADP	O
the	O	DET	O
contralateral	O	ADJ	B
parietal	O	ADJ	B
locus	O	NOUN	I
.	O	PUNCT	O


Based	O	VERB	O
on	O	ADP	O
16S	B-GENE	NOUN	B
rRNA	I-GENE	NOUN	I
gene	I-GENE	NOUN	B
sequence	I-GENE	NOUN	I
analysis	O	NOUN	I
,	O	PUNCT	O
the	O	DET	O
11	O	NUM	O
species	O	NOUN	B
having	O	VERB	O
two	O	NUM	O
tuf	B-GENE	NOUN	B
genes	I-GENE	NOUN	I
all	O	DET	O
have	O	AUX	O
a	O	DET	O
common	O	ADJ	O
ancestor	O	NOUN	B
,	O	PUNCT	O
while	O	SCONJ	O
the	O	DET	O
six	O	NUM	O
species	O	NOUN	B
having	O	VERB	O
only	O	ADV	O
one	O	NUM	O
copy	O	NOUN	B
diverged	O	VERB	I
from	O	ADP	O
the	O	DET	O
enterococcal	O	ADJ	B
lineage	O	NOUN	I
before	O	ADP	O
that	O	DET	O
common	O	ADJ	O
ancestor	O	NOUN	B
.	O	PUNCT	O


This	O	DET	O
transcriptional	O	ADJ	B
regulation	O	NOUN	I
occurs	O	VERB	O
through	O	ADP	O
modulation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
forkhead	B-GENE	NOUN	B
transcription	I-GENE	NOUN	I
factor	I-GENE	NOUN	I
FKHR	B-GENE	NOUN	I
-	I-GENE	PUNCT	O
L1	I-GENE	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
IL	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
3	I-GENE	NUM	B
inhibited	O	VERB	B
FKHR	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
L1	I-GENE	NOUN	B
activity	O	NOUN	B
in	O	ADP	O
a	O	DET	O
PI3K	B-GENE	NOUN	B
-	O	PUNCT	O
dependent	O	ADJ	B
manner	O	NOUN	O
.	O	PUNCT	O


Taken	O	VERB	O
together	O	ADV	O
,	O	PUNCT	O
these	O	DET	O
observations	O	NOUN	B
indicate	O	VERB	O
that	O	SCONJ	O
inhibition	O	NOUN	B
of	O	ADP	O
p27	B-GENE	NOUN	B
(	O	PUNCT	O
KIP1	B-GENE	NOUN	B
)	O	PUNCT	O
transcription	O	NOUN	B
through	O	ADP	O
PI3K	B-GENE	NOUN	B
-	O	PUNCT	O
induced	O	VERB	B
FKHR	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
L1	I-GENE	NOUN	B
phosphorylation	O	NOUN	B
provides	O	VERB	O
a	O	DET	O
novel	O	ADJ	O
mechanism	O	NOUN	B
of	O	ADP	O
regulating	O	VERB	B
cytokine	O	NOUN	B
-	O	PUNCT	O
mediated	O	VERB	B
survival	O	NOUN	B
and	O	CCONJ	O
proliferation	O	NOUN	B
.	O	PUNCT	O


DNase	B-GENE	NOUN	B
I	I-GENE	NUM	I
genomic	O	ADJ	B
footprinting	O	NOUN	I
revealed	O	VERB	B
that	O	SCONJ	O
the	O	DET	O
c	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
Myb	I-GENE	NOUN	B
site	I-GENE	NOUN	B
is	O	AUX	O
occupied	O	VERB	B
in	O	ADP	O
a	O	DET	O
tissue	O	NOUN	B
-	O	PUNCT	O
specific	O	ADJ	B
fashion	O	NOUN	B
in	O	X	B
vivo	O	X	I
.	O	PUNCT	O


We	O	PRON	O
conclude	O	VERB	O
that	O	SCONJ	O
c	B-GENE	X	B
-	I-GENE	PUNCT	O
Myb	I-GENE	PROPN	B
regulates	O	VERB	B
the	O	DET	O
RAG	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
2	I-GENE	NUM	O
promoter	I-GENE	NOUN	B
in	O	ADP	O
T	O	NOUN	B
cells	O	NOUN	I
by	O	ADP	O
binding	O	VERB	B
to	O	PART	O
this	O	DET	O
consensus	B-GENE	NOUN	B
c	I-GENE	NOUN	I
-	I-GENE	PUNCT	O
Myb	I-GENE	NOUN	B
binding	I-GENE	NOUN	B
site	I-GENE	NOUN	I
.	O	PUNCT	O


RESULTS	O	NOUN	B
:	O	PUNCT	O
Average	O	ADJ	O
age	O	NOUN	B
at	O	ADP	O
symptom	O	NOUN	B
onset	O	NOUN	I
was	O	AUX	O
41	O	NUM	O
.	O	PUNCT	O
2	O	NUM	O
years	O	NOUN	B
.	O	PUNCT	O


Unlike	O	ADP	O
the	O	DET	O
mammalian	O	ADJ	B
proteins	O	NOUN	I
,	O	PUNCT	O
XFGF3	B-GENE	NOUN	B
is	O	AUX	O
efficiently	O	ADV	O
secreted	O	VERB	B
as	O	ADP	O
a	O	DET	O
Mr	O	NOUN	O
31	O	NUM	O
,	O	PUNCT	O
000	O	NUM	O
glycoprotein	O	NOUN	B
,	O	PUNCT	O
gp31	B-GENE	NOUN	B
,	O	PUNCT	O
which	O	DET	O
undergoes	O	VERB	O
proteolytic	O	ADJ	B
cleavage	O	NOUN	I
to	O	PART	O
produce	O	VERB	O
an	O	DET	O
NH2	O	NOUN	B
-	O	PUNCT	O
terminally	O	ADV	B
truncated	O	VERB	O
product	O	NOUN	O
,	O	PUNCT	O
gp27	B-GENE	NOUN	B
.	O	PUNCT	O


NH2	O	NOUN	B
-	O	PUNCT	O
terminal	O	ADJ	B
trimming	O	NOUN	B
of	O	ADP	O
Xenopus	O	NOUN	B
and	O	CCONJ	O
mammalian	B-GENE	ADJ	B
FGF3s	I-GENE	NOUN	B
may	O	AUX	O
therefore	O	ADV	O
be	O	AUX	O
a	O	DET	O
prerequisite	O	NOUN	O
of	O	ADP	O
optimal	O	ADJ	B
biological	O	ADJ	B
activity	O	NOUN	I
.	O	PUNCT	O


Here	O	ADV	O
,	O	PUNCT	O
we	O	PRON	O
identified	O	VERB	B
three	O	NUM	O
cis	O	ADJ	B
-	O	PUNCT	O
elements	O	NOUN	B
required	O	VERB	O
for	O	ADP	O
replication	O	NOUN	B
within	O	ADP	O
the	O	DET	O
200	O	NUM	O
bp	O	NOUN	O
promoter	O	NOUN	B
,	O	PUNCT	O
using	O	VERB	O
autonomously	O	ADV	O
replicating	O	VERB	O
plasmids	O	NOUN	B
carrying	O	VERB	O
various	O	ADJ	O
mutations	O	NOUN	B
and	O	CCONJ	O
deletions	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
objectives	O	NOUN	O
of	O	ADP	O
the	O	DET	O
present	O	ADJ	O
study	O	NOUN	B
were	O	AUX	O
to	O	PART	O
evaluate	O	VERB	B
the	O	DET	O
effects	O	NOUN	B
of	O	ADP	I
adding	O	VERB	O
Equex	O	PROPN	B
to	O	PART	O
a	O	DET	O
TRIS	O	NOUN	B
-	O	PUNCT	O
extender	O	NOUN	B
,	O	PUNCT	O
diluting	O	VERB	B
the	O	DET	O
semen	O	NOUN	B
in	O	ADP	O
1	O	NUM	O
or	O	CCONJ	O
2	O	NUM	O
steps	O	NOUN	B
,	O	PUNCT	O
freezing	O	VERB	B
according	O	VERB	O
to	O	ADP	O
2	O	NUM	O
methods	O	NOUN	B
,	O	PUNCT	O
thawing	O	NOUN	B
at	O	ADP	O
2	O	NUM	O
rates	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
the	O	DET	O
interactions	O	NOUN	B
between	O	ADP	O
these	O	DET	O
treatments	O	NOUN	B
,	O	PUNCT	O
on	O	ADP	O
the	O	DET	O
post	O	NOUN	B
-	O	PUNCT	O
thaw	O	NOUN	B
survival	O	NOUN	B
of	O	ADP	O
dog	O	NOUN	B
spermatozoa	O	NOUN	B
at	O	ADP	O
38	O	NUM	O
degrees	O	NOUN	B
C	O	NOUN	I
.	O	PUNCT	O


Molecular	O	ADJ	B
cloning	O	NOUN	I
and	O	CCONJ	O
expression	O	NOUN	B
of	O	ADP	O
human	B-GENE	ADJ	B
UDP	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
d	I-GENE	X	B
-	I-GENE	PUNCT	O
Xylose	I-GENE	NOUN	B
:	I-GENE	PUNCT	O
proteoglycan	I-GENE	NOUN	B
core	I-GENE	NOUN	B
protein	I-GENE	NOUN	I
beta	B-GENE	NOUN	O
-	I-GENE	PUNCT	O
d	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
xylosyltransferase	I-GENE	NOUN	B
and	O	CCONJ	O
its	O	PRON	O
first	O	ADJ	O
isoform	B-GENE	NOUN	B
XT	I-GENE	PROPN	B
-	I-GENE	PUNCT	O
II	I-GENE	PROPN	B
.	O	PUNCT	O


Oncogenic	O	ADJ	B
signalling	O	NOUN	O
by	O	ADP	O
E2F1	B-GENE	NOUN	B
has	O	AUX	O
recently	O	ADV	O
been	O	AUX	O
linked	O	VERB	O
to	O	PART	O
stabilization	O	NOUN	B
and	O	CCONJ	O
activation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
tumour	O	NOUN	B
suppressor	O	NOUN	I
p53	B-GENE	NOUN	I
(	O	PUNCT	O
refs	O	NOUN	O
1	O	NUM	O
,	O	PUNCT	O
3	O	NUM	O
,	O	PUNCT	O
4	O	NUM	O
)	O	PUNCT	O
.	O	PUNCT	O


We	O	PRON	O
describe	O	VERB	O
the	O	DET	O
identification	O	NOUN	B
and	O	CCONJ	O
initial	O	ADJ	O
characterization	O	NOUN	B
of	O	ADP	O
neurobeachin	B-GENE	NOUN	B
,	O	PUNCT	O
a	O	DET	O
neuron	O	NOUN	B
-	O	PUNCT	O
specific	O	ADJ	B
multidomain	O	NOUN	B
protein	O	NOUN	I
of	O	ADP	O
327	O	NUM	O
kDa	O	NOUN	O
with	O	ADP	O
a	O	DET	O
high	O	ADJ	B
-	O	PUNCT	O
affinity	O	NOUN	B
binding	O	NOUN	I
site	O	NOUN	I
(	O	PUNCT	O
K	O	NOUN	B
(	O	PUNCT	O
d	O	NOUN	O
)	O	PUNCT	O
,	O	PUNCT	O
10	O	NUM	O
nm	O	NOUN	O
)	O	PUNCT	O
for	O	ADP	O
the	O	DET	O
type	B-GENE	NOUN	B
II	I-GENE	NUM	I
regulatory	I-GENE	ADJ	I
subunit	I-GENE	NOUN	I
of	I-GENE	ADP	O
protein	I-GENE	NOUN	B
kinase	I-GENE	NOUN	I
A	I-GENE	NOUN	I
(	O	PUNCT	O
PKA	B-GENE	NOUN	B
RII	I-GENE	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Antimicrobial	O	ADJ	B
Susceptibility	O	PROPN	B
of	O	ADP	O
Klebsiella	O	X	B
pneumoniae	O	X	I
Producing	O	PROPN	O
Extended	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
Spectrum	I-GENE	PROPN	B
beta	I-GENE	PROPN	B
-	I-GENE	PUNCT	O
lactamase	I-GENE	NOUN	B
(	O	PUNCT	O
ESBL	B-GENE	NOUN	B
)	O	PUNCT	O
Isolated	O	VERB	B
in	O	ADP	O
Hospitals	O	NOUN	B
in	O	ADP	O
Brazil	O	PROPN	B
.	O	PUNCT	O


CONCLUSION	O	NOUN	O
:	O	PUNCT	O
Our	O	PRON	O
results	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
AIF	O	NOUN	B
peak	O	NOUN	B
saturation	O	NOUN	I
leads	O	VERB	O
to	O	PART	O
a	O	DET	O
significant	O	ADJ	O
systematic	O	ADJ	B
error	O	NOUN	I
in	O	ADP	O
the	O	DET	O
determination	O	NOUN	B
of	O	ADP	O
CBV	O	NOUN	B
and	O	CCONJ	O
CBF	O	NOUN	B
values	O	NOUN	B
and	O	CCONJ	O
has	O	AUX	O
necessarily	O	ADV	O
to	O	PART	O
be	O	AUX	O
taken	O	VERB	O
into	O	ADP	O
account	O	NOUN	O
for	O	ADP	O
dynamic	O	ADJ	B
contrast	O	NOUN	O
-	O	PUNCT	O
enhanced	O	VERB	B
MR	O	NOUN	B
perfusion	O	NOUN	I
studies	O	NOUN	B
.	O	PUNCT	O


Toward	O	ADP	O
this	O	DET	O
end	O	NOUN	O
,	O	PUNCT	O
we	O	PRON	O
prepared	O	VERB	O
synthetic	O	ADJ	B
proteins	O	NOUN	I
with	O	ADP	O
either	O	CCONJ	O
the	O	DET	O
catalytic	O	ADJ	B
domain	O	NOUN	I
of	O	ADP	O
FAP	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	B
(	I-GENE	PUNCT	O
C	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
terminal	I-GENE	ADJ	B
399	I-GENE	NUM	O
amino	I-GENE	NOUN	B
acids	I-GENE	NOUN	I
)	I-GENE	PUNCT	O
or	O	CCONJ	O
its	O	PRON	O
inactive	O	ADJ	B
form	O	NOUN	O
(	O	PUNCT	O
Cys2408	O	NOUN	B
-	O	PUNCT	O
-	O	PUNCT	O
>	O	X	O
Ser	O	NOUN	B
)	O	PUNCT	O
fused	O	VERB	O
to	O	PART	O
glutathione	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
S	I-GENE	PROPN	B
-	I-GENE	PUNCT	O
transferase	I-GENE	NOUN	B
(	O	PUNCT	O
GST	B-GENE	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Furthermore	O	ADV	O
,	O	PUNCT	O
transfection	O	NOUN	B
of	O	ADP	O
cells	O	NOUN	O
with	O	ADP	O
the	O	DET	O
spacer	O	NOUN	B
-	O	PUNCT	O
RING	O	NOUN	B
domain	O	NOUN	B
alone	O	ADV	O
suppressed	O	VERB	B
the	O	DET	O
antiapoptotic	O	ADJ	B
function	O	NOUN	O
of	O	ADP	O
the	O	DET	O
N	O	NOUN	B
-	O	PUNCT	O
terminal	O	ADJ	B
BIR	B-GENE	NOUN	B
domain	O	NOUN	O
of	O	ADP	O
c	B-GENE	NOUN	O
-	I-GENE	PUNCT	O
IAP1	I-GENE	NOUN	B
and	O	CCONJ	O
induced	O	VERB	B
apoptosis	O	NOUN	B
.	O	PUNCT	O


MS	O	NOUN	B
characteristics	O	NOUN	B
of	O	ADP	O
coumarins	O	NOUN	B
,	O	PUNCT	O
psoralens	O	NOUN	B
and	O	CCONJ	O
polymethoxylated	O	VERB	B
flavones	O	NOUN	I
with	O	ADP	O
different	O	ADJ	O
substitution	O	NOUN	B
patterns	O	NOUN	B
were	O	AUX	O
determined	O	VERB	O
on	O	ADP	O
the	O	DET	O
basis	O	NOUN	O
of	O	ADP	O
the	O	DET	O
response	O	NOUN	B
obtained	O	VERB	B
with	O	ADP	O
the	O	DET	O
APcI	O	NOUN	B
interface	O	NOUN	B
.	O	PUNCT	O


Copyright	O	NOUN	O
2000	O	NUM	O
Academic	O	PROPN	B
Press	O	PROPN	I
.	O	PUNCT	O


Plectin	B-GENE	NOUN	B
and	O	CCONJ	O
desmoplakin	B-GENE	NOUN	B
have	O	AUX	O
GSR	O	PROPN	B
-	O	PUNCT	O
containing	O	VERB	B
domains	O	NOUN	B
at	O	ADP	O
their	O	PRON	O
C	O	NOUN	B
-	O	PUNCT	O
termini	O	NOUN	B
and	O	CCONJ	O
we	O	PRON	O
further	O	ADV	O
demonstrate	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
GSR	O	PROPN	B
-	O	PUNCT	O
containing	O	VERB	B
domain	O	NOUN	B
of	O	ADP	O
plectin	B-GENE	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
not	O	PART	O
desmoplakin	B-GENE	NOUN	B
,	O	PUNCT	O
can	O	AUX	O
bind	O	VERB	B
to	O	PART	O
MTs	O	NOUN	B
in	O	X	B
vivo	O	X	I
.	O	PUNCT	O


Characterization	O	NOUN	B
of	O	ADP	O
the	O	DET	O
microtubule	O	NOUN	B
binding	O	NOUN	I
domain	O	NOUN	I
of	O	ADP	O
microtubule	B-GENE	NOUN	B
actin	I-GENE	NOUN	I
crosslinking	I-GENE	NOUN	I
factor	I-GENE	NOUN	I
(	O	PUNCT	O
MACF	B-GENE	NOUN	B
)	O	PUNCT	O
:	O	PUNCT	O
identification	O	NOUN	B
of	O	ADP	O
a	O	DET	O
novel	O	ADJ	O
group	O	NOUN	B
of	O	ADP	O
microtubule	B-GENE	ADJ	B
associated	I-GENE	ADJ	O
proteins	I-GENE	NOUN	O
.	O	PUNCT	O


Fecal	O	ADJ	B
samples	O	NOUN	O
were	O	AUX	O
collected	O	VERB	B
at	O	ADP	O
the	O	DET	O
beginning	O	NOUN	B
and	O	CCONJ	O
end	O	NOUN	O
of	O	ADP	O
each	O	DET	O
trial	O	NOUN	B
period	O	NOUN	B
and	O	CCONJ	O
were	O	AUX	O
analyzed	O	VERB	B
for	O	ADP	O
gastrointestinal	O	ADJ	B
nematode	O	NOUN	I
eggs	O	NOUN	B
and	O	CCONJ	O
Giardia	O	NOUN	B
cyst	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
aim	O	NOUN	O
of	O	ADP	O
this	O	DET	O
study	O	NOUN	B
was	O	AUX	O
to	O	PART	O
determine	O	VERB	O
the	O	DET	O
risk	O	NOUN	B
factors	O	NOUN	I
for	O	ADP	O
background	O	NOUN	B
diabetic	O	ADJ	I
retinopathy	O	NOUN	I
(	O	PUNCT	O
BDR	O	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
PDR	O	PROPN	B
by	O	ADP	O
following	O	VERB	O
394	O	NUM	O
Japanese	O	ADJ	B
patients	O	NOUN	B
with	O	ADP	O
early	O	ADJ	B
-	O	PUNCT	O
onset	O	NOUN	B
type	O	NOUN	I
2	O	NUM	I
diabetes	O	NOUN	I
diagnosed	O	VERB	B
before	O	ADP	O
30	O	NUM	O
years	O	NOUN	B
of	O	ADP	O
age	O	NOUN	B
(	O	PUNCT	O
mean	O	ADJ	O
age	O	NOUN	B
27	O	NUM	O
,	O	PUNCT	O
mean	O	ADJ	B
blood	O	NOUN	I
pressure	O	NOUN	I
at	O	ADP	O
entry	O	NOUN	O
116	O	NUM	O
/	O	SYM	O
73	O	NUM	O
mm	O	NOUN	B
Hg	O	NOUN	I
)	O	PUNCT	O
.	O	PUNCT	O


These	O	DET	O
cells	O	NOUN	B
produced	O	VERB	O
P2Y	B-GENE	NOUN	B
(	I-GENE	PUNCT	O
11	I-GENE	NUM	O
)	I-GENE	PUNCT	O
mRNA	I-GENE	NOUN	B
during	O	ADP	O
culture	O	NOUN	B
.	O	PUNCT	O


Differential	O	ADJ	B
association	O	NOUN	B
of	O	ADP	O
products	O	NOUN	B
of	O	ADP	O
alternative	O	ADJ	B
transcripts	O	NOUN	B
of	O	ADP	O
the	O	DET	O
candidate	O	NOUN	O
tumor	B-GENE	NOUN	B
suppressor	I-GENE	NOUN	I
ING1	I-GENE	NOUN	B
with	O	ADP	O
the	O	DET	O
mSin3	B-GENE	NOUN	B
/	O	SYM	O
HDAC1	B-GENE	NOUN	B
transcriptional	O	ADJ	B
corepressor	O	NOUN	I
complex	O	NOUN	I
.	O	PUNCT	O


As	O	ADP	O
hypothesized	O	VERB	O
,	O	PUNCT	O
believers	O	NOUN	B
showed	O	VERB	O
relatively	O	ADV	O
higher	O	ADJ	O
right	O	ADJ	O
hemispheric	O	ADJ	B
activation	O	NOUN	O
and	O	CCONJ	O
reduced	O	VERB	B
hemispheric	O	ADJ	B
asymmetry	O	NOUN	O
of	O	ADP	O
functional	O	ADJ	B
complexity	O	NOUN	I
.	O	PUNCT	O


Nucleotide	O	NOUN	B
sequence	O	NOUN	I
,	O	PUNCT	O
genome	O	NOUN	B
organization	O	NOUN	I
and	O	CCONJ	O
phylogenetic	O	ADJ	B
analysis	O	NOUN	I
of	O	ADP	O
pineapple	O	NOUN	B
mealybug	O	NOUN	I
wilt	O	NOUN	B
-	O	PUNCT	O
associated	O	VERB	B
virus	O	NOUN	B
-	O	PUNCT	O
2	O	NUM	B
.	O	PUNCT	O


Adjuvant	O	NOUN	B
therapy	O	NOUN	I
for	O	ADP	O
colon	O	NOUN	B
cancer	O	NOUN	I
]	O	PUNCT	O
Surgery	O	NOUN	O
alone	O	ADV	O
may	O	AUX	O
fail	O	VERB	O
to	O	PART	O
cure	O	VERB	B
a	O	DET	O
considerable	O	ADJ	O
number	O	NOUN	O
of	O	ADP	O
locally	O	ADV	B
advanced	O	ADJ	I
colon	O	NOUN	I
cancers	O	NOUN	I
.	O	PUNCT	O


Effects	O	NOUN	B
of	O	ADP	I
Trypanosoma	O	X	B
vivax	O	NOUN	I
on	O	ADP	O
pregnancy	O	NOUN	B
of	O	ADP	O
Yankasa	O	PROPN	B
sheep	O	NOUN	I
and	O	CCONJ	O
the	O	DET	O
results	O	NOUN	B
of	O	ADP	O
homidum	O	ADJ	O
chloride	O	NOUN	B
chemotherapy	O	NOUN	I
.	O	PUNCT	O


NF	B-GENE	NOUN	B
kappa	I-GENE	NOUN	I
B	I-GENE	NOUN	I
was	O	AUX	O
activated	O	VERB	B
to	O	PART	O
a	O	DET	O
much	O	ADV	O
greater	O	ADJ	O
extent	O	NOUN	O
by	O	ADP	O
roscovitine	O	NOUN	B
in	O	ADP	O
the	O	DET	O
WT	O	NOUN	B
cells	O	NOUN	I
than	O	ADP	O
in	O	ADP	O
Y8	O	NOUN	B
cells	O	NOUN	I
.	O	PUNCT	O


Additionally	O	ADV	O
,	O	PUNCT	O
MIP	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
2A	I-GENE	NOUN	B
antagonizes	O	VERB	B
cell	O	NOUN	B
growth	O	NOUN	I
regulatory	O	ADJ	O
role	O	NOUN	O
of	O	ADP	O
MBP	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	O
.	O	PUNCT	O


3	O	X	O
.	O	PUNCT	O
04	O	NUM	O
+	O	CCONJ	O
/	O	SYM	O
-	O	PUNCT	O
1	O	NUM	O
.	O	PUNCT	O
2	O	NUM	O
,	O	PUNCT	O
P	O	NOUN	O
<	O	X	O
0	O	NUM	O
.	O	PUNCT	O
0001	O	NUM	O
)	O	PUNCT	O
,	O	PUNCT	O
large	O	ADJ	O
accelerations	O	NOUN	B
/	O	SYM	O
30	O	NUM	O
min	O	NOUN	O
(	O	PUNCT	O
1	O	NUM	O
.	O	PUNCT	O
46	O	NUM	O
+	O	CCONJ	O
/	O	SYM	O
-	O	PUNCT	O
1	O	NUM	O
.	O	PUNCT	O
96	O	NUM	O
vs	O	CCONJ	O
.	O	PUNCT	O


In	O	ADP	O
addition	O	NOUN	O
,	O	PUNCT	O
we	O	PRON	O
identified	O	VERB	B
two	O	NUM	O
mutations	O	NOUN	B
,	O	PUNCT	O
Delta	O	PROPN	B
M1281	O	PROPN	I
and	O	CCONJ	O
IVS51	O	NOUN	B
+	O	CCONJ	O
5G	O	NOUN	B
-	O	PUNCT	O
-	O	PUNCT	O
>	O	PROPN	O
A	O	PROPN	O
,	O	PUNCT	O
in	O	ADP	O
a	O	DET	O
German	O	ADJ	B
USH1	B-GENE	NOUN	B
patient	O	NOUN	B
.	O	PUNCT	O


Nuclease	O	NOUN	B
probing	O	NOUN	I
and	O	CCONJ	O
structure	O	NOUN	B
-	O	PUNCT	O
directed	O	VERB	B
mutagenesis	O	NOUN	B
revealed	O	VERB	B
that	O	SCONJ	O
the	O	DET	O
105	O	NUM	O
-	O	PUNCT	O
nt	O	NOUN	B
TE	O	NOUN	B
(	O	PUNCT	O
TE105	O	NOUN	B
)	O	PUNCT	O
forms	O	VERB	O
a	O	DET	O
cruciform	O	ADJ	B
secondary	O	ADJ	O
structure	O	NOUN	O
containing	O	VERB	O
four	O	NUM	O
helices	O	NOUN	B
connected	O	VERB	O
by	O	ADP	O
single	O	ADJ	B
-	O	PUNCT	O
stranded	O	VERB	B
regions	O	NOUN	O
.	O	PUNCT	O


Tele	O	PROPN	B
-	O	PUNCT	O
Talk	O	PROPN	B
has	O	AUX	O
the	O	DET	O
extra	O	ADJ	O
capability	O	NOUN	B
of	O	ADP	O
operating	O	VERB	B
in	O	ADP	O
live	O	ADJ	B
conference	O	NOUN	B
situations	O	NOUN	O
using	O	VERB	O
microphone	O	NOUN	B
input	O	NOUN	B
.	O	PUNCT	O


Perfusion	O	NOUN	B
technique	O	NOUN	I
for	O	ADP	O
perfusion	O	NOUN	B
-	O	PUNCT	O
assisted	O	VERB	B
direct	O	ADJ	O
coronary	O	ADJ	B
artery	O	NOUN	I
bypass	O	NOUN	I
(	O	PUNCT	O
PADCAB	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


As	O	ADV	O
well	O	ADV	O
,	O	PUNCT	O
mixtures	O	NOUN	B
of	O	ADP	O
(	O	PUNCT	O
LA	O	PROPN	B
)	O	PUNCT	O
(	O	PUNCT	O
12	O	NUM	O
)	O	PUNCT	O
with	O	ADP	O
the	O	DET	O
longer	O	ADJ	O
chain	O	NOUN	B
PEs	O	NOUN	I
exhibit	O	VERB	O
unusual	O	ADJ	O
biomodal	O	ADJ	B
enthalpy	O	NOUN	I
variations	O	NOUN	B
,	O	PUNCT	O
suggesting	O	VERB	O
peptide	O	NOUN	B
immiscibility	O	NOUN	B
in	O	ADP	O
thicker	O	ADJ	B
gel	O	NOUN	I
state	O	NOUN	I
bilayers	O	NOUN	I
.	O	PUNCT	O


Energy	O	NOUN	B
expenditure	O	NOUN	I
was	O	AUX	O
obtained	O	VERB	O
using	O	VERB	O
a	O	DET	O
primed	O	ADJ	B
,	O	PUNCT	O
3	O	NUM	O
-	O	PUNCT	O
hour	O	NOUN	B
infusion	O	NOUN	B
of	O	ADP	O
NaH	O	NOUN	B
(	O	PUNCT	O
13	O	NUM	O
)	O	PUNCT	O
CO	O	NOUN	B
(	O	PUNCT	O
3	O	NUM	O
'	O	PUNCT	O
)	O	PUNCT	O
,	O	PUNCT	O
breath	O	NOUN	B
(	O	PUNCT	O
13	O	NUM	O
)	O	PUNCT	O
CO	O	NOUN	B
(	O	PUNCT	O
2	O	NUM	O
)	O	PUNCT	O
enrichment	O	NOUN	O
determination	O	NOUN	B
by	O	ADP	O
isotope	O	NOUN	B
ratio	O	NOUN	I
mass	O	NOUN	I
spectroscopy	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
the	O	DET	O
application	O	NOUN	B
of	O	ADP	O
a	O	DET	O
standard	O	ADJ	B
regression	O	NOUN	I
equation	O	NOUN	I
.	O	PUNCT	O


Workload	O	NOUN	B
,	O	PUNCT	O
UAPs	O	PROPN	B
,	O	PUNCT	O
and	O	CCONJ	O
you	O	PRON	O
.	O	PUNCT	O


Naltrexone	O	NOUN	B
hydrochloride	O	NOUN	B
is	O	AUX	O
a	O	DET	O
synthetic	O	ADJ	B
opioid	B-GENE	NOUN	O
receptor	I-GENE	NOUN	O
antagonist	O	NOUN	B
recently	O	ADV	O
used	O	VERB	O
in	O	ADP	O
efforts	O	NOUN	O
to	O	PART	O
provide	O	VERB	O
rapid	O	ADJ	O
opioid	O	NOUN	B
detoxification	O	NOUN	B
.	O	PUNCT	O


Derivation	O	NOUN	B
and	O	CCONJ	O
initial	O	ADJ	O
characterization	O	NOUN	B
of	O	ADP	O
a	O	DET	O
mouse	O	NOUN	B
mammary	O	ADJ	B
tumor	O	NOUN	O
cell	O	NOUN	O
line	O	NOUN	O
carrying	O	VERB	O
the	O	DET	O
polyomavirus	B-GENE	NOUN	B
middle	I-GENE	ADJ	I
T	I-GENE	NOUN	I
antigen	I-GENE	NOUN	I
:	O	PUNCT	O
utility	O	NOUN	O
in	O	ADP	O
the	O	DET	O
development	O	NOUN	B
of	O	ADP	O
novel	O	ADJ	B
cancer	O	NOUN	B
therapeutics	O	NOUN	B
.	O	PUNCT	O


Hypomorphic	O	ADJ	B
dSLBP	B-GENE	NOUN	B
alleles	I-GENE	NOUN	O
support	O	VERB	O
zygotic	O	ADJ	B
development	O	NOUN	O
but	O	CCONJ	O
cause	O	VERB	O
female	O	ADJ	B
sterility	O	NOUN	O
.	O	PUNCT	O


We	O	PRON	O
mapped	O	VERB	B
the	O	DET	O
DGCR6	B-GENE	NOUN	B
gene	I-GENE	NOUN	I
to	O	PART	O
chromosome	O	NOUN	O
22q11	O	NOUN	O
within	O	ADP	O
a	O	DET	O
low	O	ADJ	B
copy	O	NOUN	B
repeat	O	NOUN	I
,	O	PUNCT	O
termed	O	VERB	O
sc11	O	NOUN	B
.	O	PUNCT	O
1a	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
identified	O	VERB	B
a	O	DET	O
second	O	ADJ	O
copy	O	NOUN	B
of	O	ADP	I
the	O	DET	I
gene	O	NOUN	B
,	O	PUNCT	O
DGCR6L	B-GENE	NOUN	B
,	O	PUNCT	O
within	O	ADP	O
the	O	DET	O
duplicate	O	NOUN	B
locus	O	NOUN	I
,	O	PUNCT	O
termed	O	VERB	O
sc11	O	NOUN	B
.	O	PUNCT	O
1b	O	NOUN	O
.	O	PUNCT	O


Recruitment	O	NOUN	B
of	O	ADP	O
an	O	DET	O
RNA	B-GENE	NOUN	B
polymerase	I-GENE	NOUN	I
II	I-GENE	NUM	I
complex	I-GENE	NOUN	I
is	O	AUX	O
mediated	O	VERB	O
by	O	ADP	O
the	O	DET	O
constitutive	O	ADJ	B
activation	O	NOUN	B
domain	O	NOUN	I
in	O	ADP	O
CREB	B-GENE	NOUN	B
,	O	PUNCT	O
independently	O	ADV	O
of	O	ADP	O
CREB	B-GENE	NOUN	B
phosphorylation	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
observed	O	VERB	O
phenotypes	O	NOUN	B
may	O	AUX	O
be	O	AUX	O
explained	O	VERB	O
by	O	ADP	O
(	O	PUNCT	O
i	O	X	O
)	O	PUNCT	O
a	O	DET	O
selective	O	ADJ	O
disruption	O	NOUN	B
of	O	ADP	O
very	B-GENE	ADV	B
-	I-GENE	PUNCT	O
low	I-GENE	ADJ	B
-	I-GENE	PUNCT	O
density	I-GENE	NOUN	B
lipoprotein	I-GENE	NOUN	B
secretion	O	NOUN	I
due	O	ADJ	O
to	O	PART	O
decreased	O	VERB	B
expression	O	NOUN	B
of	O	ADP	O
genes	O	NOUN	B
encoding	O	VERB	O
apolipoprotein	B-GENE	NOUN	B
B	I-GENE	NOUN	I
and	O	CCONJ	O
microsomal	B-GENE	ADJ	B
triglyceride	I-GENE	NOUN	I
transfer	I-GENE	NOUN	I
protein	I-GENE	NOUN	I
,	O	PUNCT	O
(	O	PUNCT	O
ii	O	X	O
)	O	PUNCT	O
an	O	DET	O
increase	O	NOUN	B
in	O	ADP	O
hepatic	O	ADJ	B
cholesterol	O	NOUN	I
uptake	O	NOUN	B
due	O	ADJ	O
to	O	PART	O
increased	O	VERB	B
expression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
major	O	ADJ	O
high	B-GENE	ADJ	B
-	I-GENE	PUNCT	O
density	I-GENE	NOUN	B
lipoprotein	I-GENE	NOUN	I
receptor	I-GENE	NOUN	I
,	O	PUNCT	O
scavenger	B-GENE	NOUN	B
receptor	I-GENE	NOUN	I
BI	I-GENE	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
(	O	PUNCT	O
iii	O	X	O
)	O	PUNCT	O
a	O	DET	O
decrease	O	NOUN	B
in	O	ADP	O
bile	O	NOUN	B
acid	O	NOUN	I
uptake	O	NOUN	B
to	O	PART	O
the	O	DET	O
liver	O	NOUN	B
due	O	ADP	O
to	O	ADP	O
down	O	ADV	B
-	O	PUNCT	O
regulation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
major	O	ADJ	O
basolateral	B-GENE	ADJ	B
bile	I-GENE	NOUN	I
acid	I-GENE	NOUN	I
transporters	I-GENE	NOUN	I
sodium	I-GENE	NOUN	B
taurocholate	I-GENE	NOUN	I
cotransporter	I-GENE	NOUN	I
protein	I-GENE	NOUN	I
and	O	CCONJ	O
organic	B-GENE	ADJ	B
anion	I-GENE	NOUN	I
transporter	I-GENE	NOUN	I
protein	I-GENE	NOUN	I
1	I-GENE	NUM	I
.	O	PUNCT	O


Inactivity	O	NOUN	B
of	O	ADP	O
the	O	DET	O
human	B-GENE	ADJ	B
cytomegalovirus	I-GENE	NOUN	I
(	I-GENE	PUNCT	O
HCMV	I-GENE	NOUN	B
)	I-GENE	PUNCT	O
major	I-GENE	ADJ	O
immediate	I-GENE	ADJ	B
-	I-GENE	PUNCT	O
early	I-GENE	ADJ	B
regulatory	I-GENE	ADJ	B
region	I-GENE	NOUN	I
(	O	PUNCT	O
MIERR	B-GENE	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
which	O	DET	O
is	O	AUX	O
composed	O	VERB	O
of	O	ADP	O
promoter	O	NOUN	B
,	O	PUNCT	O
enhancer	O	NOUN	B
,	O	PUNCT	O
unique	O	ADJ	B
region	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
modulator	O	NOUN	B
,	O	PUNCT	O
is	O	AUX	O
linked	O	VERB	O
to	O	PART	O
lack	O	NOUN	B
of	O	ADP	O
HCMV	O	NOUN	B
replication	O	NOUN	B
in	O	ADP	O
latently	O	ADV	B
infected	O	ADJ	I
cells	O	NOUN	B
and	O	CCONJ	O
in	O	ADP	O
other	O	ADJ	O
nonpermissive	O	ADJ	B
cell	O	NOUN	I
types	O	NOUN	O
,	O	PUNCT	O
including	O	VERB	O
human	O	ADJ	B
embryonal	O	ADJ	B
NTera2	O	NOUN	B
carcinoma	O	NOUN	I
(	O	PUNCT	O
NT2	O	NOUN	B
)	O	PUNCT	O
cells	O	NOUN	O
.	O	PUNCT	O


Both	O	CCONJ	O
Z	B-GENE	NOUN	B
and	O	CCONJ	O
R	B-GENE	NOUN	B
expression	O	NOUN	B
resulted	O	VERB	O
in	O	ADP	O
PML	O	NOUN	B
dispersion	O	NOUN	B
in	O	ADP	O
EBV	O	NOUN	B
-	O	PUNCT	O
positive	O	ADJ	B
cells	O	NOUN	B
.	O	PUNCT	O


Immunofluorescence	O	NOUN	B
studies	O	NOUN	I
in	O	ADP	O
C2C12	O	NOUN	B
myotubes	O	NOUN	I
show	O	VERB	O
that	O	SCONJ	O
Smad2	B-GENE	NOUN	B
and	O	CCONJ	O
MEF2A	B-GENE	NOUN	B
co	O	X	B
-	O	PUNCT	O
localise	O	NOUN	B
in	O	ADP	O
the	O	DET	O
nucleus	O	NOUN	B
of	O	ADP	O
multinuclear	O	ADJ	B
myotubes	O	NOUN	I
during	O	ADP	O
differentiation	O	NOUN	B
.	O	PUNCT	O


Southern	O	NOUN	B
blot	O	NOUN	I
analysis	O	NOUN	I
of	O	ADP	O
genomic	O	ADJ	B
DNA	O	NOUN	I
from	O	ADP	O
somatic	O	ADJ	B
cell	O	NOUN	I
hybrids	O	NOUN	O
showed	O	VERB	O
that	O	SCONJ	O
endothelial	B-GENE	ADJ	B
-	I-GENE	PUNCT	O
TACC	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
related	I-GENE	VERB	B
cDNA	I-GENE	NOUN	B
maps	O	NOUN	O
to	O	PART	O
chromosome	O	NOUN	B
10	O	NUM	I
.	O	PUNCT	O


The	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
truncated	O	VERB	B
receptor	O	NOUN	I
isoforms	O	NOUN	B
in	O	ADP	O
diverse	O	ADJ	B
species	O	NOUN	B
suggests	O	VERB	O
that	O	SCONJ	O
these	O	DET	O
proteins	O	NOUN	B
may	O	AUX	O
have	O	AUX	O
important	O	ADJ	O
functional	O	ADJ	B
roles	O	NOUN	I
in	O	ADP	O
regulating	O	VERB	B
EGFR	B-GENE	NOUN	B
activity	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
continuing	O	VERB	B
development	O	NOUN	I
of	O	ADP	O
ligands	O	NOUN	B
that	O	PRON	O
function	O	VERB	B
as	O	ADP	O
selective	O	ADJ	O
estrogens	O	NOUN	B
or	O	CCONJ	O
antiestrogens	O	NOUN	B
for	O	ADP	O
ERalpha	B-GENE	NOUN	B
or	O	CCONJ	O
ERbeta	B-GENE	NOUN	B
should	O	AUX	O
allow	O	VERB	O
optimized	O	ADJ	O
tissue	O	NOUN	B
selectivity	O	NOUN	B
of	O	ADP	O
these	O	DET	O
agents	O	NOUN	B
for	O	ADP	O
menopausal	O	ADJ	B
hormone	O	NOUN	I
replacement	O	NOUN	I
therapy	O	NOUN	I
and	O	CCONJ	O
the	O	DET	O
treatment	O	NOUN	B
and	O	CCONJ	O
prevention	O	NOUN	B
of	O	ADP	O
breast	O	NOUN	B
cancer	O	NOUN	I
.	O	PUNCT	O


Behavioural	O	ADJ	B
tests	O	NOUN	I
with	O	ADP	O
192	O	NUM	O
specimen	O	NOUN	B
of	O	ADP	O
the	O	DET	O
roman	O	ADJ	B
garden	O	NOUN	I
snail	O	NOUN	B
Helix	O	NOUN	B
pomatia	O	NOUN	I
L	O	NOUN	I
.	O	PUNCT	O
were	O	AUX	O
performed	O	VERB	O
in	O	ADP	O
order	O	NOUN	O
to	O	PART	O
clarify	O	VERB	O
whether	O	SCONJ	O
the	O	DET	O
thermopreferendum	O	NOUN	B
of	O	ADP	O
this	O	DET	O
pulmonate	O	NOUN	B
is	O	AUX	O
influenced	O	VERB	B
not	O	PART	O
only	O	ADV	O
by	O	ADP	O
the	O	DET	O
temperature	O	NOUN	B
of	O	ADP	O
the	O	DET	O
substratum	O	NOUN	B
but	O	CCONJ	O
also	O	ADV	O
by	O	ADP	O
air	O	NOUN	B
temperature	O	NOUN	B
.	O	PUNCT	O


Increased	O	VERB	B
erythropoietin	B-GENE	NOUN	B
synthesis	O	NOUN	B
in	O	ADP	O
patients	O	NOUN	B
with	O	ADP	O
COLD	O	PROPN	B
or	O	CCONJ	O
left	O	VERB	B
heart	O	NOUN	I
failure	O	NOUN	I
is	O	AUX	O
related	O	ADJ	O
to	O	PART	O
alterations	O	NOUN	B
in	O	ADP	O
renal	O	ADJ	B
haemodynamics	O	NOUN	I
.	O	PUNCT	O


Using	O	VERB	O
immunochemical	O	ADJ	B
co	O	X	B
-	O	PUNCT	O
precipitation	O	NOUN	B
methods	O	NOUN	O
,	O	PUNCT	O
we	O	PRON	O
also	O	ADV	O
found	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
two	O	NUM	O
proteins	O	NOUN	B
are	O	AUX	O
bound	O	VERB	B
in	O	X	B
vivo	O	X	I
.	O	PUNCT	O


An	O	DET	O
additional	O	ADJ	O
9	O	NUM	O
patients	O	NOUN	B
achieved	O	VERB	O
normal	O	ADJ	O
levels	O	NOUN	O
with	O	ADP	O
adjunctive	O	ADJ	B
drug	O	NOUN	I
therapy	O	NOUN	I
.	O	PUNCT	O


For	O	ADP	O
immunological	O	ADJ	B
methods	O	NOUN	I
,	O	PUNCT	O
identification	O	NOUN	B
of	O	ADP	O
such	O	ADJ	O
antigens	O	NOUN	B
with	O	ADP	O
intermolecular	O	ADJ	B
variability	O	NOUN	B
,	O	PUNCT	O
e	O	X	O
.	O	PUNCT	O
g	O	NOUN	O
.	O	PUNCT	O
,	O	PUNCT	O
the	O	DET	O
structural	O	ADJ	B
aescin	O	NOUN	B
analogs	O	NOUN	B
,	O	PUNCT	O
is	O	AUX	O
of	O	ADP	O
unknown	O	ADJ	O
validity	O	NOUN	B
.	O	PUNCT	O


Blood	O	NOUN	B
from	O	ADP	O
dams	O	NOUN	B
was	O	AUX	O
collected	O	VERB	O
prior	O	ADV	O
to	O	PART	O
inoculation	O	NOUN	B
and	O	CCONJ	O
at	O	ADP	O
time	O	NOUN	O
of	O	ADP	O
necropsy	O	NOUN	B
for	O	ADP	O
measurement	O	NOUN	B
of	O	ADP	O
IgM	B-GENE	NOUN	B
and	O	CCONJ	O
IgG	B-GENE	NOUN	B
antibodies	I-GENE	NOUN	I
to	O	PART	O
M	O	NOUN	B
.	O	PUNCT	O
pulmonis	O	NOUN	B
.	O	PUNCT	O


Single	O	ADJ	B
amino	O	NOUN	I
acid	O	NOUN	I
substitutions	O	NOUN	I
at	O	ADP	O
the	O	DET	O
acyl	O	ADJ	B
-	O	PUNCT	O
CoA	O	NOUN	B
-	O	PUNCT	O
binding	O	VERB	B
domain	O	NOUN	O
interrupt	O	VERB	O
14	O	NUM	O
[	O	PUNCT	O
C	O	NOUN	O
]	O	PUNCT	O
palmitoyl	O	NOUN	B
-	O	PUNCT	O
CoA	O	NOUN	B
binding	O	NOUN	B
of	O	ADP	O
ACBP2	B-GENE	NOUN	B
,	O	PUNCT	O
an	O	DET	O
Arabidopsis	O	NOUN	B
acyl	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
CoA	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
binding	I-GENE	VERB	B
protein	I-GENE	NOUN	I
with	O	ADP	O
ankyrin	B-GENE	NOUN	B
repeats	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
bovine	B-GENE	ADJ	B
PGHS	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
2	I-GENE	NUM	B
cDNA	I-GENE	NOUN	B
was	O	AUX	O
cloned	O	VERB	B
by	O	ADP	O
a	O	DET	O
combination	O	NOUN	B
of	O	ADP	O
reverse	O	ADJ	B
transcription	O	NOUN	I
-	O	PUNCT	O
polymerase	O	NOUN	B
chain	O	NOUN	I
reaction	O	NOUN	I
and	O	CCONJ	O
cDNA	O	NOUN	B
library	O	NOUN	I
screening	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
regulation	O	NOUN	B
of	O	ADP	O
PGHS	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
2	I-GENE	NUM	O
mRNA	I-GENE	NOUN	B
and	O	CCONJ	O
protein	O	NOUN	B
was	O	AUX	O
studied	O	VERB	O
in	O	ADP	O
primary	O	ADJ	B
cultures	O	NOUN	I
of	O	ADP	O
bovine	O	ADJ	B
uterine	O	ADJ	B
stromal	O	ADJ	I
cells	O	NOUN	I
stimulated	O	VERB	B
with	O	ADP	O
phorbol	O	NOUN	B
12	O	NUM	I
-	O	PUNCT	O
myristate	O	NOUN	B
13	O	NUM	I
-	O	PUNCT	O
acetate	O	NOUN	B
(	O	PUNCT	O
PMA	O	NOUN	B
;	O	PUNCT	O
100	O	NUM	O
nM	O	NOUN	O
)	O	PUNCT	O
.	O	PUNCT	O


Anti	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
nucleolin	I-GENE	NOUN	B
mAb	I-GENE	NOUN	B
was	O	AUX	O
used	O	VERB	O
to	O	PART	O
confirm	O	VERB	O
the	O	DET	O
antigenic	O	ADJ	B
properties	O	NOUN	B
of	O	ADP	O
this	O	DET	O
p95	B-GENE	NOUN	B
component	I-GENE	NOUN	B
.	O	PUNCT	O


Furthermore	O	ADV	O
,	O	PUNCT	O
stable	O	ADJ	B
expression	O	NOUN	B
of	O	ADP	O
a	O	DET	O
constitutively	O	ADV	B
active	O	ADJ	O
form	O	NOUN	O
of	O	ADP	O
chicken	O	NOUN	B
Notch1	B-GENE	NOUN	B
or	O	CCONJ	O
Notch2	B-GENE	NOUN	B
in	O	ADP	O
a	O	DET	O
B	O	NOUN	B
cell	O	NOUN	I
line	O	NOUN	I
results	O	VERB	O
in	O	ADP	O
a	O	DET	O
down	O	NOUN	B
-	O	PUNCT	O
regulation	O	NOUN	B
of	O	ADP	O
surface	O	NOUN	B
IgM	B-GENE	NOUN	B
expression	O	NOUN	B
,	O	PUNCT	O
which	O	DET	O
is	O	AUX	O
accompanied	O	VERB	O
by	O	ADP	O
the	O	DET	O
reduction	O	NOUN	B
of	O	ADP	O
IgH	B-GENE	NOUN	B
gene	I-GENE	NOUN	I
transcripts	I-GENE	NOUN	O
.	O	PUNCT	O


The	O	DET	O
effects	O	NOUN	B
of	O	ADP	O
the	O	DET	O
transfected	O	VERB	B
receptors	O	NOUN	I
were	O	AUX	O
associated	O	VERB	B
with	O	ADP	I
antagonism	O	NOUN	B
of	O	ADP	O
activator	B-GENE	NOUN	B
protein	I-GENE	NOUN	I
1	I-GENE	NUM	I
(	O	PUNCT	O
AP	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	O
)	O	PUNCT	O
activity	O	NOUN	B
.	O	PUNCT	O


Recent	O	ADJ	O
studies	O	NOUN	B
using	O	VERB	O
isolated	O	VERB	B
rat	O	NOUN	B
adipocytes	O	NOUN	B
and	O	CCONJ	O
chemically	O	ADV	B
synthesized	O	VERB	I
PIG	O	NOUN	B
compounds	O	NOUN	B
point	O	VERB	O
to	O	PART	O
IRS1	B-GENE	NOUN	B
/	I-GENE	SYM	O
3	I-GENE	NUM	B
tyrosine	O	NOUN	I
phosphorylation	O	NOUN	B
by	O	ADP	O
p59Lyn	B-GENE	NOUN	B
kinase	I-GENE	NOUN	I
as	O	ADP	O
the	O	DET	O
site	O	NOUN	B
of	O	ADP	O
cross	O	NOUN	B
-	O	PUNCT	O
talk	O	NOUN	B
,	O	PUNCT	O
the	O	DET	O
negative	O	ADJ	B
regulation	O	NOUN	B
of	O	ADP	O
which	O	DET	O
by	O	ADP	O
interaction	O	NOUN	B
with	O	ADP	O
caveolin	B-GENE	NOUN	B
is	O	AUX	O
apparently	O	ADV	O
abrogated	O	VERB	O
by	O	ADP	O
PIG	O	PROPN	B
.	O	PUNCT	O


As	O	ADP	O
an	O	DET	O
oral	O	ADJ	B
,	O	PUNCT	O
nontoxic	O	ADJ	B
compound	O	NOUN	I
with	O	ADP	O
a	O	DET	O
mechanism	O	NOUN	B
of	O	ADP	O
action	O	NOUN	B
distinct	O	ADJ	O
from	O	ADP	O
that	O	DET	O
of	O	ADP	O
ABL	B-GENE	NOUN	B
tyrosine	I-GENE	NOUN	I
kinase	I-GENE	NOUN	I
inhibition	O	NOUN	B
,	O	PUNCT	O
FTI	O	NOUN	B
SCH66336	O	NOUN	B
shows	O	VERB	O
promise	O	NOUN	O
for	O	ADP	O
the	O	DET	O
treatment	O	NOUN	B
of	O	ADP	O
BCR	B-GENE	NOUN	B
/	O	SYM	O
ABL	B-GENE	NOUN	B
-	O	PUNCT	O
induced	O	VERB	B
leukemia	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
conclude	O	VERB	O
that	O	SCONJ	O
RPMS	B-GENE	NOUN	B
acts	O	VERB	O
as	O	ADP	O
a	O	DET	O
negative	O	ADJ	B
regulator	O	NOUN	B
of	O	ADP	O
EBNA2	B-GENE	NOUN	B
and	O	CCONJ	O
Notch	B-GENE	NOUN	B
activity	O	NOUN	I
through	O	ADP	O
its	O	PRON	O
interactions	O	NOUN	B
with	O	ADP	O
the	O	DET	O
CBF1	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
associated	I-GENE	VERB	B
corepressor	I-GENE	NOUN	B
complex	I-GENE	NOUN	I
.	O	PUNCT	O


Transactivation	O	NOUN	B
of	O	ADP	O
oIFNtau	B-GENE	NOUN	B
enhancer	O	NOUN	I
-	O	PUNCT	O
reporter	O	NOUN	B
constructs	O	NOUN	B
was	O	AUX	O
primarily	O	ADV	O
regulated	O	VERB	O
by	O	ADP	O
three	O	NUM	O
regions	O	NOUN	B
containing	O	VERB	O
AP	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	O
site	I-GENE	NOUN	B
,	O	PUNCT	O
GATA	B-GENE	NOUN	B
like	I-GENE	ADP	O
sequence	I-GENE	NOUN	B
and	O	CCONJ	O
site	O	NOUN	B
(	O	PUNCT	O
s	O	NOUN	O
)	O	PUNCT	O
unidentified	O	ADJ	O
.	O	PUNCT	O


Copyright	O	NOUN	O
2000	O	NUM	O
John	O	PROPN	O
Wiley	O	PROPN	O
&	O	CCONJ	O
Sons	O	PROPN	O
,	O	PUNCT	O
Ltd	O	PROPN	B
.	O	PUNCT	O


Fluorimetric	O	ADJ	B
determination	O	NOUN	B
of	O	ADP	O
methylmercury	O	NOUN	B
as	O	ADP	O
an	O	DET	O
ion	O	NOUN	B
-	O	PUNCT	O
association	O	NOUN	B
complex	O	NOUN	B
with	O	ADP	O
rhodamine	O	NOUN	B
B	O	NOUN	I
in	O	ADP	O
the	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
iodide	O	NOUN	B
.	O	PUNCT	O


Cells	O	NOUN	B
containing	O	VERB	O
alpha	O	NOUN	B
subunits	O	NOUN	I
that	O	PRON	O
lacked	O	VERB	O
a	O	DET	O
distal	O	ADJ	B
domain	O	NOUN	I
(	O	PUNCT	O
term	O	NOUN	B
-	O	PUNCT	O
3	O	NUM	O
)	O	PUNCT	O
or	O	CCONJ	O
had	O	AUX	O
the	O	DET	O
alternatively	O	ADV	O
spliced	O	VERB	O
alpha	O	NOUN	O
-	O	PUNCT	O
2	O	NUM	B
distal	O	ADJ	I
domain	O	NOUN	I
showed	O	VERB	O
markedly	O	ADV	O
decreased	O	VERB	B
ability	O	NOUN	O
to	O	PART	O
support	O	VERB	O
tyrosine	O	NOUN	B
phosphorylation	O	NOUN	I
of	O	ADP	O
Jak	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
2	I-GENE	NUM	O
and	O	CCONJ	O
its	O	PRON	O
substrates	O	NOUN	B
or	O	CCONJ	O
to	O	ADP	O
up	O	ADV	B
-	O	PUNCT	O
regulate	O	VERB	B
CD86	B-GENE	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
Saccharomyces	O	X	B
cerevisiae	O	X	I
,	O	PUNCT	O
eIF6	B-GENE	NOUN	B
is	O	AUX	O
encoded	O	VERB	B
by	O	ADP	O
a	O	DET	O
single	O	ADJ	B
-	O	PUNCT	O
copy	O	NOUN	B
essential	O	ADJ	I
gene	O	NOUN	I
.	O	PUNCT	O


TaqMan	O	NOUN	B
analysis	O	NOUN	I
of	O	ADP	O
gene	O	NOUN	B
expression	O	NOUN	I
following	O	VERB	O
chronic	O	ADJ	B
FA	O	NOUN	B
treatment	O	NOUN	B
showed	O	VERB	O
neither	O	CCONJ	O
a	O	DET	O
decrease	O	NOUN	B
in	O	ADP	O
the	O	DET	O
amount	O	NOUN	B
of	O	ADP	O
leptin	B-GENE	NOUN	B
receptor	I-GENE	NOUN	I
(	O	PUNCT	O
Ob	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
R	I-GENE	NOUN	B
)	O	PUNCT	O
mRNA	O	NOUN	B
,	O	PUNCT	O
nor	O	CCONJ	O
an	O	DET	O
increase	O	NOUN	B
in	O	ADP	O
the	O	DET	O
negative	O	ADJ	B
regulators	O	NOUN	B
of	O	ADP	O
STAT	B-GENE	NOUN	B
signalling	O	NOUN	I
,	O	PUNCT	O
SOCS3	B-GENE	NOUN	B
(	O	PUNCT	O
suppressors	B-GENE	NOUN	B
of	I-GENE	ADP	O
cytokine	I-GENE	NOUN	B
signalling	I-GENE	NOUN	I
)	O	PUNCT	O
or	O	CCONJ	O
cytokine	B-GENE	NOUN	B
inducible	I-GENE	ADJ	I
sequence	I-GENE	NOUN	I
(	O	PUNCT	O
CIS	B-GENE	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


The	O	DET	O
blood	O	NOUN	B
levels	O	NOUN	I
of	O	ADP	I
lactate	O	NOUN	I
,	O	PUNCT	O
pyruvate	O	NOUN	B
and	O	CCONJ	O
amino	O	NOUN	B
acids	O	NOUN	I
were	O	AUX	O
not	O	PART	O
elevated	O	ADJ	B
.	O	PUNCT	O


The	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
alpha	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
amylase	I-GENE	NOUN	B
can	O	AUX	O
be	O	AUX	O
transactivated	O	VERB	B
by	O	ADP	O
the	O	DET	O
transcription	O	NOUN	B
factor	O	NOUN	I
GAMyb	B-GENE	NOUN	I
,	O	PUNCT	O
which	O	DET	O
is	O	AUX	O
itself	O	PRON	O
induced	O	VERB	B
by	O	ADP	O
GA	O	PROPN	B
.	O	PUNCT	O


Only	O	ADV	O
nine	O	NUM	O
patients	O	NOUN	B
were	O	AUX	O
offered	O	VERB	O
surgery	O	NOUN	B
(	O	PUNCT	O
six	O	NUM	O
were	O	AUX	O
resected	O	VERB	B
and	O	CCONJ	O
three	O	NUM	O
were	O	AUX	O
found	O	VERB	O
inoperable	O	ADJ	B
)	O	PUNCT	O
.	O	PUNCT	O


Adjuvant	O	NOUN	B
and	O	CCONJ	O
neoadjuvant	O	ADJ	B
treatment	O	NOUN	I
of	O	ADP	O
breast	O	NOUN	B
cancer	O	NOUN	I
.	O	PUNCT	O


Sequence	O	NOUN	B
analysis	O	NOUN	I
revealed	O	VERB	O
significant	O	ADJ	O
differences	O	NOUN	O
between	O	ADP	O
the	O	DET	O
5	O	NUM	O
'	O	PART	O
region	O	NOUN	B
of	O	ADP	O
the	O	DET	O
beta	O	NOUN	B
subunit	O	NOUN	I
gene	O	NOUN	I
and	O	CCONJ	O
the	O	DET	O
corresponding	O	ADJ	O
regions	O	NOUN	B
of	O	ADP	O
the	O	DET	O
homologous	B-GENE	ADJ	B
GlyR	I-GENE	NOUN	B
alpha	I-GENE	NOUN	I
subunit	I-GENE	NOUN	I
genes	I-GENE	NOUN	O
;	O	PUNCT	O
it	O	PRON	O
also	O	ADV	O
identified	O	VERB	O
a	O	DET	O
novel	O	ADJ	O
exon	O	NOUN	O
(	O	PUNCT	O
exon	O	NOUN	O
0	O	NUM	O
)	O	PUNCT	O
that	O	PRON	O
encodes	O	VERB	B
most	O	ADJ	O
of	O	ADP	O
the	O	DET	O
5	O	NUM	O
'	O	PART	O
-	O	PUNCT	O
untranslated	O	ADJ	B
portion	O	NOUN	B
of	O	ADP	O
the	O	DET	O
GlyR	B-GENE	NOUN	B
beta	I-GENE	NOUN	O
mRNA	I-GENE	NOUN	B
.	O	PUNCT	O


Anecdotal	O	ADJ	B
observations	O	NOUN	B
scattered	O	VERB	B
throughout	O	ADP	O
the	O	DET	O
literature	O	NOUN	B
have	O	AUX	O
often	O	ADV	O
provided	O	VERB	O
clues	O	NOUN	O
to	O	PART	O
underlying	O	VERB	O
variations	O	NOUN	B
in	O	ADP	O
humans	O	NOUN	B
'	O	PART	O
ability	O	NOUN	O
to	O	PART	O
handle	O	VERB	O
dietary	O	ADJ	B
chemicals	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
human	B-GENE	ADJ	B
cytomegalovirus	I-GENE	NOUN	I
(	I-GENE	PUNCT	O
HCMV	I-GENE	NOUN	B
)	I-GENE	PUNCT	O
major	I-GENE	ADJ	O
immediate	I-GENE	ADJ	B
-	I-GENE	PUNCT	O
early	I-GENE	ADJ	B
protein	I-GENE	NOUN	B
IE2	I-GENE	NOUN	B
is	O	AUX	O
a	O	DET	O
nuclear	O	ADJ	B
phosphoprotein	O	NOUN	I
that	O	PRON	O
is	O	AUX	O
believed	O	VERB	O
to	O	PART	O
be	O	AUX	O
a	O	DET	O
key	O	ADJ	O
regulator	O	NOUN	B
in	O	ADP	O
both	O	CCONJ	O
lytic	O	ADJ	B
and	O	CCONJ	O
latent	O	ADJ	O
infections	O	NOUN	O
.	O	PUNCT	O


OBJECTIVE	O	NOUN	B
:	O	PUNCT	O
To	O	PART	O
determine	O	VERB	O
whether	O	SCONJ	O
RSTD	O	NOUN	B
predicts	O	VERB	O
coronary	O	ADJ	B
anatomy	O	NOUN	B
during	O	ADP	O
acute	O	ADJ	B
coronary	O	ADJ	I
occlusion	O	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
now	O	ADV	O
tested	O	VERB	B
all	O	DET	O
known	O	VERB	O
mammalian	B-GENE	ADJ	B
Groucho	I-GENE	NOUN	B
family	I-GENE	NOUN	I
members	I-GENE	NOUN	I
for	O	ADP	O
their	O	PRON	O
ability	O	NOUN	O
to	O	PART	O
interact	O	VERB	B
specifically	O	ADV	O
with	O	ADP	O
individual	O	ADJ	O
Tcf	B-GENE	NOUN	B
/	O	PUNCT	O
Lef	B-GENE	NOUN	B
family	O	NOUN	B
members	O	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
show	O	VERB	O
here	O	ADV	O
that	O	SCONJ	O
the	O	DET	O
in	O	X	B
vitro	O	X	I
transcription	O	NOUN	B
extract	O	NOUN	I
contains	O	VERB	O
a	O	DET	O
binding	O	NOUN	B
activity	O	NOUN	I
that	O	PRON	O
is	O	AUX	O
specific	O	ADJ	O
for	O	ADP	O
the	O	DET	O
initiator	O	NOUN	B
element	O	NOUN	I
and	O	CCONJ	O
thus	O	ADV	O
may	O	AUX	O
participate	O	VERB	B
in	O	ADP	O
recruiting	O	VERB	O
RNA	B-GENE	NOUN	B
polymerase	I-GENE	NOUN	I
II	I-GENE	NUM	I
to	O	PART	O
the	O	DET	O
SL	O	NOUN	B
RNA	O	NOUN	I
gene	O	NOUN	I
promoter	O	NOUN	O
.	O	PUNCT	O


The	O	DET	O
438	B-GENE	NUM	O
bp	I-GENE	NOUN	O
EcoRI	I-GENE	NOUN	O
fragment	I-GENE	NOUN	O
,	O	PUNCT	O
which	O	DET	O
was	O	AUX	O
detected	O	VERB	B
by	O	ADP	O
Southern	O	NOUN	B
hybridization	O	NOUN	I
,	O	PUNCT	O
reveals	O	VERB	O
an	O	DET	O
open	O	ADJ	B
reading	O	NOUN	I
frame	O	NOUN	I
which	O	DET	O
encodes	O	VERB	B
a	O	DET	O
protein	O	NOUN	B
of	O	ADP	O
103	O	NUM	O
amino	O	NOUN	B
acids	O	NOUN	I
.	O	PUNCT	O


Furthermore	O	ADV	O
,	O	PUNCT	O
this	O	DET	O
kinase	O	NOUN	B
-	O	PUNCT	O
deficient	O	ADJ	B
mutant	O	NOUN	B
inhibited	O	VERB	B
2	O	NUM	O
-	O	PUNCT	O
MeSADP	O	NOUN	B
-	O	PUNCT	O
induced	O	VERB	B
caspase	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
3	I-GENE	NUM	O
stimulation	O	NOUN	B
and	O	CCONJ	O
the	O	DET	O
associated	O	VERB	O
decrease	O	NOUN	B
in	O	ADP	O
cell	O	NOUN	B
number	O	NOUN	I
.	O	PUNCT	O


A	O	DET	O
20	O	NUM	O
-	O	PUNCT	O
base	O	NOUN	B
pair	O	NOUN	I
oligonucleotide	O	NOUN	I
containing	O	VERB	O
this	O	DET	O
nonamer	O	NOUN	B
confers	O	VERB	O
up	O	ADP	B
-	O	PUNCT	O
regulation	O	NOUN	B
by	O	ADP	O
hypoxia	O	NOUN	B
and	O	CCONJ	O
inhibition	O	NOUN	B
by	O	ADP	O
unsaturated	O	ADJ	B
fatty	O	ADJ	I
acids	O	NOUN	I
when	O	SCONJ	O
placed	O	VERB	O
upstream	O	ADV	B
of	O	ADP	O
a	O	DET	O
heterologous	O	ADJ	B
promoter	O	NOUN	B
in	O	ADP	O
a	O	DET	O
lacZ	B-GENE	NOUN	B
reporter	I-GENE	NOUN	I
construct	I-GENE	NOUN	I
.	O	PUNCT	O


Deletion	O	NOUN	B
analyses	O	NOUN	I
implicate	O	VERB	O
the	O	DET	O
N	O	NOUN	B
-	O	PUNCT	O
terminal	O	ADJ	B
110	O	NUM	O
amino	O	NOUN	B
acids	O	NOUN	I
of	O	ADP	O
Grb14	B-GENE	NOUN	B
and	O	CCONJ	O
ankyrin	B-GENE	NOUN	B
repeats	O	NOUN	I
10	O	NUM	I
-	O	SYM	O
19	O	NUM	O
of	O	ADP	O
tankyrase	B-GENE	NOUN	B
2	I-GENE	NUM	I
in	O	ADP	O
mediating	O	VERB	O
this	O	DET	O
interaction	O	NOUN	B
.	O	PUNCT	O


Finally	O	ADV	O
a	O	DET	O
10	O	NUM	O
-	O	PUNCT	O
nucleotide	O	NOUN	B
region	O	NOUN	I
flanking	O	VERB	O
the	O	DET	O
exon	O	NOUN	B
4	O	NUM	I
protein	O	NOUN	I
-	O	PUNCT	O
binding	O	VERB	B
site	O	NOUN	I
is	O	AUX	O
homologous	O	ADJ	O
to	O	PART	O
instability	O	NOUN	B
elements	O	NOUN	B
within	O	ADP	O
five	O	NUM	O
other	O	ADJ	O
transcripts	O	NOUN	B
,	O	PUNCT	O
suggesting	O	VERB	O
that	O	SCONJ	O
a	O	DET	O
common	O	ADJ	O
coding	O	VERB	B
region	O	NOUN	I
determinant	O	NOUN	B
may	O	AUX	O
exist	O	VERB	O
.	O	PUNCT	O


Analysis	O	NOUN	B
of	O	ADP	O
regulatory	O	ADJ	B
regions	O	NOUN	I
in	O	ADP	O
the	O	DET	O
promoter	O	NOUN	B
of	O	ADP	O
the	O	DET	O
ctr4	B-GENE	NOUN	B
(	I-GENE	PUNCT	O
+	I-GENE	CCONJ	O
)	I-GENE	PUNCT	O
copper	I-GENE	NOUN	B
transporter	I-GENE	NOUN	I
gene	I-GENE	NOUN	I
in	O	ADP	O
fission	O	NOUN	B
yeast	O	NOUN	I
Schizosaccharomyces	O	X	I
pombe	O	X	I
reveals	O	VERB	O
the	O	DET	O
identity	O	NOUN	B
of	O	ADP	O
a	O	DET	O
conserved	O	VERB	O
copper	O	NOUN	B
-	O	PUNCT	O
signaling	O	NOUN	B
element	O	NOUN	I
(	O	PUNCT	O
CuSE	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
which	O	DET	O
is	O	AUX	O
recognized	O	VERB	O
by	O	ADP	O
the	O	DET	O
transcription	B-GENE	NOUN	B
factor	I-GENE	NOUN	I
Cuf1	I-GENE	NOUN	I
.	O	PUNCT	O


WRN	B-GENE	NOUN	B
helicase	I-GENE	NOUN	O
resolves	O	VERB	O
alternate	O	ADJ	O
DNA	O	NOUN	B
structures	O	NOUN	I
including	O	VERB	O
tetraplex	O	ADJ	B
and	O	CCONJ	O
triplex	O	ADJ	B
DNA	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
Holliday	O	NOUN	B
junctions	O	NOUN	I
.	O	PUNCT	O


These	O	DET	O
data	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
ADAM	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
TS12	I-GENE	PROPN	B
may	O	AUX	O
play	O	VERB	O
roles	O	NOUN	O
in	O	ADP	O
pulmonary	O	ADJ	B
cells	O	NOUN	I
during	O	ADP	O
fetal	O	ADJ	B
development	O	NOUN	I
or	O	CCONJ	O
in	O	ADP	O
tumor	O	NOUN	B
processes	O	NOUN	I
through	O	ADP	O
its	O	PRON	O
proteolytic	O	ADJ	B
activity	O	NOUN	I
or	O	CCONJ	O
as	O	ADP	O
a	O	DET	O
molecule	O	NOUN	B
potentially	O	ADV	O
involved	O	VERB	O
in	O	ADP	O
regulation	O	NOUN	B
of	O	ADP	O
cell	O	NOUN	B
adhesion	O	NOUN	I
.	O	PUNCT	O


Biol	O	NOUN	B
.	O	PUNCT	O


CONCLUSIONS	O	NOUN	O
:	O	PUNCT	O
Using	O	VERB	O
icodextrin	O	NOUN	B
-	O	PUNCT	O
based	O	VERB	B
instead	O	ADV	O
of	O	ADP	O
glucose	O	NOUN	B
-	O	PUNCT	O
based	O	VERB	B
PD	O	NOUN	B
fluids	O	NOUN	I
can	O	AUX	O
largely	O	ADV	O
reduce	O	VERB	B
the	O	DET	O
formation	O	NOUN	B
of	O	ADP	O
Amadori	O	NOUN	B
albumin	B-GENE	NOUN	I
and	O	CCONJ	O
AGEs	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
contrast	O	NOUN	O
,	O	PUNCT	O
exogenous	B-GENE	ADJ	B
PTHrP1	I-GENE	NUM	B
-	I-GENE	PUNCT	O
34	I-GENE	NUM	O
and	I-GENE	CCONJ	O
1	I-GENE	NUM	O
-	I-GENE	PUNCT	O
86	I-GENE	NUM	O
peptides	I-GENE	NOUN	B
did	O	AUX	O
not	O	PART	O
significantly	O	ADV	O
affect	O	VERB	O
IL	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
8	I-GENE	NUM	O
production	O	NOUN	B
;	O	PUNCT	O
moreover	O	ADV	O
,	O	PUNCT	O
PTHrP	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
neutralizing	I-GENE	VERB	B
antibodies	I-GENE	NOUN	I
did	O	AUX	O
not	O	PART	O
inhibit	O	VERB	B
the	O	DET	O
production	O	NOUN	B
of	O	ADP	O
IL	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
8	I-GENE	NUM	O
by	O	ADP	O
transfected	O	VERB	B
PTHrP	B-GENE	NOUN	B
.	O	PUNCT	O


Our	O	PRON	O
results	O	NOUN	O
suggest	O	VERB	O
that	O	SCONJ	O
WASP	B-GENE	NOUN	B
activates	O	VERB	B
transcription	O	NOUN	B
following	O	VERB	O
TCR	B-GENE	NOUN	B
stimulation	O	NOUN	B
in	O	ADP	O
a	O	DET	O
manner	O	NOUN	O
that	O	PRON	O
is	O	AUX	O
independent	O	ADJ	B
of	O	ADP	O
its	O	PRON	O
role	O	NOUN	O
in	O	ADP	O
Arp2	B-GENE	NOUN	B
/	I-GENE	SYM	O
3	I-GENE	NUM	B
-	O	PUNCT	O
directed	O	VERB	B
actin	B-GENE	NOUN	B
polymerization	O	NOUN	B
.	O	PUNCT	O


These	O	DET	O
data	O	NOUN	B
define	O	VERB	O
a	O	DET	O
conserved	O	VERB	B
pathway	O	NOUN	I
wherein	O	ADP	O
sequential	O	ADJ	B
histone	B-GENE	NOUN	B
modifications	O	NOUN	B
establish	O	VERB	O
a	O	DET	O
"	O	PUNCT	O
histone	B-GENE	NOUN	B
code	O	NOUN	I
"	O	PUNCT	O
essential	O	ADJ	B
for	O	ADP	O
the	O	DET	O
epigenetic	O	ADJ	B
inheritance	O	NOUN	I
of	O	ADP	O
heterochromatin	O	NOUN	B
assembly	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
Delta6CCI	O	NOUN	B
virus	O	NOUN	I
was	O	AUX	O
extremely	O	ADV	O
attenuated	O	VERB	B
in	O	ADP	O
replication	O	NOUN	B
capacity	O	NOUN	B
yet	O	ADV	O
retained	O	VERB	O
infectiousness	O	NOUN	B
for	O	ADP	O
CEMx174	O	NOUN	B
and	O	CCONJ	O
MT4	O	NOUN	B
cells	O	NOUN	I
.	O	PUNCT	O


PABP	B-GENE	NOUN	B
is	O	AUX	O
a	O	DET	O
modular	O	ADJ	B
protein	O	NOUN	I
,	O	PUNCT	O
with	O	ADP	O
four	O	NUM	O
N	O	NOUN	B
-	O	PUNCT	O
terminal	O	ADJ	B
RNA	O	NOUN	B
-	O	PUNCT	O
binding	O	VERB	B
domains	O	NOUN	O
and	O	CCONJ	O
an	O	DET	O
extensive	O	ADJ	B
C	O	NOUN	B
terminus	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
addition	O	NOUN	O
,	O	PUNCT	O
another	O	DET	O
derivative	O	NOUN	B
of	O	ADP	O
pCMVJS21	O	NOUN	O
(	O	PUNCT	O
pCMVJS21DeltaGP	O	NOUN	B
)	O	PUNCT	O
in	O	ADP	O
which	O	DET	O
the	O	DET	O
gag	B-GENE	NOUN	B
,	O	PUNCT	O
pol	B-GENE	NOUN	B
(	O	PUNCT	O
and	O	CCONJ	O
orf	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
x	I-GENE	NOUN	B
)	O	PUNCT	O
coding	O	NOUN	B
sequences	O	NOUN	I
were	O	AUX	O
deleted	O	VERB	B
also	O	ADV	O
gave	O	VERB	O
transformed	O	VERB	O
foci	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
contrast	O	NOUN	O
,	O	PUNCT	O
neither	O	CCONJ	O
I	O	PRON	O
.	O	PUNCT	O
argentina	O	X	B
nor	O	CCONJ	I
I	O	PRON	I
.	O	PUNCT	O
theezans	O	NOUN	B
exerted	O	VERB	O
any	O	DET	O
effect	O	NOUN	B
on	O	ADP	O
BF	O	NOUN	B
or	O	CCONJ	O
intestinal	O	ADJ	B
propulsion	O	NOUN	B
.	O	PUNCT	O


These	O	DET	O
data	O	NOUN	B
reveal	O	VERB	O
a	O	DET	O
complex	O	ADJ	B
network	O	NOUN	B
of	O	ADP	O
interactions	O	NOUN	B
between	O	ADP	O
GTPases	B-GENE	NOUN	B
in	O	ADP	O
the	O	DET	O
ARF	B-GENE	NOUN	B
family	I-GENE	NOUN	B
and	O	CCONJ	O
their	O	PRON	O
effectors	O	NOUN	B
and	O	CCONJ	O
reveal	O	VERB	O
a	O	DET	O
potential	O	NOUN	B
for	O	ADP	O
cross	O	NOUN	B
-	O	PUNCT	O
talk	O	NOUN	B
not	O	PART	O
demonstrated	O	VERB	O
previously	O	ADV	O
.	O	PUNCT	O


A	O	DET	O
mutation	O	NOUN	B
in	O	ADP	O
the	O	DET	O
C	O	NOUN	B
domain	O	NOUN	I
of	O	ADP	O
Rb	B-GENE	NOUN	B
,	O	PUNCT	O
L901Q	O	NOUN	B
,	O	PUNCT	O
has	O	AUX	O
been	O	AUX	O
identified	O	VERB	B
that	O	PRON	O
completely	O	ADV	O
abolishes	O	VERB	O
cdk4	B-GENE	NOUN	B
/	O	SYM	O
D1	B-GENE	NOUN	B
phosphorylation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
isolated	O	VERB	B
C	O	NOUN	O
domain	O	NOUN	O
.	O	PUNCT	O


We	O	PRON	O
previously	O	ADV	O
showed	O	VERB	O
that	O	SCONJ	O
this	O	DET	O
proteolysis	O	NOUN	B
1	O	NUM	O
)	O	PUNCT	O
can	O	AUX	O
be	O	AUX	O
acutely	O	ADV	O
promoted	O	VERB	B
by	O	ADP	O
the	O	DET	O
phorbol	O	NOUN	B
ester	O	NOUN	I
phorbol	O	NOUN	B
12	O	NUM	O
-	O	PUNCT	O
myristate	O	NOUN	B
13	O	NUM	I
-	O	PUNCT	O
acetate	O	NOUN	B
(	O	PUNCT	O
PMA	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
2	O	NUM	O
)	O	PUNCT	O
requires	O	VERB	O
a	O	DET	O
metalloprotease	B-GENE	NOUN	B
activity	O	NOUN	I
,	O	PUNCT	O
3	O	NUM	O
)	O	PUNCT	O
generates	O	VERB	O
both	O	DET	O
shed	O	VERB	O
GHBP	B-GENE	NOUN	B
and	O	CCONJ	O
a	O	DET	O
membrane	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
associated	I-GENE	VERB	B
GHR	I-GENE	NOUN	B
transmembrane	I-GENE	NOUN	B
/	I-GENE	PUNCT	O
cytoplasmic	I-GENE	ADJ	B
domain	I-GENE	NOUN	I
remnant	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
4	O	X	O
)	O	PUNCT	O
results	O	VERB	B
in	O	ADP	O
down	O	ADJ	B
-	O	PUNCT	O
regulation	O	NOUN	B
of	O	ADP	O
GHR	B-GENE	NOUN	B
abundance	O	NOUN	B
and	O	CCONJ	O
GH	B-GENE	NOUN	B
signaling	O	NOUN	I
.	O	PUNCT	O


These	O	DET	O
disorders	O	NOUN	B
include	O	VERB	O
low	O	ADJ	B
-	O	PUNCT	O
back	O	NOUN	B
pain	O	NOUN	I
,	O	PUNCT	O
saddle	O	ADJ	B
anesthesia	O	NOUN	I
,	O	PUNCT	O
bilateral	O	ADJ	B
sciatica	O	NOUN	I
,	O	PUNCT	O
then	O	ADV	O
motor	O	NOUN	B
weakness	O	NOUN	I
of	O	ADP	O
the	O	DET	O
lower	O	ADJ	B
extremities	O	NOUN	I
or	O	CCONJ	O
chronic	O	ADJ	B
paraplegia	O	NOUN	I
and	O	CCONJ	O
,	O	PUNCT	O
bladder	O	ADJ	B
dysfunction	O	NOUN	I
.	O	PUNCT	O


Sural	O	ADJ	B
nerve	O	NOUN	I
biopsy	O	NOUN	I
showed	O	VERB	O
mild	O	ADJ	B
thickening	O	NOUN	B
of	O	ADP	O
the	O	DET	O
perineurium	O	NOUN	B
,	O	PUNCT	O
vascular	O	ADJ	B
alterations	O	NOUN	B
with	O	ADP	O
inflammatory	O	ADJ	B
cell	O	NOUN	I
infiltration	O	NOUN	B
in	O	ADP	O
the	O	DET	O
perineurium	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
remarkable	O	ADJ	O
loss	O	NOUN	O
of	O	ADP	O
large	O	ADJ	O
and	O	CCONJ	O
small	O	ADJ	O
myelinated	O	ADJ	B
fibers	O	NOUN	I
.	O	PUNCT	O


When	O	SCONJ	O
this	O	DET	O
CCAAT	O	NOUN	B
box	O	NOUN	I
was	O	AUX	O
inserted	O	VERB	O
into	O	ADP	O
a	O	DET	O
heterologous	O	ADJ	B
promoter	O	NOUN	B
construct	O	NOUN	I
,	O	PUNCT	O
OA	O	NOUN	B
induction	O	NOUN	B
was	O	AUX	O
dependent	O	ADJ	B
on	O	ADP	O
an	O	DET	O
intact	O	ADJ	B
CCAAT	O	NOUN	B
box	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
JHRLSS	O	PROPN	B
has	O	AUX	O
been	O	AUX	O
used	O	VERB	O
in	O	ADP	O
prior	O	ADJ	O
studies	O	NOUN	B
to	O	PART	O
assess	O	VERB	O
RLS	O	PROPN	B
severity	O	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
has	O	AUX	O
not	O	PART	O
previously	O	ADV	O
been	O	AUX	O
validated	O	VERB	O
in	O	ADP	O
relation	O	NOUN	O
to	O	PART	O
direct	O	VERB	O
measures	O	NOUN	B
of	O	ADP	O
the	O	DET	O
morbidity	O	NOUN	B
associated	O	VERB	B
with	O	ADP	I
RLS	O	PROPN	B
.	O	PUNCT	O


Our	O	PRON	O
results	O	NOUN	O
suggest	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
C	O	PROPN	B
-	O	PUNCT	O
terminal	O	ADJ	B
region	O	NOUN	B
of	O	ADP	O
Crk	B-GENE	NOUN	B
contains	O	VERB	O
negative	O	ADJ	B
regulatory	O	ADJ	B
elements	O	NOUN	I
important	O	ADJ	O
for	O	ADP	O
both	O	CCONJ	O
Abl	B-GENE	NOUN	B
and	O	CCONJ	O
FAK	B-GENE	NOUN	B
dependent	O	ADJ	O
signal	O	NOUN	B
pathways	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
offers	O	VERB	O
a	O	DET	O
paradigm	O	NOUN	B
for	O	ADP	O
an	O	DET	O
autoinhibitory	O	ADJ	B
region	O	NOUN	I
in	O	ADP	O
the	O	DET	O
SH3	B-GENE	NOUN	B
linker	O	NOUN	I
/	O	SYM	O
C	O	NOUN	B
-	O	PUNCT	O
terminal	O	ADJ	B
SH3	B-GENE	NOUN	B
domain	O	NOUN	I
.	O	PUNCT	O


This	O	DET	O
unique	O	ADJ	B
location	O	NOUN	B
of	O	ADP	O
cavernous	O	ADJ	B
malformation	O	NOUN	I
is	O	AUX	O
associated	O	VERB	B
with	O	ADP	I
a	O	DET	O
risk	O	NOUN	B
of	O	ADP	O
permanent	O	ADJ	B
loss	O	NOUN	I
of	O	ADP	O
the	O	DET	O
vision	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
MSL	B-GENE	PROPN	B
complex	I-GENE	NOUN	I
is	O	AUX	O
specifically	O	ADV	O
localized	O	ADJ	B
on	O	ADP	O
the	O	DET	O
male	O	NOUN	B
X	O	NOUN	O
chromosome	O	NOUN	O
to	O	PART	O
increase	O	VERB	B
its	O	PRON	O
expression	O	NOUN	B
approximately	O	ADV	O
2	O	NUM	O
-	O	PUNCT	O
fold	O	NOUN	B
.	O	PUNCT	O


Consistent	O	ADJ	O
effects	O	NOUN	O
on	O	ADP	O
pVHL	B-GENE	NOUN	B
function	O	NOUN	O
were	O	AUX	O
observed	O	VERB	O
for	O	ADP	O
all	O	DET	O
mutations	O	NOUN	B
within	O	ADP	O
each	O	DET	O
subclass	O	NOUN	B
.	O	PUNCT	O


Here	O	ADV	O
,	O	PUNCT	O
we	O	PRON	O
identify	O	VERB	O
Rsc3	B-GENE	NOUN	B
and	O	CCONJ	O
Rsc30	B-GENE	NOUN	B
as	O	ADP	O
novel	O	ADJ	O
components	O	NOUN	B
of	O	ADP	O
the	O	DET	O
essential	O	ADJ	B
yeast	B-GENE	NOUN	B
remodeler	I-GENE	NOUN	O
RSC	I-GENE	NOUN	B
complex	I-GENE	NOUN	I
.	O	PUNCT	O


Early	O	ADJ	B
indicators	O	NOUN	I
of	O	ADP	O
the	O	DET	O
effect	O	NOUN	B
of	O	ADP	O
a	O	DET	O
breast	O	NOUN	B
cancer	O	NOUN	I
screening	O	NOUN	B
program	O	NOUN	I
for	O	ADP	O
low	O	ADJ	B
-	O	PUNCT	O
income	O	NOUN	B
women	O	NOUN	B
.	O	PUNCT	O


Linear	O	ADJ	B
eight	O	NUM	O
-	O	PUNCT	O
or	O	CCONJ	O
nine	O	NUM	B
-	O	PUNCT	O
residue	O	NOUN	B
D	O	NOUN	I
-	O	PUNCT	O
peptides	O	NOUN	B
derived	O	VERB	O
from	O	ADP	O
the	O	DET	O
pocket	O	NOUN	B
-	O	PUNCT	O
binding	O	VERB	B
domain	O	NOUN	B
of	O	ADP	O
the	O	DET	O
cyclic	O	ADJ	B
molecules	O	NOUN	I
also	O	ADV	O
bind	O	VERB	B
specifically	O	ADV	O
.	O	PUNCT	O


Here	O	ADV	O
we	O	PRON	O
present	O	VERB	O
evidence	O	NOUN	B
that	O	SCONJ	O
the	O	DET	O
distal	O	ADJ	B
half	O	NOUN	B
(	O	PUNCT	O
Stem	O	NOUN	B
2	O	NUM	I
)	O	PUNCT	O
of	O	ADP	O
the	O	DET	O
conserved	O	VERB	O
base	O	NOUN	B
-	O	PUNCT	O
paired	O	ADJ	B
stem	O	NOUN	O
structure	O	NOUN	O
found	O	VERB	O
in	O	ADP	O
all	O	DET	O
hY	B-GENE	NOUN	B
RNAs	I-GENE	NOUN	B
also	O	ADV	O
plays	O	VERB	O
a	O	DET	O
critical	O	ADJ	O
role	O	NOUN	O
in	O	ADP	O
the	O	DET	O
export	O	NOUN	B
process	O	NOUN	I
.	O	PUNCT	O


Here	O	ADV	O
we	O	PRON	O
provide	O	VERB	O
the	O	DET	O
first	O	ADJ	O
evidence	O	NOUN	B
for	O	ADP	O
the	O	DET	O
involvement	O	NOUN	B
of	O	ADP	O
GCN1	B-GENE	NOUN	B
-	O	PUNCT	O
GCN2	B-GENE	NOUN	B
interaction	O	NOUN	B
in	O	ADP	O
activation	O	NOUN	B
of	O	ADP	O
GCN2	B-GENE	NOUN	B
per	O	X	O
se	O	X	O
.	O	PUNCT	O


Expression	O	NOUN	B
of	O	ADP	O
human	B-GENE	ADJ	B
RACK1	I-GENE	NOUN	B
efficiently	O	ADV	O
relieves	O	VERB	O
E1A	B-GENE	NOUN	B
-	O	PUNCT	O
mediated	O	VERB	B
growth	O	NOUN	B
inhibition	O	NOUN	I
in	O	ADP	O
HF7c	O	NOUN	B
and	O	CCONJ	O
protects	O	VERB	B
human	O	ADJ	B
tumor	O	NOUN	O
cells	O	NOUN	O
from	O	ADP	O
E1A	B-GENE	NOUN	B
-	O	PUNCT	O
induced	O	VERB	B
apoptosis	O	NOUN	B
.	O	PUNCT	O


Molecular	O	ADJ	B
analysis	O	NOUN	I
of	O	ADP	O
the	O	DET	O
pRA2	O	NOUN	B
partitioning	O	NOUN	B
region	O	NOUN	I
:	O	PUNCT	O
ParB	B-GENE	NOUN	B
autoregulates	O	VERB	B
parAB	B-GENE	NOUN	B
transcription	O	NOUN	B
and	O	CCONJ	O
forms	O	VERB	O
a	O	DET	O
nucleoprotein	O	NOUN	B
complex	O	NOUN	I
with	O	ADP	O
the	O	DET	O
plasmid	O	NOUN	B
partition	O	NOUN	B
site	O	NOUN	I
,	O	PUNCT	O
parS	B-GENE	NOUN	B
.	O	PUNCT	O


SERS	O	NOUN	B
spectra	O	NOUN	B
were	O	AUX	O
obtained	O	VERB	O
by	O	ADP	O
vacuum	O	NOUN	B
evaporation	O	NOUN	I
and	O	CCONJ	O
casting	O	NOUN	B
of	O	ADP	O
p	O	NOUN	B
-	O	PUNCT	O
NTP	O	PROPN	B
onto	O	ADP	O
silver	O	ADJ	B
island	O	NOUN	I
films	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
also	O	ADV	O
from	O	ADP	O
colloidal	O	ADJ	B
silver	O	NOUN	B
solutions	O	NOUN	I
.	O	PUNCT	O


Copyright	O	NOUN	O
2001	O	NUM	O
Academic	O	PROPN	B
Press	O	PROPN	I
.	O	PUNCT	O


These	O	DET	O
corrections	O	NOUN	B
do	O	AUX	O
not	O	PART	O
involve	O	VERB	O
sequences	O	NOUN	B
predicted	O	VERB	O
to	O	PART	O
function	O	VERB	B
as	O	ADP	O
transcription	O	NOUN	B
factor	O	NOUN	I
binding	O	NOUN	I
sites	O	NOUN	I
.	O	PUNCT	O


A	O	DET	O
patient	O	NOUN	B
is	O	AUX	O
described	O	VERB	O
with	O	ADP	O
skin	O	NOUN	B
lesions	O	NOUN	I
resembling	O	VERB	O
Kaposi	O	NOUN	B
'	O	PART	I
s	O	NOUN	I
sarcoma	O	NOUN	I
(	O	PUNCT	O
KS	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


The	O	DET	O
images	O	NOUN	B
showed	O	VERB	O
rapid	O	ADJ	O
,	O	PUNCT	O
predominantly	O	ADV	O
urinary	O	ADJ	B
excretion	O	NOUN	B
of	O	ADP	O
99mTc	O	ADJ	O
ciprofloxacin	O	NOUN	B
,	O	PUNCT	O
with	O	ADP	O
low	O	ADJ	O
to	O	PART	O
absent	O	ADJ	B
brain	O	NOUN	B
,	O	PUNCT	O
lung	O	NOUN	B
and	O	CCONJ	O
bone	O	NOUN	B
marrow	O	NOUN	I
uptake	O	NOUN	B
and	O	CCONJ	O
low	O	ADJ	B
liver	O	NOUN	B
uptake	O	NOUN	O
and	O	CCONJ	O
excretion	O	NOUN	B
.	O	PUNCT	O


To	O	ADP	O
this	O	DET	O
end	O	NOUN	O
,	O	PUNCT	O
an	O	DET	O
expression	O	NOUN	B
cassette	O	NOUN	I
consisting	O	VERB	O
of	O	ADP	O
the	O	DET	O
gene	O	NOUN	B
for	O	ADP	O
a	O	DET	O
green	B-GENE	ADJ	B
fluorescent	I-GENE	ADJ	I
protein	I-GENE	NOUN	I
(	O	PUNCT	O
GFP	B-GENE	NOUN	B
)	O	PUNCT	O
flanked	O	VERB	B
at	O	ADP	O
its	O	PRON	O
3	O	NUM	O
'	O	PART	O
end	O	NOUN	O
by	O	ADP	O
EAV	O	PROPN	B
-	O	PUNCT	O
specific	O	ADJ	B
transcription	O	NOUN	B
-	O	PUNCT	O
regulating	O	VERB	B
sequences	O	NOUN	I
was	O	AUX	O
constructed	O	VERB	O
.	O	PUNCT	O


In	O	ADP	O
addition	O	NOUN	O
,	O	PUNCT	O
severe	O	ADJ	B
vision	O	NOUN	B
loss	O	NOUN	I
can	O	AUX	O
be	O	AUX	O
seen	O	VERB	O
with	O	ADP	O
interferon	B-GENE	NOUN	B
alfa	I-GENE	X	I
-	I-GENE	PUNCT	O
2b	I-GENE	NOUN	B
-	O	PUNCT	O
associated	O	VERB	B
retinopathy	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
mechanism	O	NOUN	B
of	O	ADP	O
the	O	DET	O
induction	O	NOUN	B
of	O	ADP	O
3beta	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
HSD	I-GENE	NOUN	B
type	I-GENE	NOUN	O
1	I-GENE	NUM	O
gene	I-GENE	NOUN	B
expression	O	NOUN	I
was	O	AUX	O
further	O	ADV	O
characterized	O	VERB	B
in	O	ADP	O
ZR	O	PROPN	B
-	O	PUNCT	O
75	O	NUM	O
-	O	PUNCT	O
1	O	NUM	O
human	O	ADJ	B
breast	O	NOUN	O
cancer	O	NOUN	O
cells	O	NOUN	O
.	O	PUNCT	O


The	O	DET	O
application	O	NOUN	B
of	O	ADP	O
the	O	DET	O
biotechnology	O	NOUN	B
at	O	ADP	O
the	O	DET	O
plants	O	NOUN	B
for	O	ADP	O
treatment	O	NOUN	B
of	O	ADP	O
the	O	DET	O
surface	O	NOUN	B
storm	O	NOUN	O
waters	O	NOUN	O
from	O	ADP	O
the	O	DET	O
industrial	O	ADJ	B
zone	O	NOUN	B
Telychka	O	PROPN	B
of	O	ADP	O
the	O	DET	O
city	O	NOUN	B
of	O	ADP	O
Kyiv	O	PROPN	B
has	O	AUX	O
allowed	O	VERB	O
the	O	DET	O
content	O	NOUN	B
of	O	ADP	O
petroleum	O	NOUN	B
in	O	ADP	O
water	O	NOUN	B
dropped	O	VERB	O
to	O	ADP	O
the	O	DET	O
Dnieper	O	PROPN	B
to	O	PART	O
be	O	AUX	O
constantly	O	ADV	O
reduced	O	VERB	B
50	O	NUM	O
-	O	SYM	O
100	O	NUM	O
times	O	NOUN	O
.	O	PUNCT	O


Fans	O	NOUN	B
in	O	ADP	O
tunnels	O	NOUN	B
and	O	CCONJ	O
open	O	ADJ	B
windows	O	NOUN	I
at	O	ADP	O
aboveground	O	ADJ	B
locations	O	NOUN	B
appeared	O	VERB	O
to	O	PART	O
greatly	O	ADV	O
reduce	O	VERB	B
the	O	DET	O
likelihood	O	NOUN	B
of	O	ADP	O
high	O	ADJ	B
PH3	O	NOUN	B
concentrations	O	NOUN	B
in	O	ADP	O
enclosed	O	VERB	O
areas	O	NOUN	O
.	O	PUNCT	O


The	O	DET	O
first	O	ADJ	O
case	O	NOUN	B
of	O	ADP	O
HCV	O	NOUN	B
seroconversion	O	NOUN	B
in	O	ADP	O
Portugal	O	PROPN	B
after	O	ADP	O
the	O	DET	O
introduction	O	NOUN	B
of	O	ADP	O
HCV	O	NOUN	B
NAT	O	NOUN	B
screening	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
observed	O	VERB	O
triplexes	O	NOUN	B
depend	O	VERB	O
on	O	ADP	O
the	O	DET	O
length	O	NOUN	B
of	O	ADP	O
the	O	DET	O
repeat	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
used	O	VERB	O
stored	O	VERB	B
plasma	O	NOUN	B
samples	O	NOUN	O
from	O	ADP	O
409	O	NUM	O
patients	O	NOUN	B
in	O	ADP	O
the	O	DET	O
National	O	PROPN	B
Institute	O	PROPN	I
of	O	ADP	I
Neurological	O	PROPN	I
Diseases	O	PROPN	I
and	O	CCONJ	O
Stroke	O	PROPN	B
(	O	PUNCT	O
NINDS	O	NOUN	B
)	O	PUNCT	O
tissue	B-GENE	NOUN	B
plasminogen	I-GENE	NOUN	O
activator	I-GENE	NOUN	O
(	O	PUNCT	O
t	B-GENE	NOUN	O
-	I-GENE	PUNCT	O
PA	I-GENE	PROPN	B
)	O	PUNCT	O
Stroke	O	PROPN	B
Trial	O	PROPN	I
to	O	PART	O
examine	O	VERB	O
the	O	DET	O
relationship	O	NOUN	B
between	O	ADP	O
an	O	DET	O
apolipoprotein	B-GENE	NOUN	B
(	I-GENE	PUNCT	I
Apo	I-GENE	NOUN	B
)	I-GENE	PUNCT	O
E2	I-GENE	NOUN	B
or	O	CCONJ	O
an	O	DET	O
Apo	B-GENE	NOUN	B
E4	I-GENE	NOUN	I
phenotype	O	NOUN	B
and	O	CCONJ	O
a	O	DET	O
favorable	O	ADJ	O
outcome	O	NOUN	B
3	O	NUM	O
months	O	NOUN	B
after	O	ADP	O
stroke	O	NOUN	B
,	O	PUNCT	O
the	O	DET	O
risk	O	NOUN	B
of	O	ADP	O
intracerebral	O	ADJ	B
hemorrhage	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
the	O	DET	O
response	O	NOUN	B
to	O	PART	O
intravenous	O	ADJ	B
t	B-GENE	NOUN	O
-	I-GENE	PUNCT	O
PA	I-GENE	NOUN	B
therapy	O	NOUN	I
.	O	PUNCT	O


Colorectal	O	NOUN	B
cancer	O	NOUN	I
was	O	AUX	O
shown	O	VERB	O
to	O	PART	O
disproportionately	O	ADV	O
overburden	O	ADJ	B
Ashkenazi	O	PROPN	B
Jews	O	PROPN	B
,	O	PUNCT	O
who	O	PRON	O
may	O	AUX	O
also	O	ADV	O
be	O	AUX	O
at	O	ADP	O
increased	O	VERB	B
risk	O	NOUN	B
for	O	ADP	O
ovarian	O	ADJ	B
,	O	PUNCT	O
pancreatic	O	ADJ	B
and	O	CCONJ	O
stomach	O	NOUN	B
cancer	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
non	O	NOUN	B
-	O	PUNCT	O
Hodgkin	O	NOUN	B
'	O	PART	O
s	O	NOUN	O
lymphoma	O	NOUN	B
.	O	PUNCT	O


RANTES	B-GENE	NOUN	B
(	O	PUNCT	O
regulated	B-GENE	VERB	O
upon	I-GENE	SCONJ	O
activation	I-GENE	NOUN	B
,	I-GENE	PUNCT	O
normally	I-GENE	ADV	O
T	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
cell	I-GENE	NOUN	B
expressed	I-GENE	VERB	B
and	I-GENE	CCONJ	O
presumably	I-GENE	ADV	O
secreted	I-GENE	VERB	B
)	O	PUNCT	O
is	O	AUX	O
a	O	DET	O
CC	O	NOUN	B
chemokine	O	NOUN	I
which	O	DET	O
recruits	O	VERB	O
and	O	CCONJ	O
activates	O	VERB	B
monocytes	O	NOUN	B
,	O	PUNCT	O
lymphocytes	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
eosinophils	O	NOUN	B
,	O	PUNCT	O
all	O	DET	O
cell	O	NOUN	B
types	O	NOUN	I
present	O	ADJ	O
in	O	ADP	O
the	O	DET	O
lung	O	NOUN	B
inflammatory	O	ADJ	I
infiltrate	O	NOUN	I
induced	O	VERB	B
by	O	ADP	O
RSV	O	NOUN	B
infection	O	NOUN	B
.	O	PUNCT	O


Five	O	NUM	O
modalities	O	NOUN	B
of	O	ADP	O
nonpharmacologic	O	ADJ	B
approaches	O	NOUN	I
are	O	AUX	O
recommended	O	VERB	B
at	O	ADP	O
present	O	ADJ	O
for	O	ADP	O
lifestyle	O	NOUN	B
modification	O	NOUN	B
and	O	CCONJ	O
control	O	NOUN	B
of	O	ADP	O
arterial	O	ADJ	B
blood	O	NOUN	I
pressure	O	NOUN	I
elevation	O	NOUN	I
:	O	PUNCT	O
1	O	X	O
)	O	PUNCT	O
weight	O	NOUN	B
reduction	O	NOUN	I
to	O	PART	O
ideal	O	ADJ	B
body	O	NOUN	B
weight	O	NOUN	I
,	O	PUNCT	O
since	O	SCONJ	O
it	O	PRON	O
reduces	O	VERB	O
risk	O	NOUN	B
of	O	ADP	O
hypertension	O	NOUN	B
as	O	ADV	O
well	O	ADV	O
as	O	ADP	O
overall	O	ADJ	O
cardiovascular	O	ADJ	B
morbidity	O	NOUN	B
and	O	CCONJ	O
mortality	O	NOUN	B
;	O	PUNCT	O
2	O	X	O
)	O	PUNCT	O
dietary	O	ADJ	B
sodium	O	NOUN	I
restriction	O	NOUN	I
to	O	ADP	O
less	O	ADJ	O
than	O	ADP	O
2	O	NUM	O
g	O	NOUN	O
a	O	DET	O
day	O	NOUN	B
,	O	PUNCT	O
without	O	ADP	O
assurance	O	NOUN	B
that	O	SCONJ	O
it	O	PRON	O
will	O	AUX	O
normalize	O	VERB	O
arterial	O	ADJ	B
pressure	O	NOUN	I
although	O	SCONJ	O
it	O	PRON	O
may	O	AUX	O
help	O	VERB	O
reduce	O	VERB	B
dosage	O	NOUN	B
and	O	CCONJ	O
numbers	O	NOUN	B
of	O	ADP	O
prescribed	O	VERB	B
antihypertensive	O	ADJ	B
drugs	O	NOUN	I
;	O	PUNCT	O
3	O	X	O
)	O	PUNCT	O
moderation	O	NOUN	B
of	O	ADP	O
alcohol	O	NOUN	B
consumption	O	NOUN	I
to	O	ADP	O
less	O	ADJ	O
than	O	ADP	O
1	O	NUM	O
ounce	O	NOUN	B
a	O	DET	O
day	O	NOUN	B
;	O	PUNCT	O
4	O	X	O
)	O	PUNCT	O
a	O	DET	O
regular	O	ADJ	O
isotonic	O	ADJ	B
exercise	O	NOUN	I
program	O	NOUN	I
;	O	PUNCT	O
and	O	CCONJ	O
5	O	X	O
)	O	PUNCT	O
cessation	O	NOUN	B
of	O	ADP	O
tobacco	O	NOUN	B
consumption	O	NOUN	I
.	O	PUNCT	O


Ga	O	PROPN	B
-	O	PUNCT	O
67	O	NUM	O
and	O	CCONJ	O
Tl	O	NOUN	B
-	O	PUNCT	O
201	O	NUM	O
scintigraphy	O	NOUN	B
in	O	ADP	O
extramedullary	O	ADJ	B
plasmacytoma	O	NOUN	I
:	O	PUNCT	O
a	O	DET	O
case	O	NOUN	B
report	O	NOUN	I
.	O	PUNCT	O


Arterial	O	ADJ	B
blood	O	NOUN	I
gas	O	NOUN	I
tensions	O	NOUN	B
were	O	AUX	O
similar	O	ADJ	O
across	O	ADP	O
all	O	DET	O
ventilation	O	NOUN	B
modes	O	NOUN	I
.	O	PUNCT	O


As	O	ADP	O
expected	O	VERB	O
,	O	PUNCT	O
homologous	B-GENE	ADJ	B
loxP	I-GENE	NOUN	B
sequences	I-GENE	NOUN	I
efficiently	O	ADV	B
underwent	O	VERB	O
Cre	B-GENE	PROPN	B
-	O	PUNCT	O
mediated	O	VERB	B
recombination	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
Van	O	PROPN	O
der	O	NOUN	O
Hoeve	O	PROPN	O
'	O	PART	O
s	O	NOUN	O
syndrome	O	NOUN	B
lesions	O	NOUN	B
as	O	ADP	O
poorly	O	ADV	O
mineralized	O	VERB	B
,	O	PUNCT	O
with	O	ADP	O
low	O	ADJ	B
calcium	O	NOUN	B
salt	O	NOUN	I
and	O	CCONJ	O
apparent	O	ADJ	B
increase	O	NOUN	B
of	O	ADP	O
phosphates	O	NOUN	B
.	O	PUNCT	O


A	O	DET	O
5	O	NUM	O
-	O	PUNCT	O
month	O	NOUN	B
-	O	PUNCT	O
old	O	ADJ	B
infant	O	NOUN	B
with	O	ADP	O
persistent	O	ADJ	B
congenital	O	ADJ	B
stridor	O	NOUN	I
and	O	CCONJ	O
acute	O	ADJ	B
respiratory	O	ADJ	I
distress	O	NOUN	I
is	O	AUX	O
presented	O	VERB	O
.	O	PUNCT	O


PURPOSE	O	NOUN	B
:	O	PUNCT	O
The	O	DET	O
objective	O	NOUN	B
of	O	ADP	O
this	O	DET	O
study	O	NOUN	B
was	O	AUX	O
to	O	PART	O
assess	O	VERB	O
first	O	ADJ	O
embryo	O	NOUN	B
cleavage	O	NOUN	B
(	O	PUNCT	O
FEC	O	NOUN	B
)	O	PUNCT	O
25	O	NUM	O
-	O	SYM	O
27	O	NUM	O
h	O	NOUN	O
after	O	ADP	O
intracytoplasmic	O	ADJ	B
sperm	O	NOUN	I
injection	O	NOUN	I
(	O	PUNCT	O
ICSI	O	NOUN	B
)	O	PUNCT	O
as	O	ADP	O
a	O	DET	O
parameter	O	NOUN	B
for	O	ADP	O
the	O	DET	O
embryo	O	NOUN	B
selection	O	NOUN	B
process	O	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
35	O	NUM	O
of	O	ADP	O
those	O	DET	O
patients	O	NOUN	B
DD	O	NOUN	B
was	O	AUX	O
measured	O	VERB	B
also	O	ADV	O
with	O	ADP	O
microlatex	O	NOUN	B
tests	O	NOUN	I
-	O	PUNCT	O
-	O	PUNCT	O
Tinaquant	O	PROPN	B
and	O	CCONJ	O
BC	O	PROPN	B
d	O	X	O
-	O	PUNCT	O
dimer	O	NOUN	B
.	O	PUNCT	O


Cytosolic	B-GENE	ADJ	B
acetyl	I-GENE	ADJ	I
-	I-GENE	PUNCT	O
CoA	I-GENE	NOUN	B
synthetase	I-GENE	NOUN	O
(	O	PUNCT	O
AceCS1	B-GENE	NOUN	B
)	O	PUNCT	O
activates	O	VERB	B
acetate	O	NOUN	B
to	O	PART	O
supply	O	VERB	O
the	O	DET	O
cells	O	NOUN	B
with	O	ADP	O
acetyl	O	ADJ	B
-	O	PUNCT	O
CoA	O	NOUN	B
for	O	ADP	O
lipid	O	NOUN	B
synthesis	O	NOUN	I
.	O	PUNCT	O


Tolerance	O	NOUN	B
in	O	ADP	O
renal	O	ADJ	B
transplantation	O	NOUN	I
after	O	ADP	O
allogeneic	O	ADJ	B
bone	O	NOUN	I
marrow	O	NOUN	I
transplantation	O	NOUN	I
-	O	PUNCT	O
6	O	NUM	O
-	O	PUNCT	O
year	O	NOUN	B
follow	O	NOUN	B
-	O	PUNCT	O
up	O	NOUN	B
.	O	PUNCT	O


Foreigners	O	NOUN	B
return	O	VERB	B
.	O	PUNCT	O


The	O	DET	O
present	O	ADJ	O
chemotherapy	O	NOUN	B
of	O	ADP	O
AE	O	NOUN	B
is	O	AUX	O
based	O	VERB	O
on	O	ADP	O
the	O	DET	O
administration	O	NOUN	B
of	O	ADP	O
benzimidazole	O	ADJ	B
carbamate	O	NOUN	I
derivatives	O	NOUN	I
,	O	PUNCT	O
such	O	ADJ	O
as	O	ADP	O
mebendazole	O	NOUN	B
and	O	CCONJ	O
albendazole	O	NOUN	B
.	O	PUNCT	O


Topological	O	ADJ	B
and	O	CCONJ	O
mutational	O	ADJ	B
analysis	O	NOUN	I
of	O	ADP	O
Saccharomyces	B-GENE	X	B
cerevisiae	I-GENE	X	I
Ste14p	I-GENE	PROPN	B
,	O	PUNCT	O
founding	O	VERB	O
member	O	NOUN	O
of	O	ADP	O
the	O	DET	O
isoprenylcysteine	B-GENE	NOUN	B
carboxyl	I-GENE	NOUN	I
methyltransferase	I-GENE	NOUN	I
family	I-GENE	NOUN	B
.	O	PUNCT	O


Hormonal	O	ADJ	B
regulation	O	NOUN	I
of	O	ADP	O
multiple	O	ADJ	B
promoters	O	NOUN	I
of	O	ADP	O
the	O	DET	O
rat	B-GENE	NOUN	B
mitochondrial	I-GENE	ADJ	B
glycerol	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
3	I-GENE	NUM	B
-	I-GENE	PUNCT	O
phosphate	I-GENE	NOUN	B
dehydrogenase	I-GENE	NOUN	I
gene	I-GENE	NOUN	I
:	O	PUNCT	O
identification	O	NOUN	B
of	O	ADP	O
a	O	DET	O
complex	O	ADJ	B
hormone	O	NOUN	B
-	O	PUNCT	O
response	O	NOUN	B
element	O	NOUN	B
in	O	ADP	O
the	O	DET	O
ubiquitous	O	ADJ	O
promoter	O	NOUN	B
B	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
telomerase	B-GENE	NOUN	B
RNA	I-GENE	NOUN	I
-	I-GENE	PUNCT	O
protein	I-GENE	NOUN	B
complex	I-GENE	NOUN	I
responsible	O	ADJ	O
for	O	ADP	O
maintenance	O	NOUN	B
of	O	ADP	O
telomeric	O	ADJ	B
DNA	O	NOUN	I
at	O	ADP	O
chromosome	O	NOUN	B
ends	O	NOUN	I
,	O	PUNCT	O
is	O	AUX	O
usually	O	ADV	O
inactive	O	ADJ	B
in	O	ADP	O
most	O	ADJ	O
primary	O	ADJ	O
somatic	O	ADJ	B
human	O	ADJ	O
cells	O	NOUN	O
,	O	PUNCT	O
but	O	CCONJ	O
is	O	AUX	O
specifically	O	ADV	O
activated	O	VERB	B
with	O	ADP	O
in	O	X	B
vitro	O	X	I
immortalization	O	NOUN	B
and	O	CCONJ	O
during	O	ADP	O
tumorigenesis	O	NOUN	B
.	O	PUNCT	O


Our	O	PRON	O
results	O	NOUN	B
show	O	VERB	O
that	O	SCONJ	O
CVN	B-GENE	PROPN	B
specifically	O	ADV	O
recognizes	O	VERB	O
with	O	ADP	O
nanomolar	O	ADJ	B
affinity	O	NOUN	O
Man	O	NOUN	O
(	O	PUNCT	O
9	O	NUM	O
)	O	PUNCT	O
GlcNAc	O	NOUN	B
(	O	PUNCT	O
2	O	NUM	O
)	O	PUNCT	O
and	O	CCONJ	O
the	O	DET	O
D1D3	O	NOUN	B
isomer	O	NOUN	B
of	O	ADP	O
Man	O	PROPN	O
(	O	PUNCT	O
8	O	NUM	O
)	O	PUNCT	O
GlcNAc	O	NOUN	B
(	O	PUNCT	O
2	O	NUM	O
)	O	PUNCT	O
.	O	PUNCT	O


Zhu	O	PROPN	O
,	O	PUNCT	O
V	O	PROPN	B
.	O	PUNCT	O


The	O	DET	O
novel	O	ADJ	O
approach	O	NOUN	O
to	O	PART	O
insulin	B-GENE	NOUN	B
administration	O	NOUN	B
known	O	VERB	O
as	O	ADP	O
chronic	O	ADJ	B
intermittent	O	ADJ	I
intravenous	O	ADJ	I
insulin	B-GENE	NOUN	I
therapy	O	NOUN	I
(	O	PUNCT	O
CIIIT	O	NOUN	B
)	O	PUNCT	O
delivers	O	VERB	O
insulin	B-GENE	NOUN	B
in	O	ADP	O
a	O	DET	O
pulsatile	O	ADJ	B
fashion	O	NOUN	I
and	O	CCONJ	O
achieves	O	VERB	O
physiological	O	ADJ	B
insulin	B-GENE	NOUN	B
concentration	O	NOUN	B
in	O	ADP	O
the	O	DET	O
portal	O	ADJ	B
vein	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
activity	O	NOUN	B
of	O	ADP	O
Rac1	B-GENE	NOUN	B
leads	O	VERB	O
to	O	PART	O
STAT3	B-GENE	NOUN	B
translocation	O	NOUN	B
to	O	PART	O
the	O	DET	O
nucleus	O	NOUN	B
coincident	O	ADJ	B
with	O	ADP	O
STAT3	B-GENE	NOUN	B
-	O	PUNCT	O
dependent	O	ADJ	B
gene	O	NOUN	B
expression	O	NOUN	I
.	O	PUNCT	O


Mss4	B-GENE	NOUN	B
also	O	ADV	O
acts	O	VERB	O
as	O	ADP	O
a	O	DET	O
relatively	O	ADV	O
inefficient	O	ADJ	O
guanine	B-GENE	NOUN	B
nucleotide	I-GENE	NOUN	I
exchange	I-GENE	NOUN	I
factor	I-GENE	NOUN	I
(	O	PUNCT	O
GEF	B-GENE	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


She	O	PRON	O
has	O	AUX	O
since	O	SCONJ	O
developed	O	VERB	O
a	O	DET	O
positive	O	ADJ	B
anti	B-GENE	ADJ	B
-	I-GENE	PUNCT	O
cardiolipin	I-GENE	NOUN	B
antibody	I-GENE	NOUN	B
but	O	CCONJ	O
does	O	AUX	O
not	O	PART	O
meet	O	VERB	O
diagnostic	O	ADJ	B
criteria	O	NOUN	I
for	O	ADP	O
systemic	O	ADJ	B
lupus	O	NOUN	I
erythematosis	O	NOUN	I
.	O	PUNCT	O
CONCLUSION	O	NOUN	O
:	O	PUNCT	O
The	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
known	O	VERB	O
autoimmune	O	ADJ	B
disease	O	NOUN	I
in	O	ADP	O
a	O	DET	O
woman	O	NOUN	B
with	O	ADP	O
POF	O	NOUN	B
should	O	AUX	O
not	O	PART	O
dissuade	O	VERB	O
the	O	DET	O
clinician	O	NOUN	B
from	O	ADP	O
evaluating	O	VERB	B
for	O	ADP	O
a	O	DET	O
potential	O	ADJ	B
genetic	O	ADJ	B
cause	O	NOUN	O
.	O	PUNCT	O


Effects	O	NOUN	B
of	O	ADP	I
aerosol	O	NOUN	B
-	O	PUNCT	O
vapor	O	ADJ	B
JP	O	PROPN	B
-	O	PUNCT	O
8	O	NUM	O
jet	O	NOUN	B
fuel	O	NOUN	I
on	O	ADP	O
the	O	DET	O
functional	O	ADJ	B
observational	O	ADJ	I
battery	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
learning	O	NOUN	B
and	O	CCONJ	O
memory	O	NOUN	B
in	O	ADP	O
the	O	DET	O
rat	O	NOUN	B
.	O	PUNCT	O


CONCLUSION	O	NOUN	O
:	O	PUNCT	O
There	O	PRON	O
are	O	AUX	O
no	O	DET	O
differences	O	NOUN	O
in	O	ADP	O
the	O	DET	O
measurement	O	NOUN	B
data	O	NOUN	B
derived	O	VERB	O
from	O	ADP	O
this	O	DET	O
method	O	NOUN	B
and	O	CCONJ	O
actual	O	ADJ	B
measurement	O	NOUN	B
data	O	NOUN	B
from	O	ADP	O
an	O	DET	O
object	O	NOUN	B
created	O	VERB	O
by	O	ADP	O
the	O	DET	O
computer	O	NOUN	B
-	O	PUNCT	O
aided	O	VERB	B
dental	O	NOUN	B
design	O	NOUN	I
program	O	NOUN	I
.	O	PUNCT	O


Many	O	ADJ	O
factors	O	NOUN	B
do	O	AUX	O
influence	O	VERB	B
the	O	DET	O
educational	O	ADJ	B
outcome	O	NOUN	I
in	O	ADP	O
students	O	NOUN	B
and	O	CCONJ	O
large	O	ADJ	O
statistical	O	ADJ	B
power	O	NOUN	I
(	O	PUNCT	O
such	O	ADJ	O
as	O	ADP	O
meta	O	ADJ	B
analysis	O	NOUN	I
)	O	PUNCT	O
should	O	AUX	O
be	O	AUX	O
helpful	O	ADJ	O
to	O	PART	O
eliminate	O	VERB	O
many	O	ADJ	O
sources	O	NOUN	B
of	O	ADP	I
error	O	NOUN	B
.	O	PUNCT	O


Our	O	PRON	O
results	O	NOUN	B
demonstrated	O	VERB	O
that	O	SCONJ	O
50	O	NUM	O
%	O	NOUN	O
of	O	ADP	O
the	O	DET	O
hepatic	O	ADJ	B
artery	O	NOUN	I
-	O	PUNCT	O
alone	O	ADJ	B
ALT	O	NOUN	B
graft	O	NOUN	I
showed	O	VERB	O
almost	O	ADV	O
normal	O	ADJ	O
structure	O	NOUN	O
histologically	O	ADV	B
at	O	ADP	O
1	O	NUM	O
month	O	NOUN	B
after	O	ADP	O
grafting	O	NOUN	B
,	O	PUNCT	O
with	O	ADP	O
bile	O	NOUN	B
secretion	O	NOUN	I
preserved	O	VERB	O
.	O	PUNCT	O


The	O	DET	O
human	B-GENE	ADJ	B
ABCG1	I-GENE	NOUN	O
gene	I-GENE	NOUN	O
encodes	O	VERB	B
a	O	DET	O
member	O	NOUN	B
of	O	ADP	O
the	O	DET	O
ATP	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
binding	I-GENE	VERB	B
cassette	I-GENE	NOUN	I
(	O	PUNCT	O
ABC	B-GENE	NOUN	B
)	O	PUNCT	O
superfamily	O	NOUN	O
of	O	ADP	O
transporter	B-GENE	NOUN	B
proteins	I-GENE	NOUN	I
and	O	CCONJ	O
is	O	AUX	O
highly	O	ADV	O
induced	O	VERB	B
when	O	SCONJ	O
macrophages	O	NOUN	B
are	O	AUX	O
incubated	O	VERB	B
with	O	ADP	O
oxysterols	O	NOUN	B
.	O	PUNCT	O


C	B-GENE	NOUN	B
/	I-GENE	SYM	O
EBPbeta	I-GENE	NOUN	B
LIP	I-GENE	NOUN	B
overexpressing	O	VERB	B
HC11	O	NOUN	B
cells	O	NOUN	I
did	O	AUX	O
not	O	PART	O
express	O	VERB	O
beta	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
casein	I-GENE	NOUN	B
mRNA	I-GENE	NOUN	B
(	O	PUNCT	O
mammary	O	ADJ	B
epithelial	O	ADJ	I
cell	O	NOUN	I
differentiation	O	NOUN	I
marker	O	NOUN	B
)	O	PUNCT	O
in	O	ADP	O
response	O	NOUN	B
to	O	PART	O
lactogenic	O	ADJ	B
hormones	O	NOUN	I
.	O	PUNCT	O


EXAFS	O	NOUN	B
measurements	O	NOUN	B
around	O	ADP	O
the	O	DET	O
Ge	O	PROPN	B
-	O	PUNCT	O
K	O	PROPN	B
edge	O	NOUN	O
have	O	AUX	O
been	O	AUX	O
carried	O	VERB	O
out	O	ADP	O
for	O	ADP	O
liquid	O	ADJ	B
Ge	O	PROPN	B
-	O	PUNCT	O
Si	O	PROPN	B
alloys	O	NOUN	B
for	O	ADP	O
the	O	DET	O
first	O	ADJ	O
time	O	NOUN	O
to	O	PART	O
investigate	O	VERB	B
the	O	DET	O
local	O	ADJ	B
structure	O	NOUN	I
around	O	ADP	O
a	O	DET	O
Ge	O	NOUN	B
atom	O	NOUN	I
.	O	PUNCT	O


Although	O	SCONJ	O
metabolized	O	VERB	B
by	O	ADP	O
the	O	DET	O
cytochrome	B-GENE	NOUN	B
P	I-GENE	NOUN	I
-	I-GENE	PUNCT	O
450	I-GENE	NUM	O
(	O	PUNCT	O
CYP	B-GENE	NOUN	B
)	O	PUNCT	O
system	O	NOUN	O
,	O	PUNCT	O
venlafaxine	O	NOUN	B
inhibits	O	VERB	B
CYP	B-GENE	NOUN	B
2D6	I-GENE	NOUN	O
and	I-GENE	CCONJ	O
3A4	I-GENE	NOUN	B
to	O	PART	O
a	O	DET	O
far	O	ADV	O
lesser	O	ADJ	B
extent	O	NOUN	B
than	O	ADP	O
do	O	AUX	O
the	O	DET	O
SSRIs	O	NOUN	B
.	O	PUNCT	O


Analysis	O	NOUN	B
of	O	ADP	O
the	O	DET	O
promoter	O	NOUN	B
sequence	O	NOUN	I
revealed	O	VERB	O
the	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
a	O	DET	O
major	O	ADJ	O
transcriptional	O	ADJ	B
start	O	NOUN	O
site	O	NOUN	O
,	O	PUNCT	O
a	O	DET	O
canonical	O	ADJ	O
TATA	O	NOUN	O
box	O	NOUN	O
and	O	CCONJ	O
putative	O	ADJ	B
cis	O	ADJ	I
regulatory	O	ADJ	I
elements	O	NOUN	I
for	O	ADP	O
pituitary	O	ADJ	B
specific	O	ADJ	O
expression	O	NOUN	B
as	O	ADV	O
well	O	ADV	O
as	O	ADP	O
an	O	DET	O
E	O	PROPN	B
-	O	PUNCT	O
responsive	O	ADJ	B
element	O	NOUN	B
.	O	PUNCT	O


Novel	O	ADJ	B
intronic	O	ADJ	B
promoter	O	NOUN	I
in	O	ADP	O
the	O	DET	O
rat	B-GENE	NOUN	B
ER	I-GENE	NOUN	O
alpha	I-GENE	NOUN	O
gene	I-GENE	NOUN	O
responsible	O	ADJ	O
for	O	ADP	O
the	O	DET	O
transient	O	ADJ	B
transcription	O	NOUN	B
of	O	ADP	O
a	O	DET	O
variant	O	ADJ	B
receptor	O	NOUN	I
.	O	PUNCT	O


Pitx2	B-GENE	NOUN	B
rescues	O	VERB	B
the	O	DET	O
GABAergic	O	ADJ	B
differentiation	O	NOUN	I
defect	O	NOUN	I
and	O	CCONJ	O
partially	O	ADV	O
rescues	O	VERB	B
the	O	DET	O
axon	O	NOUN	B
guidance	O	NOUN	I
and	O	CCONJ	O
behavioral	O	ADJ	B
phenotypes	O	NOUN	B
of	O	ADP	O
unc	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
30	I-GENE	NUM	O
mutants	I-GENE	NOUN	B
,	O	PUNCT	O
indicating	O	VERB	O
a	O	DET	O
high	O	ADJ	O
degree	O	NOUN	B
of	O	ADP	O
functional	O	ADJ	B
conservation	O	NOUN	B
between	O	ADP	O
these	O	DET	O
evolutionarily	O	ADV	O
related	O	ADJ	O
genes	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
previously	O	ADV	O
shown	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
adenoviral	B-GENE	ADJ	B
12S	I-GENE	ADJ	I
E1A	I-GENE	NOUN	I
protein	I-GENE	NOUN	I
modulates	O	VERB	B
the	O	DET	O
phosphorylation	O	NOUN	B
status	O	NOUN	B
of	O	ADP	O
p130	B-GENE	NOUN	B
and	O	CCONJ	O
p107	B-GENE	NOUN	B
without	O	ADP	O
apparent	O	ADJ	B
changes	O	NOUN	B
in	O	ADP	O
the	O	DET	O
cell	O	NOUN	B
cycle	O	NOUN	I
dependent	O	ADJ	O
phosphorylation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
retinoblastoma	B-GENE	NOUN	B
protein	I-GENE	NOUN	I
.	O	PUNCT	O


The	O	DET	O
prevalence	O	NOUN	B
of	O	ADP	O
tobacco	O	NOUN	B
dependence	O	NOUN	I
diagnosed	O	VERB	B
according	O	VERB	O
to	O	ADP	O
the	O	DET	O
ICD	O	PROPN	B
-	O	PUNCT	O
10	O	NUM	O
criteria	O	NOUN	B
was	O	AUX	O
higher	O	ADJ	O
in	O	ADP	O
alcohol	O	NOUN	B
-	O	PUNCT	O
dependent	O	ADJ	B
individuals	O	NOUN	B
(	O	PUNCT	O
58	O	NUM	O
.	O	PUNCT	O
1	O	NUM	O
%	O	NOUN	O
)	O	PUNCT	O
than	O	ADP	O
in	O	ADP	O
nondrinkers	O	NOUN	B
or	O	CCONJ	O
social	O	ADJ	B
drinkers	O	NOUN	I
(	O	PUNCT	O
12	O	NUM	O
.	O	PUNCT	O
8	O	NUM	O
%	O	NOUN	O
)	O	PUNCT	O
.	O	PUNCT	O


Diffuse	O	ADJ	B
myalgias	O	NOUN	I
were	O	AUX	O
more	O	ADV	O
frequent	O	ADJ	B
in	O	ADP	O
patients	O	NOUN	B
with	O	ADP	O
than	O	ADP	O
without	O	ADP	O
an	O	DET	O
MMF	O	NOUN	B
lesion	O	NOUN	B
at	O	ADP	O
deltoid	O	ADJ	B
muscle	O	NOUN	I
biopsy	O	NOUN	O
(	O	PUNCT	O
P	O	NOUN	O
<	O	X	O
0	O	NUM	O
.	O	PUNCT	O
0001	O	NUM	O
)	O	PUNCT	O
.	O	PUNCT	O


Additionally	O	ADV	O
,	O	PUNCT	O
a	O	DET	O
CaCO3	O	NOUN	B
-	O	PUNCT	O
CO2	O	PROPN	B
/	O	SYM	O
N2	O	ADJ	B
buffered	O	NOUN	O
solution	O	NOUN	O
was	O	AUX	O
necessary	O	ADJ	O
to	O	PART	O
maintain	O	VERB	O
a	O	DET	O
pH	O	NOUN	B
of	O	ADP	O
8	O	NUM	O
.	O	PUNCT	O


Copyright	O	NOUN	O
2001	O	NUM	O
S	O	NOUN	B
.	O	PUNCT	O


NF	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
kappaB	I-GENE	NOUN	B
is	O	AUX	O
involved	O	VERB	O
in	O	ADP	O
the	O	DET	O
regulation	O	NOUN	B
of	O	ADP	O
CD154	B-GENE	NOUN	B
(	O	PUNCT	O
CD40	B-GENE	NOUN	B
ligand	I-GENE	NOUN	B
)	O	PUNCT	O
expression	O	NOUN	B
in	O	ADP	O
primary	O	ADJ	O
human	O	ADJ	B
T	O	NOUN	B
cells	O	NOUN	I
.	O	PUNCT	O


Mutation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
octamer	O	NOUN	B
element	O	NOUN	O
also	O	ADV	O
significantly	O	ADV	O
reduced	O	VERB	B
the	O	DET	O
ability	O	NOUN	O
of	O	ADP	O
HDAC1	B-GENE	NOUN	B
to	O	PART	O
confer	O	VERB	O
repression	O	NOUN	B
of	O	ADP	O
inducible	O	ADJ	B
HLA	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
DRA	I-GENE	NOUN	B
promoter	I-GENE	NOUN	B
activation	O	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
such	O	ADJ	O
conditions	O	NOUN	B
,	O	PUNCT	O
the	O	DET	O
following	O	VERB	O
kinetic	O	ADJ	B
reactions	O	NOUN	I
have	O	AUX	O
been	O	AUX	O
studied	O	VERB	O
:	O	PUNCT	O
N2	O	ADJ	B
(	O	PUNCT	O
A	O	NOUN	O
)	O	PUNCT	O
+	O	CCONJ	O
N2	O	ADJ	B
(	O	PUNCT	O
A	O	PROPN	O
)	O	PUNCT	O
-	O	PUNCT	O
-	O	PUNCT	O
>	O	PROPN	O
N2	O	NOUN	B
(	O	PUNCT	O
C	O	NOUN	B
,	O	PUNCT	O
B	O	NOUN	B
,	O	PUNCT	O
V	O	NOUN	O
'	O	PUNCT	O
)	O	PUNCT	O
+	O	CCONJ	O
N2	O	ADJ	O
(	O	PUNCT	O
X	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
N2	O	NOUN	B
(	O	PUNCT	O
A	O	NOUN	O
)	O	PUNCT	O
+	O	CCONJ	O
N2	O	ADJ	B
(	O	PUNCT	O
X	O	NOUN	B
,	O	PUNCT	O
V	O	PROPN	O
>	O	X	O
5	O	NUM	O
)	O	PUNCT	O
-	O	PUNCT	O
-	O	PUNCT	O
>	O	PROPN	O
N2	O	NOUN	B
(	O	PUNCT	O
X	O	NOUN	B
)	O	PUNCT	O
+	O	CCONJ	O
N2	O	ADJ	B
(	O	PUNCT	O
B	O	NOUN	B
,	O	PUNCT	O
V	O	PROPN	O
'	O	PUNCT	O
)	O	PUNCT	O
in	O	ADP	O
pure	O	ADJ	B
N2	O	ADJ	I
post	O	NOUN	B
-	O	PUNCT	O
discharges	O	NOUN	B
and	O	CCONJ	O
N2	O	NOUN	B
(	O	PUNCT	O
A	O	NOUN	O
)	O	PUNCT	O
+	O	CCONJ	O
CH4	O	NOUN	B
-	O	PUNCT	O
-	O	PUNCT	O
>	O	PROPN	O
products	O	NOUN	B
,	O	PUNCT	O
C	O	NOUN	B
+	O	CCONJ	O
N	O	NOUN	B
+	O	CCONJ	O
M2	O	NOUN	B
-	O	PUNCT	O
-	O	PUNCT	O
>	O	X	O
CN	O	NOUN	B
(	O	PUNCT	O
B	O	NOUN	B
,	O	PUNCT	O
V	O	NOUN	O
'	O	PUNCT	O
)	O	PUNCT	O
+	O	CCONJ	O
M2	O	NOUN	B
,	O	PUNCT	O
N2	O	ADJ	B
(	O	PUNCT	O
X	O	NOUN	B
,	O	PUNCT	O
V	O	PROPN	O
>	O	X	O
4	O	NUM	O
)	O	PUNCT	O
+	O	CCONJ	O
CN	O	NOUN	B
-	O	PUNCT	O
-	O	PUNCT	O
>	O	PROPN	O
N2	O	NOUN	B
(	O	PUNCT	O
X	O	NOUN	B
)	O	PUNCT	O
+	O	CCONJ	O
CN	O	NOUN	B
(	O	PUNCT	O
B	O	NOUN	B
,	O	PUNCT	O
A	O	NOUN	O
,	O	PUNCT	O
V	O	PROPN	O
'	O	PUNCT	O
)	O	PUNCT	O
,	O	PUNCT	O
in	O	ADP	O
N2	O	PROPN	B
-	O	PUNCT	O
1	O	NUM	O
%	O	NOUN	O
CH4	O	NOUN	B
post	O	NOUN	B
-	O	PUNCT	O
discharges	O	NOUN	B
.	O	PUNCT	O


Six	O	NUM	O
of	O	ADP	O
the	O	DET	O
gstC	B-GENE	NOUN	B
'	I-GENE	PART	O
mutants	I-GENE	NOUN	B
,	O	PUNCT	O
primarily	O	ADV	O
in	O	ADP	O
the	O	DET	O
C	O	NOUN	B
-	O	PUNCT	O
terminal	O	ADJ	B
half	O	NOUN	B
of	O	ADP	O
C	B-GENE	NOUN	O
'	I-GENE	PUNCT	O
,	O	PUNCT	O
exhibited	O	VERB	O
a	O	DET	O
defect	O	NOUN	B
in	O	ADP	O
the	O	DET	O
ability	O	NOUN	O
to	O	PART	O
bind	O	VERB	B
L	B-GENE	NOUN	B
protein	I-GENE	NOUN	I
.	O	PUNCT	O


A	O	DET	O
proposal	O	NOUN	B
of	O	ADP	O
50	O	NUM	O
performance	O	NOUN	B
indicators	O	NOUN	B
divided	O	VERB	O
into	O	ADP	O
five	O	NUM	O
different	O	ADJ	O
groups	O	NOUN	B
is	O	AUX	O
presented	O	VERB	O
here	O	ADV	O
,	O	PUNCT	O
namely	O	ADV	O
structural	O	ADJ	B
indicators	O	NOUN	I
,	O	PUNCT	O
operational	O	ADJ	B
indicators	O	NOUN	I
,	O	PUNCT	O
water	O	NOUN	B
and	O	CCONJ	O
service	O	VERB	B
quality	O	NOUN	B
indicators	O	NOUN	B
,	O	PUNCT	O
personnel	O	NOUN	B
indicators	O	NOUN	I
and	O	CCONJ	O
economic	O	ADJ	B
indicators	O	NOUN	I
.	O	PUNCT	O


CONCLUSIONS	O	NOUN	O
:	O	PUNCT	O
ChromaFlo	O	PROPN	B
-	O	PUNCT	O
enhanced	O	VERB	B
IVUS	O	NOUN	B
demonstrates	O	VERB	O
colorized	O	VERB	B
blood	O	NOUN	I
flow	O	NOUN	I
inside	O	ADP	O
the	O	DET	O
vessel	O	NOUN	B
lumen	O	NOUN	B
,	O	PUNCT	O
which	O	DET	O
is	O	AUX	O
helpful	O	ADJ	O
in	O	ADP	O
distinguishing	O	VERB	O
echolucent	O	ADJ	B
disease	O	NOUN	I
from	O	ADP	O
luminal	O	ADJ	B
blood	O	NOUN	I
flow	O	NOUN	I
and	O	CCONJ	O
can	O	AUX	O
also	O	ADV	O
be	O	AUX	O
used	O	VERB	O
to	O	PART	O
perform	O	VERB	O
peripheral	O	ADJ	B
interventions	O	NOUN	B
in	O	ADP	O
patients	O	NOUN	B
with	O	ADP	O
renal	O	ADJ	B
failure	O	NOUN	I
or	O	CCONJ	O
allergy	O	NOUN	B
,	O	PUNCT	O
avoiding	O	VERB	O
the	O	DET	O
use	O	NOUN	O
of	O	ADP	O
contrast	O	NOUN	B
media	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
hatcher	O	NOUN	B
incubators	O	NOUN	B
of	O	ADP	O
both	O	DET	O
companies	O	NOUN	B
were	O	AUX	O
also	O	ADV	O
persistently	O	ADV	B
contaminated	O	VERB	B
with	O	ADP	O
Salmonella	O	X	B
livingstone	O	NOUN	I
and	O	CCONJ	O
Salmonella	O	NOUN	B
thomasville	O	NOUN	B
in	O	ADP	O
company	O	NOUN	B
A	O	NOUN	I
and	O	CCONJ	O
with	O	ADP	O
Salmonella	O	X	B
senftenberg	O	X	I
in	O	ADP	O
company	O	NOUN	B
B	O	NOUN	I
.	O	PUNCT	O


At	O	ADP	O
both	O	DET	O
companies	O	NOUN	B
sites	O	NOUN	O
Salmonella	O	X	B
enteritidis	O	NOUN	I
and	O	CCONJ	O
Salmonella	O	X	B
typhimurium	O	X	I
Tr104	O	NOUN	B
were	O	AUX	O
also	O	ADV	O
isolated	O	VERB	B
occasionally	O	ADV	O
from	O	ADP	O
various	O	ADJ	O
locations	O	NOUN	B
.	O	PUNCT	O


E2F1	B-GENE	NOUN	B
-	O	PUNCT	O
mediated	O	VERB	B
transcriptional	O	ADJ	B
inhibition	O	NOUN	I
of	O	ADP	O
the	O	DET	O
plasminogen	B-GENE	NOUN	B
activator	I-GENE	NOUN	I
inhibitor	I-GENE	NOUN	I
type	I-GENE	NOUN	I
1	I-GENE	NUM	I
gene	I-GENE	NOUN	I
.	O	PUNCT	O


The	O	DET	O
small	O	ADJ	B
copepod	O	NOUN	B
Pseudonychocamptus	O	PROPN	B
proximus	O	NOUN	I
progressively	O	ADV	O
replaced	O	VERB	O
the	O	DET	O
large	O	ADJ	O
Tisbe	O	PROPN	B
furcata	O	VERB	I
in	O	ADP	O
sand	O	NOUN	B
filters	O	NOUN	I
during	O	ADP	O
the	O	DET	O
fall	O	NOUN	B
of	O	ADP	O
1995	O	NUM	O
and	O	CCONJ	O
was	O	AUX	O
responsible	O	ADJ	O
for	O	ADP	O
the	O	DET	O
large	O	ADJ	O
increase	O	NOUN	B
in	O	ADP	O
meiofaunal	O	ADJ	B
biomass	O	NOUN	B
observed	O	VERB	O
after	O	ADP	O
spring	O	NOUN	B
1996	O	NUM	O
.	O	PUNCT	O


The	O	DET	O
probability	O	NOUN	B
of	O	ADP	O
treatment	O	NOUN	B
with	O	ADP	O
lamotrigine	O	NOUN	B
being	O	AUX	O
maintained	O	VERB	B
for	O	ADP	O
six	O	NUM	O
months	O	NOUN	B
was	O	AUX	O
86	O	NUM	O
%	O	NOUN	O
,	O	PUNCT	O
for	O	ADP	O
twelve	O	NUM	O
months	O	NOUN	B
61	O	NUM	O
%	O	NOUN	O
and	O	CCONJ	O
for	O	ADP	O
three	O	NUM	O
years	O	NOUN	B
31	O	NUM	O
%	O	NOUN	O
.	O	PUNCT	O


Data	O	NOUN	B
from	O	ADP	O
in	O	X	B
vitro	O	X	I
splicing	O	NOUN	B
assays	O	NOUN	I
,	O	PUNCT	O
UV	O	NOUN	B
crosslinking	O	NOUN	B
and	O	CCONJ	O
RNA	O	NOUN	B
-	O	PUNCT	O
binding	O	VERB	B
competition	O	NOUN	O
experiments	O	NOUN	O
indicates	O	VERB	O
a	O	DET	O
strong	O	ADJ	O
correlation	O	NOUN	B
between	O	ADP	O
the	O	DET	O
binding	O	NOUN	B
affinities	O	NOUN	B
of	O	ADP	O
PSI	B-GENE	NOUN	B
for	O	ADP	O
the	O	DET	O
SELEX	O	NOUN	B
sequences	O	NOUN	O
and	O	CCONJ	O
their	O	PRON	O
ability	O	NOUN	O
to	O	PART	O
modulate	O	VERB	B
splicing	O	NOUN	B
of	O	ADP	O
P	B-GENE	NOUN	B
element	I-GENE	NOUN	I
IVS3	B-GENE	NOUN	B
in	O	X	B
vitro	O	X	I
.	O	PUNCT	O


This	O	DET	O
paper	O	NOUN	B
describes	O	VERB	O
the	O	DET	O
results	O	NOUN	B
of	O	ADP	O
an	O	DET	O
initial	O	ADJ	O
study	O	NOUN	B
on	O	ADP	O
the	O	DET	O
application	O	NOUN	B
of	O	ADP	O
linear	O	ADJ	B
solvation	O	NOUN	I
energy	O	NOUN	I
relationships	O	NOUN	I
(	O	PUNCT	O
LSERs	O	NOUN	B
)	O	PUNCT	O
to	O	PART	O
the	O	DET	O
prediction	O	NOUN	B
of	O	ADP	O
internal	O	ADJ	B
standard	O	ADJ	I
compounds	O	NOUN	I
in	O	ADP	O
reversed	O	VERB	B
-	O	PUNCT	O
phase	O	NOUN	B
liquid	O	ADJ	I
chromatographic	O	ADJ	I
(	O	PUNCT	O
RPLC	O	NOUN	B
)	O	PUNCT	O
method	O	NOUN	B
development	O	NOUN	I
.	O	PUNCT	O


ICAM	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	O
has	O	AUX	O
been	O	AUX	O
suggested	O	VERB	O
a	O	DET	O
predictor	O	NOUN	B
of	O	ADP	O
the	O	DET	O
onset	O	NOUN	B
of	O	ADP	I
GO	O	NOUN	B
.	O	PUNCT	O


Northern	O	NOUN	B
blot	O	NOUN	I
analysis	O	NOUN	I
with	O	ADP	O
one	O	NUM	O
of	O	ADP	O
the	O	DET	O
PARNAs	B-GENE	NOUN	B
revealed	O	VERB	O
a	O	DET	O
highly	O	ADV	O
abundant	O	ADJ	B
signal	O	NOUN	B
of	O	ADP	O
approximately	O	ADV	O
2	O	NUM	O
.	O	PUNCT	O
0	O	NUM	O
kilobases	O	NOUN	B
(	O	PUNCT	O
kb	O	NOUN	O
)	O	PUNCT	O
present	O	ADJ	O
in	O	ADP	O
all	O	DET	O
cell	O	NOUN	B
lines	O	NOUN	I
tested	O	VERB	B
.	O	PUNCT	O


The	O	DET	O
corresponding	O	ADJ	O
orifice	O	NOUN	B
voltages	O	NOUN	I
for	O	ADP	O
the	O	DET	O
three	O	NUM	O
instruments	O	NOUN	B
were	O	AUX	O
20	O	NUM	O
/	O	SYM	O
50	O	NUM	B
/	O	SYM	O
80	O	NUM	O
V	O	NOUN	O
(	O	PUNCT	O
API	O	PROPN	B
365	O	NUM	O
)	O	PUNCT	O
,	O	PUNCT	O
30	O	NUM	O
/	O	SYM	O
90	O	NUM	B
/	O	SYM	O
130	O	NUM	B
V	O	NOUN	I
(	O	PUNCT	O
API	O	PROPN	B
2000	O	NUM	O
)	O	PUNCT	O
and	O	CCONJ	O
40	O	NUM	O
/	O	SYM	O
80	O	NUM	B
/	O	SYM	O
120	O	NUM	B
V	O	NOUN	I
(	O	PUNCT	O
API	O	PROPN	B
3000	O	NUM	O
)	O	PUNCT	O
.	O	PUNCT	O


The	O	DET	O
LA	O	PROPN	B
50s	O	NOUN	O
derived	O	VERB	O
from	O	ADP	O
this	O	DET	O
combined	O	ADJ	O
data	O	NOUN	B
when	O	SCONJ	O
compared	O	VERB	B
with	O	ADP	O
our	O	PRON	O
earlier	O	ADJ	O
series	O	NOUN	O
from	O	ADP	O
1965	O	NUM	O
to	O	ADP	O
1970	O	NUM	O
also	O	ADV	O
did	O	AUX	O
not	O	PART	O
show	O	VERB	O
a	O	DET	O
significant	O	ADJ	O
change	O	NOUN	O
in	O	ADP	O
mortality	O	NOUN	B
.	O	PUNCT	O


Treatment	O	NOUN	B
of	O	ADP	O
ischemic	O	ADJ	B
heart	O	NOUN	I
disease	O	NOUN	I
in	O	ADP	O
the	O	DET	O
elderly	O	ADJ	B


A	O	DET	O
peculiar	O	ADJ	B
people	O	NOUN	B
:	O	PUNCT	O
"	O	PUNCT	O
the	O	DET	O
physiological	O	ADJ	B
aspects	O	NOUN	I
of	O	ADP	O
Mormonism	O	PROPN	B
1850	O	NUM	O
-	O	SYM	O
1975	O	NUM	O
.	O	PUNCT	O
"	O	PUNCT	O


She	O	PRON	O
drank	O	VERB	O
alcohol	O	NOUN	B
once	O	ADV	O
or	O	CCONJ	O
twice	O	ADV	O
a	O	DET	O
week	O	NOUN	B
and	O	CCONJ	O
regularly	O	ADV	B
took	O	VERB	O
an	O	DET	O
analgesic	O	NOUN	B
preparation	O	NOUN	I
,	O	PUNCT	O
containing	O	VERB	O
aspirin	O	NOUN	B
and	O	CCONJ	O
acetaminophen	O	NOUN	B
,	O	PUNCT	O
for	O	ADP	O
alleviation	O	NOUN	B
of	O	ADP	O
headaches	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
most	O	ADV	O
important	O	ADJ	O
risk	O	NOUN	B
factors	O	NOUN	I
are	O	AUX	O
:	O	PUNCT	O
1	O	X	O
)	O	PUNCT	O
genetic	O	ADJ	B
;	O	PUNCT	O
2	O	X	O
)	O	PUNCT	O
Epstein	O	PROPN	B
-	O	PUNCT	O
Barr	O	PROPN	B
virus	O	NOUN	I
(	O	PUNCT	O
infectious	O	ADJ	B
mononucleosis	O	NOUN	I
)	O	PUNCT	O
;	O	PUNCT	O
3	O	X	O
)	O	PUNCT	O
congenital	O	ADJ	B
and	O	CCONJ	O
acquired	O	VERB	B
immunodeficiency	O	NOUN	I
;	O	PUNCT	O
4	O	X	O
)	O	PUNCT	O
occupational	O	ADJ	B
exposure	O	NOUN	I
(	O	PUNCT	O
the	O	DET	O
wood	O	NOUN	B
industry	O	NOUN	I
)	O	PUNCT	O
.	O	PUNCT	O


OBJECTIVES	O	NOUN	O
:	O	PUNCT	O
The	O	DET	O
objective	O	NOUN	B
of	O	ADP	O
this	O	DET	O
review	O	NOUN	B
was	O	AUX	O
to	O	PART	O
assess	O	VERB	B
the	O	DET	O
effects	O	NOUN	B
of	O	ADP	I
prophylactic	O	ADJ	B
prostaglandin	O	NOUN	B
use	O	NOUN	O
in	O	ADP	O
the	O	DET	O
third	O	ADJ	B
stage	O	NOUN	I
of	O	ADP	O
labour	O	NOUN	O
.	O	PUNCT	O


Under	O	ADP	O
our	O	PRON	O
conditions	O	NOUN	B
,	O	PUNCT	O
the	O	DET	O
combination	O	NOUN	B
O3	O	PROPN	B
/	O	PUNCT	O
UV	O	NOUN	B
did	O	AUX	O
not	O	PART	O
improve	O	VERB	O
the	O	DET	O
degradation	O	NOUN	B
rate	O	NOUN	B
obtained	O	VERB	O
by	O	ADP	O
ozonation	O	NOUN	B
.	O	PUNCT	O


On	O	ADP	O
the	O	DET	O
other	O	ADJ	O
hand	O	NOUN	B
,	O	PUNCT	O
hepatic	O	ADJ	B
arterial	O	ADJ	I
infusion	O	NOUN	I
therapy	O	NOUN	I
prolongs	O	VERB	B
the	O	DET	O
survival	O	NOUN	B
of	O	ADP	O
H3	O	NOUN	B
patients	O	NOUN	B
only	O	ADV	O
.	O	PUNCT	O


Finally	O	ADV	O
,	O	PUNCT	O
there	O	PRON	O
are	O	AUX	O
a	O	DET	O
growing	O	VERB	O
number	O	NOUN	O
of	O	ADP	O
arguments	O	NOUN	B
favouring	O	VERB	O
the	O	DET	O
use	O	NOUN	O
of	O	ADP	O
ACE	B-GENE	NOUN	B
inhibitors	O	NOUN	B
very	O	ADV	O
early	O	ADV	O
in	O	ADP	O
patients	O	NOUN	B
with	O	ADP	O
diabetes	O	NOUN	B
mellitus	O	NOUN	I
.	O	PUNCT	O


Is	O	AUX	O
clopidogrel	O	NOUN	B
superior	O	ADJ	B
to	O	PART	O
aspirin	O	NOUN	B
in	O	ADP	O
secondary	O	ADJ	B
prevention	O	NOUN	I
of	O	ADP	O
vascular	O	ADJ	B
disease	O	NOUN	I
?	O	PUNCT	O
The	O	DET	O
cornerstone	O	ADJ	O
in	O	ADP	O
clinical	O	ADJ	B
evidence	O	NOUN	I
of	O	ADP	O
the	O	DET	O
relative	O	ADJ	O
efficacy	O	NOUN	B
of	O	ADP	O
thienopyridines	O	NOUN	B
(	O	PUNCT	O
clopidogrel	O	NOUN	B
,	O	PUNCT	O
ticlopidine	O	NOUN	B
)	O	PUNCT	O
versus	O	CCONJ	O
aspirin	O	NOUN	B
in	O	ADP	O
the	O	DET	O
secondary	O	ADJ	B
prevention	O	NOUN	I
of	O	ADP	O
vascular	O	ADJ	B
disease	O	NOUN	I
is	O	AUX	O
the	O	DET	O
Clopidogrel	O	NOUN	B
versus	O	CCONJ	O
Aspirin	O	NOUN	B
in	O	ADP	O
Patients	O	NOUN	B
at	O	ADP	O
Risk	O	NOUN	B
of	O	ADP	O
Ischaemic	O	PROPN	B
Events	O	PROPN	I
trial	O	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
hypothesize	O	VERB	O
that	O	SCONJ	O
proprioception	O	NOUN	B
may	O	AUX	O
be	O	AUX	O
used	O	VERB	O
to	O	PART	O
calibrate	O	VERB	B
the	O	DET	O
efference	O	NOUN	B
copy	O	NOUN	O
during	O	ADP	O
development	O	NOUN	B
and	O	CCONJ	O
in	O	ADP	O
response	O	NOUN	B
to	O	PART	O
perturbations	O	NOUN	B
by	O	ADP	O
signaling	O	VERB	B
potential	O	ADJ	O
mismatches	O	NOUN	B
between	O	ADP	O
eye	O	NOUN	B
movement	O	NOUN	B
information	O	NOUN	B
derived	O	VERB	O
from	O	ADP	O
the	O	DET	O
efferent	O	ADJ	B
command	O	NOUN	B
and	O	CCONJ	O
the	O	DET	O
actual	O	ADJ	B
motion	O	NOUN	B
of	O	ADP	O
the	O	DET	O
eye	O	NOUN	B
transduced	O	VERB	I
by	O	ADP	O
the	O	DET	O
proprioceptive	O	ADJ	B
organs	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
severity	O	NOUN	B
of	O	ADP	O
clinical	O	ADJ	B
course	O	NOUN	I
was	O	AUX	O
expressed	O	VERB	B
by	O	ADP	O
means	O	NOUN	O
of	O	ADP	O
SOFA	O	NOUN	B
score	O	NOUN	O
(	O	PUNCT	O
group	O	NOUN	B
A	O	NOUN	O
0	O	NUM	O
.	O	PUNCT	O
3	O	NUM	O
-	O	SYM	O
1	O	NUM	O
-	O	SYM	O
1	O	NUM	O
.	O	PUNCT	O
3	O	NUM	O
point	O	NOUN	O
,	O	PUNCT	O
group	O	NOUN	B
B	O	NOUN	I
2	O	NUM	I
.	O	PUNCT	O
2	O	NUM	O
-	O	SYM	O
2	O	NUM	O
.	O	PUNCT	O
9	O	NUM	O
-	O	SYM	O
2	O	NUM	O
.	O	PUNCT	O
6	O	NUM	O
point	O	NOUN	O
,	O	PUNCT	O
group	O	NOUN	B
C	O	NOUN	O
7	O	NUM	O
.	O	PUNCT	O
4	O	NUM	O
-	O	SYM	O
8	O	NUM	O
.	O	PUNCT	O
3	O	NUM	O
-	O	SYM	O
7	O	NUM	O
.	O	PUNCT	O
7	O	NUM	O
point	O	NOUN	O
)	O	PUNCT	O
and	O	CCONJ	O
APACHE	O	NOUN	B
II	O	NUM	I
score	O	NOUN	I
(	O	PUNCT	O
group	O	NOUN	B
A	O	DET	O
3	O	NUM	O
.	O	PUNCT	O
7	O	NUM	O
-	O	SYM	O
7	O	NUM	O
.	O	PUNCT	O
6	O	NUM	O
-	O	SYM	O
8	O	NUM	O
.	O	PUNCT	O
1	O	NUM	O
point	O	NOUN	O
,	O	PUNCT	O
group	O	NOUN	B
B	O	NOUN	I
8	O	NUM	O
.	O	PUNCT	O
6	O	NUM	O
-	O	SYM	O
11	O	NUM	O
.	O	PUNCT	O
1	O	NUM	O
-	O	SYM	O
10	O	NUM	O
.	O	PUNCT	O
5	O	NUM	O
point	O	NOUN	O
,	O	PUNCT	O
group	O	NOUN	B
C	O	NOUN	O
16	O	NUM	O
.	O	PUNCT	O
3	O	NUM	O
-	O	SYM	O
15	O	NUM	O
.	O	PUNCT	O
2	O	NUM	O
-	O	SYM	O
14	O	NUM	O
.	O	PUNCT	O
3	O	NUM	O
point	O	NOUN	O
)	O	PUNCT	O
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
were	O	AUX	O
compared	O	VERB	B
with	O	ADP	O
the	O	DET	O
estimates	O	NOUN	B
of	O	ADP	O
penetration	O	NOUN	B
from	O	ADP	O
steady	O	ADJ	B
-	O	PUNCT	O
state	O	NOUN	B
calculations	O	NOUN	B
,	O	PUNCT	O
square	O	ADJ	B
root	O	NOUN	I
of	O	ADP	I
time	O	NOUN	I
calculations	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
a	O	DET	O
biologically	O	ADV	B
based	O	VERB	O
mathematical	O	ADJ	B
model	O	NOUN	I
.	O	PUNCT	O


Treadmill	O	NOUN	B
training	O	NOUN	B
at	O	ADP	O
least	O	ADJ	O
for	O	ADP	O
2	O	NUM	O
weeks	O	NOUN	B
can	O	AUX	O
reduce	O	VERB	B
the	O	DET	O
infarction	O	NOUN	B
size	O	NOUN	B
and	O	CCONJ	O
edema	O	NOUN	B
caused	O	VERB	O
by	O	ADP	O
MCA	O	NOUN	B
occlusion	O	NOUN	I
(	O	PUNCT	O
P	O	NOUN	O
<	O	X	O
0	O	NUM	O
.	O	PUNCT	O
01	O	NUM	O
)	O	PUNCT	O
.	O	PUNCT	O


Modality	O	NOUN	B
-	O	PUNCT	O
specific	O	ADJ	B
areas	O	NOUN	B
(	O	PUNCT	O
e	O	X	O
.	O	PUNCT	O
g	O	NOUN	O
.	O	PUNCT	O
,	O	PUNCT	O
right	O	ADJ	B
Wernicke	O	NOUN	I
,	O	PUNCT	O
left	O	VERB	B
fusiform	O	ADJ	I
gyrus	O	NOUN	I
,	O	PUNCT	O
Broca	O	PROPN	B
BA44	O	PROPN	I
,	O	PUNCT	O
supramarginal	O	ADJ	B
gyrus	O	NOUN	I
)	O	PUNCT	O
,	O	PUNCT	O
appear	O	VERB	O
to	O	PART	O
cope	O	VERB	O
with	O	ADP	O
the	O	DET	O
computations	O	NOUN	B
relevant	O	ADJ	B
to	O	ADP	O
making	O	VERB	O
contact	O	NOUN	B
with	O	ADP	I
these	O	DET	O
more	O	ADV	O
abstract	O	ADJ	B
dimensions	O	NOUN	O
.	O	PUNCT	O


We	O	PRON	O
found	O	VERB	O
no	O	DET	O
correlation	O	NOUN	B
between	O	ADP	O
plasma	O	NOUN	B
COP	O	NOUN	B
and	O	CCONJ	O
body	O	NOUN	B
weight	O	NOUN	I
at	O	ADP	O
the	O	DET	O
same	O	ADJ	O
age	O	NOUN	B
(	O	PUNCT	O
r2	O	NOUN	O
=	O	ADJ	O
0	O	NUM	O
.	O	PUNCT	O
05	O	NUM	O
,	O	PUNCT	O
P	O	NOUN	O
=	O	ADJ	O
0	O	NUM	O
.	O	PUNCT	O
155	O	NUM	O
)	O	PUNCT	O
.	O	PUNCT	O


Both	O	DET	O
toxins	O	NOUN	B
in	O	ADP	O
a	O	DET	O
dose	O	NOUN	B
10	O	NUM	O
-	O	PUNCT	O
fold	O	NOUN	B
surpassing	O	VERB	O
the	O	DET	O
maximum	O	ADJ	B
permissible	O	ADJ	O
concentration	O	NOUN	B
increased	O	VERB	B
activity	O	NOUN	B
of	O	ADP	O
glutathione	B-GENE	NOUN	B
peroxidase	I-GENE	NOUN	I
in	O	ADP	O
brain	O	NOUN	B
tissue	O	NOUN	I
;	O	PUNCT	O
moreover	O	ADV	O
,	O	PUNCT	O
toluene	O	NOUN	B
increased	O	VERB	B
chemiluminescence	O	NOUN	B
intensity	O	NOUN	B
,	O	PUNCT	O
which	O	DET	O
attested	O	VERB	O
to	O	PART	O
activation	O	NOUN	B
of	O	ADP	O
free	O	ADJ	B
radical	O	ADJ	I
processes	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
performance	O	NOUN	B
of	O	ADP	O
pH	O	NOUN	B
-	O	PUNCT	O
sensitive	O	ADJ	B
particles	O	NOUN	B
is	O	AUX	O
attributed	O	VERB	O
to	O	PART	O
their	O	PRON	O
ability	O	NOUN	O
to	O	PART	O
release	O	VERB	B
the	O	DET	O
drug	O	NOUN	B
selectively	O	ADV	O
in	O	ADP	O
the	O	DET	O
upper	O	ADJ	B
part	O	NOUN	I
of	O	ADP	O
the	O	DET	O
intestine	O	NOUN	B
in	O	ADP	O
a	O	DET	O
molecular	O	ADJ	B
or	O	CCONJ	O
amorphous	O	ADJ	B
form	O	NOUN	O
.	O	PUNCT	O


Comparison	O	NOUN	B
of	O	ADP	O
remnant	O	NOUN	B
-	O	PUNCT	O
like	O	ADJ	B
lipoprotein	O	NOUN	B
particles	O	NOUN	I
in	O	ADP	O
postmenopausal	O	ADJ	B
women	O	NOUN	B
with	O	ADP	O
and	O	CCONJ	O
without	O	ADP	O
coronary	O	ADJ	B
artery	O	NOUN	I
disease	O	NOUN	I
and	O	CCONJ	O
in	O	ADP	O
men	O	NOUN	B
with	O	ADP	O
coronary	O	ADJ	B
artery	O	NOUN	I
disease	O	NOUN	I
.	O	PUNCT	O


Because	O	SCONJ	O
results	O	NOUN	B
of	O	ADP	O
recent	O	ADJ	O
randomized	O	ADJ	B
trials	O	NOUN	I
indicate	O	VERB	O
minimal	O	ADJ	O
efficacy	O	NOUN	B
of	O	ADP	O
continuing	O	VERB	B
MAC	O	NOUN	B
prophylaxis	O	NOUN	B
in	O	ADP	O
patients	O	NOUN	B
who	O	PRON	O
respond	O	VERB	O
to	O	PART	O
potent	O	ADJ	O
combination	O	NOUN	O
antiretroviral	O	ADJ	B
therapy	O	NOUN	I
,	O	PUNCT	O
the	O	DET	O
observed	O	VERB	O
high	O	ADJ	B
incidence	O	NOUN	B
of	O	ADP	O
macrolide	O	NOUN	B
-	O	PUNCT	O
resistant	O	ADJ	B
bacterial	O	ADJ	B
colonization	O	NOUN	O
of	O	ADP	O
the	O	DET	O
respiratory	O	ADJ	B
tract	O	NOUN	I
in	O	ADP	O
this	O	DET	O
trial	O	NOUN	B
supports	O	VERB	O
the	O	DET	O
discontinuation	O	NOUN	B
of	O	ADP	O
macrolide	O	NOUN	B
prophylaxis	O	NOUN	B
in	O	ADP	O
all	O	DET	O
AIDS	O	NOUN	B
patients	O	NOUN	B
whose	O	DET	O
CD4	B-GENE	NOUN	B
counts	O	NOUN	I
have	O	AUX	O
risen	O	VERB	O
above	O	ADP	O
100	O	NUM	O
cells	O	NOUN	B
/	O	PUNCT	O
microL	O	NOUN	B
.	O	PUNCT	O


METHODS	O	NOUN	O
:	O	PUNCT	O
302	O	NUM	O
consecutive	O	ADJ	B
patients	O	NOUN	B
with	O	ADP	O
BS	O	NOUN	B
and	O	CCONJ	O
438	O	NUM	O
patients	O	NOUN	B
with	O	ADP	O
other	O	ADJ	O
rheumatological	O	ADJ	B
conditions	O	NOUN	I
were	O	AUX	O
surveyed	O	VERB	B
for	O	ADP	O
the	O	DET	O
presence	O	NOUN	B
or	O	CCONJ	O
absence	O	NOUN	B
of	O	ADP	O
the	O	DET	O
features	O	NOUN	B
of	O	ADP	O
BS	O	NOUN	B
by	O	ADP	O
means	O	NOUN	O
of	O	ADP	O
a	O	DET	O
standard	O	ADJ	B
form	O	NOUN	O
which	O	DET	O
had	O	AUX	O
been	O	AUX	O
prepared	O	VERB	O
according	O	VERB	O
to	O	ADP	O
ISG	O	NOUN	B
criteria	O	NOUN	B
.	O	PUNCT	O


A	O	DET	O
computer	O	NOUN	B
program	O	NOUN	I
,	O	PUNCT	O
ACCESS	O	PROPN	B
-	O	PUNCT	O
IAQ	O	PROPN	B
,	O	PUNCT	O
is	O	AUX	O
developed	O	VERB	O
to	O	PART	O
simulate	O	VERB	B
the	O	DET	O
airflow	O	NOUN	B
pattern	O	NOUN	I
,	O	PUNCT	O
the	O	DET	O
time	O	NOUN	B
history	O	NOUN	I
of	O	ADP	O
the	O	DET	O
contaminant	O	ADJ	B
concentrations	O	NOUN	B
in	O	ADP	O
the	O	DET	O
occupied	O	VERB	B
zone	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
the	O	DET	O
inhalation	O	NOUN	B
exposures	O	NOUN	O
.	O	PUNCT	O


Classification	O	NOUN	B
according	O	VERB	O
to	O	ADP	O
the	O	DET	O
ILAR	O	PROPN	B
criteria	O	NOUN	B
was	O	AUX	O
possible	O	ADJ	O
in	O	ADP	O
321	O	NUM	O
patients	O	NOUN	B
;	O	PUNCT	O
290	O	NUM	O
patients	O	NOUN	B
had	O	AUX	O
a	O	DET	O
disease	O	NOUN	B
duration	O	NOUN	I
>	O	X	O
or	O	CCONJ	O
=	O	ADJ	O
3	O	NUM	O
months	O	NOUN	B
and	O	CCONJ	O
were	O	AUX	O
classified	O	VERB	B
according	O	VERB	O
to	O	ADP	O
the	O	DET	O
EULAR	O	PROPN	B
criteria	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
conducted	O	VERB	O
a	O	DET	O
clinical	O	ADJ	B
and	O	CCONJ	O
pathologic	O	ADJ	B
review	O	NOUN	I
of	O	ADP	O
nine	O	NUM	O
patients	O	NOUN	B
with	O	ADP	O
immature	O	ADJ	B
ovarian	O	ADJ	O
teratoma	O	NOUN	O
.	O	PUNCT	O


The	O	DET	O
results	O	NOUN	B
are	O	AUX	O
discussed	O	VERB	O
in	O	ADP	O
relation	O	NOUN	O
to	O	ADP	O
acoustical	O	ADJ	B
models	O	NOUN	I
of	O	ADP	O
sound	O	ADJ	B
propagation	O	NOUN	I
and	O	CCONJ	O
physiology	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
it	O	PRON	O
is	O	AUX	O
suggested	O	VERB	O
that	O	SCONJ	O
height	O	NOUN	B
-	O	PUNCT	O
dependent	O	ADJ	B
degradation	O	NOUN	B
within	O	ADP	O
a	O	DET	O
forest	O	NOUN	B
is	O	AUX	O
an	O	DET	O
important	O	ADJ	O
selection	O	NOUN	B
pressure	O	NOUN	I
for	O	ADP	O
transmissibility	O	NOUN	B
in	O	ADP	O
avian	O	ADJ	B
communication	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
sterilized	O	VERB	B
milk	O	NOUN	I
there	O	PRON	O
was	O	AUX	O
a	O	DET	O
slight	O	ADJ	O
decrease	O	NOUN	B
of	O	ADP	O
linoleic	O	ADJ	B
acid	O	NOUN	I
(	O	PUNCT	O
C18	O	NOUN	O
:	O	PUNCT	O
2n6	O	NOUN	O
;	O	PUNCT	O
-	O	PUNCT	O
0	O	NUM	O
.	O	PUNCT	O
7	O	NUM	O
%	O	NOUN	O
vs	O	CCONJ	O
.	O	PUNCT	O
fresh	O	ADJ	B
;	O	PUNCT	O
P	O	NOUN	O
=	O	ADJ	O
0	O	NUM	O
.	O	PUNCT	O
006	O	NUM	O
)	O	PUNCT	O
and	O	CCONJ	O
arachidonic	O	ADJ	B
acid	O	NOUN	I
(	O	PUNCT	O
C20	O	NOUN	B
:	O	PUNCT	O
4n6	O	NOUN	O
;	O	PUNCT	O
-	O	PUNCT	O
2	O	NUM	O
.	O	PUNCT	O
5	O	NUM	O
%	O	NOUN	O
;	O	PUNCT	O
P	O	NOUN	O
=	O	ADJ	O
0	O	NUM	O
.	O	PUNCT	O
045	O	NUM	O
)	O	PUNCT	O
.	O	PUNCT	O


The	O	DET	O
electrodes	O	NOUN	B
themselves	O	PRON	O
do	O	AUX	O
not	O	PART	O
need	O	VERB	O
to	O	PART	O
be	O	AUX	O
polished	O	VERB	B
prior	O	ADV	O
to	O	ADP	O
their	O	PRON	O
use	O	NOUN	O
but	O	CCONJ	O
are	O	AUX	O
observed	O	VERB	O
to	O	PART	O
be	O	AUX	O
slightly	O	ADV	O
recessed	O	VERB	B
from	O	ADP	O
the	O	DET	O
surrounding	O	VERB	B
insulating	O	VERB	B
surface	O	NOUN	I
.	O	PUNCT	O


Because	O	SCONJ	O
the	O	DET	O
DPPD	B-GENE	NOUN	B
gene	I-GENE	NOUN	I
is	O	AUX	O
not	O	PART	O
present	O	ADJ	O
in	O	ADP	O
non	O	ADJ	B
-	O	PUNCT	O
tuberculous	O	ADJ	B
bacilli	O	NOUN	I
,	O	PUNCT	O
these	O	DET	O
results	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
this	O	DET	O
molecule	O	NOUN	B
can	O	AUX	O
be	O	AUX	O
an	O	DET	O
additional	O	ADJ	O
tool	O	NOUN	O
for	O	ADP	O
a	O	DET	O
more	O	ADV	O
specific	O	ADJ	O
diagnosis	O	NOUN	B
of	O	ADP	O
tuberculosis	O	NOUN	B
.	O	PUNCT	O


Patients	O	NOUN	B
with	O	ADP	O
a	O	DET	O
secondary	O	ADJ	B
cardiac	O	ADJ	I
event	O	NOUN	I
had	O	AUX	O
more	O	ADV	O
common	O	ADJ	O
Type	O	NOUN	B
A	O	NOUN	I
behavior	O	NOUN	I
patterns	O	NOUN	O
and	O	CCONJ	O
higher	O	ADJ	B
Bortner	O	ADJ	B
scores	O	NOUN	I
than	O	ADP	O
patients	O	NOUN	B
without	O	ADP	O
a	O	DET	O
secondary	O	ADJ	B
cardiac	O	ADJ	I
event	O	NOUN	I
.	O	PUNCT	O


Interestingly	O	ADV	O
,	O	PUNCT	O
continuation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
interferon	B-GENE	NOUN	B
therapy	O	NOUN	I
in	O	ADP	O
the	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
a	O	DET	O
mild	O	ADJ	B
-	O	PUNCT	O
to	O	ADP	O
-	O	PUNCT	O
moderate	O	ADJ	B
exacerbation	O	NOUN	B
of	O	ADP	O
sarcoidosis	O	NOUN	B
may	O	AUX	O
be	O	AUX	O
safe	O	ADJ	O
in	O	ADP	O
a	O	DET	O
minority	O	NOUN	B
of	O	ADP	O
patients	O	NOUN	B
with	O	ADP	O
noncritical	O	ADJ	B
organ	O	NOUN	I
involvement	O	NOUN	B
.	O	PUNCT	O


There	O	PRON	O
was	O	AUX	O
no	O	DET	O
difference	O	NOUN	O
in	O	ADP	O
apnea	O	NOUN	B
duration	O	NOUN	I
between	O	ADP	O
the	O	DET	O
supine	O	NOUN	B
and	O	CCONJ	O
prone	O	ADJ	O
positions	O	NOUN	B
.	O	PUNCT	O


TNFalpha	B-GENE	NOUN	B
and	O	CCONJ	O
IL	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
6	I-GENE	NUM	O
levels	O	NOUN	B
were	O	AUX	O
determined	O	VERB	O
in	O	ADP	O
the	O	DET	O
culture	O	NOUN	B
supernatants	O	NOUN	I
.	O	PUNCT	O


Therefore	O	ADV	O
,	O	PUNCT	O
this	O	DET	O
study	O	NOUN	B
has	O	AUX	O
demonstrated	O	VERB	O
that	O	SCONJ	O
prenatal	O	ADJ	B
disturbance	O	NOUN	I
can	O	AUX	O
induce	O	VERB	B
a	O	DET	O
lasting	O	ADJ	O
change	O	NOUN	O
in	O	ADP	O
cytokine	O	NOUN	B
biology	O	NOUN	I
,	O	PUNCT	O
which	O	DET	O
persists	O	VERB	O
well	O	ADV	O
beyond	O	ADP	O
the	O	DET	O
fetal	O	ADJ	B
and	O	CCONJ	O
infant	O	ADJ	B
stage	O	NOUN	I
.	O	PUNCT	O


Based	O	VERB	O
on	O	ADP	O
analytic	O	ADJ	B
precisions	O	NOUN	B
,	O	PUNCT	O
a	O	DET	O
+	O	CCONJ	O
/	O	SYM	O
-	O	PUNCT	O
2	O	NUM	O
%	O	NOUN	O
urine	O	NOUN	B
-	O	PUNCT	O
plasma	O	NOUN	B
difference	O	NOUN	B
was	O	AUX	O
set	O	VERB	O
as	O	ADP	O
the	O	DET	O
cut	O	NOUN	B
-	O	PUNCT	O
off	O	ADP	B
value	O	NOUN	I
.	O	PUNCT	O


Schistosoma	O	X	B
mansoni	O	NOUN	I
schistosomiasis	O	NOUN	B
]	O	PUNCT	O
Schistosomosis	O	NOUN	B
are	O	AUX	O
parasitic	O	ADJ	B
diseases	O	NOUN	I
caused	O	VERB	O
by	O	ADP	O
blood	O	NOUN	B
flukes	O	NOUN	I
of	O	ADP	O
the	O	DET	O
Schistosoma	O	PROPN	B
genus	O	NOUN	I
.	O	PUNCT	O


Emphysematous	O	ADJ	B
cholecystitis	O	NOUN	I
:	O	PUNCT	O
sonographic	O	ADJ	B
findings	O	NOUN	B
.	O	PUNCT	O


Age	O	NOUN	B
was	O	AUX	O
categorized	O	VERB	O
into	O	ADP	O
four	O	NUM	O
groups	O	NOUN	B
:	O	PUNCT	O
20	O	NUM	O
-	O	SYM	O
44	O	NUM	O
,	O	PUNCT	O
45	O	NUM	O
-	O	SYM	O
64	O	NUM	O
,	O	PUNCT	O
65	O	NUM	O
-	O	SYM	O
74	O	NUM	O
,	O	PUNCT	O
and	O	CCONJ	O
75	O	NUM	O
+	O	CCONJ	O
.	O	PUNCT	O
RESULTS	O	NOUN	O
:	O	PUNCT	O
At	O	ADP	O
the	O	DET	O
initiation	O	NOUN	B
of	O	ADP	O
dialysis	O	NOUN	B
PD	O	NOUN	I
patients	O	NOUN	B
were	O	AUX	O
approximately	O	ADV	O
6	O	NUM	O
years	O	NOUN	B
younger	O	ADJ	B
(	O	PUNCT	O
P	O	NOUN	O
<	O	X	O
0	O	NUM	O
.	O	PUNCT	O
0001	O	NUM	O
)	O	PUNCT	O
than	O	ADP	O
HD	O	NOUN	B
patients	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
utility	O	NOUN	O
of	O	ADP	O
such	O	ADJ	O
analyses	O	NOUN	B
in	O	ADP	O
the	O	DET	O
design	O	NOUN	B
of	O	ADP	O
ceramic	O	ADJ	B
/	O	SYM	O
substrate	O	ADJ	B
bilayer	O	NOUN	B
systems	O	NOUN	O
for	O	ADP	O
optimal	O	ADJ	B
resistance	O	NOUN	B
to	O	ADP	O
lifetime	O	NOUN	B
-	O	PUNCT	O
threatening	O	VERB	B
damage	O	NOUN	B
is	O	AUX	O
discussed	O	VERB	O
.	O	PUNCT	O


Adjacent	O	ADJ	B
to	O	ADP	O
those	O	DET	O
lesions	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
in	O	ADP	O
homologous	O	ADJ	B
contralateral	O	ADJ	O
structures	O	NOUN	O
,	O	PUNCT	O
FMZ	O	NOUN	B
binding	O	NOUN	B
was	O	AUX	O
analysed	O	VERB	B
in	O	ADP	O
four	O	NUM	O
pairs	O	NOUN	B
of	O	ADP	O
cortical	O	ADJ	B
9	O	NUM	I
x	O	NOUN	O
9	O	NUM	O
-	O	PUNCT	O
mm	O	NOUN	O
regions	O	NOUN	B
of	O	ADP	O
interest	O	NOUN	O
(	O	PUNCT	O
ROIs	O	NOUN	B
)	O	PUNCT	O
placed	O	VERB	O
on	O	ADP	O
transaxial	O	ADJ	B
and	O	CCONJ	O
coronal	O	ADJ	B
slices	O	NOUN	I
,	O	PUNCT	O
respectively	O	ADV	O
,	O	PUNCT	O
as	O	ADV	O
well	O	ADV	O
as	O	ADP	O
in	O	ADP	O
the	O	DET	O
lesion	O	NOUN	B
volume	O	NOUN	I
and	O	CCONJ	O
its	O	PRON	O
mirror	O	NOUN	B
region	O	NOUN	I
.	O	PUNCT	O


Because	O	SCONJ	O
a	O	DET	O
close	O	ADJ	O
correlation	O	NOUN	B
between	O	ADP	O
regional	O	ADJ	B
decreases	O	NOUN	B
in	O	ADP	O
FMZ	O	NOUN	B
binding	O	NOUN	B
and	O	CCONJ	O
spiking	O	NOUN	O
activity	O	NOUN	B
was	O	AUX	O
recently	O	ADV	O
demonstrated	O	VERB	O
in	O	ADP	O
neocortical	O	ADJ	B
epilepsies	O	NOUN	I
,	O	PUNCT	O
abnormal	O	ADJ	B
peri	O	X	B
-	O	PUNCT	O
lesional	O	ADJ	B
FMZ	O	NOUN	B
binding	O	NOUN	B
may	O	AUX	O
bear	O	VERB	O
some	O	DET	O
relation	O	NOUN	O
to	O	PART	O
the	O	DET	O
mechanisms	O	NOUN	B
of	O	ADP	O
epileptogenesis	O	NOUN	B
in	O	ADP	O
symptomatic	O	ADJ	B
epilepsies	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
found	O	VERB	O
three	O	NUM	O
out	O	ADP	O
of	O	ADP	O
four	O	NUM	O
original	O	ADJ	B
(	O	PUNCT	O
Volkan	O	PROPN	B
'	O	PART	I
s	O	NOUN	I
)	O	PUNCT	O
groups	O	NOUN	B
of	O	ADP	O
linking	O	VERB	O
objects	O	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
also	O	ADV	O
an	O	DET	O
additional	O	ADJ	O
one	O	NUM	O
,	O	PUNCT	O
hitherto	O	ADV	O
undescribed	O	ADJ	O
,	O	PUNCT	O
comprising	O	VERB	O
objects	O	NOUN	B
used	O	VERB	O
for	O	ADP	O
designing	O	VERB	B
a	O	DET	O
memorial	O	ADJ	B
shrine	O	NOUN	I
to	O	ADP	O
the	O	DET	O
deceased	O	NOUN	B
.	O	PUNCT	O


One	O	NUM	O
CKD	O	NOUN	B
patient	O	NOUN	B
'	O	PART	O
s	O	NOUN	O
journey	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
patients	O	NOUN	B
who	O	PRON	O
respond	O	VERB	O
to	O	PART	O
quetiapine	O	NOUN	B
,	O	PUNCT	O
therapy	O	NOUN	B
should	O	AUX	O
be	O	AUX	O
continued	O	VERB	O
at	O	ADP	O
the	O	DET	O
optimal	O	ADJ	B
dose	O	NOUN	B
that	O	PRON	O
maintains	O	VERB	O
remission	O	NOUN	B
,	O	PUNCT	O
within	O	ADP	O
the	O	DET	O
range	O	NOUN	B
of	O	ADP	O
150	O	NUM	O
to	O	PART	O
750	O	NUM	O
mg	O	NOUN	O
/	O	SYM	O
d	O	NOUN	O
.	O	PUNCT	O


With	O	ADP	O
such	O	ADJ	O
analysis	O	NOUN	B
,	O	PUNCT	O
one	O	PRON	O
can	O	AUX	O
test	O	VERB	O
hypotheses	O	NOUN	B
about	O	ADP	O
the	O	DET	O
structure	O	NOUN	B
of	O	ADP	O
latent	O	ADJ	B
variability	O	NOUN	B
within	O	ADP	O
a	O	DET	O
given	O	VERB	O
data	O	NOUN	B
set	O	VERB	I
.	O	PUNCT	O


In	O	ADP	O
this	O	DET	O
study	O	NOUN	B
we	O	PRON	O
wanted	O	VERB	O
to	O	PART	O
assess	O	VERB	B
the	O	DET	O
DR	O	NOUN	B
using	O	VERB	O
the	O	DET	O
'	O	PUNCT	O
combined	O	ADJ	O
test	O	NOUN	O
'	O	PUNCT	O
in	O	ADP	O
an	O	DET	O
unselected	O	ADJ	O
population	O	NOUN	B
of	O	ADP	O
self	O	NOUN	B
-	O	PUNCT	O
referred	O	VERB	B
pregnant	O	ADJ	B
women	O	NOUN	I
at	O	ADP	O
a	O	DET	O
false	O	ADJ	B
-	O	PUNCT	O
positive	O	ADJ	B
rate	O	NOUN	B
(	O	PUNCT	O
FPR	O	NOUN	B
)	O	PUNCT	O
of	O	ADP	O
about	O	ADV	O
5	O	NUM	O
%	O	NOUN	O
.	O	PUNCT	O


